data_2l5o_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l5o _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.127 0 CA-C-O 120.909 0.385 . . . . 0.0 111.715 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -141.68 141.79 33.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.049 177.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.8 m -137.78 100.07 4.09 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.509 HD13 ' HD2' ' A' ' 11' ' ' PRO . 56.2 tp -115.16 120.2 37.23 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.426 -171.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.509 ' HD2' HD13 ' A' ' 10' ' ' LEU . 60.3 Cg_endo -75.07 129.71 12.53 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.497 2.131 . . . . 0.0 111.327 172.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.469 ' HB3' ' HE3' ' A' ' 88' ' ' MET . 2.3 p30 -86.55 -171.86 3.75 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.988 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.8 mt -67.12 -9.26 37.79 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -175.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -96.36 -9.56 29.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.932 0.396 . . . . 0.0 110.33 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.4 2.69 61.75 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.125 177.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 11' ' ' PRO . 20.6 pttp -96.13 144.79 26.05 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 28.5 m -94.45 125.55 39.16 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.889 -174.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.3 m -102.38 141.3 18.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 172.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 45.3 t -145.6 -178.08 5.91 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 121.076 -0.25 . . . . 0.0 110.963 -173.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -53.92 -39.22 65.65 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.258 0.623 . . . . 0.0 111.956 -175.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.77 -27.64 65.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.812 -177.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -78.49 -24.05 46.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.235 -176.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 81.5 mt -78.54 -21.37 48.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.895 0.379 . . . . 0.0 110.953 -178.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -72.27 103.33 3.34 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.02 0.438 . . . . 0.0 110.673 -176.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.0 -25.92 12.19 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.34 177.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.17 148.83 26.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.941 0.401 . . . . 0.0 110.343 178.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.489 HG12 ' O ' ' A' ' 110' ' ' ILE . 97.1 t -102.96 138.0 28.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 172.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 60' ' ' GLN . 22.3 m -132.06 135.12 46.24 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.614 -165.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.752 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 6.8 tt -106.88 106.43 16.96 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 173.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.898 HG12 ' HB2' ' A' ' 62' ' ' LEU . 39.9 mt -104.56 111.95 36.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 177.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' A' ' 106' ' ' THR . 26.7 p-10 -110.72 134.18 52.69 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.413 0.625 . . . . 0.0 110.645 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -91.66 119.25 31.37 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.615 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.627 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 4.5 p-90 -147.82 -174.13 4.47 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.615 -173.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -155.28 150.35 20.77 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 173.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.42 ' HD2' ' HB2' ' A' ' 69' ' ' ASP . 92.8 Cg_exo -43.72 -47.08 9.99 Favored 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 123.148 2.566 . . . . 0.0 114.13 -177.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.1 m -85.82 27.46 0.87 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -177.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.518 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 52.8 t -79.91 129.55 70.13 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.015 0.436 . . . . 0.0 111.101 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -63.54 -26.85 69.77 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.641 2.227 . . . . 0.0 111.922 176.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.2 -16.55 73.24 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.836 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.518 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 92.0 m -58.16 -29.4 65.56 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.72 0.26 . . . . 0.0 111.392 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.6 t -55.02 -43.08 67.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.997 0.427 . . . . 0.0 110.364 177.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.556 ' O ' ' HB3' ' A' ' 46' ' ' LYS . 15.1 m -86.5 -55.79 3.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.873 178.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.447 ' O ' HG12 ' A' ' 47' ' ' ILE . 43.3 mt-10 -59.46 -50.4 74.06 Favored 'General case' 0 C--O 1.213 -0.86 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -173.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.728 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 31.8 tpp -58.85 -61.02 8.6 Favored Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -164.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.728 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 33.1 Cg_exo -59.38 -35.96 95.25 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 121.652 1.568 . . . . 0.0 111.206 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.556 ' HB3' ' O ' ' A' ' 42' ' ' SER . 5.9 tptt -59.17 -49.3 78.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.956 176.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.549 HD12 ' HE3' ' A' ' 46' ' ' LYS . 43.8 mm -74.54 -31.58 27.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.63 -174.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.648 HG12 ' O ' ' A' ' 44' ' ' MET . 46.8 mm -54.72 -53.26 33.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-O 121.034 0.445 . . . . 0.0 109.901 176.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.674 ' HZ1' ' HB2' ' A' ' 53' ' ' ASP . 20.4 tptp -71.74 -35.97 70.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.969 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.3 m -62.11 -54.18 44.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.838 0.351 . . . . 0.0 111.202 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.594 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . -68.53 -27.38 66.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.981 -176.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.09 -39.3 60.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.493 177.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.674 ' HB2' ' HZ1' ' A' ' 49' ' ' LYS . 6.9 t70 -76.05 -52.19 10.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.233 0.54 . . . . 0.0 111.057 -173.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.841 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 90.8 m-85 -81.58 -2.47 50.18 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.363 -174.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.594 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 13.0 tppt? -59.4 -37.61 78.45 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.434 0.635 . . . . 0.0 109.916 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.2 m-20 -91.51 12.03 22.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.294 -175.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.584 ' O ' ' HB3' ' A' ' 58' ' ' ASN . 16.9 tptp -112.03 -61.68 1.68 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.711 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.584 ' HB3' ' O ' ' A' ' 57' ' ' LYS . 2.9 p-10 162.79 14.93 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 O-C-N 124.202 0.939 . . . . 0.0 110.279 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.841 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 57.2 t80 -112.53 143.03 44.38 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.924 0.392 . . . . 0.0 110.284 -175.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.524 ' O ' ' HA ' ' A' ' 28' ' ' THR . 11.7 pt20 -136.76 147.55 46.74 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.669 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.457 HG13 HG22 ' A' ' 47' ' ' ILE . 87.3 t -115.07 132.2 65.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.007 178.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.898 ' HB2' HG12 ' A' ' 30' ' ' ILE . 77.6 mt -122.37 110.9 16.22 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.632 ' HB2' HG21 ' A' ' 87' ' ' VAL . . . -94.48 116.42 28.77 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.171 -177.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.0 t -105.17 111.81 36.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.065 0.46 . . . . 0.0 110.528 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.627 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -95.83 124.77 39.99 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.929 177.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.5 169.73 8.18 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.604 ' HD3' ' O ' ' A' ' 90' ' ' ASP . 16.4 Cg_exo -67.33 80.77 0.41 Allowed 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.617 2.211 . . . . 0.0 113.781 -172.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 50.2 mm -117.69 -54.66 4.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 168.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.42 ' HB2' ' HD2' ' A' ' 35' ' ' PRO . 17.2 m-20 -101.86 151.94 38.05 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.738 170.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.31 151.12 30.53 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.73 2.287 . . . . 0.0 112.902 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.3 tt -57.19 -36.3 51.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.894 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.501 ' HA ' ' HD2' ' A' ' 75' ' ' ARG . 31.1 tp10 -69.61 -35.31 75.17 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.533 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.9 m -62.27 -32.45 73.16 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.206 0.527 . . . . 0.0 110.081 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.471 ' O ' HG12 ' A' ' 78' ' ' VAL . 45.2 t -65.42 -44.31 94.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.692 174.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.753 ' HA ' HG23 ' A' ' 78' ' ' VAL . 91.4 mtt180 -64.67 -31.92 73.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.388 177.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -60.98 -44.48 97.3 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 177.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.422 ' CE1' ' HE1' ' A' ' 44' ' ' MET . 1.8 t80 -63.53 -46.16 87.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.272 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.753 HG23 ' HA ' ' A' ' 75' ' ' ARG . 11.1 m -67.08 -37.45 79.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.642 -177.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -75.64 -48.12 23.5 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -66.34 -48.38 70.44 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.103 -172.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -92.4 2.22 56.78 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -173.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 57.9 63.72 5.01 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.308 -0.473 . . . . 0.0 113.033 177.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.497 HD22 HG11 ' A' ' 78' ' ' VAL . 10.0 mp -73.22 115.85 45.01 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 120.702 0.287 . . . . 0.0 111.231 -177.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.39 15.98 1.78 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.177 2.584 . . . . 0.0 113.022 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.528 ' HE1' HD13 ' A' ' 48' ' ' ILE . 24.1 p90 -128.76 153.56 47.26 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.071 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.402 ' HB ' ' CD2' ' A' ' 62' ' ' LEU . 32.2 m -79.39 130.39 35.38 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.953 -174.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.632 HG21 ' HB2' ' A' ' 63' ' ' ALA . 60.9 t -116.44 139.43 43.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.334 -178.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.503 ' HE1' HD21 ' A' ' 62' ' ' LEU . 2.6 mpt? -119.24 169.3 10.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.078 177.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -123.5 110.3 14.9 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.604 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 0.9 OUTLIER -81.78 72.25 8.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.893 -175.646 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.78 -46.84 86.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.374 -172.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -87.78 -10.91 49.59 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.673 -0.24 . . . . 0.0 110.776 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.774 ' HZ1' ' HB2' ' A' ' 93' ' ' LYS . 8.1 mtmp? 69.23 7.49 6.26 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.562 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.65 -32.04 70.47 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -172.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.6 t -71.24 -42.91 74.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.58 -37.87 94.09 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.887 174.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -67.02 -32.05 73.0 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 122.486 0.315 . . . . 0.0 111.01 177.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.29 -45.29 85.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.648 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -66.62 -28.22 68.32 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.788 0.328 . . . . 0.0 110.644 176.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 71.96 59.95 4.45 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.804 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.6 p -99.88 -66.64 0.89 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.591 0.234 . . . . 0.0 111.069 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 72.53 -38.54 0.42 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.681 0.792 . . . . 0.0 112.296 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.8 m -97.83 132.3 42.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.139 0.495 . . . . 0.0 110.567 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -128.29 153.04 78.88 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.047 -175.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -80.86 161.01 83.2 Favored 'Cis proline' 0 C--O 1.234 0.314 0 C-N-CA 123.376 -1.51 . . . . 0.0 112.353 -0.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 10.2 t -150.25 127.53 11.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.15 0.5 . . . . 0.0 111.358 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.3 m -101.24 122.53 43.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.089 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 48.5 t -106.06 132.46 53.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.83 0.347 . . . . 0.0 110.207 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.548 HD22 ' HB3' ' A' ' 118' ' ' LYS . 2.8 mm? -102.03 118.77 37.6 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.943 -178.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.489 ' O ' HG12 ' A' ' 27' ' ' VAL . 53.5 mt -100.99 127.74 53.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.037 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -72.14 -179.51 33.68 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.204 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -86.61 -5.11 59.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.919 0.39 . . . . 0.0 110.764 -175.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -98.34 -31.6 11.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.856 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 113.89 19.83 6.29 Favored Glycine 0 C--O 1.225 -0.431 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.553 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.93 -26.2 60.38 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -172.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.467 HD12 HG21 ' A' ' 110' ' ' ILE . 20.8 mm 58.34 96.92 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-O 121.216 0.531 . . . . 0.0 109.582 -167.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.7 mt -93.68 -76.03 0.49 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -165.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.548 ' HB3' HD22 ' A' ' 109' ' ' LEU . 21.9 tptm -109.22 145.05 36.51 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.049 -164.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 7.7 p -122.67 108.01 12.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.382 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -94.88 128.7 41.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.994 173.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.7 t -120.1 132.39 69.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.668 0.271 . . . . 0.0 110.549 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 84.19 -102.51 2.51 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.122 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -106.78 108.78 62.5 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.456 ' HB2' HD22 ' A' ' 129' ' ' LEU . 68.7 Cg_endo -76.65 104.69 1.95 Allowed 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.198 1.932 . . . . 0.0 112.16 178.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -48.75 107.66 0.14 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.676 178.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -60.15 -43.4 95.77 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.095 -173.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -59.5 -51.0 61.68 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.495 -176.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -80.27 -21.0 43.18 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 122.973 -0.133 . . . . 0.0 111.248 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.466 ' O ' HG13 ' A' ' 133' ' ' ILE . 52.0 tp -68.69 -47.04 67.46 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.162 -0.311 . . . . 0.0 110.162 176.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -66.96 -40.54 87.5 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.908 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -68.11 -30.49 69.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.728 0.299 . . . . 0.0 111.309 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.495 ' OE1' ' HG2' ' A' ' 118' ' ' LYS . 35.3 tt0 -77.82 -34.34 52.06 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.663 0.268 . . . . 0.0 110.488 178.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 129' ' ' LEU . 76.1 mt -65.66 -38.94 83.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-O 121.212 0.529 . . . . 0.0 109.659 172.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.37 -36.42 84.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.461 172.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 91.1 m -63.35 -31.67 72.89 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.13 174.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.596 175.63 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.24 0 CA-C-O 121.164 0.507 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -129.49 148.86 51.44 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.352 0.596 . . . . 0.0 111.134 -177.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.9 m -141.23 90.75 2.33 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 171.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.521 HD12 ' HD2' ' A' ' 11' ' ' PRO . 28.4 tp -112.57 124.35 32.07 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.216 -172.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.583 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 58.3 Cg_endo -73.07 138.71 28.6 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.406 2.071 . . . . 0.0 111.908 176.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.497 ' HA ' ' HG2' ' A' ' 88' ' ' MET . 0.0 OUTLIER -75.29 169.44 18.05 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 175.488 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.517 HD11 ' HG2' ' A' ' 75' ' ' ARG . 84.6 mt -66.03 -17.79 64.92 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -175.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.429 ' H ' ' CG ' ' A' ' 12' ' ' ASP . 48.8 t-80 -86.89 -19.55 28.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.945 177.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.7 4.4 21.47 Favored Glycine 0 CA--C 1.517 0.208 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.058 177.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -85.62 110.75 19.49 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 122.595 -0.356 . . . . 0.0 110.263 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.583 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 8.3 m -64.3 122.88 17.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.678 178.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.602 HG13 HD23 ' A' ' 62' ' ' LEU . 59.6 t -110.89 125.07 68.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.924 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 51.0 p -140.94 -174.35 3.97 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.236 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -55.87 -32.27 63.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.109 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.6 -28.53 67.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.202 -176.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -78.84 -23.89 44.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.031 0.443 . . . . 0.0 110.549 -175.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 81.3 mt -77.64 -19.98 54.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.172 -177.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.478 ' OE1' ' HA ' ' A' ' 113' ' ' LYS . 16.5 mm-40 -64.57 119.04 9.72 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.775 -174.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.13 -21.29 46.77 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.035 -0.602 . . . . 0.0 113.078 174.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 112' ' ' LYS . 31.3 mtmt -117.77 160.58 21.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.808 0.337 . . . . 0.0 111.167 -174.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 13.2 t -101.71 144.76 12.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -178.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.607 HG21 HD11 ' A' ' 62' ' ' LEU . 40.6 m -139.34 140.41 37.52 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.06 0.457 . . . . 0.0 112.102 -168.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.877 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 28.1 tp -109.4 106.18 15.85 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.333 171.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.66 ' HB ' ' CG2' ' A' ' 108' ' ' VAL . 37.2 mt -91.09 111.59 23.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 C-N-CA 120.303 -0.559 . . . . 0.0 109.51 176.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -108.83 114.81 28.91 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.897 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -87.69 118.24 27.05 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.483 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 8.0 p-90 -144.71 -173.81 4.16 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.014 0.435 . . . . 0.0 110.464 -176.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -161.71 144.3 8.99 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.351 176.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -58.53 163.98 9.87 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.366 2.044 . . . . 0.0 111.84 175.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 44.5 m 66.84 11.89 8.56 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.408 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.1 t -95.67 126.11 46.59 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.47 177.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.43 ' O ' HG12 ' A' ' 41' ' ' VAL . 35.2 Cg_exo -61.87 -18.2 59.66 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.977 2.451 . . . . 0.0 112.978 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.55 -6.73 56.11 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 121.125 -0.559 . . . . 0.0 113.112 -178.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.684 ' HB2' ' HH ' ' A' ' 77' ' ' TYR . 26.3 p -62.19 -30.58 71.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.559 0.219 . . . . 0.0 110.887 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.43 HG12 ' O ' ' A' ' 38' ' ' PRO . 13.0 p -66.73 -28.92 44.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.845 0.355 . . . . 0.0 110.899 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.6 m -88.0 -56.74 3.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.014 0.435 . . . . 0.0 111.268 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.548 ' HA ' ' HE2' ' A' ' 46' ' ' LYS . 2.9 mt-10 -74.32 -40.69 62.04 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -170.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.536 ' HE3' ' CE1' ' A' ' 77' ' ' TYR . 35.2 tpp -59.57 -54.87 51.65 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -172.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 44' ' ' MET . 15.9 Cg_endo -57.52 -35.48 98.83 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 121.829 1.686 . . . . 0.0 111.731 177.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.592 ' HG3' ' HE2' ' A' ' 126' ' ' PHE . 28.8 ttpt -61.14 -51.94 66.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.541 175.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.545 HG12 ' O ' ' A' ' 43' ' ' GLU . 47.3 mm -57.17 -41.03 77.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.788 -178.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.46 HG12 ' O ' ' A' ' 44' ' ' MET . 48.8 mm -57.9 -45.87 87.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.995 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -75.4 -40.96 57.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.498 0.19 . . . . 0.0 111.248 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.527 ' HA ' ' HH ' ' A' ' 130' ' ' TYR . 60.7 m -59.55 -50.01 75.55 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.859 0.361 . . . . 0.0 110.435 177.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.76 -31.8 72.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.598 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -54.22 -44.06 71.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.958 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -79.01 -51.89 8.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.35 0.595 . . . . 0.0 111.142 177.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.995 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 50.8 m-85 -72.3 -20.46 61.5 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -167.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -68.52 -15.23 63.47 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 122.207 -0.308 . . . . 0.0 110.793 176.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -106.83 8.16 30.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.36 0.6 . . . . 0.0 109.874 177.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.408 ' CG ' ' HA ' ' A' ' 54' ' ' TYR . 30.8 mmtp -100.87 -69.71 0.76 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.376 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.41 ' ND2' ' HG2' ' A' ' 26' ' ' LYS . 4.5 t-20 164.23 29.59 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -172.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.995 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 48.6 t80 -131.41 138.22 49.0 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.799 -167.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.415 ' O ' ' HA ' ' A' ' 28' ' ' THR . 10.8 pt20 -128.26 140.96 51.6 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.464 178.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.412 HG12 HG23 ' A' ' 47' ' ' ILE . 60.4 t -100.61 125.85 54.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.012 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.607 HD11 HG21 ' A' ' 28' ' ' THR . 10.9 mp -112.48 99.11 7.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.85 107.32 16.95 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.863 178.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.1 t -99.22 104.35 15.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.064 0.459 . . . . 0.0 110.458 -177.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -90.89 120.3 31.79 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 175.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.636 ' HB3' ' HD2' ' A' ' 67' ' ' PRO . 37.0 mt-30 -94.83 170.79 7.47 Favored Pre-proline 0 C--N 1.317 -0.821 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -177.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.636 ' HD2' ' HB3' ' A' ' 66' ' ' GLN . 72.5 Cg_endo -71.01 57.92 2.1 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 123.135 2.557 . . . . 0.0 115.225 -164.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 49.8 mm -92.24 -51.56 11.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 171.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.512 ' OD1' ' HD2' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -109.23 149.81 40.22 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.362 -0.835 . . . . 0.0 108.779 174.104 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.512 ' HD2' ' OD1' ' A' ' 69' ' ' ASP . 84.4 Cg_exo -49.56 155.76 3.39 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 123.058 2.506 . . . . 0.0 113.737 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.606 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 11.1 tt -54.95 -40.87 55.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.695 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -65.79 -33.47 75.93 Favored 'General case' 0 C--O 1.215 -0.746 0 C-N-CA 120.864 -0.335 . . . . 0.0 110.694 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.7 m -58.26 -40.8 82.8 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.374 0.607 . . . . 0.0 109.943 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.0 t -65.59 -44.07 93.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.284 175.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.776 ' HA ' HG22 ' A' ' 78' ' ' VAL . 20.1 mtm180 -67.53 -24.98 65.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.019 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -68.63 -43.07 77.1 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.684 ' HH ' ' HB2' ' A' ' 40' ' ' CYS . 9.3 t80 -63.78 -47.59 80.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.147 178.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.776 HG22 ' HA ' ' A' ' 75' ' ' ARG . 12.6 m -65.83 -26.63 39.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.129 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.593 ' HB2' ' O ' ' A' ' 75' ' ' ARG . 3.6 ttmp? -74.21 -52.15 13.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.892 -177.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -67.19 -49.43 64.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.204 -174.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -85.82 -10.43 55.44 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -174.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.62 60.28 8.77 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.308 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.552 HD13 ' HA ' ' A' ' 78' ' ' VAL . 10.1 mp -63.64 116.01 22.98 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 120.879 0.371 . . . . 0.0 111.461 -176.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -86.45 25.26 0.69 Allowed 'Trans proline' 0 C--O 1.241 0.636 0 C-N-CA 123.314 2.676 . . . . 0.0 113.467 -177.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -136.23 159.71 40.9 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 30.7 m -67.71 122.68 18.61 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.434 -174.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.8 t -119.29 127.57 75.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.956 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.497 ' HG2' ' HA ' ' A' ' 12' ' ' ASP . 67.2 mtm -122.76 164.36 18.48 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.263 -177.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.449 ' OH ' ' HA ' ' A' ' 67' ' ' PRO . 67.6 t80 -126.1 125.65 42.9 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.373 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.489 ' HB3' ' HA ' ' A' ' 66' ' ' GLN . 28.4 t0 -88.89 135.91 33.29 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.25 -32.84 61.21 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.435 ' O ' ' HB3' ' A' ' 93' ' ' LYS . 31.9 t70 -130.07 -11.08 4.25 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -172.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.685 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER 82.93 17.94 0.28 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 122.89 1.329 . . . . 0.0 108.744 -172.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.583 ' HA ' HE21 ' A' ' 97' ' ' GLN . . . -74.02 -27.17 60.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.007 -176.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.7 t -69.14 -41.19 81.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.57 -33.59 87.64 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 174.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.583 HE21 ' HA ' ' A' ' 94' ' ' ALA . 47.0 mt-30 -64.14 -39.05 93.19 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 122.595 0.358 . . . . 0.0 111.098 176.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.48 -39.82 92.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.058 0.456 . . . . 0.0 110.967 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -73.01 -27.78 61.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.556 177.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.98 34.44 5.68 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.425 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 29.1 p -106.17 126.25 51.98 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.742 0.305 . . . . 0.0 110.804 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.486 ' HG3' HG11 ' A' ' 103' ' ' VAL . 11.8 pt20 -108.82 -36.32 6.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.907 0.384 . . . . 0.0 110.839 178.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.486 HG11 ' HG3' ' A' ' 102' ' ' GLN . 19.7 m -102.85 142.1 17.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.21 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.519 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 37.6 m-85 -130.46 158.67 73.82 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.09 -177.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.519 ' HA ' ' HB3' ' A' ' 104' ' ' TYR . 94.1 Cg_endo -81.41 165.05 75.51 Favored 'Cis proline' 0 CA--C 1.53 0.311 0 C-N-CA 123.587 -1.422 . . . . 0.0 113.17 0.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.52 HG22 ' HA ' ' A' ' 121' ' ' VAL . 95.8 m -150.82 133.32 15.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.787 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.542 ' HB3' HD11 ' A' ' 29' ' ' LEU . 68.0 m -108.09 117.47 34.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.969 0.414 . . . . 0.0 111.003 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.66 ' CG2' ' HB ' ' A' ' 30' ' ' ILE . 29.0 m -106.36 146.15 13.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.121 0.486 . . . . 0.0 110.839 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.658 ' HB2' ' HB3' ' A' ' 118' ' ' LYS . 2.6 mm? -102.37 124.47 48.0 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.065 -176.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.55 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 22.7 mm -104.4 134.59 45.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 27' ' ' VAL . . . -67.79 -93.66 0.04 OUTLIER Glycine 0 C--O 1.226 -0.353 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.868 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 10.9 ptpt -166.8 23.73 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.271 0.557 . . . . 0.0 110.844 171.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.478 ' HA ' ' OE1' ' A' ' 24' ' ' GLN . 36.8 mtmm -136.12 10.1 3.27 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 174.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 78.25 18.35 76.45 Favored Glycine 0 C--O 1.223 -0.535 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.54 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -69.71 -24.63 63.6 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -171.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 8.5 mt 64.02 89.63 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.66 0.743 . . . . 0.0 109.701 -175.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 23.2 mt -87.54 -34.93 18.42 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.257 -0.883 . . . . 0.0 113.109 -167.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.658 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 22.0 tptm -150.27 157.53 43.18 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.302 -168.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.524 HG23 HG11 ' A' ' 108' ' ' VAL . 51.4 m -140.28 107.86 5.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.859 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.639 ' HB3' ' HB3' ' A' ' 124' ' ' PRO . 67.8 m-85 -101.68 107.39 18.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.117 173.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.52 ' HA ' HG22 ' A' ' 106' ' ' THR . 48.1 t -82.93 126.78 40.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.46 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 80.31 -138.58 20.01 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.029 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.456 ' CD ' ' HZ3' ' A' ' 46' ' ' LYS . 12.7 tp10 -96.64 109.33 47.74 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 110.229 -0.285 . . . . 0.0 110.229 -178.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.639 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 91.9 Cg_endo -81.72 174.11 10.65 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 123.234 2.623 . . . . 0.0 113.359 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.478 ' OD2' ' HB3' ' A' ' 128' ' ' LYS . 11.2 p-10 -88.3 120.0 29.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.091 175.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.592 ' HE2' ' HG3' ' A' ' 46' ' ' LYS . 92.2 m-85 -58.47 -46.94 85.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.832 -173.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -56.34 -53.63 41.72 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 121.045 -0.598 . . . . 0.0 113.443 -172.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.553 ' NZ ' ' HB3' ' A' ' 128' ' ' LYS . 2.1 ttpm? -76.17 -26.14 55.94 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.464 0.173 . . . . 0.0 110.694 -177.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.486 ' O ' HG13 ' A' ' 133' ' ' ILE . 7.5 tt -64.41 -46.99 80.87 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 177.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.527 ' HH ' ' HA ' ' A' ' 50' ' ' THR . 7.0 m-85 -61.78 -56.04 23.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.479 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.409 ' HG2' ' HA ' ' A' ' 128' ' ' LYS . 4.5 pt20 -60.91 -29.61 69.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.718 0.294 . . . . 0.0 111.292 -176.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -72.46 -36.37 68.48 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.711 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 129' ' ' LEU . 69.1 mt -69.36 -53.0 27.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -62.78 -27.32 69.22 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.767 0.318 . . . . 0.0 111.413 -176.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 90.4 m -73.76 -30.85 63.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.012 0.434 . . . . 0.0 110.964 177.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.563 -177.25 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 120.711 0.291 . . . . 0.0 110.397 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -122.74 140.92 52.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.587 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.529 ' HA ' ' HG ' ' A' ' 19' ' ' SER . 68.4 m -128.15 90.64 3.12 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.516 HD11 ' HD2' ' A' ' 11' ' ' PRO . 35.6 tp -114.88 125.01 29.51 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.314 -175.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.516 ' HD2' HD11 ' A' ' 10' ' ' LEU . 61.0 Cg_endo -75.57 153.59 39.24 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.215 1.944 . . . . 0.0 112.184 176.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.508 ' HA ' ' HG2' ' A' ' 88' ' ' MET . 1.9 p-10 -83.23 -166.24 1.3 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.824 177.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 87' ' ' VAL . 89.9 mt -77.35 3.03 14.08 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -176.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.427 ' CE1' ' HB2' ' A' ' 16' ' ' LYS . 4.7 p-80 -128.07 -20.65 3.75 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 119.924 -0.711 . . . . 0.0 111.731 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 125.88 27.82 1.1 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.085 -1.055 . . . . 0.0 113.898 174.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.438 ' C ' ' HD3' ' A' ' 16' ' ' LYS . 13.2 tmtt? -100.58 112.48 24.87 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 175.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.6 m -66.97 122.32 17.47 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.943 0.402 . . . . 0.0 110.696 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.484 HG13 HD13 ' A' ' 62' ' ' LEU . 60.2 t -108.73 131.98 57.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.808 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.529 ' HG ' ' HA ' ' A' ' 9' ' ' SER . 50.4 m -145.55 -174.21 4.33 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.97 0.414 . . . . 0.0 111.148 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -61.04 -25.07 66.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.462 -177.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.22 -34.09 74.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.352 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -70.34 -30.39 67.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.323 0.583 . . . . 0.0 110.398 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.555 HD13 HG23 ' A' ' 110' ' ' ILE . 35.0 mt -85.36 -40.47 16.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.632 -171.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -71.49 21.69 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -159.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -152.19 11.19 0.66 Allowed Glycine 0 C--N 1.321 -0.279 0 C-N-CA 120.033 -1.08 . . . . 0.0 113.114 177.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 58' ' ' ASN . 11.4 ptmm? -160.02 179.58 8.63 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.595 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 21.4 t -102.89 139.32 24.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 C-N-CA 120.472 -0.491 . . . . 0.0 109.71 -175.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.573 HG22 ' HG3' ' A' ' 60' ' ' GLN . 44.3 m -136.88 148.14 46.89 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.705 -171.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.777 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 62.7 tp -112.79 105.8 14.01 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 175.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.509 HD11 ' HB2' ' A' ' 62' ' ' LEU . 48.5 mm -88.48 110.56 21.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 172.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.467 ' HA ' ' O ' ' A' ' 106' ' ' THR . 9.2 t30 -120.13 110.29 16.45 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.0 -173.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -84.03 120.45 26.15 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.394 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.427 ' NE1' ' HB1' ' A' ' 63' ' ' ALA . 2.8 p-90 -150.33 -171.82 4.01 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.651 -176.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.435 ' HB3' ' NE2' ' A' ' 66' ' ' GLN . 40.0 p90 -155.98 138.48 10.36 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.512 -0.767 . . . . 0.0 108.955 174.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.719 ' HD2' ' HB2' ' A' ' 69' ' ' ASP . 71.2 Cg_exo -41.96 -46.23 6.92 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.868 3.045 . . . . 0.0 115.167 -174.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.1 m -80.92 8.53 8.14 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -173.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.4 p -75.61 157.86 83.75 Favored Pre-proline 0 C--N 1.327 -0.398 0 O-C-N 122.263 -0.273 . . . . 0.0 110.651 -178.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -62.15 -11.29 21.32 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.652 2.234 . . . . 0.0 112.008 175.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.794 ' O ' ' HB2' ' A' ' 43' ' ' GLU . . . -75.86 4.55 44.76 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.756 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 12.5 p -78.43 -56.15 4.67 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 121.338 -1.095 . . . . 0.0 110.555 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.65 -42.77 71.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.787 -175.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.0 m -86.79 -42.81 13.0 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -175.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.794 ' HB2' ' O ' ' A' ' 39' ' ' GLY . 20.8 mm-40 -83.47 -41.69 17.75 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -171.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.606 ' O ' HG12 ' A' ' 48' ' ' ILE . 33.7 tpp -51.74 -53.18 53.54 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -171.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.59 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 52.9 Cg_exo -55.6 -40.39 85.64 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.872 1.715 . . . . 0.0 112.599 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.467 ' HZ1' ' CD ' ' A' ' 43' ' ' GLU . 23.8 ttpp -71.14 -34.94 71.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.56 -179.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.7 mm -69.14 -43.02 81.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.757 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.606 HG12 ' O ' ' A' ' 44' ' ' MET . 47.3 mm -55.55 -52.65 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.028 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.434 ' HE2' ' O ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -58.56 -46.07 87.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.642 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 84.0 m -62.18 -53.14 59.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.639 -178.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.83 -36.18 77.88 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -173.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.73 -33.84 62.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.821 0.343 . . . . 0.0 110.264 -178.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -70.69 -51.41 27.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.572 0.701 . . . . 0.0 109.937 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 1.012 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 22.6 m-85 -72.01 -7.39 48.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.411 -178.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.9 tptt -57.68 -41.77 82.29 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.488 0.492 . . . . 0.0 110.642 -177.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -101.56 10.07 40.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.272 -177.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.631 ' HG3' ' OD1' ' A' ' 58' ' ' ASN . 25.9 tptp -95.33 -62.81 1.24 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.365 -177.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.631 ' OD1' ' HG3' ' A' ' 57' ' ' LYS . 2.4 p-10 169.66 7.31 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.422 0.689 . . . . 0.0 109.763 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 1.012 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 54.2 t80 -118.33 148.6 42.32 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.542 -165.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.573 ' HG3' HG22 ' A' ' 28' ' ' THR . 10.8 pt20 -141.62 129.73 22.11 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.102 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.6 t -95.52 115.62 35.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 120.973 0.416 . . . . 0.0 110.117 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.509 ' HB2' HD11 ' A' ' 30' ' ' ILE . 84.2 mt -109.81 95.96 5.94 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.432 -0.804 . . . . 0.0 108.926 177.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.509 ' HB3' HG23 ' A' ' 87' ' ' VAL . . . -80.83 125.57 30.25 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.117 -177.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.454 HG22 ' HE2' ' A' ' 88' ' ' MET . 29.1 t -106.03 115.75 48.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 120.908 0.385 . . . . 0.0 110.106 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.09 112.62 22.88 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.245 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.571 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 0.8 OUTLIER -93.91 162.04 28.15 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.979 -179.364 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.581 ' HD3' ' O ' ' A' ' 90' ' ' ASP . 60.1 Cg_endo -69.3 66.49 1.5 Allowed 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 123.081 2.521 . . . . 0.0 115.862 -164.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.4 mp -107.55 -51.34 7.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 162.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.719 ' HB2' ' HD2' ' A' ' 35' ' ' PRO . 30.5 m-20 -101.44 135.3 19.86 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.515 174.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -57.2 160.88 12.18 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.946 2.431 . . . . 0.0 112.336 177.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.557 ' O ' ' HG2' ' A' ' 75' ' ' ARG . 9.4 tt -58.27 -36.09 56.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.325 -177.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.755 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . 2.2 pm0 -68.97 -29.93 68.25 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.981 -0.287 . . . . 0.0 111.444 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.1 m -65.12 -38.38 90.5 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 174.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.1 t -71.98 -49.16 46.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.772 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.833 ' HA ' HG22 ' A' ' 78' ' ' VAL . 13.4 ptt180 -70.11 -24.95 63.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.702 -177.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -69.35 -42.84 74.75 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 170.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.415 ' CE1' ' HE2' ' A' ' 44' ' ' MET . 4.5 t80 -62.24 -50.06 73.24 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.118 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.833 HG22 ' HA ' ' A' ' 75' ' ' ARG . 21.5 m -62.41 -27.01 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.063 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.22 -55.09 6.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.236 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -62.45 -43.93 97.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.44 -171.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -97.75 -3.16 39.6 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -173.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 56.56 65.52 3.51 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.446 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.543 HD13 ' HA ' ' A' ' 78' ' ' VAL . 9.7 mp -68.98 117.62 53.37 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-O 120.907 0.384 . . . . 0.0 111.575 -175.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -78.65 -4.65 14.25 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.32 2.68 . . . . 0.0 113.14 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -106.31 138.81 41.83 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.445 ' HB ' HD23 ' A' ' 62' ' ' LEU . 22.0 m -72.0 126.29 29.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.242 -172.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.509 HG23 ' HB3' ' A' ' 63' ' ' ALA . 46.1 t -110.68 131.79 60.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.788 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.508 ' HG2' ' HA ' ' A' ' 12' ' ' ASP . 63.2 mtm -112.74 168.36 9.74 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.06 176.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -121.6 127.18 50.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.827 0.346 . . . . 0.0 110.429 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.581 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 63.5 t0 -105.14 106.53 17.06 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.71 -47.75 37.16 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -173.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -91.93 -5.2 53.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.639 -175.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.577 ' O ' ' HG3' ' A' ' 97' ' ' GLN . 34.5 ttmt 65.66 20.2 11.53 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -173.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.93 -25.65 60.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.169 -175.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.443 HG23 HD23 ' A' ' 10' ' ' LEU . 22.5 t -74.01 -39.05 50.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 174.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.95 -33.3 86.87 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.772 173.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.577 ' HG3' ' O ' ' A' ' 93' ' ' LYS . 78.0 mt-30 -66.19 -33.27 75.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.98 0.419 . . . . 0.0 110.815 176.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.53 -39.87 70.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.478 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -87.27 -27.05 23.15 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.36 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 97.58 62.42 0.9 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.924 176.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 66.5 p -79.76 112.01 16.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.673 0.273 . . . . 0.0 111.147 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -103.51 -38.37 7.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.895 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.457 ' CG1' ' HB ' ' A' ' 121' ' ' VAL . 9.7 p -144.47 144.15 22.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -108.51 146.93 34.7 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.08 -173.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -75.33 151.48 96.48 Favored 'Cis proline' 0 C--N 1.343 0.279 0 C-N-CA 122.814 -1.744 . . . . 0.0 112.801 0.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 23.9 m -108.09 112.65 25.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.591 176.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.533 ' HB3' HD13 ' A' ' 29' ' ' LEU . 9.4 m -102.5 109.8 21.55 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.952 0.406 . . . . 0.0 110.6 -176.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 36.3 t -108.28 133.2 53.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.471 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.542 HD12 ' HB3' ' A' ' 118' ' ' LYS . 97.2 mt -101.58 116.34 32.54 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.085 0.469 . . . . 0.0 110.168 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.555 HG23 HD13 ' A' ' 23' ' ' LEU . 11.0 mm -107.33 157.21 7.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.066 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -146.22 -155.9 6.69 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 119.93 -1.129 . . . . 0.0 112.774 176.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.525 ' O ' ' HG2' ' A' ' 115' ' ' GLU . 16.5 pttp -56.99 156.13 7.26 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 124.014 0.925 . . . . 0.0 109.365 178.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.517 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 3.0 ttmp? 71.92 -16.76 0.39 Allowed 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.981 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 112' ' ' LYS . . . 91.38 7.37 65.35 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 -174.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.525 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 17.2 pt-20 -67.77 135.73 53.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.123 0.487 . . . . 0.0 111.052 -176.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 57.0 mt -80.98 107.25 13.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 174.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.01 -40.56 38.6 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.761 -173.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.542 ' HB3' HD12 ' A' ' 109' ' ' LEU . 21.9 tptm -161.24 154.78 21.79 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.421 -171.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.3 m -136.62 115.59 12.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.867 0.365 . . . . 0.0 110.966 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.458 ' OH ' ' HE3' ' A' ' 128' ' ' LYS . 75.2 m-85 -108.04 144.65 35.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.446 174.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.457 ' HB ' ' CG1' ' A' ' 103' ' ' VAL . 6.2 m -123.92 137.23 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-O 120.731 0.3 . . . . 0.0 110.947 177.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 89.68 -84.67 1.39 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.2 177.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.05 106.74 7.37 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -75.9 119.76 5.52 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.502 2.135 . . . . 0.0 112.112 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.545 ' HB2' ' HE2' ' A' ' 128' ' ' LYS . 0.5 OUTLIER -53.4 93.07 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.078 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.534 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 14.7 m-85 -61.93 -33.29 74.0 Favored 'General case' 0 C--O 1.219 -0.53 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -172.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -59.32 -49.15 81.58 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 119.821 -1.18 . . . . 0.0 111.335 175.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.545 ' HE2' ' HB2' ' A' ' 125' ' ' ASP . 32.2 ttpt -68.5 -36.88 79.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.09 -0.555 . . . . 0.0 110.265 177.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.534 ' HB3' ' HA ' ' A' ' 126' ' ' PHE . 8.8 tt -64.33 -44.17 92.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.984 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -56.36 -56.4 21.55 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.017 0.437 . . . . 0.0 110.625 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -65.27 -34.26 77.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.882 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -64.49 -38.09 89.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.598 -0.273 . . . . 0.0 111.102 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.485 HG22 HG11 ' A' ' 27' ' ' VAL . 66.1 mt -62.66 -52.87 54.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.721 0.296 . . . . 0.0 110.895 177.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -69.56 -17.63 63.58 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 97.2 m -71.68 -26.63 62.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.307 0.575 . . . . 0.0 109.836 172.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.35 179.653 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 121.13 0.49 . . . . 0.0 110.648 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -125.36 150.16 47.45 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.652 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.8 p -145.3 90.59 2.04 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.518 176.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -110.25 134.73 20.69 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.416 -173.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.577 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 56.5 Cg_endo -72.98 131.74 17.28 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.177 1.918 . . . . 0.0 111.553 174.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.24 176.38 9.73 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.67 HD12 HG21 ' A' ' 78' ' ' VAL . 75.1 mt -70.69 -13.76 62.2 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -173.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -102.19 -2.82 28.47 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.195 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.78 17.76 11.57 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.478 -0.868 . . . . 0.0 114.75 169.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.613 ' HZ3' HG23 ' A' ' 18' ' ' VAL . 41.4 tttm -105.46 126.65 52.36 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 117.761 0.781 . . . . 0.0 110.062 175.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.577 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 10.2 t -72.28 125.09 26.48 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.433 0.635 . . . . 0.0 109.499 173.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.752 ' HB ' ' SD ' ' A' ' 88' ' ' MET . 60.2 t -113.31 124.29 69.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.238 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.1 m -121.82 -173.94 2.76 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.179 -177.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -68.89 -23.22 64.17 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.873 0.368 . . . . 0.0 110.678 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.14 -28.05 69.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.707 176.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -71.9 -12.41 61.25 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.179 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.405 HD21 HD12 ' A' ' 30' ' ' ILE . 96.2 mt -84.59 -27.87 26.95 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.012 0.434 . . . . 0.0 111.604 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.6 mm100 -74.21 144.4 44.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.121 -170.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.42 -25.47 17.64 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 121.14 -0.553 . . . . 0.0 114.014 170.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.527 ' HG3' ' HG3' ' A' ' 60' ' ' GLN . 0.0 OUTLIER -143.59 -168.18 2.76 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -177.897 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 14.2 t -101.93 144.4 13.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 176.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.556 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 30.0 m -140.29 149.34 42.67 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.964 -0.295 . . . . 0.0 110.255 -173.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.751 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 6.4 tt -121.64 117.75 27.47 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 173.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.679 ' HB ' ' CG2' ' A' ' 108' ' ' VAL . 51.2 mt -102.56 119.97 51.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.333 -0.394 . . . . 0.0 109.972 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.471 ' OD1' ' HA ' ' A' ' 63' ' ' ALA . 21.7 p-10 -109.62 124.41 51.12 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.604 0.716 . . . . 0.0 111.036 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.425 ' HB2' ' HB ' ' A' ' 106' ' ' THR . 66.1 m-85 -98.11 129.51 44.92 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.58 178.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.607 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 42.4 p-90 -163.16 173.54 13.32 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.434 -177.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.439 ' HD1' ' OE1' ' A' ' 66' ' ' GLN . 29.2 p90 -131.48 141.78 43.0 Favored Pre-proline 0 C--N 1.318 -0.769 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 171.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.65 ' HG2' ' HA ' ' A' ' 74' ' ' VAL . 31.4 Cg_exo -62.74 0.55 1.45 Allowed 'Trans proline' 0 N--CA 1.476 0.459 0 C-N-CA 123.59 2.86 . . . . 0.0 114.592 -173.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.436 ' OG ' ' HD2' ' A' ' 34' ' ' PHE . 0.5 OUTLIER -102.28 18.0 22.04 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.133 0.492 . . . . 0.0 110.799 173.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 87.5 m -85.56 135.62 38.2 Favored Pre-proline 0 CA--C 1.528 0.096 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.601 176.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 12.7 Cg_exo -71.17 -8.56 23.76 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.008 2.472 . . . . 0.0 111.939 173.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.773 ' O ' ' HB2' ' A' ' 43' ' ' GLU . . . -68.37 5.97 3.66 Favored Glycine 0 C--O 1.22 -0.734 0 CA-C-N 115.762 -0.654 . . . . 0.0 113.667 -177.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.744 ' HA ' ' HG2' ' A' ' 44' ' ' MET . 25.0 p -78.03 -30.25 49.8 Favored 'General case' 0 C--N 1.317 -0.824 0 O-C-N 121.909 -0.759 . . . . 0.0 111.905 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.409 HG21 ' H ' ' A' ' 42' ' ' SER . 6.6 m -56.38 -64.99 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 -166.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.514 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -93.57 -39.72 10.69 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 121.79 -0.569 . . . . 0.0 110.785 178.798 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.773 ' HB2' ' O ' ' A' ' 39' ' ' GLY . 8.3 mp0 -64.21 -41.72 96.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.207 -169.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.744 ' HG2' ' HA ' ' A' ' 40' ' ' CYS . 19.9 mmt -60.37 -53.12 67.89 Favored Pre-proline 0 C--N 1.329 -0.308 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.295 -178.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' A' ' 44' ' ' MET . 80.6 Cg_exo -51.06 -37.85 58.39 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 122.335 2.023 . . . . 0.0 112.848 172.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.514 ' HD3' ' O ' ' A' ' 42' ' ' SER . 23.2 mtpt -61.32 -41.21 96.63 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 120.823 0.344 . . . . 0.0 110.621 176.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 43' ' ' GLU . 27.2 mt -71.82 -32.09 43.54 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.578 177.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.604 HG12 ' O ' ' A' ' 44' ' ' MET . 47.5 mm -54.51 -52.14 43.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-O 120.893 0.378 . . . . 0.0 110.434 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 46' ' ' LYS . 16.6 pttm -65.4 -44.87 86.1 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.642 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.5 m -70.6 -46.87 62.6 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.984 0.421 . . . . 0.0 111.863 -174.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . -69.25 -33.11 72.76 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.906 -174.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.597 ' HA ' ' NZ ' ' A' ' 55' ' ' LYS . 62.1 t30 -76.41 -50.37 14.34 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.118 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -64.99 -46.1 82.85 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.017 -172.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.717 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 38.1 m-85 -79.67 -10.12 59.74 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.57 -175.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.599 ' HA ' ' O ' ' A' ' 59' ' ' PHE . 7.1 ttpm? -63.59 -21.28 66.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.208 0.527 . . . . 0.0 110.518 178.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -106.37 17.23 23.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.625 176.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.6 mtmm -136.62 44.69 2.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.771 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.518 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 17.2 t-20 62.91 31.46 16.24 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.592 0.71 . . . . 0.0 110.745 175.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.751 ' HZ ' ' HB2' ' A' ' 29' ' ' LEU . 48.8 t80 -135.82 137.51 41.61 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.142 176.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.527 ' HG3' ' HG3' ' A' ' 26' ' ' LYS . 4.5 mt-30 -127.69 157.46 40.24 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.224 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 98.6 t -130.88 126.34 59.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 177.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.4 mt -121.39 121.04 36.74 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.122 0.487 . . . . 0.0 110.605 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.536 ' HB2' ' HA ' ' A' ' 87' ' ' VAL . . . -91.19 132.0 36.37 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.458 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.7 t -123.81 101.31 8.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.074 0.464 . . . . 0.0 110.37 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.607 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -85.78 117.38 24.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.685 175.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.61 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -90.92 163.97 27.54 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.34 -0.391 . . . . 0.0 109.981 -176.466 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.657 ' HD3' ' O ' ' A' ' 90' ' ' ASP . 60.8 Cg_endo -70.17 93.56 0.56 Allowed 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.027 1.818 . . . . 0.0 113.253 -169.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 46.5 mm -124.75 -60.81 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 172.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.503 ' OD2' ' HD2' ' A' ' 35' ' ' PRO . 1.8 p30 -105.67 154.21 39.4 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.602 168.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.42 ' HB2' ' OE2' ' A' ' 72' ' ' GLU . 12.9 Cg_exo -69.33 -179.96 3.07 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 122.83 2.353 . . . . 0.0 114.131 -171.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.1 tp -64.24 -35.81 75.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.879 -169.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.552 ' HA ' ' CD ' ' A' ' 75' ' ' ARG . 0.1 OUTLIER -73.39 -29.13 62.41 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.168 -0.332 . . . . 0.0 110.406 -177.645 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 45.5 m -68.72 -41.99 78.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.996 175.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.65 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 92.3 t -60.44 -55.01 27.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.297 176.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.552 ' CD ' ' HA ' ' A' ' 72' ' ' GLU . 1.4 ptm180 -63.69 -27.59 69.32 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.741 -177.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.438 ' HB2' ' O ' ' A' ' 72' ' ' GLU . 8.0 tt0 -66.14 -45.53 80.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.234 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.416 ' HB2' ' HB3' ' A' ' 35' ' ' PRO . 0.1 OUTLIER -63.31 -35.85 81.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.847 -178.862 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.67 HG21 HD12 ' A' ' 13' ' ' LEU . 60.5 t -61.26 -39.55 82.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.637 176.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.426 ' HG3' ' O ' ' A' ' 75' ' ' ARG . 95.2 mttt -70.73 -40.96 72.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.951 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -60.0 -49.38 77.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.239 -173.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.425 ' HB2' ' CD1' ' A' ' 83' ' ' LEU . 77.9 m-85 -99.8 3.7 44.9 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.699 -176.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 57.16 57.91 17.32 Favored Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.123 -178.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.628 ' HB2' HG12 ' A' ' 78' ' ' VAL . 10.5 mp -62.17 114.01 10.35 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-O 120.672 0.272 . . . . 0.0 111.476 -176.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -89.99 13.98 2.2 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.369 2.713 . . . . 0.0 112.936 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -117.96 150.21 39.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.836 176.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.7 m -69.83 115.43 9.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.756 0.312 . . . . 0.0 111.319 -173.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.536 ' HA ' ' HB2' ' A' ' 63' ' ' ALA . 31.4 t -104.5 126.59 59.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.138 -176.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.752 ' SD ' ' HB ' ' A' ' 18' ' ' VAL . 63.6 mtm -112.44 169.15 9.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.745 175.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -115.49 123.49 48.67 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.13 176.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.729 ' OD2' ' HA ' ' A' ' 93' ' ' LYS . 20.0 t0 -88.84 107.33 18.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.434 177.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.96 -47.58 20.48 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -175.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -99.85 -12.24 20.04 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -169.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.729 ' HA ' ' OD2' ' A' ' 90' ' ' ASP . 57.2 tttp 68.61 -2.31 1.69 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.015 0.526 . . . . 0.0 111.821 176.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.21 -23.88 43.51 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.919 0.39 . . . . 0.0 110.484 -177.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.451 ' O ' ' HD1' ' A' ' 99' ' ' PHE . 28.3 m -71.39 -38.04 67.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 171.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.52 -33.7 85.44 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 173.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 67.9 mm-40 -66.75 -32.28 73.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.811 0.338 . . . . 0.0 110.856 175.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.67 -39.9 95.49 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.253 0.549 . . . . 0.0 110.487 177.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.5 ' CE2' HD11 ' A' ' 116' ' ' ILE . 29.7 m-85 -73.63 -28.69 61.93 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.062 175.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.33 44.84 2.9 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.424 178.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.525 HG21 HG22 ' A' ' 106' ' ' THR . 52.5 p -104.48 112.91 26.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.253 0.549 . . . . 0.0 111.568 -176.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -111.95 -39.5 4.5 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.356 177.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.6 m -117.78 149.97 20.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 177.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.552 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 92.3 m-85 -129.44 161.62 57.74 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.75 -172.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.552 ' HA ' ' HB3' ' A' ' 104' ' ' TYR . 63.5 Cg_endo -73.03 165.71 83.46 Favored 'Cis proline' 0 C--N 1.349 0.603 0 C-N-CA 123.689 -1.379 . . . . 0.0 113.439 0.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.525 HG22 HG21 ' A' ' 101' ' ' THR . 4.2 m -135.05 148.88 50.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.433 177.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 37.8 m -137.69 114.59 10.66 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.971 0.415 . . . . 0.0 110.621 178.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.679 ' CG2' ' HB ' ' A' ' 30' ' ' ILE . 20.5 m -106.77 145.13 14.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.136 0.493 . . . . 0.0 111.053 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.495 HD11 HD11 ' A' ' 129' ' ' LEU . 9.5 mp -101.69 133.32 46.58 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.542 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.556 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 34.5 mm -110.49 135.02 50.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.943 -176.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -77.17 -150.21 3.74 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.831 -0.7 . . . . 0.0 111.706 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.454 ' HD3' HG21 ' A' ' 27' ' ' VAL . 10.2 mmmm -101.05 -7.58 23.12 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -176.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 2.7 mtmp? -124.55 19.72 8.73 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 113.485 -1.689 . . . . 0.0 109.291 -175.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.2 -90.97 1.58 Allowed Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -173.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 69.17 -30.55 0.19 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 167.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.5 HD11 ' CE2' ' A' ' 99' ' ' PHE . 23.5 mm 53.38 64.87 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 CA-C-O 121.946 0.879 . . . . 0.0 108.997 -169.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.455 ' HA ' HD23 ' A' ' 117' ' ' LEU . 0.2 OUTLIER -62.02 -45.44 93.58 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 113.885 -1.507 . . . . 0.0 112.983 -169.28 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.694 ' HG3' ' OE2' ' A' ' 132' ' ' GLU . 4.3 tmtp? -143.91 153.83 42.71 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.257 -169.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.3 m -139.96 108.01 5.74 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.944 0.402 . . . . 0.0 111.427 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -98.95 137.87 36.88 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.294 170.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.6 p -109.91 140.82 27.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 82.22 -109.8 3.11 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 -176.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -111.44 126.31 28.83 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 173.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.485 ' HB2' HD12 ' A' ' 129' ' ' LEU . 56.0 Cg_endo -72.14 125.64 11.05 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.206 1.937 . . . . 0.0 111.369 175.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.22 121.86 12.4 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -70.33 -29.67 66.44 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.28 -174.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -65.97 -54.91 22.0 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.32 -174.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -75.74 -33.08 60.24 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.495 HD11 HD11 ' A' ' 109' ' ' LEU . 0.9 OUTLIER -58.31 -48.34 80.8 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.008 0.193 . . . . 0.0 110.974 179.276 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -67.1 -45.14 78.13 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.191 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -64.57 -36.31 83.81 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.387 0.613 . . . . 0.0 110.885 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.694 ' OE2' ' HG3' ' A' ' 118' ' ' LYS . 21.3 tt0 -74.73 -40.02 61.52 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.44 -175.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.518 HG22 HG12 ' A' ' 27' ' ' VAL . 79.7 mt -64.4 -42.3 94.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.876 173.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -54.47 -39.03 67.1 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.462 177.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.8 m -60.51 -39.44 87.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.08 0.467 . . . . 0.0 110.713 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.395 -177.271 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.183 0 CA-C-O 121.08 0.467 . . . . 0.0 110.796 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.502 ' CE1' HD12 ' A' ' 23' ' ' LEU . 45.4 p90 -132.35 168.42 18.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.197 0.522 . . . . 0.0 111.355 -175.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 48.6 m -148.46 95.03 2.38 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 172.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 22.0 tp -115.87 133.61 22.83 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.415 -171.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 8.1 Cg_exo -72.59 134.97 23.21 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.562 2.175 . . . . 0.0 112.414 178.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.58 ' HB3' ' O ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -76.07 164.36 26.2 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.822 174.8 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.648 ' HB3' ' HG2' ' A' ' 75' ' ' ARG . 69.4 mt -67.13 -7.03 20.25 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 -170.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -123.6 17.71 9.59 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 121.809 -0.557 . . . . 0.0 110.959 174.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.02 22.35 25.59 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.931 -0.652 . . . . 0.0 114.045 169.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.58 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 11.3 tmtt? -97.03 102.5 14.29 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 173.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 12.0 m -63.52 122.42 16.25 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.894 0.378 . . . . 0.0 110.262 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.509 ' HB ' ' SD ' ' A' ' 88' ' ' MET . 60.8 t -106.24 116.44 50.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.801 178.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 83.4 p -103.15 -176.91 3.22 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.432 -177.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -73.3 -23.01 60.23 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.688 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.52 ' O ' ' HG3' ' A' ' 24' ' ' GLN . . . -68.34 -28.57 67.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.051 178.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -70.84 -15.53 62.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.871 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.502 HD12 ' CE1' ' A' ' 8' ' ' PHE . 92.3 mt -83.87 -20.21 33.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.706 -177.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.52 ' HG3' ' O ' ' A' ' 21' ' ' ALA . 0.4 OUTLIER -100.24 141.56 32.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.46 0.648 . . . . 0.0 112.457 -172.784 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.76 -8.32 68.26 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.101 -176.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.681 ' HB3' ' HZ3' ' A' ' 26' ' ' LYS . 9.3 mtpm? -142.31 164.23 30.71 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.68 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 25.2 t -102.5 141.73 18.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -177.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.442 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 26.8 m -132.78 138.47 47.16 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -165.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.615 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 36.7 tp -121.49 112.31 18.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.192 170.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.542 HG12 ' HB2' ' A' ' 62' ' ' LEU . 54.4 mt -102.33 115.6 44.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.801 0.334 . . . . 0.0 110.411 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.42 ' HA ' ' O ' ' A' ' 106' ' ' THR . 4.5 p-10 -109.06 126.87 53.62 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.326 0.584 . . . . 0.0 110.281 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.465 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 86.1 m-85 -92.97 127.9 38.65 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.829 178.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.496 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 5.3 p-90 -153.04 -178.05 6.68 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.065 0.46 . . . . 0.0 111.218 -175.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -149.48 148.22 25.47 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.757 172.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.519 ' HD2' ' HB2' ' A' ' 69' ' ' ASP . 96.3 Cg_exo -44.94 -47.87 11.49 Favored 'Trans proline' 0 N--CA 1.475 0.437 0 C-N-CA 123.592 2.861 . . . . 0.0 114.569 -175.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.9 m -82.67 17.14 1.91 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -175.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 53.3 t -73.61 126.51 89.72 Favored Pre-proline 0 C--N 1.328 -0.333 0 O-C-N 122.355 -0.215 . . . . 0.0 110.638 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -62.72 -22.28 73.77 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.907 2.405 . . . . 0.0 113.048 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.84 -17.01 80.28 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.181 -177.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 31.2 p -67.7 -41.5 83.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.069 0.434 . . . . 0.0 111.187 -174.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.8 p -59.99 -32.03 49.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.855 0.36 . . . . 0.0 111.169 -176.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.0 m -86.89 -54.09 4.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.818 0.342 . . . . 0.0 111.328 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.406 ' CD ' ' HZ2' ' A' ' 46' ' ' LYS . 9.4 mm-40 -85.22 -29.69 24.47 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -168.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.571 ' O ' HG12 ' A' ' 48' ' ' ILE . 41.1 ttm -58.7 -46.7 99.56 Favored Pre-proline 0 N--CA 1.47 0.535 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -173.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 44' ' ' MET . 7.0 Cg_endo -50.97 -38.11 58.03 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.017 1.811 . . . . 0.0 112.246 175.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.406 ' HZ2' ' CD ' ' A' ' 43' ' ' GLU . 83.6 mttt -65.2 -44.15 89.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.209 0.528 . . . . 0.0 109.76 176.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 42.5 mm -60.87 -41.46 88.86 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.359 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.74 178.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.571 HG12 ' O ' ' A' ' 44' ' ' MET . 43.0 mm -54.34 -49.2 65.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.249 0.547 . . . . 0.0 110.086 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.5 ttpp -64.96 -57.58 8.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.576 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.6 m -63.24 -41.91 99.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.766 -173.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.05 -50.24 62.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.126 -177.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -64.85 -43.04 94.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.858 0.361 . . . . 0.0 110.889 -173.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.604 ' CG ' ' HZ3' ' A' ' 57' ' ' LYS . 14.1 t70 -59.93 -42.2 93.45 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.001 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 1.038 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 14.9 m-85 -81.34 -26.18 35.79 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.218 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.4 mmmm -58.59 -30.63 67.35 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.854 0.359 . . . . 0.0 110.564 176.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -94.15 19.36 9.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.034 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.604 ' HZ3' ' CG ' ' A' ' 53' ' ' ASP . 27.3 mtmm -128.25 -59.09 1.18 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.325 176.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.412 ' O ' ' HB3' ' A' ' 26' ' ' LYS . 27.2 t-20 176.99 -14.64 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.321 0.582 . . . . 0.0 110.892 -174.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 1.038 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 62.9 t80 -98.31 147.71 24.38 Favored 'General case' 0 C--N 1.316 -0.849 0 O-C-N 122.032 -0.417 . . . . 0.0 109.938 -174.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -137.83 127.66 25.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.134 0.493 . . . . 0.0 111.324 -176.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 92.3 t -99.23 120.43 48.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.426 174.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.542 ' HB2' HG12 ' A' ' 30' ' ' ILE . 72.4 mt -113.78 112.84 24.08 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.708 -178.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.477 ' HB1' ' NE1' ' A' ' 33' ' ' TRP . . . -93.5 107.51 19.35 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.645 -177.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.559 HG22 ' HE3' ' A' ' 88' ' ' MET . 88.4 t -95.66 113.92 31.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.075 0.464 . . . . 0.0 110.448 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -86.11 131.9 34.15 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.697 176.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.575 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -100.24 163.91 17.37 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.514 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.575 ' HD2' ' HB2' ' A' ' 66' ' ' GLN . 32.8 Cg_endo -64.12 79.27 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.542 2.162 . . . . 0.0 113.784 -175.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.447 HG12 ' HG2' ' A' ' 66' ' ' GLN . 40.1 mm -117.83 -63.35 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 171.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.519 ' HB2' ' HD2' ' A' ' 35' ' ' PRO . 14.8 m-20 -96.62 149.55 35.95 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 168.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.45 150.51 34.02 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.633 2.222 . . . . 0.0 112.893 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.0 tt -55.14 -38.5 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.629 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -66.18 -37.39 85.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.107 0.48 . . . . 0.0 110.419 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.4 m -61.35 -35.01 76.25 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.387 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.437 ' O ' HG11 ' A' ' 78' ' ' VAL . 10.9 t -67.67 -41.0 85.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.114 178.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.807 ' HA ' HG22 ' A' ' 78' ' ' VAL . 41.8 mtp180 -69.08 -32.82 72.54 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.368 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.75 -38.81 92.01 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 175.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.464 ' HE1' ' SD ' ' A' ' 44' ' ' MET . 7.7 t80 -67.85 -48.68 65.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.267 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.807 HG22 ' HA ' ' A' ' 75' ' ' ARG . 25.8 m -62.9 -31.93 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -177.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.468 ' HB3' ' HE2' ' A' ' 79' ' ' LYS . 44.9 mtpt -74.64 -54.27 7.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.75 0.309 . . . . 0.0 111.408 177.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -65.71 -41.29 92.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.918 -171.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -89.75 -21.76 22.51 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.604 -175.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.0 75.48 0.91 Allowed Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.429 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.551 HD11 ' HA ' ' A' ' 78' ' ' VAL . 10.6 mp -95.26 112.32 58.18 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 120.798 0.332 . . . . 0.0 111.107 -177.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -81.0 -11.41 12.33 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.185 2.59 . . . . 0.0 113.326 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.447 ' HE1' HD11 ' A' ' 48' ' ' ILE . 29.1 p90 -91.06 145.21 24.88 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 176.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.406 ' HB ' ' CD2' ' A' ' 62' ' ' LEU . 19.4 m -71.83 118.21 14.4 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.976 -172.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.437 HG21 ' HB3' ' A' ' 63' ' ' ALA . 39.0 t -107.49 129.26 61.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.573 -178.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.559 ' HE3' HG22 ' A' ' 64' ' ' VAL . 70.9 mtm -119.85 171.17 8.61 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.45 178.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -137.48 115.27 11.39 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.741 0.305 . . . . 0.0 110.329 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.573 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 47.8 t0 -98.73 102.41 14.13 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.36 -28.27 61.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.723 -176.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -83.71 -7.11 59.55 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.872 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.3 pttp 47.41 25.2 0.57 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.214 1.005 . . . . 0.0 111.774 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -81.59 -34.38 31.03 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.601 -172.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.537 HG21 ' OD2' ' A' ' 90' ' ' ASP . 31.5 m -76.31 -30.68 20.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 119.989 -0.684 . . . . 0.0 109.604 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -69.92 -38.51 75.17 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 172.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 -69.97 -23.75 63.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.567 -0.317 . . . . 0.0 111.346 176.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.42 -36.33 71.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.667 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -86.86 -19.27 29.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.082 176.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 81.84 41.94 9.32 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.904 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.517 HG22 HG21 ' A' ' 106' ' ' THR . 50.4 p -76.15 86.86 3.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.223 0.535 . . . . 0.0 111.054 -178.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -93.09 -45.23 7.99 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.638 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.536 ' HB ' HG22 ' A' ' 121' ' ' VAL . 21.3 t -100.28 123.41 53.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.981 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -104.09 144.37 28.55 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.077 -177.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -76.47 165.27 85.67 Favored 'Cis proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.724 -1.365 . . . . 0.0 113.304 0.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.517 HG21 HG22 ' A' ' 101' ' ' THR . 5.5 m -129.54 125.93 37.4 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.82 174.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.425 ' HB3' HD12 ' A' ' 29' ' ' LEU . 16.5 m -111.62 114.51 27.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.857 0.36 . . . . 0.0 110.884 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.52 HG22 HG23 ' A' ' 119' ' ' THR . 47.3 t -105.98 130.82 56.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.325 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.525 HD13 ' HB3' ' A' ' 118' ' ' LYS . 85.8 mt -101.7 120.2 39.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.567 -178.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.442 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 31.1 mt -112.58 144.13 20.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.405 179.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.68 ' O ' ' HA ' ' A' ' 27' ' ' VAL . . . -72.88 -112.03 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 121.117 -0.563 . . . . 0.0 113.071 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 18.0 pttm -140.54 -8.06 1.12 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -173.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -121.44 -9.75 8.97 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 173.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 127.9 -4.41 6.94 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.592 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 115' ' ' GLU . 5.9 pm0 -58.36 116.95 3.95 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.43 0.633 . . . . 0.0 110.225 -177.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 60.7 mt -78.12 112.33 15.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.589 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.3 mt -90.17 -50.5 5.96 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.416 -173.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.525 ' HB3' HD13 ' A' ' 109' ' ' LEU . 18.0 tptm -152.08 158.35 42.87 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.427 -167.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.52 HG23 HG22 ' A' ' 108' ' ' VAL . 32.0 m -143.15 103.73 4.19 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.147 0.498 . . . . 0.0 110.526 174.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -88.93 106.21 18.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.075 174.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.536 HG22 ' HB ' ' A' ' 103' ' ' VAL . 7.7 p -95.92 121.43 46.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.265 0.555 . . . . 0.0 110.711 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 105.14 -80.6 0.3 Allowed Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.11 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -138.82 118.57 9.53 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.89 143.12 20.51 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.629 2.219 . . . . 0.0 113.323 -177.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.525 ' O ' ' HB2' ' A' ' 129' ' ' LEU . 24.8 t0 -77.45 107.6 10.01 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 172.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -66.35 -43.49 85.88 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -174.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.25 -43.75 98.65 Favored Glycine 0 C--O 1.239 0.437 0 C-N-CA 120.261 -0.971 . . . . 0.0 111.161 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.726 ' HZ1' ' HB2' ' A' ' 128' ' ' LYS . 1.7 ttmp? -71.82 -31.59 66.69 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.21 -0.495 . . . . 0.0 109.994 178.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.533 ' O ' HG13 ' A' ' 133' ' ' ILE . 0.2 OUTLIER -56.55 -48.01 78.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.001 177.397 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -65.92 -48.97 69.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.386 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.42 ' HG2' ' HA ' ' A' ' 128' ' ' LYS . 3.3 pt20 -68.36 -32.23 72.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.964 0.412 . . . . 0.0 111.459 -177.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -74.68 -32.66 62.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.322 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.533 HG13 ' O ' ' A' ' 129' ' ' LEU . 59.5 mt -62.85 -49.69 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 172.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -56.65 -38.23 71.89 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.409 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 88.0 m -55.48 -40.62 71.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.012 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.42 0 CA-C-O 121.039 0.447 . . . . 0.0 111.039 179.357 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.19 0 CA-C-O 121.025 0.44 . . . . 0.0 111.587 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -129.14 135.55 49.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.624 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.3 t -150.2 88.89 1.54 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 171.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.442 HD13 ' HB3' ' A' ' 88' ' ' MET . 1.4 pt? -121.71 155.25 60.21 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.593 -178.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.579 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 8.1 Cg_exo -73.23 130.3 15.06 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.633 2.222 . . . . 0.0 112.522 177.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.54 160.81 31.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.516 173.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.434 HD12 HG11 ' A' ' 78' ' ' VAL . 41.4 mt -60.91 -24.01 65.67 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 -174.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -83.14 -11.7 57.69 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.06 -15.07 16.18 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 121.167 -0.54 . . . . 0.0 113.256 174.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -76.37 121.44 23.03 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.869 0.335 . . . . 0.0 111.114 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.579 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 20.5 m -69.75 123.18 20.76 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 172.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.455 ' HB ' ' HE2' ' A' ' 88' ' ' MET . 39.9 t -119.56 130.01 74.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.981 0.42 . . . . 0.0 110.778 -176.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.9 t -132.05 173.99 10.65 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.494 178.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.657 ' HA ' HD12 ' A' ' 23' ' ' LEU . 30.0 p-10 -61.01 -22.8 64.88 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -172.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.59 ' HA ' HE21 ' A' ' 24' ' ' GLN . . . -67.68 -27.95 67.28 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 178.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -67.63 -32.81 73.77 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.18 0.514 . . . . 0.0 110.93 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.738 HD22 HD11 ' A' ' 110' ' ' ILE . 5.2 mp -71.46 -20.36 62.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.064 -175.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.59 HE21 ' HA ' ' A' ' 21' ' ' ALA . 46.5 mt-30 -68.21 98.5 0.81 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.211 -177.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 132.17 -22.85 4.18 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.079 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.4 mtmm -111.47 162.56 14.97 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -103.46 123.34 56.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 168.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 60' ' ' GLN . 11.0 m -126.59 150.9 48.6 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.092 0.472 . . . . 0.0 111.842 -164.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.411 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 51.9 tp -123.71 120.45 32.74 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.921 174.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.959 ' HB ' HG12 ' A' ' 108' ' ' VAL . 34.5 mm -97.19 132.79 40.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 175.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -128.17 125.07 38.33 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.245 0.545 . . . . 0.0 109.879 174.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -90.56 122.63 33.54 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.991 176.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.443 ' NE1' ' HB3' ' A' ' 63' ' ' ALA . 6.1 p-90 -148.4 -169.84 3.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.454 -177.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.4 ' CE2' ' HB2' ' A' ' 37' ' ' CYS . 36.7 p90 -159.4 143.8 11.17 Favored Pre-proline 0 C--N 1.321 -0.656 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 174.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.479 ' HG2' ' CB ' ' A' ' 69' ' ' ASP . 12.8 Cg_endo -59.0 158.93 23.31 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.414 2.076 . . . . 0.0 111.521 176.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.8 m 68.32 18.41 9.14 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.19 -177.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.458 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 52.8 t -101.3 136.78 19.59 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.547 177.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.47 ' O ' HG23 ' A' ' 41' ' ' VAL . 19.9 Cg_exo -67.15 -13.8 40.99 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 123.014 2.476 . . . . 0.0 112.919 178.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.42 -4.78 19.13 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 121.515 -0.374 . . . . 0.0 113.467 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.707 ' O ' ' HB2' ' A' ' 44' ' ' MET . 61.0 m -63.22 -34.88 78.61 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 122.725 -0.28 . . . . 0.0 110.897 176.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 38' ' ' PRO . 33.0 m -67.98 -33.99 64.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.176 -177.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.9 p -88.87 -56.41 3.3 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.554 ' HG2' ' HG3' ' A' ' 105' ' ' PRO . 1.4 mp0 -84.09 -34.77 24.09 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -168.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.707 ' HB2' ' O ' ' A' ' 40' ' ' CYS . 8.6 mmt -61.12 -48.11 93.0 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -175.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 44' ' ' MET . 13.2 Cg_endo -57.25 -34.19 97.38 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 121.838 1.692 . . . . 0.0 112.305 175.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.468 ' HD2' ' HA ' ' A' ' 43' ' ' GLU . 93.9 mttt -64.32 -51.66 62.34 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 176.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.661 HG21 HG12 ' A' ' 61' ' ' VAL . 45.1 mm -57.43 -46.91 85.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.834 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.447 HG12 ' O ' ' A' ' 44' ' ' MET . 46.1 mm -56.57 -53.36 42.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.184 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -69.3 -51.34 38.22 Favored 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.384 -174.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 62.4 m -57.2 -42.39 81.18 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.071 0.463 . . . . 0.0 111.196 -176.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.04 -31.5 70.32 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.751 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -73.88 -45.5 50.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.783 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -54.59 -51.58 64.86 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.745 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.564 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 61.6 m-85 -97.22 8.53 44.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.433 -175.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.536 ' HE3' ' HA ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -60.54 -45.62 93.19 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.254 0.55 . . . . 0.0 110.169 -179.903 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -89.95 33.56 0.86 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.617 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.564 ' HE2' ' HA ' ' A' ' 54' ' ' TYR . 0.7 OUTLIER -126.08 -68.35 0.83 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.7 171.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 177.03 13.72 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.767 -177.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.411 ' HZ ' ' HB2' ' A' ' 29' ' ' LEU . 22.1 t80 -99.96 147.52 25.49 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.032 -173.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.497 ' O ' ' HA ' ' A' ' 28' ' ' THR . 50.5 tp60 -138.91 147.3 42.15 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.918 -177.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.661 HG12 HG21 ' A' ' 47' ' ' ILE . 86.9 t -129.2 129.64 67.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.748 0.309 . . . . 0.0 110.465 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.814 ' HG ' ' HB ' ' A' ' 86' ' ' THR . 9.9 mp -121.53 121.91 38.53 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.78 177.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.443 ' HB3' ' NE1' ' A' ' 33' ' ' TRP . . . -101.44 119.63 39.06 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.347 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.9 t -97.29 107.65 20.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.916 0.389 . . . . 0.0 110.748 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.5 126.42 36.58 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.101 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.584 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 2.8 pt20 -97.91 168.78 9.45 Favored Pre-proline 0 C--N 1.317 -0.839 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.491 -178.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.618 ' HD2' ' HG3' ' A' ' 93' ' ' LYS . 98.7 Cg_endo -75.91 45.07 1.42 Allowed 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 122.81 2.34 . . . . 0.0 114.85 -165.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 50.7 mm -78.67 -32.61 16.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 171.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.479 ' CB ' ' HG2' ' A' ' 35' ' ' PRO . 0.2 OUTLIER -136.48 136.32 21.94 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 114.64 -1.164 . . . . 0.0 107.926 170.792 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 69' ' ' ASP . 35.7 Cg_exo -58.2 174.02 0.82 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.079 2.519 . . . . 0.0 113.681 -175.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.493 ' HA ' HG11 ' A' ' 74' ' ' VAL . 19.8 tt -71.87 -27.07 26.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.591 -169.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 pm0 -74.02 -28.81 61.62 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.671 175.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 63.0 m -64.51 -48.63 74.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.98 0.419 . . . . 0.0 110.35 174.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.493 HG11 ' HA ' ' A' ' 71' ' ' ILE . 9.6 p -67.62 -34.36 67.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.65 -178.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.877 ' HA ' HG23 ' A' ' 78' ' ' VAL . 66.7 mtt180 -71.66 -29.01 64.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.999 175.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -64.76 -41.52 95.82 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 173.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -64.78 -51.73 60.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.073 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 1.091 ' HA ' HD22 ' A' ' 83' ' ' LEU . 35.8 m -61.8 -26.63 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.379 -178.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.838 ' HZ2' ' HB3' ' A' ' 79' ' ' LYS . 1.6 ttpm? -72.06 -49.43 36.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.303 0.573 . . . . 0.0 110.052 174.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.48 -48.07 77.91 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.681 -1.145 . . . . 0.0 112.857 -173.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -103.19 4.41 36.78 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.428 -174.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 57.12 55.27 31.22 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 116.037 -0.529 . . . . 0.0 113.101 177.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 1.091 HD22 ' HA ' ' A' ' 78' ' ' VAL . 3.1 mm? -71.18 111.65 10.79 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-O 120.784 0.326 . . . . 0.0 110.556 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -85.59 -6.99 8.8 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.11 2.54 . . . . 0.0 113.77 -173.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.539 ' CE2' HD12 ' A' ' 83' ' ' LEU . 28.7 p90 -90.54 169.87 10.66 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.936 0.398 . . . . 0.0 110.929 -178.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.814 ' HB ' ' HG ' ' A' ' 62' ' ' LEU . 18.3 m -75.25 132.13 40.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.174 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.2 t -130.06 130.9 66.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -177.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.473 ' HE3' HD21 ' A' ' 62' ' ' LEU . 57.5 mtt -111.94 163.76 13.87 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.42 -178.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 92.4 t80 -126.42 115.18 19.21 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.835 176.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.519 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 40.0 t0 -87.56 127.08 35.26 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.53 -30.12 59.65 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -177.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.59 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 17.2 t70 -127.22 -10.94 5.85 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -169.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.618 ' HG3' ' HD2' ' A' ' 67' ' ' PRO . 25.0 mtpp 76.69 14.09 2.23 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -169.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.563 ' HA ' HE21 ' A' ' 97' ' ' GLN . . . -61.17 -44.41 97.34 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -170.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.505 HG23 ' OD2' ' A' ' 90' ' ' ASP . 27.7 m -72.32 -33.55 46.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.197 -178.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -70.23 -33.9 69.2 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.499 -0.857 . . . . 0.0 111.086 173.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.563 HE21 ' HA ' ' A' ' 94' ' ' ALA . 14.8 mt-30 -71.43 -24.29 62.0 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 122.751 0.42 . . . . 0.0 110.722 176.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.59 -35.42 73.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.185 173.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -82.43 -11.31 58.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.855 175.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 76.73 32.34 50.6 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.383 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 38.0 p -80.21 96.2 6.51 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.248 0.547 . . . . 0.0 111.466 -177.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -89.34 -31.46 17.79 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.365 0.602 . . . . 0.0 109.618 174.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.3 p -107.1 150.22 9.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.181 -176.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -140.02 155.41 70.81 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.399 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.554 ' HG3' ' HG2' ' A' ' 43' ' ' GLU . 90.5 Cg_endo -77.73 162.58 89.69 Favored 'Cis proline' 0 C--N 1.343 0.259 0 C-N-CA 123.293 -1.545 . . . . 0.0 112.796 0.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.49 HG21 HG11 ' A' ' 121' ' ' VAL . 55.1 m -138.28 131.34 29.99 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.824 178.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 35.1 p -116.25 148.52 40.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.015 0.436 . . . . 0.0 111.376 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.959 HG12 ' HB ' ' A' ' 30' ' ' ILE . 1.9 p -124.57 148.4 28.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 176.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.484 HD21 ' HD1' ' A' ' 120' ' ' TYR . 4.3 mm? -100.51 123.55 44.87 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 121.002 0.43 . . . . 0.0 109.986 -177.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.746 HG22 ' HA ' ' A' ' 115' ' ' GLU . 59.6 mt -109.01 130.21 62.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.693 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.532 ' HA2' ' HB2' ' A' ' 136' ' ' ALA . . . -84.6 -152.25 15.69 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.12 175.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -110.56 15.1 22.28 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.0 mtpp -104.72 19.22 20.83 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 113.6 -1.636 . . . . 0.0 109.646 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 108.25 -77.98 0.23 Allowed Glycine 0 C--O 1.223 -0.562 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.546 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.746 ' HA ' HG22 ' A' ' 110' ' ' ILE . 0.7 OUTLIER -166.83 161.08 15.11 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 117.689 0.745 . . . . 0.0 112.322 -179.823 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 13.5 mt 75.93 85.24 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 125.826 1.65 . . . . 0.0 112.761 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 109' ' ' LEU . 1.3 mm? -110.74 -51.5 2.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.372 171.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.511 ' HG3' ' OE2' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -155.27 174.55 15.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.768 -174.726 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 21.0 m -141.53 133.94 28.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.668 0.27 . . . . 0.0 110.919 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.484 ' HD1' HD21 ' A' ' 109' ' ' LEU . 54.1 m-85 -132.31 110.19 10.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.567 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.49 HG11 HG21 ' A' ' 106' ' ' THR . 22.6 m -92.9 141.57 14.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.025 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 70.38 -113.71 5.03 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.447 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -94.55 109.92 46.02 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.73 121.16 4.97 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.425 2.084 . . . . 0.0 112.428 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.54 ' CG ' ' HG2' ' A' ' 128' ' ' LYS . 8.3 t0 -57.14 105.16 0.2 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 175.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -61.72 -31.34 71.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.852 -175.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -63.35 -49.31 71.43 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.468 -0.872 . . . . 0.0 111.381 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.54 ' HG2' ' CG ' ' A' ' 125' ' ' ASP . 33.2 mmtm -70.54 -34.97 72.85 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.571 ' O ' HG13 ' A' ' 133' ' ' ILE . 0.2 OUTLIER -56.34 -47.92 77.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.385 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -64.27 -55.72 19.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.778 -0.192 . . . . 0.0 110.867 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -58.25 -32.2 68.13 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.372 0.606 . . . . 0.0 111.337 -177.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.511 ' OE2' ' HG3' ' A' ' 118' ' ' LYS . 24.7 tt0 -80.59 -29.59 36.94 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.677 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.571 HG13 ' O ' ' A' ' 129' ' ' LEU . 51.5 mt -62.62 -44.77 99.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 171.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -59.06 -31.03 68.5 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.348 0.594 . . . . 0.0 110.517 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.407 ' HB ' ' O ' ' A' ' 132' ' ' GLU . 92.3 m -66.43 -35.91 81.47 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.431 176.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.532 ' HB2' ' HA2' ' A' ' 111' ' ' GLY . . . . . . . . 0 C--O 1.236 0.351 0 CA-C-O 121.069 0.462 . . . . 0.0 110.388 176.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.263 0 CA-C-O 120.727 0.299 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 55.9 p90 -135.63 137.25 41.69 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.331 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 40.7 m -149.39 88.85 1.6 Allowed 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 173.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -122.29 146.16 46.25 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.141 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.506 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 16.6 Cg_exo -68.25 137.2 39.59 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.285 1.99 . . . . 0.0 111.083 172.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.58 -179.29 1.68 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.519 HD22 HG23 ' A' ' 78' ' ' VAL . 2.9 pp -70.76 -9.2 56.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.741 0.305 . . . . 0.0 111.759 -176.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -92.24 -55.8 3.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.493 172.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 150.46 22.5 0.06 OUTLIER Glycine 0 CA--C 1.522 0.472 0 C-N-CA 120.06 -1.066 . . . . 0.0 114.175 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 41.1 tttm -105.8 126.24 51.93 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 117.445 0.623 . . . . 0.0 109.941 175.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 7.0 t -65.28 127.67 32.71 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.054 0.454 . . . . 0.0 109.79 174.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 9' ' ' SER . 46.8 t -111.12 124.57 68.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 50.4 p -129.38 -175.11 3.47 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.216 -173.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -73.8 -23.97 59.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.928 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.78 -27.48 68.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.015 177.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -69.25 -24.44 63.99 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.484 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.67 HD13 HG22 ' A' ' 110' ' ' ILE . 38.5 mt -82.22 -44.1 16.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.23 -174.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -60.85 126.26 26.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.363 0.601 . . . . 0.0 111.208 -175.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.37 -25.3 10.59 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.639 -176.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.619 ' O ' ' HA ' ' A' ' 112' ' ' LYS . 65.9 mttm -131.72 175.44 9.19 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.988 0.423 . . . . 0.0 110.049 177.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 58.9 t -103.48 146.88 10.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 170.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.57 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 22.2 m -134.67 143.65 47.37 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 121.782 -0.574 . . . . 0.0 111.862 -170.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.661 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 53.8 tp -113.92 113.92 25.51 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 171.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.666 ' HB ' ' CG1' ' A' ' 108' ' ' VAL . 30.2 mt -96.82 112.13 28.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 175.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -111.49 130.66 55.65 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.28 0.562 . . . . 0.0 109.867 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.506 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 94.3 m-85 -98.69 119.24 37.08 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.755 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.639 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 7.7 p-90 -139.1 -177.36 4.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.859 -174.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.633 ' HB3' ' OE1' ' A' ' 66' ' ' GLN . 33.0 p90 -157.9 150.62 18.12 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.837 175.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.49 157.59 35.74 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.116 1.877 . . . . 0.0 110.862 173.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.2 m 65.33 17.61 11.05 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.98 0.419 . . . . 0.0 111.2 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 51.9 t -80.13 133.41 57.56 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.846 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 26.1 Cg_exo -63.72 -26.59 68.39 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.64 2.227 . . . . 0.0 111.557 174.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.58 -16.78 78.77 Favored Glycine 0 C--O 1.225 -0.465 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.659 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 48.9 t -57.81 -30.85 66.04 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 122.446 0.299 . . . . 0.0 111.673 -175.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.1 p -61.1 -33.15 54.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.156 0.503 . . . . 0.0 110.21 177.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.594 ' O ' ' HE3' ' A' ' 46' ' ' LYS . 15.2 m -89.11 -49.76 6.56 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.097 175.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.531 ' O ' HG12 ' A' ' 47' ' ' ILE . 41.9 mt-10 -59.27 -52.68 64.61 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.85 -172.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.655 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 41.1 tpp -59.21 -58.06 22.38 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.402 -170.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.655 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 50.4 Cg_exo -57.05 -36.86 99.43 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.088 1.859 . . . . 0.0 112.56 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.594 ' HE3' ' O ' ' A' ' 42' ' ' SER . 0.0 OUTLIER -65.3 -51.26 61.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.482 179.217 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 43' ' ' GLU . 49.5 mm -60.91 -42.2 91.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.152 -178.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.606 HD12 ' HE1' ' A' ' 85' ' ' PHE . 47.7 mm -54.6 -53.26 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.803 0.335 . . . . 0.0 110.861 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -67.73 -51.49 48.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.405 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.458 ' O ' ' HD2' ' A' ' 54' ' ' TYR . 89.2 m -58.51 -47.0 85.58 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.263 -177.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . -69.15 -24.29 64.06 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -177.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -68.85 -51.73 37.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.265 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -68.17 -52.64 32.27 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.607 0.718 . . . . 0.0 111.002 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 1.045 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 54.6 m-85 -64.58 -21.85 66.81 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.107 -173.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.504 ' HZ2' ' HB2' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -53.95 -49.6 68.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.0 0.428 . . . . 0.0 110.752 179.82 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 -88.08 -18.58 28.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.426 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 58' ' ' ASN . 4.5 tppp? -61.26 -71.88 0.13 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.055 176.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.51 ' OD1' ' HE2' ' A' ' 112' ' ' LYS . 3.7 t-20 169.35 31.29 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 1.045 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 50.7 t80 -140.02 156.2 46.73 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.983 -171.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.451 ' O ' ' HA ' ' A' ' 28' ' ' THR . 10.6 pt20 -148.85 159.14 44.45 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.291 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 86.3 t -123.96 130.69 73.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.465 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 85.6 mt -113.17 104.59 12.51 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.596 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.5 102.47 15.14 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.378 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.566 HG22 ' HE2' ' A' ' 88' ' ' MET . 59.0 t -99.23 114.67 37.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.053 0.454 . . . . 0.0 110.444 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.639 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -86.17 134.44 33.79 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.722 175.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.633 ' OE1' ' HB3' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -100.78 163.93 17.13 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.622 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.605 ' HD2' ' HB2' ' A' ' 93' ' ' LYS . 33.0 Cg_endo -61.87 89.88 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.324 2.016 . . . . 0.0 113.365 -174.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 41.2 mm -130.82 -66.18 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 172.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.78 147.7 34.6 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 171.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -53.78 158.51 8.32 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 122.656 2.238 . . . . 0.0 113.698 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.609 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 5.9 tp -56.52 -33.16 38.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.167 178.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.465 ' OE2' ' HD2' ' A' ' 75' ' ' ARG . 6.1 tp10 -64.25 -41.35 97.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.233 0.539 . . . . 0.0 110.222 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.5 m -60.14 -44.47 94.91 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.824 -177.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.454 ' O ' HG22 ' A' ' 78' ' ' VAL . 7.5 p -70.65 -33.62 53.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.852 -179.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.609 ' HG3' ' O ' ' A' ' 71' ' ' ILE . 98.7 mtt180 -55.29 -53.16 59.55 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.4 0.619 . . . . 0.0 110.327 175.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -63.66 -45.11 91.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.705 -176.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -55.4 -45.19 76.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.047 -176.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.647 ' HA ' HD21 ' A' ' 83' ' ' LEU . 86.1 t -64.36 -44.85 97.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.497 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.765 ' HA ' ' HE3' ' A' ' 79' ' ' LYS . 1.3 mmmt -76.96 -33.59 57.65 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.276 -0.57 . . . . 0.0 112.336 -175.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.94 -48.14 77.71 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 123.412 0.445 . . . . 0.0 110.909 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.438 ' HB2' ' CD1' ' A' ' 83' ' ' LEU . 80.8 m-85 -97.57 12.92 31.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.901 0.381 . . . . 0.0 111.18 -178.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.64 -60.49 4.35 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 121.103 -0.57 . . . . 0.0 113.029 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.647 HD21 ' HA ' ' A' ' 78' ' ' VAL . 10.2 mp 48.71 87.12 0.13 Allowed Pre-proline 0 N--CA 1.467 0.407 0 C-N-CA 123.756 0.822 . . . . 0.0 112.346 -177.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -79.27 44.52 1.71 Allowed 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.409 2.739 . . . . 0.0 112.953 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.606 ' HE1' HD12 ' A' ' 48' ' ' ILE . 21.1 p90 -152.27 157.5 41.48 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.7 m -74.78 117.9 17.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.96 0.409 . . . . 0.0 111.001 -174.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 36.0 t -110.2 126.62 67.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.577 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.566 ' HE2' HG22 ' A' ' 64' ' ' VAL . 76.0 mtm -119.13 167.73 11.53 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.626 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -138.56 117.18 12.17 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.559 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 43.9 t0 -92.13 128.72 38.08 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.68 -32.08 62.09 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -177.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.433 ' O ' ' HB3' ' A' ' 93' ' ' LYS . 25.9 t70 -112.1 -11.88 13.75 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.795 0.331 . . . . 0.0 110.807 -175.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.605 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 33.8 ttmt 73.15 15.68 4.4 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.533 -177.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.83 -39.84 93.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.423 -173.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.547 HG23 ' OD2' ' A' ' 90' ' ' ASP . 27.0 m -70.85 -31.93 47.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.863 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -72.1 -34.09 61.79 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 174.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 93' ' ' LYS . 44.5 mt-30 -64.35 -29.16 70.24 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 122.554 0.342 . . . . 0.0 110.482 176.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.22 -38.87 65.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.02 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -80.44 -13.14 59.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.823 0.344 . . . . 0.0 111.158 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.01 45.6 5.34 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.938 176.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 56.9 p -75.7 89.54 2.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.172 0.51 . . . . 0.0 111.2 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.6 mm100 -96.39 -52.52 3.94 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.251 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.438 ' HB ' ' CG2' ' A' ' 121' ' ' VAL . 47.1 t -106.73 134.68 47.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.613 177.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -105.1 145.83 31.5 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -75.95 165.41 85.57 Favored 'Cis proline' 0 C--N 1.342 0.227 0 C-N-CA 123.333 -1.528 . . . . 0.0 112.902 -0.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.7 m -124.19 133.67 53.48 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 176.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.511 ' HB3' HD13 ' A' ' 29' ' ' LEU . 25.0 m -127.47 110.57 12.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.863 0.363 . . . . 0.0 111.159 -175.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.666 ' CG1' ' HB ' ' A' ' 30' ' ' ILE . 12.3 p -106.97 138.54 32.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.972 0.415 . . . . 0.0 110.36 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.724 ' HB2' ' HB2' ' A' ' 118' ' ' LYS . 88.2 mt -102.01 124.52 47.76 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.268 0.556 . . . . 0.0 110.355 -177.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.67 HG22 HD13 ' A' ' 23' ' ' LEU . 18.7 mm -108.31 138.36 35.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.994 -174.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -86.22 -177.4 49.82 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.652 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.619 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 98.5 mttt -73.53 1.99 8.82 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.98 0.419 . . . . 0.0 111.557 -177.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.467 ' HZ2' ' CD ' ' A' ' 115' ' ' GLU . 19.9 tptp -134.21 6.55 3.6 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.543 ' HA2' ' CG2' ' A' ' 110' ' ' ILE . . . 85.81 -104.41 2.85 Favored Glycine 0 N--CA 1.433 -1.543 0 CA-C-N 114.376 -1.283 . . . . 0.0 110.346 -172.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.467 ' CD ' ' HZ2' ' A' ' 113' ' ' LYS . 1.1 mm-40 52.72 -9.1 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.215 1.806 . . . . 0.0 115.772 174.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.48 ' H ' ' C ' ' A' ' 114' ' ' GLY . 13.2 mt 68.17 115.43 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 122.969 0.508 . . . . 0.0 111.189 -178.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 79.6 mt -101.85 -48.14 4.37 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.183 0.516 . . . . 0.0 111.235 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.724 ' HB2' ' HB2' ' A' ' 109' ' ' LEU . 5.0 mmmm -146.48 155.13 42.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.777 -169.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 18.4 m -135.98 110.76 8.71 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.643 178.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -112.67 146.91 37.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.243 176.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.438 ' CG2' ' HB ' ' A' ' 103' ' ' VAL . 7.3 p -123.67 133.52 68.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.892 177.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 79.88 -140.37 22.34 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.921 -178.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -85.23 112.31 42.8 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -81.25 162.94 19.96 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.651 2.234 . . . . 0.0 113.256 -177.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.607 ' OD2' ' HB3' ' A' ' 128' ' ' LYS . 7.4 p-10 -75.5 76.9 2.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.308 177.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -52.26 -40.41 61.66 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -175.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -57.91 -51.23 59.44 Favored Glycine 0 C--O 1.24 0.511 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.229 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.607 ' HB3' ' OD2' ' A' ' 125' ' ' ASP . 1.9 ttpm? -80.11 -18.75 49.03 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.666 ' O ' HG12 ' A' ' 133' ' ' ILE . 10.0 tt -70.95 -44.82 65.3 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 174.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -57.67 -55.59 32.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.665 0.269 . . . . 0.0 110.701 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.444 ' HG2' ' HA ' ' A' ' 128' ' ' LYS . 9.9 pt20 -61.69 -27.7 68.88 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.043 0.449 . . . . 0.0 110.988 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.441 ' OE2' ' HG3' ' A' ' 118' ' ' LYS . 32.0 tt0 -72.59 -42.86 64.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.555 178.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.666 HG12 ' O ' ' A' ' 129' ' ' LEU . 45.1 mm -69.65 -49.91 54.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.225 179.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.48 -16.4 62.42 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.965 0.412 . . . . 0.0 111.411 -178.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 15.4 m -66.74 -29.11 69.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.958 0.408 . . . . 0.0 110.705 171.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.464 -178.203 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.355 0 CA-C-O 121.089 0.471 . . . . 0.0 110.449 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -104.13 111.87 24.64 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 122.377 1.084 . . . . 0.0 112.621 -170.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.5 m -150.35 89.6 1.59 Allowed 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 113.388 -1.733 . . . . 0.0 108.102 171.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.428 ' HB3' ' HE1' ' A' ' 88' ' ' MET . 23.8 tp -120.65 139.17 28.48 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.855 -169.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -73.58 141.77 31.69 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.394 2.063 . . . . 0.0 111.556 172.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.41 ' CG ' ' H ' ' A' ' 14' ' ' HIS . 0.6 OUTLIER -87.35 -176.04 5.49 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 177.847 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.7 mt -73.01 -1.14 15.95 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -177.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.41 ' H ' ' CG ' ' A' ' 12' ' ' ASP . 67.7 m80 -109.92 8.61 24.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.997 0.427 . . . . 0.0 109.998 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.72 34.95 59.14 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.363 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.5 mmtm -115.29 134.0 55.53 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 175.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.5 m -79.0 122.46 26.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.826 0.346 . . . . 0.0 110.506 -178.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.8 t -112.48 122.36 66.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 90.4 p -108.13 178.86 4.38 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.313 0.578 . . . . 0.0 110.713 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -76.17 -21.22 56.79 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.498 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.03 -28.91 69.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.715 175.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -73.6 -13.93 61.1 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.32 0.581 . . . . 0.0 110.583 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 61.6 mt -83.69 -48.29 10.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.186 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -56.25 150.84 13.68 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.254 0.55 . . . . 0.0 111.864 -175.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.25 -19.5 46.43 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -172.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.547 ' HB2' ' HZ1' ' A' ' 26' ' ' LYS . 4.4 mtmp? -135.39 167.92 20.15 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.2 t -108.04 140.52 26.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 175.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.43 HG22 ' HG3' ' A' ' 60' ' ' GLN . 29.9 m -134.32 140.86 46.67 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.013 0.435 . . . . 0.0 111.867 -171.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.452 HD13 ' HB3' ' A' ' 107' ' ' SER . 47.7 tp -113.85 115.45 27.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.305 173.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.837 HG12 ' HB2' ' A' ' 62' ' ' LEU . 46.2 mt -107.01 112.77 41.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.547 ' HA ' ' O ' ' A' ' 106' ' ' THR . 23.6 p-10 -113.9 129.39 56.6 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.246 0.546 . . . . 0.0 111.248 -178.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -83.09 128.74 34.75 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.048 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.577 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 5.5 p-90 -154.12 -175.71 5.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.49 -176.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.745 ' HB3' HE22 ' A' ' 66' ' ' GLN . 13.1 p90 -171.44 159.86 5.03 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.084 174.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.423 ' HD2' ' HB2' ' A' ' 34' ' ' PHE . 19.8 Cg_endo -62.86 156.25 55.07 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.119 1.879 . . . . 0.0 111.639 176.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.5 m 67.59 13.56 9.31 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.653 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 49.2 t -83.83 136.26 41.91 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.81 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.528 ' O ' HG13 ' A' ' 41' ' ' VAL . 35.9 Cg_exo -60.13 -25.83 80.9 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.615 2.21 . . . . 0.0 112.25 176.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.21 -13.7 65.17 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 121.228 -0.51 . . . . 0.0 113.145 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 88.1 m -63.25 -30.79 71.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.783 0.292 . . . . 0.0 111.684 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.528 HG13 ' O ' ' A' ' 38' ' ' PRO . 14.6 p -65.39 -37.55 80.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.814 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.443 ' O ' ' HE2' ' A' ' 46' ' ' LYS . 22.8 m -87.11 -56.6 3.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.997 0.427 . . . . 0.0 111.284 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.461 ' HG3' ' HG3' ' A' ' 105' ' ' PRO . 74.4 mm-40 -69.99 -41.55 74.26 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.205 0.816 . . . . 0.0 113.205 -169.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.721 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 39.6 tpp -49.32 -59.96 5.66 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -169.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.721 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 31.2 Cg_exo -58.74 -44.3 37.48 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 121.84 1.693 . . . . 0.0 112.27 -178.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.461 ' HE2' ' HA ' ' A' ' 43' ' ' GLU . 45.1 mtmt -60.2 -51.3 70.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.442 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.6 mm -62.64 -38.3 81.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.367 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.558 HG12 ' O ' ' A' ' 44' ' ' MET . 30.4 mm -54.91 -54.02 27.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 116.807 -0.179 . . . . 0.0 110.956 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.767 ' HZ3' ' HB2' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -75.48 -38.77 59.34 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 119.659 -0.817 . . . . 0.0 110.815 -178.628 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.557 ' O ' ' HD2' ' A' ' 54' ' ' TYR . 91.6 m -58.39 -44.85 89.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.826 0.346 . . . . 0.0 110.811 -178.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.0 -44.65 79.81 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.127 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -67.26 -50.45 60.48 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.747 0.308 . . . . 0.0 111.088 -178.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.63 -45.38 73.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.257 0.551 . . . . 0.0 111.035 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 1.036 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 50.6 m-85 -82.28 -26.24 33.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.308 -174.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.458 ' NZ ' ' HB3' ' A' ' 60' ' ' GLN . 18.0 tppt? -61.93 -32.45 72.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.899 0.381 . . . . 0.0 110.117 176.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -84.76 45.84 1.19 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.464 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.478 ' HE2' ' HA ' ' A' ' 54' ' ' TYR . 9.0 pttm -166.07 -58.48 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.681 170.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.456 ' OD1' ' HG2' ' A' ' 26' ' ' LYS . 59.7 t30 176.46 38.06 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 120.989 0.424 . . . . 0.0 111.521 -177.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 1.036 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 44.4 t80 -138.5 157.42 46.22 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 122.003 -0.435 . . . . 0.0 109.828 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.458 ' HB3' ' NZ ' ' A' ' 55' ' ' LYS . 11.1 pt20 -152.16 152.33 32.15 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.935 0.398 . . . . 0.0 110.985 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 90.2 t -117.96 126.19 74.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.669 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.837 ' HB2' HG12 ' A' ' 30' ' ' ILE . 86.1 mt -112.13 106.46 15.09 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.469 ' HB3' ' CD1' ' A' ' 33' ' ' TRP . . . -90.85 105.86 18.12 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.682 -176.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 91.9 t -90.44 115.86 30.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.936 0.398 . . . . 0.0 110.716 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.577 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -88.0 111.27 21.32 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.791 176.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.745 HE22 ' HB3' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -83.17 163.04 52.35 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.015 -177.29 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.555 ' HD2' ' HB2' ' A' ' 66' ' ' GLN . 57.1 Cg_endo -69.62 97.35 0.62 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.352 2.035 . . . . 0.0 113.073 -171.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 52.6 mt -141.19 -65.05 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.332 173.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.34 144.42 30.9 Favored Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 166.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.95 152.56 23.11 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.442 2.095 . . . . 0.0 112.471 178.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.642 ' O ' HG21 ' A' ' 74' ' ' VAL . 12.8 tt -58.38 -23.24 21.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.021 176.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -65.83 -45.13 83.41 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.613 174.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.4 m -59.77 -41.13 90.41 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.506 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.642 HG21 ' O ' ' A' ' 71' ' ' ILE . 13.0 m -68.85 -33.91 61.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.972 -177.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.723 ' HA ' HG22 ' A' ' 78' ' ' VAL . 76.2 mtt180 -70.69 -39.88 73.24 Favored 'General case' 0 C--O 1.22 -0.488 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 174.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -61.31 -37.45 83.3 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -63.35 -53.8 46.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.206 176.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.723 HG22 ' HA ' ' A' ' 75' ' ' ARG . 35.0 m -63.4 -27.26 42.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.996 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.63 ' HZ3' ' HB3' ' A' ' 79' ' ' LYS . 5.6 mmmp? -75.69 -40.16 56.27 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -73.3 -49.63 26.53 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.659 0.599 . . . . 0.0 111.798 -172.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -88.58 -1.89 58.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.493 -174.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 58.03 51.2 59.72 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.257 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.515 ' CD1' ' HA ' ' A' ' 78' ' ' VAL . 1.2 mp -74.61 117.06 59.24 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 121.011 0.434 . . . . 0.0 111.151 -175.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.59 -28.37 4.39 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.28 2.654 . . . . 0.0 114.415 -172.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -71.3 146.39 48.91 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.402 -178.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.414 ' HB ' HD23 ' A' ' 62' ' ' LEU . 12.3 m -70.4 113.42 7.52 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.453 -172.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.9 t -99.41 132.58 44.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.244 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.428 ' HE1' ' HB3' ' A' ' 10' ' ' LEU . 60.3 mtp -118.65 164.71 14.93 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.513 -0.767 . . . . 0.0 108.964 -177.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -120.6 129.35 53.71 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.283 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.788 ' OD2' ' HA ' ' A' ' 93' ' ' LYS . 10.7 t0 -102.07 115.75 31.21 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.322 177.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.15 -47.46 24.23 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -172.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -115.04 -10.96 12.17 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -169.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.788 ' HA ' ' OD2' ' A' ' 90' ' ' ASP . 34.9 ttmt 68.63 18.65 8.78 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 122.826 0.45 . . . . 0.0 111.506 177.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.03 -33.95 76.65 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.589 -0.694 . . . . 0.0 109.65 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.8 p -63.39 -47.63 90.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.723 172.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.92 -36.81 93.53 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.207 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -64.59 -30.48 71.51 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 122.542 0.337 . . . . 0.0 111.016 178.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.63 -34.2 76.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.935 0.398 . . . . 0.0 110.451 176.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.474 ' HB2' HG21 ' A' ' 101' ' ' THR . 65.4 m-85 -83.21 -17.9 41.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.031 174.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.8 31.76 38.97 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.942 -175.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.474 HG21 ' HB2' ' A' ' 99' ' ' PHE . 78.1 p -78.36 91.11 4.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.538 0.685 . . . . 0.0 111.98 -175.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 73.6 mm-40 -108.95 -26.39 10.24 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 171.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.5 m -109.18 140.48 27.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.527 174.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.525 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 37.2 m-85 -127.87 160.61 60.32 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.373 -173.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.525 ' HA ' ' HB3' ' A' ' 104' ' ' TYR . 87.3 Cg_endo -78.95 166.52 79.06 Favored 'Cis proline' 0 C--N 1.347 0.484 0 C-N-CA 123.866 -1.306 . . . . 0.0 113.269 0.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.547 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 22.1 m -126.03 120.47 30.35 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.99 175.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.452 ' HB3' HD13 ' A' ' 29' ' ' LEU . 33.9 m -107.89 113.17 26.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.009 0.433 . . . . 0.0 111.496 -174.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.591 HG21 HG21 ' A' ' 119' ' ' THR . 45.8 t -105.54 129.19 58.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.377 -178.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.552 ' HB2' ' HB3' ' A' ' 118' ' ' LYS . 96.5 mt -102.74 126.25 49.78 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.466 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 65.7 mt -116.87 125.36 73.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.086 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.405 ' H ' HD23 ' A' ' 117' ' ' LEU . . . -72.84 177.63 41.26 Favored Glycine 0 N--CA 1.453 -0.224 0 CA-C-N 115.896 -0.593 . . . . 0.0 113.21 -175.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 7.2 ptpp? -68.48 -6.2 23.7 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -175.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 7.7 ptmm? -105.97 6.99 31.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.684 0.278 . . . . 0.0 110.438 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.33 70.68 1.01 Allowed Glycine 0 C--O 1.225 -0.449 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 -177.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -153.72 165.21 36.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.551 0.215 . . . . 0.0 110.466 -174.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 86.7 mt -72.97 103.32 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.087 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.405 HD23 ' H ' ' A' ' 111' ' ' GLY . 3.1 mm? -97.92 -44.05 6.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.615 177.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.552 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -163.18 152.51 14.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.839 0.352 . . . . 0.0 111.872 -175.775 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.591 HG21 HG21 ' A' ' 108' ' ' VAL . 38.0 m -138.77 102.93 4.7 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.845 168.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -79.54 138.38 37.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.653 174.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.3 p -103.86 114.99 44.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 173.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 94.13 -157.91 22.88 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.889 -177.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -80.59 119.73 77.12 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 120.72 0.295 . . . . 0.0 110.681 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -87.56 151.47 7.63 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.818 2.345 . . . . 0.0 112.716 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.96 127.86 33.02 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.541 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 7.6 m-85 -71.57 -18.8 62.22 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -176.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -68.23 -54.48 16.7 Favored Glycine 0 C--O 1.238 0.367 0 C-N-CA 120.096 -1.049 . . . . 0.0 111.648 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.689 ' HA ' HE21 ' A' ' 131' ' ' GLN . 5.2 ttpp -74.87 -20.82 59.57 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 176.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.541 ' HB3' ' HA ' ' A' ' 126' ' ' PHE . 63.0 tp -65.7 -48.02 73.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.049 175.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 14.9 m-30 -61.56 -52.72 63.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.263 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.689 HE21 ' HA ' ' A' ' 128' ' ' LYS . 19.8 pt20 -65.92 -27.54 68.26 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.863 0.363 . . . . 0.0 111.909 -177.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -80.02 -37.26 34.49 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.184 -0.323 . . . . 0.0 110.428 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 129' ' ' LEU . 51.2 mt -65.64 -48.49 82.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.717 176.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -25.37 67.92 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 -177.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 68.7 m -60.99 -43.69 98.49 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.067 0.461 . . . . 0.0 110.145 173.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.637 178.081 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.377 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -110.56 112.93 25.16 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.596 0.712 . . . . 0.0 111.319 -173.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.4 m -96.15 90.04 5.36 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 169.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.445 HD12 ' HD2' ' A' ' 11' ' ' PRO . 29.7 tp -102.73 123.35 42.75 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.259 -169.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.508 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 8.4 Cg_exo -72.96 147.06 42.94 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.819 2.346 . . . . 0.0 112.222 176.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.08 -177.91 5.3 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 174.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.3 mt -63.5 -22.73 67.05 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -177.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -89.22 -54.53 4.06 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.053 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.22 18.25 0.05 OUTLIER Glycine 0 CA--C 1.523 0.548 0 C-N-CA 119.61 -1.281 . . . . 0.0 114.683 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 11' ' ' PRO . 51.2 mttt -92.0 140.39 29.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 118.026 0.913 . . . . 0.0 110.119 174.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.6 m -88.26 122.36 31.7 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.1 0.476 . . . . 0.0 111.397 -177.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.0 t -107.25 132.66 54.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.737 174.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -140.81 -177.3 5.01 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.44 -173.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -58.21 -23.33 55.32 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.702 -176.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.86 -27.92 69.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.483 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -83.04 -19.59 36.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.148 0.499 . . . . 0.0 110.541 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.591 ' HB3' ' HA2' ' A' ' 114' ' ' GLY . 9.3 mp -83.53 -20.08 34.52 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.306 -176.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -95.74 134.58 38.5 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.063 0.459 . . . . 0.0 110.942 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.97 -7.13 82.28 Favored Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.752 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.583 ' HG2' ' OD1' ' A' ' 58' ' ' ASN . 29.9 mtpp -129.61 168.19 16.81 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.489 HG21 ' HA ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -103.25 130.93 52.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 174.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.445 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 21.0 m -133.26 146.41 51.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.98 0.419 . . . . 0.0 112.057 -166.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.523 HD21 ' HB3' ' A' ' 107' ' ' SER . 8.0 tt -131.73 124.22 29.3 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 174.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.798 ' HB ' HG13 ' A' ' 108' ' ' VAL . 45.0 mm -109.89 125.35 67.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -109.38 112.87 25.24 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -84.79 119.57 25.45 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.579 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 4.2 p-90 -154.32 177.11 11.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.2 0.524 . . . . 0.0 111.484 -176.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.626 ' HB3' ' OE1' ' A' ' 66' ' ' GLN . 9.3 p90 -148.81 136.32 10.99 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.602 172.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.452 ' HD2' ' OD1' ' A' ' 69' ' ' ASP . 44.8 Cg_exo -59.59 -15.71 32.46 Favored 'Trans proline' 0 N--CA 1.475 0.396 0 C-N-CA 123.421 2.747 . . . . 0.0 114.414 -173.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.4 p -95.45 13.81 24.72 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 122.017 -0.427 . . . . 0.0 111.991 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 25.0 p -88.37 146.0 36.88 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.854 0.359 . . . . 0.0 111.375 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 5.8 Cg_exo -79.09 -8.68 15.41 Favored 'Trans proline' 0 CA--C 1.532 0.406 0 C-N-CA 123.119 2.546 . . . . 0.0 113.011 176.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -86.18 -61.27 1.67 Allowed Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.676 -173.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.475 ' SG ' ' HB2' ' A' ' 33' ' ' TRP . 82.0 m -52.06 -30.06 24.05 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -169.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.8 p -56.12 -24.52 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.112 0.482 . . . . 0.0 111.16 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.651 ' HB2' ' OE2' ' A' ' 43' ' ' GLU . 1.7 m -86.23 -45.15 11.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.952 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.651 ' OE2' ' HB2' ' A' ' 42' ' ' SER . 3.9 mp0 -80.13 -33.36 38.65 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -174.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.599 ' O ' HG12 ' A' ' 48' ' ' ILE . 13.2 ptp -57.43 -38.9 72.83 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -166.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.562 ' HD3' ' CG ' ' A' ' 44' ' ' MET . 47.2 Cg_exo -58.28 -43.94 42.68 Favored 'Trans proline' 0 C--N 1.361 1.225 0 CA-C-N 121.749 1.66 . . . . 0.0 111.797 175.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -59.16 -38.09 78.91 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.483 176.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.2 mt -68.52 -36.42 74.62 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.4 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.733 177.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.599 HG12 ' O ' ' A' ' 44' ' ' MET . 47.2 mm -53.57 -55.49 13.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-O 120.799 0.333 . . . . 0.0 110.32 -175.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -75.86 -53.74 7.98 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.272 -177.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.8 m -58.01 -45.03 87.52 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -174.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.49 ' HB3' HG23 ' A' ' 61' ' ' VAL . . . -70.03 -36.05 74.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.874 -0.148 . . . . 0.0 111.32 -178.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -68.78 -45.43 71.36 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.017 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -59.77 -27.28 66.4 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.779 176.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.652 ' HH ' ' HB ' ' A' ' 133' ' ' ILE . 0.1 OUTLIER -87.18 -39.48 15.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.946 -179.649 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.425 ' HB3' ' HZ1' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -60.07 -31.27 69.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.296 -175.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -80.34 37.54 0.39 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -174.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.402 ' HB3' ' HE3' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -162.57 65.84 0.21 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.073 0.463 . . . . 0.0 111.068 172.276 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.583 ' OD1' ' HG2' ' A' ' 26' ' ' LYS . 66.9 t30 66.1 11.0 7.5 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.525 176.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.489 ' HA ' HG21 ' A' ' 27' ' ' VAL . 43.9 t80 -105.57 148.69 27.0 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -141.4 126.33 18.22 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.135 0.493 . . . . 0.0 111.506 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.49 HG23 ' HB3' ' A' ' 51' ' ' ALA . 58.2 t -106.07 117.39 51.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.686 177.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.423 ' HB3' ' HE1' ' A' ' 88' ' ' MET . 5.5 mp -120.2 117.82 28.87 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.017 0.437 . . . . 0.0 110.227 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.442 ' O ' ' HA ' ' A' ' 87' ' ' VAL . . . -94.22 114.26 26.33 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.839 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.3 p -101.23 119.95 50.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.353 0.596 . . . . 0.0 111.137 -176.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.579 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -89.59 129.68 36.01 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.447 175.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.626 ' OE1' ' HB3' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -104.74 165.88 12.5 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.594 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.618 ' HD3' ' O ' ' A' ' 90' ' ' ASP . 57.7 Cg_endo -70.83 80.15 1.21 Allowed 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.291 1.994 . . . . 0.0 113.525 -169.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 70.6 mt -120.78 -43.9 2.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 172.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.452 ' OD1' ' HD2' ' A' ' 35' ' ' PRO . 5.3 p-10 -121.78 141.43 33.84 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 163.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 69' ' ' ASP . 36.4 Cg_exo -57.66 158.33 20.35 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.056 2.504 . . . . 0.0 113.176 -174.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.613 ' O ' ' HG2' ' A' ' 75' ' ' ARG . 13.1 tt -53.69 -28.35 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.288 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.567 ' HA ' ' CG ' ' A' ' 75' ' ' ARG . 22.6 tp10 -64.16 -36.75 85.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.117 0.484 . . . . 0.0 110.958 178.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.0 t -68.71 -34.96 76.52 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 178.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.48 ' O ' HG21 ' A' ' 78' ' ' VAL . 24.0 t -60.35 -44.38 95.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.216 173.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.613 ' HG2' ' O ' ' A' ' 71' ' ' ILE . 14.1 mmt180 -52.83 -51.93 59.03 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.751 0.786 . . . . 0.0 109.601 176.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -61.47 -42.04 98.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.157 -1.383 . . . . 0.0 111.781 -175.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.443 ' CE1' ' HE2' ' A' ' 44' ' ' MET . 24.5 t80 -70.99 -43.21 68.47 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.076 -176.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.531 HG11 ' HB2' ' A' ' 83' ' ' LEU . 80.1 t -59.89 -43.84 93.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.341 -177.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -74.0 -28.57 61.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.662 0.268 . . . . 0.0 111.348 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -73.37 -48.58 32.99 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.352 -175.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -97.42 -2.77 41.47 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -177.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 64.44 64.08 3.85 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.555 178.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.531 ' HB2' HG11 ' A' ' 78' ' ' VAL . 10.3 mp -79.67 115.34 52.95 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-O 120.644 0.259 . . . . 0.0 110.914 -178.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.414 ' CD ' HD12 ' A' ' 48' ' ' ILE . 93.4 Cg_endo -89.6 -21.45 1.09 Allowed 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.004 2.469 . . . . 0.0 113.568 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -76.19 155.56 34.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.799 0.333 . . . . 0.0 110.503 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 29.5 m -73.41 121.19 20.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.344 -175.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 63' ' ' ALA . 38.9 t -109.42 138.7 35.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.677 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.423 ' HE1' ' HB3' ' A' ' 62' ' ' LEU . 71.6 mtm -122.25 171.29 9.13 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 176.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -139.47 115.24 10.1 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.545 -0.169 . . . . 0.0 110.545 -178.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.618 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 13.3 t70 -107.83 127.53 53.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.898 0.38 . . . . 0.0 110.793 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.48 -28.12 56.35 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -175.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -112.65 -12.96 13.34 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -165.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt 69.42 7.63 6.34 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 122.739 0.415 . . . . 0.0 110.978 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.35 -32.53 70.19 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.246 0.546 . . . . 0.0 110.192 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.539 ' O ' ' HD1' ' A' ' 99' ' ' PHE . 2.0 p -60.43 -49.8 82.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.42 173.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -67.18 -33.67 83.69 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.938 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -58.82 -51.65 69.11 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 122.653 0.381 . . . . 0.0 111.485 177.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.79 -29.67 62.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.888 -177.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.733 ' HA ' HD12 ' A' ' 116' ' ' ILE . 17.2 m-85 -76.35 -27.79 56.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.753 0.311 . . . . 0.0 111.093 177.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.36 46.43 4.67 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.785 -0.722 . . . . 0.0 111.718 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 24.5 m -118.43 99.35 6.77 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.981 0.42 . . . . 0.0 111.158 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -91.82 -48.78 6.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.9 176.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 9.2 p -100.4 159.44 3.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.327 -174.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.426 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 34.1 m-85 -135.49 156.85 77.45 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -175.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.426 ' HA ' ' HB3' ' A' ' 104' ' ' TYR . 89.4 Cg_endo -85.16 141.59 32.38 Favored 'Cis proline' 0 C--N 1.347 0.478 0 C-N-CA 123.524 -1.449 . . . . 0.0 112.725 -0.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 89.5 m -129.77 129.98 44.79 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.379 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.523 ' HB3' HD21 ' A' ' 29' ' ' LEU . 14.0 m -111.79 131.92 55.02 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.148 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.798 HG13 ' HB ' ' A' ' 30' ' ' ILE . 8.3 p -105.97 142.77 18.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 120.887 0.375 . . . . 0.0 109.995 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.704 HD21 HD12 ' A' ' 129' ' ' LEU . 66.5 mt -103.86 127.86 51.35 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.779 177.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.51 HD11 HD22 ' A' ' 23' ' ' LEU . 72.5 mt -115.62 127.38 73.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.859 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.63 -97.84 0.01 OUTLIER Glycine 0 C--N 1.334 0.44 0 O-C-N 123.953 0.783 . . . . 0.0 112.716 -177.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -150.97 13.27 0.69 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.011 0.434 . . . . 0.0 110.649 176.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 49.1 mttp -111.9 -3.11 14.96 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.48 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.591 ' HA2' ' HB3' ' A' ' 23' ' ' LEU . . . 76.65 42.45 21.54 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.654 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -139.14 165.15 27.92 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.741 0.305 . . . . 0.0 110.335 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.733 HD12 ' HA ' ' A' ' 99' ' ' PHE . 59.5 mt -69.74 116.69 11.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.667 -177.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 19.5 tp -105.71 -51.65 2.96 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.283 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.586 ' HB2' ' HB2' ' A' ' 109' ' ' LEU . 3.1 mmmm -139.56 169.65 17.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.091 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 23.2 m -148.88 129.62 14.16 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.767 0.318 . . . . 0.0 110.746 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -126.29 118.49 25.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.771 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.7 p -110.99 139.67 33.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.762 -178.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 73.52 66.71 1.95 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.093 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 65.48 116.21 0.02 OUTLIER Pre-proline 0 N--CA 1.464 0.264 0 C-N-CA 123.45 0.7 . . . . 0.0 111.805 -175.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.75 117.76 3.69 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.181 1.92 . . . . 0.0 111.633 174.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -61.49 105.58 0.54 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -64.49 -31.65 72.96 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -171.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.467 ' HA2' ' CZ ' ' A' ' 130' ' ' TYR . . . -58.86 -54.07 41.01 Favored Glycine 0 C--O 1.238 0.371 0 C-N-CA 120.371 -0.918 . . . . 0.0 111.661 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.57 ' HA ' ' HG2' ' A' ' 131' ' ' GLN . 35.7 mtmm -76.16 -17.95 59.33 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.657 0.265 . . . . 0.0 110.637 177.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.704 HD12 HD21 ' A' ' 109' ' ' LEU . 18.6 tp -69.17 -51.22 40.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.662 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.467 ' CZ ' ' HA2' ' A' ' 127' ' ' GLY . 2.0 p90 -73.94 -33.94 64.12 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 119.579 -0.848 . . . . 0.0 112.249 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.57 ' HG2' ' HA ' ' A' ' 128' ' ' LYS . 3.3 pt20 -68.47 -30.73 69.65 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.79 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -76.12 -45.33 34.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.7 177.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.652 ' HB ' ' HH ' ' A' ' 54' ' ' TYR . 78.0 mt -63.54 -38.88 83.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.628 178.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -56.65 -40.26 75.16 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.01 0.433 . . . . 0.0 110.218 176.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 89.6 m -58.32 -35.28 71.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.657 177.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.198 178.317 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.357 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -148.59 143.85 26.85 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.099 175.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.3 m -149.0 98.33 2.82 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 175.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.525 HD13 ' HD2' ' A' ' 11' ' ' PRO . 25.4 tp -114.39 126.87 27.42 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.196 -175.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.558 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 50.1 Cg_endo -70.17 150.53 65.84 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.388 2.059 . . . . 0.0 112.405 177.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.415 ' CG ' ' H ' ' A' ' 14' ' ' HIS . 0.8 OUTLIER -81.49 -174.26 4.86 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 176.277 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.731 HD13 ' HA ' ' A' ' 75' ' ' ARG . 70.4 mt -69.98 -16.36 63.18 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.415 ' H ' ' CG ' ' A' ' 12' ' ' ASP . 33.7 t-80 -87.98 -42.75 12.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.712 176.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.37 12.07 1.11 Allowed Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.294 177.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 11' ' ' PRO . 66.3 tttt -86.77 116.18 24.7 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 177.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.558 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 8.9 t -69.33 123.54 21.48 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.318 0.58 . . . . 0.0 109.617 175.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.494 ' HB ' ' CE ' ' A' ' 88' ' ' MET . 53.9 t -112.87 126.95 70.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.273 -177.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.409 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 61.0 p -132.32 -176.22 4.01 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.254 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -62.03 -23.29 66.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.072 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.41 ' HA ' ' NE2' ' A' ' 24' ' ' GLN . . . -67.03 -30.63 70.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.948 0.404 . . . . 0.0 110.837 178.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -82.45 -25.03 33.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.043 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.763 HD22 HD13 ' A' ' 62' ' ' LEU . 70.2 mt -83.19 -48.34 10.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.125 -175.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.519 ' HA ' ' H ' ' A' ' 113' ' ' LYS . 10.5 pt20 -51.22 144.31 9.69 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.384 0.611 . . . . 0.0 112.602 -171.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.67 -24.71 22.28 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.298 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.515 ' NZ ' ' HB2' ' A' ' 26' ' ' LYS . 7.7 mtmp? -121.96 171.29 9.05 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 14.1 t -101.9 140.47 20.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -178.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.558 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 17.0 m -131.78 145.65 51.71 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.139 0.495 . . . . 0.0 111.871 -171.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.666 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 6.2 tt -121.98 114.01 20.38 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 172.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.674 ' HB ' ' CG2' ' A' ' 108' ' ' VAL . 36.0 mt -98.54 112.6 31.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -118.21 121.21 39.91 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.569 0.223 . . . . 0.0 110.47 -178.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -92.73 119.77 32.44 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.561 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.48 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 10.5 p-90 -141.73 -176.36 4.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.142 -175.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -168.92 156.64 7.13 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 175.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.592 ' HD3' HG13 ' A' ' 74' ' ' VAL . 33.1 Cg_exo -59.68 158.92 26.2 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.544 2.163 . . . . 0.0 112.326 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 81.6 p 60.77 11.05 2.97 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.031 0.932 . . . . 0.0 112.141 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.727 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 34.6 t -72.96 129.96 85.75 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 177.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.69 -20.73 66.68 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.965 2.443 . . . . 0.0 112.461 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.82 -19.47 61.43 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.755 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.873 ' HA ' ' HG2' ' A' ' 43' ' ' GLU . 93.6 m -63.33 -30.78 71.85 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -174.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.3 m -64.16 -29.07 46.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.111 0.481 . . . . 0.0 110.417 177.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.514 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 29.4 t -88.94 -56.09 3.43 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.21 176.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.873 ' HG2' ' HA ' ' A' ' 40' ' ' CYS . 17.1 pt-20 -64.6 -50.14 68.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.092 -0.503 . . . . 0.0 112.043 -170.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.641 ' O ' HG12 ' A' ' 48' ' ' ILE . 33.5 ttm -57.87 -55.08 48.74 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -167.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 52.7 Cg_exo -53.35 -47.35 27.86 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.899 1.733 . . . . 0.0 112.433 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.514 ' HD3' ' O ' ' A' ' 42' ' ' SER . 23.9 mtpt -64.41 -40.04 95.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.09 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 43' ' ' GLU . 29.6 mm -64.31 -37.65 80.49 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.307 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.9 177.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.641 HG12 ' O ' ' A' ' 44' ' ' MET . 50.4 mm -54.67 -50.6 58.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 121.296 0.569 . . . . 0.0 109.939 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -67.69 -53.62 26.12 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.16 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 14.4 p -62.02 -54.69 38.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.912 -176.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.12 -39.0 91.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.841 -174.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -71.55 -35.36 70.61 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.411 -174.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -77.1 -48.53 17.52 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.299 -0.561 . . . . 0.0 110.463 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.722 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 25.6 m-85 -62.68 -27.77 69.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.801 0.334 . . . . 0.0 110.939 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 59' ' ' PHE . 36.9 ttpt -53.88 -37.4 63.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.797 173.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -89.13 10.04 23.33 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.683 -177.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.23 -66.68 0.96 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.293 0.568 . . . . 0.0 109.689 177.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.482 ' OD1' ' HA ' ' A' ' 26' ' ' LYS . 21.0 t-20 174.25 21.71 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.111 -174.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.722 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 34.0 t80 -122.82 132.09 54.05 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.731 -168.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.501 ' O ' ' HA ' ' A' ' 28' ' ' THR . 4.1 pt20 -121.63 137.64 54.66 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.221 178.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.443 HG23 ' HE1' ' A' ' 59' ' ' PHE . 97.6 t -110.19 124.85 67.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.433 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.763 HD13 HD22 ' A' ' 23' ' ' LEU . 86.9 mt -106.4 95.83 6.03 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.52 177.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.74 97.23 10.78 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.535 ' HA ' ' HB2' ' A' ' 88' ' ' MET . 15.0 t -85.08 110.12 18.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.117 -176.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -87.0 117.17 25.54 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.86 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.517 ' HB2' ' CD ' ' A' ' 67' ' ' PRO . 4.1 pt20 -81.11 -178.01 1.08 Allowed Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.583 ' HD3' ' O ' ' A' ' 90' ' ' ASP . 16.1 Cg_exo -69.0 -135.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 122.25 1.967 . . . . 0.0 112.812 -176.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.553 ' HB ' ' O ' ' A' ' 67' ' ' PRO . 90.7 mt 77.14 -57.65 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -175.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.407 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -104.78 133.64 20.06 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 168.309 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.494 ' O ' HG22 ' A' ' 74' ' ' VAL . 21.6 Cg_exo -65.52 173.31 6.71 Favored 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 122.843 2.362 . . . . 0.0 113.351 -174.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.595 ' HA ' ' CG2' ' A' ' 74' ' ' VAL . 7.1 tp -63.76 -33.01 59.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.726 -170.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.435 ' HA ' ' HD2' ' A' ' 75' ' ' ARG . 0.6 OUTLIER -73.4 -32.85 64.68 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.605 178.782 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 75.2 m -67.42 -51.13 55.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.889 176.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.595 ' CG2' ' HA ' ' A' ' 71' ' ' ILE . 3.1 m -61.45 -42.64 94.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.354 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.731 ' HA ' HD13 ' A' ' 13' ' ' LEU . 4.4 ptm180 -74.46 -34.02 63.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.135 -176.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -71.12 -36.94 72.32 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 110.329 -0.248 . . . . 0.0 110.329 177.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.437 ' CE1' ' HE3' ' A' ' 44' ' ' MET . 3.7 t80 -55.1 -44.05 74.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.276 0.56 . . . . 0.0 109.52 178.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.795 HG13 ' HB2' ' A' ' 83' ' ' LEU . 84.1 t -59.84 -48.76 86.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.742 175.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -75.14 -29.34 60.48 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -173.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -74.29 -46.94 38.03 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.804 0.335 . . . . 0.0 111.222 -176.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -85.77 -10.77 55.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.743 0.306 . . . . 0.0 111.523 -176.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.96 53.65 3.88 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.821 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.795 ' HB2' HG13 ' A' ' 78' ' ' VAL . 9.9 mp -78.74 111.23 17.95 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-O 120.692 0.282 . . . . 0.0 110.508 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -92.73 32.76 0.25 Allowed 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.2 2.6 . . . . 0.0 113.237 -177.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.579 ' HE2' HD11 ' A' ' 48' ' ' ILE . 29.0 p90 -135.64 165.37 25.71 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.9 m -74.51 128.11 34.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.091 0.472 . . . . 0.0 111.277 -175.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.9 t -120.43 137.08 55.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.075 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.535 ' HB2' ' HA ' ' A' ' 64' ' ' VAL . 48.8 mtt -111.47 175.87 5.25 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.328 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.411 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 73.3 t80 -131.83 107.57 8.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.32 175.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.583 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 67.3 t0 -91.51 91.87 8.26 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.76 -35.07 62.58 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -175.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.426 ' O ' ' HB3' ' A' ' 93' ' ' LYS . 3.6 p30 -94.44 -12.49 27.66 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.821 -0.351 . . . . 0.0 111.86 -173.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.437 ' HE3' ' HB3' ' A' ' 93' ' ' LYS . 0.6 OUTLIER 72.39 -10.93 0.86 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 120.989 0.423 . . . . 0.0 111.126 174.514 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.85 -22.64 39.72 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 122.271 -0.268 . . . . 0.0 110.371 -177.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 83.6 t -59.83 -49.76 82.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 172.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -58.99 -32.97 71.97 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.303 174.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 93' ' ' LYS . 43.7 mt-30 -69.71 -34.22 73.59 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 122.801 -0.235 . . . . 0.0 111.12 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.24 -37.44 85.51 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.088 0.47 . . . . 0.0 110.736 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -76.71 -26.98 55.28 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.026 0.441 . . . . 0.0 110.521 176.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.6 44.68 2.08 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.798 174.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.48 ' HA ' HG21 ' A' ' 106' ' ' THR . 29.9 p -69.77 100.77 1.57 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.199 0.523 . . . . 0.0 111.116 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.05 -61.65 1.74 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.457 0.646 . . . . 0.0 109.262 177.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.9 p -139.55 140.84 36.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.576 -177.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -94.8 147.5 33.23 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 -173.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.546 ' HD2' ' HA2' ' A' ' 122' ' ' GLY . 6.4 Cg_exo -73.63 146.44 86.92 Favored 'Cis proline' 0 C--O 1.234 0.321 0 C-N-CA 123.663 -1.39 . . . . 0.0 112.558 0.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.48 HG21 ' HA ' ' A' ' 101' ' ' THR . 19.9 m -115.26 112.24 22.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.18 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.0 m -109.47 112.26 24.26 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.611 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.674 ' CG2' ' HB ' ' A' ' 30' ' ' ILE . 15.3 m -105.75 142.96 17.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.132 0.491 . . . . 0.0 110.71 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.441 HD11 HD21 ' A' ' 129' ' ' LEU . 81.6 mt -101.42 125.81 48.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.288 -176.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.558 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 10.0 mm -114.33 110.04 30.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 O-C-N 124.59 1.181 . . . . 0.0 109.136 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.508 ' O ' ' HG3' ' A' ' 112' ' ' LYS . . . -61.99 -59.29 9.83 Favored Glycine 0 C--O 1.225 -0.414 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.383 -178.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.523 ' O ' ' HB2' ' A' ' 113' ' ' LYS . 19.3 mttt -169.46 166.89 10.13 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 178.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.523 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 28.6 mttt 77.45 -52.12 0.54 Allowed 'General case' 0 C--N 1.323 -0.563 0 O-C-N 123.642 0.588 . . . . 0.0 111.814 176.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 137.49 3.57 2.08 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.247 -177.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.29 144.58 54.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.892 0.377 . . . . 0.0 110.722 -179.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 51.0 mm -90.5 108.02 19.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -178.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 21.6 mt -94.39 -68.24 0.81 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.811 -173.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.427 ' HB3' HD12 ' A' ' 109' ' ' LEU . 21.4 tptm -122.78 148.24 45.6 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.865 -172.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 28.7 m -128.75 107.6 9.8 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.859 0.361 . . . . 0.0 111.046 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.483 ' CE1' ' HB3' ' A' ' 125' ' ' ASP . 51.4 m-85 -104.44 137.39 42.37 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.368 176.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.0 m -118.42 128.99 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-O 120.821 0.343 . . . . 0.0 110.977 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.546 ' HA2' ' HD2' ' A' ' 105' ' ' PRO . . . 79.32 -69.69 2.93 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.756 178.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.412 ' OE1' ' HD2' ' A' ' 124' ' ' PRO . 6.9 tp10 -126.49 114.54 23.1 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.412 ' HD2' ' OE1' ' A' ' 123' ' ' GLU . 56.4 Cg_endo -72.25 122.25 8.21 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.386 2.057 . . . . 0.0 112.366 177.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.582 ' O ' ' HB2' ' A' ' 129' ' ' LEU . 3.7 t0 -61.5 105.2 0.49 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.34 175.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.471 ' HA ' ' CB ' ' A' ' 129' ' ' LEU . 75.6 m-85 -69.26 -21.84 63.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.695 -172.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -63.64 -54.46 31.34 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 119.793 -1.194 . . . . 0.0 111.448 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -81.63 -17.29 48.66 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.633 -0.283 . . . . 0.0 110.907 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.582 ' HB2' ' O ' ' A' ' 125' ' ' ASP . 0.9 OUTLIER -61.42 -49.04 78.48 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 174.584 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -71.61 -40.72 69.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.964 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -61.12 -43.5 98.79 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.319 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -62.39 -47.26 84.94 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.73 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 129' ' ' LEU . 68.0 mt -58.24 -45.13 89.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.097 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -64.54 -38.65 91.75 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.996 0.427 . . . . 0.0 111.005 177.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 87.8 m -60.59 -39.29 87.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.393 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.17 176.331 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.215 0 CA-C-O 121.073 0.463 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -96.18 131.17 42.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.313 0.578 . . . . 0.0 110.907 -176.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.9 m -129.23 90.51 3.03 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 169.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.544 HD12 ' HD2' ' A' ' 11' ' ' PRO . 30.5 tp -114.65 128.53 25.79 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.292 -167.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.645 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 56.1 Cg_endo -73.43 126.61 11.1 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.371 2.047 . . . . 0.0 111.434 170.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.543 ' HA ' ' HG2' ' A' ' 88' ' ' MET . 0.9 OUTLIER -71.91 166.73 21.52 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.913 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 pp -77.71 8.45 4.47 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -171.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.467 ' HD1' ' CG ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -105.08 -17.99 14.3 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 170.41 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.79 23.35 3.69 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 115.445 0.938 . . . . 0.0 115.445 170.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.829 ' HZ1' HG13 ' A' ' 18' ' ' VAL . 48.5 tttm -115.05 126.87 55.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 118.638 1.219 . . . . 0.0 110.712 173.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.645 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 9.6 t -76.51 129.31 36.3 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.075 0.464 . . . . 0.0 109.794 173.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.829 HG13 ' HZ1' ' A' ' 16' ' ' LYS . 28.1 m -116.12 142.74 28.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.547 174.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.5 t -145.47 -173.4 4.11 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -62.9 -22.08 66.48 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.969 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.16 -27.74 68.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.413 176.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -78.78 -22.55 46.18 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.196 0.522 . . . . 0.0 110.181 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 43.4 mt -84.46 -38.49 20.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.8 -174.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -59.77 129.76 43.46 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -171.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.33 -14.03 64.84 Favored Glycine 0 C--N 1.331 0.294 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.986 175.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.456 ' HE3' ' CD ' ' A' ' 60' ' ' GLN . 0.0 OUTLIER -137.17 -178.74 5.34 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 -177.468 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.61 HG12 ' HA ' ' A' ' 59' ' ' PHE . 6.9 p -114.05 149.56 16.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -174.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 61.2 m -148.41 139.39 23.11 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.669 0.271 . . . . 0.0 111.127 -171.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.713 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 43.4 tp -105.73 127.26 52.97 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.358 173.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.402 HD11 HD11 ' A' ' 110' ' ' ILE . 38.3 mt -113.3 112.46 40.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 171.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -112.43 111.06 21.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.485 -175.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.432 ' HB2' ' CG2' ' A' ' 106' ' ' THR . 79.5 m-85 -81.37 119.65 23.96 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 177.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.465 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 4.3 p-90 -150.53 -173.01 4.34 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.455 -176.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -154.85 144.9 15.68 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 170.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.636 ' HD2' ' HB2' ' A' ' 69' ' ' ASP . 57.4 Cg_exo -40.39 -43.49 4.05 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 123.606 2.871 . . . . 0.0 114.886 -175.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.4 p -80.44 16.77 1.22 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -176.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 24.9 m -68.04 132.39 92.04 Favored Pre-proline 0 C--N 1.33 -0.252 0 O-C-N 122.066 -0.396 . . . . 0.0 111.533 178.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 16.4 Cg_exo -68.43 -26.16 34.94 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.034 2.489 . . . . 0.0 112.272 177.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.28 -15.13 72.22 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 121.155 -0.545 . . . . 0.0 113.229 -177.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.751 ' HA ' ' HG2' ' A' ' 44' ' ' MET . 73.1 m -52.99 -36.44 60.38 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -178.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.2 m -64.63 -38.61 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-O 120.695 0.283 . . . . 0.0 111.438 -178.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.401 ' O ' ' HE3' ' A' ' 46' ' ' LYS . 18.7 m -88.37 -55.53 3.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.985 0.421 . . . . 0.0 111.62 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.476 ' O ' HG12 ' A' ' 47' ' ' ILE . 32.7 mt-10 -72.29 -50.1 29.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.324 -170.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.751 ' HG2' ' HA ' ' A' ' 40' ' ' CYS . 20.0 mmt -57.84 -46.78 99.7 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -167.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.75 -43.32 58.52 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 121.746 1.63 . . . . 0.0 112.203 177.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.464 ' HZ3' ' CD ' ' A' ' 123' ' ' GLU . 81.3 mttt -66.52 -33.95 76.83 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.933 178.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.476 HG12 ' O ' ' A' ' 43' ' ' GLU . 41.9 mm -67.58 -38.79 81.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.449 177.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.584 HG12 ' O ' ' A' ' 44' ' ' MET . 49.1 mm -54.55 -53.45 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 120.857 0.361 . . . . 0.0 110.289 178.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.431 ' HE3' ' HB3' ' A' ' 49' ' ' LYS . 14.9 ttpp -55.09 -52.3 63.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.491 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.541 ' O ' ' HD2' ' A' ' 54' ' ' TYR . 17.0 m -67.48 -47.51 69.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.428 -174.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.553 ' HB2' HG21 ' A' ' 61' ' ' VAL . . . -67.5 -28.3 67.72 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.891 -174.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -75.87 -50.17 15.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.833 0.349 . . . . 0.0 111.09 -178.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -64.72 -47.98 76.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.097 -0.502 . . . . 0.0 112.326 -173.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.797 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 96.5 m-85 -77.35 1.79 17.83 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -170.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 37.8 mmtm -56.15 -49.91 72.61 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.286 0.565 . . . . 0.0 110.317 174.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -95.07 21.11 8.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.117 -177.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.62 ' HB2' ' HA ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -113.76 -65.85 1.14 Allowed 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.442 179.42 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 24.1 p30 171.6 -11.93 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.797 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 68.5 t80 -98.68 125.96 44.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.062 0.458 . . . . 0.0 109.876 -174.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.456 ' CD ' ' HE3' ' A' ' 26' ' ' LYS . 27.8 mt-30 -102.19 167.31 10.08 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 121.448 0.642 . . . . 0.0 110.943 -178.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.553 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -148.33 111.43 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.775 -171.806 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.513 HD22 ' HB ' ' A' ' 86' ' ' THR . 78.4 mt -124.22 97.34 5.29 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.585 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.739 ' HB3' HG12 ' A' ' 87' ' ' VAL . . . -86.15 101.79 13.31 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.727 178.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.549 HG11 ' HB2' ' A' ' 90' ' ' ASP . 12.2 t -85.92 108.27 17.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.216 -176.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -85.78 115.93 23.73 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.107 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.626 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 3.9 pt20 -78.29 -174.66 0.47 Allowed Pre-proline 0 C--N 1.315 -0.892 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.626 ' HD2' ' HB2' ' A' ' 66' ' ' GLN . 47.6 Cg_endo -69.33 -146.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 121.552 1.501 . . . . 0.0 112.366 -177.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.558 ' HB ' ' O ' ' A' ' 67' ' ' PRO . 62.8 mt 77.54 -61.1 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -172.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.636 ' HB2' ' HD2' ' A' ' 35' ' ' PRO . 34.2 m-20 -97.1 128.97 33.43 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 171.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.458 ' HD2' ' OG ' ' A' ' 73' ' ' SER . 51.5 Cg_exo -57.14 165.61 5.13 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.667 2.245 . . . . 0.0 112.505 175.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.605 ' O ' ' HG2' ' A' ' 75' ' ' ARG . 6.6 tt -66.52 -29.3 46.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.894 0.378 . . . . 0.0 110.675 -177.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.697 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . 2.1 pm0 -69.65 -28.85 66.24 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 122.112 -0.367 . . . . 0.0 110.666 175.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.458 ' OG ' ' HD2' ' A' ' 70' ' ' PRO . 67.0 m -64.66 -43.85 92.31 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.664 0.268 . . . . 0.0 110.358 175.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 71' ' ' ILE . 13.8 p -71.6 -39.8 70.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.113 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.826 ' HA ' HG22 ' A' ' 78' ' ' VAL . 28.9 ptt180 -75.19 -25.55 58.33 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 122.312 -0.242 . . . . 0.0 111.475 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -70.29 -41.27 73.6 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 169.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -62.17 -47.2 85.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.202 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.826 HG22 ' HA ' ' A' ' 75' ' ' ARG . 33.0 m -67.15 -28.74 43.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.069 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.7 tptp -73.09 -55.78 6.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.373 0.606 . . . . 0.0 111.459 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -65.52 -49.03 70.47 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.896 -171.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -81.05 -19.55 43.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.754 -177.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.07 65.02 2.1 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.904 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.422 HD22 HG11 ' A' ' 78' ' ' VAL . 8.6 mp -84.27 113.51 48.89 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-O 120.695 0.283 . . . . 0.0 110.933 -177.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -81.25 -2.77 11.83 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.879 2.386 . . . . 0.0 113.371 -177.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.478 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 28.4 p90 -99.02 140.28 33.42 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 122.149 -0.344 . . . . 0.0 110.532 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.513 ' HB ' HD22 ' A' ' 62' ' ' LEU . 10.7 m -67.93 137.9 55.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.742 -176.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.739 HG12 ' HB3' ' A' ' 63' ' ' ALA . 10.8 m -122.97 137.19 57.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.398 0.618 . . . . 0.0 111.708 -176.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.543 ' HG2' ' HA ' ' A' ' 12' ' ' ASP . 79.6 mtm -115.95 176.01 5.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.497 -0.774 . . . . 0.0 108.988 175.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -125.34 112.35 16.24 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.216 0.531 . . . . 0.0 111.041 -178.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.701 ' OD2' ' HA ' ' A' ' 93' ' ' LYS . 23.0 t70 -84.63 74.83 10.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.553 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.22 -42.4 62.68 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.476 -174.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -83.02 -12.99 56.74 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.226 -177.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.701 ' HA ' ' OD2' ' A' ' 90' ' ' ASP . 2.6 mtpm? 64.54 -5.2 0.37 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.35 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.22 -32.03 38.56 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -168.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.476 ' O ' ' HD1' ' A' ' 99' ' ' PHE . 31.2 m -66.8 -34.35 69.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.495 174.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -67.56 -34.08 83.05 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.41 172.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.61 ' HG3' ' O ' ' A' ' 93' ' ' LYS . 79.9 mt-30 -63.59 -39.06 93.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.646 -0.277 . . . . 0.0 110.408 175.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.69 -34.11 77.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.052 178.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.476 ' HD1' ' O ' ' A' ' 95' ' ' VAL . 42.2 m-85 -72.31 -24.01 61.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.822 174.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.31 23.17 49.08 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.494 -178.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.521 ' HB ' HG21 ' A' ' 106' ' ' THR . 50.9 p -86.07 110.02 19.24 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.007 0.432 . . . . 0.0 111.064 -176.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -108.66 -24.55 11.29 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.786 177.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.9 t -99.63 131.98 45.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.909 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -128.66 143.39 48.27 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.334 -178.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.419 ' HG2' ' OE1' ' A' ' 43' ' ' GLU . 5.3 Cg_exo -74.78 160.33 96.62 Favored 'Cis proline' 0 C--N 1.346 0.407 0 C-N-CA 123.715 -1.369 . . . . 0.0 112.161 0.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.521 HG21 ' HB ' ' A' ' 101' ' ' THR . 9.8 t -142.46 120.93 12.43 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.712 0.768 . . . . 0.0 111.239 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.512 ' HB3' HD13 ' A' ' 29' ' ' LEU . 25.5 m -95.8 111.97 23.81 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.253 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 55.3 t -105.5 128.48 59.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.261 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.556 HD13 ' HB3' ' A' ' 118' ' ' LYS . 95.3 mt -101.97 122.97 45.07 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.778 -176.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.402 HD11 HD11 ' A' ' 30' ' ' ILE . 41.6 mt -110.61 130.09 64.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.475 178.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -88.31 -158.11 33.08 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.235 -0.983 . . . . 0.0 112.973 -178.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 44.0 mtpt -87.67 -17.98 30.59 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.976 0.893 . . . . 0.0 109.72 -168.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.769 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -81.07 -14.22 58.03 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.416 177.881 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.41 -7.97 79.57 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -173.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -72.21 146.88 47.02 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.165 0.507 . . . . 0.0 110.975 -178.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 47.0 mm -81.12 110.4 16.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.025 178.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.8 mt -90.7 -59.82 2.08 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -170.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.556 ' HB3' HD13 ' A' ' 109' ' ' LEU . 23.6 tptm -133.36 153.19 51.8 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.248 -170.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.3 m -134.59 128.03 32.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.522 177.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.428 ' OH ' ' HB2' ' A' ' 128' ' ' LYS . 80.5 m-85 -116.88 141.47 48.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.83 174.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.6 m -124.86 109.64 22.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.699 0.285 . . . . 0.0 111.304 178.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 68.52 97.66 0.04 OUTLIER Glycine 0 C--N 1.331 0.286 0 C-N-CA 121.174 -0.536 . . . . 0.0 113.07 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.464 ' CD ' ' HZ3' ' A' ' 46' ' ' LYS . 9.0 tp10 66.13 92.92 0.06 OUTLIER Pre-proline 0 C--O 1.235 0.316 0 CA-C-O 121.509 0.671 . . . . 0.0 110.217 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -77.23 141.62 20.74 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.494 2.129 . . . . 0.0 113.019 -176.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.518 ' OD1' ' HG2' ' A' ' 128' ' ' LYS . 10.6 t0 -65.75 96.05 0.27 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.6 174.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.567 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 50.1 m-85 -69.19 -14.36 62.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.867 -178.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -68.36 -50.63 37.14 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.271 -0.966 . . . . 0.0 110.854 174.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.518 ' HG2' ' OD1' ' A' ' 125' ' ' ASP . 31.1 mmtm -77.95 -20.56 52.5 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.567 ' HB3' ' HA ' ' A' ' 126' ' ' PHE . 3.2 tm? -63.59 -47.9 79.56 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 174.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -68.18 -45.65 72.84 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.236 178.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -60.88 -36.47 79.29 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.938 0.348 . . . . 0.0 111.938 178.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -66.63 -51.77 52.5 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 129' ' ' LEU . 67.9 mt -57.27 -43.03 81.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.902 0.382 . . . . 0.0 110.392 176.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -56.7 -40.32 75.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.85 177.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 63.8 m -62.07 -44.07 97.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.316 176.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.191 178.776 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.049 0 CA-C-O 121.394 0.616 . . . . 0.0 110.03 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.492 ' HB2' HG13 ' A' ' 95' ' ' VAL . 13.0 p90 -67.4 148.17 51.94 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.384 -175.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.0 m -142.59 89.79 2.17 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 172.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.748 HD22 ' HE3' ' A' ' 88' ' ' MET . 35.5 tp -115.88 120.59 35.4 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.597 -173.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.572 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 24.3 Cg_exo -64.44 144.43 85.36 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.584 2.189 . . . . 0.0 111.799 176.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.689 ' HA ' ' HA ' ' A' ' 88' ' ' MET . 1.6 p-10 -81.95 -173.21 4.35 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.501 HD23 ' HA ' ' A' ' 89' ' ' TYR . 73.8 mt -87.02 2.27 50.14 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.672 -177.031 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 64.3 t60 -95.69 -40.49 9.36 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 172.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.22 22.76 0.79 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.109 -1.043 . . . . 0.0 114.121 174.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.415 ' HE2' HG23 ' A' ' 18' ' ' VAL . 2.3 ptmt -114.31 134.51 54.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.72 0.76 . . . . 0.0 110.244 175.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.572 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 16.1 m -67.93 121.59 16.37 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.314 177.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.531 ' HB ' ' HE1' ' A' ' 88' ' ' MET . 46.3 t -97.28 128.77 48.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 177.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 63.6 p -129.01 -175.59 3.6 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.874 0.369 . . . . 0.0 111.025 -175.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -68.95 -22.28 64.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.78 177.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.86 -28.95 69.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.736 176.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -67.01 -21.08 65.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.942 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 74.2 mt -80.7 -20.53 42.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.432 -176.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.465 ' HA ' ' OE1' ' A' ' 24' ' ' GLN . 15.9 mm-40 -78.59 138.61 38.44 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.077 0.465 . . . . 0.0 112.137 -172.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.98 3.38 89.18 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.771 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 112' ' ' LYS . 41.1 mtmt -146.75 165.03 30.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.668 0.271 . . . . 0.0 110.527 -177.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.0 t -103.16 138.62 26.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 173.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.599 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 11.1 m -131.93 145.29 51.41 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.63 -0.428 . . . . 0.0 112.126 -168.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.652 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 6.9 tt -119.5 108.75 14.9 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 170.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.8 mt -94.6 111.12 24.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -104.97 125.11 50.61 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.459 -177.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.45 ' CE2' ' HA2' ' A' ' 96' ' ' GLY . 87.0 m-85 -96.26 118.18 32.3 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 9.1 p-90 -144.59 -176.49 5.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.484 -175.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -159.63 151.96 17.46 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.239 176.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.33 155.58 51.06 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.404 2.069 . . . . 0.0 111.887 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.3 m 65.08 16.51 10.6 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.588 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.515 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 42.7 t -84.14 130.76 53.25 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.596 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -61.13 -26.82 83.19 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.7 2.267 . . . . 0.0 111.922 176.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -64.52 -30.02 76.74 Favored Glycine 0 C--O 1.227 -0.303 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.473 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.515 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 83.9 m -58.26 -30.5 66.63 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 122.16 0.184 . . . . 0.0 111.445 -178.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.6 t -61.18 -38.14 79.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.211 0.529 . . . . 0.0 110.157 177.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.446 ' HB3' ' OE2' ' A' ' 123' ' ' GLU . 32.6 m -87.09 -51.28 6.09 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.513 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -70.21 -45.06 67.36 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -171.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.547 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 39.2 tpp -54.72 -51.35 79.58 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -171.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.547 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 57.3 Cg_exo -53.28 -36.44 78.2 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 121.962 1.775 . . . . 0.0 112.47 175.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.62 ' HB3' ' CZ ' ' A' ' 126' ' ' PHE . 30.5 mmtm -65.16 -47.52 76.72 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.238 0.542 . . . . 0.0 109.796 177.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.7 mm -65.5 -38.65 82.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.823 -177.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 44' ' ' MET . 47.2 mm -54.68 -53.34 32.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 120.777 0.322 . . . . 0.0 110.188 177.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.1 tttm -62.16 -57.69 10.58 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.632 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 29.0 m -60.32 -44.82 95.12 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -171.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . -69.31 -36.08 76.62 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.118 -0.233 . . . . 0.0 111.598 -175.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -77.06 -40.35 46.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.158 0.504 . . . . 0.0 110.626 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -55.28 -53.04 61.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.902 -1.045 . . . . 0.0 111.15 -177.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.529 ' CB ' ' HB3' ' A' ' 59' ' ' PHE . 67.1 m-85 -96.88 8.16 45.01 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.465 -175.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -62.25 -52.31 64.24 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.093 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -82.4 66.81 8.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.802 176.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.6 ' HZ1' ' HB2' ' A' ' 57' ' ' LYS . 0.3 OUTLIER -166.94 -75.31 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.597 -173.819 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 6.9 t-20 173.62 7.96 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.203 0.525 . . . . 0.0 110.415 -176.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.652 ' HZ ' ' HB2' ' A' ' 29' ' ' LEU . 41.0 t80 -110.43 135.22 51.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.914 0.388 . . . . 0.0 110.581 -173.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.579 ' HG3' HG22 ' A' ' 28' ' ' THR . 21.4 pt20 -125.75 144.48 50.61 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.725 178.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 97.2 t -113.93 111.52 36.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 97.9 mt -95.03 95.57 8.68 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 177.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -86.6 95.65 9.83 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.555 ' HA ' ' HB2' ' A' ' 88' ' ' MET . 2.4 p -88.08 118.53 33.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.117 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.539 ' O ' ' HA ' ' A' ' 90' ' ' ASP . . . -89.53 162.69 15.56 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.948 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 90' ' ' ASP . 18.6 pt20 -137.54 154.38 75.06 Favored Pre-proline 0 C--N 1.305 -1.358 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 169.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.986 ' HD3' ' HA ' ' A' ' 91' ' ' ALA . 56.2 Cg_endo -59.36 -92.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.038 1.826 . . . . 0.0 113.965 -150.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.3 mm 65.66 -70.34 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -175.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.57 147.23 32.88 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 171.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -52.88 157.66 7.57 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 122.869 2.38 . . . . 0.0 113.902 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.0 tp -53.85 -33.74 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.875 179.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.446 ' CD ' HH21 ' A' ' 75' ' ' ARG . 9.1 tp10 -68.87 -29.59 67.92 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 122.154 -0.341 . . . . 0.0 110.289 178.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.6 m -70.29 -48.65 55.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.951 0.405 . . . . 0.0 110.63 -177.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.1 p -61.43 -32.82 54.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-O 121.929 0.871 . . . . 0.0 109.305 175.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.617 ' HA ' HG22 ' A' ' 78' ' ' VAL . 50.5 ttp180 -75.28 -29.24 60.06 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.592 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -70.41 -41.7 72.62 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 172.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.424 ' CE1' ' HE1' ' A' ' 44' ' ' MET . 2.6 t80 -57.06 -51.28 69.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.285 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.617 HG22 ' HA ' ' A' ' 75' ' ' ARG . 24.2 m -61.59 -36.94 76.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.127 -178.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -75.3 -52.22 11.36 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -58.6 -48.52 80.67 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.165 -170.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -92.58 1.11 57.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.388 -175.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 54.46 60.01 9.24 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.458 -179.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.471 HD21 HG11 ' A' ' 78' ' ' VAL . 10.8 mp -60.87 109.71 2.32 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.867 0.365 . . . . 0.0 111.462 -176.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -85.18 37.82 0.62 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.339 2.693 . . . . 0.0 113.044 -175.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -149.56 159.57 44.2 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.197 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.49 109.34 4.76 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.84 -176.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.2 t -101.96 136.78 32.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.515 177.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.748 ' HE3' HD22 ' A' ' 10' ' ' LEU . 80.1 mtp -111.24 162.17 15.25 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.267 -174.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.625 ' HB3' HD11 ' A' ' 10' ' ' LEU . 12.6 t80 -62.73 141.55 58.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.469 0.652 . . . . 0.0 112.087 -174.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.539 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 5.1 p-10 -56.52 -135.21 0.0 OUTLIER 'General case' 0 C--O 1.217 -0.649 0 CA-C-N 113.659 -1.609 . . . . 0.0 111.56 162.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.986 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . . . -28.66 -6.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 120.583 3.549 . . . . 0.0 120.583 -146.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.589 ' HB3' HD13 ' A' ' 10' ' ' LEU . 37.5 t70 -71.73 38.73 0.07 Allowed 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 120.31 1.414 . . . . 0.0 108.809 163.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.577 ' H ' ' C ' ' A' ' 91' ' ' ALA . 0.0 OUTLIER -58.47 -3.72 0.32 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.194 0.998 . . . . 0.0 112.675 -174.4 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.427 ' H ' ' C ' ' A' ' 92' ' ' ASP . . . -64.63 -23.91 67.41 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 122.77 0.428 . . . . 0.0 111.179 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.492 HG13 ' HB2' ' A' ' 8' ' ' PHE . 35.9 m -60.73 -37.38 75.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.106 0.479 . . . . 0.0 110.099 174.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.45 ' HA2' ' CE2' ' A' ' 32' ' ' PHE . . . -67.87 -32.17 77.01 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 174.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -69.78 -28.84 66.08 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.006 -0.597 . . . . 0.0 110.719 177.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.45 -28.34 61.91 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.074 0.464 . . . . 0.0 110.89 176.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.401 ' HD2' ' O ' ' A' ' 95' ' ' VAL . 50.4 m-85 -79.86 -24.53 41.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.738 173.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.74 -8.02 76.83 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.936 -0.65 . . . . 0.0 111.843 -177.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.559 ' HB ' HG21 ' A' ' 106' ' ' THR . 18.1 p -78.94 91.89 4.86 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.736 0.303 . . . . 0.0 111.396 -177.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -105.82 0.19 25.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.029 0.442 . . . . 0.0 111.311 177.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.5 m -97.95 125.81 51.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.513 173.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -121.28 149.77 52.61 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.526 -172.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -85.31 164.79 58.25 Favored 'Cis proline' 0 C--N 1.343 0.277 0 C-N-CA 123.548 -1.438 . . . . 0.0 112.002 -0.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.559 HG21 ' HB ' ' A' ' 101' ' ' THR . 5.9 t -151.88 142.79 23.03 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.895 -177.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.474 ' HB3' HD23 ' A' ' 29' ' ' LEU . 56.4 m -120.51 122.85 41.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.367 177.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.3 t -105.85 137.13 37.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.331 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.4 HD21 ' N ' ' A' ' 109' ' ' LEU . 2.8 mm? -101.82 122.34 43.79 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.18 -177.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.599 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 8.5 mm -110.13 129.94 64.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.344 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -79.35 -176.47 48.82 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.326 -0.94 . . . . 0.0 111.87 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 16.8 pttm -92.52 43.21 1.12 Allowed 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 122.532 1.158 . . . . 0.0 107.93 -178.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 51.3 mmtt -140.32 -5.77 1.23 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 113.302 -1.772 . . . . 0.0 111.367 -168.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.47 12.66 82.19 Favored Glycine 0 C--O 1.226 -0.371 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.464 -172.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -103.17 147.97 26.36 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 -178.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 51.5 mt -91.97 111.55 24.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -85.11 -61.52 1.75 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.195 -173.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.48 ' HZ3' ' CD ' ' A' ' 132' ' ' GLU . 6.7 mmmm -141.27 167.7 21.55 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -169.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 62.1 m -146.3 105.87 3.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.366 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -102.87 113.16 26.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.577 177.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' A' ' 106' ' ' THR . 22.2 m -88.54 141.0 14.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 120.849 0.357 . . . . 0.0 110.985 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 71.62 -150.93 47.29 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.438 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.446 ' OE2' ' HB3' ' A' ' 42' ' ' SER . 6.3 tp10 -70.2 111.64 9.99 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -84.45 140.08 8.25 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.47 2.114 . . . . 0.0 113.195 -176.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -66.89 102.88 1.02 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.989 173.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.62 ' CZ ' ' HB3' ' A' ' 46' ' ' LYS . 25.3 m-85 -70.32 -19.42 63.08 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -175.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -63.69 -54.08 33.82 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 119.932 -1.128 . . . . 0.0 111.055 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.646 ' HB3' ' HZ3' ' A' ' 128' ' ' LYS . 6.6 ttpm? -79.68 -26.78 40.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.614 -0.293 . . . . 0.0 110.608 177.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.583 ' HB3' ' HA ' ' A' ' 126' ' ' PHE . 41.8 tp -63.18 -47.67 81.62 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.432 178.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -66.34 -47.21 74.23 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.741 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -56.9 -34.17 67.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.99 0.424 . . . . 0.0 111.991 176.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.48 ' CD ' ' HZ3' ' A' ' 118' ' ' LYS . 31.9 tt0 -80.37 -37.96 31.35 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.015 -179.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 129' ' ' LEU . 78.8 mt -65.46 -38.06 81.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.153 0.502 . . . . 0.0 110.002 174.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -67.05 -23.38 65.88 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.686 176.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 87.6 m -67.27 -30.71 70.65 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 172.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.318 174.019 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.351 0 CA-C-O 121.331 0.586 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -106.57 132.76 52.2 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.728 -177.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.7 m -114.9 90.76 3.42 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 172.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.574 HD22 HG21 ' A' ' 95' ' ' VAL . 36.6 tp -102.51 121.23 50.58 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.825 -172.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.54 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 3.9 Cg_exo -80.58 137.2 11.38 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.023 2.482 . . . . 0.0 112.059 176.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.618 ' HB3' ' HB3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -67.99 172.6 5.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.006 175.152 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.6 mt -55.21 -29.64 58.35 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -175.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -102.54 -26.05 13.37 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.453 -176.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.62 16.97 0.43 Allowed Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.073 -1.061 . . . . 0.0 113.917 175.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.618 ' HB3' ' HB3' ' A' ' 12' ' ' ASP . 1.8 tpmt? -81.8 96.85 7.73 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 117.441 0.621 . . . . 0.0 109.84 176.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 23.8 m -86.45 124.33 32.66 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.057 -177.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.5 m -127.16 163.16 30.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.619 179.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 62.1 p -132.17 -173.83 3.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.045 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 29.7 p30 -67.91 -22.19 65.09 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.765 0.317 . . . . 0.0 111.508 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.486 ' HA ' HE21 ' A' ' 24' ' ' GLN . . . -66.92 -27.35 67.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.067 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -70.39 -28.76 65.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.88 0.371 . . . . 0.0 110.25 178.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 45.3 mt -69.72 -20.34 63.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.806 -178.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.678 ' HG2' ' HA ' ' A' ' 113' ' ' LYS . 50.6 mt-30 -73.22 132.88 43.71 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.163 -174.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.66 -25.31 19.43 Favored Glycine 0 N--CA 1.452 -0.282 0 CA-C-N 115.954 -0.567 . . . . 0.0 113.167 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 112' ' ' LYS . 52.0 mtmt -108.25 -175.08 2.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.923 0.392 . . . . 0.0 110.675 -178.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 8.3 t -127.53 141.45 46.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 173.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.544 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 85.5 m -145.58 145.31 30.94 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.121 0.486 . . . . 0.0 111.995 -169.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.57 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 27.9 tp -114.15 112.99 24.08 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.129 170.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.662 ' HB ' ' CG1' ' A' ' 108' ' ' VAL . 41.6 mt -97.28 112.52 29.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 176.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.418 ' HA ' ' O ' ' A' ' 106' ' ' THR . 46.6 t30 -114.39 114.48 25.93 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.099 -177.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.432 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 92.5 m-85 -83.74 123.76 30.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.172 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.549 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 6.1 p-90 -143.93 -177.57 5.5 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.398 0.618 . . . . 0.0 111.321 -173.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -162.67 153.4 14.34 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.848 174.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -63.27 158.08 46.51 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.157 1.905 . . . . 0.0 111.472 175.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.8 m 65.7 14.38 9.49 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 123.465 0.478 . . . . 0.0 111.42 -177.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 29.9 t -84.98 133.88 42.36 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.594 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.8 -22.49 68.29 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 122.523 2.149 . . . . 0.0 111.967 176.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.61 -12.13 75.86 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.287 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 21.6 p -69.19 -45.72 69.25 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 117.85 0.825 . . . . 0.0 110.53 -177.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.6 p -65.06 -25.57 37.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.123 0.487 . . . . 0.0 110.593 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.7 m -86.7 -49.51 7.43 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.684 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.485 ' CD ' ' HZ1' ' A' ' 46' ' ' LYS . 22.2 mm-40 -85.13 -41.48 15.66 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -172.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.503 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 47.2 tpp -51.48 -50.2 78.03 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -171.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 44' ' ' MET . 9.8 Cg_endo -51.88 -44.77 42.85 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 122.285 1.99 . . . . 0.0 112.603 177.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.485 ' HZ1' ' CD ' ' A' ' 43' ' ' GLU . 8.0 mppt? -68.79 -40.12 79.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.722 178.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.0 mm -60.45 -43.53 94.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.699 178.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.608 HD13 ' HE1' ' A' ' 85' ' ' PHE . 43.9 mm -55.78 -52.99 42.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.775 178.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.53 -46.52 85.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.886 0.374 . . . . 0.0 110.622 -177.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 29.2 m -65.99 -51.59 57.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.552 -175.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.551 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . -67.86 -36.31 80.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.834 -174.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -74.03 -29.83 62.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.043 0.449 . . . . 0.0 110.592 -177.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -74.49 -50.4 18.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.152 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 1.03 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 66.4 m-85 -80.59 -10.08 59.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.933 -175.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.551 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 22.1 tptm -58.41 -33.27 69.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.194 0.521 . . . . 0.0 110.401 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 44.3 m-20 -95.06 20.86 8.44 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.643 -176.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.69 ' HE3' ' HA ' ' A' ' 54' ' ' TYR . 33.1 mtmt -125.98 -63.27 1.12 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.477 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 172.33 -13.29 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 O-C-N 123.322 0.389 . . . . 0.0 111.37 -172.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 1.03 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 56.7 t80 -100.72 122.78 43.93 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.093 0.473 . . . . 0.0 110.356 -177.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.462 HE21 HD12 ' A' ' 62' ' ' LEU . 12.7 pt20 -122.75 154.92 37.51 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.666 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.531 HG22 ' HB3' ' A' ' 29' ' ' LEU . 94.2 t -115.27 128.66 72.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.267 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.462 HD12 HE21 ' A' ' 60' ' ' GLN . 11.0 mp -108.12 109.26 20.64 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.542 177.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.45 98.35 10.81 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.169 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 51.3 t -91.79 116.16 32.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.331 -177.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -96.56 126.53 41.8 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.481 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.567 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 4.7 pm0 -96.0 161.5 27.08 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.657 ' HD3' ' O ' ' A' ' 90' ' ' ASP . 53.0 Cg_endo -70.43 84.95 0.73 Allowed 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.296 1.997 . . . . 0.0 113.515 -171.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 48.2 mm -115.7 -44.94 3.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 172.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.59 ' OD1' ' HD2' ' A' ' 70' ' ' PRO . 0.7 OUTLIER -116.8 141.99 29.05 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 172.595 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.59 ' HD2' ' OD1' ' A' ' 69' ' ' ASP . 61.2 Cg_exo -42.1 155.27 0.1 OUTLIER 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.676 2.917 . . . . 0.0 114.438 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.58 HG22 ' OE1' ' A' ' 72' ' ' GLU . 3.3 tp -58.7 -36.79 62.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.026 -176.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.594 ' HA ' ' CG ' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -59.4 -39.32 83.03 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.534 176.125 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.8 m -58.15 -42.44 85.95 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.304 0.573 . . . . 0.0 109.974 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.2 t -67.72 -52.2 42.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.016 178.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.594 ' CG ' ' HA ' ' A' ' 72' ' ' GLU . 16.0 ptt180 -68.3 -33.46 74.38 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -174.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -65.61 -42.04 92.03 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 178.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -56.36 -47.82 78.06 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.971 178.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.574 HG23 HD21 ' A' ' 83' ' ' LEU . 41.2 t -63.1 -53.0 51.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.328 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 75' ' ' ARG . 95.6 mttt -63.01 -36.61 84.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.726 0.298 . . . . 0.0 111.669 -175.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -75.07 -48.29 24.65 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -176.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -98.48 7.37 46.26 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -173.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.5 -70.09 2.66 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.949 -0.644 . . . . 0.0 112.743 175.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.574 HD21 HG23 ' A' ' 78' ' ' VAL . 10.3 mp 52.25 84.72 0.2 Allowed Pre-proline 0 N--CA 1.468 0.472 0 C-N-CA 122.959 0.504 . . . . 0.0 111.732 -178.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -76.92 16.52 0.95 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.365 2.71 . . . . 0.0 113.563 -176.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.608 ' HE1' HD13 ' A' ' 48' ' ' ILE . 23.1 p90 -117.73 159.4 23.06 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.4 m -74.76 112.08 10.61 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.342 0.591 . . . . 0.0 111.081 -174.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.7 t -99.64 136.74 29.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.831 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.557 ' HG2' ' HA ' ' A' ' 12' ' ' ASP . 62.5 mtt -131.23 166.45 21.14 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.415 -176.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -130.07 117.06 19.42 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.099 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.657 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 67.2 t0 -103.28 108.05 19.12 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 179.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.4 -21.95 59.4 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -176.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.521 ' OD2' ' HB3' ' A' ' 94' ' ' ALA . 28.3 t70 -106.44 -11.43 15.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.08 0.467 . . . . 0.0 110.691 -174.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.401 ' O ' ' HG2' ' A' ' 97' ' ' GLN . 17.4 ttpp 65.85 17.7 10.91 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.496 -177.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.521 ' HB3' ' OD2' ' A' ' 92' ' ' ASP . . . -67.92 -31.95 72.07 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.418 -174.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.574 HG21 HD22 ' A' ' 10' ' ' LEU . 46.8 t -67.92 -42.6 85.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 177.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.79 -33.99 87.47 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.538 175.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.401 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 15.0 mm100 -64.6 -42.81 95.31 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 122.607 0.363 . . . . 0.0 111.494 177.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.94 -47.18 66.31 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.331 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.504 ' HA ' HD13 ' A' ' 116' ' ' ILE . 36.9 m-85 -72.24 -27.21 62.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.735 -177.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.37 55.21 1.72 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.605 176.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 20.1 p -68.99 104.75 2.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.942 0.401 . . . . 0.0 111.57 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 48.4 tp60 -69.45 -58.32 4.13 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.533 0.682 . . . . 0.0 110.108 178.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.4 p -148.36 143.37 19.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.271 -176.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -94.57 141.9 24.06 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.715 -175.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.56 151.42 97.01 Favored 'Cis proline' 0 C--N 1.346 0.405 0 C-N-CA 123.385 -1.506 . . . . 0.0 113.18 0.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 26.3 m -119.54 116.08 25.32 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.884 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.507 ' HB2' HD12 ' A' ' 29' ' ' LEU . 4.3 p -105.56 111.84 24.7 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.085 0.469 . . . . 0.0 111.035 -177.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.662 ' CG1' ' HB ' ' A' ' 30' ' ' ILE . 11.7 p -106.68 143.25 17.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.053 0.454 . . . . 0.0 110.455 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.586 ' HB2' ' HB3' ' A' ' 118' ' ' LYS . 96.3 mt -100.98 121.43 41.75 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.123 -178.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.585 HG21 ' HA2' ' A' ' 114' ' ' GLY . 43.2 mm -102.49 127.29 56.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.303 -176.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -85.64 -168.27 44.51 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.98 177.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.444 ' HE3' ' HB2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -76.69 44.97 0.39 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 117.038 0.419 . . . . 0.0 111.779 -178.495 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.678 ' HA ' ' HG2' ' A' ' 24' ' ' GLN . 64.4 tttm 177.31 -29.63 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -178.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.585 ' HA2' HG21 ' A' ' 110' ' ' ILE . . . 115.62 -87.04 0.43 Allowed Glycine 0 N--CA 1.437 -1.285 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.832 177.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 55.68 2.79 0.07 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.545 1.138 . . . . 0.0 113.56 178.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.504 HD13 ' HA ' ' A' ' 99' ' ' PHE . 4.8 mt 49.54 77.27 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 121.574 0.702 . . . . 0.0 109.934 -174.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.8 mt -77.15 -73.62 0.29 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.435 -171.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.586 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 21.7 tptm -119.21 149.2 42.15 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.678 -170.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 31.5 m -134.19 118.69 17.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.023 0.439 . . . . 0.0 111.348 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -109.55 145.66 35.97 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.393 175.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.2 m -105.21 121.39 57.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.543 176.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.76 -126.48 8.47 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.466 -0.874 . . . . 0.0 111.649 -177.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -87.07 119.06 70.83 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.678 0.275 . . . . 0.0 111.074 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -77.37 121.62 5.73 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.42 2.08 . . . . 0.0 111.091 172.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -60.73 112.0 1.85 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.3 0.571 . . . . 0.0 110.304 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.53 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 81.3 m-85 -59.47 -29.64 67.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.317 -0.856 . . . . 0.0 113.024 -171.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -57.05 -53.93 40.78 Favored Glycine 0 C--O 1.237 0.289 0 C-N-CA 120.156 -1.021 . . . . 0.0 112.081 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.775 ' HB3' ' HZ3' ' A' ' 128' ' ' LYS . 5.9 ttpm? -80.18 -28.22 38.78 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.53 ' HB3' ' HA ' ' A' ' 126' ' ' PHE . 48.7 tp -61.15 -47.58 85.53 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 177.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -62.45 -48.84 77.86 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.369 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.584 ' HG2' ' HA ' ' A' ' 128' ' ' LYS . 4.2 pt20 -68.47 -31.4 70.66 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.494 -178.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -71.79 -39.14 70.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.73 0.3 . . . . 0.0 110.338 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 80.4 mt -67.82 -39.37 81.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 173.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -63.56 -27.9 69.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.47 176.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 88.1 m -64.16 -45.73 87.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.335 -0.393 . . . . 0.0 109.96 174.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.171 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.29 176.303 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.516 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -66.02 137.99 57.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.884 -178.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.8 m -143.69 94.48 2.6 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.195 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 1.5 pt? -119.96 156.48 54.33 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-O 120.555 0.217 . . . . 0.0 110.581 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.599 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 3.7 Cg_exo -77.37 144.48 23.02 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 123.046 2.497 . . . . 0.0 112.416 178.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 2.3 p30 -95.7 -176.88 3.87 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 175.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.567 HD11 HG13 ' A' ' 74' ' ' VAL . 63.2 mt -60.33 -20.75 60.51 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -173.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -76.77 -11.39 59.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.821 0.343 . . . . 0.0 110.771 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.7 16.55 58.19 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.839 -0.695 . . . . 0.0 112.377 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 11' ' ' PRO . 21.0 pttp -114.84 151.23 34.25 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 177.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.599 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 23.6 m -93.57 123.63 37.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.015 0.436 . . . . 0.0 112.083 -174.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.4 m -97.81 153.65 3.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 173.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.2 p -141.01 -178.5 5.59 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.198 0.523 . . . . 0.0 111.326 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.458 ' N ' HD21 ' A' ' 20' ' ' ASN . 0.9 OUTLIER -68.54 -22.0 64.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.583 177.639 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.48 -31.75 72.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.051 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -70.69 -20.82 62.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.016 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.566 HD12 HG22 ' A' ' 110' ' ' ILE . 24.6 mt -83.26 -22.04 33.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.126 -174.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -62.92 144.37 56.82 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.631 -173.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.67 -25.24 4.02 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.791 -0.641 . . . . 0.0 113.847 173.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -121.26 -176.01 3.19 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 122.412 -0.464 . . . . 0.0 110.626 -174.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.2 t -108.46 141.89 22.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 175.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.573 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 33.1 m -133.93 137.98 45.21 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.83 0.347 . . . . 0.0 111.281 -174.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.516 HD12 ' HB2' ' A' ' 107' ' ' SER . 52.3 tp -109.63 107.51 17.59 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.23 175.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.662 ' HB ' ' CG2' ' A' ' 108' ' ' VAL . 50.6 mt -93.74 112.41 26.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 172.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -119.82 124.22 45.59 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.872 0.368 . . . . 0.0 110.862 -176.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -90.47 125.43 35.58 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.827 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.543 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 10.5 p-90 -146.17 -174.06 4.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.057 -178.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -156.92 146.57 15.39 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 172.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.404 ' HG3' ' HA ' ' A' ' 74' ' ' VAL . 78.3 Cg_exo -43.96 -59.17 1.15 Allowed 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 123.781 2.988 . . . . 0.0 114.744 -175.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.3 t -83.44 24.78 0.8 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.99 0.424 . . . . 0.0 111.322 -173.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 54.0 t -75.62 132.84 74.49 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.346 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -61.88 -19.01 64.17 Favored 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 122.662 2.242 . . . . 0.0 112.022 176.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.97 -10.98 84.08 Favored Glycine 0 C--O 1.224 -0.521 0 C-N-CA 121.226 -0.511 . . . . 0.0 112.99 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 25.4 p -58.12 -39.37 78.51 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 117.213 0.506 . . . . 0.0 111.648 -175.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.1 p -62.24 -34.42 63.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.855 0.36 . . . . 0.0 110.929 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.8 m -88.03 -54.72 4.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.052 0.453 . . . . 0.0 111.03 178.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -66.27 -50.14 64.75 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -172.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.717 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 49.6 tpp -53.3 -55.53 33.48 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -168.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.717 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 24.5 Cg_exo -64.51 -36.02 45.62 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 121.822 1.682 . . . . 0.0 112.264 178.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -64.36 -40.06 95.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.577 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 30.5 mm -60.87 -46.68 95.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.699 177.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 49.2 mm -55.66 -53.32 38.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.43 -177.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -69.37 -43.11 74.21 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.606 -174.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.3 m -65.26 -44.92 86.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.994 0.426 . . . . 0.0 110.921 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.476 ' HB1' HG21 ' A' ' 61' ' ' VAL . . . -65.65 -42.84 90.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.806 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -56.26 -40.05 73.59 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.51 -178.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -68.38 -51.14 47.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.341 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 1.017 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 60.5 m-85 -74.8 -28.99 60.95 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -174.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -59.44 -27.02 65.69 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 122.479 0.312 . . . . 0.0 111.61 -177.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -73.92 -22.51 59.66 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -172.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 1.017 ' HE2' ' HA ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -95.78 -62.08 1.35 Allowed 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.625 176.121 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 176.96 68.46 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.806 0.813 . . . . 0.0 111.303 -173.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.494 ' HZ ' ' HB2' ' A' ' 29' ' ' LEU . 41.2 t80 -135.83 132.43 36.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.287 -178.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -105.89 143.07 34.55 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.476 HG21 ' HB1' ' A' ' 51' ' ' ALA . 43.7 t -122.8 115.38 45.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.087 -177.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.444 HD22 ' HE3' ' A' ' 88' ' ' MET . 88.5 mt -116.69 95.91 5.25 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.335 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.07 105.46 17.83 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.494 HG21 ' HE1' ' A' ' 88' ' ' MET . 43.0 t -98.94 114.09 35.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 120.969 0.414 . . . . 0.0 110.564 -175.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.543 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -82.71 117.57 22.73 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.723 176.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.6 ' HG3' HG12 ' A' ' 68' ' ' ILE . 3.5 pt20 -74.1 163.43 68.39 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.965 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.585 ' HD2' ' HB2' ' A' ' 66' ' ' GLN . 72.1 Cg_endo -74.91 55.09 3.79 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.735 2.29 . . . . 0.0 114.035 -172.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.6 HG12 ' HG3' ' A' ' 66' ' ' GLN . 50.0 mm -93.12 -69.99 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 172.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -81.74 153.55 70.37 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.779 176.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -61.26 157.26 41.05 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.479 2.119 . . . . 0.0 112.33 177.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.0 tp -57.26 -31.3 37.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.917 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -64.54 -42.92 95.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.532 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.3 m -63.27 -34.76 78.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.814 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.567 HG13 HD11 ' A' ' 13' ' ' LEU . 34.8 t -64.13 -44.92 97.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.17 176.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -65.53 -34.62 78.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.651 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -62.48 -41.78 99.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.888 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.88 -43.1 97.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.751 -0.204 . . . . 0.0 110.863 178.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.541 ' HA ' HD12 ' A' ' 83' ' ' LEU . 42.1 t -63.16 -37.44 79.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.156 0.503 . . . . 0.0 110.345 176.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.0 tttm -61.97 -55.25 31.32 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.655 0.74 . . . . 0.0 111.141 176.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.03 -39.39 69.16 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.539 -1.21 . . . . 0.0 113.204 -173.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -104.99 0.76 28.02 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -174.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.05 -82.25 1.68 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.192 177.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.541 HD12 ' HA ' ' A' ' 78' ' ' VAL . 54.6 mt 61.59 93.33 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.417 0.627 . . . . 0.0 112.523 171.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -87.33 2.36 6.84 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 123.11 2.54 . . . . 0.0 113.667 -177.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -90.91 166.02 13.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.636 0.255 . . . . 0.0 110.625 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 20.2 m -77.04 113.52 14.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.069 0.462 . . . . 0.0 110.908 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.4 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 14.8 t -107.67 125.49 64.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.599 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.494 ' HE1' HG21 ' A' ' 64' ' ' VAL . 72.4 mtm -116.67 173.09 6.82 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.149 177.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -132.04 122.55 25.66 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.865 0.364 . . . . 0.0 110.245 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.511 ' HB3' ' HA ' ' A' ' 66' ' ' GLN . 45.8 t0 -82.81 119.23 24.1 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 176.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.74 -42.44 61.12 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -171.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -126.89 15.26 7.43 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.527 0.203 . . . . 0.0 111.124 -174.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.629 ' HZ2' ' HB3' ' A' ' 93' ' ' LYS . 5.9 ttpm? 68.35 20.34 8.68 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.544 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -77.23 -25.65 51.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.967 -174.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 41.0 t -74.82 -40.47 46.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.93 -38.9 96.07 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.485 173.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -68.72 -26.48 65.28 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 122.546 0.338 . . . . 0.0 111.173 176.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.94 -47.03 72.91 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.832 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -82.89 -26.9 31.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.484 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 95.64 55.4 1.33 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.404 178.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.422 HG21 HG22 ' A' ' 106' ' ' THR . 21.3 p -63.31 112.14 2.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.085 0.469 . . . . 0.0 111.71 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -77.52 -58.16 3.42 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.014 177.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.459 HG13 ' HB ' ' A' ' 121' ' ' VAL . 7.8 p -145.71 147.44 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.656 -175.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.462 ' HA ' ' C ' ' A' ' 105' ' ' PRO . 76.5 m-85 -102.54 147.44 34.02 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.036 -174.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.462 ' C ' ' HA ' ' A' ' 104' ' ' TYR . 38.1 Cg_endo -70.06 154.45 94.07 Favored 'Cis proline' 0 C--N 1.346 0.436 0 C-N-CA 123.305 -1.54 . . . . 0.0 112.838 0.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.422 HG22 HG21 ' A' ' 101' ' ' THR . 24.7 m -121.7 112.45 18.42 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.163 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.516 ' HB2' HD12 ' A' ' 29' ' ' LEU . 5.4 p -110.49 114.18 27.4 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.271 0.558 . . . . 0.0 111.176 -177.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.662 ' CG2' ' HB ' ' A' ' 30' ' ' ILE . 17.2 m -105.74 142.33 19.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.058 0.456 . . . . 0.0 110.737 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 118' ' ' LYS . 81.5 mt -102.35 125.36 49.04 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.715 -177.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.573 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 12.1 mm -103.95 137.18 33.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.717 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -86.85 -167.6 43.91 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.274 -177.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.8 mttm -86.97 34.44 0.67 Allowed 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 122.003 0.906 . . . . 0.0 108.967 -175.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.499 ' HB3' ' OE1' ' A' ' 115' ' ' GLU . 29.0 mmtm -148.59 -35.46 0.2 Allowed 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 114.206 -1.361 . . . . 0.0 110.846 -165.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 113.65 -28.7 8.35 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -174.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.499 ' OE1' ' HB3' ' A' ' 113' ' ' LYS . 1.2 mp0 -54.61 141.23 32.48 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 114.89 -0.655 . . . . 0.0 110.944 176.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 6.7 mt -80.19 122.96 36.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.592 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.6 mt -98.88 -60.53 1.52 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.048 0.451 . . . . 0.0 111.466 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.525 ' HB2' ' HB2' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -124.95 159.22 31.71 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.989 -170.542 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 57.9 m -141.13 103.58 4.48 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.414 170.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -92.46 131.87 37.25 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.4 176.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.459 ' HB ' HG13 ' A' ' 103' ' ' VAL . 6.0 m -101.22 116.04 44.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.906 178.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 83.48 -106.82 2.86 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.191 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -89.68 114.11 59.35 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-O 120.524 0.202 . . . . 0.0 110.783 -176.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.24 98.34 0.92 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.375 2.05 . . . . 0.0 111.85 175.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -49.67 111.97 0.58 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.92 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -66.73 -34.11 77.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.179 -175.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -60.12 -52.18 54.32 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.597 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.556 ' HA ' ' HG2' ' A' ' 131' ' ' GLN . 25.9 mtmm -76.86 -24.31 52.65 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.678 -0.261 . . . . 0.0 110.837 178.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.443 ' O ' HG13 ' A' ' 133' ' ' ILE . 53.5 tp -62.48 -48.76 78.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.913 0.387 . . . . 0.0 110.087 175.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -63.3 -46.22 87.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.412 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.556 ' HG2' ' HA ' ' A' ' 128' ' ' LYS . 13.5 pt20 -70.93 -34.13 71.2 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.418 -176.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.4 ' O ' ' HB ' ' A' ' 135' ' ' THR . 20.3 tt0 -78.96 -31.88 45.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.57 0.224 . . . . 0.0 110.746 -177.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 129' ' ' LEU . 59.0 mt -61.28 -47.52 93.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 172.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -60.14 -32.98 71.54 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.594 175.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.4 ' HB ' ' O ' ' A' ' 132' ' ' GLU . 69.9 m -57.25 -52.06 66.86 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.856 0.36 . . . . 0.0 110.459 177.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 121.32 0.581 . . . . 0.0 110.616 178.182 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.235 0 CA-C-O 120.909 0.385 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -114.33 140.95 48.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.222 0.534 . . . . 0.0 111.005 -176.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.5 t -139.7 90.22 2.38 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 173.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.513 ' O ' HG11 ' A' ' 18' ' ' VAL . 1.8 tm? -116.9 119.83 34.76 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.261 -166.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.574 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 40.0 Cg_endo -68.41 128.48 17.37 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.749 2.299 . . . . 0.0 112.213 176.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.537 ' HA ' ' HG3' ' A' ' 88' ' ' MET . 0.0 OUTLIER -62.67 164.91 7.05 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.416 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 87' ' ' VAL . 4.2 pp -66.3 -18.22 65.22 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.668 -172.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 16.6 t-80 -84.7 -25.95 28.03 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.926 0.393 . . . . 0.0 110.373 176.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.459 ' C ' ' HE2' ' A' ' 16' ' ' LYS . . . 123.6 8.54 6.28 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.572 -0.823 . . . . 0.0 113.735 174.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.459 ' HE2' ' C ' ' A' ' 15' ' ' GLY . 0.8 OUTLIER -94.55 120.31 34.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 117.378 0.589 . . . . 0.0 110.612 179.147 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.574 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 10.3 m -67.28 126.09 28.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.448 -177.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.543 HG13 ' HE3' ' A' ' 88' ' ' MET . 1.7 p -116.55 135.31 57.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 177.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.5 m -146.54 -173.08 4.11 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 122.11 -0.369 . . . . 0.0 111.303 -177.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -54.81 -39.66 68.73 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -176.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.04 -27.21 66.74 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -177.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -73.2 -25.93 60.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.021 0.438 . . . . 0.0 110.515 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.564 HD23 HG22 ' A' ' 28' ' ' THR . 33.5 mt -83.39 -51.7 7.16 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.087 -176.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -56.11 130.92 46.09 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.367 -172.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.76 -25.15 28.45 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.104 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.721 ' HZ2' ' HB3' ' A' ' 26' ' ' LYS . 8.1 mtpm? -124.49 172.97 8.77 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -177.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.1 t -103.82 139.71 24.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 176.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.792 HG21 HD11 ' A' ' 62' ' ' LEU . 85.2 m -126.73 139.14 53.36 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -168.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.705 ' HB2' ' CE2' ' A' ' 59' ' ' PHE . 27.0 tp -110.02 107.37 17.23 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.74 172.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 28.6 mt -98.62 111.35 28.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.316 173.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -109.29 122.84 48.22 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.106 -177.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.416 ' CE1' ' HA2' ' A' ' 96' ' ' GLY . 97.2 m-85 -91.15 118.93 30.84 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.86 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.652 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 10.6 p-90 -148.5 -178.86 6.56 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.829 -177.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.537 ' O ' ' HB2' ' A' ' 37' ' ' CYS . 41.0 p90 -155.09 144.84 15.49 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 178.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.796 ' HG2' ' HB3' ' A' ' 69' ' ' ASP . 12.4 Cg_endo -59.71 152.03 65.98 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.168 1.912 . . . . 0.0 111.433 174.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.9 m 68.89 18.81 8.46 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 123.529 0.518 . . . . 0.0 111.091 -177.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.537 ' HB2' ' O ' ' A' ' 34' ' ' PHE . 45.1 t -68.33 140.45 92.8 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.452 -178.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -72.61 -22.96 20.27 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.821 2.347 . . . . 0.0 111.893 173.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.3 -1.21 88.08 Favored Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.923 -0.581 . . . . 0.0 113.147 -176.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.424 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 90.9 m -56.92 -30.4 63.94 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.876 0.338 . . . . 0.0 111.672 -177.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.4 t -49.97 -50.11 19.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.081 0.467 . . . . 0.0 110.641 177.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.4 m -87.2 -54.87 4.08 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.05 177.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.477 ' HA ' ' HD3' ' A' ' 46' ' ' LYS . 49.3 mm-40 -59.79 -40.85 89.7 Favored 'General case' 0 C--O 1.226 -0.139 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -168.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.808 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -59.12 -60.86 9.17 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -169.667 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.808 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 19.5 Cg_exo -67.11 -29.48 39.77 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 121.958 1.772 . . . . 0.0 111.488 178.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.477 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 64.8 tttt -59.79 -42.91 94.42 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.09 177.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 43' ' ' GLU . 41.0 mm -71.63 -38.95 68.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.352 177.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.721 HD13 ' HE2' ' A' ' 85' ' ' PHE . 47.6 mm -55.46 -53.63 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.2 -179.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -66.03 -49.33 68.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.287 -178.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 31.6 m -61.8 -54.67 39.12 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.782 -174.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.52 -33.59 73.03 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -173.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -75.79 -40.48 55.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.816 0.341 . . . . 0.0 111.173 -178.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -70.93 -42.99 69.12 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.844 0.354 . . . . 0.0 110.769 -176.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.594 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 42.8 m-85 -76.06 -10.32 59.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.714 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -56.71 -27.65 59.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.041 0.448 . . . . 0.0 110.954 -178.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -102.89 14.81 31.04 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.519 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.562 ' HD3' ' HA ' ' A' ' 54' ' ' TYR . 13.6 mptt -111.62 23.49 13.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.755 176.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.585 ' OD1' ' HG2' ' A' ' 26' ' ' LYS . 66.2 t30 68.11 18.46 9.37 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 122.078 0.942 . . . . 0.0 109.795 -176.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.705 ' CE2' ' HB2' ' A' ' 29' ' ' LEU . 38.5 t80 -100.03 162.01 13.25 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.557 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -150.42 152.55 34.5 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.248 0.547 . . . . 0.0 112.064 -177.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 1.014 HG12 ' HB3' ' A' ' 85' ' ' PHE . 1.5 p -101.08 125.88 54.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 114.816 -1.083 . . . . 0.0 111.119 -178.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.792 HD11 HG21 ' A' ' 28' ' ' THR . 8.7 mp -128.63 94.31 3.83 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 169.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -101.05 102.01 12.9 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.546 -176.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.964 HG13 ' HB2' ' A' ' 88' ' ' MET . 26.7 m -97.08 127.47 49.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.441 0.638 . . . . 0.0 111.118 -176.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.652 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -95.2 135.83 36.28 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.676 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.654 ' HB2' ' HG2' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -95.2 161.47 28.0 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 175.231 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.588 ' HD3' ' O ' ' A' ' 90' ' ' ASP . 73.8 Cg_endo -74.04 54.03 3.05 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.903 2.402 . . . . 0.0 114.555 -168.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 45.7 mm -83.27 -27.85 7.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 170.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.796 ' HB3' ' HG2' ' A' ' 35' ' ' PRO . 0.6 OUTLIER -138.89 136.17 18.24 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 173.44 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 69' ' ' ASP . 73.0 Cg_exo -51.83 163.98 1.18 Allowed 'Trans proline' 0 N--CA 1.477 0.553 0 C-N-CA 123.509 2.806 . . . . 0.0 114.587 -175.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.8 tp -56.73 -34.92 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.574 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -66.47 -35.47 80.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.195 0.522 . . . . 0.0 110.419 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 27.3 m -64.89 -47.69 76.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.306 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.483 ' HB ' ' HG3' ' A' ' 35' ' ' PRO . 9.2 p -67.18 -33.95 66.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.652 0.263 . . . . 0.0 110.814 -178.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -65.89 -37.54 86.39 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.005 0.431 . . . . 0.0 110.993 176.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -69.76 -36.55 75.89 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -64.2 -50.75 66.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.979 -178.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.599 HG23 ' HB2' ' A' ' 83' ' ' LEU . 10.4 p -60.5 -30.21 46.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-O 120.754 0.312 . . . . 0.0 110.643 178.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -70.67 -55.37 8.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.239 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -66.25 -48.38 70.7 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.117 -174.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -82.55 -18.41 41.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.441 -176.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 69.08 63.74 3.31 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.98 177.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.599 ' HB2' HG23 ' A' ' 78' ' ' VAL . 8.4 mp -87.64 111.03 39.21 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 120.633 0.254 . . . . 0.0 110.383 178.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -89.98 24.54 0.62 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.899 2.399 . . . . 0.0 113.168 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 1.014 ' HB3' HG12 ' A' ' 61' ' ' VAL . 13.0 m-85 -121.15 155.28 34.85 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.1 m -68.2 123.56 21.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.1 0.476 . . . . 0.0 111.86 -173.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.449 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 48.7 t -122.62 135.19 63.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.822 -178.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.964 ' HB2' HG13 ' A' ' 64' ' ' VAL . 2.3 mpt? -117.13 175.5 5.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 93.6 t80 -138.51 117.18 12.21 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.241 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.588 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 21.1 t0 -103.98 114.26 28.38 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.0 -14.87 61.09 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -174.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -122.4 0.67 9.49 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.46 -175.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.654 ' HG2' ' HB2' ' A' ' 66' ' ' GLN . 49.3 mtmt 64.37 15.1 9.28 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 123.58 0.55 . . . . 0.0 109.903 -171.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.9 -44.27 93.47 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -165.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.534 HG21 ' OD2' ' A' ' 90' ' ' ASP . 28.2 m -74.14 -29.32 24.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.231 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.416 ' HA2' ' CE1' ' A' ' 32' ' ' PHE . . . -72.1 -34.78 61.3 Favored Glycine 0 CA--C 1.509 -0.282 0 C-N-CA 120.541 -0.837 . . . . 0.0 111.29 174.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.547 ' HA ' HE21 ' A' ' 97' ' ' GLN . 0.0 OUTLIER -71.03 -28.84 64.69 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.007 -0.596 . . . . 0.0 110.224 174.652 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.21 -22.71 59.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.233 175.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -87.65 -22.91 24.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.998 176.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 93.23 62.99 1.09 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.574 176.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.9 p -103.95 127.16 51.49 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.878 0.371 . . . . 0.0 111.244 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -87.81 -50.75 6.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.127 0.489 . . . . 0.0 110.31 176.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.4 p -145.08 149.15 17.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.087 -176.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.532 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 59.2 m-85 -106.21 161.46 22.78 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.215 -176.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.532 ' HA ' ' HB3' ' A' ' 104' ' ' TYR . 74.4 Cg_endo -74.39 165.5 85.24 Favored 'Cis proline' 0 C--N 1.351 0.684 0 C-N-CA 123.772 -1.345 . . . . 0.0 113.233 0.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.3 m -139.77 132.44 28.92 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.623 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.528 ' HB3' ' HB2' ' A' ' 120' ' ' TYR . 18.8 t -112.33 112.15 23.52 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.656 HG22 HG23 ' A' ' 119' ' ' THR . 55.5 t -105.99 131.6 55.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.898 0.38 . . . . 0.0 111.489 -175.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 90.2 mt -102.98 125.73 49.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.997 177.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.539 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 53.6 mt -118.05 141.09 38.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 123.445 0.466 . . . . 0.0 110.715 -179.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -85.8 -167.17 43.11 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 116.155 -0.475 . . . . 0.0 113.574 -177.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.4 -20.58 50.87 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -173.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.598 ' HB2' ' HZ3' ' A' ' 113' ' ' LYS . 3.7 ttmp? -99.17 -3.18 35.01 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.554 0.692 . . . . 0.0 109.2 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 97.29 12.64 48.01 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.67 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -68.15 122.15 17.68 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 29.8 mt -74.01 93.76 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 174.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 93.4 mt -75.38 -70.3 0.43 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.596 -171.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.479 ' HD2' ' HA ' ' A' ' 118' ' ' LYS . 22.7 mmmt -125.44 144.72 50.4 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.148 -171.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.656 HG23 HG22 ' A' ' 108' ' ' VAL . 1.6 p -120.99 104.16 9.59 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.374 175.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.528 ' HB2' ' HB3' ' A' ' 107' ' ' SER . 22.6 m-85 -85.05 103.43 14.07 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.87 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.6 t -83.0 109.74 17.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.988 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 86.31 -116.83 4.48 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.375 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.435 ' OE1' ' HD2' ' A' ' 124' ' ' PRO . 7.1 tp10 -103.72 116.63 61.49 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-O 120.531 0.205 . . . . 0.0 110.812 -174.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.469 ' HB3' ' CG ' ' A' ' 120' ' ' TYR . 93.2 Cg_endo -86.54 -159.58 0.1 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 123.027 2.485 . . . . 0.0 112.254 175.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.857 ' HB3' ' HG2' ' A' ' 128' ' ' LYS . 18.2 t70 -125.27 124.27 41.29 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.861 177.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -65.54 -37.53 86.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.504 -175.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.77 -50.98 55.69 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.201 -178.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.857 ' HG2' ' HB3' ' A' ' 125' ' ' ASP . 11.9 ptmm? -67.5 -26.13 66.19 Favored 'General case' 0 C--O 1.221 -0.443 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.184 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 51.4 tp -61.08 -47.36 86.69 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.233 0.333 . . . . 0.0 110.224 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -62.24 -54.48 40.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.149 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.483 ' HG2' ' HA ' ' A' ' 128' ' ' LYS . 13.7 pt20 -65.99 -33.88 76.82 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -175.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -71.02 -45.78 63.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.477 0.18 . . . . 0.0 110.69 -177.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 72.7 mt -66.51 -36.26 76.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 177.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -61.46 -47.87 83.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.61 175.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 45.0 m -55.57 -35.23 65.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.185 0.517 . . . . 0.0 110.328 176.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.162 -178.085 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.564 0 CA-C-O 121.651 0.739 . . . . 0.0 112.893 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -141.78 131.58 24.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.912 171.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 26.0 p -149.35 103.09 3.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.868 0.365 . . . . 0.0 110.921 -179.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.417 ' O ' HG13 ' A' ' 18' ' ' VAL . 1.6 pt? -120.1 157.27 53.49 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.766 178.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.13 150.65 26.33 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 121.992 1.795 . . . . 0.0 112.228 177.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.557 ' HA ' ' HG3' ' A' ' 88' ' ' MET . 0.0 OUTLIER -81.41 176.6 9.57 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.035 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 87' ' ' VAL . 78.4 mt -57.42 -26.25 60.85 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -177.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 47.4 t60 -91.29 -40.84 11.27 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 121.355 -0.138 . . . . 0.0 110.783 178.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.93 4.01 0.87 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.063 -1.065 . . . . 0.0 113.804 176.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -78.47 126.74 31.19 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 117.468 0.634 . . . . 0.0 110.212 178.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.7 m -66.97 130.51 43.38 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.851 0.358 . . . . 0.0 110.12 176.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 9' ' ' SER . 9.8 p -118.21 138.13 49.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.0 p -138.69 -177.63 4.95 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.312 0.577 . . . . 0.0 112.091 -173.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -71.36 -21.7 62.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.665 175.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.65 -31.34 72.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.682 178.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -63.72 -23.26 67.3 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.805 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.604 HD21 HG23 ' A' ' 28' ' ' THR . 25.0 mt -84.06 -20.53 32.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.125 -172.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.436 ' HA ' ' OE1' ' A' ' 24' ' ' GLN . 14.7 mm-40 -60.82 113.09 2.31 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -172.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 113.23 -19.57 19.97 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.341 174.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.439 ' HB2' ' OE1' ' A' ' 60' ' ' GLN . 68.0 mttm -124.87 169.84 11.65 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.036 0.418 . . . . 0.0 110.945 -176.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.571 HG12 ' CD1' ' A' ' 59' ' ' PHE . 3.3 p -102.63 123.77 56.18 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.625 -177.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.604 HG23 HD21 ' A' ' 23' ' ' LEU . 39.0 m -116.01 142.99 46.07 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -160.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.489 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 55.7 tp -112.04 111.04 21.67 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.712 170.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.572 ' HB ' ' HB ' ' A' ' 108' ' ' VAL . 62.8 mt -97.9 111.96 28.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 171.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -112.73 122.39 47.54 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.5 -176.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.514 ' HB2' ' HB ' ' A' ' 106' ' ' THR . 89.5 m-85 -94.85 119.89 34.16 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.515 178.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.54 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 18.0 p-90 -147.54 175.33 10.93 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.338 -177.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -154.43 145.04 16.02 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 174.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.499 ' HG2' ' HB3' ' A' ' 69' ' ' ASP . 6.0 Cg_exo -39.12 -66.3 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 124.323 3.349 . . . . 0.0 114.419 -173.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.8 m -77.12 57.12 1.35 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.005 0.431 . . . . 0.0 112.049 -178.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.3 t -117.27 132.74 23.36 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.292 177.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.576 ' O ' HG12 ' A' ' 41' ' ' VAL . 31.4 Cg_exo -60.42 -20.05 61.6 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.565 2.177 . . . . 0.0 112.174 176.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.69 -22.46 78.68 Favored Glycine 0 C--O 1.224 -0.521 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.76 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.686 ' HA ' ' HG3' ' A' ' 44' ' ' MET . 64.1 m -60.36 -35.08 74.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.912 0.356 . . . . 0.0 111.464 -177.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.576 HG12 ' O ' ' A' ' 38' ' ' PRO . 13.5 p -67.33 -40.23 84.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.168 -176.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.8 p -89.25 -49.72 6.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.942 0.401 . . . . 0.0 111.894 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.498 ' O ' HG12 ' A' ' 47' ' ' ILE . 27.0 mm-40 -80.18 -41.2 25.75 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -168.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.686 ' HG3' ' HA ' ' A' ' 40' ' ' CYS . 59.0 mtp -58.28 -49.46 93.46 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -172.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -59.12 -36.37 96.1 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 121.945 1.763 . . . . 0.0 111.811 175.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.408 ' HB3' ' O ' ' A' ' 43' ' ' GLU . 33.7 ttmt -63.42 -38.04 89.6 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.162 177.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.498 HG12 ' O ' ' A' ' 43' ' ' GLU . 46.0 mm -67.4 -35.41 73.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.202 176.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.517 HG12 ' O ' ' A' ' 44' ' ' MET . 47.2 mm -54.73 -52.36 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.616 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.425 ' C ' ' HD3' ' A' ' 49' ' ' LYS . 12.7 tmtt? -59.65 -56.25 24.25 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.892 178.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 27.7 m -54.02 -51.96 62.34 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.903 -174.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.525 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -68.91 -44.76 72.51 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.138 -174.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -75.82 -37.35 59.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.737 -173.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -74.48 -52.45 11.94 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -175.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -78.62 -2.87 41.06 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.82 0.343 . . . . 0.0 111.244 -175.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 24.0 tptm -59.58 -35.74 74.87 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.245 177.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -88.6 2.9 52.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.626 -177.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -96.19 -66.16 0.92 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.327 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 66.2 t30 174.63 18.59 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.436 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.571 ' CD1' HG12 ' A' ' 27' ' ' VAL . 20.7 t80 -104.03 148.47 26.19 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.236 -172.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.439 ' OE1' ' HB2' ' A' ' 26' ' ' LYS . 51.1 mt-30 -122.89 150.9 42.3 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.01 0.524 . . . . 0.0 109.967 178.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.525 HG11 ' HB2' ' A' ' 51' ' ' ALA . 5.9 p -127.1 121.06 56.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 121.175 0.512 . . . . 0.0 110.594 177.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.539 ' HB3' ' HE3' ' A' ' 88' ' ' MET . 8.6 mp -126.77 96.31 4.61 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.443 177.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.55 113.36 25.6 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.536 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 63.7 t -98.19 116.39 40.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.026 0.441 . . . . 0.0 110.132 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -87.7 121.56 30.28 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.789 175.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.675 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 4.8 pm0 -89.65 169.16 13.2 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.675 ' HD2' ' HB2' ' A' ' 66' ' ' GLN . 30.0 Cg_endo -62.26 -138.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 122.701 2.267 . . . . 0.0 113.825 -178.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.542 ' HB ' ' O ' ' A' ' 67' ' ' PRO . 90.6 mt 78.9 -49.36 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 C-N-CA 123.163 0.585 . . . . 0.0 109.771 -173.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.499 ' HB3' ' HG2' ' A' ' 35' ' ' PRO . 0.6 OUTLIER -107.03 138.53 19.85 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 173.249 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 69' ' ' ASP . 33.8 Cg_exo -59.18 158.31 26.53 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.749 2.299 . . . . 0.0 112.821 -178.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.0 tp -62.26 -31.27 51.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.396 -175.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -66.57 -29.2 69.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.905 177.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.1 t -68.48 -40.55 80.92 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.7 t -62.66 -42.74 97.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.209 176.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -62.79 -36.0 81.71 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.176 177.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -61.46 -45.02 96.05 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.825 0.345 . . . . 0.0 110.75 -177.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -63.43 -52.49 61.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.303 -179.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.517 ' HA ' HD13 ' A' ' 83' ' ' LEU . 10.0 p -65.23 -26.53 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-O 121.035 0.445 . . . . 0.0 111.038 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -73.31 -54.77 7.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.356 0.598 . . . . 0.0 110.661 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -73.38 -48.87 30.54 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.862 -172.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -91.77 -4.49 54.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.523 -174.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.08 -58.0 4.59 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.755 177.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.517 HD13 ' HA ' ' A' ' 78' ' ' VAL . 11.2 mp 63.62 95.28 0.05 OUTLIER Pre-proline 0 N--CA 1.466 0.355 0 CA-C-O 121.275 0.56 . . . . 0.0 111.666 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -75.94 10.58 1.97 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.574 2.85 . . . . 0.0 113.07 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -120.38 145.03 47.57 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.2 m -67.68 124.46 23.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.16 -176.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.469 HG23 HD21 ' A' ' 83' ' ' LEU . 33.3 t -118.87 134.38 62.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.702 -179.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.557 ' HG3' ' HA ' ' A' ' 12' ' ' ASP . 3.2 mpp? -123.66 175.25 6.95 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -134.93 125.46 26.73 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.123 -177.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.544 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 56.4 t0 -107.68 111.16 23.23 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 174.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.11 -24.76 60.67 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -174.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.59 7.01 22.27 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.081 -174.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.4 pttp 46.45 32.0 1.47 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.992 0.917 . . . . 0.0 111.563 -179.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.33 -35.12 58.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.661 -173.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.541 HG22 ' OD2' ' A' ' 90' ' ' ASP . 32.6 m -73.44 -29.88 28.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 175.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -68.99 -39.5 84.92 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 172.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -58.83 -32.75 69.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.025 0.44 . . . . 0.0 111.142 175.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.95 -47.7 65.01 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.043 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.468 ' HD2' ' CZ ' ' A' ' 32' ' ' PHE . 30.2 m-85 -81.27 -14.17 57.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.978 -176.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 93.34 38.46 5.34 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.233 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.489 HG23 ' OG1' ' A' ' 106' ' ' THR . 39.9 m -75.9 89.22 2.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.285 0.564 . . . . 0.0 111.18 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 52.5 tp60 -101.44 -57.85 2.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.703 175.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.434 ' CG1' ' HB ' ' A' ' 121' ' ' VAL . 8.4 p -98.95 148.72 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.823 -177.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -114.65 144.28 31.57 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.968 -173.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.461 ' HG3' ' HG3' ' A' ' 43' ' ' GLU . 94.1 Cg_endo -85.58 165.23 55.92 Favored 'Cis proline' 0 N--CA 1.463 -0.279 0 C-N-CA 123.232 -1.57 . . . . 0.0 112.307 -0.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.514 ' HB ' ' HB2' ' A' ' 32' ' ' PHE . 36.5 m -110.45 134.07 52.69 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 176.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.5 m -121.72 110.18 15.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.992 0.425 . . . . 0.0 110.559 -176.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.572 ' HB ' ' HB ' ' A' ' 30' ' ' ILE . 46.4 t -109.41 125.13 66.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.513 -179.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.719 HD13 HD12 ' A' ' 129' ' ' LEU . 85.4 mt -103.4 136.3 43.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.545 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.548 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 51.8 mt -124.49 138.12 55.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 176.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 27' ' ' VAL . . . -78.06 -92.98 0.28 Allowed Glycine 0 C--O 1.223 -0.572 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.137 -172.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -144.63 -2.79 0.83 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.402 0.601 . . . . 0.0 111.351 -178.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.575 ' HB2' ' HZ2' ' A' ' 113' ' ' LYS . 10.4 mtmp? -126.15 13.74 7.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.816 0.341 . . . . 0.0 110.89 -174.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.02 28.74 73.91 Favored Glycine 0 C--O 1.227 -0.316 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.246 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.475 ' OE2' ' HB2' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -90.48 -11.05 41.46 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.856 0.36 . . . . 0.0 110.75 -176.292 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 19.3 mt 62.9 91.67 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.556 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.55 -34.55 72.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.934 -1.03 . . . . 0.0 112.699 -173.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.616 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 2.4 tppp? -155.43 139.87 16.8 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -168.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.539 HG22 HG23 ' A' ' 108' ' ' VAL . 18.3 m -126.07 101.99 7.03 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 120.91 0.386 . . . . 0.0 110.375 170.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.501 ' CD2' ' HB3' ' A' ' 124' ' ' PRO . 41.9 m-85 -94.07 137.69 32.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.285 173.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.434 ' HB ' ' CG1' ' A' ' 103' ' ' VAL . 3.7 m -102.59 108.9 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-O 121.247 0.546 . . . . 0.0 109.737 170.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 99.85 -162.91 19.38 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.341 -0.703 . . . . 0.0 111.341 -174.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -83.09 125.88 73.71 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.812 0.306 . . . . 0.0 110.352 176.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.501 ' HB3' ' CD2' ' A' ' 120' ' ' TYR . 96.5 Cg_endo -80.1 175.13 10.69 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.726 2.284 . . . . 0.0 112.435 177.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.454 ' HB2' ' HB3' ' A' ' 128' ' ' LYS . 7.1 m-20 -65.52 110.43 2.7 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 173.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -63.39 -39.7 95.23 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -170.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -73.21 -46.82 25.77 Favored Glycine 0 C--O 1.237 0.338 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.856 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.454 ' HB3' ' HB2' ' A' ' 125' ' ' ASP . 51.1 tttm -60.71 -36.86 79.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.653 0.263 . . . . 0.0 110.476 177.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.719 HD12 HD13 ' A' ' 109' ' ' LEU . 28.0 tp -58.92 -46.85 86.93 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.719 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -56.54 -45.29 81.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.848 0.356 . . . . 0.0 110.803 178.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -68.4 -37.23 80.16 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.865 -178.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.499 ' HG2' ' HA ' ' A' ' 129' ' ' LEU . 8.9 pt-20 -77.02 -23.65 52.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.78 0.324 . . . . 0.0 110.145 -179.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.2 mp -62.64 -48.72 86.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.017 172.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -61.89 -34.93 76.93 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.273 0.559 . . . . 0.0 110.316 177.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 35.6 m -60.65 -40.84 93.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.376 178.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.239 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.986 177.922 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.556 ' HA ' ' HB2' ' A' ' 20' ' ' ASN . . . . . . . . 0 N--CA 1.455 -0.221 0 CA-C-O 121.146 0.498 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.408 ' CZ ' HD12 ' A' ' 23' ' ' LEU . 50.3 p90 -86.43 148.68 25.45 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 176.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.9 t -149.56 88.76 1.58 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.419 ' H ' HD21 ' A' ' 10' ' ' LEU . 2.4 pt? -123.14 147.11 50.9 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.582 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.602 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 16.5 Cg_exo -68.67 132.23 24.66 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.445 2.097 . . . . 0.0 110.928 172.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.567 ' HA ' ' HG2' ' A' ' 88' ' ' MET . 0.0 OUTLIER -70.43 171.08 10.66 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.055 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.615 HD21 HG22 ' A' ' 78' ' ' VAL . 13.5 tp -81.54 10.38 5.99 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-O 121.403 0.621 . . . . 0.0 111.291 -171.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.407 ' H ' ' CG ' ' A' ' 12' ' ' ASP . 77.3 m80 -109.58 -27.52 9.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.48 170.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 124.13 16.69 3.17 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.687 177.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.472 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 59.0 mttp -112.8 115.39 28.41 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 122.649 -0.324 . . . . 0.0 110.619 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.602 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 35.4 m -61.16 127.22 30.48 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.987 0.423 . . . . 0.0 111.574 -178.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.7 t -111.69 125.81 69.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 174.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.8 p -131.51 175.25 9.31 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.196 0.522 . . . . 0.0 111.433 -176.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.556 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . 4.7 t-20 -58.17 -31.44 67.26 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.094 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.47 -28.09 67.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.651 -178.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -74.1 -18.66 60.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.212 0.53 . . . . 0.0 110.605 -177.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.415 HD13 HD21 ' A' ' 20' ' ' ASN . 79.9 mt -79.4 -19.73 49.35 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.434 -178.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -71.01 98.58 1.65 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.699 -172.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.59 -8.23 19.93 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.711 175.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 112' ' ' LYS . 56.2 mttm -115.98 167.47 10.93 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.4 ' HB ' ' HD2' ' A' ' 59' ' ' PHE . 22.5 t -104.12 139.81 24.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 174.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.775 HG22 ' HG3' ' A' ' 60' ' ' GLN . 4.6 m -129.81 142.23 50.72 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.042 0.448 . . . . 0.0 112.095 -166.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.674 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 7.4 tt -123.69 105.75 9.96 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 171.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.683 ' HB ' ' CG1' ' A' ' 108' ' ' VAL . 61.2 mt -97.49 115.1 36.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.454 ' HA ' ' O ' ' A' ' 106' ' ' THR . 27.4 t-20 -109.5 113.43 26.22 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.366 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.512 ' HE1' HG22 ' A' ' 95' ' ' VAL . 90.4 m-85 -81.92 119.71 24.29 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 175.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 9.7 p-90 -141.78 -179.06 5.97 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.287 0.565 . . . . 0.0 110.775 -175.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -158.12 149.94 17.18 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.766 174.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -63.04 170.08 8.11 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.445 2.097 . . . . 0.0 111.972 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.8 m 63.5 5.58 2.18 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.985 178.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 51.7 t -84.65 131.11 50.69 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.771 0.319 . . . . 0.0 111.046 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -61.62 -22.43 74.41 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.805 2.337 . . . . 0.0 112.112 176.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.37 -19.1 66.18 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.312 -0.471 . . . . 0.0 112.644 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 72.0 m -62.17 -33.41 74.46 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.663 0.268 . . . . 0.0 110.764 178.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 52.8 t -62.76 -35.63 71.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.231 0.538 . . . . 0.0 110.411 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.3 m -86.39 -53.29 5.09 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.944 -177.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.408 ' O ' HG12 ' A' ' 47' ' ' ILE . 17.7 mm-40 -84.46 -31.78 24.39 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -168.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.597 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 50.0 tpp -57.59 -52.1 76.86 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 111.998 0.369 . . . . 0.0 111.998 -174.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.597 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 54.4 Cg_exo -53.39 -39.8 80.4 Favored 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 121.927 1.751 . . . . 0.0 112.404 176.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.441 ' HD3' ' CZ ' ' A' ' 126' ' ' PHE . 56.2 mttp -59.78 -51.45 69.69 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.12 178.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.408 HG12 ' O ' ' A' ' 43' ' ' GLU . 49.8 mm -61.24 -42.11 92.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.224 -177.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.571 HG12 ' O ' ' A' ' 44' ' ' MET . 49.3 mm -55.03 -53.29 35.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.588 0.232 . . . . 0.0 111.434 -178.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.578 ' HZ3' ' HB3' ' A' ' 49' ' ' LYS . 0.2 OUTLIER -74.98 -47.39 29.54 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.793 -175.085 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.5 m -63.88 -44.06 94.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.757 0.313 . . . . 0.0 111.362 -176.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.435 ' HB1' HG21 ' A' ' 61' ' ' VAL . . . -69.22 -33.12 72.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.796 -0.184 . . . . 0.0 110.734 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -56.4 -50.94 70.16 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.366 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.457 ' CG ' ' HZ3' ' A' ' 57' ' ' LYS . 10.6 t70 -68.93 -51.09 43.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.122 0.487 . . . . 0.0 111.034 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 1.036 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 8.8 m-85 -66.5 -31.07 71.56 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -172.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -63.49 -27.3 69.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.083 0.468 . . . . 0.0 110.397 178.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -96.5 19.4 12.25 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.127 0.489 . . . . 0.0 110.499 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.457 ' HZ3' ' CG ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -121.16 -65.4 1.14 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.728 178.131 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 66.6 t30 171.17 19.68 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.646 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 1.036 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 55.4 t80 -114.74 128.27 56.21 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -176.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.775 ' HG3' HG22 ' A' ' 28' ' ' THR . 4.5 pt20 -114.24 128.34 56.31 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.192 0.52 . . . . 0.0 111.151 -175.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.435 HG21 ' HB1' ' A' ' 51' ' ' ALA . 88.5 t -102.87 121.03 53.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.587 175.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.526 ' HB3' ' HE3' ' A' ' 88' ' ' MET . 79.5 mt -113.39 101.58 9.52 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.846 -177.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.69 100.46 12.84 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.396 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.487 HG23 ' HE1' ' A' ' 88' ' ' MET . 55.3 t -88.52 106.36 16.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.467 -176.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.86 133.08 34.32 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 174.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.584 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 3.4 pt20 -109.3 164.86 13.78 Favored Pre-proline 0 C--N 1.316 -0.89 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.584 ' HD2' ' HB2' ' A' ' 66' ' ' GLN . 37.8 Cg_endo -64.9 95.79 0.25 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.312 2.008 . . . . 0.0 113.485 -174.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 45.9 mm -128.13 -65.01 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 171.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -89.53 151.64 46.26 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.046 169.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -58.22 160.25 16.72 Favored 'Trans proline' 0 C--O 1.236 0.411 0 C-N-CA 122.506 2.137 . . . . 0.0 112.504 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.0 tp -56.63 -33.2 39.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.793 -176.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.654 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -65.89 -38.55 89.05 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 122.257 -0.277 . . . . 0.0 110.469 179.418 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.8 m -63.86 -44.86 91.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.776 0.322 . . . . 0.0 110.734 -178.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.47 -35.7 52.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.348 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.654 ' HG2' ' HA ' ' A' ' 72' ' ' GLU . 11.8 ptt180 -73.9 -35.42 64.67 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.569 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -64.98 -39.56 93.66 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 176.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -54.61 -55.21 31.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.405 178.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 1.059 ' HA ' HD21 ' A' ' 83' ' ' LEU . 61.9 t -60.01 -37.86 74.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.658 -178.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.565 ' HG2' ' O ' ' A' ' 75' ' ' ARG . 33.3 mmtp -69.59 -51.21 37.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.81 0.338 . . . . 0.0 110.987 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -63.95 -48.96 74.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.026 -173.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -88.23 -2.89 58.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.371 -175.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 59.87 53.47 45.63 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.919 176.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 1.059 HD21 ' HA ' ' A' ' 78' ' ' VAL . 2.9 mm? -69.92 114.1 22.51 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 120.789 0.328 . . . . 0.0 110.646 -179.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -84.24 -20.32 4.22 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.036 2.491 . . . . 0.0 113.964 -174.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.501 ' CE1' HD13 ' A' ' 83' ' ' LEU . 40.0 p90 -79.99 169.6 17.64 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.693 0.282 . . . . 0.0 110.486 -179.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 24.2 m -78.48 105.46 9.76 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.562 0.696 . . . . 0.0 111.22 -175.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.1 t -99.59 141.91 16.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.233 177.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.567 ' HG2' ' HA ' ' A' ' 12' ' ' ASP . 60.6 mtm -136.63 168.98 18.47 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -134.97 104.74 6.08 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.879 0.371 . . . . 0.0 110.743 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.524 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 20.0 t70 -91.11 101.99 14.74 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.34 -10.64 59.96 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.226 -171.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.493 ' OD2' ' HB2' ' A' ' 94' ' ' ALA . 13.5 t70 -105.14 -12.05 16.29 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.544 -0.463 . . . . 0.0 111.345 -176.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 63.2 tttp 65.32 4.97 2.88 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 121.349 0.595 . . . . 0.0 111.365 177.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.493 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . . . -70.62 -29.49 65.89 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -170.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.512 HG22 ' HE1' ' A' ' 32' ' ' PHE . 22.5 m -73.08 -33.94 43.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.353 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -70.89 -33.89 65.81 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 173.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -70.6 -32.03 69.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.213 -0.493 . . . . 0.0 110.876 176.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.69 -45.57 89.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.87 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -73.11 -27.07 61.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.986 0.422 . . . . 0.0 110.814 175.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.31 39.63 7.24 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.873 -0.68 . . . . 0.0 111.782 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.8 p -84.08 115.24 22.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.624 0.25 . . . . 0.0 110.601 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -103.23 -40.03 6.59 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.998 0.428 . . . . 0.0 110.148 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 40.1 t -98.75 145.27 10.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.967 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.423 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 87.0 m-85 -132.62 155.82 80.78 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.423 ' HA ' ' HB3' ' A' ' 104' ' ' TYR . 86.9 Cg_endo -78.63 160.28 90.94 Favored 'Cis proline' 0 C--N 1.345 0.373 0 C-N-CA 123.25 -1.562 . . . . 0.0 112.772 0.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 53.9 m -131.71 123.83 28.54 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.727 178.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.1 m -107.99 117.69 34.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.52 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.683 ' CG1' ' HB ' ' A' ' 30' ' ' ILE . 10.1 p -106.09 135.9 42.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.939 0.4 . . . . 0.0 110.144 178.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.526 HD21 ' HB2' ' A' ' 118' ' ' LYS . 2.3 mm? -102.84 124.99 49.4 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.244 -178.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.556 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 53.5 mt -109.26 133.96 52.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.964 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -80.04 159.11 43.17 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.289 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.551 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 46.8 pttt -67.68 86.15 0.21 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.75 0.786 . . . . 0.0 111.112 -177.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.696 ' HB2' ' HZ2' ' A' ' 113' ' ' LYS . 4.6 ttmp? 165.73 -30.02 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.373 -178.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.46 39.97 1.84 Allowed Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.345 -176.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -113.35 132.35 55.62 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.422 HD12 HG12 ' A' ' 110' ' ' ILE . 49.2 mm -78.46 117.91 24.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.827 0.346 . . . . 0.0 110.083 -178.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.2 mt -103.14 -68.59 0.83 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.769 -175.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.526 ' HB2' HD21 ' A' ' 109' ' ' LEU . 20.1 mmmt -124.33 157.3 35.32 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -168.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -138.32 108.74 6.51 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.026 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -108.8 109.37 20.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.202 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 36.5 t -96.92 138.19 22.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.08 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 90.12 -77.63 1.58 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.124 178.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -151.71 119.81 3.33 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 178.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.509 ' HB2' HD22 ' A' ' 129' ' ' LEU . 38.1 Cg_endo -67.81 130.23 21.43 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.561 2.174 . . . . 0.0 112.427 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.607 ' OD1' ' HG2' ' A' ' 128' ' ' LYS . 12.7 t70 -69.32 110.85 4.86 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 177.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.441 ' CZ ' ' HD3' ' A' ' 46' ' ' LYS . 34.6 m-85 -58.58 -44.15 89.7 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -173.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -56.66 -52.89 47.72 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.915 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.607 ' HG2' ' OD1' ' A' ' 125' ' ' ASP . 38.4 mmtm -63.93 -48.87 74.83 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.509 HD22 ' HB2' ' A' ' 124' ' ' PRO . 28.0 tp -63.16 -48.66 77.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.989 -171.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -64.39 -37.88 89.06 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.958 -177.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -73.34 -39.73 64.98 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.43 178.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.484 ' OE1' ' HG3' ' A' ' 118' ' ' LYS . 9.5 pt-20 -75.24 -38.13 60.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.276 -174.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 57.6 mt -64.37 -45.97 94.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 175.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -61.32 -32.18 72.04 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.002 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 90.4 m -58.37 -47.43 83.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.975 0.417 . . . . 0.0 110.653 177.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.351 0 CA-C-O 121.077 0.465 . . . . 0.0 111.062 177.875 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 -0.236 0 CA-C-O 121.105 0.479 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -119.07 144.41 46.59 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.353 0.597 . . . . 0.0 111.558 -174.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.2 p -149.43 88.58 1.58 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.85 170.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.415 ' H ' HD23 ' A' ' 10' ' ' LEU . 2.6 pt? -121.98 155.71 60.5 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.896 -174.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.92 145.7 19.99 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.742 2.295 . . . . 0.0 111.584 173.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 51.7 p-10 -89.53 -172.65 3.67 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.141 177.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.6 mt -79.06 20.7 0.47 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.765 0.316 . . . . 0.0 111.441 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -118.33 -24.34 6.93 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 174.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.45 14.93 14.81 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.719 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -113.37 141.61 46.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.972 0.386 . . . . 0.0 110.315 178.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.2 m -75.27 122.53 23.84 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.404 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.5 t -108.01 142.84 19.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.733 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.5 p -145.35 -173.8 4.21 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.202 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -66.47 -22.73 66.2 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -176.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.63 -31.73 71.83 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.833 0.349 . . . . 0.0 111.81 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.62 -37.03 84.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.45 0.643 . . . . 0.0 109.704 177.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.475 HD22 HG22 ' A' ' 28' ' ' THR . 21.7 mt -72.21 -21.33 61.42 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.475 -174.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -64.8 102.1 0.55 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.248 0.547 . . . . 0.0 111.686 -174.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.05 -26.04 10.22 Favored Glycine 0 CA--C 1.511 -0.208 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.991 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.688 ' O ' ' HA ' ' A' ' 112' ' ' LYS . 31.5 mttp -97.18 163.09 13.06 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 177.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.463 HG22 ' HB3' ' A' ' 112' ' ' LYS . 4.9 t -103.08 127.3 57.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 175.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.563 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 27.7 m -131.33 142.23 50.06 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.397 0.618 . . . . 0.0 112.361 -168.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.462 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 24.8 tp -115.69 115.27 26.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.396 172.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.814 ' HB ' ' CG2' ' A' ' 108' ' ' VAL . 51.2 mt -94.27 112.86 27.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 176.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -117.0 118.3 32.01 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.855 0.36 . . . . 0.0 110.932 -176.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 87.7 m-85 -84.25 125.09 31.9 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.406 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.496 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 22.7 p-90 -147.07 175.54 10.62 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.217 0.532 . . . . 0.0 111.097 -177.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.425 ' HD2' ' OD2' ' A' ' 69' ' ' ASP . 27.2 p90 -161.67 149.58 12.23 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.714 173.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.568 ' HD2' ' HB2' ' A' ' 69' ' ' ASP . 84.7 Cg_exo -49.61 -46.69 25.85 Favored 'Trans proline' 0 N--CA 1.474 0.375 0 C-N-CA 123.422 2.748 . . . . 0.0 114.284 -174.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.1 m -79.35 17.81 0.78 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -174.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.604 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 48.0 t -85.2 126.5 67.23 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 120.704 0.288 . . . . 0.0 110.734 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 17.0 Cg_exo -67.79 -19.32 47.16 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.963 2.442 . . . . 0.0 112.305 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.24 -11.52 84.93 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.803 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 89.2 m -60.96 -43.57 98.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.704 0.252 . . . . 0.0 111.381 -178.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.9 m -59.71 -27.86 38.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.02 0.438 . . . . 0.0 111.403 -177.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.9 m -87.45 -55.14 3.92 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.265 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.425 ' O ' HG12 ' A' ' 47' ' ' ILE . 26.5 mm-40 -84.55 -33.18 23.5 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -168.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.639 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 47.9 tpp -57.52 -53.76 62.11 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -172.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.639 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 43.2 Cg_exo -57.15 -36.59 99.18 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 122.096 1.864 . . . . 0.0 111.98 178.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.476 ' HB3' ' HE2' ' A' ' 46' ' ' LYS . 4.6 tmmm? -66.74 -39.8 88.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.108 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.425 HG12 ' O ' ' A' ' 43' ' ' GLU . 34.1 mm -63.52 -39.4 85.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.581 177.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.559 HD11 ' HE1' ' A' ' 85' ' ' PHE . 44.9 mm -54.62 -53.38 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.287 178.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -63.24 -51.5 65.93 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.803 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 30.9 m -56.02 -47.17 78.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.945 0.402 . . . . 0.0 111.491 -176.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . -65.62 -41.09 93.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.433 -177.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -73.76 -37.76 64.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.954 -176.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.07 -49.54 76.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.689 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -92.08 -1.49 57.17 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.524 -174.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 24.2 tptm -59.26 -35.32 73.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.102 0.477 . . . . 0.0 110.49 178.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -74.85 -24.25 58.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.403 -176.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -71.35 -70.35 0.32 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 175.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 171.63 22.24 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.456 -176.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.462 ' HZ ' ' HB2' ' A' ' 29' ' ' LEU . 29.5 t80 -100.48 139.72 35.75 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.969 -174.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.506 ' O ' ' HA ' ' A' ' 28' ' ' THR . 12.1 pt20 -134.64 137.15 43.4 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.147 176.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.455 HG23 ' HE1' ' A' ' 59' ' ' PHE . 98.3 t -104.98 119.16 53.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.476 ' HB3' ' HE2' ' A' ' 88' ' ' MET . 70.0 mt -104.04 98.59 8.39 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.7 177.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.496 ' HB3' ' CD1' ' A' ' 33' ' ' TRP . . . -84.52 109.29 17.82 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.271 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.484 HG12 HG13 ' A' ' 95' ' ' VAL . 86.4 t -93.93 108.37 20.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.257 0.551 . . . . 0.0 110.495 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -80.14 127.83 32.79 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 174.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.73 ' HG2' HG12 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -99.85 162.34 21.41 Favored Pre-proline 0 C--N 1.318 -0.785 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -179.135 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.579 ' HD2' ' HB2' ' A' ' 66' ' ' GLN . 58.6 Cg_endo -70.9 42.4 0.42 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.994 2.463 . . . . 0.0 115.157 -170.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.73 HG12 ' HG2' ' A' ' 66' ' ' GLN . 43.6 mm -84.09 -30.96 7.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 172.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.568 ' HB2' ' HD2' ' A' ' 35' ' ' PRO . 23.6 m-20 -125.12 150.93 68.39 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.784 169.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -58.12 154.76 37.8 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.352 2.035 . . . . 0.0 111.954 176.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.555 ' O ' HG23 ' A' ' 74' ' ' VAL . 11.9 tt -63.0 -27.62 43.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.633 0.254 . . . . 0.0 111.177 -178.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.43 ' HA ' ' NE ' ' A' ' 75' ' ' ARG . 10.1 pt-20 -67.38 -33.97 76.32 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.189 177.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.6 m -68.92 -45.0 71.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.27 175.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 71' ' ' ILE . 5.2 m -70.39 -35.79 63.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.973 -175.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.43 ' NE ' ' HA ' ' A' ' 72' ' ' GLU . 30.5 ptt180 -75.27 -27.53 59.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.561 -179.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 -68.52 -37.83 80.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.369 176.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -63.48 -47.84 80.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.075 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.676 HG13 ' HB2' ' A' ' 83' ' ' LEU . 43.6 t -61.24 -42.18 92.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.682 177.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.4 tttt -62.84 -55.95 21.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.005 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -63.03 -48.81 77.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.306 -170.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -83.59 -17.6 41.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.711 0.291 . . . . 0.0 111.294 -176.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.0 60.8 4.02 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.961 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.676 ' HB2' HG13 ' A' ' 78' ' ' VAL . 9.9 mp -67.6 118.73 60.05 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.723 -0.238 . . . . 0.0 110.533 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -75.84 -28.89 7.46 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.787 2.324 . . . . 0.0 112.862 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.559 ' HE1' HD11 ' A' ' 48' ' ' ILE . 33.6 p90 -80.34 150.98 29.69 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.464 ' HB ' HD23 ' A' ' 62' ' ' LEU . 22.2 m -75.21 131.32 40.32 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.117 0.484 . . . . 0.0 111.335 -173.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.446 HG21 ' HB2' ' A' ' 63' ' ' ALA . 68.5 t -114.09 139.46 39.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.418 -179.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.476 ' HE2' ' HB3' ' A' ' 62' ' ' LEU . 70.1 mtm -127.26 167.56 15.93 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 176.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -137.72 112.0 8.58 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.563 0.22 . . . . 0.0 110.441 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.545 ' OD2' HG11 ' A' ' 95' ' ' VAL . 55.8 t0 -91.53 119.07 31.14 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.56 -20.84 60.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.928 -176.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -111.64 -11.7 13.99 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -175.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt 65.52 16.57 10.58 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.965 0.412 . . . . 0.0 109.964 175.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.09 -29.27 70.2 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.608 0.718 . . . . 0.0 109.59 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.545 HG11 ' OD2' ' A' ' 90' ' ' ASP . 7.7 p -60.65 -46.53 95.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.136 174.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -76.13 -33.2 50.38 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.888 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -58.6 -36.34 73.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.014 0.435 . . . . 0.0 111.242 177.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.03 -46.33 52.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.305 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -72.76 -27.58 62.1 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 95.13 36.58 5.42 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -175.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.491 HG23 ' OG1' ' A' ' 106' ' ' THR . 20.0 m -76.51 88.15 3.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.134 0.492 . . . . 0.0 111.2 -177.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -103.12 -46.03 4.75 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.317 177.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 38.4 t -101.82 131.43 49.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.0 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -104.98 149.21 37.32 Favored Pre-proline 0 C--N 1.317 -0.826 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -178.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -79.73 165.99 78.43 Favored 'Cis proline' 0 C--N 1.344 0.319 0 C-N-CA 124.123 -1.199 . . . . 0.0 112.907 0.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.491 ' OG1' HG23 ' A' ' 101' ' ' THR . 58.1 m -131.43 114.95 15.57 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.205 176.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.6 m -108.74 115.39 30.0 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.026 0.441 . . . . 0.0 110.368 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.814 ' CG2' ' HB ' ' A' ' 30' ' ' ILE . 26.9 m -106.16 148.85 10.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.312 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.679 ' HB2' ' HB3' ' A' ' 118' ' ' LYS . 11.0 mp -101.09 124.32 46.62 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.943 -174.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.563 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 25.8 mm -112.3 118.59 58.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.027 174.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -71.04 -168.33 8.15 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.72 178.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.688 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 10.7 ptmm? -95.79 21.06 8.95 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 122.687 1.232 . . . . 0.0 107.935 -175.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.422 ' HD2' ' HA ' ' A' ' 113' ' ' LYS . 1.8 mmmp? -106.39 -1.2 23.52 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 113.439 -1.71 . . . . 0.0 108.866 174.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 61.97 46.48 93.99 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 114.952 -1.022 . . . . 0.0 113.326 177.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -148.53 167.01 26.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.023 0.439 . . . . 0.0 111.632 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.2 mt -61.87 127.46 21.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.703 -178.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 36.9 mt -121.28 -61.06 1.58 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.477 174.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.679 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 1.7 tppt? -133.63 154.96 50.49 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -174.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.644 ' N ' ' HG3' ' A' ' 118' ' ' LYS . 42.8 m -131.86 102.23 5.77 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.11 172.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.641 ' CE2' ' HE3' ' A' ' 118' ' ' LYS . 45.9 m-85 -88.63 136.63 32.9 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.887 0.375 . . . . 0.0 110.914 169.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 6.0 p -123.17 123.1 67.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.258 0.551 . . . . 0.0 110.739 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 95.55 -62.91 1.38 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.285 175.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -167.09 116.57 0.71 Allowed Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 120.501 0.191 . . . . 0.0 111.349 -173.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -93.86 163.17 2.21 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 123.159 2.573 . . . . 0.0 113.087 177.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -99.05 108.79 21.54 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.411 0.624 . . . . 0.0 109.605 174.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.611 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 34.8 m-85 -70.19 -30.21 67.26 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -164.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -59.9 -54.12 40.2 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 119.663 -1.256 . . . . 0.0 111.807 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.421 ' HE2' ' HB3' ' A' ' 128' ' ' LYS . 22.0 ttpt -66.14 -35.29 80.1 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.959 -0.62 . . . . 0.0 110.008 176.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.611 ' HB3' ' HA ' ' A' ' 126' ' ' PHE . 2.9 tm? -61.45 -47.3 86.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.961 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -60.24 -38.59 83.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.813 0.34 . . . . 0.0 110.299 178.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -71.83 -33.07 68.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.762 178.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.588 ' HG2' ' HA ' ' A' ' 129' ' ' LEU . 18.7 pt-20 -80.96 -23.6 38.69 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.419 -177.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 56.1 mt -67.0 -42.12 88.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 168.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -63.13 -27.02 69.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.302 174.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.524 ' HB ' ' O ' ' A' ' 132' ' ' GLU . 52.3 m -60.81 -31.45 70.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.819 176.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.243 0 CA-C-O 121.042 0.449 . . . . 0.0 110.296 177.575 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.493 ' HA ' ' OD1' ' A' ' 20' ' ' ASN . . . . . . . . 0 N--CA 1.465 0.318 0 CA-C-O 121.238 0.542 . . . . 0.0 110.74 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -80.48 150.44 29.69 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.773 -171.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.5 m -136.1 96.3 3.37 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 173.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.486 HD13 ' HD2' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -119.6 126.14 27.11 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.249 -171.161 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.486 ' HD2' HD13 ' A' ' 10' ' ' LEU . 47.2 Cg_endo -71.19 131.56 19.47 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.102 1.868 . . . . 0.0 111.558 173.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.28 177.84 7.59 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.589 HD13 HG23 ' A' ' 78' ' ' VAL . 51.8 mt -64.41 -31.27 72.42 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -176.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.81 -17.03 42.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.661 0.267 . . . . 0.0 111.261 -175.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.12 32.1 3.13 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.419 -0.896 . . . . 0.0 114.017 170.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -114.4 135.35 54.18 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.128 0.464 . . . . 0.0 110.086 172.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.1 m -77.65 124.48 27.99 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 175.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.692 HG23 ' HE1' ' A' ' 88' ' ' MET . 31.0 m -124.56 153.55 31.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.873 0.368 . . . . 0.0 110.277 177.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 51.1 p -140.35 -179.6 6.1 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.486 -177.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.493 ' OD1' ' HA ' ' A' ' 7' ' ' ALA . 4.4 p-10 -73.88 -20.89 60.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.571 178.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.423 ' HA ' HE21 ' A' ' 24' ' ' GLN . . . -62.61 -27.56 69.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.012 174.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -68.33 -29.44 68.18 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.269 0.557 . . . . 0.0 110.329 176.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.928 HD11 HG21 ' A' ' 110' ' ' ILE . 25.3 mt -74.07 -19.31 60.65 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.16 -175.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.423 HE21 ' HA ' ' A' ' 21' ' ' ALA . 76.3 mt-30 -55.58 128.6 35.36 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.361 -178.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.9 -24.66 10.19 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.515 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -95.98 -171.25 2.29 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.372 0.605 . . . . 0.0 111.019 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -133.05 138.01 52.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 169.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.594 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 89.2 m -141.57 150.01 41.5 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.697 -169.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.652 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 6.5 tt -127.23 123.03 35.59 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 173.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.646 ' HB ' ' CG2' ' A' ' 108' ' ' VAL . 44.5 mt -104.1 115.16 45.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.843 0.354 . . . . 0.0 110.585 -178.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -107.8 117.44 34.13 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.582 -178.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.52 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 96.1 m-85 -90.3 119.08 30.3 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 177.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.502 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 5.3 p-90 -146.23 -176.8 5.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.106 -175.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -153.45 159.12 32.52 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.256 -0.884 . . . . 0.0 108.767 177.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -51.8 128.02 25.04 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.279 1.986 . . . . 0.0 112.16 177.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.7 t 71.62 26.06 3.2 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.427 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.517 ' O ' ' HB3' ' A' ' 40' ' ' CYS . 42.9 t -63.41 134.02 95.7 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.011 176.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -57.25 -49.14 14.82 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.977 2.452 . . . . 0.0 112.657 178.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.533 ' HA3' ' HG3' ' A' ' 105' ' ' PRO . . . -66.64 -24.85 72.75 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.292 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.517 ' HB3' ' O ' ' A' ' 37' ' ' CYS . 29.6 t -58.26 -33.57 69.53 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 122.624 0.37 . . . . 0.0 111.106 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.2 t -62.17 -36.69 75.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.947 0.403 . . . . 0.0 110.543 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.9 m -87.9 -54.68 4.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.001 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.48 ' O ' HG13 ' A' ' 47' ' ' ILE . 54.8 mt-10 -63.81 -50.18 69.96 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -172.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.578 ' O ' HG12 ' A' ' 48' ' ' ILE . 40.5 ttm -51.29 -50.26 77.03 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -170.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.411 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 86.9 Cg_exo -48.57 -48.55 17.07 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 122.205 1.937 . . . . 0.0 112.857 176.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -63.1 -46.23 88.32 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.144 177.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 43' ' ' GLU . 51.1 mt -60.39 -35.33 62.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.961 -178.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.578 HG12 ' O ' ' A' ' 44' ' ' MET . 46.7 mm -58.69 -52.9 54.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.925 0.393 . . . . 0.0 110.376 176.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -70.68 -39.38 73.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.121 -177.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.563 ' O ' ' HD1' ' A' ' 54' ' ' TYR . 87.7 m -68.37 -54.75 15.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.938 -178.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.619 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . -65.73 -34.74 78.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.236 -174.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -63.82 -48.39 77.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.905 0.383 . . . . 0.0 110.722 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -69.37 -51.64 34.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.01 0.433 . . . . 0.0 111.166 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 1.039 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 77.2 m-85 -70.79 -12.08 61.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.559 -175.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.619 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 16.0 tptm -60.99 -35.78 77.74 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 175.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -84.79 -6.2 59.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.342 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 58' ' ' ASN . 43.5 mmtm -89.57 -69.65 0.7 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 176.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 63.3 t30 164.03 12.13 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 114.904 -1.043 . . . . 0.0 109.241 -175.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 1.039 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 60.6 t80 -105.74 129.43 53.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.542 -178.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.401 ' O ' ' HA ' ' A' ' 28' ' ' THR . 12.7 pt20 -126.68 140.86 52.09 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.952 0.405 . . . . 0.0 110.501 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 91.9 t -104.59 126.9 59.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.866 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.513 ' HB3' ' HE2' ' A' ' 88' ' ' MET . 75.7 mt -114.21 99.57 7.71 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.605 -179.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.01 106.29 18.38 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.695 -178.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 41.9 t -94.66 115.25 33.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.047 0.451 . . . . 0.0 110.516 -178.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.502 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -82.45 138.24 34.44 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.859 176.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.663 ' HB2' ' HG2' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -101.83 163.45 17.77 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.808 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.692 ' HD3' ' O ' ' A' ' 90' ' ' ASP . 37.4 Cg_endo -66.19 82.08 0.28 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.538 2.158 . . . . 0.0 113.688 -173.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 50.7 mm -112.22 -44.29 5.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 170.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -129.67 153.59 80.8 Favored Pre-proline 0 C--O 1.237 0.403 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 173.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -54.64 161.89 5.43 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.932 2.422 . . . . 0.0 114.714 -175.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.7 tp -51.16 -35.46 15.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.488 177.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -62.1 -46.18 90.19 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.049 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.6 m -58.32 -41.95 85.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.131 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.547 HG12 HD12 ' A' ' 13' ' ' LEU . 26.4 t -65.05 -46.57 90.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.357 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.497 ' HG2' ' HB3' ' A' ' 13' ' ' LEU . 67.1 mtt180 -60.16 -34.95 74.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.012 177.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.448 ' CD ' ' HZ2' ' A' ' 79' ' ' LYS . 50.3 tp60 -61.27 -53.48 56.26 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.591 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -55.86 -48.86 74.78 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.242 -176.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.589 HG23 HD13 ' A' ' 13' ' ' LEU . 61.9 t -56.36 -44.29 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 112.26 0.466 . . . . 0.0 112.26 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.747 ' HB2' ' HZ3' ' A' ' 79' ' ' LYS . 9.6 mtmp? -67.56 -48.56 66.58 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.59 0.709 . . . . 0.0 110.487 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.32 -39.93 93.06 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.497 -1.229 . . . . 0.0 112.456 -170.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -95.82 -9.99 30.15 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.475 -178.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 63.15 67.32 2.12 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.209 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.51 HD12 ' HA ' ' A' ' 78' ' ' VAL . 1.1 mt -94.25 127.57 44.05 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-O 120.94 0.4 . . . . 0.0 111.891 -174.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -83.48 -12.96 8.77 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.456 2.77 . . . . 0.0 114.553 -172.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.455 ' CZ ' HD23 ' A' ' 83' ' ' LEU . 26.8 p90 -93.16 153.61 18.54 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.421 178.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.405 ' HB ' HD21 ' A' ' 62' ' ' LEU . 14.5 m -78.59 126.76 31.19 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.596 -175.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.481 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 47.0 t -110.52 135.74 48.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.011 0.434 . . . . 0.0 110.63 -178.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.692 ' HE1' HG23 ' A' ' 18' ' ' VAL . 52.3 mtt -116.0 172.1 7.37 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.59 178.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -140.53 109.6 6.12 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.622 0.249 . . . . 0.0 110.548 176.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.692 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 38.4 t0 -91.57 118.39 30.56 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 176.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.72 -14.97 60.79 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -175.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.53 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 24.2 t70 -125.62 -9.66 6.79 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 122.149 -0.344 . . . . 0.0 111.514 -173.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.663 ' HG2' ' HB2' ' A' ' 66' ' ' GLN . 51.8 mtpt 78.18 5.23 2.72 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.881 0.872 . . . . 0.0 111.679 -177.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.05 -40.63 81.43 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -169.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.545 HG21 ' OD2' ' A' ' 90' ' ' ASP . 22.1 m -70.21 -35.23 62.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 119.977 -0.689 . . . . 0.0 109.834 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -71.68 -33.23 63.59 Favored Glycine 0 N--CA 1.451 -0.321 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 176.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.59 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 8.5 mm-40 -61.69 -32.54 72.75 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.087 0.47 . . . . 0.0 110.552 176.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.24 -40.17 64.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.177 176.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -74.03 -22.66 59.48 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.715 0.293 . . . . 0.0 111.25 179.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.91 50.5 1.77 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.664 177.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 22.6 p -72.75 88.42 1.31 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.041 0.448 . . . . 0.0 111.002 176.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -84.23 -51.76 6.77 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.38 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 46.8 t -128.91 142.41 44.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.87 -179.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -86.41 137.76 34.36 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.533 ' HG3' ' HA3' ' A' ' 39' ' ' GLY . 94.4 Cg_endo -90.74 166.47 30.39 Favored 'Cis proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.88 -1.3 . . . . 0.0 112.808 -0.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 33.0 m -128.16 112.65 14.77 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.484 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.472 ' HB3' HD22 ' A' ' 29' ' ' LEU . 73.1 m -110.5 112.62 24.66 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.979 0.419 . . . . 0.0 110.83 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.646 ' CG2' ' HB ' ' A' ' 30' ' ' ILE . 15.9 m -106.83 148.7 10.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.537 -176.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.752 ' HB2' ' HB3' ' A' ' 118' ' ' LYS . 10.8 mp -101.91 132.87 47.46 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.033 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.928 HG21 HD11 ' A' ' 23' ' ' LEU . 31.3 mm -114.38 133.45 60.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.93 -174.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -85.86 -174.29 49.73 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.929 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 24' ' ' GLN . 62.1 mttm -74.97 21.49 0.12 Allowed 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -172.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.516 ' HD3' ' HB3' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -150.59 11.31 0.68 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.059 0.457 . . . . 0.0 110.604 -179.55 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.07 -14.19 57.86 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.52 -0.847 . . . . 0.0 111.669 -176.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.516 ' HB3' ' HD3' ' A' ' 113' ' ' LYS . 38.7 tt0 -54.93 135.13 48.72 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.234 0.614 . . . . 0.0 111.096 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.0 mt -80.3 111.77 17.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.014 -174.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 79.9 mt -91.42 -40.16 11.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.598 -175.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.752 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 19.8 tptm -152.5 153.71 34.02 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.618 -170.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.8 m -136.61 108.79 7.24 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.937 177.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -99.33 118.16 35.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.341 174.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 61.3 t -108.49 123.12 63.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.732 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 90.74 -72.75 1.87 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.959 176.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -132.42 105.45 13.28 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-O 120.726 0.298 . . . . 0.0 110.624 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -82.66 126.57 4.67 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.549 2.166 . . . . 0.0 112.563 176.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -65.46 102.47 0.7 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 176.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -67.15 -45.73 76.17 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -172.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -57.97 -48.17 84.28 Favored Glycine 0 C--O 1.239 0.408 0 C-N-CA 120.434 -0.889 . . . . 0.0 111.874 178.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -67.39 -31.28 71.4 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-N 115.491 -0.354 . . . . 0.0 110.404 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.673 ' O ' HG12 ' A' ' 133' ' ' ILE . 2.6 tm? -59.32 -45.26 91.81 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 176.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -61.68 -49.89 74.67 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -178.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -69.83 -27.51 64.93 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.959 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -73.5 -37.43 65.7 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.052 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.673 HG12 ' O ' ' A' ' 129' ' ' LEU . 50.8 mm -64.38 -41.92 93.79 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 172.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -57.15 -38.42 73.52 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.159 178.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 32.6 m -66.33 -38.12 86.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.62 178.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.02 178.496 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.253 0 CA-C-O 121.189 0.519 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -111.86 130.27 55.88 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.098 0.475 . . . . 0.0 111.157 -175.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.508 ' HA ' ' HG ' ' A' ' 19' ' ' SER . 63.7 p -110.46 90.23 3.26 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 172.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.521 HD13 ' HD2' ' A' ' 11' ' ' PRO . 22.6 tp -111.51 126.92 27.68 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.751 -172.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.521 ' HD2' HD13 ' A' ' 10' ' ' LEU . 58.3 Cg_endo -73.3 147.55 42.15 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.308 2.006 . . . . 0.0 112.136 176.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.412 ' CG ' ' H ' ' A' ' 14' ' ' HIS . 0.2 OUTLIER -80.46 -175.65 5.28 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 176.948 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 53.8 mt -70.37 -18.68 63.06 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -176.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.412 ' H ' ' CG ' ' A' ' 12' ' ' ASP . 76.6 m80 -89.65 -48.25 7.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.775 0.321 . . . . 0.0 110.427 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.56 24.91 0.19 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.374 -0.917 . . . . 0.0 113.668 176.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 11' ' ' PRO . 67.6 mttm -101.17 139.56 36.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.314 0.557 . . . . 0.0 110.152 175.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.4 m -84.77 123.38 30.35 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.899 0.381 . . . . 0.0 111.089 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.2 t -107.93 134.82 48.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.509 176.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.508 ' HG ' ' HA ' ' A' ' 9' ' ' SER . 36.6 m -145.25 177.48 8.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.746 0.308 . . . . 0.0 111.462 -177.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -51.64 -32.28 28.62 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.641 0.776 . . . . 0.0 112.849 -175.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.47 -27.48 64.45 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -174.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -82.94 -23.32 33.5 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.456 -176.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.584 HD21 HG23 ' A' ' 110' ' ' ILE . 7.7 mp -80.88 -26.94 36.52 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -173.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -64.53 130.86 45.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.189 0.518 . . . . 0.0 111.517 -176.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.34 -12.14 70.28 Favored Glycine 0 C--N 1.329 0.154 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.338 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 112' ' ' LYS . 79.4 mttt -115.71 -173.28 2.31 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 15.9 t -126.51 139.0 52.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 171.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.546 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 26.7 m -137.14 145.74 44.17 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.687 -168.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.604 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 31.8 tp -115.89 105.84 13.13 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 172.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.8 mt -89.46 111.67 23.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 175.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.498 ' HA ' ' O ' ' A' ' 106' ' ' THR . 7.9 t30 -117.01 111.17 19.19 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.827 0.346 . . . . 0.0 110.864 -175.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.467 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 63.5 m-85 -81.38 131.55 35.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.652 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.6 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 4.2 p-90 -158.19 -170.47 3.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.416 -175.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.443 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 24.5 p90 -158.86 138.69 8.66 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 171.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.721 ' HG2' ' HA ' ' A' ' 74' ' ' VAL . 50.6 Cg_exo -56.48 -28.31 72.87 Favored 'Trans proline' 0 N--CA 1.473 0.299 0 C-N-CA 123.358 2.705 . . . . 0.0 114.051 -173.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.7 t -89.84 26.57 1.76 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.023 0.439 . . . . 0.0 110.984 -178.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 53.5 t -100.32 132.11 23.02 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.255 -179.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -61.73 -28.39 82.04 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.799 2.333 . . . . 0.0 112.009 175.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.74 -22.3 69.92 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.388 179.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.431 ' SG ' ' HE1' ' A' ' 44' ' ' MET . 46.9 t -63.3 -40.17 96.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.761 0.315 . . . . 0.0 110.315 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.4 t -58.77 -35.9 58.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.105 -178.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.0 m -87.45 -49.44 7.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.852 -178.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.435 ' OE1' ' HG3' ' A' ' 46' ' ' LYS . 12.4 mm-40 -84.68 -28.21 26.54 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -170.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.563 ' O ' HG12 ' A' ' 48' ' ' ILE . 27.7 ttm -55.18 -47.26 98.95 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 120.249 -0.581 . . . . 0.0 111.91 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -51.05 -41.59 56.24 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.093 1.862 . . . . 0.0 112.314 172.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.435 ' HG3' ' OE1' ' A' ' 43' ' ' GLU . 26.0 mmtp -59.7 -48.16 82.77 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.2 mm -61.71 -44.19 98.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.209 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.563 HG12 ' O ' ' A' ' 44' ' ' MET . 45.1 mm -54.87 -53.97 28.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.685 -175.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -70.88 -38.34 73.07 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.432 -175.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.9 m -67.58 -48.79 65.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.967 0.413 . . . . 0.0 110.88 -178.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.548 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . -65.95 -45.28 82.38 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.988 -178.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -55.13 -44.21 74.85 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.831 0.348 . . . . 0.0 110.996 -177.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -67.23 -51.4 53.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.662 -179.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 1.006 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 54.2 m-85 -79.6 -20.55 46.62 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -173.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 9.0 tmtt? -60.71 -39.02 87.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.073 0.463 . . . . 0.0 109.944 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -86.18 6.21 30.43 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.736 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 58' ' ' ASN . 14.4 tppt? -98.68 -67.5 0.84 Allowed 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 175.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 65.6 t30 171.79 19.45 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.878 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 1.006 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 45.1 t80 -117.68 120.28 37.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.637 -177.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.413 ' HG3' HG22 ' A' ' 28' ' ' THR . 29.8 pt20 -114.78 148.56 38.25 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.083 0.468 . . . . 0.0 110.601 -178.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 84.9 t -109.87 120.27 60.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.237 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.458 ' HB3' ' HE3' ' A' ' 88' ' ' MET . 90.2 mt -103.03 95.64 6.27 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.387 177.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -86.11 106.92 17.58 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.826 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.578 HG22 ' HE1' ' A' ' 88' ' ' MET . 25.7 t -100.09 120.38 49.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 120.961 0.41 . . . . 0.0 110.411 -176.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.6 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -94.82 127.94 41.19 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.701 176.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.428 ' HB2' ' CD ' ' A' ' 67' ' ' PRO . 3.4 pt20 -97.12 170.94 6.57 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -178.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 90' ' ' ASP . 17.6 Cg_exo -67.0 79.11 0.39 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.806 2.337 . . . . 0.0 113.884 -175.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 47.7 mm -112.39 -68.63 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 167.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.497 ' OD1' ' HD2' ' A' ' 35' ' ' PRO . 3.5 p-10 -93.66 153.72 41.15 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 167.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.757 ' HG2' ' HG ' ' A' ' 73' ' ' SER . 24.5 Cg_endo -63.04 159.25 39.48 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 122.537 2.158 . . . . 0.0 113.266 -177.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.4 tp -53.95 -34.76 26.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.482 -178.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -60.69 -42.15 96.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.899 0.38 . . . . 0.0 110.899 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.757 ' HG ' ' HG2' ' A' ' 70' ' ' PRO . 51.0 m -62.98 -38.57 91.67 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.393 -177.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.721 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 20.0 t -60.77 -41.94 90.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.425 176.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.73 ' HA ' HG22 ' A' ' 78' ' ' VAL . 89.6 mtt180 -68.03 -32.53 72.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.819 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -61.71 -41.65 97.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.185 0.516 . . . . 0.0 109.863 177.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -67.72 -48.11 67.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.472 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.73 HG22 ' HA ' ' A' ' 75' ' ' ARG . 27.3 m -67.96 -29.08 43.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.988 -178.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -74.3 -55.09 6.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.146 0.498 . . . . 0.0 110.755 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -64.23 -48.35 76.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.339 -173.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -88.07 -21.49 24.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.728 0.299 . . . . 0.0 111.488 -175.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 71.47 59.9 4.65 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.271 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.515 HD13 ' HA ' ' A' ' 78' ' ' VAL . 10.8 mp -63.38 121.79 71.95 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 120.603 0.24 . . . . 0.0 110.901 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -82.26 -23.06 4.53 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.055 2.503 . . . . 0.0 113.377 -177.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -84.15 148.94 26.5 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.431 ' HB ' HD23 ' A' ' 62' ' ' LEU . 21.4 m -69.21 116.44 9.65 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.167 0.508 . . . . 0.0 111.305 -174.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 39.3 t -107.42 132.15 55.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.676 -178.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.578 ' HE1' HG22 ' A' ' 64' ' ' VAL . 73.3 mtm -123.4 173.72 7.81 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.497 ' CD1' HG23 ' A' ' 74' ' ' VAL . 60.1 t80 -140.0 116.49 10.71 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.515 ' HA ' HD12 ' A' ' 10' ' ' LEU . 10.0 p-10 -97.26 95.44 7.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.908 0.861 . . . . 0.0 110.23 178.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.45 ' HA ' ' HG3' ' A' ' 67' ' ' PRO . . . -73.28 -10.98 60.33 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.136 -176.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.485 ' C ' ' H ' ' A' ' 94' ' ' ALA . 19.1 m-20 -92.8 -14.95 27.12 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.352 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.5 ' O ' ' HG3' ' A' ' 97' ' ' GLN . 37.0 ttpt 63.36 -24.96 0.07 Allowed 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 175.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.485 ' H ' ' C ' ' A' ' 92' ' ' ASP . . . -61.9 -25.3 67.48 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -173.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.424 ' O ' ' HD1' ' A' ' 99' ' ' PHE . 26.8 m -70.95 -41.73 77.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.249 179.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.5 -36.36 91.37 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.109 174.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.5 ' HG3' ' O ' ' A' ' 93' ' ' LYS . 24.8 mt-30 -62.3 -33.13 74.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.249 -0.475 . . . . 0.0 110.418 176.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.85 -41.6 71.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.068 177.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.424 ' HD1' ' O ' ' A' ' 95' ' ' VAL . 7.8 m-85 -66.71 -27.3 67.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.481 178.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 94.1 39.19 4.91 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.106 177.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.53 ' HB ' ' CE1' ' A' ' 104' ' ' TYR . 39.9 p -71.26 100.73 2.17 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.063 0.459 . . . . 0.0 111.154 -178.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -86.56 -58.41 2.63 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.363 0.601 . . . . 0.0 109.997 177.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.511 HG13 ' HB ' ' A' ' 121' ' ' VAL . 14.6 p -122.01 143.67 33.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.755 -177.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.53 ' CE1' ' HB ' ' A' ' 101' ' ' THR . 39.7 m-85 -111.01 148.53 38.83 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.58 -174.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -75.26 152.65 98.07 Favored 'Cis proline' 0 CA--C 1.529 0.261 0 C-N-CA 123.272 -1.553 . . . . 0.0 112.869 0.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 23.8 m -111.48 112.65 24.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.0 177.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.446 ' HB3' HD12 ' A' ' 29' ' ' LEU . 24.4 m -94.73 110.17 22.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.243 0.544 . . . . 0.0 110.841 -178.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.536 HG21 HG22 ' A' ' 119' ' ' THR . 60.7 t -107.79 134.33 49.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.316 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 118' ' ' LYS . 7.2 mp -101.58 130.88 47.97 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.906 0.384 . . . . 0.0 110.039 -177.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.584 HG23 HD21 ' A' ' 23' ' ' LEU . 40.0 mm -110.83 130.27 64.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.206 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -77.38 -170.56 34.35 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.435 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 79.0 mttt -78.73 -7.56 57.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.715 0.769 . . . . 0.0 109.482 -174.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.31 -7.17 32.66 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.579 -1.191 . . . . 0.0 111.103 -172.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.08 60.94 3.17 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.673 -176.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -161.51 153.81 19.92 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -178.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 53.6 mt -66.7 105.46 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.925 -178.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.439 HD22 ' HA ' ' A' ' 117' ' ' LEU . 0.2 OUTLIER -84.07 -38.58 20.64 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.744 179.469 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.513 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 22.4 tptm -153.41 154.09 33.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.082 -174.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.536 HG22 HG21 ' A' ' 108' ' ' VAL . 33.0 m -140.66 116.84 10.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.059 0.457 . . . . 0.0 111.501 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -109.49 134.36 51.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.471 173.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.511 ' HB ' HG13 ' A' ' 103' ' ' VAL . 3.4 m -105.73 112.56 39.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.028 0.442 . . . . 0.0 110.442 175.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 91.76 -159.65 25.91 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.583 -176.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 54.7 tt0 -73.15 119.44 75.7 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.78 0.324 . . . . 0.0 110.54 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -88.36 165.19 6.73 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.833 2.356 . . . . 0.0 112.753 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.634 ' HB2' ' HE2' ' A' ' 128' ' ' LYS . 4.9 m-20 -67.87 102.81 1.32 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 173.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -62.95 -40.37 97.47 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -173.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -58.44 -47.81 87.67 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.444 -0.884 . . . . 0.0 111.605 177.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.634 ' HE2' ' HB2' ' A' ' 125' ' ' ASP . 33.6 ttpt -69.15 -36.99 78.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.438 -0.381 . . . . 0.0 110.33 177.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -61.48 -46.0 91.88 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.6 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -61.44 -47.91 83.58 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.62 0.248 . . . . 0.0 110.937 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -67.45 -38.62 84.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.399 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -65.44 -38.79 90.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.713 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 38.1 mt -60.59 -46.29 95.88 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 172.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -60.51 -36.54 78.61 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.963 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 66.5 m -60.97 -43.45 98.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.765 176.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.376 0 CA-C-O 121.224 0.535 . . . . 0.0 110.809 176.979 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.45 ' OD1' ' HB2' ' A' ' 6' ' ' PRO . 23.2 p-10 . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.418 ' HB3' ' HG2' ' A' ' 6' ' ' PRO . 20.2 t -83.72 -162.71 0.67 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.982 0.42 . . . . 0.0 110.231 176.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.453 ' HA ' HG13 ' A' ' 116' ' ' ILE . 23.9 mtmt -78.3 152.59 32.37 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.127 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.8 m 68.08 13.62 9.15 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.993 0.902 . . . . 0.0 109.717 -170.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 46.05 72.53 1.21 Allowed Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 114.204 -1.362 . . . . 0.0 114.267 174.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.45 ' HB2' ' OD1' ' A' ' 1' ' ' ASP . 32.4 Cg_exo -62.2 169.52 7.68 Favored 'Trans proline' 0 C--O 1.236 0.413 0 C-N-CA 122.202 1.935 . . . . 0.0 110.934 166.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.92 117.29 4.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.909 0.385 . . . . 0.0 111.715 -175.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -141.68 141.79 33.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.049 177.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.8 m -137.78 100.07 4.09 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.509 HD13 ' HD2' ' A' ' 11' ' ' PRO . 56.2 tp -115.16 120.2 37.23 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.426 -171.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.509 ' HD2' HD13 ' A' ' 10' ' ' LEU . 60.3 Cg_endo -75.07 129.71 12.53 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.497 2.131 . . . . 0.0 111.327 172.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.469 ' HB3' ' HE3' ' A' ' 88' ' ' MET . 2.3 p30 -86.55 -171.86 3.75 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.988 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.8 mt -67.12 -9.26 37.79 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -175.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -96.36 -9.56 29.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.932 0.396 . . . . 0.0 110.33 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.4 2.69 61.75 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.125 177.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 11' ' ' PRO . 20.6 pttp -96.13 144.79 26.05 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 28.5 m -94.45 125.55 39.16 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.889 -174.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.3 m -102.38 141.3 18.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 172.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 45.3 t -145.6 -178.08 5.91 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 121.076 -0.25 . . . . 0.0 110.963 -173.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -53.92 -39.22 65.65 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.258 0.623 . . . . 0.0 111.956 -175.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.77 -27.64 65.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.812 -177.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -78.49 -24.05 46.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.235 -176.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 81.5 mt -78.54 -21.37 48.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.895 0.379 . . . . 0.0 110.953 -178.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -72.27 103.33 3.34 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.02 0.438 . . . . 0.0 110.673 -176.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.0 -25.92 12.19 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.34 177.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.17 148.83 26.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.941 0.401 . . . . 0.0 110.343 178.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.489 HG12 ' O ' ' A' ' 110' ' ' ILE . 97.1 t -102.96 138.0 28.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 172.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 60' ' ' GLN . 22.3 m -132.06 135.12 46.24 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.614 -165.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.752 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 6.8 tt -106.88 106.43 16.96 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 173.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.898 HG12 ' HB2' ' A' ' 62' ' ' LEU . 39.9 mt -104.56 111.95 36.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 177.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' A' ' 106' ' ' THR . 26.7 p-10 -110.72 134.18 52.69 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.413 0.625 . . . . 0.0 110.645 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -91.66 119.25 31.37 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.615 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.627 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 4.5 p-90 -147.82 -174.13 4.47 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.615 -173.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -155.28 150.35 20.77 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 173.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.42 ' HD2' ' HB2' ' A' ' 69' ' ' ASP . 92.8 Cg_exo -43.72 -47.08 9.99 Favored 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 123.148 2.566 . . . . 0.0 114.13 -177.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.1 m -85.82 27.46 0.87 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -177.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.518 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 52.8 t -79.91 129.55 70.13 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.015 0.436 . . . . 0.0 111.101 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -63.54 -26.85 69.77 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.641 2.227 . . . . 0.0 111.922 176.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.2 -16.55 73.24 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.836 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.518 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 92.0 m -58.16 -29.4 65.56 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.72 0.26 . . . . 0.0 111.392 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.6 t -55.02 -43.08 67.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.997 0.427 . . . . 0.0 110.364 177.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.556 ' O ' ' HB3' ' A' ' 46' ' ' LYS . 15.1 m -86.5 -55.79 3.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.873 178.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.447 ' O ' HG12 ' A' ' 47' ' ' ILE . 43.3 mt-10 -59.46 -50.4 74.06 Favored 'General case' 0 C--O 1.213 -0.86 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -173.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.728 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 31.8 tpp -58.85 -61.02 8.6 Favored Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -164.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.728 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 33.1 Cg_exo -59.38 -35.96 95.25 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 121.652 1.568 . . . . 0.0 111.206 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.556 ' HB3' ' O ' ' A' ' 42' ' ' SER . 5.9 tptt -59.17 -49.3 78.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.956 176.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.549 HD12 ' HE3' ' A' ' 46' ' ' LYS . 43.8 mm -74.54 -31.58 27.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.63 -174.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.648 HG12 ' O ' ' A' ' 44' ' ' MET . 46.8 mm -54.72 -53.26 33.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-O 121.034 0.445 . . . . 0.0 109.901 176.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.674 ' HZ1' ' HB2' ' A' ' 53' ' ' ASP . 20.4 tptp -71.74 -35.97 70.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.969 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.3 m -62.11 -54.18 44.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.838 0.351 . . . . 0.0 111.202 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.594 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . -68.53 -27.38 66.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.981 -176.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.09 -39.3 60.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.493 177.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.674 ' HB2' ' HZ1' ' A' ' 49' ' ' LYS . 6.9 t70 -76.05 -52.19 10.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.233 0.54 . . . . 0.0 111.057 -173.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.841 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 90.8 m-85 -81.58 -2.47 50.18 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.363 -174.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.594 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 13.0 tppt? -59.4 -37.61 78.45 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.434 0.635 . . . . 0.0 109.916 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.2 m-20 -91.51 12.03 22.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.294 -175.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.584 ' O ' ' HB3' ' A' ' 58' ' ' ASN . 16.9 tptp -112.03 -61.68 1.68 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.711 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.584 ' HB3' ' O ' ' A' ' 57' ' ' LYS . 2.9 p-10 162.79 14.93 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 O-C-N 124.202 0.939 . . . . 0.0 110.279 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.841 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 57.2 t80 -112.53 143.03 44.38 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.924 0.392 . . . . 0.0 110.284 -175.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.524 ' O ' ' HA ' ' A' ' 28' ' ' THR . 11.7 pt20 -136.76 147.55 46.74 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.669 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.457 HG13 HG22 ' A' ' 47' ' ' ILE . 87.3 t -115.07 132.2 65.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.007 178.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.898 ' HB2' HG12 ' A' ' 30' ' ' ILE . 77.6 mt -122.37 110.9 16.22 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.632 ' HB2' HG21 ' A' ' 87' ' ' VAL . . . -94.48 116.42 28.77 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.171 -177.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.0 t -105.17 111.81 36.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.065 0.46 . . . . 0.0 110.528 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.627 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -95.83 124.77 39.99 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.929 177.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.5 169.73 8.18 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.604 ' HD3' ' O ' ' A' ' 90' ' ' ASP . 16.4 Cg_exo -67.33 80.77 0.41 Allowed 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.617 2.211 . . . . 0.0 113.781 -172.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 50.2 mm -117.69 -54.66 4.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 168.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.42 ' HB2' ' HD2' ' A' ' 35' ' ' PRO . 17.2 m-20 -101.86 151.94 38.05 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.738 170.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.31 151.12 30.53 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.73 2.287 . . . . 0.0 112.902 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.3 tt -57.19 -36.3 51.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.894 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.501 ' HA ' ' HD2' ' A' ' 75' ' ' ARG . 31.1 tp10 -69.61 -35.31 75.17 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.533 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.9 m -62.27 -32.45 73.16 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.206 0.527 . . . . 0.0 110.081 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.471 ' O ' HG12 ' A' ' 78' ' ' VAL . 45.2 t -65.42 -44.31 94.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.692 174.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.753 ' HA ' HG23 ' A' ' 78' ' ' VAL . 91.4 mtt180 -64.67 -31.92 73.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.388 177.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -60.98 -44.48 97.3 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 177.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.422 ' CE1' ' HE1' ' A' ' 44' ' ' MET . 1.8 t80 -63.53 -46.16 87.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.272 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.753 HG23 ' HA ' ' A' ' 75' ' ' ARG . 11.1 m -67.08 -37.45 79.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.642 -177.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -75.64 -48.12 23.5 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -66.34 -48.38 70.44 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.103 -172.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -92.4 2.22 56.78 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -173.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 57.9 63.72 5.01 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.308 -0.473 . . . . 0.0 113.033 177.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.497 HD22 HG11 ' A' ' 78' ' ' VAL . 10.0 mp -73.22 115.85 45.01 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 120.702 0.287 . . . . 0.0 111.231 -177.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.39 15.98 1.78 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.177 2.584 . . . . 0.0 113.022 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.528 ' HE1' HD13 ' A' ' 48' ' ' ILE . 24.1 p90 -128.76 153.56 47.26 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.071 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.402 ' HB ' ' CD2' ' A' ' 62' ' ' LEU . 32.2 m -79.39 130.39 35.38 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.953 -174.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.632 HG21 ' HB2' ' A' ' 63' ' ' ALA . 60.9 t -116.44 139.43 43.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.334 -178.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.503 ' HE1' HD21 ' A' ' 62' ' ' LEU . 2.6 mpt? -119.24 169.3 10.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.078 177.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -123.5 110.3 14.9 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.604 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 0.9 OUTLIER -81.78 72.25 8.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.893 -175.646 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.78 -46.84 86.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.374 -172.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -87.78 -10.91 49.59 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.673 -0.24 . . . . 0.0 110.776 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.774 ' HZ1' ' HB2' ' A' ' 93' ' ' LYS . 8.1 mtmp? 69.23 7.49 6.26 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.562 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.65 -32.04 70.47 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -172.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.6 t -71.24 -42.91 74.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.58 -37.87 94.09 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.887 174.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -67.02 -32.05 73.0 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 122.486 0.315 . . . . 0.0 111.01 177.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.29 -45.29 85.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.648 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -66.62 -28.22 68.32 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.788 0.328 . . . . 0.0 110.644 176.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 71.96 59.95 4.45 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.804 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.6 p -99.88 -66.64 0.89 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.591 0.234 . . . . 0.0 111.069 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 72.53 -38.54 0.42 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.681 0.792 . . . . 0.0 112.296 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.8 m -97.83 132.3 42.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.139 0.495 . . . . 0.0 110.567 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -128.29 153.04 78.88 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.047 -175.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -80.86 161.01 83.2 Favored 'Cis proline' 0 C--O 1.234 0.314 0 C-N-CA 123.376 -1.51 . . . . 0.0 112.353 -0.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 10.2 t -150.25 127.53 11.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.15 0.5 . . . . 0.0 111.358 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.3 m -101.24 122.53 43.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.089 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 48.5 t -106.06 132.46 53.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.83 0.347 . . . . 0.0 110.207 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.548 HD22 ' HB3' ' A' ' 118' ' ' LYS . 2.8 mm? -102.03 118.77 37.6 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.943 -178.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.489 ' O ' HG12 ' A' ' 27' ' ' VAL . 53.5 mt -100.99 127.74 53.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.037 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -72.14 -179.51 33.68 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.204 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -86.61 -5.11 59.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.919 0.39 . . . . 0.0 110.764 -175.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -98.34 -31.6 11.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.856 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 113.89 19.83 6.29 Favored Glycine 0 C--O 1.225 -0.431 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.553 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.93 -26.2 60.38 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -172.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.467 HD12 HG21 ' A' ' 110' ' ' ILE . 20.8 mm 58.34 96.92 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-O 121.216 0.531 . . . . 0.0 109.582 -167.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.7 mt -93.68 -76.03 0.49 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -165.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.548 ' HB3' HD22 ' A' ' 109' ' ' LEU . 21.9 tptm -109.22 145.05 36.51 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.049 -164.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 7.7 p -122.67 108.01 12.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.382 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -94.88 128.7 41.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.994 173.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.7 t -120.1 132.39 69.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.668 0.271 . . . . 0.0 110.549 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 84.19 -102.51 2.51 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.122 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -106.78 108.78 62.5 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.456 ' HB2' HD22 ' A' ' 129' ' ' LEU . 68.7 Cg_endo -76.65 104.69 1.95 Allowed 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.198 1.932 . . . . 0.0 112.16 178.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -48.75 107.66 0.14 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.676 178.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -60.15 -43.4 95.77 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.095 -173.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -59.5 -51.0 61.68 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.495 -176.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -80.27 -21.0 43.18 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 122.973 -0.133 . . . . 0.0 111.248 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.466 ' O ' HG13 ' A' ' 133' ' ' ILE . 52.0 tp -68.69 -47.04 67.46 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.162 -0.311 . . . . 0.0 110.162 176.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -66.96 -40.54 87.5 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.908 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -68.11 -30.49 69.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.728 0.299 . . . . 0.0 111.309 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.495 ' OE1' ' HG2' ' A' ' 118' ' ' LYS . 35.3 tt0 -77.82 -34.34 52.06 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.663 0.268 . . . . 0.0 110.488 178.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 129' ' ' LEU . 76.1 mt -65.66 -38.94 83.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-O 121.212 0.529 . . . . 0.0 109.659 172.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.37 -36.42 84.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.461 172.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 91.1 m -63.35 -31.67 72.89 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.13 174.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -65.14 -30.63 71.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.596 175.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.766 ' HH2' ' HB2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -69.09 -54.93 12.43 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 172.392 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 17.7 ttp-105 -56.45 -40.57 75.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.142 -1.39 . . . . 0.0 112.147 -176.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -64.19 93.28 0.09 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 173.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 5.6 m -60.8 -63.94 1.12 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.143 -172.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -99.03 -44.81 6.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.671 -173.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . 70.02 52.17 0.39 Allowed 'General case' 0 N--CA 1.465 0.305 0 O-C-N 123.796 0.685 . . . . 0.0 109.498 -167.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 62.94 101.83 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 114.214 -1.357 . . . . 0.0 112.565 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -116.77 27.68 7.77 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 172.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 65.49 24.12 11.86 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.43 0.692 . . . . 0.0 110.196 -176.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 27.8 m80 67.34 10.76 7.97 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.453 175.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -147.6 82.89 1.53 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 175.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -64.83 114.56 4.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.255 -173.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 52.5 p-80 -137.58 20.46 2.91 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.261 175.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 71.9 t60 . . . . . 0 C--O 1.245 0.833 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.011 176.749 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.514 ' HA ' ' O ' ' A' ' 5' ' ' ALA . 12.7 t70 . . . . . 0 N--CA 1.48 1.04 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.3 t 62.29 100.92 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 O-C-N 123.922 0.764 . . . . 0.0 110.846 -176.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.536 ' HA ' HD13 ' A' ' 116' ' ' ILE . 44.8 mttp 66.92 13.87 9.61 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.931 0.872 . . . . 0.0 110.932 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.6 p -148.86 35.86 0.77 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.946 -1.479 . . . . 0.0 107.981 173.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.514 ' O ' ' HA ' ' A' ' 1' ' ' ASP . . . 66.13 108.34 0.03 OUTLIER Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 113.747 -1.57 . . . . 0.0 111.224 -172.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.03 163.32 38.61 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.432 2.088 . . . . 0.0 111.39 176.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.21 88.44 2.49 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.164 0.507 . . . . 0.0 110.156 176.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -129.49 148.86 51.44 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.352 0.596 . . . . 0.0 111.134 -177.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.9 m -141.23 90.75 2.33 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 171.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.521 HD12 ' HD2' ' A' ' 11' ' ' PRO . 28.4 tp -112.57 124.35 32.07 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.216 -172.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.583 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 58.3 Cg_endo -73.07 138.71 28.6 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.406 2.071 . . . . 0.0 111.908 176.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.497 ' HA ' ' HG2' ' A' ' 88' ' ' MET . 0.0 OUTLIER -75.29 169.44 18.05 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 175.488 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.517 HD11 ' HG2' ' A' ' 75' ' ' ARG . 84.6 mt -66.03 -17.79 64.92 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -175.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.429 ' H ' ' CG ' ' A' ' 12' ' ' ASP . 48.8 t-80 -86.89 -19.55 28.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.945 177.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.7 4.4 21.47 Favored Glycine 0 CA--C 1.517 0.208 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.058 177.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -85.62 110.75 19.49 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 122.595 -0.356 . . . . 0.0 110.263 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.583 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 8.3 m -64.3 122.88 17.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.678 178.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.602 HG13 HD23 ' A' ' 62' ' ' LEU . 59.6 t -110.89 125.07 68.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.924 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 51.0 p -140.94 -174.35 3.97 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.236 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -55.87 -32.27 63.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.109 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.6 -28.53 67.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.202 -176.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -78.84 -23.89 44.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.031 0.443 . . . . 0.0 110.549 -175.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 81.3 mt -77.64 -19.98 54.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.172 -177.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.478 ' OE1' ' HA ' ' A' ' 113' ' ' LYS . 16.5 mm-40 -64.57 119.04 9.72 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.775 -174.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.13 -21.29 46.77 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.035 -0.602 . . . . 0.0 113.078 174.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 112' ' ' LYS . 31.3 mtmt -117.77 160.58 21.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.808 0.337 . . . . 0.0 111.167 -174.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.587 HG21 ' CD1' ' A' ' 137' ' ' TRP . 13.2 t -101.71 144.76 12.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -178.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.607 HG21 HD11 ' A' ' 62' ' ' LEU . 40.6 m -139.34 140.41 37.52 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.06 0.457 . . . . 0.0 112.102 -168.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.877 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 28.1 tp -109.4 106.18 15.85 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.333 171.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.66 ' HB ' ' CG2' ' A' ' 108' ' ' VAL . 37.2 mt -91.09 111.59 23.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 C-N-CA 120.303 -0.559 . . . . 0.0 109.51 176.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -108.83 114.81 28.91 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.897 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -87.69 118.24 27.05 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.483 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 8.0 p-90 -144.71 -173.81 4.16 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.014 0.435 . . . . 0.0 110.464 -176.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -161.71 144.3 8.99 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.351 176.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -58.53 163.98 9.87 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.366 2.044 . . . . 0.0 111.84 175.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 44.5 m 66.84 11.89 8.56 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.408 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.1 t -95.67 126.11 46.59 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.47 177.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.43 ' O ' HG12 ' A' ' 41' ' ' VAL . 35.2 Cg_exo -61.87 -18.2 59.66 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.977 2.451 . . . . 0.0 112.978 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.55 -6.73 56.11 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 121.125 -0.559 . . . . 0.0 113.112 -178.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.684 ' HB2' ' HH ' ' A' ' 77' ' ' TYR . 26.3 p -62.19 -30.58 71.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.559 0.219 . . . . 0.0 110.887 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.43 HG12 ' O ' ' A' ' 38' ' ' PRO . 13.0 p -66.73 -28.92 44.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.845 0.355 . . . . 0.0 110.899 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.6 m -88.0 -56.74 3.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.014 0.435 . . . . 0.0 111.268 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.548 ' HA ' ' HE2' ' A' ' 46' ' ' LYS . 2.9 mt-10 -74.32 -40.69 62.04 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -170.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.536 ' HE3' ' CE1' ' A' ' 77' ' ' TYR . 35.2 tpp -59.57 -54.87 51.65 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -172.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 44' ' ' MET . 15.9 Cg_endo -57.52 -35.48 98.83 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 121.829 1.686 . . . . 0.0 111.731 177.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.592 ' HG3' ' HE2' ' A' ' 126' ' ' PHE . 28.8 ttpt -61.14 -51.94 66.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.541 175.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.545 HG12 ' O ' ' A' ' 43' ' ' GLU . 47.3 mm -57.17 -41.03 77.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.788 -178.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.46 HG12 ' O ' ' A' ' 44' ' ' MET . 48.8 mm -57.9 -45.87 87.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.995 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -75.4 -40.96 57.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.498 0.19 . . . . 0.0 111.248 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.527 ' HA ' ' HH ' ' A' ' 130' ' ' TYR . 60.7 m -59.55 -50.01 75.55 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.859 0.361 . . . . 0.0 110.435 177.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.76 -31.8 72.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.598 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -54.22 -44.06 71.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.958 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -79.01 -51.89 8.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.35 0.595 . . . . 0.0 111.142 177.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.995 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 50.8 m-85 -72.3 -20.46 61.5 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -167.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -68.52 -15.23 63.47 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 122.207 -0.308 . . . . 0.0 110.793 176.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -106.83 8.16 30.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.36 0.6 . . . . 0.0 109.874 177.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.959 ' HD2' ' HH2' ' A' ' 137' ' ' TRP . 30.8 mmtp -100.87 -69.71 0.76 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.376 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.41 ' ND2' ' HG2' ' A' ' 26' ' ' LYS . 4.5 t-20 164.23 29.59 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -172.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.995 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 48.6 t80 -131.41 138.22 49.0 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.799 -167.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.415 ' O ' ' HA ' ' A' ' 28' ' ' THR . 10.8 pt20 -128.26 140.96 51.6 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.464 178.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.412 HG12 HG23 ' A' ' 47' ' ' ILE . 60.4 t -100.61 125.85 54.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.012 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.607 HD11 HG21 ' A' ' 28' ' ' THR . 10.9 mp -112.48 99.11 7.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.85 107.32 16.95 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.863 178.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.1 t -99.22 104.35 15.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.064 0.459 . . . . 0.0 110.458 -177.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -90.89 120.3 31.79 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 175.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.636 ' HB3' ' HD2' ' A' ' 67' ' ' PRO . 37.0 mt-30 -94.83 170.79 7.47 Favored Pre-proline 0 C--N 1.317 -0.821 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -177.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.636 ' HD2' ' HB3' ' A' ' 66' ' ' GLN . 72.5 Cg_endo -71.01 57.92 2.1 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 123.135 2.557 . . . . 0.0 115.225 -164.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 49.8 mm -92.24 -51.56 11.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 171.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.512 ' OD1' ' HD2' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -109.23 149.81 40.22 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.362 -0.835 . . . . 0.0 108.779 174.104 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.512 ' HD2' ' OD1' ' A' ' 69' ' ' ASP . 84.4 Cg_exo -49.56 155.76 3.39 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 123.058 2.506 . . . . 0.0 113.737 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.606 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 11.1 tt -54.95 -40.87 55.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.695 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -65.79 -33.47 75.93 Favored 'General case' 0 C--O 1.215 -0.746 0 C-N-CA 120.864 -0.335 . . . . 0.0 110.694 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.7 m -58.26 -40.8 82.8 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.374 0.607 . . . . 0.0 109.943 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.0 t -65.59 -44.07 93.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.284 175.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.776 ' HA ' HG22 ' A' ' 78' ' ' VAL . 20.1 mtm180 -67.53 -24.98 65.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.019 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -68.63 -43.07 77.1 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.684 ' HH ' ' HB2' ' A' ' 40' ' ' CYS . 9.3 t80 -63.78 -47.59 80.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.147 178.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.776 HG22 ' HA ' ' A' ' 75' ' ' ARG . 12.6 m -65.83 -26.63 39.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.129 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.593 ' HB2' ' O ' ' A' ' 75' ' ' ARG . 3.6 ttmp? -74.21 -52.15 13.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.892 -177.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -67.19 -49.43 64.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.204 -174.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -85.82 -10.43 55.44 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -174.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.62 60.28 8.77 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.308 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.552 HD13 ' HA ' ' A' ' 78' ' ' VAL . 10.1 mp -63.64 116.01 22.98 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 120.879 0.371 . . . . 0.0 111.461 -176.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -86.45 25.26 0.69 Allowed 'Trans proline' 0 C--O 1.241 0.636 0 C-N-CA 123.314 2.676 . . . . 0.0 113.467 -177.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -136.23 159.71 40.9 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 30.7 m -67.71 122.68 18.61 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.434 -174.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.8 t -119.29 127.57 75.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.956 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.497 ' HG2' ' HA ' ' A' ' 12' ' ' ASP . 67.2 mtm -122.76 164.36 18.48 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.263 -177.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.449 ' OH ' ' HA ' ' A' ' 67' ' ' PRO . 67.6 t80 -126.1 125.65 42.9 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.373 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.489 ' HB3' ' HA ' ' A' ' 66' ' ' GLN . 28.4 t0 -88.89 135.91 33.29 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.25 -32.84 61.21 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.435 ' O ' ' HB3' ' A' ' 93' ' ' LYS . 31.9 t70 -130.07 -11.08 4.25 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -172.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.685 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER 82.93 17.94 0.28 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 122.89 1.329 . . . . 0.0 108.744 -172.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.583 ' HA ' HE21 ' A' ' 97' ' ' GLN . . . -74.02 -27.17 60.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.007 -176.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.7 t -69.14 -41.19 81.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.57 -33.59 87.64 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 174.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.583 HE21 ' HA ' ' A' ' 94' ' ' ALA . 47.0 mt-30 -64.14 -39.05 93.19 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 122.595 0.358 . . . . 0.0 111.098 176.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.48 -39.82 92.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.058 0.456 . . . . 0.0 110.967 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -73.01 -27.78 61.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.556 177.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.98 34.44 5.68 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.425 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 29.1 p -106.17 126.25 51.98 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.742 0.305 . . . . 0.0 110.804 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.486 ' HG3' HG11 ' A' ' 103' ' ' VAL . 11.8 pt20 -108.82 -36.32 6.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.907 0.384 . . . . 0.0 110.839 178.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.486 HG11 ' HG3' ' A' ' 102' ' ' GLN . 19.7 m -102.85 142.1 17.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.21 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.519 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 37.6 m-85 -130.46 158.67 73.82 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.09 -177.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.519 ' HA ' ' HB3' ' A' ' 104' ' ' TYR . 94.1 Cg_endo -81.41 165.05 75.51 Favored 'Cis proline' 0 CA--C 1.53 0.311 0 C-N-CA 123.587 -1.422 . . . . 0.0 113.17 0.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.52 HG22 ' HA ' ' A' ' 121' ' ' VAL . 95.8 m -150.82 133.32 15.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.787 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.542 ' HB3' HD11 ' A' ' 29' ' ' LEU . 68.0 m -108.09 117.47 34.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.969 0.414 . . . . 0.0 111.003 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.66 ' CG2' ' HB ' ' A' ' 30' ' ' ILE . 29.0 m -106.36 146.15 13.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.121 0.486 . . . . 0.0 110.839 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.658 ' HB2' ' HB3' ' A' ' 118' ' ' LYS . 2.6 mm? -102.37 124.47 48.0 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.065 -176.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.55 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 22.7 mm -104.4 134.59 45.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 27' ' ' VAL . . . -67.79 -93.66 0.04 OUTLIER Glycine 0 C--O 1.226 -0.353 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.868 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 10.9 ptpt -166.8 23.73 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.271 0.557 . . . . 0.0 110.844 171.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.478 ' HA ' ' OE1' ' A' ' 24' ' ' GLN . 36.8 mtmm -136.12 10.1 3.27 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 174.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.488 ' O ' ' HB3' ' A' ' 5' ' ' ALA . . . 78.25 18.35 76.45 Favored Glycine 0 C--O 1.223 -0.535 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.54 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -69.71 -24.63 63.6 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -171.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.536 HD13 ' HA ' ' A' ' 3' ' ' LYS . 8.5 mt 64.02 89.63 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.66 0.743 . . . . 0.0 109.701 -175.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 23.2 mt -87.54 -34.93 18.42 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.257 -0.883 . . . . 0.0 113.109 -167.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.658 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 22.0 tptm -150.27 157.53 43.18 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.302 -168.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.524 HG23 HG11 ' A' ' 108' ' ' VAL . 51.4 m -140.28 107.86 5.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.859 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.639 ' HB3' ' HB3' ' A' ' 124' ' ' PRO . 67.8 m-85 -101.68 107.39 18.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.117 173.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.52 ' HA ' HG22 ' A' ' 106' ' ' THR . 48.1 t -82.93 126.78 40.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.46 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 80.31 -138.58 20.01 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.029 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.456 ' CD ' ' HZ3' ' A' ' 46' ' ' LYS . 12.7 tp10 -96.64 109.33 47.74 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 110.229 -0.285 . . . . 0.0 110.229 -178.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.639 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 91.9 Cg_endo -81.72 174.11 10.65 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 123.234 2.623 . . . . 0.0 113.359 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.478 ' OD2' ' HB3' ' A' ' 128' ' ' LYS . 11.2 p-10 -88.3 120.0 29.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.091 175.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.592 ' HE2' ' HG3' ' A' ' 46' ' ' LYS . 92.2 m-85 -58.47 -46.94 85.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.832 -173.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -56.34 -53.63 41.72 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 121.045 -0.598 . . . . 0.0 113.443 -172.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.553 ' NZ ' ' HB3' ' A' ' 128' ' ' LYS . 2.1 ttpm? -76.17 -26.14 55.94 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.464 0.173 . . . . 0.0 110.694 -177.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.486 ' O ' HG13 ' A' ' 133' ' ' ILE . 7.5 tt -64.41 -46.99 80.87 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 177.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.527 ' HH ' ' HA ' ' A' ' 50' ' ' THR . 7.0 m-85 -61.78 -56.04 23.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.479 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.409 ' HG2' ' HA ' ' A' ' 128' ' ' LYS . 4.5 pt20 -60.91 -29.61 69.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.718 0.294 . . . . 0.0 111.292 -176.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -72.46 -36.37 68.48 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.711 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 129' ' ' LEU . 69.1 mt -69.36 -53.0 27.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -62.78 -27.32 69.22 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.767 0.318 . . . . 0.0 111.413 -176.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 90.4 m -73.76 -30.85 63.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.012 0.434 . . . . 0.0 110.964 177.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.448 ' HA ' ' ND2' ' A' ' 139' ' ' ASN . . . -65.83 -18.38 65.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.563 -177.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.959 ' HH2' ' HD2' ' A' ' 57' ' ' LYS . 38.6 m0 -56.93 -36.69 70.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.812 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.451 ' C ' ' H ' ' A' ' 140' ' ' SER . 7.3 tpt180 -81.49 -15.46 54.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.24 -173.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.448 ' ND2' ' HA ' ' A' ' 136' ' ' ALA . 89.7 m-20 -73.1 35.38 0.08 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -175.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.451 ' H ' ' C ' ' A' ' 138' ' ' ARG . 47.2 m -150.09 13.06 0.77 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.045 0.45 . . . . 0.0 109.844 175.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -95.16 149.21 21.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.988 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -155.35 101.12 2.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.949 0.404 . . . . 0.0 112.044 -175.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -67.75 142.57 56.22 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 171.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 129.8 -29.63 3.72 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 -173.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -75.17 80.37 2.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.234 0.54 . . . . 0.0 109.656 177.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -99.32 110.49 23.0 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.694 -172.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -94.34 -0.68 54.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.359 0.599 . . . . 0.0 109.388 172.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -110.03 118.89 37.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.745 176.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -99.12 154.93 17.74 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.686 -173.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 63.5 m-70 . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.044 -0.979 . . . . 0.0 108.659 167.148 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 . . . . . 0 N--CA 1.481 1.118 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.3 p -65.73 -72.74 0.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 O-C-N 123.214 0.321 . . . . 0.0 110.358 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 55.21 -125.02 2.16 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.232 173.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.1 p -92.76 28.86 1.92 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.839 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 72.94 124.51 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.334 1.021 . . . . 0.0 111.668 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.21 169.22 22.05 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.529 2.153 . . . . 0.0 111.583 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.69 101.85 8.64 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.711 0.291 . . . . 0.0 110.397 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -122.74 140.92 52.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.587 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.529 ' HA ' ' HG ' ' A' ' 19' ' ' SER . 68.4 m -128.15 90.64 3.12 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.516 HD11 ' HD2' ' A' ' 11' ' ' PRO . 35.6 tp -114.88 125.01 29.51 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.314 -175.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.516 ' HD2' HD11 ' A' ' 10' ' ' LEU . 61.0 Cg_endo -75.57 153.59 39.24 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.215 1.944 . . . . 0.0 112.184 176.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.508 ' HA ' ' HG2' ' A' ' 88' ' ' MET . 1.9 p-10 -83.23 -166.24 1.3 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.824 177.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 87' ' ' VAL . 89.9 mt -77.35 3.03 14.08 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -176.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.427 ' CE1' ' HB2' ' A' ' 16' ' ' LYS . 4.7 p-80 -128.07 -20.65 3.75 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 119.924 -0.711 . . . . 0.0 111.731 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 125.88 27.82 1.1 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.085 -1.055 . . . . 0.0 113.898 174.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.438 ' C ' ' HD3' ' A' ' 16' ' ' LYS . 13.2 tmtt? -100.58 112.48 24.87 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 175.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.6 m -66.97 122.32 17.47 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.943 0.402 . . . . 0.0 110.696 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.484 HG13 HD13 ' A' ' 62' ' ' LEU . 60.2 t -108.73 131.98 57.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.808 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.529 ' HG ' ' HA ' ' A' ' 9' ' ' SER . 50.4 m -145.55 -174.21 4.33 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.97 0.414 . . . . 0.0 111.148 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -61.04 -25.07 66.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.462 -177.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.22 -34.09 74.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.352 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -70.34 -30.39 67.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.323 0.583 . . . . 0.0 110.398 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.555 HD13 HG23 ' A' ' 110' ' ' ILE . 35.0 mt -85.36 -40.47 16.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.632 -171.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -71.49 21.69 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -159.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -152.19 11.19 0.66 Allowed Glycine 0 C--N 1.321 -0.279 0 C-N-CA 120.033 -1.08 . . . . 0.0 113.114 177.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 58' ' ' ASN . 11.4 ptmm? -160.02 179.58 8.63 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.595 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 21.4 t -102.89 139.32 24.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 C-N-CA 120.472 -0.491 . . . . 0.0 109.71 -175.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.573 HG22 ' HG3' ' A' ' 60' ' ' GLN . 44.3 m -136.88 148.14 46.89 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.705 -171.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.777 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 62.7 tp -112.79 105.8 14.01 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 175.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.509 HD11 ' HB2' ' A' ' 62' ' ' LEU . 48.5 mm -88.48 110.56 21.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 172.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.467 ' HA ' ' O ' ' A' ' 106' ' ' THR . 9.2 t30 -120.13 110.29 16.45 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.0 -173.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -84.03 120.45 26.15 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.394 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.427 ' NE1' ' HB1' ' A' ' 63' ' ' ALA . 2.8 p-90 -150.33 -171.82 4.01 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.651 -176.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.435 ' HB3' ' NE2' ' A' ' 66' ' ' GLN . 40.0 p90 -155.98 138.48 10.36 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.512 -0.767 . . . . 0.0 108.955 174.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.719 ' HD2' ' HB2' ' A' ' 69' ' ' ASP . 71.2 Cg_exo -41.96 -46.23 6.92 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.868 3.045 . . . . 0.0 115.167 -174.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.1 m -80.92 8.53 8.14 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -173.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.4 p -75.61 157.86 83.75 Favored Pre-proline 0 C--N 1.327 -0.398 0 O-C-N 122.263 -0.273 . . . . 0.0 110.651 -178.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -62.15 -11.29 21.32 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.652 2.234 . . . . 0.0 112.008 175.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.794 ' O ' ' HB2' ' A' ' 43' ' ' GLU . . . -75.86 4.55 44.76 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.756 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 12.5 p -78.43 -56.15 4.67 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 121.338 -1.095 . . . . 0.0 110.555 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.65 -42.77 71.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.787 -175.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.0 m -86.79 -42.81 13.0 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -175.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.794 ' HB2' ' O ' ' A' ' 39' ' ' GLY . 20.8 mm-40 -83.47 -41.69 17.75 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -171.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.606 ' O ' HG12 ' A' ' 48' ' ' ILE . 33.7 tpp -51.74 -53.18 53.54 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -171.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.59 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 52.9 Cg_exo -55.6 -40.39 85.64 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.872 1.715 . . . . 0.0 112.599 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.467 ' HZ1' ' CD ' ' A' ' 43' ' ' GLU . 23.8 ttpp -71.14 -34.94 71.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.56 -179.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.7 mm -69.14 -43.02 81.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.757 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.606 HG12 ' O ' ' A' ' 44' ' ' MET . 47.3 mm -55.55 -52.65 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.028 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.434 ' HE2' ' O ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -58.56 -46.07 87.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.642 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 84.0 m -62.18 -53.14 59.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.639 -178.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.83 -36.18 77.88 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -173.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.73 -33.84 62.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.821 0.343 . . . . 0.0 110.264 -178.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -70.69 -51.41 27.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.572 0.701 . . . . 0.0 109.937 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 1.012 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 22.6 m-85 -72.01 -7.39 48.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.411 -178.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.9 tptt -57.68 -41.77 82.29 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.488 0.492 . . . . 0.0 110.642 -177.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -101.56 10.07 40.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.272 -177.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.631 ' HG3' ' OD1' ' A' ' 58' ' ' ASN . 25.9 tptp -95.33 -62.81 1.24 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.365 -177.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.631 ' OD1' ' HG3' ' A' ' 57' ' ' LYS . 2.4 p-10 169.66 7.31 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.422 0.689 . . . . 0.0 109.763 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 1.012 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 54.2 t80 -118.33 148.6 42.32 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.542 -165.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.573 ' HG3' HG22 ' A' ' 28' ' ' THR . 10.8 pt20 -141.62 129.73 22.11 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.102 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.6 t -95.52 115.62 35.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 120.973 0.416 . . . . 0.0 110.117 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.509 ' HB2' HD11 ' A' ' 30' ' ' ILE . 84.2 mt -109.81 95.96 5.94 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.432 -0.804 . . . . 0.0 108.926 177.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.509 ' HB3' HG23 ' A' ' 87' ' ' VAL . . . -80.83 125.57 30.25 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.117 -177.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.454 HG22 ' HE2' ' A' ' 88' ' ' MET . 29.1 t -106.03 115.75 48.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 120.908 0.385 . . . . 0.0 110.106 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.09 112.62 22.88 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.245 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.571 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 0.8 OUTLIER -93.91 162.04 28.15 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.979 -179.364 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.581 ' HD3' ' O ' ' A' ' 90' ' ' ASP . 60.1 Cg_endo -69.3 66.49 1.5 Allowed 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 123.081 2.521 . . . . 0.0 115.862 -164.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.4 mp -107.55 -51.34 7.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 162.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.719 ' HB2' ' HD2' ' A' ' 35' ' ' PRO . 30.5 m-20 -101.44 135.3 19.86 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.515 174.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -57.2 160.88 12.18 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.946 2.431 . . . . 0.0 112.336 177.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.557 ' O ' ' HG2' ' A' ' 75' ' ' ARG . 9.4 tt -58.27 -36.09 56.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.325 -177.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.755 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . 2.2 pm0 -68.97 -29.93 68.25 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.981 -0.287 . . . . 0.0 111.444 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.1 m -65.12 -38.38 90.5 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 174.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.1 t -71.98 -49.16 46.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.772 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.833 ' HA ' HG22 ' A' ' 78' ' ' VAL . 13.4 ptt180 -70.11 -24.95 63.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.702 -177.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -69.35 -42.84 74.75 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 170.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.415 ' CE1' ' HE2' ' A' ' 44' ' ' MET . 4.5 t80 -62.24 -50.06 73.24 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.118 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.833 HG22 ' HA ' ' A' ' 75' ' ' ARG . 21.5 m -62.41 -27.01 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.063 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.22 -55.09 6.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.236 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -62.45 -43.93 97.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.44 -171.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -97.75 -3.16 39.6 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -173.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 56.56 65.52 3.51 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.446 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.543 HD13 ' HA ' ' A' ' 78' ' ' VAL . 9.7 mp -68.98 117.62 53.37 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-O 120.907 0.384 . . . . 0.0 111.575 -175.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -78.65 -4.65 14.25 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.32 2.68 . . . . 0.0 113.14 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -106.31 138.81 41.83 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.445 ' HB ' HD23 ' A' ' 62' ' ' LEU . 22.0 m -72.0 126.29 29.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.242 -172.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.509 HG23 ' HB3' ' A' ' 63' ' ' ALA . 46.1 t -110.68 131.79 60.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.788 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.508 ' HG2' ' HA ' ' A' ' 12' ' ' ASP . 63.2 mtm -112.74 168.36 9.74 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.06 176.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -121.6 127.18 50.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.827 0.346 . . . . 0.0 110.429 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.581 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 63.5 t0 -105.14 106.53 17.06 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.71 -47.75 37.16 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -173.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -91.93 -5.2 53.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.639 -175.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.577 ' O ' ' HG3' ' A' ' 97' ' ' GLN . 34.5 ttmt 65.66 20.2 11.53 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -173.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.93 -25.65 60.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.169 -175.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.443 HG23 HD23 ' A' ' 10' ' ' LEU . 22.5 t -74.01 -39.05 50.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 174.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.95 -33.3 86.87 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.772 173.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.577 ' HG3' ' O ' ' A' ' 93' ' ' LYS . 78.0 mt-30 -66.19 -33.27 75.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.98 0.419 . . . . 0.0 110.815 176.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.53 -39.87 70.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.478 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -87.27 -27.05 23.15 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.36 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 97.58 62.42 0.9 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.924 176.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 66.5 p -79.76 112.01 16.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.673 0.273 . . . . 0.0 111.147 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -103.51 -38.37 7.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.895 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.457 ' CG1' ' HB ' ' A' ' 121' ' ' VAL . 9.7 p -144.47 144.15 22.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -108.51 146.93 34.7 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.08 -173.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -75.33 151.48 96.48 Favored 'Cis proline' 0 C--N 1.343 0.279 0 C-N-CA 122.814 -1.744 . . . . 0.0 112.801 0.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 23.9 m -108.09 112.65 25.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.591 176.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.533 ' HB3' HD13 ' A' ' 29' ' ' LEU . 9.4 m -102.5 109.8 21.55 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.952 0.406 . . . . 0.0 110.6 -176.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 36.3 t -108.28 133.2 53.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.471 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.542 HD12 ' HB3' ' A' ' 118' ' ' LYS . 97.2 mt -101.58 116.34 32.54 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.085 0.469 . . . . 0.0 110.168 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.555 HG23 HD13 ' A' ' 23' ' ' LEU . 11.0 mm -107.33 157.21 7.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.066 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -146.22 -155.9 6.69 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 119.93 -1.129 . . . . 0.0 112.774 176.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.525 ' O ' ' HG2' ' A' ' 115' ' ' GLU . 16.5 pttp -56.99 156.13 7.26 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 124.014 0.925 . . . . 0.0 109.365 178.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.517 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 3.0 ttmp? 71.92 -16.76 0.39 Allowed 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.981 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 112' ' ' LYS . . . 91.38 7.37 65.35 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 -174.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.525 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 17.2 pt-20 -67.77 135.73 53.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.123 0.487 . . . . 0.0 111.052 -176.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 57.0 mt -80.98 107.25 13.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 174.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.01 -40.56 38.6 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.761 -173.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.542 ' HB3' HD12 ' A' ' 109' ' ' LEU . 21.9 tptm -161.24 154.78 21.79 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.421 -171.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.3 m -136.62 115.59 12.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.867 0.365 . . . . 0.0 110.966 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.458 ' OH ' ' HE3' ' A' ' 128' ' ' LYS . 75.2 m-85 -108.04 144.65 35.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.446 174.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.457 ' HB ' ' CG1' ' A' ' 103' ' ' VAL . 6.2 m -123.92 137.23 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-O 120.731 0.3 . . . . 0.0 110.947 177.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 89.68 -84.67 1.39 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.2 177.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.05 106.74 7.37 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -75.9 119.76 5.52 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.502 2.135 . . . . 0.0 112.112 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.545 ' HB2' ' HE2' ' A' ' 128' ' ' LYS . 0.5 OUTLIER -53.4 93.07 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.078 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.534 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 14.7 m-85 -61.93 -33.29 74.0 Favored 'General case' 0 C--O 1.219 -0.53 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -172.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -59.32 -49.15 81.58 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 119.821 -1.18 . . . . 0.0 111.335 175.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.545 ' HE2' ' HB2' ' A' ' 125' ' ' ASP . 32.2 ttpt -68.5 -36.88 79.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.09 -0.555 . . . . 0.0 110.265 177.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.534 ' HB3' ' HA ' ' A' ' 126' ' ' PHE . 8.8 tt -64.33 -44.17 92.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.984 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -56.36 -56.4 21.55 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.017 0.437 . . . . 0.0 110.625 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -65.27 -34.26 77.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.882 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -64.49 -38.09 89.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.598 -0.273 . . . . 0.0 111.102 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.485 HG22 HG11 ' A' ' 27' ' ' VAL . 66.1 mt -62.66 -52.87 54.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.721 0.296 . . . . 0.0 110.895 177.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -69.56 -17.63 63.58 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 97.2 m -71.68 -26.63 62.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.307 0.575 . . . . 0.0 109.836 172.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.27 -17.9 64.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.35 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 4.0 m95 -59.17 -48.8 80.26 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-O 121.191 0.52 . . . . 0.0 109.819 175.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -59.73 -33.41 71.6 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.261 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -86.16 59.69 5.78 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 176.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 11.0 m -60.64 -52.57 64.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.347 -175.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.0 t70 178.39 -164.6 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . 63.25 27.33 15.48 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 122.819 0.448 . . . . 0.0 111.273 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -86.48 116.53 24.68 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -116.94 36.41 3.76 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.274 -176.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 41.48 67.17 0.58 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.979 0.912 . . . . 0.0 111.578 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 -68.85 105.02 2.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.194 -178.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -60.17 94.56 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.143 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -101.4 76.55 1.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.596 0.712 . . . . 0.0 110.244 178.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 176.25 166.16 0.43 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -176.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 28.3 t60 . . . . . 0 C--N 1.319 -0.724 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 168.426 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.661 ' H ' ' HB1' ' A' ' 98' ' ' ALA . 3.2 p-10 . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 110.932 -0.025 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.465 ' H ' ' CG ' ' A' ' 1' ' ' ASP . 11.9 m -103.06 -170.35 1.78 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.693 0.282 . . . . 0.0 110.538 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 46.1 mttp -102.13 -166.8 1.33 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 173.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.454 ' HA ' ' CA ' ' A' ' 115' ' ' GLU . 3.4 m 68.52 29.24 5.66 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.563 0.697 . . . . 0.0 109.285 -173.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.682 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . . . 75.28 101.55 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 114.277 -1.329 . . . . 0.0 110.657 -176.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.416 ' HG3' ' O ' ' A' ' 2' ' ' SER . 11.2 Cg_exo -69.04 171.08 14.29 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.381 2.721 . . . . 0.0 112.811 -174.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.33 75.92 10.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.13 0.49 . . . . 0.0 110.648 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -125.36 150.16 47.45 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.652 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.8 p -145.3 90.59 2.04 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.518 176.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -110.25 134.73 20.69 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.416 -173.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.577 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 56.5 Cg_endo -72.98 131.74 17.28 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.177 1.918 . . . . 0.0 111.553 174.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.24 176.38 9.73 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.67 HD12 HG21 ' A' ' 78' ' ' VAL . 75.1 mt -70.69 -13.76 62.2 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -173.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -102.19 -2.82 28.47 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.195 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.78 17.76 11.57 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.478 -0.868 . . . . 0.0 114.75 169.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.613 ' HZ3' HG23 ' A' ' 18' ' ' VAL . 41.4 tttm -105.46 126.65 52.36 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 117.761 0.781 . . . . 0.0 110.062 175.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.577 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 10.2 t -72.28 125.09 26.48 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.433 0.635 . . . . 0.0 109.499 173.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.752 ' HB ' ' SD ' ' A' ' 88' ' ' MET . 60.2 t -113.31 124.29 69.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.238 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.1 m -121.82 -173.94 2.76 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.179 -177.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.682 ' HB2' ' HB3' ' A' ' 5' ' ' ALA . 31.4 p-10 -68.89 -23.22 64.17 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.873 0.368 . . . . 0.0 110.678 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.14 -28.05 69.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.707 176.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -71.9 -12.41 61.25 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.179 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.405 HD21 HD12 ' A' ' 30' ' ' ILE . 96.2 mt -84.59 -27.87 26.95 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.012 0.434 . . . . 0.0 111.604 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.6 mm100 -74.21 144.4 44.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.121 -170.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.42 -25.47 17.64 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 121.14 -0.553 . . . . 0.0 114.014 170.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.527 ' HG3' ' HG3' ' A' ' 60' ' ' GLN . 0.0 OUTLIER -143.59 -168.18 2.76 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -177.897 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 14.2 t -101.93 144.4 13.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 176.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.556 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 30.0 m -140.29 149.34 42.67 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.964 -0.295 . . . . 0.0 110.255 -173.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.751 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 6.4 tt -121.64 117.75 27.47 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 173.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.679 ' HB ' ' CG2' ' A' ' 108' ' ' VAL . 51.2 mt -102.56 119.97 51.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.333 -0.394 . . . . 0.0 109.972 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.471 ' OD1' ' HA ' ' A' ' 63' ' ' ALA . 21.7 p-10 -109.62 124.41 51.12 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.604 0.716 . . . . 0.0 111.036 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.425 ' HB2' ' HB ' ' A' ' 106' ' ' THR . 66.1 m-85 -98.11 129.51 44.92 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.58 178.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.607 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 42.4 p-90 -163.16 173.54 13.32 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.434 -177.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.439 ' HD1' ' OE1' ' A' ' 66' ' ' GLN . 29.2 p90 -131.48 141.78 43.0 Favored Pre-proline 0 C--N 1.318 -0.769 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 171.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.65 ' HG2' ' HA ' ' A' ' 74' ' ' VAL . 31.4 Cg_exo -62.74 0.55 1.45 Allowed 'Trans proline' 0 N--CA 1.476 0.459 0 C-N-CA 123.59 2.86 . . . . 0.0 114.592 -173.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.436 ' OG ' ' HD2' ' A' ' 34' ' ' PHE . 0.5 OUTLIER -102.28 18.0 22.04 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.133 0.492 . . . . 0.0 110.799 173.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 87.5 m -85.56 135.62 38.2 Favored Pre-proline 0 CA--C 1.528 0.096 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.601 176.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 12.7 Cg_exo -71.17 -8.56 23.76 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.008 2.472 . . . . 0.0 111.939 173.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.773 ' O ' ' HB2' ' A' ' 43' ' ' GLU . . . -68.37 5.97 3.66 Favored Glycine 0 C--O 1.22 -0.734 0 CA-C-N 115.762 -0.654 . . . . 0.0 113.667 -177.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.744 ' HA ' ' HG2' ' A' ' 44' ' ' MET . 25.0 p -78.03 -30.25 49.8 Favored 'General case' 0 C--N 1.317 -0.824 0 O-C-N 121.909 -0.759 . . . . 0.0 111.905 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.409 HG21 ' H ' ' A' ' 42' ' ' SER . 6.6 m -56.38 -64.99 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 -166.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.514 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -93.57 -39.72 10.69 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 121.79 -0.569 . . . . 0.0 110.785 178.798 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.773 ' HB2' ' O ' ' A' ' 39' ' ' GLY . 8.3 mp0 -64.21 -41.72 96.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.207 -169.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.744 ' HG2' ' HA ' ' A' ' 40' ' ' CYS . 19.9 mmt -60.37 -53.12 67.89 Favored Pre-proline 0 C--N 1.329 -0.308 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.295 -178.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' A' ' 44' ' ' MET . 80.6 Cg_exo -51.06 -37.85 58.39 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 122.335 2.023 . . . . 0.0 112.848 172.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.514 ' HD3' ' O ' ' A' ' 42' ' ' SER . 23.2 mtpt -61.32 -41.21 96.63 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 120.823 0.344 . . . . 0.0 110.621 176.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 43' ' ' GLU . 27.2 mt -71.82 -32.09 43.54 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.578 177.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.604 HG12 ' O ' ' A' ' 44' ' ' MET . 47.5 mm -54.51 -52.14 43.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-O 120.893 0.378 . . . . 0.0 110.434 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 46' ' ' LYS . 16.6 pttm -65.4 -44.87 86.1 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.642 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.5 m -70.6 -46.87 62.6 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.984 0.421 . . . . 0.0 111.863 -174.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . -69.25 -33.11 72.76 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.906 -174.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.597 ' HA ' ' NZ ' ' A' ' 55' ' ' LYS . 62.1 t30 -76.41 -50.37 14.34 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.118 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -64.99 -46.1 82.85 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.017 -172.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.717 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 38.1 m-85 -79.67 -10.12 59.74 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.57 -175.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.599 ' HA ' ' O ' ' A' ' 59' ' ' PHE . 7.1 ttpm? -63.59 -21.28 66.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.208 0.527 . . . . 0.0 110.518 178.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -106.37 17.23 23.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.625 176.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.6 mtmm -136.62 44.69 2.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.771 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.518 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 17.2 t-20 62.91 31.46 16.24 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.592 0.71 . . . . 0.0 110.745 175.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.751 ' HZ ' ' HB2' ' A' ' 29' ' ' LEU . 48.8 t80 -135.82 137.51 41.61 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.142 176.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.527 ' HG3' ' HG3' ' A' ' 26' ' ' LYS . 4.5 mt-30 -127.69 157.46 40.24 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.224 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 98.6 t -130.88 126.34 59.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 177.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.4 mt -121.39 121.04 36.74 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.122 0.487 . . . . 0.0 110.605 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.536 ' HB2' ' HA ' ' A' ' 87' ' ' VAL . . . -91.19 132.0 36.37 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.458 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.7 t -123.81 101.31 8.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.074 0.464 . . . . 0.0 110.37 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.607 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -85.78 117.38 24.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.685 175.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.61 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -90.92 163.97 27.54 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.34 -0.391 . . . . 0.0 109.981 -176.466 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.657 ' HD3' ' O ' ' A' ' 90' ' ' ASP . 60.8 Cg_endo -70.17 93.56 0.56 Allowed 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.027 1.818 . . . . 0.0 113.253 -169.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 46.5 mm -124.75 -60.81 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 172.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.503 ' OD2' ' HD2' ' A' ' 35' ' ' PRO . 1.8 p30 -105.67 154.21 39.4 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.602 168.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.42 ' HB2' ' OE2' ' A' ' 72' ' ' GLU . 12.9 Cg_exo -69.33 -179.96 3.07 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 122.83 2.353 . . . . 0.0 114.131 -171.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.1 tp -64.24 -35.81 75.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.879 -169.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.552 ' HA ' ' CD ' ' A' ' 75' ' ' ARG . 0.1 OUTLIER -73.39 -29.13 62.41 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.168 -0.332 . . . . 0.0 110.406 -177.645 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 45.5 m -68.72 -41.99 78.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.996 175.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.65 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 92.3 t -60.44 -55.01 27.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.297 176.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.552 ' CD ' ' HA ' ' A' ' 72' ' ' GLU . 1.4 ptm180 -63.69 -27.59 69.32 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.741 -177.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.438 ' HB2' ' O ' ' A' ' 72' ' ' GLU . 8.0 tt0 -66.14 -45.53 80.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.234 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.416 ' HB2' ' HB3' ' A' ' 35' ' ' PRO . 0.1 OUTLIER -63.31 -35.85 81.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.847 -178.862 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.67 HG21 HD12 ' A' ' 13' ' ' LEU . 60.5 t -61.26 -39.55 82.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.637 176.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.426 ' HG3' ' O ' ' A' ' 75' ' ' ARG . 95.2 mttt -70.73 -40.96 72.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.951 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -60.0 -49.38 77.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.239 -173.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.425 ' HB2' ' CD1' ' A' ' 83' ' ' LEU . 77.9 m-85 -99.8 3.7 44.9 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.699 -176.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 57.16 57.91 17.32 Favored Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.123 -178.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.628 ' HB2' HG12 ' A' ' 78' ' ' VAL . 10.5 mp -62.17 114.01 10.35 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-O 120.672 0.272 . . . . 0.0 111.476 -176.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -89.99 13.98 2.2 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.369 2.713 . . . . 0.0 112.936 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -117.96 150.21 39.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.836 176.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.7 m -69.83 115.43 9.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.756 0.312 . . . . 0.0 111.319 -173.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.536 ' HA ' ' HB2' ' A' ' 63' ' ' ALA . 31.4 t -104.5 126.59 59.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.138 -176.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.752 ' SD ' ' HB ' ' A' ' 18' ' ' VAL . 63.6 mtm -112.44 169.15 9.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.745 175.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -115.49 123.49 48.67 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.13 176.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.729 ' OD2' ' HA ' ' A' ' 93' ' ' LYS . 20.0 t0 -88.84 107.33 18.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.434 177.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.96 -47.58 20.48 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -175.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -99.85 -12.24 20.04 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -169.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.729 ' HA ' ' OD2' ' A' ' 90' ' ' ASP . 57.2 tttp 68.61 -2.31 1.69 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.015 0.526 . . . . 0.0 111.821 176.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.21 -23.88 43.51 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.919 0.39 . . . . 0.0 110.484 -177.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.451 ' O ' ' HD1' ' A' ' 99' ' ' PHE . 28.3 m -71.39 -38.04 67.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 171.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.52 -33.7 85.44 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 173.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 67.9 mm-40 -66.75 -32.28 73.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.811 0.338 . . . . 0.0 110.856 175.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.661 ' HB1' ' H ' ' A' ' 1' ' ' ASP . . . -63.67 -39.9 95.49 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.253 0.549 . . . . 0.0 110.487 177.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.5 ' CE2' HD11 ' A' ' 116' ' ' ILE . 29.7 m-85 -73.63 -28.69 61.93 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.062 175.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.33 44.84 2.9 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.424 178.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.525 HG21 HG22 ' A' ' 106' ' ' THR . 52.5 p -104.48 112.91 26.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.253 0.549 . . . . 0.0 111.568 -176.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -111.95 -39.5 4.5 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.356 177.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.6 m -117.78 149.97 20.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 177.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.552 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 92.3 m-85 -129.44 161.62 57.74 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.75 -172.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.552 ' HA ' ' HB3' ' A' ' 104' ' ' TYR . 63.5 Cg_endo -73.03 165.71 83.46 Favored 'Cis proline' 0 C--N 1.349 0.603 0 C-N-CA 123.689 -1.379 . . . . 0.0 113.439 0.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.525 HG22 HG21 ' A' ' 101' ' ' THR . 4.2 m -135.05 148.88 50.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.433 177.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 37.8 m -137.69 114.59 10.66 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.971 0.415 . . . . 0.0 110.621 178.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.679 ' CG2' ' HB ' ' A' ' 30' ' ' ILE . 20.5 m -106.77 145.13 14.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.136 0.493 . . . . 0.0 111.053 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.495 HD11 HD11 ' A' ' 129' ' ' LEU . 9.5 mp -101.69 133.32 46.58 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.542 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.556 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 34.5 mm -110.49 135.02 50.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.943 -176.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -77.17 -150.21 3.74 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.831 -0.7 . . . . 0.0 111.706 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.454 ' HD3' HG21 ' A' ' 27' ' ' VAL . 10.2 mmmm -101.05 -7.58 23.12 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -176.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 2.7 mtmp? -124.55 19.72 8.73 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 113.485 -1.689 . . . . 0.0 109.291 -175.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.2 -90.97 1.58 Allowed Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -173.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.454 ' CA ' ' HA ' ' A' ' 4' ' ' THR . 26.0 mt-10 69.17 -30.55 0.19 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 167.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.5 HD11 ' CE2' ' A' ' 99' ' ' PHE . 23.5 mm 53.38 64.87 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 CA-C-O 121.946 0.879 . . . . 0.0 108.997 -169.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.455 ' HA ' HD23 ' A' ' 117' ' ' LEU . 0.2 OUTLIER -62.02 -45.44 93.58 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 113.885 -1.507 . . . . 0.0 112.983 -169.28 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.694 ' HG3' ' OE2' ' A' ' 132' ' ' GLU . 4.3 tmtp? -143.91 153.83 42.71 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.257 -169.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.3 m -139.96 108.01 5.74 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.944 0.402 . . . . 0.0 111.427 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -98.95 137.87 36.88 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.294 170.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.6 p -109.91 140.82 27.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 82.22 -109.8 3.11 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 -176.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -111.44 126.31 28.83 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 173.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.485 ' HB2' HD12 ' A' ' 129' ' ' LEU . 56.0 Cg_endo -72.14 125.64 11.05 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.206 1.937 . . . . 0.0 111.369 175.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.22 121.86 12.4 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -70.33 -29.67 66.44 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.28 -174.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -65.97 -54.91 22.0 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.32 -174.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -75.74 -33.08 60.24 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.495 HD11 HD11 ' A' ' 109' ' ' LEU . 0.9 OUTLIER -58.31 -48.34 80.8 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.008 0.193 . . . . 0.0 110.974 179.276 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -67.1 -45.14 78.13 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.191 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -64.57 -36.31 83.81 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.387 0.613 . . . . 0.0 110.885 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.694 ' OE2' ' HG3' ' A' ' 118' ' ' LYS . 21.3 tt0 -74.73 -40.02 61.52 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.44 -175.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.518 HG22 HG12 ' A' ' 27' ' ' VAL . 79.7 mt -64.4 -42.3 94.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.876 173.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -54.47 -39.03 67.1 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.462 177.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.8 m -60.51 -39.44 87.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.08 0.467 . . . . 0.0 110.713 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.06 -19.28 60.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.395 -177.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.4 ' HD1' HG23 ' A' ' 27' ' ' VAL . 17.1 m0 -65.48 -55.34 18.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.69 0.281 . . . . 0.0 110.898 177.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 64.4 mtt85 -68.66 -15.83 63.64 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.028 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.455 ' O ' ' HB2' ' A' ' 140' ' ' SER . 7.9 t-20 -72.47 66.23 0.68 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.612 175.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 139' ' ' ASN . 22.1 t 169.75 121.94 0.01 OUTLIER 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.006 -178.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -72.7 88.48 1.29 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.976 0.417 . . . . 0.0 110.865 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -162.62 108.49 1.2 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.529 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.417 ' CD ' ' HD1' ' A' ' 145' ' ' HIS . 7.2 tp10 -107.19 119.91 40.67 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.273 0.558 . . . . 0.0 110.71 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -104.08 0.32 44.46 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.34 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.417 ' HD1' ' CD ' ' A' ' 143' ' ' GLU . 25.9 m80 -66.17 86.95 0.1 Allowed 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 121.492 0.663 . . . . 0.0 110.999 176.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -120.27 66.8 0.83 Allowed 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 172.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 62.62 -86.28 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.097 -175.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 61.08 -84.64 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -171.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -116.02 -11.6 11.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.058 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 69.9 t60 . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.218 -0.896 . . . . 0.0 109.777 179.527 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.381 0.134 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.737 ' H ' ' HA ' ' A' ' 6' ' ' PRO . 61.5 m 62.87 -168.07 0.2 Allowed 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -169.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.639 ' HZ1' ' HB3' ' A' ' 3' ' ' LYS . 0.6 OUTLIER 64.76 98.95 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 -177.201 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.3 m 63.99 46.56 3.74 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.929 0.871 . . . . 0.0 109.162 -172.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.408 ' H ' HG13 ' A' ' 116' ' ' ILE . . . 77.02 151.14 0.13 Allowed Pre-proline 0 N--CA 1.466 0.328 0 CA-C-N 113.789 -1.551 . . . . 0.0 110.77 -178.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.737 ' HA ' ' H ' ' A' ' 2' ' ' SER . 73.2 Cg_endo -76.56 2.28 7.55 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.076 1.851 . . . . 0.0 113.759 -173.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 56.62 84.93 0.08 Allowed 'General case' 0 C--N 1.327 -0.409 0 O-C-N 124.325 1.016 . . . . 0.0 110.796 -175.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.502 ' CE1' HD12 ' A' ' 23' ' ' LEU . 45.4 p90 -132.35 168.42 18.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.197 0.522 . . . . 0.0 111.355 -175.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 48.6 m -148.46 95.03 2.38 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 172.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 22.0 tp -115.87 133.61 22.83 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.415 -171.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 8.1 Cg_exo -72.59 134.97 23.21 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.562 2.175 . . . . 0.0 112.414 178.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.58 ' HB3' ' O ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -76.07 164.36 26.2 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.822 174.8 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.648 ' HB3' ' HG2' ' A' ' 75' ' ' ARG . 69.4 mt -67.13 -7.03 20.25 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 -170.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -123.6 17.71 9.59 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 121.809 -0.557 . . . . 0.0 110.959 174.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.02 22.35 25.59 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.931 -0.652 . . . . 0.0 114.045 169.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.58 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 11.3 tmtt? -97.03 102.5 14.29 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 173.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 12.0 m -63.52 122.42 16.25 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.894 0.378 . . . . 0.0 110.262 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.509 ' HB ' ' SD ' ' A' ' 88' ' ' MET . 60.8 t -106.24 116.44 50.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.801 178.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 83.4 p -103.15 -176.91 3.22 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.432 -177.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -73.3 -23.01 60.23 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.688 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.52 ' O ' ' HG3' ' A' ' 24' ' ' GLN . . . -68.34 -28.57 67.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.051 178.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -70.84 -15.53 62.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.871 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.502 HD12 ' CE1' ' A' ' 8' ' ' PHE . 92.3 mt -83.87 -20.21 33.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.706 -177.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.52 ' HG3' ' O ' ' A' ' 21' ' ' ALA . 0.4 OUTLIER -100.24 141.56 32.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.46 0.648 . . . . 0.0 112.457 -172.784 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.76 -8.32 68.26 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.101 -176.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.681 ' HB3' ' HZ3' ' A' ' 26' ' ' LYS . 9.3 mtpm? -142.31 164.23 30.71 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.68 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 25.2 t -102.5 141.73 18.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -177.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.442 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 26.8 m -132.78 138.47 47.16 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -165.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.615 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 36.7 tp -121.49 112.31 18.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.192 170.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.542 HG12 ' HB2' ' A' ' 62' ' ' LEU . 54.4 mt -102.33 115.6 44.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.801 0.334 . . . . 0.0 110.411 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.42 ' HA ' ' O ' ' A' ' 106' ' ' THR . 4.5 p-10 -109.06 126.87 53.62 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.326 0.584 . . . . 0.0 110.281 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.465 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 86.1 m-85 -92.97 127.9 38.65 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.829 178.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.496 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 5.3 p-90 -153.04 -178.05 6.68 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.065 0.46 . . . . 0.0 111.218 -175.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -149.48 148.22 25.47 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.757 172.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.519 ' HD2' ' HB2' ' A' ' 69' ' ' ASP . 96.3 Cg_exo -44.94 -47.87 11.49 Favored 'Trans proline' 0 N--CA 1.475 0.437 0 C-N-CA 123.592 2.861 . . . . 0.0 114.569 -175.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.9 m -82.67 17.14 1.91 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -175.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 53.3 t -73.61 126.51 89.72 Favored Pre-proline 0 C--N 1.328 -0.333 0 O-C-N 122.355 -0.215 . . . . 0.0 110.638 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -62.72 -22.28 73.77 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.907 2.405 . . . . 0.0 113.048 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.84 -17.01 80.28 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.181 -177.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 31.2 p -67.7 -41.5 83.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.069 0.434 . . . . 0.0 111.187 -174.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.8 p -59.99 -32.03 49.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.855 0.36 . . . . 0.0 111.169 -176.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.0 m -86.89 -54.09 4.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.818 0.342 . . . . 0.0 111.328 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.406 ' CD ' ' HZ2' ' A' ' 46' ' ' LYS . 9.4 mm-40 -85.22 -29.69 24.47 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -168.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.571 ' O ' HG12 ' A' ' 48' ' ' ILE . 41.1 ttm -58.7 -46.7 99.56 Favored Pre-proline 0 N--CA 1.47 0.535 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -173.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 44' ' ' MET . 7.0 Cg_endo -50.97 -38.11 58.03 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.017 1.811 . . . . 0.0 112.246 175.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.406 ' HZ2' ' CD ' ' A' ' 43' ' ' GLU . 83.6 mttt -65.2 -44.15 89.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.209 0.528 . . . . 0.0 109.76 176.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 42.5 mm -60.87 -41.46 88.86 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.359 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.74 178.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.571 HG12 ' O ' ' A' ' 44' ' ' MET . 43.0 mm -54.34 -49.2 65.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.249 0.547 . . . . 0.0 110.086 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.5 ttpp -64.96 -57.58 8.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.576 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.6 m -63.24 -41.91 99.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.766 -173.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.05 -50.24 62.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.126 -177.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -64.85 -43.04 94.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.858 0.361 . . . . 0.0 110.889 -173.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.604 ' CG ' ' HZ3' ' A' ' 57' ' ' LYS . 14.1 t70 -59.93 -42.2 93.45 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.001 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 1.038 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 14.9 m-85 -81.34 -26.18 35.79 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.218 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.4 mmmm -58.59 -30.63 67.35 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.854 0.359 . . . . 0.0 110.564 176.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -94.15 19.36 9.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.034 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.604 ' HZ3' ' CG ' ' A' ' 53' ' ' ASP . 27.3 mtmm -128.25 -59.09 1.18 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.325 176.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.412 ' O ' ' HB3' ' A' ' 26' ' ' LYS . 27.2 t-20 176.99 -14.64 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.321 0.582 . . . . 0.0 110.892 -174.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 1.038 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 62.9 t80 -98.31 147.71 24.38 Favored 'General case' 0 C--N 1.316 -0.849 0 O-C-N 122.032 -0.417 . . . . 0.0 109.938 -174.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -137.83 127.66 25.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.134 0.493 . . . . 0.0 111.324 -176.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 92.3 t -99.23 120.43 48.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.426 174.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.542 ' HB2' HG12 ' A' ' 30' ' ' ILE . 72.4 mt -113.78 112.84 24.08 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.708 -178.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.477 ' HB1' ' NE1' ' A' ' 33' ' ' TRP . . . -93.5 107.51 19.35 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.645 -177.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.559 HG22 ' HE3' ' A' ' 88' ' ' MET . 88.4 t -95.66 113.92 31.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.075 0.464 . . . . 0.0 110.448 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -86.11 131.9 34.15 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.697 176.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.575 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -100.24 163.91 17.37 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.514 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.575 ' HD2' ' HB2' ' A' ' 66' ' ' GLN . 32.8 Cg_endo -64.12 79.27 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.542 2.162 . . . . 0.0 113.784 -175.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.447 HG12 ' HG2' ' A' ' 66' ' ' GLN . 40.1 mm -117.83 -63.35 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 171.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.519 ' HB2' ' HD2' ' A' ' 35' ' ' PRO . 14.8 m-20 -96.62 149.55 35.95 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 168.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.45 150.51 34.02 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.633 2.222 . . . . 0.0 112.893 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.0 tt -55.14 -38.5 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.629 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -66.18 -37.39 85.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.107 0.48 . . . . 0.0 110.419 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.4 m -61.35 -35.01 76.25 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.387 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.437 ' O ' HG11 ' A' ' 78' ' ' VAL . 10.9 t -67.67 -41.0 85.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.114 178.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.807 ' HA ' HG22 ' A' ' 78' ' ' VAL . 41.8 mtp180 -69.08 -32.82 72.54 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.368 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.75 -38.81 92.01 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 175.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.464 ' HE1' ' SD ' ' A' ' 44' ' ' MET . 7.7 t80 -67.85 -48.68 65.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.267 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.807 HG22 ' HA ' ' A' ' 75' ' ' ARG . 25.8 m -62.9 -31.93 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -177.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.468 ' HB3' ' HE2' ' A' ' 79' ' ' LYS . 44.9 mtpt -74.64 -54.27 7.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.75 0.309 . . . . 0.0 111.408 177.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -65.71 -41.29 92.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.918 -171.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -89.75 -21.76 22.51 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.604 -175.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.0 75.48 0.91 Allowed Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.429 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.551 HD11 ' HA ' ' A' ' 78' ' ' VAL . 10.6 mp -95.26 112.32 58.18 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 120.798 0.332 . . . . 0.0 111.107 -177.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -81.0 -11.41 12.33 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.185 2.59 . . . . 0.0 113.326 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.447 ' HE1' HD11 ' A' ' 48' ' ' ILE . 29.1 p90 -91.06 145.21 24.88 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 176.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.406 ' HB ' ' CD2' ' A' ' 62' ' ' LEU . 19.4 m -71.83 118.21 14.4 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.976 -172.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.437 HG21 ' HB3' ' A' ' 63' ' ' ALA . 39.0 t -107.49 129.26 61.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.573 -178.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.559 ' HE3' HG22 ' A' ' 64' ' ' VAL . 70.9 mtm -119.85 171.17 8.61 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.45 178.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -137.48 115.27 11.39 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.741 0.305 . . . . 0.0 110.329 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.573 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 47.8 t0 -98.73 102.41 14.13 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.36 -28.27 61.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.723 -176.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -83.71 -7.11 59.55 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.872 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.3 pttp 47.41 25.2 0.57 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.214 1.005 . . . . 0.0 111.774 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -81.59 -34.38 31.03 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.601 -172.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.537 HG21 ' OD2' ' A' ' 90' ' ' ASP . 31.5 m -76.31 -30.68 20.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 119.989 -0.684 . . . . 0.0 109.604 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -69.92 -38.51 75.17 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 172.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 -69.97 -23.75 63.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.567 -0.317 . . . . 0.0 111.346 176.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.42 -36.33 71.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.667 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -86.86 -19.27 29.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.082 176.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 81.84 41.94 9.32 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.904 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.517 HG22 HG21 ' A' ' 106' ' ' THR . 50.4 p -76.15 86.86 3.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.223 0.535 . . . . 0.0 111.054 -178.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -93.09 -45.23 7.99 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.638 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.536 ' HB ' HG22 ' A' ' 121' ' ' VAL . 21.3 t -100.28 123.41 53.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.981 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -104.09 144.37 28.55 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.077 -177.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -76.47 165.27 85.67 Favored 'Cis proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.724 -1.365 . . . . 0.0 113.304 0.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.517 HG21 HG22 ' A' ' 101' ' ' THR . 5.5 m -129.54 125.93 37.4 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.82 174.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.425 ' HB3' HD12 ' A' ' 29' ' ' LEU . 16.5 m -111.62 114.51 27.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.857 0.36 . . . . 0.0 110.884 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.52 HG22 HG23 ' A' ' 119' ' ' THR . 47.3 t -105.98 130.82 56.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.325 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.525 HD13 ' HB3' ' A' ' 118' ' ' LYS . 85.8 mt -101.7 120.2 39.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.567 -178.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.442 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 31.1 mt -112.58 144.13 20.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.405 179.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.68 ' O ' ' HA ' ' A' ' 27' ' ' VAL . . . -72.88 -112.03 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 121.117 -0.563 . . . . 0.0 113.071 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 18.0 pttm -140.54 -8.06 1.12 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -173.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -121.44 -9.75 8.97 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 173.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 127.9 -4.41 6.94 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.592 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 115' ' ' GLU . 5.9 pm0 -58.36 116.95 3.95 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.43 0.633 . . . . 0.0 110.225 -177.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.408 HG13 ' H ' ' A' ' 5' ' ' ALA . 60.7 mt -78.12 112.33 15.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.589 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.3 mt -90.17 -50.5 5.96 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.416 -173.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.525 ' HB3' HD13 ' A' ' 109' ' ' LEU . 18.0 tptm -152.08 158.35 42.87 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.427 -167.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.52 HG23 HG22 ' A' ' 108' ' ' VAL . 32.0 m -143.15 103.73 4.19 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.147 0.498 . . . . 0.0 110.526 174.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -88.93 106.21 18.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.075 174.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.536 HG22 ' HB ' ' A' ' 103' ' ' VAL . 7.7 p -95.92 121.43 46.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.265 0.555 . . . . 0.0 110.711 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 105.14 -80.6 0.3 Allowed Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.11 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -138.82 118.57 9.53 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.89 143.12 20.51 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.629 2.219 . . . . 0.0 113.323 -177.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.525 ' O ' ' HB2' ' A' ' 129' ' ' LEU . 24.8 t0 -77.45 107.6 10.01 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 172.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -66.35 -43.49 85.88 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -174.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.25 -43.75 98.65 Favored Glycine 0 C--O 1.239 0.437 0 C-N-CA 120.261 -0.971 . . . . 0.0 111.161 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.726 ' HZ1' ' HB2' ' A' ' 128' ' ' LYS . 1.7 ttmp? -71.82 -31.59 66.69 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.21 -0.495 . . . . 0.0 109.994 178.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.533 ' O ' HG13 ' A' ' 133' ' ' ILE . 0.2 OUTLIER -56.55 -48.01 78.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.001 177.397 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -65.92 -48.97 69.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.386 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.42 ' HG2' ' HA ' ' A' ' 128' ' ' LYS . 3.3 pt20 -68.36 -32.23 72.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.964 0.412 . . . . 0.0 111.459 -177.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -74.68 -32.66 62.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.322 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.533 HG13 ' O ' ' A' ' 129' ' ' LEU . 59.5 mt -62.85 -49.69 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 172.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.555 ' O ' ' HG2' ' A' ' 138' ' ' ARG . 14.9 t70 -56.65 -38.23 71.89 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.409 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 88.0 m -55.48 -40.62 71.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.012 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.12 -30.86 71.9 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.039 0.447 . . . . 0.0 111.039 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.456 ' NE1' HG23 ' A' ' 27' ' ' VAL . 11.3 m0 -72.94 -29.57 63.2 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.106 177.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.555 ' HG2' ' O ' ' A' ' 134' ' ' ASP . 22.5 mmt180 -85.13 -17.89 35.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.507 -178.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -80.88 66.85 6.56 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.57 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 11.2 p -95.08 -59.53 1.88 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.382 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -88.21 92.86 9.31 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.942 -175.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.57 -19.15 23.05 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.967 174.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 56.22 -98.03 0.08 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.001 -1.0 . . . . 0.0 112.798 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.01 40.18 81.55 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -170.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -70.47 75.75 0.56 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.085 0.469 . . . . 0.0 112.179 -170.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -137.62 -2.52 1.95 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.086 172.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -84.18 108.45 17.08 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.814 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -80.2 149.45 30.46 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.509 175.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 -99.35 -13.35 19.65 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 168.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 . . . . . 0 C--O 1.244 0.786 0 CA-C-N 113.711 -1.586 . . . . 0.0 107.674 -179.884 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.583 ' OD2' ' HG3' ' A' ' 3' ' ' LYS . 25.4 t70 . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.2 m 73.33 17.67 3.88 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.77 0.669 . . . . 0.0 112.37 169.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.583 ' HG3' ' OD2' ' A' ' 1' ' ' ASP . 0.4 OUTLIER -125.19 168.88 12.82 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 175.193 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.66 HG22 ' HA3' ' A' ' 114' ' ' GLY . 63.6 p 51.86 53.97 11.71 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.265 0.555 . . . . 0.0 111.084 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.496 ' H ' HG13 ' A' ' 116' ' ' ILE . . . 63.74 163.42 0.12 Allowed Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 114.372 -1.285 . . . . 0.0 112.021 -178.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -57.84 141.24 95.75 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 121.74 1.626 . . . . 0.0 109.991 168.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -50.94 104.67 0.08 Allowed 'General case' 0 C--N 1.331 -0.231 0 O-C-N 123.461 0.475 . . . . 0.0 111.587 -175.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -129.14 135.55 49.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.624 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.3 t -150.2 88.89 1.54 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 171.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.442 HD13 ' HB3' ' A' ' 88' ' ' MET . 1.4 pt? -121.71 155.25 60.21 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.593 -178.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.579 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 8.1 Cg_exo -73.23 130.3 15.06 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.633 2.222 . . . . 0.0 112.522 177.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.54 160.81 31.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.516 173.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.434 HD12 HG11 ' A' ' 78' ' ' VAL . 41.4 mt -60.91 -24.01 65.67 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 -174.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -83.14 -11.7 57.69 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.06 -15.07 16.18 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 121.167 -0.54 . . . . 0.0 113.256 174.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -76.37 121.44 23.03 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.869 0.335 . . . . 0.0 111.114 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.579 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 20.5 m -69.75 123.18 20.76 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 172.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.455 ' HB ' ' HE2' ' A' ' 88' ' ' MET . 39.9 t -119.56 130.01 74.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.981 0.42 . . . . 0.0 110.778 -176.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.9 t -132.05 173.99 10.65 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.494 178.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.657 ' HA ' HD12 ' A' ' 23' ' ' LEU . 30.0 p-10 -61.01 -22.8 64.88 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -172.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.59 ' HA ' HE21 ' A' ' 24' ' ' GLN . . . -67.68 -27.95 67.28 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 178.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -67.63 -32.81 73.77 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.18 0.514 . . . . 0.0 110.93 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.738 HD22 HD11 ' A' ' 110' ' ' ILE . 5.2 mp -71.46 -20.36 62.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.064 -175.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.59 HE21 ' HA ' ' A' ' 21' ' ' ALA . 46.5 mt-30 -68.21 98.5 0.81 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.211 -177.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 132.17 -22.85 4.18 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.079 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.4 mtmm -111.47 162.56 14.97 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -103.46 123.34 56.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 168.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 60' ' ' GLN . 11.0 m -126.59 150.9 48.6 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.092 0.472 . . . . 0.0 111.842 -164.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.411 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 51.9 tp -123.71 120.45 32.74 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.921 174.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.959 ' HB ' HG12 ' A' ' 108' ' ' VAL . 34.5 mm -97.19 132.79 40.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 175.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -128.17 125.07 38.33 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.245 0.545 . . . . 0.0 109.879 174.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -90.56 122.63 33.54 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.991 176.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.443 ' NE1' ' HB3' ' A' ' 63' ' ' ALA . 6.1 p-90 -148.4 -169.84 3.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.454 -177.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.4 ' CE2' ' HB2' ' A' ' 37' ' ' CYS . 36.7 p90 -159.4 143.8 11.17 Favored Pre-proline 0 C--N 1.321 -0.656 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 174.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.479 ' HG2' ' CB ' ' A' ' 69' ' ' ASP . 12.8 Cg_endo -59.0 158.93 23.31 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.414 2.076 . . . . 0.0 111.521 176.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.8 m 68.32 18.41 9.14 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.19 -177.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.458 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 52.8 t -101.3 136.78 19.59 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.547 177.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.47 ' O ' HG23 ' A' ' 41' ' ' VAL . 19.9 Cg_exo -67.15 -13.8 40.99 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 123.014 2.476 . . . . 0.0 112.919 178.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.42 -4.78 19.13 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 121.515 -0.374 . . . . 0.0 113.467 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.707 ' O ' ' HB2' ' A' ' 44' ' ' MET . 61.0 m -63.22 -34.88 78.61 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 122.725 -0.28 . . . . 0.0 110.897 176.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 38' ' ' PRO . 33.0 m -67.98 -33.99 64.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.176 -177.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.9 p -88.87 -56.41 3.3 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.554 ' HG2' ' HG3' ' A' ' 105' ' ' PRO . 1.4 mp0 -84.09 -34.77 24.09 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -168.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.707 ' HB2' ' O ' ' A' ' 40' ' ' CYS . 8.6 mmt -61.12 -48.11 93.0 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -175.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 44' ' ' MET . 13.2 Cg_endo -57.25 -34.19 97.38 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 121.838 1.692 . . . . 0.0 112.305 175.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.468 ' HD2' ' HA ' ' A' ' 43' ' ' GLU . 93.9 mttt -64.32 -51.66 62.34 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 176.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.661 HG21 HG12 ' A' ' 61' ' ' VAL . 45.1 mm -57.43 -46.91 85.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.834 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.447 HG12 ' O ' ' A' ' 44' ' ' MET . 46.1 mm -56.57 -53.36 42.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.184 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -69.3 -51.34 38.22 Favored 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.384 -174.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 62.4 m -57.2 -42.39 81.18 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.071 0.463 . . . . 0.0 111.196 -176.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.04 -31.5 70.32 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.751 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -73.88 -45.5 50.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.783 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -54.59 -51.58 64.86 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.745 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.564 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 61.6 m-85 -97.22 8.53 44.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.433 -175.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.536 ' HE3' ' HA ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -60.54 -45.62 93.19 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.254 0.55 . . . . 0.0 110.169 -179.903 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -89.95 33.56 0.86 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.617 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.564 ' HE2' ' HA ' ' A' ' 54' ' ' TYR . 0.7 OUTLIER -126.08 -68.35 0.83 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.7 171.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 177.03 13.72 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.767 -177.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.411 ' HZ ' ' HB2' ' A' ' 29' ' ' LEU . 22.1 t80 -99.96 147.52 25.49 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.032 -173.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.497 ' O ' ' HA ' ' A' ' 28' ' ' THR . 50.5 tp60 -138.91 147.3 42.15 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.918 -177.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.661 HG12 HG21 ' A' ' 47' ' ' ILE . 86.9 t -129.2 129.64 67.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.748 0.309 . . . . 0.0 110.465 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.814 ' HG ' ' HB ' ' A' ' 86' ' ' THR . 9.9 mp -121.53 121.91 38.53 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.78 177.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.443 ' HB3' ' NE1' ' A' ' 33' ' ' TRP . . . -101.44 119.63 39.06 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.347 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.9 t -97.29 107.65 20.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.916 0.389 . . . . 0.0 110.748 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.5 126.42 36.58 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.101 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.584 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 2.8 pt20 -97.91 168.78 9.45 Favored Pre-proline 0 C--N 1.317 -0.839 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.491 -178.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.618 ' HD2' ' HG3' ' A' ' 93' ' ' LYS . 98.7 Cg_endo -75.91 45.07 1.42 Allowed 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 122.81 2.34 . . . . 0.0 114.85 -165.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 50.7 mm -78.67 -32.61 16.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 171.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.479 ' CB ' ' HG2' ' A' ' 35' ' ' PRO . 0.2 OUTLIER -136.48 136.32 21.94 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 114.64 -1.164 . . . . 0.0 107.926 170.792 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 69' ' ' ASP . 35.7 Cg_exo -58.2 174.02 0.82 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.079 2.519 . . . . 0.0 113.681 -175.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.493 ' HA ' HG11 ' A' ' 74' ' ' VAL . 19.8 tt -71.87 -27.07 26.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.591 -169.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 pm0 -74.02 -28.81 61.62 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.671 175.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 63.0 m -64.51 -48.63 74.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.98 0.419 . . . . 0.0 110.35 174.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.493 HG11 ' HA ' ' A' ' 71' ' ' ILE . 9.6 p -67.62 -34.36 67.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.65 -178.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.877 ' HA ' HG23 ' A' ' 78' ' ' VAL . 66.7 mtt180 -71.66 -29.01 64.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.999 175.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -64.76 -41.52 95.82 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 173.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -64.78 -51.73 60.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.073 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 1.091 ' HA ' HD22 ' A' ' 83' ' ' LEU . 35.8 m -61.8 -26.63 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.379 -178.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.838 ' HZ2' ' HB3' ' A' ' 79' ' ' LYS . 1.6 ttpm? -72.06 -49.43 36.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.303 0.573 . . . . 0.0 110.052 174.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.48 -48.07 77.91 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.681 -1.145 . . . . 0.0 112.857 -173.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -103.19 4.41 36.78 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.428 -174.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 57.12 55.27 31.22 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 116.037 -0.529 . . . . 0.0 113.101 177.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 1.091 HD22 ' HA ' ' A' ' 78' ' ' VAL . 3.1 mm? -71.18 111.65 10.79 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-O 120.784 0.326 . . . . 0.0 110.556 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -85.59 -6.99 8.8 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.11 2.54 . . . . 0.0 113.77 -173.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.539 ' CE2' HD12 ' A' ' 83' ' ' LEU . 28.7 p90 -90.54 169.87 10.66 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.936 0.398 . . . . 0.0 110.929 -178.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.814 ' HB ' ' HG ' ' A' ' 62' ' ' LEU . 18.3 m -75.25 132.13 40.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.174 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.2 t -130.06 130.9 66.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -177.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.473 ' HE3' HD21 ' A' ' 62' ' ' LEU . 57.5 mtt -111.94 163.76 13.87 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.42 -178.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 92.4 t80 -126.42 115.18 19.21 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.835 176.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.519 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 40.0 t0 -87.56 127.08 35.26 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.53 -30.12 59.65 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -177.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.59 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 17.2 t70 -127.22 -10.94 5.85 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -169.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.618 ' HG3' ' HD2' ' A' ' 67' ' ' PRO . 25.0 mtpp 76.69 14.09 2.23 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -169.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.563 ' HA ' HE21 ' A' ' 97' ' ' GLN . . . -61.17 -44.41 97.34 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -170.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.505 HG23 ' OD2' ' A' ' 90' ' ' ASP . 27.7 m -72.32 -33.55 46.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.197 -178.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -70.23 -33.9 69.2 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.499 -0.857 . . . . 0.0 111.086 173.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.563 HE21 ' HA ' ' A' ' 94' ' ' ALA . 14.8 mt-30 -71.43 -24.29 62.0 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 122.751 0.42 . . . . 0.0 110.722 176.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.59 -35.42 73.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.185 173.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -82.43 -11.31 58.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.855 175.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 76.73 32.34 50.6 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.383 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 38.0 p -80.21 96.2 6.51 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.248 0.547 . . . . 0.0 111.466 -177.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -89.34 -31.46 17.79 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.365 0.602 . . . . 0.0 109.618 174.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.3 p -107.1 150.22 9.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.181 -176.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -140.02 155.41 70.81 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.399 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.554 ' HG3' ' HG2' ' A' ' 43' ' ' GLU . 90.5 Cg_endo -77.73 162.58 89.69 Favored 'Cis proline' 0 C--N 1.343 0.259 0 C-N-CA 123.293 -1.545 . . . . 0.0 112.796 0.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.49 HG21 HG11 ' A' ' 121' ' ' VAL . 55.1 m -138.28 131.34 29.99 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.824 178.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 35.1 p -116.25 148.52 40.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.015 0.436 . . . . 0.0 111.376 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.959 HG12 ' HB ' ' A' ' 30' ' ' ILE . 1.9 p -124.57 148.4 28.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 176.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.484 HD21 ' HD1' ' A' ' 120' ' ' TYR . 4.3 mm? -100.51 123.55 44.87 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 121.002 0.43 . . . . 0.0 109.986 -177.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.746 HG22 ' HA ' ' A' ' 115' ' ' GLU . 59.6 mt -109.01 130.21 62.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.693 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.532 ' HA2' ' HB2' ' A' ' 136' ' ' ALA . . . -84.6 -152.25 15.69 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.12 175.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -110.56 15.1 22.28 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.0 mtpp -104.72 19.22 20.83 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 113.6 -1.636 . . . . 0.0 109.646 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.66 ' HA3' HG22 ' A' ' 4' ' ' THR . . . 108.25 -77.98 0.23 Allowed Glycine 0 C--O 1.223 -0.562 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.546 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.746 ' HA ' HG22 ' A' ' 110' ' ' ILE . 0.7 OUTLIER -166.83 161.08 15.11 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 117.689 0.745 . . . . 0.0 112.322 -179.823 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.496 HG13 ' H ' ' A' ' 5' ' ' ALA . 13.5 mt 75.93 85.24 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 125.826 1.65 . . . . 0.0 112.761 177.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 109' ' ' LEU . 1.3 mm? -110.74 -51.5 2.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.372 171.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.511 ' HG3' ' OE2' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -155.27 174.55 15.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.768 -174.726 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 21.0 m -141.53 133.94 28.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.668 0.27 . . . . 0.0 110.919 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.484 ' HD1' HD21 ' A' ' 109' ' ' LEU . 54.1 m-85 -132.31 110.19 10.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.567 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.49 HG11 HG21 ' A' ' 106' ' ' THR . 22.6 m -92.9 141.57 14.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.025 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 70.38 -113.71 5.03 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.447 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -94.55 109.92 46.02 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.73 121.16 4.97 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.425 2.084 . . . . 0.0 112.428 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.54 ' CG ' ' HG2' ' A' ' 128' ' ' LYS . 8.3 t0 -57.14 105.16 0.2 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 175.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -61.72 -31.34 71.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.852 -175.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -63.35 -49.31 71.43 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.468 -0.872 . . . . 0.0 111.381 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.54 ' HG2' ' CG ' ' A' ' 125' ' ' ASP . 33.2 mmtm -70.54 -34.97 72.85 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.571 ' O ' HG13 ' A' ' 133' ' ' ILE . 0.2 OUTLIER -56.34 -47.92 77.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.385 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -64.27 -55.72 19.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.778 -0.192 . . . . 0.0 110.867 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -58.25 -32.2 68.13 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.372 0.606 . . . . 0.0 111.337 -177.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.511 ' OE2' ' HG3' ' A' ' 118' ' ' LYS . 24.7 tt0 -80.59 -29.59 36.94 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.677 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.571 HG13 ' O ' ' A' ' 129' ' ' LEU . 51.5 mt -62.62 -44.77 99.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 171.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -59.06 -31.03 68.5 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.348 0.594 . . . . 0.0 110.517 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.407 ' HB ' ' O ' ' A' ' 132' ' ' GLU . 92.3 m -66.43 -35.91 81.47 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.431 176.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.532 ' HB2' ' HA2' ' A' ' 111' ' ' GLY . . . -69.92 -36.6 75.47 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.069 0.462 . . . . 0.0 110.388 176.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 10.0 m0 -60.26 -53.16 61.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.545 174.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 34.9 ttp-105 -74.88 -59.13 2.87 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.213 -174.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -67.69 124.56 23.6 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.48 0.657 . . . . 0.0 111.177 -173.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.9 m -131.29 -12.29 3.56 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.166 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.437 ' CG ' ' H ' ' A' ' 142' ' ' ALA . 1.8 p-10 -81.35 -96.16 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 113.969 -1.469 . . . . 0.0 112.971 -169.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.437 ' H ' ' CG ' ' A' ' 141' ' ' ASP . . . 70.95 -59.25 0.55 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.828 0.851 . . . . 0.0 109.594 -167.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.444 ' HB2' ' CE1' ' A' ' 145' ' ' HIS . 0.9 OUTLIER -179.16 -41.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.527 -0.761 . . . . 0.0 108.961 172.451 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 59.49 36.19 88.34 Favored Glycine 0 C--N 1.332 0.334 0 CA-C-N 115.363 -0.835 . . . . 0.0 114.303 170.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.665 ' HA ' ' HB2' ' A' ' 148' ' ' HIS . 30.2 p-80 -151.91 10.58 0.55 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.49 0.645 . . . . 0.0 112.363 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -60.74 -33.63 73.21 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.957 0.408 . . . . 0.0 110.841 175.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -153.34 37.91 0.48 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.353 175.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . 0.665 ' HB2' ' HA ' ' A' ' 145' ' ' HIS . 3.2 t60 -63.29 -30.88 71.94 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -110.01 132.52 54.09 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.978 171.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 11.1 p80 . . . . . 0 C--N 1.317 -0.806 0 CA-C-O 117.444 -1.265 . . . . 0.0 109.438 174.394 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.426 ' HB3' ' OG1' ' A' ' 4' ' ' THR . 21.8 t70 . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.4 m -60.57 -29.04 68.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.817 0.341 . . . . 0.0 111.132 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.7 mttp -91.09 -46.19 8.26 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.959 0.885 . . . . 0.0 109.857 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.426 ' OG1' ' HB3' ' A' ' 1' ' ' ASP . 6.6 p -105.83 87.3 2.55 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 114.138 -1.392 . . . . 0.0 111.525 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.636 ' H ' HG13 ' A' ' 116' ' ' ILE . . . 59.74 100.87 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.506 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 175.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.55 ' HD3' HD13 ' A' ' 116' ' ' ILE . 27.5 Cg_exo -63.17 146.35 94.11 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.699 2.266 . . . . 0.0 111.169 173.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.45 114.58 22.02 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.868 -177.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 55.9 p90 -135.63 137.25 41.69 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.331 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 40.7 m -149.39 88.85 1.6 Allowed 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 173.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -122.29 146.16 46.25 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.141 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.506 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 16.6 Cg_exo -68.25 137.2 39.59 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.285 1.99 . . . . 0.0 111.083 172.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.58 -179.29 1.68 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.519 HD22 HG23 ' A' ' 78' ' ' VAL . 2.9 pp -70.76 -9.2 56.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.741 0.305 . . . . 0.0 111.759 -176.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -92.24 -55.8 3.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.493 172.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 150.46 22.5 0.06 OUTLIER Glycine 0 CA--C 1.522 0.472 0 C-N-CA 120.06 -1.066 . . . . 0.0 114.175 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 41.1 tttm -105.8 126.24 51.93 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 117.445 0.623 . . . . 0.0 109.941 175.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 7.0 t -65.28 127.67 32.71 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.054 0.454 . . . . 0.0 109.79 174.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 9' ' ' SER . 46.8 t -111.12 124.57 68.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 50.4 p -129.38 -175.11 3.47 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.216 -173.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -73.8 -23.97 59.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.928 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.78 -27.48 68.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.015 177.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -69.25 -24.44 63.99 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.484 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.67 HD13 HG22 ' A' ' 110' ' ' ILE . 38.5 mt -82.22 -44.1 16.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.23 -174.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -60.85 126.26 26.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.363 0.601 . . . . 0.0 111.208 -175.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.37 -25.3 10.59 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.639 -176.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.619 ' O ' ' HA ' ' A' ' 112' ' ' LYS . 65.9 mttm -131.72 175.44 9.19 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.988 0.423 . . . . 0.0 110.049 177.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 58.9 t -103.48 146.88 10.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 170.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.57 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 22.2 m -134.67 143.65 47.37 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 121.782 -0.574 . . . . 0.0 111.862 -170.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.661 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 53.8 tp -113.92 113.92 25.51 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 171.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.666 ' HB ' ' CG1' ' A' ' 108' ' ' VAL . 30.2 mt -96.82 112.13 28.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 175.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -111.49 130.66 55.65 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.28 0.562 . . . . 0.0 109.867 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.506 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 94.3 m-85 -98.69 119.24 37.08 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.755 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.639 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 7.7 p-90 -139.1 -177.36 4.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.859 -174.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.633 ' HB3' ' OE1' ' A' ' 66' ' ' GLN . 33.0 p90 -157.9 150.62 18.12 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.837 175.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.49 157.59 35.74 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.116 1.877 . . . . 0.0 110.862 173.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.2 m 65.33 17.61 11.05 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.98 0.419 . . . . 0.0 111.2 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 51.9 t -80.13 133.41 57.56 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.846 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 26.1 Cg_exo -63.72 -26.59 68.39 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.64 2.227 . . . . 0.0 111.557 174.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.58 -16.78 78.77 Favored Glycine 0 C--O 1.225 -0.465 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.659 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 48.9 t -57.81 -30.85 66.04 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 122.446 0.299 . . . . 0.0 111.673 -175.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.1 p -61.1 -33.15 54.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.156 0.503 . . . . 0.0 110.21 177.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.594 ' O ' ' HE3' ' A' ' 46' ' ' LYS . 15.2 m -89.11 -49.76 6.56 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.097 175.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.531 ' O ' HG12 ' A' ' 47' ' ' ILE . 41.9 mt-10 -59.27 -52.68 64.61 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.85 -172.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.655 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 41.1 tpp -59.21 -58.06 22.38 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.402 -170.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.655 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 50.4 Cg_exo -57.05 -36.86 99.43 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.088 1.859 . . . . 0.0 112.56 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.594 ' HE3' ' O ' ' A' ' 42' ' ' SER . 0.0 OUTLIER -65.3 -51.26 61.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.482 179.217 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 43' ' ' GLU . 49.5 mm -60.91 -42.2 91.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.152 -178.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.606 HD12 ' HE1' ' A' ' 85' ' ' PHE . 47.7 mm -54.6 -53.26 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.803 0.335 . . . . 0.0 110.861 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -67.73 -51.49 48.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.405 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.458 ' O ' ' HD2' ' A' ' 54' ' ' TYR . 89.2 m -58.51 -47.0 85.58 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.263 -177.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . -69.15 -24.29 64.06 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -177.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -68.85 -51.73 37.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.265 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -68.17 -52.64 32.27 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.607 0.718 . . . . 0.0 111.002 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 1.045 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 54.6 m-85 -64.58 -21.85 66.81 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.107 -173.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.504 ' HZ2' ' HB2' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -53.95 -49.6 68.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.0 0.428 . . . . 0.0 110.752 179.82 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 -88.08 -18.58 28.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.426 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 58' ' ' ASN . 4.5 tppp? -61.26 -71.88 0.13 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.055 176.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.538 ' HB3' ' CZ3' ' A' ' 137' ' ' TRP . 3.7 t-20 169.35 31.29 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 1.045 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 50.7 t80 -140.02 156.2 46.73 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.983 -171.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.451 ' O ' ' HA ' ' A' ' 28' ' ' THR . 10.6 pt20 -148.85 159.14 44.45 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.291 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 86.3 t -123.96 130.69 73.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.465 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 85.6 mt -113.17 104.59 12.51 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.596 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.5 102.47 15.14 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.378 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.566 HG22 ' HE2' ' A' ' 88' ' ' MET . 59.0 t -99.23 114.67 37.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.053 0.454 . . . . 0.0 110.444 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.639 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -86.17 134.44 33.79 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.722 175.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.633 ' OE1' ' HB3' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -100.78 163.93 17.13 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.622 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.605 ' HD2' ' HB2' ' A' ' 93' ' ' LYS . 33.0 Cg_endo -61.87 89.88 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.324 2.016 . . . . 0.0 113.365 -174.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 41.2 mm -130.82 -66.18 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 172.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.78 147.7 34.6 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 171.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -53.78 158.51 8.32 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 122.656 2.238 . . . . 0.0 113.698 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.609 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 5.9 tp -56.52 -33.16 38.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.167 178.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.465 ' OE2' ' HD2' ' A' ' 75' ' ' ARG . 6.1 tp10 -64.25 -41.35 97.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.233 0.539 . . . . 0.0 110.222 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.5 m -60.14 -44.47 94.91 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.824 -177.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.454 ' O ' HG22 ' A' ' 78' ' ' VAL . 7.5 p -70.65 -33.62 53.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.852 -179.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.609 ' HG3' ' O ' ' A' ' 71' ' ' ILE . 98.7 mtt180 -55.29 -53.16 59.55 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.4 0.619 . . . . 0.0 110.327 175.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -63.66 -45.11 91.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.705 -176.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -55.4 -45.19 76.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.047 -176.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.647 ' HA ' HD21 ' A' ' 83' ' ' LEU . 86.1 t -64.36 -44.85 97.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.497 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.765 ' HA ' ' HE3' ' A' ' 79' ' ' LYS . 1.3 mmmt -76.96 -33.59 57.65 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.276 -0.57 . . . . 0.0 112.336 -175.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.94 -48.14 77.71 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 123.412 0.445 . . . . 0.0 110.909 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.438 ' HB2' ' CD1' ' A' ' 83' ' ' LEU . 80.8 m-85 -97.57 12.92 31.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.901 0.381 . . . . 0.0 111.18 -178.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.64 -60.49 4.35 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 121.103 -0.57 . . . . 0.0 113.029 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.647 HD21 ' HA ' ' A' ' 78' ' ' VAL . 10.2 mp 48.71 87.12 0.13 Allowed Pre-proline 0 N--CA 1.467 0.407 0 C-N-CA 123.756 0.822 . . . . 0.0 112.346 -177.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -79.27 44.52 1.71 Allowed 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.409 2.739 . . . . 0.0 112.953 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.606 ' HE1' HD12 ' A' ' 48' ' ' ILE . 21.1 p90 -152.27 157.5 41.48 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.7 m -74.78 117.9 17.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.96 0.409 . . . . 0.0 111.001 -174.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 36.0 t -110.2 126.62 67.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.577 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.566 ' HE2' HG22 ' A' ' 64' ' ' VAL . 76.0 mtm -119.13 167.73 11.53 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.626 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -138.56 117.18 12.17 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.559 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 43.9 t0 -92.13 128.72 38.08 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.68 -32.08 62.09 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -177.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.433 ' O ' ' HB3' ' A' ' 93' ' ' LYS . 25.9 t70 -112.1 -11.88 13.75 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.795 0.331 . . . . 0.0 110.807 -175.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.605 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 33.8 ttmt 73.15 15.68 4.4 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.533 -177.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.83 -39.84 93.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.423 -173.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.547 HG23 ' OD2' ' A' ' 90' ' ' ASP . 27.0 m -70.85 -31.93 47.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.863 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -72.1 -34.09 61.79 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 174.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 93' ' ' LYS . 44.5 mt-30 -64.35 -29.16 70.24 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 122.554 0.342 . . . . 0.0 110.482 176.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.22 -38.87 65.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.02 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -80.44 -13.14 59.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.823 0.344 . . . . 0.0 111.158 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.01 45.6 5.34 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.938 176.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 56.9 p -75.7 89.54 2.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.172 0.51 . . . . 0.0 111.2 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.6 mm100 -96.39 -52.52 3.94 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.251 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.438 ' HB ' ' CG2' ' A' ' 121' ' ' VAL . 47.1 t -106.73 134.68 47.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.613 177.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -105.1 145.83 31.5 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -75.95 165.41 85.57 Favored 'Cis proline' 0 C--N 1.342 0.227 0 C-N-CA 123.333 -1.528 . . . . 0.0 112.902 -0.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.7 m -124.19 133.67 53.48 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 176.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.511 ' HB3' HD13 ' A' ' 29' ' ' LEU . 25.0 m -127.47 110.57 12.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.863 0.363 . . . . 0.0 111.159 -175.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.666 ' CG1' ' HB ' ' A' ' 30' ' ' ILE . 12.3 p -106.97 138.54 32.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.972 0.415 . . . . 0.0 110.36 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.724 ' HB2' ' HB2' ' A' ' 118' ' ' LYS . 88.2 mt -102.01 124.52 47.76 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.268 0.556 . . . . 0.0 110.355 -177.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.67 HG22 HD13 ' A' ' 23' ' ' LEU . 18.7 mm -108.31 138.36 35.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.994 -174.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -86.22 -177.4 49.82 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.652 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.619 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 98.5 mttt -73.53 1.99 8.82 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.98 0.419 . . . . 0.0 111.557 -177.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.467 ' HZ2' ' CD ' ' A' ' 115' ' ' GLU . 19.9 tptp -134.21 6.55 3.6 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.543 ' HA2' ' CG2' ' A' ' 110' ' ' ILE . . . 85.81 -104.41 2.85 Favored Glycine 0 N--CA 1.433 -1.543 0 CA-C-N 114.376 -1.283 . . . . 0.0 110.346 -172.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.512 ' N ' ' HB3' ' A' ' 5' ' ' ALA . 1.1 mm-40 52.72 -9.1 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.215 1.806 . . . . 0.0 115.772 174.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.636 HG13 ' H ' ' A' ' 5' ' ' ALA . 13.2 mt 68.17 115.43 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 122.969 0.508 . . . . 0.0 111.189 -178.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 79.6 mt -101.85 -48.14 4.37 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.183 0.516 . . . . 0.0 111.235 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.724 ' HB2' ' HB2' ' A' ' 109' ' ' LEU . 5.0 mmmm -146.48 155.13 42.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.777 -169.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 18.4 m -135.98 110.76 8.71 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.643 178.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -112.67 146.91 37.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.243 176.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.438 ' CG2' ' HB ' ' A' ' 103' ' ' VAL . 7.3 p -123.67 133.52 68.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.892 177.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 79.88 -140.37 22.34 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.921 -178.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -85.23 112.31 42.8 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -81.25 162.94 19.96 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.651 2.234 . . . . 0.0 113.256 -177.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.607 ' OD2' ' HB3' ' A' ' 128' ' ' LYS . 7.4 p-10 -75.5 76.9 2.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.308 177.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -52.26 -40.41 61.66 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -175.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -57.91 -51.23 59.44 Favored Glycine 0 C--O 1.24 0.511 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.229 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.607 ' HB3' ' OD2' ' A' ' 125' ' ' ASP . 1.9 ttpm? -80.11 -18.75 49.03 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.666 ' O ' HG12 ' A' ' 133' ' ' ILE . 10.0 tt -70.95 -44.82 65.3 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 174.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -57.67 -55.59 32.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.665 0.269 . . . . 0.0 110.701 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.444 ' HG2' ' HA ' ' A' ' 128' ' ' LYS . 9.9 pt20 -61.69 -27.7 68.88 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.043 0.449 . . . . 0.0 110.988 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.441 ' OE2' ' HG3' ' A' ' 118' ' ' LYS . 32.0 tt0 -72.59 -42.86 64.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.555 178.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.666 HG12 ' O ' ' A' ' 129' ' ' LEU . 45.1 mm -69.65 -49.91 54.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.225 179.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.555 ' HA ' ' NE1' ' A' ' 137' ' ' TRP . 5.1 m-20 -64.48 -16.4 62.42 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.965 0.412 . . . . 0.0 111.411 -178.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 15.4 m -66.74 -29.11 69.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.958 0.408 . . . . 0.0 110.705 171.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.13 -18.2 64.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.464 -178.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.555 ' NE1' ' HA ' ' A' ' 134' ' ' ASP . 3.7 m95 -74.95 -38.42 61.73 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 174.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 138' ' ' ARG . 34.4 mtm105 -84.95 -60.01 2.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.099 -172.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 50.69 31.57 5.99 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.057 -177.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.8 m -105.14 17.36 24.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.605 0.717 . . . . 0.0 110.034 -176.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -83.75 36.56 0.55 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.831 -175.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.83 112.08 11.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.148 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 26.6 tp10 -96.19 24.15 5.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 122.038 0.923 . . . . 0.0 109.986 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -82.54 54.67 4.94 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.423 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -69.77 142.42 53.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.982 0.42 . . . . 0.0 110.306 178.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -92.12 175.81 6.73 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.341 0.591 . . . . 0.0 111.477 -169.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 45.3 m80 -114.9 99.61 7.6 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 172.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -117.93 89.07 3.04 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.016 0.436 . . . . 0.0 111.676 -172.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 40.3 t60 -178.27 131.91 0.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.667 174.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 7.5 p80 . . . . . 0 C--O 1.246 0.921 0 CA-C-O 118.747 -0.645 . . . . 0.0 110.254 178.078 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.413 ' OD2' ' HG3' ' A' ' 3' ' ' LYS . 6.8 p-10 . . . . . 0 N--CA 1.481 1.124 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.4 p -61.96 -26.76 68.39 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -177.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.573 ' O ' ' HB ' ' A' ' 4' ' ' THR . 58.4 mttp -43.64 109.73 0.16 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.625 HG21 ' HB3' ' A' ' 20' ' ' ASN . 14.0 t 151.49 -25.17 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 O-C-N 124.702 1.251 . . . . 0.0 109.276 177.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.651 ' HB2' ' HD2' ' A' ' 6' ' ' PRO . . . 165.2 -159.72 0.0 OUTLIER Pre-proline 0 C--N 1.315 -0.904 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 -168.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.651 ' HD2' ' HB2' ' A' ' 5' ' ' ALA . 9.6 Cg_endo -57.89 163.69 9.06 Favored 'Trans proline' 0 C--N 1.347 0.498 0 CA-C-N 121.163 1.451 . . . . 0.0 109.394 154.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -52.29 104.75 0.09 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.089 0.471 . . . . 0.0 110.449 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -104.13 111.87 24.64 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 122.377 1.084 . . . . 0.0 112.621 -170.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.5 m -150.35 89.6 1.59 Allowed 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 113.388 -1.733 . . . . 0.0 108.102 171.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.428 ' HB3' ' HE1' ' A' ' 88' ' ' MET . 23.8 tp -120.65 139.17 28.48 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.855 -169.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -73.58 141.77 31.69 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.394 2.063 . . . . 0.0 111.556 172.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.41 ' CG ' ' H ' ' A' ' 14' ' ' HIS . 0.6 OUTLIER -87.35 -176.04 5.49 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 177.847 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.7 mt -73.01 -1.14 15.95 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -177.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.41 ' H ' ' CG ' ' A' ' 12' ' ' ASP . 67.7 m80 -109.92 8.61 24.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.997 0.427 . . . . 0.0 109.998 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.72 34.95 59.14 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.363 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.5 mmtm -115.29 134.0 55.53 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 175.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.5 m -79.0 122.46 26.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.826 0.346 . . . . 0.0 110.506 -178.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.8 t -112.48 122.36 66.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 90.4 p -108.13 178.86 4.38 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.313 0.578 . . . . 0.0 110.713 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.625 ' HB3' HG21 ' A' ' 4' ' ' THR . 31.6 p-10 -76.17 -21.22 56.79 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.498 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.03 -28.91 69.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.715 175.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -73.6 -13.93 61.1 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.32 0.581 . . . . 0.0 110.583 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 61.6 mt -83.69 -48.29 10.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.186 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -56.25 150.84 13.68 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.254 0.55 . . . . 0.0 111.864 -175.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.25 -19.5 46.43 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -172.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.547 ' HB2' ' HZ1' ' A' ' 26' ' ' LYS . 4.4 mtmp? -135.39 167.92 20.15 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.425 HG21 ' CD1' ' A' ' 137' ' ' TRP . 35.2 t -108.04 140.52 26.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 175.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.43 HG22 ' HG3' ' A' ' 60' ' ' GLN . 29.9 m -134.32 140.86 46.67 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.013 0.435 . . . . 0.0 111.867 -171.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.452 HD13 ' HB3' ' A' ' 107' ' ' SER . 47.7 tp -113.85 115.45 27.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.305 173.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.837 HG12 ' HB2' ' A' ' 62' ' ' LEU . 46.2 mt -107.01 112.77 41.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.547 ' HA ' ' O ' ' A' ' 106' ' ' THR . 23.6 p-10 -113.9 129.39 56.6 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.246 0.546 . . . . 0.0 111.248 -178.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -83.09 128.74 34.75 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.048 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.577 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 5.5 p-90 -154.12 -175.71 5.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.49 -176.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.745 ' HB3' HE22 ' A' ' 66' ' ' GLN . 13.1 p90 -171.44 159.86 5.03 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.084 174.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.423 ' HD2' ' HB2' ' A' ' 34' ' ' PHE . 19.8 Cg_endo -62.86 156.25 55.07 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.119 1.879 . . . . 0.0 111.639 176.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.5 m 67.59 13.56 9.31 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.653 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 49.2 t -83.83 136.26 41.91 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.81 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.528 ' O ' HG13 ' A' ' 41' ' ' VAL . 35.9 Cg_exo -60.13 -25.83 80.9 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.615 2.21 . . . . 0.0 112.25 176.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.21 -13.7 65.17 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 121.228 -0.51 . . . . 0.0 113.145 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 88.1 m -63.25 -30.79 71.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.783 0.292 . . . . 0.0 111.684 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.528 HG13 ' O ' ' A' ' 38' ' ' PRO . 14.6 p -65.39 -37.55 80.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.814 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.443 ' O ' ' HE2' ' A' ' 46' ' ' LYS . 22.8 m -87.11 -56.6 3.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.997 0.427 . . . . 0.0 111.284 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.461 ' HG3' ' HG3' ' A' ' 105' ' ' PRO . 74.4 mm-40 -69.99 -41.55 74.26 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.205 0.816 . . . . 0.0 113.205 -169.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.721 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 39.6 tpp -49.32 -59.96 5.66 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -169.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.721 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 31.2 Cg_exo -58.74 -44.3 37.48 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 121.84 1.693 . . . . 0.0 112.27 -178.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.461 ' HE2' ' HA ' ' A' ' 43' ' ' GLU . 45.1 mtmt -60.2 -51.3 70.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.442 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.6 mm -62.64 -38.3 81.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.367 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.558 HG12 ' O ' ' A' ' 44' ' ' MET . 30.4 mm -54.91 -54.02 27.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 116.807 -0.179 . . . . 0.0 110.956 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.767 ' HZ3' ' HB2' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -75.48 -38.77 59.34 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 119.659 -0.817 . . . . 0.0 110.815 -178.628 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.557 ' O ' ' HD2' ' A' ' 54' ' ' TYR . 91.6 m -58.39 -44.85 89.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.826 0.346 . . . . 0.0 110.811 -178.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.0 -44.65 79.81 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.127 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -67.26 -50.45 60.48 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.747 0.308 . . . . 0.0 111.088 -178.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.63 -45.38 73.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.257 0.551 . . . . 0.0 111.035 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 1.036 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 50.6 m-85 -82.28 -26.24 33.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.308 -174.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.458 ' NZ ' ' HB3' ' A' ' 60' ' ' GLN . 18.0 tppt? -61.93 -32.45 72.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.899 0.381 . . . . 0.0 110.117 176.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -84.76 45.84 1.19 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.464 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.478 ' HE2' ' HA ' ' A' ' 54' ' ' TYR . 9.0 pttm -166.07 -58.48 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.681 170.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.456 ' OD1' ' HG2' ' A' ' 26' ' ' LYS . 59.7 t30 176.46 38.06 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 120.989 0.424 . . . . 0.0 111.521 -177.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 1.036 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 44.4 t80 -138.5 157.42 46.22 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 122.003 -0.435 . . . . 0.0 109.828 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.458 ' HB3' ' NZ ' ' A' ' 55' ' ' LYS . 11.1 pt20 -152.16 152.33 32.15 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.935 0.398 . . . . 0.0 110.985 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 90.2 t -117.96 126.19 74.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.669 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.837 ' HB2' HG12 ' A' ' 30' ' ' ILE . 86.1 mt -112.13 106.46 15.09 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.469 ' HB3' ' CD1' ' A' ' 33' ' ' TRP . . . -90.85 105.86 18.12 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.682 -176.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 91.9 t -90.44 115.86 30.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.936 0.398 . . . . 0.0 110.716 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.577 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -88.0 111.27 21.32 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.791 176.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.745 HE22 ' HB3' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -83.17 163.04 52.35 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.015 -177.29 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.555 ' HD2' ' HB2' ' A' ' 66' ' ' GLN . 57.1 Cg_endo -69.62 97.35 0.62 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.352 2.035 . . . . 0.0 113.073 -171.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 52.6 mt -141.19 -65.05 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.332 173.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.34 144.42 30.9 Favored Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 166.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.95 152.56 23.11 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.442 2.095 . . . . 0.0 112.471 178.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.642 ' O ' HG21 ' A' ' 74' ' ' VAL . 12.8 tt -58.38 -23.24 21.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.021 176.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -65.83 -45.13 83.41 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.613 174.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.4 m -59.77 -41.13 90.41 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.506 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.642 HG21 ' O ' ' A' ' 71' ' ' ILE . 13.0 m -68.85 -33.91 61.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.972 -177.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.723 ' HA ' HG22 ' A' ' 78' ' ' VAL . 76.2 mtt180 -70.69 -39.88 73.24 Favored 'General case' 0 C--O 1.22 -0.488 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 174.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -61.31 -37.45 83.3 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -63.35 -53.8 46.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.206 176.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.723 HG22 ' HA ' ' A' ' 75' ' ' ARG . 35.0 m -63.4 -27.26 42.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.996 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.63 ' HZ3' ' HB3' ' A' ' 79' ' ' LYS . 5.6 mmmp? -75.69 -40.16 56.27 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -73.3 -49.63 26.53 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.659 0.599 . . . . 0.0 111.798 -172.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -88.58 -1.89 58.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.493 -174.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 58.03 51.2 59.72 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.257 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.515 ' CD1' ' HA ' ' A' ' 78' ' ' VAL . 1.2 mp -74.61 117.06 59.24 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 121.011 0.434 . . . . 0.0 111.151 -175.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.59 -28.37 4.39 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.28 2.654 . . . . 0.0 114.415 -172.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -71.3 146.39 48.91 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.402 -178.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.414 ' HB ' HD23 ' A' ' 62' ' ' LEU . 12.3 m -70.4 113.42 7.52 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.453 -172.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.9 t -99.41 132.58 44.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.244 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.428 ' HE1' ' HB3' ' A' ' 10' ' ' LEU . 60.3 mtp -118.65 164.71 14.93 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.513 -0.767 . . . . 0.0 108.964 -177.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -120.6 129.35 53.71 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.283 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.788 ' OD2' ' HA ' ' A' ' 93' ' ' LYS . 10.7 t0 -102.07 115.75 31.21 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.322 177.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.15 -47.46 24.23 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -172.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -115.04 -10.96 12.17 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -169.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.788 ' HA ' ' OD2' ' A' ' 90' ' ' ASP . 34.9 ttmt 68.63 18.65 8.78 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 122.826 0.45 . . . . 0.0 111.506 177.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.03 -33.95 76.65 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.589 -0.694 . . . . 0.0 109.65 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.8 p -63.39 -47.63 90.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.723 172.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.92 -36.81 93.53 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.207 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -64.59 -30.48 71.51 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 122.542 0.337 . . . . 0.0 111.016 178.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.499 ' HB1' ' HG3' ' A' ' 6' ' ' PRO . . . -67.63 -34.2 76.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.935 0.398 . . . . 0.0 110.451 176.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.474 ' HB2' HG21 ' A' ' 101' ' ' THR . 65.4 m-85 -83.21 -17.9 41.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.031 174.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.8 31.76 38.97 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.942 -175.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.474 HG21 ' HB2' ' A' ' 99' ' ' PHE . 78.1 p -78.36 91.11 4.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.538 0.685 . . . . 0.0 111.98 -175.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 73.6 mm-40 -108.95 -26.39 10.24 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 171.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.5 m -109.18 140.48 27.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.527 174.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.525 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 37.2 m-85 -127.87 160.61 60.32 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.373 -173.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.525 ' HA ' ' HB3' ' A' ' 104' ' ' TYR . 87.3 Cg_endo -78.95 166.52 79.06 Favored 'Cis proline' 0 C--N 1.347 0.484 0 C-N-CA 123.866 -1.306 . . . . 0.0 113.269 0.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.547 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 22.1 m -126.03 120.47 30.35 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.99 175.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.452 ' HB3' HD13 ' A' ' 29' ' ' LEU . 33.9 m -107.89 113.17 26.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.009 0.433 . . . . 0.0 111.496 -174.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.591 HG21 HG21 ' A' ' 119' ' ' THR . 45.8 t -105.54 129.19 58.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.377 -178.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.552 ' HB2' ' HB3' ' A' ' 118' ' ' LYS . 96.5 mt -102.74 126.25 49.78 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.466 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 65.7 mt -116.87 125.36 73.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.086 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.405 ' H ' HD23 ' A' ' 117' ' ' LEU . . . -72.84 177.63 41.26 Favored Glycine 0 N--CA 1.453 -0.224 0 CA-C-N 115.896 -0.593 . . . . 0.0 113.21 -175.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 7.2 ptpp? -68.48 -6.2 23.7 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -175.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.831 ' HE3' ' HB3' ' A' ' 143' ' ' GLU . 7.7 ptmm? -105.97 6.99 31.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.684 0.278 . . . . 0.0 110.438 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.33 70.68 1.01 Allowed Glycine 0 C--O 1.225 -0.449 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 -177.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.538 ' CA ' ' HA ' ' A' ' 4' ' ' THR . 23.2 tt0 -153.72 165.21 36.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.551 0.215 . . . . 0.0 110.466 -174.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 86.7 mt -72.97 103.32 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.087 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.405 HD23 ' H ' ' A' ' 111' ' ' GLY . 3.1 mm? -97.92 -44.05 6.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.615 177.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.552 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -163.18 152.51 14.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.839 0.352 . . . . 0.0 111.872 -175.775 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.591 HG21 HG21 ' A' ' 108' ' ' VAL . 38.0 m -138.77 102.93 4.7 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.845 168.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -79.54 138.38 37.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.653 174.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.3 p -103.86 114.99 44.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 173.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 94.13 -157.91 22.88 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.889 -177.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -80.59 119.73 77.12 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 120.72 0.295 . . . . 0.0 110.681 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -87.56 151.47 7.63 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.818 2.345 . . . . 0.0 112.716 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.96 127.86 33.02 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.541 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 7.6 m-85 -71.57 -18.8 62.22 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -176.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -68.23 -54.48 16.7 Favored Glycine 0 C--O 1.238 0.367 0 C-N-CA 120.096 -1.049 . . . . 0.0 111.648 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.689 ' HA ' HE21 ' A' ' 131' ' ' GLN . 5.2 ttpp -74.87 -20.82 59.57 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 176.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.541 ' HB3' ' HA ' ' A' ' 126' ' ' PHE . 63.0 tp -65.7 -48.02 73.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.049 175.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 14.9 m-30 -61.56 -52.72 63.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.263 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.689 HE21 ' HA ' ' A' ' 128' ' ' LYS . 19.8 pt20 -65.92 -27.54 68.26 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.863 0.363 . . . . 0.0 111.909 -177.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -80.02 -37.26 34.49 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.184 -0.323 . . . . 0.0 110.428 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 129' ' ' LEU . 51.2 mt -65.64 -48.49 82.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.717 176.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.422 ' CG ' HH21 ' A' ' 138' ' ' ARG . 0.0 OUTLIER -64.67 -25.37 67.92 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 -177.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.449 ' HA ' ' HG2' ' A' ' 138' ' ' ARG . 68.7 m -60.99 -43.69 98.49 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.067 0.461 . . . . 0.0 110.145 173.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.52 -23.86 64.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.637 178.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.792 ' HZ2' ' HB2' ' A' ' 59' ' ' PHE . 14.3 m95 -78.13 -54.36 6.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.098 175.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.449 ' HG2' ' HA ' ' A' ' 135' ' ' THR . 5.0 ptp180 -65.63 -36.16 82.89 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.745 -173.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -71.19 102.78 2.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.725 0.298 . . . . 0.0 110.434 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.8 p -71.49 -76.02 0.12 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.281 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -112.21 53.63 0.73 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.901 -176.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.94 -35.29 80.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.381 0.61 . . . . 0.0 109.804 175.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.831 ' HB3' ' HE3' ' A' ' 113' ' ' LYS . 0.7 OUTLIER -118.37 172.56 7.37 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 177.542 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.591 ' H ' ' CD ' ' A' ' 143' ' ' GLU . . . 98.04 19.57 23.59 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -174.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 18.6 m170 -91.76 14.44 15.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.023 -0.588 . . . . 0.0 110.916 -174.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -68.96 -9.46 52.26 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.967 0.413 . . . . 0.0 110.592 -178.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -78.06 -5.53 51.77 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.375 0.607 . . . . 0.0 110.06 175.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 73.3 m-70 -125.53 144.26 50.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.892 175.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 21.0 p80 -155.73 161.73 40.66 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.623 178.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 54.4 p-80 . . . . . 0 C--O 1.245 0.846 0 CA-C-O 118.588 -0.72 . . . . 0.0 109.641 -179.92 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 . . . . . 0 N--CA 1.482 1.168 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.512 ' HB2' ' HE2' ' A' ' 147' ' ' HIS . 14.3 m 53.17 72.71 0.41 Allowed 'General case' 0 C--O 1.235 0.331 0 O-C-N 123.571 0.544 . . . . 0.0 109.642 -175.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.582 ' HZ3' ' C ' ' A' ' 150' ' ' HIS . 14.7 mmmm 67.27 -168.84 0.2 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.834 -166.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.479 HG21 ' H ' ' A' ' 147' ' ' HIS . 12.4 m 60.9 18.5 8.85 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.216 0.531 . . . . 0.0 110.821 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 68.13 150.06 0.12 Allowed Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.293 -176.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.514 ' HG3' ' HA ' ' A' ' 95' ' ' VAL . 69.6 Cg_endo -88.96 178.88 2.56 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.435 2.09 . . . . 0.0 111.309 175.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.95 83.73 7.46 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 172.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -110.56 112.93 25.16 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.596 0.712 . . . . 0.0 111.319 -173.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.4 m -96.15 90.04 5.36 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 169.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.445 HD12 ' HD2' ' A' ' 11' ' ' PRO . 29.7 tp -102.73 123.35 42.75 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.259 -169.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.508 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 8.4 Cg_exo -72.96 147.06 42.94 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.819 2.346 . . . . 0.0 112.222 176.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.08 -177.91 5.3 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 174.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.3 mt -63.5 -22.73 67.05 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -177.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -89.22 -54.53 4.06 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.053 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.22 18.25 0.05 OUTLIER Glycine 0 CA--C 1.523 0.548 0 C-N-CA 119.61 -1.281 . . . . 0.0 114.683 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 11' ' ' PRO . 51.2 mttt -92.0 140.39 29.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 118.026 0.913 . . . . 0.0 110.119 174.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.6 m -88.26 122.36 31.7 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.1 0.476 . . . . 0.0 111.397 -177.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.0 t -107.25 132.66 54.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.737 174.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -140.81 -177.3 5.01 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.44 -173.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -58.21 -23.33 55.32 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.702 -176.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.86 -27.92 69.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.483 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -83.04 -19.59 36.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.148 0.499 . . . . 0.0 110.541 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.591 ' HB3' ' HA2' ' A' ' 114' ' ' GLY . 9.3 mp -83.53 -20.08 34.52 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.306 -176.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -95.74 134.58 38.5 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.063 0.459 . . . . 0.0 110.942 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.97 -7.13 82.28 Favored Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.752 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.583 ' HG2' ' OD1' ' A' ' 58' ' ' ASN . 29.9 mtpp -129.61 168.19 16.81 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.489 HG21 ' HA ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -103.25 130.93 52.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 174.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.445 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 21.0 m -133.26 146.41 51.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.98 0.419 . . . . 0.0 112.057 -166.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.523 HD21 ' HB3' ' A' ' 107' ' ' SER . 8.0 tt -131.73 124.22 29.3 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 174.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.798 ' HB ' HG13 ' A' ' 108' ' ' VAL . 45.0 mm -109.89 125.35 67.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -109.38 112.87 25.24 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -84.79 119.57 25.45 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.579 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 4.2 p-90 -154.32 177.11 11.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.2 0.524 . . . . 0.0 111.484 -176.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.626 ' HB3' ' OE1' ' A' ' 66' ' ' GLN . 9.3 p90 -148.81 136.32 10.99 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.602 172.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.452 ' HD2' ' OD1' ' A' ' 69' ' ' ASP . 44.8 Cg_exo -59.59 -15.71 32.46 Favored 'Trans proline' 0 N--CA 1.475 0.396 0 C-N-CA 123.421 2.747 . . . . 0.0 114.414 -173.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.4 p -95.45 13.81 24.72 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 122.017 -0.427 . . . . 0.0 111.991 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 25.0 p -88.37 146.0 36.88 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.854 0.359 . . . . 0.0 111.375 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 5.8 Cg_exo -79.09 -8.68 15.41 Favored 'Trans proline' 0 CA--C 1.532 0.406 0 C-N-CA 123.119 2.546 . . . . 0.0 113.011 176.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -86.18 -61.27 1.67 Allowed Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.676 -173.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.475 ' SG ' ' HB2' ' A' ' 33' ' ' TRP . 82.0 m -52.06 -30.06 24.05 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -169.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.8 p -56.12 -24.52 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.112 0.482 . . . . 0.0 111.16 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.651 ' HB2' ' OE2' ' A' ' 43' ' ' GLU . 1.7 m -86.23 -45.15 11.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.952 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.651 ' OE2' ' HB2' ' A' ' 42' ' ' SER . 3.9 mp0 -80.13 -33.36 38.65 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -174.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.599 ' O ' HG12 ' A' ' 48' ' ' ILE . 13.2 ptp -57.43 -38.9 72.83 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -166.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.562 ' HD3' ' CG ' ' A' ' 44' ' ' MET . 47.2 Cg_exo -58.28 -43.94 42.68 Favored 'Trans proline' 0 C--N 1.361 1.225 0 CA-C-N 121.749 1.66 . . . . 0.0 111.797 175.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -59.16 -38.09 78.91 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.483 176.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.2 mt -68.52 -36.42 74.62 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.4 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.733 177.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.599 HG12 ' O ' ' A' ' 44' ' ' MET . 47.2 mm -53.57 -55.49 13.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-O 120.799 0.333 . . . . 0.0 110.32 -175.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -75.86 -53.74 7.98 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.272 -177.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.8 m -58.01 -45.03 87.52 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -174.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.49 ' HB3' HG23 ' A' ' 61' ' ' VAL . . . -70.03 -36.05 74.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.874 -0.148 . . . . 0.0 111.32 -178.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -68.78 -45.43 71.36 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.017 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -59.77 -27.28 66.4 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.779 176.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.652 ' HH ' ' HB ' ' A' ' 133' ' ' ILE . 0.1 OUTLIER -87.18 -39.48 15.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.946 -179.649 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.425 ' HB3' ' HZ1' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -60.07 -31.27 69.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.296 -175.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -80.34 37.54 0.39 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -174.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.402 ' HB3' ' HE3' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -162.57 65.84 0.21 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.073 0.463 . . . . 0.0 111.068 172.276 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.583 ' OD1' ' HG2' ' A' ' 26' ' ' LYS . 66.9 t30 66.1 11.0 7.5 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.525 176.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.489 ' HA ' HG21 ' A' ' 27' ' ' VAL . 43.9 t80 -105.57 148.69 27.0 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -141.4 126.33 18.22 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.135 0.493 . . . . 0.0 111.506 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.49 HG23 ' HB3' ' A' ' 51' ' ' ALA . 58.2 t -106.07 117.39 51.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.686 177.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.423 ' HB3' ' HE1' ' A' ' 88' ' ' MET . 5.5 mp -120.2 117.82 28.87 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.017 0.437 . . . . 0.0 110.227 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.442 ' O ' ' HA ' ' A' ' 87' ' ' VAL . . . -94.22 114.26 26.33 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.839 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.3 p -101.23 119.95 50.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.353 0.596 . . . . 0.0 111.137 -176.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.579 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -89.59 129.68 36.01 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.447 175.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.626 ' OE1' ' HB3' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -104.74 165.88 12.5 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.594 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.618 ' HD3' ' O ' ' A' ' 90' ' ' ASP . 57.7 Cg_endo -70.83 80.15 1.21 Allowed 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.291 1.994 . . . . 0.0 113.525 -169.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 70.6 mt -120.78 -43.9 2.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 172.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.452 ' OD1' ' HD2' ' A' ' 35' ' ' PRO . 5.3 p-10 -121.78 141.43 33.84 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 163.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 69' ' ' ASP . 36.4 Cg_exo -57.66 158.33 20.35 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.056 2.504 . . . . 0.0 113.176 -174.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.613 ' O ' ' HG2' ' A' ' 75' ' ' ARG . 13.1 tt -53.69 -28.35 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.288 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.567 ' HA ' ' CG ' ' A' ' 75' ' ' ARG . 22.6 tp10 -64.16 -36.75 85.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.117 0.484 . . . . 0.0 110.958 178.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.0 t -68.71 -34.96 76.52 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 178.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.48 ' O ' HG21 ' A' ' 78' ' ' VAL . 24.0 t -60.35 -44.38 95.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.216 173.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.613 ' HG2' ' O ' ' A' ' 71' ' ' ILE . 14.1 mmt180 -52.83 -51.93 59.03 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.751 0.786 . . . . 0.0 109.601 176.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -61.47 -42.04 98.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.157 -1.383 . . . . 0.0 111.781 -175.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.443 ' CE1' ' HE2' ' A' ' 44' ' ' MET . 24.5 t80 -70.99 -43.21 68.47 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.076 -176.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.531 HG11 ' HB2' ' A' ' 83' ' ' LEU . 80.1 t -59.89 -43.84 93.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.341 -177.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -74.0 -28.57 61.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.662 0.268 . . . . 0.0 111.348 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -73.37 -48.58 32.99 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.352 -175.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -97.42 -2.77 41.47 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -177.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 64.44 64.08 3.85 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.555 178.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.531 ' HB2' HG11 ' A' ' 78' ' ' VAL . 10.3 mp -79.67 115.34 52.95 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-O 120.644 0.259 . . . . 0.0 110.914 -178.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.414 ' CD ' HD12 ' A' ' 48' ' ' ILE . 93.4 Cg_endo -89.6 -21.45 1.09 Allowed 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.004 2.469 . . . . 0.0 113.568 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -76.19 155.56 34.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.799 0.333 . . . . 0.0 110.503 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 29.5 m -73.41 121.19 20.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.344 -175.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 63' ' ' ALA . 38.9 t -109.42 138.7 35.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.677 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.423 ' HE1' ' HB3' ' A' ' 62' ' ' LEU . 71.6 mtm -122.25 171.29 9.13 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 176.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -139.47 115.24 10.1 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.545 -0.169 . . . . 0.0 110.545 -178.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.618 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 13.3 t70 -107.83 127.53 53.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.898 0.38 . . . . 0.0 110.793 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.48 -28.12 56.35 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -175.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -112.65 -12.96 13.34 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -165.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt 69.42 7.63 6.34 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 122.739 0.415 . . . . 0.0 110.978 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.35 -32.53 70.19 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.246 0.546 . . . . 0.0 110.192 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.539 ' O ' ' HD1' ' A' ' 99' ' ' PHE . 2.0 p -60.43 -49.8 82.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.42 173.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -67.18 -33.67 83.69 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.938 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -58.82 -51.65 69.11 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 122.653 0.381 . . . . 0.0 111.485 177.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.79 -29.67 62.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.888 -177.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.733 ' HA ' HD12 ' A' ' 116' ' ' ILE . 17.2 m-85 -76.35 -27.79 56.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.753 0.311 . . . . 0.0 111.093 177.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.36 46.43 4.67 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.785 -0.722 . . . . 0.0 111.718 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 24.5 m -118.43 99.35 6.77 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.981 0.42 . . . . 0.0 111.158 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -91.82 -48.78 6.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.9 176.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 9.2 p -100.4 159.44 3.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.327 -174.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.426 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 34.1 m-85 -135.49 156.85 77.45 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -175.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.426 ' HA ' ' HB3' ' A' ' 104' ' ' TYR . 89.4 Cg_endo -85.16 141.59 32.38 Favored 'Cis proline' 0 C--N 1.347 0.478 0 C-N-CA 123.524 -1.449 . . . . 0.0 112.725 -0.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 89.5 m -129.77 129.98 44.79 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.379 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.523 ' HB3' HD21 ' A' ' 29' ' ' LEU . 14.0 m -111.79 131.92 55.02 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.148 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.798 HG13 ' HB ' ' A' ' 30' ' ' ILE . 8.3 p -105.97 142.77 18.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 120.887 0.375 . . . . 0.0 109.995 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.704 HD21 HD12 ' A' ' 129' ' ' LEU . 66.5 mt -103.86 127.86 51.35 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.779 177.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.51 HD11 HD22 ' A' ' 23' ' ' LEU . 72.5 mt -115.62 127.38 73.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.859 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.63 -97.84 0.01 OUTLIER Glycine 0 C--N 1.334 0.44 0 O-C-N 123.953 0.783 . . . . 0.0 112.716 -177.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.477 ' HG2' ' OE2' ' A' ' 143' ' ' GLU . 8.8 ptpp? -150.97 13.27 0.69 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.011 0.434 . . . . 0.0 110.649 176.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 49.1 mttp -111.9 -3.11 14.96 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.48 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.591 ' HA2' ' HB3' ' A' ' 23' ' ' LEU . . . 76.65 42.45 21.54 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.654 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -139.14 165.15 27.92 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.741 0.305 . . . . 0.0 110.335 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.733 HD12 ' HA ' ' A' ' 99' ' ' PHE . 59.5 mt -69.74 116.69 11.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.667 -177.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 19.5 tp -105.71 -51.65 2.96 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.283 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.586 ' HB2' ' HB2' ' A' ' 109' ' ' LEU . 3.1 mmmm -139.56 169.65 17.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.091 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 23.2 m -148.88 129.62 14.16 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.767 0.318 . . . . 0.0 110.746 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -126.29 118.49 25.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.771 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.7 p -110.99 139.67 33.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.762 -178.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 73.52 66.71 1.95 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.093 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 65.48 116.21 0.02 OUTLIER Pre-proline 0 N--CA 1.464 0.264 0 C-N-CA 123.45 0.7 . . . . 0.0 111.805 -175.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.75 117.76 3.69 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.181 1.92 . . . . 0.0 111.633 174.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -61.49 105.58 0.54 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -64.49 -31.65 72.96 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -171.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.467 ' HA2' ' CZ ' ' A' ' 130' ' ' TYR . . . -58.86 -54.07 41.01 Favored Glycine 0 C--O 1.238 0.371 0 C-N-CA 120.371 -0.918 . . . . 0.0 111.661 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.57 ' HA ' ' HG2' ' A' ' 131' ' ' GLN . 35.7 mtmm -76.16 -17.95 59.33 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.657 0.265 . . . . 0.0 110.637 177.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.704 HD12 HD21 ' A' ' 109' ' ' LEU . 18.6 tp -69.17 -51.22 40.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.662 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.467 ' CZ ' ' HA2' ' A' ' 127' ' ' GLY . 2.0 p90 -73.94 -33.94 64.12 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 119.579 -0.848 . . . . 0.0 112.249 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.57 ' HG2' ' HA ' ' A' ' 128' ' ' LYS . 3.3 pt20 -68.47 -30.73 69.65 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.79 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -76.12 -45.33 34.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.7 177.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.652 ' HB ' ' HH ' ' A' ' 54' ' ' TYR . 78.0 mt -63.54 -38.88 83.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.628 178.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.587 ' O ' ' HG2' ' A' ' 138' ' ' ARG . 12.3 t70 -56.65 -40.26 75.16 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.01 0.433 . . . . 0.0 110.218 176.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 89.6 m -58.32 -35.28 71.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.657 177.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.762 ' HA ' ' ND2' ' A' ' 139' ' ' ASN . . . -75.72 -17.92 59.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.198 178.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.437 ' HB2' ' O ' ' A' ' 134' ' ' ASP . 11.7 m0 -74.03 -35.12 64.33 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 171.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.587 ' HG2' ' O ' ' A' ' 134' ' ' ASP . 20.7 mmt180 -84.82 -30.87 24.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.367 -174.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.762 ' ND2' ' HA ' ' A' ' 136' ' ' ALA . 37.5 p30 -69.76 131.52 44.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.815 0.817 . . . . 0.0 111.437 -175.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.418 ' C ' ' H ' ' A' ' 142' ' ' ALA . 14.9 m -89.73 92.0 8.87 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.293 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 33.2 t70 73.64 -26.41 0.19 Allowed 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.77 175.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.418 ' H ' ' C ' ' A' ' 140' ' ' SER . . . -73.01 76.43 1.2 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.098 0.475 . . . . 0.0 111.77 -178.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.477 ' OE2' ' HG2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -155.54 -57.15 0.1 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.193 175.813 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -126.83 167.55 19.24 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.486 174.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -158.2 17.02 0.22 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.827 0.313 . . . . 0.0 110.86 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.434 ' C ' ' H ' ' A' ' 148' ' ' HIS . 31.6 m170 63.33 103.76 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.704 0.802 . . . . 0.0 112.998 176.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.512 ' HE2' ' HB2' ' A' ' 2' ' ' SER . 1.7 t-160 71.67 -7.46 1.23 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.24 175.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . 0.434 ' H ' ' C ' ' A' ' 146' ' ' HIS . 75.6 m-70 -88.56 -24.42 22.88 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 172.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -94.98 117.48 30.22 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 174.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.582 ' C ' ' HZ3' ' A' ' 3' ' ' LYS . 35.9 m-70 . . . . . 0 C--O 1.245 0.823 0 CA-C-O 118.567 -0.73 . . . . 0.0 110.795 -175.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.52 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 26.0 t0 . . . . . 0 N--CA 1.483 1.178 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.726 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 50.0 m -86.53 126.46 34.47 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -173.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.488 ' HA ' HG13 ' A' ' 116' ' ' ILE . 2.5 mppt? 68.62 139.56 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 171.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.576 ' H ' HG12 ' A' ' 116' ' ' ILE . 11.1 m 71.93 17.37 5.28 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.701 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.528 ' HB3' ' CE1' ' A' ' 8' ' ' PHE . . . 49.1 56.55 18.15 Favored Pre-proline 0 N--CA 1.468 0.432 0 CA-C-N 115.076 -0.966 . . . . 0.0 112.918 177.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 5' ' ' ALA . 15.9 Cg_exo -70.4 106.7 1.83 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.827 2.351 . . . . 0.0 112.766 -177.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 48.63 88.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 O-C-N 124.552 1.157 . . . . 0.0 113.121 173.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.528 ' CE1' ' HB3' ' A' ' 5' ' ' ALA . 7.0 p90 -148.59 143.85 26.85 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.099 175.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.3 m -149.0 98.33 2.82 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 175.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.525 HD13 ' HD2' ' A' ' 11' ' ' PRO . 25.4 tp -114.39 126.87 27.42 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.196 -175.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.558 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 50.1 Cg_endo -70.17 150.53 65.84 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.388 2.059 . . . . 0.0 112.405 177.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.415 ' CG ' ' H ' ' A' ' 14' ' ' HIS . 0.8 OUTLIER -81.49 -174.26 4.86 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 176.277 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.731 HD13 ' HA ' ' A' ' 75' ' ' ARG . 70.4 mt -69.98 -16.36 63.18 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.415 ' H ' ' CG ' ' A' ' 12' ' ' ASP . 33.7 t-80 -87.98 -42.75 12.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.712 176.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.37 12.07 1.11 Allowed Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.294 177.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 11' ' ' PRO . 66.3 tttt -86.77 116.18 24.7 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 177.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.558 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 8.9 t -69.33 123.54 21.48 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.318 0.58 . . . . 0.0 109.617 175.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.494 ' HB ' ' CE ' ' A' ' 88' ' ' MET . 53.9 t -112.87 126.95 70.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.273 -177.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.409 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 61.0 p -132.32 -176.22 4.01 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.254 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -62.03 -23.29 66.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.072 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.41 ' HA ' ' NE2' ' A' ' 24' ' ' GLN . . . -67.03 -30.63 70.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.948 0.404 . . . . 0.0 110.837 178.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -82.45 -25.03 33.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.043 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.763 HD22 HD13 ' A' ' 62' ' ' LEU . 70.2 mt -83.19 -48.34 10.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.125 -175.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.519 ' HA ' ' H ' ' A' ' 113' ' ' LYS . 10.5 pt20 -51.22 144.31 9.69 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.384 0.611 . . . . 0.0 112.602 -171.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.67 -24.71 22.28 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.298 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.515 ' NZ ' ' HB2' ' A' ' 26' ' ' LYS . 7.7 mtmp? -121.96 171.29 9.05 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 14.1 t -101.9 140.47 20.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -178.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.558 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 17.0 m -131.78 145.65 51.71 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.139 0.495 . . . . 0.0 111.871 -171.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.666 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 6.2 tt -121.98 114.01 20.38 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 172.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.674 ' HB ' ' CG2' ' A' ' 108' ' ' VAL . 36.0 mt -98.54 112.6 31.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -118.21 121.21 39.91 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.569 0.223 . . . . 0.0 110.47 -178.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -92.73 119.77 32.44 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.561 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.48 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 10.5 p-90 -141.73 -176.36 4.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.142 -175.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -168.92 156.64 7.13 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 175.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.592 ' HD3' HG13 ' A' ' 74' ' ' VAL . 33.1 Cg_exo -59.68 158.92 26.2 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.544 2.163 . . . . 0.0 112.326 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 81.6 p 60.77 11.05 2.97 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.031 0.932 . . . . 0.0 112.141 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.727 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 34.6 t -72.96 129.96 85.75 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 177.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.69 -20.73 66.68 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.965 2.443 . . . . 0.0 112.461 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.82 -19.47 61.43 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.755 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.873 ' HA ' ' HG2' ' A' ' 43' ' ' GLU . 93.6 m -63.33 -30.78 71.85 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -174.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.3 m -64.16 -29.07 46.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.111 0.481 . . . . 0.0 110.417 177.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.514 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 29.4 t -88.94 -56.09 3.43 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.21 176.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.873 ' HG2' ' HA ' ' A' ' 40' ' ' CYS . 17.1 pt-20 -64.6 -50.14 68.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.092 -0.503 . . . . 0.0 112.043 -170.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.641 ' O ' HG12 ' A' ' 48' ' ' ILE . 33.5 ttm -57.87 -55.08 48.74 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -167.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 52.7 Cg_exo -53.35 -47.35 27.86 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.899 1.733 . . . . 0.0 112.433 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.514 ' HD3' ' O ' ' A' ' 42' ' ' SER . 23.9 mtpt -64.41 -40.04 95.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.09 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 43' ' ' GLU . 29.6 mm -64.31 -37.65 80.49 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.307 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.9 177.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.641 HG12 ' O ' ' A' ' 44' ' ' MET . 50.4 mm -54.67 -50.6 58.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 121.296 0.569 . . . . 0.0 109.939 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -67.69 -53.62 26.12 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.16 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 14.4 p -62.02 -54.69 38.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.912 -176.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.12 -39.0 91.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.841 -174.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -71.55 -35.36 70.61 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.411 -174.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -77.1 -48.53 17.52 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.299 -0.561 . . . . 0.0 110.463 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.722 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 25.6 m-85 -62.68 -27.77 69.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.801 0.334 . . . . 0.0 110.939 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 59' ' ' PHE . 36.9 ttpt -53.88 -37.4 63.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.797 173.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -89.13 10.04 23.33 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.683 -177.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.23 -66.68 0.96 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.293 0.568 . . . . 0.0 109.689 177.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.482 ' OD1' ' HA ' ' A' ' 26' ' ' LYS . 21.0 t-20 174.25 21.71 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.111 -174.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.723 ' HB2' ' HH2' ' A' ' 137' ' ' TRP . 34.0 t80 -122.82 132.09 54.05 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.731 -168.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.501 ' O ' ' HA ' ' A' ' 28' ' ' THR . 4.1 pt20 -121.63 137.64 54.66 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.221 178.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.443 HG23 ' HE1' ' A' ' 59' ' ' PHE . 97.6 t -110.19 124.85 67.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.433 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.763 HD13 HD22 ' A' ' 23' ' ' LEU . 86.9 mt -106.4 95.83 6.03 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.52 177.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.74 97.23 10.78 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.535 ' HA ' ' HB2' ' A' ' 88' ' ' MET . 15.0 t -85.08 110.12 18.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.117 -176.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -87.0 117.17 25.54 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.86 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.517 ' HB2' ' CD ' ' A' ' 67' ' ' PRO . 4.1 pt20 -81.11 -178.01 1.08 Allowed Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.583 ' HD3' ' O ' ' A' ' 90' ' ' ASP . 16.1 Cg_exo -69.0 -135.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 122.25 1.967 . . . . 0.0 112.812 -176.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.553 ' HB ' ' O ' ' A' ' 67' ' ' PRO . 90.7 mt 77.14 -57.65 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -175.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.407 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -104.78 133.64 20.06 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 168.309 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.494 ' O ' HG22 ' A' ' 74' ' ' VAL . 21.6 Cg_exo -65.52 173.31 6.71 Favored 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 122.843 2.362 . . . . 0.0 113.351 -174.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.595 ' HA ' ' CG2' ' A' ' 74' ' ' VAL . 7.1 tp -63.76 -33.01 59.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.726 -170.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.435 ' HA ' ' HD2' ' A' ' 75' ' ' ARG . 0.6 OUTLIER -73.4 -32.85 64.68 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.605 178.782 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 75.2 m -67.42 -51.13 55.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.889 176.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.595 ' CG2' ' HA ' ' A' ' 71' ' ' ILE . 3.1 m -61.45 -42.64 94.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.354 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.731 ' HA ' HD13 ' A' ' 13' ' ' LEU . 4.4 ptm180 -74.46 -34.02 63.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.135 -176.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -71.12 -36.94 72.32 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 110.329 -0.248 . . . . 0.0 110.329 177.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.437 ' CE1' ' HE3' ' A' ' 44' ' ' MET . 3.7 t80 -55.1 -44.05 74.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.276 0.56 . . . . 0.0 109.52 178.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.795 HG13 ' HB2' ' A' ' 83' ' ' LEU . 84.1 t -59.84 -48.76 86.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.742 175.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -75.14 -29.34 60.48 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -173.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -74.29 -46.94 38.03 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.804 0.335 . . . . 0.0 111.222 -176.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -85.77 -10.77 55.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.743 0.306 . . . . 0.0 111.523 -176.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.96 53.65 3.88 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.821 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.795 ' HB2' HG13 ' A' ' 78' ' ' VAL . 9.9 mp -78.74 111.23 17.95 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-O 120.692 0.282 . . . . 0.0 110.508 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -92.73 32.76 0.25 Allowed 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.2 2.6 . . . . 0.0 113.237 -177.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.579 ' HE2' HD11 ' A' ' 48' ' ' ILE . 29.0 p90 -135.64 165.37 25.71 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.9 m -74.51 128.11 34.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.091 0.472 . . . . 0.0 111.277 -175.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.9 t -120.43 137.08 55.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.075 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.535 ' HB2' ' HA ' ' A' ' 64' ' ' VAL . 48.8 mtt -111.47 175.87 5.25 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.328 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.411 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 73.3 t80 -131.83 107.57 8.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.32 175.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.583 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 67.3 t0 -91.51 91.87 8.26 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.76 -35.07 62.58 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -175.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.426 ' O ' ' HB3' ' A' ' 93' ' ' LYS . 3.6 p30 -94.44 -12.49 27.66 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.821 -0.351 . . . . 0.0 111.86 -173.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.437 ' HE3' ' HB3' ' A' ' 93' ' ' LYS . 0.6 OUTLIER 72.39 -10.93 0.86 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 120.989 0.423 . . . . 0.0 111.126 174.514 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.85 -22.64 39.72 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 122.271 -0.268 . . . . 0.0 110.371 -177.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 83.6 t -59.83 -49.76 82.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 172.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -58.99 -32.97 71.97 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.303 174.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 93' ' ' LYS . 43.7 mt-30 -69.71 -34.22 73.59 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 122.801 -0.235 . . . . 0.0 111.12 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.726 ' O ' ' HA ' ' A' ' 2' ' ' SER . . . -66.24 -37.44 85.51 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.088 0.47 . . . . 0.0 110.736 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -76.71 -26.98 55.28 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.026 0.441 . . . . 0.0 110.521 176.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.6 44.68 2.08 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.798 174.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.48 ' HA ' HG21 ' A' ' 106' ' ' THR . 29.9 p -69.77 100.77 1.57 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.199 0.523 . . . . 0.0 111.116 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.05 -61.65 1.74 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.457 0.646 . . . . 0.0 109.262 177.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.9 p -139.55 140.84 36.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.576 -177.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -94.8 147.5 33.23 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 -173.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.546 ' HD2' ' HA2' ' A' ' 122' ' ' GLY . 6.4 Cg_exo -73.63 146.44 86.92 Favored 'Cis proline' 0 C--O 1.234 0.321 0 C-N-CA 123.663 -1.39 . . . . 0.0 112.558 0.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.48 HG21 ' HA ' ' A' ' 101' ' ' THR . 19.9 m -115.26 112.24 22.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.18 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.0 m -109.47 112.26 24.26 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.611 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.674 ' CG2' ' HB ' ' A' ' 30' ' ' ILE . 15.3 m -105.75 142.96 17.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.132 0.491 . . . . 0.0 110.71 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.441 HD11 HD21 ' A' ' 129' ' ' LEU . 81.6 mt -101.42 125.81 48.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.288 -176.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.558 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 10.0 mm -114.33 110.04 30.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 O-C-N 124.59 1.181 . . . . 0.0 109.136 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.508 ' O ' ' HG3' ' A' ' 112' ' ' LYS . . . -61.99 -59.29 9.83 Favored Glycine 0 C--O 1.225 -0.414 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.383 -178.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.523 ' O ' ' HB2' ' A' ' 113' ' ' LYS . 19.3 mttt -169.46 166.89 10.13 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 178.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.523 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 28.6 mttt 77.45 -52.12 0.54 Allowed 'General case' 0 C--N 1.323 -0.563 0 O-C-N 123.642 0.588 . . . . 0.0 111.814 176.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 137.49 3.57 2.08 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.247 -177.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.555 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -68.29 144.58 54.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.892 0.377 . . . . 0.0 110.722 -179.127 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.576 HG12 ' H ' ' A' ' 4' ' ' THR . 51.0 mm -90.5 108.02 19.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.503 HD12 ' CD2' ' A' ' 145' ' ' HIS . 21.6 mt -94.39 -68.24 0.81 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.811 -173.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.427 ' HB3' HD12 ' A' ' 109' ' ' LEU . 21.4 tptm -122.78 148.24 45.6 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.865 -172.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 28.7 m -128.75 107.6 9.8 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.859 0.361 . . . . 0.0 111.046 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.483 ' CE1' ' HB3' ' A' ' 125' ' ' ASP . 51.4 m-85 -104.44 137.39 42.37 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.368 176.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.0 m -118.42 128.99 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-O 120.821 0.343 . . . . 0.0 110.977 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.546 ' HA2' ' HD2' ' A' ' 105' ' ' PRO . . . 79.32 -69.69 2.93 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.756 178.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.412 ' OE1' ' HD2' ' A' ' 124' ' ' PRO . 6.9 tp10 -126.49 114.54 23.1 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.412 ' HD2' ' OE1' ' A' ' 123' ' ' GLU . 56.4 Cg_endo -72.25 122.25 8.21 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.386 2.057 . . . . 0.0 112.366 177.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.582 ' O ' ' HB2' ' A' ' 129' ' ' LEU . 3.7 t0 -61.5 105.2 0.49 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.34 175.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.471 ' HA ' ' CB ' ' A' ' 129' ' ' LEU . 75.6 m-85 -69.26 -21.84 63.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.695 -172.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -63.64 -54.46 31.34 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 119.793 -1.194 . . . . 0.0 111.448 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -81.63 -17.29 48.66 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.633 -0.283 . . . . 0.0 110.907 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.582 ' HB2' ' O ' ' A' ' 125' ' ' ASP . 0.9 OUTLIER -61.42 -49.04 78.48 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 174.584 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -71.61 -40.72 69.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.964 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -61.12 -43.5 98.79 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.319 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -62.39 -47.26 84.94 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.73 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 129' ' ' LEU . 68.0 mt -58.24 -45.13 89.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.097 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -64.54 -38.65 91.75 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.996 0.427 . . . . 0.0 111.005 177.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 87.8 m -60.59 -39.29 87.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.393 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.09 -30.93 58.47 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.17 176.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.723 ' HH2' ' HB2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -56.66 -58.16 9.26 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.237 0.541 . . . . 0.0 110.596 176.909 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 43.1 mtm105 -86.06 -25.54 25.82 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.244 -177.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.5 40.43 17.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.679 175.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.6 p -70.2 -19.25 63.18 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.135 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -119.78 157.28 28.94 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 173.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -58.27 152.09 18.08 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 123.072 0.232 . . . . 0.0 110.575 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.441 ' HG2' ' HB2' ' A' ' 112' ' ' LYS . 17.1 mp0 -55.58 -60.21 3.76 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -70.37 99.73 0.75 Allowed Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.471 -1.051 . . . . 0.0 110.471 172.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.503 ' CD2' HD12 ' A' ' 117' ' ' LEU . 88.4 m-70 -65.76 175.69 1.83 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.964 0.411 . . . . 0.0 111.534 -173.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -75.98 70.37 2.69 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.281 0.562 . . . . 0.0 111.608 -171.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 40.2 p-80 -91.43 85.14 5.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.708 0.766 . . . . 0.0 109.883 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 35.4 p80 -97.88 6.34 47.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.244 -176.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 80.3 t60 69.02 155.02 0.12 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.414 0.626 . . . . 0.0 111.783 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 . . . . . 0 C--O 1.245 0.827 0 CA-C-O 118.273 -0.87 . . . . 0.0 109.864 171.985 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.5 t70 . . . . . 0 N--CA 1.477 0.925 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.538 ' O ' ' HG2' ' A' ' 3' ' ' LYS . 7.8 t 53.42 88.64 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -168.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.538 ' HG2' ' O ' ' A' ' 2' ' ' SER . 0.0 OUTLIER 75.14 164.94 0.27 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.488 1.115 . . . . 0.0 109.426 -165.305 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 115' ' ' GLU . 4.6 m 60.66 25.13 14.9 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.352 0.596 . . . . 0.0 110.229 -174.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.499 ' HB1' ' O ' ' A' ' 114' ' ' GLY . . . 69.59 120.09 0.03 OUTLIER Pre-proline 0 C--O 1.235 0.319 0 CA-C-N 114.89 -1.05 . . . . 0.0 112.264 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.485 ' HG2' ' CD1' ' A' ' 8' ' ' PHE . 38.1 Cg_endo -68.7 162.42 41.22 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.33 2.02 . . . . 0.0 111.505 175.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.63 51.37 1.26 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.073 0.463 . . . . 0.0 110.909 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.485 ' CD1' ' HG2' ' A' ' 6' ' ' PRO . 13.8 p90 -96.18 131.17 42.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.313 0.578 . . . . 0.0 110.907 -176.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.9 m -129.23 90.51 3.03 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 169.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.544 HD12 ' HD2' ' A' ' 11' ' ' PRO . 30.5 tp -114.65 128.53 25.79 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.292 -167.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.645 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 56.1 Cg_endo -73.43 126.61 11.1 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.371 2.047 . . . . 0.0 111.434 170.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.543 ' HA ' ' HG2' ' A' ' 88' ' ' MET . 0.9 OUTLIER -71.91 166.73 21.52 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.913 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 pp -77.71 8.45 4.47 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -171.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.467 ' HD1' ' CG ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -105.08 -17.99 14.3 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 170.41 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.79 23.35 3.69 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 115.445 0.938 . . . . 0.0 115.445 170.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.829 ' HZ1' HG13 ' A' ' 18' ' ' VAL . 48.5 tttm -115.05 126.87 55.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 118.638 1.219 . . . . 0.0 110.712 173.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.645 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 9.6 t -76.51 129.31 36.3 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.075 0.464 . . . . 0.0 109.794 173.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.829 HG13 ' HZ1' ' A' ' 16' ' ' LYS . 28.1 m -116.12 142.74 28.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.547 174.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.5 t -145.47 -173.4 4.11 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -62.9 -22.08 66.48 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.969 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.16 -27.74 68.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.413 176.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -78.78 -22.55 46.18 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.196 0.522 . . . . 0.0 110.181 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 43.4 mt -84.46 -38.49 20.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.8 -174.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -59.77 129.76 43.46 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -171.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.33 -14.03 64.84 Favored Glycine 0 C--N 1.331 0.294 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.986 175.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.456 ' HE3' ' CD ' ' A' ' 60' ' ' GLN . 0.0 OUTLIER -137.17 -178.74 5.34 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 -177.468 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.61 HG12 ' HA ' ' A' ' 59' ' ' PHE . 6.9 p -114.05 149.56 16.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -174.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 61.2 m -148.41 139.39 23.11 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.669 0.271 . . . . 0.0 111.127 -171.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.713 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 43.4 tp -105.73 127.26 52.97 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.358 173.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.402 HD11 HD11 ' A' ' 110' ' ' ILE . 38.3 mt -113.3 112.46 40.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 171.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -112.43 111.06 21.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.485 -175.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.432 ' HB2' ' CG2' ' A' ' 106' ' ' THR . 79.5 m-85 -81.37 119.65 23.96 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 177.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.465 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 4.3 p-90 -150.53 -173.01 4.34 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.455 -176.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -154.85 144.9 15.68 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 170.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.636 ' HD2' ' HB2' ' A' ' 69' ' ' ASP . 57.4 Cg_exo -40.39 -43.49 4.05 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 123.606 2.871 . . . . 0.0 114.886 -175.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.4 p -80.44 16.77 1.22 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -176.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 24.9 m -68.04 132.39 92.04 Favored Pre-proline 0 C--N 1.33 -0.252 0 O-C-N 122.066 -0.396 . . . . 0.0 111.533 178.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 16.4 Cg_exo -68.43 -26.16 34.94 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.034 2.489 . . . . 0.0 112.272 177.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.28 -15.13 72.22 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 121.155 -0.545 . . . . 0.0 113.229 -177.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.751 ' HA ' ' HG2' ' A' ' 44' ' ' MET . 73.1 m -52.99 -36.44 60.38 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -178.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.2 m -64.63 -38.61 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-O 120.695 0.283 . . . . 0.0 111.438 -178.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.401 ' O ' ' HE3' ' A' ' 46' ' ' LYS . 18.7 m -88.37 -55.53 3.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.985 0.421 . . . . 0.0 111.62 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.476 ' O ' HG12 ' A' ' 47' ' ' ILE . 32.7 mt-10 -72.29 -50.1 29.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.324 -170.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.751 ' HG2' ' HA ' ' A' ' 40' ' ' CYS . 20.0 mmt -57.84 -46.78 99.7 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -167.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.75 -43.32 58.52 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 121.746 1.63 . . . . 0.0 112.203 177.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.464 ' HZ3' ' CD ' ' A' ' 123' ' ' GLU . 81.3 mttt -66.52 -33.95 76.83 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.933 178.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.476 HG12 ' O ' ' A' ' 43' ' ' GLU . 41.9 mm -67.58 -38.79 81.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.449 177.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.584 HG12 ' O ' ' A' ' 44' ' ' MET . 49.1 mm -54.55 -53.45 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 120.857 0.361 . . . . 0.0 110.289 178.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.431 ' HE3' ' HB3' ' A' ' 49' ' ' LYS . 14.9 ttpp -55.09 -52.3 63.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.491 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.541 ' O ' ' HD2' ' A' ' 54' ' ' TYR . 17.0 m -67.48 -47.51 69.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.428 -174.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.553 ' HB2' HG21 ' A' ' 61' ' ' VAL . . . -67.5 -28.3 67.72 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.891 -174.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -75.87 -50.17 15.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.833 0.349 . . . . 0.0 111.09 -178.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -64.72 -47.98 76.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.097 -0.502 . . . . 0.0 112.326 -173.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.797 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 96.5 m-85 -77.35 1.79 17.83 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -170.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 37.8 mmtm -56.15 -49.91 72.61 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.286 0.565 . . . . 0.0 110.317 174.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -95.07 21.11 8.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.117 -177.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.62 ' HB2' ' HA ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -113.76 -65.85 1.14 Allowed 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.442 179.42 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 24.1 p30 171.6 -11.93 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.797 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 68.5 t80 -98.68 125.96 44.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.062 0.458 . . . . 0.0 109.876 -174.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.456 ' CD ' ' HE3' ' A' ' 26' ' ' LYS . 27.8 mt-30 -102.19 167.31 10.08 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 121.448 0.642 . . . . 0.0 110.943 -178.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.553 HG21 ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -148.33 111.43 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.775 -171.806 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.513 HD22 ' HB ' ' A' ' 86' ' ' THR . 78.4 mt -124.22 97.34 5.29 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.585 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.739 ' HB3' HG12 ' A' ' 87' ' ' VAL . . . -86.15 101.79 13.31 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.727 178.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.549 HG11 ' HB2' ' A' ' 90' ' ' ASP . 12.2 t -85.92 108.27 17.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.216 -176.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -85.78 115.93 23.73 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.107 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.626 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 3.9 pt20 -78.29 -174.66 0.47 Allowed Pre-proline 0 C--N 1.315 -0.892 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.626 ' HD2' ' HB2' ' A' ' 66' ' ' GLN . 47.6 Cg_endo -69.33 -146.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 121.552 1.501 . . . . 0.0 112.366 -177.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.558 ' HB ' ' O ' ' A' ' 67' ' ' PRO . 62.8 mt 77.54 -61.1 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -172.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.636 ' HB2' ' HD2' ' A' ' 35' ' ' PRO . 34.2 m-20 -97.1 128.97 33.43 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 171.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.458 ' HD2' ' OG ' ' A' ' 73' ' ' SER . 51.5 Cg_exo -57.14 165.61 5.13 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.667 2.245 . . . . 0.0 112.505 175.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.605 ' O ' ' HG2' ' A' ' 75' ' ' ARG . 6.6 tt -66.52 -29.3 46.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.894 0.378 . . . . 0.0 110.675 -177.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.697 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . 2.1 pm0 -69.65 -28.85 66.24 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 122.112 -0.367 . . . . 0.0 110.666 175.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.458 ' OG ' ' HD2' ' A' ' 70' ' ' PRO . 67.0 m -64.66 -43.85 92.31 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.664 0.268 . . . . 0.0 110.358 175.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 71' ' ' ILE . 13.8 p -71.6 -39.8 70.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.113 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.826 ' HA ' HG22 ' A' ' 78' ' ' VAL . 28.9 ptt180 -75.19 -25.55 58.33 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 122.312 -0.242 . . . . 0.0 111.475 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -70.29 -41.27 73.6 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 169.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -62.17 -47.2 85.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.202 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.826 HG22 ' HA ' ' A' ' 75' ' ' ARG . 33.0 m -67.15 -28.74 43.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.069 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.7 tptp -73.09 -55.78 6.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.373 0.606 . . . . 0.0 111.459 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -65.52 -49.03 70.47 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.896 -171.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -81.05 -19.55 43.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.754 -177.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.07 65.02 2.1 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.904 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.422 HD22 HG11 ' A' ' 78' ' ' VAL . 8.6 mp -84.27 113.51 48.89 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-O 120.695 0.283 . . . . 0.0 110.933 -177.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -81.25 -2.77 11.83 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.879 2.386 . . . . 0.0 113.371 -177.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.478 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 28.4 p90 -99.02 140.28 33.42 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 122.149 -0.344 . . . . 0.0 110.532 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.513 ' HB ' HD22 ' A' ' 62' ' ' LEU . 10.7 m -67.93 137.9 55.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.742 -176.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.739 HG12 ' HB3' ' A' ' 63' ' ' ALA . 10.8 m -122.97 137.19 57.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.398 0.618 . . . . 0.0 111.708 -176.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.543 ' HG2' ' HA ' ' A' ' 12' ' ' ASP . 79.6 mtm -115.95 176.01 5.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.497 -0.774 . . . . 0.0 108.988 175.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -125.34 112.35 16.24 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.216 0.531 . . . . 0.0 111.041 -178.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.701 ' OD2' ' HA ' ' A' ' 93' ' ' LYS . 23.0 t70 -84.63 74.83 10.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.553 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.22 -42.4 62.68 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.476 -174.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -83.02 -12.99 56.74 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.226 -177.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.701 ' HA ' ' OD2' ' A' ' 90' ' ' ASP . 2.6 mtpm? 64.54 -5.2 0.37 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.35 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.22 -32.03 38.56 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -168.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.476 ' O ' ' HD1' ' A' ' 99' ' ' PHE . 31.2 m -66.8 -34.35 69.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.495 174.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -67.56 -34.08 83.05 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.41 172.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.61 ' HG3' ' O ' ' A' ' 93' ' ' LYS . 79.9 mt-30 -63.59 -39.06 93.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.646 -0.277 . . . . 0.0 110.408 175.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.69 -34.11 77.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.052 178.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.476 ' HD1' ' O ' ' A' ' 95' ' ' VAL . 42.2 m-85 -72.31 -24.01 61.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.822 174.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.31 23.17 49.08 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.494 -178.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.521 ' HB ' HG21 ' A' ' 106' ' ' THR . 50.9 p -86.07 110.02 19.24 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.007 0.432 . . . . 0.0 111.064 -176.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -108.66 -24.55 11.29 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.786 177.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.9 t -99.63 131.98 45.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.909 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -128.66 143.39 48.27 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.334 -178.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.419 ' HG2' ' OE1' ' A' ' 43' ' ' GLU . 5.3 Cg_exo -74.78 160.33 96.62 Favored 'Cis proline' 0 C--N 1.346 0.407 0 C-N-CA 123.715 -1.369 . . . . 0.0 112.161 0.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.521 HG21 ' HB ' ' A' ' 101' ' ' THR . 9.8 t -142.46 120.93 12.43 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.712 0.768 . . . . 0.0 111.239 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.512 ' HB3' HD13 ' A' ' 29' ' ' LEU . 25.5 m -95.8 111.97 23.81 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.253 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 55.3 t -105.5 128.48 59.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.261 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.556 HD13 ' HB3' ' A' ' 118' ' ' LYS . 95.3 mt -101.97 122.97 45.07 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.778 -176.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.402 HD11 HD11 ' A' ' 30' ' ' ILE . 41.6 mt -110.61 130.09 64.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.475 178.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -88.31 -158.11 33.08 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.235 -0.983 . . . . 0.0 112.973 -178.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 44.0 mtpt -87.67 -17.98 30.59 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.976 0.893 . . . . 0.0 109.72 -168.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.769 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -81.07 -14.22 58.03 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.416 177.881 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.499 ' O ' ' HB1' ' A' ' 5' ' ' ALA . . . 91.41 -7.97 79.57 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -173.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 11.6 tp10 -72.21 146.88 47.02 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.165 0.507 . . . . 0.0 110.975 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.452 HG13 ' HA ' ' A' ' 3' ' ' LYS . 47.0 mm -81.12 110.4 16.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.025 178.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.8 mt -90.7 -59.82 2.08 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -170.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.556 ' HB3' HD13 ' A' ' 109' ' ' LEU . 23.6 tptm -133.36 153.19 51.8 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.248 -170.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.3 m -134.59 128.03 32.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.522 177.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.428 ' OH ' ' HB2' ' A' ' 128' ' ' LYS . 80.5 m-85 -116.88 141.47 48.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.83 174.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.6 m -124.86 109.64 22.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.699 0.285 . . . . 0.0 111.304 178.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 68.52 97.66 0.04 OUTLIER Glycine 0 C--N 1.331 0.286 0 C-N-CA 121.174 -0.536 . . . . 0.0 113.07 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.464 ' CD ' ' HZ3' ' A' ' 46' ' ' LYS . 9.0 tp10 66.13 92.92 0.06 OUTLIER Pre-proline 0 C--O 1.235 0.316 0 CA-C-O 121.509 0.671 . . . . 0.0 110.217 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -77.23 141.62 20.74 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.494 2.129 . . . . 0.0 113.019 -176.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.518 ' OD1' ' HG2' ' A' ' 128' ' ' LYS . 10.6 t0 -65.75 96.05 0.27 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.6 174.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.567 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 50.1 m-85 -69.19 -14.36 62.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.867 -178.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -68.36 -50.63 37.14 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.271 -0.966 . . . . 0.0 110.854 174.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.518 ' HG2' ' OD1' ' A' ' 125' ' ' ASP . 31.1 mmtm -77.95 -20.56 52.5 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.567 ' HB3' ' HA ' ' A' ' 126' ' ' PHE . 3.2 tm? -63.59 -47.9 79.56 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 174.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -68.18 -45.65 72.84 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.236 178.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -60.88 -36.47 79.29 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.938 0.348 . . . . 0.0 111.938 178.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -66.63 -51.77 52.5 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 129' ' ' LEU . 67.9 mt -57.27 -43.03 81.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.902 0.382 . . . . 0.0 110.392 176.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -56.7 -40.32 75.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.85 177.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 63.8 m -62.07 -44.07 97.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.316 176.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.68 -28.18 69.72 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.191 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 12.6 m0 -69.62 -55.64 9.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.963 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 57.0 mtt180 -70.62 -43.41 69.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.592 -173.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -68.75 110.22 4.21 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.236 0.541 . . . . 0.0 111.756 -174.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 18.1 p -67.99 102.69 1.33 Allowed 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.151 171.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.481 ' CG ' ' HZ1' ' A' ' 113' ' ' LYS . 26.3 t70 -72.12 146.24 47.61 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.644 -174.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.98 162.68 16.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.266 -177.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -51.82 116.13 2.0 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.249 -176.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -89.15 -156.28 31.47 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.899 -175.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -68.69 105.9 2.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.129 0.49 . . . . 0.0 110.63 -178.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 13.3 p80 -128.69 135.52 49.37 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.762 179.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 61.6 t60 -172.5 107.76 0.19 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.35 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -125.14 96.89 5.01 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.55 0.69 . . . . 0.0 109.329 173.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -75.26 124.58 27.33 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.402 -173.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 . . . . . 0 C--N 1.319 -0.748 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.508 -179.379 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.613 ' HA ' ' HA ' ' A' ' 6' ' ' PRO . 2.0 m-20 . . . . . 0 N--CA 1.482 1.149 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.567 ' O ' ' HB2' ' A' ' 3' ' ' LYS . 45.3 m 57.47 91.87 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 O-C-N 123.926 0.766 . . . . 0.0 109.832 -171.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.816 ' HB3' ' HZ2' ' A' ' 3' ' ' LYS . 3.8 mmmp? 76.14 144.2 0.08 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.979 -171.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.6 m 58.3 30.64 19.81 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.688 0.756 . . . . 0.0 111.08 177.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.463 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . . . 69.27 150.4 0.12 Allowed Pre-proline 0 N--CA 1.467 0.382 0 CA-C-N 114.677 -1.147 . . . . 0.0 112.705 175.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.613 ' HA ' ' HA ' ' A' ' 1' ' ' ASP . 1.8 Cg_endo -85.95 171.41 8.09 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.292 2.662 . . . . 0.0 112.192 174.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -92.87 25.62 3.09 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.394 0.616 . . . . 0.0 110.03 176.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.492 ' HB2' HG13 ' A' ' 95' ' ' VAL . 13.0 p90 -67.4 148.17 51.94 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.384 -175.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.0 m -142.59 89.79 2.17 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 172.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.748 HD22 ' HE3' ' A' ' 88' ' ' MET . 35.5 tp -115.88 120.59 35.4 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.597 -173.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.572 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 24.3 Cg_exo -64.44 144.43 85.36 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.584 2.189 . . . . 0.0 111.799 176.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.689 ' HA ' ' HA ' ' A' ' 88' ' ' MET . 1.6 p-10 -81.95 -173.21 4.35 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.501 HD23 ' HA ' ' A' ' 89' ' ' TYR . 73.8 mt -87.02 2.27 50.14 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.672 -177.031 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 64.3 t60 -95.69 -40.49 9.36 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 172.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.22 22.76 0.79 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.109 -1.043 . . . . 0.0 114.121 174.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.415 ' HE2' HG23 ' A' ' 18' ' ' VAL . 2.3 ptmt -114.31 134.51 54.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.72 0.76 . . . . 0.0 110.244 175.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.572 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 16.1 m -67.93 121.59 16.37 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.314 177.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.531 ' HB ' ' HE1' ' A' ' 88' ' ' MET . 46.3 t -97.28 128.77 48.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 177.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 63.6 p -129.01 -175.59 3.6 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.874 0.369 . . . . 0.0 111.025 -175.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -68.95 -22.28 64.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.78 177.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.86 -28.95 69.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.736 176.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -67.01 -21.08 65.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.942 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 74.2 mt -80.7 -20.53 42.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.432 -176.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.465 ' HA ' ' OE1' ' A' ' 24' ' ' GLN . 15.9 mm-40 -78.59 138.61 38.44 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.077 0.465 . . . . 0.0 112.137 -172.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.98 3.38 89.18 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.771 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 112' ' ' LYS . 41.1 mtmt -146.75 165.03 30.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.668 0.271 . . . . 0.0 110.527 -177.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.0 t -103.16 138.62 26.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 173.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.599 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 11.1 m -131.93 145.29 51.41 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.63 -0.428 . . . . 0.0 112.126 -168.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.652 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 6.9 tt -119.5 108.75 14.9 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 170.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.8 mt -94.6 111.12 24.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -104.97 125.11 50.61 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.459 -177.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.45 ' CE2' ' HA2' ' A' ' 96' ' ' GLY . 87.0 m-85 -96.26 118.18 32.3 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 9.1 p-90 -144.59 -176.49 5.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.484 -175.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -159.63 151.96 17.46 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.239 176.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.33 155.58 51.06 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.404 2.069 . . . . 0.0 111.887 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.3 m 65.08 16.51 10.6 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.588 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.515 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 42.7 t -84.14 130.76 53.25 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.596 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -61.13 -26.82 83.19 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.7 2.267 . . . . 0.0 111.922 176.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -64.52 -30.02 76.74 Favored Glycine 0 C--O 1.227 -0.303 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.473 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.515 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 83.9 m -58.26 -30.5 66.63 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 122.16 0.184 . . . . 0.0 111.445 -178.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.6 t -61.18 -38.14 79.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.211 0.529 . . . . 0.0 110.157 177.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.446 ' HB3' ' OE2' ' A' ' 123' ' ' GLU . 32.6 m -87.09 -51.28 6.09 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.513 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -70.21 -45.06 67.36 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -171.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.547 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 39.2 tpp -54.72 -51.35 79.58 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -171.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.547 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 57.3 Cg_exo -53.28 -36.44 78.2 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 121.962 1.775 . . . . 0.0 112.47 175.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.62 ' HB3' ' CZ ' ' A' ' 126' ' ' PHE . 30.5 mmtm -65.16 -47.52 76.72 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.238 0.542 . . . . 0.0 109.796 177.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.7 mm -65.5 -38.65 82.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.823 -177.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 44' ' ' MET . 47.2 mm -54.68 -53.34 32.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 120.777 0.322 . . . . 0.0 110.188 177.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.1 tttm -62.16 -57.69 10.58 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.632 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 29.0 m -60.32 -44.82 95.12 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -171.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . -69.31 -36.08 76.62 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.118 -0.233 . . . . 0.0 111.598 -175.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -77.06 -40.35 46.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.158 0.504 . . . . 0.0 110.626 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -55.28 -53.04 61.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.902 -1.045 . . . . 0.0 111.15 -177.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.529 ' CB ' ' HB3' ' A' ' 59' ' ' PHE . 67.1 m-85 -96.88 8.16 45.01 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.465 -175.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -62.25 -52.31 64.24 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.093 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -82.4 66.81 8.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.802 176.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.6 ' HZ1' ' HB2' ' A' ' 57' ' ' LYS . 0.3 OUTLIER -166.94 -75.31 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.597 -173.819 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 6.9 t-20 173.62 7.96 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.203 0.525 . . . . 0.0 110.415 -176.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.652 ' HZ ' ' HB2' ' A' ' 29' ' ' LEU . 41.0 t80 -110.43 135.22 51.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.914 0.388 . . . . 0.0 110.581 -173.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.579 ' HG3' HG22 ' A' ' 28' ' ' THR . 21.4 pt20 -125.75 144.48 50.61 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.725 178.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 97.2 t -113.93 111.52 36.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 97.9 mt -95.03 95.57 8.68 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 177.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -86.6 95.65 9.83 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.555 ' HA ' ' HB2' ' A' ' 88' ' ' MET . 2.4 p -88.08 118.53 33.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.117 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.539 ' O ' ' HA ' ' A' ' 90' ' ' ASP . . . -89.53 162.69 15.56 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.948 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 90' ' ' ASP . 18.6 pt20 -137.54 154.38 75.06 Favored Pre-proline 0 C--N 1.305 -1.358 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 169.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.986 ' HD3' ' HA ' ' A' ' 91' ' ' ALA . 56.2 Cg_endo -59.36 -92.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.038 1.826 . . . . 0.0 113.965 -150.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.3 mm 65.66 -70.34 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -175.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.57 147.23 32.88 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 171.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -52.88 157.66 7.57 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 122.869 2.38 . . . . 0.0 113.902 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.0 tp -53.85 -33.74 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.875 179.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.446 ' CD ' HH21 ' A' ' 75' ' ' ARG . 9.1 tp10 -68.87 -29.59 67.92 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 122.154 -0.341 . . . . 0.0 110.289 178.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.6 m -70.29 -48.65 55.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.951 0.405 . . . . 0.0 110.63 -177.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.1 p -61.43 -32.82 54.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-O 121.929 0.871 . . . . 0.0 109.305 175.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.617 ' HA ' HG22 ' A' ' 78' ' ' VAL . 50.5 ttp180 -75.28 -29.24 60.06 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.592 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -70.41 -41.7 72.62 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 172.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.424 ' CE1' ' HE1' ' A' ' 44' ' ' MET . 2.6 t80 -57.06 -51.28 69.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.285 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.617 HG22 ' HA ' ' A' ' 75' ' ' ARG . 24.2 m -61.59 -36.94 76.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.127 -178.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -75.3 -52.22 11.36 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -58.6 -48.52 80.67 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.165 -170.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -92.58 1.11 57.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.388 -175.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 54.46 60.01 9.24 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.458 -179.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.471 HD21 HG11 ' A' ' 78' ' ' VAL . 10.8 mp -60.87 109.71 2.32 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.867 0.365 . . . . 0.0 111.462 -176.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -85.18 37.82 0.62 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.339 2.693 . . . . 0.0 113.044 -175.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -149.56 159.57 44.2 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.197 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.49 109.34 4.76 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.84 -176.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.2 t -101.96 136.78 32.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.515 177.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.748 ' HE3' HD22 ' A' ' 10' ' ' LEU . 80.1 mtp -111.24 162.17 15.25 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.267 -174.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.625 ' HB3' HD11 ' A' ' 10' ' ' LEU . 12.6 t80 -62.73 141.55 58.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.469 0.652 . . . . 0.0 112.087 -174.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.539 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 5.1 p-10 -56.52 -135.21 0.0 OUTLIER 'General case' 0 C--O 1.217 -0.649 0 CA-C-N 113.659 -1.609 . . . . 0.0 111.56 162.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.986 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . . . -28.66 -6.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 120.583 3.549 . . . . 0.0 120.583 -146.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.589 ' HB3' HD13 ' A' ' 10' ' ' LEU . 37.5 t70 -71.73 38.73 0.07 Allowed 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 120.31 1.414 . . . . 0.0 108.809 163.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.577 ' H ' ' C ' ' A' ' 91' ' ' ALA . 0.0 OUTLIER -58.47 -3.72 0.32 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.194 0.998 . . . . 0.0 112.675 -174.4 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.427 ' H ' ' C ' ' A' ' 92' ' ' ASP . . . -64.63 -23.91 67.41 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 122.77 0.428 . . . . 0.0 111.179 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.492 HG13 ' HB2' ' A' ' 8' ' ' PHE . 35.9 m -60.73 -37.38 75.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.106 0.479 . . . . 0.0 110.099 174.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.45 ' HA2' ' CE2' ' A' ' 32' ' ' PHE . . . -67.87 -32.17 77.01 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 174.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -69.78 -28.84 66.08 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.006 -0.597 . . . . 0.0 110.719 177.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.45 -28.34 61.91 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.074 0.464 . . . . 0.0 110.89 176.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.401 ' HD2' ' O ' ' A' ' 95' ' ' VAL . 50.4 m-85 -79.86 -24.53 41.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.738 173.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.74 -8.02 76.83 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.936 -0.65 . . . . 0.0 111.843 -177.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.559 ' HB ' HG21 ' A' ' 106' ' ' THR . 18.1 p -78.94 91.89 4.86 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.736 0.303 . . . . 0.0 111.396 -177.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -105.82 0.19 25.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.029 0.442 . . . . 0.0 111.311 177.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.5 m -97.95 125.81 51.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.513 173.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -121.28 149.77 52.61 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.526 -172.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -85.31 164.79 58.25 Favored 'Cis proline' 0 C--N 1.343 0.277 0 C-N-CA 123.548 -1.438 . . . . 0.0 112.002 -0.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.559 HG21 ' HB ' ' A' ' 101' ' ' THR . 5.9 t -151.88 142.79 23.03 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.895 -177.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.474 ' HB3' HD23 ' A' ' 29' ' ' LEU . 56.4 m -120.51 122.85 41.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.367 177.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.3 t -105.85 137.13 37.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.331 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.4 HD21 ' N ' ' A' ' 109' ' ' LEU . 2.8 mm? -101.82 122.34 43.79 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.18 -177.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.599 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 8.5 mm -110.13 129.94 64.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.344 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -79.35 -176.47 48.82 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.326 -0.94 . . . . 0.0 111.87 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 16.8 pttm -92.52 43.21 1.12 Allowed 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 122.532 1.158 . . . . 0.0 107.93 -178.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 51.3 mmtt -140.32 -5.77 1.23 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 113.302 -1.772 . . . . 0.0 111.367 -168.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.47 12.66 82.19 Favored Glycine 0 C--O 1.226 -0.371 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.464 -172.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.58 ' CD ' ' HZ3' ' A' ' 3' ' ' LYS . 10.6 tp10 -103.17 147.97 26.36 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 -178.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.546 HD12 ' H ' ' A' ' 3' ' ' LYS . 51.5 mt -91.97 111.55 24.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -85.11 -61.52 1.75 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.195 -173.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.48 ' HZ3' ' CD ' ' A' ' 132' ' ' GLU . 6.7 mmmm -141.27 167.7 21.55 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -169.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 62.1 m -146.3 105.87 3.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.366 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -102.87 113.16 26.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.577 177.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' A' ' 106' ' ' THR . 22.2 m -88.54 141.0 14.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 120.849 0.357 . . . . 0.0 110.985 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 71.62 -150.93 47.29 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.438 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.446 ' OE2' ' HB3' ' A' ' 42' ' ' SER . 6.3 tp10 -70.2 111.64 9.99 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -84.45 140.08 8.25 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.47 2.114 . . . . 0.0 113.195 -176.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -66.89 102.88 1.02 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.989 173.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.62 ' CZ ' ' HB3' ' A' ' 46' ' ' LYS . 25.3 m-85 -70.32 -19.42 63.08 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -175.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -63.69 -54.08 33.82 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 119.932 -1.128 . . . . 0.0 111.055 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.646 ' HB3' ' HZ3' ' A' ' 128' ' ' LYS . 6.6 ttpm? -79.68 -26.78 40.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.614 -0.293 . . . . 0.0 110.608 177.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.583 ' HB3' ' HA ' ' A' ' 126' ' ' PHE . 41.8 tp -63.18 -47.67 81.62 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.432 178.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -66.34 -47.21 74.23 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.741 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -56.9 -34.17 67.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.99 0.424 . . . . 0.0 111.991 176.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.48 ' CD ' ' HZ3' ' A' ' 118' ' ' LYS . 31.9 tt0 -80.37 -37.96 31.35 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.015 -179.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 129' ' ' LEU . 78.8 mt -65.46 -38.06 81.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.153 0.502 . . . . 0.0 110.002 174.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.698 ' HA ' ' CD1' ' A' ' 137' ' ' TRP . 12.2 t70 -67.05 -23.38 65.88 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.686 176.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 87.6 m -67.27 -30.71 70.65 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 172.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.24 -28.58 59.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.318 174.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.698 ' CD1' ' HA ' ' A' ' 134' ' ' ASP . 3.2 m95 -67.79 -56.55 8.77 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.809 0.814 . . . . 0.0 109.684 172.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 21.7 ttm180 -60.16 -51.04 71.31 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 113.429 -1.714 . . . . 0.0 112.962 -169.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -56.66 108.28 0.48 Allowed 'General case' 0 C--O 1.239 0.507 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -172.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.0 p -79.94 100.3 8.02 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 169.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -120.6 19.57 11.9 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.731 -168.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -108.84 -62.42 1.47 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.497 0.665 . . . . 0.0 109.279 177.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.498 ' CD ' ' H ' ' A' ' 143' ' ' GLU . 0.1 OUTLIER -67.76 -41.26 83.58 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.636 171.935 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.9 102.79 1.7 Allowed Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 173.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -74.45 97.62 3.13 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.191 0.519 . . . . 0.0 110.915 -176.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -69.86 94.6 0.84 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.608 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 16.8 p80 -61.72 145.94 50.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.36 177.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -104.43 177.19 4.92 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.052 -177.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.416 ' O ' ' HB3' ' A' ' 150' ' ' HIS . 53.5 t-80 -174.26 -59.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 O-C-N 123.3 0.375 . . . . 0.0 110.668 176.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.416 ' HB3' ' O ' ' A' ' 149' ' ' HIS . 83.3 t60 . . . . . 0 C--O 1.244 0.813 0 CA-C-O 117.568 -1.206 . . . . 0.0 108.594 -167.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.406 ' CG ' ' H ' ' A' ' 2' ' ' SER . 1.9 p-10 . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 120.303 0.097 . . . . 0.0 110.978 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.406 ' H ' ' CG ' ' A' ' 1' ' ' ASP . 34.3 m -101.6 158.0 16.41 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 122.2 -0.312 . . . . 0.0 110.674 178.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.479 ' HG3' ' H ' ' A' ' 4' ' ' THR . 3.8 tptm -89.56 -175.59 4.74 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 170.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.538 ' HB ' ' HA ' ' A' ' 115' ' ' GLU . 32.5 p 53.75 -160.79 0.13 Allowed 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 -161.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.439 ' HB1' ' H ' ' A' ' 115' ' ' GLU . . . -66.69 109.08 2.91 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 119.049 0.84 . . . . 0.0 109.86 179.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -73.86 169.52 22.21 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.0 2.466 . . . . 0.0 112.822 -170.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.17 67.07 9.85 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.331 0.586 . . . . 0.0 110.051 -178.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -106.57 132.76 52.2 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.728 -177.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.7 m -114.9 90.76 3.42 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 172.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.574 HD22 HG21 ' A' ' 95' ' ' VAL . 36.6 tp -102.51 121.23 50.58 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.825 -172.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.54 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 3.9 Cg_exo -80.58 137.2 11.38 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.023 2.482 . . . . 0.0 112.059 176.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.618 ' HB3' ' HB3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -67.99 172.6 5.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.006 175.152 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.6 mt -55.21 -29.64 58.35 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -175.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -102.54 -26.05 13.37 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.453 -176.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.62 16.97 0.43 Allowed Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.073 -1.061 . . . . 0.0 113.917 175.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.618 ' HB3' ' HB3' ' A' ' 12' ' ' ASP . 1.8 tpmt? -81.8 96.85 7.73 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 117.441 0.621 . . . . 0.0 109.84 176.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 23.8 m -86.45 124.33 32.66 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.057 -177.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.5 m -127.16 163.16 30.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.619 179.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 62.1 p -132.17 -173.83 3.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.045 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 29.7 p30 -67.91 -22.19 65.09 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.765 0.317 . . . . 0.0 111.508 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.486 ' HA ' HE21 ' A' ' 24' ' ' GLN . . . -66.92 -27.35 67.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.067 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -70.39 -28.76 65.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.88 0.371 . . . . 0.0 110.25 178.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 45.3 mt -69.72 -20.34 63.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.806 -178.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.678 ' HG2' ' HA ' ' A' ' 113' ' ' LYS . 50.6 mt-30 -73.22 132.88 43.71 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.163 -174.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.66 -25.31 19.43 Favored Glycine 0 N--CA 1.452 -0.282 0 CA-C-N 115.954 -0.567 . . . . 0.0 113.167 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 112' ' ' LYS . 52.0 mtmt -108.25 -175.08 2.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.923 0.392 . . . . 0.0 110.675 -178.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.53 HG23 ' CZ3' ' A' ' 137' ' ' TRP . 8.3 t -127.53 141.45 46.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 173.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.544 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 85.5 m -145.58 145.31 30.94 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.121 0.486 . . . . 0.0 111.995 -169.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.57 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 27.9 tp -114.15 112.99 24.08 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.129 170.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.662 ' HB ' ' CG1' ' A' ' 108' ' ' VAL . 41.6 mt -97.28 112.52 29.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 176.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.418 ' HA ' ' O ' ' A' ' 106' ' ' THR . 46.6 t30 -114.39 114.48 25.93 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.099 -177.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.432 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 92.5 m-85 -83.74 123.76 30.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.172 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.549 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 6.1 p-90 -143.93 -177.57 5.5 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.398 0.618 . . . . 0.0 111.321 -173.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -162.67 153.4 14.34 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.848 174.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -63.27 158.08 46.51 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.157 1.905 . . . . 0.0 111.472 175.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.8 m 65.7 14.38 9.49 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 123.465 0.478 . . . . 0.0 111.42 -177.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 29.9 t -84.98 133.88 42.36 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.594 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.8 -22.49 68.29 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 122.523 2.149 . . . . 0.0 111.967 176.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.61 -12.13 75.86 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.287 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 21.6 p -69.19 -45.72 69.25 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 117.85 0.825 . . . . 0.0 110.53 -177.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.6 p -65.06 -25.57 37.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.123 0.487 . . . . 0.0 110.593 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.7 m -86.7 -49.51 7.43 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.684 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.485 ' CD ' ' HZ1' ' A' ' 46' ' ' LYS . 22.2 mm-40 -85.13 -41.48 15.66 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -172.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.503 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 47.2 tpp -51.48 -50.2 78.03 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -171.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 44' ' ' MET . 9.8 Cg_endo -51.88 -44.77 42.85 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 122.285 1.99 . . . . 0.0 112.603 177.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.485 ' HZ1' ' CD ' ' A' ' 43' ' ' GLU . 8.0 mppt? -68.79 -40.12 79.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.722 178.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.0 mm -60.45 -43.53 94.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.699 178.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.608 HD13 ' HE1' ' A' ' 85' ' ' PHE . 43.9 mm -55.78 -52.99 42.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.775 178.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.53 -46.52 85.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.886 0.374 . . . . 0.0 110.622 -177.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 29.2 m -65.99 -51.59 57.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.552 -175.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.551 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . -67.86 -36.31 80.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.834 -174.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -74.03 -29.83 62.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.043 0.449 . . . . 0.0 110.592 -177.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -74.49 -50.4 18.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.152 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 1.03 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 66.4 m-85 -80.59 -10.08 59.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.933 -175.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.551 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 22.1 tptm -58.41 -33.27 69.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.194 0.521 . . . . 0.0 110.401 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 44.3 m-20 -95.06 20.86 8.44 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.643 -176.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.69 ' HE3' ' HA ' ' A' ' 54' ' ' TYR . 33.1 mtmt -125.98 -63.27 1.12 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.477 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 172.33 -13.29 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 O-C-N 123.322 0.389 . . . . 0.0 111.37 -172.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 1.03 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 56.7 t80 -100.72 122.78 43.93 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.093 0.473 . . . . 0.0 110.356 -177.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.462 HE21 HD12 ' A' ' 62' ' ' LEU . 12.7 pt20 -122.75 154.92 37.51 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.666 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.531 HG22 ' HB3' ' A' ' 29' ' ' LEU . 94.2 t -115.27 128.66 72.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.267 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.462 HD12 HE21 ' A' ' 60' ' ' GLN . 11.0 mp -108.12 109.26 20.64 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.542 177.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.45 98.35 10.81 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.169 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 51.3 t -91.79 116.16 32.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.331 -177.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -96.56 126.53 41.8 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.481 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.567 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 4.7 pm0 -96.0 161.5 27.08 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.657 ' HD3' ' O ' ' A' ' 90' ' ' ASP . 53.0 Cg_endo -70.43 84.95 0.73 Allowed 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.296 1.997 . . . . 0.0 113.515 -171.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 48.2 mm -115.7 -44.94 3.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 172.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.59 ' OD1' ' HD2' ' A' ' 70' ' ' PRO . 0.7 OUTLIER -116.8 141.99 29.05 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 172.595 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.59 ' HD2' ' OD1' ' A' ' 69' ' ' ASP . 61.2 Cg_exo -42.1 155.27 0.1 OUTLIER 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.676 2.917 . . . . 0.0 114.438 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.58 HG22 ' OE1' ' A' ' 72' ' ' GLU . 3.3 tp -58.7 -36.79 62.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.026 -176.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.594 ' HA ' ' CG ' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -59.4 -39.32 83.03 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.534 176.125 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.8 m -58.15 -42.44 85.95 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.304 0.573 . . . . 0.0 109.974 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.2 t -67.72 -52.2 42.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.016 178.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.594 ' CG ' ' HA ' ' A' ' 72' ' ' GLU . 16.0 ptt180 -68.3 -33.46 74.38 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -174.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -65.61 -42.04 92.03 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 178.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -56.36 -47.82 78.06 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.971 178.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.574 HG23 HD21 ' A' ' 83' ' ' LEU . 41.2 t -63.1 -53.0 51.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.328 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 75' ' ' ARG . 95.6 mttt -63.01 -36.61 84.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.726 0.298 . . . . 0.0 111.669 -175.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -75.07 -48.29 24.65 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -176.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -98.48 7.37 46.26 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -173.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.5 -70.09 2.66 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.949 -0.644 . . . . 0.0 112.743 175.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.574 HD21 HG23 ' A' ' 78' ' ' VAL . 10.3 mp 52.25 84.72 0.2 Allowed Pre-proline 0 N--CA 1.468 0.472 0 C-N-CA 122.959 0.504 . . . . 0.0 111.732 -178.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -76.92 16.52 0.95 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.365 2.71 . . . . 0.0 113.563 -176.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.608 ' HE1' HD13 ' A' ' 48' ' ' ILE . 23.1 p90 -117.73 159.4 23.06 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.4 m -74.76 112.08 10.61 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.342 0.591 . . . . 0.0 111.081 -174.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.7 t -99.64 136.74 29.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.831 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.557 ' HG2' ' HA ' ' A' ' 12' ' ' ASP . 62.5 mtt -131.23 166.45 21.14 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.415 -176.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -130.07 117.06 19.42 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.099 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.657 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 67.2 t0 -103.28 108.05 19.12 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 179.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.4 -21.95 59.4 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -176.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.521 ' OD2' ' HB3' ' A' ' 94' ' ' ALA . 28.3 t70 -106.44 -11.43 15.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.08 0.467 . . . . 0.0 110.691 -174.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.401 ' O ' ' HG2' ' A' ' 97' ' ' GLN . 17.4 ttpp 65.85 17.7 10.91 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.496 -177.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.521 ' HB3' ' OD2' ' A' ' 92' ' ' ASP . . . -67.92 -31.95 72.07 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.418 -174.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.574 HG21 HD22 ' A' ' 10' ' ' LEU . 46.8 t -67.92 -42.6 85.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 177.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.79 -33.99 87.47 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.538 175.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.401 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 15.0 mm100 -64.6 -42.81 95.31 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 122.607 0.363 . . . . 0.0 111.494 177.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.94 -47.18 66.31 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.331 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.504 ' HA ' HD13 ' A' ' 116' ' ' ILE . 36.9 m-85 -72.24 -27.21 62.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.735 -177.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.37 55.21 1.72 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.605 176.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 20.1 p -68.99 104.75 2.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.942 0.401 . . . . 0.0 111.57 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 48.4 tp60 -69.45 -58.32 4.13 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.533 0.682 . . . . 0.0 110.108 178.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.4 p -148.36 143.37 19.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.271 -176.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -94.57 141.9 24.06 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.715 -175.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.56 151.42 97.01 Favored 'Cis proline' 0 C--N 1.346 0.405 0 C-N-CA 123.385 -1.506 . . . . 0.0 113.18 0.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 26.3 m -119.54 116.08 25.32 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.884 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.507 ' HB2' HD12 ' A' ' 29' ' ' LEU . 4.3 p -105.56 111.84 24.7 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.085 0.469 . . . . 0.0 111.035 -177.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.662 ' CG1' ' HB ' ' A' ' 30' ' ' ILE . 11.7 p -106.68 143.25 17.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.053 0.454 . . . . 0.0 110.455 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.586 ' HB2' ' HB3' ' A' ' 118' ' ' LYS . 96.3 mt -100.98 121.43 41.75 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.123 -178.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.585 HG21 ' HA2' ' A' ' 114' ' ' GLY . 43.2 mm -102.49 127.29 56.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.303 -176.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -85.64 -168.27 44.51 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.98 177.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.444 ' HE3' ' HB2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -76.69 44.97 0.39 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 117.038 0.419 . . . . 0.0 111.779 -178.495 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.678 ' HA ' ' HG2' ' A' ' 24' ' ' GLN . 64.4 tttm 177.31 -29.63 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -178.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.585 ' HA2' HG21 ' A' ' 110' ' ' ILE . . . 115.62 -87.04 0.43 Allowed Glycine 0 N--CA 1.437 -1.285 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.832 177.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.538 ' HA ' ' HB ' ' A' ' 4' ' ' THR . 2.6 mm-40 55.68 2.79 0.07 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.545 1.138 . . . . 0.0 113.56 178.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.504 HD13 ' HA ' ' A' ' 99' ' ' PHE . 4.8 mt 49.54 77.27 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 121.574 0.702 . . . . 0.0 109.934 -174.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.8 mt -77.15 -73.62 0.29 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.435 -171.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.586 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 21.7 tptm -119.21 149.2 42.15 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.678 -170.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 31.5 m -134.19 118.69 17.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.023 0.439 . . . . 0.0 111.348 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -109.55 145.66 35.97 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.393 175.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.2 m -105.21 121.39 57.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.543 176.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.76 -126.48 8.47 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.466 -0.874 . . . . 0.0 111.649 -177.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -87.07 119.06 70.83 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.678 0.275 . . . . 0.0 111.074 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -77.37 121.62 5.73 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.42 2.08 . . . . 0.0 111.091 172.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -60.73 112.0 1.85 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.3 0.571 . . . . 0.0 110.304 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.53 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 81.3 m-85 -59.47 -29.64 67.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.317 -0.856 . . . . 0.0 113.024 -171.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -57.05 -53.93 40.78 Favored Glycine 0 C--O 1.237 0.289 0 C-N-CA 120.156 -1.021 . . . . 0.0 112.081 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.775 ' HB3' ' HZ3' ' A' ' 128' ' ' LYS . 5.9 ttpm? -80.18 -28.22 38.78 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.53 ' HB3' ' HA ' ' A' ' 126' ' ' PHE . 48.7 tp -61.15 -47.58 85.53 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 177.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -62.45 -48.84 77.86 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.369 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.584 ' HG2' ' HA ' ' A' ' 128' ' ' LYS . 4.2 pt20 -68.47 -31.4 70.66 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.494 -178.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -71.79 -39.14 70.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.73 0.3 . . . . 0.0 110.338 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 80.4 mt -67.82 -39.37 81.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 173.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.541 ' HA ' ' HB2' ' A' ' 137' ' ' TRP . 27.6 t70 -63.56 -27.9 69.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.47 176.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 88.1 m -64.16 -45.73 87.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.335 -0.393 . . . . 0.0 109.96 174.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -65.56 -31.11 71.98 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.29 176.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.541 ' HB2' ' HA ' ' A' ' 134' ' ' ASP . 0.6 OUTLIER -62.16 -44.39 96.71 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.668 174.088 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 138' ' ' ARG . 34.8 mmt180 -74.99 -31.08 61.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.51 -178.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.96 88.97 2.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.11 0.481 . . . . 0.0 110.798 -178.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 20.8 p -81.39 95.11 6.94 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.231 176.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -67.92 98.92 0.79 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.628 0.728 . . . . 0.0 111.165 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -163.35 -53.16 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.749 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -150.31 136.08 18.35 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 174.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -161.65 21.88 0.21 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.285 -177.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 50.71 81.79 0.06 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.307 0.575 . . . . 0.0 111.892 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -127.85 126.34 41.44 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.237 179.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -158.18 77.78 0.8 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.709 175.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -168.67 -59.45 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.573 ' O ' ' HB2' ' A' ' 150' ' ' HIS . 56.6 t-80 -100.65 66.52 1.22 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 167.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.573 ' HB2' ' O ' ' A' ' 149' ' ' HIS . 77.3 m-70 . . . . . 0 C--O 1.247 0.958 0 O-C-N 124.845 1.34 . . . . 0.0 109.056 -161.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.482 1.144 0 N-CA-C 110.665 -0.124 . . . . 0.0 110.665 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.5 m -55.85 133.94 51.56 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 123.446 0.466 . . . . 0.0 111.026 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.2 ptmt -85.29 175.09 9.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.444 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.412 ' HB ' ' HG3' ' A' ' 115' ' ' GLU . 47.1 p 49.94 68.82 0.69 Allowed 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 123.421 0.689 . . . . 0.0 111.782 -173.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.519 ' HB2' ' O ' ' A' ' 114' ' ' GLY . . . 60.75 107.45 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.403 0 CA-C-N 114.572 -1.194 . . . . 0.0 112.85 177.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.468 ' HD2' ' HD1' ' A' ' 8' ' ' PHE . 3.7 Cg_exo -81.15 16.0 1.74 Allowed 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 123.169 2.579 . . . . 0.0 113.122 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 56.58 28.79 14.46 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.13 0.572 . . . . 0.0 112.251 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.468 ' HD1' ' HD2' ' A' ' 6' ' ' PRO . 54.5 p90 -66.02 137.99 57.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.884 -178.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.8 m -143.69 94.48 2.6 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.195 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 1.5 pt? -119.96 156.48 54.33 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-O 120.555 0.217 . . . . 0.0 110.581 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.599 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 3.7 Cg_exo -77.37 144.48 23.02 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 123.046 2.497 . . . . 0.0 112.416 178.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 2.3 p30 -95.7 -176.88 3.87 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 175.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.567 HD11 HG13 ' A' ' 74' ' ' VAL . 63.2 mt -60.33 -20.75 60.51 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -173.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -76.77 -11.39 59.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.821 0.343 . . . . 0.0 110.771 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.7 16.55 58.19 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.839 -0.695 . . . . 0.0 112.377 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 11' ' ' PRO . 21.0 pttp -114.84 151.23 34.25 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 177.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.599 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 23.6 m -93.57 123.63 37.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.015 0.436 . . . . 0.0 112.083 -174.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.4 m -97.81 153.65 3.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 173.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.2 p -141.01 -178.5 5.59 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.198 0.523 . . . . 0.0 111.326 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.478 ' OD1' ' HB1' ' A' ' 5' ' ' ALA . 0.9 OUTLIER -68.54 -22.0 64.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.583 177.639 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.48 -31.75 72.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.051 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -70.69 -20.82 62.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.016 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.566 HD12 HG22 ' A' ' 110' ' ' ILE . 24.6 mt -83.26 -22.04 33.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.126 -174.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -62.92 144.37 56.82 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.631 -173.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.67 -25.24 4.02 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.791 -0.641 . . . . 0.0 113.847 173.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -121.26 -176.01 3.19 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 122.412 -0.464 . . . . 0.0 110.626 -174.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.2 t -108.46 141.89 22.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 175.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.573 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 33.1 m -133.93 137.98 45.21 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.83 0.347 . . . . 0.0 111.281 -174.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.516 HD12 ' HB2' ' A' ' 107' ' ' SER . 52.3 tp -109.63 107.51 17.59 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.23 175.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.662 ' HB ' ' CG2' ' A' ' 108' ' ' VAL . 50.6 mt -93.74 112.41 26.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 172.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -119.82 124.22 45.59 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.872 0.368 . . . . 0.0 110.862 -176.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -90.47 125.43 35.58 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.827 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.543 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 10.5 p-90 -146.17 -174.06 4.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.057 -178.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -156.92 146.57 15.39 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 172.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.404 ' HG3' ' HA ' ' A' ' 74' ' ' VAL . 78.3 Cg_exo -43.96 -59.17 1.15 Allowed 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 123.781 2.988 . . . . 0.0 114.744 -175.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.3 t -83.44 24.78 0.8 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.99 0.424 . . . . 0.0 111.322 -173.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 54.0 t -75.62 132.84 74.49 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.346 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -61.88 -19.01 64.17 Favored 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 122.662 2.242 . . . . 0.0 112.022 176.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.97 -10.98 84.08 Favored Glycine 0 C--O 1.224 -0.521 0 C-N-CA 121.226 -0.511 . . . . 0.0 112.99 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 25.4 p -58.12 -39.37 78.51 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 117.213 0.506 . . . . 0.0 111.648 -175.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.1 p -62.24 -34.42 63.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.855 0.36 . . . . 0.0 110.929 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.8 m -88.03 -54.72 4.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.052 0.453 . . . . 0.0 111.03 178.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -66.27 -50.14 64.75 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -172.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.717 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 49.6 tpp -53.3 -55.53 33.48 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -168.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.717 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 24.5 Cg_exo -64.51 -36.02 45.62 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 121.822 1.682 . . . . 0.0 112.264 178.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -64.36 -40.06 95.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.577 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 30.5 mm -60.87 -46.68 95.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.699 177.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 49.2 mm -55.66 -53.32 38.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.43 -177.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -69.37 -43.11 74.21 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.606 -174.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.3 m -65.26 -44.92 86.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.994 0.426 . . . . 0.0 110.921 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.476 ' HB1' HG21 ' A' ' 61' ' ' VAL . . . -65.65 -42.84 90.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.806 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -56.26 -40.05 73.59 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.51 -178.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -68.38 -51.14 47.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.341 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 1.017 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 60.5 m-85 -74.8 -28.99 60.95 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -174.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -59.44 -27.02 65.69 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 122.479 0.312 . . . . 0.0 111.61 -177.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -73.92 -22.51 59.66 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -172.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 1.017 ' HE2' ' HA ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -95.78 -62.08 1.35 Allowed 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.625 176.121 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 176.96 68.46 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.806 0.813 . . . . 0.0 111.303 -173.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.494 ' HZ ' ' HB2' ' A' ' 29' ' ' LEU . 41.2 t80 -135.83 132.43 36.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.287 -178.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -105.89 143.07 34.55 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.476 HG21 ' HB1' ' A' ' 51' ' ' ALA . 43.7 t -122.8 115.38 45.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.087 -177.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.444 HD22 ' HE3' ' A' ' 88' ' ' MET . 88.5 mt -116.69 95.91 5.25 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.335 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.07 105.46 17.83 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.494 HG21 ' HE1' ' A' ' 88' ' ' MET . 43.0 t -98.94 114.09 35.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 120.969 0.414 . . . . 0.0 110.564 -175.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.543 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -82.71 117.57 22.73 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.723 176.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.6 ' HG3' HG12 ' A' ' 68' ' ' ILE . 3.5 pt20 -74.1 163.43 68.39 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.965 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.585 ' HD2' ' HB2' ' A' ' 66' ' ' GLN . 72.1 Cg_endo -74.91 55.09 3.79 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.735 2.29 . . . . 0.0 114.035 -172.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.6 HG12 ' HG3' ' A' ' 66' ' ' GLN . 50.0 mm -93.12 -69.99 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 172.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -81.74 153.55 70.37 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.779 176.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -61.26 157.26 41.05 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.479 2.119 . . . . 0.0 112.33 177.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.0 tp -57.26 -31.3 37.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.917 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -64.54 -42.92 95.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.532 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.3 m -63.27 -34.76 78.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.814 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.567 HG13 HD11 ' A' ' 13' ' ' LEU . 34.8 t -64.13 -44.92 97.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.17 176.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -65.53 -34.62 78.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.651 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -62.48 -41.78 99.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.888 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.88 -43.1 97.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.751 -0.204 . . . . 0.0 110.863 178.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.541 ' HA ' HD12 ' A' ' 83' ' ' LEU . 42.1 t -63.16 -37.44 79.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.156 0.503 . . . . 0.0 110.345 176.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.0 tttm -61.97 -55.25 31.32 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.655 0.74 . . . . 0.0 111.141 176.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.03 -39.39 69.16 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.539 -1.21 . . . . 0.0 113.204 -173.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -104.99 0.76 28.02 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -174.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.05 -82.25 1.68 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.192 177.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.541 HD12 ' HA ' ' A' ' 78' ' ' VAL . 54.6 mt 61.59 93.33 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.417 0.627 . . . . 0.0 112.523 171.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -87.33 2.36 6.84 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 123.11 2.54 . . . . 0.0 113.667 -177.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -90.91 166.02 13.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.636 0.255 . . . . 0.0 110.625 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 20.2 m -77.04 113.52 14.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.069 0.462 . . . . 0.0 110.908 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.4 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 14.8 t -107.67 125.49 64.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.599 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.494 ' HE1' HG21 ' A' ' 64' ' ' VAL . 72.4 mtm -116.67 173.09 6.82 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.149 177.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -132.04 122.55 25.66 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.865 0.364 . . . . 0.0 110.245 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.511 ' HB3' ' HA ' ' A' ' 66' ' ' GLN . 45.8 t0 -82.81 119.23 24.1 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 176.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.74 -42.44 61.12 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -171.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -126.89 15.26 7.43 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.527 0.203 . . . . 0.0 111.124 -174.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.629 ' HZ2' ' HB3' ' A' ' 93' ' ' LYS . 5.9 ttpm? 68.35 20.34 8.68 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.544 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -77.23 -25.65 51.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.967 -174.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 41.0 t -74.82 -40.47 46.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.93 -38.9 96.07 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.485 173.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -68.72 -26.48 65.28 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 122.546 0.338 . . . . 0.0 111.173 176.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.94 -47.03 72.91 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.832 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -82.89 -26.9 31.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.484 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 95.64 55.4 1.33 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.404 178.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.422 HG21 HG22 ' A' ' 106' ' ' THR . 21.3 p -63.31 112.14 2.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.085 0.469 . . . . 0.0 111.71 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -77.52 -58.16 3.42 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.014 177.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.459 HG13 ' HB ' ' A' ' 121' ' ' VAL . 7.8 p -145.71 147.44 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.656 -175.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.462 ' HA ' ' C ' ' A' ' 105' ' ' PRO . 76.5 m-85 -102.54 147.44 34.02 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.036 -174.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.462 ' C ' ' HA ' ' A' ' 104' ' ' TYR . 38.1 Cg_endo -70.06 154.45 94.07 Favored 'Cis proline' 0 C--N 1.346 0.436 0 C-N-CA 123.305 -1.54 . . . . 0.0 112.838 0.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.422 HG22 HG21 ' A' ' 101' ' ' THR . 24.7 m -121.7 112.45 18.42 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.163 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.516 ' HB2' HD12 ' A' ' 29' ' ' LEU . 5.4 p -110.49 114.18 27.4 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.271 0.558 . . . . 0.0 111.176 -177.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.662 ' CG2' ' HB ' ' A' ' 30' ' ' ILE . 17.2 m -105.74 142.33 19.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.058 0.456 . . . . 0.0 110.737 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 118' ' ' LYS . 81.5 mt -102.35 125.36 49.04 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.715 -177.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.573 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 12.1 mm -103.95 137.18 33.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.717 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -86.85 -167.6 43.91 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.274 -177.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.688 ' HD3' ' HA ' ' A' ' 141' ' ' ASP . 36.8 mttm -86.97 34.44 0.67 Allowed 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 122.003 0.906 . . . . 0.0 108.967 -175.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.499 ' HB3' ' OE1' ' A' ' 115' ' ' GLU . 29.0 mmtm -148.59 -35.46 0.2 Allowed 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 114.206 -1.361 . . . . 0.0 110.846 -165.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.519 ' O ' ' HB2' ' A' ' 5' ' ' ALA . . . 113.65 -28.7 8.35 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -174.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.499 ' OE1' ' HB3' ' A' ' 113' ' ' LYS . 1.2 mp0 -54.61 141.23 32.48 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 114.89 -0.655 . . . . 0.0 110.944 176.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 6.7 mt -80.19 122.96 36.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.592 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.6 mt -98.88 -60.53 1.52 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.048 0.451 . . . . 0.0 111.466 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.525 ' HB2' ' HB2' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -124.95 159.22 31.71 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.989 -170.542 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 57.9 m -141.13 103.58 4.48 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.414 170.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -92.46 131.87 37.25 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.4 176.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.459 ' HB ' HG13 ' A' ' 103' ' ' VAL . 6.0 m -101.22 116.04 44.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.906 178.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 83.48 -106.82 2.86 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.191 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -89.68 114.11 59.35 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-O 120.524 0.202 . . . . 0.0 110.783 -176.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.24 98.34 0.92 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.375 2.05 . . . . 0.0 111.85 175.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -49.67 111.97 0.58 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.92 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -66.73 -34.11 77.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.179 -175.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -60.12 -52.18 54.32 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.597 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.556 ' HA ' ' HG2' ' A' ' 131' ' ' GLN . 25.9 mtmm -76.86 -24.31 52.65 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.678 -0.261 . . . . 0.0 110.837 178.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.443 ' O ' HG13 ' A' ' 133' ' ' ILE . 53.5 tp -62.48 -48.76 78.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.913 0.387 . . . . 0.0 110.087 175.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -63.3 -46.22 87.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.412 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.556 ' HG2' ' HA ' ' A' ' 128' ' ' LYS . 13.5 pt20 -70.93 -34.13 71.2 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.418 -176.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.4 ' O ' ' HB ' ' A' ' 135' ' ' THR . 20.3 tt0 -78.96 -31.88 45.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.57 0.224 . . . . 0.0 110.746 -177.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 129' ' ' LEU . 59.0 mt -61.28 -47.52 93.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 172.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.497 ' O ' ' HG2' ' A' ' 138' ' ' ARG . 21.5 t70 -60.14 -32.98 71.54 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.594 175.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.4 ' HB ' ' O ' ' A' ' 132' ' ' GLU . 69.9 m -57.25 -52.06 66.86 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.856 0.36 . . . . 0.0 110.459 177.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.34 -24.09 57.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.32 0.581 . . . . 0.0 110.616 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.423 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 21.7 t-105 -66.07 -30.62 71.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.263 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' A' ' 134' ' ' ASP . 7.2 mmp_? -85.35 -37.14 20.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.11 178.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -87.59 107.35 18.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.204 -171.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 11.6 t 59.74 70.3 0.65 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.466 175.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.688 ' HA ' ' HD3' ' A' ' 112' ' ' LYS . 9.7 t70 -59.24 -42.83 91.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.127 177.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -120.85 -66.43 1.06 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.669 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -123.05 171.31 9.37 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -75.07 -72.07 1.08 Allowed Glycine 0 CA--C 1.521 0.457 0 C-N-CA 121.362 -0.447 . . . . 0.0 114.068 -175.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 -159.23 30.39 0.2 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 117.095 0.448 . . . . 0.0 110.773 -172.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 31.4 m80 64.04 51.88 2.16 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.667 0.746 . . . . 0.0 109.383 -170.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 -69.67 147.68 50.3 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.746 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -69.19 155.12 40.93 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.007 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -75.64 -18.16 59.76 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.305 0.574 . . . . 0.0 109.587 176.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 74.7 t60 . . . . . 0 C--O 1.244 0.785 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.326 174.728 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.593 ' HA ' ' HB3' ' A' ' 6' ' ' PRO . 3.5 p30 . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 110.585 -0.154 . . . . 0.0 110.585 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.1 m 61.56 -169.62 0.17 Allowed 'General case' 0 C--O 1.234 0.254 0 O-C-N 123.859 0.724 . . . . 0.0 111.612 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.0 tttm 60.96 -101.47 0.11 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.724 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.3 p -122.63 80.04 1.7 Allowed 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.714 -178.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.64 ' H ' HG13 ' A' ' 116' ' ' ILE . . . 67.94 128.73 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.4 0 CA-C-N 114.826 -1.079 . . . . 0.0 113.087 176.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.593 ' HB3' ' HA ' ' A' ' 1' ' ' ASP . 86.3 Cg_endo -90.26 -174.19 0.76 Allowed 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 123.016 2.478 . . . . 0.0 110.905 171.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.86 83.42 2.54 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.909 0.385 . . . . 0.0 110.117 175.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -114.33 140.95 48.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.222 0.534 . . . . 0.0 111.005 -176.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.5 t -139.7 90.22 2.38 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 173.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.513 ' O ' HG11 ' A' ' 18' ' ' VAL . 1.8 tm? -116.9 119.83 34.76 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.261 -166.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.574 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 40.0 Cg_endo -68.41 128.48 17.37 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.749 2.299 . . . . 0.0 112.213 176.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.537 ' HA ' ' HG3' ' A' ' 88' ' ' MET . 0.0 OUTLIER -62.67 164.91 7.05 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.416 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 87' ' ' VAL . 4.2 pp -66.3 -18.22 65.22 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.668 -172.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 16.6 t-80 -84.7 -25.95 28.03 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.926 0.393 . . . . 0.0 110.373 176.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.459 ' C ' ' HE2' ' A' ' 16' ' ' LYS . . . 123.6 8.54 6.28 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.572 -0.823 . . . . 0.0 113.735 174.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.459 ' HE2' ' C ' ' A' ' 15' ' ' GLY . 0.8 OUTLIER -94.55 120.31 34.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 117.378 0.589 . . . . 0.0 110.612 179.147 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.574 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 10.3 m -67.28 126.09 28.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.448 -177.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.543 HG13 ' HE3' ' A' ' 88' ' ' MET . 1.7 p -116.55 135.31 57.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 177.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.5 m -146.54 -173.08 4.11 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 122.11 -0.369 . . . . 0.0 111.303 -177.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -54.81 -39.66 68.73 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -176.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.04 -27.21 66.74 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -177.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -73.2 -25.93 60.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.021 0.438 . . . . 0.0 110.515 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.564 HD23 HG22 ' A' ' 28' ' ' THR . 33.5 mt -83.39 -51.7 7.16 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.087 -176.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -56.11 130.92 46.09 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.367 -172.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.76 -25.15 28.45 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.104 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.721 ' HZ2' ' HB3' ' A' ' 26' ' ' LYS . 8.1 mtpm? -124.49 172.97 8.77 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -177.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.53 HG23 ' HZ3' ' A' ' 137' ' ' TRP . 11.1 t -103.82 139.71 24.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 176.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.792 HG21 HD11 ' A' ' 62' ' ' LEU . 85.2 m -126.73 139.14 53.36 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -168.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.705 ' HB2' ' CE2' ' A' ' 59' ' ' PHE . 27.0 tp -110.02 107.37 17.23 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.74 172.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 28.6 mt -98.62 111.35 28.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.316 173.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -109.29 122.84 48.22 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.106 -177.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.416 ' CE1' ' HA2' ' A' ' 96' ' ' GLY . 97.2 m-85 -91.15 118.93 30.84 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.86 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.652 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 10.6 p-90 -148.5 -178.86 6.56 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.829 -177.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.537 ' O ' ' HB2' ' A' ' 37' ' ' CYS . 41.0 p90 -155.09 144.84 15.49 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 178.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.796 ' HG2' ' HB3' ' A' ' 69' ' ' ASP . 12.4 Cg_endo -59.71 152.03 65.98 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.168 1.912 . . . . 0.0 111.433 174.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.9 m 68.89 18.81 8.46 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 123.529 0.518 . . . . 0.0 111.091 -177.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.537 ' HB2' ' O ' ' A' ' 34' ' ' PHE . 45.1 t -68.33 140.45 92.8 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.452 -178.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -72.61 -22.96 20.27 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.821 2.347 . . . . 0.0 111.893 173.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.3 -1.21 88.08 Favored Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.923 -0.581 . . . . 0.0 113.147 -176.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.424 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 90.9 m -56.92 -30.4 63.94 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.876 0.338 . . . . 0.0 111.672 -177.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.4 t -49.97 -50.11 19.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.081 0.467 . . . . 0.0 110.641 177.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.4 m -87.2 -54.87 4.08 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.05 177.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.477 ' HA ' ' HD3' ' A' ' 46' ' ' LYS . 49.3 mm-40 -59.79 -40.85 89.7 Favored 'General case' 0 C--O 1.226 -0.139 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -168.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.808 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -59.12 -60.86 9.17 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -169.667 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.808 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 19.5 Cg_exo -67.11 -29.48 39.77 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 121.958 1.772 . . . . 0.0 111.488 178.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.477 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 64.8 tttt -59.79 -42.91 94.42 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.09 177.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 43' ' ' GLU . 41.0 mm -71.63 -38.95 68.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.352 177.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.721 HD13 ' HE2' ' A' ' 85' ' ' PHE . 47.6 mm -55.46 -53.63 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.2 -179.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -66.03 -49.33 68.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.287 -178.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 31.6 m -61.8 -54.67 39.12 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.782 -174.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.52 -33.59 73.03 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -173.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -75.79 -40.48 55.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.816 0.341 . . . . 0.0 111.173 -178.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -70.93 -42.99 69.12 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.844 0.354 . . . . 0.0 110.769 -176.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.594 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 42.8 m-85 -76.06 -10.32 59.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.714 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -56.71 -27.65 59.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.041 0.448 . . . . 0.0 110.954 -178.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -102.89 14.81 31.04 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.519 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.562 ' HD3' ' HA ' ' A' ' 54' ' ' TYR . 13.6 mptt -111.62 23.49 13.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.755 176.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.585 ' OD1' ' HG2' ' A' ' 26' ' ' LYS . 66.2 t30 68.11 18.46 9.37 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 122.078 0.942 . . . . 0.0 109.795 -176.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.705 ' CE2' ' HB2' ' A' ' 29' ' ' LEU . 38.5 t80 -100.03 162.01 13.25 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.557 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -150.42 152.55 34.5 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.248 0.547 . . . . 0.0 112.064 -177.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 1.014 HG12 ' HB3' ' A' ' 85' ' ' PHE . 1.5 p -101.08 125.88 54.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 114.816 -1.083 . . . . 0.0 111.119 -178.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.792 HD11 HG21 ' A' ' 28' ' ' THR . 8.7 mp -128.63 94.31 3.83 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 169.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -101.05 102.01 12.9 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.546 -176.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.964 HG13 ' HB2' ' A' ' 88' ' ' MET . 26.7 m -97.08 127.47 49.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.441 0.638 . . . . 0.0 111.118 -176.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.652 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -95.2 135.83 36.28 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.676 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.654 ' HB2' ' HG2' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -95.2 161.47 28.0 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 175.231 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.588 ' HD3' ' O ' ' A' ' 90' ' ' ASP . 73.8 Cg_endo -74.04 54.03 3.05 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.903 2.402 . . . . 0.0 114.555 -168.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 45.7 mm -83.27 -27.85 7.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 170.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.796 ' HB3' ' HG2' ' A' ' 35' ' ' PRO . 0.6 OUTLIER -138.89 136.17 18.24 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 173.44 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 69' ' ' ASP . 73.0 Cg_exo -51.83 163.98 1.18 Allowed 'Trans proline' 0 N--CA 1.477 0.553 0 C-N-CA 123.509 2.806 . . . . 0.0 114.587 -175.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.8 tp -56.73 -34.92 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.574 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -66.47 -35.47 80.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.195 0.522 . . . . 0.0 110.419 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 27.3 m -64.89 -47.69 76.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.306 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.483 ' HB ' ' HG3' ' A' ' 35' ' ' PRO . 9.2 p -67.18 -33.95 66.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.652 0.263 . . . . 0.0 110.814 -178.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -65.89 -37.54 86.39 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.005 0.431 . . . . 0.0 110.993 176.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -69.76 -36.55 75.89 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -64.2 -50.75 66.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.979 -178.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.599 HG23 ' HB2' ' A' ' 83' ' ' LEU . 10.4 p -60.5 -30.21 46.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-O 120.754 0.312 . . . . 0.0 110.643 178.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -70.67 -55.37 8.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.239 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -66.25 -48.38 70.7 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.117 -174.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -82.55 -18.41 41.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.441 -176.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 69.08 63.74 3.31 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.98 177.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.599 ' HB2' HG23 ' A' ' 78' ' ' VAL . 8.4 mp -87.64 111.03 39.21 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 120.633 0.254 . . . . 0.0 110.383 178.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -89.98 24.54 0.62 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.899 2.399 . . . . 0.0 113.168 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 1.014 ' HB3' HG12 ' A' ' 61' ' ' VAL . 13.0 m-85 -121.15 155.28 34.85 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.1 m -68.2 123.56 21.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.1 0.476 . . . . 0.0 111.86 -173.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.449 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 48.7 t -122.62 135.19 63.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.822 -178.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.964 ' HB2' HG13 ' A' ' 64' ' ' VAL . 2.3 mpt? -117.13 175.5 5.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 93.6 t80 -138.51 117.18 12.21 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.241 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.588 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 21.1 t0 -103.98 114.26 28.38 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.0 -14.87 61.09 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -174.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -122.4 0.67 9.49 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.46 -175.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.654 ' HG2' ' HB2' ' A' ' 66' ' ' GLN . 49.3 mtmt 64.37 15.1 9.28 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 123.58 0.55 . . . . 0.0 109.903 -171.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.9 -44.27 93.47 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -165.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.534 HG21 ' OD2' ' A' ' 90' ' ' ASP . 28.2 m -74.14 -29.32 24.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.231 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.416 ' HA2' ' CE1' ' A' ' 32' ' ' PHE . . . -72.1 -34.78 61.3 Favored Glycine 0 CA--C 1.509 -0.282 0 C-N-CA 120.541 -0.837 . . . . 0.0 111.29 174.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.547 ' HA ' HE21 ' A' ' 97' ' ' GLN . 0.0 OUTLIER -71.03 -28.84 64.69 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.007 -0.596 . . . . 0.0 110.224 174.652 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.21 -22.71 59.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.233 175.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -87.65 -22.91 24.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.998 176.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 93.23 62.99 1.09 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.574 176.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.9 p -103.95 127.16 51.49 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.878 0.371 . . . . 0.0 111.244 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -87.81 -50.75 6.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.127 0.489 . . . . 0.0 110.31 176.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.4 p -145.08 149.15 17.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.087 -176.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.532 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 59.2 m-85 -106.21 161.46 22.78 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.215 -176.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.532 ' HA ' ' HB3' ' A' ' 104' ' ' TYR . 74.4 Cg_endo -74.39 165.5 85.24 Favored 'Cis proline' 0 C--N 1.351 0.684 0 C-N-CA 123.772 -1.345 . . . . 0.0 113.233 0.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.3 m -139.77 132.44 28.92 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.623 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.528 ' HB3' ' HB2' ' A' ' 120' ' ' TYR . 18.8 t -112.33 112.15 23.52 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.656 HG22 HG23 ' A' ' 119' ' ' THR . 55.5 t -105.99 131.6 55.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.898 0.38 . . . . 0.0 111.489 -175.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 90.2 mt -102.98 125.73 49.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.997 177.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.539 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 53.6 mt -118.05 141.09 38.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 123.445 0.466 . . . . 0.0 110.715 -179.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -85.8 -167.17 43.11 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 116.155 -0.475 . . . . 0.0 113.574 -177.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.4 -20.58 50.87 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -173.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.598 ' HB2' ' HZ3' ' A' ' 113' ' ' LYS . 3.7 ttmp? -99.17 -3.18 35.01 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.554 0.692 . . . . 0.0 109.2 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.572 ' O ' ' HB1' ' A' ' 5' ' ' ALA . . . 97.29 12.64 48.01 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.67 -178.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -68.15 122.15 17.68 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.64 HG13 ' H ' ' A' ' 5' ' ' ALA . 29.8 mt -74.01 93.76 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 174.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 93.4 mt -75.38 -70.3 0.43 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.596 -171.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.479 ' HD2' ' HA ' ' A' ' 118' ' ' LYS . 22.7 mmmt -125.44 144.72 50.4 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.148 -171.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.656 HG23 HG22 ' A' ' 108' ' ' VAL . 1.6 p -120.99 104.16 9.59 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.374 175.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.528 ' HB2' ' HB3' ' A' ' 107' ' ' SER . 22.6 m-85 -85.05 103.43 14.07 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.87 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.6 t -83.0 109.74 17.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.988 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 86.31 -116.83 4.48 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.375 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.435 ' OE1' ' HD2' ' A' ' 124' ' ' PRO . 7.1 tp10 -103.72 116.63 61.49 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-O 120.531 0.205 . . . . 0.0 110.812 -174.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.469 ' HB3' ' CG ' ' A' ' 120' ' ' TYR . 93.2 Cg_endo -86.54 -159.58 0.1 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 123.027 2.485 . . . . 0.0 112.254 175.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.857 ' HB3' ' HG2' ' A' ' 128' ' ' LYS . 18.2 t70 -125.27 124.27 41.29 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.861 177.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -65.54 -37.53 86.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.504 -175.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.77 -50.98 55.69 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.201 -178.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.857 ' HG2' ' HB3' ' A' ' 125' ' ' ASP . 11.9 ptmm? -67.5 -26.13 66.19 Favored 'General case' 0 C--O 1.221 -0.443 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.184 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 51.4 tp -61.08 -47.36 86.69 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.233 0.333 . . . . 0.0 110.224 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -62.24 -54.48 40.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.149 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.483 ' HG2' ' HA ' ' A' ' 128' ' ' LYS . 13.7 pt20 -65.99 -33.88 76.82 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -175.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -71.02 -45.78 63.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.477 0.18 . . . . 0.0 110.69 -177.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 72.7 mt -66.51 -36.26 76.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 177.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.612 ' HA ' ' CD1' ' A' ' 137' ' ' TRP . 14.2 t70 -61.46 -47.87 83.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.61 175.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 45.0 m -55.57 -35.23 65.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.185 0.517 . . . . 0.0 110.328 176.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.6 -18.5 62.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.162 -178.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.612 ' CD1' ' HA ' ' A' ' 134' ' ' ASP . 2.9 m95 -56.71 -56.96 14.8 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.304 0.573 . . . . 0.0 109.848 177.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.76 -57.55 2.87 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.015 -179.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -87.4 91.3 8.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.669 -169.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 20.5 m -110.86 78.38 1.11 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 171.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -143.23 169.34 17.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.906 -171.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -78.55 -0.5 29.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.933 0.397 . . . . 0.0 110.893 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -80.7 5.92 14.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.973 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.3 -61.85 6.66 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 121.253 -0.498 . . . . 0.0 112.861 -178.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -141.9 136.42 30.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.62 0.248 . . . . 0.0 110.394 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -90.71 -2.58 57.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.008 0.432 . . . . 0.0 111.068 178.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -98.11 118.56 35.01 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 171.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -76.99 81.78 3.52 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.415 0.626 . . . . 0.0 111.085 -174.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 50.6 m-70 -119.59 -177.06 3.29 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.308 173.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.415 ' HE1' HG23 ' A' ' 116' ' ' ILE . 8.1 t-80 . . . . . 0 C--O 1.246 0.869 0 CA-C-O 118.885 -0.578 . . . . 0.0 109.707 -179.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.769 ' HB2' ' HB3' ' A' ' 8' ' ' PHE . 4.5 t70 . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.536 ' HB2' ' HG2' ' A' ' 6' ' ' PRO . 16.3 m -167.03 -70.28 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -178.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -161.92 142.34 10.41 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 175.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.547 ' H ' HD12 ' A' ' 116' ' ' ILE . 10.8 m 69.63 31.16 3.72 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 122.083 0.944 . . . . 0.0 110.274 -178.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.491 ' N ' ' HD3' ' A' ' 6' ' ' PRO . . . 58.9 61.52 4.7 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 114.245 -1.343 . . . . 0.0 114.116 173.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.569 ' HD2' ' CG ' ' A' ' 1' ' ' ASP . 17.3 Cg_exo -73.76 39.59 0.51 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.156 2.57 . . . . 0.0 112.473 167.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.435 ' H ' ' C ' ' A' ' 5' ' ' ALA . . . 75.27 113.65 0.07 Allowed 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.954 0.901 . . . . 0.0 112.893 174.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.769 ' HB3' ' HB2' ' A' ' 1' ' ' ASP . 27.3 p90 -141.78 131.58 24.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.912 171.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 26.0 p -149.35 103.09 3.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.868 0.365 . . . . 0.0 110.921 -179.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.417 ' O ' HG13 ' A' ' 18' ' ' VAL . 1.6 pt? -120.1 157.27 53.49 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.766 178.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.13 150.65 26.33 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 121.992 1.795 . . . . 0.0 112.228 177.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.557 ' HA ' ' HG3' ' A' ' 88' ' ' MET . 0.0 OUTLIER -81.41 176.6 9.57 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.035 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 87' ' ' VAL . 78.4 mt -57.42 -26.25 60.85 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -177.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 47.4 t60 -91.29 -40.84 11.27 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 121.355 -0.138 . . . . 0.0 110.783 178.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.93 4.01 0.87 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.063 -1.065 . . . . 0.0 113.804 176.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -78.47 126.74 31.19 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 117.468 0.634 . . . . 0.0 110.212 178.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.7 m -66.97 130.51 43.38 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.851 0.358 . . . . 0.0 110.12 176.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 9' ' ' SER . 9.8 p -118.21 138.13 49.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.0 p -138.69 -177.63 4.95 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.312 0.577 . . . . 0.0 112.091 -173.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -71.36 -21.7 62.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.665 175.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.65 -31.34 72.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.682 178.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -63.72 -23.26 67.3 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.805 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.604 HD21 HG23 ' A' ' 28' ' ' THR . 25.0 mt -84.06 -20.53 32.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.125 -172.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.436 ' HA ' ' OE1' ' A' ' 24' ' ' GLN . 14.7 mm-40 -60.82 113.09 2.31 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -172.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 113.23 -19.57 19.97 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.341 174.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.439 ' HB2' ' OE1' ' A' ' 60' ' ' GLN . 68.0 mttm -124.87 169.84 11.65 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.036 0.418 . . . . 0.0 110.945 -176.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.571 HG12 ' CD1' ' A' ' 59' ' ' PHE . 3.3 p -102.63 123.77 56.18 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.625 -177.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.604 HG23 HD21 ' A' ' 23' ' ' LEU . 39.0 m -116.01 142.99 46.07 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -160.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.489 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 55.7 tp -112.04 111.04 21.67 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.712 170.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.572 ' HB ' ' HB ' ' A' ' 108' ' ' VAL . 62.8 mt -97.9 111.96 28.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 171.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -112.73 122.39 47.54 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.5 -176.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.514 ' HB2' ' HB ' ' A' ' 106' ' ' THR . 89.5 m-85 -94.85 119.89 34.16 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.515 178.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.54 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 18.0 p-90 -147.54 175.33 10.93 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.338 -177.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -154.43 145.04 16.02 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 174.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.499 ' HG2' ' HB3' ' A' ' 69' ' ' ASP . 6.0 Cg_exo -39.12 -66.3 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 124.323 3.349 . . . . 0.0 114.419 -173.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.8 m -77.12 57.12 1.35 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.005 0.431 . . . . 0.0 112.049 -178.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.3 t -117.27 132.74 23.36 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.292 177.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.576 ' O ' HG12 ' A' ' 41' ' ' VAL . 31.4 Cg_exo -60.42 -20.05 61.6 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.565 2.177 . . . . 0.0 112.174 176.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.69 -22.46 78.68 Favored Glycine 0 C--O 1.224 -0.521 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.76 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.686 ' HA ' ' HG3' ' A' ' 44' ' ' MET . 64.1 m -60.36 -35.08 74.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.912 0.356 . . . . 0.0 111.464 -177.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.576 HG12 ' O ' ' A' ' 38' ' ' PRO . 13.5 p -67.33 -40.23 84.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.168 -176.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.8 p -89.25 -49.72 6.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.942 0.401 . . . . 0.0 111.894 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.498 ' O ' HG12 ' A' ' 47' ' ' ILE . 27.0 mm-40 -80.18 -41.2 25.75 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -168.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.686 ' HG3' ' HA ' ' A' ' 40' ' ' CYS . 59.0 mtp -58.28 -49.46 93.46 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -172.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -59.12 -36.37 96.1 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 121.945 1.763 . . . . 0.0 111.811 175.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.408 ' HB3' ' O ' ' A' ' 43' ' ' GLU . 33.7 ttmt -63.42 -38.04 89.6 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.162 177.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.498 HG12 ' O ' ' A' ' 43' ' ' GLU . 46.0 mm -67.4 -35.41 73.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.202 176.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.517 HG12 ' O ' ' A' ' 44' ' ' MET . 47.2 mm -54.73 -52.36 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.616 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.425 ' C ' ' HD3' ' A' ' 49' ' ' LYS . 12.7 tmtt? -59.65 -56.25 24.25 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.892 178.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 27.7 m -54.02 -51.96 62.34 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.903 -174.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.525 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -68.91 -44.76 72.51 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.138 -174.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -75.82 -37.35 59.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.737 -173.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -74.48 -52.45 11.94 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -175.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -78.62 -2.87 41.06 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.82 0.343 . . . . 0.0 111.244 -175.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 24.0 tptm -59.58 -35.74 74.87 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.245 177.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -88.6 2.9 52.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.626 -177.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -96.19 -66.16 0.92 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.327 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 66.2 t30 174.63 18.59 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.436 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.571 ' CD1' HG12 ' A' ' 27' ' ' VAL . 20.7 t80 -104.03 148.47 26.19 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.236 -172.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.439 ' OE1' ' HB2' ' A' ' 26' ' ' LYS . 51.1 mt-30 -122.89 150.9 42.3 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.01 0.524 . . . . 0.0 109.967 178.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.525 HG11 ' HB2' ' A' ' 51' ' ' ALA . 5.9 p -127.1 121.06 56.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 121.175 0.512 . . . . 0.0 110.594 177.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.539 ' HB3' ' HE3' ' A' ' 88' ' ' MET . 8.6 mp -126.77 96.31 4.61 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.443 177.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.55 113.36 25.6 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.536 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 63.7 t -98.19 116.39 40.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.026 0.441 . . . . 0.0 110.132 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -87.7 121.56 30.28 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.789 175.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.675 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 4.8 pm0 -89.65 169.16 13.2 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.675 ' HD2' ' HB2' ' A' ' 66' ' ' GLN . 30.0 Cg_endo -62.26 -138.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 122.701 2.267 . . . . 0.0 113.825 -178.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.542 ' HB ' ' O ' ' A' ' 67' ' ' PRO . 90.6 mt 78.9 -49.36 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 C-N-CA 123.163 0.585 . . . . 0.0 109.771 -173.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.499 ' HB3' ' HG2' ' A' ' 35' ' ' PRO . 0.6 OUTLIER -107.03 138.53 19.85 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 173.249 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 69' ' ' ASP . 33.8 Cg_exo -59.18 158.31 26.53 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.749 2.299 . . . . 0.0 112.821 -178.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.0 tp -62.26 -31.27 51.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.396 -175.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -66.57 -29.2 69.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.905 177.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.1 t -68.48 -40.55 80.92 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.7 t -62.66 -42.74 97.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.209 176.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -62.79 -36.0 81.71 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.176 177.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -61.46 -45.02 96.05 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.825 0.345 . . . . 0.0 110.75 -177.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -63.43 -52.49 61.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.303 -179.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.517 ' HA ' HD13 ' A' ' 83' ' ' LEU . 10.0 p -65.23 -26.53 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-O 121.035 0.445 . . . . 0.0 111.038 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -73.31 -54.77 7.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.356 0.598 . . . . 0.0 110.661 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -73.38 -48.87 30.54 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.862 -172.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -91.77 -4.49 54.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.523 -174.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.08 -58.0 4.59 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.755 177.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.517 HD13 ' HA ' ' A' ' 78' ' ' VAL . 11.2 mp 63.62 95.28 0.05 OUTLIER Pre-proline 0 N--CA 1.466 0.355 0 CA-C-O 121.275 0.56 . . . . 0.0 111.666 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -75.94 10.58 1.97 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.574 2.85 . . . . 0.0 113.07 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -120.38 145.03 47.57 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.2 m -67.68 124.46 23.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.16 -176.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.469 HG23 HD21 ' A' ' 83' ' ' LEU . 33.3 t -118.87 134.38 62.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.702 -179.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.557 ' HG3' ' HA ' ' A' ' 12' ' ' ASP . 3.2 mpp? -123.66 175.25 6.95 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -134.93 125.46 26.73 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.123 -177.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.544 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 56.4 t0 -107.68 111.16 23.23 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 174.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.11 -24.76 60.67 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -174.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.59 7.01 22.27 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.081 -174.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.4 pttp 46.45 32.0 1.47 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.992 0.917 . . . . 0.0 111.563 -179.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.33 -35.12 58.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.661 -173.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.541 HG22 ' OD2' ' A' ' 90' ' ' ASP . 32.6 m -73.44 -29.88 28.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 175.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -68.99 -39.5 84.92 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 172.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -58.83 -32.75 69.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.025 0.44 . . . . 0.0 111.142 175.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.95 -47.7 65.01 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.043 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.468 ' HD2' ' CZ ' ' A' ' 32' ' ' PHE . 30.2 m-85 -81.27 -14.17 57.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.978 -176.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 93.34 38.46 5.34 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.233 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.489 HG23 ' OG1' ' A' ' 106' ' ' THR . 39.9 m -75.9 89.22 2.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.285 0.564 . . . . 0.0 111.18 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 52.5 tp60 -101.44 -57.85 2.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.703 175.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.434 ' CG1' ' HB ' ' A' ' 121' ' ' VAL . 8.4 p -98.95 148.72 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.823 -177.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -114.65 144.28 31.57 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.968 -173.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.461 ' HG3' ' HG3' ' A' ' 43' ' ' GLU . 94.1 Cg_endo -85.58 165.23 55.92 Favored 'Cis proline' 0 N--CA 1.463 -0.279 0 C-N-CA 123.232 -1.57 . . . . 0.0 112.307 -0.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.514 ' HB ' ' HB2' ' A' ' 32' ' ' PHE . 36.5 m -110.45 134.07 52.69 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 176.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.5 m -121.72 110.18 15.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.992 0.425 . . . . 0.0 110.559 -176.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.572 ' HB ' ' HB ' ' A' ' 30' ' ' ILE . 46.4 t -109.41 125.13 66.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.513 -179.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.719 HD13 HD12 ' A' ' 129' ' ' LEU . 85.4 mt -103.4 136.3 43.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.545 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.548 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 51.8 mt -124.49 138.12 55.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 176.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 27' ' ' VAL . . . -78.06 -92.98 0.28 Allowed Glycine 0 C--O 1.223 -0.572 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.137 -172.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -144.63 -2.79 0.83 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.402 0.601 . . . . 0.0 111.351 -178.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.575 ' HB2' ' HZ2' ' A' ' 113' ' ' LYS . 10.4 mtmp? -126.15 13.74 7.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.816 0.341 . . . . 0.0 110.89 -174.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.02 28.74 73.91 Favored Glycine 0 C--O 1.227 -0.316 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.246 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.475 ' OE2' ' HB2' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -90.48 -11.05 41.46 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.856 0.36 . . . . 0.0 110.75 -176.292 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.547 HD12 ' H ' ' A' ' 4' ' ' THR . 19.3 mt 62.9 91.67 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.556 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.55 -34.55 72.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.934 -1.03 . . . . 0.0 112.699 -173.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.616 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 2.4 tppp? -155.43 139.87 16.8 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -168.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.539 HG22 HG23 ' A' ' 108' ' ' VAL . 18.3 m -126.07 101.99 7.03 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 120.91 0.386 . . . . 0.0 110.375 170.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.501 ' CD2' ' HB3' ' A' ' 124' ' ' PRO . 41.9 m-85 -94.07 137.69 32.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.285 173.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.434 ' HB ' ' CG1' ' A' ' 103' ' ' VAL . 3.7 m -102.59 108.9 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-O 121.247 0.546 . . . . 0.0 109.737 170.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 99.85 -162.91 19.38 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.341 -0.703 . . . . 0.0 111.341 -174.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -83.09 125.88 73.71 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.812 0.306 . . . . 0.0 110.352 176.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.501 ' HB3' ' CD2' ' A' ' 120' ' ' TYR . 96.5 Cg_endo -80.1 175.13 10.69 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.726 2.284 . . . . 0.0 112.435 177.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.454 ' HB2' ' HB3' ' A' ' 128' ' ' LYS . 7.1 m-20 -65.52 110.43 2.7 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 173.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -63.39 -39.7 95.23 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -170.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -73.21 -46.82 25.77 Favored Glycine 0 C--O 1.237 0.338 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.856 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.454 ' HB3' ' HB2' ' A' ' 125' ' ' ASP . 51.1 tttm -60.71 -36.86 79.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.653 0.263 . . . . 0.0 110.476 177.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.719 HD12 HD13 ' A' ' 109' ' ' LEU . 28.0 tp -58.92 -46.85 86.93 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.719 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -56.54 -45.29 81.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.848 0.356 . . . . 0.0 110.803 178.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -68.4 -37.23 80.16 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.865 -178.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.499 ' HG2' ' HA ' ' A' ' 129' ' ' LEU . 8.9 pt-20 -77.02 -23.65 52.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.78 0.324 . . . . 0.0 110.145 -179.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.2 mp -62.64 -48.72 86.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.017 172.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -61.89 -34.93 76.93 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.273 0.559 . . . . 0.0 110.316 177.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 35.6 m -60.65 -40.84 93.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.376 178.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.1 -32.16 68.71 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.986 177.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 37.8 m0 -62.01 -37.61 85.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.068 0.461 . . . . 0.0 110.408 176.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 -86.26 -43.96 12.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.751 -176.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.464 HD22 ' HB2' ' A' ' 142' ' ' ALA . 52.4 t30 -74.13 92.71 2.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.105 0.479 . . . . 0.0 111.185 -175.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.0 m -104.73 -13.83 15.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.891 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -92.49 15.12 14.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.227 -176.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.464 ' HB2' HD22 ' A' ' 139' ' ' ASN . . . -88.6 99.96 12.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.563 176.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -128.75 133.81 48.23 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.963 179.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -136.5 76.29 0.38 Allowed Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.659 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -128.94 19.7 6.0 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 122.706 -0.291 . . . . 0.0 110.734 -178.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -60.01 -36.79 77.97 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.893 0.378 . . . . 0.0 110.625 -178.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -121.81 112.56 18.51 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.783 177.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -76.32 135.11 39.57 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.982 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -91.5 3.74 54.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.457 0.646 . . . . 0.0 109.391 175.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 30.9 p80 . . . . . 0 C--O 1.24 0.588 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.164 177.338 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.496 ' HB2' ' HB3' ' A' ' 6' ' ' PRO . 5.1 p-10 . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.9 m 69.39 93.39 0.08 Allowed 'General case' 0 C--O 1.234 0.242 0 O-C-N 123.884 0.74 . . . . 0.0 111.389 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.436 ' HG3' ' H ' ' A' ' 4' ' ' THR . 15.1 tppt? 66.42 168.99 0.23 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.603 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.436 ' H ' ' HG3' ' A' ' 3' ' ' LYS . 3.5 m 59.31 28.42 17.76 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.26 0.552 . . . . 0.0 111.107 179.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 63.04 103.77 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.332 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.012 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.496 ' HB3' ' HB2' ' A' ' 1' ' ' ASP . 21.3 Cg_endo -60.13 150.72 77.66 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.907 2.405 . . . . 0.0 112.045 178.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.556 ' HA ' ' HB2' ' A' ' 20' ' ' ASN . . . -76.12 73.08 2.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.146 0.498 . . . . 0.0 110.973 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.408 ' CZ ' HD12 ' A' ' 23' ' ' LEU . 50.3 p90 -86.43 148.68 25.45 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 176.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.9 t -149.56 88.76 1.58 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.419 ' H ' HD21 ' A' ' 10' ' ' LEU . 2.4 pt? -123.14 147.11 50.9 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.582 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.602 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 16.5 Cg_exo -68.67 132.23 24.66 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.445 2.097 . . . . 0.0 110.928 172.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.567 ' HA ' ' HG2' ' A' ' 88' ' ' MET . 0.0 OUTLIER -70.43 171.08 10.66 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.055 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.615 HD21 HG22 ' A' ' 78' ' ' VAL . 13.5 tp -81.54 10.38 5.99 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-O 121.403 0.621 . . . . 0.0 111.291 -171.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.407 ' H ' ' CG ' ' A' ' 12' ' ' ASP . 77.3 m80 -109.58 -27.52 9.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.48 170.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 124.13 16.69 3.17 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.687 177.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.472 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 59.0 mttp -112.8 115.39 28.41 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 122.649 -0.324 . . . . 0.0 110.619 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.602 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 35.4 m -61.16 127.22 30.48 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.987 0.423 . . . . 0.0 111.574 -178.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.7 t -111.69 125.81 69.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 174.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.8 p -131.51 175.25 9.31 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.196 0.522 . . . . 0.0 111.433 -176.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.556 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . 4.7 t-20 -58.17 -31.44 67.26 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.094 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.47 -28.09 67.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.651 -178.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -74.1 -18.66 60.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.212 0.53 . . . . 0.0 110.605 -177.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.415 HD13 HD21 ' A' ' 20' ' ' ASN . 79.9 mt -79.4 -19.73 49.35 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.434 -178.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -71.01 98.58 1.65 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.699 -172.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.59 -8.23 19.93 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.711 175.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 112' ' ' LYS . 56.2 mttm -115.98 167.47 10.93 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.4 ' HB ' ' HD2' ' A' ' 59' ' ' PHE . 22.5 t -104.12 139.81 24.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 174.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.775 HG22 ' HG3' ' A' ' 60' ' ' GLN . 4.6 m -129.81 142.23 50.72 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.042 0.448 . . . . 0.0 112.095 -166.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.674 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 7.4 tt -123.69 105.75 9.96 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 171.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.683 ' HB ' ' CG1' ' A' ' 108' ' ' VAL . 61.2 mt -97.49 115.1 36.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.454 ' HA ' ' O ' ' A' ' 106' ' ' THR . 27.4 t-20 -109.5 113.43 26.22 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.366 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.512 ' HE1' HG22 ' A' ' 95' ' ' VAL . 90.4 m-85 -81.92 119.71 24.29 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 175.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 9.7 p-90 -141.78 -179.06 5.97 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.287 0.565 . . . . 0.0 110.775 -175.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -158.12 149.94 17.18 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.766 174.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -63.04 170.08 8.11 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.445 2.097 . . . . 0.0 111.972 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.8 m 63.5 5.58 2.18 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.985 178.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 51.7 t -84.65 131.11 50.69 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.771 0.319 . . . . 0.0 111.046 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -61.62 -22.43 74.41 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.805 2.337 . . . . 0.0 112.112 176.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.37 -19.1 66.18 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.312 -0.471 . . . . 0.0 112.644 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 72.0 m -62.17 -33.41 74.46 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.663 0.268 . . . . 0.0 110.764 178.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 52.8 t -62.76 -35.63 71.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.231 0.538 . . . . 0.0 110.411 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.3 m -86.39 -53.29 5.09 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.944 -177.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.408 ' O ' HG12 ' A' ' 47' ' ' ILE . 17.7 mm-40 -84.46 -31.78 24.39 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -168.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.597 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 50.0 tpp -57.59 -52.1 76.86 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 111.998 0.369 . . . . 0.0 111.998 -174.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.597 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 54.4 Cg_exo -53.39 -39.8 80.4 Favored 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 121.927 1.751 . . . . 0.0 112.404 176.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.441 ' HD3' ' CZ ' ' A' ' 126' ' ' PHE . 56.2 mttp -59.78 -51.45 69.69 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.12 178.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.408 HG12 ' O ' ' A' ' 43' ' ' GLU . 49.8 mm -61.24 -42.11 92.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.224 -177.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.571 HG12 ' O ' ' A' ' 44' ' ' MET . 49.3 mm -55.03 -53.29 35.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.588 0.232 . . . . 0.0 111.434 -178.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.578 ' HZ3' ' HB3' ' A' ' 49' ' ' LYS . 0.2 OUTLIER -74.98 -47.39 29.54 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.793 -175.085 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.5 m -63.88 -44.06 94.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.757 0.313 . . . . 0.0 111.362 -176.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.435 ' HB1' HG21 ' A' ' 61' ' ' VAL . . . -69.22 -33.12 72.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.796 -0.184 . . . . 0.0 110.734 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -56.4 -50.94 70.16 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.366 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.457 ' CG ' ' HZ3' ' A' ' 57' ' ' LYS . 10.6 t70 -68.93 -51.09 43.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.122 0.487 . . . . 0.0 111.034 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 1.036 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 8.8 m-85 -66.5 -31.07 71.56 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -172.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -63.49 -27.3 69.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.083 0.468 . . . . 0.0 110.397 178.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -96.5 19.4 12.25 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.127 0.489 . . . . 0.0 110.499 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.457 ' HZ3' ' CG ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -121.16 -65.4 1.14 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.728 178.131 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 66.6 t30 171.17 19.68 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.646 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 1.036 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 55.4 t80 -114.74 128.27 56.21 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -176.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.775 ' HG3' HG22 ' A' ' 28' ' ' THR . 4.5 pt20 -114.24 128.34 56.31 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.192 0.52 . . . . 0.0 111.151 -175.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.435 HG21 ' HB1' ' A' ' 51' ' ' ALA . 88.5 t -102.87 121.03 53.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.587 175.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.526 ' HB3' ' HE3' ' A' ' 88' ' ' MET . 79.5 mt -113.39 101.58 9.52 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.846 -177.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.69 100.46 12.84 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.396 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.487 HG23 ' HE1' ' A' ' 88' ' ' MET . 55.3 t -88.52 106.36 16.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.467 -176.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.86 133.08 34.32 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 174.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.584 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 3.4 pt20 -109.3 164.86 13.78 Favored Pre-proline 0 C--N 1.316 -0.89 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.584 ' HD2' ' HB2' ' A' ' 66' ' ' GLN . 37.8 Cg_endo -64.9 95.79 0.25 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.312 2.008 . . . . 0.0 113.485 -174.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 45.9 mm -128.13 -65.01 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 171.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -89.53 151.64 46.26 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.046 169.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -58.22 160.25 16.72 Favored 'Trans proline' 0 C--O 1.236 0.411 0 C-N-CA 122.506 2.137 . . . . 0.0 112.504 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.0 tp -56.63 -33.2 39.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.793 -176.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.654 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -65.89 -38.55 89.05 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 122.257 -0.277 . . . . 0.0 110.469 179.418 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.8 m -63.86 -44.86 91.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.776 0.322 . . . . 0.0 110.734 -178.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.47 -35.7 52.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.348 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.654 ' HG2' ' HA ' ' A' ' 72' ' ' GLU . 11.8 ptt180 -73.9 -35.42 64.67 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.569 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -64.98 -39.56 93.66 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 176.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -54.61 -55.21 31.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.405 178.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 1.059 ' HA ' HD21 ' A' ' 83' ' ' LEU . 61.9 t -60.01 -37.86 74.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.658 -178.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.565 ' HG2' ' O ' ' A' ' 75' ' ' ARG . 33.3 mmtp -69.59 -51.21 37.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.81 0.338 . . . . 0.0 110.987 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -63.95 -48.96 74.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.026 -173.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -88.23 -2.89 58.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.371 -175.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 59.87 53.47 45.63 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.919 176.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 1.059 HD21 ' HA ' ' A' ' 78' ' ' VAL . 2.9 mm? -69.92 114.1 22.51 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 120.789 0.328 . . . . 0.0 110.646 -179.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -84.24 -20.32 4.22 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.036 2.491 . . . . 0.0 113.964 -174.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.501 ' CE1' HD13 ' A' ' 83' ' ' LEU . 40.0 p90 -79.99 169.6 17.64 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.693 0.282 . . . . 0.0 110.486 -179.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 24.2 m -78.48 105.46 9.76 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.562 0.696 . . . . 0.0 111.22 -175.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.1 t -99.59 141.91 16.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.233 177.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.567 ' HG2' ' HA ' ' A' ' 12' ' ' ASP . 60.6 mtm -136.63 168.98 18.47 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -134.97 104.74 6.08 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.879 0.371 . . . . 0.0 110.743 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.524 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 20.0 t70 -91.11 101.99 14.74 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.34 -10.64 59.96 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.226 -171.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.493 ' OD2' ' HB2' ' A' ' 94' ' ' ALA . 13.5 t70 -105.14 -12.05 16.29 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.544 -0.463 . . . . 0.0 111.345 -176.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 63.2 tttp 65.32 4.97 2.88 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 121.349 0.595 . . . . 0.0 111.365 177.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.493 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . . . -70.62 -29.49 65.89 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -170.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.512 HG22 ' HE1' ' A' ' 32' ' ' PHE . 22.5 m -73.08 -33.94 43.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.353 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -70.89 -33.89 65.81 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 173.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -70.6 -32.03 69.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.213 -0.493 . . . . 0.0 110.876 176.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.69 -45.57 89.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.87 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -73.11 -27.07 61.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.986 0.422 . . . . 0.0 110.814 175.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.31 39.63 7.24 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.873 -0.68 . . . . 0.0 111.782 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.8 p -84.08 115.24 22.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.624 0.25 . . . . 0.0 110.601 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -103.23 -40.03 6.59 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.998 0.428 . . . . 0.0 110.148 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 40.1 t -98.75 145.27 10.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.967 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.423 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 87.0 m-85 -132.62 155.82 80.78 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.423 ' HA ' ' HB3' ' A' ' 104' ' ' TYR . 86.9 Cg_endo -78.63 160.28 90.94 Favored 'Cis proline' 0 C--N 1.345 0.373 0 C-N-CA 123.25 -1.562 . . . . 0.0 112.772 0.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 53.9 m -131.71 123.83 28.54 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.727 178.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.1 m -107.99 117.69 34.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.52 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.683 ' CG1' ' HB ' ' A' ' 30' ' ' ILE . 10.1 p -106.09 135.9 42.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.939 0.4 . . . . 0.0 110.144 178.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.526 HD21 ' HB2' ' A' ' 118' ' ' LYS . 2.3 mm? -102.84 124.99 49.4 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.244 -178.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.556 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 53.5 mt -109.26 133.96 52.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.964 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -80.04 159.11 43.17 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.289 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.551 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 46.8 pttt -67.68 86.15 0.21 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.75 0.786 . . . . 0.0 111.112 -177.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.696 ' HB2' ' HZ2' ' A' ' 113' ' ' LYS . 4.6 ttmp? 165.73 -30.02 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.373 -178.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.46 39.97 1.84 Allowed Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.345 -176.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -113.35 132.35 55.62 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.422 HD12 HG12 ' A' ' 110' ' ' ILE . 49.2 mm -78.46 117.91 24.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.827 0.346 . . . . 0.0 110.083 -178.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.2 mt -103.14 -68.59 0.83 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.769 -175.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.526 ' HB2' HD21 ' A' ' 109' ' ' LEU . 20.1 mmmt -124.33 157.3 35.32 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -168.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -138.32 108.74 6.51 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.026 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -108.8 109.37 20.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.202 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 36.5 t -96.92 138.19 22.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.08 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 90.12 -77.63 1.58 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.124 178.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -151.71 119.81 3.33 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 178.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.509 ' HB2' HD22 ' A' ' 129' ' ' LEU . 38.1 Cg_endo -67.81 130.23 21.43 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.561 2.174 . . . . 0.0 112.427 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.607 ' OD1' ' HG2' ' A' ' 128' ' ' LYS . 12.7 t70 -69.32 110.85 4.86 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 177.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.441 ' CZ ' ' HD3' ' A' ' 46' ' ' LYS . 34.6 m-85 -58.58 -44.15 89.7 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -173.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -56.66 -52.89 47.72 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.915 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.607 ' HG2' ' OD1' ' A' ' 125' ' ' ASP . 38.4 mmtm -63.93 -48.87 74.83 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.509 HD22 ' HB2' ' A' ' 124' ' ' PRO . 28.0 tp -63.16 -48.66 77.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.989 -171.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -64.39 -37.88 89.06 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.958 -177.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -73.34 -39.73 64.98 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.43 178.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.484 ' OE1' ' HG3' ' A' ' 118' ' ' LYS . 9.5 pt-20 -75.24 -38.13 60.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.276 -174.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 57.6 mt -64.37 -45.97 94.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 175.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.45 ' HA ' ' HB3' ' A' ' 137' ' ' TRP . 21.0 t70 -61.32 -32.18 72.04 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.002 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 90.4 m -58.37 -47.43 83.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.975 0.417 . . . . 0.0 110.653 177.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.99 -28.25 57.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.077 0.465 . . . . 0.0 111.062 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.45 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . 40.0 t-105 -73.41 -55.19 6.7 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.331 -177.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 34.4 ttp-105 -65.95 -35.47 80.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.8 -172.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -77.23 109.94 11.52 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.08 0.466 . . . . 0.0 110.371 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 11.9 p -130.1 -29.65 2.05 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.31 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -82.07 93.33 6.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.06 0.457 . . . . 0.0 110.114 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -112.82 -176.13 2.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.959 -178.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -114.35 -174.82 2.55 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.303 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -97.6 -99.15 2.01 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.535 173.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 64.3 -83.45 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.117 0.567 . . . . 0.0 110.666 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -168.82 44.03 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 25.9 t60 75.95 -45.86 0.54 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.527 -178.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -89.55 135.75 33.42 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.302 176.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -77.46 129.53 35.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.904 0.383 . . . . 0.0 110.823 177.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 21.3 t60 . . . . . 0 C--O 1.243 0.731 0 CA-C-O 118.356 -0.83 . . . . 0.0 109.125 173.273 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.576 ' OD2' ' HA ' ' A' ' 7' ' ' ALA . 36.5 t70 . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.6 m -157.29 119.2 3.77 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.567 ' HD2' ' H ' ' A' ' 4' ' ' THR . 28.0 tptp 65.95 163.74 0.17 Allowed 'General case' 0 N--CA 1.466 0.375 0 O-C-N 123.525 0.516 . . . . 0.0 109.827 -178.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.608 ' O ' ' HA ' ' A' ' 115' ' ' GLU . 4.2 m 74.94 -0.33 3.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 122.121 0.962 . . . . 0.0 109.4 -174.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.666 ' HB2' ' HB3' ' A' ' 20' ' ' ASN . . . 175.42 168.49 0.36 Allowed Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 113.973 -1.467 . . . . 0.0 108.701 -178.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.555 ' HD2' ' HB1' ' A' ' 5' ' ' ALA . 39.3 Cg_endo -69.74 24.93 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.629 2.22 . . . . 0.0 113.239 174.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.576 ' HA ' ' OD2' ' A' ' 1' ' ' ASP . . . 62.2 58.92 1.7 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.905 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.514 ' CE1' ' HB1' ' A' ' 5' ' ' ALA . 37.7 p90 -119.07 144.41 46.59 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.353 0.597 . . . . 0.0 111.558 -174.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.2 p -149.43 88.58 1.58 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.85 170.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.415 ' H ' HD23 ' A' ' 10' ' ' LEU . 2.6 pt? -121.98 155.71 60.5 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.896 -174.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.92 145.7 19.99 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.742 2.295 . . . . 0.0 111.584 173.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 51.7 p-10 -89.53 -172.65 3.67 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.141 177.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.6 mt -79.06 20.7 0.47 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.765 0.316 . . . . 0.0 111.441 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -118.33 -24.34 6.93 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 174.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.45 14.93 14.81 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.719 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -113.37 141.61 46.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.972 0.386 . . . . 0.0 110.315 178.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.2 m -75.27 122.53 23.84 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.404 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.5 t -108.01 142.84 19.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.733 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.5 p -145.35 -173.8 4.21 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.202 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.666 ' HB3' ' HB2' ' A' ' 5' ' ' ALA . 20.8 p30 -66.47 -22.73 66.2 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -176.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.63 -31.73 71.83 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.833 0.349 . . . . 0.0 111.81 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.62 -37.03 84.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.45 0.643 . . . . 0.0 109.704 177.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.475 HD22 HG22 ' A' ' 28' ' ' THR . 21.7 mt -72.21 -21.33 61.42 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.475 -174.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -64.8 102.1 0.55 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.248 0.547 . . . . 0.0 111.686 -174.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.05 -26.04 10.22 Favored Glycine 0 CA--C 1.511 -0.208 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.991 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.688 ' O ' ' HA ' ' A' ' 112' ' ' LYS . 31.5 mttp -97.18 163.09 13.06 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 177.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.463 HG22 ' HB3' ' A' ' 112' ' ' LYS . 4.9 t -103.08 127.3 57.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 175.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.563 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 27.7 m -131.33 142.23 50.06 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.397 0.618 . . . . 0.0 112.361 -168.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.462 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 24.8 tp -115.69 115.27 26.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.396 172.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.814 ' HB ' ' CG2' ' A' ' 108' ' ' VAL . 51.2 mt -94.27 112.86 27.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 176.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -117.0 118.3 32.01 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.855 0.36 . . . . 0.0 110.932 -176.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 87.7 m-85 -84.25 125.09 31.9 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.406 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.496 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 22.7 p-90 -147.07 175.54 10.62 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.217 0.532 . . . . 0.0 111.097 -177.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.425 ' HD2' ' OD2' ' A' ' 69' ' ' ASP . 27.2 p90 -161.67 149.58 12.23 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.714 173.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.568 ' HD2' ' HB2' ' A' ' 69' ' ' ASP . 84.7 Cg_exo -49.61 -46.69 25.85 Favored 'Trans proline' 0 N--CA 1.474 0.375 0 C-N-CA 123.422 2.748 . . . . 0.0 114.284 -174.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.1 m -79.35 17.81 0.78 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -174.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.604 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 48.0 t -85.2 126.5 67.23 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 120.704 0.288 . . . . 0.0 110.734 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 17.0 Cg_exo -67.79 -19.32 47.16 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.963 2.442 . . . . 0.0 112.305 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.24 -11.52 84.93 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.803 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 89.2 m -60.96 -43.57 98.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.704 0.252 . . . . 0.0 111.381 -178.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.9 m -59.71 -27.86 38.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.02 0.438 . . . . 0.0 111.403 -177.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.9 m -87.45 -55.14 3.92 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.265 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.425 ' O ' HG12 ' A' ' 47' ' ' ILE . 26.5 mm-40 -84.55 -33.18 23.5 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -168.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.639 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 47.9 tpp -57.52 -53.76 62.11 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -172.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.639 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 43.2 Cg_exo -57.15 -36.59 99.18 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 122.096 1.864 . . . . 0.0 111.98 178.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.476 ' HB3' ' HE2' ' A' ' 46' ' ' LYS . 4.6 tmmm? -66.74 -39.8 88.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.108 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.425 HG12 ' O ' ' A' ' 43' ' ' GLU . 34.1 mm -63.52 -39.4 85.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.581 177.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.559 HD11 ' HE1' ' A' ' 85' ' ' PHE . 44.9 mm -54.62 -53.38 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.287 178.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -63.24 -51.5 65.93 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.803 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 30.9 m -56.02 -47.17 78.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.945 0.402 . . . . 0.0 111.491 -176.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . -65.62 -41.09 93.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.433 -177.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -73.76 -37.76 64.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.954 -176.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.07 -49.54 76.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.689 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -92.08 -1.49 57.17 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.524 -174.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 24.2 tptm -59.26 -35.32 73.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.102 0.477 . . . . 0.0 110.49 178.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -74.85 -24.25 58.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.403 -176.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -71.35 -70.35 0.32 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 175.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 171.63 22.24 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.456 -176.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.462 ' HZ ' ' HB2' ' A' ' 29' ' ' LEU . 29.5 t80 -100.48 139.72 35.75 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.969 -174.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.506 ' O ' ' HA ' ' A' ' 28' ' ' THR . 12.1 pt20 -134.64 137.15 43.4 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.147 176.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.455 HG23 ' HE1' ' A' ' 59' ' ' PHE . 98.3 t -104.98 119.16 53.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.476 ' HB3' ' HE2' ' A' ' 88' ' ' MET . 70.0 mt -104.04 98.59 8.39 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.7 177.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.496 ' HB3' ' CD1' ' A' ' 33' ' ' TRP . . . -84.52 109.29 17.82 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.271 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.484 HG12 HG13 ' A' ' 95' ' ' VAL . 86.4 t -93.93 108.37 20.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.257 0.551 . . . . 0.0 110.495 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -80.14 127.83 32.79 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 174.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.73 ' HG2' HG12 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -99.85 162.34 21.41 Favored Pre-proline 0 C--N 1.318 -0.785 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -179.135 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.579 ' HD2' ' HB2' ' A' ' 66' ' ' GLN . 58.6 Cg_endo -70.9 42.4 0.42 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.994 2.463 . . . . 0.0 115.157 -170.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.73 HG12 ' HG2' ' A' ' 66' ' ' GLN . 43.6 mm -84.09 -30.96 7.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 172.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.568 ' HB2' ' HD2' ' A' ' 35' ' ' PRO . 23.6 m-20 -125.12 150.93 68.39 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.784 169.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -58.12 154.76 37.8 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.352 2.035 . . . . 0.0 111.954 176.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.555 ' O ' HG23 ' A' ' 74' ' ' VAL . 11.9 tt -63.0 -27.62 43.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.633 0.254 . . . . 0.0 111.177 -178.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.43 ' HA ' ' NE ' ' A' ' 75' ' ' ARG . 10.1 pt-20 -67.38 -33.97 76.32 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.189 177.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.6 m -68.92 -45.0 71.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.27 175.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 71' ' ' ILE . 5.2 m -70.39 -35.79 63.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.973 -175.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.43 ' NE ' ' HA ' ' A' ' 72' ' ' GLU . 30.5 ptt180 -75.27 -27.53 59.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.561 -179.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 -68.52 -37.83 80.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.369 176.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -63.48 -47.84 80.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.075 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.676 HG13 ' HB2' ' A' ' 83' ' ' LEU . 43.6 t -61.24 -42.18 92.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.682 177.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.4 tttt -62.84 -55.95 21.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.005 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -63.03 -48.81 77.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.306 -170.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -83.59 -17.6 41.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.711 0.291 . . . . 0.0 111.294 -176.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.0 60.8 4.02 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.961 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.676 ' HB2' HG13 ' A' ' 78' ' ' VAL . 9.9 mp -67.6 118.73 60.05 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.723 -0.238 . . . . 0.0 110.533 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -75.84 -28.89 7.46 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.787 2.324 . . . . 0.0 112.862 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.559 ' HE1' HD11 ' A' ' 48' ' ' ILE . 33.6 p90 -80.34 150.98 29.69 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.464 ' HB ' HD23 ' A' ' 62' ' ' LEU . 22.2 m -75.21 131.32 40.32 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.117 0.484 . . . . 0.0 111.335 -173.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.446 HG21 ' HB2' ' A' ' 63' ' ' ALA . 68.5 t -114.09 139.46 39.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.418 -179.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.476 ' HE2' ' HB3' ' A' ' 62' ' ' LEU . 70.1 mtm -127.26 167.56 15.93 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 176.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -137.72 112.0 8.58 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.563 0.22 . . . . 0.0 110.441 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.545 ' OD2' HG11 ' A' ' 95' ' ' VAL . 55.8 t0 -91.53 119.07 31.14 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.56 -20.84 60.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.928 -176.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -111.64 -11.7 13.99 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -175.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt 65.52 16.57 10.58 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.965 0.412 . . . . 0.0 109.964 175.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.09 -29.27 70.2 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.608 0.718 . . . . 0.0 109.59 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.545 HG11 ' OD2' ' A' ' 90' ' ' ASP . 7.7 p -60.65 -46.53 95.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.136 174.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -76.13 -33.2 50.38 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.888 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -58.6 -36.34 73.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.014 0.435 . . . . 0.0 111.242 177.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.03 -46.33 52.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.305 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.469 ' CE2' ' HG3' ' A' ' 6' ' ' PRO . 27.0 m-85 -72.76 -27.58 62.1 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 95.13 36.58 5.42 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -175.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.491 HG23 ' OG1' ' A' ' 106' ' ' THR . 20.0 m -76.51 88.15 3.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.134 0.492 . . . . 0.0 111.2 -177.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -103.12 -46.03 4.75 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.317 177.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 38.4 t -101.82 131.43 49.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.0 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -104.98 149.21 37.32 Favored Pre-proline 0 C--N 1.317 -0.826 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -178.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -79.73 165.99 78.43 Favored 'Cis proline' 0 C--N 1.344 0.319 0 C-N-CA 124.123 -1.199 . . . . 0.0 112.907 0.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.491 ' OG1' HG23 ' A' ' 101' ' ' THR . 58.1 m -131.43 114.95 15.57 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.205 176.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.6 m -108.74 115.39 30.0 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.026 0.441 . . . . 0.0 110.368 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.814 ' CG2' ' HB ' ' A' ' 30' ' ' ILE . 26.9 m -106.16 148.85 10.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.312 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.679 ' HB2' ' HB3' ' A' ' 118' ' ' LYS . 11.0 mp -101.09 124.32 46.62 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.943 -174.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.563 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 25.8 mm -112.3 118.59 58.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.027 174.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -71.04 -168.33 8.15 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.72 178.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.688 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 10.7 ptmm? -95.79 21.06 8.95 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 122.687 1.232 . . . . 0.0 107.935 -175.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.422 ' HD2' ' HA ' ' A' ' 113' ' ' LYS . 1.8 mmmp? -106.39 -1.2 23.52 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 113.439 -1.71 . . . . 0.0 108.866 174.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.402 ' O ' HG22 ' A' ' 4' ' ' THR . . . 61.97 46.48 93.99 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 114.952 -1.022 . . . . 0.0 113.326 177.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.608 ' HA ' ' O ' ' A' ' 4' ' ' THR . 16.4 pt-20 -148.53 167.01 26.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.023 0.439 . . . . 0.0 111.632 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.2 mt -61.87 127.46 21.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.703 -178.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 36.9 mt -121.28 -61.06 1.58 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.477 174.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.679 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 1.7 tppt? -133.63 154.96 50.49 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -174.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.644 ' N ' ' HG3' ' A' ' 118' ' ' LYS . 42.8 m -131.86 102.23 5.77 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.11 172.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.641 ' CE2' ' HE3' ' A' ' 118' ' ' LYS . 45.9 m-85 -88.63 136.63 32.9 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.887 0.375 . . . . 0.0 110.914 169.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 6.0 p -123.17 123.1 67.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.258 0.551 . . . . 0.0 110.739 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 95.55 -62.91 1.38 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.285 175.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -167.09 116.57 0.71 Allowed Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 120.501 0.191 . . . . 0.0 111.349 -173.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -93.86 163.17 2.21 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 123.159 2.573 . . . . 0.0 113.087 177.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -99.05 108.79 21.54 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.411 0.624 . . . . 0.0 109.605 174.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.611 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 34.8 m-85 -70.19 -30.21 67.26 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -164.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -59.9 -54.12 40.2 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 119.663 -1.256 . . . . 0.0 111.807 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.421 ' HE2' ' HB3' ' A' ' 128' ' ' LYS . 22.0 ttpt -66.14 -35.29 80.1 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.959 -0.62 . . . . 0.0 110.008 176.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.611 ' HB3' ' HA ' ' A' ' 126' ' ' PHE . 2.9 tm? -61.45 -47.3 86.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.961 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -60.24 -38.59 83.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.813 0.34 . . . . 0.0 110.299 178.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -71.83 -33.07 68.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.762 178.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.588 ' HG2' ' HA ' ' A' ' 129' ' ' LEU . 18.7 pt-20 -80.96 -23.6 38.69 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.419 -177.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 56.1 mt -67.0 -42.12 88.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 168.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -63.13 -27.02 69.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.302 174.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.524 ' HB ' ' O ' ' A' ' 132' ' ' GLU . 52.3 m -60.81 -31.45 70.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.819 176.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.0 -31.38 72.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.042 0.449 . . . . 0.0 110.296 177.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.401 ' HE1' HG21 ' A' ' 27' ' ' VAL . 10.8 m0 -77.86 -40.53 39.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.472 0.653 . . . . 0.0 109.683 177.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -71.11 -16.93 62.59 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.601 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' A' ' 135' ' ' THR . 62.6 t30 -79.15 -15.29 58.33 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.33 -174.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.3 p -101.2 -35.78 9.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.42 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 66.25 -80.43 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 O-C-N 123.635 0.584 . . . . 0.0 111.136 -176.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -178.31 -33.88 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.774 -175.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -119.16 88.48 2.94 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.93 175.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -69.11 -4.09 40.76 Favored Glycine 0 N--CA 1.454 -0.129 0 CA-C-N 115.621 -0.718 . . . . 0.0 113.389 -172.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 14.9 t60 -65.06 -20.57 66.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.756 0.312 . . . . 0.0 110.692 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -77.9 -25.73 48.66 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.014 0.435 . . . . 0.0 110.464 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -97.17 -34.72 11.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.745 -177.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 32.5 m80 70.01 -68.42 0.2 Allowed 'General case' 0 N--CA 1.47 0.573 0 O-C-N 123.793 0.683 . . . . 0.0 109.789 -176.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 14.3 t60 179.33 -36.99 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 . . . . . 0 C--O 1.249 1.057 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.186 175.632 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 . . . . . 0 N--CA 1.484 1.249 0 CA-C-O 120.86 0.362 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.663 ' H ' ' HA ' ' A' ' 6' ' ' PRO . 50.6 m 63.07 -74.45 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.786 -170.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -74.34 142.18 45.14 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 172.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.536 HG23 ' HG3' ' A' ' 115' ' ' GLU . 33.2 p 47.9 77.39 0.09 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.17 0.51 . . . . 0.0 111.426 -175.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.653 ' H ' HG13 ' A' ' 116' ' ' ILE . . . 65.8 118.74 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.774 -176.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.663 ' HA ' ' H ' ' A' ' 2' ' ' SER . 3.1 Cg_exo -76.58 15.47 1.05 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.825 2.35 . . . . 0.0 113.704 -177.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.493 ' HA ' ' OD1' ' A' ' 20' ' ' ASN . . . 51.12 41.38 27.53 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.238 0.542 . . . . 0.0 110.74 -177.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.534 ' HD1' ' HD2' ' A' ' 6' ' ' PRO . 51.2 p90 -80.48 150.44 29.69 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.773 -171.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.5 m -136.1 96.3 3.37 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 173.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.486 HD13 ' HD2' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -119.6 126.14 27.11 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.249 -171.161 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.486 ' HD2' HD13 ' A' ' 10' ' ' LEU . 47.2 Cg_endo -71.19 131.56 19.47 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.102 1.868 . . . . 0.0 111.558 173.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.28 177.84 7.59 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.589 HD13 HG23 ' A' ' 78' ' ' VAL . 51.8 mt -64.41 -31.27 72.42 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -176.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.81 -17.03 42.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.661 0.267 . . . . 0.0 111.261 -175.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.12 32.1 3.13 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.419 -0.896 . . . . 0.0 114.017 170.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -114.4 135.35 54.18 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.128 0.464 . . . . 0.0 110.086 172.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.1 m -77.65 124.48 27.99 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 175.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.692 HG23 ' HE1' ' A' ' 88' ' ' MET . 31.0 m -124.56 153.55 31.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.873 0.368 . . . . 0.0 110.277 177.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 51.1 p -140.35 -179.6 6.1 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.486 -177.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.493 ' OD1' ' HA ' ' A' ' 7' ' ' ALA . 4.4 p-10 -73.88 -20.89 60.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.571 178.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.423 ' HA ' HE21 ' A' ' 24' ' ' GLN . . . -62.61 -27.56 69.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.012 174.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -68.33 -29.44 68.18 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.269 0.557 . . . . 0.0 110.329 176.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.928 HD11 HG21 ' A' ' 110' ' ' ILE . 25.3 mt -74.07 -19.31 60.65 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.16 -175.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.423 HE21 ' HA ' ' A' ' 21' ' ' ALA . 76.3 mt-30 -55.58 128.6 35.36 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.361 -178.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.9 -24.66 10.19 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.515 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -95.98 -171.25 2.29 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.372 0.605 . . . . 0.0 111.019 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -133.05 138.01 52.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 169.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.594 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 89.2 m -141.57 150.01 41.5 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.697 -169.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.652 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 6.5 tt -127.23 123.03 35.59 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 173.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.646 ' HB ' ' CG2' ' A' ' 108' ' ' VAL . 44.5 mt -104.1 115.16 45.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.843 0.354 . . . . 0.0 110.585 -178.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -107.8 117.44 34.13 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.582 -178.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.52 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 96.1 m-85 -90.3 119.08 30.3 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 177.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.502 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 5.3 p-90 -146.23 -176.8 5.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.106 -175.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -153.45 159.12 32.52 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.256 -0.884 . . . . 0.0 108.767 177.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -51.8 128.02 25.04 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.279 1.986 . . . . 0.0 112.16 177.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.7 t 71.62 26.06 3.2 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.427 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.517 ' O ' ' HB3' ' A' ' 40' ' ' CYS . 42.9 t -63.41 134.02 95.7 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.011 176.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -57.25 -49.14 14.82 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.977 2.452 . . . . 0.0 112.657 178.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.533 ' HA3' ' HG3' ' A' ' 105' ' ' PRO . . . -66.64 -24.85 72.75 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.292 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.517 ' HB3' ' O ' ' A' ' 37' ' ' CYS . 29.6 t -58.26 -33.57 69.53 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 122.624 0.37 . . . . 0.0 111.106 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.2 t -62.17 -36.69 75.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.947 0.403 . . . . 0.0 110.543 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.9 m -87.9 -54.68 4.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.001 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.48 ' O ' HG13 ' A' ' 47' ' ' ILE . 54.8 mt-10 -63.81 -50.18 69.96 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -172.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.578 ' O ' HG12 ' A' ' 48' ' ' ILE . 40.5 ttm -51.29 -50.26 77.03 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -170.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.411 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 86.9 Cg_exo -48.57 -48.55 17.07 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 122.205 1.937 . . . . 0.0 112.857 176.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -63.1 -46.23 88.32 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.144 177.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 43' ' ' GLU . 51.1 mt -60.39 -35.33 62.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.961 -178.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.578 HG12 ' O ' ' A' ' 44' ' ' MET . 46.7 mm -58.69 -52.9 54.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.925 0.393 . . . . 0.0 110.376 176.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -70.68 -39.38 73.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.121 -177.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.563 ' O ' ' HD1' ' A' ' 54' ' ' TYR . 87.7 m -68.37 -54.75 15.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.938 -178.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.619 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . -65.73 -34.74 78.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.236 -174.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -63.82 -48.39 77.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.905 0.383 . . . . 0.0 110.722 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -69.37 -51.64 34.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.01 0.433 . . . . 0.0 111.166 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 1.039 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 77.2 m-85 -70.79 -12.08 61.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.559 -175.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.619 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 16.0 tptm -60.99 -35.78 77.74 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 175.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -84.79 -6.2 59.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.342 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 58' ' ' ASN . 43.5 mmtm -89.57 -69.65 0.7 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 176.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 63.3 t30 164.03 12.13 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 114.904 -1.043 . . . . 0.0 109.241 -175.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 1.039 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 60.6 t80 -105.74 129.43 53.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.542 -178.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.401 ' O ' ' HA ' ' A' ' 28' ' ' THR . 12.7 pt20 -126.68 140.86 52.09 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.952 0.405 . . . . 0.0 110.501 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 91.9 t -104.59 126.9 59.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.866 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.513 ' HB3' ' HE2' ' A' ' 88' ' ' MET . 75.7 mt -114.21 99.57 7.71 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.605 -179.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.01 106.29 18.38 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.695 -178.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 41.9 t -94.66 115.25 33.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.047 0.451 . . . . 0.0 110.516 -178.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.502 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -82.45 138.24 34.44 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.859 176.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.663 ' HB2' ' HG2' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -101.83 163.45 17.77 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.808 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.692 ' HD3' ' O ' ' A' ' 90' ' ' ASP . 37.4 Cg_endo -66.19 82.08 0.28 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.538 2.158 . . . . 0.0 113.688 -173.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 50.7 mm -112.22 -44.29 5.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 170.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -129.67 153.59 80.8 Favored Pre-proline 0 C--O 1.237 0.403 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 173.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -54.64 161.89 5.43 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.932 2.422 . . . . 0.0 114.714 -175.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.7 tp -51.16 -35.46 15.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.488 177.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -62.1 -46.18 90.19 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.049 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.6 m -58.32 -41.95 85.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.131 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.547 HG12 HD12 ' A' ' 13' ' ' LEU . 26.4 t -65.05 -46.57 90.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.357 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.497 ' HG2' ' HB3' ' A' ' 13' ' ' LEU . 67.1 mtt180 -60.16 -34.95 74.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.012 177.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.448 ' CD ' ' HZ2' ' A' ' 79' ' ' LYS . 50.3 tp60 -61.27 -53.48 56.26 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.591 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -55.86 -48.86 74.78 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.242 -176.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.589 HG23 HD13 ' A' ' 13' ' ' LEU . 61.9 t -56.36 -44.29 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 112.26 0.466 . . . . 0.0 112.26 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.747 ' HB2' ' HZ3' ' A' ' 79' ' ' LYS . 9.6 mtmp? -67.56 -48.56 66.58 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.59 0.709 . . . . 0.0 110.487 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.32 -39.93 93.06 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.497 -1.229 . . . . 0.0 112.456 -170.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -95.82 -9.99 30.15 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.475 -178.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 63.15 67.32 2.12 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.209 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.51 HD12 ' HA ' ' A' ' 78' ' ' VAL . 1.1 mt -94.25 127.57 44.05 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-O 120.94 0.4 . . . . 0.0 111.891 -174.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -83.48 -12.96 8.77 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.456 2.77 . . . . 0.0 114.553 -172.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.455 ' CZ ' HD23 ' A' ' 83' ' ' LEU . 26.8 p90 -93.16 153.61 18.54 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.421 178.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.405 ' HB ' HD21 ' A' ' 62' ' ' LEU . 14.5 m -78.59 126.76 31.19 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.596 -175.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.481 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 47.0 t -110.52 135.74 48.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.011 0.434 . . . . 0.0 110.63 -178.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.692 ' HE1' HG23 ' A' ' 18' ' ' VAL . 52.3 mtt -116.0 172.1 7.37 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.59 178.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -140.53 109.6 6.12 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.622 0.249 . . . . 0.0 110.548 176.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.692 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 38.4 t0 -91.57 118.39 30.56 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 176.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.72 -14.97 60.79 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -175.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.53 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 24.2 t70 -125.62 -9.66 6.79 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 122.149 -0.344 . . . . 0.0 111.514 -173.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.663 ' HG2' ' HB2' ' A' ' 66' ' ' GLN . 51.8 mtpt 78.18 5.23 2.72 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.881 0.872 . . . . 0.0 111.679 -177.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.05 -40.63 81.43 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -169.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.545 HG21 ' OD2' ' A' ' 90' ' ' ASP . 22.1 m -70.21 -35.23 62.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 119.977 -0.689 . . . . 0.0 109.834 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -71.68 -33.23 63.59 Favored Glycine 0 N--CA 1.451 -0.321 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 176.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.59 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 8.5 mm-40 -61.69 -32.54 72.75 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.087 0.47 . . . . 0.0 110.552 176.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.24 -40.17 64.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.177 176.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -74.03 -22.66 59.48 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.715 0.293 . . . . 0.0 111.25 179.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.91 50.5 1.77 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.664 177.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 22.6 p -72.75 88.42 1.31 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.041 0.448 . . . . 0.0 111.002 176.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -84.23 -51.76 6.77 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.38 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 46.8 t -128.91 142.41 44.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.87 -179.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -86.41 137.76 34.36 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.533 ' HG3' ' HA3' ' A' ' 39' ' ' GLY . 94.4 Cg_endo -90.74 166.47 30.39 Favored 'Cis proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.88 -1.3 . . . . 0.0 112.808 -0.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 33.0 m -128.16 112.65 14.77 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.484 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.472 ' HB3' HD22 ' A' ' 29' ' ' LEU . 73.1 m -110.5 112.62 24.66 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.979 0.419 . . . . 0.0 110.83 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.646 ' CG2' ' HB ' ' A' ' 30' ' ' ILE . 15.9 m -106.83 148.7 10.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.537 -176.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.752 ' HB2' ' HB3' ' A' ' 118' ' ' LYS . 10.8 mp -101.91 132.87 47.46 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.033 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.928 HG21 HD11 ' A' ' 23' ' ' LEU . 31.3 mm -114.38 133.45 60.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.93 -174.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -85.86 -174.29 49.73 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.929 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 24' ' ' GLN . 62.1 mttm -74.97 21.49 0.12 Allowed 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -172.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.516 ' HD3' ' HB3' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -150.59 11.31 0.68 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.059 0.457 . . . . 0.0 110.604 -179.55 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.07 -14.19 57.86 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.52 -0.847 . . . . 0.0 111.669 -176.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.536 ' HG3' HG23 ' A' ' 4' ' ' THR . 38.7 tt0 -54.93 135.13 48.72 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.234 0.614 . . . . 0.0 111.096 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.653 HG13 ' H ' ' A' ' 5' ' ' ALA . 4.0 mt -80.3 111.77 17.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.014 -174.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 79.9 mt -91.42 -40.16 11.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.598 -175.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.752 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 19.8 tptm -152.5 153.71 34.02 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.618 -170.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.8 m -136.61 108.79 7.24 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.937 177.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -99.33 118.16 35.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.341 174.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 61.3 t -108.49 123.12 63.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.732 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 90.74 -72.75 1.87 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.959 176.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -132.42 105.45 13.28 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-O 120.726 0.298 . . . . 0.0 110.624 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -82.66 126.57 4.67 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.549 2.166 . . . . 0.0 112.563 176.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -65.46 102.47 0.7 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 176.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -67.15 -45.73 76.17 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -172.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -57.97 -48.17 84.28 Favored Glycine 0 C--O 1.239 0.408 0 C-N-CA 120.434 -0.889 . . . . 0.0 111.874 178.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -67.39 -31.28 71.4 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-N 115.491 -0.354 . . . . 0.0 110.404 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.673 ' O ' HG12 ' A' ' 133' ' ' ILE . 2.6 tm? -59.32 -45.26 91.81 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 176.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -61.68 -49.89 74.67 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -178.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -69.83 -27.51 64.93 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.959 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -73.5 -37.43 65.7 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.052 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.673 HG12 ' O ' ' A' ' 129' ' ' LEU . 50.8 mm -64.38 -41.92 93.79 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 172.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.402 ' O ' ' HG2' ' A' ' 138' ' ' ARG . 12.8 t70 -57.15 -38.42 73.52 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.159 178.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 32.6 m -66.33 -38.12 86.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.62 178.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.53 -22.88 65.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.02 178.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 9.8 m0 -75.6 -26.57 57.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.792 176.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 138' ' ' ARG . 11.6 mmt180 -72.59 -40.89 66.22 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.228 -179.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -68.44 106.96 2.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.624 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.4 t -147.91 111.12 4.88 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.747 -178.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -75.69 101.51 5.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.816 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -146.53 175.71 10.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.932 0.396 . . . . 0.0 111.568 -175.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.472 ' OE1' ' HB2' ' A' ' 145' ' ' HIS . 0.5 OUTLIER -90.33 158.95 16.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.753 -178.868 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -108.15 28.55 11.72 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.675 -175.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.472 ' HB2' ' OE1' ' A' ' 143' ' ' GLU . 4.6 t-80 -74.93 96.33 3.13 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -61.02 -48.34 82.27 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.048 -175.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -82.49 76.03 9.37 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -84.52 -17.55 38.59 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.393 178.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 177.66 -34.96 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -178.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 . . . . . 0 C--O 1.244 0.787 0 CA-C-N 113.881 -1.509 . . . . 0.0 108.532 173.046 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.645 ' H ' ' HB2' ' A' ' 98' ' ' ALA . 24.9 t70 . . . . . 0 N--CA 1.479 0.98 0 CA-C-O 120.552 0.215 . . . . 0.0 111.009 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.9 m -144.15 168.67 19.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.842 0.353 . . . . 0.0 110.791 -176.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.473 ' HB3' HD12 ' A' ' 116' ' ' ILE . 50.4 mttp -90.58 -162.39 0.9 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.084 175.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.425 ' HA ' ' H ' ' A' ' 116' ' ' ILE . 3.6 m 64.49 25.61 13.3 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.335 0.588 . . . . 0.0 110.045 -177.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 64.01 96.07 0.05 OUTLIER Pre-proline 0 CA--C 1.53 0.196 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.908 -178.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.53 35.35 0.5 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 123.19 2.593 . . . . 0.0 113.824 -174.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 57.16 84.9 0.09 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.364 0.666 . . . . 0.0 111.03 -177.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -111.86 130.27 55.88 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.098 0.475 . . . . 0.0 111.157 -175.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.508 ' HA ' ' HG ' ' A' ' 19' ' ' SER . 63.7 p -110.46 90.23 3.26 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 172.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.521 HD13 ' HD2' ' A' ' 11' ' ' PRO . 22.6 tp -111.51 126.92 27.68 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.751 -172.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.521 ' HD2' HD13 ' A' ' 10' ' ' LEU . 58.3 Cg_endo -73.3 147.55 42.15 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.308 2.006 . . . . 0.0 112.136 176.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.412 ' CG ' ' H ' ' A' ' 14' ' ' HIS . 0.2 OUTLIER -80.46 -175.65 5.28 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 176.948 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 53.8 mt -70.37 -18.68 63.06 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -176.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.412 ' H ' ' CG ' ' A' ' 12' ' ' ASP . 76.6 m80 -89.65 -48.25 7.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.775 0.321 . . . . 0.0 110.427 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.56 24.91 0.19 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.374 -0.917 . . . . 0.0 113.668 176.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 11' ' ' PRO . 67.6 mttm -101.17 139.56 36.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.314 0.557 . . . . 0.0 110.152 175.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.4 m -84.77 123.38 30.35 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.899 0.381 . . . . 0.0 111.089 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.2 t -107.93 134.82 48.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.509 176.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.508 ' HG ' ' HA ' ' A' ' 9' ' ' SER . 36.6 m -145.25 177.48 8.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.746 0.308 . . . . 0.0 111.462 -177.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -51.64 -32.28 28.62 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.641 0.776 . . . . 0.0 112.849 -175.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.47 -27.48 64.45 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -174.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -82.94 -23.32 33.5 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.456 -176.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.584 HD21 HG23 ' A' ' 110' ' ' ILE . 7.7 mp -80.88 -26.94 36.52 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -173.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -64.53 130.86 45.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.189 0.518 . . . . 0.0 111.517 -176.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.34 -12.14 70.28 Favored Glycine 0 C--N 1.329 0.154 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.338 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 112' ' ' LYS . 79.4 mttt -115.71 -173.28 2.31 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 15.9 t -126.51 139.0 52.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 171.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.546 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 26.7 m -137.14 145.74 44.17 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.687 -168.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.604 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 31.8 tp -115.89 105.84 13.13 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 172.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.8 mt -89.46 111.67 23.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 175.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.498 ' HA ' ' O ' ' A' ' 106' ' ' THR . 7.9 t30 -117.01 111.17 19.19 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.827 0.346 . . . . 0.0 110.864 -175.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.467 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 63.5 m-85 -81.38 131.55 35.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.652 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.6 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 4.2 p-90 -158.19 -170.47 3.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.416 -175.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.443 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 24.5 p90 -158.86 138.69 8.66 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 171.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.721 ' HG2' ' HA ' ' A' ' 74' ' ' VAL . 50.6 Cg_exo -56.48 -28.31 72.87 Favored 'Trans proline' 0 N--CA 1.473 0.299 0 C-N-CA 123.358 2.705 . . . . 0.0 114.051 -173.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.7 t -89.84 26.57 1.76 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.023 0.439 . . . . 0.0 110.984 -178.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 53.5 t -100.32 132.11 23.02 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.255 -179.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -61.73 -28.39 82.04 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.799 2.333 . . . . 0.0 112.009 175.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.74 -22.3 69.92 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.388 179.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.431 ' SG ' ' HE1' ' A' ' 44' ' ' MET . 46.9 t -63.3 -40.17 96.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.761 0.315 . . . . 0.0 110.315 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.4 t -58.77 -35.9 58.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.105 -178.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.0 m -87.45 -49.44 7.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.852 -178.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.435 ' OE1' ' HG3' ' A' ' 46' ' ' LYS . 12.4 mm-40 -84.68 -28.21 26.54 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -170.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.563 ' O ' HG12 ' A' ' 48' ' ' ILE . 27.7 ttm -55.18 -47.26 98.95 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 120.249 -0.581 . . . . 0.0 111.91 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -51.05 -41.59 56.24 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.093 1.862 . . . . 0.0 112.314 172.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.435 ' HG3' ' OE1' ' A' ' 43' ' ' GLU . 26.0 mmtp -59.7 -48.16 82.77 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.2 mm -61.71 -44.19 98.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.209 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.563 HG12 ' O ' ' A' ' 44' ' ' MET . 45.1 mm -54.87 -53.97 28.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.685 -175.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -70.88 -38.34 73.07 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.432 -175.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.9 m -67.58 -48.79 65.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.967 0.413 . . . . 0.0 110.88 -178.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.548 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . -65.95 -45.28 82.38 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.988 -178.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -55.13 -44.21 74.85 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.831 0.348 . . . . 0.0 110.996 -177.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -67.23 -51.4 53.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.662 -179.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 1.006 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 54.2 m-85 -79.6 -20.55 46.62 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -173.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 9.0 tmtt? -60.71 -39.02 87.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.073 0.463 . . . . 0.0 109.944 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -86.18 6.21 30.43 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.736 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 58' ' ' ASN . 14.4 tppt? -98.68 -67.5 0.84 Allowed 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 175.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 65.6 t30 171.79 19.45 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.878 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 1.006 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 45.1 t80 -117.68 120.28 37.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.637 -177.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.413 ' HG3' HG22 ' A' ' 28' ' ' THR . 29.8 pt20 -114.78 148.56 38.25 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.083 0.468 . . . . 0.0 110.601 -178.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 84.9 t -109.87 120.27 60.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.237 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.458 ' HB3' ' HE3' ' A' ' 88' ' ' MET . 90.2 mt -103.03 95.64 6.27 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.387 177.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -86.11 106.92 17.58 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.826 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.578 HG22 ' HE1' ' A' ' 88' ' ' MET . 25.7 t -100.09 120.38 49.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 120.961 0.41 . . . . 0.0 110.411 -176.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.6 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -94.82 127.94 41.19 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.701 176.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.428 ' HB2' ' CD ' ' A' ' 67' ' ' PRO . 3.4 pt20 -97.12 170.94 6.57 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -178.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 90' ' ' ASP . 17.6 Cg_exo -67.0 79.11 0.39 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.806 2.337 . . . . 0.0 113.884 -175.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 47.7 mm -112.39 -68.63 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 167.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.497 ' OD1' ' HD2' ' A' ' 35' ' ' PRO . 3.5 p-10 -93.66 153.72 41.15 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 167.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.757 ' HG2' ' HG ' ' A' ' 73' ' ' SER . 24.5 Cg_endo -63.04 159.25 39.48 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 122.537 2.158 . . . . 0.0 113.266 -177.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.4 tp -53.95 -34.76 26.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.482 -178.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -60.69 -42.15 96.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.899 0.38 . . . . 0.0 110.899 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.757 ' HG ' ' HG2' ' A' ' 70' ' ' PRO . 51.0 m -62.98 -38.57 91.67 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.393 -177.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.721 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 20.0 t -60.77 -41.94 90.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.425 176.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.73 ' HA ' HG22 ' A' ' 78' ' ' VAL . 89.6 mtt180 -68.03 -32.53 72.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.819 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -61.71 -41.65 97.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.185 0.516 . . . . 0.0 109.863 177.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -67.72 -48.11 67.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.472 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.73 HG22 ' HA ' ' A' ' 75' ' ' ARG . 27.3 m -67.96 -29.08 43.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.988 -178.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -74.3 -55.09 6.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.146 0.498 . . . . 0.0 110.755 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -64.23 -48.35 76.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.339 -173.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -88.07 -21.49 24.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.728 0.299 . . . . 0.0 111.488 -175.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 71.47 59.9 4.65 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.271 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.515 HD13 ' HA ' ' A' ' 78' ' ' VAL . 10.8 mp -63.38 121.79 71.95 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 120.603 0.24 . . . . 0.0 110.901 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -82.26 -23.06 4.53 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.055 2.503 . . . . 0.0 113.377 -177.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -84.15 148.94 26.5 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.431 ' HB ' HD23 ' A' ' 62' ' ' LEU . 21.4 m -69.21 116.44 9.65 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.167 0.508 . . . . 0.0 111.305 -174.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 39.3 t -107.42 132.15 55.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.676 -178.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.578 ' HE1' HG22 ' A' ' 64' ' ' VAL . 73.3 mtm -123.4 173.72 7.81 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.497 ' CD1' HG23 ' A' ' 74' ' ' VAL . 60.1 t80 -140.0 116.49 10.71 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.515 ' HA ' HD12 ' A' ' 10' ' ' LEU . 10.0 p-10 -97.26 95.44 7.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.908 0.861 . . . . 0.0 110.23 178.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.45 ' HA ' ' HG3' ' A' ' 67' ' ' PRO . . . -73.28 -10.98 60.33 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.136 -176.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.485 ' C ' ' H ' ' A' ' 94' ' ' ALA . 19.1 m-20 -92.8 -14.95 27.12 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.352 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.5 ' O ' ' HG3' ' A' ' 97' ' ' GLN . 37.0 ttpt 63.36 -24.96 0.07 Allowed 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 175.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.485 ' H ' ' C ' ' A' ' 92' ' ' ASP . . . -61.9 -25.3 67.48 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -173.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.424 ' O ' ' HD1' ' A' ' 99' ' ' PHE . 26.8 m -70.95 -41.73 77.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.249 179.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.5 -36.36 91.37 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.109 174.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.5 ' HG3' ' O ' ' A' ' 93' ' ' LYS . 24.8 mt-30 -62.3 -33.13 74.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.249 -0.475 . . . . 0.0 110.418 176.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.645 ' HB2' ' H ' ' A' ' 1' ' ' ASP . . . -70.85 -41.6 71.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.068 177.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.424 ' HD1' ' O ' ' A' ' 95' ' ' VAL . 7.8 m-85 -66.71 -27.3 67.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.481 178.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 94.1 39.19 4.91 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.106 177.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.53 ' HB ' ' CE1' ' A' ' 104' ' ' TYR . 39.9 p -71.26 100.73 2.17 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.063 0.459 . . . . 0.0 111.154 -178.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -86.56 -58.41 2.63 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.363 0.601 . . . . 0.0 109.997 177.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.511 HG13 ' HB ' ' A' ' 121' ' ' VAL . 14.6 p -122.01 143.67 33.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.755 -177.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.53 ' CE1' ' HB ' ' A' ' 101' ' ' THR . 39.7 m-85 -111.01 148.53 38.83 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.58 -174.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -75.26 152.65 98.07 Favored 'Cis proline' 0 CA--C 1.529 0.261 0 C-N-CA 123.272 -1.553 . . . . 0.0 112.869 0.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 23.8 m -111.48 112.65 24.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.0 177.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.446 ' HB3' HD12 ' A' ' 29' ' ' LEU . 24.4 m -94.73 110.17 22.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.243 0.544 . . . . 0.0 110.841 -178.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.536 HG21 HG22 ' A' ' 119' ' ' THR . 60.7 t -107.79 134.33 49.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.316 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 118' ' ' LYS . 7.2 mp -101.58 130.88 47.97 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.906 0.384 . . . . 0.0 110.039 -177.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.584 HG23 HD21 ' A' ' 23' ' ' LEU . 40.0 mm -110.83 130.27 64.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.206 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -77.38 -170.56 34.35 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.435 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 79.0 mttt -78.73 -7.56 57.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.715 0.769 . . . . 0.0 109.482 -174.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.31 -7.17 32.66 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.579 -1.191 . . . . 0.0 111.103 -172.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.08 60.94 3.17 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.673 -176.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -161.51 153.81 19.92 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -178.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.473 HD12 ' HB3' ' A' ' 3' ' ' LYS . 53.6 mt -66.7 105.46 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.925 -178.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.439 HD22 ' HA ' ' A' ' 117' ' ' LEU . 0.2 OUTLIER -84.07 -38.58 20.64 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.744 179.469 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.513 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 22.4 tptm -153.41 154.09 33.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.082 -174.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.536 HG22 HG21 ' A' ' 108' ' ' VAL . 33.0 m -140.66 116.84 10.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.059 0.457 . . . . 0.0 111.501 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -109.49 134.36 51.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.471 173.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.511 ' HB ' HG13 ' A' ' 103' ' ' VAL . 3.4 m -105.73 112.56 39.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.028 0.442 . . . . 0.0 110.442 175.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 91.76 -159.65 25.91 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.583 -176.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 54.7 tt0 -73.15 119.44 75.7 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.78 0.324 . . . . 0.0 110.54 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -88.36 165.19 6.73 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.833 2.356 . . . . 0.0 112.753 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.634 ' HB2' ' HE2' ' A' ' 128' ' ' LYS . 4.9 m-20 -67.87 102.81 1.32 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 173.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -62.95 -40.37 97.47 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -173.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -58.44 -47.81 87.67 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.444 -0.884 . . . . 0.0 111.605 177.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.634 ' HE2' ' HB2' ' A' ' 125' ' ' ASP . 33.6 ttpt -69.15 -36.99 78.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.438 -0.381 . . . . 0.0 110.33 177.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -61.48 -46.0 91.88 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.6 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -61.44 -47.91 83.58 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.62 0.248 . . . . 0.0 110.937 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -67.45 -38.62 84.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.399 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -65.44 -38.79 90.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.713 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 38.1 mt -60.59 -46.29 95.88 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 172.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -60.51 -36.54 78.61 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.963 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 66.5 m -60.97 -43.45 98.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.765 176.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.55 -29.96 59.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.224 0.535 . . . . 0.0 110.809 176.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -65.24 -55.41 18.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.792 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 47.3 mtm180 -79.37 -45.25 19.92 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.984 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.59 ' HB3' ' OE2' ' A' ' 143' ' ' GLU . 19.3 t-20 51.65 -89.81 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 O-C-N 124.382 1.052 . . . . 0.0 113.111 174.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.568 ' HB2' ' HG3' ' A' ' 143' ' ' GLU . 33.2 m -94.03 -20.48 19.9 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 121.251 -0.18 . . . . 0.0 111.438 -175.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 21.1 t70 72.31 -40.07 0.47 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.447 0.699 . . . . 0.0 111.972 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.404 ' H ' ' C ' ' A' ' 140' ' ' SER . . . -82.35 19.99 1.14 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.093 0.473 . . . . 0.0 110.941 178.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.59 ' OE2' ' HB3' ' A' ' 139' ' ' ASN . 46.2 mt-10 -79.87 152.3 29.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.643 179.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 169.11 -128.92 1.76 Allowed Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.742 178.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -99.92 -44.55 6.0 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 175.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -175.81 102.33 0.07 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.277 175.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -83.39 85.62 7.2 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.281 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -162.87 120.6 2.0 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.517 174.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -158.57 154.44 26.62 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 20.1 p80 . . . . . 0 C--O 1.247 0.93 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 172.115 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.127 0 CA-C-O 120.909 0.385 . . . . 0.0 111.715 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -141.68 141.79 33.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.049 177.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.8 m -137.78 100.07 4.09 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.52 HD12 ' HD2' ' A' ' 11' ' ' PRO . 56.2 tp -115.16 120.2 37.23 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.426 -171.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.52 ' HD2' HD12 ' A' ' 10' ' ' LEU . 60.3 Cg_endo -75.07 129.71 12.53 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.497 2.131 . . . . 0.0 111.327 172.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.41 ' HA ' ' HG3' ' A' ' 88' ' ' MET . 2.3 p30 -86.55 -171.86 3.75 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.988 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.8 mt -67.12 -9.26 37.79 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -175.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -96.36 -9.56 29.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.932 0.396 . . . . 0.0 110.33 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.4 2.69 61.75 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.125 177.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 11' ' ' PRO . 20.6 pttp -96.13 144.79 26.05 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 28.5 m -94.45 125.55 39.16 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.889 -174.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.3 m -102.38 141.3 18.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 172.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 45.3 t -145.6 -178.08 5.91 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 121.076 -0.25 . . . . 0.0 110.963 -173.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -53.92 -39.22 65.65 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.258 0.623 . . . . 0.0 111.956 -175.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.77 -27.64 65.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.812 -177.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -78.49 -24.05 46.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.235 -176.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 81.5 mt -78.54 -21.37 48.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.895 0.379 . . . . 0.0 110.953 -178.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -72.27 103.33 3.34 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.02 0.438 . . . . 0.0 110.673 -176.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.0 -25.92 12.19 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.34 177.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.17 148.83 26.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.941 0.401 . . . . 0.0 110.343 178.045 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.49 HG13 ' O ' ' A' ' 110' ' ' ILE . 97.1 t -102.96 138.0 28.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 172.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 60' ' ' GLN . 22.3 m -132.06 135.12 46.24 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.614 -165.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.764 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 6.8 tt -106.88 106.43 16.96 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 173.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.917 HG12 ' HB2' ' A' ' 62' ' ' LEU . 39.9 mt -104.56 111.95 36.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 177.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.449 ' HA ' ' O ' ' A' ' 106' ' ' THR . 26.7 p-10 -110.72 134.18 52.69 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.413 0.625 . . . . 0.0 110.645 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -91.66 119.25 31.37 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.615 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.64 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 4.5 p-90 -147.82 -174.13 4.47 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.615 -173.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -155.28 150.35 20.77 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 173.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.413 ' HG3' ' HA ' ' A' ' 74' ' ' VAL . 92.8 Cg_exo -43.72 -47.08 9.99 Favored 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 123.148 2.566 . . . . 0.0 114.13 -177.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.1 m -85.82 27.46 0.87 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -177.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.524 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 52.8 t -79.91 129.55 70.13 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.015 0.436 . . . . 0.0 111.101 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 24.7 Cg_exo -63.54 -26.85 69.77 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.641 2.227 . . . . 0.0 111.922 176.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.2 -16.55 73.24 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.836 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.524 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 92.0 m -58.16 -29.4 65.56 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.72 0.26 . . . . 0.0 111.392 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.6 t -55.02 -43.08 67.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.997 0.427 . . . . 0.0 110.364 177.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.571 ' O ' ' HB3' ' A' ' 46' ' ' LYS . 15.1 m -86.5 -55.79 3.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.873 178.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.468 ' O ' HG12 ' A' ' 47' ' ' ILE . 43.3 mt-10 -59.46 -50.4 74.06 Favored 'General case' 0 C--O 1.213 -0.86 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -173.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.732 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 31.8 tpp -58.85 -61.02 8.6 Favored Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -164.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.732 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 33.1 Cg_exo -59.38 -35.96 95.25 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 121.652 1.568 . . . . 0.0 111.206 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.571 ' HB3' ' O ' ' A' ' 42' ' ' SER . 5.9 tptt -59.17 -49.3 78.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.956 176.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.546 HD13 ' HE3' ' A' ' 46' ' ' LYS . 43.8 mm -74.54 -31.58 27.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.63 -174.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.66 HG12 ' O ' ' A' ' 44' ' ' MET . 46.8 mm -54.72 -53.26 33.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-O 121.034 0.445 . . . . 0.0 109.901 176.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.648 ' HZ2' ' HB2' ' A' ' 53' ' ' ASP . 20.4 tptp -71.74 -35.97 70.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.969 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.3 m -62.11 -54.18 44.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.838 0.351 . . . . 0.0 111.202 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.605 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . -68.53 -27.38 66.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.981 -176.112 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.09 -39.3 60.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.493 177.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.648 ' HB2' ' HZ2' ' A' ' 49' ' ' LYS . 6.9 t70 -76.05 -52.19 10.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.233 0.54 . . . . 0.0 111.057 -173.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.879 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 90.8 m-85 -81.58 -2.47 50.18 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.363 -174.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.605 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 13.0 tppt? -59.4 -37.61 78.45 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.434 0.635 . . . . 0.0 109.916 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.2 m-20 -91.51 12.03 22.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.294 -175.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.578 ' O ' ' HB3' ' A' ' 58' ' ' ASN . 16.9 tptp -112.03 -61.68 1.68 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.711 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.578 ' HB3' ' O ' ' A' ' 57' ' ' LYS . 2.9 p-10 162.79 14.93 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 O-C-N 124.202 0.939 . . . . 0.0 110.279 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.879 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 57.2 t80 -112.53 143.03 44.38 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.924 0.392 . . . . 0.0 110.284 -175.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.531 ' O ' ' HA ' ' A' ' 28' ' ' THR . 11.7 pt20 -136.76 147.55 46.74 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.669 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.46 HG11 HG23 ' A' ' 47' ' ' ILE . 87.3 t -115.07 132.2 65.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.007 178.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.917 ' HB2' HG12 ' A' ' 30' ' ' ILE . 77.6 mt -122.37 110.9 16.22 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.654 ' HB3' HG22 ' A' ' 87' ' ' VAL . . . -94.48 116.42 28.77 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.171 -177.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.0 t -105.17 111.81 36.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.065 0.46 . . . . 0.0 110.528 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.64 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -95.83 124.77 39.99 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.929 177.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.5 169.73 8.18 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.613 ' HD3' ' O ' ' A' ' 90' ' ' ASP . 16.4 Cg_exo -67.33 80.77 0.41 Allowed 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.617 2.211 . . . . 0.0 113.781 -172.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 50.2 mm -117.69 -54.66 4.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 168.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.406 ' HB2' ' HD2' ' A' ' 35' ' ' PRO . 17.2 m-20 -101.86 151.94 38.05 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.738 170.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.31 151.12 30.53 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.73 2.287 . . . . 0.0 112.902 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.3 tt -57.19 -36.3 51.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.894 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.502 ' HA ' ' HD2' ' A' ' 75' ' ' ARG . 31.1 tp10 -69.61 -35.31 75.17 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.533 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.9 m -62.27 -32.45 73.16 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.206 0.527 . . . . 0.0 110.081 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.478 ' O ' HG13 ' A' ' 78' ' ' VAL . 45.2 t -65.42 -44.31 94.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.692 174.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.759 ' HA ' HG22 ' A' ' 78' ' ' VAL . 91.4 mtt180 -64.67 -31.92 73.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.388 177.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -60.98 -44.48 97.3 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 177.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -63.53 -46.16 87.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.272 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.759 HG22 ' HA ' ' A' ' 75' ' ' ARG . 11.1 m -67.08 -37.45 79.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.642 -177.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -75.64 -48.12 23.5 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -66.34 -48.38 70.44 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.103 -172.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -92.4 2.22 56.78 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -173.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 57.9 63.72 5.01 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.308 -0.473 . . . . 0.0 113.033 177.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.511 HD22 HG12 ' A' ' 78' ' ' VAL . 10.0 mp -73.22 115.85 45.01 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 120.702 0.287 . . . . 0.0 111.231 -177.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.39 15.98 1.78 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.177 2.584 . . . . 0.0 113.022 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.543 ' HE1' HD13 ' A' ' 48' ' ' ILE . 24.1 p90 -128.76 153.56 47.26 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.071 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.408 ' HB ' ' CD2' ' A' ' 62' ' ' LEU . 32.2 m -79.39 130.39 35.38 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.953 -174.054 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.654 HG22 ' HB3' ' A' ' 63' ' ' ALA . 60.9 t -116.44 139.43 43.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.334 -178.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.41 ' HG3' ' HA ' ' A' ' 12' ' ' ASP . 2.6 mpt? -119.24 169.3 10.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.078 177.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -123.5 110.3 14.9 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.613 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 0.9 OUTLIER -81.78 72.25 8.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.893 -175.646 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.78 -46.84 86.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.374 -172.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -87.78 -10.91 49.59 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.673 -0.24 . . . . 0.0 110.776 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.581 ' HB2' ' NZ ' ' A' ' 93' ' ' LYS . 8.1 mtmp? 69.23 7.49 6.26 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.562 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.65 -32.04 70.47 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -172.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.6 t -71.24 -42.91 74.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.58 -37.87 94.09 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.887 174.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -67.02 -32.05 73.0 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 122.486 0.315 . . . . 0.0 111.01 177.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.29 -45.29 85.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.648 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -66.62 -28.22 68.32 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.788 0.328 . . . . 0.0 110.644 176.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 71.96 59.95 4.45 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.804 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.6 p -99.88 -66.64 0.89 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.591 0.234 . . . . 0.0 111.069 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 72.53 -38.54 0.42 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.681 0.792 . . . . 0.0 112.296 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.8 m -97.83 132.3 42.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.139 0.495 . . . . 0.0 110.567 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -128.29 153.04 78.88 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.047 -175.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -80.86 161.01 83.2 Favored 'Cis proline' 0 C--O 1.234 0.314 0 C-N-CA 123.376 -1.51 . . . . 0.0 112.353 -0.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 10.2 t -150.25 127.53 11.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.15 0.5 . . . . 0.0 111.358 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.3 m -101.24 122.53 43.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.089 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 48.5 t -106.06 132.46 53.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.83 0.347 . . . . 0.0 110.207 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.573 HD23 ' HB3' ' A' ' 118' ' ' LYS . 2.8 mm? -102.03 118.77 37.6 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.943 -178.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.49 ' O ' HG13 ' A' ' 27' ' ' VAL . 53.5 mt -100.99 127.74 53.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.037 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -72.14 -179.51 33.68 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.204 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -86.61 -5.11 59.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.919 0.39 . . . . 0.0 110.764 -175.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -98.34 -31.6 11.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.856 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 113.89 19.83 6.29 Favored Glycine 0 C--O 1.225 -0.431 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.553 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.93 -26.2 60.38 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -172.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.471 HD13 HG23 ' A' ' 110' ' ' ILE . 20.8 mm 58.34 96.92 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-O 121.216 0.531 . . . . 0.0 109.582 -167.2 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.7 mt -93.68 -76.03 0.49 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -165.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.573 ' HB3' HD23 ' A' ' 109' ' ' LEU . 21.9 tptm -109.22 145.05 36.51 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.049 -164.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 7.7 p -122.67 108.01 12.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.382 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -94.88 128.7 41.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.994 173.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.7 t -120.1 132.39 69.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.668 0.271 . . . . 0.0 110.549 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 84.19 -102.51 2.51 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.122 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -106.78 108.78 62.5 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.485 ' HB2' HD22 ' A' ' 129' ' ' LEU . 68.7 Cg_endo -76.65 104.69 1.95 Allowed 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.198 1.932 . . . . 0.0 112.16 178.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -48.75 107.66 0.14 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.676 178.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -60.15 -43.4 95.77 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.095 -173.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -59.5 -51.0 61.68 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.495 -176.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -80.27 -21.0 43.18 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 122.973 -0.133 . . . . 0.0 111.248 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.485 HD22 ' HB2' ' A' ' 124' ' ' PRO . 52.0 tp -68.69 -47.04 67.46 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.162 -0.311 . . . . 0.0 110.162 176.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -66.96 -40.54 87.5 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.908 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -68.11 -30.49 69.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.728 0.299 . . . . 0.0 111.309 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.494 ' OE1' ' HG2' ' A' ' 118' ' ' LYS . 35.3 tt0 -77.82 -34.34 52.06 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.663 0.268 . . . . 0.0 110.488 178.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 129' ' ' LEU . 76.1 mt -65.66 -38.94 83.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-O 121.212 0.529 . . . . 0.0 109.659 172.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.37 -36.42 84.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.461 172.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 91.1 m -63.35 -31.67 72.89 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.13 174.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 133' ' ' ILE . . . . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.596 175.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.24 0 CA-C-O 121.164 0.507 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -129.49 148.86 51.44 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.352 0.596 . . . . 0.0 111.134 -177.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.9 m -141.23 90.75 2.33 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 171.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.581 HD12 ' HD2' ' A' ' 11' ' ' PRO . 28.4 tp -112.57 124.35 32.07 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.216 -172.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.581 ' HD2' HD12 ' A' ' 10' ' ' LEU . 58.3 Cg_endo -73.07 138.71 28.6 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.406 2.071 . . . . 0.0 111.908 176.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.515 ' HA ' ' HG2' ' A' ' 88' ' ' MET . 0.0 OUTLIER -75.29 169.44 18.05 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 175.488 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.543 HD13 ' HG2' ' A' ' 75' ' ' ARG . 84.6 mt -66.03 -17.79 64.92 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -175.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.474 ' H ' ' CG ' ' A' ' 12' ' ' ASP . 48.8 t-80 -86.89 -19.55 28.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.945 177.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.7 4.4 21.47 Favored Glycine 0 CA--C 1.517 0.208 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.058 177.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -85.62 110.75 19.49 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 122.595 -0.356 . . . . 0.0 110.263 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 8.3 m -64.3 122.88 17.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.678 178.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.594 HG11 HD21 ' A' ' 62' ' ' LEU . 59.6 t -110.89 125.07 68.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.924 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 51.0 p -140.94 -174.35 3.97 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.236 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -55.87 -32.27 63.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.109 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.6 -28.53 67.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.202 -176.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -78.84 -23.89 44.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.031 0.443 . . . . 0.0 110.549 -175.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 81.3 mt -77.64 -19.98 54.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.172 -177.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.498 ' OE1' ' HA ' ' A' ' 113' ' ' LYS . 16.5 mm-40 -64.57 119.04 9.72 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.775 -174.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.13 -21.29 46.77 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.035 -0.602 . . . . 0.0 113.078 174.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 112' ' ' LYS . 31.3 mtmt -117.77 160.58 21.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.808 0.337 . . . . 0.0 111.167 -174.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 13.2 t -101.71 144.76 12.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -178.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.618 HG23 HD13 ' A' ' 62' ' ' LEU . 40.6 m -139.34 140.41 37.52 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.06 0.457 . . . . 0.0 112.102 -168.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.889 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 28.1 tp -109.4 106.18 15.85 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.333 171.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.661 ' HB ' ' CG2' ' A' ' 108' ' ' VAL . 37.2 mt -91.09 111.59 23.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 C-N-CA 120.303 -0.559 . . . . 0.0 109.51 176.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -108.83 114.81 28.91 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.897 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -87.69 118.24 27.05 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.496 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 8.0 p-90 -144.71 -173.81 4.16 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.014 0.435 . . . . 0.0 110.464 -176.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.402 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 38.6 p90 -161.71 144.3 8.99 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.351 176.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -58.53 163.98 9.87 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.366 2.044 . . . . 0.0 111.84 175.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 44.5 m 66.84 11.89 8.56 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.408 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 42.1 t -95.67 126.11 46.59 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.47 177.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.434 ' O ' HG12 ' A' ' 41' ' ' VAL . 35.2 Cg_exo -61.87 -18.2 59.66 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.977 2.451 . . . . 0.0 112.978 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.55 -6.73 56.11 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 121.125 -0.559 . . . . 0.0 113.112 -178.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 26.3 p -62.19 -30.58 71.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.559 0.219 . . . . 0.0 110.887 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 38' ' ' PRO . 13.0 p -66.73 -28.92 44.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.845 0.355 . . . . 0.0 110.899 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.6 m -88.0 -56.74 3.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.014 0.435 . . . . 0.0 111.268 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.559 ' HA ' ' HE2' ' A' ' 46' ' ' LYS . 2.9 mt-10 -74.32 -40.69 62.04 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -170.053 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.476 ' O ' HG12 ' A' ' 48' ' ' ILE . 35.2 tpp -59.57 -54.87 51.65 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -172.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.406 ' HD2' ' N ' ' A' ' 44' ' ' MET . 15.9 Cg_endo -57.52 -35.48 98.83 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 121.829 1.686 . . . . 0.0 111.731 177.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.65 ' HZ2' ' HD2' ' A' ' 124' ' ' PRO . 28.8 ttpt -61.14 -51.94 66.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.541 175.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.557 HG12 ' O ' ' A' ' 43' ' ' GLU . 47.3 mm -57.17 -41.03 77.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.788 -178.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.476 HG12 ' O ' ' A' ' 44' ' ' MET . 48.8 mm -57.9 -45.87 87.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.995 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -75.4 -40.96 57.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.498 0.19 . . . . 0.0 111.248 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.462 ' O ' ' HD2' ' A' ' 54' ' ' TYR . 60.7 m -59.55 -50.01 75.55 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.859 0.361 . . . . 0.0 110.435 177.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.76 -31.8 72.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.598 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -54.22 -44.06 71.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.958 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -79.01 -51.89 8.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.35 0.595 . . . . 0.0 111.142 177.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.983 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 50.8 m-85 -72.3 -20.46 61.5 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -167.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -68.52 -15.23 63.47 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 122.207 -0.308 . . . . 0.0 110.793 176.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -106.83 8.16 30.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.36 0.6 . . . . 0.0 109.874 177.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.429 ' CG ' ' HA ' ' A' ' 54' ' ' TYR . 30.8 mmtp -100.87 -69.71 0.76 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.376 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 4.5 t-20 164.23 29.59 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -172.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.983 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 48.6 t80 -131.41 138.22 49.0 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.799 -167.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.419 ' O ' ' HA ' ' A' ' 28' ' ' THR . 10.8 pt20 -128.26 140.96 51.6 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.464 178.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.432 HG11 HG23 ' A' ' 47' ' ' ILE . 60.4 t -100.61 125.85 54.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.012 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.618 HD13 HG23 ' A' ' 28' ' ' THR . 10.9 mp -112.48 99.11 7.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.85 107.32 16.95 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.863 178.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.1 t -99.22 104.35 15.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.064 0.459 . . . . 0.0 110.458 -177.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -90.89 120.3 31.79 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 175.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.687 ' HB3' ' HD2' ' A' ' 67' ' ' PRO . 37.0 mt-30 -94.83 170.79 7.47 Favored Pre-proline 0 C--N 1.317 -0.821 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -177.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.687 ' HD2' ' HB3' ' A' ' 66' ' ' GLN . 72.5 Cg_endo -71.01 57.92 2.1 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 123.135 2.557 . . . . 0.0 115.225 -164.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.402 ' HB ' ' HB2' ' A' ' 34' ' ' PHE . 49.8 mm -92.24 -51.56 11.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 171.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.538 ' OD1' ' HD2' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -109.23 149.81 40.22 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.362 -0.835 . . . . 0.0 108.779 174.104 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.538 ' HD2' ' OD1' ' A' ' 69' ' ' ASP . 84.4 Cg_exo -49.56 155.76 3.39 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 123.058 2.506 . . . . 0.0 113.737 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.615 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 11.1 tt -54.95 -40.87 55.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.695 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -65.79 -33.47 75.93 Favored 'General case' 0 C--O 1.215 -0.746 0 C-N-CA 120.864 -0.335 . . . . 0.0 110.694 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.7 m -58.26 -40.8 82.8 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.374 0.607 . . . . 0.0 109.943 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.401 ' O ' HG13 ' A' ' 78' ' ' VAL . 20.0 t -65.59 -44.07 93.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.284 175.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.764 ' HA ' HG22 ' A' ' 78' ' ' VAL . 20.1 mtm180 -67.53 -24.98 65.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.019 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -68.63 -43.07 77.1 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -63.78 -47.59 80.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.147 178.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.764 HG22 ' HA ' ' A' ' 75' ' ' ARG . 12.6 m -65.83 -26.63 39.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.129 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.609 ' HB2' ' O ' ' A' ' 75' ' ' ARG . 3.6 ttmp? -74.21 -52.15 13.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.892 -177.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -67.19 -49.43 64.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.204 -174.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -85.82 -10.43 55.44 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -174.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.62 60.28 8.77 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.308 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.604 HD22 HG12 ' A' ' 78' ' ' VAL . 10.1 mp -63.64 116.01 22.98 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 120.879 0.371 . . . . 0.0 111.461 -176.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -86.45 25.26 0.69 Allowed 'Trans proline' 0 C--O 1.241 0.636 0 C-N-CA 123.314 2.676 . . . . 0.0 113.467 -177.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -136.23 159.71 40.9 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 30.7 m -67.71 122.68 18.61 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.434 -174.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.8 t -119.29 127.57 75.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.956 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.515 ' HG2' ' HA ' ' A' ' 12' ' ' ASP . 67.2 mtm -122.76 164.36 18.48 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.263 -177.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.444 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 67.6 t80 -126.1 125.65 42.9 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.373 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.537 ' HB3' ' HA ' ' A' ' 66' ' ' GLN . 28.4 t0 -88.89 135.91 33.29 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.25 -32.84 61.21 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.435 ' O ' ' HB3' ' A' ' 93' ' ' LYS . 31.9 t70 -130.07 -11.08 4.25 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -172.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.675 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER 82.93 17.94 0.28 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 122.89 1.329 . . . . 0.0 108.744 -172.938 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.02 -27.17 60.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.007 -176.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.7 t -69.14 -41.19 81.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.57 -33.59 87.64 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 174.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -64.14 -39.05 93.19 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 122.595 0.358 . . . . 0.0 111.098 176.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.48 -39.82 92.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.058 0.456 . . . . 0.0 110.967 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -73.01 -27.78 61.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.556 177.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.98 34.44 5.68 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.425 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 29.1 p -106.17 126.25 51.98 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.742 0.305 . . . . 0.0 110.804 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.512 ' HG3' HG13 ' A' ' 103' ' ' VAL . 11.8 pt20 -108.82 -36.32 6.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.907 0.384 . . . . 0.0 110.839 178.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.512 HG13 ' HG3' ' A' ' 102' ' ' GLN . 19.7 m -102.85 142.1 17.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.21 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.517 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 37.6 m-85 -130.46 158.67 73.82 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.09 -177.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.517 ' HA ' ' HB3' ' A' ' 104' ' ' TYR . 94.1 Cg_endo -81.41 165.05 75.51 Favored 'Cis proline' 0 CA--C 1.53 0.311 0 C-N-CA 123.587 -1.422 . . . . 0.0 113.17 0.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.535 HG23 ' HA ' ' A' ' 121' ' ' VAL . 95.8 m -150.82 133.32 15.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.787 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.604 ' HB3' HD11 ' A' ' 29' ' ' LEU . 68.0 m -108.09 117.47 34.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.969 0.414 . . . . 0.0 111.003 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.661 ' CG2' ' HB ' ' A' ' 30' ' ' ILE . 29.0 m -106.36 146.15 13.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.121 0.486 . . . . 0.0 110.839 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.676 ' HB2' ' HB3' ' A' ' 118' ' ' LYS . 2.6 mm? -102.37 124.47 48.0 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.065 -176.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.576 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 22.7 mm -104.4 134.59 45.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.512 ' O ' ' HA ' ' A' ' 27' ' ' VAL . . . -67.79 -93.66 0.04 OUTLIER Glycine 0 C--O 1.226 -0.353 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.868 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 10.9 ptpt -166.8 23.73 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.271 0.557 . . . . 0.0 110.844 171.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.498 ' HA ' ' OE1' ' A' ' 24' ' ' GLN . 36.8 mtmm -136.12 10.1 3.27 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 174.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 78.25 18.35 76.45 Favored Glycine 0 C--O 1.223 -0.535 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.54 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -69.71 -24.63 63.6 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -171.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 8.5 mt 64.02 89.63 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.66 0.743 . . . . 0.0 109.701 -175.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 23.2 mt -87.54 -34.93 18.42 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.257 -0.883 . . . . 0.0 113.109 -167.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.676 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 22.0 tptm -150.27 157.53 43.18 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.302 -168.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.537 HG23 HG12 ' A' ' 108' ' ' VAL . 51.4 m -140.28 107.86 5.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.859 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.649 ' HB3' ' HB3' ' A' ' 124' ' ' PRO . 67.8 m-85 -101.68 107.39 18.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.117 173.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.535 ' HA ' HG23 ' A' ' 106' ' ' THR . 48.1 t -82.93 126.78 40.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.46 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 80.31 -138.58 20.01 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.029 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.444 ' OE2' ' HD2' ' A' ' 124' ' ' PRO . 12.7 tp10 -96.64 109.33 47.74 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 110.229 -0.285 . . . . 0.0 110.229 -178.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.65 ' HD2' ' HZ2' ' A' ' 46' ' ' LYS . 91.9 Cg_endo -81.72 174.11 10.65 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 123.234 2.623 . . . . 0.0 113.359 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.497 ' OD2' ' HB3' ' A' ' 128' ' ' LYS . 11.2 p-10 -88.3 120.0 29.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.091 175.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.581 ' HE2' ' HG3' ' A' ' 46' ' ' LYS . 92.2 m-85 -58.47 -46.94 85.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.832 -173.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -56.34 -53.63 41.72 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 121.045 -0.598 . . . . 0.0 113.443 -172.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.551 ' NZ ' ' HB3' ' A' ' 128' ' ' LYS . 2.1 ttpm? -76.17 -26.14 55.94 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.464 0.173 . . . . 0.0 110.694 -177.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.482 ' O ' HG13 ' A' ' 133' ' ' ILE . 7.5 tt -64.41 -46.99 80.87 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 177.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -61.78 -56.04 23.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.479 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.441 ' HG2' ' HA ' ' A' ' 128' ' ' LYS . 4.5 pt20 -60.91 -29.61 69.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.718 0.294 . . . . 0.0 111.292 -176.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -72.46 -36.37 68.48 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.711 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.482 HG13 ' O ' ' A' ' 129' ' ' LEU . 69.1 mt -69.36 -53.0 27.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -62.78 -27.32 69.22 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.767 0.318 . . . . 0.0 111.413 -176.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 90.4 m -73.76 -30.85 63.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.012 0.434 . . . . 0.0 110.964 177.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.563 -177.25 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 120.711 0.291 . . . . 0.0 110.397 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -122.74 140.92 52.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.587 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.4 m -128.15 90.64 3.12 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.546 HD12 ' HD2' ' A' ' 11' ' ' PRO . 35.6 tp -114.88 125.01 29.51 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.314 -175.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.546 ' HD2' HD12 ' A' ' 10' ' ' LEU . 61.0 Cg_endo -75.57 153.59 39.24 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.215 1.944 . . . . 0.0 112.184 176.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.525 ' HA ' ' HG2' ' A' ' 88' ' ' MET . 1.9 p-10 -83.23 -166.24 1.3 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.824 177.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 87' ' ' VAL . 89.9 mt -77.35 3.03 14.08 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -176.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.445 ' CE1' ' HB2' ' A' ' 16' ' ' LYS . 4.7 p-80 -128.07 -20.65 3.75 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 119.924 -0.711 . . . . 0.0 111.731 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 125.88 27.82 1.1 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.085 -1.055 . . . . 0.0 113.898 174.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.445 ' HB2' ' CE1' ' A' ' 14' ' ' HIS . 13.2 tmtt? -100.58 112.48 24.87 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 175.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.6 m -66.97 122.32 17.47 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.943 0.402 . . . . 0.0 110.696 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.519 HG11 HD13 ' A' ' 62' ' ' LEU . 60.2 t -108.73 131.98 57.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.808 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 50.4 m -145.55 -174.21 4.33 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.97 0.414 . . . . 0.0 111.148 -178.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -61.04 -25.07 66.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.462 -177.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.22 -34.09 74.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.352 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -70.34 -30.39 67.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.323 0.583 . . . . 0.0 110.398 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.573 HD13 HG21 ' A' ' 110' ' ' ILE . 35.0 mt -85.36 -40.47 16.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.632 -171.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -71.49 21.69 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -159.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -152.19 11.19 0.66 Allowed Glycine 0 C--N 1.321 -0.279 0 C-N-CA 120.033 -1.08 . . . . 0.0 113.114 177.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 58' ' ' ASN . 11.4 ptmm? -160.02 179.58 8.63 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.629 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 21.4 t -102.89 139.32 24.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 C-N-CA 120.472 -0.491 . . . . 0.0 109.71 -175.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.618 HG23 ' HG3' ' A' ' 60' ' ' GLN . 44.3 m -136.88 148.14 46.89 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.705 -171.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.783 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 62.7 tp -112.79 105.8 14.01 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 175.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.532 HD13 ' HB2' ' A' ' 62' ' ' LEU . 48.5 mm -88.48 110.56 21.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 172.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.481 ' HA ' ' O ' ' A' ' 106' ' ' THR . 9.2 t30 -120.13 110.29 16.45 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.0 -173.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -84.03 120.45 26.15 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.394 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.463 ' NE1' ' HB1' ' A' ' 63' ' ' ALA . 2.8 p-90 -150.33 -171.82 4.01 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.651 -176.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.43 ' HB3' ' NE2' ' A' ' 66' ' ' GLN . 40.0 p90 -155.98 138.48 10.36 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.512 -0.767 . . . . 0.0 108.955 174.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.724 ' HD2' ' HB2' ' A' ' 69' ' ' ASP . 71.2 Cg_exo -41.96 -46.23 6.92 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.868 3.045 . . . . 0.0 115.167 -174.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.1 m -80.92 8.53 8.14 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -173.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.4 p -75.61 157.86 83.75 Favored Pre-proline 0 C--N 1.327 -0.398 0 O-C-N 122.263 -0.273 . . . . 0.0 110.651 -178.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -62.15 -11.29 21.32 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.652 2.234 . . . . 0.0 112.008 175.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.816 ' O ' ' HB2' ' A' ' 43' ' ' GLU . . . -75.86 4.55 44.76 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.756 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 12.5 p -78.43 -56.15 4.67 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 121.338 -1.095 . . . . 0.0 110.555 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.65 -42.77 71.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.787 -175.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.0 m -86.79 -42.81 13.0 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -175.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.816 ' HB2' ' O ' ' A' ' 39' ' ' GLY . 20.8 mm-40 -83.47 -41.69 17.75 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -171.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.614 ' O ' HG12 ' A' ' 48' ' ' ILE . 33.7 tpp -51.74 -53.18 53.54 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -171.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.6 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 52.9 Cg_exo -55.6 -40.39 85.64 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.872 1.715 . . . . 0.0 112.599 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -71.14 -34.94 71.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.56 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.7 mm -69.14 -43.02 81.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.757 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.614 HG12 ' O ' ' A' ' 44' ' ' MET . 47.3 mm -55.55 -52.65 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.028 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.431 ' HE2' ' O ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -58.56 -46.07 87.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.642 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.42 HG23 ' HE1' ' A' ' 130' ' ' TYR . 84.0 m -62.18 -53.14 59.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.639 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.83 -36.18 77.88 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -173.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.73 -33.84 62.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.821 0.343 . . . . 0.0 110.264 -178.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -70.69 -51.41 27.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.572 0.701 . . . . 0.0 109.937 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 1.01 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 22.6 m-85 -72.01 -7.39 48.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.411 -178.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.9 tptt -57.68 -41.77 82.29 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.488 0.492 . . . . 0.0 110.642 -177.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -101.56 10.07 40.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.272 -177.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.635 ' HG3' ' OD1' ' A' ' 58' ' ' ASN . 25.9 tptp -95.33 -62.81 1.24 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.365 -177.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.635 ' OD1' ' HG3' ' A' ' 57' ' ' LYS . 2.4 p-10 169.66 7.31 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.422 0.689 . . . . 0.0 109.763 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 1.01 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 54.2 t80 -118.33 148.6 42.32 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.542 -165.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.618 ' HG3' HG23 ' A' ' 28' ' ' THR . 10.8 pt20 -141.62 129.73 22.11 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.102 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.6 t -95.52 115.62 35.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 120.973 0.416 . . . . 0.0 110.117 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.532 ' HB2' HD13 ' A' ' 30' ' ' ILE . 84.2 mt -109.81 95.96 5.94 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.432 -0.804 . . . . 0.0 108.926 177.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.54 ' HB3' HG22 ' A' ' 87' ' ' VAL . . . -80.83 125.57 30.25 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.117 -177.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.1 t -106.03 115.75 48.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 120.908 0.385 . . . . 0.0 110.106 -178.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.09 112.62 22.88 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.245 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.598 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 0.8 OUTLIER -93.91 162.04 28.15 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.979 -179.364 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.598 ' HD2' ' HB2' ' A' ' 66' ' ' GLN . 60.1 Cg_endo -69.3 66.49 1.5 Allowed 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 123.081 2.521 . . . . 0.0 115.862 -164.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.4 mp -107.55 -51.34 7.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 162.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.724 ' HB2' ' HD2' ' A' ' 35' ' ' PRO . 30.5 m-20 -101.44 135.3 19.86 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.515 174.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -57.2 160.88 12.18 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.946 2.431 . . . . 0.0 112.336 177.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.552 ' O ' ' HG2' ' A' ' 75' ' ' ARG . 9.4 tt -58.27 -36.09 56.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.325 -177.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.768 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . 2.2 pm0 -68.97 -29.93 68.25 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.981 -0.287 . . . . 0.0 111.444 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.1 m -65.12 -38.38 90.5 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 174.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.432 ' HA ' ' HG3' ' A' ' 35' ' ' PRO . 14.1 t -71.98 -49.16 46.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.772 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.817 ' HA ' HG22 ' A' ' 78' ' ' VAL . 13.4 ptt180 -70.11 -24.95 63.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.702 -177.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -69.35 -42.84 74.75 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 170.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -62.24 -50.06 73.24 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.118 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.817 HG22 ' HA ' ' A' ' 75' ' ' ARG . 21.5 m -62.41 -27.01 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.063 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.22 -55.09 6.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.236 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -62.45 -43.93 97.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.44 -171.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -97.75 -3.16 39.6 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -173.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 56.56 65.52 3.51 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.446 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.571 HD22 HG12 ' A' ' 78' ' ' VAL . 9.7 mp -68.98 117.62 53.37 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-O 120.907 0.384 . . . . 0.0 111.575 -175.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -78.65 -4.65 14.25 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.32 2.68 . . . . 0.0 113.14 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -106.31 138.81 41.83 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.447 ' HB ' HD23 ' A' ' 62' ' ' LEU . 22.0 m -72.0 126.29 29.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.242 -172.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.54 HG22 ' HB3' ' A' ' 63' ' ' ALA . 46.1 t -110.68 131.79 60.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.788 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.525 ' HG2' ' HA ' ' A' ' 12' ' ' ASP . 63.2 mtm -112.74 168.36 9.74 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.06 176.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -121.6 127.18 50.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.827 0.346 . . . . 0.0 110.429 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.587 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 63.5 t0 -105.14 106.53 17.06 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.71 -47.75 37.16 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -173.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -91.93 -5.2 53.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.639 -175.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.576 ' O ' ' HG3' ' A' ' 97' ' ' GLN . 34.5 ttmt 65.66 20.2 11.53 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -173.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.93 -25.65 60.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.169 -175.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.462 HG21 HD22 ' A' ' 10' ' ' LEU . 22.5 t -74.01 -39.05 50.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 174.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.95 -33.3 86.87 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.772 173.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.576 ' HG3' ' O ' ' A' ' 93' ' ' LYS . 78.0 mt-30 -66.19 -33.27 75.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.98 0.419 . . . . 0.0 110.815 176.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.53 -39.87 70.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.478 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -87.27 -27.05 23.15 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.36 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 97.58 62.42 0.9 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.924 176.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 66.5 p -79.76 112.01 16.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.673 0.273 . . . . 0.0 111.147 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -103.51 -38.37 7.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.895 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.473 ' CG1' ' HB ' ' A' ' 121' ' ' VAL . 9.7 p -144.47 144.15 22.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -108.51 146.93 34.7 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.08 -173.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -75.33 151.48 96.48 Favored 'Cis proline' 0 C--N 1.343 0.279 0 C-N-CA 122.814 -1.744 . . . . 0.0 112.801 0.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 23.9 m -108.09 112.65 25.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.591 176.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.55 ' HB3' HD11 ' A' ' 29' ' ' LEU . 9.4 m -102.5 109.8 21.55 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.952 0.406 . . . . 0.0 110.6 -176.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 36.3 t -108.28 133.2 53.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.471 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.588 HD12 ' HB3' ' A' ' 118' ' ' LYS . 97.2 mt -101.58 116.34 32.54 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.085 0.469 . . . . 0.0 110.168 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.573 HG21 HD13 ' A' ' 23' ' ' LEU . 11.0 mm -107.33 157.21 7.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.066 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -146.22 -155.9 6.69 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 119.93 -1.129 . . . . 0.0 112.774 176.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.519 ' O ' ' HB3' ' A' ' 113' ' ' LYS . 16.5 pttp -56.99 156.13 7.26 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 124.014 0.925 . . . . 0.0 109.365 178.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.519 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 3.0 ttmp? 71.92 -16.76 0.39 Allowed 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.981 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.442 ' H ' ' C ' ' A' ' 112' ' ' LYS . . . 91.38 7.37 65.35 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 -174.191 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.518 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 17.2 pt-20 -67.77 135.73 53.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.123 0.487 . . . . 0.0 111.052 -176.182 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 57.0 mt -80.98 107.25 13.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 174.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.01 -40.56 38.6 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.761 -173.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.588 ' HB3' HD12 ' A' ' 109' ' ' LEU . 21.9 tptm -161.24 154.78 21.79 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.421 -171.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.3 m -136.62 115.59 12.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.867 0.365 . . . . 0.0 110.966 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.469 ' OH ' ' HE3' ' A' ' 128' ' ' LYS . 75.2 m-85 -108.04 144.65 35.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.446 174.099 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.473 ' HB ' ' CG1' ' A' ' 103' ' ' VAL . 6.2 m -123.92 137.23 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-O 120.731 0.3 . . . . 0.0 110.947 177.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 89.68 -84.67 1.39 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.2 177.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.05 106.74 7.37 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -75.9 119.76 5.52 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.502 2.135 . . . . 0.0 112.112 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.553 ' HB2' ' HE2' ' A' ' 128' ' ' LYS . 0.5 OUTLIER -53.4 93.07 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.078 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.565 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 14.7 m-85 -61.93 -33.29 74.0 Favored 'General case' 0 C--O 1.219 -0.53 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -172.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -59.32 -49.15 81.58 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 119.821 -1.18 . . . . 0.0 111.335 175.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.553 ' HE2' ' HB2' ' A' ' 125' ' ' ASP . 32.2 ttpt -68.5 -36.88 79.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.09 -0.555 . . . . 0.0 110.265 177.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.565 ' HB3' ' HA ' ' A' ' 126' ' ' PHE . 8.8 tt -64.33 -44.17 92.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.984 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.42 ' HE1' HG23 ' A' ' 50' ' ' THR . 18.2 m-30 -56.36 -56.4 21.55 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.017 0.437 . . . . 0.0 110.625 179.141 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -65.27 -34.26 77.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.882 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -64.49 -38.09 89.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.598 -0.273 . . . . 0.0 111.102 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.522 HG23 HG11 ' A' ' 27' ' ' VAL . 66.1 mt -62.66 -52.87 54.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.721 0.296 . . . . 0.0 110.895 177.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -69.56 -17.63 63.58 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 97.2 m -71.68 -26.63 62.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.307 0.575 . . . . 0.0 109.836 172.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.35 179.653 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 121.13 0.49 . . . . 0.0 110.648 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -125.36 150.16 47.45 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.652 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.8 p -145.3 90.59 2.04 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.518 176.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -110.25 134.73 20.69 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.416 -173.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.566 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 56.5 Cg_endo -72.98 131.74 17.28 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.177 1.918 . . . . 0.0 111.553 174.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.24 176.38 9.73 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.674 HD12 HG21 ' A' ' 78' ' ' VAL . 75.1 mt -70.69 -13.76 62.2 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -173.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -102.19 -2.82 28.47 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.195 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.78 17.76 11.57 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.478 -0.868 . . . . 0.0 114.75 169.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.463 ' HZ2' HG22 ' A' ' 18' ' ' VAL . 41.4 tttm -105.46 126.65 52.36 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 117.761 0.781 . . . . 0.0 110.062 175.065 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 10.2 t -72.28 125.09 26.48 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.433 0.635 . . . . 0.0 109.499 173.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.757 ' HB ' ' SD ' ' A' ' 88' ' ' MET . 60.2 t -113.31 124.29 69.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.238 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.1 m -121.82 -173.94 2.76 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.179 -177.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -68.89 -23.22 64.17 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.873 0.368 . . . . 0.0 110.678 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.14 -28.05 69.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.707 176.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -71.9 -12.41 61.25 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.179 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.2 mt -84.59 -27.87 26.95 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.012 0.434 . . . . 0.0 111.604 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.6 mm100 -74.21 144.4 44.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.121 -170.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.42 -25.47 17.64 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 121.14 -0.553 . . . . 0.0 114.014 170.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.565 ' HG3' ' HG3' ' A' ' 60' ' ' GLN . 0.0 OUTLIER -143.59 -168.18 2.76 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -177.897 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.612 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 14.2 t -101.93 144.4 13.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 176.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.582 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 30.0 m -140.29 149.34 42.67 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.964 -0.295 . . . . 0.0 110.255 -173.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.761 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 6.4 tt -121.64 117.75 27.47 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 173.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.682 ' HB ' ' CG2' ' A' ' 108' ' ' VAL . 51.2 mt -102.56 119.97 51.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.333 -0.394 . . . . 0.0 109.972 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.468 ' OD1' ' HA ' ' A' ' 63' ' ' ALA . 21.7 p-10 -109.62 124.41 51.12 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.604 0.716 . . . . 0.0 111.036 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.439 ' HB2' ' HB ' ' A' ' 106' ' ' THR . 66.1 m-85 -98.11 129.51 44.92 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.58 178.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.62 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 42.4 p-90 -163.16 173.54 13.32 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.434 -177.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.587 ' HD1' ' NE2' ' A' ' 66' ' ' GLN . 29.2 p90 -131.48 141.78 43.0 Favored Pre-proline 0 C--N 1.318 -0.769 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 171.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.696 ' HG2' ' HA ' ' A' ' 74' ' ' VAL . 31.4 Cg_exo -62.74 0.55 1.45 Allowed 'Trans proline' 0 N--CA 1.476 0.459 0 C-N-CA 123.59 2.86 . . . . 0.0 114.592 -173.052 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.44 ' OG ' ' HD2' ' A' ' 34' ' ' PHE . 0.5 OUTLIER -102.28 18.0 22.04 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.133 0.492 . . . . 0.0 110.799 173.967 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 87.5 m -85.56 135.62 38.2 Favored Pre-proline 0 CA--C 1.528 0.096 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.601 176.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 12.7 Cg_exo -71.17 -8.56 23.76 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.008 2.472 . . . . 0.0 111.939 173.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.781 ' O ' ' HB2' ' A' ' 43' ' ' GLU . . . -68.37 5.97 3.66 Favored Glycine 0 C--O 1.22 -0.734 0 CA-C-N 115.762 -0.654 . . . . 0.0 113.667 -177.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.764 ' HA ' ' HG2' ' A' ' 44' ' ' MET . 25.0 p -78.03 -30.25 49.8 Favored 'General case' 0 C--N 1.317 -0.824 0 O-C-N 121.909 -0.759 . . . . 0.0 111.905 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.59 HG23 ' H ' ' A' ' 42' ' ' SER . 6.6 m -56.38 -64.99 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 -166.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.59 ' H ' HG23 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -93.57 -39.72 10.69 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 121.79 -0.569 . . . . 0.0 110.785 178.798 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.781 ' HB2' ' O ' ' A' ' 39' ' ' GLY . 8.3 mp0 -64.21 -41.72 96.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.207 -169.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.764 ' HG2' ' HA ' ' A' ' 40' ' ' CYS . 19.9 mmt -60.37 -53.12 67.89 Favored Pre-proline 0 C--N 1.329 -0.308 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.295 -178.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.481 ' HD3' ' HB2' ' A' ' 44' ' ' MET . 80.6 Cg_exo -51.06 -37.85 58.39 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 122.335 2.023 . . . . 0.0 112.848 172.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.522 ' HD3' ' O ' ' A' ' 42' ' ' SER . 23.2 mtpt -61.32 -41.21 96.63 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 120.823 0.344 . . . . 0.0 110.621 176.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.531 HG13 ' O ' ' A' ' 43' ' ' GLU . 27.2 mt -71.82 -32.09 43.54 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.578 177.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.607 HG12 ' O ' ' A' ' 44' ' ' MET . 47.5 mm -54.51 -52.14 43.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-O 120.893 0.378 . . . . 0.0 110.434 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 46' ' ' LYS . 16.6 pttm -65.4 -44.87 86.1 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.642 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.5 m -70.6 -46.87 62.6 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.984 0.421 . . . . 0.0 111.863 -174.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . -69.25 -33.11 72.76 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.906 -174.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.605 ' HA ' ' NZ ' ' A' ' 55' ' ' LYS . 62.1 t30 -76.41 -50.37 14.34 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.118 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -64.99 -46.1 82.85 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.017 -172.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.758 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 38.1 m-85 -79.67 -10.12 59.74 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.57 -175.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.605 ' NZ ' ' HA ' ' A' ' 52' ' ' ASN . 7.1 ttpm? -63.59 -21.28 66.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.208 0.527 . . . . 0.0 110.518 178.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -106.37 17.23 23.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.625 176.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.6 mtmm -136.62 44.69 2.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.771 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.527 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 17.2 t-20 62.91 31.46 16.24 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.592 0.71 . . . . 0.0 110.745 175.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.761 ' HZ ' ' HB2' ' A' ' 29' ' ' LEU . 48.8 t80 -135.82 137.51 41.61 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.142 176.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.565 ' HG3' ' HG3' ' A' ' 26' ' ' LYS . 4.5 mt-30 -127.69 157.46 40.24 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.224 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 98.6 t -130.88 126.34 59.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 177.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.4 mt -121.39 121.04 36.74 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.122 0.487 . . . . 0.0 110.605 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.582 ' HB3' ' HA ' ' A' ' 87' ' ' VAL . . . -91.19 132.0 36.37 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.458 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.7 t -123.81 101.31 8.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.074 0.464 . . . . 0.0 110.37 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.62 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -85.78 117.38 24.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.685 175.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.642 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 5.8 pm0 -90.92 163.97 27.54 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.34 -0.391 . . . . 0.0 109.981 -176.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.652 ' HD3' ' O ' ' A' ' 90' ' ' ASP . 60.8 Cg_endo -70.17 93.56 0.56 Allowed 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.027 1.818 . . . . 0.0 113.253 -169.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 46.5 mm -124.75 -60.81 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 172.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.493 ' OD2' ' HD2' ' A' ' 35' ' ' PRO . 1.8 p30 -105.67 154.21 39.4 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.602 168.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.414 ' HB2' ' OE2' ' A' ' 72' ' ' GLU . 12.9 Cg_exo -69.33 -179.96 3.07 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 122.83 2.353 . . . . 0.0 114.131 -171.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.1 tp -64.24 -35.81 75.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.879 -169.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.561 ' HA ' ' CD ' ' A' ' 75' ' ' ARG . 0.1 OUTLIER -73.39 -29.13 62.41 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.168 -0.332 . . . . 0.0 110.406 -177.645 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 45.5 m -68.72 -41.99 78.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.996 175.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.696 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 92.3 t -60.44 -55.01 27.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.297 176.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.561 ' CD ' ' HA ' ' A' ' 72' ' ' GLU . 1.4 ptm180 -63.69 -27.59 69.32 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.741 -177.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.457 ' HB2' ' O ' ' A' ' 72' ' ' GLU . 47.3 tt0 -66.14 -45.53 80.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.234 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.435 ' HB2' ' HB3' ' A' ' 35' ' ' PRO . 0.1 OUTLIER -63.31 -35.85 81.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.847 -178.862 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.674 HG21 HD12 ' A' ' 13' ' ' LEU . 60.5 t -61.26 -39.55 82.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.637 176.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 75' ' ' ARG . 95.2 mttt -70.73 -40.96 72.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.951 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -60.0 -49.38 77.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.239 -173.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.439 ' HB2' ' CD1' ' A' ' 83' ' ' LEU . 77.9 m-85 -99.8 3.7 44.9 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.699 -176.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 57.16 57.91 17.32 Favored Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.123 -178.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.655 ' HB2' HG13 ' A' ' 78' ' ' VAL . 10.5 mp -62.17 114.01 10.35 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-O 120.672 0.272 . . . . 0.0 111.476 -176.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -89.99 13.98 2.2 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.369 2.713 . . . . 0.0 112.936 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -117.96 150.21 39.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.836 176.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.7 m -69.83 115.43 9.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.756 0.312 . . . . 0.0 111.319 -173.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.582 ' HA ' ' HB3' ' A' ' 63' ' ' ALA . 31.4 t -104.5 126.59 59.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.138 -176.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.757 ' SD ' ' HB ' ' A' ' 18' ' ' VAL . 63.6 mtm -112.44 169.15 9.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.745 175.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -115.49 123.49 48.67 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.13 176.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.736 ' OD2' ' HA ' ' A' ' 93' ' ' LYS . 20.0 t0 -88.84 107.33 18.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.434 177.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.96 -47.58 20.48 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -175.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -99.85 -12.24 20.04 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -169.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.736 ' HA ' ' OD2' ' A' ' 90' ' ' ASP . 57.2 tttp 68.61 -2.31 1.69 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.015 0.526 . . . . 0.0 111.821 176.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.21 -23.88 43.51 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.919 0.39 . . . . 0.0 110.484 -177.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.453 ' O ' ' HD1' ' A' ' 99' ' ' PHE . 28.3 m -71.39 -38.04 67.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 171.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.52 -33.7 85.44 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 173.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 67.9 mm-40 -66.75 -32.28 73.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.811 0.338 . . . . 0.0 110.856 175.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.67 -39.9 95.49 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.253 0.549 . . . . 0.0 110.487 177.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.499 ' CE2' HD12 ' A' ' 116' ' ' ILE . 29.7 m-85 -73.63 -28.69 61.93 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.062 175.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.33 44.84 2.9 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.424 178.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.547 HG22 HG21 ' A' ' 106' ' ' THR . 52.5 p -104.48 112.91 26.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.253 0.549 . . . . 0.0 111.568 -176.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -111.95 -39.5 4.5 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.356 177.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.6 m -117.78 149.97 20.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 177.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.59 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 92.3 m-85 -129.44 161.62 57.74 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.75 -172.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.59 ' HA ' ' HB3' ' A' ' 104' ' ' TYR . 63.5 Cg_endo -73.03 165.71 83.46 Favored 'Cis proline' 0 C--N 1.349 0.603 0 C-N-CA 123.689 -1.379 . . . . 0.0 113.439 0.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.547 HG21 HG22 ' A' ' 101' ' ' THR . 4.2 m -135.05 148.88 50.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.433 177.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 37.8 m -137.69 114.59 10.66 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.971 0.415 . . . . 0.0 110.621 178.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.682 ' CG2' ' HB ' ' A' ' 30' ' ' ILE . 20.5 m -106.77 145.13 14.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.136 0.493 . . . . 0.0 111.053 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.553 HD11 HD12 ' A' ' 129' ' ' LEU . 9.5 mp -101.69 133.32 46.58 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.542 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.582 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 34.5 mm -110.49 135.02 50.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.943 -176.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -77.17 -150.21 3.74 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.831 -0.7 . . . . 0.0 111.706 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.485 ' HD3' HG22 ' A' ' 27' ' ' VAL . 10.2 mmmm -101.05 -7.58 23.12 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -176.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 2.7 mtmp? -124.55 19.72 8.73 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 113.485 -1.689 . . . . 0.0 109.291 -175.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.2 -90.97 1.58 Allowed Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -173.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 69.17 -30.55 0.19 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 167.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.499 HD12 ' CE2' ' A' ' 99' ' ' PHE . 23.5 mm 53.38 64.87 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 CA-C-O 121.946 0.879 . . . . 0.0 108.997 -169.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.438 HD22 ' HA ' ' A' ' 117' ' ' LEU . 0.2 OUTLIER -62.02 -45.44 93.58 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 113.885 -1.507 . . . . 0.0 112.983 -169.28 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.7 ' HG3' ' OE2' ' A' ' 132' ' ' GLU . 4.3 tmtp? -143.91 153.83 42.71 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.257 -169.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.4 ' H ' ' HD3' ' A' ' 118' ' ' LYS . 40.3 m -139.96 108.01 5.74 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.944 0.402 . . . . 0.0 111.427 178.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -98.95 137.87 36.88 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.294 170.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.6 p -109.91 140.82 27.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 82.22 -109.8 3.11 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 -176.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -111.44 126.31 28.83 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 173.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.54 ' HB2' HD13 ' A' ' 129' ' ' LEU . 56.0 Cg_endo -72.14 125.64 11.05 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.206 1.937 . . . . 0.0 111.369 175.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.418 ' OD2' ' HB3' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -59.22 121.86 12.4 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.234 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -70.33 -29.67 66.44 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.28 -174.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -65.97 -54.91 22.0 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.32 -174.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.418 ' HB3' ' OD2' ' A' ' 125' ' ' ASP . 26.2 tptp -75.74 -33.08 60.24 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.553 HD12 HD11 ' A' ' 109' ' ' LEU . 0.9 OUTLIER -58.31 -48.34 80.8 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.008 0.193 . . . . 0.0 110.974 179.276 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -67.1 -45.14 78.13 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.191 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -64.57 -36.31 83.81 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.387 0.613 . . . . 0.0 110.885 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.7 ' OE2' ' HG3' ' A' ' 118' ' ' LYS . 21.3 tt0 -74.73 -40.02 61.52 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.44 -175.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.506 HG23 HG11 ' A' ' 27' ' ' VAL . 79.7 mt -64.4 -42.3 94.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.876 173.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -54.47 -39.03 67.1 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.462 177.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.8 m -60.51 -39.44 87.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.08 0.467 . . . . 0.0 110.713 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.395 -177.271 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.183 0 CA-C-O 121.08 0.467 . . . . 0.0 110.796 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.515 ' CE1' HD11 ' A' ' 23' ' ' LEU . 45.4 p90 -132.35 168.42 18.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.197 0.522 . . . . 0.0 111.355 -175.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 48.6 m -148.46 95.03 2.38 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 172.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 22.0 tp -115.87 133.61 22.83 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.415 -171.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.503 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 8.1 Cg_exo -72.59 134.97 23.21 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.562 2.175 . . . . 0.0 112.414 178.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.589 ' HB3' ' O ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -76.07 164.36 26.2 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.822 174.8 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.663 ' HB3' ' HG2' ' A' ' 75' ' ' ARG . 69.4 mt -67.13 -7.03 20.25 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 -170.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -123.6 17.71 9.59 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 121.809 -0.557 . . . . 0.0 110.959 174.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.02 22.35 25.59 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.931 -0.652 . . . . 0.0 114.045 169.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.589 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 11.3 tmtt? -97.03 102.5 14.29 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 173.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 12.0 m -63.52 122.42 16.25 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.894 0.378 . . . . 0.0 110.262 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.511 ' HB ' ' SD ' ' A' ' 88' ' ' MET . 60.8 t -106.24 116.44 50.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.801 178.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 83.4 p -103.15 -176.91 3.22 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.432 -177.015 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -73.3 -23.01 60.23 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.688 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.53 ' O ' ' HG3' ' A' ' 24' ' ' GLN . . . -68.34 -28.57 67.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.051 178.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -70.84 -15.53 62.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.871 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.515 HD11 ' CE1' ' A' ' 8' ' ' PHE . 92.3 mt -83.87 -20.21 33.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.706 -177.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.53 ' HG3' ' O ' ' A' ' 21' ' ' ALA . 0.4 OUTLIER -100.24 141.56 32.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.46 0.648 . . . . 0.0 112.457 -172.784 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.76 -8.32 68.26 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.101 -176.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 112' ' ' LYS . 9.3 mtpm? -142.31 164.23 30.71 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.697 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 25.2 t -102.5 141.73 18.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -177.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.466 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 26.8 m -132.78 138.47 47.16 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -165.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.63 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 36.7 tp -121.49 112.31 18.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.192 170.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.564 HG12 ' HB2' ' A' ' 62' ' ' LEU . 54.4 mt -102.33 115.6 44.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.801 0.334 . . . . 0.0 110.411 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.434 ' HA ' ' O ' ' A' ' 106' ' ' THR . 4.5 p-10 -109.06 126.87 53.62 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.326 0.584 . . . . 0.0 110.281 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.479 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 86.1 m-85 -92.97 127.9 38.65 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.829 178.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.51 ' NE1' ' HB1' ' A' ' 63' ' ' ALA . 5.3 p-90 -153.04 -178.05 6.68 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.065 0.46 . . . . 0.0 111.218 -175.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -149.48 148.22 25.47 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.757 172.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.518 ' HD2' ' HB2' ' A' ' 69' ' ' ASP . 96.3 Cg_exo -44.94 -47.87 11.49 Favored 'Trans proline' 0 N--CA 1.475 0.437 0 C-N-CA 123.592 2.861 . . . . 0.0 114.569 -175.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.9 m -82.67 17.14 1.91 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -175.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 53.3 t -73.61 126.51 89.72 Favored Pre-proline 0 C--N 1.328 -0.333 0 O-C-N 122.355 -0.215 . . . . 0.0 110.638 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -62.72 -22.28 73.77 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.907 2.405 . . . . 0.0 113.048 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.84 -17.01 80.28 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.181 -177.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 31.2 p -67.7 -41.5 83.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.069 0.434 . . . . 0.0 111.187 -174.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.8 p -59.99 -32.03 49.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.855 0.36 . . . . 0.0 111.169 -176.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.0 m -86.89 -54.09 4.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.818 0.342 . . . . 0.0 111.328 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -85.22 -29.69 24.47 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -168.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.578 ' O ' HG12 ' A' ' 48' ' ' ILE . 41.1 ttm -58.7 -46.7 99.56 Favored Pre-proline 0 N--CA 1.47 0.535 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -173.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 44' ' ' MET . 7.0 Cg_endo -50.97 -38.11 58.03 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.017 1.811 . . . . 0.0 112.246 175.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -65.2 -44.15 89.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.209 0.528 . . . . 0.0 109.76 176.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 42.5 mm -60.87 -41.46 88.86 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.359 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.74 178.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.578 HG12 ' O ' ' A' ' 44' ' ' MET . 43.0 mm -54.34 -49.2 65.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.249 0.547 . . . . 0.0 110.086 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.437 ' HE3' ' HB3' ' A' ' 49' ' ' LYS . 18.5 ttpp -64.96 -57.58 8.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.576 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.6 m -63.24 -41.91 99.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.766 -173.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.05 -50.24 62.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.126 -177.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -64.85 -43.04 94.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.858 0.361 . . . . 0.0 110.889 -173.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.434 ' CG ' ' HZ1' ' A' ' 57' ' ' LYS . 14.1 t70 -59.93 -42.2 93.45 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.001 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 1.037 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 14.9 m-85 -81.34 -26.18 35.79 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.218 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.4 mmmm -58.59 -30.63 67.35 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.854 0.359 . . . . 0.0 110.564 176.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -94.15 19.36 9.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.034 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.434 ' HZ1' ' CG ' ' A' ' 53' ' ' ASP . 27.3 mtmm -128.25 -59.09 1.18 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.325 176.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.408 ' O ' ' HB3' ' A' ' 26' ' ' LYS . 27.2 t-20 176.99 -14.64 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.321 0.582 . . . . 0.0 110.892 -174.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 1.037 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 62.9 t80 -98.31 147.71 24.38 Favored 'General case' 0 C--N 1.316 -0.849 0 O-C-N 122.032 -0.417 . . . . 0.0 109.938 -174.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -137.83 127.66 25.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.134 0.493 . . . . 0.0 111.324 -176.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 92.3 t -99.23 120.43 48.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.426 174.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.564 ' HB2' HG12 ' A' ' 30' ' ' ILE . 72.4 mt -113.78 112.84 24.08 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.708 -178.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.51 ' HB1' ' NE1' ' A' ' 33' ' ' TRP . . . -93.5 107.51 19.35 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.645 -177.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 88.4 t -95.66 113.92 31.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.075 0.464 . . . . 0.0 110.448 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.51 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -86.11 131.9 34.15 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.697 176.06 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.598 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -100.24 163.91 17.37 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.514 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.598 ' HD2' ' HB2' ' A' ' 66' ' ' GLN . 32.8 Cg_endo -64.12 79.27 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.542 2.162 . . . . 0.0 113.784 -175.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.469 HG12 ' HG2' ' A' ' 66' ' ' GLN . 40.1 mm -117.83 -63.35 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 171.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.518 ' HB2' ' HD2' ' A' ' 35' ' ' PRO . 14.8 m-20 -96.62 149.55 35.95 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 168.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.45 150.51 34.02 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.633 2.222 . . . . 0.0 112.893 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.0 tt -55.14 -38.5 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.629 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -66.18 -37.39 85.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.107 0.48 . . . . 0.0 110.419 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.4 m -61.35 -35.01 76.25 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.387 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.477 ' HA ' ' HG3' ' A' ' 35' ' ' PRO . 10.9 t -67.67 -41.0 85.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.114 178.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.801 ' HA ' HG22 ' A' ' 78' ' ' VAL . 41.8 mtp180 -69.08 -32.82 72.54 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.368 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.3 tm0? -62.75 -38.81 92.01 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 175.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.466 ' HE1' ' SD ' ' A' ' 44' ' ' MET . 7.7 t80 -67.85 -48.68 65.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.267 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.801 HG22 ' HA ' ' A' ' 75' ' ' ARG . 25.8 m -62.9 -31.93 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -177.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.479 ' HB3' ' HE2' ' A' ' 79' ' ' LYS . 44.9 mtpt -74.64 -54.27 7.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.75 0.309 . . . . 0.0 111.408 177.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -65.71 -41.29 92.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.918 -171.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -89.75 -21.76 22.51 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.604 -175.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.0 75.48 0.91 Allowed Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.429 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.64 HD22 HG12 ' A' ' 78' ' ' VAL . 10.6 mp -95.26 112.32 58.18 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 120.798 0.332 . . . . 0.0 111.107 -177.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -81.0 -11.41 12.33 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.185 2.59 . . . . 0.0 113.326 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.471 ' HE1' HD13 ' A' ' 48' ' ' ILE . 29.1 p90 -91.06 145.21 24.88 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 176.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.41 ' HB ' ' CD2' ' A' ' 62' ' ' LEU . 19.4 m -71.83 118.21 14.4 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.976 -172.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.46 HG22 ' HB3' ' A' ' 63' ' ' ALA . 39.0 t -107.49 129.26 61.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.573 -178.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.511 ' SD ' ' HB ' ' A' ' 18' ' ' VAL . 70.9 mtm -119.85 171.17 8.61 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.45 178.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -137.48 115.27 11.39 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.741 0.305 . . . . 0.0 110.329 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.593 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 47.8 t0 -98.73 102.41 14.13 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.36 -28.27 61.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.723 -176.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -83.71 -7.11 59.55 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.872 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.3 pttp 47.41 25.2 0.57 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.214 1.005 . . . . 0.0 111.774 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -81.59 -34.38 31.03 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.601 -172.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.539 HG22 ' OD2' ' A' ' 90' ' ' ASP . 31.5 m -76.31 -30.68 20.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 119.989 -0.684 . . . . 0.0 109.604 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -69.92 -38.51 75.17 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 172.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 -69.97 -23.75 63.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.567 -0.317 . . . . 0.0 111.346 176.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.42 -36.33 71.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.667 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -86.86 -19.27 29.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.082 176.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 81.84 41.94 9.32 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.904 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.562 HG22 HG21 ' A' ' 106' ' ' THR . 50.4 p -76.15 86.86 3.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.223 0.535 . . . . 0.0 111.054 -178.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -93.09 -45.23 7.99 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.638 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.558 ' HB ' HG22 ' A' ' 121' ' ' VAL . 21.3 t -100.28 123.41 53.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.981 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -104.09 144.37 28.55 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.077 -177.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -76.47 165.27 85.67 Favored 'Cis proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.724 -1.365 . . . . 0.0 113.304 0.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.562 HG21 HG22 ' A' ' 101' ' ' THR . 5.5 m -129.54 125.93 37.4 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.82 174.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.443 ' HB3' HD11 ' A' ' 29' ' ' LEU . 16.5 m -111.62 114.51 27.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.857 0.36 . . . . 0.0 110.884 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.527 HG22 HG23 ' A' ' 119' ' ' THR . 47.3 t -105.98 130.82 56.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.325 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.547 HD12 ' HB3' ' A' ' 118' ' ' LYS . 85.8 mt -101.7 120.2 39.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.567 -178.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.466 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 31.1 mt -112.58 144.13 20.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.405 179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.697 ' O ' ' HA ' ' A' ' 27' ' ' VAL . . . -72.88 -112.03 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 121.117 -0.563 . . . . 0.0 113.071 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 18.0 pttm -140.54 -8.06 1.12 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -173.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -121.44 -9.75 8.97 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 173.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 127.9 -4.41 6.94 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.592 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 115' ' ' GLU . 5.9 pm0 -58.36 116.95 3.95 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.43 0.633 . . . . 0.0 110.225 -177.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 60.7 mt -78.12 112.33 15.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.589 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.404 ' CD1' ' HB2' ' A' ' 136' ' ' ALA . 61.3 mt -90.17 -50.5 5.96 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.416 -173.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.547 ' HB3' HD12 ' A' ' 109' ' ' LEU . 18.0 tptm -152.08 158.35 42.87 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.427 -167.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.527 HG23 HG22 ' A' ' 108' ' ' VAL . 32.0 m -143.15 103.73 4.19 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.147 0.498 . . . . 0.0 110.526 174.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -88.93 106.21 18.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.075 174.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.558 HG22 ' HB ' ' A' ' 103' ' ' VAL . 7.7 p -95.92 121.43 46.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.265 0.555 . . . . 0.0 110.711 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 105.14 -80.6 0.3 Allowed Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.11 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -138.82 118.57 9.53 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.89 143.12 20.51 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.629 2.219 . . . . 0.0 113.323 -177.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.53 ' O ' ' HB2' ' A' ' 129' ' ' LEU . 24.8 t0 -77.45 107.6 10.01 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 172.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -66.35 -43.49 85.88 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -174.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.25 -43.75 98.65 Favored Glycine 0 C--O 1.239 0.437 0 C-N-CA 120.261 -0.971 . . . . 0.0 111.161 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.638 ' HB2' ' NZ ' ' A' ' 128' ' ' LYS . 1.7 ttmp? -71.82 -31.59 66.69 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.21 -0.495 . . . . 0.0 109.994 178.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.533 ' O ' HG13 ' A' ' 133' ' ' ILE . 0.2 OUTLIER -56.55 -48.01 78.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.001 177.397 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -65.92 -48.97 69.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.386 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.45 ' HG2' ' HA ' ' A' ' 128' ' ' LYS . 3.3 pt20 -68.36 -32.23 72.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.964 0.412 . . . . 0.0 111.459 -177.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -74.68 -32.66 62.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.322 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.533 HG13 ' O ' ' A' ' 129' ' ' LEU . 59.5 mt -62.85 -49.69 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 172.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -56.65 -38.23 71.89 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.409 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 88.0 m -55.48 -40.62 71.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.012 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.404 ' HB2' ' CD1' ' A' ' 117' ' ' LEU . . . . . . . . 0 C--O 1.237 0.42 0 CA-C-O 121.039 0.447 . . . . 0.0 111.039 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.19 0 CA-C-O 121.025 0.44 . . . . 0.0 111.587 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -129.14 135.55 49.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.624 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.3 t -150.2 88.89 1.54 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 171.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.477 HD11 ' HB3' ' A' ' 88' ' ' MET . 1.4 pt? -121.71 155.25 60.21 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.593 -178.015 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.601 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 8.1 Cg_exo -73.23 130.3 15.06 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.633 2.222 . . . . 0.0 112.522 177.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.54 160.81 31.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.516 173.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.453 HD12 HG11 ' A' ' 78' ' ' VAL . 41.4 mt -60.91 -24.01 65.67 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 -174.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -83.14 -11.7 57.69 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.06 -15.07 16.18 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 121.167 -0.54 . . . . 0.0 113.256 174.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -76.37 121.44 23.03 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.869 0.335 . . . . 0.0 111.114 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.601 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 20.5 m -69.75 123.18 20.76 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 172.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.9 t -119.56 130.01 74.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.981 0.42 . . . . 0.0 110.778 -176.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.9 t -132.05 173.99 10.65 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.494 178.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.756 ' HA ' HD13 ' A' ' 23' ' ' LEU . 30.0 p-10 -61.01 -22.8 64.88 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -172.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.68 -27.95 67.28 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 178.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -67.63 -32.81 73.77 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.18 0.514 . . . . 0.0 110.93 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.756 HD13 ' HA ' ' A' ' 20' ' ' ASN . 5.2 mp -71.46 -20.36 62.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.064 -175.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -68.21 98.5 0.81 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.211 -177.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 132.17 -22.85 4.18 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.079 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.4 mtmm -111.47 162.56 14.97 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -103.46 123.34 56.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 168.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.53 ' HB ' HD12 ' A' ' 110' ' ' ILE . 11.0 m -126.59 150.9 48.6 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.092 0.472 . . . . 0.0 111.842 -164.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.422 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 51.9 tp -123.71 120.45 32.74 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.921 174.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.982 ' HB ' HG12 ' A' ' 108' ' ' VAL . 34.5 mm -97.19 132.79 40.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 175.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -128.17 125.07 38.33 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.245 0.545 . . . . 0.0 109.879 174.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.413 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 48.3 m-85 -90.56 122.63 33.54 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.991 176.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.474 ' NE1' ' HB1' ' A' ' 63' ' ' ALA . 6.1 p-90 -148.4 -169.84 3.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.454 -177.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -159.4 143.8 11.17 Favored Pre-proline 0 C--N 1.321 -0.656 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 174.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.494 ' HG2' ' CB ' ' A' ' 69' ' ' ASP . 12.8 Cg_endo -59.0 158.93 23.31 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.414 2.076 . . . . 0.0 111.521 176.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.8 m 68.32 18.41 9.14 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.19 -177.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.475 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 52.8 t -101.3 136.78 19.59 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.547 177.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.482 ' O ' HG22 ' A' ' 41' ' ' VAL . 19.9 Cg_exo -67.15 -13.8 40.99 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 123.014 2.476 . . . . 0.0 112.919 178.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.42 -4.78 19.13 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 121.515 -0.374 . . . . 0.0 113.467 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.707 ' O ' ' HB2' ' A' ' 44' ' ' MET . 61.0 m -63.22 -34.88 78.61 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 122.725 -0.28 . . . . 0.0 110.897 176.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 38' ' ' PRO . 33.0 m -67.98 -33.99 64.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.176 -177.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.9 p -88.87 -56.41 3.3 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.575 ' HG2' ' HG3' ' A' ' 105' ' ' PRO . 1.4 mp0 -84.09 -34.77 24.09 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -168.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.707 ' HB2' ' O ' ' A' ' 40' ' ' CYS . 8.6 mmt -61.12 -48.11 93.0 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -175.023 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 44' ' ' MET . 13.2 Cg_endo -57.25 -34.19 97.38 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 121.838 1.692 . . . . 0.0 112.305 175.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.48 ' HD2' ' HA ' ' A' ' 43' ' ' GLU . 93.9 mttt -64.32 -51.66 62.34 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 176.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.674 HG23 HG11 ' A' ' 61' ' ' VAL . 45.1 mm -57.43 -46.91 85.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.834 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.469 HG12 ' O ' ' A' ' 44' ' ' MET . 46.1 mm -56.57 -53.36 42.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.184 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -69.3 -51.34 38.22 Favored 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.384 -174.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 62.4 m -57.2 -42.39 81.18 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.071 0.463 . . . . 0.0 111.196 -176.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.04 -31.5 70.32 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.751 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -73.88 -45.5 50.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.783 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -54.59 -51.58 64.86 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.745 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.606 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 61.6 m-85 -97.22 8.53 44.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.433 -175.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.516 ' HE3' ' HA ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -60.54 -45.62 93.19 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.254 0.55 . . . . 0.0 110.169 -179.903 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -89.95 33.56 0.86 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.617 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.606 ' HE2' ' HA ' ' A' ' 54' ' ' TYR . 0.7 OUTLIER -126.08 -68.35 0.83 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.7 171.981 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 177.03 13.72 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.767 -177.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.422 ' HZ ' ' HB2' ' A' ' 29' ' ' LEU . 22.1 t80 -99.96 147.52 25.49 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.032 -173.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.507 ' O ' ' HA ' ' A' ' 28' ' ' THR . 50.5 tp60 -138.91 147.3 42.15 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.918 -177.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.674 HG11 HG23 ' A' ' 47' ' ' ILE . 86.9 t -129.2 129.64 67.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.748 0.309 . . . . 0.0 110.465 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.843 ' HG ' ' HB ' ' A' ' 86' ' ' THR . 9.9 mp -121.53 121.91 38.53 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.78 177.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.474 ' HB1' ' NE1' ' A' ' 33' ' ' TRP . . . -101.44 119.63 39.06 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.347 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.9 t -97.29 107.65 20.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.916 0.389 . . . . 0.0 110.748 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 89' ' ' TYR . . . -91.5 126.42 36.58 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.101 177.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.617 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 2.8 pt20 -97.91 168.78 9.45 Favored Pre-proline 0 C--N 1.317 -0.839 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.491 -178.09 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.652 ' HD2' ' HG3' ' A' ' 93' ' ' LYS . 98.7 Cg_endo -75.91 45.07 1.42 Allowed 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 122.81 2.34 . . . . 0.0 114.85 -165.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 50.7 mm -78.67 -32.61 16.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 171.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.494 ' CB ' ' HG2' ' A' ' 35' ' ' PRO . 0.2 OUTLIER -136.48 136.32 21.94 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 114.64 -1.164 . . . . 0.0 107.926 170.792 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 69' ' ' ASP . 35.7 Cg_exo -58.2 174.02 0.82 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.079 2.519 . . . . 0.0 113.681 -175.026 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.532 ' HA ' HG12 ' A' ' 74' ' ' VAL . 19.8 tt -71.87 -27.07 26.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.591 -169.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.414 ' OE2' ' HB2' ' A' ' 70' ' ' PRO . 9.2 pm0 -74.02 -28.81 61.62 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.671 175.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 63.0 m -64.51 -48.63 74.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.98 0.419 . . . . 0.0 110.35 174.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.532 HG12 ' HA ' ' A' ' 71' ' ' ILE . 9.6 p -67.62 -34.36 67.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.65 -178.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.872 ' HA ' HG22 ' A' ' 78' ' ' VAL . 66.7 mtt180 -71.66 -29.01 64.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.999 175.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -64.76 -41.52 95.82 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 173.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -64.78 -51.73 60.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.073 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.104 ' HA ' HD23 ' A' ' 83' ' ' LEU . 35.8 m -61.8 -26.63 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.379 -178.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.701 ' HZ2' ' HB3' ' A' ' 79' ' ' LYS . 1.6 ttpm? -72.06 -49.43 36.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.303 0.573 . . . . 0.0 110.052 174.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.48 -48.07 77.91 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.681 -1.145 . . . . 0.0 112.857 -173.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -103.19 4.41 36.78 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.428 -174.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 57.12 55.27 31.22 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 116.037 -0.529 . . . . 0.0 113.101 177.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 1.104 HD23 ' HA ' ' A' ' 78' ' ' VAL . 3.1 mm? -71.18 111.65 10.79 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-O 120.784 0.326 . . . . 0.0 110.556 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -85.59 -6.99 8.8 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.11 2.54 . . . . 0.0 113.77 -173.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.55 ' CE2' HD12 ' A' ' 83' ' ' LEU . 28.7 p90 -90.54 169.87 10.66 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.936 0.398 . . . . 0.0 110.929 -178.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.843 ' HB ' ' HG ' ' A' ' 62' ' ' LEU . 18.3 m -75.25 132.13 40.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.174 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.2 t -130.06 130.9 66.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -177.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.477 ' HB3' HD11 ' A' ' 10' ' ' LEU . 57.5 mtt -111.94 163.76 13.87 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.42 -178.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 92.4 t80 -126.42 115.18 19.21 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.835 176.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.507 ' OD2' HG22 ' A' ' 95' ' ' VAL . 40.0 t0 -87.56 127.08 35.26 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.53 -30.12 59.65 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -177.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.588 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 17.2 t70 -127.22 -10.94 5.85 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -169.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.652 ' HG3' ' HD2' ' A' ' 67' ' ' PRO . 25.0 mtpp 76.69 14.09 2.23 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -169.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.17 -44.41 97.34 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -170.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.507 HG22 ' OD2' ' A' ' 90' ' ' ASP . 27.7 m -72.32 -33.55 46.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.197 -178.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -70.23 -33.9 69.2 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.499 -0.857 . . . . 0.0 111.086 173.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -71.43 -24.29 62.0 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 122.751 0.42 . . . . 0.0 110.722 176.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.59 -35.42 73.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.185 173.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -82.43 -11.31 58.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.855 175.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 76.73 32.34 50.6 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.383 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 38.0 p -80.21 96.2 6.51 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.248 0.547 . . . . 0.0 111.466 -177.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -89.34 -31.46 17.79 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.365 0.602 . . . . 0.0 109.618 174.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.3 p -107.1 150.22 9.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.181 -176.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.413 ' CE1' ' HB3' ' A' ' 32' ' ' PHE . 93.6 m-85 -140.02 155.41 70.81 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.399 -178.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.575 ' HG3' ' HG2' ' A' ' 43' ' ' GLU . 90.5 Cg_endo -77.73 162.58 89.69 Favored 'Cis proline' 0 C--N 1.343 0.259 0 C-N-CA 123.293 -1.545 . . . . 0.0 112.796 0.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.504 HG23 HG12 ' A' ' 121' ' ' VAL . 55.1 m -138.28 131.34 29.99 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.824 178.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 35.1 p -116.25 148.52 40.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.015 0.436 . . . . 0.0 111.376 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.982 HG12 ' HB ' ' A' ' 30' ' ' ILE . 1.9 p -124.57 148.4 28.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 176.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.49 ' O ' ' HB2' ' A' ' 117' ' ' LEU . 4.3 mm? -100.51 123.55 44.87 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 121.002 0.43 . . . . 0.0 109.986 -177.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.774 HG23 ' HA ' ' A' ' 115' ' ' GLU . 59.6 mt -109.01 130.21 62.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.693 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.545 ' HA2' ' HB1' ' A' ' 136' ' ' ALA . . . -84.6 -152.25 15.69 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.12 175.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -110.56 15.1 22.28 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.0 mtpp -104.72 19.22 20.83 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 113.6 -1.636 . . . . 0.0 109.646 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 108.25 -77.98 0.23 Allowed Glycine 0 C--O 1.223 -0.562 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.546 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.774 ' HA ' HG23 ' A' ' 110' ' ' ILE . 0.7 OUTLIER -166.83 161.08 15.11 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 117.689 0.745 . . . . 0.0 112.322 -179.823 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 13.5 mt 75.93 85.24 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 125.826 1.65 . . . . 0.0 112.761 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.494 HD23 ' H ' ' A' ' 111' ' ' GLY . 1.3 mm? -110.74 -51.5 2.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.372 171.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.52 ' HG3' ' OE2' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -155.27 174.55 15.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.768 -174.726 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 21.0 m -141.53 133.94 28.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.668 0.27 . . . . 0.0 110.919 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.482 ' HD1' HD23 ' A' ' 109' ' ' LEU . 54.1 m-85 -132.31 110.19 10.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.567 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.504 HG12 HG23 ' A' ' 106' ' ' THR . 22.6 m -92.9 141.57 14.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.025 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 70.38 -113.71 5.03 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.447 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -94.55 109.92 46.02 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.73 121.16 4.97 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.425 2.084 . . . . 0.0 112.428 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.556 ' CG ' ' HG2' ' A' ' 128' ' ' LYS . 8.3 t0 -57.14 105.16 0.2 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 175.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -61.72 -31.34 71.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.852 -175.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -63.35 -49.31 71.43 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.468 -0.872 . . . . 0.0 111.381 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.556 ' HG2' ' CG ' ' A' ' 125' ' ' ASP . 33.2 mmtm -70.54 -34.97 72.85 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.57 ' O ' HG13 ' A' ' 133' ' ' ILE . 0.2 OUTLIER -56.34 -47.92 77.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.385 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -64.27 -55.72 19.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.778 -0.192 . . . . 0.0 110.867 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -58.25 -32.2 68.13 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.372 0.606 . . . . 0.0 111.337 -177.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.52 ' OE2' ' HG3' ' A' ' 118' ' ' LYS . 24.7 tt0 -80.59 -29.59 36.94 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.677 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.57 HG13 ' O ' ' A' ' 129' ' ' LEU . 51.5 mt -62.62 -44.77 99.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 171.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -59.06 -31.03 68.5 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.348 0.594 . . . . 0.0 110.517 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 132' ' ' GLU . 92.3 m -66.43 -35.91 81.47 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.431 176.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.545 ' HB1' ' HA2' ' A' ' 111' ' ' GLY . . . . . . . . 0 C--O 1.236 0.351 0 CA-C-O 121.069 0.462 . . . . 0.0 110.388 176.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.263 0 CA-C-O 120.727 0.299 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 19' ' ' SER . 55.9 p90 -135.63 137.25 41.69 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.331 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.513 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 40.7 m -149.39 88.85 1.6 Allowed 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 173.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.417 ' H ' HD23 ' A' ' 10' ' ' LEU . 1.7 pt? -122.29 146.16 46.25 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.141 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 16.6 Cg_exo -68.25 137.2 39.59 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.285 1.99 . . . . 0.0 111.083 172.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.419 ' CG ' ' H ' ' A' ' 14' ' ' HIS . 0.8 OUTLIER -69.58 -179.29 1.68 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.943 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.548 HD21 HG21 ' A' ' 78' ' ' VAL . 2.9 pp -70.76 -9.2 56.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.741 0.305 . . . . 0.0 111.759 -176.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.419 ' H ' ' CG ' ' A' ' 12' ' ' ASP . 22.9 t-80 -92.24 -55.8 3.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.493 172.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 150.46 22.5 0.06 OUTLIER Glycine 0 CA--C 1.522 0.472 0 C-N-CA 120.06 -1.066 . . . . 0.0 114.175 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 41.1 tttm -105.8 126.24 51.93 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 117.445 0.623 . . . . 0.0 109.941 175.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 7.0 t -65.28 127.67 32.71 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.054 0.454 . . . . 0.0 109.79 174.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 9' ' ' SER . 46.8 t -111.12 124.57 68.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 8' ' ' PHE . 50.4 p -129.38 -175.11 3.47 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.216 -173.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -73.8 -23.97 59.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.928 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.78 -27.48 68.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.015 177.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -69.25 -24.44 63.99 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.484 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.693 HD13 HG21 ' A' ' 110' ' ' ILE . 38.5 mt -82.22 -44.1 16.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.23 -174.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -60.85 126.26 26.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.363 0.601 . . . . 0.0 111.208 -175.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.37 -25.3 10.59 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.639 -176.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.624 ' O ' ' HA ' ' A' ' 112' ' ' LYS . 65.9 mttm -131.72 175.44 9.19 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.988 0.423 . . . . 0.0 110.049 177.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 58.9 t -103.48 146.88 10.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 170.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.596 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 22.2 m -134.67 143.65 47.37 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 121.782 -0.574 . . . . 0.0 111.862 -170.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.675 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 53.8 tp -113.92 113.92 25.51 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 171.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.673 ' HB ' ' CG1' ' A' ' 108' ' ' VAL . 30.2 mt -96.82 112.13 28.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 175.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -111.49 130.66 55.65 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.28 0.562 . . . . 0.0 109.867 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.522 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 94.3 m-85 -98.69 119.24 37.08 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.755 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.657 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 7.7 p-90 -139.1 -177.36 4.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.859 -174.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.637 ' HB3' ' OE1' ' A' ' 66' ' ' GLN . 33.0 p90 -157.9 150.62 18.12 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.837 175.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.49 157.59 35.74 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.116 1.877 . . . . 0.0 110.862 173.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.2 m 65.33 17.61 11.05 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.98 0.419 . . . . 0.0 111.2 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 51.9 t -80.13 133.41 57.56 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.846 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 26.1 Cg_exo -63.72 -26.59 68.39 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.64 2.227 . . . . 0.0 111.557 174.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.58 -16.78 78.77 Favored Glycine 0 C--O 1.225 -0.465 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.659 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 48.9 t -57.81 -30.85 66.04 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 122.446 0.299 . . . . 0.0 111.673 -175.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.1 p -61.1 -33.15 54.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.156 0.503 . . . . 0.0 110.21 177.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.606 ' O ' ' HE3' ' A' ' 46' ' ' LYS . 15.2 m -89.11 -49.76 6.56 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.097 175.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.546 ' O ' HG12 ' A' ' 47' ' ' ILE . 41.9 mt-10 -59.27 -52.68 64.61 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.85 -172.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.682 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 41.1 tpp -59.21 -58.06 22.38 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.402 -170.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.682 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 50.4 Cg_exo -57.05 -36.86 99.43 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.088 1.859 . . . . 0.0 112.56 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.606 ' HE3' ' O ' ' A' ' 42' ' ' SER . 0.0 OUTLIER -65.3 -51.26 61.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.482 179.217 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.546 HG12 ' O ' ' A' ' 43' ' ' GLU . 49.5 mm -60.91 -42.2 91.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.152 -178.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.634 HD13 ' HE1' ' A' ' 85' ' ' PHE . 47.7 mm -54.6 -53.26 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.803 0.335 . . . . 0.0 110.861 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -67.73 -51.49 48.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.405 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.456 ' O ' ' HD2' ' A' ' 54' ' ' TYR . 89.2 m -58.51 -47.0 85.58 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.263 -177.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . -69.15 -24.29 64.06 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -177.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -68.85 -51.73 37.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.265 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -68.17 -52.64 32.27 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.607 0.718 . . . . 0.0 111.002 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 1.034 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 54.6 m-85 -64.58 -21.85 66.81 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.107 -173.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -53.95 -49.6 68.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.0 0.428 . . . . 0.0 110.752 179.82 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 -88.08 -18.58 28.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.426 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.463 ' HE3' ' HB2' ' A' ' 57' ' ' LYS . 4.5 tppp? -61.26 -71.88 0.13 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.055 176.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.515 ' OD1' ' HE2' ' A' ' 112' ' ' LYS . 3.7 t-20 169.35 31.29 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 1.034 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 50.7 t80 -140.02 156.2 46.73 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.983 -171.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.452 ' O ' ' HA ' ' A' ' 28' ' ' THR . 10.6 pt20 -148.85 159.14 44.45 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.291 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 86.3 t -123.96 130.69 73.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.465 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.404 HD23 ' HB ' ' A' ' 86' ' ' THR . 85.6 mt -113.17 104.59 12.51 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.596 178.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.407 ' HB1' ' NE1' ' A' ' 33' ' ' TRP . . . -89.5 102.47 15.14 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.378 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 59.0 t -99.23 114.67 37.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.053 0.454 . . . . 0.0 110.444 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.657 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -86.17 134.44 33.79 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.722 175.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.637 ' OE1' ' HB3' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -100.78 163.93 17.13 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.622 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.621 ' HD2' ' HB2' ' A' ' 93' ' ' LYS . 33.0 Cg_endo -61.87 89.88 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.324 2.016 . . . . 0.0 113.365 -174.002 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 41.2 mm -130.82 -66.18 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 172.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.427 ' OD1' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -92.78 147.7 34.6 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 171.244 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.427 ' HD2' ' OD1' ' A' ' 69' ' ' ASP . 54.3 Cg_exo -53.78 158.51 8.32 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 122.656 2.238 . . . . 0.0 113.698 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.606 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 5.9 tp -56.52 -33.16 38.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.167 178.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.486 ' OE2' ' HD2' ' A' ' 75' ' ' ARG . 6.1 tp10 -64.25 -41.35 97.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.233 0.539 . . . . 0.0 110.222 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.5 m -60.14 -44.47 94.91 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.824 -177.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.46 ' O ' HG23 ' A' ' 78' ' ' VAL . 7.5 p -70.65 -33.62 53.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.852 -179.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.606 ' HG3' ' O ' ' A' ' 71' ' ' ILE . 98.7 mtt180 -55.29 -53.16 59.55 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.4 0.619 . . . . 0.0 110.327 175.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -63.66 -45.11 91.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.705 -176.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -55.4 -45.19 76.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.047 -176.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.657 ' HA ' HD22 ' A' ' 83' ' ' LEU . 86.1 t -64.36 -44.85 97.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.497 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.756 ' HA ' ' HE3' ' A' ' 79' ' ' LYS . 1.3 mmmt -76.96 -33.59 57.65 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.276 -0.57 . . . . 0.0 112.336 -175.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.94 -48.14 77.71 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 123.412 0.445 . . . . 0.0 110.909 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.457 ' HB2' ' CD1' ' A' ' 83' ' ' LEU . 80.8 m-85 -97.57 12.92 31.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.901 0.381 . . . . 0.0 111.18 -178.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.64 -60.49 4.35 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 121.103 -0.57 . . . . 0.0 113.029 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.657 HD22 ' HA ' ' A' ' 78' ' ' VAL . 10.2 mp 48.71 87.12 0.13 Allowed Pre-proline 0 N--CA 1.467 0.407 0 C-N-CA 123.756 0.822 . . . . 0.0 112.346 -177.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -79.27 44.52 1.71 Allowed 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.409 2.739 . . . . 0.0 112.953 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.634 ' HE1' HD13 ' A' ' 48' ' ' ILE . 21.1 p90 -152.27 157.5 41.48 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.404 ' HB ' HD23 ' A' ' 62' ' ' LEU . 18.7 m -74.78 117.9 17.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.96 0.409 . . . . 0.0 111.001 -174.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 36.0 t -110.2 126.62 67.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.577 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.415 ' SD ' ' HB ' ' A' ' 18' ' ' VAL . 76.0 mtm -119.13 167.73 11.53 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.626 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.426 ' HD1' ' HB3' ' A' ' 65' ' ' ALA . 78.2 t80 -138.56 117.18 12.17 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.559 ' OD2' HG22 ' A' ' 95' ' ' VAL . 43.9 t0 -92.13 128.72 38.08 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.68 -32.08 62.09 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -177.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' A' ' 93' ' ' LYS . 25.9 t70 -112.1 -11.88 13.75 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.795 0.331 . . . . 0.0 110.807 -175.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.621 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 33.8 ttmt 73.15 15.68 4.4 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.533 -177.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.83 -39.84 93.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.423 -173.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.559 HG22 ' OD2' ' A' ' 90' ' ' ASP . 27.0 m -70.85 -31.93 47.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.863 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -72.1 -34.09 61.79 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 174.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.462 ' HG3' ' O ' ' A' ' 93' ' ' LYS . 51.8 mt-30 -64.35 -29.16 70.24 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 122.554 0.342 . . . . 0.0 110.482 176.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.22 -38.87 65.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.02 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -80.44 -13.14 59.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.823 0.344 . . . . 0.0 111.158 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.01 45.6 5.34 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.938 176.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 56.9 p -75.7 89.54 2.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.172 0.51 . . . . 0.0 111.2 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -96.39 -52.52 3.94 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.251 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.451 ' HB ' ' CG2' ' A' ' 121' ' ' VAL . 47.1 t -106.73 134.68 47.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.613 177.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -105.1 145.83 31.5 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -75.95 165.41 85.57 Favored 'Cis proline' 0 C--N 1.342 0.227 0 C-N-CA 123.333 -1.528 . . . . 0.0 112.902 -0.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.7 m -124.19 133.67 53.48 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 176.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.532 ' HB3' HD11 ' A' ' 29' ' ' LEU . 25.0 m -127.47 110.57 12.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.863 0.363 . . . . 0.0 111.159 -175.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.673 ' CG1' ' HB ' ' A' ' 30' ' ' ILE . 12.3 p -106.97 138.54 32.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.972 0.415 . . . . 0.0 110.36 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.741 ' HB2' ' HB2' ' A' ' 118' ' ' LYS . 88.2 mt -102.01 124.52 47.76 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.268 0.556 . . . . 0.0 110.355 -177.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.693 HG21 HD13 ' A' ' 23' ' ' LEU . 18.7 mm -108.31 138.36 35.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.994 -174.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -86.22 -177.4 49.82 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.652 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.624 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 98.5 mttt -73.53 1.99 8.82 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.98 0.419 . . . . 0.0 111.557 -177.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 19.9 tptp -134.21 6.55 3.6 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.554 ' HA2' ' CG2' ' A' ' 110' ' ' ILE . . . 85.81 -104.41 2.85 Favored Glycine 0 N--CA 1.433 -1.543 0 CA-C-N 114.376 -1.283 . . . . 0.0 110.346 -172.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 52.72 -9.1 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.215 1.806 . . . . 0.0 115.772 174.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.443 ' H ' ' C ' ' A' ' 114' ' ' GLY . 13.2 mt 68.17 115.43 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 122.969 0.508 . . . . 0.0 111.189 -178.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 79.6 mt -101.85 -48.14 4.37 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.183 0.516 . . . . 0.0 111.235 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.741 ' HB2' ' HB2' ' A' ' 109' ' ' LEU . 5.0 mmmm -146.48 155.13 42.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.777 -169.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 18.4 m -135.98 110.76 8.71 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.643 178.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -112.67 146.91 37.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.243 176.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.451 ' CG2' ' HB ' ' A' ' 103' ' ' VAL . 7.3 p -123.67 133.52 68.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.892 177.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 79.88 -140.37 22.34 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.921 -178.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -85.23 112.31 42.8 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -81.25 162.94 19.96 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.651 2.234 . . . . 0.0 113.256 -177.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.614 ' OD2' ' HB3' ' A' ' 128' ' ' LYS . 7.4 p-10 -75.5 76.9 2.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.308 177.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.41 ' CE2' ' HG2' ' A' ' 46' ' ' LYS . 18.4 m-85 -52.26 -40.41 61.66 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -175.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -57.91 -51.23 59.44 Favored Glycine 0 C--O 1.24 0.511 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.229 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.614 ' HB3' ' OD2' ' A' ' 125' ' ' ASP . 1.9 ttpm? -80.11 -18.75 49.03 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.676 ' O ' HG12 ' A' ' 133' ' ' ILE . 10.0 tt -70.95 -44.82 65.3 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 174.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -57.67 -55.59 32.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.665 0.269 . . . . 0.0 110.701 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.453 ' HG2' ' HA ' ' A' ' 128' ' ' LYS . 9.9 pt20 -61.69 -27.7 68.88 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.043 0.449 . . . . 0.0 110.988 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.454 ' OE2' ' HG3' ' A' ' 118' ' ' LYS . 32.0 tt0 -72.59 -42.86 64.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.555 178.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.676 HG12 ' O ' ' A' ' 129' ' ' LEU . 45.1 mm -69.65 -49.91 54.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.225 179.15 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.48 -16.4 62.42 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.965 0.412 . . . . 0.0 111.411 -178.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 15.4 m -66.74 -29.11 69.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.958 0.408 . . . . 0.0 110.705 171.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.464 -178.203 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.355 0 CA-C-O 121.089 0.471 . . . . 0.0 110.449 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -104.13 111.87 24.64 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 122.377 1.084 . . . . 0.0 112.621 -170.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.5 m -150.35 89.6 1.59 Allowed 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 113.388 -1.733 . . . . 0.0 108.102 171.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.526 ' HB3' ' HE2' ' A' ' 88' ' ' MET . 23.8 tp -120.65 139.17 28.48 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.855 -169.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 10' ' ' LEU . 8.4 Cg_exo -73.58 141.77 31.69 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.394 2.063 . . . . 0.0 111.556 172.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.458 ' CG ' ' H ' ' A' ' 14' ' ' HIS . 0.6 OUTLIER -87.35 -176.04 5.49 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 177.847 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.7 mt -73.01 -1.14 15.95 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -177.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.458 ' H ' ' CG ' ' A' ' 12' ' ' ASP . 67.7 m80 -109.92 8.61 24.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.997 0.427 . . . . 0.0 109.998 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.72 34.95 59.14 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.363 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 16' ' ' LYS . 28.5 mmtm -115.29 134.0 55.53 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 175.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.5 m -79.0 122.46 26.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.826 0.346 . . . . 0.0 110.506 -178.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.8 t -112.48 122.36 66.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 90.4 p -108.13 178.86 4.38 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.313 0.578 . . . . 0.0 110.713 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -76.17 -21.22 56.79 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.498 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.03 -28.91 69.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.715 175.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -73.6 -13.93 61.1 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.32 0.581 . . . . 0.0 110.583 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 61.6 mt -83.69 -48.29 10.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.186 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -56.25 150.84 13.68 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.254 0.55 . . . . 0.0 111.864 -175.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.25 -19.5 46.43 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -172.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.53 ' HZ3' ' HB2' ' A' ' 26' ' ' LYS . 4.4 mtmp? -135.39 167.92 20.15 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.154 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.402 ' HB ' ' HD2' ' A' ' 59' ' ' PHE . 35.2 t -108.04 140.52 26.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 175.066 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.451 HG23 ' HG3' ' A' ' 60' ' ' GLN . 29.9 m -134.32 140.86 46.67 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.013 0.435 . . . . 0.0 111.867 -171.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.464 HD11 ' HB3' ' A' ' 107' ' ' SER . 47.7 tp -113.85 115.45 27.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.305 173.021 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.852 HG12 ' HB2' ' A' ' 62' ' ' LEU . 46.2 mt -107.01 112.77 41.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.558 ' HA ' ' O ' ' A' ' 106' ' ' THR . 23.6 p-10 -113.9 129.39 56.6 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.246 0.546 . . . . 0.0 111.248 -178.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -83.09 128.74 34.75 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.048 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.592 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 5.5 p-90 -154.12 -175.71 5.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.49 -176.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.472 ' HB3' ' OE1' ' A' ' 66' ' ' GLN . 13.1 p90 -171.44 159.86 5.03 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.084 174.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' A' ' 34' ' ' PHE . 19.8 Cg_endo -62.86 156.25 55.07 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.119 1.879 . . . . 0.0 111.639 176.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.5 m 67.59 13.56 9.31 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.653 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 49.2 t -83.83 136.26 41.91 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.81 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.541 ' O ' HG12 ' A' ' 41' ' ' VAL . 35.9 Cg_exo -60.13 -25.83 80.9 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.615 2.21 . . . . 0.0 112.25 176.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.21 -13.7 65.17 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 121.228 -0.51 . . . . 0.0 113.145 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 88.1 m -63.25 -30.79 71.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.783 0.292 . . . . 0.0 111.684 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.541 HG12 ' O ' ' A' ' 38' ' ' PRO . 14.6 p -65.39 -37.55 80.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.814 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.447 ' O ' ' HE2' ' A' ' 46' ' ' LYS . 22.8 m -87.11 -56.6 3.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.997 0.427 . . . . 0.0 111.284 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.514 ' HA ' ' HE2' ' A' ' 46' ' ' LYS . 74.4 mm-40 -69.99 -41.55 74.26 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.205 0.816 . . . . 0.0 113.205 -169.054 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.73 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 39.6 tpp -49.32 -59.96 5.66 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -169.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.73 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 31.2 Cg_exo -58.74 -44.3 37.48 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 121.84 1.693 . . . . 0.0 112.27 -178.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.514 ' HE2' ' HA ' ' A' ' 43' ' ' GLU . 45.1 mtmt -60.2 -51.3 70.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.442 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.6 mm -62.64 -38.3 81.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.367 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.578 HG12 ' O ' ' A' ' 44' ' ' MET . 30.4 mm -54.91 -54.02 27.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 116.807 -0.179 . . . . 0.0 110.956 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.573 ' NZ ' ' HB2' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -75.48 -38.77 59.34 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 119.659 -0.817 . . . . 0.0 110.815 -178.628 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.557 ' O ' ' HD2' ' A' ' 54' ' ' TYR . 91.6 m -58.39 -44.85 89.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.826 0.346 . . . . 0.0 110.811 -178.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.0 -44.65 79.81 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.127 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -67.26 -50.45 60.48 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.747 0.308 . . . . 0.0 111.088 -178.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.63 -45.38 73.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.257 0.551 . . . . 0.0 111.035 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 1.07 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 50.6 m-85 -82.28 -26.24 33.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.308 -174.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.475 ' NZ ' ' HB3' ' A' ' 60' ' ' GLN . 18.0 tppt? -61.93 -32.45 72.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.899 0.381 . . . . 0.0 110.117 176.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -84.76 45.84 1.19 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.464 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.472 ' HE2' ' HA ' ' A' ' 54' ' ' TYR . 9.0 pttm -166.07 -58.48 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.681 170.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.479 ' OD1' ' HG2' ' A' ' 26' ' ' LYS . 59.7 t30 176.46 38.06 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 120.989 0.424 . . . . 0.0 111.521 -177.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 1.07 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 44.4 t80 -138.5 157.42 46.22 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 122.003 -0.435 . . . . 0.0 109.828 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.475 ' HB3' ' NZ ' ' A' ' 55' ' ' LYS . 11.1 pt20 -152.16 152.33 32.15 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.935 0.398 . . . . 0.0 110.985 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 90.2 t -117.96 126.19 74.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.669 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.852 ' HB2' HG12 ' A' ' 30' ' ' ILE . 86.1 mt -112.13 106.46 15.09 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.484 ' HB1' ' CD1' ' A' ' 33' ' ' TRP . . . -90.85 105.86 18.12 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.682 -176.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 91.9 t -90.44 115.86 30.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.936 0.398 . . . . 0.0 110.716 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.592 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -88.0 111.27 21.32 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.791 176.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.632 ' HA ' ' HB3' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -83.17 163.04 52.35 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.015 -177.29 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.578 ' HD2' ' HB2' ' A' ' 66' ' ' GLN . 57.1 Cg_endo -69.62 97.35 0.62 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.352 2.035 . . . . 0.0 113.073 -171.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 52.6 mt -141.19 -65.05 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.332 173.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.34 144.42 30.9 Favored Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 166.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.95 152.56 23.11 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.442 2.095 . . . . 0.0 112.471 178.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.61 ' HA ' HG22 ' A' ' 74' ' ' VAL . 12.8 tt -58.38 -23.24 21.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.021 176.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -65.83 -45.13 83.41 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.613 174.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.4 m -59.77 -41.13 90.41 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.506 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.61 HG22 ' HA ' ' A' ' 71' ' ' ILE . 13.0 m -68.85 -33.91 61.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.972 -177.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.681 ' HA ' HG22 ' A' ' 78' ' ' VAL . 76.2 mtt180 -70.69 -39.88 73.24 Favored 'General case' 0 C--O 1.22 -0.488 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 174.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -61.31 -37.45 83.3 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -63.35 -53.8 46.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.206 176.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.681 HG22 ' HA ' ' A' ' 75' ' ' ARG . 35.0 m -63.4 -27.26 42.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.996 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 75' ' ' ARG . 5.6 mmmp? -75.69 -40.16 56.27 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -73.3 -49.63 26.53 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.659 0.599 . . . . 0.0 111.798 -172.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -88.58 -1.89 58.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.493 -174.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 58.03 51.2 59.72 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.257 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.531 ' CD1' ' HA ' ' A' ' 78' ' ' VAL . 1.2 mp -74.61 117.06 59.24 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 121.011 0.434 . . . . 0.0 111.151 -175.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.59 -28.37 4.39 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.28 2.654 . . . . 0.0 114.415 -172.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -71.3 146.39 48.91 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.402 -178.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.431 ' HB ' HD23 ' A' ' 62' ' ' LEU . 12.3 m -70.4 113.42 7.52 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.453 -172.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.9 t -99.41 132.58 44.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.244 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.526 ' HE2' ' HB3' ' A' ' 10' ' ' LEU . 60.3 mtp -118.65 164.71 14.93 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.513 -0.767 . . . . 0.0 108.964 -177.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -120.6 129.35 53.71 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.283 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.795 ' OD2' ' HA ' ' A' ' 93' ' ' LYS . 10.7 t0 -102.07 115.75 31.21 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.322 177.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.15 -47.46 24.23 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -172.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -115.04 -10.96 12.17 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -169.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.795 ' HA ' ' OD2' ' A' ' 90' ' ' ASP . 34.9 ttmt 68.63 18.65 8.78 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 122.826 0.45 . . . . 0.0 111.506 177.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.03 -33.95 76.65 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.589 -0.694 . . . . 0.0 109.65 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.8 p -63.39 -47.63 90.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.723 172.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.92 -36.81 93.53 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.207 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -64.59 -30.48 71.51 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 122.542 0.337 . . . . 0.0 111.016 178.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.63 -34.2 76.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.935 0.398 . . . . 0.0 110.451 176.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.533 ' HB2' HG23 ' A' ' 101' ' ' THR . 65.4 m-85 -83.21 -17.9 41.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.031 174.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.8 31.76 38.97 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.942 -175.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.533 HG23 ' HB2' ' A' ' 99' ' ' PHE . 78.1 p -78.36 91.11 4.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.538 0.685 . . . . 0.0 111.98 -175.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 73.6 mm-40 -108.95 -26.39 10.24 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 171.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.5 m -109.18 140.48 27.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.527 174.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.569 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 37.2 m-85 -127.87 160.61 60.32 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.373 -173.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.569 ' HA ' ' HB3' ' A' ' 104' ' ' TYR . 87.3 Cg_endo -78.95 166.52 79.06 Favored 'Cis proline' 0 C--N 1.347 0.484 0 C-N-CA 123.866 -1.306 . . . . 0.0 113.269 0.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.558 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 22.1 m -126.03 120.47 30.35 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.99 175.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.464 ' HB3' HD11 ' A' ' 29' ' ' LEU . 33.9 m -107.89 113.17 26.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.009 0.433 . . . . 0.0 111.496 -174.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.601 HG22 HG23 ' A' ' 119' ' ' THR . 45.8 t -105.54 129.19 58.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.377 -178.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.569 ' HB2' ' HB3' ' A' ' 118' ' ' LYS . 96.5 mt -102.74 126.25 49.78 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.466 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 65.7 mt -116.87 125.36 73.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.086 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.473 ' H ' HD23 ' A' ' 117' ' ' LEU . . . -72.84 177.63 41.26 Favored Glycine 0 N--CA 1.453 -0.224 0 CA-C-N 115.896 -0.593 . . . . 0.0 113.21 -175.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 7.2 ptpp? -68.48 -6.2 23.7 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -175.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 7.7 ptmm? -105.97 6.99 31.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.684 0.278 . . . . 0.0 110.438 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.33 70.68 1.01 Allowed Glycine 0 C--O 1.225 -0.449 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 -177.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -153.72 165.21 36.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.551 0.215 . . . . 0.0 110.466 -174.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 86.7 mt -72.97 103.32 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.087 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.473 HD23 ' H ' ' A' ' 111' ' ' GLY . 3.1 mm? -97.92 -44.05 6.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.615 177.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.569 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -163.18 152.51 14.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.839 0.352 . . . . 0.0 111.872 -175.775 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.601 HG23 HG22 ' A' ' 108' ' ' VAL . 38.0 m -138.77 102.93 4.7 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.845 168.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -79.54 138.38 37.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.653 174.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.3 p -103.86 114.99 44.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 173.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 94.13 -157.91 22.88 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.889 -177.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -80.59 119.73 77.12 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 120.72 0.295 . . . . 0.0 110.681 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -87.56 151.47 7.63 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.818 2.345 . . . . 0.0 112.716 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.96 127.86 33.02 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.583 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 7.6 m-85 -71.57 -18.8 62.22 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -176.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -68.23 -54.48 16.7 Favored Glycine 0 C--O 1.238 0.367 0 C-N-CA 120.096 -1.049 . . . . 0.0 111.648 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.455 ' HE3' ' HB3' ' A' ' 128' ' ' LYS . 5.2 ttpp -74.87 -20.82 59.57 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 176.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.583 ' HB3' ' HA ' ' A' ' 126' ' ' PHE . 63.0 tp -65.7 -48.02 73.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.049 175.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 14.9 m-30 -61.56 -52.72 63.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.263 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -65.92 -27.54 68.26 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.863 0.363 . . . . 0.0 111.909 -177.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -80.02 -37.26 34.49 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.184 -0.323 . . . . 0.0 110.428 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 129' ' ' LEU . 51.2 mt -65.64 -48.49 82.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.717 176.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -25.37 67.92 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 -177.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 68.7 m -60.99 -43.69 98.49 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.067 0.461 . . . . 0.0 110.145 173.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.637 178.081 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.377 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -110.56 112.93 25.16 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.596 0.712 . . . . 0.0 111.319 -173.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.4 m -96.15 90.04 5.36 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 169.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.483 HD12 ' HD2' ' A' ' 11' ' ' PRO . 29.7 tp -102.73 123.35 42.75 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.259 -169.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.542 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 8.4 Cg_exo -72.96 147.06 42.94 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.819 2.346 . . . . 0.0 112.222 176.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.08 -177.91 5.3 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 174.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.3 mt -63.5 -22.73 67.05 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -177.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -89.22 -54.53 4.06 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.053 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.22 18.25 0.05 OUTLIER Glycine 0 CA--C 1.523 0.548 0 C-N-CA 119.61 -1.281 . . . . 0.0 114.683 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 11' ' ' PRO . 51.2 mttt -92.0 140.39 29.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 118.026 0.913 . . . . 0.0 110.119 174.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.6 m -88.26 122.36 31.7 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.1 0.476 . . . . 0.0 111.397 -177.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.0 t -107.25 132.66 54.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.737 174.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -140.81 -177.3 5.01 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.44 -173.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -58.21 -23.33 55.32 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.702 -176.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.86 -27.92 69.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.483 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -83.04 -19.59 36.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.148 0.499 . . . . 0.0 110.541 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.632 ' HB3' ' HA2' ' A' ' 114' ' ' GLY . 9.3 mp -83.53 -20.08 34.52 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.306 -176.206 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -95.74 134.58 38.5 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.063 0.459 . . . . 0.0 110.942 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.97 -7.13 82.28 Favored Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.752 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.582 ' HG2' ' OD1' ' A' ' 58' ' ' ASN . 29.9 mtpp -129.61 168.19 16.81 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -103.25 130.93 52.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 174.956 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.475 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 21.0 m -133.26 146.41 51.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.98 0.419 . . . . 0.0 112.057 -166.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.519 HD21 ' HB3' ' A' ' 107' ' ' SER . 8.0 tt -131.73 124.22 29.3 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 174.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.823 ' HB ' HG12 ' A' ' 108' ' ' VAL . 45.0 mm -109.89 125.35 67.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -109.38 112.87 25.24 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -84.79 119.57 25.45 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.593 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 4.2 p-90 -154.32 177.11 11.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.2 0.524 . . . . 0.0 111.484 -176.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.63 ' HB3' ' OE1' ' A' ' 66' ' ' GLN . 9.3 p90 -148.81 136.32 10.99 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.602 172.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 34' ' ' PHE . 44.8 Cg_exo -59.59 -15.71 32.46 Favored 'Trans proline' 0 N--CA 1.475 0.396 0 C-N-CA 123.421 2.747 . . . . 0.0 114.414 -173.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.4 p -95.45 13.81 24.72 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 122.017 -0.427 . . . . 0.0 111.991 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.446 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 25.0 p -88.37 146.0 36.88 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.854 0.359 . . . . 0.0 111.375 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 5.8 Cg_exo -79.09 -8.68 15.41 Favored 'Trans proline' 0 CA--C 1.532 0.406 0 C-N-CA 123.119 2.546 . . . . 0.0 113.011 176.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -86.18 -61.27 1.67 Allowed Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.676 -173.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' A' ' 33' ' ' TRP . 82.0 m -52.06 -30.06 24.05 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -169.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.8 p -56.12 -24.52 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.112 0.482 . . . . 0.0 111.16 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.657 ' HB2' ' OE2' ' A' ' 43' ' ' GLU . 1.7 m -86.23 -45.15 11.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.952 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.657 ' OE2' ' HB2' ' A' ' 42' ' ' SER . 3.9 mp0 -80.13 -33.36 38.65 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -174.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.596 ' O ' HG12 ' A' ' 48' ' ' ILE . 13.2 ptp -57.43 -38.9 72.83 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -166.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.56 ' HD3' ' CG ' ' A' ' 44' ' ' MET . 47.2 Cg_exo -58.28 -43.94 42.68 Favored 'Trans proline' 0 C--N 1.361 1.225 0 CA-C-N 121.749 1.66 . . . . 0.0 111.797 175.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -59.16 -38.09 78.91 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.483 176.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.2 mt -68.52 -36.42 74.62 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.4 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.733 177.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.596 HG12 ' O ' ' A' ' 44' ' ' MET . 47.2 mm -53.57 -55.49 13.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-O 120.799 0.333 . . . . 0.0 110.32 -175.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -75.86 -53.74 7.98 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.272 -177.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.8 m -58.01 -45.03 87.52 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -174.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.509 ' HB1' HG21 ' A' ' 61' ' ' VAL . . . -70.03 -36.05 74.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.874 -0.148 . . . . 0.0 111.32 -178.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -68.78 -45.43 71.36 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.017 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -59.77 -27.28 66.4 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.779 176.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.48 ' O ' ' HB3' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -87.18 -39.48 15.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.946 -179.649 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.409 ' C ' ' HD2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -60.07 -31.27 69.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.296 -175.978 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -80.34 37.54 0.39 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -174.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.57 65.84 0.21 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.073 0.463 . . . . 0.0 111.068 172.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.582 ' OD1' ' HG2' ' A' ' 26' ' ' LYS . 66.9 t30 66.1 11.0 7.5 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.525 176.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.495 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 43.9 t80 -105.57 148.69 27.0 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -141.4 126.33 18.22 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.135 0.493 . . . . 0.0 111.506 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.509 HG21 ' HB1' ' A' ' 51' ' ' ALA . 58.2 t -106.07 117.39 51.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.686 177.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.5 mp -120.2 117.82 28.87 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.017 0.437 . . . . 0.0 110.227 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.442 ' O ' ' HA ' ' A' ' 87' ' ' VAL . . . -94.22 114.26 26.33 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.839 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.3 p -101.23 119.95 50.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.353 0.596 . . . . 0.0 111.137 -176.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.593 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -89.59 129.68 36.01 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.447 175.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.63 ' OE1' ' HB3' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -104.74 165.88 12.5 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.594 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.621 ' HD3' ' O ' ' A' ' 90' ' ' ASP . 57.7 Cg_endo -70.83 80.15 1.21 Allowed 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.291 1.994 . . . . 0.0 113.525 -169.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 70.6 mt -120.78 -43.9 2.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 172.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.451 ' OD1' ' HD2' ' A' ' 35' ' ' PRO . 5.3 p-10 -121.78 141.43 33.84 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 163.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 69' ' ' ASP . 36.4 Cg_exo -57.66 158.33 20.35 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.056 2.504 . . . . 0.0 113.176 -174.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.618 ' O ' ' HG2' ' A' ' 75' ' ' ARG . 13.1 tt -53.69 -28.35 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.288 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.571 ' HA ' ' CG ' ' A' ' 75' ' ' ARG . 22.6 tp10 -64.16 -36.75 85.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.117 0.484 . . . . 0.0 110.958 178.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.0 t -68.71 -34.96 76.52 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 178.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.48 ' O ' HG23 ' A' ' 78' ' ' VAL . 24.0 t -60.35 -44.38 95.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.216 173.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.618 ' HG2' ' O ' ' A' ' 71' ' ' ILE . 14.1 mmt180 -52.83 -51.93 59.03 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.751 0.786 . . . . 0.0 109.601 176.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -61.47 -42.04 98.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.157 -1.383 . . . . 0.0 111.781 -175.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -70.99 -43.21 68.47 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.076 -176.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.554 HG13 ' HB2' ' A' ' 83' ' ' LEU . 80.1 t -59.89 -43.84 93.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.341 -177.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -74.0 -28.57 61.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.662 0.268 . . . . 0.0 111.348 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -73.37 -48.58 32.99 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.352 -175.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -97.42 -2.77 41.47 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -177.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 64.44 64.08 3.85 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.555 178.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.554 ' HB2' HG13 ' A' ' 78' ' ' VAL . 10.3 mp -79.67 115.34 52.95 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-O 120.644 0.259 . . . . 0.0 110.914 -178.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.423 ' CD ' HD12 ' A' ' 48' ' ' ILE . 93.4 Cg_endo -89.6 -21.45 1.09 Allowed 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.004 2.469 . . . . 0.0 113.568 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -76.19 155.56 34.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.799 0.333 . . . . 0.0 110.503 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 29.5 m -73.41 121.19 20.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.344 -175.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 63' ' ' ALA . 38.9 t -109.42 138.7 35.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.677 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 71.6 mtm -122.25 171.29 9.13 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 176.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -139.47 115.24 10.1 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.545 -0.169 . . . . 0.0 110.545 -178.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.621 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 13.3 t70 -107.83 127.53 53.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.898 0.38 . . . . 0.0 110.793 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.48 -28.12 56.35 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -175.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -112.65 -12.96 13.34 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -165.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.4 ' HG2' ' HB2' ' A' ' 66' ' ' GLN . 57.0 mtpt 69.42 7.63 6.34 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 122.739 0.415 . . . . 0.0 110.978 178.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.35 -32.53 70.19 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.246 0.546 . . . . 0.0 110.192 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.537 ' O ' ' HD1' ' A' ' 99' ' ' PHE . 2.0 p -60.43 -49.8 82.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.42 173.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -67.18 -33.67 83.69 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.938 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -58.82 -51.65 69.11 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 122.653 0.381 . . . . 0.0 111.485 177.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.79 -29.67 62.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.888 -177.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.728 ' HA ' HD11 ' A' ' 116' ' ' ILE . 17.2 m-85 -76.35 -27.79 56.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.753 0.311 . . . . 0.0 111.093 177.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.36 46.43 4.67 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.785 -0.722 . . . . 0.0 111.718 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 24.5 m -118.43 99.35 6.77 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.981 0.42 . . . . 0.0 111.158 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -91.82 -48.78 6.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.9 176.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 9.2 p -100.4 159.44 3.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.327 -174.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.431 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 34.1 m-85 -135.49 156.85 77.45 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -175.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.437 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 89.4 Cg_endo -85.16 141.59 32.38 Favored 'Cis proline' 0 C--N 1.347 0.478 0 C-N-CA 123.524 -1.449 . . . . 0.0 112.725 -0.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 89.5 m -129.77 129.98 44.79 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.379 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.519 ' HB3' HD21 ' A' ' 29' ' ' LEU . 14.0 m -111.79 131.92 55.02 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.148 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.823 HG12 ' HB ' ' A' ' 30' ' ' ILE . 8.3 p -105.97 142.77 18.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 120.887 0.375 . . . . 0.0 109.995 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.751 HD21 HD11 ' A' ' 129' ' ' LEU . 66.5 mt -103.86 127.86 51.35 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.779 177.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.496 HD13 HD23 ' A' ' 23' ' ' LEU . 72.5 mt -115.62 127.38 73.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.859 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.63 -97.84 0.01 OUTLIER Glycine 0 C--N 1.334 0.44 0 O-C-N 123.953 0.783 . . . . 0.0 112.716 -177.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -150.97 13.27 0.69 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.011 0.434 . . . . 0.0 110.649 176.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 49.1 mttp -111.9 -3.11 14.96 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.48 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.632 ' HA2' ' HB3' ' A' ' 23' ' ' LEU . . . 76.65 42.45 21.54 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.654 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -139.14 165.15 27.92 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.741 0.305 . . . . 0.0 110.335 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.728 HD11 ' HA ' ' A' ' 99' ' ' PHE . 59.5 mt -69.74 116.69 11.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.667 -177.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 19.5 tp -105.71 -51.65 2.96 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.283 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.608 ' HB2' ' HB2' ' A' ' 109' ' ' LEU . 3.1 mmmm -139.56 169.65 17.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.091 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 23.2 m -148.88 129.62 14.16 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.767 0.318 . . . . 0.0 110.746 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -126.29 118.49 25.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.771 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.7 p -110.99 139.67 33.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.762 -178.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 73.52 66.71 1.95 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.093 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 65.48 116.21 0.02 OUTLIER Pre-proline 0 N--CA 1.464 0.264 0 C-N-CA 123.45 0.7 . . . . 0.0 111.805 -175.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.75 117.76 3.69 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.181 1.92 . . . . 0.0 111.633 174.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 129' ' ' LEU . 14.5 t70 -61.49 105.58 0.54 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 175.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -64.49 -31.65 72.96 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -171.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.473 ' HA2' ' CZ ' ' A' ' 130' ' ' TYR . . . -58.86 -54.07 41.01 Favored Glycine 0 C--O 1.238 0.371 0 C-N-CA 120.371 -0.918 . . . . 0.0 111.661 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.591 ' HA ' ' HG2' ' A' ' 131' ' ' GLN . 35.7 mtmm -76.16 -17.95 59.33 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.657 0.265 . . . . 0.0 110.637 177.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.751 HD11 HD21 ' A' ' 109' ' ' LEU . 18.6 tp -69.17 -51.22 40.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.662 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.479 ' HB3' ' HE2' ' A' ' 54' ' ' TYR . 2.0 p90 -73.94 -33.94 64.12 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 119.579 -0.848 . . . . 0.0 112.249 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.591 ' HG2' ' HA ' ' A' ' 128' ' ' LYS . 3.3 pt20 -68.47 -30.73 69.65 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.79 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -76.12 -45.33 34.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.7 177.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 129' ' ' LEU . 78.0 mt -63.54 -38.88 83.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.628 178.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -56.65 -40.26 75.16 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.01 0.433 . . . . 0.0 110.218 176.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 89.6 m -58.32 -35.28 71.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.657 177.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.198 178.317 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.357 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -148.59 143.85 26.85 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.099 175.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.3 m -149.0 98.33 2.82 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 175.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.559 HD12 ' HD2' ' A' ' 11' ' ' PRO . 25.4 tp -114.39 126.87 27.42 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.196 -175.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.559 ' HD2' HD12 ' A' ' 10' ' ' LEU . 50.1 Cg_endo -70.17 150.53 65.84 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.388 2.059 . . . . 0.0 112.405 177.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.466 ' CG ' ' H ' ' A' ' 14' ' ' HIS . 0.8 OUTLIER -81.49 -174.26 4.86 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 176.277 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.735 HD13 ' HA ' ' A' ' 75' ' ' ARG . 70.4 mt -69.98 -16.36 63.18 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.466 ' H ' ' CG ' ' A' ' 12' ' ' ASP . 33.7 t-80 -87.98 -42.75 12.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.712 176.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.37 12.07 1.11 Allowed Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.294 177.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 11' ' ' PRO . 66.3 tttt -86.77 116.18 24.7 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 177.215 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 8.9 t -69.33 123.54 21.48 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.318 0.58 . . . . 0.0 109.617 175.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.501 ' HB ' ' CE ' ' A' ' 88' ' ' MET . 53.9 t -112.87 126.95 70.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.273 -177.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.419 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 61.0 p -132.32 -176.22 4.01 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.254 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -62.03 -23.29 66.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.072 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.03 -30.63 70.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.948 0.404 . . . . 0.0 110.837 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -82.45 -25.03 33.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.043 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.765 HD21 HD11 ' A' ' 62' ' ' LEU . 70.2 mt -83.19 -48.34 10.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.125 -175.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.616 ' HA ' ' H ' ' A' ' 113' ' ' LYS . 18.1 pt20 -51.22 144.31 9.69 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.384 0.611 . . . . 0.0 112.602 -171.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.67 -24.71 22.28 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.298 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.508 ' NZ ' ' HB2' ' A' ' 26' ' ' LYS . 7.7 mtmp? -121.96 171.29 9.05 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 14.1 t -101.9 140.47 20.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -178.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.585 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 17.0 m -131.78 145.65 51.71 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.139 0.495 . . . . 0.0 111.871 -171.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.677 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 6.2 tt -121.98 114.01 20.38 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 172.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.679 ' HB ' ' CG2' ' A' ' 108' ' ' VAL . 36.0 mt -98.54 112.6 31.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -118.21 121.21 39.91 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.569 0.223 . . . . 0.0 110.47 -178.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -92.73 119.77 32.44 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.561 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.49 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 10.5 p-90 -141.73 -176.36 4.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.142 -175.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -168.92 156.64 7.13 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 175.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.614 ' HD3' HG12 ' A' ' 74' ' ' VAL . 33.1 Cg_exo -59.68 158.92 26.2 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.544 2.163 . . . . 0.0 112.326 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 81.6 p 60.77 11.05 2.97 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.031 0.932 . . . . 0.0 112.141 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.731 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 34.6 t -72.96 129.96 85.75 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 177.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.69 -20.73 66.68 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.965 2.443 . . . . 0.0 112.461 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.82 -19.47 61.43 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.755 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.907 ' HA ' ' HG2' ' A' ' 43' ' ' GLU . 93.6 m -63.33 -30.78 71.85 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -174.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.3 m -64.16 -29.07 46.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.111 0.481 . . . . 0.0 110.417 177.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.519 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 29.4 t -88.94 -56.09 3.43 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.21 176.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.907 ' HG2' ' HA ' ' A' ' 40' ' ' CYS . 17.1 pt-20 -64.6 -50.14 68.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.092 -0.503 . . . . 0.0 112.043 -170.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.653 ' O ' HG12 ' A' ' 48' ' ' ILE . 33.5 ttm -57.87 -55.08 48.74 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -167.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.56 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 52.7 Cg_exo -53.35 -47.35 27.86 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.899 1.733 . . . . 0.0 112.433 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.519 ' HD3' ' O ' ' A' ' 42' ' ' SER . 23.9 mtpt -64.41 -40.04 95.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.09 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.471 HG12 ' O ' ' A' ' 43' ' ' GLU . 29.6 mm -64.31 -37.65 80.49 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.307 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.9 177.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.653 HG12 ' O ' ' A' ' 44' ' ' MET . 50.4 mm -54.67 -50.6 58.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 121.296 0.569 . . . . 0.0 109.939 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -67.69 -53.62 26.12 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.16 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 14.4 p -62.02 -54.69 38.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.912 -176.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.12 -39.0 91.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.841 -174.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -71.55 -35.36 70.61 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.411 -174.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -77.1 -48.53 17.52 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.299 -0.561 . . . . 0.0 110.463 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.751 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 25.6 m-85 -62.68 -27.77 69.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.801 0.334 . . . . 0.0 110.939 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.545 ' HA ' ' O ' ' A' ' 59' ' ' PHE . 36.9 ttpt -53.88 -37.4 63.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.797 173.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -89.13 10.04 23.33 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.683 -177.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.406 ' CG ' ' HA ' ' A' ' 54' ' ' TYR . 0.3 OUTLIER -105.23 -66.68 0.96 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.293 0.568 . . . . 0.0 109.689 177.375 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.491 ' OD1' ' HA ' ' A' ' 26' ' ' LYS . 21.0 t-20 174.25 21.71 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.111 -174.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.751 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 34.0 t80 -122.82 132.09 54.05 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.731 -168.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.504 ' O ' ' HA ' ' A' ' 28' ' ' THR . 4.1 pt20 -121.63 137.64 54.66 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.221 178.006 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.438 HG22 ' HE1' ' A' ' 59' ' ' PHE . 97.6 t -110.19 124.85 67.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.433 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.765 HD11 HD21 ' A' ' 23' ' ' LEU . 86.9 mt -106.4 95.83 6.03 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.52 177.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.74 97.23 10.78 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.562 ' HA ' ' HB2' ' A' ' 88' ' ' MET . 15.0 t -85.08 110.12 18.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.117 -176.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -87.0 117.17 25.54 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.86 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.516 ' HB2' ' CD ' ' A' ' 67' ' ' PRO . 29.9 pt20 -81.11 -178.01 1.08 Allowed Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.569 ' HD3' ' O ' ' A' ' 90' ' ' ASP . 16.1 Cg_exo -69.0 -135.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 122.25 1.967 . . . . 0.0 112.812 -176.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.548 ' HB ' ' O ' ' A' ' 67' ' ' PRO . 90.7 mt 77.14 -57.65 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -175.102 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.41 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -104.78 133.64 20.06 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 168.309 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.505 ' O ' HG22 ' A' ' 74' ' ' VAL . 21.6 Cg_exo -65.52 173.31 6.71 Favored 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 122.843 2.362 . . . . 0.0 113.351 -174.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.608 ' HA ' ' CG2' ' A' ' 74' ' ' VAL . 7.1 tp -63.76 -33.01 59.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.726 -170.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.436 ' HA ' ' HD2' ' A' ' 75' ' ' ARG . 0.6 OUTLIER -73.4 -32.85 64.68 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.605 178.782 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 75.2 m -67.42 -51.13 55.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.889 176.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.614 HG12 ' HD3' ' A' ' 35' ' ' PRO . 3.1 m -61.45 -42.64 94.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.354 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.735 ' HA ' HD13 ' A' ' 13' ' ' LEU . 4.4 ptm180 -74.46 -34.02 63.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.135 -176.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -71.12 -36.94 72.32 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 110.329 -0.248 . . . . 0.0 110.329 177.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -55.1 -44.05 74.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.276 0.56 . . . . 0.0 109.52 178.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.796 HG13 ' HB2' ' A' ' 83' ' ' LEU . 84.1 t -59.84 -48.76 86.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.742 175.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -75.14 -29.34 60.48 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -173.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -74.29 -46.94 38.03 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.804 0.335 . . . . 0.0 111.222 -176.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -85.77 -10.77 55.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.743 0.306 . . . . 0.0 111.523 -176.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.96 53.65 3.88 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.821 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.796 ' HB2' HG13 ' A' ' 78' ' ' VAL . 9.9 mp -78.74 111.23 17.95 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-O 120.692 0.282 . . . . 0.0 110.508 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -92.73 32.76 0.25 Allowed 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.2 2.6 . . . . 0.0 113.237 -177.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.604 ' HE2' HD13 ' A' ' 48' ' ' ILE . 29.0 p90 -135.64 165.37 25.71 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.9 m -74.51 128.11 34.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.091 0.472 . . . . 0.0 111.277 -175.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.9 t -120.43 137.08 55.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.075 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.562 ' HB2' ' HA ' ' A' ' 64' ' ' VAL . 48.8 mtt -111.47 175.87 5.25 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.328 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.42 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 73.3 t80 -131.83 107.57 8.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.32 175.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.569 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 67.3 t0 -91.51 91.87 8.26 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.76 -35.07 62.58 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -175.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.431 ' O ' ' HB3' ' A' ' 93' ' ' LYS . 3.6 p30 -94.44 -12.49 27.66 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.821 -0.351 . . . . 0.0 111.86 -173.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.438 ' HE3' ' HB3' ' A' ' 93' ' ' LYS . 0.6 OUTLIER 72.39 -10.93 0.86 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 120.989 0.423 . . . . 0.0 111.126 174.514 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.85 -22.64 39.72 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 122.271 -0.268 . . . . 0.0 110.371 -177.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 83.6 t -59.83 -49.76 82.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 172.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -58.99 -32.97 71.97 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.303 174.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 93' ' ' LYS . 43.7 mt-30 -69.71 -34.22 73.59 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 122.801 -0.235 . . . . 0.0 111.12 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.24 -37.44 85.51 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.088 0.47 . . . . 0.0 110.736 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -76.71 -26.98 55.28 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.026 0.441 . . . . 0.0 110.521 176.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.6 44.68 2.08 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.798 174.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.495 ' HA ' HG21 ' A' ' 106' ' ' THR . 29.9 p -69.77 100.77 1.57 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.199 0.523 . . . . 0.0 111.116 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.05 -61.65 1.74 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.457 0.646 . . . . 0.0 109.262 177.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.9 p -139.55 140.84 36.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.576 -177.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.406 ' HA ' ' C ' ' A' ' 105' ' ' PRO . 72.9 m-85 -94.8 147.5 33.23 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 -173.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.568 ' HD2' ' HA2' ' A' ' 122' ' ' GLY . 6.4 Cg_exo -73.63 146.44 86.92 Favored 'Cis proline' 0 C--O 1.234 0.321 0 C-N-CA 123.663 -1.39 . . . . 0.0 112.558 0.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.495 HG21 ' HA ' ' A' ' 101' ' ' THR . 19.9 m -115.26 112.24 22.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.18 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.0 m -109.47 112.26 24.26 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.611 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.679 ' CG2' ' HB ' ' A' ' 30' ' ' ILE . 15.3 m -105.75 142.96 17.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.132 0.491 . . . . 0.0 110.71 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.454 HD11 HD22 ' A' ' 129' ' ' LEU . 81.6 mt -101.42 125.81 48.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.288 -176.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.585 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 10.0 mm -114.33 110.04 30.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 O-C-N 124.59 1.181 . . . . 0.0 109.136 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.5 ' O ' ' HG3' ' A' ' 112' ' ' LYS . . . -61.99 -59.29 9.83 Favored Glycine 0 C--O 1.225 -0.414 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.383 -178.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.527 ' O ' ' HB2' ' A' ' 113' ' ' LYS . 19.3 mttt -169.46 166.89 10.13 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 178.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.616 ' H ' ' HA ' ' A' ' 24' ' ' GLN . 28.6 mttt 77.45 -52.12 0.54 Allowed 'General case' 0 C--N 1.323 -0.563 0 O-C-N 123.642 0.588 . . . . 0.0 111.814 176.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 137.49 3.57 2.08 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.247 -177.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.29 144.58 54.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.892 0.377 . . . . 0.0 110.722 -179.127 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 51.0 mm -90.5 108.02 19.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -178.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 21.6 mt -94.39 -68.24 0.81 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.811 -173.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.444 ' HB3' HD12 ' A' ' 109' ' ' LEU . 21.4 tptm -122.78 148.24 45.6 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.865 -172.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 28.7 m -128.75 107.6 9.8 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.859 0.361 . . . . 0.0 111.046 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.496 ' CE1' ' HB3' ' A' ' 125' ' ' ASP . 51.4 m-85 -104.44 137.39 42.37 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.368 176.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.0 m -118.42 128.99 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-O 120.821 0.343 . . . . 0.0 110.977 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.568 ' HA2' ' HD2' ' A' ' 105' ' ' PRO . . . 79.32 -69.69 2.93 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.756 178.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.424 ' OE1' ' HD2' ' A' ' 124' ' ' PRO . 6.9 tp10 -126.49 114.54 23.1 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.424 ' HD2' ' OE1' ' A' ' 123' ' ' GLU . 56.4 Cg_endo -72.25 122.25 8.21 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.386 2.057 . . . . 0.0 112.366 177.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.593 ' O ' ' HB2' ' A' ' 129' ' ' LEU . 3.7 t0 -61.5 105.2 0.49 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.34 175.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.492 ' HA ' ' CB ' ' A' ' 129' ' ' LEU . 75.6 m-85 -69.26 -21.84 63.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.695 -172.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -63.64 -54.46 31.34 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 119.793 -1.194 . . . . 0.0 111.448 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -81.63 -17.29 48.66 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.633 -0.283 . . . . 0.0 110.907 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.593 ' HB2' ' O ' ' A' ' 125' ' ' ASP . 0.9 OUTLIER -61.42 -49.04 78.48 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 174.584 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -71.61 -40.72 69.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.964 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -61.12 -43.5 98.79 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.319 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -62.39 -47.26 84.94 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.73 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 129' ' ' LEU . 68.0 mt -58.24 -45.13 89.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.097 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -64.54 -38.65 91.75 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.996 0.427 . . . . 0.0 111.005 177.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 87.8 m -60.59 -39.29 87.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.393 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.17 176.331 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.215 0 CA-C-O 121.073 0.463 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -96.18 131.17 42.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.313 0.578 . . . . 0.0 110.907 -176.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.9 m -129.23 90.51 3.03 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 169.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.579 HD12 ' HD2' ' A' ' 11' ' ' PRO . 30.5 tp -114.65 128.53 25.79 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.292 -167.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.646 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 56.1 Cg_endo -73.43 126.61 11.1 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.371 2.047 . . . . 0.0 111.434 170.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.581 ' HA ' ' HG2' ' A' ' 88' ' ' MET . 0.9 OUTLIER -71.91 166.73 21.52 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.913 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.412 HD13 ' HB3' ' A' ' 75' ' ' ARG . 1.5 pp -77.71 8.45 4.47 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -171.221 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.483 ' HD1' ' CG ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -105.08 -17.99 14.3 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 170.41 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.79 23.35 3.69 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 115.445 0.938 . . . . 0.0 115.445 170.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.572 ' HZ2' HG12 ' A' ' 18' ' ' VAL . 48.5 tttm -115.05 126.87 55.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 118.638 1.219 . . . . 0.0 110.712 173.292 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.646 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 9.6 t -76.51 129.31 36.3 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.075 0.464 . . . . 0.0 109.794 173.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.572 HG12 ' HZ2' ' A' ' 16' ' ' LYS . 28.1 m -116.12 142.74 28.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.547 174.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.5 t -145.47 -173.4 4.11 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -62.9 -22.08 66.48 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.969 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.16 -27.74 68.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.413 176.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -78.78 -22.55 46.18 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.196 0.522 . . . . 0.0 110.181 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.407 HD13 HG21 ' A' ' 110' ' ' ILE . 43.4 mt -84.46 -38.49 20.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.8 -174.411 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -59.77 129.76 43.46 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -171.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.33 -14.03 64.84 Favored Glycine 0 C--N 1.331 0.294 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.986 175.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.473 ' HE3' ' CD ' ' A' ' 60' ' ' GLN . 0.0 OUTLIER -137.17 -178.74 5.34 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 -177.468 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.612 HG13 ' HA ' ' A' ' 59' ' ' PHE . 6.9 p -114.05 149.56 16.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -174.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 61.2 m -148.41 139.39 23.11 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.669 0.271 . . . . 0.0 111.127 -171.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.721 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 43.4 tp -105.73 127.26 52.97 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.358 173.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.3 mt -113.3 112.46 40.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 171.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -112.43 111.06 21.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.485 -175.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.455 ' HB2' HG22 ' A' ' 106' ' ' THR . 79.5 m-85 -81.37 119.65 23.96 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 177.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.477 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 4.3 p-90 -150.53 -173.01 4.34 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.455 -176.177 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -154.85 144.9 15.68 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 170.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.648 ' HD2' ' HB2' ' A' ' 69' ' ' ASP . 57.4 Cg_exo -40.39 -43.49 4.05 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 123.606 2.871 . . . . 0.0 114.886 -175.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.4 p -80.44 16.77 1.22 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -176.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.44 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 24.9 m -68.04 132.39 92.04 Favored Pre-proline 0 C--N 1.33 -0.252 0 O-C-N 122.066 -0.396 . . . . 0.0 111.533 178.15 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 16.4 Cg_exo -68.43 -26.16 34.94 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.034 2.489 . . . . 0.0 112.272 177.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.28 -15.13 72.22 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 121.155 -0.545 . . . . 0.0 113.229 -177.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.771 ' HA ' ' HG2' ' A' ' 44' ' ' MET . 73.1 m -52.99 -36.44 60.38 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -178.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 38' ' ' PRO . 27.2 m -64.63 -38.61 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-O 120.695 0.283 . . . . 0.0 111.438 -178.033 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.7 m -88.37 -55.53 3.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.985 0.421 . . . . 0.0 111.62 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.496 ' O ' HG12 ' A' ' 47' ' ' ILE . 32.7 mt-10 -72.29 -50.1 29.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.324 -170.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.771 ' HG2' ' HA ' ' A' ' 40' ' ' CYS . 20.0 mmt -57.84 -46.78 99.7 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -167.376 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 40' ' ' CYS . 51.4 Cg_exo -55.75 -43.32 58.52 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 121.746 1.63 . . . . 0.0 112.203 177.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -66.52 -33.95 76.83 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.933 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 43' ' ' GLU . 41.9 mm -67.58 -38.79 81.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.449 177.181 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.591 HG12 ' O ' ' A' ' 44' ' ' MET . 49.1 mm -54.55 -53.45 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 120.857 0.361 . . . . 0.0 110.289 178.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.415 ' HB3' ' HE3' ' A' ' 49' ' ' LYS . 14.9 ttpp -55.09 -52.3 63.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.491 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.54 ' O ' ' HD2' ' A' ' 54' ' ' TYR . 17.0 m -67.48 -47.51 69.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.428 -174.134 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.61 ' HB1' HG21 ' A' ' 61' ' ' VAL . . . -67.5 -28.3 67.72 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.891 -174.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -75.87 -50.17 15.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.833 0.349 . . . . 0.0 111.09 -178.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -64.72 -47.98 76.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.097 -0.502 . . . . 0.0 112.326 -173.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.836 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 96.5 m-85 -77.35 1.79 17.83 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -170.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 37.8 mmtm -56.15 -49.91 72.61 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.286 0.565 . . . . 0.0 110.317 174.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -95.07 21.11 8.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.117 -177.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.663 ' HB2' ' HA ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -113.76 -65.85 1.14 Allowed 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.442 179.42 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 24.1 p30 171.6 -11.93 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.836 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 68.5 t80 -98.68 125.96 44.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.062 0.458 . . . . 0.0 109.876 -174.081 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.473 ' CD ' ' HE3' ' A' ' 26' ' ' LYS . 27.8 mt-30 -102.19 167.31 10.08 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 121.448 0.642 . . . . 0.0 110.943 -178.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.61 HG21 ' HB1' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -148.33 111.43 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.775 -171.806 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.534 HD23 ' HB ' ' A' ' 86' ' ' THR . 78.4 mt -124.22 97.34 5.29 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.585 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.727 ' HB3' HG12 ' A' ' 87' ' ' VAL . . . -86.15 101.79 13.31 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.727 178.509 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.585 HG12 ' HB2' ' A' ' 90' ' ' ASP . 12.2 t -85.92 108.27 17.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.216 -176.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -85.78 115.93 23.73 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.107 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.671 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 3.9 pt20 -78.29 -174.66 0.47 Allowed Pre-proline 0 C--N 1.315 -0.892 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.671 ' HD2' ' HB2' ' A' ' 66' ' ' GLN . 47.6 Cg_endo -69.33 -146.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 121.552 1.501 . . . . 0.0 112.366 -177.354 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.554 ' HB ' ' O ' ' A' ' 67' ' ' PRO . 62.8 mt 77.54 -61.1 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -172.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.648 ' HB2' ' HD2' ' A' ' 35' ' ' PRO . 34.2 m-20 -97.1 128.97 33.43 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 171.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.45 ' HD2' ' OG ' ' A' ' 73' ' ' SER . 51.5 Cg_exo -57.14 165.61 5.13 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.667 2.245 . . . . 0.0 112.505 175.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.598 ' O ' ' HG2' ' A' ' 75' ' ' ARG . 6.6 tt -66.52 -29.3 46.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.894 0.378 . . . . 0.0 110.675 -177.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.718 ' HA ' ' HE ' ' A' ' 75' ' ' ARG . 2.1 pm0 -69.65 -28.85 66.24 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 122.112 -0.367 . . . . 0.0 110.666 175.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.45 ' OG ' ' HD2' ' A' ' 70' ' ' PRO . 67.0 m -64.66 -43.85 92.31 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.664 0.268 . . . . 0.0 110.358 175.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.522 ' HA ' ' HG3' ' A' ' 35' ' ' PRO . 13.8 p -71.6 -39.8 70.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.113 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.816 ' HA ' HG22 ' A' ' 78' ' ' VAL . 28.9 ptt180 -75.19 -25.55 58.33 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 122.312 -0.242 . . . . 0.0 111.475 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -70.29 -41.27 73.6 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 169.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -62.17 -47.2 85.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.202 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.816 HG22 ' HA ' ' A' ' 75' ' ' ARG . 33.0 m -67.15 -28.74 43.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.069 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.7 tptp -73.09 -55.78 6.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.373 0.606 . . . . 0.0 111.459 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -65.52 -49.03 70.47 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.896 -171.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -81.05 -19.55 43.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.754 -177.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.07 65.02 2.1 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.904 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.467 HD22 HG12 ' A' ' 78' ' ' VAL . 8.6 mp -84.27 113.51 48.89 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-O 120.695 0.283 . . . . 0.0 110.933 -177.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -81.25 -2.77 11.83 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.879 2.386 . . . . 0.0 113.371 -177.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.507 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 28.4 p90 -99.02 140.28 33.42 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 122.149 -0.344 . . . . 0.0 110.532 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.534 ' HB ' HD23 ' A' ' 62' ' ' LEU . 10.7 m -67.93 137.9 55.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.742 -176.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.727 HG12 ' HB3' ' A' ' 63' ' ' ALA . 10.8 m -122.97 137.19 57.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.398 0.618 . . . . 0.0 111.708 -176.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.581 ' HG2' ' HA ' ' A' ' 12' ' ' ASP . 79.6 mtm -115.95 176.01 5.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.497 -0.774 . . . . 0.0 108.988 175.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 37.9 t80 -125.34 112.35 16.24 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.216 0.531 . . . . 0.0 111.041 -178.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.703 ' OD2' ' HA ' ' A' ' 93' ' ' LYS . 23.0 t70 -84.63 74.83 10.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.553 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.22 -42.4 62.68 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.476 -174.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -83.02 -12.99 56.74 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.226 -177.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.703 ' HA ' ' OD2' ' A' ' 90' ' ' ASP . 2.6 mtpm? 64.54 -5.2 0.37 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.35 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.22 -32.03 38.56 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -168.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.477 ' O ' ' HD1' ' A' ' 99' ' ' PHE . 31.2 m -66.8 -34.35 69.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.495 174.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -67.56 -34.08 83.05 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.41 172.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.615 ' HG3' ' O ' ' A' ' 93' ' ' LYS . 79.9 mt-30 -63.59 -39.06 93.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.646 -0.277 . . . . 0.0 110.408 175.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.69 -34.11 77.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.052 178.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.477 ' HD1' ' O ' ' A' ' 95' ' ' VAL . 42.2 m-85 -72.31 -24.01 61.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.822 174.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.31 23.17 49.08 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.494 -178.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.533 ' HB ' HG21 ' A' ' 106' ' ' THR . 50.9 p -86.07 110.02 19.24 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.007 0.432 . . . . 0.0 111.064 -176.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -108.66 -24.55 11.29 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.786 177.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.9 t -99.63 131.98 45.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.909 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -128.66 143.39 48.27 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.334 -178.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.424 ' HG2' ' OE1' ' A' ' 43' ' ' GLU . 5.3 Cg_exo -74.78 160.33 96.62 Favored 'Cis proline' 0 C--N 1.346 0.407 0 C-N-CA 123.715 -1.369 . . . . 0.0 112.161 0.041 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.533 HG21 ' HB ' ' A' ' 101' ' ' THR . 9.8 t -142.46 120.93 12.43 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.712 0.768 . . . . 0.0 111.239 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.599 ' HB3' HD11 ' A' ' 29' ' ' LEU . 25.5 m -95.8 111.97 23.81 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.253 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 55.3 t -105.5 128.48 59.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.261 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.612 HD12 ' HB3' ' A' ' 118' ' ' LYS . 95.3 mt -101.97 122.97 45.07 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.778 -176.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 23' ' ' LEU . 41.6 mt -110.61 130.09 64.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.475 178.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -88.31 -158.11 33.08 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.235 -0.983 . . . . 0.0 112.973 -178.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 44.0 mtpt -87.67 -17.98 30.59 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.976 0.893 . . . . 0.0 109.72 -168.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.771 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -81.07 -14.22 58.03 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.416 177.881 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.41 -7.97 79.57 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -173.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -72.21 146.88 47.02 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.165 0.507 . . . . 0.0 110.975 -178.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 47.0 mm -81.12 110.4 16.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.025 178.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.8 mt -90.7 -59.82 2.08 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -170.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.612 ' HB3' HD12 ' A' ' 109' ' ' LEU . 23.6 tptm -133.36 153.19 51.8 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.248 -170.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.3 m -134.59 128.03 32.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.522 177.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.442 ' OH ' ' HB2' ' A' ' 128' ' ' LYS . 80.5 m-85 -116.88 141.47 48.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.83 174.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.6 m -124.86 109.64 22.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.699 0.285 . . . . 0.0 111.304 178.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 68.52 97.66 0.04 OUTLIER Glycine 0 C--N 1.331 0.286 0 C-N-CA 121.174 -0.536 . . . . 0.0 113.07 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.423 ' HA ' ' HG2' ' A' ' 43' ' ' GLU . 9.0 tp10 66.13 92.92 0.06 OUTLIER Pre-proline 0 C--O 1.235 0.316 0 CA-C-O 121.509 0.671 . . . . 0.0 110.217 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -77.23 141.62 20.74 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.494 2.129 . . . . 0.0 113.019 -176.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.52 ' OD1' ' HG2' ' A' ' 128' ' ' LYS . 10.6 t0 -65.75 96.05 0.27 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.6 174.244 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.595 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 50.1 m-85 -69.19 -14.36 62.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.867 -178.031 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -68.36 -50.63 37.14 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.271 -0.966 . . . . 0.0 110.854 174.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.52 ' HG2' ' OD1' ' A' ' 125' ' ' ASP . 31.1 mmtm -77.95 -20.56 52.5 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.595 ' HB3' ' HA ' ' A' ' 126' ' ' PHE . 3.2 tm? -63.59 -47.9 79.56 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 174.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -68.18 -45.65 72.84 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.236 178.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -60.88 -36.47 79.29 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.938 0.348 . . . . 0.0 111.938 178.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -66.63 -51.77 52.5 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 67.9 mt -57.27 -43.03 81.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.902 0.382 . . . . 0.0 110.392 176.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -56.7 -40.32 75.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.85 177.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 63.8 m -62.07 -44.07 97.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.316 176.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.191 178.776 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.049 0 CA-C-O 121.394 0.616 . . . . 0.0 110.03 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.593 ' HB2' HG12 ' A' ' 95' ' ' VAL . 13.0 p90 -67.4 148.17 51.94 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.384 -175.339 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.0 m -142.59 89.79 2.17 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 172.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.647 HD11 ' HB3' ' A' ' 89' ' ' TYR . 35.5 tp -115.88 120.59 35.4 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.597 -173.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.558 ' HD2' HD12 ' A' ' 10' ' ' LEU . 24.3 Cg_exo -64.44 144.43 85.36 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.584 2.189 . . . . 0.0 111.799 176.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.717 ' HA ' ' HA ' ' A' ' 88' ' ' MET . 1.6 p-10 -81.95 -173.21 4.35 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.502 HD21 ' HA ' ' A' ' 89' ' ' TYR . 73.8 mt -87.02 2.27 50.14 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.672 -177.031 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.451 ' H ' ' CG ' ' A' ' 12' ' ' ASP . 64.3 t60 -95.69 -40.49 9.36 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 172.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.22 22.76 0.79 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.109 -1.043 . . . . 0.0 114.121 174.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.427 ' HE2' HG22 ' A' ' 18' ' ' VAL . 2.3 ptmt -114.31 134.51 54.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.72 0.76 . . . . 0.0 110.244 175.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 16.1 m -67.93 121.59 16.37 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.314 177.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.427 HG22 ' HE2' ' A' ' 16' ' ' LYS . 46.3 t -97.28 128.77 48.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 177.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 63.6 p -129.01 -175.59 3.6 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.874 0.369 . . . . 0.0 111.025 -175.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -68.95 -22.28 64.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.78 177.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.86 -28.95 69.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.736 176.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -67.01 -21.08 65.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.942 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 74.2 mt -80.7 -20.53 42.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.432 -176.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.455 ' HA ' ' OE1' ' A' ' 24' ' ' GLN . 15.9 mm-40 -78.59 138.61 38.44 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.077 0.465 . . . . 0.0 112.137 -172.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.98 3.38 89.18 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.771 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 112' ' ' LYS . 41.1 mtmt -146.75 165.03 30.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.668 0.271 . . . . 0.0 110.527 -177.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 26.0 t -103.16 138.62 26.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 173.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.631 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 11.1 m -131.93 145.29 51.41 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.63 -0.428 . . . . 0.0 112.126 -168.142 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.665 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 6.9 tt -119.5 108.75 14.9 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 170.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.8 mt -94.6 111.12 24.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -104.97 125.11 50.61 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.459 -177.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.466 ' CE2' ' HA2' ' A' ' 96' ' ' GLY . 87.0 m-85 -96.26 118.18 32.3 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 9.1 p-90 -144.59 -176.49 5.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.484 -175.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -159.63 151.96 17.46 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.239 176.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.33 155.58 51.06 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.404 2.069 . . . . 0.0 111.887 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.3 m 65.08 16.51 10.6 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.588 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.523 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 42.7 t -84.14 130.76 53.25 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.596 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -61.13 -26.82 83.19 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.7 2.267 . . . . 0.0 111.922 176.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -64.52 -30.02 76.74 Favored Glycine 0 C--O 1.227 -0.303 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.473 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.523 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 83.9 m -58.26 -30.5 66.63 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 122.16 0.184 . . . . 0.0 111.445 -178.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.6 t -61.18 -38.14 79.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.211 0.529 . . . . 0.0 110.157 177.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.463 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 32.6 m -87.09 -51.28 6.09 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.513 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -70.21 -45.06 67.36 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -171.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.569 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 39.2 tpp -54.72 -51.35 79.58 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -171.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.569 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 57.3 Cg_exo -53.28 -36.44 78.2 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 121.962 1.775 . . . . 0.0 112.47 175.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.633 ' HB3' ' CZ ' ' A' ' 126' ' ' PHE . 30.5 mmtm -65.16 -47.52 76.72 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.238 0.542 . . . . 0.0 109.796 177.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.7 mm -65.5 -38.65 82.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.823 -177.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.528 HG12 ' O ' ' A' ' 44' ' ' MET . 47.2 mm -54.68 -53.34 32.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 120.777 0.322 . . . . 0.0 110.188 177.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.1 tttm -62.16 -57.69 10.58 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.632 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 29.0 m -60.32 -44.82 95.12 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -171.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . -69.31 -36.08 76.62 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.118 -0.233 . . . . 0.0 111.598 -175.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -77.06 -40.35 46.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.158 0.504 . . . . 0.0 110.626 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -55.28 -53.04 61.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.902 -1.045 . . . . 0.0 111.15 -177.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.542 ' CB ' ' HB3' ' A' ' 59' ' ' PHE . 67.1 m-85 -96.88 8.16 45.01 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.465 -175.335 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -62.25 -52.31 64.24 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.093 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -82.4 66.81 8.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.802 176.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.705 ' HB2' ' HZ2' ' A' ' 57' ' ' LYS . 0.3 OUTLIER -166.94 -75.31 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.597 -173.819 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 6.9 t-20 173.62 7.96 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.203 0.525 . . . . 0.0 110.415 -176.252 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.665 ' HZ ' ' HB2' ' A' ' 29' ' ' LEU . 41.0 t80 -110.43 135.22 51.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.914 0.388 . . . . 0.0 110.581 -173.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.605 ' HG3' HG23 ' A' ' 28' ' ' THR . 21.4 pt20 -125.75 144.48 50.61 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.725 178.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 97.2 t -113.93 111.52 36.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 97.9 mt -95.03 95.57 8.68 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 177.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -86.6 95.65 9.83 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.574 ' HA ' ' HB2' ' A' ' 88' ' ' MET . 2.4 p -88.08 118.53 33.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.117 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 90' ' ' ASP . . . -89.53 162.69 15.56 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.948 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.41 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 18.6 pt20 -137.54 154.38 75.06 Favored Pre-proline 0 C--N 1.305 -1.358 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 169.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 1.074 ' HD3' ' HA ' ' A' ' 91' ' ' ALA . 56.2 Cg_endo -59.36 -92.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.038 1.826 . . . . 0.0 113.965 -150.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.3 mm 65.66 -70.34 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -175.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.41 ' OD1' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -94.57 147.23 32.88 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 171.316 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.41 ' HD2' ' OD1' ' A' ' 69' ' ' ASP . 65.6 Cg_exo -52.88 157.66 7.57 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 122.869 2.38 . . . . 0.0 113.902 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.4 ' O ' HG12 ' A' ' 74' ' ' VAL . 4.0 tp -53.85 -33.74 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.875 179.016 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.448 ' CD ' HH21 ' A' ' 75' ' ' ARG . 9.1 tp10 -68.87 -29.59 67.92 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 122.154 -0.341 . . . . 0.0 110.289 178.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.6 m -70.29 -48.65 55.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.951 0.405 . . . . 0.0 110.63 -177.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' ' 71' ' ' ILE . 11.1 p -61.43 -32.82 54.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-O 121.929 0.871 . . . . 0.0 109.305 175.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.656 ' HA ' HG22 ' A' ' 78' ' ' VAL . 50.5 ttp180 -75.28 -29.24 60.06 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.592 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -70.41 -41.7 72.62 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 172.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -57.06 -51.28 69.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.285 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.656 HG22 ' HA ' ' A' ' 75' ' ' ARG . 24.2 m -61.59 -36.94 76.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.127 -178.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -75.3 -52.22 11.36 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -58.6 -48.52 80.67 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.165 -170.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -92.58 1.11 57.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.388 -175.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 54.46 60.01 9.24 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.458 -179.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.488 HD22 HG12 ' A' ' 78' ' ' VAL . 10.8 mp -60.87 109.71 2.32 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.867 0.365 . . . . 0.0 111.462 -176.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -85.18 37.82 0.62 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.339 2.693 . . . . 0.0 113.044 -175.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -149.56 159.57 44.2 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.197 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.49 109.34 4.76 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.84 -176.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.2 t -101.96 136.78 32.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.515 177.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.717 ' HA ' ' HA ' ' A' ' 12' ' ' ASP . 80.1 mtp -111.24 162.17 15.25 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.267 -174.096 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.647 ' HB3' HD11 ' A' ' 10' ' ' LEU . 12.6 t80 -62.73 141.55 58.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.469 0.652 . . . . 0.0 112.087 -174.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.544 ' O ' ' N ' ' A' ' 92' ' ' ASP . 5.1 p-10 -56.52 -135.21 0.0 OUTLIER 'General case' 0 C--O 1.217 -0.649 0 CA-C-N 113.659 -1.609 . . . . 0.0 111.56 162.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 1.074 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . . . -28.66 -6.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 120.583 3.549 . . . . 0.0 120.583 -146.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.613 ' HB3' HD13 ' A' ' 10' ' ' LEU . 37.5 t70 -71.73 38.73 0.07 Allowed 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 120.31 1.414 . . . . 0.0 108.809 163.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.542 ' H ' ' C ' ' A' ' 91' ' ' ALA . 0.0 OUTLIER -58.47 -3.72 0.32 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.194 0.998 . . . . 0.0 112.675 -174.4 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.63 -23.91 67.41 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 122.77 0.428 . . . . 0.0 111.179 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.593 HG12 ' HB2' ' A' ' 8' ' ' PHE . 35.9 m -60.73 -37.38 75.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.106 0.479 . . . . 0.0 110.099 174.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.466 ' HA2' ' CE2' ' A' ' 32' ' ' PHE . . . -67.87 -32.17 77.01 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 174.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -69.78 -28.84 66.08 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.006 -0.597 . . . . 0.0 110.719 177.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.45 -28.34 61.91 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.074 0.464 . . . . 0.0 110.89 176.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.402 ' HD2' ' O ' ' A' ' 95' ' ' VAL . 50.4 m-85 -79.86 -24.53 41.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.738 173.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.74 -8.02 76.83 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.936 -0.65 . . . . 0.0 111.843 -177.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.579 ' HB ' HG21 ' A' ' 106' ' ' THR . 18.1 p -78.94 91.89 4.86 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.736 0.303 . . . . 0.0 111.396 -177.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -105.82 0.19 25.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.029 0.442 . . . . 0.0 111.311 177.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.5 m -97.95 125.81 51.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.513 173.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -121.28 149.77 52.61 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.526 -172.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -85.31 164.79 58.25 Favored 'Cis proline' 0 C--N 1.343 0.277 0 C-N-CA 123.548 -1.438 . . . . 0.0 112.002 -0.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.579 HG21 ' HB ' ' A' ' 101' ' ' THR . 5.9 t -151.88 142.79 23.03 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.895 -177.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.477 ' HB3' HD21 ' A' ' 29' ' ' LEU . 56.4 m -120.51 122.85 41.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.367 177.219 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.3 t -105.85 137.13 37.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.331 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.401 HD22 ' N ' ' A' ' 109' ' ' LEU . 2.8 mm? -101.82 122.34 43.79 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.18 -177.079 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.631 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 8.5 mm -110.13 129.94 64.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.344 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -79.35 -176.47 48.82 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.326 -0.94 . . . . 0.0 111.87 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 16.8 pttm -92.52 43.21 1.12 Allowed 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 122.532 1.158 . . . . 0.0 107.93 -178.436 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 51.3 mmtt -140.32 -5.77 1.23 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 113.302 -1.772 . . . . 0.0 111.367 -168.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.47 12.66 82.19 Favored Glycine 0 C--O 1.226 -0.371 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.464 -172.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -103.17 147.97 26.36 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 -178.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 51.5 mt -91.97 111.55 24.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -85.11 -61.52 1.75 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.195 -173.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.434 ' HD2' ' HA ' ' A' ' 118' ' ' LYS . 6.7 mmmm -141.27 167.7 21.55 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -169.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 62.1 m -146.3 105.87 3.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.366 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -102.87 113.16 26.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.577 177.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 106' ' ' THR . 22.2 m -88.54 141.0 14.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 120.849 0.357 . . . . 0.0 110.985 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 71.62 -150.93 47.29 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.438 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.455 ' OE2' ' HB3' ' A' ' 42' ' ' SER . 6.3 tp10 -70.2 111.64 9.99 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -84.45 140.08 8.25 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.47 2.114 . . . . 0.0 113.195 -176.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -66.89 102.88 1.02 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.989 173.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.633 ' CZ ' ' HB3' ' A' ' 46' ' ' LYS . 25.3 m-85 -70.32 -19.42 63.08 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -175.326 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -63.69 -54.08 33.82 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 119.932 -1.128 . . . . 0.0 111.055 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -79.68 -26.78 40.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.614 -0.293 . . . . 0.0 110.608 177.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.629 ' HB3' ' HA ' ' A' ' 126' ' ' PHE . 41.8 tp -63.18 -47.67 81.62 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.432 178.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -66.34 -47.21 74.23 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.741 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -56.9 -34.17 67.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.99 0.424 . . . . 0.0 111.991 176.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -80.37 -37.96 31.35 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.015 -179.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 129' ' ' LEU . 78.8 mt -65.46 -38.06 81.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.153 0.502 . . . . 0.0 110.002 174.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -67.05 -23.38 65.88 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.686 176.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 87.6 m -67.27 -30.71 70.65 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 172.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.318 174.019 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.351 0 CA-C-O 121.331 0.586 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -106.57 132.76 52.2 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.728 -177.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.7 m -114.9 90.76 3.42 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 172.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.597 HD22 HG21 ' A' ' 95' ' ' VAL . 36.6 tp -102.51 121.23 50.58 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.825 -172.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.553 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 3.9 Cg_exo -80.58 137.2 11.38 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.023 2.482 . . . . 0.0 112.059 176.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.62 ' HB3' ' HB3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -67.99 172.6 5.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.006 175.152 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.6 mt -55.21 -29.64 58.35 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -175.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -102.54 -26.05 13.37 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.453 -176.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.62 16.97 0.43 Allowed Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.073 -1.061 . . . . 0.0 113.917 175.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.62 ' HB3' ' HB3' ' A' ' 12' ' ' ASP . 1.8 tpmt? -81.8 96.85 7.73 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 117.441 0.621 . . . . 0.0 109.84 176.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 23.8 m -86.45 124.33 32.66 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.057 -177.393 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.5 m -127.16 163.16 30.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.619 179.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 62.1 p -132.17 -173.83 3.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.045 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 29.7 p30 -67.91 -22.19 65.09 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.765 0.317 . . . . 0.0 111.508 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.92 -27.35 67.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.067 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -70.39 -28.76 65.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.88 0.371 . . . . 0.0 110.25 178.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 45.3 mt -69.72 -20.34 63.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.806 -178.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.699 ' HG2' ' HA ' ' A' ' 113' ' ' LYS . 11.4 mt-30 -73.22 132.88 43.71 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.163 -174.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.66 -25.31 19.43 Favored Glycine 0 N--CA 1.452 -0.282 0 CA-C-N 115.954 -0.567 . . . . 0.0 113.167 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 112' ' ' LYS . 52.0 mtmt -108.25 -175.08 2.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.923 0.392 . . . . 0.0 110.675 -178.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 8.3 t -127.53 141.45 46.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 173.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.557 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 85.5 m -145.58 145.31 30.94 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.121 0.486 . . . . 0.0 111.995 -169.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.584 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 27.9 tp -114.15 112.99 24.08 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.129 170.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.671 ' HB ' ' CG1' ' A' ' 108' ' ' VAL . 41.6 mt -97.28 112.52 29.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 176.19 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.427 ' HA ' ' O ' ' A' ' 106' ' ' THR . 46.6 t30 -114.39 114.48 25.93 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.099 -177.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 92.5 m-85 -83.74 123.76 30.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.172 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.563 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 6.1 p-90 -143.93 -177.57 5.5 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.398 0.618 . . . . 0.0 111.321 -173.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -162.67 153.4 14.34 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.848 174.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -63.27 158.08 46.51 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.157 1.905 . . . . 0.0 111.472 175.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.8 m 65.7 14.38 9.49 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 123.465 0.478 . . . . 0.0 111.42 -177.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 29.9 t -84.98 133.88 42.36 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.594 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.8 -22.49 68.29 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 122.523 2.149 . . . . 0.0 111.967 176.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.61 -12.13 75.86 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.287 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 21.6 p -69.19 -45.72 69.25 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 117.85 0.825 . . . . 0.0 110.53 -177.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.6 p -65.06 -25.57 37.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.123 0.487 . . . . 0.0 110.593 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.7 m -86.7 -49.51 7.43 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.684 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.424 ' CD ' ' HZ1' ' A' ' 46' ' ' LYS . 22.2 mm-40 -85.13 -41.48 15.66 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -172.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.509 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 47.2 tpp -51.48 -50.2 78.03 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -171.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 44' ' ' MET . 9.8 Cg_endo -51.88 -44.77 42.85 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 122.285 1.99 . . . . 0.0 112.603 177.578 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.424 ' HZ1' ' CD ' ' A' ' 43' ' ' GLU . 8.0 mppt? -68.79 -40.12 79.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.722 178.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.0 mm -60.45 -43.53 94.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.699 178.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.592 HD13 ' HE1' ' A' ' 85' ' ' PHE . 43.9 mm -55.78 -52.99 42.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.775 178.324 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.53 -46.52 85.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.886 0.374 . . . . 0.0 110.622 -177.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 29.2 m -65.99 -51.59 57.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.552 -175.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.562 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . -67.86 -36.31 80.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.834 -174.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -74.03 -29.83 62.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.043 0.449 . . . . 0.0 110.592 -177.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -74.49 -50.4 18.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.152 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 1.066 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 66.4 m-85 -80.59 -10.08 59.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.933 -175.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 22.1 tptm -58.41 -33.27 69.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.194 0.521 . . . . 0.0 110.401 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 44.3 m-20 -95.06 20.86 8.44 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.643 -176.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.718 ' HE3' ' HA ' ' A' ' 54' ' ' TYR . 33.1 mtmt -125.98 -63.27 1.12 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.477 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 172.33 -13.29 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 O-C-N 123.322 0.389 . . . . 0.0 111.37 -172.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 1.066 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 56.7 t80 -100.72 122.78 43.93 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.093 0.473 . . . . 0.0 110.356 -177.313 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.52 HE21 HD11 ' A' ' 62' ' ' LEU . 12.7 pt20 -122.75 154.92 37.51 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.666 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.551 HG22 ' HB3' ' A' ' 29' ' ' LEU . 94.2 t -115.27 128.66 72.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.267 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.52 HD11 HE21 ' A' ' 60' ' ' GLN . 11.0 mp -108.12 109.26 20.64 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.542 177.098 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.45 98.35 10.81 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.169 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 51.3 t -91.79 116.16 32.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.331 -177.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -96.56 126.53 41.8 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.481 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.592 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 4.7 pm0 -96.0 161.5 27.08 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.679 ' HD3' ' O ' ' A' ' 90' ' ' ASP . 53.0 Cg_endo -70.43 84.95 0.73 Allowed 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.296 1.997 . . . . 0.0 113.515 -171.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 48.2 mm -115.7 -44.94 3.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 172.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.597 ' OD1' ' HD2' ' A' ' 70' ' ' PRO . 0.7 OUTLIER -116.8 141.99 29.05 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 172.595 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.597 ' HD2' ' OD1' ' A' ' 69' ' ' ASP . 61.2 Cg_exo -42.1 155.27 0.1 OUTLIER 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.676 2.917 . . . . 0.0 114.438 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.594 HG23 ' OE1' ' A' ' 72' ' ' GLU . 3.3 tp -58.7 -36.79 62.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.026 -176.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.598 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -59.4 -39.32 83.03 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.534 176.125 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.8 m -58.15 -42.44 85.95 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.304 0.573 . . . . 0.0 109.974 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.2 t -67.72 -52.2 42.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.016 178.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.598 ' HG2' ' HA ' ' A' ' 72' ' ' GLU . 16.0 ptt180 -68.3 -33.46 74.38 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -174.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -65.61 -42.04 92.03 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 178.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -56.36 -47.82 78.06 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.971 178.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.6 HG22 HD22 ' A' ' 83' ' ' LEU . 41.2 t -63.1 -53.0 51.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.328 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 75' ' ' ARG . 95.6 mttt -63.01 -36.61 84.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.726 0.298 . . . . 0.0 111.669 -175.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -75.07 -48.29 24.65 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -176.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -98.48 7.37 46.26 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -173.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.5 -70.09 2.66 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.949 -0.644 . . . . 0.0 112.743 175.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.6 HD22 HG22 ' A' ' 78' ' ' VAL . 10.3 mp 52.25 84.72 0.2 Allowed Pre-proline 0 N--CA 1.468 0.472 0 C-N-CA 122.959 0.504 . . . . 0.0 111.732 -178.289 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -76.92 16.52 0.95 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.365 2.71 . . . . 0.0 113.563 -176.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.592 ' HE1' HD13 ' A' ' 48' ' ' ILE . 23.1 p90 -117.73 159.4 23.06 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.4 m -74.76 112.08 10.61 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.342 0.591 . . . . 0.0 111.081 -174.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.7 t -99.64 136.74 29.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.831 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.569 ' HG2' ' HA ' ' A' ' 12' ' ' ASP . 62.5 mtt -131.23 166.45 21.14 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.415 -176.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -130.07 117.06 19.42 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.099 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.679 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 67.2 t0 -103.28 108.05 19.12 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 179.147 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.4 -21.95 59.4 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -176.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.528 ' OD2' ' HB2' ' A' ' 94' ' ' ALA . 28.3 t70 -106.44 -11.43 15.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.08 0.467 . . . . 0.0 110.691 -174.114 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 97' ' ' GLN . 17.4 ttpp 65.85 17.7 10.91 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.496 -177.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.528 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . . . -67.92 -31.95 72.07 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.418 -174.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.597 HG21 HD22 ' A' ' 10' ' ' LEU . 46.8 t -67.92 -42.6 85.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 177.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.79 -33.99 87.47 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.538 175.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.414 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 15.0 mm100 -64.6 -42.81 95.31 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 122.607 0.363 . . . . 0.0 111.494 177.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.94 -47.18 66.31 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.331 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.511 ' HA ' HD13 ' A' ' 116' ' ' ILE . 36.9 m-85 -72.24 -27.21 62.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.735 -177.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.37 55.21 1.72 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.605 176.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.403 ' HA ' HG21 ' A' ' 106' ' ' THR . 20.1 p -68.99 104.75 2.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.942 0.401 . . . . 0.0 111.57 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 48.4 tp60 -69.45 -58.32 4.13 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.533 0.682 . . . . 0.0 110.108 178.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.4 p -148.36 143.37 19.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.271 -176.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -94.57 141.9 24.06 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.715 -175.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.56 151.42 97.01 Favored 'Cis proline' 0 C--N 1.346 0.405 0 C-N-CA 123.385 -1.506 . . . . 0.0 113.18 0.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 26.3 m -119.54 116.08 25.32 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.884 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.538 ' HB2' HD11 ' A' ' 29' ' ' LEU . 4.3 p -105.56 111.84 24.7 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.085 0.469 . . . . 0.0 111.035 -177.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.671 ' CG1' ' HB ' ' A' ' 30' ' ' ILE . 11.7 p -106.68 143.25 17.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.053 0.454 . . . . 0.0 110.455 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.604 ' HB2' ' HB3' ' A' ' 118' ' ' LYS . 96.3 mt -100.98 121.43 41.75 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.123 -178.208 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.781 HG23 ' HA2' ' A' ' 114' ' ' GLY . 43.2 mm -102.49 127.29 56.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.303 -176.078 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -85.64 -168.27 44.51 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.98 177.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.424 ' HE3' ' HB2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -76.69 44.97 0.39 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 117.038 0.419 . . . . 0.0 111.779 -178.495 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.699 ' HA ' ' HG2' ' A' ' 24' ' ' GLN . 64.4 tttm 177.31 -29.63 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -178.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.781 ' HA2' HG23 ' A' ' 110' ' ' ILE . . . 115.62 -87.04 0.43 Allowed Glycine 0 N--CA 1.437 -1.285 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.832 177.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 55.68 2.79 0.07 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.545 1.138 . . . . 0.0 113.56 178.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.511 HD13 ' HA ' ' A' ' 99' ' ' PHE . 4.8 mt 49.54 77.27 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 121.574 0.702 . . . . 0.0 109.934 -174.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.8 mt -77.15 -73.62 0.29 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.435 -171.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.604 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 21.7 tptm -119.21 149.2 42.15 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.678 -170.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 31.5 m -134.19 118.69 17.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.023 0.439 . . . . 0.0 111.348 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -109.55 145.66 35.97 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.393 175.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.2 m -105.21 121.39 57.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.543 176.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.76 -126.48 8.47 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.466 -0.874 . . . . 0.0 111.649 -177.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -87.07 119.06 70.83 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.678 0.275 . . . . 0.0 111.074 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -77.37 121.62 5.73 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.42 2.08 . . . . 0.0 111.091 172.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -60.73 112.0 1.85 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.3 0.571 . . . . 0.0 110.304 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.57 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 81.3 m-85 -59.47 -29.64 67.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.317 -0.856 . . . . 0.0 113.024 -171.009 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -57.05 -53.93 40.78 Favored Glycine 0 C--O 1.237 0.289 0 C-N-CA 120.156 -1.021 . . . . 0.0 112.081 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.599 ' HA ' ' HG2' ' A' ' 131' ' ' GLN . 5.9 ttpm? -80.18 -28.22 38.78 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.57 ' HB3' ' HA ' ' A' ' 126' ' ' PHE . 48.7 tp -61.15 -47.58 85.53 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 177.002 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -62.45 -48.84 77.86 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.369 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.599 ' HG2' ' HA ' ' A' ' 128' ' ' LYS . 4.2 pt20 -68.47 -31.4 70.66 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.494 -178.141 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -71.79 -39.14 70.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.73 0.3 . . . . 0.0 110.338 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 80.4 mt -67.82 -39.37 81.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 173.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -63.56 -27.9 69.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.47 176.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 88.1 m -64.16 -45.73 87.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.335 -0.393 . . . . 0.0 109.96 174.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.171 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.29 176.303 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.516 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -66.02 137.99 57.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.884 -178.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.8 m -143.69 94.48 2.6 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.195 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.411 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 1.5 pt? -119.96 156.48 54.33 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-O 120.555 0.217 . . . . 0.0 110.581 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.592 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 3.7 Cg_exo -77.37 144.48 23.02 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 123.046 2.497 . . . . 0.0 112.416 178.424 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.418 ' HA ' ' HG2' ' A' ' 88' ' ' MET . 2.3 p30 -95.7 -176.88 3.87 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 175.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.551 HD11 HG12 ' A' ' 74' ' ' VAL . 63.2 mt -60.33 -20.75 60.51 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -173.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -76.77 -11.39 59.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.821 0.343 . . . . 0.0 110.771 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.7 16.55 58.19 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.839 -0.695 . . . . 0.0 112.377 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 11' ' ' PRO . 21.0 pttp -114.84 151.23 34.25 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 177.372 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.592 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 23.6 m -93.57 123.63 37.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.015 0.436 . . . . 0.0 112.083 -174.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.4 m -97.81 153.65 3.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 173.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.2 p -141.01 -178.5 5.59 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.198 0.523 . . . . 0.0 111.326 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -68.54 -22.0 64.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.583 177.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.48 -31.75 72.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.051 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -70.69 -20.82 62.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.016 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.594 HD13 HG21 ' A' ' 110' ' ' ILE . 24.6 mt -83.26 -22.04 33.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.126 -174.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -62.92 144.37 56.82 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.631 -173.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.67 -25.24 4.02 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.791 -0.641 . . . . 0.0 113.847 173.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -121.26 -176.01 3.19 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 122.412 -0.464 . . . . 0.0 110.626 -174.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.2 t -108.46 141.89 22.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 175.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.602 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 33.1 m -133.93 137.98 45.21 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.83 0.347 . . . . 0.0 111.281 -174.083 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.578 HD11 ' HB2' ' A' ' 107' ' ' SER . 52.3 tp -109.63 107.51 17.59 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.23 175.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.669 ' HB ' ' CG2' ' A' ' 108' ' ' VAL . 50.6 mt -93.74 112.41 26.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 172.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -119.82 124.22 45.59 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.872 0.368 . . . . 0.0 110.862 -176.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.406 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 95.9 m-85 -90.47 125.43 35.58 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.827 -178.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.557 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 10.5 p-90 -146.17 -174.06 4.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.057 -178.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -156.92 146.57 15.39 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 172.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.446 ' HG3' ' HA ' ' A' ' 74' ' ' VAL . 78.3 Cg_exo -43.96 -59.17 1.15 Allowed 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 123.781 2.988 . . . . 0.0 114.744 -175.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.3 t -83.44 24.78 0.8 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.99 0.424 . . . . 0.0 111.322 -173.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 54.0 t -75.62 132.84 74.49 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.346 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -61.88 -19.01 64.17 Favored 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 122.662 2.242 . . . . 0.0 112.022 176.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.97 -10.98 84.08 Favored Glycine 0 C--O 1.224 -0.521 0 C-N-CA 121.226 -0.511 . . . . 0.0 112.99 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 25.4 p -58.12 -39.37 78.51 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 117.213 0.506 . . . . 0.0 111.648 -175.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.1 p -62.24 -34.42 63.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.855 0.36 . . . . 0.0 110.929 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.8 m -88.03 -54.72 4.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.052 0.453 . . . . 0.0 111.03 178.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.402 ' O ' HG12 ' A' ' 47' ' ' ILE . 73.7 mm-40 -66.27 -50.14 64.75 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -172.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.726 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 49.6 tpp -53.3 -55.53 33.48 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -168.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.726 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 24.5 Cg_exo -64.51 -36.02 45.62 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 121.822 1.682 . . . . 0.0 112.264 178.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -64.36 -40.06 95.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.577 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 43' ' ' GLU . 30.5 mm -60.87 -46.68 95.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.699 177.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 49.2 mm -55.66 -53.32 38.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.43 -177.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -69.37 -43.11 74.21 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.606 -174.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.3 m -65.26 -44.92 86.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.994 0.426 . . . . 0.0 110.921 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.52 ' HB1' HG21 ' A' ' 61' ' ' VAL . . . -65.65 -42.84 90.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.806 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -56.26 -40.05 73.59 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.51 -178.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -68.38 -51.14 47.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.341 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 1.006 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 60.5 m-85 -74.8 -28.99 60.95 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -174.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -59.44 -27.02 65.69 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 122.479 0.312 . . . . 0.0 111.61 -177.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -73.92 -22.51 59.66 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -172.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 1.006 ' HE2' ' HA ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -95.78 -62.08 1.35 Allowed 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.625 176.121 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 176.96 68.46 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.806 0.813 . . . . 0.0 111.303 -173.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.506 ' HZ ' ' HB2' ' A' ' 29' ' ' LEU . 41.2 t80 -135.83 132.43 36.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.287 -178.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -105.89 143.07 34.55 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.52 HG21 ' HB1' ' A' ' 51' ' ' ALA . 43.7 t -122.8 115.38 45.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.087 -177.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 88.5 mt -116.69 95.91 5.25 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.335 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.07 105.46 17.83 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 43.0 t -98.94 114.09 35.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 120.969 0.414 . . . . 0.0 110.564 -175.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.557 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -82.71 117.57 22.73 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.723 176.414 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.623 ' HG3' HG12 ' A' ' 68' ' ' ILE . 27.9 pt20 -74.1 163.43 68.39 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.965 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.604 ' HD2' ' HB2' ' A' ' 66' ' ' GLN . 72.1 Cg_endo -74.91 55.09 3.79 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.735 2.29 . . . . 0.0 114.035 -172.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.623 HG12 ' HG3' ' A' ' 66' ' ' GLN . 50.0 mm -93.12 -69.99 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 172.339 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -81.74 153.55 70.37 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.779 176.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -61.26 157.26 41.05 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.479 2.119 . . . . 0.0 112.33 177.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.0 tp -57.26 -31.3 37.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.917 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -64.54 -42.92 95.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.532 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.3 m -63.27 -34.76 78.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.814 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.551 HG12 HD11 ' A' ' 13' ' ' LEU . 34.8 t -64.13 -44.92 97.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.17 176.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -65.53 -34.62 78.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.651 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -62.48 -41.78 99.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.888 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.88 -43.1 97.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.751 -0.204 . . . . 0.0 110.863 178.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.563 ' HA ' HD12 ' A' ' 83' ' ' LEU . 42.1 t -63.16 -37.44 79.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.156 0.503 . . . . 0.0 110.345 176.272 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.0 tttm -61.97 -55.25 31.32 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.655 0.74 . . . . 0.0 111.141 176.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.03 -39.39 69.16 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.539 -1.21 . . . . 0.0 113.204 -173.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -104.99 0.76 28.02 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -174.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.05 -82.25 1.68 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.192 177.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.563 HD12 ' HA ' ' A' ' 78' ' ' VAL . 54.6 mt 61.59 93.33 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.417 0.627 . . . . 0.0 112.523 171.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -87.33 2.36 6.84 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 123.11 2.54 . . . . 0.0 113.667 -177.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -90.91 166.02 13.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.636 0.255 . . . . 0.0 110.625 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 20.2 m -77.04 113.52 14.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.069 0.462 . . . . 0.0 110.908 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.407 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 14.8 t -107.67 125.49 64.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.599 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.418 ' HG2' ' HA ' ' A' ' 12' ' ' ASP . 72.4 mtm -116.67 173.09 6.82 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.149 177.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -132.04 122.55 25.66 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.865 0.364 . . . . 0.0 110.245 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.544 ' HB3' ' HA ' ' A' ' 66' ' ' GLN . 45.8 t0 -82.81 119.23 24.1 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 176.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.74 -42.44 61.12 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -171.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -126.89 15.26 7.43 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.527 0.203 . . . . 0.0 111.124 -174.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.413 ' NZ ' ' HB3' ' A' ' 93' ' ' LYS . 5.9 ttpm? 68.35 20.34 8.68 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.544 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -77.23 -25.65 51.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.967 -174.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 41.0 t -74.82 -40.47 46.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.93 -38.9 96.07 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.485 173.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -68.72 -26.48 65.28 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 122.546 0.338 . . . . 0.0 111.173 176.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.94 -47.03 72.91 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.832 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -82.89 -26.9 31.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.484 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 95.64 55.4 1.33 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.404 178.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.452 HG22 HG21 ' A' ' 106' ' ' THR . 21.3 p -63.31 112.14 2.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.085 0.469 . . . . 0.0 111.71 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -77.52 -58.16 3.42 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.014 177.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.466 HG12 ' HB ' ' A' ' 121' ' ' VAL . 7.8 p -145.71 147.44 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.656 -175.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.485 ' HA ' ' C ' ' A' ' 105' ' ' PRO . 76.5 m-85 -102.54 147.44 34.02 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.036 -174.022 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.485 ' C ' ' HA ' ' A' ' 104' ' ' TYR . 38.1 Cg_endo -70.06 154.45 94.07 Favored 'Cis proline' 0 C--N 1.346 0.436 0 C-N-CA 123.305 -1.54 . . . . 0.0 112.838 0.362 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.452 HG21 HG22 ' A' ' 101' ' ' THR . 24.7 m -121.7 112.45 18.42 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.163 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.578 ' HB2' HD11 ' A' ' 29' ' ' LEU . 5.4 p -110.49 114.18 27.4 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.271 0.558 . . . . 0.0 111.176 -177.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.669 ' CG2' ' HB ' ' A' ' 30' ' ' ILE . 17.2 m -105.74 142.33 19.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.058 0.456 . . . . 0.0 110.737 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.554 ' HB2' ' HB2' ' A' ' 118' ' ' LYS . 81.5 mt -102.35 125.36 49.04 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.715 -177.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.602 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 12.1 mm -103.95 137.18 33.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.717 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -86.85 -167.6 43.91 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.274 -177.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.8 mttm -86.97 34.44 0.67 Allowed 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 122.003 0.906 . . . . 0.0 108.967 -175.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.519 ' HB3' ' OE1' ' A' ' 115' ' ' GLU . 29.0 mmtm -148.59 -35.46 0.2 Allowed 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 114.206 -1.361 . . . . 0.0 110.846 -165.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 113.65 -28.7 8.35 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -174.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.519 ' OE1' ' HB3' ' A' ' 113' ' ' LYS . 1.2 mp0 -54.61 141.23 32.48 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 114.89 -0.655 . . . . 0.0 110.944 176.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 6.7 mt -80.19 122.96 36.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.592 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.6 mt -98.88 -60.53 1.52 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.048 0.451 . . . . 0.0 111.466 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.554 ' HB2' ' HB2' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -124.95 159.22 31.71 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.989 -170.542 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 57.9 m -141.13 103.58 4.48 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.414 170.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -92.46 131.87 37.25 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.4 176.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.466 ' HB ' HG12 ' A' ' 103' ' ' VAL . 6.0 m -101.22 116.04 44.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.906 178.072 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 83.48 -106.82 2.86 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.191 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -89.68 114.11 59.35 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-O 120.524 0.202 . . . . 0.0 110.783 -176.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.24 98.34 0.92 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.375 2.05 . . . . 0.0 111.85 175.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -49.67 111.97 0.58 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.92 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.403 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 80.8 m-85 -66.73 -34.11 77.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.179 -175.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -60.12 -52.18 54.32 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.597 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.581 ' HA ' ' HG2' ' A' ' 131' ' ' GLN . 25.9 mtmm -76.86 -24.31 52.65 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.678 -0.261 . . . . 0.0 110.837 178.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.439 ' O ' HG13 ' A' ' 133' ' ' ILE . 53.5 tp -62.48 -48.76 78.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.913 0.387 . . . . 0.0 110.087 175.039 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -63.3 -46.22 87.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.412 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.581 ' HG2' ' HA ' ' A' ' 128' ' ' LYS . 13.5 pt20 -70.93 -34.13 71.2 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.418 -176.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.411 ' O ' ' HB ' ' A' ' 135' ' ' THR . 20.3 tt0 -78.96 -31.88 45.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.57 0.224 . . . . 0.0 110.746 -177.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 129' ' ' LEU . 59.0 mt -61.28 -47.52 93.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 172.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -60.14 -32.98 71.54 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.594 175.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 132' ' ' GLU . 69.9 m -57.25 -52.06 66.86 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.856 0.36 . . . . 0.0 110.459 177.098 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 121.32 0.581 . . . . 0.0 110.616 178.182 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.235 0 CA-C-O 120.909 0.385 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.438 ' HZ ' HD11 ' A' ' 23' ' ' LEU . 34.3 p90 -114.33 140.95 48.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.222 0.534 . . . . 0.0 111.005 -176.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.5 t -139.7 90.22 2.38 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 173.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.552 HD22 ' HD2' ' A' ' 11' ' ' PRO . 1.8 tm? -116.9 119.83 34.76 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.261 -166.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.565 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 40.0 Cg_endo -68.41 128.48 17.37 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.749 2.299 . . . . 0.0 112.213 176.087 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.557 ' HA ' ' HG3' ' A' ' 88' ' ' MET . 0.0 OUTLIER -62.67 164.91 7.05 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.416 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 87' ' ' VAL . 4.2 pp -66.3 -18.22 65.22 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.668 -172.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 16.6 t-80 -84.7 -25.95 28.03 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.926 0.393 . . . . 0.0 110.373 176.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.475 ' C ' ' HE2' ' A' ' 16' ' ' LYS . . . 123.6 8.54 6.28 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.572 -0.823 . . . . 0.0 113.735 174.05 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.475 ' HE2' ' C ' ' A' ' 15' ' ' GLY . 0.8 OUTLIER -94.55 120.31 34.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 117.378 0.589 . . . . 0.0 110.612 179.147 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 10.3 m -67.28 126.09 28.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.448 -177.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.534 HG12 ' O ' ' A' ' 10' ' ' LEU . 1.7 p -116.55 135.31 57.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 177.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.5 m -146.54 -173.08 4.11 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 122.11 -0.369 . . . . 0.0 111.303 -177.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -54.81 -39.66 68.73 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -176.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.04 -27.21 66.74 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -177.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -73.2 -25.93 60.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.021 0.438 . . . . 0.0 110.515 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.582 HD22 HG21 ' A' ' 28' ' ' THR . 33.5 mt -83.39 -51.7 7.16 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.087 -176.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -56.11 130.92 46.09 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.367 -172.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.76 -25.15 28.45 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.104 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.585 ' HG2' ' OD1' ' A' ' 58' ' ' ASN . 8.1 mtpm? -124.49 172.97 8.77 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -177.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.405 ' HB ' ' HD1' ' A' ' 59' ' ' PHE . 11.1 t -103.82 139.71 24.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 176.214 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.805 HG23 HD13 ' A' ' 62' ' ' LEU . 85.2 m -126.73 139.14 53.36 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -168.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.718 ' HB2' ' CE2' ' A' ' 59' ' ' PHE . 27.0 tp -110.02 107.37 17.23 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.74 172.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.554 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 28.6 mt -98.62 111.35 28.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.316 173.022 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -109.29 122.84 48.22 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.106 -177.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.436 ' CE1' ' HA2' ' A' ' 96' ' ' GLY . 97.2 m-85 -91.15 118.93 30.84 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.86 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.664 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 10.6 p-90 -148.5 -178.86 6.56 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.829 -177.332 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.558 ' O ' ' HB2' ' A' ' 37' ' ' CYS . 41.0 p90 -155.09 144.84 15.49 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 178.013 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.838 ' HG2' ' HB3' ' A' ' 69' ' ' ASP . 12.4 Cg_endo -59.71 152.03 65.98 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.168 1.912 . . . . 0.0 111.433 174.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.9 m 68.89 18.81 8.46 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 123.529 0.518 . . . . 0.0 111.091 -177.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.558 ' HB2' ' O ' ' A' ' 34' ' ' PHE . 45.1 t -68.33 140.45 92.8 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.452 -178.123 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -72.61 -22.96 20.27 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.821 2.347 . . . . 0.0 111.893 173.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.3 -1.21 88.08 Favored Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.923 -0.581 . . . . 0.0 113.147 -176.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.43 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 90.9 m -56.92 -30.4 63.94 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.876 0.338 . . . . 0.0 111.672 -177.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.4 t -49.97 -50.11 19.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.081 0.467 . . . . 0.0 110.641 177.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.4 m -87.2 -54.87 4.08 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.05 177.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.506 ' HA ' ' HD3' ' A' ' 46' ' ' LYS . 49.3 mm-40 -59.79 -40.85 89.7 Favored 'General case' 0 C--O 1.226 -0.139 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -168.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.817 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -59.12 -60.86 9.17 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -169.667 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.817 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 19.5 Cg_exo -67.11 -29.48 39.77 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 121.958 1.772 . . . . 0.0 111.488 178.101 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.506 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 64.8 tttt -59.79 -42.91 94.42 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.09 177.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.435 HG12 ' O ' ' A' ' 43' ' ' GLU . 41.0 mm -71.63 -38.95 68.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.352 177.141 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.722 HD13 ' HE2' ' A' ' 85' ' ' PHE . 47.6 mm -55.46 -53.63 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.2 -179.242 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -66.03 -49.33 68.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.287 -178.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 31.6 m -61.8 -54.67 39.12 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.782 -174.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.52 -33.59 73.03 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -173.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -75.79 -40.48 55.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.816 0.341 . . . . 0.0 111.173 -178.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -70.93 -42.99 69.12 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.844 0.354 . . . . 0.0 110.769 -176.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.617 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 42.8 m-85 -76.06 -10.32 59.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.714 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -56.71 -27.65 59.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.041 0.448 . . . . 0.0 110.954 -178.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -102.89 14.81 31.04 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.519 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.591 ' HD3' ' HA ' ' A' ' 54' ' ' TYR . 13.6 mptt -111.62 23.49 13.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.755 176.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.585 ' OD1' ' HG2' ' A' ' 26' ' ' LYS . 66.2 t30 68.11 18.46 9.37 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 122.078 0.942 . . . . 0.0 109.795 -176.259 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.718 ' CE2' ' HB2' ' A' ' 29' ' ' LEU . 38.5 t80 -100.03 162.01 13.25 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.557 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -150.42 152.55 34.5 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.248 0.547 . . . . 0.0 112.064 -177.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 1.026 HG11 ' HB3' ' A' ' 85' ' ' PHE . 1.5 p -101.08 125.88 54.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 114.816 -1.083 . . . . 0.0 111.119 -178.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.805 HD13 HG23 ' A' ' 28' ' ' THR . 8.7 mp -128.63 94.31 3.83 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 169.112 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -101.05 102.01 12.9 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.546 -176.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.979 HG12 ' HB2' ' A' ' 88' ' ' MET . 26.7 m -97.08 127.47 49.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.441 0.638 . . . . 0.0 111.118 -176.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.664 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -95.2 135.83 36.28 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.676 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.679 ' HB2' ' HG2' ' A' ' 93' ' ' LYS . 4.3 pm0 -95.2 161.47 28.0 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 175.231 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.607 ' HD2' ' HB2' ' A' ' 66' ' ' GLN . 73.8 Cg_endo -74.04 54.03 3.05 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.903 2.402 . . . . 0.0 114.555 -168.055 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 45.7 mm -83.27 -27.85 7.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 170.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.838 ' HB3' ' HG2' ' A' ' 35' ' ' PRO . 0.6 OUTLIER -138.89 136.17 18.24 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 173.44 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -51.83 163.98 1.18 Allowed 'Trans proline' 0 N--CA 1.477 0.553 0 C-N-CA 123.509 2.806 . . . . 0.0 114.587 -175.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.8 tp -56.73 -34.92 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.574 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -66.47 -35.47 80.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.195 0.522 . . . . 0.0 110.419 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 27.3 m -64.89 -47.69 76.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.306 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.491 ' HB ' ' HG3' ' A' ' 35' ' ' PRO . 9.2 p -67.18 -33.95 66.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.652 0.263 . . . . 0.0 110.814 -178.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -65.89 -37.54 86.39 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.005 0.431 . . . . 0.0 110.993 176.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 15.4 tm0? -69.76 -36.55 75.89 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -64.2 -50.75 66.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.979 -178.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.635 HG23 ' HB2' ' A' ' 83' ' ' LEU . 10.4 p -60.5 -30.21 46.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-O 120.754 0.312 . . . . 0.0 110.643 178.358 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -70.67 -55.37 8.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.239 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -66.25 -48.38 70.7 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.117 -174.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -82.55 -18.41 41.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.441 -176.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 69.08 63.74 3.31 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.98 177.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.635 ' HB2' HG23 ' A' ' 78' ' ' VAL . 8.4 mp -87.64 111.03 39.21 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 120.633 0.254 . . . . 0.0 110.383 178.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -89.98 24.54 0.62 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.899 2.399 . . . . 0.0 113.168 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 1.026 ' HB3' HG11 ' A' ' 61' ' ' VAL . 13.0 m-85 -121.15 155.28 34.85 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.1 m -68.2 123.56 21.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.1 0.476 . . . . 0.0 111.86 -173.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.448 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 48.7 t -122.62 135.19 63.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.822 -178.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.979 ' HB2' HG12 ' A' ' 64' ' ' VAL . 2.3 mpt? -117.13 175.5 5.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 93.6 t80 -138.51 117.18 12.21 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.241 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.598 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 21.1 t0 -103.98 114.26 28.38 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.49 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.0 -14.87 61.09 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -174.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -122.4 0.67 9.49 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.46 -175.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.679 ' HG2' ' HB2' ' A' ' 66' ' ' GLN . 49.3 mtmt 64.37 15.1 9.28 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 123.58 0.55 . . . . 0.0 109.903 -171.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.9 -44.27 93.47 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -165.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.545 HG22 ' OD2' ' A' ' 90' ' ' ASP . 28.2 m -74.14 -29.32 24.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.231 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.436 ' HA2' ' CE1' ' A' ' 32' ' ' PHE . . . -72.1 -34.78 61.3 Favored Glycine 0 CA--C 1.509 -0.282 0 C-N-CA 120.541 -0.837 . . . . 0.0 111.29 174.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -71.03 -28.84 64.69 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.007 -0.596 . . . . 0.0 110.224 174.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.21 -22.71 59.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.233 175.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -87.65 -22.91 24.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.998 176.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 93.23 62.99 1.09 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.574 176.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.9 p -103.95 127.16 51.49 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.878 0.371 . . . . 0.0 111.244 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -87.81 -50.75 6.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.127 0.489 . . . . 0.0 110.31 176.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.4 p -145.08 149.15 17.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.087 -176.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.556 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 59.2 m-85 -106.21 161.46 22.78 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.215 -176.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.556 ' HA ' ' HB3' ' A' ' 104' ' ' TYR . 74.4 Cg_endo -74.39 165.5 85.24 Favored 'Cis proline' 0 C--N 1.351 0.684 0 C-N-CA 123.772 -1.345 . . . . 0.0 113.233 0.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.3 m -139.77 132.44 28.92 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.623 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.546 ' HB3' ' HB2' ' A' ' 120' ' ' TYR . 18.8 t -112.33 112.15 23.52 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.697 HG22 HG22 ' A' ' 119' ' ' THR . 55.5 t -105.99 131.6 55.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.898 0.38 . . . . 0.0 111.489 -175.094 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 90.2 mt -102.98 125.73 49.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.997 177.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.566 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 53.6 mt -118.05 141.09 38.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 123.445 0.466 . . . . 0.0 110.715 -179.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -85.8 -167.17 43.11 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 116.155 -0.475 . . . . 0.0 113.574 -177.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.4 -20.58 50.87 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -173.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.416 ' HB3' ' CD ' ' A' ' 115' ' ' GLU . 3.7 ttmp? -99.17 -3.18 35.01 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.554 0.692 . . . . 0.0 109.2 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 97.29 12.64 48.01 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.67 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.416 ' CD ' ' HB3' ' A' ' 113' ' ' LYS . 3.7 mp0 -68.15 122.15 17.68 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -178.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 29.8 mt -74.01 93.76 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 174.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 93.4 mt -75.38 -70.3 0.43 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.596 -171.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.452 ' HD2' ' HA ' ' A' ' 118' ' ' LYS . 22.7 mmmt -125.44 144.72 50.4 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.148 -171.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.697 HG22 HG22 ' A' ' 108' ' ' VAL . 1.6 p -120.99 104.16 9.59 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.374 175.023 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.546 ' HB2' ' HB3' ' A' ' 107' ' ' SER . 22.6 m-85 -85.05 103.43 14.07 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.87 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.6 t -83.0 109.74 17.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.988 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 86.31 -116.83 4.48 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.375 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.453 ' OE1' ' HD2' ' A' ' 124' ' ' PRO . 7.1 tp10 -103.72 116.63 61.49 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-O 120.531 0.205 . . . . 0.0 110.812 -174.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.492 ' HB3' ' CG ' ' A' ' 120' ' ' TYR . 93.2 Cg_endo -86.54 -159.58 0.1 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 123.027 2.485 . . . . 0.0 112.254 175.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.848 ' HB3' ' HG2' ' A' ' 128' ' ' LYS . 18.2 t70 -125.27 124.27 41.29 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.861 177.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -65.54 -37.53 86.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.504 -175.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.77 -50.98 55.69 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.201 -178.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.848 ' HG2' ' HB3' ' A' ' 125' ' ' ASP . 11.9 ptmm? -67.5 -26.13 66.19 Favored 'General case' 0 C--O 1.221 -0.443 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.184 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 51.4 tp -61.08 -47.36 86.69 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.233 0.333 . . . . 0.0 110.224 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -62.24 -54.48 40.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.149 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.492 ' HG2' ' HA ' ' A' ' 128' ' ' LYS . 13.7 pt20 -65.99 -33.88 76.82 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -175.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -71.02 -45.78 63.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.477 0.18 . . . . 0.0 110.69 -177.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 72.7 mt -66.51 -36.26 76.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 177.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -61.46 -47.87 83.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.61 175.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 45.0 m -55.57 -35.23 65.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.185 0.517 . . . . 0.0 110.328 176.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.162 -178.085 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.564 0 CA-C-O 121.651 0.739 . . . . 0.0 112.893 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -141.78 131.58 24.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.912 171.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 26.0 p -149.35 103.09 3.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.868 0.365 . . . . 0.0 110.921 -179.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.451 ' H ' HD23 ' A' ' 10' ' ' LEU . 1.6 pt? -120.1 157.27 53.49 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.766 178.162 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.13 150.65 26.33 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 121.992 1.795 . . . . 0.0 112.228 177.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.591 ' HA ' ' HG3' ' A' ' 88' ' ' MET . 0.0 OUTLIER -81.41 176.6 9.57 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.035 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 87' ' ' VAL . 78.4 mt -57.42 -26.25 60.85 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -177.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 47.4 t60 -91.29 -40.84 11.27 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 121.355 -0.138 . . . . 0.0 110.783 178.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.93 4.01 0.87 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.063 -1.065 . . . . 0.0 113.804 176.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -78.47 126.74 31.19 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 117.468 0.634 . . . . 0.0 110.212 178.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.7 m -66.97 130.51 43.38 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.851 0.358 . . . . 0.0 110.12 176.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 9' ' ' SER . 9.8 p -118.21 138.13 49.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.342 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.0 p -138.69 -177.63 4.95 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.312 0.577 . . . . 0.0 112.091 -173.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -71.36 -21.7 62.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.665 175.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.65 -31.34 72.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.682 178.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -63.72 -23.26 67.3 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.805 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.62 HD22 HG21 ' A' ' 28' ' ' THR . 25.0 mt -84.06 -20.53 32.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.125 -172.349 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.418 ' HA ' ' OE1' ' A' ' 24' ' ' GLN . 14.7 mm-40 -60.82 113.09 2.31 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -172.592 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 113.23 -19.57 19.97 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.341 174.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.449 ' HB2' ' OE1' ' A' ' 60' ' ' GLN . 68.0 mttm -124.87 169.84 11.65 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.036 0.418 . . . . 0.0 110.945 -176.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.612 HG13 ' CD1' ' A' ' 59' ' ' PHE . 3.3 p -102.63 123.77 56.18 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.625 -177.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.62 HG21 HD22 ' A' ' 23' ' ' LEU . 39.0 m -116.01 142.99 46.07 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -160.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.498 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 55.7 tp -112.04 111.04 21.67 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.712 170.286 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.596 ' HB ' ' HB ' ' A' ' 108' ' ' VAL . 62.8 mt -97.9 111.96 28.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 171.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -112.73 122.39 47.54 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.5 -176.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.505 ' HB2' ' HB ' ' A' ' 106' ' ' THR . 89.5 m-85 -94.85 119.89 34.16 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.515 178.023 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.557 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 18.0 p-90 -147.54 175.33 10.93 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.338 -177.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -154.43 145.04 16.02 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 174.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.526 ' HG2' ' HB3' ' A' ' 69' ' ' ASP . 6.0 Cg_exo -39.12 -66.3 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 124.323 3.349 . . . . 0.0 114.419 -173.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.8 m -77.12 57.12 1.35 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.005 0.431 . . . . 0.0 112.049 -178.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.3 t -117.27 132.74 23.36 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.292 177.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.588 ' O ' HG12 ' A' ' 41' ' ' VAL . 31.4 Cg_exo -60.42 -20.05 61.6 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.565 2.177 . . . . 0.0 112.174 176.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.69 -22.46 78.68 Favored Glycine 0 C--O 1.224 -0.521 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.76 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.682 ' HA ' ' HG3' ' A' ' 44' ' ' MET . 64.1 m -60.36 -35.08 74.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.912 0.356 . . . . 0.0 111.464 -177.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.588 HG12 ' O ' ' A' ' 38' ' ' PRO . 13.5 p -67.33 -40.23 84.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.168 -176.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.8 p -89.25 -49.72 6.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.942 0.401 . . . . 0.0 111.894 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.511 ' O ' HG12 ' A' ' 47' ' ' ILE . 27.0 mm-40 -80.18 -41.2 25.75 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -168.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.682 ' HG3' ' HA ' ' A' ' 40' ' ' CYS . 59.0 mtp -58.28 -49.46 93.46 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -172.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -59.12 -36.37 96.1 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 121.945 1.763 . . . . 0.0 111.811 175.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.419 ' HB3' ' O ' ' A' ' 43' ' ' GLU . 33.7 ttmt -63.42 -38.04 89.6 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.162 177.334 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.511 HG12 ' O ' ' A' ' 43' ' ' GLU . 46.0 mm -67.4 -35.41 73.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.202 176.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.519 HG12 ' O ' ' A' ' 44' ' ' MET . 47.2 mm -54.73 -52.36 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.616 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.432 ' C ' ' HD3' ' A' ' 49' ' ' LYS . 12.7 tmtt? -59.65 -56.25 24.25 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.892 178.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 27.7 m -54.02 -51.96 62.34 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.903 -174.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.569 ' HB1' HG11 ' A' ' 61' ' ' VAL . . . -68.91 -44.76 72.51 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.138 -174.034 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -75.82 -37.35 59.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.737 -173.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -74.48 -52.45 11.94 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -175.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -78.62 -2.87 41.06 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.82 0.343 . . . . 0.0 111.244 -175.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 24.0 tptm -59.58 -35.74 74.87 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.245 177.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -88.6 2.9 52.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.626 -177.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -96.19 -66.16 0.92 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.327 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 66.2 t30 174.63 18.59 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.436 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.612 ' CD1' HG13 ' A' ' 27' ' ' VAL . 20.7 t80 -104.03 148.47 26.19 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.236 -172.055 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.449 ' OE1' ' HB2' ' A' ' 26' ' ' LYS . 51.1 mt-30 -122.89 150.9 42.3 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.01 0.524 . . . . 0.0 109.967 178.367 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.569 HG11 ' HB1' ' A' ' 51' ' ' ALA . 5.9 p -127.1 121.06 56.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 121.175 0.512 . . . . 0.0 110.594 177.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 8.6 mp -126.77 96.31 4.61 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.443 177.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.55 113.36 25.6 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.536 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 63.7 t -98.19 116.39 40.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.026 0.441 . . . . 0.0 110.132 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.557 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -87.7 121.56 30.28 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.789 175.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.701 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 4.8 pm0 -89.65 169.16 13.2 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.035 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.701 ' HD2' ' HB2' ' A' ' 66' ' ' GLN . 30.0 Cg_endo -62.26 -138.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 122.701 2.267 . . . . 0.0 113.825 -178.287 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.539 ' HB ' ' O ' ' A' ' 67' ' ' PRO . 90.6 mt 78.9 -49.36 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 C-N-CA 123.163 0.585 . . . . 0.0 109.771 -173.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.526 ' HB3' ' HG2' ' A' ' 35' ' ' PRO . 0.6 OUTLIER -107.03 138.53 19.85 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 173.249 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 69' ' ' ASP . 33.8 Cg_exo -59.18 158.31 26.53 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.749 2.299 . . . . 0.0 112.821 -178.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.0 tp -62.26 -31.27 51.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.396 -175.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -66.57 -29.2 69.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.905 177.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.1 t -68.48 -40.55 80.92 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.7 t -62.66 -42.74 97.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.209 176.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -62.79 -36.0 81.71 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.176 177.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -61.46 -45.02 96.05 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.825 0.345 . . . . 0.0 110.75 -177.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -63.43 -52.49 61.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.303 -179.52 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.538 ' HA ' HD13 ' A' ' 83' ' ' LEU . 10.0 p -65.23 -26.53 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-O 121.035 0.445 . . . . 0.0 111.038 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -73.31 -54.77 7.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.356 0.598 . . . . 0.0 110.661 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -73.38 -48.87 30.54 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.862 -172.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -91.77 -4.49 54.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.523 -174.039 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.08 -58.0 4.59 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.755 177.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.538 HD13 ' HA ' ' A' ' 78' ' ' VAL . 11.2 mp 63.62 95.28 0.05 OUTLIER Pre-proline 0 N--CA 1.466 0.355 0 CA-C-O 121.275 0.56 . . . . 0.0 111.666 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -75.94 10.58 1.97 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.574 2.85 . . . . 0.0 113.07 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -120.38 145.03 47.57 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.2 m -67.68 124.46 23.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.16 -176.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.482 HG21 HD23 ' A' ' 83' ' ' LEU . 33.3 t -118.87 134.38 62.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.702 -179.131 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.591 ' HG3' ' HA ' ' A' ' 12' ' ' ASP . 3.2 mpp? -123.66 175.25 6.95 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -134.93 125.46 26.73 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.123 -177.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.566 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 56.4 t0 -107.68 111.16 23.23 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 174.479 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.11 -24.76 60.67 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -174.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.59 7.01 22.27 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.081 -174.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.4 pttp 46.45 32.0 1.47 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.992 0.917 . . . . 0.0 111.563 -179.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.33 -35.12 58.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.661 -173.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.546 HG22 ' OD2' ' A' ' 90' ' ' ASP . 32.6 m -73.44 -29.88 28.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 175.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -68.99 -39.5 84.92 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 172.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -58.83 -32.75 69.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.025 0.44 . . . . 0.0 111.142 175.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.95 -47.7 65.01 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.043 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.469 ' HD2' ' CZ ' ' A' ' 32' ' ' PHE . 30.2 m-85 -81.27 -14.17 57.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.978 -176.223 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 93.34 38.46 5.34 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.233 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.499 HG23 ' OG1' ' A' ' 106' ' ' THR . 39.9 m -75.9 89.22 2.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.285 0.564 . . . . 0.0 111.18 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 52.5 tp60 -101.44 -57.85 2.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.703 175.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.446 ' CG1' ' HB ' ' A' ' 121' ' ' VAL . 8.4 p -98.95 148.72 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.823 -177.283 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -114.65 144.28 31.57 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.968 -173.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.505 ' HG3' ' HG3' ' A' ' 43' ' ' GLU . 94.1 Cg_endo -85.58 165.23 55.92 Favored 'Cis proline' 0 N--CA 1.463 -0.279 0 C-N-CA 123.232 -1.57 . . . . 0.0 112.307 -0.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.505 ' HB ' ' HB2' ' A' ' 32' ' ' PHE . 36.5 m -110.45 134.07 52.69 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 176.64 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.5 m -121.72 110.18 15.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.992 0.425 . . . . 0.0 110.559 -176.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.596 ' HB ' ' HB ' ' A' ' 30' ' ' ILE . 46.4 t -109.41 125.13 66.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.513 -179.197 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.717 HD11 HD11 ' A' ' 129' ' ' LEU . 85.4 mt -103.4 136.3 43.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.545 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.564 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 51.8 mt -124.49 138.12 55.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 176.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.512 ' O ' ' HA ' ' A' ' 27' ' ' VAL . . . -78.06 -92.98 0.28 Allowed Glycine 0 C--O 1.223 -0.572 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.137 -172.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -144.63 -2.79 0.83 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.402 0.601 . . . . 0.0 111.351 -178.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.474 ' HB2' ' OE2' ' A' ' 115' ' ' GLU . 10.4 mtmp? -126.15 13.74 7.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.816 0.341 . . . . 0.0 110.89 -174.37 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.02 28.74 73.91 Favored Glycine 0 C--O 1.227 -0.316 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.246 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.512 ' CD ' ' H ' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -90.48 -11.05 41.46 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.856 0.36 . . . . 0.0 110.75 -176.292 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 19.3 mt 62.9 91.67 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.556 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.55 -34.55 72.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.934 -1.03 . . . . 0.0 112.699 -173.412 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.63 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 2.4 tppp? -155.43 139.87 16.8 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -168.264 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.56 HG23 HG22 ' A' ' 108' ' ' VAL . 18.3 m -126.07 101.99 7.03 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 120.91 0.386 . . . . 0.0 110.375 170.185 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.53 ' CD2' ' HB3' ' A' ' 124' ' ' PRO . 41.9 m-85 -94.07 137.69 32.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.285 173.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.446 ' HB ' ' CG1' ' A' ' 103' ' ' VAL . 3.7 m -102.59 108.9 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-O 121.247 0.546 . . . . 0.0 109.737 170.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 99.85 -162.91 19.38 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.341 -0.703 . . . . 0.0 111.341 -174.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -83.09 125.88 73.71 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.812 0.306 . . . . 0.0 110.352 176.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.53 ' HB3' ' CD2' ' A' ' 120' ' ' TYR . 96.5 Cg_endo -80.1 175.13 10.69 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.726 2.284 . . . . 0.0 112.435 177.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.485 ' HB2' ' HB3' ' A' ' 128' ' ' LYS . 7.1 m-20 -65.52 110.43 2.7 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 173.353 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -63.39 -39.7 95.23 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -170.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -73.21 -46.82 25.77 Favored Glycine 0 C--O 1.237 0.338 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.856 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.485 ' HB3' ' HB2' ' A' ' 125' ' ' ASP . 51.1 tttm -60.71 -36.86 79.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.653 0.263 . . . . 0.0 110.476 177.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.717 HD11 HD11 ' A' ' 109' ' ' LEU . 28.0 tp -58.92 -46.85 86.93 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.719 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -56.54 -45.29 81.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.848 0.356 . . . . 0.0 110.803 178.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -68.4 -37.23 80.16 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.865 -178.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.505 ' HG2' ' HA ' ' A' ' 129' ' ' LEU . 8.9 pt-20 -77.02 -23.65 52.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.78 0.324 . . . . 0.0 110.145 -179.01 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.2 mp -62.64 -48.72 86.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.017 172.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -61.89 -34.93 76.93 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.273 0.559 . . . . 0.0 110.316 177.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 35.6 m -60.65 -40.84 93.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.376 178.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.239 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.986 177.922 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.573 ' HA ' ' HB2' ' A' ' 20' ' ' ASN . . . . . . . . 0 N--CA 1.455 -0.221 0 CA-C-O 121.146 0.498 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.423 ' CZ ' HD11 ' A' ' 23' ' ' LEU . 50.3 p90 -86.43 148.68 25.45 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 176.352 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.9 t -149.56 88.76 1.58 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.175 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.529 ' H ' HD23 ' A' ' 10' ' ' LEU . 2.4 pt? -123.14 147.11 50.9 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.582 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.644 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 16.5 Cg_exo -68.67 132.23 24.66 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.445 2.097 . . . . 0.0 110.928 172.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.602 ' HA ' ' HG2' ' A' ' 88' ' ' MET . 0.0 OUTLIER -70.43 171.08 10.66 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.055 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.558 HD23 HG21 ' A' ' 78' ' ' VAL . 13.5 tp -81.54 10.38 5.99 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-O 121.403 0.621 . . . . 0.0 111.291 -171.278 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.453 ' H ' ' CG ' ' A' ' 12' ' ' ASP . 77.3 m80 -109.58 -27.52 9.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.48 170.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 124.13 16.69 3.17 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.687 177.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.468 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 59.0 mttp -112.8 115.39 28.41 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 122.649 -0.324 . . . . 0.0 110.619 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.644 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 35.4 m -61.16 127.22 30.48 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.987 0.423 . . . . 0.0 111.574 -178.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.7 t -111.69 125.81 69.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 174.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.8 p -131.51 175.25 9.31 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.196 0.522 . . . . 0.0 111.433 -176.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.573 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . 65.2 t30 -58.17 -31.44 67.26 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.094 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.47 -28.09 67.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.651 -178.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -74.1 -18.66 60.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.212 0.53 . . . . 0.0 110.605 -177.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.423 HD11 ' CZ ' ' A' ' 8' ' ' PHE . 79.9 mt -79.4 -19.73 49.35 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.434 -178.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -71.01 98.58 1.65 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.699 -172.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.59 -8.23 19.93 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.711 175.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 112' ' ' LYS . 56.2 mttm -115.98 167.47 10.93 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.415 ' HB ' ' HD2' ' A' ' 59' ' ' PHE . 22.5 t -104.12 139.81 24.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 174.264 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.796 HG23 ' HG3' ' A' ' 60' ' ' GLN . 4.6 m -129.81 142.23 50.72 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.042 0.448 . . . . 0.0 112.095 -166.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.685 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 7.4 tt -123.69 105.75 9.96 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 171.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.69 ' HB ' ' CG1' ' A' ' 108' ' ' VAL . 61.2 mt -97.49 115.1 36.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.459 ' HA ' ' O ' ' A' ' 106' ' ' THR . 27.4 t-20 -109.5 113.43 26.22 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.366 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.517 ' HE1' HG23 ' A' ' 95' ' ' VAL . 90.4 m-85 -81.92 119.71 24.29 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 175.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 9.7 p-90 -141.78 -179.06 5.97 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.287 0.565 . . . . 0.0 110.775 -175.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -158.12 149.94 17.18 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.766 174.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -63.04 170.08 8.11 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.445 2.097 . . . . 0.0 111.972 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.8 m 63.5 5.58 2.18 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.985 178.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 51.7 t -84.65 131.11 50.69 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.771 0.319 . . . . 0.0 111.046 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -61.62 -22.43 74.41 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.805 2.337 . . . . 0.0 112.112 176.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.37 -19.1 66.18 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.312 -0.471 . . . . 0.0 112.644 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 72.0 m -62.17 -33.41 74.46 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.663 0.268 . . . . 0.0 110.764 178.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 52.8 t -62.76 -35.63 71.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.231 0.538 . . . . 0.0 110.411 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.3 m -86.39 -53.29 5.09 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.944 -177.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.419 ' O ' HG12 ' A' ' 47' ' ' ILE . 17.7 mm-40 -84.46 -31.78 24.39 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -168.422 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.612 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 50.0 tpp -57.59 -52.1 76.86 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 111.998 0.369 . . . . 0.0 111.998 -174.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.612 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 54.4 Cg_exo -53.39 -39.8 80.4 Favored 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 121.927 1.751 . . . . 0.0 112.404 176.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.429 ' HD3' ' CZ ' ' A' ' 126' ' ' PHE . 56.2 mttp -59.78 -51.45 69.69 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.12 178.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.419 HG12 ' O ' ' A' ' 43' ' ' GLU . 49.8 mm -61.24 -42.11 92.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.224 -177.302 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.583 HG12 ' O ' ' A' ' 44' ' ' MET . 49.3 mm -55.03 -53.29 35.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.588 0.232 . . . . 0.0 111.434 -178.132 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.409 ' HB3' ' NZ ' ' A' ' 49' ' ' LYS . 0.2 OUTLIER -74.98 -47.39 29.54 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.793 -175.085 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.5 m -63.88 -44.06 94.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.757 0.313 . . . . 0.0 111.362 -176.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.468 ' HB2' HG21 ' A' ' 61' ' ' VAL . . . -69.22 -33.12 72.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.796 -0.184 . . . . 0.0 110.734 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -56.4 -50.94 70.16 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.366 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -68.93 -51.09 43.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.122 0.487 . . . . 0.0 111.034 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 1.048 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 8.8 m-85 -66.5 -31.07 71.56 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -172.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -63.49 -27.3 69.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.083 0.468 . . . . 0.0 110.397 178.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -96.5 19.4 12.25 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.127 0.489 . . . . 0.0 110.499 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 58' ' ' ASN . 0.0 OUTLIER -121.16 -65.4 1.14 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.728 178.131 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 66.6 t30 171.17 19.68 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.646 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 1.048 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 55.4 t80 -114.74 128.27 56.21 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -176.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.796 ' HG3' HG23 ' A' ' 28' ' ' THR . 4.5 pt20 -114.24 128.34 56.31 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.192 0.52 . . . . 0.0 111.151 -175.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.468 HG21 ' HB2' ' A' ' 51' ' ' ALA . 88.5 t -102.87 121.03 53.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.587 175.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.435 ' HB2' HG12 ' A' ' 30' ' ' ILE . 79.5 mt -113.39 101.58 9.52 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.846 -177.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.69 100.46 12.84 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.396 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.3 t -88.52 106.36 16.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.467 -176.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.86 133.08 34.32 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 174.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.608 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 3.4 pt20 -109.3 164.86 13.78 Favored Pre-proline 0 C--N 1.316 -0.89 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.608 ' HD2' ' HB2' ' A' ' 66' ' ' GLN . 37.8 Cg_endo -64.9 95.79 0.25 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.312 2.008 . . . . 0.0 113.485 -174.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 45.9 mm -128.13 -65.01 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 171.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -89.53 151.64 46.26 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.046 169.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -58.22 160.25 16.72 Favored 'Trans proline' 0 C--O 1.236 0.411 0 C-N-CA 122.506 2.137 . . . . 0.0 112.504 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.0 tp -56.63 -33.2 39.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.793 -176.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.644 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -65.89 -38.55 89.05 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 122.257 -0.277 . . . . 0.0 110.469 179.418 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.8 m -63.86 -44.86 91.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.776 0.322 . . . . 0.0 110.734 -178.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.47 -35.7 52.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.348 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.644 ' HG2' ' HA ' ' A' ' 72' ' ' GLU . 11.8 ptt180 -73.9 -35.42 64.67 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.569 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -64.98 -39.56 93.66 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 176.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -54.61 -55.21 31.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.405 178.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.07 ' HA ' HD23 ' A' ' 83' ' ' LEU . 61.9 t -60.01 -37.86 74.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.658 -178.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.578 ' HG2' ' O ' ' A' ' 75' ' ' ARG . 33.3 mmtp -69.59 -51.21 37.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.81 0.338 . . . . 0.0 110.987 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -63.95 -48.96 74.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.026 -173.195 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.409 ' HB2' ' CD2' ' A' ' 83' ' ' LEU . 96.9 m-85 -88.23 -2.89 58.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.371 -175.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 59.87 53.47 45.63 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.919 176.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 1.07 HD23 ' HA ' ' A' ' 78' ' ' VAL . 2.9 mm? -69.92 114.1 22.51 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 120.789 0.328 . . . . 0.0 110.646 -179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -84.24 -20.32 4.22 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.036 2.491 . . . . 0.0 113.964 -174.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.511 ' CE1' HD12 ' A' ' 83' ' ' LEU . 40.0 p90 -79.99 169.6 17.64 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.693 0.282 . . . . 0.0 110.486 -179.034 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 24.2 m -78.48 105.46 9.76 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.562 0.696 . . . . 0.0 111.22 -175.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.1 t -99.59 141.91 16.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.233 177.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.602 ' HG2' ' HA ' ' A' ' 12' ' ' ASP . 60.6 mtm -136.63 168.98 18.47 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -134.97 104.74 6.08 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.879 0.371 . . . . 0.0 110.743 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.548 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 20.0 t70 -91.11 101.99 14.74 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.34 -10.64 59.96 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.226 -171.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.474 ' OD2' ' HB2' ' A' ' 94' ' ' ALA . 13.5 t70 -105.14 -12.05 16.29 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.544 -0.463 . . . . 0.0 111.345 -176.102 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 63.2 tttp 65.32 4.97 2.88 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 121.349 0.595 . . . . 0.0 111.365 177.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.474 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . . . -70.62 -29.49 65.89 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -170.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.517 HG23 ' HE1' ' A' ' 32' ' ' PHE . 22.5 m -73.08 -33.94 43.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.353 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -70.89 -33.89 65.81 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 173.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -70.6 -32.03 69.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.213 -0.493 . . . . 0.0 110.876 176.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.69 -45.57 89.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.87 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -73.11 -27.07 61.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.986 0.422 . . . . 0.0 110.814 175.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.31 39.63 7.24 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.873 -0.68 . . . . 0.0 111.782 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.8 p -84.08 115.24 22.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.624 0.25 . . . . 0.0 110.601 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -103.23 -40.03 6.59 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.998 0.428 . . . . 0.0 110.148 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 40.1 t -98.75 145.27 10.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.967 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.411 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 87.0 m-85 -132.62 155.82 80.78 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.411 ' HA ' ' HB3' ' A' ' 104' ' ' TYR . 86.9 Cg_endo -78.63 160.28 90.94 Favored 'Cis proline' 0 C--N 1.345 0.373 0 C-N-CA 123.25 -1.562 . . . . 0.0 112.772 0.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 53.9 m -131.71 123.83 28.54 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.727 178.093 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.1 m -107.99 117.69 34.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.52 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.69 ' CG1' ' HB ' ' A' ' 30' ' ' ILE . 10.1 p -106.09 135.9 42.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.939 0.4 . . . . 0.0 110.144 178.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.55 HD23 ' HB2' ' A' ' 118' ' ' LYS . 2.3 mm? -102.84 124.99 49.4 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.244 -178.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.575 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 53.5 mt -109.26 133.96 52.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.964 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -80.04 159.11 43.17 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.289 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 46.8 pttt -67.68 86.15 0.21 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.75 0.786 . . . . 0.0 111.112 -177.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 4.6 ttmp? 165.73 -30.02 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.373 -178.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.46 39.97 1.84 Allowed Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.345 -176.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -113.35 132.35 55.62 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.428 HD13 HG12 ' A' ' 110' ' ' ILE . 49.2 mm -78.46 117.91 24.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.827 0.346 . . . . 0.0 110.083 -178.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.2 mt -103.14 -68.59 0.83 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.769 -175.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.55 ' HB2' HD23 ' A' ' 109' ' ' LEU . 20.1 mmmt -124.33 157.3 35.32 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -168.239 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -138.32 108.74 6.51 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.026 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -108.8 109.37 20.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.202 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 36.5 t -96.92 138.19 22.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.08 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 90.12 -77.63 1.58 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.124 178.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -151.71 119.81 3.33 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 178.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.54 ' HB2' HD22 ' A' ' 129' ' ' LEU . 38.1 Cg_endo -67.81 130.23 21.43 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.561 2.174 . . . . 0.0 112.427 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.616 ' OD1' ' HG2' ' A' ' 128' ' ' LYS . 12.7 t70 -69.32 110.85 4.86 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 177.245 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.429 ' CZ ' ' HD3' ' A' ' 46' ' ' LYS . 34.6 m-85 -58.58 -44.15 89.7 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -173.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -56.66 -52.89 47.72 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.915 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.616 ' HG2' ' OD1' ' A' ' 125' ' ' ASP . 38.4 mmtm -63.93 -48.87 74.83 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.54 HD22 ' HB2' ' A' ' 124' ' ' PRO . 28.0 tp -63.16 -48.66 77.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.989 -171.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -64.39 -37.88 89.06 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.958 -177.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -73.34 -39.73 64.98 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.43 178.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.489 ' OE1' ' HG3' ' A' ' 118' ' ' LYS . 9.5 pt-20 -75.24 -38.13 60.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.276 -174.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 57.6 mt -64.37 -45.97 94.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 175.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -61.32 -32.18 72.04 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.002 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 90.4 m -58.37 -47.43 83.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.975 0.417 . . . . 0.0 110.653 177.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.351 0 CA-C-O 121.077 0.465 . . . . 0.0 111.062 177.875 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 -0.236 0 CA-C-O 121.105 0.479 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -119.07 144.41 46.59 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.353 0.597 . . . . 0.0 111.558 -174.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.2 p -149.43 88.58 1.58 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.85 170.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.56 ' H ' HD23 ' A' ' 10' ' ' LEU . 2.6 pt? -121.98 155.71 60.5 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.896 -174.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.92 145.7 19.99 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.742 2.295 . . . . 0.0 111.584 173.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 51.7 p-10 -89.53 -172.65 3.67 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.141 177.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.6 mt -79.06 20.7 0.47 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.765 0.316 . . . . 0.0 111.441 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -118.33 -24.34 6.93 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 174.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.45 14.93 14.81 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.719 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -113.37 141.61 46.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.972 0.386 . . . . 0.0 110.315 178.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.2 m -75.27 122.53 23.84 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.404 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.5 t -108.01 142.84 19.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.733 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.5 p -145.35 -173.8 4.21 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.202 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -66.47 -22.73 66.2 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -176.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.63 -31.73 71.83 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.833 0.349 . . . . 0.0 111.81 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.62 -37.03 84.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.45 0.643 . . . . 0.0 109.704 177.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.493 HD22 HG21 ' A' ' 28' ' ' THR . 21.7 mt -72.21 -21.33 61.42 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.475 -174.202 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -64.8 102.1 0.55 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.248 0.547 . . . . 0.0 111.686 -174.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.05 -26.04 10.22 Favored Glycine 0 CA--C 1.511 -0.208 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.991 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.708 ' O ' ' HA ' ' A' ' 112' ' ' LYS . 31.5 mttp -97.18 163.09 13.06 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 177.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.471 HG22 ' HB3' ' A' ' 112' ' ' LYS . 4.9 t -103.08 127.3 57.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 175.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.59 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 27.7 m -131.33 142.23 50.06 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.397 0.618 . . . . 0.0 112.361 -168.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.474 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 24.8 tp -115.69 115.27 26.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.396 172.086 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.819 ' HB ' ' CG2' ' A' ' 108' ' ' VAL . 51.2 mt -94.27 112.86 27.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 176.272 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -117.0 118.3 32.01 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.855 0.36 . . . . 0.0 110.932 -176.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.483 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 87.7 m-85 -84.25 125.09 31.9 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.406 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.532 ' CD1' ' HB1' ' A' ' 63' ' ' ALA . 22.7 p-90 -147.07 175.54 10.62 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.217 0.532 . . . . 0.0 111.097 -177.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.425 ' HD2' ' OD2' ' A' ' 69' ' ' ASP . 27.2 p90 -161.67 149.58 12.23 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.714 173.188 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.583 ' HD2' ' HB2' ' A' ' 69' ' ' ASP . 84.7 Cg_exo -49.61 -46.69 25.85 Favored 'Trans proline' 0 N--CA 1.474 0.375 0 C-N-CA 123.422 2.748 . . . . 0.0 114.284 -174.589 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.1 m -79.35 17.81 0.78 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -174.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.612 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 48.0 t -85.2 126.5 67.23 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 120.704 0.288 . . . . 0.0 110.734 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 17.0 Cg_exo -67.79 -19.32 47.16 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.963 2.442 . . . . 0.0 112.305 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.24 -11.52 84.93 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.803 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.612 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 89.2 m -60.96 -43.57 98.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.704 0.252 . . . . 0.0 111.381 -178.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.9 m -59.71 -27.86 38.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.02 0.438 . . . . 0.0 111.403 -177.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.9 m -87.45 -55.14 3.92 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.265 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.445 ' O ' HG12 ' A' ' 47' ' ' ILE . 26.5 mm-40 -84.55 -33.18 23.5 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -168.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.649 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 47.9 tpp -57.52 -53.76 62.11 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -172.41 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.649 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 43.2 Cg_exo -57.15 -36.59 99.18 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 122.096 1.864 . . . . 0.0 111.98 178.129 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.464 ' HB3' ' HE2' ' A' ' 46' ' ' LYS . 4.6 tmmm? -66.74 -39.8 88.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.108 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 43' ' ' GLU . 34.1 mm -63.52 -39.4 85.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.581 177.565 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.548 HD13 ' HE1' ' A' ' 85' ' ' PHE . 44.9 mm -54.62 -53.38 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.287 178.47 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -63.24 -51.5 65.93 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.803 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 30.9 m -56.02 -47.17 78.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.945 0.402 . . . . 0.0 111.491 -176.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . -65.62 -41.09 93.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.433 -177.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -73.76 -37.76 64.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.954 -176.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.07 -49.54 76.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.689 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -92.08 -1.49 57.17 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.524 -174.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 24.2 tptm -59.26 -35.32 73.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.102 0.477 . . . . 0.0 110.49 178.011 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -74.85 -24.25 58.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.403 -176.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -71.35 -70.35 0.32 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 175.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 171.63 22.24 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.456 -176.416 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.474 ' HZ ' ' HB2' ' A' ' 29' ' ' LEU . 29.5 t80 -100.48 139.72 35.75 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.969 -174.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.501 ' O ' ' HA ' ' A' ' 28' ' ' THR . 12.1 pt20 -134.64 137.15 43.4 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.147 176.078 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.447 HG22 ' HE1' ' A' ' 59' ' ' PHE . 98.3 t -104.98 119.16 53.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.47 HD23 ' HB ' ' A' ' 86' ' ' THR . 70.0 mt -104.04 98.59 8.39 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.7 177.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.532 ' HB1' ' CD1' ' A' ' 33' ' ' TRP . . . -84.52 109.29 17.82 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.271 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.509 HG11 HG11 ' A' ' 95' ' ' VAL . 86.4 t -93.93 108.37 20.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.257 0.551 . . . . 0.0 110.495 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -80.14 127.83 32.79 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 174.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.759 ' HG2' HG12 ' A' ' 68' ' ' ILE . 5.5 pm0 -99.85 162.34 21.41 Favored Pre-proline 0 C--N 1.318 -0.785 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -179.135 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.603 ' HD2' ' HB2' ' A' ' 66' ' ' GLN . 58.6 Cg_endo -70.9 42.4 0.42 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.994 2.463 . . . . 0.0 115.157 -170.394 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.759 HG12 ' HG2' ' A' ' 66' ' ' GLN . 43.6 mm -84.09 -30.96 7.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 172.323 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.583 ' HB2' ' HD2' ' A' ' 35' ' ' PRO . 23.6 m-20 -125.12 150.93 68.39 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.784 169.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -58.12 154.76 37.8 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.352 2.035 . . . . 0.0 111.954 176.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.699 ' HA ' HG22 ' A' ' 74' ' ' VAL . 11.9 tt -63.0 -27.62 43.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.633 0.254 . . . . 0.0 111.177 -178.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.446 ' HA ' ' NE ' ' A' ' 75' ' ' ARG . 10.1 pt-20 -67.38 -33.97 76.32 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.189 177.135 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.6 m -68.92 -45.0 71.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.27 175.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.699 HG22 ' HA ' ' A' ' 71' ' ' ILE . 5.2 m -70.39 -35.79 63.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.973 -175.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.446 ' NE ' ' HA ' ' A' ' 72' ' ' GLU . 30.5 ptt180 -75.27 -27.53 59.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.561 -179.121 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 -68.52 -37.83 80.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.369 176.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -63.48 -47.84 80.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.075 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.688 HG13 ' HB2' ' A' ' 83' ' ' LEU . 43.6 t -61.24 -42.18 92.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.682 177.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.4 tttt -62.84 -55.95 21.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.005 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -63.03 -48.81 77.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.306 -170.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -83.59 -17.6 41.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.711 0.291 . . . . 0.0 111.294 -176.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.0 60.8 4.02 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.961 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.688 ' HB2' HG13 ' A' ' 78' ' ' VAL . 9.9 mp -67.6 118.73 60.05 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.723 -0.238 . . . . 0.0 110.533 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -75.84 -28.89 7.46 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.787 2.324 . . . . 0.0 112.862 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.548 ' HE1' HD13 ' A' ' 48' ' ' ILE . 33.6 p90 -80.34 150.98 29.69 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.47 ' HB ' HD23 ' A' ' 62' ' ' LEU . 22.2 m -75.21 131.32 40.32 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.117 0.484 . . . . 0.0 111.335 -173.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.465 HG22 ' HB3' ' A' ' 63' ' ' ALA . 68.5 t -114.09 139.46 39.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.418 -179.12 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 70.1 mtm -127.26 167.56 15.93 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 176.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -137.72 112.0 8.58 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.563 0.22 . . . . 0.0 110.441 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.56 ' OD2' HG12 ' A' ' 95' ' ' VAL . 55.8 t0 -91.53 119.07 31.14 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.141 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.56 -20.84 60.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.928 -176.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -111.64 -11.7 13.99 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -175.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.412 ' HE2' ' HB3' ' A' ' 93' ' ' LYS . 32.2 ttpt 65.52 16.57 10.58 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.965 0.412 . . . . 0.0 109.964 175.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.09 -29.27 70.2 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.608 0.718 . . . . 0.0 109.59 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.56 HG12 ' OD2' ' A' ' 90' ' ' ASP . 7.7 p -60.65 -46.53 95.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.136 174.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.402 ' N ' HG13 ' A' ' 95' ' ' VAL . . . -76.13 -33.2 50.38 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.888 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -58.6 -36.34 73.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.014 0.435 . . . . 0.0 111.242 177.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.03 -46.33 52.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.305 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -72.76 -27.58 62.1 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 95.13 36.58 5.42 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -175.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.502 HG23 ' OG1' ' A' ' 106' ' ' THR . 20.0 m -76.51 88.15 3.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.134 0.492 . . . . 0.0 111.2 -177.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -103.12 -46.03 4.75 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.317 177.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 38.4 t -101.82 131.43 49.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.0 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -104.98 149.21 37.32 Favored Pre-proline 0 C--N 1.317 -0.826 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -178.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -79.73 165.99 78.43 Favored 'Cis proline' 0 C--N 1.344 0.319 0 C-N-CA 124.123 -1.199 . . . . 0.0 112.907 0.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.502 ' OG1' HG23 ' A' ' 101' ' ' THR . 58.1 m -131.43 114.95 15.57 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.205 176.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.6 m -108.74 115.39 30.0 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.026 0.441 . . . . 0.0 110.368 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.819 ' CG2' ' HB ' ' A' ' 30' ' ' ILE . 26.9 m -106.16 148.85 10.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.312 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.7 ' HB2' ' HB3' ' A' ' 118' ' ' LYS . 11.0 mp -101.09 124.32 46.62 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.943 -174.284 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.59 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 25.8 mm -112.3 118.59 58.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.027 174.657 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -71.04 -168.33 8.15 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.72 178.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.708 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 10.7 ptmm? -95.79 21.06 8.95 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 122.687 1.232 . . . . 0.0 107.935 -175.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.498 ' HD2' ' HA ' ' A' ' 113' ' ' LYS . 1.8 mmmp? -106.39 -1.2 23.52 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 113.439 -1.71 . . . . 0.0 108.866 174.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 61.97 46.48 93.99 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 114.952 -1.022 . . . . 0.0 113.326 177.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -148.53 167.01 26.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.023 0.439 . . . . 0.0 111.632 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.2 mt -61.87 127.46 21.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.703 -178.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 36.9 mt -121.28 -61.06 1.58 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.477 174.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.7 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 1.7 tppt? -133.63 154.96 50.49 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -174.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.668 HG23 HG12 ' A' ' 108' ' ' VAL . 42.8 m -131.86 102.23 5.77 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.11 172.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.634 ' CE2' ' HE3' ' A' ' 118' ' ' LYS . 45.9 m-85 -88.63 136.63 32.9 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.887 0.375 . . . . 0.0 110.914 169.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 6.0 p -123.17 123.1 67.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.258 0.551 . . . . 0.0 110.739 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 95.55 -62.91 1.38 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.285 175.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -167.09 116.57 0.71 Allowed Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 120.501 0.191 . . . . 0.0 111.349 -173.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -93.86 163.17 2.21 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 123.159 2.573 . . . . 0.0 113.087 177.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -99.05 108.79 21.54 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.411 0.624 . . . . 0.0 109.605 174.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.668 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 34.8 m-85 -70.19 -30.21 67.26 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -164.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -59.9 -54.12 40.2 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 119.663 -1.256 . . . . 0.0 111.807 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.421 ' HE2' ' HB3' ' A' ' 128' ' ' LYS . 22.0 ttpt -66.14 -35.29 80.1 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.959 -0.62 . . . . 0.0 110.008 176.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.668 ' HB3' ' HA ' ' A' ' 126' ' ' PHE . 2.9 tm? -61.45 -47.3 86.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.961 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -60.24 -38.59 83.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.813 0.34 . . . . 0.0 110.299 178.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -71.83 -33.07 68.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.762 178.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.614 ' HG2' ' HA ' ' A' ' 129' ' ' LEU . 18.7 pt-20 -80.96 -23.6 38.69 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.419 -177.1 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 56.1 mt -67.0 -42.12 88.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 168.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -63.13 -27.02 69.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.302 174.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.527 ' HB ' ' O ' ' A' ' 132' ' ' GLU . 52.3 m -60.81 -31.45 70.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.819 176.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.243 0 CA-C-O 121.042 0.449 . . . . 0.0 110.296 177.575 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.506 ' HA ' ' OD1' ' A' ' 20' ' ' ASN . . . . . . . . 0 N--CA 1.465 0.318 0 CA-C-O 121.238 0.542 . . . . 0.0 110.74 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -80.48 150.44 29.69 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.773 -171.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.5 m -136.1 96.3 3.37 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 173.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.489 HD13 ' HD2' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -119.6 126.14 27.11 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.249 -171.161 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.489 ' HD2' HD13 ' A' ' 10' ' ' LEU . 47.2 Cg_endo -71.19 131.56 19.47 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.102 1.868 . . . . 0.0 111.558 173.258 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.28 177.84 7.59 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.613 HD11 HG12 ' A' ' 74' ' ' VAL . 51.8 mt -64.41 -31.27 72.42 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -176.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.81 -17.03 42.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.661 0.267 . . . . 0.0 111.261 -175.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.12 32.1 3.13 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.419 -0.896 . . . . 0.0 114.017 170.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -114.4 135.35 54.18 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.128 0.464 . . . . 0.0 110.086 172.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.1 m -77.65 124.48 27.99 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 175.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 31.0 m -124.56 153.55 31.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.873 0.368 . . . . 0.0 110.277 177.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 51.1 p -140.35 -179.6 6.1 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.486 -177.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.506 ' OD1' ' HA ' ' A' ' 7' ' ' ALA . 4.4 p-10 -73.88 -20.89 60.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.571 178.625 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.448 ' HA ' HE21 ' A' ' 24' ' ' GLN . . . -62.61 -27.56 69.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.012 174.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -68.33 -29.44 68.18 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.269 0.557 . . . . 0.0 110.329 176.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.957 HD13 HG21 ' A' ' 110' ' ' ILE . 25.3 mt -74.07 -19.31 60.65 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.16 -175.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.448 HE21 ' HA ' ' A' ' 21' ' ' ALA . 76.3 mt-30 -55.58 128.6 35.36 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.361 -178.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.9 -24.66 10.19 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.515 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -95.98 -171.25 2.29 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.372 0.605 . . . . 0.0 111.019 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 0.7 OUTLIER -133.05 138.01 52.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 169.422 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.634 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 89.2 m -141.57 150.01 41.5 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.697 -169.49 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.665 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 6.5 tt -127.23 123.03 35.59 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 173.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.653 ' HB ' ' CG2' ' A' ' 108' ' ' VAL . 44.5 mt -104.1 115.16 45.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.843 0.354 . . . . 0.0 110.585 -178.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -107.8 117.44 34.13 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.582 -178.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.535 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 96.1 m-85 -90.3 119.08 30.3 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 177.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.515 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 5.3 p-90 -146.23 -176.8 5.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.106 -175.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -153.45 159.12 32.52 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.256 -0.884 . . . . 0.0 108.767 177.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -51.8 128.02 25.04 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.279 1.986 . . . . 0.0 112.16 177.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.7 t 71.62 26.06 3.2 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.427 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.537 ' O ' ' HB3' ' A' ' 40' ' ' CYS . 42.9 t -63.41 134.02 95.7 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.011 176.221 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -57.25 -49.14 14.82 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.977 2.452 . . . . 0.0 112.657 178.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.551 ' HA3' ' HG3' ' A' ' 105' ' ' PRO . . . -66.64 -24.85 72.75 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.292 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.537 ' HB3' ' O ' ' A' ' 37' ' ' CYS . 29.6 t -58.26 -33.57 69.53 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 122.624 0.37 . . . . 0.0 111.106 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.2 t -62.17 -36.69 75.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.947 0.403 . . . . 0.0 110.543 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.9 m -87.9 -54.68 4.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.001 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.488 ' O ' HG13 ' A' ' 47' ' ' ILE . 54.8 mt-10 -63.81 -50.18 69.96 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -172.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.588 ' O ' HG12 ' A' ' 48' ' ' ILE . 40.5 ttm -51.29 -50.26 77.03 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -170.49 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.425 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 86.9 Cg_exo -48.57 -48.55 17.07 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 122.205 1.937 . . . . 0.0 112.857 176.319 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -63.1 -46.23 88.32 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.144 177.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 43' ' ' GLU . 51.1 mt -60.39 -35.33 62.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.961 -178.212 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.588 HG12 ' O ' ' A' ' 44' ' ' MET . 46.7 mm -58.69 -52.9 54.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.925 0.393 . . . . 0.0 110.376 176.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -70.68 -39.38 73.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.121 -177.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.561 ' O ' ' HD1' ' A' ' 54' ' ' TYR . 87.7 m -68.37 -54.75 15.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.938 -178.48 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.627 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . -65.73 -34.74 78.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.236 -174.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -63.82 -48.39 77.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.905 0.383 . . . . 0.0 110.722 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -69.37 -51.64 34.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.01 0.433 . . . . 0.0 111.166 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 1.064 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 77.2 m-85 -70.79 -12.08 61.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.559 -175.396 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.627 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 16.0 tptm -60.99 -35.78 77.74 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 175.181 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -84.79 -6.2 59.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.342 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.489 ' O ' ' HB2' ' A' ' 58' ' ' ASN . 43.5 mmtm -89.57 -69.65 0.7 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 176.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 63.3 t30 164.03 12.13 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 114.904 -1.043 . . . . 0.0 109.241 -175.449 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 1.064 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 60.6 t80 -105.74 129.43 53.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.542 -178.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.404 ' O ' ' HA ' ' A' ' 28' ' ' THR . 12.7 pt20 -126.68 140.86 52.09 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.952 0.405 . . . . 0.0 110.501 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 91.9 t -104.59 126.9 59.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.866 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.56 ' HB3' ' HE3' ' A' ' 88' ' ' MET . 75.7 mt -114.21 99.57 7.71 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.605 -179.188 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.01 106.29 18.38 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.695 -178.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 41.9 t -94.66 115.25 33.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.047 0.451 . . . . 0.0 110.516 -178.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -82.45 138.24 34.44 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.859 176.384 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.698 ' HB2' ' HG2' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -101.83 163.45 17.77 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.808 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.698 ' HD3' ' O ' ' A' ' 90' ' ' ASP . 37.4 Cg_endo -66.19 82.08 0.28 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.538 2.158 . . . . 0.0 113.688 -173.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 50.7 mm -112.22 -44.29 5.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 170.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -129.67 153.59 80.8 Favored Pre-proline 0 C--O 1.237 0.403 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 173.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -54.64 161.89 5.43 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.932 2.422 . . . . 0.0 114.714 -175.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.7 tp -51.16 -35.46 15.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.488 177.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -62.1 -46.18 90.19 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.049 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.6 m -58.32 -41.95 85.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.131 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.613 HG12 HD11 ' A' ' 13' ' ' LEU . 26.4 t -65.05 -46.57 90.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.357 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.525 ' HG2' ' HB3' ' A' ' 13' ' ' LEU . 67.1 mtt180 -60.16 -34.95 74.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.012 177.615 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.444 ' HA ' ' NZ ' ' A' ' 79' ' ' LYS . 50.3 tp60 -61.27 -53.48 56.26 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.591 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -55.86 -48.86 74.78 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.242 -176.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.66 ' HA ' HD12 ' A' ' 83' ' ' LEU . 61.9 t -56.36 -44.29 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 112.26 0.466 . . . . 0.0 112.26 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.56 ' HB2' ' NZ ' ' A' ' 79' ' ' LYS . 9.6 mtmp? -67.56 -48.56 66.58 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.59 0.709 . . . . 0.0 110.487 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.32 -39.93 93.06 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.497 -1.229 . . . . 0.0 112.456 -170.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -95.82 -9.99 30.15 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.475 -178.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 63.15 67.32 2.12 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.209 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.66 HD12 ' HA ' ' A' ' 78' ' ' VAL . 1.1 mt -94.25 127.57 44.05 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-O 120.94 0.4 . . . . 0.0 111.891 -174.393 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -83.48 -12.96 8.77 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.456 2.77 . . . . 0.0 114.553 -172.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.456 ' CZ ' HD22 ' A' ' 83' ' ' LEU . 26.8 p90 -93.16 153.61 18.54 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.421 178.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.401 ' HB ' HD23 ' A' ' 62' ' ' LEU . 14.5 m -78.59 126.76 31.19 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.596 -175.005 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.489 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 47.0 t -110.52 135.74 48.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.011 0.434 . . . . 0.0 110.63 -178.285 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.56 ' HE3' ' HB3' ' A' ' 62' ' ' LEU . 52.3 mtt -116.0 172.1 7.37 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.59 178.438 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -140.53 109.6 6.12 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.622 0.249 . . . . 0.0 110.548 176.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.698 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 38.4 t0 -91.57 118.39 30.56 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 176.021 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.72 -14.97 60.79 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -175.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.53 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 24.2 t70 -125.62 -9.66 6.79 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 122.149 -0.344 . . . . 0.0 111.514 -173.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.698 ' HG2' ' HB2' ' A' ' 66' ' ' GLN . 51.8 mtpt 78.18 5.23 2.72 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.881 0.872 . . . . 0.0 111.679 -177.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.05 -40.63 81.43 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -169.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.555 HG22 ' OD2' ' A' ' 90' ' ' ASP . 22.1 m -70.21 -35.23 62.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 119.977 -0.689 . . . . 0.0 109.834 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -71.68 -33.23 63.59 Favored Glycine 0 N--CA 1.451 -0.321 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 176.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.602 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 8.5 mm-40 -61.69 -32.54 72.75 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.087 0.47 . . . . 0.0 110.552 176.436 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.24 -40.17 64.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.177 176.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -74.03 -22.66 59.48 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.715 0.293 . . . . 0.0 111.25 179.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.91 50.5 1.77 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.664 177.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 22.6 p -72.75 88.42 1.31 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.041 0.448 . . . . 0.0 111.002 176.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -84.23 -51.76 6.77 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.38 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 46.8 t -128.91 142.41 44.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.87 -179.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -86.41 137.76 34.36 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.551 ' HG3' ' HA3' ' A' ' 39' ' ' GLY . 94.4 Cg_endo -90.74 166.47 30.39 Favored 'Cis proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.88 -1.3 . . . . 0.0 112.808 -0.161 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 33.0 m -128.16 112.65 14.77 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.484 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.477 ' HB3' HD21 ' A' ' 29' ' ' LEU . 73.1 m -110.5 112.62 24.66 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.979 0.419 . . . . 0.0 110.83 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.653 ' CG2' ' HB ' ' A' ' 30' ' ' ILE . 15.9 m -106.83 148.7 10.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.537 -176.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.774 ' HB2' ' HB3' ' A' ' 118' ' ' LYS . 10.8 mp -101.91 132.87 47.46 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.033 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.957 HG21 HD13 ' A' ' 23' ' ' LEU . 31.3 mm -114.38 133.45 60.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.93 -174.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -85.86 -174.29 49.73 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.929 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 24' ' ' GLN . 62.1 mttm -74.97 21.49 0.12 Allowed 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -172.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.53 ' HD3' ' HB3' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -150.59 11.31 0.68 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.059 0.457 . . . . 0.0 110.604 -179.55 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.07 -14.19 57.86 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.52 -0.847 . . . . 0.0 111.669 -176.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.53 ' HB3' ' HD3' ' A' ' 113' ' ' LYS . 38.7 tt0 -54.93 135.13 48.72 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.234 0.614 . . . . 0.0 111.096 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.0 mt -80.3 111.77 17.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.014 -174.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 79.9 mt -91.42 -40.16 11.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.598 -175.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.774 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 19.8 tptm -152.5 153.71 34.02 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.618 -170.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.8 m -136.61 108.79 7.24 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.937 177.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -99.33 118.16 35.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.341 174.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 61.3 t -108.49 123.12 63.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.732 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 90.74 -72.75 1.87 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.959 176.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -132.42 105.45 13.28 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-O 120.726 0.298 . . . . 0.0 110.624 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -82.66 126.57 4.67 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.549 2.166 . . . . 0.0 112.563 176.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -65.46 102.47 0.7 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 176.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -67.15 -45.73 76.17 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -172.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -57.97 -48.17 84.28 Favored Glycine 0 C--O 1.239 0.408 0 C-N-CA 120.434 -0.889 . . . . 0.0 111.874 178.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -67.39 -31.28 71.4 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-N 115.491 -0.354 . . . . 0.0 110.404 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.687 ' O ' HG12 ' A' ' 133' ' ' ILE . 2.6 tm? -59.32 -45.26 91.81 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 176.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -61.68 -49.89 74.67 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -178.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -69.83 -27.51 64.93 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.959 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -73.5 -37.43 65.7 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.052 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.687 HG12 ' O ' ' A' ' 129' ' ' LEU . 50.8 mm -64.38 -41.92 93.79 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 172.266 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -57.15 -38.42 73.52 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.159 178.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 32.6 m -66.33 -38.12 86.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.62 178.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.02 178.496 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.253 0 CA-C-O 121.189 0.519 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -111.86 130.27 55.88 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.098 0.475 . . . . 0.0 111.157 -175.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 63.7 p -110.46 90.23 3.26 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 172.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.591 HD12 ' HD2' ' A' ' 11' ' ' PRO . 22.6 tp -111.51 126.92 27.68 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.751 -172.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.591 ' HD2' HD12 ' A' ' 10' ' ' LEU . 58.3 Cg_endo -73.3 147.55 42.15 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.308 2.006 . . . . 0.0 112.136 176.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.452 ' CG ' ' H ' ' A' ' 14' ' ' HIS . 0.2 OUTLIER -80.46 -175.65 5.28 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 176.948 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 53.8 mt -70.37 -18.68 63.06 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -176.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.452 ' H ' ' CG ' ' A' ' 12' ' ' ASP . 76.6 m80 -89.65 -48.25 7.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.775 0.321 . . . . 0.0 110.427 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.56 24.91 0.19 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.374 -0.917 . . . . 0.0 113.668 176.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 11' ' ' PRO . 67.6 mttm -101.17 139.56 36.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.314 0.557 . . . . 0.0 110.152 175.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.4 m -84.77 123.38 30.35 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.899 0.381 . . . . 0.0 111.089 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.2 t -107.93 134.82 48.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.509 176.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 36.6 m -145.25 177.48 8.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.746 0.308 . . . . 0.0 111.462 -177.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -51.64 -32.28 28.62 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.641 0.776 . . . . 0.0 112.849 -175.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.47 -27.48 64.45 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -174.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -82.94 -23.32 33.5 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.456 -176.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.614 HD23 HG21 ' A' ' 110' ' ' ILE . 7.7 mp -80.88 -26.94 36.52 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -173.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -64.53 130.86 45.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.189 0.518 . . . . 0.0 111.517 -176.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.34 -12.14 70.28 Favored Glycine 0 C--N 1.329 0.154 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.338 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 112' ' ' LYS . 79.4 mttt -115.71 -173.28 2.31 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 15.9 t -126.51 139.0 52.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 171.028 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.571 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 26.7 m -137.14 145.74 44.17 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.687 -168.478 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.611 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 31.8 tp -115.89 105.84 13.13 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 172.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.8 mt -89.46 111.67 23.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 175.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.512 ' HA ' ' O ' ' A' ' 106' ' ' THR . 7.9 t30 -117.01 111.17 19.19 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.827 0.346 . . . . 0.0 110.864 -175.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 63.5 m-85 -81.38 131.55 35.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.652 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.616 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 4.2 p-90 -158.19 -170.47 3.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.416 -175.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.453 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 24.5 p90 -158.86 138.69 8.66 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 171.131 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.763 ' HG2' ' HA ' ' A' ' 74' ' ' VAL . 50.6 Cg_exo -56.48 -28.31 72.87 Favored 'Trans proline' 0 N--CA 1.473 0.299 0 C-N-CA 123.358 2.705 . . . . 0.0 114.051 -173.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.7 t -89.84 26.57 1.76 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.023 0.439 . . . . 0.0 110.984 -178.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 53.5 t -100.32 132.11 23.02 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.255 -179.149 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 37.2 Cg_exo -61.73 -28.39 82.04 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.799 2.333 . . . . 0.0 112.009 175.246 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.74 -22.3 69.92 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.388 179.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 46.9 t -63.3 -40.17 96.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.761 0.315 . . . . 0.0 110.315 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.4 t -58.77 -35.9 58.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.105 -178.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.0 m -87.45 -49.44 7.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.852 -178.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.447 ' OE1' ' HG3' ' A' ' 46' ' ' LYS . 12.4 mm-40 -84.68 -28.21 26.54 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -170.267 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.575 ' O ' HG12 ' A' ' 48' ' ' ILE . 27.7 ttm -55.18 -47.26 98.95 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 120.249 -0.581 . . . . 0.0 111.91 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -51.05 -41.59 56.24 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.093 1.862 . . . . 0.0 112.314 172.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.447 ' HG3' ' OE1' ' A' ' 43' ' ' GLU . 26.0 mmtp -59.7 -48.16 82.77 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.011 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 43' ' ' GLU . 45.2 mm -61.71 -44.19 98.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.209 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.575 HG12 ' O ' ' A' ' 44' ' ' MET . 45.1 mm -54.87 -53.97 28.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.685 -175.623 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -70.88 -38.34 73.07 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.432 -175.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.9 m -67.58 -48.79 65.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.967 0.413 . . . . 0.0 110.88 -178.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.565 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . -65.95 -45.28 82.38 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.988 -178.36 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -55.13 -44.21 74.85 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.831 0.348 . . . . 0.0 110.996 -177.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -67.23 -51.4 53.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.662 -179.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 1.011 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 54.2 m-85 -79.6 -20.55 46.62 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -173.319 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.565 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 9.0 tmtt? -60.71 -39.02 87.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.073 0.463 . . . . 0.0 109.944 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -86.18 6.21 30.43 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.736 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 58' ' ' ASN . 14.4 tppt? -98.68 -67.5 0.84 Allowed 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 175.12 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.422 ' H ' ' H ' ' A' ' 59' ' ' PHE . 65.6 t30 171.79 19.45 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.878 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 1.011 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 45.1 t80 -117.68 120.28 37.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.637 -177.193 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.441 ' HG3' HG23 ' A' ' 28' ' ' THR . 29.8 pt20 -114.78 148.56 38.25 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.083 0.468 . . . . 0.0 110.601 -178.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.42 HG22 ' HB3' ' A' ' 29' ' ' LEU . 84.9 t -109.87 120.27 60.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.237 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.44 HD23 ' HB ' ' A' ' 86' ' ' THR . 90.2 mt -103.03 95.64 6.27 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.387 177.251 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.401 ' HB1' ' NE1' ' A' ' 33' ' ' TRP . . . -86.11 106.92 17.58 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.826 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 25.7 t -100.09 120.38 49.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 120.961 0.41 . . . . 0.0 110.411 -176.256 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.616 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -94.82 127.94 41.19 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.701 176.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.424 ' HB2' ' CD ' ' A' ' 67' ' ' PRO . 3.4 pt20 -97.12 170.94 6.57 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -178.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 90' ' ' ASP . 17.6 Cg_exo -67.0 79.11 0.39 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.806 2.337 . . . . 0.0 113.884 -175.305 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 47.7 mm -112.39 -68.63 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 167.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.496 ' OD1' ' HD2' ' A' ' 35' ' ' PRO . 3.5 p-10 -93.66 153.72 41.15 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 167.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -63.04 159.25 39.48 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 122.537 2.158 . . . . 0.0 113.266 -177.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.4 tp -53.95 -34.76 26.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.482 -178.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -60.69 -42.15 96.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.899 0.38 . . . . 0.0 110.899 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 51.0 m -62.98 -38.57 91.67 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.393 -177.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.763 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 20.0 t -60.77 -41.94 90.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.425 176.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.729 ' HA ' HG22 ' A' ' 78' ' ' VAL . 89.6 mtt180 -68.03 -32.53 72.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.819 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -61.71 -41.65 97.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.185 0.516 . . . . 0.0 109.863 177.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -67.72 -48.11 67.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.472 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.729 HG22 ' HA ' ' A' ' 75' ' ' ARG . 27.3 m -67.96 -29.08 43.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.988 -178.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -74.3 -55.09 6.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.146 0.498 . . . . 0.0 110.755 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -64.23 -48.35 76.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.339 -173.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -88.07 -21.49 24.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.728 0.299 . . . . 0.0 111.488 -175.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 71.47 59.9 4.65 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.271 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.553 HD22 HG12 ' A' ' 78' ' ' VAL . 10.8 mp -63.38 121.79 71.95 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 120.603 0.24 . . . . 0.0 110.901 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -82.26 -23.06 4.53 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.055 2.503 . . . . 0.0 113.377 -177.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -84.15 148.94 26.5 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.44 ' HB ' HD23 ' A' ' 62' ' ' LEU . 21.4 m -69.21 116.44 9.65 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.167 0.508 . . . . 0.0 111.305 -174.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 39.3 t -107.42 132.15 55.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.676 -178.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 73.3 mtm -123.4 173.72 7.81 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.491 ' CD1' HG21 ' A' ' 74' ' ' VAL . 60.1 t80 -140.0 116.49 10.71 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.564 ' HA ' HD11 ' A' ' 10' ' ' LEU . 10.0 p-10 -97.26 95.44 7.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.908 0.861 . . . . 0.0 110.23 178.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.484 ' HA ' ' HG3' ' A' ' 67' ' ' PRO . . . -73.28 -10.98 60.33 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.136 -176.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.443 ' C ' ' H ' ' A' ' 94' ' ' ALA . 19.1 m-20 -92.8 -14.95 27.12 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.352 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.518 ' HA ' ' OD2' ' A' ' 90' ' ' ASP . 37.0 ttpt 63.36 -24.96 0.07 Allowed 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 175.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.443 ' H ' ' C ' ' A' ' 92' ' ' ASP . . . -61.9 -25.3 67.48 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -173.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.424 ' O ' ' HD1' ' A' ' 99' ' ' PHE . 26.8 m -70.95 -41.73 77.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.249 179.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.5 -36.36 91.37 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.109 174.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.504 ' HG3' ' O ' ' A' ' 93' ' ' LYS . 91.3 mt-30 -62.3 -33.13 74.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.249 -0.475 . . . . 0.0 110.418 176.294 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.85 -41.6 71.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.068 177.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.424 ' HD1' ' O ' ' A' ' 95' ' ' VAL . 7.8 m-85 -66.71 -27.3 67.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.481 178.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 94.1 39.19 4.91 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.106 177.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.534 ' HB ' ' CE1' ' A' ' 104' ' ' TYR . 39.9 p -71.26 100.73 2.17 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.063 0.459 . . . . 0.0 111.154 -178.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -86.56 -58.41 2.63 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.363 0.601 . . . . 0.0 109.997 177.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.521 HG12 ' HB ' ' A' ' 121' ' ' VAL . 14.6 p -122.01 143.67 33.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.755 -177.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.534 ' CE1' ' HB ' ' A' ' 101' ' ' THR . 39.7 m-85 -111.01 148.53 38.83 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.58 -174.188 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -75.26 152.65 98.07 Favored 'Cis proline' 0 CA--C 1.529 0.261 0 C-N-CA 123.272 -1.553 . . . . 0.0 112.869 0.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 23.8 m -111.48 112.65 24.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.0 177.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.463 ' HB3' HD11 ' A' ' 29' ' ' LEU . 24.4 m -94.73 110.17 22.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.243 0.544 . . . . 0.0 110.841 -178.333 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.566 HG22 HG23 ' A' ' 119' ' ' THR . 60.7 t -107.79 134.33 49.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.316 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.532 ' HB2' ' HB3' ' A' ' 118' ' ' LYS . 7.2 mp -101.58 130.88 47.97 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.906 0.384 . . . . 0.0 110.039 -177.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.614 HG21 HD23 ' A' ' 23' ' ' LEU . 40.0 mm -110.83 130.27 64.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.206 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -77.38 -170.56 34.35 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.435 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 79.0 mttt -78.73 -7.56 57.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.715 0.769 . . . . 0.0 109.482 -174.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.31 -7.17 32.66 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.579 -1.191 . . . . 0.0 111.103 -172.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.08 60.94 3.17 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.673 -176.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -161.51 153.81 19.92 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -178.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 53.6 mt -66.7 105.46 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.925 -178.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.439 HD22 ' HA ' ' A' ' 117' ' ' LEU . 0.2 OUTLIER -84.07 -38.58 20.64 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.744 179.469 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.532 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 22.4 tptm -153.41 154.09 33.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.082 -174.371 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.566 HG23 HG22 ' A' ' 108' ' ' VAL . 33.0 m -140.66 116.84 10.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.059 0.457 . . . . 0.0 111.501 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -109.49 134.36 51.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.471 173.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.521 ' HB ' HG12 ' A' ' 103' ' ' VAL . 3.4 m -105.73 112.56 39.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.028 0.442 . . . . 0.0 110.442 175.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 91.76 -159.65 25.91 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.583 -176.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 54.7 tt0 -73.15 119.44 75.7 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.78 0.324 . . . . 0.0 110.54 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -88.36 165.19 6.73 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.833 2.356 . . . . 0.0 112.753 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.643 ' HB2' ' HE2' ' A' ' 128' ' ' LYS . 4.9 m-20 -67.87 102.81 1.32 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 173.234 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -62.95 -40.37 97.47 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -173.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -58.44 -47.81 87.67 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.444 -0.884 . . . . 0.0 111.605 177.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.643 ' HE2' ' HB2' ' A' ' 125' ' ' ASP . 33.6 ttpt -69.15 -36.99 78.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.438 -0.381 . . . . 0.0 110.33 177.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -61.48 -46.0 91.88 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.6 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -61.44 -47.91 83.58 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.62 0.248 . . . . 0.0 110.937 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -67.45 -38.62 84.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.399 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -65.44 -38.79 90.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.713 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 38.1 mt -60.59 -46.29 95.88 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 172.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -60.51 -36.54 78.61 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.963 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 66.5 m -60.97 -43.45 98.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.765 176.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.376 0 CA-C-O 121.224 0.535 . . . . 0.0 110.809 176.979 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.455 ' OD1' ' HB2' ' A' ' 6' ' ' PRO . 23.2 p-10 . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.444 ' HB3' ' HG2' ' A' ' 6' ' ' PRO . 20.2 t -83.72 -162.71 0.67 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.982 0.42 . . . . 0.0 110.231 176.075 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.477 ' HA ' HG13 ' A' ' 116' ' ' ILE . 23.9 mtmt -78.3 152.59 32.37 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.127 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.8 m 68.08 13.62 9.15 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.993 0.902 . . . . 0.0 109.717 -170.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 46.05 72.53 1.21 Allowed Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 114.204 -1.362 . . . . 0.0 114.267 174.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.455 ' HB2' ' OD1' ' A' ' 1' ' ' ASP . 32.4 Cg_exo -62.2 169.52 7.68 Favored 'Trans proline' 0 C--O 1.236 0.413 0 C-N-CA 122.202 1.935 . . . . 0.0 110.934 166.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.92 117.29 4.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.909 0.385 . . . . 0.0 111.715 -175.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -141.68 141.79 33.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.049 177.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.8 m -137.78 100.07 4.09 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.52 HD12 ' HD2' ' A' ' 11' ' ' PRO . 56.2 tp -115.16 120.2 37.23 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.426 -171.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.52 ' HD2' HD12 ' A' ' 10' ' ' LEU . 60.3 Cg_endo -75.07 129.71 12.53 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.497 2.131 . . . . 0.0 111.327 172.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.41 ' HA ' ' HG3' ' A' ' 88' ' ' MET . 2.3 p30 -86.55 -171.86 3.75 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.988 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.8 mt -67.12 -9.26 37.79 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -175.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -96.36 -9.56 29.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.932 0.396 . . . . 0.0 110.33 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.4 2.69 61.75 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.125 177.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 11' ' ' PRO . 20.6 pttp -96.13 144.79 26.05 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 28.5 m -94.45 125.55 39.16 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.889 -174.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.3 m -102.38 141.3 18.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 172.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 45.3 t -145.6 -178.08 5.91 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 121.076 -0.25 . . . . 0.0 110.963 -173.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -53.92 -39.22 65.65 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.258 0.623 . . . . 0.0 111.956 -175.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.77 -27.64 65.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.812 -177.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -78.49 -24.05 46.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.235 -176.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 81.5 mt -78.54 -21.37 48.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.895 0.379 . . . . 0.0 110.953 -178.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -72.27 103.33 3.34 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.02 0.438 . . . . 0.0 110.673 -176.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.0 -25.92 12.19 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.34 177.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.17 148.83 26.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.941 0.401 . . . . 0.0 110.343 178.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.49 HG13 ' O ' ' A' ' 110' ' ' ILE . 97.1 t -102.96 138.0 28.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 172.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 60' ' ' GLN . 22.3 m -132.06 135.12 46.24 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.614 -165.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.764 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 6.8 tt -106.88 106.43 16.96 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 173.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.917 HG12 ' HB2' ' A' ' 62' ' ' LEU . 39.9 mt -104.56 111.95 36.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 177.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.449 ' HA ' ' O ' ' A' ' 106' ' ' THR . 26.7 p-10 -110.72 134.18 52.69 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.413 0.625 . . . . 0.0 110.645 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -91.66 119.25 31.37 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.615 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.64 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 4.5 p-90 -147.82 -174.13 4.47 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.615 -173.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -155.28 150.35 20.77 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 173.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.413 ' HG3' ' HA ' ' A' ' 74' ' ' VAL . 92.8 Cg_exo -43.72 -47.08 9.99 Favored 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 123.148 2.566 . . . . 0.0 114.13 -177.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.1 m -85.82 27.46 0.87 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -177.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.524 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 52.8 t -79.91 129.55 70.13 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.015 0.436 . . . . 0.0 111.101 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 24.7 Cg_exo -63.54 -26.85 69.77 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.641 2.227 . . . . 0.0 111.922 176.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.2 -16.55 73.24 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.836 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.524 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 92.0 m -58.16 -29.4 65.56 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.72 0.26 . . . . 0.0 111.392 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.6 t -55.02 -43.08 67.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.997 0.427 . . . . 0.0 110.364 177.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.571 ' O ' ' HB3' ' A' ' 46' ' ' LYS . 15.1 m -86.5 -55.79 3.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.873 178.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.468 ' O ' HG12 ' A' ' 47' ' ' ILE . 43.3 mt-10 -59.46 -50.4 74.06 Favored 'General case' 0 C--O 1.213 -0.86 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -173.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.732 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 31.8 tpp -58.85 -61.02 8.6 Favored Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -164.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.732 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 33.1 Cg_exo -59.38 -35.96 95.25 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 121.652 1.568 . . . . 0.0 111.206 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.571 ' HB3' ' O ' ' A' ' 42' ' ' SER . 5.9 tptt -59.17 -49.3 78.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.956 176.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.546 HD13 ' HE3' ' A' ' 46' ' ' LYS . 43.8 mm -74.54 -31.58 27.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.63 -174.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.66 HG12 ' O ' ' A' ' 44' ' ' MET . 46.8 mm -54.72 -53.26 33.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-O 121.034 0.445 . . . . 0.0 109.901 176.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.648 ' HZ2' ' HB2' ' A' ' 53' ' ' ASP . 20.4 tptp -71.74 -35.97 70.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.969 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.3 m -62.11 -54.18 44.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.838 0.351 . . . . 0.0 111.202 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.605 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . -68.53 -27.38 66.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.981 -176.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.09 -39.3 60.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.493 177.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.648 ' HB2' ' HZ2' ' A' ' 49' ' ' LYS . 6.9 t70 -76.05 -52.19 10.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.233 0.54 . . . . 0.0 111.057 -173.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.879 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 90.8 m-85 -81.58 -2.47 50.18 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.363 -174.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.605 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 13.0 tppt? -59.4 -37.61 78.45 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.434 0.635 . . . . 0.0 109.916 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.2 m-20 -91.51 12.03 22.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.294 -175.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.578 ' O ' ' HB3' ' A' ' 58' ' ' ASN . 16.9 tptp -112.03 -61.68 1.68 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.711 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.578 ' HB3' ' O ' ' A' ' 57' ' ' LYS . 2.9 p-10 162.79 14.93 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 O-C-N 124.202 0.939 . . . . 0.0 110.279 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.879 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 57.2 t80 -112.53 143.03 44.38 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.924 0.392 . . . . 0.0 110.284 -175.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.531 ' O ' ' HA ' ' A' ' 28' ' ' THR . 11.7 pt20 -136.76 147.55 46.74 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.669 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.46 HG11 HG23 ' A' ' 47' ' ' ILE . 87.3 t -115.07 132.2 65.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.007 178.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.917 ' HB2' HG12 ' A' ' 30' ' ' ILE . 77.6 mt -122.37 110.9 16.22 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.654 ' HB3' HG22 ' A' ' 87' ' ' VAL . . . -94.48 116.42 28.77 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.171 -177.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.0 t -105.17 111.81 36.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.065 0.46 . . . . 0.0 110.528 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.64 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -95.83 124.77 39.99 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.929 177.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.5 169.73 8.18 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.613 ' HD3' ' O ' ' A' ' 90' ' ' ASP . 16.4 Cg_exo -67.33 80.77 0.41 Allowed 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.617 2.211 . . . . 0.0 113.781 -172.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 50.2 mm -117.69 -54.66 4.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 168.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.406 ' HB2' ' HD2' ' A' ' 35' ' ' PRO . 17.2 m-20 -101.86 151.94 38.05 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.738 170.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.31 151.12 30.53 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.73 2.287 . . . . 0.0 112.902 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.3 tt -57.19 -36.3 51.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.894 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.502 ' HA ' ' HD2' ' A' ' 75' ' ' ARG . 31.1 tp10 -69.61 -35.31 75.17 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.533 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.9 m -62.27 -32.45 73.16 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.206 0.527 . . . . 0.0 110.081 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.478 ' O ' HG13 ' A' ' 78' ' ' VAL . 45.2 t -65.42 -44.31 94.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.692 174.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.759 ' HA ' HG22 ' A' ' 78' ' ' VAL . 91.4 mtt180 -64.67 -31.92 73.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.388 177.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -60.98 -44.48 97.3 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 177.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -63.53 -46.16 87.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.272 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.759 HG22 ' HA ' ' A' ' 75' ' ' ARG . 11.1 m -67.08 -37.45 79.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.642 -177.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -75.64 -48.12 23.5 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -66.34 -48.38 70.44 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.103 -172.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -92.4 2.22 56.78 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -173.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 57.9 63.72 5.01 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.308 -0.473 . . . . 0.0 113.033 177.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.511 HD22 HG12 ' A' ' 78' ' ' VAL . 10.0 mp -73.22 115.85 45.01 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 120.702 0.287 . . . . 0.0 111.231 -177.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.39 15.98 1.78 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.177 2.584 . . . . 0.0 113.022 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.543 ' HE1' HD13 ' A' ' 48' ' ' ILE . 24.1 p90 -128.76 153.56 47.26 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.071 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.408 ' HB ' ' CD2' ' A' ' 62' ' ' LEU . 32.2 m -79.39 130.39 35.38 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.953 -174.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.654 HG22 ' HB3' ' A' ' 63' ' ' ALA . 60.9 t -116.44 139.43 43.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.334 -178.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.41 ' HG3' ' HA ' ' A' ' 12' ' ' ASP . 2.6 mpt? -119.24 169.3 10.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.078 177.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -123.5 110.3 14.9 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.613 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 0.9 OUTLIER -81.78 72.25 8.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.893 -175.646 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.78 -46.84 86.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.374 -172.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -87.78 -10.91 49.59 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.673 -0.24 . . . . 0.0 110.776 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.581 ' HB2' ' NZ ' ' A' ' 93' ' ' LYS . 8.1 mtmp? 69.23 7.49 6.26 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.562 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.65 -32.04 70.47 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -172.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.6 t -71.24 -42.91 74.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.58 -37.87 94.09 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.887 174.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -67.02 -32.05 73.0 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 122.486 0.315 . . . . 0.0 111.01 177.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.29 -45.29 85.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.648 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -66.62 -28.22 68.32 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.788 0.328 . . . . 0.0 110.644 176.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 71.96 59.95 4.45 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.804 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.6 p -99.88 -66.64 0.89 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.591 0.234 . . . . 0.0 111.069 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 72.53 -38.54 0.42 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.681 0.792 . . . . 0.0 112.296 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.8 m -97.83 132.3 42.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.139 0.495 . . . . 0.0 110.567 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -128.29 153.04 78.88 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.047 -175.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -80.86 161.01 83.2 Favored 'Cis proline' 0 C--O 1.234 0.314 0 C-N-CA 123.376 -1.51 . . . . 0.0 112.353 -0.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 10.2 t -150.25 127.53 11.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.15 0.5 . . . . 0.0 111.358 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.3 m -101.24 122.53 43.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.089 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 48.5 t -106.06 132.46 53.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.83 0.347 . . . . 0.0 110.207 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.573 HD23 ' HB3' ' A' ' 118' ' ' LYS . 2.8 mm? -102.03 118.77 37.6 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.943 -178.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.49 ' O ' HG13 ' A' ' 27' ' ' VAL . 53.5 mt -100.99 127.74 53.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.037 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -72.14 -179.51 33.68 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.204 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -86.61 -5.11 59.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.919 0.39 . . . . 0.0 110.764 -175.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -98.34 -31.6 11.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.856 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 113.89 19.83 6.29 Favored Glycine 0 C--O 1.225 -0.431 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.553 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.93 -26.2 60.38 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -172.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.477 HG13 ' HA ' ' A' ' 3' ' ' LYS . 20.8 mm 58.34 96.92 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-O 121.216 0.531 . . . . 0.0 109.582 -167.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.7 mt -93.68 -76.03 0.49 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -165.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.573 ' HB3' HD23 ' A' ' 109' ' ' LEU . 21.9 tptm -109.22 145.05 36.51 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.049 -164.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 7.7 p -122.67 108.01 12.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.382 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -94.88 128.7 41.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.994 173.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.7 t -120.1 132.39 69.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.668 0.271 . . . . 0.0 110.549 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 84.19 -102.51 2.51 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.122 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -106.78 108.78 62.5 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.485 ' HB2' HD22 ' A' ' 129' ' ' LEU . 68.7 Cg_endo -76.65 104.69 1.95 Allowed 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.198 1.932 . . . . 0.0 112.16 178.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -48.75 107.66 0.14 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.676 178.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -60.15 -43.4 95.77 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.095 -173.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -59.5 -51.0 61.68 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.495 -176.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -80.27 -21.0 43.18 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 122.973 -0.133 . . . . 0.0 111.248 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.485 HD22 ' HB2' ' A' ' 124' ' ' PRO . 52.0 tp -68.69 -47.04 67.46 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.162 -0.311 . . . . 0.0 110.162 176.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -66.96 -40.54 87.5 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.908 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -68.11 -30.49 69.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.728 0.299 . . . . 0.0 111.309 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.494 ' OE1' ' HG2' ' A' ' 118' ' ' LYS . 35.3 tt0 -77.82 -34.34 52.06 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.663 0.268 . . . . 0.0 110.488 178.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 129' ' ' LEU . 76.1 mt -65.66 -38.94 83.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-O 121.212 0.529 . . . . 0.0 109.659 172.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.37 -36.42 84.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.461 172.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 91.1 m -63.35 -31.67 72.89 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.13 174.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 133' ' ' ILE . . . -65.14 -30.63 71.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.596 175.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.774 ' HH2' ' HB2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -69.09 -54.93 12.43 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 172.392 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 17.7 ttp-105 -56.45 -40.57 75.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.142 -1.39 . . . . 0.0 112.147 -176.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -64.19 93.28 0.09 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 173.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 5.6 m -60.8 -63.94 1.12 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.143 -172.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 13.7 t0 -99.03 -44.81 6.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.671 -173.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 141' ' ' ASP . . . 70.02 52.17 0.39 Allowed 'General case' 0 N--CA 1.465 0.305 0 O-C-N 123.796 0.685 . . . . 0.0 109.498 -167.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 62.94 101.83 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 114.214 -1.357 . . . . 0.0 112.565 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -116.77 27.68 7.77 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 172.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 65.49 24.12 11.86 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.43 0.692 . . . . 0.0 110.196 -176.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 27.8 m80 67.34 10.76 7.97 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.453 175.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -147.6 82.89 1.53 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 175.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -64.83 114.56 4.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.255 -173.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 52.5 p-80 -137.58 20.46 2.91 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.261 175.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 71.9 t60 . . . . . 0 C--O 1.245 0.833 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.011 176.749 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.516 ' HA ' ' O ' ' A' ' 5' ' ' ALA . 12.7 t70 . . . . . 0 N--CA 1.48 1.04 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.3 t 62.29 100.92 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 O-C-N 123.922 0.764 . . . . 0.0 110.846 -176.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.527 ' HA ' HD12 ' A' ' 116' ' ' ILE . 44.8 mttp 66.92 13.87 9.61 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.931 0.872 . . . . 0.0 110.932 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.6 p -148.86 35.86 0.77 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.946 -1.479 . . . . 0.0 107.981 173.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.516 ' O ' ' HA ' ' A' ' 1' ' ' ASP . . . 66.13 108.34 0.03 OUTLIER Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 113.747 -1.57 . . . . 0.0 111.224 -172.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.03 163.32 38.61 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.432 2.088 . . . . 0.0 111.39 176.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.21 88.44 2.49 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.164 0.507 . . . . 0.0 110.156 176.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -129.49 148.86 51.44 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.352 0.596 . . . . 0.0 111.134 -177.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.9 m -141.23 90.75 2.33 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 171.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.581 HD12 ' HD2' ' A' ' 11' ' ' PRO . 28.4 tp -112.57 124.35 32.07 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.216 -172.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.581 ' HD2' HD12 ' A' ' 10' ' ' LEU . 58.3 Cg_endo -73.07 138.71 28.6 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.406 2.071 . . . . 0.0 111.908 176.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.515 ' HA ' ' HG2' ' A' ' 88' ' ' MET . 0.0 OUTLIER -75.29 169.44 18.05 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 175.488 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.543 HD13 ' HG2' ' A' ' 75' ' ' ARG . 84.6 mt -66.03 -17.79 64.92 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -175.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.474 ' H ' ' CG ' ' A' ' 12' ' ' ASP . 48.8 t-80 -86.89 -19.55 28.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.945 177.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.7 4.4 21.47 Favored Glycine 0 CA--C 1.517 0.208 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.058 177.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -85.62 110.75 19.49 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 122.595 -0.356 . . . . 0.0 110.263 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 8.3 m -64.3 122.88 17.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.678 178.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.594 HG11 HD21 ' A' ' 62' ' ' LEU . 59.6 t -110.89 125.07 68.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.924 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 51.0 p -140.94 -174.35 3.97 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.236 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -55.87 -32.27 63.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.109 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.6 -28.53 67.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.202 -176.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -78.84 -23.89 44.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.031 0.443 . . . . 0.0 110.549 -175.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 81.3 mt -77.64 -19.98 54.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.172 -177.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.498 ' OE1' ' HA ' ' A' ' 113' ' ' LYS . 16.5 mm-40 -64.57 119.04 9.72 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.775 -174.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.13 -21.29 46.77 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.035 -0.602 . . . . 0.0 113.078 174.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 112' ' ' LYS . 31.3 mtmt -117.77 160.58 21.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.808 0.337 . . . . 0.0 111.167 -174.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.596 HG21 ' CD1' ' A' ' 137' ' ' TRP . 13.2 t -101.71 144.76 12.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -178.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.618 HG23 HD13 ' A' ' 62' ' ' LEU . 40.6 m -139.34 140.41 37.52 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.06 0.457 . . . . 0.0 112.102 -168.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.889 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 28.1 tp -109.4 106.18 15.85 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.333 171.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.661 ' HB ' ' CG2' ' A' ' 108' ' ' VAL . 37.2 mt -91.09 111.59 23.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 C-N-CA 120.303 -0.559 . . . . 0.0 109.51 176.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -108.83 114.81 28.91 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.897 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -87.69 118.24 27.05 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.496 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 8.0 p-90 -144.71 -173.81 4.16 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.014 0.435 . . . . 0.0 110.464 -176.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.402 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 38.6 p90 -161.71 144.3 8.99 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.351 176.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -58.53 163.98 9.87 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.366 2.044 . . . . 0.0 111.84 175.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 44.5 m 66.84 11.89 8.56 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.408 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 42.1 t -95.67 126.11 46.59 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.47 177.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.434 ' O ' HG12 ' A' ' 41' ' ' VAL . 35.2 Cg_exo -61.87 -18.2 59.66 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.977 2.451 . . . . 0.0 112.978 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.55 -6.73 56.11 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 121.125 -0.559 . . . . 0.0 113.112 -178.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 26.3 p -62.19 -30.58 71.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.559 0.219 . . . . 0.0 110.887 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 38' ' ' PRO . 13.0 p -66.73 -28.92 44.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.845 0.355 . . . . 0.0 110.899 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.6 m -88.0 -56.74 3.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.014 0.435 . . . . 0.0 111.268 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.559 ' HA ' ' HE2' ' A' ' 46' ' ' LYS . 2.9 mt-10 -74.32 -40.69 62.04 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -170.053 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.476 ' O ' HG12 ' A' ' 48' ' ' ILE . 35.2 tpp -59.57 -54.87 51.65 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -172.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.406 ' HD2' ' N ' ' A' ' 44' ' ' MET . 15.9 Cg_endo -57.52 -35.48 98.83 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 121.829 1.686 . . . . 0.0 111.731 177.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.65 ' HZ2' ' HD2' ' A' ' 124' ' ' PRO . 28.8 ttpt -61.14 -51.94 66.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.541 175.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.557 HG12 ' O ' ' A' ' 43' ' ' GLU . 47.3 mm -57.17 -41.03 77.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.788 -178.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.476 HG12 ' O ' ' A' ' 44' ' ' MET . 48.8 mm -57.9 -45.87 87.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.995 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -75.4 -40.96 57.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.498 0.19 . . . . 0.0 111.248 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.462 ' O ' ' HD2' ' A' ' 54' ' ' TYR . 60.7 m -59.55 -50.01 75.55 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.859 0.361 . . . . 0.0 110.435 177.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.76 -31.8 72.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.598 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -54.22 -44.06 71.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.958 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -79.01 -51.89 8.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.35 0.595 . . . . 0.0 111.142 177.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.983 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 50.8 m-85 -72.3 -20.46 61.5 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -167.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -68.52 -15.23 63.47 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 122.207 -0.308 . . . . 0.0 110.793 176.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -106.83 8.16 30.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.36 0.6 . . . . 0.0 109.874 177.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.967 ' HD2' ' HH2' ' A' ' 137' ' ' TRP . 30.8 mmtp -100.87 -69.71 0.76 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.376 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 4.5 t-20 164.23 29.59 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -172.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.983 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 48.6 t80 -131.41 138.22 49.0 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.799 -167.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.419 ' O ' ' HA ' ' A' ' 28' ' ' THR . 10.8 pt20 -128.26 140.96 51.6 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.464 178.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.432 HG11 HG23 ' A' ' 47' ' ' ILE . 60.4 t -100.61 125.85 54.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.012 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.618 HD13 HG23 ' A' ' 28' ' ' THR . 10.9 mp -112.48 99.11 7.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.85 107.32 16.95 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.863 178.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.1 t -99.22 104.35 15.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.064 0.459 . . . . 0.0 110.458 -177.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -90.89 120.3 31.79 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 175.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.687 ' HB3' ' HD2' ' A' ' 67' ' ' PRO . 37.0 mt-30 -94.83 170.79 7.47 Favored Pre-proline 0 C--N 1.317 -0.821 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -177.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.687 ' HD2' ' HB3' ' A' ' 66' ' ' GLN . 72.5 Cg_endo -71.01 57.92 2.1 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 123.135 2.557 . . . . 0.0 115.225 -164.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.402 ' HB ' ' HB2' ' A' ' 34' ' ' PHE . 49.8 mm -92.24 -51.56 11.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 171.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.538 ' OD1' ' HD2' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -109.23 149.81 40.22 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.362 -0.835 . . . . 0.0 108.779 174.104 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.538 ' HD2' ' OD1' ' A' ' 69' ' ' ASP . 84.4 Cg_exo -49.56 155.76 3.39 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 123.058 2.506 . . . . 0.0 113.737 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.615 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 11.1 tt -54.95 -40.87 55.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.695 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -65.79 -33.47 75.93 Favored 'General case' 0 C--O 1.215 -0.746 0 C-N-CA 120.864 -0.335 . . . . 0.0 110.694 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.7 m -58.26 -40.8 82.8 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.374 0.607 . . . . 0.0 109.943 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.401 ' O ' HG13 ' A' ' 78' ' ' VAL . 20.0 t -65.59 -44.07 93.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.284 175.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.764 ' HA ' HG22 ' A' ' 78' ' ' VAL . 20.1 mtm180 -67.53 -24.98 65.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.019 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -68.63 -43.07 77.1 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -63.78 -47.59 80.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.147 178.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.764 HG22 ' HA ' ' A' ' 75' ' ' ARG . 12.6 m -65.83 -26.63 39.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.129 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.609 ' HB2' ' O ' ' A' ' 75' ' ' ARG . 3.6 ttmp? -74.21 -52.15 13.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.892 -177.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -67.19 -49.43 64.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.204 -174.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -85.82 -10.43 55.44 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -174.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.62 60.28 8.77 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.308 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.604 HD22 HG12 ' A' ' 78' ' ' VAL . 10.1 mp -63.64 116.01 22.98 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 120.879 0.371 . . . . 0.0 111.461 -176.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -86.45 25.26 0.69 Allowed 'Trans proline' 0 C--O 1.241 0.636 0 C-N-CA 123.314 2.676 . . . . 0.0 113.467 -177.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -136.23 159.71 40.9 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 30.7 m -67.71 122.68 18.61 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.434 -174.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.8 t -119.29 127.57 75.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.956 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.515 ' HG2' ' HA ' ' A' ' 12' ' ' ASP . 67.2 mtm -122.76 164.36 18.48 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.263 -177.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.444 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 67.6 t80 -126.1 125.65 42.9 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.373 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.537 ' HB3' ' HA ' ' A' ' 66' ' ' GLN . 28.4 t0 -88.89 135.91 33.29 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.25 -32.84 61.21 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.435 ' O ' ' HB3' ' A' ' 93' ' ' LYS . 31.9 t70 -130.07 -11.08 4.25 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -172.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.675 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER 82.93 17.94 0.28 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 122.89 1.329 . . . . 0.0 108.744 -172.938 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.02 -27.17 60.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.007 -176.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.7 t -69.14 -41.19 81.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.57 -33.59 87.64 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 174.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -64.14 -39.05 93.19 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 122.595 0.358 . . . . 0.0 111.098 176.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.48 -39.82 92.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.058 0.456 . . . . 0.0 110.967 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -73.01 -27.78 61.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.556 177.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.98 34.44 5.68 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.425 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 29.1 p -106.17 126.25 51.98 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.742 0.305 . . . . 0.0 110.804 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.512 ' HG3' HG13 ' A' ' 103' ' ' VAL . 11.8 pt20 -108.82 -36.32 6.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.907 0.384 . . . . 0.0 110.839 178.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.512 HG13 ' HG3' ' A' ' 102' ' ' GLN . 19.7 m -102.85 142.1 17.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.21 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.517 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 37.6 m-85 -130.46 158.67 73.82 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.09 -177.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.517 ' HA ' ' HB3' ' A' ' 104' ' ' TYR . 94.1 Cg_endo -81.41 165.05 75.51 Favored 'Cis proline' 0 CA--C 1.53 0.311 0 C-N-CA 123.587 -1.422 . . . . 0.0 113.17 0.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.535 HG23 ' HA ' ' A' ' 121' ' ' VAL . 95.8 m -150.82 133.32 15.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.787 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.604 ' HB3' HD11 ' A' ' 29' ' ' LEU . 68.0 m -108.09 117.47 34.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.969 0.414 . . . . 0.0 111.003 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.661 ' CG2' ' HB ' ' A' ' 30' ' ' ILE . 29.0 m -106.36 146.15 13.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.121 0.486 . . . . 0.0 110.839 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.676 ' HB2' ' HB3' ' A' ' 118' ' ' LYS . 2.6 mm? -102.37 124.47 48.0 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.065 -176.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.576 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 22.7 mm -104.4 134.59 45.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.512 ' O ' ' HA ' ' A' ' 27' ' ' VAL . . . -67.79 -93.66 0.04 OUTLIER Glycine 0 C--O 1.226 -0.353 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.868 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 10.9 ptpt -166.8 23.73 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.271 0.557 . . . . 0.0 110.844 171.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.498 ' HA ' ' OE1' ' A' ' 24' ' ' GLN . 36.8 mtmm -136.12 10.1 3.27 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 174.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 5' ' ' ALA . . . 78.25 18.35 76.45 Favored Glycine 0 C--O 1.223 -0.535 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.54 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -69.71 -24.63 63.6 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -171.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.527 HD12 ' HA ' ' A' ' 3' ' ' LYS . 8.5 mt 64.02 89.63 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.66 0.743 . . . . 0.0 109.701 -175.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 23.2 mt -87.54 -34.93 18.42 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.257 -0.883 . . . . 0.0 113.109 -167.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.676 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 22.0 tptm -150.27 157.53 43.18 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.302 -168.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.537 HG23 HG12 ' A' ' 108' ' ' VAL . 51.4 m -140.28 107.86 5.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.859 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.649 ' HB3' ' HB3' ' A' ' 124' ' ' PRO . 67.8 m-85 -101.68 107.39 18.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.117 173.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.535 ' HA ' HG23 ' A' ' 106' ' ' THR . 48.1 t -82.93 126.78 40.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.46 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 80.31 -138.58 20.01 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.029 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.444 ' OE2' ' HD2' ' A' ' 124' ' ' PRO . 12.7 tp10 -96.64 109.33 47.74 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 110.229 -0.285 . . . . 0.0 110.229 -178.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.65 ' HD2' ' HZ2' ' A' ' 46' ' ' LYS . 91.9 Cg_endo -81.72 174.11 10.65 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 123.234 2.623 . . . . 0.0 113.359 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.497 ' OD2' ' HB3' ' A' ' 128' ' ' LYS . 11.2 p-10 -88.3 120.0 29.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.091 175.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.581 ' HE2' ' HG3' ' A' ' 46' ' ' LYS . 92.2 m-85 -58.47 -46.94 85.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.832 -173.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -56.34 -53.63 41.72 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 121.045 -0.598 . . . . 0.0 113.443 -172.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.551 ' NZ ' ' HB3' ' A' ' 128' ' ' LYS . 2.1 ttpm? -76.17 -26.14 55.94 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.464 0.173 . . . . 0.0 110.694 -177.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.482 ' O ' HG13 ' A' ' 133' ' ' ILE . 7.5 tt -64.41 -46.99 80.87 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 177.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -61.78 -56.04 23.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.479 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.441 ' HG2' ' HA ' ' A' ' 128' ' ' LYS . 4.5 pt20 -60.91 -29.61 69.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.718 0.294 . . . . 0.0 111.292 -176.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -72.46 -36.37 68.48 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.711 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.482 HG13 ' O ' ' A' ' 129' ' ' LEU . 69.1 mt -69.36 -53.0 27.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -62.78 -27.32 69.22 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.767 0.318 . . . . 0.0 111.413 -176.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 90.4 m -73.76 -30.85 63.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.012 0.434 . . . . 0.0 110.964 177.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.46 ' HA ' ' ND2' ' A' ' 139' ' ' ASN . . . -65.83 -18.38 65.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.563 -177.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.967 ' HH2' ' HD2' ' A' ' 57' ' ' LYS . 38.6 m0 -56.93 -36.69 70.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.812 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.421 ' C ' ' H ' ' A' ' 140' ' ' SER . 7.3 tpt180 -81.49 -15.46 54.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.24 -173.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.46 ' ND2' ' HA ' ' A' ' 136' ' ' ALA . 89.7 m-20 -73.1 35.38 0.08 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -175.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.421 ' H ' ' C ' ' A' ' 138' ' ' ARG . 47.2 m -150.09 13.06 0.77 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.045 0.45 . . . . 0.0 109.844 175.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -95.16 149.21 21.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.988 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -155.35 101.12 2.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.949 0.404 . . . . 0.0 112.044 -175.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -67.75 142.57 56.22 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 171.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 129.8 -29.63 3.72 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 -173.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -75.17 80.37 2.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.234 0.54 . . . . 0.0 109.656 177.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -99.32 110.49 23.0 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.694 -172.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -94.34 -0.68 54.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.359 0.599 . . . . 0.0 109.388 172.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -110.03 118.89 37.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.745 176.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -99.12 154.93 17.74 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.686 -173.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 63.5 m-70 . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.044 -0.979 . . . . 0.0 108.659 167.148 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 . . . . . 0 N--CA 1.481 1.118 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.3 p -65.73 -72.74 0.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 O-C-N 123.214 0.321 . . . . 0.0 110.358 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 55.21 -125.02 2.16 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.232 173.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.1 p -92.76 28.86 1.92 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.839 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 72.94 124.51 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.334 1.021 . . . . 0.0 111.668 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.21 169.22 22.05 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.529 2.153 . . . . 0.0 111.583 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.69 101.85 8.64 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.711 0.291 . . . . 0.0 110.397 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -122.74 140.92 52.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.587 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.4 m -128.15 90.64 3.12 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.546 HD12 ' HD2' ' A' ' 11' ' ' PRO . 35.6 tp -114.88 125.01 29.51 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.314 -175.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.546 ' HD2' HD12 ' A' ' 10' ' ' LEU . 61.0 Cg_endo -75.57 153.59 39.24 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.215 1.944 . . . . 0.0 112.184 176.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.525 ' HA ' ' HG2' ' A' ' 88' ' ' MET . 1.9 p-10 -83.23 -166.24 1.3 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.824 177.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 87' ' ' VAL . 89.9 mt -77.35 3.03 14.08 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -176.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.445 ' CE1' ' HB2' ' A' ' 16' ' ' LYS . 4.7 p-80 -128.07 -20.65 3.75 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 119.924 -0.711 . . . . 0.0 111.731 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 125.88 27.82 1.1 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.085 -1.055 . . . . 0.0 113.898 174.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.445 ' HB2' ' CE1' ' A' ' 14' ' ' HIS . 13.2 tmtt? -100.58 112.48 24.87 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 175.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.6 m -66.97 122.32 17.47 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.943 0.402 . . . . 0.0 110.696 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.519 HG11 HD13 ' A' ' 62' ' ' LEU . 60.2 t -108.73 131.98 57.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.808 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 50.4 m -145.55 -174.21 4.33 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.97 0.414 . . . . 0.0 111.148 -178.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -61.04 -25.07 66.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.462 -177.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.22 -34.09 74.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.352 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -70.34 -30.39 67.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.323 0.583 . . . . 0.0 110.398 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.573 HD13 HG21 ' A' ' 110' ' ' ILE . 35.0 mt -85.36 -40.47 16.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.632 -171.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -71.49 21.69 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -159.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -152.19 11.19 0.66 Allowed Glycine 0 C--N 1.321 -0.279 0 C-N-CA 120.033 -1.08 . . . . 0.0 113.114 177.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 58' ' ' ASN . 11.4 ptmm? -160.02 179.58 8.63 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.629 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 21.4 t -102.89 139.32 24.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 C-N-CA 120.472 -0.491 . . . . 0.0 109.71 -175.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.618 HG23 ' HG3' ' A' ' 60' ' ' GLN . 44.3 m -136.88 148.14 46.89 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.705 -171.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.783 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 62.7 tp -112.79 105.8 14.01 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 175.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.532 HD13 ' HB2' ' A' ' 62' ' ' LEU . 48.5 mm -88.48 110.56 21.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 172.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.481 ' HA ' ' O ' ' A' ' 106' ' ' THR . 9.2 t30 -120.13 110.29 16.45 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.0 -173.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -84.03 120.45 26.15 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.394 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.463 ' NE1' ' HB1' ' A' ' 63' ' ' ALA . 2.8 p-90 -150.33 -171.82 4.01 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.651 -176.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.43 ' HB3' ' NE2' ' A' ' 66' ' ' GLN . 40.0 p90 -155.98 138.48 10.36 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.512 -0.767 . . . . 0.0 108.955 174.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.724 ' HD2' ' HB2' ' A' ' 69' ' ' ASP . 71.2 Cg_exo -41.96 -46.23 6.92 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.868 3.045 . . . . 0.0 115.167 -174.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.1 m -80.92 8.53 8.14 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -173.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.4 p -75.61 157.86 83.75 Favored Pre-proline 0 C--N 1.327 -0.398 0 O-C-N 122.263 -0.273 . . . . 0.0 110.651 -178.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -62.15 -11.29 21.32 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.652 2.234 . . . . 0.0 112.008 175.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.816 ' O ' ' HB2' ' A' ' 43' ' ' GLU . . . -75.86 4.55 44.76 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.756 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 12.5 p -78.43 -56.15 4.67 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 121.338 -1.095 . . . . 0.0 110.555 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.65 -42.77 71.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.787 -175.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.0 m -86.79 -42.81 13.0 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -175.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.816 ' HB2' ' O ' ' A' ' 39' ' ' GLY . 20.8 mm-40 -83.47 -41.69 17.75 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -171.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.614 ' O ' HG12 ' A' ' 48' ' ' ILE . 33.7 tpp -51.74 -53.18 53.54 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -171.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.6 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 52.9 Cg_exo -55.6 -40.39 85.64 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.872 1.715 . . . . 0.0 112.599 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -71.14 -34.94 71.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.56 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.7 mm -69.14 -43.02 81.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.757 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.614 HG12 ' O ' ' A' ' 44' ' ' MET . 47.3 mm -55.55 -52.65 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.028 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.431 ' HE2' ' O ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -58.56 -46.07 87.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.642 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.42 HG23 ' HE1' ' A' ' 130' ' ' TYR . 84.0 m -62.18 -53.14 59.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.639 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.83 -36.18 77.88 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -173.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.73 -33.84 62.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.821 0.343 . . . . 0.0 110.264 -178.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -70.69 -51.41 27.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.572 0.701 . . . . 0.0 109.937 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 1.01 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 22.6 m-85 -72.01 -7.39 48.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.411 -178.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.9 tptt -57.68 -41.77 82.29 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.488 0.492 . . . . 0.0 110.642 -177.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -101.56 10.07 40.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.272 -177.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.635 ' HG3' ' OD1' ' A' ' 58' ' ' ASN . 25.9 tptp -95.33 -62.81 1.24 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.365 -177.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.635 ' OD1' ' HG3' ' A' ' 57' ' ' LYS . 2.4 p-10 169.66 7.31 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.422 0.689 . . . . 0.0 109.763 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 1.01 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 54.2 t80 -118.33 148.6 42.32 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.542 -165.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.618 ' HG3' HG23 ' A' ' 28' ' ' THR . 10.8 pt20 -141.62 129.73 22.11 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.102 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.6 t -95.52 115.62 35.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 120.973 0.416 . . . . 0.0 110.117 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.532 ' HB2' HD13 ' A' ' 30' ' ' ILE . 84.2 mt -109.81 95.96 5.94 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.432 -0.804 . . . . 0.0 108.926 177.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.54 ' HB3' HG22 ' A' ' 87' ' ' VAL . . . -80.83 125.57 30.25 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.117 -177.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.1 t -106.03 115.75 48.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 120.908 0.385 . . . . 0.0 110.106 -178.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.09 112.62 22.88 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.245 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.598 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 0.8 OUTLIER -93.91 162.04 28.15 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.979 -179.364 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.598 ' HD2' ' HB2' ' A' ' 66' ' ' GLN . 60.1 Cg_endo -69.3 66.49 1.5 Allowed 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 123.081 2.521 . . . . 0.0 115.862 -164.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.4 mp -107.55 -51.34 7.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 162.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.724 ' HB2' ' HD2' ' A' ' 35' ' ' PRO . 30.5 m-20 -101.44 135.3 19.86 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.515 174.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -57.2 160.88 12.18 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.946 2.431 . . . . 0.0 112.336 177.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.552 ' O ' ' HG2' ' A' ' 75' ' ' ARG . 9.4 tt -58.27 -36.09 56.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.325 -177.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.768 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . 2.2 pm0 -68.97 -29.93 68.25 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.981 -0.287 . . . . 0.0 111.444 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.1 m -65.12 -38.38 90.5 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 174.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.432 ' HA ' ' HG3' ' A' ' 35' ' ' PRO . 14.1 t -71.98 -49.16 46.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.772 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.817 ' HA ' HG22 ' A' ' 78' ' ' VAL . 13.4 ptt180 -70.11 -24.95 63.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.702 -177.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -69.35 -42.84 74.75 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 170.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -62.24 -50.06 73.24 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.118 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.817 HG22 ' HA ' ' A' ' 75' ' ' ARG . 21.5 m -62.41 -27.01 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.063 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.22 -55.09 6.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.236 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -62.45 -43.93 97.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.44 -171.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -97.75 -3.16 39.6 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -173.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 56.56 65.52 3.51 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.446 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.571 HD22 HG12 ' A' ' 78' ' ' VAL . 9.7 mp -68.98 117.62 53.37 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-O 120.907 0.384 . . . . 0.0 111.575 -175.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -78.65 -4.65 14.25 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.32 2.68 . . . . 0.0 113.14 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -106.31 138.81 41.83 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.447 ' HB ' HD23 ' A' ' 62' ' ' LEU . 22.0 m -72.0 126.29 29.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.242 -172.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.54 HG22 ' HB3' ' A' ' 63' ' ' ALA . 46.1 t -110.68 131.79 60.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.788 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.525 ' HG2' ' HA ' ' A' ' 12' ' ' ASP . 63.2 mtm -112.74 168.36 9.74 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.06 176.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -121.6 127.18 50.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.827 0.346 . . . . 0.0 110.429 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.587 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 63.5 t0 -105.14 106.53 17.06 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.71 -47.75 37.16 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -173.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -91.93 -5.2 53.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.639 -175.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.576 ' O ' ' HG3' ' A' ' 97' ' ' GLN . 34.5 ttmt 65.66 20.2 11.53 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -173.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.93 -25.65 60.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.169 -175.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.462 HG21 HD22 ' A' ' 10' ' ' LEU . 22.5 t -74.01 -39.05 50.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 174.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.95 -33.3 86.87 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.772 173.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.576 ' HG3' ' O ' ' A' ' 93' ' ' LYS . 78.0 mt-30 -66.19 -33.27 75.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.98 0.419 . . . . 0.0 110.815 176.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.53 -39.87 70.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.478 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -87.27 -27.05 23.15 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.36 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 97.58 62.42 0.9 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.924 176.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 66.5 p -79.76 112.01 16.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.673 0.273 . . . . 0.0 111.147 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -103.51 -38.37 7.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.895 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.473 ' CG1' ' HB ' ' A' ' 121' ' ' VAL . 9.7 p -144.47 144.15 22.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -108.51 146.93 34.7 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.08 -173.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -75.33 151.48 96.48 Favored 'Cis proline' 0 C--N 1.343 0.279 0 C-N-CA 122.814 -1.744 . . . . 0.0 112.801 0.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 23.9 m -108.09 112.65 25.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.591 176.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.55 ' HB3' HD11 ' A' ' 29' ' ' LEU . 9.4 m -102.5 109.8 21.55 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.952 0.406 . . . . 0.0 110.6 -176.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 36.3 t -108.28 133.2 53.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.471 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.588 HD12 ' HB3' ' A' ' 118' ' ' LYS . 97.2 mt -101.58 116.34 32.54 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.085 0.469 . . . . 0.0 110.168 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.573 HG21 HD13 ' A' ' 23' ' ' LEU . 11.0 mm -107.33 157.21 7.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.066 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -146.22 -155.9 6.69 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 119.93 -1.129 . . . . 0.0 112.774 176.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.519 ' O ' ' HB3' ' A' ' 113' ' ' LYS . 16.5 pttp -56.99 156.13 7.26 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 124.014 0.925 . . . . 0.0 109.365 178.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.519 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 3.0 ttmp? 71.92 -16.76 0.39 Allowed 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.981 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.442 ' H ' ' C ' ' A' ' 112' ' ' LYS . . . 91.38 7.37 65.35 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 -174.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.518 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 17.2 pt-20 -67.77 135.73 53.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.123 0.487 . . . . 0.0 111.052 -176.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 57.0 mt -80.98 107.25 13.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 174.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.01 -40.56 38.6 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.761 -173.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.588 ' HB3' HD12 ' A' ' 109' ' ' LEU . 21.9 tptm -161.24 154.78 21.79 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.421 -171.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.3 m -136.62 115.59 12.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.867 0.365 . . . . 0.0 110.966 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.469 ' OH ' ' HE3' ' A' ' 128' ' ' LYS . 75.2 m-85 -108.04 144.65 35.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.446 174.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.473 ' HB ' ' CG1' ' A' ' 103' ' ' VAL . 6.2 m -123.92 137.23 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-O 120.731 0.3 . . . . 0.0 110.947 177.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 89.68 -84.67 1.39 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.2 177.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.05 106.74 7.37 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -75.9 119.76 5.52 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.502 2.135 . . . . 0.0 112.112 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.553 ' HB2' ' HE2' ' A' ' 128' ' ' LYS . 0.5 OUTLIER -53.4 93.07 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.078 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.565 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 14.7 m-85 -61.93 -33.29 74.0 Favored 'General case' 0 C--O 1.219 -0.53 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -172.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -59.32 -49.15 81.58 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 119.821 -1.18 . . . . 0.0 111.335 175.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.553 ' HE2' ' HB2' ' A' ' 125' ' ' ASP . 32.2 ttpt -68.5 -36.88 79.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.09 -0.555 . . . . 0.0 110.265 177.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.565 ' HB3' ' HA ' ' A' ' 126' ' ' PHE . 8.8 tt -64.33 -44.17 92.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.984 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.42 ' HE1' HG23 ' A' ' 50' ' ' THR . 18.2 m-30 -56.36 -56.4 21.55 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.017 0.437 . . . . 0.0 110.625 179.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -65.27 -34.26 77.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.882 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -64.49 -38.09 89.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.598 -0.273 . . . . 0.0 111.102 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.522 HG23 HG11 ' A' ' 27' ' ' VAL . 66.1 mt -62.66 -52.87 54.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.721 0.296 . . . . 0.0 110.895 177.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -69.56 -17.63 63.58 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 97.2 m -71.68 -26.63 62.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.307 0.575 . . . . 0.0 109.836 172.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.27 -17.9 64.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.35 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.41 ' HE3' ' HA ' ' A' ' 137' ' ' TRP . 4.0 m95 -59.17 -48.8 80.26 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-O 121.191 0.52 . . . . 0.0 109.819 175.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -59.73 -33.41 71.6 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.261 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -86.16 59.69 5.78 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 176.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 11.0 m -60.64 -52.57 64.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.347 -175.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.0 t70 178.39 -164.6 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . 63.25 27.33 15.48 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 122.819 0.448 . . . . 0.0 111.273 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.405 ' CD ' ' H ' ' A' ' 145' ' ' HIS . 1.3 tm-20 -86.48 116.53 24.68 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -116.94 36.41 3.76 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.274 -176.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.405 ' H ' ' CD ' ' A' ' 143' ' ' GLU . 12.4 p-80 41.48 67.17 0.58 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.979 0.912 . . . . 0.0 111.578 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 -68.85 105.02 2.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.194 -178.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -60.17 94.56 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.143 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -101.4 76.55 1.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.596 0.712 . . . . 0.0 110.244 178.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 176.25 166.16 0.43 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -176.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 28.3 t60 . . . . . 0 C--N 1.319 -0.724 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 168.426 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.453 ' CG ' ' H ' ' A' ' 2' ' ' SER . 3.2 p-10 . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 110.932 -0.025 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.453 ' H ' ' CG ' ' A' ' 1' ' ' ASP . 11.9 m -103.06 -170.35 1.78 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.693 0.282 . . . . 0.0 110.538 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 46.1 mttp -102.13 -166.8 1.33 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 173.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 115' ' ' GLU . 3.4 m 68.52 29.24 5.66 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.563 0.697 . . . . 0.0 109.285 -173.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.764 ' HB1' ' HB2' ' A' ' 20' ' ' ASN . . . 75.28 101.55 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 114.277 -1.329 . . . . 0.0 110.657 -176.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.408 ' HG3' ' O ' ' A' ' 2' ' ' SER . 11.2 Cg_exo -69.04 171.08 14.29 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.381 2.721 . . . . 0.0 112.811 -174.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.33 75.92 10.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.13 0.49 . . . . 0.0 110.648 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -125.36 150.16 47.45 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.652 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.8 p -145.3 90.59 2.04 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.518 176.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -110.25 134.73 20.69 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.416 -173.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.566 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 56.5 Cg_endo -72.98 131.74 17.28 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.177 1.918 . . . . 0.0 111.553 174.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.24 176.38 9.73 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.674 HD12 HG21 ' A' ' 78' ' ' VAL . 75.1 mt -70.69 -13.76 62.2 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -173.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -102.19 -2.82 28.47 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.195 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.78 17.76 11.57 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.478 -0.868 . . . . 0.0 114.75 169.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.463 ' HZ2' HG22 ' A' ' 18' ' ' VAL . 41.4 tttm -105.46 126.65 52.36 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 117.761 0.781 . . . . 0.0 110.062 175.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 10.2 t -72.28 125.09 26.48 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.433 0.635 . . . . 0.0 109.499 173.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.757 ' HB ' ' SD ' ' A' ' 88' ' ' MET . 60.2 t -113.31 124.29 69.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.238 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.1 m -121.82 -173.94 2.76 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.179 -177.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.764 ' HB2' ' HB1' ' A' ' 5' ' ' ALA . 31.4 p-10 -68.89 -23.22 64.17 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.873 0.368 . . . . 0.0 110.678 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.14 -28.05 69.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.707 176.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -71.9 -12.41 61.25 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.179 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.2 mt -84.59 -27.87 26.95 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.012 0.434 . . . . 0.0 111.604 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.6 mm100 -74.21 144.4 44.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.121 -170.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.42 -25.47 17.64 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 121.14 -0.553 . . . . 0.0 114.014 170.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.565 ' HG3' ' HG3' ' A' ' 60' ' ' GLN . 0.0 OUTLIER -143.59 -168.18 2.76 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -177.897 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.612 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 14.2 t -101.93 144.4 13.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 176.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.582 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 30.0 m -140.29 149.34 42.67 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.964 -0.295 . . . . 0.0 110.255 -173.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.761 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 6.4 tt -121.64 117.75 27.47 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 173.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.682 ' HB ' ' CG2' ' A' ' 108' ' ' VAL . 51.2 mt -102.56 119.97 51.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.333 -0.394 . . . . 0.0 109.972 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.468 ' OD1' ' HA ' ' A' ' 63' ' ' ALA . 21.7 p-10 -109.62 124.41 51.12 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.604 0.716 . . . . 0.0 111.036 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.439 ' HB2' ' HB ' ' A' ' 106' ' ' THR . 66.1 m-85 -98.11 129.51 44.92 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.58 178.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.62 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 42.4 p-90 -163.16 173.54 13.32 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.434 -177.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.587 ' HD1' ' NE2' ' A' ' 66' ' ' GLN . 29.2 p90 -131.48 141.78 43.0 Favored Pre-proline 0 C--N 1.318 -0.769 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 171.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.696 ' HG2' ' HA ' ' A' ' 74' ' ' VAL . 31.4 Cg_exo -62.74 0.55 1.45 Allowed 'Trans proline' 0 N--CA 1.476 0.459 0 C-N-CA 123.59 2.86 . . . . 0.0 114.592 -173.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.44 ' OG ' ' HD2' ' A' ' 34' ' ' PHE . 0.5 OUTLIER -102.28 18.0 22.04 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.133 0.492 . . . . 0.0 110.799 173.967 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 87.5 m -85.56 135.62 38.2 Favored Pre-proline 0 CA--C 1.528 0.096 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.601 176.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 12.7 Cg_exo -71.17 -8.56 23.76 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.008 2.472 . . . . 0.0 111.939 173.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.781 ' O ' ' HB2' ' A' ' 43' ' ' GLU . . . -68.37 5.97 3.66 Favored Glycine 0 C--O 1.22 -0.734 0 CA-C-N 115.762 -0.654 . . . . 0.0 113.667 -177.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.764 ' HA ' ' HG2' ' A' ' 44' ' ' MET . 25.0 p -78.03 -30.25 49.8 Favored 'General case' 0 C--N 1.317 -0.824 0 O-C-N 121.909 -0.759 . . . . 0.0 111.905 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.59 HG23 ' H ' ' A' ' 42' ' ' SER . 6.6 m -56.38 -64.99 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 -166.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.59 ' H ' HG23 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -93.57 -39.72 10.69 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 121.79 -0.569 . . . . 0.0 110.785 178.798 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.781 ' HB2' ' O ' ' A' ' 39' ' ' GLY . 8.3 mp0 -64.21 -41.72 96.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.207 -169.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.764 ' HG2' ' HA ' ' A' ' 40' ' ' CYS . 19.9 mmt -60.37 -53.12 67.89 Favored Pre-proline 0 C--N 1.329 -0.308 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.295 -178.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.481 ' HD3' ' HB2' ' A' ' 44' ' ' MET . 80.6 Cg_exo -51.06 -37.85 58.39 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 122.335 2.023 . . . . 0.0 112.848 172.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.522 ' HD3' ' O ' ' A' ' 42' ' ' SER . 23.2 mtpt -61.32 -41.21 96.63 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 120.823 0.344 . . . . 0.0 110.621 176.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.531 HG13 ' O ' ' A' ' 43' ' ' GLU . 27.2 mt -71.82 -32.09 43.54 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.578 177.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.607 HG12 ' O ' ' A' ' 44' ' ' MET . 47.5 mm -54.51 -52.14 43.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-O 120.893 0.378 . . . . 0.0 110.434 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 46' ' ' LYS . 16.6 pttm -65.4 -44.87 86.1 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.642 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.5 m -70.6 -46.87 62.6 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.984 0.421 . . . . 0.0 111.863 -174.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . -69.25 -33.11 72.76 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.906 -174.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.605 ' HA ' ' NZ ' ' A' ' 55' ' ' LYS . 62.1 t30 -76.41 -50.37 14.34 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.118 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -64.99 -46.1 82.85 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.017 -172.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.758 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 38.1 m-85 -79.67 -10.12 59.74 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.57 -175.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.605 ' NZ ' ' HA ' ' A' ' 52' ' ' ASN . 7.1 ttpm? -63.59 -21.28 66.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.208 0.527 . . . . 0.0 110.518 178.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -106.37 17.23 23.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.625 176.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.6 mtmm -136.62 44.69 2.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.771 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.527 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 17.2 t-20 62.91 31.46 16.24 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.592 0.71 . . . . 0.0 110.745 175.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.761 ' HZ ' ' HB2' ' A' ' 29' ' ' LEU . 48.8 t80 -135.82 137.51 41.61 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.142 176.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.565 ' HG3' ' HG3' ' A' ' 26' ' ' LYS . 4.5 mt-30 -127.69 157.46 40.24 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.224 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 98.6 t -130.88 126.34 59.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 177.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.4 mt -121.39 121.04 36.74 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.122 0.487 . . . . 0.0 110.605 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.582 ' HB3' ' HA ' ' A' ' 87' ' ' VAL . . . -91.19 132.0 36.37 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.458 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.7 t -123.81 101.31 8.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.074 0.464 . . . . 0.0 110.37 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.62 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -85.78 117.38 24.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.685 175.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.642 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 5.8 pm0 -90.92 163.97 27.54 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.34 -0.391 . . . . 0.0 109.981 -176.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.652 ' HD3' ' O ' ' A' ' 90' ' ' ASP . 60.8 Cg_endo -70.17 93.56 0.56 Allowed 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.027 1.818 . . . . 0.0 113.253 -169.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 46.5 mm -124.75 -60.81 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 172.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.493 ' OD2' ' HD2' ' A' ' 35' ' ' PRO . 1.8 p30 -105.67 154.21 39.4 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.602 168.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.414 ' HB2' ' OE2' ' A' ' 72' ' ' GLU . 12.9 Cg_exo -69.33 -179.96 3.07 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 122.83 2.353 . . . . 0.0 114.131 -171.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.1 tp -64.24 -35.81 75.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.879 -169.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.561 ' HA ' ' CD ' ' A' ' 75' ' ' ARG . 0.1 OUTLIER -73.39 -29.13 62.41 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.168 -0.332 . . . . 0.0 110.406 -177.645 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 45.5 m -68.72 -41.99 78.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.996 175.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.696 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 92.3 t -60.44 -55.01 27.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.297 176.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.561 ' CD ' ' HA ' ' A' ' 72' ' ' GLU . 1.4 ptm180 -63.69 -27.59 69.32 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.741 -177.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.457 ' HB2' ' O ' ' A' ' 72' ' ' GLU . 47.3 tt0 -66.14 -45.53 80.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.234 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.435 ' HB2' ' HB3' ' A' ' 35' ' ' PRO . 0.1 OUTLIER -63.31 -35.85 81.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.847 -178.862 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.674 HG21 HD12 ' A' ' 13' ' ' LEU . 60.5 t -61.26 -39.55 82.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.637 176.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 75' ' ' ARG . 95.2 mttt -70.73 -40.96 72.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.951 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -60.0 -49.38 77.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.239 -173.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.439 ' HB2' ' CD1' ' A' ' 83' ' ' LEU . 77.9 m-85 -99.8 3.7 44.9 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.699 -176.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 57.16 57.91 17.32 Favored Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.123 -178.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.655 ' HB2' HG13 ' A' ' 78' ' ' VAL . 10.5 mp -62.17 114.01 10.35 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-O 120.672 0.272 . . . . 0.0 111.476 -176.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -89.99 13.98 2.2 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.369 2.713 . . . . 0.0 112.936 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -117.96 150.21 39.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.836 176.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.7 m -69.83 115.43 9.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.756 0.312 . . . . 0.0 111.319 -173.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.582 ' HA ' ' HB3' ' A' ' 63' ' ' ALA . 31.4 t -104.5 126.59 59.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.138 -176.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.757 ' SD ' ' HB ' ' A' ' 18' ' ' VAL . 63.6 mtm -112.44 169.15 9.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.745 175.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -115.49 123.49 48.67 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.13 176.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.736 ' OD2' ' HA ' ' A' ' 93' ' ' LYS . 20.0 t0 -88.84 107.33 18.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.434 177.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.96 -47.58 20.48 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -175.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -99.85 -12.24 20.04 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -169.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.736 ' HA ' ' OD2' ' A' ' 90' ' ' ASP . 57.2 tttp 68.61 -2.31 1.69 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.015 0.526 . . . . 0.0 111.821 176.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.21 -23.88 43.51 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.919 0.39 . . . . 0.0 110.484 -177.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.453 ' O ' ' HD1' ' A' ' 99' ' ' PHE . 28.3 m -71.39 -38.04 67.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 171.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.52 -33.7 85.44 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 173.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 67.9 mm-40 -66.75 -32.28 73.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.811 0.338 . . . . 0.0 110.856 175.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.67 -39.9 95.49 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.253 0.549 . . . . 0.0 110.487 177.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.499 ' CE2' HD12 ' A' ' 116' ' ' ILE . 29.7 m-85 -73.63 -28.69 61.93 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.062 175.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.33 44.84 2.9 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.424 178.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.547 HG22 HG21 ' A' ' 106' ' ' THR . 52.5 p -104.48 112.91 26.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.253 0.549 . . . . 0.0 111.568 -176.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -111.95 -39.5 4.5 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.356 177.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.6 m -117.78 149.97 20.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 177.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.59 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 92.3 m-85 -129.44 161.62 57.74 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.75 -172.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.59 ' HA ' ' HB3' ' A' ' 104' ' ' TYR . 63.5 Cg_endo -73.03 165.71 83.46 Favored 'Cis proline' 0 C--N 1.349 0.603 0 C-N-CA 123.689 -1.379 . . . . 0.0 113.439 0.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.547 HG21 HG22 ' A' ' 101' ' ' THR . 4.2 m -135.05 148.88 50.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.433 177.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 37.8 m -137.69 114.59 10.66 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.971 0.415 . . . . 0.0 110.621 178.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.682 ' CG2' ' HB ' ' A' ' 30' ' ' ILE . 20.5 m -106.77 145.13 14.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.136 0.493 . . . . 0.0 111.053 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.553 HD11 HD12 ' A' ' 129' ' ' LEU . 9.5 mp -101.69 133.32 46.58 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.542 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.582 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 34.5 mm -110.49 135.02 50.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.943 -176.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -77.17 -150.21 3.74 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.831 -0.7 . . . . 0.0 111.706 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.485 ' HD3' HG22 ' A' ' 27' ' ' VAL . 10.2 mmmm -101.05 -7.58 23.12 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -176.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 2.7 mtmp? -124.55 19.72 8.73 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 113.485 -1.689 . . . . 0.0 109.291 -175.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.2 -90.97 1.58 Allowed Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -173.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 26.0 mt-10 69.17 -30.55 0.19 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 167.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.499 HD12 ' CE2' ' A' ' 99' ' ' PHE . 23.5 mm 53.38 64.87 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 CA-C-O 121.946 0.879 . . . . 0.0 108.997 -169.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.438 HD22 ' HA ' ' A' ' 117' ' ' LEU . 0.2 OUTLIER -62.02 -45.44 93.58 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 113.885 -1.507 . . . . 0.0 112.983 -169.28 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.7 ' HG3' ' OE2' ' A' ' 132' ' ' GLU . 4.3 tmtp? -143.91 153.83 42.71 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.257 -169.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.4 ' H ' ' HD3' ' A' ' 118' ' ' LYS . 40.3 m -139.96 108.01 5.74 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.944 0.402 . . . . 0.0 111.427 178.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -98.95 137.87 36.88 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.294 170.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.6 p -109.91 140.82 27.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 82.22 -109.8 3.11 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 -176.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -111.44 126.31 28.83 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 173.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.54 ' HB2' HD13 ' A' ' 129' ' ' LEU . 56.0 Cg_endo -72.14 125.64 11.05 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.206 1.937 . . . . 0.0 111.369 175.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.418 ' OD2' ' HB3' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -59.22 121.86 12.4 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.234 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -70.33 -29.67 66.44 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.28 -174.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -65.97 -54.91 22.0 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.32 -174.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.418 ' HB3' ' OD2' ' A' ' 125' ' ' ASP . 26.2 tptp -75.74 -33.08 60.24 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.553 HD12 HD11 ' A' ' 109' ' ' LEU . 0.9 OUTLIER -58.31 -48.34 80.8 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.008 0.193 . . . . 0.0 110.974 179.276 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -67.1 -45.14 78.13 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.191 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -64.57 -36.31 83.81 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.387 0.613 . . . . 0.0 110.885 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.7 ' OE2' ' HG3' ' A' ' 118' ' ' LYS . 21.3 tt0 -74.73 -40.02 61.52 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.44 -175.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.506 HG23 HG11 ' A' ' 27' ' ' VAL . 79.7 mt -64.4 -42.3 94.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.876 173.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -54.47 -39.03 67.1 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.462 177.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.8 m -60.51 -39.44 87.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.08 0.467 . . . . 0.0 110.713 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.06 -19.28 60.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.395 -177.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.411 ' HD1' HG21 ' A' ' 27' ' ' VAL . 17.1 m0 -65.48 -55.34 18.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.69 0.281 . . . . 0.0 110.898 177.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 64.4 mtt85 -68.66 -15.83 63.64 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.028 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' A' ' 140' ' ' SER . 7.9 t-20 -72.47 66.23 0.68 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.612 175.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 139' ' ' ASN . 22.1 t 169.75 121.94 0.01 OUTLIER 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.006 -178.007 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -72.7 88.48 1.29 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.976 0.417 . . . . 0.0 110.865 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -162.62 108.49 1.2 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.529 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.429 ' CD ' ' HD1' ' A' ' 145' ' ' HIS . 7.2 tp10 -107.19 119.91 40.67 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.273 0.558 . . . . 0.0 110.71 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -104.08 0.32 44.46 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.34 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.429 ' HD1' ' CD ' ' A' ' 143' ' ' GLU . 25.9 m80 -66.17 86.95 0.1 Allowed 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 121.492 0.663 . . . . 0.0 110.999 176.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -120.27 66.8 0.83 Allowed 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 172.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 62.62 -86.28 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.097 -175.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 61.08 -84.64 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -171.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -116.02 -11.6 11.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.058 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 69.9 t60 . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.218 -0.896 . . . . 0.0 109.777 179.527 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.381 0.134 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.811 ' H ' ' HA ' ' A' ' 6' ' ' PRO . 61.5 m 62.87 -168.07 0.2 Allowed 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -169.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.556 ' HB3' ' NZ ' ' A' ' 3' ' ' LYS . 0.6 OUTLIER 64.76 98.95 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 -177.201 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.3 m 63.99 46.56 3.74 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.929 0.871 . . . . 0.0 109.162 -172.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.45 ' H ' HG13 ' A' ' 116' ' ' ILE . . . 77.02 151.14 0.13 Allowed Pre-proline 0 N--CA 1.466 0.328 0 CA-C-N 113.789 -1.551 . . . . 0.0 110.77 -178.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.811 ' HA ' ' H ' ' A' ' 2' ' ' SER . 73.2 Cg_endo -76.56 2.28 7.55 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.076 1.851 . . . . 0.0 113.759 -173.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 56.62 84.93 0.08 Allowed 'General case' 0 C--N 1.327 -0.409 0 O-C-N 124.325 1.016 . . . . 0.0 110.796 -175.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.515 ' CE1' HD11 ' A' ' 23' ' ' LEU . 45.4 p90 -132.35 168.42 18.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.197 0.522 . . . . 0.0 111.355 -175.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 48.6 m -148.46 95.03 2.38 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 172.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 22.0 tp -115.87 133.61 22.83 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.415 -171.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.503 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 8.1 Cg_exo -72.59 134.97 23.21 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.562 2.175 . . . . 0.0 112.414 178.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.589 ' HB3' ' O ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -76.07 164.36 26.2 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.822 174.8 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.663 ' HB3' ' HG2' ' A' ' 75' ' ' ARG . 69.4 mt -67.13 -7.03 20.25 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 -170.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -123.6 17.71 9.59 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 121.809 -0.557 . . . . 0.0 110.959 174.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.02 22.35 25.59 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.931 -0.652 . . . . 0.0 114.045 169.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.589 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 11.3 tmtt? -97.03 102.5 14.29 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 173.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 12.0 m -63.52 122.42 16.25 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.894 0.378 . . . . 0.0 110.262 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.511 ' HB ' ' SD ' ' A' ' 88' ' ' MET . 60.8 t -106.24 116.44 50.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.801 178.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 83.4 p -103.15 -176.91 3.22 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.432 -177.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -73.3 -23.01 60.23 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.688 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.53 ' O ' ' HG3' ' A' ' 24' ' ' GLN . . . -68.34 -28.57 67.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.051 178.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -70.84 -15.53 62.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.871 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.515 HD11 ' CE1' ' A' ' 8' ' ' PHE . 92.3 mt -83.87 -20.21 33.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.706 -177.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.53 ' HG3' ' O ' ' A' ' 21' ' ' ALA . 0.4 OUTLIER -100.24 141.56 32.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.46 0.648 . . . . 0.0 112.457 -172.784 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.76 -8.32 68.26 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.101 -176.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 112' ' ' LYS . 9.3 mtpm? -142.31 164.23 30.71 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.697 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 25.2 t -102.5 141.73 18.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -177.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.466 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 26.8 m -132.78 138.47 47.16 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -165.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.63 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 36.7 tp -121.49 112.31 18.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.192 170.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.564 HG12 ' HB2' ' A' ' 62' ' ' LEU . 54.4 mt -102.33 115.6 44.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.801 0.334 . . . . 0.0 110.411 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.434 ' HA ' ' O ' ' A' ' 106' ' ' THR . 4.5 p-10 -109.06 126.87 53.62 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.326 0.584 . . . . 0.0 110.281 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.479 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 86.1 m-85 -92.97 127.9 38.65 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.829 178.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.51 ' NE1' ' HB1' ' A' ' 63' ' ' ALA . 5.3 p-90 -153.04 -178.05 6.68 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.065 0.46 . . . . 0.0 111.218 -175.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -149.48 148.22 25.47 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.757 172.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.518 ' HD2' ' HB2' ' A' ' 69' ' ' ASP . 96.3 Cg_exo -44.94 -47.87 11.49 Favored 'Trans proline' 0 N--CA 1.475 0.437 0 C-N-CA 123.592 2.861 . . . . 0.0 114.569 -175.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.9 m -82.67 17.14 1.91 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -175.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 53.3 t -73.61 126.51 89.72 Favored Pre-proline 0 C--N 1.328 -0.333 0 O-C-N 122.355 -0.215 . . . . 0.0 110.638 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -62.72 -22.28 73.77 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.907 2.405 . . . . 0.0 113.048 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.84 -17.01 80.28 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.181 -177.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 31.2 p -67.7 -41.5 83.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.069 0.434 . . . . 0.0 111.187 -174.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.8 p -59.99 -32.03 49.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.855 0.36 . . . . 0.0 111.169 -176.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.0 m -86.89 -54.09 4.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.818 0.342 . . . . 0.0 111.328 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -85.22 -29.69 24.47 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -168.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.578 ' O ' HG12 ' A' ' 48' ' ' ILE . 41.1 ttm -58.7 -46.7 99.56 Favored Pre-proline 0 N--CA 1.47 0.535 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -173.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 44' ' ' MET . 7.0 Cg_endo -50.97 -38.11 58.03 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.017 1.811 . . . . 0.0 112.246 175.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -65.2 -44.15 89.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.209 0.528 . . . . 0.0 109.76 176.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 42.5 mm -60.87 -41.46 88.86 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.359 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.74 178.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.578 HG12 ' O ' ' A' ' 44' ' ' MET . 43.0 mm -54.34 -49.2 65.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.249 0.547 . . . . 0.0 110.086 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.437 ' HE3' ' HB3' ' A' ' 49' ' ' LYS . 18.5 ttpp -64.96 -57.58 8.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.576 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.6 m -63.24 -41.91 99.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.766 -173.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.05 -50.24 62.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.126 -177.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -64.85 -43.04 94.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.858 0.361 . . . . 0.0 110.889 -173.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.434 ' CG ' ' HZ1' ' A' ' 57' ' ' LYS . 14.1 t70 -59.93 -42.2 93.45 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.001 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 1.037 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 14.9 m-85 -81.34 -26.18 35.79 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.218 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.4 mmmm -58.59 -30.63 67.35 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.854 0.359 . . . . 0.0 110.564 176.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -94.15 19.36 9.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.034 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.434 ' HZ1' ' CG ' ' A' ' 53' ' ' ASP . 27.3 mtmm -128.25 -59.09 1.18 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.325 176.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.408 ' O ' ' HB3' ' A' ' 26' ' ' LYS . 27.2 t-20 176.99 -14.64 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.321 0.582 . . . . 0.0 110.892 -174.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 1.037 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 62.9 t80 -98.31 147.71 24.38 Favored 'General case' 0 C--N 1.316 -0.849 0 O-C-N 122.032 -0.417 . . . . 0.0 109.938 -174.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -137.83 127.66 25.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.134 0.493 . . . . 0.0 111.324 -176.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 92.3 t -99.23 120.43 48.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.426 174.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.564 ' HB2' HG12 ' A' ' 30' ' ' ILE . 72.4 mt -113.78 112.84 24.08 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.708 -178.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.51 ' HB1' ' NE1' ' A' ' 33' ' ' TRP . . . -93.5 107.51 19.35 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.645 -177.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 88.4 t -95.66 113.92 31.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.075 0.464 . . . . 0.0 110.448 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.51 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -86.11 131.9 34.15 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.697 176.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.598 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -100.24 163.91 17.37 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.514 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.598 ' HD2' ' HB2' ' A' ' 66' ' ' GLN . 32.8 Cg_endo -64.12 79.27 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.542 2.162 . . . . 0.0 113.784 -175.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.469 HG12 ' HG2' ' A' ' 66' ' ' GLN . 40.1 mm -117.83 -63.35 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 171.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.518 ' HB2' ' HD2' ' A' ' 35' ' ' PRO . 14.8 m-20 -96.62 149.55 35.95 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 168.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.45 150.51 34.02 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.633 2.222 . . . . 0.0 112.893 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.0 tt -55.14 -38.5 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.629 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -66.18 -37.39 85.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.107 0.48 . . . . 0.0 110.419 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.4 m -61.35 -35.01 76.25 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.387 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.477 ' HA ' ' HG3' ' A' ' 35' ' ' PRO . 10.9 t -67.67 -41.0 85.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.114 178.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.801 ' HA ' HG22 ' A' ' 78' ' ' VAL . 41.8 mtp180 -69.08 -32.82 72.54 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.368 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.3 tm0? -62.75 -38.81 92.01 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 175.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.466 ' HE1' ' SD ' ' A' ' 44' ' ' MET . 7.7 t80 -67.85 -48.68 65.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.267 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.801 HG22 ' HA ' ' A' ' 75' ' ' ARG . 25.8 m -62.9 -31.93 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -177.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.479 ' HB3' ' HE2' ' A' ' 79' ' ' LYS . 44.9 mtpt -74.64 -54.27 7.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.75 0.309 . . . . 0.0 111.408 177.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -65.71 -41.29 92.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.918 -171.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -89.75 -21.76 22.51 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.604 -175.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.0 75.48 0.91 Allowed Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.429 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.64 HD22 HG12 ' A' ' 78' ' ' VAL . 10.6 mp -95.26 112.32 58.18 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 120.798 0.332 . . . . 0.0 111.107 -177.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -81.0 -11.41 12.33 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.185 2.59 . . . . 0.0 113.326 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.471 ' HE1' HD13 ' A' ' 48' ' ' ILE . 29.1 p90 -91.06 145.21 24.88 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 176.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.41 ' HB ' ' CD2' ' A' ' 62' ' ' LEU . 19.4 m -71.83 118.21 14.4 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.976 -172.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.46 HG22 ' HB3' ' A' ' 63' ' ' ALA . 39.0 t -107.49 129.26 61.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.573 -178.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.511 ' SD ' ' HB ' ' A' ' 18' ' ' VAL . 70.9 mtm -119.85 171.17 8.61 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.45 178.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -137.48 115.27 11.39 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.741 0.305 . . . . 0.0 110.329 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.593 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 47.8 t0 -98.73 102.41 14.13 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.36 -28.27 61.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.723 -176.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -83.71 -7.11 59.55 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.872 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.3 pttp 47.41 25.2 0.57 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.214 1.005 . . . . 0.0 111.774 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -81.59 -34.38 31.03 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.601 -172.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.539 HG22 ' OD2' ' A' ' 90' ' ' ASP . 31.5 m -76.31 -30.68 20.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 119.989 -0.684 . . . . 0.0 109.604 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -69.92 -38.51 75.17 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 172.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 -69.97 -23.75 63.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.567 -0.317 . . . . 0.0 111.346 176.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.42 -36.33 71.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.667 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -86.86 -19.27 29.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.082 176.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 81.84 41.94 9.32 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.904 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.562 HG22 HG21 ' A' ' 106' ' ' THR . 50.4 p -76.15 86.86 3.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.223 0.535 . . . . 0.0 111.054 -178.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -93.09 -45.23 7.99 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.638 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.558 ' HB ' HG22 ' A' ' 121' ' ' VAL . 21.3 t -100.28 123.41 53.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.981 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -104.09 144.37 28.55 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.077 -177.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -76.47 165.27 85.67 Favored 'Cis proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.724 -1.365 . . . . 0.0 113.304 0.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.562 HG21 HG22 ' A' ' 101' ' ' THR . 5.5 m -129.54 125.93 37.4 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.82 174.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.443 ' HB3' HD11 ' A' ' 29' ' ' LEU . 16.5 m -111.62 114.51 27.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.857 0.36 . . . . 0.0 110.884 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.527 HG22 HG23 ' A' ' 119' ' ' THR . 47.3 t -105.98 130.82 56.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.325 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.547 HD12 ' HB3' ' A' ' 118' ' ' LYS . 85.8 mt -101.7 120.2 39.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.567 -178.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.466 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 31.1 mt -112.58 144.13 20.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.405 179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.697 ' O ' ' HA ' ' A' ' 27' ' ' VAL . . . -72.88 -112.03 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 121.117 -0.563 . . . . 0.0 113.071 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 18.0 pttm -140.54 -8.06 1.12 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -173.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -121.44 -9.75 8.97 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 173.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 127.9 -4.41 6.94 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.592 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 115' ' ' GLU . 5.9 pm0 -58.36 116.95 3.95 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.43 0.633 . . . . 0.0 110.225 -177.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.45 HG13 ' H ' ' A' ' 5' ' ' ALA . 60.7 mt -78.12 112.33 15.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.589 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.404 ' CD1' ' HB2' ' A' ' 136' ' ' ALA . 61.3 mt -90.17 -50.5 5.96 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.416 -173.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.547 ' HB3' HD12 ' A' ' 109' ' ' LEU . 18.0 tptm -152.08 158.35 42.87 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.427 -167.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.527 HG23 HG22 ' A' ' 108' ' ' VAL . 32.0 m -143.15 103.73 4.19 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.147 0.498 . . . . 0.0 110.526 174.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -88.93 106.21 18.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.075 174.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.558 HG22 ' HB ' ' A' ' 103' ' ' VAL . 7.7 p -95.92 121.43 46.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.265 0.555 . . . . 0.0 110.711 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 105.14 -80.6 0.3 Allowed Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.11 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -138.82 118.57 9.53 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.89 143.12 20.51 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.629 2.219 . . . . 0.0 113.323 -177.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.53 ' O ' ' HB2' ' A' ' 129' ' ' LEU . 24.8 t0 -77.45 107.6 10.01 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 172.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -66.35 -43.49 85.88 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -174.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.25 -43.75 98.65 Favored Glycine 0 C--O 1.239 0.437 0 C-N-CA 120.261 -0.971 . . . . 0.0 111.161 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.638 ' HB2' ' NZ ' ' A' ' 128' ' ' LYS . 1.7 ttmp? -71.82 -31.59 66.69 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.21 -0.495 . . . . 0.0 109.994 178.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.533 ' O ' HG13 ' A' ' 133' ' ' ILE . 0.2 OUTLIER -56.55 -48.01 78.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.001 177.397 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -65.92 -48.97 69.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.386 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.45 ' HG2' ' HA ' ' A' ' 128' ' ' LYS . 3.3 pt20 -68.36 -32.23 72.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.964 0.412 . . . . 0.0 111.459 -177.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -74.68 -32.66 62.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.322 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.533 HG13 ' O ' ' A' ' 129' ' ' LEU . 59.5 mt -62.85 -49.69 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 172.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.562 ' O ' ' HG2' ' A' ' 138' ' ' ARG . 14.9 t70 -56.65 -38.23 71.89 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.409 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 88.0 m -55.48 -40.62 71.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.012 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.404 ' HB2' ' CD1' ' A' ' 117' ' ' LEU . . . -64.12 -30.86 71.9 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.039 0.447 . . . . 0.0 111.039 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.462 ' NE1' HG21 ' A' ' 27' ' ' VAL . 11.3 m0 -72.94 -29.57 63.2 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.106 177.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.562 ' HG2' ' O ' ' A' ' 134' ' ' ASP . 22.5 mmt180 -85.13 -17.89 35.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.507 -178.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -80.88 66.85 6.56 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.57 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 11.2 p -95.08 -59.53 1.88 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.382 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -88.21 92.86 9.31 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.942 -175.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.57 -19.15 23.05 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.967 174.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 56.22 -98.03 0.08 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.001 -1.0 . . . . 0.0 112.798 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.01 40.18 81.55 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -170.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -70.47 75.75 0.56 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.085 0.469 . . . . 0.0 112.179 -170.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -137.62 -2.52 1.95 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.086 172.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -84.18 108.45 17.08 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.814 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -80.2 149.45 30.46 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.509 175.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 -99.35 -13.35 19.65 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 168.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 . . . . . 0 C--O 1.244 0.786 0 CA-C-N 113.711 -1.586 . . . . 0.0 107.674 -179.884 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.591 ' OD2' ' HG3' ' A' ' 3' ' ' LYS . 25.4 t70 . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.2 m 73.33 17.67 3.88 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.77 0.669 . . . . 0.0 112.37 169.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.591 ' HG3' ' OD2' ' A' ' 1' ' ' ASP . 0.4 OUTLIER -125.19 168.88 12.82 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 175.193 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.713 HG22 ' HA3' ' A' ' 114' ' ' GLY . 63.6 p 51.86 53.97 11.71 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.265 0.555 . . . . 0.0 111.084 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.543 ' H ' HG13 ' A' ' 116' ' ' ILE . . . 63.74 163.42 0.12 Allowed Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 114.372 -1.285 . . . . 0.0 112.021 -178.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -57.84 141.24 95.75 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 121.74 1.626 . . . . 0.0 109.991 168.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -50.94 104.67 0.08 Allowed 'General case' 0 C--N 1.331 -0.231 0 O-C-N 123.461 0.475 . . . . 0.0 111.587 -175.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -129.14 135.55 49.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.624 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.3 t -150.2 88.89 1.54 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 171.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.477 HD11 ' HB3' ' A' ' 88' ' ' MET . 1.4 pt? -121.71 155.25 60.21 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.593 -178.015 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.601 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 8.1 Cg_exo -73.23 130.3 15.06 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.633 2.222 . . . . 0.0 112.522 177.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.54 160.81 31.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.516 173.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.453 HD12 HG11 ' A' ' 78' ' ' VAL . 41.4 mt -60.91 -24.01 65.67 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 -174.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -83.14 -11.7 57.69 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.06 -15.07 16.18 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 121.167 -0.54 . . . . 0.0 113.256 174.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -76.37 121.44 23.03 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.869 0.335 . . . . 0.0 111.114 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.601 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 20.5 m -69.75 123.18 20.76 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 172.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.9 t -119.56 130.01 74.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.981 0.42 . . . . 0.0 110.778 -176.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.9 t -132.05 173.99 10.65 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.494 178.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.756 ' HA ' HD13 ' A' ' 23' ' ' LEU . 30.0 p-10 -61.01 -22.8 64.88 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -172.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.68 -27.95 67.28 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 178.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -67.63 -32.81 73.77 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.18 0.514 . . . . 0.0 110.93 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.756 HD13 ' HA ' ' A' ' 20' ' ' ASN . 5.2 mp -71.46 -20.36 62.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.064 -175.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -68.21 98.5 0.81 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.211 -177.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 132.17 -22.85 4.18 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.079 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.4 mtmm -111.47 162.56 14.97 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -103.46 123.34 56.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 168.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.53 ' HB ' HD12 ' A' ' 110' ' ' ILE . 11.0 m -126.59 150.9 48.6 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.092 0.472 . . . . 0.0 111.842 -164.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.422 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 51.9 tp -123.71 120.45 32.74 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.921 174.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.982 ' HB ' HG12 ' A' ' 108' ' ' VAL . 34.5 mm -97.19 132.79 40.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 175.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -128.17 125.07 38.33 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.245 0.545 . . . . 0.0 109.879 174.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.413 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 48.3 m-85 -90.56 122.63 33.54 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.991 176.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.474 ' NE1' ' HB1' ' A' ' 63' ' ' ALA . 6.1 p-90 -148.4 -169.84 3.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.454 -177.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -159.4 143.8 11.17 Favored Pre-proline 0 C--N 1.321 -0.656 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 174.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.494 ' HG2' ' CB ' ' A' ' 69' ' ' ASP . 12.8 Cg_endo -59.0 158.93 23.31 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.414 2.076 . . . . 0.0 111.521 176.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.8 m 68.32 18.41 9.14 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.19 -177.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.475 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 52.8 t -101.3 136.78 19.59 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.547 177.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.482 ' O ' HG22 ' A' ' 41' ' ' VAL . 19.9 Cg_exo -67.15 -13.8 40.99 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 123.014 2.476 . . . . 0.0 112.919 178.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.42 -4.78 19.13 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 121.515 -0.374 . . . . 0.0 113.467 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.707 ' O ' ' HB2' ' A' ' 44' ' ' MET . 61.0 m -63.22 -34.88 78.61 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 122.725 -0.28 . . . . 0.0 110.897 176.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 38' ' ' PRO . 33.0 m -67.98 -33.99 64.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.176 -177.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.9 p -88.87 -56.41 3.3 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.575 ' HG2' ' HG3' ' A' ' 105' ' ' PRO . 1.4 mp0 -84.09 -34.77 24.09 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -168.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.707 ' HB2' ' O ' ' A' ' 40' ' ' CYS . 8.6 mmt -61.12 -48.11 93.0 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -175.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 44' ' ' MET . 13.2 Cg_endo -57.25 -34.19 97.38 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 121.838 1.692 . . . . 0.0 112.305 175.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.48 ' HD2' ' HA ' ' A' ' 43' ' ' GLU . 93.9 mttt -64.32 -51.66 62.34 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 176.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.674 HG23 HG11 ' A' ' 61' ' ' VAL . 45.1 mm -57.43 -46.91 85.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.834 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.469 HG12 ' O ' ' A' ' 44' ' ' MET . 46.1 mm -56.57 -53.36 42.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.184 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -69.3 -51.34 38.22 Favored 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.384 -174.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 62.4 m -57.2 -42.39 81.18 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.071 0.463 . . . . 0.0 111.196 -176.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.04 -31.5 70.32 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.751 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -73.88 -45.5 50.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.783 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -54.59 -51.58 64.86 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.745 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.606 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 61.6 m-85 -97.22 8.53 44.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.433 -175.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.516 ' HE3' ' HA ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -60.54 -45.62 93.19 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.254 0.55 . . . . 0.0 110.169 -179.903 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -89.95 33.56 0.86 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.617 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.606 ' HE2' ' HA ' ' A' ' 54' ' ' TYR . 0.7 OUTLIER -126.08 -68.35 0.83 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.7 171.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 177.03 13.72 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.767 -177.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.422 ' HZ ' ' HB2' ' A' ' 29' ' ' LEU . 22.1 t80 -99.96 147.52 25.49 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.032 -173.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.507 ' O ' ' HA ' ' A' ' 28' ' ' THR . 50.5 tp60 -138.91 147.3 42.15 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.918 -177.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.674 HG11 HG23 ' A' ' 47' ' ' ILE . 86.9 t -129.2 129.64 67.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.748 0.309 . . . . 0.0 110.465 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.843 ' HG ' ' HB ' ' A' ' 86' ' ' THR . 9.9 mp -121.53 121.91 38.53 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.78 177.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.474 ' HB1' ' NE1' ' A' ' 33' ' ' TRP . . . -101.44 119.63 39.06 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.347 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.9 t -97.29 107.65 20.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.916 0.389 . . . . 0.0 110.748 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 89' ' ' TYR . . . -91.5 126.42 36.58 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.101 177.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.617 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 2.8 pt20 -97.91 168.78 9.45 Favored Pre-proline 0 C--N 1.317 -0.839 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.491 -178.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.652 ' HD2' ' HG3' ' A' ' 93' ' ' LYS . 98.7 Cg_endo -75.91 45.07 1.42 Allowed 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 122.81 2.34 . . . . 0.0 114.85 -165.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 50.7 mm -78.67 -32.61 16.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 171.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.494 ' CB ' ' HG2' ' A' ' 35' ' ' PRO . 0.2 OUTLIER -136.48 136.32 21.94 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 114.64 -1.164 . . . . 0.0 107.926 170.792 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 69' ' ' ASP . 35.7 Cg_exo -58.2 174.02 0.82 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.079 2.519 . . . . 0.0 113.681 -175.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.532 ' HA ' HG12 ' A' ' 74' ' ' VAL . 19.8 tt -71.87 -27.07 26.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.591 -169.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.414 ' OE2' ' HB2' ' A' ' 70' ' ' PRO . 9.2 pm0 -74.02 -28.81 61.62 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.671 175.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 63.0 m -64.51 -48.63 74.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.98 0.419 . . . . 0.0 110.35 174.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.532 HG12 ' HA ' ' A' ' 71' ' ' ILE . 9.6 p -67.62 -34.36 67.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.65 -178.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.872 ' HA ' HG22 ' A' ' 78' ' ' VAL . 66.7 mtt180 -71.66 -29.01 64.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.999 175.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -64.76 -41.52 95.82 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 173.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -64.78 -51.73 60.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.073 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.104 ' HA ' HD23 ' A' ' 83' ' ' LEU . 35.8 m -61.8 -26.63 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.379 -178.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.701 ' HZ2' ' HB3' ' A' ' 79' ' ' LYS . 1.6 ttpm? -72.06 -49.43 36.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.303 0.573 . . . . 0.0 110.052 174.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.48 -48.07 77.91 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.681 -1.145 . . . . 0.0 112.857 -173.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -103.19 4.41 36.78 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.428 -174.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 57.12 55.27 31.22 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 116.037 -0.529 . . . . 0.0 113.101 177.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 1.104 HD23 ' HA ' ' A' ' 78' ' ' VAL . 3.1 mm? -71.18 111.65 10.79 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-O 120.784 0.326 . . . . 0.0 110.556 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -85.59 -6.99 8.8 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.11 2.54 . . . . 0.0 113.77 -173.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.55 ' CE2' HD12 ' A' ' 83' ' ' LEU . 28.7 p90 -90.54 169.87 10.66 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.936 0.398 . . . . 0.0 110.929 -178.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.843 ' HB ' ' HG ' ' A' ' 62' ' ' LEU . 18.3 m -75.25 132.13 40.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.174 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.2 t -130.06 130.9 66.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -177.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.477 ' HB3' HD11 ' A' ' 10' ' ' LEU . 57.5 mtt -111.94 163.76 13.87 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.42 -178.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 92.4 t80 -126.42 115.18 19.21 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.835 176.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.507 ' OD2' HG22 ' A' ' 95' ' ' VAL . 40.0 t0 -87.56 127.08 35.26 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.53 -30.12 59.65 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -177.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.588 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 17.2 t70 -127.22 -10.94 5.85 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -169.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.652 ' HG3' ' HD2' ' A' ' 67' ' ' PRO . 25.0 mtpp 76.69 14.09 2.23 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -169.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.17 -44.41 97.34 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -170.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.507 HG22 ' OD2' ' A' ' 90' ' ' ASP . 27.7 m -72.32 -33.55 46.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.197 -178.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -70.23 -33.9 69.2 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.499 -0.857 . . . . 0.0 111.086 173.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -71.43 -24.29 62.0 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 122.751 0.42 . . . . 0.0 110.722 176.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.59 -35.42 73.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.185 173.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -82.43 -11.31 58.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.855 175.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 76.73 32.34 50.6 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.383 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 38.0 p -80.21 96.2 6.51 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.248 0.547 . . . . 0.0 111.466 -177.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -89.34 -31.46 17.79 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.365 0.602 . . . . 0.0 109.618 174.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.3 p -107.1 150.22 9.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.181 -176.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.413 ' CE1' ' HB3' ' A' ' 32' ' ' PHE . 93.6 m-85 -140.02 155.41 70.81 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.399 -178.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.575 ' HG3' ' HG2' ' A' ' 43' ' ' GLU . 90.5 Cg_endo -77.73 162.58 89.69 Favored 'Cis proline' 0 C--N 1.343 0.259 0 C-N-CA 123.293 -1.545 . . . . 0.0 112.796 0.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.504 HG23 HG12 ' A' ' 121' ' ' VAL . 55.1 m -138.28 131.34 29.99 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.824 178.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 35.1 p -116.25 148.52 40.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.015 0.436 . . . . 0.0 111.376 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.982 HG12 ' HB ' ' A' ' 30' ' ' ILE . 1.9 p -124.57 148.4 28.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 176.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.49 ' O ' ' HB2' ' A' ' 117' ' ' LEU . 4.3 mm? -100.51 123.55 44.87 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 121.002 0.43 . . . . 0.0 109.986 -177.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.774 HG23 ' HA ' ' A' ' 115' ' ' GLU . 59.6 mt -109.01 130.21 62.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.693 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.545 ' HA2' ' HB1' ' A' ' 136' ' ' ALA . . . -84.6 -152.25 15.69 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.12 175.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -110.56 15.1 22.28 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.0 mtpp -104.72 19.22 20.83 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 113.6 -1.636 . . . . 0.0 109.646 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.713 ' HA3' HG22 ' A' ' 4' ' ' THR . . . 108.25 -77.98 0.23 Allowed Glycine 0 C--O 1.223 -0.562 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.546 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.774 ' HA ' HG23 ' A' ' 110' ' ' ILE . 0.7 OUTLIER -166.83 161.08 15.11 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 117.689 0.745 . . . . 0.0 112.322 -179.823 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.543 HG13 ' H ' ' A' ' 5' ' ' ALA . 13.5 mt 75.93 85.24 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 125.826 1.65 . . . . 0.0 112.761 177.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.494 HD23 ' H ' ' A' ' 111' ' ' GLY . 1.3 mm? -110.74 -51.5 2.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.372 171.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.52 ' HG3' ' OE2' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -155.27 174.55 15.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.768 -174.726 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 21.0 m -141.53 133.94 28.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.668 0.27 . . . . 0.0 110.919 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.482 ' HD1' HD23 ' A' ' 109' ' ' LEU . 54.1 m-85 -132.31 110.19 10.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.567 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.504 HG12 HG23 ' A' ' 106' ' ' THR . 22.6 m -92.9 141.57 14.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.025 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 70.38 -113.71 5.03 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.447 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -94.55 109.92 46.02 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.73 121.16 4.97 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.425 2.084 . . . . 0.0 112.428 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.556 ' CG ' ' HG2' ' A' ' 128' ' ' LYS . 8.3 t0 -57.14 105.16 0.2 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 175.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -61.72 -31.34 71.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.852 -175.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -63.35 -49.31 71.43 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.468 -0.872 . . . . 0.0 111.381 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.556 ' HG2' ' CG ' ' A' ' 125' ' ' ASP . 33.2 mmtm -70.54 -34.97 72.85 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.57 ' O ' HG13 ' A' ' 133' ' ' ILE . 0.2 OUTLIER -56.34 -47.92 77.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.385 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -64.27 -55.72 19.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.778 -0.192 . . . . 0.0 110.867 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -58.25 -32.2 68.13 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.372 0.606 . . . . 0.0 111.337 -177.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.52 ' OE2' ' HG3' ' A' ' 118' ' ' LYS . 24.7 tt0 -80.59 -29.59 36.94 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.677 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.57 HG13 ' O ' ' A' ' 129' ' ' LEU . 51.5 mt -62.62 -44.77 99.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 171.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -59.06 -31.03 68.5 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.348 0.594 . . . . 0.0 110.517 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 132' ' ' GLU . 92.3 m -66.43 -35.91 81.47 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.431 176.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.545 ' HB1' ' HA2' ' A' ' 111' ' ' GLY . . . -69.92 -36.6 75.47 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.069 0.462 . . . . 0.0 110.388 176.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 10.0 m0 -60.26 -53.16 61.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.545 174.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 138' ' ' ARG . 34.9 ttp-105 -74.88 -59.13 2.87 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.213 -174.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -67.69 124.56 23.6 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.48 0.657 . . . . 0.0 111.177 -173.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.9 m -131.29 -12.29 3.56 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.166 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -81.35 -96.16 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 113.969 -1.469 . . . . 0.0 112.971 -169.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . 70.95 -59.25 0.55 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.828 0.851 . . . . 0.0 109.594 -167.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.454 ' HB2' ' CE1' ' A' ' 145' ' ' HIS . 0.9 OUTLIER -179.16 -41.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.527 -0.761 . . . . 0.0 108.961 172.451 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 59.49 36.19 88.34 Favored Glycine 0 C--N 1.332 0.334 0 CA-C-N 115.363 -0.835 . . . . 0.0 114.303 170.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.694 ' HA ' ' HB2' ' A' ' 148' ' ' HIS . 30.2 p-80 -151.91 10.58 0.55 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.49 0.645 . . . . 0.0 112.363 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -60.74 -33.63 73.21 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.957 0.408 . . . . 0.0 110.841 175.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -153.34 37.91 0.48 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.353 175.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' HIS . . . . . 0.694 ' HB2' ' HA ' ' A' ' 145' ' ' HIS . 3.2 t60 -63.29 -30.88 71.94 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -110.01 132.52 54.09 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.978 171.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 11.1 p80 . . . . . 0 C--N 1.317 -0.806 0 CA-C-O 117.444 -1.265 . . . . 0.0 109.438 174.394 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.439 ' HB3' ' OG1' ' A' ' 4' ' ' THR . 21.8 t70 . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.4 m -60.57 -29.04 68.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.817 0.341 . . . . 0.0 111.132 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.7 mttp -91.09 -46.19 8.26 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.959 0.885 . . . . 0.0 109.857 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.439 ' OG1' ' HB3' ' A' ' 1' ' ' ASP . 6.6 p -105.83 87.3 2.55 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 114.138 -1.392 . . . . 0.0 111.525 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.711 ' H ' HG13 ' A' ' 116' ' ' ILE . . . 59.74 100.87 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.506 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 175.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.613 ' HD3' HD11 ' A' ' 116' ' ' ILE . 27.5 Cg_exo -63.17 146.35 94.11 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.699 2.266 . . . . 0.0 111.169 173.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.45 114.58 22.02 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.868 -177.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 19' ' ' SER . 55.9 p90 -135.63 137.25 41.69 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.331 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.513 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 40.7 m -149.39 88.85 1.6 Allowed 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 173.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.417 ' H ' HD23 ' A' ' 10' ' ' LEU . 1.7 pt? -122.29 146.16 46.25 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.141 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 16.6 Cg_exo -68.25 137.2 39.59 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.285 1.99 . . . . 0.0 111.083 172.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.419 ' CG ' ' H ' ' A' ' 14' ' ' HIS . 0.8 OUTLIER -69.58 -179.29 1.68 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.943 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.548 HD21 HG21 ' A' ' 78' ' ' VAL . 2.9 pp -70.76 -9.2 56.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.741 0.305 . . . . 0.0 111.759 -176.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.419 ' H ' ' CG ' ' A' ' 12' ' ' ASP . 22.9 t-80 -92.24 -55.8 3.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.493 172.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 150.46 22.5 0.06 OUTLIER Glycine 0 CA--C 1.522 0.472 0 C-N-CA 120.06 -1.066 . . . . 0.0 114.175 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 41.1 tttm -105.8 126.24 51.93 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 117.445 0.623 . . . . 0.0 109.941 175.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 7.0 t -65.28 127.67 32.71 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.054 0.454 . . . . 0.0 109.79 174.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 9' ' ' SER . 46.8 t -111.12 124.57 68.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 8' ' ' PHE . 50.4 p -129.38 -175.11 3.47 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.216 -173.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -73.8 -23.97 59.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.928 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.78 -27.48 68.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.015 177.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -69.25 -24.44 63.99 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.484 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.693 HD13 HG21 ' A' ' 110' ' ' ILE . 38.5 mt -82.22 -44.1 16.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.23 -174.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -60.85 126.26 26.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.363 0.601 . . . . 0.0 111.208 -175.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.37 -25.3 10.59 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.639 -176.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.624 ' O ' ' HA ' ' A' ' 112' ' ' LYS . 65.9 mttm -131.72 175.44 9.19 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.988 0.423 . . . . 0.0 110.049 177.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 58.9 t -103.48 146.88 10.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 170.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.596 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 22.2 m -134.67 143.65 47.37 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 121.782 -0.574 . . . . 0.0 111.862 -170.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.675 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 53.8 tp -113.92 113.92 25.51 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 171.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.673 ' HB ' ' CG1' ' A' ' 108' ' ' VAL . 30.2 mt -96.82 112.13 28.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 175.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -111.49 130.66 55.65 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.28 0.562 . . . . 0.0 109.867 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.522 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 94.3 m-85 -98.69 119.24 37.08 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.755 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.657 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 7.7 p-90 -139.1 -177.36 4.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.859 -174.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.637 ' HB3' ' OE1' ' A' ' 66' ' ' GLN . 33.0 p90 -157.9 150.62 18.12 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.837 175.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.49 157.59 35.74 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.116 1.877 . . . . 0.0 110.862 173.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.2 m 65.33 17.61 11.05 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.98 0.419 . . . . 0.0 111.2 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 51.9 t -80.13 133.41 57.56 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.846 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 26.1 Cg_exo -63.72 -26.59 68.39 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.64 2.227 . . . . 0.0 111.557 174.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.58 -16.78 78.77 Favored Glycine 0 C--O 1.225 -0.465 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.659 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 48.9 t -57.81 -30.85 66.04 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 122.446 0.299 . . . . 0.0 111.673 -175.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.1 p -61.1 -33.15 54.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.156 0.503 . . . . 0.0 110.21 177.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.606 ' O ' ' HE3' ' A' ' 46' ' ' LYS . 15.2 m -89.11 -49.76 6.56 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.097 175.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.546 ' O ' HG12 ' A' ' 47' ' ' ILE . 41.9 mt-10 -59.27 -52.68 64.61 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.85 -172.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.682 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 41.1 tpp -59.21 -58.06 22.38 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.402 -170.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.682 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 50.4 Cg_exo -57.05 -36.86 99.43 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.088 1.859 . . . . 0.0 112.56 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.606 ' HE3' ' O ' ' A' ' 42' ' ' SER . 0.0 OUTLIER -65.3 -51.26 61.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.482 179.217 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.546 HG12 ' O ' ' A' ' 43' ' ' GLU . 49.5 mm -60.91 -42.2 91.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.152 -178.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.634 HD13 ' HE1' ' A' ' 85' ' ' PHE . 47.7 mm -54.6 -53.26 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.803 0.335 . . . . 0.0 110.861 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -67.73 -51.49 48.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.405 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.456 ' O ' ' HD2' ' A' ' 54' ' ' TYR . 89.2 m -58.51 -47.0 85.58 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.263 -177.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . -69.15 -24.29 64.06 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -177.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -68.85 -51.73 37.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.265 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -68.17 -52.64 32.27 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.607 0.718 . . . . 0.0 111.002 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 1.034 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 54.6 m-85 -64.58 -21.85 66.81 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.107 -173.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -53.95 -49.6 68.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.0 0.428 . . . . 0.0 110.752 179.82 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 -88.08 -18.58 28.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.426 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.463 ' HE3' ' HB2' ' A' ' 57' ' ' LYS . 4.5 tppp? -61.26 -71.88 0.13 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.055 176.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.54 ' HB3' ' CZ3' ' A' ' 137' ' ' TRP . 3.7 t-20 169.35 31.29 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 1.034 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 50.7 t80 -140.02 156.2 46.73 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.983 -171.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.452 ' O ' ' HA ' ' A' ' 28' ' ' THR . 10.6 pt20 -148.85 159.14 44.45 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.291 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 86.3 t -123.96 130.69 73.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.465 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.404 HD23 ' HB ' ' A' ' 86' ' ' THR . 85.6 mt -113.17 104.59 12.51 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.596 178.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.407 ' HB1' ' NE1' ' A' ' 33' ' ' TRP . . . -89.5 102.47 15.14 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.378 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 59.0 t -99.23 114.67 37.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.053 0.454 . . . . 0.0 110.444 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.657 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -86.17 134.44 33.79 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.722 175.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.637 ' OE1' ' HB3' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -100.78 163.93 17.13 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.622 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.621 ' HD2' ' HB2' ' A' ' 93' ' ' LYS . 33.0 Cg_endo -61.87 89.88 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.324 2.016 . . . . 0.0 113.365 -174.002 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 41.2 mm -130.82 -66.18 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 172.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.427 ' OD1' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -92.78 147.7 34.6 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 171.244 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.427 ' HD2' ' OD1' ' A' ' 69' ' ' ASP . 54.3 Cg_exo -53.78 158.51 8.32 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 122.656 2.238 . . . . 0.0 113.698 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.606 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 5.9 tp -56.52 -33.16 38.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.167 178.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.486 ' OE2' ' HD2' ' A' ' 75' ' ' ARG . 6.1 tp10 -64.25 -41.35 97.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.233 0.539 . . . . 0.0 110.222 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.5 m -60.14 -44.47 94.91 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.824 -177.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.46 ' O ' HG23 ' A' ' 78' ' ' VAL . 7.5 p -70.65 -33.62 53.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.852 -179.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.606 ' HG3' ' O ' ' A' ' 71' ' ' ILE . 98.7 mtt180 -55.29 -53.16 59.55 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.4 0.619 . . . . 0.0 110.327 175.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -63.66 -45.11 91.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.705 -176.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -55.4 -45.19 76.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.047 -176.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.657 ' HA ' HD22 ' A' ' 83' ' ' LEU . 86.1 t -64.36 -44.85 97.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.497 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.756 ' HA ' ' HE3' ' A' ' 79' ' ' LYS . 1.3 mmmt -76.96 -33.59 57.65 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.276 -0.57 . . . . 0.0 112.336 -175.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.94 -48.14 77.71 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 123.412 0.445 . . . . 0.0 110.909 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.457 ' HB2' ' CD1' ' A' ' 83' ' ' LEU . 80.8 m-85 -97.57 12.92 31.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.901 0.381 . . . . 0.0 111.18 -178.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.64 -60.49 4.35 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 121.103 -0.57 . . . . 0.0 113.029 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.657 HD22 ' HA ' ' A' ' 78' ' ' VAL . 10.2 mp 48.71 87.12 0.13 Allowed Pre-proline 0 N--CA 1.467 0.407 0 C-N-CA 123.756 0.822 . . . . 0.0 112.346 -177.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -79.27 44.52 1.71 Allowed 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.409 2.739 . . . . 0.0 112.953 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.634 ' HE1' HD13 ' A' ' 48' ' ' ILE . 21.1 p90 -152.27 157.5 41.48 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.404 ' HB ' HD23 ' A' ' 62' ' ' LEU . 18.7 m -74.78 117.9 17.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.96 0.409 . . . . 0.0 111.001 -174.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 36.0 t -110.2 126.62 67.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.577 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.415 ' SD ' ' HB ' ' A' ' 18' ' ' VAL . 76.0 mtm -119.13 167.73 11.53 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.626 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.426 ' HD1' ' HB3' ' A' ' 65' ' ' ALA . 78.2 t80 -138.56 117.18 12.17 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.559 ' OD2' HG22 ' A' ' 95' ' ' VAL . 43.9 t0 -92.13 128.72 38.08 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.68 -32.08 62.09 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -177.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' A' ' 93' ' ' LYS . 25.9 t70 -112.1 -11.88 13.75 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.795 0.331 . . . . 0.0 110.807 -175.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.621 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 33.8 ttmt 73.15 15.68 4.4 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.533 -177.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.83 -39.84 93.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.423 -173.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.559 HG22 ' OD2' ' A' ' 90' ' ' ASP . 27.0 m -70.85 -31.93 47.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.863 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -72.1 -34.09 61.79 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 174.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.462 ' HG3' ' O ' ' A' ' 93' ' ' LYS . 51.8 mt-30 -64.35 -29.16 70.24 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 122.554 0.342 . . . . 0.0 110.482 176.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.22 -38.87 65.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.02 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -80.44 -13.14 59.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.823 0.344 . . . . 0.0 111.158 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.01 45.6 5.34 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.938 176.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 56.9 p -75.7 89.54 2.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.172 0.51 . . . . 0.0 111.2 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -96.39 -52.52 3.94 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.251 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.451 ' HB ' ' CG2' ' A' ' 121' ' ' VAL . 47.1 t -106.73 134.68 47.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.613 177.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -105.1 145.83 31.5 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -75.95 165.41 85.57 Favored 'Cis proline' 0 C--N 1.342 0.227 0 C-N-CA 123.333 -1.528 . . . . 0.0 112.902 -0.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.7 m -124.19 133.67 53.48 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 176.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.532 ' HB3' HD11 ' A' ' 29' ' ' LEU . 25.0 m -127.47 110.57 12.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.863 0.363 . . . . 0.0 111.159 -175.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.673 ' CG1' ' HB ' ' A' ' 30' ' ' ILE . 12.3 p -106.97 138.54 32.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.972 0.415 . . . . 0.0 110.36 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.741 ' HB2' ' HB2' ' A' ' 118' ' ' LYS . 88.2 mt -102.01 124.52 47.76 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.268 0.556 . . . . 0.0 110.355 -177.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.693 HG21 HD13 ' A' ' 23' ' ' LEU . 18.7 mm -108.31 138.36 35.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.994 -174.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -86.22 -177.4 49.82 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.652 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.624 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 98.5 mttt -73.53 1.99 8.82 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.98 0.419 . . . . 0.0 111.557 -177.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 19.9 tptp -134.21 6.55 3.6 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.554 ' HA2' ' CG2' ' A' ' 110' ' ' ILE . . . 85.81 -104.41 2.85 Favored Glycine 0 N--CA 1.433 -1.543 0 CA-C-N 114.376 -1.283 . . . . 0.0 110.346 -172.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.5 ' H ' ' HB2' ' A' ' 5' ' ' ALA . 1.1 mm-40 52.72 -9.1 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.215 1.806 . . . . 0.0 115.772 174.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.711 HG13 ' H ' ' A' ' 5' ' ' ALA . 13.2 mt 68.17 115.43 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 122.969 0.508 . . . . 0.0 111.189 -178.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 79.6 mt -101.85 -48.14 4.37 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.183 0.516 . . . . 0.0 111.235 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.741 ' HB2' ' HB2' ' A' ' 109' ' ' LEU . 5.0 mmmm -146.48 155.13 42.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.777 -169.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 18.4 m -135.98 110.76 8.71 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.643 178.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -112.67 146.91 37.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.243 176.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.451 ' CG2' ' HB ' ' A' ' 103' ' ' VAL . 7.3 p -123.67 133.52 68.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.892 177.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 79.88 -140.37 22.34 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.921 -178.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -85.23 112.31 42.8 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -81.25 162.94 19.96 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.651 2.234 . . . . 0.0 113.256 -177.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.614 ' OD2' ' HB3' ' A' ' 128' ' ' LYS . 7.4 p-10 -75.5 76.9 2.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.308 177.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.41 ' CE2' ' HG2' ' A' ' 46' ' ' LYS . 18.4 m-85 -52.26 -40.41 61.66 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -175.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -57.91 -51.23 59.44 Favored Glycine 0 C--O 1.24 0.511 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.229 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.614 ' HB3' ' OD2' ' A' ' 125' ' ' ASP . 1.9 ttpm? -80.11 -18.75 49.03 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.676 ' O ' HG12 ' A' ' 133' ' ' ILE . 10.0 tt -70.95 -44.82 65.3 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 174.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -57.67 -55.59 32.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.665 0.269 . . . . 0.0 110.701 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.453 ' HG2' ' HA ' ' A' ' 128' ' ' LYS . 9.9 pt20 -61.69 -27.7 68.88 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.043 0.449 . . . . 0.0 110.988 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.454 ' OE2' ' HG3' ' A' ' 118' ' ' LYS . 32.0 tt0 -72.59 -42.86 64.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.555 178.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.676 HG12 ' O ' ' A' ' 129' ' ' LEU . 45.1 mm -69.65 -49.91 54.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.225 179.15 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.569 ' HA ' ' NE1' ' A' ' 137' ' ' TRP . 5.1 m-20 -64.48 -16.4 62.42 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.965 0.412 . . . . 0.0 111.411 -178.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.409 ' HA ' ' HE ' ' A' ' 138' ' ' ARG . 15.4 m -66.74 -29.11 69.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.958 0.408 . . . . 0.0 110.705 171.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.13 -18.2 64.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.464 -178.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.569 ' NE1' ' HA ' ' A' ' 134' ' ' ASP . 3.7 m95 -74.95 -38.42 61.73 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 174.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 138' ' ' ARG . 34.4 mtm105 -84.95 -60.01 2.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.099 -172.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 50.69 31.57 5.99 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.057 -177.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.8 m -105.14 17.36 24.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.605 0.717 . . . . 0.0 110.034 -176.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -83.75 36.56 0.55 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.831 -175.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.83 112.08 11.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.148 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 26.6 tp10 -96.19 24.15 5.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 122.038 0.923 . . . . 0.0 109.986 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -82.54 54.67 4.94 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.423 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 12.2 p-80 -69.77 142.42 53.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.982 0.42 . . . . 0.0 110.306 178.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -92.12 175.81 6.73 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.341 0.591 . . . . 0.0 111.477 -169.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 45.3 m80 -114.9 99.61 7.6 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 172.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -117.93 89.07 3.04 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.016 0.436 . . . . 0.0 111.676 -172.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 40.3 t60 -178.27 131.91 0.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.667 174.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 7.5 p80 . . . . . 0 C--O 1.246 0.921 0 CA-C-O 118.747 -0.645 . . . . 0.0 110.254 178.078 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.417 ' OD2' ' HG3' ' A' ' 3' ' ' LYS . 6.8 p-10 . . . . . 0 N--CA 1.481 1.124 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.4 p -61.96 -26.76 68.39 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -177.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.594 ' O ' ' HB ' ' A' ' 4' ' ' THR . 58.4 mttp -43.64 109.73 0.16 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.648 HG21 ' HB3' ' A' ' 20' ' ' ASN . 14.0 t 151.49 -25.17 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 O-C-N 124.702 1.251 . . . . 0.0 109.276 177.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.726 ' HB1' ' HD2' ' A' ' 6' ' ' PRO . . . 165.2 -159.72 0.0 OUTLIER Pre-proline 0 C--N 1.315 -0.904 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 -168.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.726 ' HD2' ' HB1' ' A' ' 5' ' ' ALA . 9.6 Cg_endo -57.89 163.69 9.06 Favored 'Trans proline' 0 C--N 1.347 0.498 0 CA-C-N 121.163 1.451 . . . . 0.0 109.394 154.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -52.29 104.75 0.09 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.089 0.471 . . . . 0.0 110.449 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -104.13 111.87 24.64 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 122.377 1.084 . . . . 0.0 112.621 -170.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.5 m -150.35 89.6 1.59 Allowed 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 113.388 -1.733 . . . . 0.0 108.102 171.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.526 ' HB3' ' HE2' ' A' ' 88' ' ' MET . 23.8 tp -120.65 139.17 28.48 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.855 -169.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 10' ' ' LEU . 8.4 Cg_exo -73.58 141.77 31.69 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.394 2.063 . . . . 0.0 111.556 172.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.458 ' CG ' ' H ' ' A' ' 14' ' ' HIS . 0.6 OUTLIER -87.35 -176.04 5.49 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 177.847 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.7 mt -73.01 -1.14 15.95 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -177.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.458 ' H ' ' CG ' ' A' ' 12' ' ' ASP . 67.7 m80 -109.92 8.61 24.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.997 0.427 . . . . 0.0 109.998 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.72 34.95 59.14 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.363 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 16' ' ' LYS . 28.5 mmtm -115.29 134.0 55.53 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 175.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.5 m -79.0 122.46 26.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.826 0.346 . . . . 0.0 110.506 -178.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.8 t -112.48 122.36 66.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 90.4 p -108.13 178.86 4.38 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.313 0.578 . . . . 0.0 110.713 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.648 ' HB3' HG21 ' A' ' 4' ' ' THR . 31.6 p-10 -76.17 -21.22 56.79 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.498 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.03 -28.91 69.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.715 175.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -73.6 -13.93 61.1 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.32 0.581 . . . . 0.0 110.583 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 61.6 mt -83.69 -48.29 10.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.186 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -56.25 150.84 13.68 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.254 0.55 . . . . 0.0 111.864 -175.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.25 -19.5 46.43 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -172.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.53 ' HZ3' ' HB2' ' A' ' 26' ' ' LYS . 4.4 mtmp? -135.39 167.92 20.15 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.154 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.428 HG21 ' CD1' ' A' ' 137' ' ' TRP . 35.2 t -108.04 140.52 26.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 175.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.451 HG23 ' HG3' ' A' ' 60' ' ' GLN . 29.9 m -134.32 140.86 46.67 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.013 0.435 . . . . 0.0 111.867 -171.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.464 HD11 ' HB3' ' A' ' 107' ' ' SER . 47.7 tp -113.85 115.45 27.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.305 173.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.852 HG12 ' HB2' ' A' ' 62' ' ' LEU . 46.2 mt -107.01 112.77 41.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.558 ' HA ' ' O ' ' A' ' 106' ' ' THR . 23.6 p-10 -113.9 129.39 56.6 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.246 0.546 . . . . 0.0 111.248 -178.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -83.09 128.74 34.75 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.048 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.592 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 5.5 p-90 -154.12 -175.71 5.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.49 -176.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.472 ' HB3' ' OE1' ' A' ' 66' ' ' GLN . 13.1 p90 -171.44 159.86 5.03 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.084 174.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' A' ' 34' ' ' PHE . 19.8 Cg_endo -62.86 156.25 55.07 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.119 1.879 . . . . 0.0 111.639 176.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.5 m 67.59 13.56 9.31 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.653 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 49.2 t -83.83 136.26 41.91 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.81 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.541 ' O ' HG12 ' A' ' 41' ' ' VAL . 35.9 Cg_exo -60.13 -25.83 80.9 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.615 2.21 . . . . 0.0 112.25 176.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.21 -13.7 65.17 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 121.228 -0.51 . . . . 0.0 113.145 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 88.1 m -63.25 -30.79 71.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.783 0.292 . . . . 0.0 111.684 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.541 HG12 ' O ' ' A' ' 38' ' ' PRO . 14.6 p -65.39 -37.55 80.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.814 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.447 ' O ' ' HE2' ' A' ' 46' ' ' LYS . 22.8 m -87.11 -56.6 3.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.997 0.427 . . . . 0.0 111.284 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.514 ' HA ' ' HE2' ' A' ' 46' ' ' LYS . 74.4 mm-40 -69.99 -41.55 74.26 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.205 0.816 . . . . 0.0 113.205 -169.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.73 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 39.6 tpp -49.32 -59.96 5.66 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -169.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.73 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 31.2 Cg_exo -58.74 -44.3 37.48 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 121.84 1.693 . . . . 0.0 112.27 -178.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.514 ' HE2' ' HA ' ' A' ' 43' ' ' GLU . 45.1 mtmt -60.2 -51.3 70.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.442 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.6 mm -62.64 -38.3 81.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.367 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.578 HG12 ' O ' ' A' ' 44' ' ' MET . 30.4 mm -54.91 -54.02 27.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 116.807 -0.179 . . . . 0.0 110.956 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.573 ' NZ ' ' HB2' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -75.48 -38.77 59.34 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 119.659 -0.817 . . . . 0.0 110.815 -178.628 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.557 ' O ' ' HD2' ' A' ' 54' ' ' TYR . 91.6 m -58.39 -44.85 89.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.826 0.346 . . . . 0.0 110.811 -178.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.0 -44.65 79.81 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.127 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -67.26 -50.45 60.48 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.747 0.308 . . . . 0.0 111.088 -178.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.63 -45.38 73.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.257 0.551 . . . . 0.0 111.035 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 1.07 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 50.6 m-85 -82.28 -26.24 33.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.308 -174.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.475 ' NZ ' ' HB3' ' A' ' 60' ' ' GLN . 18.0 tppt? -61.93 -32.45 72.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.899 0.381 . . . . 0.0 110.117 176.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -84.76 45.84 1.19 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.464 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.472 ' HE2' ' HA ' ' A' ' 54' ' ' TYR . 9.0 pttm -166.07 -58.48 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.681 170.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.479 ' OD1' ' HG2' ' A' ' 26' ' ' LYS . 59.7 t30 176.46 38.06 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 120.989 0.424 . . . . 0.0 111.521 -177.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 1.07 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 44.4 t80 -138.5 157.42 46.22 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 122.003 -0.435 . . . . 0.0 109.828 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.475 ' HB3' ' NZ ' ' A' ' 55' ' ' LYS . 11.1 pt20 -152.16 152.33 32.15 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.935 0.398 . . . . 0.0 110.985 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 90.2 t -117.96 126.19 74.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.669 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.852 ' HB2' HG12 ' A' ' 30' ' ' ILE . 86.1 mt -112.13 106.46 15.09 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.484 ' HB1' ' CD1' ' A' ' 33' ' ' TRP . . . -90.85 105.86 18.12 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.682 -176.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 91.9 t -90.44 115.86 30.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.936 0.398 . . . . 0.0 110.716 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.592 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -88.0 111.27 21.32 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.791 176.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.632 ' HA ' ' HB3' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -83.17 163.04 52.35 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.015 -177.29 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.578 ' HD2' ' HB2' ' A' ' 66' ' ' GLN . 57.1 Cg_endo -69.62 97.35 0.62 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.352 2.035 . . . . 0.0 113.073 -171.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 52.6 mt -141.19 -65.05 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.332 173.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.34 144.42 30.9 Favored Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 166.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.95 152.56 23.11 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.442 2.095 . . . . 0.0 112.471 178.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.61 ' HA ' HG22 ' A' ' 74' ' ' VAL . 12.8 tt -58.38 -23.24 21.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.021 176.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -65.83 -45.13 83.41 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.613 174.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.4 m -59.77 -41.13 90.41 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.506 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.61 HG22 ' HA ' ' A' ' 71' ' ' ILE . 13.0 m -68.85 -33.91 61.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.972 -177.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.681 ' HA ' HG22 ' A' ' 78' ' ' VAL . 76.2 mtt180 -70.69 -39.88 73.24 Favored 'General case' 0 C--O 1.22 -0.488 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 174.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -61.31 -37.45 83.3 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -63.35 -53.8 46.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.206 176.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.681 HG22 ' HA ' ' A' ' 75' ' ' ARG . 35.0 m -63.4 -27.26 42.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.996 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 75' ' ' ARG . 5.6 mmmp? -75.69 -40.16 56.27 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -73.3 -49.63 26.53 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.659 0.599 . . . . 0.0 111.798 -172.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -88.58 -1.89 58.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.493 -174.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 58.03 51.2 59.72 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.257 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.531 ' CD1' ' HA ' ' A' ' 78' ' ' VAL . 1.2 mp -74.61 117.06 59.24 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 121.011 0.434 . . . . 0.0 111.151 -175.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.59 -28.37 4.39 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.28 2.654 . . . . 0.0 114.415 -172.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -71.3 146.39 48.91 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.402 -178.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.431 ' HB ' HD23 ' A' ' 62' ' ' LEU . 12.3 m -70.4 113.42 7.52 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.453 -172.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.9 t -99.41 132.58 44.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.244 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.526 ' HE2' ' HB3' ' A' ' 10' ' ' LEU . 60.3 mtp -118.65 164.71 14.93 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.513 -0.767 . . . . 0.0 108.964 -177.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -120.6 129.35 53.71 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.283 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.795 ' OD2' ' HA ' ' A' ' 93' ' ' LYS . 10.7 t0 -102.07 115.75 31.21 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.322 177.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.15 -47.46 24.23 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -172.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -115.04 -10.96 12.17 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -169.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.795 ' HA ' ' OD2' ' A' ' 90' ' ' ASP . 34.9 ttmt 68.63 18.65 8.78 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 122.826 0.45 . . . . 0.0 111.506 177.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.03 -33.95 76.65 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.589 -0.694 . . . . 0.0 109.65 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.8 p -63.39 -47.63 90.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.723 172.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.92 -36.81 93.53 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.207 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -64.59 -30.48 71.51 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 122.542 0.337 . . . . 0.0 111.016 178.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.492 ' HB3' ' HG3' ' A' ' 6' ' ' PRO . . . -67.63 -34.2 76.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.935 0.398 . . . . 0.0 110.451 176.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.533 ' HB2' HG23 ' A' ' 101' ' ' THR . 65.4 m-85 -83.21 -17.9 41.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.031 174.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.8 31.76 38.97 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.942 -175.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.533 HG23 ' HB2' ' A' ' 99' ' ' PHE . 78.1 p -78.36 91.11 4.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.538 0.685 . . . . 0.0 111.98 -175.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 73.6 mm-40 -108.95 -26.39 10.24 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 171.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.5 m -109.18 140.48 27.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.527 174.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.569 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 37.2 m-85 -127.87 160.61 60.32 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.373 -173.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.569 ' HA ' ' HB3' ' A' ' 104' ' ' TYR . 87.3 Cg_endo -78.95 166.52 79.06 Favored 'Cis proline' 0 C--N 1.347 0.484 0 C-N-CA 123.866 -1.306 . . . . 0.0 113.269 0.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.558 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 22.1 m -126.03 120.47 30.35 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.99 175.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.464 ' HB3' HD11 ' A' ' 29' ' ' LEU . 33.9 m -107.89 113.17 26.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.009 0.433 . . . . 0.0 111.496 -174.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.601 HG22 HG23 ' A' ' 119' ' ' THR . 45.8 t -105.54 129.19 58.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.377 -178.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.569 ' HB2' ' HB3' ' A' ' 118' ' ' LYS . 96.5 mt -102.74 126.25 49.78 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.466 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 65.7 mt -116.87 125.36 73.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.086 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.473 ' H ' HD23 ' A' ' 117' ' ' LEU . . . -72.84 177.63 41.26 Favored Glycine 0 N--CA 1.453 -0.224 0 CA-C-N 115.896 -0.593 . . . . 0.0 113.21 -175.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 7.2 ptpp? -68.48 -6.2 23.7 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -175.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.846 ' HE3' ' HB3' ' A' ' 143' ' ' GLU . 7.7 ptmm? -105.97 6.99 31.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.684 0.278 . . . . 0.0 110.438 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.33 70.68 1.01 Allowed Glycine 0 C--O 1.225 -0.449 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 -177.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.577 ' CA ' ' HA ' ' A' ' 4' ' ' THR . 23.2 tt0 -153.72 165.21 36.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.551 0.215 . . . . 0.0 110.466 -174.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 86.7 mt -72.97 103.32 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.087 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.473 HD23 ' H ' ' A' ' 111' ' ' GLY . 3.1 mm? -97.92 -44.05 6.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.615 177.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.569 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -163.18 152.51 14.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.839 0.352 . . . . 0.0 111.872 -175.775 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.601 HG23 HG22 ' A' ' 108' ' ' VAL . 38.0 m -138.77 102.93 4.7 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.845 168.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -79.54 138.38 37.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.653 174.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.3 p -103.86 114.99 44.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 173.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 94.13 -157.91 22.88 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.889 -177.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -80.59 119.73 77.12 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 120.72 0.295 . . . . 0.0 110.681 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -87.56 151.47 7.63 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.818 2.345 . . . . 0.0 112.716 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.96 127.86 33.02 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.583 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 7.6 m-85 -71.57 -18.8 62.22 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -176.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -68.23 -54.48 16.7 Favored Glycine 0 C--O 1.238 0.367 0 C-N-CA 120.096 -1.049 . . . . 0.0 111.648 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.455 ' HE3' ' HB3' ' A' ' 128' ' ' LYS . 5.2 ttpp -74.87 -20.82 59.57 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 176.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.583 ' HB3' ' HA ' ' A' ' 126' ' ' PHE . 63.0 tp -65.7 -48.02 73.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.049 175.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 14.9 m-30 -61.56 -52.72 63.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.263 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -65.92 -27.54 68.26 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.863 0.363 . . . . 0.0 111.909 -177.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -80.02 -37.26 34.49 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.184 -0.323 . . . . 0.0 110.428 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 129' ' ' LEU . 51.2 mt -65.64 -48.49 82.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.717 176.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.425 ' CG ' HH21 ' A' ' 138' ' ' ARG . 0.0 OUTLIER -64.67 -25.37 67.92 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 -177.962 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.459 ' HA ' ' HG2' ' A' ' 138' ' ' ARG . 68.7 m -60.99 -43.69 98.49 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.067 0.461 . . . . 0.0 110.145 173.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.52 -23.86 64.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.637 178.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.79 ' HZ2' ' HB2' ' A' ' 59' ' ' PHE . 14.3 m95 -78.13 -54.36 6.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.098 175.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.459 ' HG2' ' HA ' ' A' ' 135' ' ' THR . 5.0 ptp180 -65.63 -36.16 82.89 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.745 -173.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -71.19 102.78 2.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.725 0.298 . . . . 0.0 110.434 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.8 p -71.49 -76.02 0.12 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.281 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -112.21 53.63 0.73 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.901 -176.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.94 -35.29 80.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.381 0.61 . . . . 0.0 109.804 175.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.846 ' HB3' ' HE3' ' A' ' 113' ' ' LYS . 0.7 OUTLIER -118.37 172.56 7.37 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 177.542 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.572 ' H ' ' CD ' ' A' ' 143' ' ' GLU . . . 98.04 19.57 23.59 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -174.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 18.6 m170 -91.76 14.44 15.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.023 -0.588 . . . . 0.0 110.916 -174.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -68.96 -9.46 52.26 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.967 0.413 . . . . 0.0 110.592 -178.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -78.06 -5.53 51.77 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.375 0.607 . . . . 0.0 110.06 175.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 73.3 m-70 -125.53 144.26 50.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.892 175.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 21.0 p80 -155.73 161.73 40.66 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.623 178.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 54.4 p-80 . . . . . 0 C--O 1.245 0.846 0 CA-C-O 118.588 -0.72 . . . . 0.0 109.641 -179.92 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 . . . . . 0 N--CA 1.482 1.168 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.3 m 53.17 72.71 0.41 Allowed 'General case' 0 C--O 1.235 0.331 0 O-C-N 123.571 0.544 . . . . 0.0 109.642 -175.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.525 ' HE2' HD12 ' A' ' 116' ' ' ILE . 14.7 mmmm 67.27 -168.84 0.2 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.834 -166.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.502 HG21 ' H ' ' A' ' 147' ' ' HIS . 12.4 m 60.9 18.5 8.85 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.216 0.531 . . . . 0.0 110.821 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 68.13 150.06 0.12 Allowed Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.293 -176.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.543 ' HG3' ' HA ' ' A' ' 95' ' ' VAL . 69.6 Cg_endo -88.96 178.88 2.56 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.435 2.09 . . . . 0.0 111.309 175.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.95 83.73 7.46 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 172.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -110.56 112.93 25.16 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.596 0.712 . . . . 0.0 111.319 -173.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.4 m -96.15 90.04 5.36 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 169.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.483 HD12 ' HD2' ' A' ' 11' ' ' PRO . 29.7 tp -102.73 123.35 42.75 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.259 -169.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.542 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 8.4 Cg_exo -72.96 147.06 42.94 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.819 2.346 . . . . 0.0 112.222 176.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.08 -177.91 5.3 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 174.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.3 mt -63.5 -22.73 67.05 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -177.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -89.22 -54.53 4.06 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.053 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.22 18.25 0.05 OUTLIER Glycine 0 CA--C 1.523 0.548 0 C-N-CA 119.61 -1.281 . . . . 0.0 114.683 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 11' ' ' PRO . 51.2 mttt -92.0 140.39 29.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 118.026 0.913 . . . . 0.0 110.119 174.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.6 m -88.26 122.36 31.7 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.1 0.476 . . . . 0.0 111.397 -177.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.0 t -107.25 132.66 54.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.737 174.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -140.81 -177.3 5.01 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.44 -173.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -58.21 -23.33 55.32 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.702 -176.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.86 -27.92 69.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.483 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -83.04 -19.59 36.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.148 0.499 . . . . 0.0 110.541 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.632 ' HB3' ' HA2' ' A' ' 114' ' ' GLY . 9.3 mp -83.53 -20.08 34.52 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.306 -176.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -95.74 134.58 38.5 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.063 0.459 . . . . 0.0 110.942 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.97 -7.13 82.28 Favored Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.752 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.582 ' HG2' ' OD1' ' A' ' 58' ' ' ASN . 29.9 mtpp -129.61 168.19 16.81 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -103.25 130.93 52.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 174.956 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.475 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 21.0 m -133.26 146.41 51.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.98 0.419 . . . . 0.0 112.057 -166.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.519 HD21 ' HB3' ' A' ' 107' ' ' SER . 8.0 tt -131.73 124.22 29.3 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 174.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.823 ' HB ' HG12 ' A' ' 108' ' ' VAL . 45.0 mm -109.89 125.35 67.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -109.38 112.87 25.24 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -84.79 119.57 25.45 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.593 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 4.2 p-90 -154.32 177.11 11.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.2 0.524 . . . . 0.0 111.484 -176.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.63 ' HB3' ' OE1' ' A' ' 66' ' ' GLN . 9.3 p90 -148.81 136.32 10.99 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.602 172.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 34' ' ' PHE . 44.8 Cg_exo -59.59 -15.71 32.46 Favored 'Trans proline' 0 N--CA 1.475 0.396 0 C-N-CA 123.421 2.747 . . . . 0.0 114.414 -173.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.4 p -95.45 13.81 24.72 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 122.017 -0.427 . . . . 0.0 111.991 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.446 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 25.0 p -88.37 146.0 36.88 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.854 0.359 . . . . 0.0 111.375 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 5.8 Cg_exo -79.09 -8.68 15.41 Favored 'Trans proline' 0 CA--C 1.532 0.406 0 C-N-CA 123.119 2.546 . . . . 0.0 113.011 176.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -86.18 -61.27 1.67 Allowed Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.676 -173.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' A' ' 33' ' ' TRP . 82.0 m -52.06 -30.06 24.05 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -169.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.8 p -56.12 -24.52 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.112 0.482 . . . . 0.0 111.16 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.657 ' HB2' ' OE2' ' A' ' 43' ' ' GLU . 1.7 m -86.23 -45.15 11.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.952 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.657 ' OE2' ' HB2' ' A' ' 42' ' ' SER . 3.9 mp0 -80.13 -33.36 38.65 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -174.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.596 ' O ' HG12 ' A' ' 48' ' ' ILE . 13.2 ptp -57.43 -38.9 72.83 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -166.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.56 ' HD3' ' CG ' ' A' ' 44' ' ' MET . 47.2 Cg_exo -58.28 -43.94 42.68 Favored 'Trans proline' 0 C--N 1.361 1.225 0 CA-C-N 121.749 1.66 . . . . 0.0 111.797 175.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -59.16 -38.09 78.91 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.483 176.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.2 mt -68.52 -36.42 74.62 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.4 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.733 177.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.596 HG12 ' O ' ' A' ' 44' ' ' MET . 47.2 mm -53.57 -55.49 13.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-O 120.799 0.333 . . . . 0.0 110.32 -175.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -75.86 -53.74 7.98 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.272 -177.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.8 m -58.01 -45.03 87.52 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -174.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.509 ' HB1' HG21 ' A' ' 61' ' ' VAL . . . -70.03 -36.05 74.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.874 -0.148 . . . . 0.0 111.32 -178.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -68.78 -45.43 71.36 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.017 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -59.77 -27.28 66.4 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.779 176.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.48 ' O ' ' HB3' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -87.18 -39.48 15.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.946 -179.649 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.409 ' C ' ' HD2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -60.07 -31.27 69.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.296 -175.978 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -80.34 37.54 0.39 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -174.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.57 65.84 0.21 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.073 0.463 . . . . 0.0 111.068 172.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.582 ' OD1' ' HG2' ' A' ' 26' ' ' LYS . 66.9 t30 66.1 11.0 7.5 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.525 176.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.495 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 43.9 t80 -105.57 148.69 27.0 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -141.4 126.33 18.22 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.135 0.493 . . . . 0.0 111.506 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.509 HG21 ' HB1' ' A' ' 51' ' ' ALA . 58.2 t -106.07 117.39 51.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.686 177.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.5 mp -120.2 117.82 28.87 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.017 0.437 . . . . 0.0 110.227 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.442 ' O ' ' HA ' ' A' ' 87' ' ' VAL . . . -94.22 114.26 26.33 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.839 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.3 p -101.23 119.95 50.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.353 0.596 . . . . 0.0 111.137 -176.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.593 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -89.59 129.68 36.01 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.447 175.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.63 ' OE1' ' HB3' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -104.74 165.88 12.5 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.594 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.621 ' HD3' ' O ' ' A' ' 90' ' ' ASP . 57.7 Cg_endo -70.83 80.15 1.21 Allowed 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.291 1.994 . . . . 0.0 113.525 -169.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 70.6 mt -120.78 -43.9 2.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 172.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.451 ' OD1' ' HD2' ' A' ' 35' ' ' PRO . 5.3 p-10 -121.78 141.43 33.84 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 163.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 69' ' ' ASP . 36.4 Cg_exo -57.66 158.33 20.35 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.056 2.504 . . . . 0.0 113.176 -174.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.618 ' O ' ' HG2' ' A' ' 75' ' ' ARG . 13.1 tt -53.69 -28.35 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.288 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.571 ' HA ' ' CG ' ' A' ' 75' ' ' ARG . 22.6 tp10 -64.16 -36.75 85.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.117 0.484 . . . . 0.0 110.958 178.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.0 t -68.71 -34.96 76.52 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 178.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.48 ' O ' HG23 ' A' ' 78' ' ' VAL . 24.0 t -60.35 -44.38 95.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.216 173.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.618 ' HG2' ' O ' ' A' ' 71' ' ' ILE . 14.1 mmt180 -52.83 -51.93 59.03 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.751 0.786 . . . . 0.0 109.601 176.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -61.47 -42.04 98.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.157 -1.383 . . . . 0.0 111.781 -175.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -70.99 -43.21 68.47 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.076 -176.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.554 HG13 ' HB2' ' A' ' 83' ' ' LEU . 80.1 t -59.89 -43.84 93.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.341 -177.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -74.0 -28.57 61.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.662 0.268 . . . . 0.0 111.348 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -73.37 -48.58 32.99 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.352 -175.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -97.42 -2.77 41.47 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -177.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 64.44 64.08 3.85 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.555 178.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.554 ' HB2' HG13 ' A' ' 78' ' ' VAL . 10.3 mp -79.67 115.34 52.95 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-O 120.644 0.259 . . . . 0.0 110.914 -178.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.423 ' CD ' HD12 ' A' ' 48' ' ' ILE . 93.4 Cg_endo -89.6 -21.45 1.09 Allowed 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.004 2.469 . . . . 0.0 113.568 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -76.19 155.56 34.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.799 0.333 . . . . 0.0 110.503 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 29.5 m -73.41 121.19 20.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.344 -175.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 63' ' ' ALA . 38.9 t -109.42 138.7 35.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.677 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 71.6 mtm -122.25 171.29 9.13 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 176.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -139.47 115.24 10.1 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.545 -0.169 . . . . 0.0 110.545 -178.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.621 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 13.3 t70 -107.83 127.53 53.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.898 0.38 . . . . 0.0 110.793 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.48 -28.12 56.35 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -175.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -112.65 -12.96 13.34 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -165.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.4 ' HG2' ' HB2' ' A' ' 66' ' ' GLN . 57.0 mtpt 69.42 7.63 6.34 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 122.739 0.415 . . . . 0.0 110.978 178.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.35 -32.53 70.19 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.246 0.546 . . . . 0.0 110.192 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.543 ' HA ' ' HG3' ' A' ' 6' ' ' PRO . 2.0 p -60.43 -49.8 82.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.42 173.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -67.18 -33.67 83.69 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.938 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -58.82 -51.65 69.11 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 122.653 0.381 . . . . 0.0 111.485 177.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.79 -29.67 62.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.888 -177.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.728 ' HA ' HD11 ' A' ' 116' ' ' ILE . 17.2 m-85 -76.35 -27.79 56.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.753 0.311 . . . . 0.0 111.093 177.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.36 46.43 4.67 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.785 -0.722 . . . . 0.0 111.718 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 24.5 m -118.43 99.35 6.77 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.981 0.42 . . . . 0.0 111.158 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -91.82 -48.78 6.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.9 176.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 9.2 p -100.4 159.44 3.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.327 -174.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.431 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 34.1 m-85 -135.49 156.85 77.45 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -175.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.437 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 89.4 Cg_endo -85.16 141.59 32.38 Favored 'Cis proline' 0 C--N 1.347 0.478 0 C-N-CA 123.524 -1.449 . . . . 0.0 112.725 -0.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 89.5 m -129.77 129.98 44.79 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.379 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.519 ' HB3' HD21 ' A' ' 29' ' ' LEU . 14.0 m -111.79 131.92 55.02 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.148 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.823 HG12 ' HB ' ' A' ' 30' ' ' ILE . 8.3 p -105.97 142.77 18.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 120.887 0.375 . . . . 0.0 109.995 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.751 HD21 HD11 ' A' ' 129' ' ' LEU . 66.5 mt -103.86 127.86 51.35 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.779 177.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.496 HD13 HD23 ' A' ' 23' ' ' LEU . 72.5 mt -115.62 127.38 73.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.859 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.63 -97.84 0.01 OUTLIER Glycine 0 C--N 1.334 0.44 0 O-C-N 123.953 0.783 . . . . 0.0 112.716 -177.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.484 ' HG2' ' OE2' ' A' ' 143' ' ' GLU . 8.8 ptpp? -150.97 13.27 0.69 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.011 0.434 . . . . 0.0 110.649 176.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 49.1 mttp -111.9 -3.11 14.96 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.48 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.632 ' HA2' ' HB3' ' A' ' 23' ' ' LEU . . . 76.65 42.45 21.54 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.654 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.428 ' CD ' ' H ' ' A' ' 146' ' ' HIS . 10.7 pt-20 -139.14 165.15 27.92 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.741 0.305 . . . . 0.0 110.335 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.728 HD11 ' HA ' ' A' ' 99' ' ' PHE . 59.5 mt -69.74 116.69 11.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.667 -177.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 19.5 tp -105.71 -51.65 2.96 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.283 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.608 ' HB2' ' HB2' ' A' ' 109' ' ' LEU . 3.1 mmmm -139.56 169.65 17.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.091 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 23.2 m -148.88 129.62 14.16 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.767 0.318 . . . . 0.0 110.746 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -126.29 118.49 25.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.771 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.7 p -110.99 139.67 33.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.762 -178.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 73.52 66.71 1.95 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.093 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 65.48 116.21 0.02 OUTLIER Pre-proline 0 N--CA 1.464 0.264 0 C-N-CA 123.45 0.7 . . . . 0.0 111.805 -175.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.75 117.76 3.69 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.181 1.92 . . . . 0.0 111.633 174.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 129' ' ' LEU . 14.5 t70 -61.49 105.58 0.54 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 175.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -64.49 -31.65 72.96 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -171.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.473 ' HA2' ' CZ ' ' A' ' 130' ' ' TYR . . . -58.86 -54.07 41.01 Favored Glycine 0 C--O 1.238 0.371 0 C-N-CA 120.371 -0.918 . . . . 0.0 111.661 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.591 ' HA ' ' HG2' ' A' ' 131' ' ' GLN . 35.7 mtmm -76.16 -17.95 59.33 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.657 0.265 . . . . 0.0 110.637 177.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.751 HD11 HD21 ' A' ' 109' ' ' LEU . 18.6 tp -69.17 -51.22 40.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.662 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.479 ' HB3' ' HE2' ' A' ' 54' ' ' TYR . 2.0 p90 -73.94 -33.94 64.12 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 119.579 -0.848 . . . . 0.0 112.249 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.591 ' HG2' ' HA ' ' A' ' 128' ' ' LYS . 3.3 pt20 -68.47 -30.73 69.65 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.79 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -76.12 -45.33 34.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.7 177.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 129' ' ' LEU . 78.0 mt -63.54 -38.88 83.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.628 178.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.594 ' O ' ' HG2' ' A' ' 138' ' ' ARG . 12.3 t70 -56.65 -40.26 75.16 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.01 0.433 . . . . 0.0 110.218 176.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 89.6 m -58.32 -35.28 71.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.657 177.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.759 ' HA ' ' ND2' ' A' ' 139' ' ' ASN . . . -75.72 -17.92 59.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.198 178.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.442 ' HB2' ' O ' ' A' ' 134' ' ' ASP . 11.7 m0 -74.03 -35.12 64.33 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 171.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.594 ' HG2' ' O ' ' A' ' 134' ' ' ASP . 20.7 mmt180 -84.82 -30.87 24.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.367 -174.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.759 ' ND2' ' HA ' ' A' ' 136' ' ' ALA . 37.5 p30 -69.76 131.52 44.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.815 0.817 . . . . 0.0 111.437 -175.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.9 m -89.73 92.0 8.87 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.293 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 33.2 t70 73.64 -26.41 0.19 Allowed 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.77 175.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -73.01 76.43 1.2 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.098 0.475 . . . . 0.0 111.77 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.484 ' OE2' ' HG2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -155.54 -57.15 0.1 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.193 175.813 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -126.83 167.55 19.24 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.486 174.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -158.2 17.02 0.22 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.827 0.313 . . . . 0.0 110.86 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.428 ' H ' ' CD ' ' A' ' 115' ' ' GLU . 31.6 m170 63.33 103.76 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.704 0.802 . . . . 0.0 112.998 176.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' HIS . . . . . 0.502 ' H ' HG21 ' A' ' 4' ' ' THR . 1.7 t-160 71.67 -7.46 1.23 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.24 175.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -88.56 -24.42 22.88 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 172.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -94.98 117.48 30.22 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 174.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 35.9 m-70 . . . . . 0 C--O 1.245 0.823 0 CA-C-O 118.567 -0.73 . . . . 0.0 110.795 -175.474 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.534 ' O ' ' HB1' ' A' ' 98' ' ' ALA . 26.0 t0 . . . . . 0 N--CA 1.483 1.178 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.722 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 50.0 m -86.53 126.46 34.47 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -173.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.527 ' HA ' HG13 ' A' ' 116' ' ' ILE . 2.5 mppt? 68.62 139.56 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 171.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.646 ' H ' HG12 ' A' ' 116' ' ' ILE . 11.1 m 71.93 17.37 5.28 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.701 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.518 ' N ' ' HD3' ' A' ' 6' ' ' PRO . . . 49.1 56.55 18.15 Favored Pre-proline 0 N--CA 1.468 0.432 0 CA-C-N 115.076 -0.966 . . . . 0.0 112.918 177.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.518 ' HD3' ' N ' ' A' ' 5' ' ' ALA . 15.9 Cg_exo -70.4 106.7 1.83 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.827 2.351 . . . . 0.0 112.766 -177.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 48.63 88.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 O-C-N 124.552 1.157 . . . . 0.0 113.121 173.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.508 ' CE1' ' HB1' ' A' ' 5' ' ' ALA . 7.0 p90 -148.59 143.85 26.85 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.099 175.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.3 m -149.0 98.33 2.82 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 175.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.559 HD12 ' HD2' ' A' ' 11' ' ' PRO . 25.4 tp -114.39 126.87 27.42 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.196 -175.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.559 ' HD2' HD12 ' A' ' 10' ' ' LEU . 50.1 Cg_endo -70.17 150.53 65.84 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.388 2.059 . . . . 0.0 112.405 177.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.466 ' CG ' ' H ' ' A' ' 14' ' ' HIS . 0.8 OUTLIER -81.49 -174.26 4.86 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 176.277 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.735 HD13 ' HA ' ' A' ' 75' ' ' ARG . 70.4 mt -69.98 -16.36 63.18 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.466 ' H ' ' CG ' ' A' ' 12' ' ' ASP . 33.7 t-80 -87.98 -42.75 12.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.712 176.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.37 12.07 1.11 Allowed Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.294 177.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 11' ' ' PRO . 66.3 tttt -86.77 116.18 24.7 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 177.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 8.9 t -69.33 123.54 21.48 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.318 0.58 . . . . 0.0 109.617 175.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.501 ' HB ' ' CE ' ' A' ' 88' ' ' MET . 53.9 t -112.87 126.95 70.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.273 -177.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.419 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 61.0 p -132.32 -176.22 4.01 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.254 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -62.03 -23.29 66.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.072 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.03 -30.63 70.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.948 0.404 . . . . 0.0 110.837 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -82.45 -25.03 33.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.043 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.765 HD21 HD11 ' A' ' 62' ' ' LEU . 70.2 mt -83.19 -48.34 10.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.125 -175.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.616 ' HA ' ' H ' ' A' ' 113' ' ' LYS . 18.1 pt20 -51.22 144.31 9.69 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.384 0.611 . . . . 0.0 112.602 -171.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.67 -24.71 22.28 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.298 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.508 ' NZ ' ' HB2' ' A' ' 26' ' ' LYS . 7.7 mtmp? -121.96 171.29 9.05 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 14.1 t -101.9 140.47 20.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -178.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.585 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 17.0 m -131.78 145.65 51.71 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.139 0.495 . . . . 0.0 111.871 -171.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.677 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 6.2 tt -121.98 114.01 20.38 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 172.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.679 ' HB ' ' CG2' ' A' ' 108' ' ' VAL . 36.0 mt -98.54 112.6 31.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -118.21 121.21 39.91 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.569 0.223 . . . . 0.0 110.47 -178.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -92.73 119.77 32.44 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.561 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.49 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 10.5 p-90 -141.73 -176.36 4.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.142 -175.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -168.92 156.64 7.13 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 175.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.614 ' HD3' HG12 ' A' ' 74' ' ' VAL . 33.1 Cg_exo -59.68 158.92 26.2 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.544 2.163 . . . . 0.0 112.326 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 81.6 p 60.77 11.05 2.97 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.031 0.932 . . . . 0.0 112.141 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.731 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 34.6 t -72.96 129.96 85.75 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 177.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.69 -20.73 66.68 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.965 2.443 . . . . 0.0 112.461 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.82 -19.47 61.43 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.755 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.907 ' HA ' ' HG2' ' A' ' 43' ' ' GLU . 93.6 m -63.33 -30.78 71.85 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -174.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.3 m -64.16 -29.07 46.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.111 0.481 . . . . 0.0 110.417 177.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.519 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 29.4 t -88.94 -56.09 3.43 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.21 176.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.907 ' HG2' ' HA ' ' A' ' 40' ' ' CYS . 17.1 pt-20 -64.6 -50.14 68.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.092 -0.503 . . . . 0.0 112.043 -170.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.653 ' O ' HG12 ' A' ' 48' ' ' ILE . 33.5 ttm -57.87 -55.08 48.74 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -167.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.56 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 52.7 Cg_exo -53.35 -47.35 27.86 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.899 1.733 . . . . 0.0 112.433 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.519 ' HD3' ' O ' ' A' ' 42' ' ' SER . 23.9 mtpt -64.41 -40.04 95.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.09 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.471 HG12 ' O ' ' A' ' 43' ' ' GLU . 29.6 mm -64.31 -37.65 80.49 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.307 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.9 177.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.653 HG12 ' O ' ' A' ' 44' ' ' MET . 50.4 mm -54.67 -50.6 58.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 121.296 0.569 . . . . 0.0 109.939 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -67.69 -53.62 26.12 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.16 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 14.4 p -62.02 -54.69 38.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.912 -176.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.12 -39.0 91.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.841 -174.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -71.55 -35.36 70.61 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.411 -174.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -77.1 -48.53 17.52 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.299 -0.561 . . . . 0.0 110.463 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.751 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 25.6 m-85 -62.68 -27.77 69.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.801 0.334 . . . . 0.0 110.939 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.545 ' HA ' ' O ' ' A' ' 59' ' ' PHE . 36.9 ttpt -53.88 -37.4 63.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.797 173.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -89.13 10.04 23.33 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.683 -177.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.406 ' CG ' ' HA ' ' A' ' 54' ' ' TYR . 0.3 OUTLIER -105.23 -66.68 0.96 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.293 0.568 . . . . 0.0 109.689 177.375 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.491 ' OD1' ' HA ' ' A' ' 26' ' ' LYS . 21.0 t-20 174.25 21.71 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.111 -174.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.751 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 34.0 t80 -122.82 132.09 54.05 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.731 -168.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.504 ' O ' ' HA ' ' A' ' 28' ' ' THR . 4.1 pt20 -121.63 137.64 54.66 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.221 178.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.438 HG22 ' HE1' ' A' ' 59' ' ' PHE . 97.6 t -110.19 124.85 67.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.433 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.765 HD11 HD21 ' A' ' 23' ' ' LEU . 86.9 mt -106.4 95.83 6.03 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.52 177.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.74 97.23 10.78 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.562 ' HA ' ' HB2' ' A' ' 88' ' ' MET . 15.0 t -85.08 110.12 18.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.117 -176.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -87.0 117.17 25.54 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.86 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.516 ' HB2' ' CD ' ' A' ' 67' ' ' PRO . 29.9 pt20 -81.11 -178.01 1.08 Allowed Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.569 ' HD3' ' O ' ' A' ' 90' ' ' ASP . 16.1 Cg_exo -69.0 -135.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 122.25 1.967 . . . . 0.0 112.812 -176.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.548 ' HB ' ' O ' ' A' ' 67' ' ' PRO . 90.7 mt 77.14 -57.65 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -175.102 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.41 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -104.78 133.64 20.06 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 168.309 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.505 ' O ' HG22 ' A' ' 74' ' ' VAL . 21.6 Cg_exo -65.52 173.31 6.71 Favored 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 122.843 2.362 . . . . 0.0 113.351 -174.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.608 ' HA ' ' CG2' ' A' ' 74' ' ' VAL . 7.1 tp -63.76 -33.01 59.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.726 -170.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.436 ' HA ' ' HD2' ' A' ' 75' ' ' ARG . 0.6 OUTLIER -73.4 -32.85 64.68 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.605 178.782 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 75.2 m -67.42 -51.13 55.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.889 176.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.614 HG12 ' HD3' ' A' ' 35' ' ' PRO . 3.1 m -61.45 -42.64 94.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.354 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.735 ' HA ' HD13 ' A' ' 13' ' ' LEU . 4.4 ptm180 -74.46 -34.02 63.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.135 -176.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -71.12 -36.94 72.32 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 110.329 -0.248 . . . . 0.0 110.329 177.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -55.1 -44.05 74.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.276 0.56 . . . . 0.0 109.52 178.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.796 HG13 ' HB2' ' A' ' 83' ' ' LEU . 84.1 t -59.84 -48.76 86.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.742 175.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -75.14 -29.34 60.48 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -173.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -74.29 -46.94 38.03 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.804 0.335 . . . . 0.0 111.222 -176.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -85.77 -10.77 55.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.743 0.306 . . . . 0.0 111.523 -176.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.96 53.65 3.88 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.821 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.796 ' HB2' HG13 ' A' ' 78' ' ' VAL . 9.9 mp -78.74 111.23 17.95 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-O 120.692 0.282 . . . . 0.0 110.508 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -92.73 32.76 0.25 Allowed 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.2 2.6 . . . . 0.0 113.237 -177.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.604 ' HE2' HD13 ' A' ' 48' ' ' ILE . 29.0 p90 -135.64 165.37 25.71 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.9 m -74.51 128.11 34.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.091 0.472 . . . . 0.0 111.277 -175.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.9 t -120.43 137.08 55.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.075 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.562 ' HB2' ' HA ' ' A' ' 64' ' ' VAL . 48.8 mtt -111.47 175.87 5.25 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.328 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.42 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 73.3 t80 -131.83 107.57 8.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.32 175.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.569 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 67.3 t0 -91.51 91.87 8.26 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.76 -35.07 62.58 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -175.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.431 ' O ' ' HB3' ' A' ' 93' ' ' LYS . 3.6 p30 -94.44 -12.49 27.66 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.821 -0.351 . . . . 0.0 111.86 -173.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.438 ' HE3' ' HB3' ' A' ' 93' ' ' LYS . 0.6 OUTLIER 72.39 -10.93 0.86 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 120.989 0.423 . . . . 0.0 111.126 174.514 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.85 -22.64 39.72 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 122.271 -0.268 . . . . 0.0 110.371 -177.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 83.6 t -59.83 -49.76 82.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 172.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -58.99 -32.97 71.97 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.303 174.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 93' ' ' LYS . 43.7 mt-30 -69.71 -34.22 73.59 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 122.801 -0.235 . . . . 0.0 111.12 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.722 ' O ' ' HA ' ' A' ' 2' ' ' SER . . . -66.24 -37.44 85.51 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.088 0.47 . . . . 0.0 110.736 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -76.71 -26.98 55.28 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.026 0.441 . . . . 0.0 110.521 176.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.6 44.68 2.08 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.798 174.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.495 ' HA ' HG21 ' A' ' 106' ' ' THR . 29.9 p -69.77 100.77 1.57 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.199 0.523 . . . . 0.0 111.116 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.05 -61.65 1.74 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.457 0.646 . . . . 0.0 109.262 177.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.9 p -139.55 140.84 36.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.576 -177.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.406 ' HA ' ' C ' ' A' ' 105' ' ' PRO . 72.9 m-85 -94.8 147.5 33.23 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 -173.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.568 ' HD2' ' HA2' ' A' ' 122' ' ' GLY . 6.4 Cg_exo -73.63 146.44 86.92 Favored 'Cis proline' 0 C--O 1.234 0.321 0 C-N-CA 123.663 -1.39 . . . . 0.0 112.558 0.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.495 HG21 ' HA ' ' A' ' 101' ' ' THR . 19.9 m -115.26 112.24 22.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.18 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.0 m -109.47 112.26 24.26 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.611 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.679 ' CG2' ' HB ' ' A' ' 30' ' ' ILE . 15.3 m -105.75 142.96 17.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.132 0.491 . . . . 0.0 110.71 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.454 HD11 HD22 ' A' ' 129' ' ' LEU . 81.6 mt -101.42 125.81 48.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.288 -176.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.585 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 10.0 mm -114.33 110.04 30.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 O-C-N 124.59 1.181 . . . . 0.0 109.136 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.5 ' O ' ' HG3' ' A' ' 112' ' ' LYS . . . -61.99 -59.29 9.83 Favored Glycine 0 C--O 1.225 -0.414 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.383 -178.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.527 ' O ' ' HB2' ' A' ' 113' ' ' LYS . 19.3 mttt -169.46 166.89 10.13 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 178.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.616 ' H ' ' HA ' ' A' ' 24' ' ' GLN . 28.6 mttt 77.45 -52.12 0.54 Allowed 'General case' 0 C--N 1.323 -0.563 0 O-C-N 123.642 0.588 . . . . 0.0 111.814 176.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 137.49 3.57 2.08 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.247 -177.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -68.29 144.58 54.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.892 0.377 . . . . 0.0 110.722 -179.127 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.646 HG12 ' H ' ' A' ' 4' ' ' THR . 51.0 mm -90.5 108.02 19.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.512 HD13 ' CD2' ' A' ' 145' ' ' HIS . 21.6 mt -94.39 -68.24 0.81 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.811 -173.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.444 ' HB3' HD12 ' A' ' 109' ' ' LEU . 21.4 tptm -122.78 148.24 45.6 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.865 -172.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 28.7 m -128.75 107.6 9.8 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.859 0.361 . . . . 0.0 111.046 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.496 ' CE1' ' HB3' ' A' ' 125' ' ' ASP . 51.4 m-85 -104.44 137.39 42.37 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.368 176.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.0 m -118.42 128.99 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-O 120.821 0.343 . . . . 0.0 110.977 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.568 ' HA2' ' HD2' ' A' ' 105' ' ' PRO . . . 79.32 -69.69 2.93 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.756 178.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.424 ' OE1' ' HD2' ' A' ' 124' ' ' PRO . 6.9 tp10 -126.49 114.54 23.1 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.424 ' HD2' ' OE1' ' A' ' 123' ' ' GLU . 56.4 Cg_endo -72.25 122.25 8.21 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.386 2.057 . . . . 0.0 112.366 177.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.593 ' O ' ' HB2' ' A' ' 129' ' ' LEU . 3.7 t0 -61.5 105.2 0.49 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.34 175.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.492 ' HA ' ' CB ' ' A' ' 129' ' ' LEU . 75.6 m-85 -69.26 -21.84 63.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.695 -172.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -63.64 -54.46 31.34 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 119.793 -1.194 . . . . 0.0 111.448 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -81.63 -17.29 48.66 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.633 -0.283 . . . . 0.0 110.907 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.593 ' HB2' ' O ' ' A' ' 125' ' ' ASP . 0.9 OUTLIER -61.42 -49.04 78.48 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 174.584 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -71.61 -40.72 69.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.964 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -61.12 -43.5 98.79 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.319 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -62.39 -47.26 84.94 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.73 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 129' ' ' LEU . 68.0 mt -58.24 -45.13 89.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.097 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -64.54 -38.65 91.75 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.996 0.427 . . . . 0.0 111.005 177.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 87.8 m -60.59 -39.29 87.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.393 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.09 -30.93 58.47 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.17 176.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.738 ' HH2' ' HB2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -56.66 -58.16 9.26 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.237 0.541 . . . . 0.0 110.596 176.909 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 43.1 mtm105 -86.06 -25.54 25.82 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.244 -177.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.5 40.43 17.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.679 175.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.6 p -70.2 -19.25 63.18 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.135 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -119.78 157.28 28.94 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 173.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -58.27 152.09 18.08 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 123.072 0.232 . . . . 0.0 110.575 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.484 ' HG2' ' HB2' ' A' ' 112' ' ' LYS . 17.1 mp0 -55.58 -60.21 3.76 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -70.37 99.73 0.75 Allowed Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.471 -1.051 . . . . 0.0 110.471 172.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.512 ' CD2' HD13 ' A' ' 117' ' ' LEU . 88.4 m-70 -65.76 175.69 1.83 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.964 0.411 . . . . 0.0 111.534 -173.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -75.98 70.37 2.69 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.281 0.562 . . . . 0.0 111.608 -171.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 40.2 p-80 -91.43 85.14 5.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.708 0.766 . . . . 0.0 109.883 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 35.4 p80 -97.88 6.34 47.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.244 -176.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 80.3 t60 69.02 155.02 0.12 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.414 0.626 . . . . 0.0 111.783 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 . . . . . 0 C--O 1.245 0.827 0 CA-C-O 118.273 -0.87 . . . . 0.0 109.864 171.985 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.5 t70 . . . . . 0 N--CA 1.477 0.925 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.537 ' O ' ' HG2' ' A' ' 3' ' ' LYS . 7.8 t 53.42 88.64 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -168.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.537 ' HG2' ' O ' ' A' ' 2' ' ' SER . 0.0 OUTLIER 75.14 164.94 0.27 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.488 1.115 . . . . 0.0 109.426 -165.305 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 115' ' ' GLU . 4.6 m 60.66 25.13 14.9 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.352 0.596 . . . . 0.0 110.229 -174.271 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 114' ' ' GLY . . . 69.59 120.09 0.03 OUTLIER Pre-proline 0 C--O 1.235 0.319 0 CA-C-N 114.89 -1.05 . . . . 0.0 112.264 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.488 ' HG2' ' CD1' ' A' ' 8' ' ' PHE . 38.1 Cg_endo -68.7 162.42 41.22 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.33 2.02 . . . . 0.0 111.505 175.04 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.63 51.37 1.26 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.073 0.463 . . . . 0.0 110.909 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.488 ' CD1' ' HG2' ' A' ' 6' ' ' PRO . 13.8 p90 -96.18 131.17 42.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.313 0.578 . . . . 0.0 110.907 -176.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.9 m -129.23 90.51 3.03 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 169.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.579 HD12 ' HD2' ' A' ' 11' ' ' PRO . 30.5 tp -114.65 128.53 25.79 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.292 -167.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.646 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 56.1 Cg_endo -73.43 126.61 11.1 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.371 2.047 . . . . 0.0 111.434 170.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.581 ' HA ' ' HG2' ' A' ' 88' ' ' MET . 0.9 OUTLIER -71.91 166.73 21.52 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.913 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.412 HD13 ' HB3' ' A' ' 75' ' ' ARG . 1.5 pp -77.71 8.45 4.47 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -171.221 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.483 ' HD1' ' CG ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -105.08 -17.99 14.3 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 170.41 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.79 23.35 3.69 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 115.445 0.938 . . . . 0.0 115.445 170.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.572 ' HZ2' HG12 ' A' ' 18' ' ' VAL . 48.5 tttm -115.05 126.87 55.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 118.638 1.219 . . . . 0.0 110.712 173.292 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.646 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 9.6 t -76.51 129.31 36.3 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.075 0.464 . . . . 0.0 109.794 173.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.572 HG12 ' HZ2' ' A' ' 16' ' ' LYS . 28.1 m -116.12 142.74 28.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.547 174.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.5 t -145.47 -173.4 4.11 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -62.9 -22.08 66.48 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.969 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.16 -27.74 68.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.413 176.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -78.78 -22.55 46.18 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.196 0.522 . . . . 0.0 110.181 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.407 HD13 HG21 ' A' ' 110' ' ' ILE . 43.4 mt -84.46 -38.49 20.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.8 -174.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -59.77 129.76 43.46 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -171.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.33 -14.03 64.84 Favored Glycine 0 C--N 1.331 0.294 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.986 175.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.473 ' HE3' ' CD ' ' A' ' 60' ' ' GLN . 0.0 OUTLIER -137.17 -178.74 5.34 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 -177.468 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.612 HG13 ' HA ' ' A' ' 59' ' ' PHE . 6.9 p -114.05 149.56 16.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -174.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 61.2 m -148.41 139.39 23.11 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.669 0.271 . . . . 0.0 111.127 -171.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.721 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 43.4 tp -105.73 127.26 52.97 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.358 173.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.3 mt -113.3 112.46 40.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 171.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -112.43 111.06 21.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.485 -175.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.455 ' HB2' HG22 ' A' ' 106' ' ' THR . 79.5 m-85 -81.37 119.65 23.96 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 177.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.477 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 4.3 p-90 -150.53 -173.01 4.34 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.455 -176.177 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -154.85 144.9 15.68 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 170.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.648 ' HD2' ' HB2' ' A' ' 69' ' ' ASP . 57.4 Cg_exo -40.39 -43.49 4.05 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 123.606 2.871 . . . . 0.0 114.886 -175.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.4 p -80.44 16.77 1.22 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -176.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.44 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 24.9 m -68.04 132.39 92.04 Favored Pre-proline 0 C--N 1.33 -0.252 0 O-C-N 122.066 -0.396 . . . . 0.0 111.533 178.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 16.4 Cg_exo -68.43 -26.16 34.94 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.034 2.489 . . . . 0.0 112.272 177.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.28 -15.13 72.22 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 121.155 -0.545 . . . . 0.0 113.229 -177.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.771 ' HA ' ' HG2' ' A' ' 44' ' ' MET . 73.1 m -52.99 -36.44 60.38 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -178.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 38' ' ' PRO . 27.2 m -64.63 -38.61 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-O 120.695 0.283 . . . . 0.0 111.438 -178.033 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.7 m -88.37 -55.53 3.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.985 0.421 . . . . 0.0 111.62 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.496 ' O ' HG12 ' A' ' 47' ' ' ILE . 32.7 mt-10 -72.29 -50.1 29.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.324 -170.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.771 ' HG2' ' HA ' ' A' ' 40' ' ' CYS . 20.0 mmt -57.84 -46.78 99.7 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -167.376 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 40' ' ' CYS . 51.4 Cg_exo -55.75 -43.32 58.52 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 121.746 1.63 . . . . 0.0 112.203 177.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -66.52 -33.95 76.83 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.933 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 43' ' ' GLU . 41.9 mm -67.58 -38.79 81.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.449 177.181 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.591 HG12 ' O ' ' A' ' 44' ' ' MET . 49.1 mm -54.55 -53.45 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 120.857 0.361 . . . . 0.0 110.289 178.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.415 ' HB3' ' HE3' ' A' ' 49' ' ' LYS . 14.9 ttpp -55.09 -52.3 63.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.491 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.54 ' O ' ' HD2' ' A' ' 54' ' ' TYR . 17.0 m -67.48 -47.51 69.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.428 -174.134 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.61 ' HB1' HG21 ' A' ' 61' ' ' VAL . . . -67.5 -28.3 67.72 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.891 -174.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -75.87 -50.17 15.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.833 0.349 . . . . 0.0 111.09 -178.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -64.72 -47.98 76.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.097 -0.502 . . . . 0.0 112.326 -173.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.836 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 96.5 m-85 -77.35 1.79 17.83 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -170.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 37.8 mmtm -56.15 -49.91 72.61 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.286 0.565 . . . . 0.0 110.317 174.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -95.07 21.11 8.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.117 -177.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.663 ' HB2' ' HA ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -113.76 -65.85 1.14 Allowed 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.442 179.42 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 24.1 p30 171.6 -11.93 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.836 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 68.5 t80 -98.68 125.96 44.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.062 0.458 . . . . 0.0 109.876 -174.081 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.473 ' CD ' ' HE3' ' A' ' 26' ' ' LYS . 27.8 mt-30 -102.19 167.31 10.08 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 121.448 0.642 . . . . 0.0 110.943 -178.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.61 HG21 ' HB1' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -148.33 111.43 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.775 -171.806 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.534 HD23 ' HB ' ' A' ' 86' ' ' THR . 78.4 mt -124.22 97.34 5.29 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.585 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.727 ' HB3' HG12 ' A' ' 87' ' ' VAL . . . -86.15 101.79 13.31 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.727 178.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.585 HG12 ' HB2' ' A' ' 90' ' ' ASP . 12.2 t -85.92 108.27 17.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.216 -176.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -85.78 115.93 23.73 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.107 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.671 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 3.9 pt20 -78.29 -174.66 0.47 Allowed Pre-proline 0 C--N 1.315 -0.892 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.671 ' HD2' ' HB2' ' A' ' 66' ' ' GLN . 47.6 Cg_endo -69.33 -146.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 121.552 1.501 . . . . 0.0 112.366 -177.354 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.554 ' HB ' ' O ' ' A' ' 67' ' ' PRO . 62.8 mt 77.54 -61.1 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -172.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.648 ' HB2' ' HD2' ' A' ' 35' ' ' PRO . 34.2 m-20 -97.1 128.97 33.43 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 171.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.45 ' HD2' ' OG ' ' A' ' 73' ' ' SER . 51.5 Cg_exo -57.14 165.61 5.13 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.667 2.245 . . . . 0.0 112.505 175.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.598 ' O ' ' HG2' ' A' ' 75' ' ' ARG . 6.6 tt -66.52 -29.3 46.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.894 0.378 . . . . 0.0 110.675 -177.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.718 ' HA ' ' HE ' ' A' ' 75' ' ' ARG . 2.1 pm0 -69.65 -28.85 66.24 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 122.112 -0.367 . . . . 0.0 110.666 175.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.45 ' OG ' ' HD2' ' A' ' 70' ' ' PRO . 67.0 m -64.66 -43.85 92.31 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.664 0.268 . . . . 0.0 110.358 175.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.522 ' HA ' ' HG3' ' A' ' 35' ' ' PRO . 13.8 p -71.6 -39.8 70.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.113 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.816 ' HA ' HG22 ' A' ' 78' ' ' VAL . 28.9 ptt180 -75.19 -25.55 58.33 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 122.312 -0.242 . . . . 0.0 111.475 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -70.29 -41.27 73.6 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 169.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -62.17 -47.2 85.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.202 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.816 HG22 ' HA ' ' A' ' 75' ' ' ARG . 33.0 m -67.15 -28.74 43.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.069 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.7 tptp -73.09 -55.78 6.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.373 0.606 . . . . 0.0 111.459 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -65.52 -49.03 70.47 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.896 -171.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -81.05 -19.55 43.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.754 -177.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.07 65.02 2.1 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.904 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.467 HD22 HG12 ' A' ' 78' ' ' VAL . 8.6 mp -84.27 113.51 48.89 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-O 120.695 0.283 . . . . 0.0 110.933 -177.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -81.25 -2.77 11.83 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.879 2.386 . . . . 0.0 113.371 -177.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.507 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 28.4 p90 -99.02 140.28 33.42 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 122.149 -0.344 . . . . 0.0 110.532 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.534 ' HB ' HD23 ' A' ' 62' ' ' LEU . 10.7 m -67.93 137.9 55.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.742 -176.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.727 HG12 ' HB3' ' A' ' 63' ' ' ALA . 10.8 m -122.97 137.19 57.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.398 0.618 . . . . 0.0 111.708 -176.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.581 ' HG2' ' HA ' ' A' ' 12' ' ' ASP . 79.6 mtm -115.95 176.01 5.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.497 -0.774 . . . . 0.0 108.988 175.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 37.9 t80 -125.34 112.35 16.24 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.216 0.531 . . . . 0.0 111.041 -178.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.703 ' OD2' ' HA ' ' A' ' 93' ' ' LYS . 23.0 t70 -84.63 74.83 10.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.553 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.22 -42.4 62.68 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.476 -174.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -83.02 -12.99 56.74 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.226 -177.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.703 ' HA ' ' OD2' ' A' ' 90' ' ' ASP . 2.6 mtpm? 64.54 -5.2 0.37 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.35 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.22 -32.03 38.56 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -168.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.477 ' O ' ' HD1' ' A' ' 99' ' ' PHE . 31.2 m -66.8 -34.35 69.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.495 174.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -67.56 -34.08 83.05 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.41 172.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.615 ' HG3' ' O ' ' A' ' 93' ' ' LYS . 79.9 mt-30 -63.59 -39.06 93.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.646 -0.277 . . . . 0.0 110.408 175.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.69 -34.11 77.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.052 178.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.477 ' HD1' ' O ' ' A' ' 95' ' ' VAL . 42.2 m-85 -72.31 -24.01 61.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.822 174.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.31 23.17 49.08 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.494 -178.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.533 ' HB ' HG21 ' A' ' 106' ' ' THR . 50.9 p -86.07 110.02 19.24 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.007 0.432 . . . . 0.0 111.064 -176.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -108.66 -24.55 11.29 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.786 177.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.9 t -99.63 131.98 45.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.909 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -128.66 143.39 48.27 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.334 -178.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.424 ' HG2' ' OE1' ' A' ' 43' ' ' GLU . 5.3 Cg_exo -74.78 160.33 96.62 Favored 'Cis proline' 0 C--N 1.346 0.407 0 C-N-CA 123.715 -1.369 . . . . 0.0 112.161 0.041 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.533 HG21 ' HB ' ' A' ' 101' ' ' THR . 9.8 t -142.46 120.93 12.43 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.712 0.768 . . . . 0.0 111.239 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.599 ' HB3' HD11 ' A' ' 29' ' ' LEU . 25.5 m -95.8 111.97 23.81 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.253 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 55.3 t -105.5 128.48 59.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.261 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.612 HD12 ' HB3' ' A' ' 118' ' ' LYS . 95.3 mt -101.97 122.97 45.07 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.778 -176.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 23' ' ' LEU . 41.6 mt -110.61 130.09 64.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.475 178.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -88.31 -158.11 33.08 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.235 -0.983 . . . . 0.0 112.973 -178.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 44.0 mtpt -87.67 -17.98 30.59 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.976 0.893 . . . . 0.0 109.72 -168.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.771 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -81.07 -14.22 58.03 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.416 177.881 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 5' ' ' ALA . . . 91.41 -7.97 79.57 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -173.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 11.6 tp10 -72.21 146.88 47.02 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.165 0.507 . . . . 0.0 110.975 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.476 HG13 ' HA ' ' A' ' 3' ' ' LYS . 47.0 mm -81.12 110.4 16.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.025 178.174 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.8 mt -90.7 -59.82 2.08 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -170.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.612 ' HB3' HD12 ' A' ' 109' ' ' LEU . 23.6 tptm -133.36 153.19 51.8 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.248 -170.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.3 m -134.59 128.03 32.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.522 177.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.442 ' OH ' ' HB2' ' A' ' 128' ' ' LYS . 80.5 m-85 -116.88 141.47 48.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.83 174.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.6 m -124.86 109.64 22.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.699 0.285 . . . . 0.0 111.304 178.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 68.52 97.66 0.04 OUTLIER Glycine 0 C--N 1.331 0.286 0 C-N-CA 121.174 -0.536 . . . . 0.0 113.07 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.423 ' HA ' ' HG2' ' A' ' 43' ' ' GLU . 9.0 tp10 66.13 92.92 0.06 OUTLIER Pre-proline 0 C--O 1.235 0.316 0 CA-C-O 121.509 0.671 . . . . 0.0 110.217 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -77.23 141.62 20.74 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.494 2.129 . . . . 0.0 113.019 -176.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.52 ' OD1' ' HG2' ' A' ' 128' ' ' LYS . 10.6 t0 -65.75 96.05 0.27 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.6 174.244 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.595 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 50.1 m-85 -69.19 -14.36 62.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.867 -178.031 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -68.36 -50.63 37.14 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.271 -0.966 . . . . 0.0 110.854 174.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.52 ' HG2' ' OD1' ' A' ' 125' ' ' ASP . 31.1 mmtm -77.95 -20.56 52.5 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.595 ' HB3' ' HA ' ' A' ' 126' ' ' PHE . 3.2 tm? -63.59 -47.9 79.56 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 174.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -68.18 -45.65 72.84 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.236 178.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -60.88 -36.47 79.29 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.938 0.348 . . . . 0.0 111.938 178.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -66.63 -51.77 52.5 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 67.9 mt -57.27 -43.03 81.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.902 0.382 . . . . 0.0 110.392 176.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -56.7 -40.32 75.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.85 177.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 63.8 m -62.07 -44.07 97.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.316 176.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.68 -28.18 69.72 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.191 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 12.6 m0 -69.62 -55.64 9.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.963 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 57.0 mtt180 -70.62 -43.41 69.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.592 -173.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -68.75 110.22 4.21 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.236 0.541 . . . . 0.0 111.756 -174.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 18.1 p -67.99 102.69 1.33 Allowed 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.151 171.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -72.12 146.24 47.61 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.644 -174.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.98 162.68 16.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.266 -177.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -51.82 116.13 2.0 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.249 -176.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -89.15 -156.28 31.47 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.899 -175.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -68.69 105.9 2.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.129 0.49 . . . . 0.0 110.63 -178.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 13.3 p80 -128.69 135.52 49.37 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.762 179.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 61.6 t60 -172.5 107.76 0.19 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.35 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -125.14 96.89 5.01 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.55 0.69 . . . . 0.0 109.329 173.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -75.26 124.58 27.33 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.402 -173.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 . . . . . 0 C--N 1.319 -0.748 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.508 -179.379 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.552 ' HA ' ' HA ' ' A' ' 6' ' ' PRO . 2.0 m-20 . . . . . 0 N--CA 1.482 1.149 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.567 ' O ' ' HB2' ' A' ' 3' ' ' LYS . 45.3 m 57.47 91.87 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 O-C-N 123.926 0.766 . . . . 0.0 109.832 -171.251 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.619 ' H ' HD12 ' A' ' 116' ' ' ILE . 3.8 mmmp? 76.14 144.2 0.08 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.979 -171.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.6 m 58.3 30.64 19.81 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.688 0.756 . . . . 0.0 111.08 177.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.462 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . . . 69.27 150.4 0.12 Allowed Pre-proline 0 N--CA 1.467 0.382 0 CA-C-N 114.677 -1.147 . . . . 0.0 112.705 175.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.552 ' HA ' ' HA ' ' A' ' 1' ' ' ASP . 1.8 Cg_endo -85.95 171.41 8.09 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.292 2.662 . . . . 0.0 112.192 174.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -92.87 25.62 3.09 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.394 0.616 . . . . 0.0 110.03 176.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.593 ' HB2' HG12 ' A' ' 95' ' ' VAL . 13.0 p90 -67.4 148.17 51.94 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.384 -175.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.0 m -142.59 89.79 2.17 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 172.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.647 HD11 ' HB3' ' A' ' 89' ' ' TYR . 35.5 tp -115.88 120.59 35.4 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.597 -173.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.558 ' HD2' HD12 ' A' ' 10' ' ' LEU . 24.3 Cg_exo -64.44 144.43 85.36 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.584 2.189 . . . . 0.0 111.799 176.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.717 ' HA ' ' HA ' ' A' ' 88' ' ' MET . 1.6 p-10 -81.95 -173.21 4.35 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.502 HD21 ' HA ' ' A' ' 89' ' ' TYR . 73.8 mt -87.02 2.27 50.14 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.672 -177.031 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.451 ' H ' ' CG ' ' A' ' 12' ' ' ASP . 64.3 t60 -95.69 -40.49 9.36 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 172.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.22 22.76 0.79 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.109 -1.043 . . . . 0.0 114.121 174.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.427 ' HE2' HG22 ' A' ' 18' ' ' VAL . 2.3 ptmt -114.31 134.51 54.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.72 0.76 . . . . 0.0 110.244 175.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 16.1 m -67.93 121.59 16.37 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.314 177.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.427 HG22 ' HE2' ' A' ' 16' ' ' LYS . 46.3 t -97.28 128.77 48.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 177.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 63.6 p -129.01 -175.59 3.6 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.874 0.369 . . . . 0.0 111.025 -175.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -68.95 -22.28 64.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.78 177.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.86 -28.95 69.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.736 176.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -67.01 -21.08 65.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.942 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 74.2 mt -80.7 -20.53 42.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.432 -176.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.455 ' HA ' ' OE1' ' A' ' 24' ' ' GLN . 15.9 mm-40 -78.59 138.61 38.44 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.077 0.465 . . . . 0.0 112.137 -172.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.98 3.38 89.18 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.771 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 112' ' ' LYS . 41.1 mtmt -146.75 165.03 30.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.668 0.271 . . . . 0.0 110.527 -177.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 26.0 t -103.16 138.62 26.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 173.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.631 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 11.1 m -131.93 145.29 51.41 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.63 -0.428 . . . . 0.0 112.126 -168.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.665 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 6.9 tt -119.5 108.75 14.9 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 170.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.8 mt -94.6 111.12 24.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -104.97 125.11 50.61 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.459 -177.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.466 ' CE2' ' HA2' ' A' ' 96' ' ' GLY . 87.0 m-85 -96.26 118.18 32.3 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 9.1 p-90 -144.59 -176.49 5.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.484 -175.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -159.63 151.96 17.46 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.239 176.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.33 155.58 51.06 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.404 2.069 . . . . 0.0 111.887 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.3 m 65.08 16.51 10.6 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.588 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.523 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 42.7 t -84.14 130.76 53.25 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.596 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -61.13 -26.82 83.19 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.7 2.267 . . . . 0.0 111.922 176.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -64.52 -30.02 76.74 Favored Glycine 0 C--O 1.227 -0.303 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.473 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.523 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 83.9 m -58.26 -30.5 66.63 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 122.16 0.184 . . . . 0.0 111.445 -178.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.6 t -61.18 -38.14 79.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.211 0.529 . . . . 0.0 110.157 177.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.463 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 32.6 m -87.09 -51.28 6.09 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.513 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -70.21 -45.06 67.36 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -171.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.569 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 39.2 tpp -54.72 -51.35 79.58 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -171.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.569 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 57.3 Cg_exo -53.28 -36.44 78.2 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 121.962 1.775 . . . . 0.0 112.47 175.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.633 ' HB3' ' CZ ' ' A' ' 126' ' ' PHE . 30.5 mmtm -65.16 -47.52 76.72 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.238 0.542 . . . . 0.0 109.796 177.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.7 mm -65.5 -38.65 82.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.823 -177.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.528 HG12 ' O ' ' A' ' 44' ' ' MET . 47.2 mm -54.68 -53.34 32.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 120.777 0.322 . . . . 0.0 110.188 177.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.1 tttm -62.16 -57.69 10.58 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.632 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 29.0 m -60.32 -44.82 95.12 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -171.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . -69.31 -36.08 76.62 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.118 -0.233 . . . . 0.0 111.598 -175.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -77.06 -40.35 46.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.158 0.504 . . . . 0.0 110.626 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -55.28 -53.04 61.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.902 -1.045 . . . . 0.0 111.15 -177.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.542 ' CB ' ' HB3' ' A' ' 59' ' ' PHE . 67.1 m-85 -96.88 8.16 45.01 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.465 -175.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -62.25 -52.31 64.24 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.093 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -82.4 66.81 8.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.802 176.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.705 ' HB2' ' HZ2' ' A' ' 57' ' ' LYS . 0.3 OUTLIER -166.94 -75.31 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.597 -173.819 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 6.9 t-20 173.62 7.96 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.203 0.525 . . . . 0.0 110.415 -176.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.665 ' HZ ' ' HB2' ' A' ' 29' ' ' LEU . 41.0 t80 -110.43 135.22 51.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.914 0.388 . . . . 0.0 110.581 -173.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.605 ' HG3' HG23 ' A' ' 28' ' ' THR . 21.4 pt20 -125.75 144.48 50.61 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.725 178.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 97.2 t -113.93 111.52 36.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 97.9 mt -95.03 95.57 8.68 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 177.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -86.6 95.65 9.83 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.574 ' HA ' ' HB2' ' A' ' 88' ' ' MET . 2.4 p -88.08 118.53 33.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.117 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 90' ' ' ASP . . . -89.53 162.69 15.56 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.948 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.41 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 18.6 pt20 -137.54 154.38 75.06 Favored Pre-proline 0 C--N 1.305 -1.358 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 169.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 1.074 ' HD3' ' HA ' ' A' ' 91' ' ' ALA . 56.2 Cg_endo -59.36 -92.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.038 1.826 . . . . 0.0 113.965 -150.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.3 mm 65.66 -70.34 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -175.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.41 ' OD1' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -94.57 147.23 32.88 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 171.316 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.41 ' HD2' ' OD1' ' A' ' 69' ' ' ASP . 65.6 Cg_exo -52.88 157.66 7.57 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 122.869 2.38 . . . . 0.0 113.902 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.4 ' O ' HG12 ' A' ' 74' ' ' VAL . 4.0 tp -53.85 -33.74 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.875 179.016 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.448 ' CD ' HH21 ' A' ' 75' ' ' ARG . 9.1 tp10 -68.87 -29.59 67.92 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 122.154 -0.341 . . . . 0.0 110.289 178.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.6 m -70.29 -48.65 55.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.951 0.405 . . . . 0.0 110.63 -177.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' ' 71' ' ' ILE . 11.1 p -61.43 -32.82 54.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-O 121.929 0.871 . . . . 0.0 109.305 175.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.656 ' HA ' HG22 ' A' ' 78' ' ' VAL . 50.5 ttp180 -75.28 -29.24 60.06 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.592 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -70.41 -41.7 72.62 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 172.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -57.06 -51.28 69.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.285 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.656 HG22 ' HA ' ' A' ' 75' ' ' ARG . 24.2 m -61.59 -36.94 76.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.127 -178.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -75.3 -52.22 11.36 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -58.6 -48.52 80.67 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.165 -170.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -92.58 1.11 57.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.388 -175.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 54.46 60.01 9.24 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.458 -179.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.488 HD22 HG12 ' A' ' 78' ' ' VAL . 10.8 mp -60.87 109.71 2.32 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.867 0.365 . . . . 0.0 111.462 -176.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -85.18 37.82 0.62 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.339 2.693 . . . . 0.0 113.044 -175.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -149.56 159.57 44.2 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.197 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.49 109.34 4.76 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.84 -176.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.2 t -101.96 136.78 32.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.515 177.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.717 ' HA ' ' HA ' ' A' ' 12' ' ' ASP . 80.1 mtp -111.24 162.17 15.25 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.267 -174.096 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.647 ' HB3' HD11 ' A' ' 10' ' ' LEU . 12.6 t80 -62.73 141.55 58.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.469 0.652 . . . . 0.0 112.087 -174.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.544 ' O ' ' N ' ' A' ' 92' ' ' ASP . 5.1 p-10 -56.52 -135.21 0.0 OUTLIER 'General case' 0 C--O 1.217 -0.649 0 CA-C-N 113.659 -1.609 . . . . 0.0 111.56 162.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 1.074 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . . . -28.66 -6.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 120.583 3.549 . . . . 0.0 120.583 -146.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.613 ' HB3' HD13 ' A' ' 10' ' ' LEU . 37.5 t70 -71.73 38.73 0.07 Allowed 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 120.31 1.414 . . . . 0.0 108.809 163.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.542 ' H ' ' C ' ' A' ' 91' ' ' ALA . 0.0 OUTLIER -58.47 -3.72 0.32 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.194 0.998 . . . . 0.0 112.675 -174.4 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.63 -23.91 67.41 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 122.77 0.428 . . . . 0.0 111.179 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.593 HG12 ' HB2' ' A' ' 8' ' ' PHE . 35.9 m -60.73 -37.38 75.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.106 0.479 . . . . 0.0 110.099 174.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.466 ' HA2' ' CE2' ' A' ' 32' ' ' PHE . . . -67.87 -32.17 77.01 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 174.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -69.78 -28.84 66.08 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.006 -0.597 . . . . 0.0 110.719 177.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.45 -28.34 61.91 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.074 0.464 . . . . 0.0 110.89 176.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.402 ' HD2' ' O ' ' A' ' 95' ' ' VAL . 50.4 m-85 -79.86 -24.53 41.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.738 173.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.74 -8.02 76.83 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.936 -0.65 . . . . 0.0 111.843 -177.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.579 ' HB ' HG21 ' A' ' 106' ' ' THR . 18.1 p -78.94 91.89 4.86 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.736 0.303 . . . . 0.0 111.396 -177.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -105.82 0.19 25.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.029 0.442 . . . . 0.0 111.311 177.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.5 m -97.95 125.81 51.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.513 173.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -121.28 149.77 52.61 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.526 -172.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -85.31 164.79 58.25 Favored 'Cis proline' 0 C--N 1.343 0.277 0 C-N-CA 123.548 -1.438 . . . . 0.0 112.002 -0.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.579 HG21 ' HB ' ' A' ' 101' ' ' THR . 5.9 t -151.88 142.79 23.03 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.895 -177.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.477 ' HB3' HD21 ' A' ' 29' ' ' LEU . 56.4 m -120.51 122.85 41.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.367 177.219 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.3 t -105.85 137.13 37.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.331 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.401 HD22 ' N ' ' A' ' 109' ' ' LEU . 2.8 mm? -101.82 122.34 43.79 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.18 -177.079 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.631 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 8.5 mm -110.13 129.94 64.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.344 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -79.35 -176.47 48.82 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.326 -0.94 . . . . 0.0 111.87 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 16.8 pttm -92.52 43.21 1.12 Allowed 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 122.532 1.158 . . . . 0.0 107.93 -178.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 51.3 mmtt -140.32 -5.77 1.23 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 113.302 -1.772 . . . . 0.0 111.367 -168.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.47 12.66 82.19 Favored Glycine 0 C--O 1.226 -0.371 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.464 -172.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -103.17 147.97 26.36 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 -178.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.619 HD12 ' H ' ' A' ' 3' ' ' LYS . 51.5 mt -91.97 111.55 24.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -85.11 -61.52 1.75 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.195 -173.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.434 ' HD2' ' HA ' ' A' ' 118' ' ' LYS . 6.7 mmmm -141.27 167.7 21.55 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -169.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 62.1 m -146.3 105.87 3.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.366 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -102.87 113.16 26.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.577 177.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 106' ' ' THR . 22.2 m -88.54 141.0 14.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 120.849 0.357 . . . . 0.0 110.985 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 71.62 -150.93 47.29 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.438 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.455 ' OE2' ' HB3' ' A' ' 42' ' ' SER . 6.3 tp10 -70.2 111.64 9.99 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -84.45 140.08 8.25 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.47 2.114 . . . . 0.0 113.195 -176.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -66.89 102.88 1.02 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.989 173.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.633 ' CZ ' ' HB3' ' A' ' 46' ' ' LYS . 25.3 m-85 -70.32 -19.42 63.08 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -175.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -63.69 -54.08 33.82 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 119.932 -1.128 . . . . 0.0 111.055 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -79.68 -26.78 40.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.614 -0.293 . . . . 0.0 110.608 177.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.629 ' HB3' ' HA ' ' A' ' 126' ' ' PHE . 41.8 tp -63.18 -47.67 81.62 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.432 178.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -66.34 -47.21 74.23 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.741 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -56.9 -34.17 67.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.99 0.424 . . . . 0.0 111.991 176.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -80.37 -37.96 31.35 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.015 -179.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 129' ' ' LEU . 78.8 mt -65.46 -38.06 81.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.153 0.502 . . . . 0.0 110.002 174.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.699 ' HA ' ' CD1' ' A' ' 137' ' ' TRP . 12.2 t70 -67.05 -23.38 65.88 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.686 176.012 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 87.6 m -67.27 -30.71 70.65 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 172.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.24 -28.58 59.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.318 174.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.699 ' CD1' ' HA ' ' A' ' 134' ' ' ASP . 3.2 m95 -67.79 -56.55 8.77 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.809 0.814 . . . . 0.0 109.684 172.092 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 21.7 ttm180 -60.16 -51.04 71.31 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 113.429 -1.714 . . . . 0.0 112.962 -169.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -56.66 108.28 0.48 Allowed 'General case' 0 C--O 1.239 0.507 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -172.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.0 p -79.94 100.3 8.02 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 169.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -120.6 19.57 11.9 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.731 -168.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -108.84 -62.42 1.47 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.497 0.665 . . . . 0.0 109.279 177.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.57 ' CD ' ' H ' ' A' ' 143' ' ' GLU . 0.1 OUTLIER -67.76 -41.26 83.58 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.636 171.935 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.9 102.79 1.7 Allowed Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 173.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -74.45 97.62 3.13 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.191 0.519 . . . . 0.0 110.915 -176.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -69.86 94.6 0.84 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.608 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 16.8 p80 -61.72 145.94 50.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.36 177.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -104.43 177.19 4.92 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.052 -177.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.427 ' O ' ' HB3' ' A' ' 150' ' ' HIS . 53.5 t-80 -174.26 -59.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 O-C-N 123.3 0.375 . . . . 0.0 110.668 176.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.427 ' HB3' ' O ' ' A' ' 149' ' ' HIS . 83.3 t60 . . . . . 0 C--O 1.244 0.813 0 CA-C-O 117.568 -1.206 . . . . 0.0 108.594 -167.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 120.303 0.097 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.3 m -101.6 158.0 16.41 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 122.2 -0.312 . . . . 0.0 110.674 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.467 ' HG3' ' H ' ' A' ' 4' ' ' THR . 3.8 tptm -89.56 -175.59 4.74 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 170.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.563 ' HB ' ' HA ' ' A' ' 115' ' ' GLU . 32.5 p 53.75 -160.79 0.13 Allowed 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 -161.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.444 ' HB2' ' H ' ' A' ' 115' ' ' GLU . . . -66.69 109.08 2.91 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 119.049 0.84 . . . . 0.0 109.86 179.049 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.404 ' HD3' HD11 ' A' ' 116' ' ' ILE . 65.0 Cg_endo -73.86 169.52 22.21 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.0 2.466 . . . . 0.0 112.822 -170.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.17 67.07 9.85 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.331 0.586 . . . . 0.0 110.051 -178.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -106.57 132.76 52.2 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.728 -177.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.7 m -114.9 90.76 3.42 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 172.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.597 HD22 HG21 ' A' ' 95' ' ' VAL . 36.6 tp -102.51 121.23 50.58 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.825 -172.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.553 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 3.9 Cg_exo -80.58 137.2 11.38 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.023 2.482 . . . . 0.0 112.059 176.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.62 ' HB3' ' HB3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -67.99 172.6 5.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.006 175.152 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.6 mt -55.21 -29.64 58.35 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -175.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -102.54 -26.05 13.37 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.453 -176.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.62 16.97 0.43 Allowed Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.073 -1.061 . . . . 0.0 113.917 175.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.62 ' HB3' ' HB3' ' A' ' 12' ' ' ASP . 1.8 tpmt? -81.8 96.85 7.73 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 117.441 0.621 . . . . 0.0 109.84 176.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 23.8 m -86.45 124.33 32.66 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.057 -177.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.5 m -127.16 163.16 30.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.619 179.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 62.1 p -132.17 -173.83 3.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.045 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.401 ' HB2' ' HB1' ' A' ' 5' ' ' ALA . 29.7 p30 -67.91 -22.19 65.09 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.765 0.317 . . . . 0.0 111.508 -177.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.92 -27.35 67.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.067 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -70.39 -28.76 65.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.88 0.371 . . . . 0.0 110.25 178.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 45.3 mt -69.72 -20.34 63.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.806 -178.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.699 ' HG2' ' HA ' ' A' ' 113' ' ' LYS . 11.4 mt-30 -73.22 132.88 43.71 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.163 -174.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.66 -25.31 19.43 Favored Glycine 0 N--CA 1.452 -0.282 0 CA-C-N 115.954 -0.567 . . . . 0.0 113.167 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 112' ' ' LYS . 52.0 mtmt -108.25 -175.08 2.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.923 0.392 . . . . 0.0 110.675 -178.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.54 HG21 ' CZ3' ' A' ' 137' ' ' TRP . 8.3 t -127.53 141.45 46.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 173.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.557 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 85.5 m -145.58 145.31 30.94 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.121 0.486 . . . . 0.0 111.995 -169.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.584 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 27.9 tp -114.15 112.99 24.08 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.129 170.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.671 ' HB ' ' CG1' ' A' ' 108' ' ' VAL . 41.6 mt -97.28 112.52 29.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 176.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.427 ' HA ' ' O ' ' A' ' 106' ' ' THR . 46.6 t30 -114.39 114.48 25.93 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.099 -177.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 92.5 m-85 -83.74 123.76 30.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.172 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.563 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 6.1 p-90 -143.93 -177.57 5.5 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.398 0.618 . . . . 0.0 111.321 -173.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -162.67 153.4 14.34 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.848 174.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -63.27 158.08 46.51 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.157 1.905 . . . . 0.0 111.472 175.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.8 m 65.7 14.38 9.49 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 123.465 0.478 . . . . 0.0 111.42 -177.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 29.9 t -84.98 133.88 42.36 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.594 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.8 -22.49 68.29 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 122.523 2.149 . . . . 0.0 111.967 176.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.61 -12.13 75.86 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.287 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 21.6 p -69.19 -45.72 69.25 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 117.85 0.825 . . . . 0.0 110.53 -177.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.6 p -65.06 -25.57 37.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.123 0.487 . . . . 0.0 110.593 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.7 m -86.7 -49.51 7.43 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.684 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.424 ' CD ' ' HZ1' ' A' ' 46' ' ' LYS . 22.2 mm-40 -85.13 -41.48 15.66 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -172.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.509 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 47.2 tpp -51.48 -50.2 78.03 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -171.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 44' ' ' MET . 9.8 Cg_endo -51.88 -44.77 42.85 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 122.285 1.99 . . . . 0.0 112.603 177.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.424 ' HZ1' ' CD ' ' A' ' 43' ' ' GLU . 8.0 mppt? -68.79 -40.12 79.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.722 178.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.0 mm -60.45 -43.53 94.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.699 178.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.592 HD13 ' HE1' ' A' ' 85' ' ' PHE . 43.9 mm -55.78 -52.99 42.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.775 178.324 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.53 -46.52 85.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.886 0.374 . . . . 0.0 110.622 -177.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 29.2 m -65.99 -51.59 57.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.552 -175.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.562 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . -67.86 -36.31 80.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.834 -174.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -74.03 -29.83 62.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.043 0.449 . . . . 0.0 110.592 -177.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -74.49 -50.4 18.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.152 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 1.066 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 66.4 m-85 -80.59 -10.08 59.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.933 -175.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 22.1 tptm -58.41 -33.27 69.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.194 0.521 . . . . 0.0 110.401 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 44.3 m-20 -95.06 20.86 8.44 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.643 -176.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.718 ' HE3' ' HA ' ' A' ' 54' ' ' TYR . 33.1 mtmt -125.98 -63.27 1.12 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.477 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 172.33 -13.29 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 O-C-N 123.322 0.389 . . . . 0.0 111.37 -172.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 1.066 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 56.7 t80 -100.72 122.78 43.93 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.093 0.473 . . . . 0.0 110.356 -177.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.52 HE21 HD11 ' A' ' 62' ' ' LEU . 12.7 pt20 -122.75 154.92 37.51 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.666 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.551 HG22 ' HB3' ' A' ' 29' ' ' LEU . 94.2 t -115.27 128.66 72.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.267 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.52 HD11 HE21 ' A' ' 60' ' ' GLN . 11.0 mp -108.12 109.26 20.64 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.542 177.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.45 98.35 10.81 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.169 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 51.3 t -91.79 116.16 32.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.331 -177.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -96.56 126.53 41.8 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.481 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.592 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 4.7 pm0 -96.0 161.5 27.08 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.679 ' HD3' ' O ' ' A' ' 90' ' ' ASP . 53.0 Cg_endo -70.43 84.95 0.73 Allowed 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.296 1.997 . . . . 0.0 113.515 -171.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 48.2 mm -115.7 -44.94 3.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 172.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.597 ' OD1' ' HD2' ' A' ' 70' ' ' PRO . 0.7 OUTLIER -116.8 141.99 29.05 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 172.595 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.597 ' HD2' ' OD1' ' A' ' 69' ' ' ASP . 61.2 Cg_exo -42.1 155.27 0.1 OUTLIER 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.676 2.917 . . . . 0.0 114.438 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.594 HG23 ' OE1' ' A' ' 72' ' ' GLU . 3.3 tp -58.7 -36.79 62.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.026 -176.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.598 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -59.4 -39.32 83.03 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.534 176.125 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.8 m -58.15 -42.44 85.95 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.304 0.573 . . . . 0.0 109.974 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.2 t -67.72 -52.2 42.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.016 178.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.598 ' HG2' ' HA ' ' A' ' 72' ' ' GLU . 16.0 ptt180 -68.3 -33.46 74.38 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -174.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -65.61 -42.04 92.03 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 178.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -56.36 -47.82 78.06 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.971 178.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.6 HG22 HD22 ' A' ' 83' ' ' LEU . 41.2 t -63.1 -53.0 51.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.328 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 75' ' ' ARG . 95.6 mttt -63.01 -36.61 84.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.726 0.298 . . . . 0.0 111.669 -175.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -75.07 -48.29 24.65 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -176.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -98.48 7.37 46.26 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -173.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.5 -70.09 2.66 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.949 -0.644 . . . . 0.0 112.743 175.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.6 HD22 HG22 ' A' ' 78' ' ' VAL . 10.3 mp 52.25 84.72 0.2 Allowed Pre-proline 0 N--CA 1.468 0.472 0 C-N-CA 122.959 0.504 . . . . 0.0 111.732 -178.289 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -76.92 16.52 0.95 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.365 2.71 . . . . 0.0 113.563 -176.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.592 ' HE1' HD13 ' A' ' 48' ' ' ILE . 23.1 p90 -117.73 159.4 23.06 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.4 m -74.76 112.08 10.61 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.342 0.591 . . . . 0.0 111.081 -174.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.7 t -99.64 136.74 29.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.831 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.569 ' HG2' ' HA ' ' A' ' 12' ' ' ASP . 62.5 mtt -131.23 166.45 21.14 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.415 -176.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -130.07 117.06 19.42 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.099 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.679 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 67.2 t0 -103.28 108.05 19.12 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 179.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.4 -21.95 59.4 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -176.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.528 ' OD2' ' HB2' ' A' ' 94' ' ' ALA . 28.3 t70 -106.44 -11.43 15.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.08 0.467 . . . . 0.0 110.691 -174.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 97' ' ' GLN . 17.4 ttpp 65.85 17.7 10.91 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.496 -177.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.528 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . . . -67.92 -31.95 72.07 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.418 -174.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.597 HG21 HD22 ' A' ' 10' ' ' LEU . 46.8 t -67.92 -42.6 85.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 177.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.79 -33.99 87.47 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.538 175.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.414 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 15.0 mm100 -64.6 -42.81 95.31 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 122.607 0.363 . . . . 0.0 111.494 177.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.94 -47.18 66.31 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.331 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.511 ' HA ' HD13 ' A' ' 116' ' ' ILE . 36.9 m-85 -72.24 -27.21 62.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.735 -177.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.37 55.21 1.72 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.605 176.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.403 ' HA ' HG21 ' A' ' 106' ' ' THR . 20.1 p -68.99 104.75 2.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.942 0.401 . . . . 0.0 111.57 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 48.4 tp60 -69.45 -58.32 4.13 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.533 0.682 . . . . 0.0 110.108 178.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.4 p -148.36 143.37 19.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.271 -176.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -94.57 141.9 24.06 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.715 -175.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.56 151.42 97.01 Favored 'Cis proline' 0 C--N 1.346 0.405 0 C-N-CA 123.385 -1.506 . . . . 0.0 113.18 0.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 26.3 m -119.54 116.08 25.32 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.884 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.538 ' HB2' HD11 ' A' ' 29' ' ' LEU . 4.3 p -105.56 111.84 24.7 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.085 0.469 . . . . 0.0 111.035 -177.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.671 ' CG1' ' HB ' ' A' ' 30' ' ' ILE . 11.7 p -106.68 143.25 17.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.053 0.454 . . . . 0.0 110.455 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.604 ' HB2' ' HB3' ' A' ' 118' ' ' LYS . 96.3 mt -100.98 121.43 41.75 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.123 -178.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.781 HG23 ' HA2' ' A' ' 114' ' ' GLY . 43.2 mm -102.49 127.29 56.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.303 -176.078 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -85.64 -168.27 44.51 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.98 177.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.424 ' HE3' ' HB2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -76.69 44.97 0.39 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 117.038 0.419 . . . . 0.0 111.779 -178.495 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.699 ' HA ' ' HG2' ' A' ' 24' ' ' GLN . 64.4 tttm 177.31 -29.63 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -178.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.781 ' HA2' HG23 ' A' ' 110' ' ' ILE . . . 115.62 -87.04 0.43 Allowed Glycine 0 N--CA 1.437 -1.285 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.832 177.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.563 ' HA ' ' HB ' ' A' ' 4' ' ' THR . 2.6 mm-40 55.68 2.79 0.07 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.545 1.138 . . . . 0.0 113.56 178.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.511 HD13 ' HA ' ' A' ' 99' ' ' PHE . 4.8 mt 49.54 77.27 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 121.574 0.702 . . . . 0.0 109.934 -174.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.8 mt -77.15 -73.62 0.29 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.435 -171.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.604 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 21.7 tptm -119.21 149.2 42.15 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.678 -170.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 31.5 m -134.19 118.69 17.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.023 0.439 . . . . 0.0 111.348 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -109.55 145.66 35.97 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.393 175.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.2 m -105.21 121.39 57.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.543 176.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.76 -126.48 8.47 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.466 -0.874 . . . . 0.0 111.649 -177.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -87.07 119.06 70.83 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.678 0.275 . . . . 0.0 111.074 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -77.37 121.62 5.73 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.42 2.08 . . . . 0.0 111.091 172.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -60.73 112.0 1.85 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.3 0.571 . . . . 0.0 110.304 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.57 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 81.3 m-85 -59.47 -29.64 67.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.317 -0.856 . . . . 0.0 113.024 -171.009 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -57.05 -53.93 40.78 Favored Glycine 0 C--O 1.237 0.289 0 C-N-CA 120.156 -1.021 . . . . 0.0 112.081 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.599 ' HA ' ' HG2' ' A' ' 131' ' ' GLN . 5.9 ttpm? -80.18 -28.22 38.78 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.57 ' HB3' ' HA ' ' A' ' 126' ' ' PHE . 48.7 tp -61.15 -47.58 85.53 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 177.002 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -62.45 -48.84 77.86 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.369 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.599 ' HG2' ' HA ' ' A' ' 128' ' ' LYS . 4.2 pt20 -68.47 -31.4 70.66 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.494 -178.141 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -71.79 -39.14 70.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.73 0.3 . . . . 0.0 110.338 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 80.4 mt -67.82 -39.37 81.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 173.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.563 ' HA ' ' HB2' ' A' ' 137' ' ' TRP . 27.6 t70 -63.56 -27.9 69.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.47 176.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 88.1 m -64.16 -45.73 87.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.335 -0.393 . . . . 0.0 109.96 174.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -65.56 -31.11 71.98 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.29 176.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.563 ' HB2' ' HA ' ' A' ' 134' ' ' ASP . 0.6 OUTLIER -62.16 -44.39 96.71 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.668 174.088 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.442 HH11 ' HD3' ' A' ' 138' ' ' ARG . 34.8 mmt180 -74.99 -31.08 61.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.51 -178.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -74.96 88.97 2.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.11 0.481 . . . . 0.0 110.798 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 20.8 p -81.39 95.11 6.94 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.231 176.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -67.92 98.92 0.79 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.628 0.728 . . . . 0.0 111.165 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -163.35 -53.16 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.749 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -150.31 136.08 18.35 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 174.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -161.65 21.88 0.21 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.285 -177.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 50.71 81.79 0.06 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.307 0.575 . . . . 0.0 111.892 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -127.85 126.34 41.44 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.237 179.23 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -158.18 77.78 0.8 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.709 175.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -168.67 -59.45 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.569 ' O ' ' HB2' ' A' ' 150' ' ' HIS . 56.6 t-80 -100.65 66.52 1.22 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 167.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.569 ' HB2' ' O ' ' A' ' 149' ' ' HIS . 77.3 m-70 . . . . . 0 C--O 1.247 0.958 0 O-C-N 124.845 1.34 . . . . 0.0 109.056 -161.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.482 1.144 0 N-CA-C 110.665 -0.124 . . . . 0.0 110.665 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.5 m -55.85 133.94 51.56 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 123.446 0.466 . . . . 0.0 111.026 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.2 ptmt -85.29 175.09 9.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.444 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.413 ' HB ' ' HG3' ' A' ' 115' ' ' GLU . 47.1 p 49.94 68.82 0.69 Allowed 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 123.421 0.689 . . . . 0.0 111.782 -173.135 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.552 ' HB2' ' O ' ' A' ' 114' ' ' GLY . . . 60.75 107.45 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.403 0 CA-C-N 114.572 -1.194 . . . . 0.0 112.85 177.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 5' ' ' ALA . 3.7 Cg_exo -81.15 16.0 1.74 Allowed 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 123.169 2.579 . . . . 0.0 113.122 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 56.58 28.79 14.46 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.13 0.572 . . . . 0.0 112.251 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.459 ' HD1' ' HD2' ' A' ' 6' ' ' PRO . 54.5 p90 -66.02 137.99 57.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.884 -178.329 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.8 m -143.69 94.48 2.6 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.195 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.411 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 1.5 pt? -119.96 156.48 54.33 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-O 120.555 0.217 . . . . 0.0 110.581 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.592 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 3.7 Cg_exo -77.37 144.48 23.02 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 123.046 2.497 . . . . 0.0 112.416 178.424 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.418 ' HA ' ' HG2' ' A' ' 88' ' ' MET . 2.3 p30 -95.7 -176.88 3.87 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 175.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.551 HD11 HG12 ' A' ' 74' ' ' VAL . 63.2 mt -60.33 -20.75 60.51 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -173.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -76.77 -11.39 59.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.821 0.343 . . . . 0.0 110.771 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.7 16.55 58.19 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.839 -0.695 . . . . 0.0 112.377 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 11' ' ' PRO . 21.0 pttp -114.84 151.23 34.25 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 177.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.592 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 23.6 m -93.57 123.63 37.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.015 0.436 . . . . 0.0 112.083 -174.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.4 m -97.81 153.65 3.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 173.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.2 p -141.01 -178.5 5.59 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.198 0.523 . . . . 0.0 111.326 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.487 ' OD1' ' HB1' ' A' ' 5' ' ' ALA . 0.9 OUTLIER -68.54 -22.0 64.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.583 177.639 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.48 -31.75 72.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.051 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -70.69 -20.82 62.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.016 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.594 HD13 HG21 ' A' ' 110' ' ' ILE . 24.6 mt -83.26 -22.04 33.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.126 -174.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -62.92 144.37 56.82 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.631 -173.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.67 -25.24 4.02 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.791 -0.641 . . . . 0.0 113.847 173.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -121.26 -176.01 3.19 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 122.412 -0.464 . . . . 0.0 110.626 -174.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.2 t -108.46 141.89 22.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 175.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.602 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 33.1 m -133.93 137.98 45.21 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.83 0.347 . . . . 0.0 111.281 -174.083 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.578 HD11 ' HB2' ' A' ' 107' ' ' SER . 52.3 tp -109.63 107.51 17.59 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.23 175.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.669 ' HB ' ' CG2' ' A' ' 108' ' ' VAL . 50.6 mt -93.74 112.41 26.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 172.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -119.82 124.22 45.59 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.872 0.368 . . . . 0.0 110.862 -176.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.406 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 95.9 m-85 -90.47 125.43 35.58 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.827 -178.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.557 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 10.5 p-90 -146.17 -174.06 4.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.057 -178.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -156.92 146.57 15.39 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 172.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.446 ' HG3' ' HA ' ' A' ' 74' ' ' VAL . 78.3 Cg_exo -43.96 -59.17 1.15 Allowed 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 123.781 2.988 . . . . 0.0 114.744 -175.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.3 t -83.44 24.78 0.8 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.99 0.424 . . . . 0.0 111.322 -173.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 54.0 t -75.62 132.84 74.49 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.346 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -61.88 -19.01 64.17 Favored 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 122.662 2.242 . . . . 0.0 112.022 176.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.97 -10.98 84.08 Favored Glycine 0 C--O 1.224 -0.521 0 C-N-CA 121.226 -0.511 . . . . 0.0 112.99 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 25.4 p -58.12 -39.37 78.51 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 117.213 0.506 . . . . 0.0 111.648 -175.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.1 p -62.24 -34.42 63.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.855 0.36 . . . . 0.0 110.929 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.8 m -88.03 -54.72 4.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.052 0.453 . . . . 0.0 111.03 178.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.402 ' O ' HG12 ' A' ' 47' ' ' ILE . 73.7 mm-40 -66.27 -50.14 64.75 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -172.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.726 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 49.6 tpp -53.3 -55.53 33.48 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -168.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.726 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 24.5 Cg_exo -64.51 -36.02 45.62 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 121.822 1.682 . . . . 0.0 112.264 178.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -64.36 -40.06 95.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.577 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 43' ' ' GLU . 30.5 mm -60.87 -46.68 95.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.699 177.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 49.2 mm -55.66 -53.32 38.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.43 -177.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -69.37 -43.11 74.21 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.606 -174.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.3 m -65.26 -44.92 86.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.994 0.426 . . . . 0.0 110.921 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.52 ' HB1' HG21 ' A' ' 61' ' ' VAL . . . -65.65 -42.84 90.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.806 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -56.26 -40.05 73.59 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.51 -178.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -68.38 -51.14 47.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.341 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 1.006 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 60.5 m-85 -74.8 -28.99 60.95 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -174.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -59.44 -27.02 65.69 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 122.479 0.312 . . . . 0.0 111.61 -177.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -73.92 -22.51 59.66 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -172.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 1.006 ' HE2' ' HA ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -95.78 -62.08 1.35 Allowed 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.625 176.121 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 176.96 68.46 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.806 0.813 . . . . 0.0 111.303 -173.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.506 ' HZ ' ' HB2' ' A' ' 29' ' ' LEU . 41.2 t80 -135.83 132.43 36.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.287 -178.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -105.89 143.07 34.55 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.52 HG21 ' HB1' ' A' ' 51' ' ' ALA . 43.7 t -122.8 115.38 45.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.087 -177.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 88.5 mt -116.69 95.91 5.25 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.335 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.07 105.46 17.83 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 43.0 t -98.94 114.09 35.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 120.969 0.414 . . . . 0.0 110.564 -175.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.557 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -82.71 117.57 22.73 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.723 176.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.623 ' HG3' HG12 ' A' ' 68' ' ' ILE . 27.9 pt20 -74.1 163.43 68.39 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.965 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.604 ' HD2' ' HB2' ' A' ' 66' ' ' GLN . 72.1 Cg_endo -74.91 55.09 3.79 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.735 2.29 . . . . 0.0 114.035 -172.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.623 HG12 ' HG3' ' A' ' 66' ' ' GLN . 50.0 mm -93.12 -69.99 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 172.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -81.74 153.55 70.37 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.779 176.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -61.26 157.26 41.05 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.479 2.119 . . . . 0.0 112.33 177.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.0 tp -57.26 -31.3 37.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.917 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -64.54 -42.92 95.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.532 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.3 m -63.27 -34.76 78.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.814 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.551 HG12 HD11 ' A' ' 13' ' ' LEU . 34.8 t -64.13 -44.92 97.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.17 176.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -65.53 -34.62 78.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.651 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -62.48 -41.78 99.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.888 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.88 -43.1 97.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.751 -0.204 . . . . 0.0 110.863 178.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.563 ' HA ' HD12 ' A' ' 83' ' ' LEU . 42.1 t -63.16 -37.44 79.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.156 0.503 . . . . 0.0 110.345 176.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.0 tttm -61.97 -55.25 31.32 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.655 0.74 . . . . 0.0 111.141 176.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.03 -39.39 69.16 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.539 -1.21 . . . . 0.0 113.204 -173.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -104.99 0.76 28.02 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -174.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.05 -82.25 1.68 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.192 177.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.563 HD12 ' HA ' ' A' ' 78' ' ' VAL . 54.6 mt 61.59 93.33 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.417 0.627 . . . . 0.0 112.523 171.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -87.33 2.36 6.84 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 123.11 2.54 . . . . 0.0 113.667 -177.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -90.91 166.02 13.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.636 0.255 . . . . 0.0 110.625 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 20.2 m -77.04 113.52 14.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.069 0.462 . . . . 0.0 110.908 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.407 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 14.8 t -107.67 125.49 64.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.599 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.418 ' HG2' ' HA ' ' A' ' 12' ' ' ASP . 72.4 mtm -116.67 173.09 6.82 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.149 177.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -132.04 122.55 25.66 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.865 0.364 . . . . 0.0 110.245 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.544 ' HB3' ' HA ' ' A' ' 66' ' ' GLN . 45.8 t0 -82.81 119.23 24.1 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 176.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.74 -42.44 61.12 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -171.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -126.89 15.26 7.43 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.527 0.203 . . . . 0.0 111.124 -174.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.413 ' NZ ' ' HB3' ' A' ' 93' ' ' LYS . 5.9 ttpm? 68.35 20.34 8.68 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.544 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -77.23 -25.65 51.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.967 -174.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 41.0 t -74.82 -40.47 46.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.93 -38.9 96.07 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.485 173.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -68.72 -26.48 65.28 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 122.546 0.338 . . . . 0.0 111.173 176.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.94 -47.03 72.91 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.832 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -82.89 -26.9 31.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.484 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 95.64 55.4 1.33 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.404 178.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.452 HG22 HG21 ' A' ' 106' ' ' THR . 21.3 p -63.31 112.14 2.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.085 0.469 . . . . 0.0 111.71 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -77.52 -58.16 3.42 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.014 177.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.466 HG12 ' HB ' ' A' ' 121' ' ' VAL . 7.8 p -145.71 147.44 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.656 -175.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.485 ' HA ' ' C ' ' A' ' 105' ' ' PRO . 76.5 m-85 -102.54 147.44 34.02 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.036 -174.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.485 ' C ' ' HA ' ' A' ' 104' ' ' TYR . 38.1 Cg_endo -70.06 154.45 94.07 Favored 'Cis proline' 0 C--N 1.346 0.436 0 C-N-CA 123.305 -1.54 . . . . 0.0 112.838 0.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.452 HG21 HG22 ' A' ' 101' ' ' THR . 24.7 m -121.7 112.45 18.42 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.163 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.578 ' HB2' HD11 ' A' ' 29' ' ' LEU . 5.4 p -110.49 114.18 27.4 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.271 0.558 . . . . 0.0 111.176 -177.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.669 ' CG2' ' HB ' ' A' ' 30' ' ' ILE . 17.2 m -105.74 142.33 19.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.058 0.456 . . . . 0.0 110.737 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.554 ' HB2' ' HB2' ' A' ' 118' ' ' LYS . 81.5 mt -102.35 125.36 49.04 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.715 -177.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.602 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 12.1 mm -103.95 137.18 33.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.717 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -86.85 -167.6 43.91 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.274 -177.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.72 ' HD3' ' HA ' ' A' ' 141' ' ' ASP . 36.8 mttm -86.97 34.44 0.67 Allowed 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 122.003 0.906 . . . . 0.0 108.967 -175.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.519 ' HB3' ' OE1' ' A' ' 115' ' ' GLU . 29.0 mmtm -148.59 -35.46 0.2 Allowed 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 114.206 -1.361 . . . . 0.0 110.846 -165.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.552 ' O ' ' HB2' ' A' ' 5' ' ' ALA . . . 113.65 -28.7 8.35 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -174.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.519 ' OE1' ' HB3' ' A' ' 113' ' ' LYS . 1.2 mp0 -54.61 141.23 32.48 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 114.89 -0.655 . . . . 0.0 110.944 176.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.411 HG13 ' H ' ' A' ' 5' ' ' ALA . 6.7 mt -80.19 122.96 36.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.592 -178.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.6 mt -98.88 -60.53 1.52 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.048 0.451 . . . . 0.0 111.466 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.554 ' HB2' ' HB2' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -124.95 159.22 31.71 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.989 -170.542 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 57.9 m -141.13 103.58 4.48 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.414 170.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -92.46 131.87 37.25 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.4 176.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.466 ' HB ' HG12 ' A' ' 103' ' ' VAL . 6.0 m -101.22 116.04 44.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.906 178.072 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 83.48 -106.82 2.86 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.191 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -89.68 114.11 59.35 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-O 120.524 0.202 . . . . 0.0 110.783 -176.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.24 98.34 0.92 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.375 2.05 . . . . 0.0 111.85 175.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -49.67 111.97 0.58 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.92 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.403 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 80.8 m-85 -66.73 -34.11 77.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.179 -175.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -60.12 -52.18 54.32 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.597 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.581 ' HA ' ' HG2' ' A' ' 131' ' ' GLN . 25.9 mtmm -76.86 -24.31 52.65 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.678 -0.261 . . . . 0.0 110.837 178.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.439 ' O ' HG13 ' A' ' 133' ' ' ILE . 53.5 tp -62.48 -48.76 78.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.913 0.387 . . . . 0.0 110.087 175.039 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -63.3 -46.22 87.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.412 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.581 ' HG2' ' HA ' ' A' ' 128' ' ' LYS . 13.5 pt20 -70.93 -34.13 71.2 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.418 -176.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.411 ' O ' ' HB ' ' A' ' 135' ' ' THR . 20.3 tt0 -78.96 -31.88 45.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.57 0.224 . . . . 0.0 110.746 -177.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.444 ' O ' ' HB2' ' A' ' 137' ' ' TRP . 59.0 mt -61.28 -47.52 93.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 172.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.513 ' O ' ' HG2' ' A' ' 138' ' ' ARG . 21.5 t70 -60.14 -32.98 71.54 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.594 175.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 132' ' ' GLU . 69.9 m -57.25 -52.06 66.86 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.856 0.36 . . . . 0.0 110.459 177.098 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.34 -24.09 57.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.32 0.581 . . . . 0.0 110.616 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.444 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 21.7 t-105 -66.07 -30.62 71.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.263 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.513 ' HG2' ' O ' ' A' ' 134' ' ' ASP . 7.2 mmp_? -85.35 -37.14 20.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.11 178.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -87.59 107.35 18.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.204 -171.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 11.6 t 59.74 70.3 0.65 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.466 175.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.72 ' HA ' ' HD3' ' A' ' 112' ' ' LYS . 9.7 t70 -59.24 -42.83 91.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.127 177.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -120.85 -66.43 1.06 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.669 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -123.05 171.31 9.37 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -75.07 -72.07 1.08 Allowed Glycine 0 CA--C 1.521 0.457 0 C-N-CA 121.362 -0.447 . . . . 0.0 114.068 -175.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 -159.23 30.39 0.2 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 117.095 0.448 . . . . 0.0 110.773 -172.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 31.4 m80 64.04 51.88 2.16 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.667 0.746 . . . . 0.0 109.383 -170.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 -69.67 147.68 50.3 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.746 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -69.19 155.12 40.93 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.007 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -75.64 -18.16 59.76 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.305 0.574 . . . . 0.0 109.587 176.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 74.7 t60 . . . . . 0 C--O 1.244 0.785 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.326 174.728 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.599 ' HA ' ' HB3' ' A' ' 6' ' ' PRO . 3.5 p30 . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 110.585 -0.154 . . . . 0.0 110.585 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.1 m 61.56 -169.62 0.17 Allowed 'General case' 0 C--O 1.234 0.254 0 O-C-N 123.859 0.724 . . . . 0.0 111.612 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.0 tttm 60.96 -101.47 0.11 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.724 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.3 p -122.63 80.04 1.7 Allowed 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.714 -178.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.675 ' H ' HG13 ' A' ' 116' ' ' ILE . . . 67.94 128.73 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.4 0 CA-C-N 114.826 -1.079 . . . . 0.0 113.087 176.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.599 ' HB3' ' HA ' ' A' ' 1' ' ' ASP . 86.3 Cg_endo -90.26 -174.19 0.76 Allowed 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 123.016 2.478 . . . . 0.0 110.905 171.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.86 83.42 2.54 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.909 0.385 . . . . 0.0 110.117 175.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.438 ' HZ ' HD11 ' A' ' 23' ' ' LEU . 34.3 p90 -114.33 140.95 48.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.222 0.534 . . . . 0.0 111.005 -176.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.5 t -139.7 90.22 2.38 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 173.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.552 HD22 ' HD2' ' A' ' 11' ' ' PRO . 1.8 tm? -116.9 119.83 34.76 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.261 -166.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.565 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 40.0 Cg_endo -68.41 128.48 17.37 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.749 2.299 . . . . 0.0 112.213 176.087 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.557 ' HA ' ' HG3' ' A' ' 88' ' ' MET . 0.0 OUTLIER -62.67 164.91 7.05 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.416 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 87' ' ' VAL . 4.2 pp -66.3 -18.22 65.22 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.668 -172.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 16.6 t-80 -84.7 -25.95 28.03 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.926 0.393 . . . . 0.0 110.373 176.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.475 ' C ' ' HE2' ' A' ' 16' ' ' LYS . . . 123.6 8.54 6.28 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.572 -0.823 . . . . 0.0 113.735 174.05 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.475 ' HE2' ' C ' ' A' ' 15' ' ' GLY . 0.8 OUTLIER -94.55 120.31 34.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 117.378 0.589 . . . . 0.0 110.612 179.147 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 10.3 m -67.28 126.09 28.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.448 -177.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.534 HG12 ' O ' ' A' ' 10' ' ' LEU . 1.7 p -116.55 135.31 57.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 177.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.5 m -146.54 -173.08 4.11 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 122.11 -0.369 . . . . 0.0 111.303 -177.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -54.81 -39.66 68.73 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -176.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.04 -27.21 66.74 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -177.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -73.2 -25.93 60.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.021 0.438 . . . . 0.0 110.515 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.582 HD22 HG21 ' A' ' 28' ' ' THR . 33.5 mt -83.39 -51.7 7.16 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.087 -176.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -56.11 130.92 46.09 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.367 -172.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.76 -25.15 28.45 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.104 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.585 ' HG2' ' OD1' ' A' ' 58' ' ' ASN . 8.1 mtpm? -124.49 172.97 8.77 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -177.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.511 HG21 ' HZ3' ' A' ' 137' ' ' TRP . 11.1 t -103.82 139.71 24.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 176.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.805 HG23 HD13 ' A' ' 62' ' ' LEU . 85.2 m -126.73 139.14 53.36 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -168.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.718 ' HB2' ' CE2' ' A' ' 59' ' ' PHE . 27.0 tp -110.02 107.37 17.23 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.74 172.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.554 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 28.6 mt -98.62 111.35 28.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.316 173.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -109.29 122.84 48.22 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.106 -177.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.436 ' CE1' ' HA2' ' A' ' 96' ' ' GLY . 97.2 m-85 -91.15 118.93 30.84 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.86 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.664 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 10.6 p-90 -148.5 -178.86 6.56 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.829 -177.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.558 ' O ' ' HB2' ' A' ' 37' ' ' CYS . 41.0 p90 -155.09 144.84 15.49 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 178.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.838 ' HG2' ' HB3' ' A' ' 69' ' ' ASP . 12.4 Cg_endo -59.71 152.03 65.98 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.168 1.912 . . . . 0.0 111.433 174.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.9 m 68.89 18.81 8.46 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 123.529 0.518 . . . . 0.0 111.091 -177.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.558 ' HB2' ' O ' ' A' ' 34' ' ' PHE . 45.1 t -68.33 140.45 92.8 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.452 -178.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -72.61 -22.96 20.27 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.821 2.347 . . . . 0.0 111.893 173.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.3 -1.21 88.08 Favored Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.923 -0.581 . . . . 0.0 113.147 -176.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.43 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 90.9 m -56.92 -30.4 63.94 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.876 0.338 . . . . 0.0 111.672 -177.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.4 t -49.97 -50.11 19.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.081 0.467 . . . . 0.0 110.641 177.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.4 m -87.2 -54.87 4.08 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.05 177.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.506 ' HA ' ' HD3' ' A' ' 46' ' ' LYS . 49.3 mm-40 -59.79 -40.85 89.7 Favored 'General case' 0 C--O 1.226 -0.139 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -168.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.817 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -59.12 -60.86 9.17 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -169.667 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.817 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 19.5 Cg_exo -67.11 -29.48 39.77 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 121.958 1.772 . . . . 0.0 111.488 178.101 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.506 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 64.8 tttt -59.79 -42.91 94.42 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.09 177.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.435 HG12 ' O ' ' A' ' 43' ' ' GLU . 41.0 mm -71.63 -38.95 68.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.352 177.141 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.722 HD13 ' HE2' ' A' ' 85' ' ' PHE . 47.6 mm -55.46 -53.63 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.2 -179.242 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -66.03 -49.33 68.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.287 -178.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 31.6 m -61.8 -54.67 39.12 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.782 -174.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.52 -33.59 73.03 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -173.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -75.79 -40.48 55.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.816 0.341 . . . . 0.0 111.173 -178.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -70.93 -42.99 69.12 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.844 0.354 . . . . 0.0 110.769 -176.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.617 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 42.8 m-85 -76.06 -10.32 59.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.714 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -56.71 -27.65 59.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.041 0.448 . . . . 0.0 110.954 -178.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -102.89 14.81 31.04 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.519 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.591 ' HD3' ' HA ' ' A' ' 54' ' ' TYR . 13.6 mptt -111.62 23.49 13.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.755 176.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.585 ' OD1' ' HG2' ' A' ' 26' ' ' LYS . 66.2 t30 68.11 18.46 9.37 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 122.078 0.942 . . . . 0.0 109.795 -176.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.718 ' CE2' ' HB2' ' A' ' 29' ' ' LEU . 38.5 t80 -100.03 162.01 13.25 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.557 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -150.42 152.55 34.5 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.248 0.547 . . . . 0.0 112.064 -177.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 1.026 HG11 ' HB3' ' A' ' 85' ' ' PHE . 1.5 p -101.08 125.88 54.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 114.816 -1.083 . . . . 0.0 111.119 -178.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.805 HD13 HG23 ' A' ' 28' ' ' THR . 8.7 mp -128.63 94.31 3.83 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 169.112 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -101.05 102.01 12.9 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.546 -176.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.979 HG12 ' HB2' ' A' ' 88' ' ' MET . 26.7 m -97.08 127.47 49.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.441 0.638 . . . . 0.0 111.118 -176.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.664 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -95.2 135.83 36.28 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.676 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.679 ' HB2' ' HG2' ' A' ' 93' ' ' LYS . 4.3 pm0 -95.2 161.47 28.0 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 175.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.607 ' HD2' ' HB2' ' A' ' 66' ' ' GLN . 73.8 Cg_endo -74.04 54.03 3.05 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.903 2.402 . . . . 0.0 114.555 -168.055 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 45.7 mm -83.27 -27.85 7.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 170.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.838 ' HB3' ' HG2' ' A' ' 35' ' ' PRO . 0.6 OUTLIER -138.89 136.17 18.24 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 173.44 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -51.83 163.98 1.18 Allowed 'Trans proline' 0 N--CA 1.477 0.553 0 C-N-CA 123.509 2.806 . . . . 0.0 114.587 -175.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.8 tp -56.73 -34.92 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.574 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -66.47 -35.47 80.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.195 0.522 . . . . 0.0 110.419 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 27.3 m -64.89 -47.69 76.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.306 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.491 ' HB ' ' HG3' ' A' ' 35' ' ' PRO . 9.2 p -67.18 -33.95 66.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.652 0.263 . . . . 0.0 110.814 -178.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -65.89 -37.54 86.39 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.005 0.431 . . . . 0.0 110.993 176.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 15.4 tm0? -69.76 -36.55 75.89 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -64.2 -50.75 66.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.979 -178.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.635 HG23 ' HB2' ' A' ' 83' ' ' LEU . 10.4 p -60.5 -30.21 46.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-O 120.754 0.312 . . . . 0.0 110.643 178.358 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -70.67 -55.37 8.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.239 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -66.25 -48.38 70.7 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.117 -174.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -82.55 -18.41 41.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.441 -176.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 69.08 63.74 3.31 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.98 177.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.635 ' HB2' HG23 ' A' ' 78' ' ' VAL . 8.4 mp -87.64 111.03 39.21 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 120.633 0.254 . . . . 0.0 110.383 178.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -89.98 24.54 0.62 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.899 2.399 . . . . 0.0 113.168 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 1.026 ' HB3' HG11 ' A' ' 61' ' ' VAL . 13.0 m-85 -121.15 155.28 34.85 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.1 m -68.2 123.56 21.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.1 0.476 . . . . 0.0 111.86 -173.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.448 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 48.7 t -122.62 135.19 63.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.822 -178.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.979 ' HB2' HG12 ' A' ' 64' ' ' VAL . 2.3 mpt? -117.13 175.5 5.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 93.6 t80 -138.51 117.18 12.21 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.241 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.598 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 21.1 t0 -103.98 114.26 28.38 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.49 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.0 -14.87 61.09 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -174.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -122.4 0.67 9.49 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.46 -175.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.679 ' HG2' ' HB2' ' A' ' 66' ' ' GLN . 49.3 mtmt 64.37 15.1 9.28 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 123.58 0.55 . . . . 0.0 109.903 -171.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.9 -44.27 93.47 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -165.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.545 HG22 ' OD2' ' A' ' 90' ' ' ASP . 28.2 m -74.14 -29.32 24.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.231 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.436 ' HA2' ' CE1' ' A' ' 32' ' ' PHE . . . -72.1 -34.78 61.3 Favored Glycine 0 CA--C 1.509 -0.282 0 C-N-CA 120.541 -0.837 . . . . 0.0 111.29 174.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -71.03 -28.84 64.69 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.007 -0.596 . . . . 0.0 110.224 174.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.402 ' HB1' ' HB2' ' A' ' 1' ' ' ASP . . . -74.21 -22.71 59.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.233 175.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -87.65 -22.91 24.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.998 176.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 93.23 62.99 1.09 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.574 176.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.9 p -103.95 127.16 51.49 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.878 0.371 . . . . 0.0 111.244 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -87.81 -50.75 6.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.127 0.489 . . . . 0.0 110.31 176.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.4 p -145.08 149.15 17.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.087 -176.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.556 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 59.2 m-85 -106.21 161.46 22.78 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.215 -176.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.556 ' HA ' ' HB3' ' A' ' 104' ' ' TYR . 74.4 Cg_endo -74.39 165.5 85.24 Favored 'Cis proline' 0 C--N 1.351 0.684 0 C-N-CA 123.772 -1.345 . . . . 0.0 113.233 0.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.3 m -139.77 132.44 28.92 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.623 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.546 ' HB3' ' HB2' ' A' ' 120' ' ' TYR . 18.8 t -112.33 112.15 23.52 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.697 HG22 HG22 ' A' ' 119' ' ' THR . 55.5 t -105.99 131.6 55.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.898 0.38 . . . . 0.0 111.489 -175.094 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 90.2 mt -102.98 125.73 49.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.997 177.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.566 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 53.6 mt -118.05 141.09 38.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 123.445 0.466 . . . . 0.0 110.715 -179.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -85.8 -167.17 43.11 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 116.155 -0.475 . . . . 0.0 113.574 -177.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.4 -20.58 50.87 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -173.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.416 ' HB3' ' CD ' ' A' ' 115' ' ' GLU . 3.7 ttmp? -99.17 -3.18 35.01 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.554 0.692 . . . . 0.0 109.2 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.543 ' O ' ' HB2' ' A' ' 5' ' ' ALA . . . 97.29 12.64 48.01 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.67 -178.016 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.416 ' CD ' ' HB3' ' A' ' 113' ' ' LYS . 3.7 mp0 -68.15 122.15 17.68 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -178.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.675 HG13 ' H ' ' A' ' 5' ' ' ALA . 29.8 mt -74.01 93.76 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 174.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 93.4 mt -75.38 -70.3 0.43 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.596 -171.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.452 ' HD2' ' HA ' ' A' ' 118' ' ' LYS . 22.7 mmmt -125.44 144.72 50.4 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.148 -171.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.697 HG22 HG22 ' A' ' 108' ' ' VAL . 1.6 p -120.99 104.16 9.59 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.374 175.023 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.546 ' HB2' ' HB3' ' A' ' 107' ' ' SER . 22.6 m-85 -85.05 103.43 14.07 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.87 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.6 t -83.0 109.74 17.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.988 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 86.31 -116.83 4.48 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.375 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.453 ' OE1' ' HD2' ' A' ' 124' ' ' PRO . 7.1 tp10 -103.72 116.63 61.49 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-O 120.531 0.205 . . . . 0.0 110.812 -174.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.492 ' HB3' ' CG ' ' A' ' 120' ' ' TYR . 93.2 Cg_endo -86.54 -159.58 0.1 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 123.027 2.485 . . . . 0.0 112.254 175.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.848 ' HB3' ' HG2' ' A' ' 128' ' ' LYS . 18.2 t70 -125.27 124.27 41.29 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.861 177.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -65.54 -37.53 86.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.504 -175.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.77 -50.98 55.69 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.201 -178.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.848 ' HG2' ' HB3' ' A' ' 125' ' ' ASP . 11.9 ptmm? -67.5 -26.13 66.19 Favored 'General case' 0 C--O 1.221 -0.443 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.184 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 51.4 tp -61.08 -47.36 86.69 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.233 0.333 . . . . 0.0 110.224 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -62.24 -54.48 40.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.149 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.492 ' HG2' ' HA ' ' A' ' 128' ' ' LYS . 13.7 pt20 -65.99 -33.88 76.82 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -175.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -71.02 -45.78 63.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.477 0.18 . . . . 0.0 110.69 -177.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 72.7 mt -66.51 -36.26 76.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 177.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.616 ' HA ' ' CD1' ' A' ' 137' ' ' TRP . 14.2 t70 -61.46 -47.87 83.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.61 175.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 45.0 m -55.57 -35.23 65.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.185 0.517 . . . . 0.0 110.328 176.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.6 -18.5 62.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.162 -178.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.616 ' CD1' ' HA ' ' A' ' 134' ' ' ASP . 2.9 m95 -56.71 -56.96 14.8 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.304 0.573 . . . . 0.0 109.848 177.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.429 ' HD3' ' HB2' ' A' ' 137' ' ' TRP . 0.1 OUTLIER -88.76 -57.55 2.87 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.015 -179.166 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -87.4 91.3 8.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.669 -169.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 20.5 m -110.86 78.38 1.11 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 171.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -143.23 169.34 17.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.906 -171.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -78.55 -0.5 29.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.933 0.397 . . . . 0.0 110.893 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -80.7 5.92 14.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.973 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.3 -61.85 6.66 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 121.253 -0.498 . . . . 0.0 112.861 -178.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -141.9 136.42 30.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.62 0.248 . . . . 0.0 110.394 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -90.71 -2.58 57.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.008 0.432 . . . . 0.0 111.068 178.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -98.11 118.56 35.01 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 171.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -76.99 81.78 3.52 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.415 0.626 . . . . 0.0 111.085 -174.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 50.6 m-70 -119.59 -177.06 3.29 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.308 173.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 . . . . . 0 C--O 1.246 0.869 0 CA-C-O 118.885 -0.578 . . . . 0.0 109.707 -179.302 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.788 ' HB2' ' HB3' ' A' ' 8' ' ' PHE . 4.5 t70 . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.55 ' HB2' ' HG2' ' A' ' 6' ' ' PRO . 16.3 m -167.03 -70.28 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -178.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -161.92 142.34 10.41 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 175.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.559 ' H ' HD12 ' A' ' 116' ' ' ILE . 10.8 m 69.63 31.16 3.72 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 122.083 0.944 . . . . 0.0 110.274 -178.05 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.499 ' N ' ' HD3' ' A' ' 6' ' ' PRO . . . 58.9 61.52 4.7 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 114.245 -1.343 . . . . 0.0 114.116 173.103 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.582 ' HD2' ' CG ' ' A' ' 1' ' ' ASP . 17.3 Cg_exo -73.76 39.59 0.51 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.156 2.57 . . . . 0.0 112.473 167.112 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.403 ' H ' ' C ' ' A' ' 5' ' ' ALA . . . 75.27 113.65 0.07 Allowed 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.954 0.901 . . . . 0.0 112.893 174.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.788 ' HB3' ' HB2' ' A' ' 1' ' ' ASP . 27.3 p90 -141.78 131.58 24.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.912 171.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 26.0 p -149.35 103.09 3.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.868 0.365 . . . . 0.0 110.921 -179.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.451 ' H ' HD23 ' A' ' 10' ' ' LEU . 1.6 pt? -120.1 157.27 53.49 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.766 178.162 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.13 150.65 26.33 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 121.992 1.795 . . . . 0.0 112.228 177.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.591 ' HA ' ' HG3' ' A' ' 88' ' ' MET . 0.0 OUTLIER -81.41 176.6 9.57 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.035 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 87' ' ' VAL . 78.4 mt -57.42 -26.25 60.85 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -177.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 47.4 t60 -91.29 -40.84 11.27 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 121.355 -0.138 . . . . 0.0 110.783 178.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.93 4.01 0.87 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.063 -1.065 . . . . 0.0 113.804 176.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -78.47 126.74 31.19 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 117.468 0.634 . . . . 0.0 110.212 178.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.7 m -66.97 130.51 43.38 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.851 0.358 . . . . 0.0 110.12 176.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 9' ' ' SER . 9.8 p -118.21 138.13 49.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.342 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.0 p -138.69 -177.63 4.95 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.312 0.577 . . . . 0.0 112.091 -173.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -71.36 -21.7 62.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.665 175.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.65 -31.34 72.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.682 178.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -63.72 -23.26 67.3 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.805 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.62 HD22 HG21 ' A' ' 28' ' ' THR . 25.0 mt -84.06 -20.53 32.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.125 -172.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.418 ' HA ' ' OE1' ' A' ' 24' ' ' GLN . 14.7 mm-40 -60.82 113.09 2.31 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -172.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 113.23 -19.57 19.97 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.341 174.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.449 ' HB2' ' OE1' ' A' ' 60' ' ' GLN . 68.0 mttm -124.87 169.84 11.65 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.036 0.418 . . . . 0.0 110.945 -176.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.612 HG13 ' CD1' ' A' ' 59' ' ' PHE . 3.3 p -102.63 123.77 56.18 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.625 -177.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.62 HG21 HD22 ' A' ' 23' ' ' LEU . 39.0 m -116.01 142.99 46.07 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -160.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.498 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 55.7 tp -112.04 111.04 21.67 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.712 170.286 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.596 ' HB ' ' HB ' ' A' ' 108' ' ' VAL . 62.8 mt -97.9 111.96 28.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 171.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -112.73 122.39 47.54 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.5 -176.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.505 ' HB2' ' HB ' ' A' ' 106' ' ' THR . 89.5 m-85 -94.85 119.89 34.16 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.515 178.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.557 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 18.0 p-90 -147.54 175.33 10.93 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.338 -177.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -154.43 145.04 16.02 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 174.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.526 ' HG2' ' HB3' ' A' ' 69' ' ' ASP . 6.0 Cg_exo -39.12 -66.3 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 124.323 3.349 . . . . 0.0 114.419 -173.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.8 m -77.12 57.12 1.35 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.005 0.431 . . . . 0.0 112.049 -178.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.3 t -117.27 132.74 23.36 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.292 177.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.588 ' O ' HG12 ' A' ' 41' ' ' VAL . 31.4 Cg_exo -60.42 -20.05 61.6 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.565 2.177 . . . . 0.0 112.174 176.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.69 -22.46 78.68 Favored Glycine 0 C--O 1.224 -0.521 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.76 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.682 ' HA ' ' HG3' ' A' ' 44' ' ' MET . 64.1 m -60.36 -35.08 74.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.912 0.356 . . . . 0.0 111.464 -177.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.588 HG12 ' O ' ' A' ' 38' ' ' PRO . 13.5 p -67.33 -40.23 84.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.168 -176.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.8 p -89.25 -49.72 6.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.942 0.401 . . . . 0.0 111.894 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.511 ' O ' HG12 ' A' ' 47' ' ' ILE . 27.0 mm-40 -80.18 -41.2 25.75 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -168.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.682 ' HG3' ' HA ' ' A' ' 40' ' ' CYS . 59.0 mtp -58.28 -49.46 93.46 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -172.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -59.12 -36.37 96.1 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 121.945 1.763 . . . . 0.0 111.811 175.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.419 ' HB3' ' O ' ' A' ' 43' ' ' GLU . 33.7 ttmt -63.42 -38.04 89.6 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.162 177.334 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.511 HG12 ' O ' ' A' ' 43' ' ' GLU . 46.0 mm -67.4 -35.41 73.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.202 176.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.519 HG12 ' O ' ' A' ' 44' ' ' MET . 47.2 mm -54.73 -52.36 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.616 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.432 ' C ' ' HD3' ' A' ' 49' ' ' LYS . 12.7 tmtt? -59.65 -56.25 24.25 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.892 178.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 27.7 m -54.02 -51.96 62.34 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.903 -174.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.569 ' HB1' HG11 ' A' ' 61' ' ' VAL . . . -68.91 -44.76 72.51 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.138 -174.034 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -75.82 -37.35 59.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.737 -173.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -74.48 -52.45 11.94 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -175.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -78.62 -2.87 41.06 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.82 0.343 . . . . 0.0 111.244 -175.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 24.0 tptm -59.58 -35.74 74.87 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.245 177.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -88.6 2.9 52.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.626 -177.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -96.19 -66.16 0.92 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.327 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 66.2 t30 174.63 18.59 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.436 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.612 ' CD1' HG13 ' A' ' 27' ' ' VAL . 20.7 t80 -104.03 148.47 26.19 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.236 -172.055 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.449 ' OE1' ' HB2' ' A' ' 26' ' ' LYS . 51.1 mt-30 -122.89 150.9 42.3 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.01 0.524 . . . . 0.0 109.967 178.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.569 HG11 ' HB1' ' A' ' 51' ' ' ALA . 5.9 p -127.1 121.06 56.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 121.175 0.512 . . . . 0.0 110.594 177.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 8.6 mp -126.77 96.31 4.61 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.443 177.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.55 113.36 25.6 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.536 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 63.7 t -98.19 116.39 40.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.026 0.441 . . . . 0.0 110.132 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.557 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -87.7 121.56 30.28 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.789 175.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.701 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 4.8 pm0 -89.65 169.16 13.2 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.701 ' HD2' ' HB2' ' A' ' 66' ' ' GLN . 30.0 Cg_endo -62.26 -138.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 122.701 2.267 . . . . 0.0 113.825 -178.287 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.539 ' HB ' ' O ' ' A' ' 67' ' ' PRO . 90.6 mt 78.9 -49.36 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 C-N-CA 123.163 0.585 . . . . 0.0 109.771 -173.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.526 ' HB3' ' HG2' ' A' ' 35' ' ' PRO . 0.6 OUTLIER -107.03 138.53 19.85 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 173.249 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 69' ' ' ASP . 33.8 Cg_exo -59.18 158.31 26.53 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.749 2.299 . . . . 0.0 112.821 -178.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.0 tp -62.26 -31.27 51.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.396 -175.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -66.57 -29.2 69.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.905 177.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.1 t -68.48 -40.55 80.92 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.7 t -62.66 -42.74 97.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.209 176.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -62.79 -36.0 81.71 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.176 177.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -61.46 -45.02 96.05 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.825 0.345 . . . . 0.0 110.75 -177.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -63.43 -52.49 61.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.303 -179.52 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.538 ' HA ' HD13 ' A' ' 83' ' ' LEU . 10.0 p -65.23 -26.53 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-O 121.035 0.445 . . . . 0.0 111.038 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -73.31 -54.77 7.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.356 0.598 . . . . 0.0 110.661 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -73.38 -48.87 30.54 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.862 -172.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -91.77 -4.49 54.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.523 -174.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.08 -58.0 4.59 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.755 177.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.538 HD13 ' HA ' ' A' ' 78' ' ' VAL . 11.2 mp 63.62 95.28 0.05 OUTLIER Pre-proline 0 N--CA 1.466 0.355 0 CA-C-O 121.275 0.56 . . . . 0.0 111.666 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -75.94 10.58 1.97 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.574 2.85 . . . . 0.0 113.07 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -120.38 145.03 47.57 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.2 m -67.68 124.46 23.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.16 -176.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.482 HG21 HD23 ' A' ' 83' ' ' LEU . 33.3 t -118.87 134.38 62.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.702 -179.131 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.591 ' HG3' ' HA ' ' A' ' 12' ' ' ASP . 3.2 mpp? -123.66 175.25 6.95 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -134.93 125.46 26.73 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.123 -177.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.566 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 56.4 t0 -107.68 111.16 23.23 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 174.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.11 -24.76 60.67 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -174.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.59 7.01 22.27 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.081 -174.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.4 pttp 46.45 32.0 1.47 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.992 0.917 . . . . 0.0 111.563 -179.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.33 -35.12 58.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.661 -173.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.546 HG22 ' OD2' ' A' ' 90' ' ' ASP . 32.6 m -73.44 -29.88 28.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 175.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -68.99 -39.5 84.92 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 172.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -58.83 -32.75 69.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.025 0.44 . . . . 0.0 111.142 175.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.95 -47.7 65.01 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.043 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.469 ' HD2' ' CZ ' ' A' ' 32' ' ' PHE . 30.2 m-85 -81.27 -14.17 57.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.978 -176.223 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 93.34 38.46 5.34 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.233 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.499 HG23 ' OG1' ' A' ' 106' ' ' THR . 39.9 m -75.9 89.22 2.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.285 0.564 . . . . 0.0 111.18 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 52.5 tp60 -101.44 -57.85 2.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.703 175.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.446 ' CG1' ' HB ' ' A' ' 121' ' ' VAL . 8.4 p -98.95 148.72 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.823 -177.283 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -114.65 144.28 31.57 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.968 -173.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.505 ' HG3' ' HG3' ' A' ' 43' ' ' GLU . 94.1 Cg_endo -85.58 165.23 55.92 Favored 'Cis proline' 0 N--CA 1.463 -0.279 0 C-N-CA 123.232 -1.57 . . . . 0.0 112.307 -0.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.505 ' HB ' ' HB2' ' A' ' 32' ' ' PHE . 36.5 m -110.45 134.07 52.69 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 176.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.5 m -121.72 110.18 15.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.992 0.425 . . . . 0.0 110.559 -176.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.596 ' HB ' ' HB ' ' A' ' 30' ' ' ILE . 46.4 t -109.41 125.13 66.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.513 -179.197 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.717 HD11 HD11 ' A' ' 129' ' ' LEU . 85.4 mt -103.4 136.3 43.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.545 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.564 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 51.8 mt -124.49 138.12 55.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 176.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.512 ' O ' ' HA ' ' A' ' 27' ' ' VAL . . . -78.06 -92.98 0.28 Allowed Glycine 0 C--O 1.223 -0.572 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.137 -172.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -144.63 -2.79 0.83 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.402 0.601 . . . . 0.0 111.351 -178.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.474 ' HB2' ' OE2' ' A' ' 115' ' ' GLU . 10.4 mtmp? -126.15 13.74 7.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.816 0.341 . . . . 0.0 110.89 -174.37 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.02 28.74 73.91 Favored Glycine 0 C--O 1.227 -0.316 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.246 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.512 ' CD ' ' H ' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -90.48 -11.05 41.46 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.856 0.36 . . . . 0.0 110.75 -176.292 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.559 HD12 ' H ' ' A' ' 4' ' ' THR . 19.3 mt 62.9 91.67 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.556 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.55 -34.55 72.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.934 -1.03 . . . . 0.0 112.699 -173.412 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.63 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 2.4 tppp? -155.43 139.87 16.8 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -168.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.56 HG23 HG22 ' A' ' 108' ' ' VAL . 18.3 m -126.07 101.99 7.03 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 120.91 0.386 . . . . 0.0 110.375 170.185 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.53 ' CD2' ' HB3' ' A' ' 124' ' ' PRO . 41.9 m-85 -94.07 137.69 32.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.285 173.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.446 ' HB ' ' CG1' ' A' ' 103' ' ' VAL . 3.7 m -102.59 108.9 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-O 121.247 0.546 . . . . 0.0 109.737 170.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 99.85 -162.91 19.38 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.341 -0.703 . . . . 0.0 111.341 -174.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -83.09 125.88 73.71 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.812 0.306 . . . . 0.0 110.352 176.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.53 ' HB3' ' CD2' ' A' ' 120' ' ' TYR . 96.5 Cg_endo -80.1 175.13 10.69 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.726 2.284 . . . . 0.0 112.435 177.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.485 ' HB2' ' HB3' ' A' ' 128' ' ' LYS . 7.1 m-20 -65.52 110.43 2.7 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 173.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -63.39 -39.7 95.23 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -170.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -73.21 -46.82 25.77 Favored Glycine 0 C--O 1.237 0.338 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.856 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.485 ' HB3' ' HB2' ' A' ' 125' ' ' ASP . 51.1 tttm -60.71 -36.86 79.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.653 0.263 . . . . 0.0 110.476 177.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.717 HD11 HD11 ' A' ' 109' ' ' LEU . 28.0 tp -58.92 -46.85 86.93 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.719 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -56.54 -45.29 81.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.848 0.356 . . . . 0.0 110.803 178.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -68.4 -37.23 80.16 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.865 -178.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.505 ' HG2' ' HA ' ' A' ' 129' ' ' LEU . 8.9 pt-20 -77.02 -23.65 52.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.78 0.324 . . . . 0.0 110.145 -179.01 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.2 mp -62.64 -48.72 86.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.017 172.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -61.89 -34.93 76.93 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.273 0.559 . . . . 0.0 110.316 177.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 35.6 m -60.65 -40.84 93.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.376 178.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.1 -32.16 68.71 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.986 177.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 37.8 m0 -62.01 -37.61 85.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.068 0.461 . . . . 0.0 110.408 176.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 -86.26 -43.96 12.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.751 -176.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -74.13 92.71 2.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.105 0.479 . . . . 0.0 111.185 -175.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.0 m -104.73 -13.83 15.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.891 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -92.49 15.12 14.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.227 -176.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.6 99.96 12.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.563 176.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -128.75 133.81 48.23 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.963 179.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -136.5 76.29 0.38 Allowed Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.659 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -128.94 19.7 6.0 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 122.706 -0.291 . . . . 0.0 110.734 -178.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -60.01 -36.79 77.97 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.893 0.378 . . . . 0.0 110.625 -178.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -121.81 112.56 18.51 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.783 177.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -76.32 135.11 39.57 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.982 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -91.5 3.74 54.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.457 0.646 . . . . 0.0 109.391 175.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 30.9 p80 . . . . . 0 C--O 1.24 0.588 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.164 177.338 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.529 ' HB2' ' HB3' ' A' ' 6' ' ' PRO . 5.1 p-10 . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.9 m 69.39 93.39 0.08 Allowed 'General case' 0 C--O 1.234 0.242 0 O-C-N 123.884 0.74 . . . . 0.0 111.389 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? 66.42 168.99 0.23 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.603 -178.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.5 m 59.31 28.42 17.76 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.26 0.552 . . . . 0.0 111.107 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.427 ' H ' HG12 ' A' ' 116' ' ' ILE . . . 63.04 103.77 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.332 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.012 177.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.529 ' HB3' ' HB2' ' A' ' 1' ' ' ASP . 21.3 Cg_endo -60.13 150.72 77.66 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.907 2.405 . . . . 0.0 112.045 178.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.573 ' HA ' ' HB2' ' A' ' 20' ' ' ASN . . . -76.12 73.08 2.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.146 0.498 . . . . 0.0 110.973 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.423 ' CZ ' HD11 ' A' ' 23' ' ' LEU . 50.3 p90 -86.43 148.68 25.45 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 176.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.9 t -149.56 88.76 1.58 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.529 ' H ' HD23 ' A' ' 10' ' ' LEU . 2.4 pt? -123.14 147.11 50.9 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.582 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.644 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 16.5 Cg_exo -68.67 132.23 24.66 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.445 2.097 . . . . 0.0 110.928 172.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.602 ' HA ' ' HG2' ' A' ' 88' ' ' MET . 0.0 OUTLIER -70.43 171.08 10.66 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.055 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.558 HD23 HG21 ' A' ' 78' ' ' VAL . 13.5 tp -81.54 10.38 5.99 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-O 121.403 0.621 . . . . 0.0 111.291 -171.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.453 ' H ' ' CG ' ' A' ' 12' ' ' ASP . 77.3 m80 -109.58 -27.52 9.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.48 170.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 124.13 16.69 3.17 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.687 177.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.468 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 59.0 mttp -112.8 115.39 28.41 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 122.649 -0.324 . . . . 0.0 110.619 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.644 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 35.4 m -61.16 127.22 30.48 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.987 0.423 . . . . 0.0 111.574 -178.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.7 t -111.69 125.81 69.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 174.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.8 p -131.51 175.25 9.31 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.196 0.522 . . . . 0.0 111.433 -176.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.573 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . 65.2 t30 -58.17 -31.44 67.26 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.094 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.47 -28.09 67.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.651 -178.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -74.1 -18.66 60.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.212 0.53 . . . . 0.0 110.605 -177.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.423 HD11 ' CZ ' ' A' ' 8' ' ' PHE . 79.9 mt -79.4 -19.73 49.35 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.434 -178.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -71.01 98.58 1.65 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.699 -172.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.59 -8.23 19.93 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.711 175.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 112' ' ' LYS . 56.2 mttm -115.98 167.47 10.93 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.415 ' HB ' ' HD2' ' A' ' 59' ' ' PHE . 22.5 t -104.12 139.81 24.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 174.264 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.796 HG23 ' HG3' ' A' ' 60' ' ' GLN . 4.6 m -129.81 142.23 50.72 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.042 0.448 . . . . 0.0 112.095 -166.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.685 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 7.4 tt -123.69 105.75 9.96 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 171.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.69 ' HB ' ' CG1' ' A' ' 108' ' ' VAL . 61.2 mt -97.49 115.1 36.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.459 ' HA ' ' O ' ' A' ' 106' ' ' THR . 27.4 t-20 -109.5 113.43 26.22 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.366 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.517 ' HE1' HG23 ' A' ' 95' ' ' VAL . 90.4 m-85 -81.92 119.71 24.29 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 175.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 9.7 p-90 -141.78 -179.06 5.97 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.287 0.565 . . . . 0.0 110.775 -175.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -158.12 149.94 17.18 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.766 174.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -63.04 170.08 8.11 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.445 2.097 . . . . 0.0 111.972 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.8 m 63.5 5.58 2.18 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.985 178.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 51.7 t -84.65 131.11 50.69 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.771 0.319 . . . . 0.0 111.046 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -61.62 -22.43 74.41 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.805 2.337 . . . . 0.0 112.112 176.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.37 -19.1 66.18 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.312 -0.471 . . . . 0.0 112.644 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 72.0 m -62.17 -33.41 74.46 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.663 0.268 . . . . 0.0 110.764 178.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 52.8 t -62.76 -35.63 71.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.231 0.538 . . . . 0.0 110.411 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.3 m -86.39 -53.29 5.09 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.944 -177.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.419 ' O ' HG12 ' A' ' 47' ' ' ILE . 17.7 mm-40 -84.46 -31.78 24.39 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -168.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.612 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 50.0 tpp -57.59 -52.1 76.86 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 111.998 0.369 . . . . 0.0 111.998 -174.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.612 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 54.4 Cg_exo -53.39 -39.8 80.4 Favored 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 121.927 1.751 . . . . 0.0 112.404 176.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.429 ' HD3' ' CZ ' ' A' ' 126' ' ' PHE . 56.2 mttp -59.78 -51.45 69.69 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.12 178.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.419 HG12 ' O ' ' A' ' 43' ' ' GLU . 49.8 mm -61.24 -42.11 92.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.224 -177.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.583 HG12 ' O ' ' A' ' 44' ' ' MET . 49.3 mm -55.03 -53.29 35.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.588 0.232 . . . . 0.0 111.434 -178.132 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.409 ' HB3' ' NZ ' ' A' ' 49' ' ' LYS . 0.2 OUTLIER -74.98 -47.39 29.54 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.793 -175.085 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.5 m -63.88 -44.06 94.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.757 0.313 . . . . 0.0 111.362 -176.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.468 ' HB2' HG21 ' A' ' 61' ' ' VAL . . . -69.22 -33.12 72.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.796 -0.184 . . . . 0.0 110.734 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -56.4 -50.94 70.16 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.366 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -68.93 -51.09 43.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.122 0.487 . . . . 0.0 111.034 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 1.048 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 8.8 m-85 -66.5 -31.07 71.56 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -172.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -63.49 -27.3 69.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.083 0.468 . . . . 0.0 110.397 178.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -96.5 19.4 12.25 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.127 0.489 . . . . 0.0 110.499 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 58' ' ' ASN . 0.0 OUTLIER -121.16 -65.4 1.14 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.728 178.131 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 66.6 t30 171.17 19.68 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.646 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 1.048 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 55.4 t80 -114.74 128.27 56.21 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -176.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.796 ' HG3' HG23 ' A' ' 28' ' ' THR . 4.5 pt20 -114.24 128.34 56.31 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.192 0.52 . . . . 0.0 111.151 -175.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.468 HG21 ' HB2' ' A' ' 51' ' ' ALA . 88.5 t -102.87 121.03 53.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.587 175.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.435 ' HB2' HG12 ' A' ' 30' ' ' ILE . 79.5 mt -113.39 101.58 9.52 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.846 -177.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.69 100.46 12.84 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.396 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.3 t -88.52 106.36 16.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.467 -176.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.86 133.08 34.32 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 174.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.608 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 3.4 pt20 -109.3 164.86 13.78 Favored Pre-proline 0 C--N 1.316 -0.89 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.608 ' HD2' ' HB2' ' A' ' 66' ' ' GLN . 37.8 Cg_endo -64.9 95.79 0.25 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.312 2.008 . . . . 0.0 113.485 -174.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 45.9 mm -128.13 -65.01 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 171.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -89.53 151.64 46.26 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.046 169.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -58.22 160.25 16.72 Favored 'Trans proline' 0 C--O 1.236 0.411 0 C-N-CA 122.506 2.137 . . . . 0.0 112.504 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.0 tp -56.63 -33.2 39.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.793 -176.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.644 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -65.89 -38.55 89.05 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 122.257 -0.277 . . . . 0.0 110.469 179.418 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.8 m -63.86 -44.86 91.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.776 0.322 . . . . 0.0 110.734 -178.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.47 -35.7 52.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.348 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.644 ' HG2' ' HA ' ' A' ' 72' ' ' GLU . 11.8 ptt180 -73.9 -35.42 64.67 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.569 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -64.98 -39.56 93.66 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 176.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -54.61 -55.21 31.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.405 178.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.07 ' HA ' HD23 ' A' ' 83' ' ' LEU . 61.9 t -60.01 -37.86 74.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.658 -178.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.578 ' HG2' ' O ' ' A' ' 75' ' ' ARG . 33.3 mmtp -69.59 -51.21 37.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.81 0.338 . . . . 0.0 110.987 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -63.95 -48.96 74.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.026 -173.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.409 ' HB2' ' CD2' ' A' ' 83' ' ' LEU . 96.9 m-85 -88.23 -2.89 58.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.371 -175.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 59.87 53.47 45.63 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.919 176.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 1.07 HD23 ' HA ' ' A' ' 78' ' ' VAL . 2.9 mm? -69.92 114.1 22.51 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 120.789 0.328 . . . . 0.0 110.646 -179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -84.24 -20.32 4.22 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.036 2.491 . . . . 0.0 113.964 -174.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.511 ' CE1' HD12 ' A' ' 83' ' ' LEU . 40.0 p90 -79.99 169.6 17.64 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.693 0.282 . . . . 0.0 110.486 -179.034 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 24.2 m -78.48 105.46 9.76 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.562 0.696 . . . . 0.0 111.22 -175.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.1 t -99.59 141.91 16.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.233 177.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.602 ' HG2' ' HA ' ' A' ' 12' ' ' ASP . 60.6 mtm -136.63 168.98 18.47 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -134.97 104.74 6.08 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.879 0.371 . . . . 0.0 110.743 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.548 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 20.0 t70 -91.11 101.99 14.74 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.34 -10.64 59.96 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.226 -171.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.474 ' OD2' ' HB2' ' A' ' 94' ' ' ALA . 13.5 t70 -105.14 -12.05 16.29 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.544 -0.463 . . . . 0.0 111.345 -176.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 63.2 tttp 65.32 4.97 2.88 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 121.349 0.595 . . . . 0.0 111.365 177.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.474 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . . . -70.62 -29.49 65.89 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -170.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.517 HG23 ' HE1' ' A' ' 32' ' ' PHE . 22.5 m -73.08 -33.94 43.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.353 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -70.89 -33.89 65.81 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 173.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -70.6 -32.03 69.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.213 -0.493 . . . . 0.0 110.876 176.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.69 -45.57 89.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.87 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -73.11 -27.07 61.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.986 0.422 . . . . 0.0 110.814 175.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.31 39.63 7.24 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.873 -0.68 . . . . 0.0 111.782 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.8 p -84.08 115.24 22.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.624 0.25 . . . . 0.0 110.601 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -103.23 -40.03 6.59 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.998 0.428 . . . . 0.0 110.148 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 40.1 t -98.75 145.27 10.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.967 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.411 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 87.0 m-85 -132.62 155.82 80.78 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.411 ' HA ' ' HB3' ' A' ' 104' ' ' TYR . 86.9 Cg_endo -78.63 160.28 90.94 Favored 'Cis proline' 0 C--N 1.345 0.373 0 C-N-CA 123.25 -1.562 . . . . 0.0 112.772 0.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 53.9 m -131.71 123.83 28.54 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.727 178.093 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.1 m -107.99 117.69 34.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.52 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.69 ' CG1' ' HB ' ' A' ' 30' ' ' ILE . 10.1 p -106.09 135.9 42.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.939 0.4 . . . . 0.0 110.144 178.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.55 HD23 ' HB2' ' A' ' 118' ' ' LYS . 2.3 mm? -102.84 124.99 49.4 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.244 -178.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.575 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 53.5 mt -109.26 133.96 52.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.964 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -80.04 159.11 43.17 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.289 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 46.8 pttt -67.68 86.15 0.21 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.75 0.786 . . . . 0.0 111.112 -177.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 4.6 ttmp? 165.73 -30.02 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.373 -178.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.46 39.97 1.84 Allowed Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.345 -176.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -113.35 132.35 55.62 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.428 HD13 HG12 ' A' ' 110' ' ' ILE . 49.2 mm -78.46 117.91 24.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.827 0.346 . . . . 0.0 110.083 -178.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.2 mt -103.14 -68.59 0.83 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.769 -175.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.55 ' HB2' HD23 ' A' ' 109' ' ' LEU . 20.1 mmmt -124.33 157.3 35.32 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -168.239 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -138.32 108.74 6.51 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.026 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -108.8 109.37 20.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.202 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 36.5 t -96.92 138.19 22.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.08 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 90.12 -77.63 1.58 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.124 178.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -151.71 119.81 3.33 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 178.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.54 ' HB2' HD22 ' A' ' 129' ' ' LEU . 38.1 Cg_endo -67.81 130.23 21.43 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.561 2.174 . . . . 0.0 112.427 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.616 ' OD1' ' HG2' ' A' ' 128' ' ' LYS . 12.7 t70 -69.32 110.85 4.86 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 177.245 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.429 ' CZ ' ' HD3' ' A' ' 46' ' ' LYS . 34.6 m-85 -58.58 -44.15 89.7 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -173.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -56.66 -52.89 47.72 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.915 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.616 ' HG2' ' OD1' ' A' ' 125' ' ' ASP . 38.4 mmtm -63.93 -48.87 74.83 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.54 HD22 ' HB2' ' A' ' 124' ' ' PRO . 28.0 tp -63.16 -48.66 77.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.989 -171.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -64.39 -37.88 89.06 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.958 -177.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -73.34 -39.73 64.98 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.43 178.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.489 ' OE1' ' HG3' ' A' ' 118' ' ' LYS . 9.5 pt-20 -75.24 -38.13 60.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.276 -174.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 57.6 mt -64.37 -45.97 94.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 175.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.472 ' HA ' ' HB3' ' A' ' 137' ' ' TRP . 21.0 t70 -61.32 -32.18 72.04 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.002 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 90.4 m -58.37 -47.43 83.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.975 0.417 . . . . 0.0 110.653 177.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.99 -28.25 57.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.077 0.465 . . . . 0.0 111.062 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.472 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . 40.0 t-105 -73.41 -55.19 6.7 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.331 -177.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 34.4 ttp-105 -65.95 -35.47 80.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.8 -172.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -77.23 109.94 11.52 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.08 0.466 . . . . 0.0 110.371 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 11.9 p -130.1 -29.65 2.05 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.31 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -82.07 93.33 6.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.06 0.457 . . . . 0.0 110.114 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -112.82 -176.13 2.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.959 -178.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -114.35 -174.82 2.55 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.303 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -97.6 -99.15 2.01 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.535 173.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 64.3 -83.45 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.117 0.567 . . . . 0.0 110.666 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -168.82 44.03 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 61.9 t-80 75.95 -45.86 0.54 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.527 -178.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -89.55 135.75 33.42 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.302 176.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -77.46 129.53 35.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.904 0.383 . . . . 0.0 110.823 177.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 21.3 t60 . . . . . 0 C--O 1.243 0.731 0 CA-C-O 118.356 -0.83 . . . . 0.0 109.125 173.273 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.578 ' OD2' ' HA ' ' A' ' 7' ' ' ALA . 36.5 t70 . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.6 m -157.29 119.2 3.77 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.558 ' HD2' ' H ' ' A' ' 4' ' ' THR . 28.0 tptp 65.95 163.74 0.17 Allowed 'General case' 0 N--CA 1.466 0.375 0 O-C-N 123.525 0.516 . . . . 0.0 109.827 -178.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.619 ' O ' ' HA ' ' A' ' 115' ' ' GLU . 4.2 m 74.94 -0.33 3.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 122.121 0.962 . . . . 0.0 109.4 -174.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.695 ' HB2' ' HB3' ' A' ' 20' ' ' ASN . . . 175.42 168.49 0.36 Allowed Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 113.973 -1.467 . . . . 0.0 108.701 -178.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.567 ' HD2' ' HB1' ' A' ' 5' ' ' ALA . 39.3 Cg_endo -69.74 24.93 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.629 2.22 . . . . 0.0 113.239 174.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.578 ' HA ' ' OD2' ' A' ' 1' ' ' ASP . . . 62.2 58.92 1.7 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.905 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.531 ' CE1' ' HB1' ' A' ' 5' ' ' ALA . 37.7 p90 -119.07 144.41 46.59 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.353 0.597 . . . . 0.0 111.558 -174.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.2 p -149.43 88.58 1.58 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.85 170.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.56 ' H ' HD23 ' A' ' 10' ' ' LEU . 2.6 pt? -121.98 155.71 60.5 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.896 -174.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.92 145.7 19.99 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.742 2.295 . . . . 0.0 111.584 173.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 51.7 p-10 -89.53 -172.65 3.67 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.141 177.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.6 mt -79.06 20.7 0.47 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.765 0.316 . . . . 0.0 111.441 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -118.33 -24.34 6.93 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 174.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.45 14.93 14.81 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.719 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -113.37 141.61 46.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.972 0.386 . . . . 0.0 110.315 178.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.2 m -75.27 122.53 23.84 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.404 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.5 t -108.01 142.84 19.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.733 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.5 p -145.35 -173.8 4.21 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.202 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.695 ' HB3' ' HB2' ' A' ' 5' ' ' ALA . 20.8 p30 -66.47 -22.73 66.2 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -176.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.63 -31.73 71.83 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.833 0.349 . . . . 0.0 111.81 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.62 -37.03 84.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.45 0.643 . . . . 0.0 109.704 177.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.493 HD22 HG21 ' A' ' 28' ' ' THR . 21.7 mt -72.21 -21.33 61.42 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.475 -174.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -64.8 102.1 0.55 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.248 0.547 . . . . 0.0 111.686 -174.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.05 -26.04 10.22 Favored Glycine 0 CA--C 1.511 -0.208 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.991 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.708 ' O ' ' HA ' ' A' ' 112' ' ' LYS . 31.5 mttp -97.18 163.09 13.06 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 177.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.471 HG22 ' HB3' ' A' ' 112' ' ' LYS . 4.9 t -103.08 127.3 57.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 175.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.59 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 27.7 m -131.33 142.23 50.06 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.397 0.618 . . . . 0.0 112.361 -168.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.474 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 24.8 tp -115.69 115.27 26.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.396 172.086 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.819 ' HB ' ' CG2' ' A' ' 108' ' ' VAL . 51.2 mt -94.27 112.86 27.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 176.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -117.0 118.3 32.01 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.855 0.36 . . . . 0.0 110.932 -176.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.483 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 87.7 m-85 -84.25 125.09 31.9 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.406 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.532 ' CD1' ' HB1' ' A' ' 63' ' ' ALA . 22.7 p-90 -147.07 175.54 10.62 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.217 0.532 . . . . 0.0 111.097 -177.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.425 ' HD2' ' OD2' ' A' ' 69' ' ' ASP . 27.2 p90 -161.67 149.58 12.23 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.714 173.188 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.583 ' HD2' ' HB2' ' A' ' 69' ' ' ASP . 84.7 Cg_exo -49.61 -46.69 25.85 Favored 'Trans proline' 0 N--CA 1.474 0.375 0 C-N-CA 123.422 2.748 . . . . 0.0 114.284 -174.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.1 m -79.35 17.81 0.78 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -174.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.612 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 48.0 t -85.2 126.5 67.23 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 120.704 0.288 . . . . 0.0 110.734 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 17.0 Cg_exo -67.79 -19.32 47.16 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.963 2.442 . . . . 0.0 112.305 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.24 -11.52 84.93 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.803 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.612 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 89.2 m -60.96 -43.57 98.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.704 0.252 . . . . 0.0 111.381 -178.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.9 m -59.71 -27.86 38.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.02 0.438 . . . . 0.0 111.403 -177.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.9 m -87.45 -55.14 3.92 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.265 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.445 ' O ' HG12 ' A' ' 47' ' ' ILE . 26.5 mm-40 -84.55 -33.18 23.5 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -168.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.649 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 47.9 tpp -57.52 -53.76 62.11 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -172.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.649 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 43.2 Cg_exo -57.15 -36.59 99.18 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 122.096 1.864 . . . . 0.0 111.98 178.129 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.464 ' HB3' ' HE2' ' A' ' 46' ' ' LYS . 4.6 tmmm? -66.74 -39.8 88.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.108 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 43' ' ' GLU . 34.1 mm -63.52 -39.4 85.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.581 177.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.548 HD13 ' HE1' ' A' ' 85' ' ' PHE . 44.9 mm -54.62 -53.38 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.287 178.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -63.24 -51.5 65.93 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.803 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 30.9 m -56.02 -47.17 78.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.945 0.402 . . . . 0.0 111.491 -176.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . -65.62 -41.09 93.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.433 -177.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -73.76 -37.76 64.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.954 -176.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.07 -49.54 76.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.689 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -92.08 -1.49 57.17 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.524 -174.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 24.2 tptm -59.26 -35.32 73.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.102 0.477 . . . . 0.0 110.49 178.011 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -74.85 -24.25 58.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.403 -176.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -71.35 -70.35 0.32 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 175.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 171.63 22.24 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.456 -176.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.474 ' HZ ' ' HB2' ' A' ' 29' ' ' LEU . 29.5 t80 -100.48 139.72 35.75 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.969 -174.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.501 ' O ' ' HA ' ' A' ' 28' ' ' THR . 12.1 pt20 -134.64 137.15 43.4 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.147 176.078 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.447 HG22 ' HE1' ' A' ' 59' ' ' PHE . 98.3 t -104.98 119.16 53.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.47 HD23 ' HB ' ' A' ' 86' ' ' THR . 70.0 mt -104.04 98.59 8.39 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.7 177.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.532 ' HB1' ' CD1' ' A' ' 33' ' ' TRP . . . -84.52 109.29 17.82 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.271 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.509 HG11 HG11 ' A' ' 95' ' ' VAL . 86.4 t -93.93 108.37 20.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.257 0.551 . . . . 0.0 110.495 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -80.14 127.83 32.79 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 174.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.759 ' HG2' HG12 ' A' ' 68' ' ' ILE . 5.5 pm0 -99.85 162.34 21.41 Favored Pre-proline 0 C--N 1.318 -0.785 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -179.135 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.603 ' HD2' ' HB2' ' A' ' 66' ' ' GLN . 58.6 Cg_endo -70.9 42.4 0.42 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.994 2.463 . . . . 0.0 115.157 -170.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.759 HG12 ' HG2' ' A' ' 66' ' ' GLN . 43.6 mm -84.09 -30.96 7.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 172.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.583 ' HB2' ' HD2' ' A' ' 35' ' ' PRO . 23.6 m-20 -125.12 150.93 68.39 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.784 169.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -58.12 154.76 37.8 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.352 2.035 . . . . 0.0 111.954 176.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.699 ' HA ' HG22 ' A' ' 74' ' ' VAL . 11.9 tt -63.0 -27.62 43.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.633 0.254 . . . . 0.0 111.177 -178.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.446 ' HA ' ' NE ' ' A' ' 75' ' ' ARG . 10.1 pt-20 -67.38 -33.97 76.32 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.189 177.135 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.6 m -68.92 -45.0 71.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.27 175.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.699 HG22 ' HA ' ' A' ' 71' ' ' ILE . 5.2 m -70.39 -35.79 63.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.973 -175.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.446 ' NE ' ' HA ' ' A' ' 72' ' ' GLU . 30.5 ptt180 -75.27 -27.53 59.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.561 -179.121 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 -68.52 -37.83 80.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.369 176.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -63.48 -47.84 80.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.075 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.688 HG13 ' HB2' ' A' ' 83' ' ' LEU . 43.6 t -61.24 -42.18 92.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.682 177.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.4 tttt -62.84 -55.95 21.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.005 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -63.03 -48.81 77.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.306 -170.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -83.59 -17.6 41.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.711 0.291 . . . . 0.0 111.294 -176.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.0 60.8 4.02 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.961 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.688 ' HB2' HG13 ' A' ' 78' ' ' VAL . 9.9 mp -67.6 118.73 60.05 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.723 -0.238 . . . . 0.0 110.533 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -75.84 -28.89 7.46 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.787 2.324 . . . . 0.0 112.862 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.548 ' HE1' HD13 ' A' ' 48' ' ' ILE . 33.6 p90 -80.34 150.98 29.69 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.47 ' HB ' HD23 ' A' ' 62' ' ' LEU . 22.2 m -75.21 131.32 40.32 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.117 0.484 . . . . 0.0 111.335 -173.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.465 HG22 ' HB3' ' A' ' 63' ' ' ALA . 68.5 t -114.09 139.46 39.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.418 -179.12 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 70.1 mtm -127.26 167.56 15.93 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 176.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -137.72 112.0 8.58 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.563 0.22 . . . . 0.0 110.441 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.56 ' OD2' HG12 ' A' ' 95' ' ' VAL . 55.8 t0 -91.53 119.07 31.14 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.141 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.56 -20.84 60.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.928 -176.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -111.64 -11.7 13.99 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -175.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.412 ' HE2' ' HB3' ' A' ' 93' ' ' LYS . 32.2 ttpt 65.52 16.57 10.58 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.965 0.412 . . . . 0.0 109.964 175.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.09 -29.27 70.2 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.608 0.718 . . . . 0.0 109.59 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.56 HG12 ' OD2' ' A' ' 90' ' ' ASP . 7.7 p -60.65 -46.53 95.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.136 174.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.402 ' N ' HG13 ' A' ' 95' ' ' VAL . . . -76.13 -33.2 50.38 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.888 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -58.6 -36.34 73.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.014 0.435 . . . . 0.0 111.242 177.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.03 -46.33 52.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.305 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.459 ' CE2' ' HG3' ' A' ' 6' ' ' PRO . 27.0 m-85 -72.76 -27.58 62.1 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 95.13 36.58 5.42 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -175.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.502 HG23 ' OG1' ' A' ' 106' ' ' THR . 20.0 m -76.51 88.15 3.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.134 0.492 . . . . 0.0 111.2 -177.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -103.12 -46.03 4.75 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.317 177.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 38.4 t -101.82 131.43 49.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.0 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -104.98 149.21 37.32 Favored Pre-proline 0 C--N 1.317 -0.826 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -178.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -79.73 165.99 78.43 Favored 'Cis proline' 0 C--N 1.344 0.319 0 C-N-CA 124.123 -1.199 . . . . 0.0 112.907 0.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.502 ' OG1' HG23 ' A' ' 101' ' ' THR . 58.1 m -131.43 114.95 15.57 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.205 176.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.6 m -108.74 115.39 30.0 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.026 0.441 . . . . 0.0 110.368 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.819 ' CG2' ' HB ' ' A' ' 30' ' ' ILE . 26.9 m -106.16 148.85 10.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.312 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.7 ' HB2' ' HB3' ' A' ' 118' ' ' LYS . 11.0 mp -101.09 124.32 46.62 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.943 -174.284 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.59 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 25.8 mm -112.3 118.59 58.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.027 174.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -71.04 -168.33 8.15 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.72 178.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.708 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 10.7 ptmm? -95.79 21.06 8.95 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 122.687 1.232 . . . . 0.0 107.935 -175.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.498 ' HD2' ' HA ' ' A' ' 113' ' ' LYS . 1.8 mmmp? -106.39 -1.2 23.52 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 113.439 -1.71 . . . . 0.0 108.866 174.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.4 ' O ' HG22 ' A' ' 4' ' ' THR . . . 61.97 46.48 93.99 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 114.952 -1.022 . . . . 0.0 113.326 177.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.619 ' HA ' ' O ' ' A' ' 4' ' ' THR . 16.4 pt-20 -148.53 167.01 26.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.023 0.439 . . . . 0.0 111.632 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.2 mt -61.87 127.46 21.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.703 -178.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 36.9 mt -121.28 -61.06 1.58 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.477 174.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.7 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 1.7 tppt? -133.63 154.96 50.49 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -174.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.668 HG23 HG12 ' A' ' 108' ' ' VAL . 42.8 m -131.86 102.23 5.77 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.11 172.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.634 ' CE2' ' HE3' ' A' ' 118' ' ' LYS . 45.9 m-85 -88.63 136.63 32.9 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.887 0.375 . . . . 0.0 110.914 169.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 6.0 p -123.17 123.1 67.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.258 0.551 . . . . 0.0 110.739 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 95.55 -62.91 1.38 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.285 175.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -167.09 116.57 0.71 Allowed Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 120.501 0.191 . . . . 0.0 111.349 -173.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -93.86 163.17 2.21 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 123.159 2.573 . . . . 0.0 113.087 177.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -99.05 108.79 21.54 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.411 0.624 . . . . 0.0 109.605 174.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.668 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 34.8 m-85 -70.19 -30.21 67.26 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -164.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -59.9 -54.12 40.2 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 119.663 -1.256 . . . . 0.0 111.807 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.421 ' HE2' ' HB3' ' A' ' 128' ' ' LYS . 22.0 ttpt -66.14 -35.29 80.1 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.959 -0.62 . . . . 0.0 110.008 176.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.668 ' HB3' ' HA ' ' A' ' 126' ' ' PHE . 2.9 tm? -61.45 -47.3 86.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.961 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -60.24 -38.59 83.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.813 0.34 . . . . 0.0 110.299 178.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -71.83 -33.07 68.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.762 178.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.614 ' HG2' ' HA ' ' A' ' 129' ' ' LEU . 18.7 pt-20 -80.96 -23.6 38.69 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.419 -177.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 56.1 mt -67.0 -42.12 88.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 168.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -63.13 -27.02 69.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.302 174.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.527 ' HB ' ' O ' ' A' ' 132' ' ' GLU . 52.3 m -60.81 -31.45 70.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.819 176.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.0 -31.38 72.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.042 0.449 . . . . 0.0 110.296 177.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.42 ' HE1' HG21 ' A' ' 27' ' ' VAL . 10.8 m0 -77.86 -40.53 39.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.472 0.653 . . . . 0.0 109.683 177.442 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -71.11 -16.93 62.59 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.601 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 135' ' ' THR . 62.6 t30 -79.15 -15.29 58.33 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.33 -174.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.3 p -101.2 -35.78 9.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.42 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 66.25 -80.43 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 O-C-N 123.635 0.584 . . . . 0.0 111.136 -176.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -178.31 -33.88 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.774 -175.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -119.16 88.48 2.94 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.93 175.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -69.11 -4.09 40.76 Favored Glycine 0 N--CA 1.454 -0.129 0 CA-C-N 115.621 -0.718 . . . . 0.0 113.389 -172.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 14.9 t60 -65.06 -20.57 66.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.756 0.312 . . . . 0.0 110.692 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -77.9 -25.73 48.66 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.014 0.435 . . . . 0.0 110.464 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -97.17 -34.72 11.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.745 -177.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 32.5 m80 70.01 -68.42 0.2 Allowed 'General case' 0 N--CA 1.47 0.573 0 O-C-N 123.793 0.683 . . . . 0.0 109.789 -176.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 14.3 t60 179.33 -36.99 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 . . . . . 0 C--O 1.249 1.057 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.186 175.632 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 . . . . . 0 N--CA 1.484 1.249 0 CA-C-O 120.86 0.362 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.755 ' H ' ' HA ' ' A' ' 6' ' ' PRO . 50.6 m 63.07 -74.45 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.786 -170.345 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -74.34 142.18 45.14 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 172.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.567 HG22 ' HG3' ' A' ' 115' ' ' GLU . 33.2 p 47.9 77.39 0.09 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.17 0.51 . . . . 0.0 111.426 -175.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.675 ' H ' HG13 ' A' ' 116' ' ' ILE . . . 65.8 118.74 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.774 -176.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.755 ' HA ' ' H ' ' A' ' 2' ' ' SER . 3.1 Cg_exo -76.58 15.47 1.05 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.825 2.35 . . . . 0.0 113.704 -177.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.506 ' HA ' ' OD1' ' A' ' 20' ' ' ASN . . . 51.12 41.38 27.53 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.238 0.542 . . . . 0.0 110.74 -177.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.531 ' HD1' ' HD2' ' A' ' 6' ' ' PRO . 51.2 p90 -80.48 150.44 29.69 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.773 -171.345 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.5 m -136.1 96.3 3.37 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 173.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.489 HD13 ' HD2' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -119.6 126.14 27.11 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.249 -171.161 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.489 ' HD2' HD13 ' A' ' 10' ' ' LEU . 47.2 Cg_endo -71.19 131.56 19.47 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.102 1.868 . . . . 0.0 111.558 173.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.28 177.84 7.59 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.613 HD11 HG12 ' A' ' 74' ' ' VAL . 51.8 mt -64.41 -31.27 72.42 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -176.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.81 -17.03 42.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.661 0.267 . . . . 0.0 111.261 -175.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.12 32.1 3.13 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.419 -0.896 . . . . 0.0 114.017 170.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -114.4 135.35 54.18 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.128 0.464 . . . . 0.0 110.086 172.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.1 m -77.65 124.48 27.99 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 175.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 31.0 m -124.56 153.55 31.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.873 0.368 . . . . 0.0 110.277 177.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 51.1 p -140.35 -179.6 6.1 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.486 -177.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.506 ' OD1' ' HA ' ' A' ' 7' ' ' ALA . 4.4 p-10 -73.88 -20.89 60.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.571 178.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.448 ' HA ' HE21 ' A' ' 24' ' ' GLN . . . -62.61 -27.56 69.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.012 174.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -68.33 -29.44 68.18 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.269 0.557 . . . . 0.0 110.329 176.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.957 HD13 HG21 ' A' ' 110' ' ' ILE . 25.3 mt -74.07 -19.31 60.65 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.16 -175.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.448 HE21 ' HA ' ' A' ' 21' ' ' ALA . 76.3 mt-30 -55.58 128.6 35.36 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.361 -178.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.9 -24.66 10.19 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.515 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -95.98 -171.25 2.29 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.372 0.605 . . . . 0.0 111.019 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 0.7 OUTLIER -133.05 138.01 52.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 169.422 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.634 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 89.2 m -141.57 150.01 41.5 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.697 -169.49 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.665 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 6.5 tt -127.23 123.03 35.59 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 173.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.653 ' HB ' ' CG2' ' A' ' 108' ' ' VAL . 44.5 mt -104.1 115.16 45.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.843 0.354 . . . . 0.0 110.585 -178.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -107.8 117.44 34.13 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.582 -178.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.535 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 96.1 m-85 -90.3 119.08 30.3 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 177.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.515 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 5.3 p-90 -146.23 -176.8 5.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.106 -175.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -153.45 159.12 32.52 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.256 -0.884 . . . . 0.0 108.767 177.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -51.8 128.02 25.04 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.279 1.986 . . . . 0.0 112.16 177.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.7 t 71.62 26.06 3.2 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.427 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.537 ' O ' ' HB3' ' A' ' 40' ' ' CYS . 42.9 t -63.41 134.02 95.7 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.011 176.221 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -57.25 -49.14 14.82 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.977 2.452 . . . . 0.0 112.657 178.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.551 ' HA3' ' HG3' ' A' ' 105' ' ' PRO . . . -66.64 -24.85 72.75 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.292 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.537 ' HB3' ' O ' ' A' ' 37' ' ' CYS . 29.6 t -58.26 -33.57 69.53 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 122.624 0.37 . . . . 0.0 111.106 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.2 t -62.17 -36.69 75.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.947 0.403 . . . . 0.0 110.543 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.9 m -87.9 -54.68 4.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.001 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.488 ' O ' HG13 ' A' ' 47' ' ' ILE . 54.8 mt-10 -63.81 -50.18 69.96 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -172.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.588 ' O ' HG12 ' A' ' 48' ' ' ILE . 40.5 ttm -51.29 -50.26 77.03 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -170.49 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.425 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 86.9 Cg_exo -48.57 -48.55 17.07 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 122.205 1.937 . . . . 0.0 112.857 176.319 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -63.1 -46.23 88.32 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.144 177.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 43' ' ' GLU . 51.1 mt -60.39 -35.33 62.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.961 -178.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.588 HG12 ' O ' ' A' ' 44' ' ' MET . 46.7 mm -58.69 -52.9 54.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.925 0.393 . . . . 0.0 110.376 176.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -70.68 -39.38 73.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.121 -177.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.561 ' O ' ' HD1' ' A' ' 54' ' ' TYR . 87.7 m -68.37 -54.75 15.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.938 -178.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.627 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . -65.73 -34.74 78.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.236 -174.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -63.82 -48.39 77.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.905 0.383 . . . . 0.0 110.722 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -69.37 -51.64 34.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.01 0.433 . . . . 0.0 111.166 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 1.064 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 77.2 m-85 -70.79 -12.08 61.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.559 -175.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.627 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 16.0 tptm -60.99 -35.78 77.74 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 175.181 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -84.79 -6.2 59.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.342 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.489 ' O ' ' HB2' ' A' ' 58' ' ' ASN . 43.5 mmtm -89.57 -69.65 0.7 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 176.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 63.3 t30 164.03 12.13 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 114.904 -1.043 . . . . 0.0 109.241 -175.449 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 1.064 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 60.6 t80 -105.74 129.43 53.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.542 -178.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.404 ' O ' ' HA ' ' A' ' 28' ' ' THR . 12.7 pt20 -126.68 140.86 52.09 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.952 0.405 . . . . 0.0 110.501 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 91.9 t -104.59 126.9 59.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.866 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.56 ' HB3' ' HE3' ' A' ' 88' ' ' MET . 75.7 mt -114.21 99.57 7.71 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.605 -179.188 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.01 106.29 18.38 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.695 -178.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 41.9 t -94.66 115.25 33.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.047 0.451 . . . . 0.0 110.516 -178.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -82.45 138.24 34.44 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.859 176.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.698 ' HB2' ' HG2' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -101.83 163.45 17.77 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.808 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.698 ' HD3' ' O ' ' A' ' 90' ' ' ASP . 37.4 Cg_endo -66.19 82.08 0.28 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.538 2.158 . . . . 0.0 113.688 -173.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 50.7 mm -112.22 -44.29 5.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 170.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -129.67 153.59 80.8 Favored Pre-proline 0 C--O 1.237 0.403 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 173.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -54.64 161.89 5.43 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.932 2.422 . . . . 0.0 114.714 -175.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.7 tp -51.16 -35.46 15.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.488 177.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -62.1 -46.18 90.19 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.049 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.6 m -58.32 -41.95 85.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.131 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.613 HG12 HD11 ' A' ' 13' ' ' LEU . 26.4 t -65.05 -46.57 90.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.357 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.525 ' HG2' ' HB3' ' A' ' 13' ' ' LEU . 67.1 mtt180 -60.16 -34.95 74.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.012 177.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.444 ' HA ' ' NZ ' ' A' ' 79' ' ' LYS . 50.3 tp60 -61.27 -53.48 56.26 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.591 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -55.86 -48.86 74.78 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.242 -176.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.66 ' HA ' HD12 ' A' ' 83' ' ' LEU . 61.9 t -56.36 -44.29 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 112.26 0.466 . . . . 0.0 112.26 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.56 ' HB2' ' NZ ' ' A' ' 79' ' ' LYS . 9.6 mtmp? -67.56 -48.56 66.58 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.59 0.709 . . . . 0.0 110.487 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.32 -39.93 93.06 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.497 -1.229 . . . . 0.0 112.456 -170.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -95.82 -9.99 30.15 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.475 -178.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 63.15 67.32 2.12 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.209 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.66 HD12 ' HA ' ' A' ' 78' ' ' VAL . 1.1 mt -94.25 127.57 44.05 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-O 120.94 0.4 . . . . 0.0 111.891 -174.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -83.48 -12.96 8.77 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.456 2.77 . . . . 0.0 114.553 -172.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.456 ' CZ ' HD22 ' A' ' 83' ' ' LEU . 26.8 p90 -93.16 153.61 18.54 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.421 178.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.401 ' HB ' HD23 ' A' ' 62' ' ' LEU . 14.5 m -78.59 126.76 31.19 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.596 -175.005 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.489 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 47.0 t -110.52 135.74 48.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.011 0.434 . . . . 0.0 110.63 -178.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.56 ' HE3' ' HB3' ' A' ' 62' ' ' LEU . 52.3 mtt -116.0 172.1 7.37 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.59 178.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -140.53 109.6 6.12 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.622 0.249 . . . . 0.0 110.548 176.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.698 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 38.4 t0 -91.57 118.39 30.56 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 176.021 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.72 -14.97 60.79 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -175.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.53 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 24.2 t70 -125.62 -9.66 6.79 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 122.149 -0.344 . . . . 0.0 111.514 -173.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.698 ' HG2' ' HB2' ' A' ' 66' ' ' GLN . 51.8 mtpt 78.18 5.23 2.72 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.881 0.872 . . . . 0.0 111.679 -177.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.05 -40.63 81.43 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -169.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.555 HG22 ' OD2' ' A' ' 90' ' ' ASP . 22.1 m -70.21 -35.23 62.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 119.977 -0.689 . . . . 0.0 109.834 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -71.68 -33.23 63.59 Favored Glycine 0 N--CA 1.451 -0.321 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 176.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.602 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 8.5 mm-40 -61.69 -32.54 72.75 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.087 0.47 . . . . 0.0 110.552 176.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.24 -40.17 64.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.177 176.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -74.03 -22.66 59.48 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.715 0.293 . . . . 0.0 111.25 179.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.91 50.5 1.77 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.664 177.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 22.6 p -72.75 88.42 1.31 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.041 0.448 . . . . 0.0 111.002 176.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -84.23 -51.76 6.77 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.38 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 46.8 t -128.91 142.41 44.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.87 -179.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -86.41 137.76 34.36 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.551 ' HG3' ' HA3' ' A' ' 39' ' ' GLY . 94.4 Cg_endo -90.74 166.47 30.39 Favored 'Cis proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.88 -1.3 . . . . 0.0 112.808 -0.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 33.0 m -128.16 112.65 14.77 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.484 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.477 ' HB3' HD21 ' A' ' 29' ' ' LEU . 73.1 m -110.5 112.62 24.66 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.979 0.419 . . . . 0.0 110.83 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.653 ' CG2' ' HB ' ' A' ' 30' ' ' ILE . 15.9 m -106.83 148.7 10.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.537 -176.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.774 ' HB2' ' HB3' ' A' ' 118' ' ' LYS . 10.8 mp -101.91 132.87 47.46 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.033 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.957 HG21 HD13 ' A' ' 23' ' ' LEU . 31.3 mm -114.38 133.45 60.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.93 -174.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -85.86 -174.29 49.73 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.929 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 24' ' ' GLN . 62.1 mttm -74.97 21.49 0.12 Allowed 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -172.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.53 ' HD3' ' HB3' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -150.59 11.31 0.68 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.059 0.457 . . . . 0.0 110.604 -179.55 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.422 ' C ' ' HB2' ' A' ' 5' ' ' ALA . . . 87.07 -14.19 57.86 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.52 -0.847 . . . . 0.0 111.669 -176.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.567 ' HG3' HG22 ' A' ' 4' ' ' THR . 38.7 tt0 -54.93 135.13 48.72 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.234 0.614 . . . . 0.0 111.096 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.675 HG13 ' H ' ' A' ' 5' ' ' ALA . 4.0 mt -80.3 111.77 17.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.014 -174.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 79.9 mt -91.42 -40.16 11.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.598 -175.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.774 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 19.8 tptm -152.5 153.71 34.02 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.618 -170.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.8 m -136.61 108.79 7.24 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.937 177.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -99.33 118.16 35.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.341 174.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 61.3 t -108.49 123.12 63.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.732 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 90.74 -72.75 1.87 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.959 176.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -132.42 105.45 13.28 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-O 120.726 0.298 . . . . 0.0 110.624 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -82.66 126.57 4.67 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.549 2.166 . . . . 0.0 112.563 176.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -65.46 102.47 0.7 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 176.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -67.15 -45.73 76.17 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -172.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -57.97 -48.17 84.28 Favored Glycine 0 C--O 1.239 0.408 0 C-N-CA 120.434 -0.889 . . . . 0.0 111.874 178.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -67.39 -31.28 71.4 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-N 115.491 -0.354 . . . . 0.0 110.404 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.687 ' O ' HG12 ' A' ' 133' ' ' ILE . 2.6 tm? -59.32 -45.26 91.81 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 176.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -61.68 -49.89 74.67 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -178.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -69.83 -27.51 64.93 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.959 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -73.5 -37.43 65.7 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.052 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.687 HG12 ' O ' ' A' ' 129' ' ' LEU . 50.8 mm -64.38 -41.92 93.79 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 172.266 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.409 ' O ' ' HG2' ' A' ' 138' ' ' ARG . 12.8 t70 -57.15 -38.42 73.52 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.159 178.029 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 32.6 m -66.33 -38.12 86.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.62 178.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.53 -22.88 65.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.02 178.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 9.8 m0 -75.6 -26.57 57.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.792 176.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 138' ' ' ARG . 11.6 mmt180 -72.59 -40.89 66.22 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.228 -179.021 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -68.44 106.96 2.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.624 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.4 t -147.91 111.12 4.88 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.747 -178.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -75.69 101.51 5.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.816 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -146.53 175.71 10.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.932 0.396 . . . . 0.0 111.568 -175.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.471 ' OE1' ' HB2' ' A' ' 145' ' ' HIS . 0.5 OUTLIER -90.33 158.95 16.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.753 -178.868 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -108.15 28.55 11.72 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.675 -175.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.471 ' HB2' ' OE1' ' A' ' 143' ' ' GLU . 4.6 t-80 -74.93 96.33 3.13 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -61.02 -48.34 82.27 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.048 -175.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -82.49 76.03 9.37 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 48.5 p-80 -84.52 -17.55 38.59 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.393 178.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 177.66 -34.96 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -178.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 . . . . . 0 C--O 1.244 0.787 0 CA-C-N 113.881 -1.509 . . . . 0.0 108.532 173.046 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 24.9 t70 . . . . . 0 N--CA 1.479 0.98 0 CA-C-O 120.552 0.215 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.9 m -144.15 168.67 19.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.842 0.353 . . . . 0.0 110.791 -176.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.473 ' HB3' HD12 ' A' ' 116' ' ' ILE . 50.4 mttp -90.58 -162.39 0.9 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.084 175.035 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.463 ' HA ' ' H ' ' A' ' 116' ' ' ILE . 3.6 m 64.49 25.61 13.3 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.335 0.588 . . . . 0.0 110.045 -177.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 64.01 96.07 0.05 OUTLIER Pre-proline 0 CA--C 1.53 0.196 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.908 -178.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.53 35.35 0.5 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 123.19 2.593 . . . . 0.0 113.824 -174.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 57.16 84.9 0.09 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.364 0.666 . . . . 0.0 111.03 -177.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -111.86 130.27 55.88 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.098 0.475 . . . . 0.0 111.157 -175.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 63.7 p -110.46 90.23 3.26 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 172.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.591 HD12 ' HD2' ' A' ' 11' ' ' PRO . 22.6 tp -111.51 126.92 27.68 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.751 -172.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.591 ' HD2' HD12 ' A' ' 10' ' ' LEU . 58.3 Cg_endo -73.3 147.55 42.15 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.308 2.006 . . . . 0.0 112.136 176.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.452 ' CG ' ' H ' ' A' ' 14' ' ' HIS . 0.2 OUTLIER -80.46 -175.65 5.28 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 176.948 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 53.8 mt -70.37 -18.68 63.06 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -176.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.452 ' H ' ' CG ' ' A' ' 12' ' ' ASP . 76.6 m80 -89.65 -48.25 7.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.775 0.321 . . . . 0.0 110.427 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.56 24.91 0.19 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.374 -0.917 . . . . 0.0 113.668 176.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 11' ' ' PRO . 67.6 mttm -101.17 139.56 36.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.314 0.557 . . . . 0.0 110.152 175.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.4 m -84.77 123.38 30.35 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.899 0.381 . . . . 0.0 111.089 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.2 t -107.93 134.82 48.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.509 176.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 36.6 m -145.25 177.48 8.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.746 0.308 . . . . 0.0 111.462 -177.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -51.64 -32.28 28.62 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.641 0.776 . . . . 0.0 112.849 -175.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.47 -27.48 64.45 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -174.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -82.94 -23.32 33.5 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.456 -176.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.614 HD23 HG21 ' A' ' 110' ' ' ILE . 7.7 mp -80.88 -26.94 36.52 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -173.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -64.53 130.86 45.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.189 0.518 . . . . 0.0 111.517 -176.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.34 -12.14 70.28 Favored Glycine 0 C--N 1.329 0.154 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.338 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 112' ' ' LYS . 79.4 mttt -115.71 -173.28 2.31 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 15.9 t -126.51 139.0 52.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 171.028 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.571 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 26.7 m -137.14 145.74 44.17 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.687 -168.478 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.611 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 31.8 tp -115.89 105.84 13.13 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 172.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.8 mt -89.46 111.67 23.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 175.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.512 ' HA ' ' O ' ' A' ' 106' ' ' THR . 7.9 t30 -117.01 111.17 19.19 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.827 0.346 . . . . 0.0 110.864 -175.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 63.5 m-85 -81.38 131.55 35.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.652 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.616 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 4.2 p-90 -158.19 -170.47 3.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.416 -175.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.453 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 24.5 p90 -158.86 138.69 8.66 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 171.131 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.763 ' HG2' ' HA ' ' A' ' 74' ' ' VAL . 50.6 Cg_exo -56.48 -28.31 72.87 Favored 'Trans proline' 0 N--CA 1.473 0.299 0 C-N-CA 123.358 2.705 . . . . 0.0 114.051 -173.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.7 t -89.84 26.57 1.76 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.023 0.439 . . . . 0.0 110.984 -178.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 53.5 t -100.32 132.11 23.02 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.255 -179.149 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 37.2 Cg_exo -61.73 -28.39 82.04 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.799 2.333 . . . . 0.0 112.009 175.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.74 -22.3 69.92 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.388 179.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 46.9 t -63.3 -40.17 96.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.761 0.315 . . . . 0.0 110.315 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.4 t -58.77 -35.9 58.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.105 -178.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.0 m -87.45 -49.44 7.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.852 -178.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.447 ' OE1' ' HG3' ' A' ' 46' ' ' LYS . 12.4 mm-40 -84.68 -28.21 26.54 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -170.267 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.575 ' O ' HG12 ' A' ' 48' ' ' ILE . 27.7 ttm -55.18 -47.26 98.95 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 120.249 -0.581 . . . . 0.0 111.91 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -51.05 -41.59 56.24 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.093 1.862 . . . . 0.0 112.314 172.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.447 ' HG3' ' OE1' ' A' ' 43' ' ' GLU . 26.0 mmtp -59.7 -48.16 82.77 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.011 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 43' ' ' GLU . 45.2 mm -61.71 -44.19 98.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.209 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.575 HG12 ' O ' ' A' ' 44' ' ' MET . 45.1 mm -54.87 -53.97 28.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.685 -175.623 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -70.88 -38.34 73.07 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.432 -175.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.9 m -67.58 -48.79 65.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.967 0.413 . . . . 0.0 110.88 -178.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.565 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . -65.95 -45.28 82.38 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.988 -178.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -55.13 -44.21 74.85 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.831 0.348 . . . . 0.0 110.996 -177.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -67.23 -51.4 53.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.662 -179.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 1.011 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 54.2 m-85 -79.6 -20.55 46.62 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -173.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.565 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 9.0 tmtt? -60.71 -39.02 87.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.073 0.463 . . . . 0.0 109.944 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -86.18 6.21 30.43 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.736 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 58' ' ' ASN . 14.4 tppt? -98.68 -67.5 0.84 Allowed 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 175.12 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.422 ' H ' ' H ' ' A' ' 59' ' ' PHE . 65.6 t30 171.79 19.45 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.878 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 1.011 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 45.1 t80 -117.68 120.28 37.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.637 -177.193 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.441 ' HG3' HG23 ' A' ' 28' ' ' THR . 29.8 pt20 -114.78 148.56 38.25 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.083 0.468 . . . . 0.0 110.601 -178.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.42 HG22 ' HB3' ' A' ' 29' ' ' LEU . 84.9 t -109.87 120.27 60.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.237 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.44 HD23 ' HB ' ' A' ' 86' ' ' THR . 90.2 mt -103.03 95.64 6.27 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.387 177.251 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.401 ' HB1' ' NE1' ' A' ' 33' ' ' TRP . . . -86.11 106.92 17.58 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.826 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 25.7 t -100.09 120.38 49.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 120.961 0.41 . . . . 0.0 110.411 -176.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.616 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -94.82 127.94 41.19 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.701 176.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.424 ' HB2' ' CD ' ' A' ' 67' ' ' PRO . 3.4 pt20 -97.12 170.94 6.57 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -178.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 90' ' ' ASP . 17.6 Cg_exo -67.0 79.11 0.39 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.806 2.337 . . . . 0.0 113.884 -175.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 47.7 mm -112.39 -68.63 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 167.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.496 ' OD1' ' HD2' ' A' ' 35' ' ' PRO . 3.5 p-10 -93.66 153.72 41.15 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 167.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -63.04 159.25 39.48 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 122.537 2.158 . . . . 0.0 113.266 -177.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.4 tp -53.95 -34.76 26.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.482 -178.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -60.69 -42.15 96.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.899 0.38 . . . . 0.0 110.899 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 51.0 m -62.98 -38.57 91.67 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.393 -177.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.763 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 20.0 t -60.77 -41.94 90.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.425 176.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.729 ' HA ' HG22 ' A' ' 78' ' ' VAL . 89.6 mtt180 -68.03 -32.53 72.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.819 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -61.71 -41.65 97.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.185 0.516 . . . . 0.0 109.863 177.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -67.72 -48.11 67.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.472 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.729 HG22 ' HA ' ' A' ' 75' ' ' ARG . 27.3 m -67.96 -29.08 43.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.988 -178.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -74.3 -55.09 6.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.146 0.498 . . . . 0.0 110.755 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -64.23 -48.35 76.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.339 -173.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -88.07 -21.49 24.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.728 0.299 . . . . 0.0 111.488 -175.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 71.47 59.9 4.65 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.271 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.553 HD22 HG12 ' A' ' 78' ' ' VAL . 10.8 mp -63.38 121.79 71.95 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 120.603 0.24 . . . . 0.0 110.901 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -82.26 -23.06 4.53 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.055 2.503 . . . . 0.0 113.377 -177.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -84.15 148.94 26.5 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.44 ' HB ' HD23 ' A' ' 62' ' ' LEU . 21.4 m -69.21 116.44 9.65 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.167 0.508 . . . . 0.0 111.305 -174.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 39.3 t -107.42 132.15 55.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.676 -178.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 73.3 mtm -123.4 173.72 7.81 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.491 ' CD1' HG21 ' A' ' 74' ' ' VAL . 60.1 t80 -140.0 116.49 10.71 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.564 ' HA ' HD11 ' A' ' 10' ' ' LEU . 10.0 p-10 -97.26 95.44 7.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.908 0.861 . . . . 0.0 110.23 178.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.484 ' HA ' ' HG3' ' A' ' 67' ' ' PRO . . . -73.28 -10.98 60.33 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.136 -176.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.443 ' C ' ' H ' ' A' ' 94' ' ' ALA . 19.1 m-20 -92.8 -14.95 27.12 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.352 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.518 ' HA ' ' OD2' ' A' ' 90' ' ' ASP . 37.0 ttpt 63.36 -24.96 0.07 Allowed 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 175.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.443 ' H ' ' C ' ' A' ' 92' ' ' ASP . . . -61.9 -25.3 67.48 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -173.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.424 ' O ' ' HD1' ' A' ' 99' ' ' PHE . 26.8 m -70.95 -41.73 77.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.249 179.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.5 -36.36 91.37 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.109 174.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.504 ' HG3' ' O ' ' A' ' 93' ' ' LYS . 91.3 mt-30 -62.3 -33.13 74.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.249 -0.475 . . . . 0.0 110.418 176.294 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.85 -41.6 71.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.068 177.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.424 ' HD1' ' O ' ' A' ' 95' ' ' VAL . 7.8 m-85 -66.71 -27.3 67.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.481 178.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 94.1 39.19 4.91 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.106 177.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.534 ' HB ' ' CE1' ' A' ' 104' ' ' TYR . 39.9 p -71.26 100.73 2.17 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.063 0.459 . . . . 0.0 111.154 -178.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -86.56 -58.41 2.63 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.363 0.601 . . . . 0.0 109.997 177.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.521 HG12 ' HB ' ' A' ' 121' ' ' VAL . 14.6 p -122.01 143.67 33.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.755 -177.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.534 ' CE1' ' HB ' ' A' ' 101' ' ' THR . 39.7 m-85 -111.01 148.53 38.83 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.58 -174.188 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -75.26 152.65 98.07 Favored 'Cis proline' 0 CA--C 1.529 0.261 0 C-N-CA 123.272 -1.553 . . . . 0.0 112.869 0.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 23.8 m -111.48 112.65 24.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.0 177.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.463 ' HB3' HD11 ' A' ' 29' ' ' LEU . 24.4 m -94.73 110.17 22.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.243 0.544 . . . . 0.0 110.841 -178.333 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.566 HG22 HG23 ' A' ' 119' ' ' THR . 60.7 t -107.79 134.33 49.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.316 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.532 ' HB2' ' HB3' ' A' ' 118' ' ' LYS . 7.2 mp -101.58 130.88 47.97 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.906 0.384 . . . . 0.0 110.039 -177.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.614 HG21 HD23 ' A' ' 23' ' ' LEU . 40.0 mm -110.83 130.27 64.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.206 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -77.38 -170.56 34.35 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.435 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 79.0 mttt -78.73 -7.56 57.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.715 0.769 . . . . 0.0 109.482 -174.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.31 -7.17 32.66 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.579 -1.191 . . . . 0.0 111.103 -172.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.08 60.94 3.17 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.673 -176.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.424 ' HB2' HG23 ' A' ' 4' ' ' THR . 12.7 pt-20 -161.51 153.81 19.92 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -178.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.473 HD12 ' HB3' ' A' ' 3' ' ' LYS . 53.6 mt -66.7 105.46 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.925 -178.094 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.439 HD22 ' HA ' ' A' ' 117' ' ' LEU . 0.2 OUTLIER -84.07 -38.58 20.64 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.744 179.469 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.532 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 22.4 tptm -153.41 154.09 33.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.082 -174.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.566 HG23 HG22 ' A' ' 108' ' ' VAL . 33.0 m -140.66 116.84 10.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.059 0.457 . . . . 0.0 111.501 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -109.49 134.36 51.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.471 173.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.521 ' HB ' HG12 ' A' ' 103' ' ' VAL . 3.4 m -105.73 112.56 39.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.028 0.442 . . . . 0.0 110.442 175.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 91.76 -159.65 25.91 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.583 -176.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 54.7 tt0 -73.15 119.44 75.7 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.78 0.324 . . . . 0.0 110.54 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -88.36 165.19 6.73 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.833 2.356 . . . . 0.0 112.753 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.643 ' HB2' ' HE2' ' A' ' 128' ' ' LYS . 4.9 m-20 -67.87 102.81 1.32 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 173.234 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -62.95 -40.37 97.47 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -173.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -58.44 -47.81 87.67 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.444 -0.884 . . . . 0.0 111.605 177.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.643 ' HE2' ' HB2' ' A' ' 125' ' ' ASP . 33.6 ttpt -69.15 -36.99 78.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.438 -0.381 . . . . 0.0 110.33 177.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -61.48 -46.0 91.88 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.6 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -61.44 -47.91 83.58 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.62 0.248 . . . . 0.0 110.937 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -67.45 -38.62 84.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.399 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -65.44 -38.79 90.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.713 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 38.1 mt -60.59 -46.29 95.88 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 172.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -60.51 -36.54 78.61 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.963 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 66.5 m -60.97 -43.45 98.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.765 176.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.55 -29.96 59.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.224 0.535 . . . . 0.0 110.809 176.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -65.24 -55.41 18.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.792 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 47.3 mtm180 -79.37 -45.25 19.92 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.984 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.597 ' HB3' ' OE2' ' A' ' 143' ' ' GLU . 19.3 t-20 51.65 -89.81 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 O-C-N 124.382 1.052 . . . . 0.0 113.111 174.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.591 ' HB2' ' HG3' ' A' ' 143' ' ' GLU . 33.2 m -94.03 -20.48 19.9 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 121.251 -0.18 . . . . 0.0 111.438 -175.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 21.1 t70 72.31 -40.07 0.47 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.447 0.699 . . . . 0.0 111.972 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.35 19.99 1.14 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.093 0.473 . . . . 0.0 110.941 178.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.597 ' OE2' ' HB3' ' A' ' 139' ' ' ASN . 46.2 mt-10 -79.87 152.3 29.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.643 179.379 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 169.11 -128.92 1.76 Allowed Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.742 178.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -99.92 -44.55 6.0 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 175.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -175.81 102.33 0.07 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.277 175.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -83.39 85.62 7.2 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.281 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -162.87 120.6 2.0 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.517 174.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -158.57 154.44 26.62 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 20.1 p80 . . . . . 0 C--O 1.247 0.93 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 172.115 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.127 0 CA-C-O 120.909 0.385 . . . . 0.0 111.715 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -141.68 141.79 33.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.049 177.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.8 m -137.78 100.07 4.09 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.52 HD12 ' HD2' ' A' ' 11' ' ' PRO . 56.2 tp -115.16 120.2 37.23 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.426 -171.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.52 ' HD2' HD12 ' A' ' 10' ' ' LEU . 60.3 Cg_endo -75.07 129.71 12.53 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.497 2.131 . . . . 0.0 111.327 172.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.41 ' HA ' ' HG3' ' A' ' 88' ' ' MET . 2.3 p30 -86.55 -171.86 3.75 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.988 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.8 mt -67.12 -9.26 37.79 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -175.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -96.36 -9.56 29.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.932 0.396 . . . . 0.0 110.33 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.4 2.69 61.75 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.125 177.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 11' ' ' PRO . 20.6 pttp -96.13 144.79 26.05 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 28.5 m -94.45 125.55 39.16 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.889 -174.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.3 m -102.38 141.3 18.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 172.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 45.3 t -145.6 -178.08 5.91 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 121.076 -0.25 . . . . 0.0 110.963 -173.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -53.92 -39.22 65.65 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.258 0.623 . . . . 0.0 111.956 -175.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.77 -27.64 65.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.812 -177.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -78.49 -24.05 46.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.235 -176.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 81.5 mt -78.54 -21.37 48.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.895 0.379 . . . . 0.0 110.953 -178.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -72.27 103.33 3.34 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.02 0.438 . . . . 0.0 110.673 -176.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.0 -25.92 12.19 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.34 177.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.17 148.83 26.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.941 0.401 . . . . 0.0 110.343 178.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.49 HG13 ' O ' ' A' ' 110' ' ' ILE . 97.1 t -102.96 138.0 28.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 172.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 60' ' ' GLN . 22.3 m -132.06 135.12 46.24 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.614 -165.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.764 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 6.8 tt -106.88 106.43 16.96 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 173.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.917 HG12 ' HB2' ' A' ' 62' ' ' LEU . 39.9 mt -104.56 111.95 36.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 177.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.449 ' HA ' ' O ' ' A' ' 106' ' ' THR . 26.7 p-10 -110.72 134.18 52.69 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.413 0.625 . . . . 0.0 110.645 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -91.66 119.25 31.37 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.615 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.64 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 4.5 p-90 -147.82 -174.13 4.47 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.615 -173.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -155.28 150.35 20.77 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 173.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.413 ' HG3' ' HA ' ' A' ' 74' ' ' VAL . 92.8 Cg_exo -43.72 -47.08 9.99 Favored 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 123.148 2.566 . . . . 0.0 114.13 -177.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.1 m -85.82 27.46 0.87 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -177.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.524 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 52.8 t -79.91 129.55 70.13 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.015 0.436 . . . . 0.0 111.101 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 24.7 Cg_exo -63.54 -26.85 69.77 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.641 2.227 . . . . 0.0 111.922 176.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.2 -16.55 73.24 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.836 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.524 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 92.0 m -58.16 -29.4 65.56 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.72 0.26 . . . . 0.0 111.392 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.6 t -55.02 -43.08 67.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.997 0.427 . . . . 0.0 110.364 177.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.571 ' O ' ' HB3' ' A' ' 46' ' ' LYS . 15.1 m -86.5 -55.79 3.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.873 178.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.468 ' O ' HG12 ' A' ' 47' ' ' ILE . 43.3 mt-10 -59.46 -50.4 74.06 Favored 'General case' 0 C--O 1.213 -0.86 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -173.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.732 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 31.8 tpp -58.85 -61.02 8.6 Favored Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -164.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.732 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 33.1 Cg_exo -59.38 -35.96 95.25 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 121.652 1.568 . . . . 0.0 111.206 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.571 ' HB3' ' O ' ' A' ' 42' ' ' SER . 5.9 tptt -59.17 -49.3 78.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.956 176.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.546 HD13 ' HE3' ' A' ' 46' ' ' LYS . 43.8 mm -74.54 -31.58 27.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.63 -174.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.66 HG12 ' O ' ' A' ' 44' ' ' MET . 46.8 mm -54.72 -53.26 33.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-O 121.034 0.445 . . . . 0.0 109.901 176.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.648 ' HZ2' ' HB2' ' A' ' 53' ' ' ASP . 20.4 tptp -71.74 -35.97 70.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.969 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.3 m -62.11 -54.18 44.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.838 0.351 . . . . 0.0 111.202 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.605 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . -68.53 -27.38 66.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.981 -176.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.09 -39.3 60.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.493 177.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.648 ' HB2' ' HZ2' ' A' ' 49' ' ' LYS . 6.9 t70 -76.05 -52.19 10.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.233 0.54 . . . . 0.0 111.057 -173.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.879 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 90.8 m-85 -81.58 -2.47 50.18 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.363 -174.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.605 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 13.0 tppt? -59.4 -37.61 78.45 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.434 0.635 . . . . 0.0 109.916 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.2 m-20 -91.51 12.03 22.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.294 -175.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.578 ' O ' ' HB3' ' A' ' 58' ' ' ASN . 16.9 tptp -112.03 -61.68 1.68 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.711 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.578 ' HB3' ' O ' ' A' ' 57' ' ' LYS . 2.9 p-10 162.79 14.93 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 O-C-N 124.202 0.939 . . . . 0.0 110.279 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.879 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 57.2 t80 -112.53 143.03 44.38 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.924 0.392 . . . . 0.0 110.284 -175.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.531 ' O ' ' HA ' ' A' ' 28' ' ' THR . 11.7 pt20 -136.76 147.55 46.74 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.669 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.46 HG11 HG23 ' A' ' 47' ' ' ILE . 87.3 t -115.07 132.2 65.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.007 178.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.917 ' HB2' HG12 ' A' ' 30' ' ' ILE . 77.6 mt -122.37 110.9 16.22 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.654 ' HB3' HG22 ' A' ' 87' ' ' VAL . . . -94.48 116.42 28.77 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.171 -177.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.0 t -105.17 111.81 36.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.065 0.46 . . . . 0.0 110.528 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.64 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -95.83 124.77 39.99 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.929 177.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.5 169.73 8.18 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.613 ' HD3' ' O ' ' A' ' 90' ' ' ASP . 16.4 Cg_exo -67.33 80.77 0.41 Allowed 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.617 2.211 . . . . 0.0 113.781 -172.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 50.2 mm -117.69 -54.66 4.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 168.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.406 ' HB2' ' HD2' ' A' ' 35' ' ' PRO . 17.2 m-20 -101.86 151.94 38.05 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.738 170.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.31 151.12 30.53 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.73 2.287 . . . . 0.0 112.902 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.3 tt -57.19 -36.3 51.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.894 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.502 ' HA ' ' HD2' ' A' ' 75' ' ' ARG . 31.1 tp10 -69.61 -35.31 75.17 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.533 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.9 m -62.27 -32.45 73.16 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.206 0.527 . . . . 0.0 110.081 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.478 ' O ' HG13 ' A' ' 78' ' ' VAL . 45.2 t -65.42 -44.31 94.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.692 174.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.759 ' HA ' HG22 ' A' ' 78' ' ' VAL . 91.4 mtt180 -64.67 -31.92 73.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.388 177.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -60.98 -44.48 97.3 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 177.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -63.53 -46.16 87.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.272 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.759 HG22 ' HA ' ' A' ' 75' ' ' ARG . 11.1 m -67.08 -37.45 79.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.642 -177.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -75.64 -48.12 23.5 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -66.34 -48.38 70.44 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.103 -172.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -92.4 2.22 56.78 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -173.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 57.9 63.72 5.01 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.308 -0.473 . . . . 0.0 113.033 177.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.511 HD22 HG12 ' A' ' 78' ' ' VAL . 10.0 mp -73.22 115.85 45.01 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 120.702 0.287 . . . . 0.0 111.231 -177.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.39 15.98 1.78 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.177 2.584 . . . . 0.0 113.022 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.543 ' HE1' HD13 ' A' ' 48' ' ' ILE . 24.1 p90 -128.76 153.56 47.26 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.071 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.408 ' HB ' ' CD2' ' A' ' 62' ' ' LEU . 32.2 m -79.39 130.39 35.38 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.953 -174.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.654 HG22 ' HB3' ' A' ' 63' ' ' ALA . 60.9 t -116.44 139.43 43.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.334 -178.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.41 ' HG3' ' HA ' ' A' ' 12' ' ' ASP . 2.6 mpt? -119.24 169.3 10.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.078 177.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -123.5 110.3 14.9 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.613 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 0.9 OUTLIER -81.78 72.25 8.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.893 -175.646 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.78 -46.84 86.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.374 -172.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -87.78 -10.91 49.59 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.673 -0.24 . . . . 0.0 110.776 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.581 ' HB2' ' NZ ' ' A' ' 93' ' ' LYS . 8.1 mtmp? 69.23 7.49 6.26 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.562 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.65 -32.04 70.47 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -172.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.6 t -71.24 -42.91 74.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.58 -37.87 94.09 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.887 174.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -67.02 -32.05 73.0 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 122.486 0.315 . . . . 0.0 111.01 177.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.29 -45.29 85.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.648 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -66.62 -28.22 68.32 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.788 0.328 . . . . 0.0 110.644 176.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 71.96 59.95 4.45 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.804 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.6 p -99.88 -66.64 0.89 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.591 0.234 . . . . 0.0 111.069 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 72.53 -38.54 0.42 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.681 0.792 . . . . 0.0 112.296 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.8 m -97.83 132.3 42.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.139 0.495 . . . . 0.0 110.567 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -128.29 153.04 78.88 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.047 -175.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -80.86 161.01 83.2 Favored 'Cis proline' 0 C--O 1.234 0.314 0 C-N-CA 123.376 -1.51 . . . . 0.0 112.353 -0.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 10.2 t -150.25 127.53 11.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.15 0.5 . . . . 0.0 111.358 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.3 m -101.24 122.53 43.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.089 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 48.5 t -106.06 132.46 53.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.83 0.347 . . . . 0.0 110.207 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.573 HD23 ' HB3' ' A' ' 118' ' ' LYS . 2.8 mm? -102.03 118.77 37.6 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.943 -178.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.49 ' O ' HG13 ' A' ' 27' ' ' VAL . 53.5 mt -100.99 127.74 53.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.037 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -72.14 -179.51 33.68 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.204 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -86.61 -5.11 59.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.919 0.39 . . . . 0.0 110.764 -175.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -98.34 -31.6 11.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.856 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 113.89 19.83 6.29 Favored Glycine 0 C--O 1.225 -0.431 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.553 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.93 -26.2 60.38 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -172.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.471 HD13 HG23 ' A' ' 110' ' ' ILE . 20.8 mm 58.34 96.92 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-O 121.216 0.531 . . . . 0.0 109.582 -167.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.7 mt -93.68 -76.03 0.49 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -165.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.573 ' HB3' HD23 ' A' ' 109' ' ' LEU . 21.9 tptm -109.22 145.05 36.51 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.049 -164.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 7.7 p -122.67 108.01 12.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.382 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -94.88 128.7 41.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.994 173.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.7 t -120.1 132.39 69.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.668 0.271 . . . . 0.0 110.549 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 84.19 -102.51 2.51 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.122 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -106.78 108.78 62.5 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.485 ' HB2' HD22 ' A' ' 129' ' ' LEU . 68.7 Cg_endo -76.65 104.69 1.95 Allowed 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.198 1.932 . . . . 0.0 112.16 178.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -48.75 107.66 0.14 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.676 178.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -60.15 -43.4 95.77 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.095 -173.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -59.5 -51.0 61.68 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.495 -176.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -80.27 -21.0 43.18 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 122.973 -0.133 . . . . 0.0 111.248 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.485 HD22 ' HB2' ' A' ' 124' ' ' PRO . 52.0 tp -68.69 -47.04 67.46 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.162 -0.311 . . . . 0.0 110.162 176.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -66.96 -40.54 87.5 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.908 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -68.11 -30.49 69.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.728 0.299 . . . . 0.0 111.309 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.494 ' OE1' ' HG2' ' A' ' 118' ' ' LYS . 35.3 tt0 -77.82 -34.34 52.06 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.663 0.268 . . . . 0.0 110.488 178.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 129' ' ' LEU . 76.1 mt -65.66 -38.94 83.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-O 121.212 0.529 . . . . 0.0 109.659 172.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.37 -36.42 84.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.461 172.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 91.1 m -63.35 -31.67 72.89 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.13 174.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 133' ' ' ILE . . . . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.596 175.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.24 0 CA-C-O 121.164 0.507 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -129.49 148.86 51.44 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.352 0.596 . . . . 0.0 111.134 -177.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.9 m -141.23 90.75 2.33 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 171.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.581 HD12 ' HD2' ' A' ' 11' ' ' PRO . 28.4 tp -112.57 124.35 32.07 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.216 -172.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.581 ' HD2' HD12 ' A' ' 10' ' ' LEU . 58.3 Cg_endo -73.07 138.71 28.6 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.406 2.071 . . . . 0.0 111.908 176.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.515 ' HA ' ' HG2' ' A' ' 88' ' ' MET . 0.0 OUTLIER -75.29 169.44 18.05 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 175.488 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.543 HD13 ' HG2' ' A' ' 75' ' ' ARG . 84.6 mt -66.03 -17.79 64.92 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -175.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.474 ' H ' ' CG ' ' A' ' 12' ' ' ASP . 48.8 t-80 -86.89 -19.55 28.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.945 177.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.7 4.4 21.47 Favored Glycine 0 CA--C 1.517 0.208 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.058 177.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -85.62 110.75 19.49 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 122.595 -0.356 . . . . 0.0 110.263 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 8.3 m -64.3 122.88 17.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.678 178.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.594 HG11 HD21 ' A' ' 62' ' ' LEU . 59.6 t -110.89 125.07 68.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.924 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 51.0 p -140.94 -174.35 3.97 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.236 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -55.87 -32.27 63.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.109 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.6 -28.53 67.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.202 -176.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -78.84 -23.89 44.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.031 0.443 . . . . 0.0 110.549 -175.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 81.3 mt -77.64 -19.98 54.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.172 -177.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.498 ' OE1' ' HA ' ' A' ' 113' ' ' LYS . 16.5 mm-40 -64.57 119.04 9.72 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.775 -174.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.13 -21.29 46.77 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.035 -0.602 . . . . 0.0 113.078 174.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 112' ' ' LYS . 31.3 mtmt -117.77 160.58 21.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.808 0.337 . . . . 0.0 111.167 -174.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 13.2 t -101.71 144.76 12.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -178.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.618 HG23 HD13 ' A' ' 62' ' ' LEU . 40.6 m -139.34 140.41 37.52 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.06 0.457 . . . . 0.0 112.102 -168.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.889 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 28.1 tp -109.4 106.18 15.85 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.333 171.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.661 ' HB ' ' CG2' ' A' ' 108' ' ' VAL . 37.2 mt -91.09 111.59 23.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 C-N-CA 120.303 -0.559 . . . . 0.0 109.51 176.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -108.83 114.81 28.91 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.897 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -87.69 118.24 27.05 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.496 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 8.0 p-90 -144.71 -173.81 4.16 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.014 0.435 . . . . 0.0 110.464 -176.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.402 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 38.6 p90 -161.71 144.3 8.99 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.351 176.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -58.53 163.98 9.87 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.366 2.044 . . . . 0.0 111.84 175.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 44.5 m 66.84 11.89 8.56 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.408 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 42.1 t -95.67 126.11 46.59 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.47 177.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.434 ' O ' HG12 ' A' ' 41' ' ' VAL . 35.2 Cg_exo -61.87 -18.2 59.66 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.977 2.451 . . . . 0.0 112.978 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.55 -6.73 56.11 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 121.125 -0.559 . . . . 0.0 113.112 -178.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 26.3 p -62.19 -30.58 71.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.559 0.219 . . . . 0.0 110.887 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 38' ' ' PRO . 13.0 p -66.73 -28.92 44.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.845 0.355 . . . . 0.0 110.899 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.6 m -88.0 -56.74 3.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.014 0.435 . . . . 0.0 111.268 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.559 ' HA ' ' HE2' ' A' ' 46' ' ' LYS . 2.9 mt-10 -74.32 -40.69 62.04 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -170.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.476 ' O ' HG12 ' A' ' 48' ' ' ILE . 35.2 tpp -59.57 -54.87 51.65 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -172.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.406 ' HD2' ' N ' ' A' ' 44' ' ' MET . 15.9 Cg_endo -57.52 -35.48 98.83 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 121.829 1.686 . . . . 0.0 111.731 177.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.65 ' HZ2' ' HD2' ' A' ' 124' ' ' PRO . 28.8 ttpt -61.14 -51.94 66.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.541 175.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.557 HG12 ' O ' ' A' ' 43' ' ' GLU . 47.3 mm -57.17 -41.03 77.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.788 -178.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.476 HG12 ' O ' ' A' ' 44' ' ' MET . 48.8 mm -57.9 -45.87 87.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.995 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -75.4 -40.96 57.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.498 0.19 . . . . 0.0 111.248 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.462 ' O ' ' HD2' ' A' ' 54' ' ' TYR . 60.7 m -59.55 -50.01 75.55 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.859 0.361 . . . . 0.0 110.435 177.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.76 -31.8 72.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.598 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -54.22 -44.06 71.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.958 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -79.01 -51.89 8.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.35 0.595 . . . . 0.0 111.142 177.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.983 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 50.8 m-85 -72.3 -20.46 61.5 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -167.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -68.52 -15.23 63.47 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 122.207 -0.308 . . . . 0.0 110.793 176.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -106.83 8.16 30.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.36 0.6 . . . . 0.0 109.874 177.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.429 ' CG ' ' HA ' ' A' ' 54' ' ' TYR . 30.8 mmtp -100.87 -69.71 0.76 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.376 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 4.5 t-20 164.23 29.59 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -172.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.983 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 48.6 t80 -131.41 138.22 49.0 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.799 -167.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.419 ' O ' ' HA ' ' A' ' 28' ' ' THR . 10.8 pt20 -128.26 140.96 51.6 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.464 178.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.432 HG11 HG23 ' A' ' 47' ' ' ILE . 60.4 t -100.61 125.85 54.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.012 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.618 HD13 HG23 ' A' ' 28' ' ' THR . 10.9 mp -112.48 99.11 7.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.85 107.32 16.95 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.863 178.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.1 t -99.22 104.35 15.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.064 0.459 . . . . 0.0 110.458 -177.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -90.89 120.3 31.79 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 175.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.687 ' HB3' ' HD2' ' A' ' 67' ' ' PRO . 37.0 mt-30 -94.83 170.79 7.47 Favored Pre-proline 0 C--N 1.317 -0.821 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -177.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.687 ' HD2' ' HB3' ' A' ' 66' ' ' GLN . 72.5 Cg_endo -71.01 57.92 2.1 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 123.135 2.557 . . . . 0.0 115.225 -164.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.402 ' HB ' ' HB2' ' A' ' 34' ' ' PHE . 49.8 mm -92.24 -51.56 11.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 171.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.538 ' OD1' ' HD2' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -109.23 149.81 40.22 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.362 -0.835 . . . . 0.0 108.779 174.104 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.538 ' HD2' ' OD1' ' A' ' 69' ' ' ASP . 84.4 Cg_exo -49.56 155.76 3.39 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 123.058 2.506 . . . . 0.0 113.737 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.615 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 11.1 tt -54.95 -40.87 55.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.695 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -65.79 -33.47 75.93 Favored 'General case' 0 C--O 1.215 -0.746 0 C-N-CA 120.864 -0.335 . . . . 0.0 110.694 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.7 m -58.26 -40.8 82.8 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.374 0.607 . . . . 0.0 109.943 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.401 ' O ' HG13 ' A' ' 78' ' ' VAL . 20.0 t -65.59 -44.07 93.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.284 175.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.764 ' HA ' HG22 ' A' ' 78' ' ' VAL . 20.1 mtm180 -67.53 -24.98 65.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.019 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -68.63 -43.07 77.1 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -63.78 -47.59 80.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.147 178.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.764 HG22 ' HA ' ' A' ' 75' ' ' ARG . 12.6 m -65.83 -26.63 39.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.129 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.609 ' HB2' ' O ' ' A' ' 75' ' ' ARG . 3.6 ttmp? -74.21 -52.15 13.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.892 -177.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -67.19 -49.43 64.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.204 -174.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -85.82 -10.43 55.44 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -174.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.62 60.28 8.77 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.308 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.604 HD22 HG12 ' A' ' 78' ' ' VAL . 10.1 mp -63.64 116.01 22.98 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 120.879 0.371 . . . . 0.0 111.461 -176.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -86.45 25.26 0.69 Allowed 'Trans proline' 0 C--O 1.241 0.636 0 C-N-CA 123.314 2.676 . . . . 0.0 113.467 -177.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -136.23 159.71 40.9 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 30.7 m -67.71 122.68 18.61 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.434 -174.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.8 t -119.29 127.57 75.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.956 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.515 ' HG2' ' HA ' ' A' ' 12' ' ' ASP . 67.2 mtm -122.76 164.36 18.48 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.263 -177.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.444 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 67.6 t80 -126.1 125.65 42.9 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.373 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.537 ' HB3' ' HA ' ' A' ' 66' ' ' GLN . 28.4 t0 -88.89 135.91 33.29 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.25 -32.84 61.21 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.435 ' O ' ' HB3' ' A' ' 93' ' ' LYS . 31.9 t70 -130.07 -11.08 4.25 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -172.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.675 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER 82.93 17.94 0.28 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 122.89 1.329 . . . . 0.0 108.744 -172.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.617 ' HA ' HE21 ' A' ' 97' ' ' GLN . . . -74.02 -27.17 60.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.007 -176.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.7 t -69.14 -41.19 81.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.57 -33.59 87.64 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 174.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.617 HE21 ' HA ' ' A' ' 94' ' ' ALA . 47.0 mt-30 -64.14 -39.05 93.19 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 122.595 0.358 . . . . 0.0 111.098 176.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.48 -39.82 92.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.058 0.456 . . . . 0.0 110.967 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -73.01 -27.78 61.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.556 177.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.98 34.44 5.68 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.425 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 29.1 p -106.17 126.25 51.98 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.742 0.305 . . . . 0.0 110.804 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.512 ' HG3' HG13 ' A' ' 103' ' ' VAL . 11.8 pt20 -108.82 -36.32 6.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.907 0.384 . . . . 0.0 110.839 178.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.512 HG13 ' HG3' ' A' ' 102' ' ' GLN . 19.7 m -102.85 142.1 17.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.21 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.517 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 37.6 m-85 -130.46 158.67 73.82 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.09 -177.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.517 ' HA ' ' HB3' ' A' ' 104' ' ' TYR . 94.1 Cg_endo -81.41 165.05 75.51 Favored 'Cis proline' 0 CA--C 1.53 0.311 0 C-N-CA 123.587 -1.422 . . . . 0.0 113.17 0.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.535 HG23 ' HA ' ' A' ' 121' ' ' VAL . 95.8 m -150.82 133.32 15.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.787 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.604 ' HB3' HD11 ' A' ' 29' ' ' LEU . 68.0 m -108.09 117.47 34.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.969 0.414 . . . . 0.0 111.003 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.661 ' CG2' ' HB ' ' A' ' 30' ' ' ILE . 29.0 m -106.36 146.15 13.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.121 0.486 . . . . 0.0 110.839 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.676 ' HB2' ' HB3' ' A' ' 118' ' ' LYS . 2.6 mm? -102.37 124.47 48.0 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.065 -176.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.576 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 22.7 mm -104.4 134.59 45.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.512 ' O ' ' HA ' ' A' ' 27' ' ' VAL . . . -67.79 -93.66 0.04 OUTLIER Glycine 0 C--O 1.226 -0.353 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.868 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 10.9 ptpt -166.8 23.73 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.271 0.557 . . . . 0.0 110.844 171.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.498 ' HA ' ' OE1' ' A' ' 24' ' ' GLN . 36.8 mtmm -136.12 10.1 3.27 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 174.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 78.25 18.35 76.45 Favored Glycine 0 C--O 1.223 -0.535 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.54 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -69.71 -24.63 63.6 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -171.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 8.5 mt 64.02 89.63 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.66 0.743 . . . . 0.0 109.701 -175.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 23.2 mt -87.54 -34.93 18.42 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.257 -0.883 . . . . 0.0 113.109 -167.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.676 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 22.0 tptm -150.27 157.53 43.18 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.302 -168.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.537 HG23 HG12 ' A' ' 108' ' ' VAL . 51.4 m -140.28 107.86 5.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.859 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.649 ' HB3' ' HB3' ' A' ' 124' ' ' PRO . 67.8 m-85 -101.68 107.39 18.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.117 173.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.535 ' HA ' HG23 ' A' ' 106' ' ' THR . 48.1 t -82.93 126.78 40.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.46 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 80.31 -138.58 20.01 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.029 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.444 ' OE2' ' HD2' ' A' ' 124' ' ' PRO . 12.7 tp10 -96.64 109.33 47.74 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 110.229 -0.285 . . . . 0.0 110.229 -178.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.65 ' HD2' ' HZ2' ' A' ' 46' ' ' LYS . 91.9 Cg_endo -81.72 174.11 10.65 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 123.234 2.623 . . . . 0.0 113.359 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.497 ' OD2' ' HB3' ' A' ' 128' ' ' LYS . 11.2 p-10 -88.3 120.0 29.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.091 175.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.581 ' HE2' ' HG3' ' A' ' 46' ' ' LYS . 92.2 m-85 -58.47 -46.94 85.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.832 -173.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -56.34 -53.63 41.72 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 121.045 -0.598 . . . . 0.0 113.443 -172.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.551 ' NZ ' ' HB3' ' A' ' 128' ' ' LYS . 2.1 ttpm? -76.17 -26.14 55.94 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.464 0.173 . . . . 0.0 110.694 -177.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.482 ' O ' HG13 ' A' ' 133' ' ' ILE . 7.5 tt -64.41 -46.99 80.87 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 177.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -61.78 -56.04 23.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.479 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.441 ' HG2' ' HA ' ' A' ' 128' ' ' LYS . 4.5 pt20 -60.91 -29.61 69.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.718 0.294 . . . . 0.0 111.292 -176.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -72.46 -36.37 68.48 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.711 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.482 HG13 ' O ' ' A' ' 129' ' ' LEU . 69.1 mt -69.36 -53.0 27.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -62.78 -27.32 69.22 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.767 0.318 . . . . 0.0 111.413 -176.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 90.4 m -73.76 -30.85 63.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.012 0.434 . . . . 0.0 110.964 177.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.563 -177.25 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 120.711 0.291 . . . . 0.0 110.397 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -122.74 140.92 52.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.587 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.4 m -128.15 90.64 3.12 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.546 HD12 ' HD2' ' A' ' 11' ' ' PRO . 35.6 tp -114.88 125.01 29.51 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.314 -175.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.546 ' HD2' HD12 ' A' ' 10' ' ' LEU . 61.0 Cg_endo -75.57 153.59 39.24 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.215 1.944 . . . . 0.0 112.184 176.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.525 ' HA ' ' HG2' ' A' ' 88' ' ' MET . 1.9 p-10 -83.23 -166.24 1.3 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.824 177.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 87' ' ' VAL . 89.9 mt -77.35 3.03 14.08 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -176.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.445 ' CE1' ' HB2' ' A' ' 16' ' ' LYS . 4.7 p-80 -128.07 -20.65 3.75 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 119.924 -0.711 . . . . 0.0 111.731 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 125.88 27.82 1.1 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.085 -1.055 . . . . 0.0 113.898 174.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.445 ' HB2' ' CE1' ' A' ' 14' ' ' HIS . 13.2 tmtt? -100.58 112.48 24.87 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 175.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.6 m -66.97 122.32 17.47 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.943 0.402 . . . . 0.0 110.696 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.519 HG11 HD13 ' A' ' 62' ' ' LEU . 60.2 t -108.73 131.98 57.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.808 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 50.4 m -145.55 -174.21 4.33 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.97 0.414 . . . . 0.0 111.148 -178.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -61.04 -25.07 66.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.462 -177.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.22 -34.09 74.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.352 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -70.34 -30.39 67.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.323 0.583 . . . . 0.0 110.398 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.573 HD13 HG21 ' A' ' 110' ' ' ILE . 35.0 mt -85.36 -40.47 16.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.632 -171.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -71.49 21.69 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -159.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -152.19 11.19 0.66 Allowed Glycine 0 C--N 1.321 -0.279 0 C-N-CA 120.033 -1.08 . . . . 0.0 113.114 177.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 58' ' ' ASN . 11.4 ptmm? -160.02 179.58 8.63 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.629 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 21.4 t -102.89 139.32 24.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 C-N-CA 120.472 -0.491 . . . . 0.0 109.71 -175.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.618 HG23 ' HG3' ' A' ' 60' ' ' GLN . 44.3 m -136.88 148.14 46.89 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.705 -171.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.783 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 62.7 tp -112.79 105.8 14.01 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 175.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.532 HD13 ' HB2' ' A' ' 62' ' ' LEU . 48.5 mm -88.48 110.56 21.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 172.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.481 ' HA ' ' O ' ' A' ' 106' ' ' THR . 9.2 t30 -120.13 110.29 16.45 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.0 -173.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -84.03 120.45 26.15 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.394 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.463 ' NE1' ' HB1' ' A' ' 63' ' ' ALA . 2.8 p-90 -150.33 -171.82 4.01 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.651 -176.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.43 ' HB3' ' NE2' ' A' ' 66' ' ' GLN . 40.0 p90 -155.98 138.48 10.36 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.512 -0.767 . . . . 0.0 108.955 174.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.724 ' HD2' ' HB2' ' A' ' 69' ' ' ASP . 71.2 Cg_exo -41.96 -46.23 6.92 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.868 3.045 . . . . 0.0 115.167 -174.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.1 m -80.92 8.53 8.14 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -173.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.4 p -75.61 157.86 83.75 Favored Pre-proline 0 C--N 1.327 -0.398 0 O-C-N 122.263 -0.273 . . . . 0.0 110.651 -178.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -62.15 -11.29 21.32 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.652 2.234 . . . . 0.0 112.008 175.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.816 ' O ' ' HB2' ' A' ' 43' ' ' GLU . . . -75.86 4.55 44.76 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.756 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 12.5 p -78.43 -56.15 4.67 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 121.338 -1.095 . . . . 0.0 110.555 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.65 -42.77 71.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.787 -175.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.0 m -86.79 -42.81 13.0 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -175.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.816 ' HB2' ' O ' ' A' ' 39' ' ' GLY . 20.8 mm-40 -83.47 -41.69 17.75 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -171.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.614 ' O ' HG12 ' A' ' 48' ' ' ILE . 33.7 tpp -51.74 -53.18 53.54 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -171.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.6 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 52.9 Cg_exo -55.6 -40.39 85.64 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.872 1.715 . . . . 0.0 112.599 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -71.14 -34.94 71.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.56 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.7 mm -69.14 -43.02 81.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.757 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.614 HG12 ' O ' ' A' ' 44' ' ' MET . 47.3 mm -55.55 -52.65 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.028 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.431 ' HE2' ' O ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -58.56 -46.07 87.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.642 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.42 HG23 ' HE1' ' A' ' 130' ' ' TYR . 84.0 m -62.18 -53.14 59.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.639 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.83 -36.18 77.88 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -173.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.73 -33.84 62.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.821 0.343 . . . . 0.0 110.264 -178.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -70.69 -51.41 27.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.572 0.701 . . . . 0.0 109.937 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 1.01 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 22.6 m-85 -72.01 -7.39 48.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.411 -178.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.9 tptt -57.68 -41.77 82.29 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.488 0.492 . . . . 0.0 110.642 -177.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -101.56 10.07 40.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.272 -177.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.635 ' HG3' ' OD1' ' A' ' 58' ' ' ASN . 25.9 tptp -95.33 -62.81 1.24 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.365 -177.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.635 ' OD1' ' HG3' ' A' ' 57' ' ' LYS . 2.4 p-10 169.66 7.31 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.422 0.689 . . . . 0.0 109.763 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 1.01 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 54.2 t80 -118.33 148.6 42.32 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.542 -165.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.618 ' HG3' HG23 ' A' ' 28' ' ' THR . 10.8 pt20 -141.62 129.73 22.11 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.102 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.6 t -95.52 115.62 35.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 120.973 0.416 . . . . 0.0 110.117 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.532 ' HB2' HD13 ' A' ' 30' ' ' ILE . 84.2 mt -109.81 95.96 5.94 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.432 -0.804 . . . . 0.0 108.926 177.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.54 ' HB3' HG22 ' A' ' 87' ' ' VAL . . . -80.83 125.57 30.25 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.117 -177.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.1 t -106.03 115.75 48.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 120.908 0.385 . . . . 0.0 110.106 -178.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.09 112.62 22.88 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.245 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.598 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 0.8 OUTLIER -93.91 162.04 28.15 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.979 -179.364 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.598 ' HD2' ' HB2' ' A' ' 66' ' ' GLN . 60.1 Cg_endo -69.3 66.49 1.5 Allowed 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 123.081 2.521 . . . . 0.0 115.862 -164.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.4 mp -107.55 -51.34 7.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 162.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.724 ' HB2' ' HD2' ' A' ' 35' ' ' PRO . 30.5 m-20 -101.44 135.3 19.86 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.515 174.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -57.2 160.88 12.18 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.946 2.431 . . . . 0.0 112.336 177.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.552 ' O ' ' HG2' ' A' ' 75' ' ' ARG . 9.4 tt -58.27 -36.09 56.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.325 -177.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.768 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . 2.2 pm0 -68.97 -29.93 68.25 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.981 -0.287 . . . . 0.0 111.444 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.1 m -65.12 -38.38 90.5 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 174.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.432 ' HA ' ' HG3' ' A' ' 35' ' ' PRO . 14.1 t -71.98 -49.16 46.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.772 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.817 ' HA ' HG22 ' A' ' 78' ' ' VAL . 13.4 ptt180 -70.11 -24.95 63.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.702 -177.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -69.35 -42.84 74.75 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 170.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -62.24 -50.06 73.24 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.118 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.817 HG22 ' HA ' ' A' ' 75' ' ' ARG . 21.5 m -62.41 -27.01 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.063 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.22 -55.09 6.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.236 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -62.45 -43.93 97.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.44 -171.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -97.75 -3.16 39.6 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -173.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 56.56 65.52 3.51 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.446 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.571 HD22 HG12 ' A' ' 78' ' ' VAL . 9.7 mp -68.98 117.62 53.37 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-O 120.907 0.384 . . . . 0.0 111.575 -175.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -78.65 -4.65 14.25 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.32 2.68 . . . . 0.0 113.14 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -106.31 138.81 41.83 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.447 ' HB ' HD23 ' A' ' 62' ' ' LEU . 22.0 m -72.0 126.29 29.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.242 -172.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.54 HG22 ' HB3' ' A' ' 63' ' ' ALA . 46.1 t -110.68 131.79 60.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.788 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.525 ' HG2' ' HA ' ' A' ' 12' ' ' ASP . 63.2 mtm -112.74 168.36 9.74 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.06 176.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -121.6 127.18 50.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.827 0.346 . . . . 0.0 110.429 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.587 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 63.5 t0 -105.14 106.53 17.06 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.71 -47.75 37.16 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -173.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -91.93 -5.2 53.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.639 -175.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.576 ' O ' ' HG3' ' A' ' 97' ' ' GLN . 34.5 ttmt 65.66 20.2 11.53 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -173.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.93 -25.65 60.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.169 -175.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.462 HG21 HD22 ' A' ' 10' ' ' LEU . 22.5 t -74.01 -39.05 50.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 174.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.95 -33.3 86.87 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.772 173.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.576 ' HG3' ' O ' ' A' ' 93' ' ' LYS . 78.0 mt-30 -66.19 -33.27 75.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.98 0.419 . . . . 0.0 110.815 176.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.53 -39.87 70.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.478 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -87.27 -27.05 23.15 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.36 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 97.58 62.42 0.9 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.924 176.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 66.5 p -79.76 112.01 16.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.673 0.273 . . . . 0.0 111.147 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -103.51 -38.37 7.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.895 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.473 ' CG1' ' HB ' ' A' ' 121' ' ' VAL . 9.7 p -144.47 144.15 22.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -108.51 146.93 34.7 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.08 -173.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -75.33 151.48 96.48 Favored 'Cis proline' 0 C--N 1.343 0.279 0 C-N-CA 122.814 -1.744 . . . . 0.0 112.801 0.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 23.9 m -108.09 112.65 25.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.591 176.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.55 ' HB3' HD11 ' A' ' 29' ' ' LEU . 9.4 m -102.5 109.8 21.55 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.952 0.406 . . . . 0.0 110.6 -176.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 36.3 t -108.28 133.2 53.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.471 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.588 HD12 ' HB3' ' A' ' 118' ' ' LYS . 97.2 mt -101.58 116.34 32.54 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.085 0.469 . . . . 0.0 110.168 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.573 HG21 HD13 ' A' ' 23' ' ' LEU . 11.0 mm -107.33 157.21 7.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.066 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -146.22 -155.9 6.69 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 119.93 -1.129 . . . . 0.0 112.774 176.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.519 ' O ' ' HB3' ' A' ' 113' ' ' LYS . 16.5 pttp -56.99 156.13 7.26 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 124.014 0.925 . . . . 0.0 109.365 178.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.519 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 3.0 ttmp? 71.92 -16.76 0.39 Allowed 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.981 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.442 ' H ' ' C ' ' A' ' 112' ' ' LYS . . . 91.38 7.37 65.35 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 -174.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.518 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 17.2 pt-20 -67.77 135.73 53.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.123 0.487 . . . . 0.0 111.052 -176.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 57.0 mt -80.98 107.25 13.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 174.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.01 -40.56 38.6 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.761 -173.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.588 ' HB3' HD12 ' A' ' 109' ' ' LEU . 21.9 tptm -161.24 154.78 21.79 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.421 -171.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.3 m -136.62 115.59 12.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.867 0.365 . . . . 0.0 110.966 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.469 ' OH ' ' HE3' ' A' ' 128' ' ' LYS . 75.2 m-85 -108.04 144.65 35.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.446 174.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.473 ' HB ' ' CG1' ' A' ' 103' ' ' VAL . 6.2 m -123.92 137.23 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-O 120.731 0.3 . . . . 0.0 110.947 177.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 89.68 -84.67 1.39 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.2 177.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.05 106.74 7.37 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -75.9 119.76 5.52 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.502 2.135 . . . . 0.0 112.112 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.553 ' HB2' ' HE2' ' A' ' 128' ' ' LYS . 0.5 OUTLIER -53.4 93.07 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.078 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.565 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 14.7 m-85 -61.93 -33.29 74.0 Favored 'General case' 0 C--O 1.219 -0.53 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -172.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -59.32 -49.15 81.58 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 119.821 -1.18 . . . . 0.0 111.335 175.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.553 ' HE2' ' HB2' ' A' ' 125' ' ' ASP . 32.2 ttpt -68.5 -36.88 79.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.09 -0.555 . . . . 0.0 110.265 177.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.565 ' HB3' ' HA ' ' A' ' 126' ' ' PHE . 8.8 tt -64.33 -44.17 92.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.984 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.42 ' HE1' HG23 ' A' ' 50' ' ' THR . 18.2 m-30 -56.36 -56.4 21.55 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.017 0.437 . . . . 0.0 110.625 179.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -65.27 -34.26 77.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.882 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -64.49 -38.09 89.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.598 -0.273 . . . . 0.0 111.102 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.522 HG23 HG11 ' A' ' 27' ' ' VAL . 66.1 mt -62.66 -52.87 54.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.721 0.296 . . . . 0.0 110.895 177.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -69.56 -17.63 63.58 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 97.2 m -71.68 -26.63 62.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.307 0.575 . . . . 0.0 109.836 172.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.35 179.653 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 121.13 0.49 . . . . 0.0 110.648 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -125.36 150.16 47.45 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.652 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.8 p -145.3 90.59 2.04 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.518 176.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -110.25 134.73 20.69 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.416 -173.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.566 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 56.5 Cg_endo -72.98 131.74 17.28 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.177 1.918 . . . . 0.0 111.553 174.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.24 176.38 9.73 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.674 HD12 HG21 ' A' ' 78' ' ' VAL . 75.1 mt -70.69 -13.76 62.2 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -173.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -102.19 -2.82 28.47 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.195 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.78 17.76 11.57 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.478 -0.868 . . . . 0.0 114.75 169.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.463 ' HZ2' HG22 ' A' ' 18' ' ' VAL . 41.4 tttm -105.46 126.65 52.36 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 117.761 0.781 . . . . 0.0 110.062 175.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 10.2 t -72.28 125.09 26.48 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.433 0.635 . . . . 0.0 109.499 173.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.757 ' HB ' ' SD ' ' A' ' 88' ' ' MET . 60.2 t -113.31 124.29 69.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.238 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.1 m -121.82 -173.94 2.76 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.179 -177.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -68.89 -23.22 64.17 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.873 0.368 . . . . 0.0 110.678 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.14 -28.05 69.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.707 176.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -71.9 -12.41 61.25 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.179 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.2 mt -84.59 -27.87 26.95 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.012 0.434 . . . . 0.0 111.604 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.6 mm100 -74.21 144.4 44.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.121 -170.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.42 -25.47 17.64 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 121.14 -0.553 . . . . 0.0 114.014 170.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.565 ' HG3' ' HG3' ' A' ' 60' ' ' GLN . 0.0 OUTLIER -143.59 -168.18 2.76 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -177.897 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.612 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 14.2 t -101.93 144.4 13.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 176.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.582 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 30.0 m -140.29 149.34 42.67 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.964 -0.295 . . . . 0.0 110.255 -173.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.761 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 6.4 tt -121.64 117.75 27.47 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 173.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.682 ' HB ' ' CG2' ' A' ' 108' ' ' VAL . 51.2 mt -102.56 119.97 51.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.333 -0.394 . . . . 0.0 109.972 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.468 ' OD1' ' HA ' ' A' ' 63' ' ' ALA . 21.7 p-10 -109.62 124.41 51.12 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.604 0.716 . . . . 0.0 111.036 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.439 ' HB2' ' HB ' ' A' ' 106' ' ' THR . 66.1 m-85 -98.11 129.51 44.92 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.58 178.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.62 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 42.4 p-90 -163.16 173.54 13.32 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.434 -177.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.459 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 29.2 p90 -131.48 141.78 43.0 Favored Pre-proline 0 C--N 1.318 -0.769 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 171.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.696 ' HG2' ' HA ' ' A' ' 74' ' ' VAL . 31.4 Cg_exo -62.74 0.55 1.45 Allowed 'Trans proline' 0 N--CA 1.476 0.459 0 C-N-CA 123.59 2.86 . . . . 0.0 114.592 -173.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.44 ' OG ' ' HD2' ' A' ' 34' ' ' PHE . 0.5 OUTLIER -102.28 18.0 22.04 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.133 0.492 . . . . 0.0 110.799 173.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 87.5 m -85.56 135.62 38.2 Favored Pre-proline 0 CA--C 1.528 0.096 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.601 176.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 12.7 Cg_exo -71.17 -8.56 23.76 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.008 2.472 . . . . 0.0 111.939 173.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.781 ' O ' ' HB2' ' A' ' 43' ' ' GLU . . . -68.37 5.97 3.66 Favored Glycine 0 C--O 1.22 -0.734 0 CA-C-N 115.762 -0.654 . . . . 0.0 113.667 -177.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.764 ' HA ' ' HG2' ' A' ' 44' ' ' MET . 25.0 p -78.03 -30.25 49.8 Favored 'General case' 0 C--N 1.317 -0.824 0 O-C-N 121.909 -0.759 . . . . 0.0 111.905 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.59 HG23 ' H ' ' A' ' 42' ' ' SER . 6.6 m -56.38 -64.99 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 -166.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.59 ' H ' HG23 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -93.57 -39.72 10.69 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 121.79 -0.569 . . . . 0.0 110.785 178.798 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.781 ' HB2' ' O ' ' A' ' 39' ' ' GLY . 8.3 mp0 -64.21 -41.72 96.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.207 -169.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.764 ' HG2' ' HA ' ' A' ' 40' ' ' CYS . 19.9 mmt -60.37 -53.12 67.89 Favored Pre-proline 0 C--N 1.329 -0.308 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.295 -178.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.481 ' HD3' ' HB2' ' A' ' 44' ' ' MET . 80.6 Cg_exo -51.06 -37.85 58.39 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 122.335 2.023 . . . . 0.0 112.848 172.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.522 ' HD3' ' O ' ' A' ' 42' ' ' SER . 23.2 mtpt -61.32 -41.21 96.63 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 120.823 0.344 . . . . 0.0 110.621 176.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.531 HG13 ' O ' ' A' ' 43' ' ' GLU . 27.2 mt -71.82 -32.09 43.54 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.578 177.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.607 HG12 ' O ' ' A' ' 44' ' ' MET . 47.5 mm -54.51 -52.14 43.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-O 120.893 0.378 . . . . 0.0 110.434 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 46' ' ' LYS . 16.6 pttm -65.4 -44.87 86.1 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.642 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.5 m -70.6 -46.87 62.6 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.984 0.421 . . . . 0.0 111.863 -174.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . -69.25 -33.11 72.76 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.906 -174.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.605 ' HA ' ' NZ ' ' A' ' 55' ' ' LYS . 62.1 t30 -76.41 -50.37 14.34 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.118 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -64.99 -46.1 82.85 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.017 -172.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.758 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 38.1 m-85 -79.67 -10.12 59.74 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.57 -175.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.605 ' NZ ' ' HA ' ' A' ' 52' ' ' ASN . 7.1 ttpm? -63.59 -21.28 66.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.208 0.527 . . . . 0.0 110.518 178.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -106.37 17.23 23.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.625 176.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.6 mtmm -136.62 44.69 2.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.771 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.527 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 17.2 t-20 62.91 31.46 16.24 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.592 0.71 . . . . 0.0 110.745 175.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.761 ' HZ ' ' HB2' ' A' ' 29' ' ' LEU . 48.8 t80 -135.82 137.51 41.61 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.142 176.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.565 ' HG3' ' HG3' ' A' ' 26' ' ' LYS . 4.5 mt-30 -127.69 157.46 40.24 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.224 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 98.6 t -130.88 126.34 59.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 177.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.4 mt -121.39 121.04 36.74 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.122 0.487 . . . . 0.0 110.605 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.582 ' HB3' ' HA ' ' A' ' 87' ' ' VAL . . . -91.19 132.0 36.37 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.458 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.7 t -123.81 101.31 8.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.074 0.464 . . . . 0.0 110.37 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.62 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -85.78 117.38 24.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.685 175.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.642 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -90.92 163.97 27.54 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.34 -0.391 . . . . 0.0 109.981 -176.466 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.652 ' HD3' ' O ' ' A' ' 90' ' ' ASP . 60.8 Cg_endo -70.17 93.56 0.56 Allowed 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.027 1.818 . . . . 0.0 113.253 -169.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 46.5 mm -124.75 -60.81 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 172.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.493 ' OD2' ' HD2' ' A' ' 35' ' ' PRO . 1.8 p30 -105.67 154.21 39.4 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.602 168.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.414 ' HB2' ' OE2' ' A' ' 72' ' ' GLU . 12.9 Cg_exo -69.33 -179.96 3.07 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 122.83 2.353 . . . . 0.0 114.131 -171.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.1 tp -64.24 -35.81 75.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.879 -169.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.561 ' HA ' ' CD ' ' A' ' 75' ' ' ARG . 0.1 OUTLIER -73.39 -29.13 62.41 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.168 -0.332 . . . . 0.0 110.406 -177.645 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 45.5 m -68.72 -41.99 78.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.996 175.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.696 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 92.3 t -60.44 -55.01 27.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.297 176.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.561 ' CD ' ' HA ' ' A' ' 72' ' ' GLU . 1.4 ptm180 -63.69 -27.59 69.32 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.741 -177.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.457 ' HB2' ' O ' ' A' ' 72' ' ' GLU . 8.0 tt0 -66.14 -45.53 80.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.234 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.435 ' HB2' ' HB3' ' A' ' 35' ' ' PRO . 0.1 OUTLIER -63.31 -35.85 81.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.847 -178.862 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.674 HG21 HD12 ' A' ' 13' ' ' LEU . 60.5 t -61.26 -39.55 82.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.637 176.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 75' ' ' ARG . 95.2 mttt -70.73 -40.96 72.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.951 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -60.0 -49.38 77.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.239 -173.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.439 ' HB2' ' CD1' ' A' ' 83' ' ' LEU . 77.9 m-85 -99.8 3.7 44.9 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.699 -176.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 57.16 57.91 17.32 Favored Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.123 -178.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.655 ' HB2' HG13 ' A' ' 78' ' ' VAL . 10.5 mp -62.17 114.01 10.35 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-O 120.672 0.272 . . . . 0.0 111.476 -176.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -89.99 13.98 2.2 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.369 2.713 . . . . 0.0 112.936 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -117.96 150.21 39.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.836 176.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.7 m -69.83 115.43 9.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.756 0.312 . . . . 0.0 111.319 -173.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.582 ' HA ' ' HB3' ' A' ' 63' ' ' ALA . 31.4 t -104.5 126.59 59.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.138 -176.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.757 ' SD ' ' HB ' ' A' ' 18' ' ' VAL . 63.6 mtm -112.44 169.15 9.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.745 175.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -115.49 123.49 48.67 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.13 176.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.736 ' OD2' ' HA ' ' A' ' 93' ' ' LYS . 20.0 t0 -88.84 107.33 18.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.434 177.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.96 -47.58 20.48 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -175.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -99.85 -12.24 20.04 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -169.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.736 ' HA ' ' OD2' ' A' ' 90' ' ' ASP . 57.2 tttp 68.61 -2.31 1.69 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.015 0.526 . . . . 0.0 111.821 176.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.21 -23.88 43.51 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.919 0.39 . . . . 0.0 110.484 -177.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.453 ' O ' ' HD1' ' A' ' 99' ' ' PHE . 28.3 m -71.39 -38.04 67.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 171.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.52 -33.7 85.44 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 173.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 67.9 mm-40 -66.75 -32.28 73.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.811 0.338 . . . . 0.0 110.856 175.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.67 -39.9 95.49 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.253 0.549 . . . . 0.0 110.487 177.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.499 ' CE2' HD12 ' A' ' 116' ' ' ILE . 29.7 m-85 -73.63 -28.69 61.93 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.062 175.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.33 44.84 2.9 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.424 178.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.547 HG22 HG21 ' A' ' 106' ' ' THR . 52.5 p -104.48 112.91 26.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.253 0.549 . . . . 0.0 111.568 -176.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -111.95 -39.5 4.5 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.356 177.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.6 m -117.78 149.97 20.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 177.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.59 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 92.3 m-85 -129.44 161.62 57.74 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.75 -172.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.59 ' HA ' ' HB3' ' A' ' 104' ' ' TYR . 63.5 Cg_endo -73.03 165.71 83.46 Favored 'Cis proline' 0 C--N 1.349 0.603 0 C-N-CA 123.689 -1.379 . . . . 0.0 113.439 0.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.547 HG21 HG22 ' A' ' 101' ' ' THR . 4.2 m -135.05 148.88 50.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.433 177.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 37.8 m -137.69 114.59 10.66 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.971 0.415 . . . . 0.0 110.621 178.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.682 ' CG2' ' HB ' ' A' ' 30' ' ' ILE . 20.5 m -106.77 145.13 14.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.136 0.493 . . . . 0.0 111.053 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.553 HD11 HD12 ' A' ' 129' ' ' LEU . 9.5 mp -101.69 133.32 46.58 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.542 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.582 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 34.5 mm -110.49 135.02 50.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.943 -176.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -77.17 -150.21 3.74 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.831 -0.7 . . . . 0.0 111.706 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.485 ' HD3' HG22 ' A' ' 27' ' ' VAL . 10.2 mmmm -101.05 -7.58 23.12 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -176.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 2.7 mtmp? -124.55 19.72 8.73 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 113.485 -1.689 . . . . 0.0 109.291 -175.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.2 -90.97 1.58 Allowed Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -173.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 69.17 -30.55 0.19 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 167.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.499 HD12 ' CE2' ' A' ' 99' ' ' PHE . 23.5 mm 53.38 64.87 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 CA-C-O 121.946 0.879 . . . . 0.0 108.997 -169.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.438 HD22 ' HA ' ' A' ' 117' ' ' LEU . 0.2 OUTLIER -62.02 -45.44 93.58 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 113.885 -1.507 . . . . 0.0 112.983 -169.28 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.7 ' HG3' ' OE2' ' A' ' 132' ' ' GLU . 4.3 tmtp? -143.91 153.83 42.71 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.257 -169.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.4 ' H ' ' HD3' ' A' ' 118' ' ' LYS . 40.3 m -139.96 108.01 5.74 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.944 0.402 . . . . 0.0 111.427 178.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -98.95 137.87 36.88 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.294 170.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.6 p -109.91 140.82 27.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 82.22 -109.8 3.11 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 -176.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -111.44 126.31 28.83 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 173.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.54 ' HB2' HD13 ' A' ' 129' ' ' LEU . 56.0 Cg_endo -72.14 125.64 11.05 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.206 1.937 . . . . 0.0 111.369 175.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.418 ' OD2' ' HB3' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -59.22 121.86 12.4 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.234 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -70.33 -29.67 66.44 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.28 -174.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -65.97 -54.91 22.0 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.32 -174.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.418 ' HB3' ' OD2' ' A' ' 125' ' ' ASP . 26.2 tptp -75.74 -33.08 60.24 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.553 HD12 HD11 ' A' ' 109' ' ' LEU . 0.9 OUTLIER -58.31 -48.34 80.8 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.008 0.193 . . . . 0.0 110.974 179.276 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -67.1 -45.14 78.13 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.191 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -64.57 -36.31 83.81 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.387 0.613 . . . . 0.0 110.885 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.7 ' OE2' ' HG3' ' A' ' 118' ' ' LYS . 21.3 tt0 -74.73 -40.02 61.52 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.44 -175.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.506 HG23 HG11 ' A' ' 27' ' ' VAL . 79.7 mt -64.4 -42.3 94.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.876 173.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -54.47 -39.03 67.1 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.462 177.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.8 m -60.51 -39.44 87.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.08 0.467 . . . . 0.0 110.713 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.395 -177.271 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.183 0 CA-C-O 121.08 0.467 . . . . 0.0 110.796 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.515 ' CE1' HD11 ' A' ' 23' ' ' LEU . 45.4 p90 -132.35 168.42 18.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.197 0.522 . . . . 0.0 111.355 -175.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 48.6 m -148.46 95.03 2.38 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 172.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 22.0 tp -115.87 133.61 22.83 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.415 -171.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.503 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 8.1 Cg_exo -72.59 134.97 23.21 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.562 2.175 . . . . 0.0 112.414 178.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.589 ' HB3' ' O ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -76.07 164.36 26.2 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.822 174.8 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.663 ' HB3' ' HG2' ' A' ' 75' ' ' ARG . 69.4 mt -67.13 -7.03 20.25 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 -170.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -123.6 17.71 9.59 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 121.809 -0.557 . . . . 0.0 110.959 174.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.02 22.35 25.59 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.931 -0.652 . . . . 0.0 114.045 169.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.589 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 11.3 tmtt? -97.03 102.5 14.29 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 173.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 12.0 m -63.52 122.42 16.25 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.894 0.378 . . . . 0.0 110.262 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.511 ' HB ' ' SD ' ' A' ' 88' ' ' MET . 60.8 t -106.24 116.44 50.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.801 178.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 83.4 p -103.15 -176.91 3.22 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.432 -177.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -73.3 -23.01 60.23 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.688 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.53 ' O ' ' HG3' ' A' ' 24' ' ' GLN . . . -68.34 -28.57 67.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.051 178.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -70.84 -15.53 62.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.871 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.515 HD11 ' CE1' ' A' ' 8' ' ' PHE . 92.3 mt -83.87 -20.21 33.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.706 -177.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.53 ' HG3' ' O ' ' A' ' 21' ' ' ALA . 0.4 OUTLIER -100.24 141.56 32.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.46 0.648 . . . . 0.0 112.457 -172.784 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.76 -8.32 68.26 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.101 -176.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 112' ' ' LYS . 9.3 mtpm? -142.31 164.23 30.71 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.697 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 25.2 t -102.5 141.73 18.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -177.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.466 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 26.8 m -132.78 138.47 47.16 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -165.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.63 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 36.7 tp -121.49 112.31 18.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.192 170.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.564 HG12 ' HB2' ' A' ' 62' ' ' LEU . 54.4 mt -102.33 115.6 44.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.801 0.334 . . . . 0.0 110.411 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.434 ' HA ' ' O ' ' A' ' 106' ' ' THR . 4.5 p-10 -109.06 126.87 53.62 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.326 0.584 . . . . 0.0 110.281 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.479 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 86.1 m-85 -92.97 127.9 38.65 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.829 178.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.51 ' NE1' ' HB1' ' A' ' 63' ' ' ALA . 5.3 p-90 -153.04 -178.05 6.68 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.065 0.46 . . . . 0.0 111.218 -175.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -149.48 148.22 25.47 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.757 172.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.518 ' HD2' ' HB2' ' A' ' 69' ' ' ASP . 96.3 Cg_exo -44.94 -47.87 11.49 Favored 'Trans proline' 0 N--CA 1.475 0.437 0 C-N-CA 123.592 2.861 . . . . 0.0 114.569 -175.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.9 m -82.67 17.14 1.91 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -175.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 53.3 t -73.61 126.51 89.72 Favored Pre-proline 0 C--N 1.328 -0.333 0 O-C-N 122.355 -0.215 . . . . 0.0 110.638 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -62.72 -22.28 73.77 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.907 2.405 . . . . 0.0 113.048 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.84 -17.01 80.28 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.181 -177.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 31.2 p -67.7 -41.5 83.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.069 0.434 . . . . 0.0 111.187 -174.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.8 p -59.99 -32.03 49.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.855 0.36 . . . . 0.0 111.169 -176.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.0 m -86.89 -54.09 4.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.818 0.342 . . . . 0.0 111.328 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -85.22 -29.69 24.47 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -168.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.578 ' O ' HG12 ' A' ' 48' ' ' ILE . 41.1 ttm -58.7 -46.7 99.56 Favored Pre-proline 0 N--CA 1.47 0.535 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -173.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 44' ' ' MET . 7.0 Cg_endo -50.97 -38.11 58.03 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.017 1.811 . . . . 0.0 112.246 175.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -65.2 -44.15 89.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.209 0.528 . . . . 0.0 109.76 176.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 42.5 mm -60.87 -41.46 88.86 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.359 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.74 178.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.578 HG12 ' O ' ' A' ' 44' ' ' MET . 43.0 mm -54.34 -49.2 65.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.249 0.547 . . . . 0.0 110.086 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.437 ' HE3' ' HB3' ' A' ' 49' ' ' LYS . 18.5 ttpp -64.96 -57.58 8.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.576 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.6 m -63.24 -41.91 99.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.766 -173.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.05 -50.24 62.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.126 -177.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -64.85 -43.04 94.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.858 0.361 . . . . 0.0 110.889 -173.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.434 ' CG ' ' HZ1' ' A' ' 57' ' ' LYS . 14.1 t70 -59.93 -42.2 93.45 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.001 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 1.037 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 14.9 m-85 -81.34 -26.18 35.79 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.218 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.4 mmmm -58.59 -30.63 67.35 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.854 0.359 . . . . 0.0 110.564 176.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -94.15 19.36 9.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.034 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.434 ' HZ1' ' CG ' ' A' ' 53' ' ' ASP . 27.3 mtmm -128.25 -59.09 1.18 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.325 176.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.408 ' O ' ' HB3' ' A' ' 26' ' ' LYS . 27.2 t-20 176.99 -14.64 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.321 0.582 . . . . 0.0 110.892 -174.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 1.037 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 62.9 t80 -98.31 147.71 24.38 Favored 'General case' 0 C--N 1.316 -0.849 0 O-C-N 122.032 -0.417 . . . . 0.0 109.938 -174.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -137.83 127.66 25.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.134 0.493 . . . . 0.0 111.324 -176.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 92.3 t -99.23 120.43 48.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.426 174.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.564 ' HB2' HG12 ' A' ' 30' ' ' ILE . 72.4 mt -113.78 112.84 24.08 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.708 -178.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.51 ' HB1' ' NE1' ' A' ' 33' ' ' TRP . . . -93.5 107.51 19.35 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.645 -177.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 88.4 t -95.66 113.92 31.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.075 0.464 . . . . 0.0 110.448 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.51 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -86.11 131.9 34.15 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.697 176.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.598 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -100.24 163.91 17.37 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.514 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.598 ' HD2' ' HB2' ' A' ' 66' ' ' GLN . 32.8 Cg_endo -64.12 79.27 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.542 2.162 . . . . 0.0 113.784 -175.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.469 HG12 ' HG2' ' A' ' 66' ' ' GLN . 40.1 mm -117.83 -63.35 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 171.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.518 ' HB2' ' HD2' ' A' ' 35' ' ' PRO . 14.8 m-20 -96.62 149.55 35.95 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 168.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.45 150.51 34.02 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.633 2.222 . . . . 0.0 112.893 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.0 tt -55.14 -38.5 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.629 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -66.18 -37.39 85.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.107 0.48 . . . . 0.0 110.419 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.4 m -61.35 -35.01 76.25 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.387 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.477 ' HA ' ' HG3' ' A' ' 35' ' ' PRO . 10.9 t -67.67 -41.0 85.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.114 178.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.801 ' HA ' HG22 ' A' ' 78' ' ' VAL . 41.8 mtp180 -69.08 -32.82 72.54 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.368 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.75 -38.81 92.01 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 175.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.466 ' HE1' ' SD ' ' A' ' 44' ' ' MET . 7.7 t80 -67.85 -48.68 65.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.267 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.801 HG22 ' HA ' ' A' ' 75' ' ' ARG . 25.8 m -62.9 -31.93 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -177.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.479 ' HB3' ' HE2' ' A' ' 79' ' ' LYS . 44.9 mtpt -74.64 -54.27 7.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.75 0.309 . . . . 0.0 111.408 177.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -65.71 -41.29 92.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.918 -171.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -89.75 -21.76 22.51 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.604 -175.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.0 75.48 0.91 Allowed Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.429 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.64 HD22 HG12 ' A' ' 78' ' ' VAL . 10.6 mp -95.26 112.32 58.18 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 120.798 0.332 . . . . 0.0 111.107 -177.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -81.0 -11.41 12.33 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.185 2.59 . . . . 0.0 113.326 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.471 ' HE1' HD13 ' A' ' 48' ' ' ILE . 29.1 p90 -91.06 145.21 24.88 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 176.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.41 ' HB ' ' CD2' ' A' ' 62' ' ' LEU . 19.4 m -71.83 118.21 14.4 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.976 -172.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.46 HG22 ' HB3' ' A' ' 63' ' ' ALA . 39.0 t -107.49 129.26 61.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.573 -178.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.511 ' SD ' ' HB ' ' A' ' 18' ' ' VAL . 70.9 mtm -119.85 171.17 8.61 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.45 178.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -137.48 115.27 11.39 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.741 0.305 . . . . 0.0 110.329 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.593 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 47.8 t0 -98.73 102.41 14.13 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.36 -28.27 61.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.723 -176.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -83.71 -7.11 59.55 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.872 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.3 pttp 47.41 25.2 0.57 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.214 1.005 . . . . 0.0 111.774 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -81.59 -34.38 31.03 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.601 -172.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.539 HG22 ' OD2' ' A' ' 90' ' ' ASP . 31.5 m -76.31 -30.68 20.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 119.989 -0.684 . . . . 0.0 109.604 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -69.92 -38.51 75.17 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 172.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 -69.97 -23.75 63.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.567 -0.317 . . . . 0.0 111.346 176.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.42 -36.33 71.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.667 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -86.86 -19.27 29.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.082 176.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 81.84 41.94 9.32 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.904 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.562 HG22 HG21 ' A' ' 106' ' ' THR . 50.4 p -76.15 86.86 3.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.223 0.535 . . . . 0.0 111.054 -178.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -93.09 -45.23 7.99 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.638 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.558 ' HB ' HG22 ' A' ' 121' ' ' VAL . 21.3 t -100.28 123.41 53.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.981 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -104.09 144.37 28.55 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.077 -177.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -76.47 165.27 85.67 Favored 'Cis proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.724 -1.365 . . . . 0.0 113.304 0.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.562 HG21 HG22 ' A' ' 101' ' ' THR . 5.5 m -129.54 125.93 37.4 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.82 174.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.443 ' HB3' HD11 ' A' ' 29' ' ' LEU . 16.5 m -111.62 114.51 27.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.857 0.36 . . . . 0.0 110.884 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.527 HG22 HG23 ' A' ' 119' ' ' THR . 47.3 t -105.98 130.82 56.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.325 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.547 HD12 ' HB3' ' A' ' 118' ' ' LYS . 85.8 mt -101.7 120.2 39.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.567 -178.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.466 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 31.1 mt -112.58 144.13 20.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.405 179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.697 ' O ' ' HA ' ' A' ' 27' ' ' VAL . . . -72.88 -112.03 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 121.117 -0.563 . . . . 0.0 113.071 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 18.0 pttm -140.54 -8.06 1.12 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -173.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -121.44 -9.75 8.97 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 173.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 127.9 -4.41 6.94 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.592 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 115' ' ' GLU . 5.9 pm0 -58.36 116.95 3.95 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.43 0.633 . . . . 0.0 110.225 -177.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 60.7 mt -78.12 112.33 15.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.589 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.404 ' CD1' ' HB2' ' A' ' 136' ' ' ALA . 61.3 mt -90.17 -50.5 5.96 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.416 -173.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.547 ' HB3' HD12 ' A' ' 109' ' ' LEU . 18.0 tptm -152.08 158.35 42.87 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.427 -167.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.527 HG23 HG22 ' A' ' 108' ' ' VAL . 32.0 m -143.15 103.73 4.19 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.147 0.498 . . . . 0.0 110.526 174.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -88.93 106.21 18.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.075 174.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.558 HG22 ' HB ' ' A' ' 103' ' ' VAL . 7.7 p -95.92 121.43 46.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.265 0.555 . . . . 0.0 110.711 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 105.14 -80.6 0.3 Allowed Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.11 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -138.82 118.57 9.53 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.89 143.12 20.51 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.629 2.219 . . . . 0.0 113.323 -177.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.53 ' O ' ' HB2' ' A' ' 129' ' ' LEU . 24.8 t0 -77.45 107.6 10.01 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 172.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -66.35 -43.49 85.88 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -174.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.25 -43.75 98.65 Favored Glycine 0 C--O 1.239 0.437 0 C-N-CA 120.261 -0.971 . . . . 0.0 111.161 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.638 ' HB2' ' NZ ' ' A' ' 128' ' ' LYS . 1.7 ttmp? -71.82 -31.59 66.69 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.21 -0.495 . . . . 0.0 109.994 178.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.533 ' O ' HG13 ' A' ' 133' ' ' ILE . 0.2 OUTLIER -56.55 -48.01 78.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.001 177.397 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -65.92 -48.97 69.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.386 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.45 ' HG2' ' HA ' ' A' ' 128' ' ' LYS . 3.3 pt20 -68.36 -32.23 72.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.964 0.412 . . . . 0.0 111.459 -177.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -74.68 -32.66 62.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.322 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.533 HG13 ' O ' ' A' ' 129' ' ' LEU . 59.5 mt -62.85 -49.69 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 172.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -56.65 -38.23 71.89 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.409 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 88.0 m -55.48 -40.62 71.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.012 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.404 ' HB2' ' CD1' ' A' ' 117' ' ' LEU . . . . . . . . 0 C--O 1.237 0.42 0 CA-C-O 121.039 0.447 . . . . 0.0 111.039 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.19 0 CA-C-O 121.025 0.44 . . . . 0.0 111.587 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -129.14 135.55 49.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.624 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.3 t -150.2 88.89 1.54 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 171.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.477 HD11 ' HB3' ' A' ' 88' ' ' MET . 1.4 pt? -121.71 155.25 60.21 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.593 -178.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.601 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 8.1 Cg_exo -73.23 130.3 15.06 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.633 2.222 . . . . 0.0 112.522 177.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.54 160.81 31.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.516 173.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.453 HD12 HG11 ' A' ' 78' ' ' VAL . 41.4 mt -60.91 -24.01 65.67 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 -174.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -83.14 -11.7 57.69 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.06 -15.07 16.18 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 121.167 -0.54 . . . . 0.0 113.256 174.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -76.37 121.44 23.03 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.869 0.335 . . . . 0.0 111.114 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.601 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 20.5 m -69.75 123.18 20.76 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 172.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.9 t -119.56 130.01 74.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.981 0.42 . . . . 0.0 110.778 -176.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.9 t -132.05 173.99 10.65 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.494 178.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.756 ' HA ' HD13 ' A' ' 23' ' ' LEU . 30.0 p-10 -61.01 -22.8 64.88 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -172.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.618 ' HA ' HE21 ' A' ' 24' ' ' GLN . . . -67.68 -27.95 67.28 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 178.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -67.63 -32.81 73.77 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.18 0.514 . . . . 0.0 110.93 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.756 HD13 ' HA ' ' A' ' 20' ' ' ASN . 5.2 mp -71.46 -20.36 62.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.064 -175.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.618 HE21 ' HA ' ' A' ' 21' ' ' ALA . 46.5 mt-30 -68.21 98.5 0.81 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.211 -177.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 132.17 -22.85 4.18 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.079 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.4 mtmm -111.47 162.56 14.97 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -103.46 123.34 56.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 168.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.53 ' HB ' HD12 ' A' ' 110' ' ' ILE . 11.0 m -126.59 150.9 48.6 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.092 0.472 . . . . 0.0 111.842 -164.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.422 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 51.9 tp -123.71 120.45 32.74 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.921 174.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.982 ' HB ' HG12 ' A' ' 108' ' ' VAL . 34.5 mm -97.19 132.79 40.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 175.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -128.17 125.07 38.33 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.245 0.545 . . . . 0.0 109.879 174.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.413 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 48.3 m-85 -90.56 122.63 33.54 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.991 176.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.474 ' NE1' ' HB1' ' A' ' 63' ' ' ALA . 6.1 p-90 -148.4 -169.84 3.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.454 -177.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -159.4 143.8 11.17 Favored Pre-proline 0 C--N 1.321 -0.656 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 174.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.494 ' HG2' ' CB ' ' A' ' 69' ' ' ASP . 12.8 Cg_endo -59.0 158.93 23.31 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.414 2.076 . . . . 0.0 111.521 176.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.8 m 68.32 18.41 9.14 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.19 -177.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.475 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 52.8 t -101.3 136.78 19.59 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.547 177.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.482 ' O ' HG22 ' A' ' 41' ' ' VAL . 19.9 Cg_exo -67.15 -13.8 40.99 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 123.014 2.476 . . . . 0.0 112.919 178.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.42 -4.78 19.13 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 121.515 -0.374 . . . . 0.0 113.467 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.707 ' O ' ' HB2' ' A' ' 44' ' ' MET . 61.0 m -63.22 -34.88 78.61 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 122.725 -0.28 . . . . 0.0 110.897 176.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 38' ' ' PRO . 33.0 m -67.98 -33.99 64.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.176 -177.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.9 p -88.87 -56.41 3.3 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.575 ' HG2' ' HG3' ' A' ' 105' ' ' PRO . 1.4 mp0 -84.09 -34.77 24.09 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -168.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.707 ' HB2' ' O ' ' A' ' 40' ' ' CYS . 8.6 mmt -61.12 -48.11 93.0 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -175.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 44' ' ' MET . 13.2 Cg_endo -57.25 -34.19 97.38 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 121.838 1.692 . . . . 0.0 112.305 175.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.48 ' HD2' ' HA ' ' A' ' 43' ' ' GLU . 93.9 mttt -64.32 -51.66 62.34 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 176.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.674 HG23 HG11 ' A' ' 61' ' ' VAL . 45.1 mm -57.43 -46.91 85.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.834 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.469 HG12 ' O ' ' A' ' 44' ' ' MET . 46.1 mm -56.57 -53.36 42.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.184 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -69.3 -51.34 38.22 Favored 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.384 -174.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 62.4 m -57.2 -42.39 81.18 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.071 0.463 . . . . 0.0 111.196 -176.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.04 -31.5 70.32 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.751 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -73.88 -45.5 50.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.783 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -54.59 -51.58 64.86 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.745 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.606 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 61.6 m-85 -97.22 8.53 44.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.433 -175.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.516 ' HE3' ' HA ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -60.54 -45.62 93.19 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.254 0.55 . . . . 0.0 110.169 -179.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -89.95 33.56 0.86 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.617 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.606 ' HE2' ' HA ' ' A' ' 54' ' ' TYR . 0.7 OUTLIER -126.08 -68.35 0.83 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.7 171.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 177.03 13.72 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.767 -177.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.422 ' HZ ' ' HB2' ' A' ' 29' ' ' LEU . 22.1 t80 -99.96 147.52 25.49 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.032 -173.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.507 ' O ' ' HA ' ' A' ' 28' ' ' THR . 50.5 tp60 -138.91 147.3 42.15 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.918 -177.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.674 HG11 HG23 ' A' ' 47' ' ' ILE . 86.9 t -129.2 129.64 67.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.748 0.309 . . . . 0.0 110.465 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.843 ' HG ' ' HB ' ' A' ' 86' ' ' THR . 9.9 mp -121.53 121.91 38.53 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.78 177.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.474 ' HB1' ' NE1' ' A' ' 33' ' ' TRP . . . -101.44 119.63 39.06 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.347 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.9 t -97.29 107.65 20.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.916 0.389 . . . . 0.0 110.748 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 89' ' ' TYR . . . -91.5 126.42 36.58 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.101 177.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.617 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 2.8 pt20 -97.91 168.78 9.45 Favored Pre-proline 0 C--N 1.317 -0.839 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.491 -178.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.652 ' HD2' ' HG3' ' A' ' 93' ' ' LYS . 98.7 Cg_endo -75.91 45.07 1.42 Allowed 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 122.81 2.34 . . . . 0.0 114.85 -165.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 50.7 mm -78.67 -32.61 16.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 171.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.494 ' CB ' ' HG2' ' A' ' 35' ' ' PRO . 0.2 OUTLIER -136.48 136.32 21.94 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 114.64 -1.164 . . . . 0.0 107.926 170.792 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 69' ' ' ASP . 35.7 Cg_exo -58.2 174.02 0.82 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.079 2.519 . . . . 0.0 113.681 -175.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.532 ' HA ' HG12 ' A' ' 74' ' ' VAL . 19.8 tt -71.87 -27.07 26.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.591 -169.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.414 ' OE2' ' HB2' ' A' ' 70' ' ' PRO . 9.2 pm0 -74.02 -28.81 61.62 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.671 175.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 63.0 m -64.51 -48.63 74.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.98 0.419 . . . . 0.0 110.35 174.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.532 HG12 ' HA ' ' A' ' 71' ' ' ILE . 9.6 p -67.62 -34.36 67.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.65 -178.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.872 ' HA ' HG22 ' A' ' 78' ' ' VAL . 66.7 mtt180 -71.66 -29.01 64.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.999 175.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -64.76 -41.52 95.82 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 173.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -64.78 -51.73 60.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.073 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.104 ' HA ' HD23 ' A' ' 83' ' ' LEU . 35.8 m -61.8 -26.63 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.379 -178.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.701 ' HZ2' ' HB3' ' A' ' 79' ' ' LYS . 1.6 ttpm? -72.06 -49.43 36.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.303 0.573 . . . . 0.0 110.052 174.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.48 -48.07 77.91 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.681 -1.145 . . . . 0.0 112.857 -173.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -103.19 4.41 36.78 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.428 -174.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 57.12 55.27 31.22 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 116.037 -0.529 . . . . 0.0 113.101 177.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 1.104 HD23 ' HA ' ' A' ' 78' ' ' VAL . 3.1 mm? -71.18 111.65 10.79 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-O 120.784 0.326 . . . . 0.0 110.556 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -85.59 -6.99 8.8 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.11 2.54 . . . . 0.0 113.77 -173.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.55 ' CE2' HD12 ' A' ' 83' ' ' LEU . 28.7 p90 -90.54 169.87 10.66 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.936 0.398 . . . . 0.0 110.929 -178.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.843 ' HB ' ' HG ' ' A' ' 62' ' ' LEU . 18.3 m -75.25 132.13 40.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.174 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.2 t -130.06 130.9 66.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -177.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.477 ' HB3' HD11 ' A' ' 10' ' ' LEU . 57.5 mtt -111.94 163.76 13.87 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.42 -178.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 92.4 t80 -126.42 115.18 19.21 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.835 176.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.507 ' OD2' HG22 ' A' ' 95' ' ' VAL . 40.0 t0 -87.56 127.08 35.26 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.53 -30.12 59.65 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -177.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.588 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 17.2 t70 -127.22 -10.94 5.85 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -169.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.652 ' HG3' ' HD2' ' A' ' 67' ' ' PRO . 25.0 mtpp 76.69 14.09 2.23 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -169.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.634 ' HA ' HE21 ' A' ' 97' ' ' GLN . . . -61.17 -44.41 97.34 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -170.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.507 HG22 ' OD2' ' A' ' 90' ' ' ASP . 27.7 m -72.32 -33.55 46.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.197 -178.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -70.23 -33.9 69.2 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.499 -0.857 . . . . 0.0 111.086 173.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.634 HE21 ' HA ' ' A' ' 94' ' ' ALA . 14.8 mt-30 -71.43 -24.29 62.0 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 122.751 0.42 . . . . 0.0 110.722 176.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.59 -35.42 73.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.185 173.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -82.43 -11.31 58.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.855 175.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 76.73 32.34 50.6 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.383 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 38.0 p -80.21 96.2 6.51 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.248 0.547 . . . . 0.0 111.466 -177.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -89.34 -31.46 17.79 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.365 0.602 . . . . 0.0 109.618 174.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.3 p -107.1 150.22 9.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.181 -176.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.413 ' CE1' ' HB3' ' A' ' 32' ' ' PHE . 93.6 m-85 -140.02 155.41 70.81 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.399 -178.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.575 ' HG3' ' HG2' ' A' ' 43' ' ' GLU . 90.5 Cg_endo -77.73 162.58 89.69 Favored 'Cis proline' 0 C--N 1.343 0.259 0 C-N-CA 123.293 -1.545 . . . . 0.0 112.796 0.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.504 HG23 HG12 ' A' ' 121' ' ' VAL . 55.1 m -138.28 131.34 29.99 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.824 178.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 35.1 p -116.25 148.52 40.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.015 0.436 . . . . 0.0 111.376 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.982 HG12 ' HB ' ' A' ' 30' ' ' ILE . 1.9 p -124.57 148.4 28.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 176.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.49 ' O ' ' HB2' ' A' ' 117' ' ' LEU . 4.3 mm? -100.51 123.55 44.87 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 121.002 0.43 . . . . 0.0 109.986 -177.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.774 HG23 ' HA ' ' A' ' 115' ' ' GLU . 59.6 mt -109.01 130.21 62.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.693 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.545 ' HA2' ' HB1' ' A' ' 136' ' ' ALA . . . -84.6 -152.25 15.69 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.12 175.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -110.56 15.1 22.28 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.0 mtpp -104.72 19.22 20.83 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 113.6 -1.636 . . . . 0.0 109.646 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 108.25 -77.98 0.23 Allowed Glycine 0 C--O 1.223 -0.562 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.546 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.774 ' HA ' HG23 ' A' ' 110' ' ' ILE . 0.7 OUTLIER -166.83 161.08 15.11 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 117.689 0.745 . . . . 0.0 112.322 -179.823 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 13.5 mt 75.93 85.24 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 125.826 1.65 . . . . 0.0 112.761 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.494 HD23 ' H ' ' A' ' 111' ' ' GLY . 1.3 mm? -110.74 -51.5 2.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.372 171.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.52 ' HG3' ' OE2' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -155.27 174.55 15.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.768 -174.726 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 21.0 m -141.53 133.94 28.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.668 0.27 . . . . 0.0 110.919 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.482 ' HD1' HD23 ' A' ' 109' ' ' LEU . 54.1 m-85 -132.31 110.19 10.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.567 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.504 HG12 HG23 ' A' ' 106' ' ' THR . 22.6 m -92.9 141.57 14.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.025 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 70.38 -113.71 5.03 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.447 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -94.55 109.92 46.02 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.73 121.16 4.97 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.425 2.084 . . . . 0.0 112.428 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.556 ' CG ' ' HG2' ' A' ' 128' ' ' LYS . 8.3 t0 -57.14 105.16 0.2 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 175.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -61.72 -31.34 71.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.852 -175.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -63.35 -49.31 71.43 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.468 -0.872 . . . . 0.0 111.381 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.556 ' HG2' ' CG ' ' A' ' 125' ' ' ASP . 33.2 mmtm -70.54 -34.97 72.85 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.57 ' O ' HG13 ' A' ' 133' ' ' ILE . 0.2 OUTLIER -56.34 -47.92 77.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.385 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -64.27 -55.72 19.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.778 -0.192 . . . . 0.0 110.867 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -58.25 -32.2 68.13 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.372 0.606 . . . . 0.0 111.337 -177.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.52 ' OE2' ' HG3' ' A' ' 118' ' ' LYS . 24.7 tt0 -80.59 -29.59 36.94 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.677 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.57 HG13 ' O ' ' A' ' 129' ' ' LEU . 51.5 mt -62.62 -44.77 99.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 171.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -59.06 -31.03 68.5 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.348 0.594 . . . . 0.0 110.517 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 132' ' ' GLU . 92.3 m -66.43 -35.91 81.47 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.431 176.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.545 ' HB1' ' HA2' ' A' ' 111' ' ' GLY . . . . . . . . 0 C--O 1.236 0.351 0 CA-C-O 121.069 0.462 . . . . 0.0 110.388 176.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.263 0 CA-C-O 120.727 0.299 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 19' ' ' SER . 55.9 p90 -135.63 137.25 41.69 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.331 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.513 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 40.7 m -149.39 88.85 1.6 Allowed 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 173.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.417 ' H ' HD23 ' A' ' 10' ' ' LEU . 1.7 pt? -122.29 146.16 46.25 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.141 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 16.6 Cg_exo -68.25 137.2 39.59 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.285 1.99 . . . . 0.0 111.083 172.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.419 ' CG ' ' H ' ' A' ' 14' ' ' HIS . 0.8 OUTLIER -69.58 -179.29 1.68 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.548 HD21 HG21 ' A' ' 78' ' ' VAL . 2.9 pp -70.76 -9.2 56.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.741 0.305 . . . . 0.0 111.759 -176.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.419 ' H ' ' CG ' ' A' ' 12' ' ' ASP . 22.9 t-80 -92.24 -55.8 3.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.493 172.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 150.46 22.5 0.06 OUTLIER Glycine 0 CA--C 1.522 0.472 0 C-N-CA 120.06 -1.066 . . . . 0.0 114.175 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 41.1 tttm -105.8 126.24 51.93 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 117.445 0.623 . . . . 0.0 109.941 175.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 7.0 t -65.28 127.67 32.71 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.054 0.454 . . . . 0.0 109.79 174.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 9' ' ' SER . 46.8 t -111.12 124.57 68.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 8' ' ' PHE . 50.4 p -129.38 -175.11 3.47 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.216 -173.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -73.8 -23.97 59.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.928 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.78 -27.48 68.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.015 177.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -69.25 -24.44 63.99 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.484 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.693 HD13 HG21 ' A' ' 110' ' ' ILE . 38.5 mt -82.22 -44.1 16.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.23 -174.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -60.85 126.26 26.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.363 0.601 . . . . 0.0 111.208 -175.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.37 -25.3 10.59 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.639 -176.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.624 ' O ' ' HA ' ' A' ' 112' ' ' LYS . 65.9 mttm -131.72 175.44 9.19 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.988 0.423 . . . . 0.0 110.049 177.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 58.9 t -103.48 146.88 10.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 170.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.596 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 22.2 m -134.67 143.65 47.37 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 121.782 -0.574 . . . . 0.0 111.862 -170.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.675 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 53.8 tp -113.92 113.92 25.51 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 171.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.673 ' HB ' ' CG1' ' A' ' 108' ' ' VAL . 30.2 mt -96.82 112.13 28.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 175.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -111.49 130.66 55.65 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.28 0.562 . . . . 0.0 109.867 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.522 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 94.3 m-85 -98.69 119.24 37.08 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.755 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.657 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 7.7 p-90 -139.1 -177.36 4.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.859 -174.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.637 ' HB3' ' OE1' ' A' ' 66' ' ' GLN . 33.0 p90 -157.9 150.62 18.12 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.837 175.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.49 157.59 35.74 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.116 1.877 . . . . 0.0 110.862 173.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.2 m 65.33 17.61 11.05 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.98 0.419 . . . . 0.0 111.2 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 51.9 t -80.13 133.41 57.56 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.846 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 26.1 Cg_exo -63.72 -26.59 68.39 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.64 2.227 . . . . 0.0 111.557 174.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.58 -16.78 78.77 Favored Glycine 0 C--O 1.225 -0.465 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.659 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 48.9 t -57.81 -30.85 66.04 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 122.446 0.299 . . . . 0.0 111.673 -175.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.1 p -61.1 -33.15 54.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.156 0.503 . . . . 0.0 110.21 177.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.606 ' O ' ' HE3' ' A' ' 46' ' ' LYS . 15.2 m -89.11 -49.76 6.56 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.097 175.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.546 ' O ' HG12 ' A' ' 47' ' ' ILE . 41.9 mt-10 -59.27 -52.68 64.61 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.85 -172.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.682 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 41.1 tpp -59.21 -58.06 22.38 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.402 -170.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.682 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 50.4 Cg_exo -57.05 -36.86 99.43 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.088 1.859 . . . . 0.0 112.56 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.606 ' HE3' ' O ' ' A' ' 42' ' ' SER . 0.0 OUTLIER -65.3 -51.26 61.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.482 179.217 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.546 HG12 ' O ' ' A' ' 43' ' ' GLU . 49.5 mm -60.91 -42.2 91.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.152 -178.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.634 HD13 ' HE1' ' A' ' 85' ' ' PHE . 47.7 mm -54.6 -53.26 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.803 0.335 . . . . 0.0 110.861 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -67.73 -51.49 48.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.405 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.456 ' O ' ' HD2' ' A' ' 54' ' ' TYR . 89.2 m -58.51 -47.0 85.58 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.263 -177.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . -69.15 -24.29 64.06 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -177.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -68.85 -51.73 37.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.265 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -68.17 -52.64 32.27 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.607 0.718 . . . . 0.0 111.002 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 1.034 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 54.6 m-85 -64.58 -21.85 66.81 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.107 -173.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -53.95 -49.6 68.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.0 0.428 . . . . 0.0 110.752 179.82 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 -88.08 -18.58 28.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.426 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.463 ' HE3' ' HB2' ' A' ' 57' ' ' LYS . 4.5 tppp? -61.26 -71.88 0.13 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.055 176.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.515 ' OD1' ' HE2' ' A' ' 112' ' ' LYS . 3.7 t-20 169.35 31.29 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 1.034 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 50.7 t80 -140.02 156.2 46.73 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.983 -171.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.452 ' O ' ' HA ' ' A' ' 28' ' ' THR . 10.6 pt20 -148.85 159.14 44.45 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.291 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 86.3 t -123.96 130.69 73.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.465 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.404 HD23 ' HB ' ' A' ' 86' ' ' THR . 85.6 mt -113.17 104.59 12.51 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.596 178.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.407 ' HB1' ' NE1' ' A' ' 33' ' ' TRP . . . -89.5 102.47 15.14 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.378 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 59.0 t -99.23 114.67 37.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.053 0.454 . . . . 0.0 110.444 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.657 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -86.17 134.44 33.79 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.722 175.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.637 ' OE1' ' HB3' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -100.78 163.93 17.13 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.622 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.621 ' HD2' ' HB2' ' A' ' 93' ' ' LYS . 33.0 Cg_endo -61.87 89.88 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.324 2.016 . . . . 0.0 113.365 -174.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 41.2 mm -130.82 -66.18 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 172.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.427 ' OD1' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -92.78 147.7 34.6 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 171.244 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.427 ' HD2' ' OD1' ' A' ' 69' ' ' ASP . 54.3 Cg_exo -53.78 158.51 8.32 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 122.656 2.238 . . . . 0.0 113.698 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.606 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 5.9 tp -56.52 -33.16 38.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.167 178.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.486 ' OE2' ' HD2' ' A' ' 75' ' ' ARG . 6.1 tp10 -64.25 -41.35 97.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.233 0.539 . . . . 0.0 110.222 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.5 m -60.14 -44.47 94.91 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.824 -177.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.46 ' O ' HG23 ' A' ' 78' ' ' VAL . 7.5 p -70.65 -33.62 53.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.852 -179.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.606 ' HG3' ' O ' ' A' ' 71' ' ' ILE . 98.7 mtt180 -55.29 -53.16 59.55 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.4 0.619 . . . . 0.0 110.327 175.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -63.66 -45.11 91.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.705 -176.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -55.4 -45.19 76.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.047 -176.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.657 ' HA ' HD22 ' A' ' 83' ' ' LEU . 86.1 t -64.36 -44.85 97.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.497 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.756 ' HA ' ' HE3' ' A' ' 79' ' ' LYS . 1.3 mmmt -76.96 -33.59 57.65 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.276 -0.57 . . . . 0.0 112.336 -175.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.94 -48.14 77.71 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 123.412 0.445 . . . . 0.0 110.909 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.457 ' HB2' ' CD1' ' A' ' 83' ' ' LEU . 80.8 m-85 -97.57 12.92 31.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.901 0.381 . . . . 0.0 111.18 -178.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.64 -60.49 4.35 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 121.103 -0.57 . . . . 0.0 113.029 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.657 HD22 ' HA ' ' A' ' 78' ' ' VAL . 10.2 mp 48.71 87.12 0.13 Allowed Pre-proline 0 N--CA 1.467 0.407 0 C-N-CA 123.756 0.822 . . . . 0.0 112.346 -177.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -79.27 44.52 1.71 Allowed 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.409 2.739 . . . . 0.0 112.953 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.634 ' HE1' HD13 ' A' ' 48' ' ' ILE . 21.1 p90 -152.27 157.5 41.48 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.404 ' HB ' HD23 ' A' ' 62' ' ' LEU . 18.7 m -74.78 117.9 17.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.96 0.409 . . . . 0.0 111.001 -174.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 36.0 t -110.2 126.62 67.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.577 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.415 ' SD ' ' HB ' ' A' ' 18' ' ' VAL . 76.0 mtm -119.13 167.73 11.53 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.626 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.426 ' HD1' ' HB3' ' A' ' 65' ' ' ALA . 78.2 t80 -138.56 117.18 12.17 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.559 ' OD2' HG22 ' A' ' 95' ' ' VAL . 43.9 t0 -92.13 128.72 38.08 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.68 -32.08 62.09 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -177.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' A' ' 93' ' ' LYS . 25.9 t70 -112.1 -11.88 13.75 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.795 0.331 . . . . 0.0 110.807 -175.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.621 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 33.8 ttmt 73.15 15.68 4.4 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.533 -177.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.406 ' HA ' HE21 ' A' ' 97' ' ' GLN . . . -61.83 -39.84 93.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.423 -173.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.559 HG22 ' OD2' ' A' ' 90' ' ' ASP . 27.0 m -70.85 -31.93 47.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.863 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -72.1 -34.09 61.79 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 174.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.462 ' HG3' ' O ' ' A' ' 93' ' ' LYS . 44.5 mt-30 -64.35 -29.16 70.24 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 122.554 0.342 . . . . 0.0 110.482 176.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.22 -38.87 65.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.02 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -80.44 -13.14 59.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.823 0.344 . . . . 0.0 111.158 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.01 45.6 5.34 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.938 176.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 56.9 p -75.7 89.54 2.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.172 0.51 . . . . 0.0 111.2 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.6 mm100 -96.39 -52.52 3.94 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.251 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.451 ' HB ' ' CG2' ' A' ' 121' ' ' VAL . 47.1 t -106.73 134.68 47.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.613 177.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -105.1 145.83 31.5 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -75.95 165.41 85.57 Favored 'Cis proline' 0 C--N 1.342 0.227 0 C-N-CA 123.333 -1.528 . . . . 0.0 112.902 -0.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.7 m -124.19 133.67 53.48 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 176.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.532 ' HB3' HD11 ' A' ' 29' ' ' LEU . 25.0 m -127.47 110.57 12.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.863 0.363 . . . . 0.0 111.159 -175.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.673 ' CG1' ' HB ' ' A' ' 30' ' ' ILE . 12.3 p -106.97 138.54 32.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.972 0.415 . . . . 0.0 110.36 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.741 ' HB2' ' HB2' ' A' ' 118' ' ' LYS . 88.2 mt -102.01 124.52 47.76 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.268 0.556 . . . . 0.0 110.355 -177.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.693 HG21 HD13 ' A' ' 23' ' ' LEU . 18.7 mm -108.31 138.36 35.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.994 -174.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -86.22 -177.4 49.82 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.652 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.624 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 98.5 mttt -73.53 1.99 8.82 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.98 0.419 . . . . 0.0 111.557 -177.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 19.9 tptp -134.21 6.55 3.6 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.554 ' HA2' ' CG2' ' A' ' 110' ' ' ILE . . . 85.81 -104.41 2.85 Favored Glycine 0 N--CA 1.433 -1.543 0 CA-C-N 114.376 -1.283 . . . . 0.0 110.346 -172.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 52.72 -9.1 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.215 1.806 . . . . 0.0 115.772 174.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.443 ' H ' ' C ' ' A' ' 114' ' ' GLY . 13.2 mt 68.17 115.43 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 122.969 0.508 . . . . 0.0 111.189 -178.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 79.6 mt -101.85 -48.14 4.37 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.183 0.516 . . . . 0.0 111.235 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.741 ' HB2' ' HB2' ' A' ' 109' ' ' LEU . 5.0 mmmm -146.48 155.13 42.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.777 -169.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 18.4 m -135.98 110.76 8.71 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.643 178.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -112.67 146.91 37.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.243 176.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.451 ' CG2' ' HB ' ' A' ' 103' ' ' VAL . 7.3 p -123.67 133.52 68.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.892 177.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 79.88 -140.37 22.34 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.921 -178.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -85.23 112.31 42.8 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -81.25 162.94 19.96 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.651 2.234 . . . . 0.0 113.256 -177.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.614 ' OD2' ' HB3' ' A' ' 128' ' ' LYS . 7.4 p-10 -75.5 76.9 2.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.308 177.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.41 ' CE2' ' HG2' ' A' ' 46' ' ' LYS . 18.4 m-85 -52.26 -40.41 61.66 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -175.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -57.91 -51.23 59.44 Favored Glycine 0 C--O 1.24 0.511 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.229 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.614 ' HB3' ' OD2' ' A' ' 125' ' ' ASP . 1.9 ttpm? -80.11 -18.75 49.03 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.676 ' O ' HG12 ' A' ' 133' ' ' ILE . 10.0 tt -70.95 -44.82 65.3 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 174.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -57.67 -55.59 32.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.665 0.269 . . . . 0.0 110.701 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.453 ' HG2' ' HA ' ' A' ' 128' ' ' LYS . 9.9 pt20 -61.69 -27.7 68.88 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.043 0.449 . . . . 0.0 110.988 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.454 ' OE2' ' HG3' ' A' ' 118' ' ' LYS . 32.0 tt0 -72.59 -42.86 64.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.555 178.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.676 HG12 ' O ' ' A' ' 129' ' ' LEU . 45.1 mm -69.65 -49.91 54.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.225 179.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.48 -16.4 62.42 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.965 0.412 . . . . 0.0 111.411 -178.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 15.4 m -66.74 -29.11 69.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.958 0.408 . . . . 0.0 110.705 171.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.464 -178.203 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.355 0 CA-C-O 121.089 0.471 . . . . 0.0 110.449 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -104.13 111.87 24.64 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 122.377 1.084 . . . . 0.0 112.621 -170.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.5 m -150.35 89.6 1.59 Allowed 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 113.388 -1.733 . . . . 0.0 108.102 171.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.526 ' HB3' ' HE2' ' A' ' 88' ' ' MET . 23.8 tp -120.65 139.17 28.48 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.855 -169.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 10' ' ' LEU . 8.4 Cg_exo -73.58 141.77 31.69 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.394 2.063 . . . . 0.0 111.556 172.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.458 ' CG ' ' H ' ' A' ' 14' ' ' HIS . 0.6 OUTLIER -87.35 -176.04 5.49 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 177.847 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.7 mt -73.01 -1.14 15.95 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -177.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.458 ' H ' ' CG ' ' A' ' 12' ' ' ASP . 67.7 m80 -109.92 8.61 24.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.997 0.427 . . . . 0.0 109.998 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.72 34.95 59.14 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.363 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 16' ' ' LYS . 28.5 mmtm -115.29 134.0 55.53 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 175.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.5 m -79.0 122.46 26.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.826 0.346 . . . . 0.0 110.506 -178.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.8 t -112.48 122.36 66.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 90.4 p -108.13 178.86 4.38 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.313 0.578 . . . . 0.0 110.713 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -76.17 -21.22 56.79 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.498 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.03 -28.91 69.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.715 175.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -73.6 -13.93 61.1 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.32 0.581 . . . . 0.0 110.583 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 61.6 mt -83.69 -48.29 10.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.186 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -56.25 150.84 13.68 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.254 0.55 . . . . 0.0 111.864 -175.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.25 -19.5 46.43 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -172.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.53 ' HZ3' ' HB2' ' A' ' 26' ' ' LYS . 4.4 mtmp? -135.39 167.92 20.15 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.402 ' HB ' ' HD2' ' A' ' 59' ' ' PHE . 35.2 t -108.04 140.52 26.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 175.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.451 HG23 ' HG3' ' A' ' 60' ' ' GLN . 29.9 m -134.32 140.86 46.67 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.013 0.435 . . . . 0.0 111.867 -171.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.464 HD11 ' HB3' ' A' ' 107' ' ' SER . 47.7 tp -113.85 115.45 27.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.305 173.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.852 HG12 ' HB2' ' A' ' 62' ' ' LEU . 46.2 mt -107.01 112.77 41.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.558 ' HA ' ' O ' ' A' ' 106' ' ' THR . 23.6 p-10 -113.9 129.39 56.6 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.246 0.546 . . . . 0.0 111.248 -178.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -83.09 128.74 34.75 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.048 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.592 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 5.5 p-90 -154.12 -175.71 5.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.49 -176.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.786 ' HB3' HE22 ' A' ' 66' ' ' GLN . 13.1 p90 -171.44 159.86 5.03 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.084 174.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' A' ' 34' ' ' PHE . 19.8 Cg_endo -62.86 156.25 55.07 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.119 1.879 . . . . 0.0 111.639 176.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.5 m 67.59 13.56 9.31 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.653 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 49.2 t -83.83 136.26 41.91 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.81 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.541 ' O ' HG12 ' A' ' 41' ' ' VAL . 35.9 Cg_exo -60.13 -25.83 80.9 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.615 2.21 . . . . 0.0 112.25 176.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.21 -13.7 65.17 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 121.228 -0.51 . . . . 0.0 113.145 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 88.1 m -63.25 -30.79 71.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.783 0.292 . . . . 0.0 111.684 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.541 HG12 ' O ' ' A' ' 38' ' ' PRO . 14.6 p -65.39 -37.55 80.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.814 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.447 ' O ' ' HE2' ' A' ' 46' ' ' LYS . 22.8 m -87.11 -56.6 3.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.997 0.427 . . . . 0.0 111.284 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.514 ' HA ' ' HE2' ' A' ' 46' ' ' LYS . 74.4 mm-40 -69.99 -41.55 74.26 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.205 0.816 . . . . 0.0 113.205 -169.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.73 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 39.6 tpp -49.32 -59.96 5.66 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -169.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.73 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 31.2 Cg_exo -58.74 -44.3 37.48 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 121.84 1.693 . . . . 0.0 112.27 -178.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.514 ' HE2' ' HA ' ' A' ' 43' ' ' GLU . 45.1 mtmt -60.2 -51.3 70.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.442 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.6 mm -62.64 -38.3 81.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.367 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.578 HG12 ' O ' ' A' ' 44' ' ' MET . 30.4 mm -54.91 -54.02 27.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 116.807 -0.179 . . . . 0.0 110.956 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.573 ' NZ ' ' HB2' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -75.48 -38.77 59.34 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 119.659 -0.817 . . . . 0.0 110.815 -178.628 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.557 ' O ' ' HD2' ' A' ' 54' ' ' TYR . 91.6 m -58.39 -44.85 89.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.826 0.346 . . . . 0.0 110.811 -178.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.0 -44.65 79.81 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.127 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -67.26 -50.45 60.48 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.747 0.308 . . . . 0.0 111.088 -178.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.63 -45.38 73.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.257 0.551 . . . . 0.0 111.035 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 1.07 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 50.6 m-85 -82.28 -26.24 33.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.308 -174.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.475 ' NZ ' ' HB3' ' A' ' 60' ' ' GLN . 18.0 tppt? -61.93 -32.45 72.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.899 0.381 . . . . 0.0 110.117 176.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -84.76 45.84 1.19 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.464 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.472 ' HE2' ' HA ' ' A' ' 54' ' ' TYR . 9.0 pttm -166.07 -58.48 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.681 170.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.479 ' OD1' ' HG2' ' A' ' 26' ' ' LYS . 59.7 t30 176.46 38.06 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 120.989 0.424 . . . . 0.0 111.521 -177.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 1.07 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 44.4 t80 -138.5 157.42 46.22 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 122.003 -0.435 . . . . 0.0 109.828 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.475 ' HB3' ' NZ ' ' A' ' 55' ' ' LYS . 11.1 pt20 -152.16 152.33 32.15 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.935 0.398 . . . . 0.0 110.985 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 90.2 t -117.96 126.19 74.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.669 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.852 ' HB2' HG12 ' A' ' 30' ' ' ILE . 86.1 mt -112.13 106.46 15.09 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.484 ' HB1' ' CD1' ' A' ' 33' ' ' TRP . . . -90.85 105.86 18.12 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.682 -176.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 91.9 t -90.44 115.86 30.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.936 0.398 . . . . 0.0 110.716 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.592 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -88.0 111.27 21.32 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.791 176.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.786 HE22 ' HB3' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -83.17 163.04 52.35 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.015 -177.29 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.578 ' HD2' ' HB2' ' A' ' 66' ' ' GLN . 57.1 Cg_endo -69.62 97.35 0.62 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.352 2.035 . . . . 0.0 113.073 -171.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 52.6 mt -141.19 -65.05 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.332 173.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.34 144.42 30.9 Favored Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 166.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.95 152.56 23.11 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.442 2.095 . . . . 0.0 112.471 178.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.61 ' HA ' HG22 ' A' ' 74' ' ' VAL . 12.8 tt -58.38 -23.24 21.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.021 176.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -65.83 -45.13 83.41 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.613 174.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.4 m -59.77 -41.13 90.41 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.506 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.61 HG22 ' HA ' ' A' ' 71' ' ' ILE . 13.0 m -68.85 -33.91 61.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.972 -177.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.681 ' HA ' HG22 ' A' ' 78' ' ' VAL . 76.2 mtt180 -70.69 -39.88 73.24 Favored 'General case' 0 C--O 1.22 -0.488 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 174.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -61.31 -37.45 83.3 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -63.35 -53.8 46.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.206 176.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.681 HG22 ' HA ' ' A' ' 75' ' ' ARG . 35.0 m -63.4 -27.26 42.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.996 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 75' ' ' ARG . 5.6 mmmp? -75.69 -40.16 56.27 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -73.3 -49.63 26.53 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.659 0.599 . . . . 0.0 111.798 -172.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -88.58 -1.89 58.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.493 -174.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 58.03 51.2 59.72 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.257 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.531 ' CD1' ' HA ' ' A' ' 78' ' ' VAL . 1.2 mp -74.61 117.06 59.24 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 121.011 0.434 . . . . 0.0 111.151 -175.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.59 -28.37 4.39 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.28 2.654 . . . . 0.0 114.415 -172.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -71.3 146.39 48.91 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.402 -178.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.431 ' HB ' HD23 ' A' ' 62' ' ' LEU . 12.3 m -70.4 113.42 7.52 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.453 -172.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.9 t -99.41 132.58 44.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.244 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.526 ' HE2' ' HB3' ' A' ' 10' ' ' LEU . 60.3 mtp -118.65 164.71 14.93 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.513 -0.767 . . . . 0.0 108.964 -177.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -120.6 129.35 53.71 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.283 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.795 ' OD2' ' HA ' ' A' ' 93' ' ' LYS . 10.7 t0 -102.07 115.75 31.21 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.322 177.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.15 -47.46 24.23 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -172.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -115.04 -10.96 12.17 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -169.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.795 ' HA ' ' OD2' ' A' ' 90' ' ' ASP . 34.9 ttmt 68.63 18.65 8.78 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 122.826 0.45 . . . . 0.0 111.506 177.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.03 -33.95 76.65 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.589 -0.694 . . . . 0.0 109.65 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.8 p -63.39 -47.63 90.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.723 172.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.92 -36.81 93.53 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.207 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -64.59 -30.48 71.51 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 122.542 0.337 . . . . 0.0 111.016 178.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.63 -34.2 76.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.935 0.398 . . . . 0.0 110.451 176.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.533 ' HB2' HG23 ' A' ' 101' ' ' THR . 65.4 m-85 -83.21 -17.9 41.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.031 174.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.8 31.76 38.97 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.942 -175.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.533 HG23 ' HB2' ' A' ' 99' ' ' PHE . 78.1 p -78.36 91.11 4.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.538 0.685 . . . . 0.0 111.98 -175.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 73.6 mm-40 -108.95 -26.39 10.24 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 171.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.5 m -109.18 140.48 27.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.527 174.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.569 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 37.2 m-85 -127.87 160.61 60.32 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.373 -173.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.569 ' HA ' ' HB3' ' A' ' 104' ' ' TYR . 87.3 Cg_endo -78.95 166.52 79.06 Favored 'Cis proline' 0 C--N 1.347 0.484 0 C-N-CA 123.866 -1.306 . . . . 0.0 113.269 0.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.558 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 22.1 m -126.03 120.47 30.35 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.99 175.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.464 ' HB3' HD11 ' A' ' 29' ' ' LEU . 33.9 m -107.89 113.17 26.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.009 0.433 . . . . 0.0 111.496 -174.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.601 HG22 HG23 ' A' ' 119' ' ' THR . 45.8 t -105.54 129.19 58.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.377 -178.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.569 ' HB2' ' HB3' ' A' ' 118' ' ' LYS . 96.5 mt -102.74 126.25 49.78 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.466 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 65.7 mt -116.87 125.36 73.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.086 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.473 ' H ' HD23 ' A' ' 117' ' ' LEU . . . -72.84 177.63 41.26 Favored Glycine 0 N--CA 1.453 -0.224 0 CA-C-N 115.896 -0.593 . . . . 0.0 113.21 -175.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 7.2 ptpp? -68.48 -6.2 23.7 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -175.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 7.7 ptmm? -105.97 6.99 31.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.684 0.278 . . . . 0.0 110.438 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.33 70.68 1.01 Allowed Glycine 0 C--O 1.225 -0.449 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 -177.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -153.72 165.21 36.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.551 0.215 . . . . 0.0 110.466 -174.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 86.7 mt -72.97 103.32 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.087 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.473 HD23 ' H ' ' A' ' 111' ' ' GLY . 3.1 mm? -97.92 -44.05 6.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.615 177.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.569 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -163.18 152.51 14.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.839 0.352 . . . . 0.0 111.872 -175.775 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.601 HG23 HG22 ' A' ' 108' ' ' VAL . 38.0 m -138.77 102.93 4.7 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.845 168.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -79.54 138.38 37.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.653 174.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.3 p -103.86 114.99 44.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 173.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 94.13 -157.91 22.88 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.889 -177.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -80.59 119.73 77.12 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 120.72 0.295 . . . . 0.0 110.681 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -87.56 151.47 7.63 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.818 2.345 . . . . 0.0 112.716 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.96 127.86 33.02 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.583 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 7.6 m-85 -71.57 -18.8 62.22 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -176.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -68.23 -54.48 16.7 Favored Glycine 0 C--O 1.238 0.367 0 C-N-CA 120.096 -1.049 . . . . 0.0 111.648 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.708 ' HA ' HE21 ' A' ' 131' ' ' GLN . 5.2 ttpp -74.87 -20.82 59.57 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 176.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.583 ' HB3' ' HA ' ' A' ' 126' ' ' PHE . 63.0 tp -65.7 -48.02 73.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.049 175.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 14.9 m-30 -61.56 -52.72 63.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.263 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.708 HE21 ' HA ' ' A' ' 128' ' ' LYS . 19.8 pt20 -65.92 -27.54 68.26 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.863 0.363 . . . . 0.0 111.909 -177.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -80.02 -37.26 34.49 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.184 -0.323 . . . . 0.0 110.428 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 129' ' ' LEU . 51.2 mt -65.64 -48.49 82.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.717 176.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -25.37 67.92 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 -177.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 68.7 m -60.99 -43.69 98.49 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.067 0.461 . . . . 0.0 110.145 173.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.637 178.081 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.377 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -110.56 112.93 25.16 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.596 0.712 . . . . 0.0 111.319 -173.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.4 m -96.15 90.04 5.36 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 169.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.483 HD12 ' HD2' ' A' ' 11' ' ' PRO . 29.7 tp -102.73 123.35 42.75 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.259 -169.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.542 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 8.4 Cg_exo -72.96 147.06 42.94 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.819 2.346 . . . . 0.0 112.222 176.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.08 -177.91 5.3 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 174.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.3 mt -63.5 -22.73 67.05 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -177.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -89.22 -54.53 4.06 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.053 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.22 18.25 0.05 OUTLIER Glycine 0 CA--C 1.523 0.548 0 C-N-CA 119.61 -1.281 . . . . 0.0 114.683 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 11' ' ' PRO . 51.2 mttt -92.0 140.39 29.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 118.026 0.913 . . . . 0.0 110.119 174.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.6 m -88.26 122.36 31.7 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.1 0.476 . . . . 0.0 111.397 -177.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.0 t -107.25 132.66 54.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.737 174.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -140.81 -177.3 5.01 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.44 -173.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -58.21 -23.33 55.32 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.702 -176.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.86 -27.92 69.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.483 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -83.04 -19.59 36.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.148 0.499 . . . . 0.0 110.541 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.632 ' HB3' ' HA2' ' A' ' 114' ' ' GLY . 9.3 mp -83.53 -20.08 34.52 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.306 -176.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -95.74 134.58 38.5 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.063 0.459 . . . . 0.0 110.942 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.97 -7.13 82.28 Favored Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.752 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.582 ' HG2' ' OD1' ' A' ' 58' ' ' ASN . 29.9 mtpp -129.61 168.19 16.81 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -103.25 130.93 52.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 174.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.475 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 21.0 m -133.26 146.41 51.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.98 0.419 . . . . 0.0 112.057 -166.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.519 HD21 ' HB3' ' A' ' 107' ' ' SER . 8.0 tt -131.73 124.22 29.3 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 174.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.823 ' HB ' HG12 ' A' ' 108' ' ' VAL . 45.0 mm -109.89 125.35 67.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -109.38 112.87 25.24 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -84.79 119.57 25.45 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.593 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 4.2 p-90 -154.32 177.11 11.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.2 0.524 . . . . 0.0 111.484 -176.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.63 ' HB3' ' OE1' ' A' ' 66' ' ' GLN . 9.3 p90 -148.81 136.32 10.99 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.602 172.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 34' ' ' PHE . 44.8 Cg_exo -59.59 -15.71 32.46 Favored 'Trans proline' 0 N--CA 1.475 0.396 0 C-N-CA 123.421 2.747 . . . . 0.0 114.414 -173.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.4 p -95.45 13.81 24.72 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 122.017 -0.427 . . . . 0.0 111.991 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.446 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 25.0 p -88.37 146.0 36.88 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.854 0.359 . . . . 0.0 111.375 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 5.8 Cg_exo -79.09 -8.68 15.41 Favored 'Trans proline' 0 CA--C 1.532 0.406 0 C-N-CA 123.119 2.546 . . . . 0.0 113.011 176.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -86.18 -61.27 1.67 Allowed Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.676 -173.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' A' ' 33' ' ' TRP . 82.0 m -52.06 -30.06 24.05 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -169.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.8 p -56.12 -24.52 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.112 0.482 . . . . 0.0 111.16 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.657 ' HB2' ' OE2' ' A' ' 43' ' ' GLU . 1.7 m -86.23 -45.15 11.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.952 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.657 ' OE2' ' HB2' ' A' ' 42' ' ' SER . 3.9 mp0 -80.13 -33.36 38.65 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -174.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.596 ' O ' HG12 ' A' ' 48' ' ' ILE . 13.2 ptp -57.43 -38.9 72.83 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -166.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.56 ' HD3' ' CG ' ' A' ' 44' ' ' MET . 47.2 Cg_exo -58.28 -43.94 42.68 Favored 'Trans proline' 0 C--N 1.361 1.225 0 CA-C-N 121.749 1.66 . . . . 0.0 111.797 175.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -59.16 -38.09 78.91 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.483 176.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.2 mt -68.52 -36.42 74.62 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.4 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.733 177.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.596 HG12 ' O ' ' A' ' 44' ' ' MET . 47.2 mm -53.57 -55.49 13.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-O 120.799 0.333 . . . . 0.0 110.32 -175.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -75.86 -53.74 7.98 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.272 -177.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.8 m -58.01 -45.03 87.52 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -174.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.509 ' HB1' HG21 ' A' ' 61' ' ' VAL . . . -70.03 -36.05 74.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.874 -0.148 . . . . 0.0 111.32 -178.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -68.78 -45.43 71.36 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.017 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -59.77 -27.28 66.4 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.779 176.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.48 ' O ' ' HB3' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -87.18 -39.48 15.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.946 -179.649 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.409 ' C ' ' HD2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -60.07 -31.27 69.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.296 -175.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -80.34 37.54 0.39 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -174.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.57 65.84 0.21 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.073 0.463 . . . . 0.0 111.068 172.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.582 ' OD1' ' HG2' ' A' ' 26' ' ' LYS . 66.9 t30 66.1 11.0 7.5 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.525 176.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.495 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 43.9 t80 -105.57 148.69 27.0 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -141.4 126.33 18.22 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.135 0.493 . . . . 0.0 111.506 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.509 HG21 ' HB1' ' A' ' 51' ' ' ALA . 58.2 t -106.07 117.39 51.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.686 177.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.5 mp -120.2 117.82 28.87 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.017 0.437 . . . . 0.0 110.227 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.442 ' O ' ' HA ' ' A' ' 87' ' ' VAL . . . -94.22 114.26 26.33 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.839 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.3 p -101.23 119.95 50.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.353 0.596 . . . . 0.0 111.137 -176.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.593 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -89.59 129.68 36.01 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.447 175.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.63 ' OE1' ' HB3' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -104.74 165.88 12.5 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.594 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.621 ' HD3' ' O ' ' A' ' 90' ' ' ASP . 57.7 Cg_endo -70.83 80.15 1.21 Allowed 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.291 1.994 . . . . 0.0 113.525 -169.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 70.6 mt -120.78 -43.9 2.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 172.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.451 ' OD1' ' HD2' ' A' ' 35' ' ' PRO . 5.3 p-10 -121.78 141.43 33.84 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 163.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 69' ' ' ASP . 36.4 Cg_exo -57.66 158.33 20.35 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.056 2.504 . . . . 0.0 113.176 -174.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.618 ' O ' ' HG2' ' A' ' 75' ' ' ARG . 13.1 tt -53.69 -28.35 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.288 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.571 ' HA ' ' CG ' ' A' ' 75' ' ' ARG . 22.6 tp10 -64.16 -36.75 85.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.117 0.484 . . . . 0.0 110.958 178.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.0 t -68.71 -34.96 76.52 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 178.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.48 ' O ' HG23 ' A' ' 78' ' ' VAL . 24.0 t -60.35 -44.38 95.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.216 173.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.618 ' HG2' ' O ' ' A' ' 71' ' ' ILE . 14.1 mmt180 -52.83 -51.93 59.03 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.751 0.786 . . . . 0.0 109.601 176.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -61.47 -42.04 98.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.157 -1.383 . . . . 0.0 111.781 -175.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -70.99 -43.21 68.47 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.076 -176.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.554 HG13 ' HB2' ' A' ' 83' ' ' LEU . 80.1 t -59.89 -43.84 93.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.341 -177.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -74.0 -28.57 61.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.662 0.268 . . . . 0.0 111.348 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -73.37 -48.58 32.99 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.352 -175.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -97.42 -2.77 41.47 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -177.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 64.44 64.08 3.85 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.555 178.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.554 ' HB2' HG13 ' A' ' 78' ' ' VAL . 10.3 mp -79.67 115.34 52.95 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-O 120.644 0.259 . . . . 0.0 110.914 -178.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.423 ' CD ' HD12 ' A' ' 48' ' ' ILE . 93.4 Cg_endo -89.6 -21.45 1.09 Allowed 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.004 2.469 . . . . 0.0 113.568 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -76.19 155.56 34.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.799 0.333 . . . . 0.0 110.503 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 29.5 m -73.41 121.19 20.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.344 -175.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 63' ' ' ALA . 38.9 t -109.42 138.7 35.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.677 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 71.6 mtm -122.25 171.29 9.13 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 176.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -139.47 115.24 10.1 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.545 -0.169 . . . . 0.0 110.545 -178.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.621 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 13.3 t70 -107.83 127.53 53.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.898 0.38 . . . . 0.0 110.793 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.48 -28.12 56.35 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -175.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -112.65 -12.96 13.34 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -165.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.4 ' HG2' ' HB2' ' A' ' 66' ' ' GLN . 57.0 mtpt 69.42 7.63 6.34 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 122.739 0.415 . . . . 0.0 110.978 178.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.35 -32.53 70.19 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.246 0.546 . . . . 0.0 110.192 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.537 ' O ' ' HD1' ' A' ' 99' ' ' PHE . 2.0 p -60.43 -49.8 82.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.42 173.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -67.18 -33.67 83.69 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.938 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -58.82 -51.65 69.11 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 122.653 0.381 . . . . 0.0 111.485 177.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.79 -29.67 62.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.888 -177.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.728 ' HA ' HD11 ' A' ' 116' ' ' ILE . 17.2 m-85 -76.35 -27.79 56.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.753 0.311 . . . . 0.0 111.093 177.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.36 46.43 4.67 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.785 -0.722 . . . . 0.0 111.718 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 24.5 m -118.43 99.35 6.77 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.981 0.42 . . . . 0.0 111.158 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -91.82 -48.78 6.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.9 176.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 9.2 p -100.4 159.44 3.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.327 -174.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.431 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 34.1 m-85 -135.49 156.85 77.45 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -175.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.437 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 89.4 Cg_endo -85.16 141.59 32.38 Favored 'Cis proline' 0 C--N 1.347 0.478 0 C-N-CA 123.524 -1.449 . . . . 0.0 112.725 -0.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 89.5 m -129.77 129.98 44.79 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.379 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.519 ' HB3' HD21 ' A' ' 29' ' ' LEU . 14.0 m -111.79 131.92 55.02 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.148 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.823 HG12 ' HB ' ' A' ' 30' ' ' ILE . 8.3 p -105.97 142.77 18.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 120.887 0.375 . . . . 0.0 109.995 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.751 HD21 HD11 ' A' ' 129' ' ' LEU . 66.5 mt -103.86 127.86 51.35 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.779 177.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.496 HD13 HD23 ' A' ' 23' ' ' LEU . 72.5 mt -115.62 127.38 73.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.859 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.63 -97.84 0.01 OUTLIER Glycine 0 C--N 1.334 0.44 0 O-C-N 123.953 0.783 . . . . 0.0 112.716 -177.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -150.97 13.27 0.69 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.011 0.434 . . . . 0.0 110.649 176.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 49.1 mttp -111.9 -3.11 14.96 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.48 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.632 ' HA2' ' HB3' ' A' ' 23' ' ' LEU . . . 76.65 42.45 21.54 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.654 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -139.14 165.15 27.92 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.741 0.305 . . . . 0.0 110.335 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.728 HD11 ' HA ' ' A' ' 99' ' ' PHE . 59.5 mt -69.74 116.69 11.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.667 -177.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 19.5 tp -105.71 -51.65 2.96 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.283 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.608 ' HB2' ' HB2' ' A' ' 109' ' ' LEU . 3.1 mmmm -139.56 169.65 17.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.091 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 23.2 m -148.88 129.62 14.16 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.767 0.318 . . . . 0.0 110.746 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -126.29 118.49 25.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.771 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.7 p -110.99 139.67 33.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.762 -178.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 73.52 66.71 1.95 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.093 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 65.48 116.21 0.02 OUTLIER Pre-proline 0 N--CA 1.464 0.264 0 C-N-CA 123.45 0.7 . . . . 0.0 111.805 -175.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.75 117.76 3.69 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.181 1.92 . . . . 0.0 111.633 174.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 129' ' ' LEU . 14.5 t70 -61.49 105.58 0.54 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 175.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -64.49 -31.65 72.96 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -171.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.473 ' HA2' ' CZ ' ' A' ' 130' ' ' TYR . . . -58.86 -54.07 41.01 Favored Glycine 0 C--O 1.238 0.371 0 C-N-CA 120.371 -0.918 . . . . 0.0 111.661 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.591 ' HA ' ' HG2' ' A' ' 131' ' ' GLN . 35.7 mtmm -76.16 -17.95 59.33 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.657 0.265 . . . . 0.0 110.637 177.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.751 HD11 HD21 ' A' ' 109' ' ' LEU . 18.6 tp -69.17 -51.22 40.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.662 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.479 ' HB3' ' HE2' ' A' ' 54' ' ' TYR . 2.0 p90 -73.94 -33.94 64.12 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 119.579 -0.848 . . . . 0.0 112.249 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.591 ' HG2' ' HA ' ' A' ' 128' ' ' LYS . 3.3 pt20 -68.47 -30.73 69.65 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.79 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -76.12 -45.33 34.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.7 177.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 129' ' ' LEU . 78.0 mt -63.54 -38.88 83.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.628 178.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -56.65 -40.26 75.16 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.01 0.433 . . . . 0.0 110.218 176.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 89.6 m -58.32 -35.28 71.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.657 177.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.198 178.317 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.357 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -148.59 143.85 26.85 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.099 175.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.3 m -149.0 98.33 2.82 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 175.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.559 HD12 ' HD2' ' A' ' 11' ' ' PRO . 25.4 tp -114.39 126.87 27.42 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.196 -175.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.559 ' HD2' HD12 ' A' ' 10' ' ' LEU . 50.1 Cg_endo -70.17 150.53 65.84 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.388 2.059 . . . . 0.0 112.405 177.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.466 ' CG ' ' H ' ' A' ' 14' ' ' HIS . 0.8 OUTLIER -81.49 -174.26 4.86 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 176.277 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.735 HD13 ' HA ' ' A' ' 75' ' ' ARG . 70.4 mt -69.98 -16.36 63.18 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.466 ' H ' ' CG ' ' A' ' 12' ' ' ASP . 33.7 t-80 -87.98 -42.75 12.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.712 176.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.37 12.07 1.11 Allowed Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.294 177.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 11' ' ' PRO . 66.3 tttt -86.77 116.18 24.7 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 177.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 8.9 t -69.33 123.54 21.48 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.318 0.58 . . . . 0.0 109.617 175.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.501 ' HB ' ' CE ' ' A' ' 88' ' ' MET . 53.9 t -112.87 126.95 70.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.273 -177.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.419 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 61.0 p -132.32 -176.22 4.01 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.254 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -62.03 -23.29 66.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.072 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.419 ' HA ' ' NE2' ' A' ' 24' ' ' GLN . . . -67.03 -30.63 70.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.948 0.404 . . . . 0.0 110.837 178.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -82.45 -25.03 33.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.043 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.765 HD21 HD11 ' A' ' 62' ' ' LEU . 70.2 mt -83.19 -48.34 10.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.125 -175.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.616 ' HA ' ' H ' ' A' ' 113' ' ' LYS . 10.5 pt20 -51.22 144.31 9.69 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.384 0.611 . . . . 0.0 112.602 -171.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.67 -24.71 22.28 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.298 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.508 ' NZ ' ' HB2' ' A' ' 26' ' ' LYS . 7.7 mtmp? -121.96 171.29 9.05 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 14.1 t -101.9 140.47 20.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -178.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.585 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 17.0 m -131.78 145.65 51.71 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.139 0.495 . . . . 0.0 111.871 -171.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.677 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 6.2 tt -121.98 114.01 20.38 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 172.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.679 ' HB ' ' CG2' ' A' ' 108' ' ' VAL . 36.0 mt -98.54 112.6 31.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -118.21 121.21 39.91 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.569 0.223 . . . . 0.0 110.47 -178.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -92.73 119.77 32.44 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.561 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.49 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 10.5 p-90 -141.73 -176.36 4.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.142 -175.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -168.92 156.64 7.13 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 175.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.614 ' HD3' HG12 ' A' ' 74' ' ' VAL . 33.1 Cg_exo -59.68 158.92 26.2 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.544 2.163 . . . . 0.0 112.326 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 81.6 p 60.77 11.05 2.97 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.031 0.932 . . . . 0.0 112.141 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.731 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 34.6 t -72.96 129.96 85.75 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 177.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.69 -20.73 66.68 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.965 2.443 . . . . 0.0 112.461 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.82 -19.47 61.43 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.755 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.907 ' HA ' ' HG2' ' A' ' 43' ' ' GLU . 93.6 m -63.33 -30.78 71.85 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -174.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.3 m -64.16 -29.07 46.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.111 0.481 . . . . 0.0 110.417 177.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.519 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 29.4 t -88.94 -56.09 3.43 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.21 176.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.907 ' HG2' ' HA ' ' A' ' 40' ' ' CYS . 17.1 pt-20 -64.6 -50.14 68.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.092 -0.503 . . . . 0.0 112.043 -170.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.653 ' O ' HG12 ' A' ' 48' ' ' ILE . 33.5 ttm -57.87 -55.08 48.74 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -167.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.56 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 52.7 Cg_exo -53.35 -47.35 27.86 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.899 1.733 . . . . 0.0 112.433 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.519 ' HD3' ' O ' ' A' ' 42' ' ' SER . 23.9 mtpt -64.41 -40.04 95.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.09 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.471 HG12 ' O ' ' A' ' 43' ' ' GLU . 29.6 mm -64.31 -37.65 80.49 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.307 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.9 177.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.653 HG12 ' O ' ' A' ' 44' ' ' MET . 50.4 mm -54.67 -50.6 58.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 121.296 0.569 . . . . 0.0 109.939 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -67.69 -53.62 26.12 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.16 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 14.4 p -62.02 -54.69 38.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.912 -176.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.12 -39.0 91.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.841 -174.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -71.55 -35.36 70.61 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.411 -174.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -77.1 -48.53 17.52 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.299 -0.561 . . . . 0.0 110.463 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.751 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 25.6 m-85 -62.68 -27.77 69.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.801 0.334 . . . . 0.0 110.939 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.545 ' HA ' ' O ' ' A' ' 59' ' ' PHE . 36.9 ttpt -53.88 -37.4 63.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.797 173.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -89.13 10.04 23.33 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.683 -177.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.406 ' CG ' ' HA ' ' A' ' 54' ' ' TYR . 0.3 OUTLIER -105.23 -66.68 0.96 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.293 0.568 . . . . 0.0 109.689 177.375 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.491 ' OD1' ' HA ' ' A' ' 26' ' ' LYS . 21.0 t-20 174.25 21.71 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.111 -174.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.751 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 34.0 t80 -122.82 132.09 54.05 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.731 -168.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.504 ' O ' ' HA ' ' A' ' 28' ' ' THR . 4.1 pt20 -121.63 137.64 54.66 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.221 178.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.438 HG22 ' HE1' ' A' ' 59' ' ' PHE . 97.6 t -110.19 124.85 67.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.433 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.765 HD11 HD21 ' A' ' 23' ' ' LEU . 86.9 mt -106.4 95.83 6.03 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.52 177.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.74 97.23 10.78 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.562 ' HA ' ' HB2' ' A' ' 88' ' ' MET . 15.0 t -85.08 110.12 18.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.117 -176.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -87.0 117.17 25.54 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.86 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.516 ' HB2' ' CD ' ' A' ' 67' ' ' PRO . 4.1 pt20 -81.11 -178.01 1.08 Allowed Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.569 ' HD3' ' O ' ' A' ' 90' ' ' ASP . 16.1 Cg_exo -69.0 -135.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 122.25 1.967 . . . . 0.0 112.812 -176.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.548 ' HB ' ' O ' ' A' ' 67' ' ' PRO . 90.7 mt 77.14 -57.65 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -175.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.41 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -104.78 133.64 20.06 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 168.309 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.505 ' O ' HG22 ' A' ' 74' ' ' VAL . 21.6 Cg_exo -65.52 173.31 6.71 Favored 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 122.843 2.362 . . . . 0.0 113.351 -174.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.608 ' HA ' ' CG2' ' A' ' 74' ' ' VAL . 7.1 tp -63.76 -33.01 59.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.726 -170.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.436 ' HA ' ' HD2' ' A' ' 75' ' ' ARG . 0.6 OUTLIER -73.4 -32.85 64.68 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.605 178.782 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 75.2 m -67.42 -51.13 55.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.889 176.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.614 HG12 ' HD3' ' A' ' 35' ' ' PRO . 3.1 m -61.45 -42.64 94.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.354 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.735 ' HA ' HD13 ' A' ' 13' ' ' LEU . 4.4 ptm180 -74.46 -34.02 63.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.135 -176.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -71.12 -36.94 72.32 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 110.329 -0.248 . . . . 0.0 110.329 177.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -55.1 -44.05 74.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.276 0.56 . . . . 0.0 109.52 178.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.796 HG13 ' HB2' ' A' ' 83' ' ' LEU . 84.1 t -59.84 -48.76 86.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.742 175.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -75.14 -29.34 60.48 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -173.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -74.29 -46.94 38.03 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.804 0.335 . . . . 0.0 111.222 -176.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -85.77 -10.77 55.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.743 0.306 . . . . 0.0 111.523 -176.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.96 53.65 3.88 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.821 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.796 ' HB2' HG13 ' A' ' 78' ' ' VAL . 9.9 mp -78.74 111.23 17.95 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-O 120.692 0.282 . . . . 0.0 110.508 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -92.73 32.76 0.25 Allowed 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.2 2.6 . . . . 0.0 113.237 -177.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.604 ' HE2' HD13 ' A' ' 48' ' ' ILE . 29.0 p90 -135.64 165.37 25.71 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.9 m -74.51 128.11 34.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.091 0.472 . . . . 0.0 111.277 -175.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.9 t -120.43 137.08 55.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.075 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.562 ' HB2' ' HA ' ' A' ' 64' ' ' VAL . 48.8 mtt -111.47 175.87 5.25 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.328 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.42 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 73.3 t80 -131.83 107.57 8.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.32 175.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.569 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 67.3 t0 -91.51 91.87 8.26 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.76 -35.07 62.58 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -175.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.431 ' O ' ' HB3' ' A' ' 93' ' ' LYS . 3.6 p30 -94.44 -12.49 27.66 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.821 -0.351 . . . . 0.0 111.86 -173.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.438 ' HE3' ' HB3' ' A' ' 93' ' ' LYS . 0.6 OUTLIER 72.39 -10.93 0.86 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 120.989 0.423 . . . . 0.0 111.126 174.514 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.85 -22.64 39.72 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 122.271 -0.268 . . . . 0.0 110.371 -177.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 83.6 t -59.83 -49.76 82.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 172.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -58.99 -32.97 71.97 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.303 174.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 93' ' ' LYS . 43.7 mt-30 -69.71 -34.22 73.59 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 122.801 -0.235 . . . . 0.0 111.12 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.24 -37.44 85.51 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.088 0.47 . . . . 0.0 110.736 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -76.71 -26.98 55.28 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.026 0.441 . . . . 0.0 110.521 176.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.6 44.68 2.08 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.798 174.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.495 ' HA ' HG21 ' A' ' 106' ' ' THR . 29.9 p -69.77 100.77 1.57 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.199 0.523 . . . . 0.0 111.116 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.05 -61.65 1.74 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.457 0.646 . . . . 0.0 109.262 177.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.9 p -139.55 140.84 36.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.576 -177.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.406 ' HA ' ' C ' ' A' ' 105' ' ' PRO . 72.9 m-85 -94.8 147.5 33.23 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 -173.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.568 ' HD2' ' HA2' ' A' ' 122' ' ' GLY . 6.4 Cg_exo -73.63 146.44 86.92 Favored 'Cis proline' 0 C--O 1.234 0.321 0 C-N-CA 123.663 -1.39 . . . . 0.0 112.558 0.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.495 HG21 ' HA ' ' A' ' 101' ' ' THR . 19.9 m -115.26 112.24 22.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.18 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.0 m -109.47 112.26 24.26 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.611 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.679 ' CG2' ' HB ' ' A' ' 30' ' ' ILE . 15.3 m -105.75 142.96 17.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.132 0.491 . . . . 0.0 110.71 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.454 HD11 HD22 ' A' ' 129' ' ' LEU . 81.6 mt -101.42 125.81 48.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.288 -176.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.585 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 10.0 mm -114.33 110.04 30.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 O-C-N 124.59 1.181 . . . . 0.0 109.136 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.5 ' O ' ' HG3' ' A' ' 112' ' ' LYS . . . -61.99 -59.29 9.83 Favored Glycine 0 C--O 1.225 -0.414 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.383 -178.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.527 ' O ' ' HB2' ' A' ' 113' ' ' LYS . 19.3 mttt -169.46 166.89 10.13 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 178.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.616 ' H ' ' HA ' ' A' ' 24' ' ' GLN . 28.6 mttt 77.45 -52.12 0.54 Allowed 'General case' 0 C--N 1.323 -0.563 0 O-C-N 123.642 0.588 . . . . 0.0 111.814 176.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 137.49 3.57 2.08 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.247 -177.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.29 144.58 54.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.892 0.377 . . . . 0.0 110.722 -179.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 51.0 mm -90.5 108.02 19.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -178.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 21.6 mt -94.39 -68.24 0.81 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.811 -173.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.444 ' HB3' HD12 ' A' ' 109' ' ' LEU . 21.4 tptm -122.78 148.24 45.6 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.865 -172.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 28.7 m -128.75 107.6 9.8 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.859 0.361 . . . . 0.0 111.046 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.496 ' CE1' ' HB3' ' A' ' 125' ' ' ASP . 51.4 m-85 -104.44 137.39 42.37 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.368 176.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.0 m -118.42 128.99 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-O 120.821 0.343 . . . . 0.0 110.977 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.568 ' HA2' ' HD2' ' A' ' 105' ' ' PRO . . . 79.32 -69.69 2.93 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.756 178.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.424 ' OE1' ' HD2' ' A' ' 124' ' ' PRO . 6.9 tp10 -126.49 114.54 23.1 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.424 ' HD2' ' OE1' ' A' ' 123' ' ' GLU . 56.4 Cg_endo -72.25 122.25 8.21 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.386 2.057 . . . . 0.0 112.366 177.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.593 ' O ' ' HB2' ' A' ' 129' ' ' LEU . 3.7 t0 -61.5 105.2 0.49 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.34 175.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.492 ' HA ' ' CB ' ' A' ' 129' ' ' LEU . 75.6 m-85 -69.26 -21.84 63.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.695 -172.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -63.64 -54.46 31.34 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 119.793 -1.194 . . . . 0.0 111.448 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -81.63 -17.29 48.66 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.633 -0.283 . . . . 0.0 110.907 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.593 ' HB2' ' O ' ' A' ' 125' ' ' ASP . 0.9 OUTLIER -61.42 -49.04 78.48 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 174.584 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -71.61 -40.72 69.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.964 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -61.12 -43.5 98.79 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.319 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -62.39 -47.26 84.94 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.73 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 129' ' ' LEU . 68.0 mt -58.24 -45.13 89.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.097 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -64.54 -38.65 91.75 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.996 0.427 . . . . 0.0 111.005 177.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 87.8 m -60.59 -39.29 87.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.393 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.17 176.331 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.215 0 CA-C-O 121.073 0.463 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -96.18 131.17 42.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.313 0.578 . . . . 0.0 110.907 -176.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.9 m -129.23 90.51 3.03 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 169.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.579 HD12 ' HD2' ' A' ' 11' ' ' PRO . 30.5 tp -114.65 128.53 25.79 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.292 -167.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.646 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 56.1 Cg_endo -73.43 126.61 11.1 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.371 2.047 . . . . 0.0 111.434 170.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.581 ' HA ' ' HG2' ' A' ' 88' ' ' MET . 0.9 OUTLIER -71.91 166.73 21.52 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.913 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.412 HD13 ' HB3' ' A' ' 75' ' ' ARG . 1.5 pp -77.71 8.45 4.47 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -171.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.483 ' HD1' ' CG ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -105.08 -17.99 14.3 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 170.41 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.79 23.35 3.69 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 115.445 0.938 . . . . 0.0 115.445 170.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.572 ' HZ2' HG12 ' A' ' 18' ' ' VAL . 48.5 tttm -115.05 126.87 55.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 118.638 1.219 . . . . 0.0 110.712 173.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.646 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 9.6 t -76.51 129.31 36.3 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.075 0.464 . . . . 0.0 109.794 173.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.572 HG12 ' HZ2' ' A' ' 16' ' ' LYS . 28.1 m -116.12 142.74 28.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.547 174.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.5 t -145.47 -173.4 4.11 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -62.9 -22.08 66.48 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.969 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.16 -27.74 68.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.413 176.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -78.78 -22.55 46.18 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.196 0.522 . . . . 0.0 110.181 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.407 HD13 HG21 ' A' ' 110' ' ' ILE . 43.4 mt -84.46 -38.49 20.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.8 -174.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -59.77 129.76 43.46 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -171.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.33 -14.03 64.84 Favored Glycine 0 C--N 1.331 0.294 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.986 175.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.473 ' HE3' ' CD ' ' A' ' 60' ' ' GLN . 0.0 OUTLIER -137.17 -178.74 5.34 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 -177.468 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.612 HG13 ' HA ' ' A' ' 59' ' ' PHE . 6.9 p -114.05 149.56 16.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -174.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 61.2 m -148.41 139.39 23.11 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.669 0.271 . . . . 0.0 111.127 -171.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.721 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 43.4 tp -105.73 127.26 52.97 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.358 173.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.3 mt -113.3 112.46 40.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 171.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -112.43 111.06 21.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.485 -175.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.455 ' HB2' HG22 ' A' ' 106' ' ' THR . 79.5 m-85 -81.37 119.65 23.96 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 177.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.477 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 4.3 p-90 -150.53 -173.01 4.34 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.455 -176.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -154.85 144.9 15.68 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 170.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.648 ' HD2' ' HB2' ' A' ' 69' ' ' ASP . 57.4 Cg_exo -40.39 -43.49 4.05 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 123.606 2.871 . . . . 0.0 114.886 -175.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.4 p -80.44 16.77 1.22 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -176.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.44 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 24.9 m -68.04 132.39 92.04 Favored Pre-proline 0 C--N 1.33 -0.252 0 O-C-N 122.066 -0.396 . . . . 0.0 111.533 178.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 16.4 Cg_exo -68.43 -26.16 34.94 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.034 2.489 . . . . 0.0 112.272 177.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.28 -15.13 72.22 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 121.155 -0.545 . . . . 0.0 113.229 -177.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.771 ' HA ' ' HG2' ' A' ' 44' ' ' MET . 73.1 m -52.99 -36.44 60.38 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -178.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 38' ' ' PRO . 27.2 m -64.63 -38.61 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-O 120.695 0.283 . . . . 0.0 111.438 -178.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.7 m -88.37 -55.53 3.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.985 0.421 . . . . 0.0 111.62 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.496 ' O ' HG12 ' A' ' 47' ' ' ILE . 32.7 mt-10 -72.29 -50.1 29.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.324 -170.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.771 ' HG2' ' HA ' ' A' ' 40' ' ' CYS . 20.0 mmt -57.84 -46.78 99.7 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -167.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 40' ' ' CYS . 51.4 Cg_exo -55.75 -43.32 58.52 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 121.746 1.63 . . . . 0.0 112.203 177.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -66.52 -33.95 76.83 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.933 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 43' ' ' GLU . 41.9 mm -67.58 -38.79 81.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.449 177.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.591 HG12 ' O ' ' A' ' 44' ' ' MET . 49.1 mm -54.55 -53.45 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 120.857 0.361 . . . . 0.0 110.289 178.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.415 ' HB3' ' HE3' ' A' ' 49' ' ' LYS . 14.9 ttpp -55.09 -52.3 63.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.491 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.54 ' O ' ' HD2' ' A' ' 54' ' ' TYR . 17.0 m -67.48 -47.51 69.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.428 -174.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.61 ' HB1' HG21 ' A' ' 61' ' ' VAL . . . -67.5 -28.3 67.72 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.891 -174.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -75.87 -50.17 15.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.833 0.349 . . . . 0.0 111.09 -178.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -64.72 -47.98 76.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.097 -0.502 . . . . 0.0 112.326 -173.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.836 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 96.5 m-85 -77.35 1.79 17.83 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -170.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 37.8 mmtm -56.15 -49.91 72.61 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.286 0.565 . . . . 0.0 110.317 174.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -95.07 21.11 8.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.117 -177.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.663 ' HB2' ' HA ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -113.76 -65.85 1.14 Allowed 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.442 179.42 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 24.1 p30 171.6 -11.93 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.836 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 68.5 t80 -98.68 125.96 44.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.062 0.458 . . . . 0.0 109.876 -174.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.473 ' CD ' ' HE3' ' A' ' 26' ' ' LYS . 27.8 mt-30 -102.19 167.31 10.08 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 121.448 0.642 . . . . 0.0 110.943 -178.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.61 HG21 ' HB1' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -148.33 111.43 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.775 -171.806 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.534 HD23 ' HB ' ' A' ' 86' ' ' THR . 78.4 mt -124.22 97.34 5.29 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.585 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.727 ' HB3' HG12 ' A' ' 87' ' ' VAL . . . -86.15 101.79 13.31 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.727 178.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.585 HG12 ' HB2' ' A' ' 90' ' ' ASP . 12.2 t -85.92 108.27 17.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.216 -176.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -85.78 115.93 23.73 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.107 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.671 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 3.9 pt20 -78.29 -174.66 0.47 Allowed Pre-proline 0 C--N 1.315 -0.892 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.671 ' HD2' ' HB2' ' A' ' 66' ' ' GLN . 47.6 Cg_endo -69.33 -146.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 121.552 1.501 . . . . 0.0 112.366 -177.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.554 ' HB ' ' O ' ' A' ' 67' ' ' PRO . 62.8 mt 77.54 -61.1 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -172.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.648 ' HB2' ' HD2' ' A' ' 35' ' ' PRO . 34.2 m-20 -97.1 128.97 33.43 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 171.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.45 ' HD2' ' OG ' ' A' ' 73' ' ' SER . 51.5 Cg_exo -57.14 165.61 5.13 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.667 2.245 . . . . 0.0 112.505 175.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.598 ' O ' ' HG2' ' A' ' 75' ' ' ARG . 6.6 tt -66.52 -29.3 46.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.894 0.378 . . . . 0.0 110.675 -177.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.718 ' HA ' ' HE ' ' A' ' 75' ' ' ARG . 2.1 pm0 -69.65 -28.85 66.24 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 122.112 -0.367 . . . . 0.0 110.666 175.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.45 ' OG ' ' HD2' ' A' ' 70' ' ' PRO . 67.0 m -64.66 -43.85 92.31 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.664 0.268 . . . . 0.0 110.358 175.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.522 ' HA ' ' HG3' ' A' ' 35' ' ' PRO . 13.8 p -71.6 -39.8 70.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.113 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.816 ' HA ' HG22 ' A' ' 78' ' ' VAL . 28.9 ptt180 -75.19 -25.55 58.33 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 122.312 -0.242 . . . . 0.0 111.475 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -70.29 -41.27 73.6 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 169.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -62.17 -47.2 85.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.202 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.816 HG22 ' HA ' ' A' ' 75' ' ' ARG . 33.0 m -67.15 -28.74 43.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.069 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.7 tptp -73.09 -55.78 6.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.373 0.606 . . . . 0.0 111.459 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -65.52 -49.03 70.47 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.896 -171.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -81.05 -19.55 43.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.754 -177.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.07 65.02 2.1 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.904 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.467 HD22 HG12 ' A' ' 78' ' ' VAL . 8.6 mp -84.27 113.51 48.89 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-O 120.695 0.283 . . . . 0.0 110.933 -177.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -81.25 -2.77 11.83 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.879 2.386 . . . . 0.0 113.371 -177.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.507 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 28.4 p90 -99.02 140.28 33.42 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 122.149 -0.344 . . . . 0.0 110.532 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.534 ' HB ' HD23 ' A' ' 62' ' ' LEU . 10.7 m -67.93 137.9 55.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.742 -176.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.727 HG12 ' HB3' ' A' ' 63' ' ' ALA . 10.8 m -122.97 137.19 57.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.398 0.618 . . . . 0.0 111.708 -176.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.581 ' HG2' ' HA ' ' A' ' 12' ' ' ASP . 79.6 mtm -115.95 176.01 5.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.497 -0.774 . . . . 0.0 108.988 175.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 37.9 t80 -125.34 112.35 16.24 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.216 0.531 . . . . 0.0 111.041 -178.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.703 ' OD2' ' HA ' ' A' ' 93' ' ' LYS . 23.0 t70 -84.63 74.83 10.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.553 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.22 -42.4 62.68 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.476 -174.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -83.02 -12.99 56.74 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.226 -177.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.703 ' HA ' ' OD2' ' A' ' 90' ' ' ASP . 2.6 mtpm? 64.54 -5.2 0.37 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.35 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.22 -32.03 38.56 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -168.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.477 ' O ' ' HD1' ' A' ' 99' ' ' PHE . 31.2 m -66.8 -34.35 69.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.495 174.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -67.56 -34.08 83.05 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.41 172.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.615 ' HG3' ' O ' ' A' ' 93' ' ' LYS . 79.9 mt-30 -63.59 -39.06 93.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.646 -0.277 . . . . 0.0 110.408 175.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.69 -34.11 77.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.052 178.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.477 ' HD1' ' O ' ' A' ' 95' ' ' VAL . 42.2 m-85 -72.31 -24.01 61.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.822 174.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.31 23.17 49.08 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.494 -178.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.533 ' HB ' HG21 ' A' ' 106' ' ' THR . 50.9 p -86.07 110.02 19.24 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.007 0.432 . . . . 0.0 111.064 -176.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -108.66 -24.55 11.29 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.786 177.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.9 t -99.63 131.98 45.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.909 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -128.66 143.39 48.27 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.334 -178.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.424 ' HG2' ' OE1' ' A' ' 43' ' ' GLU . 5.3 Cg_exo -74.78 160.33 96.62 Favored 'Cis proline' 0 C--N 1.346 0.407 0 C-N-CA 123.715 -1.369 . . . . 0.0 112.161 0.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.533 HG21 ' HB ' ' A' ' 101' ' ' THR . 9.8 t -142.46 120.93 12.43 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.712 0.768 . . . . 0.0 111.239 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.599 ' HB3' HD11 ' A' ' 29' ' ' LEU . 25.5 m -95.8 111.97 23.81 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.253 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 55.3 t -105.5 128.48 59.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.261 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.612 HD12 ' HB3' ' A' ' 118' ' ' LYS . 95.3 mt -101.97 122.97 45.07 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.778 -176.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 23' ' ' LEU . 41.6 mt -110.61 130.09 64.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.475 178.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -88.31 -158.11 33.08 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.235 -0.983 . . . . 0.0 112.973 -178.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 44.0 mtpt -87.67 -17.98 30.59 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.976 0.893 . . . . 0.0 109.72 -168.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.771 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -81.07 -14.22 58.03 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.416 177.881 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.41 -7.97 79.57 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -173.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -72.21 146.88 47.02 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.165 0.507 . . . . 0.0 110.975 -178.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 47.0 mm -81.12 110.4 16.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.025 178.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.8 mt -90.7 -59.82 2.08 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -170.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.612 ' HB3' HD12 ' A' ' 109' ' ' LEU . 23.6 tptm -133.36 153.19 51.8 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.248 -170.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.3 m -134.59 128.03 32.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.522 177.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.442 ' OH ' ' HB2' ' A' ' 128' ' ' LYS . 80.5 m-85 -116.88 141.47 48.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.83 174.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.6 m -124.86 109.64 22.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.699 0.285 . . . . 0.0 111.304 178.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 68.52 97.66 0.04 OUTLIER Glycine 0 C--N 1.331 0.286 0 C-N-CA 121.174 -0.536 . . . . 0.0 113.07 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.423 ' HA ' ' HG2' ' A' ' 43' ' ' GLU . 9.0 tp10 66.13 92.92 0.06 OUTLIER Pre-proline 0 C--O 1.235 0.316 0 CA-C-O 121.509 0.671 . . . . 0.0 110.217 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -77.23 141.62 20.74 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.494 2.129 . . . . 0.0 113.019 -176.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.52 ' OD1' ' HG2' ' A' ' 128' ' ' LYS . 10.6 t0 -65.75 96.05 0.27 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.6 174.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.595 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 50.1 m-85 -69.19 -14.36 62.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.867 -178.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -68.36 -50.63 37.14 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.271 -0.966 . . . . 0.0 110.854 174.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.52 ' HG2' ' OD1' ' A' ' 125' ' ' ASP . 31.1 mmtm -77.95 -20.56 52.5 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.595 ' HB3' ' HA ' ' A' ' 126' ' ' PHE . 3.2 tm? -63.59 -47.9 79.56 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 174.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -68.18 -45.65 72.84 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.236 178.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -60.88 -36.47 79.29 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.938 0.348 . . . . 0.0 111.938 178.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -66.63 -51.77 52.5 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 67.9 mt -57.27 -43.03 81.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.902 0.382 . . . . 0.0 110.392 176.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -56.7 -40.32 75.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.85 177.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 63.8 m -62.07 -44.07 97.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.316 176.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.191 178.776 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.049 0 CA-C-O 121.394 0.616 . . . . 0.0 110.03 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.593 ' HB2' HG12 ' A' ' 95' ' ' VAL . 13.0 p90 -67.4 148.17 51.94 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.384 -175.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.0 m -142.59 89.79 2.17 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 172.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.647 HD11 ' HB3' ' A' ' 89' ' ' TYR . 35.5 tp -115.88 120.59 35.4 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.597 -173.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.558 ' HD2' HD12 ' A' ' 10' ' ' LEU . 24.3 Cg_exo -64.44 144.43 85.36 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.584 2.189 . . . . 0.0 111.799 176.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.717 ' HA ' ' HA ' ' A' ' 88' ' ' MET . 1.6 p-10 -81.95 -173.21 4.35 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.502 HD21 ' HA ' ' A' ' 89' ' ' TYR . 73.8 mt -87.02 2.27 50.14 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.672 -177.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.451 ' H ' ' CG ' ' A' ' 12' ' ' ASP . 64.3 t60 -95.69 -40.49 9.36 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 172.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.22 22.76 0.79 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.109 -1.043 . . . . 0.0 114.121 174.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.427 ' HE2' HG22 ' A' ' 18' ' ' VAL . 2.3 ptmt -114.31 134.51 54.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.72 0.76 . . . . 0.0 110.244 175.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 16.1 m -67.93 121.59 16.37 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.314 177.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.427 HG22 ' HE2' ' A' ' 16' ' ' LYS . 46.3 t -97.28 128.77 48.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 177.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 63.6 p -129.01 -175.59 3.6 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.874 0.369 . . . . 0.0 111.025 -175.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -68.95 -22.28 64.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.78 177.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.86 -28.95 69.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.736 176.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -67.01 -21.08 65.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.942 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 74.2 mt -80.7 -20.53 42.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.432 -176.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.455 ' HA ' ' OE1' ' A' ' 24' ' ' GLN . 15.9 mm-40 -78.59 138.61 38.44 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.077 0.465 . . . . 0.0 112.137 -172.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.98 3.38 89.18 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.771 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 112' ' ' LYS . 41.1 mtmt -146.75 165.03 30.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.668 0.271 . . . . 0.0 110.527 -177.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 26.0 t -103.16 138.62 26.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 173.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.631 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 11.1 m -131.93 145.29 51.41 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.63 -0.428 . . . . 0.0 112.126 -168.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.665 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 6.9 tt -119.5 108.75 14.9 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 170.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.8 mt -94.6 111.12 24.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -104.97 125.11 50.61 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.459 -177.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.466 ' CE2' ' HA2' ' A' ' 96' ' ' GLY . 87.0 m-85 -96.26 118.18 32.3 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 9.1 p-90 -144.59 -176.49 5.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.484 -175.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -159.63 151.96 17.46 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.239 176.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.33 155.58 51.06 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.404 2.069 . . . . 0.0 111.887 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.3 m 65.08 16.51 10.6 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.588 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.523 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 42.7 t -84.14 130.76 53.25 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.596 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -61.13 -26.82 83.19 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.7 2.267 . . . . 0.0 111.922 176.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -64.52 -30.02 76.74 Favored Glycine 0 C--O 1.227 -0.303 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.473 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.523 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 83.9 m -58.26 -30.5 66.63 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 122.16 0.184 . . . . 0.0 111.445 -178.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.6 t -61.18 -38.14 79.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.211 0.529 . . . . 0.0 110.157 177.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.463 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 32.6 m -87.09 -51.28 6.09 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.513 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -70.21 -45.06 67.36 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -171.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.569 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 39.2 tpp -54.72 -51.35 79.58 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -171.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.569 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 57.3 Cg_exo -53.28 -36.44 78.2 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 121.962 1.775 . . . . 0.0 112.47 175.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.633 ' HB3' ' CZ ' ' A' ' 126' ' ' PHE . 30.5 mmtm -65.16 -47.52 76.72 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.238 0.542 . . . . 0.0 109.796 177.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.7 mm -65.5 -38.65 82.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.823 -177.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.528 HG12 ' O ' ' A' ' 44' ' ' MET . 47.2 mm -54.68 -53.34 32.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 120.777 0.322 . . . . 0.0 110.188 177.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.1 tttm -62.16 -57.69 10.58 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.632 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 29.0 m -60.32 -44.82 95.12 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -171.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . -69.31 -36.08 76.62 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.118 -0.233 . . . . 0.0 111.598 -175.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -77.06 -40.35 46.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.158 0.504 . . . . 0.0 110.626 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -55.28 -53.04 61.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.902 -1.045 . . . . 0.0 111.15 -177.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.542 ' CB ' ' HB3' ' A' ' 59' ' ' PHE . 67.1 m-85 -96.88 8.16 45.01 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.465 -175.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -62.25 -52.31 64.24 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.093 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -82.4 66.81 8.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.802 176.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.705 ' HB2' ' HZ2' ' A' ' 57' ' ' LYS . 0.3 OUTLIER -166.94 -75.31 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.597 -173.819 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 6.9 t-20 173.62 7.96 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.203 0.525 . . . . 0.0 110.415 -176.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.665 ' HZ ' ' HB2' ' A' ' 29' ' ' LEU . 41.0 t80 -110.43 135.22 51.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.914 0.388 . . . . 0.0 110.581 -173.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.605 ' HG3' HG23 ' A' ' 28' ' ' THR . 21.4 pt20 -125.75 144.48 50.61 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.725 178.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 97.2 t -113.93 111.52 36.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 97.9 mt -95.03 95.57 8.68 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 177.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -86.6 95.65 9.83 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.574 ' HA ' ' HB2' ' A' ' 88' ' ' MET . 2.4 p -88.08 118.53 33.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.117 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 90' ' ' ASP . . . -89.53 162.69 15.56 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.948 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.41 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 18.6 pt20 -137.54 154.38 75.06 Favored Pre-proline 0 C--N 1.305 -1.358 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 169.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 1.074 ' HD3' ' HA ' ' A' ' 91' ' ' ALA . 56.2 Cg_endo -59.36 -92.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.038 1.826 . . . . 0.0 113.965 -150.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.3 mm 65.66 -70.34 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -175.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.41 ' OD1' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -94.57 147.23 32.88 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 171.316 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.41 ' HD2' ' OD1' ' A' ' 69' ' ' ASP . 65.6 Cg_exo -52.88 157.66 7.57 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 122.869 2.38 . . . . 0.0 113.902 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.4 ' O ' HG12 ' A' ' 74' ' ' VAL . 4.0 tp -53.85 -33.74 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.875 179.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.448 ' CD ' HH21 ' A' ' 75' ' ' ARG . 9.1 tp10 -68.87 -29.59 67.92 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 122.154 -0.341 . . . . 0.0 110.289 178.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.6 m -70.29 -48.65 55.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.951 0.405 . . . . 0.0 110.63 -177.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' ' 71' ' ' ILE . 11.1 p -61.43 -32.82 54.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-O 121.929 0.871 . . . . 0.0 109.305 175.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.656 ' HA ' HG22 ' A' ' 78' ' ' VAL . 50.5 ttp180 -75.28 -29.24 60.06 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.592 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -70.41 -41.7 72.62 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 172.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -57.06 -51.28 69.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.285 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.656 HG22 ' HA ' ' A' ' 75' ' ' ARG . 24.2 m -61.59 -36.94 76.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.127 -178.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -75.3 -52.22 11.36 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -58.6 -48.52 80.67 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.165 -170.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -92.58 1.11 57.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.388 -175.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 54.46 60.01 9.24 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.458 -179.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.488 HD22 HG12 ' A' ' 78' ' ' VAL . 10.8 mp -60.87 109.71 2.32 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.867 0.365 . . . . 0.0 111.462 -176.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -85.18 37.82 0.62 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.339 2.693 . . . . 0.0 113.044 -175.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -149.56 159.57 44.2 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.197 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.49 109.34 4.76 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.84 -176.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.2 t -101.96 136.78 32.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.515 177.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.717 ' HA ' ' HA ' ' A' ' 12' ' ' ASP . 80.1 mtp -111.24 162.17 15.25 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.267 -174.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.647 ' HB3' HD11 ' A' ' 10' ' ' LEU . 12.6 t80 -62.73 141.55 58.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.469 0.652 . . . . 0.0 112.087 -174.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.544 ' O ' ' N ' ' A' ' 92' ' ' ASP . 5.1 p-10 -56.52 -135.21 0.0 OUTLIER 'General case' 0 C--O 1.217 -0.649 0 CA-C-N 113.659 -1.609 . . . . 0.0 111.56 162.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 1.074 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . . . -28.66 -6.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 120.583 3.549 . . . . 0.0 120.583 -146.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.613 ' HB3' HD13 ' A' ' 10' ' ' LEU . 37.5 t70 -71.73 38.73 0.07 Allowed 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 120.31 1.414 . . . . 0.0 108.809 163.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.542 ' H ' ' C ' ' A' ' 91' ' ' ALA . 0.0 OUTLIER -58.47 -3.72 0.32 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.194 0.998 . . . . 0.0 112.675 -174.4 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.63 -23.91 67.41 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 122.77 0.428 . . . . 0.0 111.179 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.593 HG12 ' HB2' ' A' ' 8' ' ' PHE . 35.9 m -60.73 -37.38 75.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.106 0.479 . . . . 0.0 110.099 174.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.466 ' HA2' ' CE2' ' A' ' 32' ' ' PHE . . . -67.87 -32.17 77.01 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 174.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -69.78 -28.84 66.08 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.006 -0.597 . . . . 0.0 110.719 177.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.45 -28.34 61.91 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.074 0.464 . . . . 0.0 110.89 176.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.402 ' HD2' ' O ' ' A' ' 95' ' ' VAL . 50.4 m-85 -79.86 -24.53 41.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.738 173.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.74 -8.02 76.83 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.936 -0.65 . . . . 0.0 111.843 -177.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.579 ' HB ' HG21 ' A' ' 106' ' ' THR . 18.1 p -78.94 91.89 4.86 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.736 0.303 . . . . 0.0 111.396 -177.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -105.82 0.19 25.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.029 0.442 . . . . 0.0 111.311 177.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.5 m -97.95 125.81 51.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.513 173.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -121.28 149.77 52.61 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.526 -172.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -85.31 164.79 58.25 Favored 'Cis proline' 0 C--N 1.343 0.277 0 C-N-CA 123.548 -1.438 . . . . 0.0 112.002 -0.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.579 HG21 ' HB ' ' A' ' 101' ' ' THR . 5.9 t -151.88 142.79 23.03 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.895 -177.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.477 ' HB3' HD21 ' A' ' 29' ' ' LEU . 56.4 m -120.51 122.85 41.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.367 177.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.3 t -105.85 137.13 37.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.331 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.401 HD22 ' N ' ' A' ' 109' ' ' LEU . 2.8 mm? -101.82 122.34 43.79 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.18 -177.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.631 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 8.5 mm -110.13 129.94 64.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.344 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -79.35 -176.47 48.82 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.326 -0.94 . . . . 0.0 111.87 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 16.8 pttm -92.52 43.21 1.12 Allowed 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 122.532 1.158 . . . . 0.0 107.93 -178.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 51.3 mmtt -140.32 -5.77 1.23 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 113.302 -1.772 . . . . 0.0 111.367 -168.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.47 12.66 82.19 Favored Glycine 0 C--O 1.226 -0.371 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.464 -172.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -103.17 147.97 26.36 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 -178.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 51.5 mt -91.97 111.55 24.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -85.11 -61.52 1.75 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.195 -173.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.434 ' HD2' ' HA ' ' A' ' 118' ' ' LYS . 6.7 mmmm -141.27 167.7 21.55 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -169.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 62.1 m -146.3 105.87 3.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.366 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -102.87 113.16 26.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.577 177.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 106' ' ' THR . 22.2 m -88.54 141.0 14.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 120.849 0.357 . . . . 0.0 110.985 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 71.62 -150.93 47.29 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.438 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.455 ' OE2' ' HB3' ' A' ' 42' ' ' SER . 6.3 tp10 -70.2 111.64 9.99 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -84.45 140.08 8.25 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.47 2.114 . . . . 0.0 113.195 -176.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -66.89 102.88 1.02 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.989 173.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.633 ' CZ ' ' HB3' ' A' ' 46' ' ' LYS . 25.3 m-85 -70.32 -19.42 63.08 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -175.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -63.69 -54.08 33.82 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 119.932 -1.128 . . . . 0.0 111.055 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -79.68 -26.78 40.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.614 -0.293 . . . . 0.0 110.608 177.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.629 ' HB3' ' HA ' ' A' ' 126' ' ' PHE . 41.8 tp -63.18 -47.67 81.62 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.432 178.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -66.34 -47.21 74.23 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.741 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -56.9 -34.17 67.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.99 0.424 . . . . 0.0 111.991 176.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -80.37 -37.96 31.35 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.015 -179.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 129' ' ' LEU . 78.8 mt -65.46 -38.06 81.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.153 0.502 . . . . 0.0 110.002 174.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -67.05 -23.38 65.88 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.686 176.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 87.6 m -67.27 -30.71 70.65 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 172.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.318 174.019 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.351 0 CA-C-O 121.331 0.586 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -106.57 132.76 52.2 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.728 -177.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.7 m -114.9 90.76 3.42 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 172.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.597 HD22 HG21 ' A' ' 95' ' ' VAL . 36.6 tp -102.51 121.23 50.58 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.825 -172.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.553 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 3.9 Cg_exo -80.58 137.2 11.38 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.023 2.482 . . . . 0.0 112.059 176.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.62 ' HB3' ' HB3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -67.99 172.6 5.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.006 175.152 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.6 mt -55.21 -29.64 58.35 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -175.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -102.54 -26.05 13.37 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.453 -176.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.62 16.97 0.43 Allowed Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.073 -1.061 . . . . 0.0 113.917 175.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.62 ' HB3' ' HB3' ' A' ' 12' ' ' ASP . 1.8 tpmt? -81.8 96.85 7.73 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 117.441 0.621 . . . . 0.0 109.84 176.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 23.8 m -86.45 124.33 32.66 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.057 -177.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.5 m -127.16 163.16 30.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.619 179.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 62.1 p -132.17 -173.83 3.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.045 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 29.7 p30 -67.91 -22.19 65.09 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.765 0.317 . . . . 0.0 111.508 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.506 ' HA ' HE21 ' A' ' 24' ' ' GLN . . . -66.92 -27.35 67.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.067 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -70.39 -28.76 65.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.88 0.371 . . . . 0.0 110.25 178.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 45.3 mt -69.72 -20.34 63.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.806 -178.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.699 ' HG2' ' HA ' ' A' ' 113' ' ' LYS . 50.6 mt-30 -73.22 132.88 43.71 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.163 -174.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.66 -25.31 19.43 Favored Glycine 0 N--CA 1.452 -0.282 0 CA-C-N 115.954 -0.567 . . . . 0.0 113.167 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 112' ' ' LYS . 52.0 mtmt -108.25 -175.08 2.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.923 0.392 . . . . 0.0 110.675 -178.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 8.3 t -127.53 141.45 46.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 173.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.557 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 85.5 m -145.58 145.31 30.94 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.121 0.486 . . . . 0.0 111.995 -169.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.584 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 27.9 tp -114.15 112.99 24.08 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.129 170.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.671 ' HB ' ' CG1' ' A' ' 108' ' ' VAL . 41.6 mt -97.28 112.52 29.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 176.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.427 ' HA ' ' O ' ' A' ' 106' ' ' THR . 46.6 t30 -114.39 114.48 25.93 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.099 -177.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 92.5 m-85 -83.74 123.76 30.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.172 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.563 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 6.1 p-90 -143.93 -177.57 5.5 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.398 0.618 . . . . 0.0 111.321 -173.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -162.67 153.4 14.34 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.848 174.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -63.27 158.08 46.51 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.157 1.905 . . . . 0.0 111.472 175.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.8 m 65.7 14.38 9.49 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 123.465 0.478 . . . . 0.0 111.42 -177.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 29.9 t -84.98 133.88 42.36 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.594 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.8 -22.49 68.29 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 122.523 2.149 . . . . 0.0 111.967 176.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.61 -12.13 75.86 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.287 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 21.6 p -69.19 -45.72 69.25 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 117.85 0.825 . . . . 0.0 110.53 -177.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.6 p -65.06 -25.57 37.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.123 0.487 . . . . 0.0 110.593 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.7 m -86.7 -49.51 7.43 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.684 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.424 ' CD ' ' HZ1' ' A' ' 46' ' ' LYS . 22.2 mm-40 -85.13 -41.48 15.66 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -172.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.509 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 47.2 tpp -51.48 -50.2 78.03 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -171.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 44' ' ' MET . 9.8 Cg_endo -51.88 -44.77 42.85 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 122.285 1.99 . . . . 0.0 112.603 177.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.424 ' HZ1' ' CD ' ' A' ' 43' ' ' GLU . 8.0 mppt? -68.79 -40.12 79.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.722 178.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.0 mm -60.45 -43.53 94.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.699 178.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.592 HD13 ' HE1' ' A' ' 85' ' ' PHE . 43.9 mm -55.78 -52.99 42.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.775 178.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.53 -46.52 85.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.886 0.374 . . . . 0.0 110.622 -177.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 29.2 m -65.99 -51.59 57.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.552 -175.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.562 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . -67.86 -36.31 80.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.834 -174.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.403 HD22 ' HA ' ' A' ' 52' ' ' ASN . 2.5 t-20 -74.03 -29.83 62.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.043 0.449 . . . . 0.0 110.592 -177.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -74.49 -50.4 18.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.152 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 1.066 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 66.4 m-85 -80.59 -10.08 59.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.933 -175.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 22.1 tptm -58.41 -33.27 69.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.194 0.521 . . . . 0.0 110.401 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 44.3 m-20 -95.06 20.86 8.44 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.643 -176.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.718 ' HE3' ' HA ' ' A' ' 54' ' ' TYR . 33.1 mtmt -125.98 -63.27 1.12 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.477 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 172.33 -13.29 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 O-C-N 123.322 0.389 . . . . 0.0 111.37 -172.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 1.066 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 56.7 t80 -100.72 122.78 43.93 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.093 0.473 . . . . 0.0 110.356 -177.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.52 HE21 HD11 ' A' ' 62' ' ' LEU . 12.7 pt20 -122.75 154.92 37.51 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.666 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.551 HG22 ' HB3' ' A' ' 29' ' ' LEU . 94.2 t -115.27 128.66 72.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.267 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.52 HD11 HE21 ' A' ' 60' ' ' GLN . 11.0 mp -108.12 109.26 20.64 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.542 177.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.45 98.35 10.81 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.169 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 51.3 t -91.79 116.16 32.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.331 -177.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -96.56 126.53 41.8 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.481 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.592 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 4.7 pm0 -96.0 161.5 27.08 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.679 ' HD3' ' O ' ' A' ' 90' ' ' ASP . 53.0 Cg_endo -70.43 84.95 0.73 Allowed 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.296 1.997 . . . . 0.0 113.515 -171.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 48.2 mm -115.7 -44.94 3.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 172.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.597 ' OD1' ' HD2' ' A' ' 70' ' ' PRO . 0.7 OUTLIER -116.8 141.99 29.05 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 172.595 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.597 ' HD2' ' OD1' ' A' ' 69' ' ' ASP . 61.2 Cg_exo -42.1 155.27 0.1 OUTLIER 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.676 2.917 . . . . 0.0 114.438 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.594 HG23 ' OE1' ' A' ' 72' ' ' GLU . 3.3 tp -58.7 -36.79 62.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.026 -176.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.598 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -59.4 -39.32 83.03 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.534 176.125 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.8 m -58.15 -42.44 85.95 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.304 0.573 . . . . 0.0 109.974 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.2 t -67.72 -52.2 42.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.016 178.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.598 ' HG2' ' HA ' ' A' ' 72' ' ' GLU . 16.0 ptt180 -68.3 -33.46 74.38 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -174.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -65.61 -42.04 92.03 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 178.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -56.36 -47.82 78.06 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.971 178.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.6 HG22 HD22 ' A' ' 83' ' ' LEU . 41.2 t -63.1 -53.0 51.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.328 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 75' ' ' ARG . 95.6 mttt -63.01 -36.61 84.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.726 0.298 . . . . 0.0 111.669 -175.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -75.07 -48.29 24.65 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -176.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -98.48 7.37 46.26 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -173.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.5 -70.09 2.66 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.949 -0.644 . . . . 0.0 112.743 175.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.6 HD22 HG22 ' A' ' 78' ' ' VAL . 10.3 mp 52.25 84.72 0.2 Allowed Pre-proline 0 N--CA 1.468 0.472 0 C-N-CA 122.959 0.504 . . . . 0.0 111.732 -178.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -76.92 16.52 0.95 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.365 2.71 . . . . 0.0 113.563 -176.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.592 ' HE1' HD13 ' A' ' 48' ' ' ILE . 23.1 p90 -117.73 159.4 23.06 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.4 m -74.76 112.08 10.61 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.342 0.591 . . . . 0.0 111.081 -174.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.7 t -99.64 136.74 29.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.831 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.569 ' HG2' ' HA ' ' A' ' 12' ' ' ASP . 62.5 mtt -131.23 166.45 21.14 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.415 -176.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -130.07 117.06 19.42 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.099 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.679 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 67.2 t0 -103.28 108.05 19.12 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 179.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.4 -21.95 59.4 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -176.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.528 ' OD2' ' HB2' ' A' ' 94' ' ' ALA . 28.3 t70 -106.44 -11.43 15.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.08 0.467 . . . . 0.0 110.691 -174.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 97' ' ' GLN . 17.4 ttpp 65.85 17.7 10.91 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.496 -177.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.528 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . . . -67.92 -31.95 72.07 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.418 -174.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.597 HG21 HD22 ' A' ' 10' ' ' LEU . 46.8 t -67.92 -42.6 85.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 177.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.79 -33.99 87.47 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.538 175.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.414 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 15.0 mm100 -64.6 -42.81 95.31 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 122.607 0.363 . . . . 0.0 111.494 177.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.94 -47.18 66.31 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.331 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.511 ' HA ' HD13 ' A' ' 116' ' ' ILE . 36.9 m-85 -72.24 -27.21 62.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.735 -177.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.37 55.21 1.72 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.605 176.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.403 ' HA ' HG21 ' A' ' 106' ' ' THR . 20.1 p -68.99 104.75 2.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.942 0.401 . . . . 0.0 111.57 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 48.4 tp60 -69.45 -58.32 4.13 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.533 0.682 . . . . 0.0 110.108 178.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.4 p -148.36 143.37 19.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.271 -176.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -94.57 141.9 24.06 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.715 -175.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.56 151.42 97.01 Favored 'Cis proline' 0 C--N 1.346 0.405 0 C-N-CA 123.385 -1.506 . . . . 0.0 113.18 0.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 26.3 m -119.54 116.08 25.32 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.884 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.538 ' HB2' HD11 ' A' ' 29' ' ' LEU . 4.3 p -105.56 111.84 24.7 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.085 0.469 . . . . 0.0 111.035 -177.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.671 ' CG1' ' HB ' ' A' ' 30' ' ' ILE . 11.7 p -106.68 143.25 17.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.053 0.454 . . . . 0.0 110.455 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.604 ' HB2' ' HB3' ' A' ' 118' ' ' LYS . 96.3 mt -100.98 121.43 41.75 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.123 -178.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.781 HG23 ' HA2' ' A' ' 114' ' ' GLY . 43.2 mm -102.49 127.29 56.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.303 -176.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -85.64 -168.27 44.51 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.98 177.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.424 ' HE3' ' HB2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -76.69 44.97 0.39 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 117.038 0.419 . . . . 0.0 111.779 -178.495 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.699 ' HA ' ' HG2' ' A' ' 24' ' ' GLN . 64.4 tttm 177.31 -29.63 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -178.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.781 ' HA2' HG23 ' A' ' 110' ' ' ILE . . . 115.62 -87.04 0.43 Allowed Glycine 0 N--CA 1.437 -1.285 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.832 177.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 55.68 2.79 0.07 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.545 1.138 . . . . 0.0 113.56 178.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.511 HD13 ' HA ' ' A' ' 99' ' ' PHE . 4.8 mt 49.54 77.27 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 121.574 0.702 . . . . 0.0 109.934 -174.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.8 mt -77.15 -73.62 0.29 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.435 -171.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.604 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 21.7 tptm -119.21 149.2 42.15 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.678 -170.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 31.5 m -134.19 118.69 17.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.023 0.439 . . . . 0.0 111.348 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -109.55 145.66 35.97 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.393 175.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.2 m -105.21 121.39 57.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.543 176.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.76 -126.48 8.47 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.466 -0.874 . . . . 0.0 111.649 -177.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -87.07 119.06 70.83 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.678 0.275 . . . . 0.0 111.074 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -77.37 121.62 5.73 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.42 2.08 . . . . 0.0 111.091 172.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -60.73 112.0 1.85 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.3 0.571 . . . . 0.0 110.304 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.57 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 81.3 m-85 -59.47 -29.64 67.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.317 -0.856 . . . . 0.0 113.024 -171.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -57.05 -53.93 40.78 Favored Glycine 0 C--O 1.237 0.289 0 C-N-CA 120.156 -1.021 . . . . 0.0 112.081 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.599 ' HA ' ' HG2' ' A' ' 131' ' ' GLN . 5.9 ttpm? -80.18 -28.22 38.78 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.57 ' HB3' ' HA ' ' A' ' 126' ' ' PHE . 48.7 tp -61.15 -47.58 85.53 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 177.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -62.45 -48.84 77.86 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.369 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.599 ' HG2' ' HA ' ' A' ' 128' ' ' LYS . 4.2 pt20 -68.47 -31.4 70.66 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.494 -178.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -71.79 -39.14 70.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.73 0.3 . . . . 0.0 110.338 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 80.4 mt -67.82 -39.37 81.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 173.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -63.56 -27.9 69.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.47 176.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 88.1 m -64.16 -45.73 87.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.335 -0.393 . . . . 0.0 109.96 174.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.171 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.29 176.303 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.516 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -66.02 137.99 57.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.884 -178.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.8 m -143.69 94.48 2.6 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.195 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.411 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 1.5 pt? -119.96 156.48 54.33 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-O 120.555 0.217 . . . . 0.0 110.581 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.592 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 3.7 Cg_exo -77.37 144.48 23.02 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 123.046 2.497 . . . . 0.0 112.416 178.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.418 ' HA ' ' HG2' ' A' ' 88' ' ' MET . 2.3 p30 -95.7 -176.88 3.87 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 175.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.551 HD11 HG12 ' A' ' 74' ' ' VAL . 63.2 mt -60.33 -20.75 60.51 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -173.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -76.77 -11.39 59.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.821 0.343 . . . . 0.0 110.771 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.7 16.55 58.19 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.839 -0.695 . . . . 0.0 112.377 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 11' ' ' PRO . 21.0 pttp -114.84 151.23 34.25 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 177.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.592 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 23.6 m -93.57 123.63 37.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.015 0.436 . . . . 0.0 112.083 -174.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.4 m -97.81 153.65 3.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 173.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.2 p -141.01 -178.5 5.59 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.198 0.523 . . . . 0.0 111.326 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.462 ' N ' HD22 ' A' ' 20' ' ' ASN . 0.9 OUTLIER -68.54 -22.0 64.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.583 177.639 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.48 -31.75 72.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.051 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -70.69 -20.82 62.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.016 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.594 HD13 HG21 ' A' ' 110' ' ' ILE . 24.6 mt -83.26 -22.04 33.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.126 -174.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -62.92 144.37 56.82 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.631 -173.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.67 -25.24 4.02 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.791 -0.641 . . . . 0.0 113.847 173.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -121.26 -176.01 3.19 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 122.412 -0.464 . . . . 0.0 110.626 -174.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.2 t -108.46 141.89 22.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 175.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.602 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 33.1 m -133.93 137.98 45.21 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.83 0.347 . . . . 0.0 111.281 -174.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.578 HD11 ' HB2' ' A' ' 107' ' ' SER . 52.3 tp -109.63 107.51 17.59 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.23 175.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.669 ' HB ' ' CG2' ' A' ' 108' ' ' VAL . 50.6 mt -93.74 112.41 26.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 172.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -119.82 124.22 45.59 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.872 0.368 . . . . 0.0 110.862 -176.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.406 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 95.9 m-85 -90.47 125.43 35.58 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.827 -178.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.557 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 10.5 p-90 -146.17 -174.06 4.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.057 -178.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -156.92 146.57 15.39 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 172.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.446 ' HG3' ' HA ' ' A' ' 74' ' ' VAL . 78.3 Cg_exo -43.96 -59.17 1.15 Allowed 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 123.781 2.988 . . . . 0.0 114.744 -175.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.3 t -83.44 24.78 0.8 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.99 0.424 . . . . 0.0 111.322 -173.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 54.0 t -75.62 132.84 74.49 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.346 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -61.88 -19.01 64.17 Favored 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 122.662 2.242 . . . . 0.0 112.022 176.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.97 -10.98 84.08 Favored Glycine 0 C--O 1.224 -0.521 0 C-N-CA 121.226 -0.511 . . . . 0.0 112.99 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 25.4 p -58.12 -39.37 78.51 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 117.213 0.506 . . . . 0.0 111.648 -175.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.1 p -62.24 -34.42 63.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.855 0.36 . . . . 0.0 110.929 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.8 m -88.03 -54.72 4.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.052 0.453 . . . . 0.0 111.03 178.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.402 ' O ' HG12 ' A' ' 47' ' ' ILE . 73.7 mm-40 -66.27 -50.14 64.75 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -172.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.726 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 49.6 tpp -53.3 -55.53 33.48 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -168.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.726 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 24.5 Cg_exo -64.51 -36.02 45.62 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 121.822 1.682 . . . . 0.0 112.264 178.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -64.36 -40.06 95.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.577 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 43' ' ' GLU . 30.5 mm -60.87 -46.68 95.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.699 177.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 49.2 mm -55.66 -53.32 38.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.43 -177.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -69.37 -43.11 74.21 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.606 -174.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.3 m -65.26 -44.92 86.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.994 0.426 . . . . 0.0 110.921 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.52 ' HB1' HG21 ' A' ' 61' ' ' VAL . . . -65.65 -42.84 90.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.806 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -56.26 -40.05 73.59 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.51 -178.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -68.38 -51.14 47.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.341 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 1.006 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 60.5 m-85 -74.8 -28.99 60.95 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -174.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -59.44 -27.02 65.69 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 122.479 0.312 . . . . 0.0 111.61 -177.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -73.92 -22.51 59.66 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -172.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 1.006 ' HE2' ' HA ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -95.78 -62.08 1.35 Allowed 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.625 176.121 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 176.96 68.46 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.806 0.813 . . . . 0.0 111.303 -173.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.506 ' HZ ' ' HB2' ' A' ' 29' ' ' LEU . 41.2 t80 -135.83 132.43 36.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.287 -178.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -105.89 143.07 34.55 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.52 HG21 ' HB1' ' A' ' 51' ' ' ALA . 43.7 t -122.8 115.38 45.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.087 -177.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 88.5 mt -116.69 95.91 5.25 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.335 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.07 105.46 17.83 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 43.0 t -98.94 114.09 35.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 120.969 0.414 . . . . 0.0 110.564 -175.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.557 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -82.71 117.57 22.73 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.723 176.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.623 ' HG3' HG12 ' A' ' 68' ' ' ILE . 3.5 pt20 -74.1 163.43 68.39 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.965 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.604 ' HD2' ' HB2' ' A' ' 66' ' ' GLN . 72.1 Cg_endo -74.91 55.09 3.79 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.735 2.29 . . . . 0.0 114.035 -172.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.623 HG12 ' HG3' ' A' ' 66' ' ' GLN . 50.0 mm -93.12 -69.99 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 172.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -81.74 153.55 70.37 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.779 176.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -61.26 157.26 41.05 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.479 2.119 . . . . 0.0 112.33 177.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.0 tp -57.26 -31.3 37.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.917 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -64.54 -42.92 95.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.532 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.3 m -63.27 -34.76 78.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.814 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.551 HG12 HD11 ' A' ' 13' ' ' LEU . 34.8 t -64.13 -44.92 97.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.17 176.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -65.53 -34.62 78.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.651 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -62.48 -41.78 99.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.888 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.88 -43.1 97.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.751 -0.204 . . . . 0.0 110.863 178.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.563 ' HA ' HD12 ' A' ' 83' ' ' LEU . 42.1 t -63.16 -37.44 79.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.156 0.503 . . . . 0.0 110.345 176.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.0 tttm -61.97 -55.25 31.32 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.655 0.74 . . . . 0.0 111.141 176.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.03 -39.39 69.16 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.539 -1.21 . . . . 0.0 113.204 -173.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -104.99 0.76 28.02 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -174.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.05 -82.25 1.68 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.192 177.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.563 HD12 ' HA ' ' A' ' 78' ' ' VAL . 54.6 mt 61.59 93.33 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.417 0.627 . . . . 0.0 112.523 171.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -87.33 2.36 6.84 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 123.11 2.54 . . . . 0.0 113.667 -177.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -90.91 166.02 13.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.636 0.255 . . . . 0.0 110.625 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 20.2 m -77.04 113.52 14.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.069 0.462 . . . . 0.0 110.908 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.407 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 14.8 t -107.67 125.49 64.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.599 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.418 ' HG2' ' HA ' ' A' ' 12' ' ' ASP . 72.4 mtm -116.67 173.09 6.82 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.149 177.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -132.04 122.55 25.66 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.865 0.364 . . . . 0.0 110.245 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.544 ' HB3' ' HA ' ' A' ' 66' ' ' GLN . 45.8 t0 -82.81 119.23 24.1 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 176.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.74 -42.44 61.12 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -171.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -126.89 15.26 7.43 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.527 0.203 . . . . 0.0 111.124 -174.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.413 ' NZ ' ' HB3' ' A' ' 93' ' ' LYS . 5.9 ttpm? 68.35 20.34 8.68 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.544 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -77.23 -25.65 51.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.967 -174.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 41.0 t -74.82 -40.47 46.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.93 -38.9 96.07 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.485 173.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -68.72 -26.48 65.28 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 122.546 0.338 . . . . 0.0 111.173 176.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.94 -47.03 72.91 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.832 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -82.89 -26.9 31.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.484 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 95.64 55.4 1.33 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.404 178.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.452 HG22 HG21 ' A' ' 106' ' ' THR . 21.3 p -63.31 112.14 2.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.085 0.469 . . . . 0.0 111.71 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -77.52 -58.16 3.42 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.014 177.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.466 HG12 ' HB ' ' A' ' 121' ' ' VAL . 7.8 p -145.71 147.44 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.656 -175.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.485 ' HA ' ' C ' ' A' ' 105' ' ' PRO . 76.5 m-85 -102.54 147.44 34.02 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.036 -174.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.485 ' C ' ' HA ' ' A' ' 104' ' ' TYR . 38.1 Cg_endo -70.06 154.45 94.07 Favored 'Cis proline' 0 C--N 1.346 0.436 0 C-N-CA 123.305 -1.54 . . . . 0.0 112.838 0.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.452 HG21 HG22 ' A' ' 101' ' ' THR . 24.7 m -121.7 112.45 18.42 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.163 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.578 ' HB2' HD11 ' A' ' 29' ' ' LEU . 5.4 p -110.49 114.18 27.4 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.271 0.558 . . . . 0.0 111.176 -177.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.669 ' CG2' ' HB ' ' A' ' 30' ' ' ILE . 17.2 m -105.74 142.33 19.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.058 0.456 . . . . 0.0 110.737 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.554 ' HB2' ' HB2' ' A' ' 118' ' ' LYS . 81.5 mt -102.35 125.36 49.04 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.715 -177.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.602 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 12.1 mm -103.95 137.18 33.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.717 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -86.85 -167.6 43.91 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.274 -177.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.8 mttm -86.97 34.44 0.67 Allowed 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 122.003 0.906 . . . . 0.0 108.967 -175.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.519 ' HB3' ' OE1' ' A' ' 115' ' ' GLU . 29.0 mmtm -148.59 -35.46 0.2 Allowed 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 114.206 -1.361 . . . . 0.0 110.846 -165.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 113.65 -28.7 8.35 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -174.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.519 ' OE1' ' HB3' ' A' ' 113' ' ' LYS . 1.2 mp0 -54.61 141.23 32.48 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 114.89 -0.655 . . . . 0.0 110.944 176.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 6.7 mt -80.19 122.96 36.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.592 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.6 mt -98.88 -60.53 1.52 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.048 0.451 . . . . 0.0 111.466 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.554 ' HB2' ' HB2' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -124.95 159.22 31.71 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.989 -170.542 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 57.9 m -141.13 103.58 4.48 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.414 170.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -92.46 131.87 37.25 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.4 176.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.466 ' HB ' HG12 ' A' ' 103' ' ' VAL . 6.0 m -101.22 116.04 44.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.906 178.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 83.48 -106.82 2.86 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.191 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -89.68 114.11 59.35 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-O 120.524 0.202 . . . . 0.0 110.783 -176.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.24 98.34 0.92 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.375 2.05 . . . . 0.0 111.85 175.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -49.67 111.97 0.58 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.92 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.403 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 80.8 m-85 -66.73 -34.11 77.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.179 -175.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -60.12 -52.18 54.32 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.597 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.581 ' HA ' ' HG2' ' A' ' 131' ' ' GLN . 25.9 mtmm -76.86 -24.31 52.65 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.678 -0.261 . . . . 0.0 110.837 178.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.439 ' O ' HG13 ' A' ' 133' ' ' ILE . 53.5 tp -62.48 -48.76 78.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.913 0.387 . . . . 0.0 110.087 175.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -63.3 -46.22 87.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.412 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.581 ' HG2' ' HA ' ' A' ' 128' ' ' LYS . 13.5 pt20 -70.93 -34.13 71.2 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.418 -176.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.411 ' O ' ' HB ' ' A' ' 135' ' ' THR . 20.3 tt0 -78.96 -31.88 45.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.57 0.224 . . . . 0.0 110.746 -177.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 129' ' ' LEU . 59.0 mt -61.28 -47.52 93.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 172.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -60.14 -32.98 71.54 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.594 175.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 132' ' ' GLU . 69.9 m -57.25 -52.06 66.86 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.856 0.36 . . . . 0.0 110.459 177.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 121.32 0.581 . . . . 0.0 110.616 178.182 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.235 0 CA-C-O 120.909 0.385 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.438 ' HZ ' HD11 ' A' ' 23' ' ' LEU . 34.3 p90 -114.33 140.95 48.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.222 0.534 . . . . 0.0 111.005 -176.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.5 t -139.7 90.22 2.38 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 173.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.552 HD22 ' HD2' ' A' ' 11' ' ' PRO . 1.8 tm? -116.9 119.83 34.76 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.261 -166.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.565 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 40.0 Cg_endo -68.41 128.48 17.37 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.749 2.299 . . . . 0.0 112.213 176.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.557 ' HA ' ' HG3' ' A' ' 88' ' ' MET . 0.0 OUTLIER -62.67 164.91 7.05 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.416 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 87' ' ' VAL . 4.2 pp -66.3 -18.22 65.22 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.668 -172.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 16.6 t-80 -84.7 -25.95 28.03 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.926 0.393 . . . . 0.0 110.373 176.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.475 ' C ' ' HE2' ' A' ' 16' ' ' LYS . . . 123.6 8.54 6.28 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.572 -0.823 . . . . 0.0 113.735 174.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.475 ' HE2' ' C ' ' A' ' 15' ' ' GLY . 0.8 OUTLIER -94.55 120.31 34.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 117.378 0.589 . . . . 0.0 110.612 179.147 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 10.3 m -67.28 126.09 28.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.448 -177.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.534 HG12 ' O ' ' A' ' 10' ' ' LEU . 1.7 p -116.55 135.31 57.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 177.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.5 m -146.54 -173.08 4.11 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 122.11 -0.369 . . . . 0.0 111.303 -177.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -54.81 -39.66 68.73 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -176.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.04 -27.21 66.74 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -177.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -73.2 -25.93 60.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.021 0.438 . . . . 0.0 110.515 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.582 HD22 HG21 ' A' ' 28' ' ' THR . 33.5 mt -83.39 -51.7 7.16 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.087 -176.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.4 ' HB3' HE21 ' A' ' 24' ' ' GLN . 3.3 pt20 -56.11 130.92 46.09 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.367 -172.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.76 -25.15 28.45 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.104 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.585 ' HG2' ' OD1' ' A' ' 58' ' ' ASN . 8.1 mtpm? -124.49 172.97 8.77 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -177.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.405 ' HB ' ' HD1' ' A' ' 59' ' ' PHE . 11.1 t -103.82 139.71 24.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 176.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.805 HG23 HD13 ' A' ' 62' ' ' LEU . 85.2 m -126.73 139.14 53.36 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -168.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.718 ' HB2' ' CE2' ' A' ' 59' ' ' PHE . 27.0 tp -110.02 107.37 17.23 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.74 172.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.554 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 28.6 mt -98.62 111.35 28.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.316 173.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -109.29 122.84 48.22 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.106 -177.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.436 ' CE1' ' HA2' ' A' ' 96' ' ' GLY . 97.2 m-85 -91.15 118.93 30.84 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.86 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.664 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 10.6 p-90 -148.5 -178.86 6.56 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.829 -177.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.558 ' O ' ' HB2' ' A' ' 37' ' ' CYS . 41.0 p90 -155.09 144.84 15.49 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 178.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.838 ' HG2' ' HB3' ' A' ' 69' ' ' ASP . 12.4 Cg_endo -59.71 152.03 65.98 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.168 1.912 . . . . 0.0 111.433 174.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.9 m 68.89 18.81 8.46 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 123.529 0.518 . . . . 0.0 111.091 -177.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.558 ' HB2' ' O ' ' A' ' 34' ' ' PHE . 45.1 t -68.33 140.45 92.8 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.452 -178.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -72.61 -22.96 20.27 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.821 2.347 . . . . 0.0 111.893 173.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.3 -1.21 88.08 Favored Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.923 -0.581 . . . . 0.0 113.147 -176.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.43 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 90.9 m -56.92 -30.4 63.94 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.876 0.338 . . . . 0.0 111.672 -177.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.4 t -49.97 -50.11 19.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.081 0.467 . . . . 0.0 110.641 177.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.4 m -87.2 -54.87 4.08 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.05 177.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.506 ' HA ' ' HD3' ' A' ' 46' ' ' LYS . 49.3 mm-40 -59.79 -40.85 89.7 Favored 'General case' 0 C--O 1.226 -0.139 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -168.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.817 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -59.12 -60.86 9.17 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -169.667 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.817 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 19.5 Cg_exo -67.11 -29.48 39.77 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 121.958 1.772 . . . . 0.0 111.488 178.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.506 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 64.8 tttt -59.79 -42.91 94.42 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.09 177.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.435 HG12 ' O ' ' A' ' 43' ' ' GLU . 41.0 mm -71.63 -38.95 68.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.352 177.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.722 HD13 ' HE2' ' A' ' 85' ' ' PHE . 47.6 mm -55.46 -53.63 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.2 -179.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -66.03 -49.33 68.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.287 -178.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 31.6 m -61.8 -54.67 39.12 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.782 -174.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.52 -33.59 73.03 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -173.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -75.79 -40.48 55.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.816 0.341 . . . . 0.0 111.173 -178.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -70.93 -42.99 69.12 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.844 0.354 . . . . 0.0 110.769 -176.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.617 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 42.8 m-85 -76.06 -10.32 59.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.714 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -56.71 -27.65 59.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.041 0.448 . . . . 0.0 110.954 -178.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -102.89 14.81 31.04 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.519 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.591 ' HD3' ' HA ' ' A' ' 54' ' ' TYR . 13.6 mptt -111.62 23.49 13.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.755 176.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.585 ' OD1' ' HG2' ' A' ' 26' ' ' LYS . 66.2 t30 68.11 18.46 9.37 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 122.078 0.942 . . . . 0.0 109.795 -176.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.718 ' CE2' ' HB2' ' A' ' 29' ' ' LEU . 38.5 t80 -100.03 162.01 13.25 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.557 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -150.42 152.55 34.5 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.248 0.547 . . . . 0.0 112.064 -177.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 1.026 HG11 ' HB3' ' A' ' 85' ' ' PHE . 1.5 p -101.08 125.88 54.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 114.816 -1.083 . . . . 0.0 111.119 -178.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.805 HD13 HG23 ' A' ' 28' ' ' THR . 8.7 mp -128.63 94.31 3.83 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 169.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -101.05 102.01 12.9 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.546 -176.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.979 HG12 ' HB2' ' A' ' 88' ' ' MET . 26.7 m -97.08 127.47 49.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.441 0.638 . . . . 0.0 111.118 -176.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.664 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -95.2 135.83 36.28 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.676 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.679 ' HB2' ' HG2' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -95.2 161.47 28.0 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 175.231 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.607 ' HD2' ' HB2' ' A' ' 66' ' ' GLN . 73.8 Cg_endo -74.04 54.03 3.05 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.903 2.402 . . . . 0.0 114.555 -168.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 45.7 mm -83.27 -27.85 7.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 170.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.838 ' HB3' ' HG2' ' A' ' 35' ' ' PRO . 0.6 OUTLIER -138.89 136.17 18.24 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 173.44 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -51.83 163.98 1.18 Allowed 'Trans proline' 0 N--CA 1.477 0.553 0 C-N-CA 123.509 2.806 . . . . 0.0 114.587 -175.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.8 tp -56.73 -34.92 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.574 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -66.47 -35.47 80.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.195 0.522 . . . . 0.0 110.419 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 27.3 m -64.89 -47.69 76.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.306 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.491 ' HB ' ' HG3' ' A' ' 35' ' ' PRO . 9.2 p -67.18 -33.95 66.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.652 0.263 . . . . 0.0 110.814 -178.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -65.89 -37.54 86.39 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.005 0.431 . . . . 0.0 110.993 176.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -69.76 -36.55 75.89 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -64.2 -50.75 66.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.979 -178.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.635 HG23 ' HB2' ' A' ' 83' ' ' LEU . 10.4 p -60.5 -30.21 46.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-O 120.754 0.312 . . . . 0.0 110.643 178.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -70.67 -55.37 8.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.239 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -66.25 -48.38 70.7 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.117 -174.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -82.55 -18.41 41.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.441 -176.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 69.08 63.74 3.31 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.98 177.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.635 ' HB2' HG23 ' A' ' 78' ' ' VAL . 8.4 mp -87.64 111.03 39.21 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 120.633 0.254 . . . . 0.0 110.383 178.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -89.98 24.54 0.62 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.899 2.399 . . . . 0.0 113.168 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 1.026 ' HB3' HG11 ' A' ' 61' ' ' VAL . 13.0 m-85 -121.15 155.28 34.85 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.1 m -68.2 123.56 21.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.1 0.476 . . . . 0.0 111.86 -173.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.448 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 48.7 t -122.62 135.19 63.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.822 -178.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.979 ' HB2' HG12 ' A' ' 64' ' ' VAL . 2.3 mpt? -117.13 175.5 5.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 93.6 t80 -138.51 117.18 12.21 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.241 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.598 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 21.1 t0 -103.98 114.26 28.38 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.0 -14.87 61.09 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -174.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -122.4 0.67 9.49 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.46 -175.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.679 ' HG2' ' HB2' ' A' ' 66' ' ' GLN . 49.3 mtmt 64.37 15.1 9.28 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 123.58 0.55 . . . . 0.0 109.903 -171.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.9 -44.27 93.47 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -165.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.545 HG22 ' OD2' ' A' ' 90' ' ' ASP . 28.2 m -74.14 -29.32 24.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.231 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.436 ' HA2' ' CE1' ' A' ' 32' ' ' PHE . . . -72.1 -34.78 61.3 Favored Glycine 0 CA--C 1.509 -0.282 0 C-N-CA 120.541 -0.837 . . . . 0.0 111.29 174.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.606 ' HA ' HE21 ' A' ' 97' ' ' GLN . 0.0 OUTLIER -71.03 -28.84 64.69 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.007 -0.596 . . . . 0.0 110.224 174.652 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.21 -22.71 59.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.233 175.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -87.65 -22.91 24.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.998 176.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 93.23 62.99 1.09 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.574 176.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.9 p -103.95 127.16 51.49 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.878 0.371 . . . . 0.0 111.244 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -87.81 -50.75 6.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.127 0.489 . . . . 0.0 110.31 176.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.4 p -145.08 149.15 17.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.087 -176.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.556 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 59.2 m-85 -106.21 161.46 22.78 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.215 -176.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.556 ' HA ' ' HB3' ' A' ' 104' ' ' TYR . 74.4 Cg_endo -74.39 165.5 85.24 Favored 'Cis proline' 0 C--N 1.351 0.684 0 C-N-CA 123.772 -1.345 . . . . 0.0 113.233 0.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.3 m -139.77 132.44 28.92 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.623 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.546 ' HB3' ' HB2' ' A' ' 120' ' ' TYR . 18.8 t -112.33 112.15 23.52 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.697 HG22 HG22 ' A' ' 119' ' ' THR . 55.5 t -105.99 131.6 55.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.898 0.38 . . . . 0.0 111.489 -175.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 90.2 mt -102.98 125.73 49.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.997 177.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.566 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 53.6 mt -118.05 141.09 38.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 123.445 0.466 . . . . 0.0 110.715 -179.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -85.8 -167.17 43.11 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 116.155 -0.475 . . . . 0.0 113.574 -177.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.4 -20.58 50.87 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -173.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.416 ' HB3' ' CD ' ' A' ' 115' ' ' GLU . 3.7 ttmp? -99.17 -3.18 35.01 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.554 0.692 . . . . 0.0 109.2 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 97.29 12.64 48.01 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.67 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.416 ' CD ' ' HB3' ' A' ' 113' ' ' LYS . 3.7 mp0 -68.15 122.15 17.68 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -178.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 29.8 mt -74.01 93.76 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 174.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 93.4 mt -75.38 -70.3 0.43 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.596 -171.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.452 ' HD2' ' HA ' ' A' ' 118' ' ' LYS . 22.7 mmmt -125.44 144.72 50.4 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.148 -171.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.697 HG22 HG22 ' A' ' 108' ' ' VAL . 1.6 p -120.99 104.16 9.59 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.374 175.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.546 ' HB2' ' HB3' ' A' ' 107' ' ' SER . 22.6 m-85 -85.05 103.43 14.07 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.87 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.6 t -83.0 109.74 17.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.988 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 86.31 -116.83 4.48 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.375 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.453 ' OE1' ' HD2' ' A' ' 124' ' ' PRO . 7.1 tp10 -103.72 116.63 61.49 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-O 120.531 0.205 . . . . 0.0 110.812 -174.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.492 ' HB3' ' CG ' ' A' ' 120' ' ' TYR . 93.2 Cg_endo -86.54 -159.58 0.1 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 123.027 2.485 . . . . 0.0 112.254 175.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.848 ' HB3' ' HG2' ' A' ' 128' ' ' LYS . 18.2 t70 -125.27 124.27 41.29 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.861 177.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -65.54 -37.53 86.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.504 -175.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.77 -50.98 55.69 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.201 -178.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.848 ' HG2' ' HB3' ' A' ' 125' ' ' ASP . 11.9 ptmm? -67.5 -26.13 66.19 Favored 'General case' 0 C--O 1.221 -0.443 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.184 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 51.4 tp -61.08 -47.36 86.69 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.233 0.333 . . . . 0.0 110.224 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -62.24 -54.48 40.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.149 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.492 ' HG2' ' HA ' ' A' ' 128' ' ' LYS . 13.7 pt20 -65.99 -33.88 76.82 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -175.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -71.02 -45.78 63.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.477 0.18 . . . . 0.0 110.69 -177.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 72.7 mt -66.51 -36.26 76.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 177.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -61.46 -47.87 83.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.61 175.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 45.0 m -55.57 -35.23 65.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.185 0.517 . . . . 0.0 110.328 176.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.162 -178.085 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.564 0 CA-C-O 121.651 0.739 . . . . 0.0 112.893 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -141.78 131.58 24.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.912 171.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 26.0 p -149.35 103.09 3.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.868 0.365 . . . . 0.0 110.921 -179.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.451 ' H ' HD23 ' A' ' 10' ' ' LEU . 1.6 pt? -120.1 157.27 53.49 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.766 178.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.13 150.65 26.33 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 121.992 1.795 . . . . 0.0 112.228 177.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.591 ' HA ' ' HG3' ' A' ' 88' ' ' MET . 0.0 OUTLIER -81.41 176.6 9.57 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.035 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 87' ' ' VAL . 78.4 mt -57.42 -26.25 60.85 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -177.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 47.4 t60 -91.29 -40.84 11.27 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 121.355 -0.138 . . . . 0.0 110.783 178.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.93 4.01 0.87 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.063 -1.065 . . . . 0.0 113.804 176.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -78.47 126.74 31.19 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 117.468 0.634 . . . . 0.0 110.212 178.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.7 m -66.97 130.51 43.38 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.851 0.358 . . . . 0.0 110.12 176.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 9' ' ' SER . 9.8 p -118.21 138.13 49.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.0 p -138.69 -177.63 4.95 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.312 0.577 . . . . 0.0 112.091 -173.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -71.36 -21.7 62.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.665 175.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.65 -31.34 72.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.682 178.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -63.72 -23.26 67.3 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.805 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.62 HD22 HG21 ' A' ' 28' ' ' THR . 25.0 mt -84.06 -20.53 32.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.125 -172.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.418 ' HA ' ' OE1' ' A' ' 24' ' ' GLN . 14.7 mm-40 -60.82 113.09 2.31 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -172.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 113.23 -19.57 19.97 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.341 174.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.449 ' HB2' ' OE1' ' A' ' 60' ' ' GLN . 68.0 mttm -124.87 169.84 11.65 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.036 0.418 . . . . 0.0 110.945 -176.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.612 HG13 ' CD1' ' A' ' 59' ' ' PHE . 3.3 p -102.63 123.77 56.18 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.625 -177.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.62 HG21 HD22 ' A' ' 23' ' ' LEU . 39.0 m -116.01 142.99 46.07 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -160.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.498 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 55.7 tp -112.04 111.04 21.67 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.712 170.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.596 ' HB ' ' HB ' ' A' ' 108' ' ' VAL . 62.8 mt -97.9 111.96 28.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 171.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -112.73 122.39 47.54 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.5 -176.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.505 ' HB2' ' HB ' ' A' ' 106' ' ' THR . 89.5 m-85 -94.85 119.89 34.16 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.515 178.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.557 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 18.0 p-90 -147.54 175.33 10.93 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.338 -177.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -154.43 145.04 16.02 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 174.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.526 ' HG2' ' HB3' ' A' ' 69' ' ' ASP . 6.0 Cg_exo -39.12 -66.3 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 124.323 3.349 . . . . 0.0 114.419 -173.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.8 m -77.12 57.12 1.35 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.005 0.431 . . . . 0.0 112.049 -178.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.3 t -117.27 132.74 23.36 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.292 177.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.588 ' O ' HG12 ' A' ' 41' ' ' VAL . 31.4 Cg_exo -60.42 -20.05 61.6 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.565 2.177 . . . . 0.0 112.174 176.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.69 -22.46 78.68 Favored Glycine 0 C--O 1.224 -0.521 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.76 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.682 ' HA ' ' HG3' ' A' ' 44' ' ' MET . 64.1 m -60.36 -35.08 74.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.912 0.356 . . . . 0.0 111.464 -177.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.588 HG12 ' O ' ' A' ' 38' ' ' PRO . 13.5 p -67.33 -40.23 84.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.168 -176.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.8 p -89.25 -49.72 6.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.942 0.401 . . . . 0.0 111.894 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.511 ' O ' HG12 ' A' ' 47' ' ' ILE . 27.0 mm-40 -80.18 -41.2 25.75 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -168.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.682 ' HG3' ' HA ' ' A' ' 40' ' ' CYS . 59.0 mtp -58.28 -49.46 93.46 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -172.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -59.12 -36.37 96.1 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 121.945 1.763 . . . . 0.0 111.811 175.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.419 ' HB3' ' O ' ' A' ' 43' ' ' GLU . 33.7 ttmt -63.42 -38.04 89.6 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.162 177.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.511 HG12 ' O ' ' A' ' 43' ' ' GLU . 46.0 mm -67.4 -35.41 73.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.202 176.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.519 HG12 ' O ' ' A' ' 44' ' ' MET . 47.2 mm -54.73 -52.36 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.616 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.432 ' C ' ' HD3' ' A' ' 49' ' ' LYS . 12.7 tmtt? -59.65 -56.25 24.25 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.892 178.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 27.7 m -54.02 -51.96 62.34 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.903 -174.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.569 ' HB1' HG11 ' A' ' 61' ' ' VAL . . . -68.91 -44.76 72.51 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.138 -174.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -75.82 -37.35 59.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.737 -173.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -74.48 -52.45 11.94 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -175.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -78.62 -2.87 41.06 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.82 0.343 . . . . 0.0 111.244 -175.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 24.0 tptm -59.58 -35.74 74.87 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.245 177.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -88.6 2.9 52.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.626 -177.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -96.19 -66.16 0.92 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.327 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 66.2 t30 174.63 18.59 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.436 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.612 ' CD1' HG13 ' A' ' 27' ' ' VAL . 20.7 t80 -104.03 148.47 26.19 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.236 -172.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.449 ' OE1' ' HB2' ' A' ' 26' ' ' LYS . 51.1 mt-30 -122.89 150.9 42.3 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.01 0.524 . . . . 0.0 109.967 178.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.569 HG11 ' HB1' ' A' ' 51' ' ' ALA . 5.9 p -127.1 121.06 56.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 121.175 0.512 . . . . 0.0 110.594 177.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 8.6 mp -126.77 96.31 4.61 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.443 177.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.55 113.36 25.6 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.536 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 63.7 t -98.19 116.39 40.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.026 0.441 . . . . 0.0 110.132 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.557 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -87.7 121.56 30.28 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.789 175.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.701 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 4.8 pm0 -89.65 169.16 13.2 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.701 ' HD2' ' HB2' ' A' ' 66' ' ' GLN . 30.0 Cg_endo -62.26 -138.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 122.701 2.267 . . . . 0.0 113.825 -178.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.539 ' HB ' ' O ' ' A' ' 67' ' ' PRO . 90.6 mt 78.9 -49.36 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 C-N-CA 123.163 0.585 . . . . 0.0 109.771 -173.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.526 ' HB3' ' HG2' ' A' ' 35' ' ' PRO . 0.6 OUTLIER -107.03 138.53 19.85 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 173.249 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 69' ' ' ASP . 33.8 Cg_exo -59.18 158.31 26.53 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.749 2.299 . . . . 0.0 112.821 -178.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.0 tp -62.26 -31.27 51.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.396 -175.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -66.57 -29.2 69.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.905 177.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.1 t -68.48 -40.55 80.92 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.7 t -62.66 -42.74 97.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.209 176.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -62.79 -36.0 81.71 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.176 177.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -61.46 -45.02 96.05 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.825 0.345 . . . . 0.0 110.75 -177.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -63.43 -52.49 61.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.303 -179.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.538 ' HA ' HD13 ' A' ' 83' ' ' LEU . 10.0 p -65.23 -26.53 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-O 121.035 0.445 . . . . 0.0 111.038 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -73.31 -54.77 7.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.356 0.598 . . . . 0.0 110.661 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -73.38 -48.87 30.54 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.862 -172.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -91.77 -4.49 54.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.523 -174.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.08 -58.0 4.59 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.755 177.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.538 HD13 ' HA ' ' A' ' 78' ' ' VAL . 11.2 mp 63.62 95.28 0.05 OUTLIER Pre-proline 0 N--CA 1.466 0.355 0 CA-C-O 121.275 0.56 . . . . 0.0 111.666 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -75.94 10.58 1.97 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.574 2.85 . . . . 0.0 113.07 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -120.38 145.03 47.57 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.2 m -67.68 124.46 23.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.16 -176.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.482 HG21 HD23 ' A' ' 83' ' ' LEU . 33.3 t -118.87 134.38 62.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.702 -179.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.591 ' HG3' ' HA ' ' A' ' 12' ' ' ASP . 3.2 mpp? -123.66 175.25 6.95 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -134.93 125.46 26.73 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.123 -177.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.566 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 56.4 t0 -107.68 111.16 23.23 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 174.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.11 -24.76 60.67 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -174.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.59 7.01 22.27 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.081 -174.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.4 pttp 46.45 32.0 1.47 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.992 0.917 . . . . 0.0 111.563 -179.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.33 -35.12 58.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.661 -173.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.546 HG22 ' OD2' ' A' ' 90' ' ' ASP . 32.6 m -73.44 -29.88 28.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 175.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -68.99 -39.5 84.92 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 172.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -58.83 -32.75 69.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.025 0.44 . . . . 0.0 111.142 175.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.95 -47.7 65.01 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.043 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.469 ' HD2' ' CZ ' ' A' ' 32' ' ' PHE . 30.2 m-85 -81.27 -14.17 57.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.978 -176.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 93.34 38.46 5.34 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.233 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.499 HG23 ' OG1' ' A' ' 106' ' ' THR . 39.9 m -75.9 89.22 2.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.285 0.564 . . . . 0.0 111.18 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 52.5 tp60 -101.44 -57.85 2.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.703 175.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.446 ' CG1' ' HB ' ' A' ' 121' ' ' VAL . 8.4 p -98.95 148.72 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.823 -177.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -114.65 144.28 31.57 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.968 -173.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.505 ' HG3' ' HG3' ' A' ' 43' ' ' GLU . 94.1 Cg_endo -85.58 165.23 55.92 Favored 'Cis proline' 0 N--CA 1.463 -0.279 0 C-N-CA 123.232 -1.57 . . . . 0.0 112.307 -0.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.505 ' HB ' ' HB2' ' A' ' 32' ' ' PHE . 36.5 m -110.45 134.07 52.69 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 176.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.5 m -121.72 110.18 15.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.992 0.425 . . . . 0.0 110.559 -176.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.596 ' HB ' ' HB ' ' A' ' 30' ' ' ILE . 46.4 t -109.41 125.13 66.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.513 -179.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.717 HD11 HD11 ' A' ' 129' ' ' LEU . 85.4 mt -103.4 136.3 43.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.545 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.564 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 51.8 mt -124.49 138.12 55.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 176.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.512 ' O ' ' HA ' ' A' ' 27' ' ' VAL . . . -78.06 -92.98 0.28 Allowed Glycine 0 C--O 1.223 -0.572 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.137 -172.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -144.63 -2.79 0.83 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.402 0.601 . . . . 0.0 111.351 -178.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.474 ' HB2' ' OE2' ' A' ' 115' ' ' GLU . 10.4 mtmp? -126.15 13.74 7.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.816 0.341 . . . . 0.0 110.89 -174.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.02 28.74 73.91 Favored Glycine 0 C--O 1.227 -0.316 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.246 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.512 ' CD ' ' H ' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -90.48 -11.05 41.46 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.856 0.36 . . . . 0.0 110.75 -176.292 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 19.3 mt 62.9 91.67 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.556 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.55 -34.55 72.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.934 -1.03 . . . . 0.0 112.699 -173.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.63 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 2.4 tppp? -155.43 139.87 16.8 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -168.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.56 HG23 HG22 ' A' ' 108' ' ' VAL . 18.3 m -126.07 101.99 7.03 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 120.91 0.386 . . . . 0.0 110.375 170.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.53 ' CD2' ' HB3' ' A' ' 124' ' ' PRO . 41.9 m-85 -94.07 137.69 32.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.285 173.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.446 ' HB ' ' CG1' ' A' ' 103' ' ' VAL . 3.7 m -102.59 108.9 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-O 121.247 0.546 . . . . 0.0 109.737 170.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 99.85 -162.91 19.38 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.341 -0.703 . . . . 0.0 111.341 -174.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -83.09 125.88 73.71 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.812 0.306 . . . . 0.0 110.352 176.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.53 ' HB3' ' CD2' ' A' ' 120' ' ' TYR . 96.5 Cg_endo -80.1 175.13 10.69 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.726 2.284 . . . . 0.0 112.435 177.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.485 ' HB2' ' HB3' ' A' ' 128' ' ' LYS . 7.1 m-20 -65.52 110.43 2.7 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 173.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -63.39 -39.7 95.23 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -170.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -73.21 -46.82 25.77 Favored Glycine 0 C--O 1.237 0.338 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.856 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.485 ' HB3' ' HB2' ' A' ' 125' ' ' ASP . 51.1 tttm -60.71 -36.86 79.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.653 0.263 . . . . 0.0 110.476 177.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.717 HD11 HD11 ' A' ' 109' ' ' LEU . 28.0 tp -58.92 -46.85 86.93 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.719 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -56.54 -45.29 81.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.848 0.356 . . . . 0.0 110.803 178.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -68.4 -37.23 80.16 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.865 -178.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.505 ' HG2' ' HA ' ' A' ' 129' ' ' LEU . 8.9 pt-20 -77.02 -23.65 52.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.78 0.324 . . . . 0.0 110.145 -179.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.2 mp -62.64 -48.72 86.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.017 172.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -61.89 -34.93 76.93 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.273 0.559 . . . . 0.0 110.316 177.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 35.6 m -60.65 -40.84 93.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.376 178.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.239 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.986 177.922 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.573 ' HA ' ' HB2' ' A' ' 20' ' ' ASN . . . . . . . . 0 N--CA 1.455 -0.221 0 CA-C-O 121.146 0.498 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.423 ' CZ ' HD11 ' A' ' 23' ' ' LEU . 50.3 p90 -86.43 148.68 25.45 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 176.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.9 t -149.56 88.76 1.58 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.529 ' H ' HD23 ' A' ' 10' ' ' LEU . 2.4 pt? -123.14 147.11 50.9 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.582 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.644 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 16.5 Cg_exo -68.67 132.23 24.66 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.445 2.097 . . . . 0.0 110.928 172.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.602 ' HA ' ' HG2' ' A' ' 88' ' ' MET . 0.0 OUTLIER -70.43 171.08 10.66 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.055 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.558 HD23 HG21 ' A' ' 78' ' ' VAL . 13.5 tp -81.54 10.38 5.99 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-O 121.403 0.621 . . . . 0.0 111.291 -171.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.453 ' H ' ' CG ' ' A' ' 12' ' ' ASP . 77.3 m80 -109.58 -27.52 9.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.48 170.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 124.13 16.69 3.17 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.687 177.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.468 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 59.0 mttp -112.8 115.39 28.41 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 122.649 -0.324 . . . . 0.0 110.619 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.644 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 35.4 m -61.16 127.22 30.48 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.987 0.423 . . . . 0.0 111.574 -178.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.7 t -111.69 125.81 69.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 174.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.8 p -131.51 175.25 9.31 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.196 0.522 . . . . 0.0 111.433 -176.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.573 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . 4.7 t-20 -58.17 -31.44 67.26 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.094 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.47 -28.09 67.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.651 -178.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -74.1 -18.66 60.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.212 0.53 . . . . 0.0 110.605 -177.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.465 HD12 HD22 ' A' ' 20' ' ' ASN . 79.9 mt -79.4 -19.73 49.35 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.434 -178.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -71.01 98.58 1.65 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.699 -172.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.59 -8.23 19.93 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.711 175.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 112' ' ' LYS . 56.2 mttm -115.98 167.47 10.93 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.415 ' HB ' ' HD2' ' A' ' 59' ' ' PHE . 22.5 t -104.12 139.81 24.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 174.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.796 HG23 ' HG3' ' A' ' 60' ' ' GLN . 4.6 m -129.81 142.23 50.72 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.042 0.448 . . . . 0.0 112.095 -166.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.685 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 7.4 tt -123.69 105.75 9.96 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 171.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.69 ' HB ' ' CG1' ' A' ' 108' ' ' VAL . 61.2 mt -97.49 115.1 36.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.459 ' HA ' ' O ' ' A' ' 106' ' ' THR . 27.4 t-20 -109.5 113.43 26.22 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.366 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.517 ' HE1' HG23 ' A' ' 95' ' ' VAL . 90.4 m-85 -81.92 119.71 24.29 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 175.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 9.7 p-90 -141.78 -179.06 5.97 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.287 0.565 . . . . 0.0 110.775 -175.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -158.12 149.94 17.18 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.766 174.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -63.04 170.08 8.11 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.445 2.097 . . . . 0.0 111.972 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.8 m 63.5 5.58 2.18 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.985 178.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 51.7 t -84.65 131.11 50.69 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.771 0.319 . . . . 0.0 111.046 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -61.62 -22.43 74.41 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.805 2.337 . . . . 0.0 112.112 176.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.37 -19.1 66.18 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.312 -0.471 . . . . 0.0 112.644 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 72.0 m -62.17 -33.41 74.46 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.663 0.268 . . . . 0.0 110.764 178.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 52.8 t -62.76 -35.63 71.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.231 0.538 . . . . 0.0 110.411 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.3 m -86.39 -53.29 5.09 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.944 -177.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.419 ' O ' HG12 ' A' ' 47' ' ' ILE . 17.7 mm-40 -84.46 -31.78 24.39 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -168.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.612 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 50.0 tpp -57.59 -52.1 76.86 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 111.998 0.369 . . . . 0.0 111.998 -174.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.612 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 54.4 Cg_exo -53.39 -39.8 80.4 Favored 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 121.927 1.751 . . . . 0.0 112.404 176.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.429 ' HD3' ' CZ ' ' A' ' 126' ' ' PHE . 56.2 mttp -59.78 -51.45 69.69 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.12 178.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.419 HG12 ' O ' ' A' ' 43' ' ' GLU . 49.8 mm -61.24 -42.11 92.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.224 -177.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.583 HG12 ' O ' ' A' ' 44' ' ' MET . 49.3 mm -55.03 -53.29 35.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.588 0.232 . . . . 0.0 111.434 -178.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.409 ' HB3' ' NZ ' ' A' ' 49' ' ' LYS . 0.2 OUTLIER -74.98 -47.39 29.54 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.793 -175.085 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.5 m -63.88 -44.06 94.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.757 0.313 . . . . 0.0 111.362 -176.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.468 ' HB2' HG21 ' A' ' 61' ' ' VAL . . . -69.22 -33.12 72.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.796 -0.184 . . . . 0.0 110.734 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -56.4 -50.94 70.16 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.366 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -68.93 -51.09 43.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.122 0.487 . . . . 0.0 111.034 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 1.048 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 8.8 m-85 -66.5 -31.07 71.56 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -172.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -63.49 -27.3 69.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.083 0.468 . . . . 0.0 110.397 178.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -96.5 19.4 12.25 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.127 0.489 . . . . 0.0 110.499 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 58' ' ' ASN . 0.0 OUTLIER -121.16 -65.4 1.14 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.728 178.131 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 66.6 t30 171.17 19.68 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.646 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 1.048 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 55.4 t80 -114.74 128.27 56.21 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -176.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.796 ' HG3' HG23 ' A' ' 28' ' ' THR . 4.5 pt20 -114.24 128.34 56.31 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.192 0.52 . . . . 0.0 111.151 -175.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.468 HG21 ' HB2' ' A' ' 51' ' ' ALA . 88.5 t -102.87 121.03 53.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.587 175.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.435 ' HB2' HG12 ' A' ' 30' ' ' ILE . 79.5 mt -113.39 101.58 9.52 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.846 -177.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.69 100.46 12.84 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.396 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.3 t -88.52 106.36 16.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.467 -176.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.86 133.08 34.32 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 174.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.608 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 3.4 pt20 -109.3 164.86 13.78 Favored Pre-proline 0 C--N 1.316 -0.89 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.608 ' HD2' ' HB2' ' A' ' 66' ' ' GLN . 37.8 Cg_endo -64.9 95.79 0.25 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.312 2.008 . . . . 0.0 113.485 -174.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 45.9 mm -128.13 -65.01 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 171.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -89.53 151.64 46.26 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.046 169.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -58.22 160.25 16.72 Favored 'Trans proline' 0 C--O 1.236 0.411 0 C-N-CA 122.506 2.137 . . . . 0.0 112.504 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.0 tp -56.63 -33.2 39.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.793 -176.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.644 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -65.89 -38.55 89.05 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 122.257 -0.277 . . . . 0.0 110.469 179.418 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.8 m -63.86 -44.86 91.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.776 0.322 . . . . 0.0 110.734 -178.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.47 -35.7 52.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.348 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.644 ' HG2' ' HA ' ' A' ' 72' ' ' GLU . 11.8 ptt180 -73.9 -35.42 64.67 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.569 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -64.98 -39.56 93.66 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 176.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -54.61 -55.21 31.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.405 178.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.07 ' HA ' HD23 ' A' ' 83' ' ' LEU . 61.9 t -60.01 -37.86 74.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.658 -178.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.578 ' HG2' ' O ' ' A' ' 75' ' ' ARG . 33.3 mmtp -69.59 -51.21 37.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.81 0.338 . . . . 0.0 110.987 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -63.95 -48.96 74.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.026 -173.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.409 ' HB2' ' CD2' ' A' ' 83' ' ' LEU . 96.9 m-85 -88.23 -2.89 58.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.371 -175.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 59.87 53.47 45.63 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.919 176.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 1.07 HD23 ' HA ' ' A' ' 78' ' ' VAL . 2.9 mm? -69.92 114.1 22.51 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 120.789 0.328 . . . . 0.0 110.646 -179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -84.24 -20.32 4.22 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.036 2.491 . . . . 0.0 113.964 -174.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.511 ' CE1' HD12 ' A' ' 83' ' ' LEU . 40.0 p90 -79.99 169.6 17.64 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.693 0.282 . . . . 0.0 110.486 -179.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 24.2 m -78.48 105.46 9.76 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.562 0.696 . . . . 0.0 111.22 -175.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.1 t -99.59 141.91 16.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.233 177.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.602 ' HG2' ' HA ' ' A' ' 12' ' ' ASP . 60.6 mtm -136.63 168.98 18.47 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -134.97 104.74 6.08 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.879 0.371 . . . . 0.0 110.743 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.548 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 20.0 t70 -91.11 101.99 14.74 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.34 -10.64 59.96 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.226 -171.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.474 ' OD2' ' HB2' ' A' ' 94' ' ' ALA . 13.5 t70 -105.14 -12.05 16.29 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.544 -0.463 . . . . 0.0 111.345 -176.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 63.2 tttp 65.32 4.97 2.88 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 121.349 0.595 . . . . 0.0 111.365 177.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.474 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . . . -70.62 -29.49 65.89 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -170.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.517 HG23 ' HE1' ' A' ' 32' ' ' PHE . 22.5 m -73.08 -33.94 43.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.353 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -70.89 -33.89 65.81 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 173.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -70.6 -32.03 69.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.213 -0.493 . . . . 0.0 110.876 176.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.69 -45.57 89.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.87 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -73.11 -27.07 61.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.986 0.422 . . . . 0.0 110.814 175.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.31 39.63 7.24 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.873 -0.68 . . . . 0.0 111.782 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.8 p -84.08 115.24 22.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.624 0.25 . . . . 0.0 110.601 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -103.23 -40.03 6.59 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.998 0.428 . . . . 0.0 110.148 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 40.1 t -98.75 145.27 10.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.967 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.411 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 87.0 m-85 -132.62 155.82 80.78 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.411 ' HA ' ' HB3' ' A' ' 104' ' ' TYR . 86.9 Cg_endo -78.63 160.28 90.94 Favored 'Cis proline' 0 C--N 1.345 0.373 0 C-N-CA 123.25 -1.562 . . . . 0.0 112.772 0.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 53.9 m -131.71 123.83 28.54 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.727 178.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.1 m -107.99 117.69 34.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.52 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.69 ' CG1' ' HB ' ' A' ' 30' ' ' ILE . 10.1 p -106.09 135.9 42.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.939 0.4 . . . . 0.0 110.144 178.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.55 HD23 ' HB2' ' A' ' 118' ' ' LYS . 2.3 mm? -102.84 124.99 49.4 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.244 -178.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.575 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 53.5 mt -109.26 133.96 52.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.964 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -80.04 159.11 43.17 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.289 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 46.8 pttt -67.68 86.15 0.21 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.75 0.786 . . . . 0.0 111.112 -177.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 4.6 ttmp? 165.73 -30.02 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.373 -178.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.46 39.97 1.84 Allowed Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.345 -176.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -113.35 132.35 55.62 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.428 HD13 HG12 ' A' ' 110' ' ' ILE . 49.2 mm -78.46 117.91 24.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.827 0.346 . . . . 0.0 110.083 -178.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.2 mt -103.14 -68.59 0.83 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.769 -175.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.55 ' HB2' HD23 ' A' ' 109' ' ' LEU . 20.1 mmmt -124.33 157.3 35.32 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -168.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -138.32 108.74 6.51 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.026 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -108.8 109.37 20.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.202 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 36.5 t -96.92 138.19 22.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.08 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 90.12 -77.63 1.58 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.124 178.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -151.71 119.81 3.33 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 178.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.54 ' HB2' HD22 ' A' ' 129' ' ' LEU . 38.1 Cg_endo -67.81 130.23 21.43 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.561 2.174 . . . . 0.0 112.427 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.616 ' OD1' ' HG2' ' A' ' 128' ' ' LYS . 12.7 t70 -69.32 110.85 4.86 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 177.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.429 ' CZ ' ' HD3' ' A' ' 46' ' ' LYS . 34.6 m-85 -58.58 -44.15 89.7 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -173.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -56.66 -52.89 47.72 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.915 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.616 ' HG2' ' OD1' ' A' ' 125' ' ' ASP . 38.4 mmtm -63.93 -48.87 74.83 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.54 HD22 ' HB2' ' A' ' 124' ' ' PRO . 28.0 tp -63.16 -48.66 77.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.989 -171.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -64.39 -37.88 89.06 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.958 -177.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -73.34 -39.73 64.98 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.43 178.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.489 ' OE1' ' HG3' ' A' ' 118' ' ' LYS . 9.5 pt-20 -75.24 -38.13 60.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.276 -174.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 57.6 mt -64.37 -45.97 94.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 175.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -61.32 -32.18 72.04 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.002 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 90.4 m -58.37 -47.43 83.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.975 0.417 . . . . 0.0 110.653 177.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.351 0 CA-C-O 121.077 0.465 . . . . 0.0 111.062 177.875 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 -0.236 0 CA-C-O 121.105 0.479 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -119.07 144.41 46.59 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.353 0.597 . . . . 0.0 111.558 -174.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.2 p -149.43 88.58 1.58 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.85 170.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.56 ' H ' HD23 ' A' ' 10' ' ' LEU . 2.6 pt? -121.98 155.71 60.5 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.896 -174.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.92 145.7 19.99 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.742 2.295 . . . . 0.0 111.584 173.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 51.7 p-10 -89.53 -172.65 3.67 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.141 177.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.6 mt -79.06 20.7 0.47 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.765 0.316 . . . . 0.0 111.441 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -118.33 -24.34 6.93 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 174.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.45 14.93 14.81 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.719 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -113.37 141.61 46.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.972 0.386 . . . . 0.0 110.315 178.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.2 m -75.27 122.53 23.84 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.404 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.5 t -108.01 142.84 19.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.733 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.5 p -145.35 -173.8 4.21 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.202 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -66.47 -22.73 66.2 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -176.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.63 -31.73 71.83 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.833 0.349 . . . . 0.0 111.81 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.62 -37.03 84.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.45 0.643 . . . . 0.0 109.704 177.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.493 HD22 HG21 ' A' ' 28' ' ' THR . 21.7 mt -72.21 -21.33 61.42 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.475 -174.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -64.8 102.1 0.55 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.248 0.547 . . . . 0.0 111.686 -174.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.05 -26.04 10.22 Favored Glycine 0 CA--C 1.511 -0.208 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.991 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.708 ' O ' ' HA ' ' A' ' 112' ' ' LYS . 31.5 mttp -97.18 163.09 13.06 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 177.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.471 HG22 ' HB3' ' A' ' 112' ' ' LYS . 4.9 t -103.08 127.3 57.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 175.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.59 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 27.7 m -131.33 142.23 50.06 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.397 0.618 . . . . 0.0 112.361 -168.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.474 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 24.8 tp -115.69 115.27 26.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.396 172.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.819 ' HB ' ' CG2' ' A' ' 108' ' ' VAL . 51.2 mt -94.27 112.86 27.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 176.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -117.0 118.3 32.01 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.855 0.36 . . . . 0.0 110.932 -176.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.483 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 87.7 m-85 -84.25 125.09 31.9 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.406 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.532 ' CD1' ' HB1' ' A' ' 63' ' ' ALA . 22.7 p-90 -147.07 175.54 10.62 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.217 0.532 . . . . 0.0 111.097 -177.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.425 ' HD2' ' OD2' ' A' ' 69' ' ' ASP . 27.2 p90 -161.67 149.58 12.23 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.714 173.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.583 ' HD2' ' HB2' ' A' ' 69' ' ' ASP . 84.7 Cg_exo -49.61 -46.69 25.85 Favored 'Trans proline' 0 N--CA 1.474 0.375 0 C-N-CA 123.422 2.748 . . . . 0.0 114.284 -174.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.1 m -79.35 17.81 0.78 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -174.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.612 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 48.0 t -85.2 126.5 67.23 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 120.704 0.288 . . . . 0.0 110.734 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 17.0 Cg_exo -67.79 -19.32 47.16 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.963 2.442 . . . . 0.0 112.305 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.24 -11.52 84.93 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.803 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.612 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 89.2 m -60.96 -43.57 98.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.704 0.252 . . . . 0.0 111.381 -178.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.9 m -59.71 -27.86 38.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.02 0.438 . . . . 0.0 111.403 -177.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.9 m -87.45 -55.14 3.92 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.265 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.445 ' O ' HG12 ' A' ' 47' ' ' ILE . 26.5 mm-40 -84.55 -33.18 23.5 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -168.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.649 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 47.9 tpp -57.52 -53.76 62.11 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -172.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.649 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 43.2 Cg_exo -57.15 -36.59 99.18 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 122.096 1.864 . . . . 0.0 111.98 178.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.464 ' HB3' ' HE2' ' A' ' 46' ' ' LYS . 4.6 tmmm? -66.74 -39.8 88.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.108 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 43' ' ' GLU . 34.1 mm -63.52 -39.4 85.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.581 177.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.548 HD13 ' HE1' ' A' ' 85' ' ' PHE . 44.9 mm -54.62 -53.38 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.287 178.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -63.24 -51.5 65.93 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.803 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 30.9 m -56.02 -47.17 78.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.945 0.402 . . . . 0.0 111.491 -176.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . -65.62 -41.09 93.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.433 -177.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -73.76 -37.76 64.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.954 -176.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.07 -49.54 76.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.689 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -92.08 -1.49 57.17 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.524 -174.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 24.2 tptm -59.26 -35.32 73.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.102 0.477 . . . . 0.0 110.49 178.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -74.85 -24.25 58.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.403 -176.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -71.35 -70.35 0.32 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 175.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 171.63 22.24 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.456 -176.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.474 ' HZ ' ' HB2' ' A' ' 29' ' ' LEU . 29.5 t80 -100.48 139.72 35.75 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.969 -174.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.501 ' O ' ' HA ' ' A' ' 28' ' ' THR . 12.1 pt20 -134.64 137.15 43.4 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.147 176.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.447 HG22 ' HE1' ' A' ' 59' ' ' PHE . 98.3 t -104.98 119.16 53.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.47 HD23 ' HB ' ' A' ' 86' ' ' THR . 70.0 mt -104.04 98.59 8.39 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.7 177.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.532 ' HB1' ' CD1' ' A' ' 33' ' ' TRP . . . -84.52 109.29 17.82 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.271 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.509 HG11 HG11 ' A' ' 95' ' ' VAL . 86.4 t -93.93 108.37 20.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.257 0.551 . . . . 0.0 110.495 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -80.14 127.83 32.79 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 174.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.759 ' HG2' HG12 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -99.85 162.34 21.41 Favored Pre-proline 0 C--N 1.318 -0.785 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -179.135 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.603 ' HD2' ' HB2' ' A' ' 66' ' ' GLN . 58.6 Cg_endo -70.9 42.4 0.42 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.994 2.463 . . . . 0.0 115.157 -170.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.759 HG12 ' HG2' ' A' ' 66' ' ' GLN . 43.6 mm -84.09 -30.96 7.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 172.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.583 ' HB2' ' HD2' ' A' ' 35' ' ' PRO . 23.6 m-20 -125.12 150.93 68.39 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.784 169.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -58.12 154.76 37.8 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.352 2.035 . . . . 0.0 111.954 176.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.699 ' HA ' HG22 ' A' ' 74' ' ' VAL . 11.9 tt -63.0 -27.62 43.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.633 0.254 . . . . 0.0 111.177 -178.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.446 ' HA ' ' NE ' ' A' ' 75' ' ' ARG . 10.1 pt-20 -67.38 -33.97 76.32 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.189 177.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.6 m -68.92 -45.0 71.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.27 175.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.699 HG22 ' HA ' ' A' ' 71' ' ' ILE . 5.2 m -70.39 -35.79 63.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.973 -175.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.446 ' NE ' ' HA ' ' A' ' 72' ' ' GLU . 30.5 ptt180 -75.27 -27.53 59.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.561 -179.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 -68.52 -37.83 80.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.369 176.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -63.48 -47.84 80.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.075 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.688 HG13 ' HB2' ' A' ' 83' ' ' LEU . 43.6 t -61.24 -42.18 92.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.682 177.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.4 tttt -62.84 -55.95 21.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.005 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -63.03 -48.81 77.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.306 -170.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -83.59 -17.6 41.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.711 0.291 . . . . 0.0 111.294 -176.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.0 60.8 4.02 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.961 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.688 ' HB2' HG13 ' A' ' 78' ' ' VAL . 9.9 mp -67.6 118.73 60.05 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.723 -0.238 . . . . 0.0 110.533 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -75.84 -28.89 7.46 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.787 2.324 . . . . 0.0 112.862 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.548 ' HE1' HD13 ' A' ' 48' ' ' ILE . 33.6 p90 -80.34 150.98 29.69 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.47 ' HB ' HD23 ' A' ' 62' ' ' LEU . 22.2 m -75.21 131.32 40.32 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.117 0.484 . . . . 0.0 111.335 -173.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.465 HG22 ' HB3' ' A' ' 63' ' ' ALA . 68.5 t -114.09 139.46 39.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.418 -179.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 70.1 mtm -127.26 167.56 15.93 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 176.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -137.72 112.0 8.58 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.563 0.22 . . . . 0.0 110.441 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.56 ' OD2' HG12 ' A' ' 95' ' ' VAL . 55.8 t0 -91.53 119.07 31.14 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.56 -20.84 60.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.928 -176.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -111.64 -11.7 13.99 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -175.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.412 ' HE2' ' HB3' ' A' ' 93' ' ' LYS . 32.2 ttpt 65.52 16.57 10.58 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.965 0.412 . . . . 0.0 109.964 175.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.09 -29.27 70.2 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.608 0.718 . . . . 0.0 109.59 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.56 HG12 ' OD2' ' A' ' 90' ' ' ASP . 7.7 p -60.65 -46.53 95.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.136 174.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.402 ' N ' HG13 ' A' ' 95' ' ' VAL . . . -76.13 -33.2 50.38 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.888 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -58.6 -36.34 73.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.014 0.435 . . . . 0.0 111.242 177.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.03 -46.33 52.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.305 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -72.76 -27.58 62.1 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 95.13 36.58 5.42 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -175.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.502 HG23 ' OG1' ' A' ' 106' ' ' THR . 20.0 m -76.51 88.15 3.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.134 0.492 . . . . 0.0 111.2 -177.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -103.12 -46.03 4.75 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.317 177.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 38.4 t -101.82 131.43 49.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.0 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -104.98 149.21 37.32 Favored Pre-proline 0 C--N 1.317 -0.826 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -178.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -79.73 165.99 78.43 Favored 'Cis proline' 0 C--N 1.344 0.319 0 C-N-CA 124.123 -1.199 . . . . 0.0 112.907 0.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.502 ' OG1' HG23 ' A' ' 101' ' ' THR . 58.1 m -131.43 114.95 15.57 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.205 176.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.6 m -108.74 115.39 30.0 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.026 0.441 . . . . 0.0 110.368 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.819 ' CG2' ' HB ' ' A' ' 30' ' ' ILE . 26.9 m -106.16 148.85 10.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.312 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.7 ' HB2' ' HB3' ' A' ' 118' ' ' LYS . 11.0 mp -101.09 124.32 46.62 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.943 -174.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.59 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 25.8 mm -112.3 118.59 58.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.027 174.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -71.04 -168.33 8.15 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.72 178.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.708 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 10.7 ptmm? -95.79 21.06 8.95 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 122.687 1.232 . . . . 0.0 107.935 -175.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.498 ' HD2' ' HA ' ' A' ' 113' ' ' LYS . 1.8 mmmp? -106.39 -1.2 23.52 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 113.439 -1.71 . . . . 0.0 108.866 174.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 61.97 46.48 93.99 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 114.952 -1.022 . . . . 0.0 113.326 177.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -148.53 167.01 26.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.023 0.439 . . . . 0.0 111.632 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.2 mt -61.87 127.46 21.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.703 -178.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 36.9 mt -121.28 -61.06 1.58 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.477 174.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.7 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 1.7 tppt? -133.63 154.96 50.49 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -174.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.668 HG23 HG12 ' A' ' 108' ' ' VAL . 42.8 m -131.86 102.23 5.77 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.11 172.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.634 ' CE2' ' HE3' ' A' ' 118' ' ' LYS . 45.9 m-85 -88.63 136.63 32.9 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.887 0.375 . . . . 0.0 110.914 169.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 6.0 p -123.17 123.1 67.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.258 0.551 . . . . 0.0 110.739 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 95.55 -62.91 1.38 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.285 175.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -167.09 116.57 0.71 Allowed Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 120.501 0.191 . . . . 0.0 111.349 -173.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -93.86 163.17 2.21 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 123.159 2.573 . . . . 0.0 113.087 177.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -99.05 108.79 21.54 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.411 0.624 . . . . 0.0 109.605 174.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.668 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 34.8 m-85 -70.19 -30.21 67.26 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -164.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -59.9 -54.12 40.2 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 119.663 -1.256 . . . . 0.0 111.807 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.421 ' HE2' ' HB3' ' A' ' 128' ' ' LYS . 22.0 ttpt -66.14 -35.29 80.1 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.959 -0.62 . . . . 0.0 110.008 176.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.668 ' HB3' ' HA ' ' A' ' 126' ' ' PHE . 2.9 tm? -61.45 -47.3 86.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.961 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -60.24 -38.59 83.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.813 0.34 . . . . 0.0 110.299 178.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -71.83 -33.07 68.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.762 178.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.614 ' HG2' ' HA ' ' A' ' 129' ' ' LEU . 18.7 pt-20 -80.96 -23.6 38.69 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.419 -177.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 56.1 mt -67.0 -42.12 88.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 168.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -63.13 -27.02 69.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.302 174.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.527 ' HB ' ' O ' ' A' ' 132' ' ' GLU . 52.3 m -60.81 -31.45 70.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.819 176.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.243 0 CA-C-O 121.042 0.449 . . . . 0.0 110.296 177.575 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.506 ' HA ' ' OD1' ' A' ' 20' ' ' ASN . . . . . . . . 0 N--CA 1.465 0.318 0 CA-C-O 121.238 0.542 . . . . 0.0 110.74 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -80.48 150.44 29.69 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.773 -171.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.5 m -136.1 96.3 3.37 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 173.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.489 HD13 ' HD2' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -119.6 126.14 27.11 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.249 -171.161 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.489 ' HD2' HD13 ' A' ' 10' ' ' LEU . 47.2 Cg_endo -71.19 131.56 19.47 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.102 1.868 . . . . 0.0 111.558 173.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.28 177.84 7.59 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.613 HD11 HG12 ' A' ' 74' ' ' VAL . 51.8 mt -64.41 -31.27 72.42 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -176.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.81 -17.03 42.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.661 0.267 . . . . 0.0 111.261 -175.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.12 32.1 3.13 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.419 -0.896 . . . . 0.0 114.017 170.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -114.4 135.35 54.18 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.128 0.464 . . . . 0.0 110.086 172.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.1 m -77.65 124.48 27.99 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 175.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 31.0 m -124.56 153.55 31.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.873 0.368 . . . . 0.0 110.277 177.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 51.1 p -140.35 -179.6 6.1 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.486 -177.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.506 ' OD1' ' HA ' ' A' ' 7' ' ' ALA . 4.4 p-10 -73.88 -20.89 60.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.571 178.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.448 ' HA ' HE21 ' A' ' 24' ' ' GLN . . . -62.61 -27.56 69.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.012 174.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -68.33 -29.44 68.18 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.269 0.557 . . . . 0.0 110.329 176.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.957 HD13 HG21 ' A' ' 110' ' ' ILE . 25.3 mt -74.07 -19.31 60.65 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.16 -175.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.448 HE21 ' HA ' ' A' ' 21' ' ' ALA . 76.3 mt-30 -55.58 128.6 35.36 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.361 -178.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.9 -24.66 10.19 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.515 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -95.98 -171.25 2.29 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.372 0.605 . . . . 0.0 111.019 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 0.7 OUTLIER -133.05 138.01 52.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 169.422 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.634 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 89.2 m -141.57 150.01 41.5 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.697 -169.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.665 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 6.5 tt -127.23 123.03 35.59 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 173.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.653 ' HB ' ' CG2' ' A' ' 108' ' ' VAL . 44.5 mt -104.1 115.16 45.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.843 0.354 . . . . 0.0 110.585 -178.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -107.8 117.44 34.13 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.582 -178.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.535 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 96.1 m-85 -90.3 119.08 30.3 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 177.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.515 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 5.3 p-90 -146.23 -176.8 5.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.106 -175.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -153.45 159.12 32.52 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.256 -0.884 . . . . 0.0 108.767 177.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -51.8 128.02 25.04 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.279 1.986 . . . . 0.0 112.16 177.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.7 t 71.62 26.06 3.2 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.427 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.537 ' O ' ' HB3' ' A' ' 40' ' ' CYS . 42.9 t -63.41 134.02 95.7 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.011 176.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -57.25 -49.14 14.82 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.977 2.452 . . . . 0.0 112.657 178.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.551 ' HA3' ' HG3' ' A' ' 105' ' ' PRO . . . -66.64 -24.85 72.75 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.292 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.537 ' HB3' ' O ' ' A' ' 37' ' ' CYS . 29.6 t -58.26 -33.57 69.53 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 122.624 0.37 . . . . 0.0 111.106 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.2 t -62.17 -36.69 75.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.947 0.403 . . . . 0.0 110.543 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.9 m -87.9 -54.68 4.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.001 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.488 ' O ' HG13 ' A' ' 47' ' ' ILE . 54.8 mt-10 -63.81 -50.18 69.96 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -172.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.588 ' O ' HG12 ' A' ' 48' ' ' ILE . 40.5 ttm -51.29 -50.26 77.03 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -170.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.425 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 86.9 Cg_exo -48.57 -48.55 17.07 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 122.205 1.937 . . . . 0.0 112.857 176.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -63.1 -46.23 88.32 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.144 177.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 43' ' ' GLU . 51.1 mt -60.39 -35.33 62.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.961 -178.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.588 HG12 ' O ' ' A' ' 44' ' ' MET . 46.7 mm -58.69 -52.9 54.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.925 0.393 . . . . 0.0 110.376 176.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -70.68 -39.38 73.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.121 -177.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.561 ' O ' ' HD1' ' A' ' 54' ' ' TYR . 87.7 m -68.37 -54.75 15.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.938 -178.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.627 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . -65.73 -34.74 78.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.236 -174.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -63.82 -48.39 77.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.905 0.383 . . . . 0.0 110.722 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -69.37 -51.64 34.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.01 0.433 . . . . 0.0 111.166 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 1.064 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 77.2 m-85 -70.79 -12.08 61.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.559 -175.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.627 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 16.0 tptm -60.99 -35.78 77.74 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 175.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -84.79 -6.2 59.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.342 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.489 ' O ' ' HB2' ' A' ' 58' ' ' ASN . 43.5 mmtm -89.57 -69.65 0.7 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 176.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 63.3 t30 164.03 12.13 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 114.904 -1.043 . . . . 0.0 109.241 -175.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 1.064 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 60.6 t80 -105.74 129.43 53.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.542 -178.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.404 ' O ' ' HA ' ' A' ' 28' ' ' THR . 12.7 pt20 -126.68 140.86 52.09 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.952 0.405 . . . . 0.0 110.501 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 91.9 t -104.59 126.9 59.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.866 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.56 ' HB3' ' HE3' ' A' ' 88' ' ' MET . 75.7 mt -114.21 99.57 7.71 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.605 -179.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.01 106.29 18.38 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.695 -178.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 41.9 t -94.66 115.25 33.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.047 0.451 . . . . 0.0 110.516 -178.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -82.45 138.24 34.44 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.859 176.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.698 ' HB2' ' HG2' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -101.83 163.45 17.77 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.808 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.698 ' HD3' ' O ' ' A' ' 90' ' ' ASP . 37.4 Cg_endo -66.19 82.08 0.28 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.538 2.158 . . . . 0.0 113.688 -173.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 50.7 mm -112.22 -44.29 5.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 170.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -129.67 153.59 80.8 Favored Pre-proline 0 C--O 1.237 0.403 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 173.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -54.64 161.89 5.43 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.932 2.422 . . . . 0.0 114.714 -175.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.7 tp -51.16 -35.46 15.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.488 177.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -62.1 -46.18 90.19 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.049 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.6 m -58.32 -41.95 85.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.131 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.613 HG12 HD11 ' A' ' 13' ' ' LEU . 26.4 t -65.05 -46.57 90.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.357 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.525 ' HG2' ' HB3' ' A' ' 13' ' ' LEU . 67.1 mtt180 -60.16 -34.95 74.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.012 177.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.444 ' HA ' ' NZ ' ' A' ' 79' ' ' LYS . 50.3 tp60 -61.27 -53.48 56.26 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.591 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -55.86 -48.86 74.78 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.242 -176.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.66 ' HA ' HD12 ' A' ' 83' ' ' LEU . 61.9 t -56.36 -44.29 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 112.26 0.466 . . . . 0.0 112.26 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.56 ' HB2' ' NZ ' ' A' ' 79' ' ' LYS . 9.6 mtmp? -67.56 -48.56 66.58 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.59 0.709 . . . . 0.0 110.487 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.32 -39.93 93.06 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.497 -1.229 . . . . 0.0 112.456 -170.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -95.82 -9.99 30.15 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.475 -178.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 63.15 67.32 2.12 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.209 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.66 HD12 ' HA ' ' A' ' 78' ' ' VAL . 1.1 mt -94.25 127.57 44.05 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-O 120.94 0.4 . . . . 0.0 111.891 -174.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -83.48 -12.96 8.77 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.456 2.77 . . . . 0.0 114.553 -172.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.456 ' CZ ' HD22 ' A' ' 83' ' ' LEU . 26.8 p90 -93.16 153.61 18.54 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.421 178.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.401 ' HB ' HD23 ' A' ' 62' ' ' LEU . 14.5 m -78.59 126.76 31.19 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.596 -175.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.489 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 47.0 t -110.52 135.74 48.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.011 0.434 . . . . 0.0 110.63 -178.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.56 ' HE3' ' HB3' ' A' ' 62' ' ' LEU . 52.3 mtt -116.0 172.1 7.37 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.59 178.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -140.53 109.6 6.12 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.622 0.249 . . . . 0.0 110.548 176.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.698 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 38.4 t0 -91.57 118.39 30.56 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 176.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.72 -14.97 60.79 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -175.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.53 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 24.2 t70 -125.62 -9.66 6.79 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 122.149 -0.344 . . . . 0.0 111.514 -173.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.698 ' HG2' ' HB2' ' A' ' 66' ' ' GLN . 51.8 mtpt 78.18 5.23 2.72 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.881 0.872 . . . . 0.0 111.679 -177.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.05 -40.63 81.43 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -169.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.555 HG22 ' OD2' ' A' ' 90' ' ' ASP . 22.1 m -70.21 -35.23 62.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 119.977 -0.689 . . . . 0.0 109.834 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -71.68 -33.23 63.59 Favored Glycine 0 N--CA 1.451 -0.321 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 176.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.602 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 8.5 mm-40 -61.69 -32.54 72.75 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.087 0.47 . . . . 0.0 110.552 176.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.24 -40.17 64.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.177 176.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -74.03 -22.66 59.48 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.715 0.293 . . . . 0.0 111.25 179.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.91 50.5 1.77 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.664 177.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 22.6 p -72.75 88.42 1.31 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.041 0.448 . . . . 0.0 111.002 176.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -84.23 -51.76 6.77 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.38 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 46.8 t -128.91 142.41 44.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.87 -179.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -86.41 137.76 34.36 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.551 ' HG3' ' HA3' ' A' ' 39' ' ' GLY . 94.4 Cg_endo -90.74 166.47 30.39 Favored 'Cis proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.88 -1.3 . . . . 0.0 112.808 -0.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 33.0 m -128.16 112.65 14.77 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.484 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.477 ' HB3' HD21 ' A' ' 29' ' ' LEU . 73.1 m -110.5 112.62 24.66 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.979 0.419 . . . . 0.0 110.83 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.653 ' CG2' ' HB ' ' A' ' 30' ' ' ILE . 15.9 m -106.83 148.7 10.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.537 -176.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.774 ' HB2' ' HB3' ' A' ' 118' ' ' LYS . 10.8 mp -101.91 132.87 47.46 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.033 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.957 HG21 HD13 ' A' ' 23' ' ' LEU . 31.3 mm -114.38 133.45 60.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.93 -174.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -85.86 -174.29 49.73 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.929 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 24' ' ' GLN . 62.1 mttm -74.97 21.49 0.12 Allowed 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -172.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.53 ' HD3' ' HB3' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -150.59 11.31 0.68 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.059 0.457 . . . . 0.0 110.604 -179.55 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.07 -14.19 57.86 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.52 -0.847 . . . . 0.0 111.669 -176.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.53 ' HB3' ' HD3' ' A' ' 113' ' ' LYS . 38.7 tt0 -54.93 135.13 48.72 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.234 0.614 . . . . 0.0 111.096 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.0 mt -80.3 111.77 17.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.014 -174.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 79.9 mt -91.42 -40.16 11.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.598 -175.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.774 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 19.8 tptm -152.5 153.71 34.02 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.618 -170.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.8 m -136.61 108.79 7.24 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.937 177.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -99.33 118.16 35.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.341 174.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 61.3 t -108.49 123.12 63.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.732 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 90.74 -72.75 1.87 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.959 176.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -132.42 105.45 13.28 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-O 120.726 0.298 . . . . 0.0 110.624 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -82.66 126.57 4.67 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.549 2.166 . . . . 0.0 112.563 176.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -65.46 102.47 0.7 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 176.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -67.15 -45.73 76.17 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -172.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -57.97 -48.17 84.28 Favored Glycine 0 C--O 1.239 0.408 0 C-N-CA 120.434 -0.889 . . . . 0.0 111.874 178.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -67.39 -31.28 71.4 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-N 115.491 -0.354 . . . . 0.0 110.404 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.687 ' O ' HG12 ' A' ' 133' ' ' ILE . 2.6 tm? -59.32 -45.26 91.81 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 176.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -61.68 -49.89 74.67 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -178.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -69.83 -27.51 64.93 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.959 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -73.5 -37.43 65.7 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.052 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.687 HG12 ' O ' ' A' ' 129' ' ' LEU . 50.8 mm -64.38 -41.92 93.79 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 172.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -57.15 -38.42 73.52 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.159 178.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 32.6 m -66.33 -38.12 86.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.62 178.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.02 178.496 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.253 0 CA-C-O 121.189 0.519 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -111.86 130.27 55.88 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.098 0.475 . . . . 0.0 111.157 -175.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 63.7 p -110.46 90.23 3.26 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 172.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.591 HD12 ' HD2' ' A' ' 11' ' ' PRO . 22.6 tp -111.51 126.92 27.68 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.751 -172.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.591 ' HD2' HD12 ' A' ' 10' ' ' LEU . 58.3 Cg_endo -73.3 147.55 42.15 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.308 2.006 . . . . 0.0 112.136 176.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.452 ' CG ' ' H ' ' A' ' 14' ' ' HIS . 0.2 OUTLIER -80.46 -175.65 5.28 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 176.948 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 53.8 mt -70.37 -18.68 63.06 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -176.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.452 ' H ' ' CG ' ' A' ' 12' ' ' ASP . 76.6 m80 -89.65 -48.25 7.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.775 0.321 . . . . 0.0 110.427 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.56 24.91 0.19 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.374 -0.917 . . . . 0.0 113.668 176.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 11' ' ' PRO . 67.6 mttm -101.17 139.56 36.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.314 0.557 . . . . 0.0 110.152 175.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.4 m -84.77 123.38 30.35 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.899 0.381 . . . . 0.0 111.089 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.2 t -107.93 134.82 48.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.509 176.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 36.6 m -145.25 177.48 8.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.746 0.308 . . . . 0.0 111.462 -177.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -51.64 -32.28 28.62 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.641 0.776 . . . . 0.0 112.849 -175.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.47 -27.48 64.45 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -174.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -82.94 -23.32 33.5 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.456 -176.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.614 HD23 HG21 ' A' ' 110' ' ' ILE . 7.7 mp -80.88 -26.94 36.52 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -173.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -64.53 130.86 45.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.189 0.518 . . . . 0.0 111.517 -176.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.34 -12.14 70.28 Favored Glycine 0 C--N 1.329 0.154 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.338 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 112' ' ' LYS . 79.4 mttt -115.71 -173.28 2.31 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 15.9 t -126.51 139.0 52.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 171.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.571 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 26.7 m -137.14 145.74 44.17 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.687 -168.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.611 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 31.8 tp -115.89 105.84 13.13 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 172.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.8 mt -89.46 111.67 23.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 175.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.512 ' HA ' ' O ' ' A' ' 106' ' ' THR . 7.9 t30 -117.01 111.17 19.19 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.827 0.346 . . . . 0.0 110.864 -175.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 63.5 m-85 -81.38 131.55 35.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.652 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.616 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 4.2 p-90 -158.19 -170.47 3.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.416 -175.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.453 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 24.5 p90 -158.86 138.69 8.66 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 171.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.763 ' HG2' ' HA ' ' A' ' 74' ' ' VAL . 50.6 Cg_exo -56.48 -28.31 72.87 Favored 'Trans proline' 0 N--CA 1.473 0.299 0 C-N-CA 123.358 2.705 . . . . 0.0 114.051 -173.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.7 t -89.84 26.57 1.76 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.023 0.439 . . . . 0.0 110.984 -178.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 53.5 t -100.32 132.11 23.02 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.255 -179.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 37.2 Cg_exo -61.73 -28.39 82.04 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.799 2.333 . . . . 0.0 112.009 175.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.74 -22.3 69.92 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.388 179.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 46.9 t -63.3 -40.17 96.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.761 0.315 . . . . 0.0 110.315 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.4 t -58.77 -35.9 58.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.105 -178.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.0 m -87.45 -49.44 7.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.852 -178.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.447 ' OE1' ' HG3' ' A' ' 46' ' ' LYS . 12.4 mm-40 -84.68 -28.21 26.54 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -170.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.575 ' O ' HG12 ' A' ' 48' ' ' ILE . 27.7 ttm -55.18 -47.26 98.95 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 120.249 -0.581 . . . . 0.0 111.91 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -51.05 -41.59 56.24 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.093 1.862 . . . . 0.0 112.314 172.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.447 ' HG3' ' OE1' ' A' ' 43' ' ' GLU . 26.0 mmtp -59.7 -48.16 82.77 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 43' ' ' GLU . 45.2 mm -61.71 -44.19 98.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.209 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.575 HG12 ' O ' ' A' ' 44' ' ' MET . 45.1 mm -54.87 -53.97 28.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.685 -175.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -70.88 -38.34 73.07 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.432 -175.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.9 m -67.58 -48.79 65.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.967 0.413 . . . . 0.0 110.88 -178.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.565 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . -65.95 -45.28 82.38 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.988 -178.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -55.13 -44.21 74.85 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.831 0.348 . . . . 0.0 110.996 -177.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -67.23 -51.4 53.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.662 -179.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 1.011 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 54.2 m-85 -79.6 -20.55 46.62 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -173.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.565 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 9.0 tmtt? -60.71 -39.02 87.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.073 0.463 . . . . 0.0 109.944 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -86.18 6.21 30.43 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.736 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 58' ' ' ASN . 14.4 tppt? -98.68 -67.5 0.84 Allowed 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 175.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.422 ' H ' ' H ' ' A' ' 59' ' ' PHE . 65.6 t30 171.79 19.45 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.878 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 1.011 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 45.1 t80 -117.68 120.28 37.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.637 -177.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.441 ' HG3' HG23 ' A' ' 28' ' ' THR . 29.8 pt20 -114.78 148.56 38.25 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.083 0.468 . . . . 0.0 110.601 -178.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.42 HG22 ' HB3' ' A' ' 29' ' ' LEU . 84.9 t -109.87 120.27 60.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.237 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.44 HD23 ' HB ' ' A' ' 86' ' ' THR . 90.2 mt -103.03 95.64 6.27 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.387 177.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.401 ' HB1' ' NE1' ' A' ' 33' ' ' TRP . . . -86.11 106.92 17.58 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.826 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 25.7 t -100.09 120.38 49.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 120.961 0.41 . . . . 0.0 110.411 -176.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.616 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -94.82 127.94 41.19 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.701 176.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.424 ' HB2' ' CD ' ' A' ' 67' ' ' PRO . 3.4 pt20 -97.12 170.94 6.57 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -178.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 90' ' ' ASP . 17.6 Cg_exo -67.0 79.11 0.39 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.806 2.337 . . . . 0.0 113.884 -175.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 47.7 mm -112.39 -68.63 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 167.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.496 ' OD1' ' HD2' ' A' ' 35' ' ' PRO . 3.5 p-10 -93.66 153.72 41.15 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 167.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -63.04 159.25 39.48 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 122.537 2.158 . . . . 0.0 113.266 -177.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.4 tp -53.95 -34.76 26.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.482 -178.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -60.69 -42.15 96.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.899 0.38 . . . . 0.0 110.899 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 51.0 m -62.98 -38.57 91.67 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.393 -177.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.763 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 20.0 t -60.77 -41.94 90.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.425 176.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.729 ' HA ' HG22 ' A' ' 78' ' ' VAL . 89.6 mtt180 -68.03 -32.53 72.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.819 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -61.71 -41.65 97.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.185 0.516 . . . . 0.0 109.863 177.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -67.72 -48.11 67.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.472 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.729 HG22 ' HA ' ' A' ' 75' ' ' ARG . 27.3 m -67.96 -29.08 43.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.988 -178.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -74.3 -55.09 6.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.146 0.498 . . . . 0.0 110.755 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -64.23 -48.35 76.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.339 -173.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -88.07 -21.49 24.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.728 0.299 . . . . 0.0 111.488 -175.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 71.47 59.9 4.65 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.271 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.553 HD22 HG12 ' A' ' 78' ' ' VAL . 10.8 mp -63.38 121.79 71.95 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 120.603 0.24 . . . . 0.0 110.901 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -82.26 -23.06 4.53 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.055 2.503 . . . . 0.0 113.377 -177.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -84.15 148.94 26.5 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.44 ' HB ' HD23 ' A' ' 62' ' ' LEU . 21.4 m -69.21 116.44 9.65 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.167 0.508 . . . . 0.0 111.305 -174.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 39.3 t -107.42 132.15 55.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.676 -178.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 73.3 mtm -123.4 173.72 7.81 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.491 ' CD1' HG21 ' A' ' 74' ' ' VAL . 60.1 t80 -140.0 116.49 10.71 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.564 ' HA ' HD11 ' A' ' 10' ' ' LEU . 10.0 p-10 -97.26 95.44 7.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.908 0.861 . . . . 0.0 110.23 178.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.484 ' HA ' ' HG3' ' A' ' 67' ' ' PRO . . . -73.28 -10.98 60.33 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.136 -176.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.443 ' C ' ' H ' ' A' ' 94' ' ' ALA . 19.1 m-20 -92.8 -14.95 27.12 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.352 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.518 ' HA ' ' OD2' ' A' ' 90' ' ' ASP . 37.0 ttpt 63.36 -24.96 0.07 Allowed 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 175.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.443 ' H ' ' C ' ' A' ' 92' ' ' ASP . . . -61.9 -25.3 67.48 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -173.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.424 ' O ' ' HD1' ' A' ' 99' ' ' PHE . 26.8 m -70.95 -41.73 77.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.249 179.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.5 -36.36 91.37 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.109 174.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.504 ' HG3' ' O ' ' A' ' 93' ' ' LYS . 24.8 mt-30 -62.3 -33.13 74.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.249 -0.475 . . . . 0.0 110.418 176.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.85 -41.6 71.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.068 177.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.424 ' HD1' ' O ' ' A' ' 95' ' ' VAL . 7.8 m-85 -66.71 -27.3 67.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.481 178.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 94.1 39.19 4.91 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.106 177.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.534 ' HB ' ' CE1' ' A' ' 104' ' ' TYR . 39.9 p -71.26 100.73 2.17 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.063 0.459 . . . . 0.0 111.154 -178.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -86.56 -58.41 2.63 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.363 0.601 . . . . 0.0 109.997 177.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.521 HG12 ' HB ' ' A' ' 121' ' ' VAL . 14.6 p -122.01 143.67 33.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.755 -177.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.534 ' CE1' ' HB ' ' A' ' 101' ' ' THR . 39.7 m-85 -111.01 148.53 38.83 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.58 -174.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -75.26 152.65 98.07 Favored 'Cis proline' 0 CA--C 1.529 0.261 0 C-N-CA 123.272 -1.553 . . . . 0.0 112.869 0.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 23.8 m -111.48 112.65 24.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.0 177.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.463 ' HB3' HD11 ' A' ' 29' ' ' LEU . 24.4 m -94.73 110.17 22.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.243 0.544 . . . . 0.0 110.841 -178.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.566 HG22 HG23 ' A' ' 119' ' ' THR . 60.7 t -107.79 134.33 49.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.316 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.532 ' HB2' ' HB3' ' A' ' 118' ' ' LYS . 7.2 mp -101.58 130.88 47.97 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.906 0.384 . . . . 0.0 110.039 -177.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.614 HG21 HD23 ' A' ' 23' ' ' LEU . 40.0 mm -110.83 130.27 64.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.206 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -77.38 -170.56 34.35 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.435 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 79.0 mttt -78.73 -7.56 57.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.715 0.769 . . . . 0.0 109.482 -174.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.31 -7.17 32.66 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.579 -1.191 . . . . 0.0 111.103 -172.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.08 60.94 3.17 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.673 -176.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -161.51 153.81 19.92 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -178.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 53.6 mt -66.7 105.46 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.925 -178.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.439 HD22 ' HA ' ' A' ' 117' ' ' LEU . 0.2 OUTLIER -84.07 -38.58 20.64 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.744 179.469 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.532 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 22.4 tptm -153.41 154.09 33.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.082 -174.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.566 HG23 HG22 ' A' ' 108' ' ' VAL . 33.0 m -140.66 116.84 10.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.059 0.457 . . . . 0.0 111.501 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -109.49 134.36 51.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.471 173.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.521 ' HB ' HG12 ' A' ' 103' ' ' VAL . 3.4 m -105.73 112.56 39.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.028 0.442 . . . . 0.0 110.442 175.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 91.76 -159.65 25.91 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.583 -176.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 54.7 tt0 -73.15 119.44 75.7 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.78 0.324 . . . . 0.0 110.54 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -88.36 165.19 6.73 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.833 2.356 . . . . 0.0 112.753 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.643 ' HB2' ' HE2' ' A' ' 128' ' ' LYS . 4.9 m-20 -67.87 102.81 1.32 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 173.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -62.95 -40.37 97.47 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -173.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -58.44 -47.81 87.67 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.444 -0.884 . . . . 0.0 111.605 177.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.643 ' HE2' ' HB2' ' A' ' 125' ' ' ASP . 33.6 ttpt -69.15 -36.99 78.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.438 -0.381 . . . . 0.0 110.33 177.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -61.48 -46.0 91.88 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.6 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -61.44 -47.91 83.58 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.62 0.248 . . . . 0.0 110.937 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -67.45 -38.62 84.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.399 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -65.44 -38.79 90.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.713 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 38.1 mt -60.59 -46.29 95.88 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 172.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -60.51 -36.54 78.61 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.963 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 66.5 m -60.97 -43.45 98.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.765 176.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.376 0 CA-C-O 121.224 0.535 . . . . 0.0 110.809 176.979 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.455 ' OD1' ' HB2' ' A' ' 6' ' ' PRO . 23.2 p-10 . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.444 ' HB3' ' HG2' ' A' ' 6' ' ' PRO . 20.2 t -83.72 -162.71 0.67 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.982 0.42 . . . . 0.0 110.231 176.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.477 ' HA ' HG13 ' A' ' 116' ' ' ILE . 23.9 mtmt -78.3 152.59 32.37 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.127 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.8 m 68.08 13.62 9.15 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.993 0.902 . . . . 0.0 109.717 -170.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 46.05 72.53 1.21 Allowed Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 114.204 -1.362 . . . . 0.0 114.267 174.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.455 ' HB2' ' OD1' ' A' ' 1' ' ' ASP . 32.4 Cg_exo -62.2 169.52 7.68 Favored 'Trans proline' 0 C--O 1.236 0.413 0 C-N-CA 122.202 1.935 . . . . 0.0 110.934 166.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.92 117.29 4.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.909 0.385 . . . . 0.0 111.715 -175.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -141.68 141.79 33.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.049 177.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.8 m -137.78 100.07 4.09 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.52 HD12 ' HD2' ' A' ' 11' ' ' PRO . 56.2 tp -115.16 120.2 37.23 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.426 -171.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.52 ' HD2' HD12 ' A' ' 10' ' ' LEU . 60.3 Cg_endo -75.07 129.71 12.53 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.497 2.131 . . . . 0.0 111.327 172.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.41 ' HA ' ' HG3' ' A' ' 88' ' ' MET . 2.3 p30 -86.55 -171.86 3.75 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.988 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.8 mt -67.12 -9.26 37.79 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -175.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -96.36 -9.56 29.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.932 0.396 . . . . 0.0 110.33 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.4 2.69 61.75 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.125 177.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 11' ' ' PRO . 20.6 pttp -96.13 144.79 26.05 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 28.5 m -94.45 125.55 39.16 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.889 -174.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.3 m -102.38 141.3 18.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 172.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 45.3 t -145.6 -178.08 5.91 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 121.076 -0.25 . . . . 0.0 110.963 -173.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -53.92 -39.22 65.65 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.258 0.623 . . . . 0.0 111.956 -175.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.77 -27.64 65.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.812 -177.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -78.49 -24.05 46.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.235 -176.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 81.5 mt -78.54 -21.37 48.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.895 0.379 . . . . 0.0 110.953 -178.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -72.27 103.33 3.34 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.02 0.438 . . . . 0.0 110.673 -176.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.0 -25.92 12.19 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.34 177.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.17 148.83 26.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.941 0.401 . . . . 0.0 110.343 178.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.49 HG13 ' O ' ' A' ' 110' ' ' ILE . 97.1 t -102.96 138.0 28.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 172.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 60' ' ' GLN . 22.3 m -132.06 135.12 46.24 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.614 -165.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.764 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 6.8 tt -106.88 106.43 16.96 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 173.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.917 HG12 ' HB2' ' A' ' 62' ' ' LEU . 39.9 mt -104.56 111.95 36.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 177.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.449 ' HA ' ' O ' ' A' ' 106' ' ' THR . 26.7 p-10 -110.72 134.18 52.69 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.413 0.625 . . . . 0.0 110.645 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -91.66 119.25 31.37 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.615 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.64 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 4.5 p-90 -147.82 -174.13 4.47 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.615 -173.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -155.28 150.35 20.77 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 173.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.413 ' HG3' ' HA ' ' A' ' 74' ' ' VAL . 92.8 Cg_exo -43.72 -47.08 9.99 Favored 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 123.148 2.566 . . . . 0.0 114.13 -177.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.1 m -85.82 27.46 0.87 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -177.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.524 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 52.8 t -79.91 129.55 70.13 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.015 0.436 . . . . 0.0 111.101 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 24.7 Cg_exo -63.54 -26.85 69.77 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.641 2.227 . . . . 0.0 111.922 176.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.2 -16.55 73.24 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.836 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.524 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 92.0 m -58.16 -29.4 65.56 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.72 0.26 . . . . 0.0 111.392 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.6 t -55.02 -43.08 67.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.997 0.427 . . . . 0.0 110.364 177.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.571 ' O ' ' HB3' ' A' ' 46' ' ' LYS . 15.1 m -86.5 -55.79 3.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.873 178.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.468 ' O ' HG12 ' A' ' 47' ' ' ILE . 43.3 mt-10 -59.46 -50.4 74.06 Favored 'General case' 0 C--O 1.213 -0.86 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -173.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.732 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 31.8 tpp -58.85 -61.02 8.6 Favored Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -164.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.732 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 33.1 Cg_exo -59.38 -35.96 95.25 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 121.652 1.568 . . . . 0.0 111.206 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.571 ' HB3' ' O ' ' A' ' 42' ' ' SER . 5.9 tptt -59.17 -49.3 78.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.956 176.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.546 HD13 ' HE3' ' A' ' 46' ' ' LYS . 43.8 mm -74.54 -31.58 27.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.63 -174.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.66 HG12 ' O ' ' A' ' 44' ' ' MET . 46.8 mm -54.72 -53.26 33.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-O 121.034 0.445 . . . . 0.0 109.901 176.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.648 ' HZ2' ' HB2' ' A' ' 53' ' ' ASP . 20.4 tptp -71.74 -35.97 70.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.969 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.3 m -62.11 -54.18 44.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.838 0.351 . . . . 0.0 111.202 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.605 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . -68.53 -27.38 66.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.981 -176.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.09 -39.3 60.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.493 177.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.648 ' HB2' ' HZ2' ' A' ' 49' ' ' LYS . 6.9 t70 -76.05 -52.19 10.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.233 0.54 . . . . 0.0 111.057 -173.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.879 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 90.8 m-85 -81.58 -2.47 50.18 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.363 -174.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.605 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 13.0 tppt? -59.4 -37.61 78.45 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.434 0.635 . . . . 0.0 109.916 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.2 m-20 -91.51 12.03 22.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.294 -175.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.578 ' O ' ' HB3' ' A' ' 58' ' ' ASN . 16.9 tptp -112.03 -61.68 1.68 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.711 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.578 ' HB3' ' O ' ' A' ' 57' ' ' LYS . 2.9 p-10 162.79 14.93 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 O-C-N 124.202 0.939 . . . . 0.0 110.279 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.879 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 57.2 t80 -112.53 143.03 44.38 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.924 0.392 . . . . 0.0 110.284 -175.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.531 ' O ' ' HA ' ' A' ' 28' ' ' THR . 11.7 pt20 -136.76 147.55 46.74 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.669 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.46 HG11 HG23 ' A' ' 47' ' ' ILE . 87.3 t -115.07 132.2 65.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.007 178.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.917 ' HB2' HG12 ' A' ' 30' ' ' ILE . 77.6 mt -122.37 110.9 16.22 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.654 ' HB3' HG22 ' A' ' 87' ' ' VAL . . . -94.48 116.42 28.77 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.171 -177.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.0 t -105.17 111.81 36.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.065 0.46 . . . . 0.0 110.528 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.64 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -95.83 124.77 39.99 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.929 177.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.5 169.73 8.18 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.613 ' HD3' ' O ' ' A' ' 90' ' ' ASP . 16.4 Cg_exo -67.33 80.77 0.41 Allowed 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.617 2.211 . . . . 0.0 113.781 -172.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 50.2 mm -117.69 -54.66 4.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 168.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.406 ' HB2' ' HD2' ' A' ' 35' ' ' PRO . 17.2 m-20 -101.86 151.94 38.05 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.738 170.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.31 151.12 30.53 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.73 2.287 . . . . 0.0 112.902 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.3 tt -57.19 -36.3 51.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.894 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.502 ' HA ' ' HD2' ' A' ' 75' ' ' ARG . 31.1 tp10 -69.61 -35.31 75.17 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.533 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.9 m -62.27 -32.45 73.16 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.206 0.527 . . . . 0.0 110.081 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.478 ' O ' HG13 ' A' ' 78' ' ' VAL . 45.2 t -65.42 -44.31 94.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.692 174.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.759 ' HA ' HG22 ' A' ' 78' ' ' VAL . 91.4 mtt180 -64.67 -31.92 73.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.388 177.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -60.98 -44.48 97.3 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 177.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -63.53 -46.16 87.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.272 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.759 HG22 ' HA ' ' A' ' 75' ' ' ARG . 11.1 m -67.08 -37.45 79.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.642 -177.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -75.64 -48.12 23.5 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -66.34 -48.38 70.44 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.103 -172.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -92.4 2.22 56.78 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -173.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 57.9 63.72 5.01 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.308 -0.473 . . . . 0.0 113.033 177.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.511 HD22 HG12 ' A' ' 78' ' ' VAL . 10.0 mp -73.22 115.85 45.01 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 120.702 0.287 . . . . 0.0 111.231 -177.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.39 15.98 1.78 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.177 2.584 . . . . 0.0 113.022 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.543 ' HE1' HD13 ' A' ' 48' ' ' ILE . 24.1 p90 -128.76 153.56 47.26 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.071 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.408 ' HB ' ' CD2' ' A' ' 62' ' ' LEU . 32.2 m -79.39 130.39 35.38 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.953 -174.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.654 HG22 ' HB3' ' A' ' 63' ' ' ALA . 60.9 t -116.44 139.43 43.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.334 -178.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.41 ' HG3' ' HA ' ' A' ' 12' ' ' ASP . 2.6 mpt? -119.24 169.3 10.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.078 177.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -123.5 110.3 14.9 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.613 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 0.9 OUTLIER -81.78 72.25 8.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.893 -175.646 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.78 -46.84 86.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.374 -172.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -87.78 -10.91 49.59 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.673 -0.24 . . . . 0.0 110.776 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.581 ' HB2' ' NZ ' ' A' ' 93' ' ' LYS . 8.1 mtmp? 69.23 7.49 6.26 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.562 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.65 -32.04 70.47 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -172.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.6 t -71.24 -42.91 74.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.58 -37.87 94.09 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.887 174.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -67.02 -32.05 73.0 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 122.486 0.315 . . . . 0.0 111.01 177.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.29 -45.29 85.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.648 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -66.62 -28.22 68.32 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.788 0.328 . . . . 0.0 110.644 176.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 71.96 59.95 4.45 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.804 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.6 p -99.88 -66.64 0.89 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.591 0.234 . . . . 0.0 111.069 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 72.53 -38.54 0.42 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.681 0.792 . . . . 0.0 112.296 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.8 m -97.83 132.3 42.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.139 0.495 . . . . 0.0 110.567 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -128.29 153.04 78.88 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.047 -175.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -80.86 161.01 83.2 Favored 'Cis proline' 0 C--O 1.234 0.314 0 C-N-CA 123.376 -1.51 . . . . 0.0 112.353 -0.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 10.2 t -150.25 127.53 11.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.15 0.5 . . . . 0.0 111.358 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.3 m -101.24 122.53 43.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.089 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 48.5 t -106.06 132.46 53.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.83 0.347 . . . . 0.0 110.207 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.573 HD23 ' HB3' ' A' ' 118' ' ' LYS . 2.8 mm? -102.03 118.77 37.6 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.943 -178.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.49 ' O ' HG13 ' A' ' 27' ' ' VAL . 53.5 mt -100.99 127.74 53.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.037 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -72.14 -179.51 33.68 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.204 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -86.61 -5.11 59.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.919 0.39 . . . . 0.0 110.764 -175.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -98.34 -31.6 11.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.856 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 113.89 19.83 6.29 Favored Glycine 0 C--O 1.225 -0.431 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.553 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.93 -26.2 60.38 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -172.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.477 HG13 ' HA ' ' A' ' 3' ' ' LYS . 20.8 mm 58.34 96.92 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-O 121.216 0.531 . . . . 0.0 109.582 -167.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.7 mt -93.68 -76.03 0.49 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -165.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.573 ' HB3' HD23 ' A' ' 109' ' ' LEU . 21.9 tptm -109.22 145.05 36.51 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.049 -164.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 7.7 p -122.67 108.01 12.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.382 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -94.88 128.7 41.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.994 173.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.7 t -120.1 132.39 69.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.668 0.271 . . . . 0.0 110.549 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 84.19 -102.51 2.51 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.122 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -106.78 108.78 62.5 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.485 ' HB2' HD22 ' A' ' 129' ' ' LEU . 68.7 Cg_endo -76.65 104.69 1.95 Allowed 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.198 1.932 . . . . 0.0 112.16 178.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -48.75 107.66 0.14 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.676 178.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -60.15 -43.4 95.77 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.095 -173.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -59.5 -51.0 61.68 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.495 -176.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -80.27 -21.0 43.18 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 122.973 -0.133 . . . . 0.0 111.248 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.485 HD22 ' HB2' ' A' ' 124' ' ' PRO . 52.0 tp -68.69 -47.04 67.46 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.162 -0.311 . . . . 0.0 110.162 176.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -66.96 -40.54 87.5 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.908 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -68.11 -30.49 69.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.728 0.299 . . . . 0.0 111.309 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.494 ' OE1' ' HG2' ' A' ' 118' ' ' LYS . 35.3 tt0 -77.82 -34.34 52.06 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.663 0.268 . . . . 0.0 110.488 178.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 129' ' ' LEU . 76.1 mt -65.66 -38.94 83.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-O 121.212 0.529 . . . . 0.0 109.659 172.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.37 -36.42 84.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.461 172.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 91.1 m -63.35 -31.67 72.89 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.13 174.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 133' ' ' ILE . . . -65.14 -30.63 71.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.596 175.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.774 ' HH2' ' HB2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -69.09 -54.93 12.43 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 172.392 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 17.7 ttp-105 -56.45 -40.57 75.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.142 -1.39 . . . . 0.0 112.147 -176.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -64.19 93.28 0.09 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 173.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 5.6 m -60.8 -63.94 1.12 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.143 -172.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 13.7 t0 -99.03 -44.81 6.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.671 -173.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 141' ' ' ASP . . . 70.02 52.17 0.39 Allowed 'General case' 0 N--CA 1.465 0.305 0 O-C-N 123.796 0.685 . . . . 0.0 109.498 -167.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 62.94 101.83 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 114.214 -1.357 . . . . 0.0 112.565 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -116.77 27.68 7.77 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 172.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 65.49 24.12 11.86 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.43 0.692 . . . . 0.0 110.196 -176.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 27.8 m80 67.34 10.76 7.97 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.453 175.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -147.6 82.89 1.53 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 175.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -64.83 114.56 4.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.255 -173.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 52.5 p-80 -137.58 20.46 2.91 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.261 175.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 71.9 t60 . . . . . 0 C--O 1.245 0.833 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.011 176.749 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.516 ' HA ' ' O ' ' A' ' 5' ' ' ALA . 12.7 t70 . . . . . 0 N--CA 1.48 1.04 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.3 t 62.29 100.92 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 O-C-N 123.922 0.764 . . . . 0.0 110.846 -176.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.527 ' HA ' HD12 ' A' ' 116' ' ' ILE . 44.8 mttp 66.92 13.87 9.61 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.931 0.872 . . . . 0.0 110.932 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.6 p -148.86 35.86 0.77 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.946 -1.479 . . . . 0.0 107.981 173.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.516 ' O ' ' HA ' ' A' ' 1' ' ' ASP . . . 66.13 108.34 0.03 OUTLIER Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 113.747 -1.57 . . . . 0.0 111.224 -172.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.03 163.32 38.61 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.432 2.088 . . . . 0.0 111.39 176.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.21 88.44 2.49 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.164 0.507 . . . . 0.0 110.156 176.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -129.49 148.86 51.44 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.352 0.596 . . . . 0.0 111.134 -177.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.9 m -141.23 90.75 2.33 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 171.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.581 HD12 ' HD2' ' A' ' 11' ' ' PRO . 28.4 tp -112.57 124.35 32.07 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.216 -172.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.581 ' HD2' HD12 ' A' ' 10' ' ' LEU . 58.3 Cg_endo -73.07 138.71 28.6 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.406 2.071 . . . . 0.0 111.908 176.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.515 ' HA ' ' HG2' ' A' ' 88' ' ' MET . 0.0 OUTLIER -75.29 169.44 18.05 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 175.488 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.543 HD13 ' HG2' ' A' ' 75' ' ' ARG . 84.6 mt -66.03 -17.79 64.92 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -175.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.474 ' H ' ' CG ' ' A' ' 12' ' ' ASP . 48.8 t-80 -86.89 -19.55 28.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.945 177.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.7 4.4 21.47 Favored Glycine 0 CA--C 1.517 0.208 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.058 177.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -85.62 110.75 19.49 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 122.595 -0.356 . . . . 0.0 110.263 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 8.3 m -64.3 122.88 17.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.678 178.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.594 HG11 HD21 ' A' ' 62' ' ' LEU . 59.6 t -110.89 125.07 68.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.924 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 51.0 p -140.94 -174.35 3.97 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.236 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -55.87 -32.27 63.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.109 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.6 -28.53 67.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.202 -176.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -78.84 -23.89 44.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.031 0.443 . . . . 0.0 110.549 -175.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 81.3 mt -77.64 -19.98 54.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.172 -177.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.498 ' OE1' ' HA ' ' A' ' 113' ' ' LYS . 16.5 mm-40 -64.57 119.04 9.72 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.775 -174.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.13 -21.29 46.77 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.035 -0.602 . . . . 0.0 113.078 174.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 112' ' ' LYS . 31.3 mtmt -117.77 160.58 21.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.808 0.337 . . . . 0.0 111.167 -174.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.596 HG21 ' CD1' ' A' ' 137' ' ' TRP . 13.2 t -101.71 144.76 12.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -178.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.618 HG23 HD13 ' A' ' 62' ' ' LEU . 40.6 m -139.34 140.41 37.52 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.06 0.457 . . . . 0.0 112.102 -168.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.889 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 28.1 tp -109.4 106.18 15.85 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.333 171.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.661 ' HB ' ' CG2' ' A' ' 108' ' ' VAL . 37.2 mt -91.09 111.59 23.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 C-N-CA 120.303 -0.559 . . . . 0.0 109.51 176.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -108.83 114.81 28.91 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.897 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -87.69 118.24 27.05 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.496 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 8.0 p-90 -144.71 -173.81 4.16 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.014 0.435 . . . . 0.0 110.464 -176.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.402 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 38.6 p90 -161.71 144.3 8.99 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.351 176.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -58.53 163.98 9.87 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.366 2.044 . . . . 0.0 111.84 175.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 44.5 m 66.84 11.89 8.56 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.408 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 42.1 t -95.67 126.11 46.59 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.47 177.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.434 ' O ' HG12 ' A' ' 41' ' ' VAL . 35.2 Cg_exo -61.87 -18.2 59.66 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.977 2.451 . . . . 0.0 112.978 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.55 -6.73 56.11 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 121.125 -0.559 . . . . 0.0 113.112 -178.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 26.3 p -62.19 -30.58 71.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.559 0.219 . . . . 0.0 110.887 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 38' ' ' PRO . 13.0 p -66.73 -28.92 44.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.845 0.355 . . . . 0.0 110.899 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.6 m -88.0 -56.74 3.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.014 0.435 . . . . 0.0 111.268 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.559 ' HA ' ' HE2' ' A' ' 46' ' ' LYS . 2.9 mt-10 -74.32 -40.69 62.04 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -170.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.476 ' O ' HG12 ' A' ' 48' ' ' ILE . 35.2 tpp -59.57 -54.87 51.65 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -172.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.406 ' HD2' ' N ' ' A' ' 44' ' ' MET . 15.9 Cg_endo -57.52 -35.48 98.83 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 121.829 1.686 . . . . 0.0 111.731 177.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.65 ' HZ2' ' HD2' ' A' ' 124' ' ' PRO . 28.8 ttpt -61.14 -51.94 66.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.541 175.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.557 HG12 ' O ' ' A' ' 43' ' ' GLU . 47.3 mm -57.17 -41.03 77.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.788 -178.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.476 HG12 ' O ' ' A' ' 44' ' ' MET . 48.8 mm -57.9 -45.87 87.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.995 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -75.4 -40.96 57.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.498 0.19 . . . . 0.0 111.248 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.462 ' O ' ' HD2' ' A' ' 54' ' ' TYR . 60.7 m -59.55 -50.01 75.55 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.859 0.361 . . . . 0.0 110.435 177.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.76 -31.8 72.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.598 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -54.22 -44.06 71.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.958 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -79.01 -51.89 8.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.35 0.595 . . . . 0.0 111.142 177.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.983 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 50.8 m-85 -72.3 -20.46 61.5 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -167.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -68.52 -15.23 63.47 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 122.207 -0.308 . . . . 0.0 110.793 176.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -106.83 8.16 30.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.36 0.6 . . . . 0.0 109.874 177.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.967 ' HD2' ' HH2' ' A' ' 137' ' ' TRP . 30.8 mmtp -100.87 -69.71 0.76 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.376 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 4.5 t-20 164.23 29.59 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -172.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.983 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 48.6 t80 -131.41 138.22 49.0 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.799 -167.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.419 ' O ' ' HA ' ' A' ' 28' ' ' THR . 10.8 pt20 -128.26 140.96 51.6 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.464 178.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.432 HG11 HG23 ' A' ' 47' ' ' ILE . 60.4 t -100.61 125.85 54.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.012 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.618 HD13 HG23 ' A' ' 28' ' ' THR . 10.9 mp -112.48 99.11 7.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.103 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.85 107.32 16.95 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.863 178.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.1 t -99.22 104.35 15.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.064 0.459 . . . . 0.0 110.458 -177.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -90.89 120.3 31.79 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 175.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.687 ' HB3' ' HD2' ' A' ' 67' ' ' PRO . 37.0 mt-30 -94.83 170.79 7.47 Favored Pre-proline 0 C--N 1.317 -0.821 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -177.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.687 ' HD2' ' HB3' ' A' ' 66' ' ' GLN . 72.5 Cg_endo -71.01 57.92 2.1 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 123.135 2.557 . . . . 0.0 115.225 -164.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.402 ' HB ' ' HB2' ' A' ' 34' ' ' PHE . 49.8 mm -92.24 -51.56 11.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 171.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.538 ' OD1' ' HD2' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -109.23 149.81 40.22 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.362 -0.835 . . . . 0.0 108.779 174.104 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.538 ' HD2' ' OD1' ' A' ' 69' ' ' ASP . 84.4 Cg_exo -49.56 155.76 3.39 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 123.058 2.506 . . . . 0.0 113.737 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.615 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 11.1 tt -54.95 -40.87 55.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.695 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -65.79 -33.47 75.93 Favored 'General case' 0 C--O 1.215 -0.746 0 C-N-CA 120.864 -0.335 . . . . 0.0 110.694 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.7 m -58.26 -40.8 82.8 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.374 0.607 . . . . 0.0 109.943 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.401 ' O ' HG13 ' A' ' 78' ' ' VAL . 20.0 t -65.59 -44.07 93.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.284 175.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.764 ' HA ' HG22 ' A' ' 78' ' ' VAL . 20.1 mtm180 -67.53 -24.98 65.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.019 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -68.63 -43.07 77.1 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -63.78 -47.59 80.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.147 178.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.764 HG22 ' HA ' ' A' ' 75' ' ' ARG . 12.6 m -65.83 -26.63 39.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.129 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.609 ' HB2' ' O ' ' A' ' 75' ' ' ARG . 3.6 ttmp? -74.21 -52.15 13.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.892 -177.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -67.19 -49.43 64.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.204 -174.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -85.82 -10.43 55.44 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -174.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.62 60.28 8.77 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.308 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.604 HD22 HG12 ' A' ' 78' ' ' VAL . 10.1 mp -63.64 116.01 22.98 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 120.879 0.371 . . . . 0.0 111.461 -176.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -86.45 25.26 0.69 Allowed 'Trans proline' 0 C--O 1.241 0.636 0 C-N-CA 123.314 2.676 . . . . 0.0 113.467 -177.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -136.23 159.71 40.9 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 30.7 m -67.71 122.68 18.61 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.434 -174.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.8 t -119.29 127.57 75.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.956 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.515 ' HG2' ' HA ' ' A' ' 12' ' ' ASP . 67.2 mtm -122.76 164.36 18.48 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.263 -177.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.444 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 67.6 t80 -126.1 125.65 42.9 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.373 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.537 ' HB3' ' HA ' ' A' ' 66' ' ' GLN . 28.4 t0 -88.89 135.91 33.29 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.25 -32.84 61.21 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.435 ' O ' ' HB3' ' A' ' 93' ' ' LYS . 31.9 t70 -130.07 -11.08 4.25 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -172.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.675 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER 82.93 17.94 0.28 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 122.89 1.329 . . . . 0.0 108.744 -172.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.617 ' HA ' HE21 ' A' ' 97' ' ' GLN . . . -74.02 -27.17 60.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.007 -176.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.7 t -69.14 -41.19 81.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.57 -33.59 87.64 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 174.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.617 HE21 ' HA ' ' A' ' 94' ' ' ALA . 47.0 mt-30 -64.14 -39.05 93.19 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 122.595 0.358 . . . . 0.0 111.098 176.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.48 -39.82 92.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.058 0.456 . . . . 0.0 110.967 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -73.01 -27.78 61.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.556 177.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.98 34.44 5.68 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.425 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 29.1 p -106.17 126.25 51.98 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.742 0.305 . . . . 0.0 110.804 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.512 ' HG3' HG13 ' A' ' 103' ' ' VAL . 11.8 pt20 -108.82 -36.32 6.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.907 0.384 . . . . 0.0 110.839 178.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.512 HG13 ' HG3' ' A' ' 102' ' ' GLN . 19.7 m -102.85 142.1 17.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.21 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.517 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 37.6 m-85 -130.46 158.67 73.82 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.09 -177.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.517 ' HA ' ' HB3' ' A' ' 104' ' ' TYR . 94.1 Cg_endo -81.41 165.05 75.51 Favored 'Cis proline' 0 CA--C 1.53 0.311 0 C-N-CA 123.587 -1.422 . . . . 0.0 113.17 0.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.535 HG23 ' HA ' ' A' ' 121' ' ' VAL . 95.8 m -150.82 133.32 15.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.787 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.604 ' HB3' HD11 ' A' ' 29' ' ' LEU . 68.0 m -108.09 117.47 34.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.969 0.414 . . . . 0.0 111.003 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.661 ' CG2' ' HB ' ' A' ' 30' ' ' ILE . 29.0 m -106.36 146.15 13.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.121 0.486 . . . . 0.0 110.839 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.676 ' HB2' ' HB3' ' A' ' 118' ' ' LYS . 2.6 mm? -102.37 124.47 48.0 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.065 -176.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.576 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 22.7 mm -104.4 134.59 45.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.512 ' O ' ' HA ' ' A' ' 27' ' ' VAL . . . -67.79 -93.66 0.04 OUTLIER Glycine 0 C--O 1.226 -0.353 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.868 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 10.9 ptpt -166.8 23.73 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.271 0.557 . . . . 0.0 110.844 171.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.498 ' HA ' ' OE1' ' A' ' 24' ' ' GLN . 36.8 mtmm -136.12 10.1 3.27 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 174.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 5' ' ' ALA . . . 78.25 18.35 76.45 Favored Glycine 0 C--O 1.223 -0.535 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.54 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -69.71 -24.63 63.6 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -171.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.527 HD12 ' HA ' ' A' ' 3' ' ' LYS . 8.5 mt 64.02 89.63 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.66 0.743 . . . . 0.0 109.701 -175.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 23.2 mt -87.54 -34.93 18.42 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.257 -0.883 . . . . 0.0 113.109 -167.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.676 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 22.0 tptm -150.27 157.53 43.18 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.302 -168.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.537 HG23 HG12 ' A' ' 108' ' ' VAL . 51.4 m -140.28 107.86 5.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.859 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.649 ' HB3' ' HB3' ' A' ' 124' ' ' PRO . 67.8 m-85 -101.68 107.39 18.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.117 173.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.535 ' HA ' HG23 ' A' ' 106' ' ' THR . 48.1 t -82.93 126.78 40.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.46 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 80.31 -138.58 20.01 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.029 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.444 ' OE2' ' HD2' ' A' ' 124' ' ' PRO . 12.7 tp10 -96.64 109.33 47.74 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 110.229 -0.285 . . . . 0.0 110.229 -178.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.65 ' HD2' ' HZ2' ' A' ' 46' ' ' LYS . 91.9 Cg_endo -81.72 174.11 10.65 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 123.234 2.623 . . . . 0.0 113.359 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.497 ' OD2' ' HB3' ' A' ' 128' ' ' LYS . 11.2 p-10 -88.3 120.0 29.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.091 175.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.581 ' HE2' ' HG3' ' A' ' 46' ' ' LYS . 92.2 m-85 -58.47 -46.94 85.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.832 -173.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -56.34 -53.63 41.72 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 121.045 -0.598 . . . . 0.0 113.443 -172.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.551 ' NZ ' ' HB3' ' A' ' 128' ' ' LYS . 2.1 ttpm? -76.17 -26.14 55.94 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.464 0.173 . . . . 0.0 110.694 -177.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.482 ' O ' HG13 ' A' ' 133' ' ' ILE . 7.5 tt -64.41 -46.99 80.87 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 177.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -61.78 -56.04 23.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.479 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.441 ' HG2' ' HA ' ' A' ' 128' ' ' LYS . 4.5 pt20 -60.91 -29.61 69.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.718 0.294 . . . . 0.0 111.292 -176.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -72.46 -36.37 68.48 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.711 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.482 HG13 ' O ' ' A' ' 129' ' ' LEU . 69.1 mt -69.36 -53.0 27.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -62.78 -27.32 69.22 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.767 0.318 . . . . 0.0 111.413 -176.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 90.4 m -73.76 -30.85 63.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.012 0.434 . . . . 0.0 110.964 177.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.46 ' HA ' ' ND2' ' A' ' 139' ' ' ASN . . . -65.83 -18.38 65.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.563 -177.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.967 ' HH2' ' HD2' ' A' ' 57' ' ' LYS . 38.6 m0 -56.93 -36.69 70.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.812 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.421 ' C ' ' H ' ' A' ' 140' ' ' SER . 7.3 tpt180 -81.49 -15.46 54.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.24 -173.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.46 ' ND2' ' HA ' ' A' ' 136' ' ' ALA . 89.7 m-20 -73.1 35.38 0.08 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -175.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.421 ' H ' ' C ' ' A' ' 138' ' ' ARG . 47.2 m -150.09 13.06 0.77 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.045 0.45 . . . . 0.0 109.844 175.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -95.16 149.21 21.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.988 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -155.35 101.12 2.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.949 0.404 . . . . 0.0 112.044 -175.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -67.75 142.57 56.22 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 171.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 129.8 -29.63 3.72 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 -173.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -75.17 80.37 2.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.234 0.54 . . . . 0.0 109.656 177.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -99.32 110.49 23.0 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.694 -172.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -94.34 -0.68 54.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.359 0.599 . . . . 0.0 109.388 172.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -110.03 118.89 37.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.745 176.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -99.12 154.93 17.74 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.686 -173.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 63.5 m-70 . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.044 -0.979 . . . . 0.0 108.659 167.148 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 . . . . . 0 N--CA 1.481 1.118 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.3 p -65.73 -72.74 0.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 O-C-N 123.214 0.321 . . . . 0.0 110.358 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 55.21 -125.02 2.16 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.232 173.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.1 p -92.76 28.86 1.92 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.839 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 72.94 124.51 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.334 1.021 . . . . 0.0 111.668 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.21 169.22 22.05 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.529 2.153 . . . . 0.0 111.583 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.69 101.85 8.64 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.711 0.291 . . . . 0.0 110.397 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -122.74 140.92 52.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.587 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.4 m -128.15 90.64 3.12 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.546 HD12 ' HD2' ' A' ' 11' ' ' PRO . 35.6 tp -114.88 125.01 29.51 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.314 -175.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.546 ' HD2' HD12 ' A' ' 10' ' ' LEU . 61.0 Cg_endo -75.57 153.59 39.24 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.215 1.944 . . . . 0.0 112.184 176.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.525 ' HA ' ' HG2' ' A' ' 88' ' ' MET . 1.9 p-10 -83.23 -166.24 1.3 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.824 177.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 87' ' ' VAL . 89.9 mt -77.35 3.03 14.08 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -176.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.445 ' CE1' ' HB2' ' A' ' 16' ' ' LYS . 4.7 p-80 -128.07 -20.65 3.75 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 119.924 -0.711 . . . . 0.0 111.731 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 125.88 27.82 1.1 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.085 -1.055 . . . . 0.0 113.898 174.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.445 ' HB2' ' CE1' ' A' ' 14' ' ' HIS . 13.2 tmtt? -100.58 112.48 24.87 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 175.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.6 m -66.97 122.32 17.47 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.943 0.402 . . . . 0.0 110.696 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.519 HG11 HD13 ' A' ' 62' ' ' LEU . 60.2 t -108.73 131.98 57.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.808 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 50.4 m -145.55 -174.21 4.33 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.97 0.414 . . . . 0.0 111.148 -178.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -61.04 -25.07 66.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.462 -177.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.22 -34.09 74.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.352 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -70.34 -30.39 67.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.323 0.583 . . . . 0.0 110.398 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.573 HD13 HG21 ' A' ' 110' ' ' ILE . 35.0 mt -85.36 -40.47 16.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.632 -171.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -71.49 21.69 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -159.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -152.19 11.19 0.66 Allowed Glycine 0 C--N 1.321 -0.279 0 C-N-CA 120.033 -1.08 . . . . 0.0 113.114 177.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 58' ' ' ASN . 11.4 ptmm? -160.02 179.58 8.63 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.629 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 21.4 t -102.89 139.32 24.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 C-N-CA 120.472 -0.491 . . . . 0.0 109.71 -175.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.618 HG23 ' HG3' ' A' ' 60' ' ' GLN . 44.3 m -136.88 148.14 46.89 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.705 -171.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.783 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 62.7 tp -112.79 105.8 14.01 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 175.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.532 HD13 ' HB2' ' A' ' 62' ' ' LEU . 48.5 mm -88.48 110.56 21.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 172.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.481 ' HA ' ' O ' ' A' ' 106' ' ' THR . 9.2 t30 -120.13 110.29 16.45 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.0 -173.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -84.03 120.45 26.15 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.394 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.463 ' NE1' ' HB1' ' A' ' 63' ' ' ALA . 2.8 p-90 -150.33 -171.82 4.01 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.651 -176.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.43 ' HB3' ' NE2' ' A' ' 66' ' ' GLN . 40.0 p90 -155.98 138.48 10.36 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.512 -0.767 . . . . 0.0 108.955 174.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.724 ' HD2' ' HB2' ' A' ' 69' ' ' ASP . 71.2 Cg_exo -41.96 -46.23 6.92 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.868 3.045 . . . . 0.0 115.167 -174.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.1 m -80.92 8.53 8.14 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -173.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.4 p -75.61 157.86 83.75 Favored Pre-proline 0 C--N 1.327 -0.398 0 O-C-N 122.263 -0.273 . . . . 0.0 110.651 -178.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -62.15 -11.29 21.32 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.652 2.234 . . . . 0.0 112.008 175.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.816 ' O ' ' HB2' ' A' ' 43' ' ' GLU . . . -75.86 4.55 44.76 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.756 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 12.5 p -78.43 -56.15 4.67 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 121.338 -1.095 . . . . 0.0 110.555 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.65 -42.77 71.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.787 -175.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.0 m -86.79 -42.81 13.0 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -175.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.816 ' HB2' ' O ' ' A' ' 39' ' ' GLY . 20.8 mm-40 -83.47 -41.69 17.75 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -171.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.614 ' O ' HG12 ' A' ' 48' ' ' ILE . 33.7 tpp -51.74 -53.18 53.54 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -171.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.6 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 52.9 Cg_exo -55.6 -40.39 85.64 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.872 1.715 . . . . 0.0 112.599 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -71.14 -34.94 71.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.56 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.7 mm -69.14 -43.02 81.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.757 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.614 HG12 ' O ' ' A' ' 44' ' ' MET . 47.3 mm -55.55 -52.65 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.028 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.431 ' HE2' ' O ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -58.56 -46.07 87.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.642 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.42 HG23 ' HE1' ' A' ' 130' ' ' TYR . 84.0 m -62.18 -53.14 59.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.639 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.83 -36.18 77.88 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -173.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.73 -33.84 62.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.821 0.343 . . . . 0.0 110.264 -178.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -70.69 -51.41 27.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.572 0.701 . . . . 0.0 109.937 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 1.01 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 22.6 m-85 -72.01 -7.39 48.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.411 -178.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.9 tptt -57.68 -41.77 82.29 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.488 0.492 . . . . 0.0 110.642 -177.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -101.56 10.07 40.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.272 -177.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.635 ' HG3' ' OD1' ' A' ' 58' ' ' ASN . 25.9 tptp -95.33 -62.81 1.24 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.365 -177.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.635 ' OD1' ' HG3' ' A' ' 57' ' ' LYS . 2.4 p-10 169.66 7.31 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.422 0.689 . . . . 0.0 109.763 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 1.01 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 54.2 t80 -118.33 148.6 42.32 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.542 -165.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.618 ' HG3' HG23 ' A' ' 28' ' ' THR . 10.8 pt20 -141.62 129.73 22.11 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.102 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.6 t -95.52 115.62 35.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 120.973 0.416 . . . . 0.0 110.117 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.532 ' HB2' HD13 ' A' ' 30' ' ' ILE . 84.2 mt -109.81 95.96 5.94 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.432 -0.804 . . . . 0.0 108.926 177.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.54 ' HB3' HG22 ' A' ' 87' ' ' VAL . . . -80.83 125.57 30.25 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.117 -177.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.1 t -106.03 115.75 48.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 120.908 0.385 . . . . 0.0 110.106 -178.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.09 112.62 22.88 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.245 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.598 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 0.8 OUTLIER -93.91 162.04 28.15 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.979 -179.364 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.598 ' HD2' ' HB2' ' A' ' 66' ' ' GLN . 60.1 Cg_endo -69.3 66.49 1.5 Allowed 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 123.081 2.521 . . . . 0.0 115.862 -164.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.4 mp -107.55 -51.34 7.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 162.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.724 ' HB2' ' HD2' ' A' ' 35' ' ' PRO . 30.5 m-20 -101.44 135.3 19.86 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.515 174.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -57.2 160.88 12.18 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.946 2.431 . . . . 0.0 112.336 177.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.552 ' O ' ' HG2' ' A' ' 75' ' ' ARG . 9.4 tt -58.27 -36.09 56.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.325 -177.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.768 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . 2.2 pm0 -68.97 -29.93 68.25 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.981 -0.287 . . . . 0.0 111.444 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.1 m -65.12 -38.38 90.5 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 174.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.432 ' HA ' ' HG3' ' A' ' 35' ' ' PRO . 14.1 t -71.98 -49.16 46.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.772 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.817 ' HA ' HG22 ' A' ' 78' ' ' VAL . 13.4 ptt180 -70.11 -24.95 63.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.702 -177.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -69.35 -42.84 74.75 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 170.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -62.24 -50.06 73.24 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.118 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.817 HG22 ' HA ' ' A' ' 75' ' ' ARG . 21.5 m -62.41 -27.01 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.063 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.22 -55.09 6.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.236 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -62.45 -43.93 97.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.44 -171.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -97.75 -3.16 39.6 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -173.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 56.56 65.52 3.51 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.446 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.571 HD22 HG12 ' A' ' 78' ' ' VAL . 9.7 mp -68.98 117.62 53.37 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-O 120.907 0.384 . . . . 0.0 111.575 -175.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -78.65 -4.65 14.25 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.32 2.68 . . . . 0.0 113.14 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -106.31 138.81 41.83 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.447 ' HB ' HD23 ' A' ' 62' ' ' LEU . 22.0 m -72.0 126.29 29.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.242 -172.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.54 HG22 ' HB3' ' A' ' 63' ' ' ALA . 46.1 t -110.68 131.79 60.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.788 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.525 ' HG2' ' HA ' ' A' ' 12' ' ' ASP . 63.2 mtm -112.74 168.36 9.74 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.06 176.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -121.6 127.18 50.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.827 0.346 . . . . 0.0 110.429 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.587 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 63.5 t0 -105.14 106.53 17.06 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.71 -47.75 37.16 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -173.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -91.93 -5.2 53.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.639 -175.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.576 ' O ' ' HG3' ' A' ' 97' ' ' GLN . 34.5 ttmt 65.66 20.2 11.53 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -173.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.93 -25.65 60.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.169 -175.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.462 HG21 HD22 ' A' ' 10' ' ' LEU . 22.5 t -74.01 -39.05 50.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 174.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.95 -33.3 86.87 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.772 173.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.576 ' HG3' ' O ' ' A' ' 93' ' ' LYS . 78.0 mt-30 -66.19 -33.27 75.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.98 0.419 . . . . 0.0 110.815 176.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.53 -39.87 70.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.478 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -87.27 -27.05 23.15 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.36 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 97.58 62.42 0.9 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.924 176.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 66.5 p -79.76 112.01 16.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.673 0.273 . . . . 0.0 111.147 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -103.51 -38.37 7.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.895 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.473 ' CG1' ' HB ' ' A' ' 121' ' ' VAL . 9.7 p -144.47 144.15 22.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -108.51 146.93 34.7 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.08 -173.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -75.33 151.48 96.48 Favored 'Cis proline' 0 C--N 1.343 0.279 0 C-N-CA 122.814 -1.744 . . . . 0.0 112.801 0.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 23.9 m -108.09 112.65 25.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.591 176.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.55 ' HB3' HD11 ' A' ' 29' ' ' LEU . 9.4 m -102.5 109.8 21.55 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.952 0.406 . . . . 0.0 110.6 -176.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 36.3 t -108.28 133.2 53.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.471 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.588 HD12 ' HB3' ' A' ' 118' ' ' LYS . 97.2 mt -101.58 116.34 32.54 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.085 0.469 . . . . 0.0 110.168 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.573 HG21 HD13 ' A' ' 23' ' ' LEU . 11.0 mm -107.33 157.21 7.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.066 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -146.22 -155.9 6.69 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 119.93 -1.129 . . . . 0.0 112.774 176.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.519 ' O ' ' HB3' ' A' ' 113' ' ' LYS . 16.5 pttp -56.99 156.13 7.26 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 124.014 0.925 . . . . 0.0 109.365 178.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.519 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 3.0 ttmp? 71.92 -16.76 0.39 Allowed 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.981 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.442 ' H ' ' C ' ' A' ' 112' ' ' LYS . . . 91.38 7.37 65.35 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 -174.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.518 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 17.2 pt-20 -67.77 135.73 53.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.123 0.487 . . . . 0.0 111.052 -176.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 57.0 mt -80.98 107.25 13.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 174.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.01 -40.56 38.6 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.761 -173.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.588 ' HB3' HD12 ' A' ' 109' ' ' LEU . 21.9 tptm -161.24 154.78 21.79 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.421 -171.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.3 m -136.62 115.59 12.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.867 0.365 . . . . 0.0 110.966 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.469 ' OH ' ' HE3' ' A' ' 128' ' ' LYS . 75.2 m-85 -108.04 144.65 35.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.446 174.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.473 ' HB ' ' CG1' ' A' ' 103' ' ' VAL . 6.2 m -123.92 137.23 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-O 120.731 0.3 . . . . 0.0 110.947 177.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 89.68 -84.67 1.39 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.2 177.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.05 106.74 7.37 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -75.9 119.76 5.52 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.502 2.135 . . . . 0.0 112.112 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.553 ' HB2' ' HE2' ' A' ' 128' ' ' LYS . 0.5 OUTLIER -53.4 93.07 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.078 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.565 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 14.7 m-85 -61.93 -33.29 74.0 Favored 'General case' 0 C--O 1.219 -0.53 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -172.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -59.32 -49.15 81.58 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 119.821 -1.18 . . . . 0.0 111.335 175.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.553 ' HE2' ' HB2' ' A' ' 125' ' ' ASP . 32.2 ttpt -68.5 -36.88 79.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.09 -0.555 . . . . 0.0 110.265 177.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.565 ' HB3' ' HA ' ' A' ' 126' ' ' PHE . 8.8 tt -64.33 -44.17 92.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.984 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.42 ' HE1' HG23 ' A' ' 50' ' ' THR . 18.2 m-30 -56.36 -56.4 21.55 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.017 0.437 . . . . 0.0 110.625 179.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -65.27 -34.26 77.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.882 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -64.49 -38.09 89.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.598 -0.273 . . . . 0.0 111.102 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.522 HG23 HG11 ' A' ' 27' ' ' VAL . 66.1 mt -62.66 -52.87 54.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.721 0.296 . . . . 0.0 110.895 177.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -69.56 -17.63 63.58 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 97.2 m -71.68 -26.63 62.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.307 0.575 . . . . 0.0 109.836 172.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.27 -17.9 64.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.35 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.41 ' HE3' ' HA ' ' A' ' 137' ' ' TRP . 4.0 m95 -59.17 -48.8 80.26 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-O 121.191 0.52 . . . . 0.0 109.819 175.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -59.73 -33.41 71.6 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.261 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -86.16 59.69 5.78 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 176.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 11.0 m -60.64 -52.57 64.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.347 -175.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.0 t70 178.39 -164.6 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . 63.25 27.33 15.48 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 122.819 0.448 . . . . 0.0 111.273 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.405 ' CD ' ' H ' ' A' ' 145' ' ' HIS . 1.3 tm-20 -86.48 116.53 24.68 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -116.94 36.41 3.76 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.274 -176.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.405 ' H ' ' CD ' ' A' ' 143' ' ' GLU . 12.4 p-80 41.48 67.17 0.58 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.979 0.912 . . . . 0.0 111.578 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 -68.85 105.02 2.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.194 -178.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -60.17 94.56 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.143 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -101.4 76.55 1.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.596 0.712 . . . . 0.0 110.244 178.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 176.25 166.16 0.43 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -176.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 28.3 t60 . . . . . 0 C--N 1.319 -0.724 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 168.426 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.453 ' CG ' ' H ' ' A' ' 2' ' ' SER . 3.2 p-10 . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 110.932 -0.025 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.453 ' H ' ' CG ' ' A' ' 1' ' ' ASP . 11.9 m -103.06 -170.35 1.78 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.693 0.282 . . . . 0.0 110.538 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 46.1 mttp -102.13 -166.8 1.33 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 173.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 115' ' ' GLU . 3.4 m 68.52 29.24 5.66 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.563 0.697 . . . . 0.0 109.285 -173.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.764 ' HB1' ' HB2' ' A' ' 20' ' ' ASN . . . 75.28 101.55 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 114.277 -1.329 . . . . 0.0 110.657 -176.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.408 ' HG3' ' O ' ' A' ' 2' ' ' SER . 11.2 Cg_exo -69.04 171.08 14.29 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.381 2.721 . . . . 0.0 112.811 -174.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.33 75.92 10.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.13 0.49 . . . . 0.0 110.648 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -125.36 150.16 47.45 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.652 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.8 p -145.3 90.59 2.04 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.518 176.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -110.25 134.73 20.69 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.416 -173.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.566 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 56.5 Cg_endo -72.98 131.74 17.28 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.177 1.918 . . . . 0.0 111.553 174.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.24 176.38 9.73 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.674 HD12 HG21 ' A' ' 78' ' ' VAL . 75.1 mt -70.69 -13.76 62.2 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -173.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -102.19 -2.82 28.47 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.195 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.78 17.76 11.57 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.478 -0.868 . . . . 0.0 114.75 169.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.463 ' HZ2' HG22 ' A' ' 18' ' ' VAL . 41.4 tttm -105.46 126.65 52.36 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 117.761 0.781 . . . . 0.0 110.062 175.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 10.2 t -72.28 125.09 26.48 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.433 0.635 . . . . 0.0 109.499 173.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.757 ' HB ' ' SD ' ' A' ' 88' ' ' MET . 60.2 t -113.31 124.29 69.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.238 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.1 m -121.82 -173.94 2.76 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.179 -177.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.764 ' HB2' ' HB1' ' A' ' 5' ' ' ALA . 31.4 p-10 -68.89 -23.22 64.17 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.873 0.368 . . . . 0.0 110.678 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.14 -28.05 69.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.707 176.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -71.9 -12.41 61.25 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.179 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.2 mt -84.59 -27.87 26.95 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.012 0.434 . . . . 0.0 111.604 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.6 mm100 -74.21 144.4 44.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.121 -170.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.42 -25.47 17.64 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 121.14 -0.553 . . . . 0.0 114.014 170.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.565 ' HG3' ' HG3' ' A' ' 60' ' ' GLN . 0.0 OUTLIER -143.59 -168.18 2.76 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -177.897 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.612 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 14.2 t -101.93 144.4 13.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 176.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.582 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 30.0 m -140.29 149.34 42.67 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.964 -0.295 . . . . 0.0 110.255 -173.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.761 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 6.4 tt -121.64 117.75 27.47 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 173.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.682 ' HB ' ' CG2' ' A' ' 108' ' ' VAL . 51.2 mt -102.56 119.97 51.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.333 -0.394 . . . . 0.0 109.972 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.468 ' OD1' ' HA ' ' A' ' 63' ' ' ALA . 21.7 p-10 -109.62 124.41 51.12 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.604 0.716 . . . . 0.0 111.036 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.439 ' HB2' ' HB ' ' A' ' 106' ' ' THR . 66.1 m-85 -98.11 129.51 44.92 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.58 178.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.62 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 42.4 p-90 -163.16 173.54 13.32 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.434 -177.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.459 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 29.2 p90 -131.48 141.78 43.0 Favored Pre-proline 0 C--N 1.318 -0.769 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 171.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.696 ' HG2' ' HA ' ' A' ' 74' ' ' VAL . 31.4 Cg_exo -62.74 0.55 1.45 Allowed 'Trans proline' 0 N--CA 1.476 0.459 0 C-N-CA 123.59 2.86 . . . . 0.0 114.592 -173.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.44 ' OG ' ' HD2' ' A' ' 34' ' ' PHE . 0.5 OUTLIER -102.28 18.0 22.04 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.133 0.492 . . . . 0.0 110.799 173.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 87.5 m -85.56 135.62 38.2 Favored Pre-proline 0 CA--C 1.528 0.096 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.601 176.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 12.7 Cg_exo -71.17 -8.56 23.76 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.008 2.472 . . . . 0.0 111.939 173.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.781 ' O ' ' HB2' ' A' ' 43' ' ' GLU . . . -68.37 5.97 3.66 Favored Glycine 0 C--O 1.22 -0.734 0 CA-C-N 115.762 -0.654 . . . . 0.0 113.667 -177.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.764 ' HA ' ' HG2' ' A' ' 44' ' ' MET . 25.0 p -78.03 -30.25 49.8 Favored 'General case' 0 C--N 1.317 -0.824 0 O-C-N 121.909 -0.759 . . . . 0.0 111.905 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.59 HG23 ' H ' ' A' ' 42' ' ' SER . 6.6 m -56.38 -64.99 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 -166.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.59 ' H ' HG23 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -93.57 -39.72 10.69 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 121.79 -0.569 . . . . 0.0 110.785 178.798 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.781 ' HB2' ' O ' ' A' ' 39' ' ' GLY . 8.3 mp0 -64.21 -41.72 96.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.207 -169.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.764 ' HG2' ' HA ' ' A' ' 40' ' ' CYS . 19.9 mmt -60.37 -53.12 67.89 Favored Pre-proline 0 C--N 1.329 -0.308 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.295 -178.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.481 ' HD3' ' HB2' ' A' ' 44' ' ' MET . 80.6 Cg_exo -51.06 -37.85 58.39 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 122.335 2.023 . . . . 0.0 112.848 172.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.522 ' HD3' ' O ' ' A' ' 42' ' ' SER . 23.2 mtpt -61.32 -41.21 96.63 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 120.823 0.344 . . . . 0.0 110.621 176.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.531 HG13 ' O ' ' A' ' 43' ' ' GLU . 27.2 mt -71.82 -32.09 43.54 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.578 177.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.607 HG12 ' O ' ' A' ' 44' ' ' MET . 47.5 mm -54.51 -52.14 43.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-O 120.893 0.378 . . . . 0.0 110.434 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 46' ' ' LYS . 16.6 pttm -65.4 -44.87 86.1 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.642 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.5 m -70.6 -46.87 62.6 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.984 0.421 . . . . 0.0 111.863 -174.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . -69.25 -33.11 72.76 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.906 -174.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.605 ' HA ' ' NZ ' ' A' ' 55' ' ' LYS . 62.1 t30 -76.41 -50.37 14.34 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.118 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -64.99 -46.1 82.85 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.017 -172.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.758 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 38.1 m-85 -79.67 -10.12 59.74 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.57 -175.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.605 ' NZ ' ' HA ' ' A' ' 52' ' ' ASN . 7.1 ttpm? -63.59 -21.28 66.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.208 0.527 . . . . 0.0 110.518 178.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -106.37 17.23 23.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.625 176.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.6 mtmm -136.62 44.69 2.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.771 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.527 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 17.2 t-20 62.91 31.46 16.24 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.592 0.71 . . . . 0.0 110.745 175.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.761 ' HZ ' ' HB2' ' A' ' 29' ' ' LEU . 48.8 t80 -135.82 137.51 41.61 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.142 176.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.565 ' HG3' ' HG3' ' A' ' 26' ' ' LYS . 4.5 mt-30 -127.69 157.46 40.24 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.224 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 98.6 t -130.88 126.34 59.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 177.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.4 mt -121.39 121.04 36.74 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.122 0.487 . . . . 0.0 110.605 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.582 ' HB3' ' HA ' ' A' ' 87' ' ' VAL . . . -91.19 132.0 36.37 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.458 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.7 t -123.81 101.31 8.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.074 0.464 . . . . 0.0 110.37 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.62 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -85.78 117.38 24.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.685 175.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.642 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -90.92 163.97 27.54 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.34 -0.391 . . . . 0.0 109.981 -176.466 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.652 ' HD3' ' O ' ' A' ' 90' ' ' ASP . 60.8 Cg_endo -70.17 93.56 0.56 Allowed 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.027 1.818 . . . . 0.0 113.253 -169.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 46.5 mm -124.75 -60.81 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 172.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.493 ' OD2' ' HD2' ' A' ' 35' ' ' PRO . 1.8 p30 -105.67 154.21 39.4 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.602 168.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.414 ' HB2' ' OE2' ' A' ' 72' ' ' GLU . 12.9 Cg_exo -69.33 -179.96 3.07 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 122.83 2.353 . . . . 0.0 114.131 -171.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.1 tp -64.24 -35.81 75.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.879 -169.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.561 ' HA ' ' CD ' ' A' ' 75' ' ' ARG . 0.1 OUTLIER -73.39 -29.13 62.41 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.168 -0.332 . . . . 0.0 110.406 -177.645 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 45.5 m -68.72 -41.99 78.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.996 175.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.696 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 92.3 t -60.44 -55.01 27.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.297 176.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.561 ' CD ' ' HA ' ' A' ' 72' ' ' GLU . 1.4 ptm180 -63.69 -27.59 69.32 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.741 -177.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.457 ' HB2' ' O ' ' A' ' 72' ' ' GLU . 8.0 tt0 -66.14 -45.53 80.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.234 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.435 ' HB2' ' HB3' ' A' ' 35' ' ' PRO . 0.1 OUTLIER -63.31 -35.85 81.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.847 -178.862 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.674 HG21 HD12 ' A' ' 13' ' ' LEU . 60.5 t -61.26 -39.55 82.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.637 176.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 75' ' ' ARG . 95.2 mttt -70.73 -40.96 72.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.951 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -60.0 -49.38 77.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.239 -173.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.439 ' HB2' ' CD1' ' A' ' 83' ' ' LEU . 77.9 m-85 -99.8 3.7 44.9 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.699 -176.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 57.16 57.91 17.32 Favored Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.123 -178.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.655 ' HB2' HG13 ' A' ' 78' ' ' VAL . 10.5 mp -62.17 114.01 10.35 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-O 120.672 0.272 . . . . 0.0 111.476 -176.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -89.99 13.98 2.2 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.369 2.713 . . . . 0.0 112.936 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -117.96 150.21 39.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.836 176.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.7 m -69.83 115.43 9.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.756 0.312 . . . . 0.0 111.319 -173.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.582 ' HA ' ' HB3' ' A' ' 63' ' ' ALA . 31.4 t -104.5 126.59 59.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.138 -176.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.757 ' SD ' ' HB ' ' A' ' 18' ' ' VAL . 63.6 mtm -112.44 169.15 9.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.745 175.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -115.49 123.49 48.67 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.13 176.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.736 ' OD2' ' HA ' ' A' ' 93' ' ' LYS . 20.0 t0 -88.84 107.33 18.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.434 177.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.96 -47.58 20.48 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -175.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -99.85 -12.24 20.04 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -169.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.736 ' HA ' ' OD2' ' A' ' 90' ' ' ASP . 57.2 tttp 68.61 -2.31 1.69 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.015 0.526 . . . . 0.0 111.821 176.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.21 -23.88 43.51 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.919 0.39 . . . . 0.0 110.484 -177.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.453 ' O ' ' HD1' ' A' ' 99' ' ' PHE . 28.3 m -71.39 -38.04 67.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 171.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.52 -33.7 85.44 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 173.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 67.9 mm-40 -66.75 -32.28 73.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.811 0.338 . . . . 0.0 110.856 175.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.67 -39.9 95.49 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.253 0.549 . . . . 0.0 110.487 177.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.499 ' CE2' HD12 ' A' ' 116' ' ' ILE . 29.7 m-85 -73.63 -28.69 61.93 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.062 175.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.33 44.84 2.9 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.424 178.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.547 HG22 HG21 ' A' ' 106' ' ' THR . 52.5 p -104.48 112.91 26.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.253 0.549 . . . . 0.0 111.568 -176.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -111.95 -39.5 4.5 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.356 177.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.6 m -117.78 149.97 20.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 177.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.59 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 92.3 m-85 -129.44 161.62 57.74 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.75 -172.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.59 ' HA ' ' HB3' ' A' ' 104' ' ' TYR . 63.5 Cg_endo -73.03 165.71 83.46 Favored 'Cis proline' 0 C--N 1.349 0.603 0 C-N-CA 123.689 -1.379 . . . . 0.0 113.439 0.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.547 HG21 HG22 ' A' ' 101' ' ' THR . 4.2 m -135.05 148.88 50.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.433 177.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 37.8 m -137.69 114.59 10.66 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.971 0.415 . . . . 0.0 110.621 178.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.682 ' CG2' ' HB ' ' A' ' 30' ' ' ILE . 20.5 m -106.77 145.13 14.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.136 0.493 . . . . 0.0 111.053 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.553 HD11 HD12 ' A' ' 129' ' ' LEU . 9.5 mp -101.69 133.32 46.58 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.542 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.582 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 34.5 mm -110.49 135.02 50.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.943 -176.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -77.17 -150.21 3.74 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.831 -0.7 . . . . 0.0 111.706 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.485 ' HD3' HG22 ' A' ' 27' ' ' VAL . 10.2 mmmm -101.05 -7.58 23.12 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -176.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 2.7 mtmp? -124.55 19.72 8.73 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 113.485 -1.689 . . . . 0.0 109.291 -175.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.2 -90.97 1.58 Allowed Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -173.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 26.0 mt-10 69.17 -30.55 0.19 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 167.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.499 HD12 ' CE2' ' A' ' 99' ' ' PHE . 23.5 mm 53.38 64.87 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 CA-C-O 121.946 0.879 . . . . 0.0 108.997 -169.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.438 HD22 ' HA ' ' A' ' 117' ' ' LEU . 0.2 OUTLIER -62.02 -45.44 93.58 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 113.885 -1.507 . . . . 0.0 112.983 -169.28 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.7 ' HG3' ' OE2' ' A' ' 132' ' ' GLU . 4.3 tmtp? -143.91 153.83 42.71 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.257 -169.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.4 ' H ' ' HD3' ' A' ' 118' ' ' LYS . 40.3 m -139.96 108.01 5.74 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.944 0.402 . . . . 0.0 111.427 178.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -98.95 137.87 36.88 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.294 170.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.6 p -109.91 140.82 27.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 82.22 -109.8 3.11 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 -176.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -111.44 126.31 28.83 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 173.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.54 ' HB2' HD13 ' A' ' 129' ' ' LEU . 56.0 Cg_endo -72.14 125.64 11.05 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.206 1.937 . . . . 0.0 111.369 175.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.418 ' OD2' ' HB3' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -59.22 121.86 12.4 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.234 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -70.33 -29.67 66.44 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.28 -174.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -65.97 -54.91 22.0 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.32 -174.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.418 ' HB3' ' OD2' ' A' ' 125' ' ' ASP . 26.2 tptp -75.74 -33.08 60.24 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.553 HD12 HD11 ' A' ' 109' ' ' LEU . 0.9 OUTLIER -58.31 -48.34 80.8 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.008 0.193 . . . . 0.0 110.974 179.276 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -67.1 -45.14 78.13 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.191 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -64.57 -36.31 83.81 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.387 0.613 . . . . 0.0 110.885 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.7 ' OE2' ' HG3' ' A' ' 118' ' ' LYS . 21.3 tt0 -74.73 -40.02 61.52 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.44 -175.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.506 HG23 HG11 ' A' ' 27' ' ' VAL . 79.7 mt -64.4 -42.3 94.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.876 173.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -54.47 -39.03 67.1 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.462 177.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.8 m -60.51 -39.44 87.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.08 0.467 . . . . 0.0 110.713 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.06 -19.28 60.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.395 -177.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.411 ' HD1' HG21 ' A' ' 27' ' ' VAL . 17.1 m0 -65.48 -55.34 18.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.69 0.281 . . . . 0.0 110.898 177.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 64.4 mtt85 -68.66 -15.83 63.64 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.028 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' A' ' 140' ' ' SER . 7.9 t-20 -72.47 66.23 0.68 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.612 175.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 139' ' ' ASN . 22.1 t 169.75 121.94 0.01 OUTLIER 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.006 -178.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -72.7 88.48 1.29 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.976 0.417 . . . . 0.0 110.865 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -162.62 108.49 1.2 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.529 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.429 ' CD ' ' HD1' ' A' ' 145' ' ' HIS . 7.2 tp10 -107.19 119.91 40.67 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.273 0.558 . . . . 0.0 110.71 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -104.08 0.32 44.46 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.34 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.429 ' HD1' ' CD ' ' A' ' 143' ' ' GLU . 25.9 m80 -66.17 86.95 0.1 Allowed 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 121.492 0.663 . . . . 0.0 110.999 176.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -120.27 66.8 0.83 Allowed 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 172.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 62.62 -86.28 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.097 -175.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 61.08 -84.64 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -171.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -116.02 -11.6 11.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.058 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 69.9 t60 . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.218 -0.896 . . . . 0.0 109.777 179.527 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.381 0.134 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.811 ' H ' ' HA ' ' A' ' 6' ' ' PRO . 61.5 m 62.87 -168.07 0.2 Allowed 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -169.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.556 ' HB3' ' NZ ' ' A' ' 3' ' ' LYS . 0.6 OUTLIER 64.76 98.95 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 -177.201 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.3 m 63.99 46.56 3.74 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.929 0.871 . . . . 0.0 109.162 -172.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.45 ' H ' HG13 ' A' ' 116' ' ' ILE . . . 77.02 151.14 0.13 Allowed Pre-proline 0 N--CA 1.466 0.328 0 CA-C-N 113.789 -1.551 . . . . 0.0 110.77 -178.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.811 ' HA ' ' H ' ' A' ' 2' ' ' SER . 73.2 Cg_endo -76.56 2.28 7.55 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.076 1.851 . . . . 0.0 113.759 -173.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 56.62 84.93 0.08 Allowed 'General case' 0 C--N 1.327 -0.409 0 O-C-N 124.325 1.016 . . . . 0.0 110.796 -175.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.515 ' CE1' HD11 ' A' ' 23' ' ' LEU . 45.4 p90 -132.35 168.42 18.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.197 0.522 . . . . 0.0 111.355 -175.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 19' ' ' SER . 48.6 m -148.46 95.03 2.38 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 172.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 22.0 tp -115.87 133.61 22.83 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.415 -171.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.503 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 8.1 Cg_exo -72.59 134.97 23.21 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.562 2.175 . . . . 0.0 112.414 178.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.589 ' HB3' ' O ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -76.07 164.36 26.2 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.822 174.8 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.663 ' HB3' ' HG2' ' A' ' 75' ' ' ARG . 69.4 mt -67.13 -7.03 20.25 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 -170.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -123.6 17.71 9.59 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 121.809 -0.557 . . . . 0.0 110.959 174.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.02 22.35 25.59 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.931 -0.652 . . . . 0.0 114.045 169.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.589 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 11.3 tmtt? -97.03 102.5 14.29 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 173.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 12.0 m -63.52 122.42 16.25 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.894 0.378 . . . . 0.0 110.262 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.511 ' HB ' ' SD ' ' A' ' 88' ' ' MET . 60.8 t -106.24 116.44 50.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.801 178.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 83.4 p -103.15 -176.91 3.22 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.432 -177.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -73.3 -23.01 60.23 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.688 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.53 ' O ' ' HG3' ' A' ' 24' ' ' GLN . . . -68.34 -28.57 67.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.051 178.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -70.84 -15.53 62.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.871 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.515 HD11 ' CE1' ' A' ' 8' ' ' PHE . 92.3 mt -83.87 -20.21 33.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.706 -177.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.53 ' HG3' ' O ' ' A' ' 21' ' ' ALA . 0.4 OUTLIER -100.24 141.56 32.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.46 0.648 . . . . 0.0 112.457 -172.784 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.76 -8.32 68.26 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.101 -176.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 112' ' ' LYS . 9.3 mtpm? -142.31 164.23 30.71 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.697 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 25.2 t -102.5 141.73 18.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -177.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.466 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 26.8 m -132.78 138.47 47.16 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -165.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.63 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 36.7 tp -121.49 112.31 18.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.192 170.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.564 HG12 ' HB2' ' A' ' 62' ' ' LEU . 54.4 mt -102.33 115.6 44.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.801 0.334 . . . . 0.0 110.411 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.434 ' HA ' ' O ' ' A' ' 106' ' ' THR . 4.5 p-10 -109.06 126.87 53.62 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.326 0.584 . . . . 0.0 110.281 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.479 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 86.1 m-85 -92.97 127.9 38.65 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.829 178.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.51 ' NE1' ' HB1' ' A' ' 63' ' ' ALA . 5.3 p-90 -153.04 -178.05 6.68 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.065 0.46 . . . . 0.0 111.218 -175.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -149.48 148.22 25.47 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.757 172.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.518 ' HD2' ' HB2' ' A' ' 69' ' ' ASP . 96.3 Cg_exo -44.94 -47.87 11.49 Favored 'Trans proline' 0 N--CA 1.475 0.437 0 C-N-CA 123.592 2.861 . . . . 0.0 114.569 -175.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.9 m -82.67 17.14 1.91 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -175.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 53.3 t -73.61 126.51 89.72 Favored Pre-proline 0 C--N 1.328 -0.333 0 O-C-N 122.355 -0.215 . . . . 0.0 110.638 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -62.72 -22.28 73.77 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.907 2.405 . . . . 0.0 113.048 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.84 -17.01 80.28 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.181 -177.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 31.2 p -67.7 -41.5 83.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.069 0.434 . . . . 0.0 111.187 -174.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.8 p -59.99 -32.03 49.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.855 0.36 . . . . 0.0 111.169 -176.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.0 m -86.89 -54.09 4.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.818 0.342 . . . . 0.0 111.328 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -85.22 -29.69 24.47 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -168.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.578 ' O ' HG12 ' A' ' 48' ' ' ILE . 41.1 ttm -58.7 -46.7 99.56 Favored Pre-proline 0 N--CA 1.47 0.535 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -173.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 44' ' ' MET . 7.0 Cg_endo -50.97 -38.11 58.03 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.017 1.811 . . . . 0.0 112.246 175.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -65.2 -44.15 89.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.209 0.528 . . . . 0.0 109.76 176.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 42.5 mm -60.87 -41.46 88.86 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.359 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.74 178.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.578 HG12 ' O ' ' A' ' 44' ' ' MET . 43.0 mm -54.34 -49.2 65.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.249 0.547 . . . . 0.0 110.086 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.437 ' HE3' ' HB3' ' A' ' 49' ' ' LYS . 18.5 ttpp -64.96 -57.58 8.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.576 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.6 m -63.24 -41.91 99.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.766 -173.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.05 -50.24 62.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.126 -177.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -64.85 -43.04 94.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.858 0.361 . . . . 0.0 110.889 -173.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.434 ' CG ' ' HZ1' ' A' ' 57' ' ' LYS . 14.1 t70 -59.93 -42.2 93.45 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.001 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 1.037 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 14.9 m-85 -81.34 -26.18 35.79 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.218 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.4 mmmm -58.59 -30.63 67.35 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.854 0.359 . . . . 0.0 110.564 176.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -94.15 19.36 9.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.034 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.434 ' HZ1' ' CG ' ' A' ' 53' ' ' ASP . 27.3 mtmm -128.25 -59.09 1.18 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.325 176.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.408 ' O ' ' HB3' ' A' ' 26' ' ' LYS . 27.2 t-20 176.99 -14.64 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.321 0.582 . . . . 0.0 110.892 -174.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 1.037 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 62.9 t80 -98.31 147.71 24.38 Favored 'General case' 0 C--N 1.316 -0.849 0 O-C-N 122.032 -0.417 . . . . 0.0 109.938 -174.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -137.83 127.66 25.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.134 0.493 . . . . 0.0 111.324 -176.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 92.3 t -99.23 120.43 48.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.426 174.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.564 ' HB2' HG12 ' A' ' 30' ' ' ILE . 72.4 mt -113.78 112.84 24.08 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.708 -178.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.51 ' HB1' ' NE1' ' A' ' 33' ' ' TRP . . . -93.5 107.51 19.35 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.645 -177.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 88.4 t -95.66 113.92 31.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.075 0.464 . . . . 0.0 110.448 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.51 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -86.11 131.9 34.15 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.697 176.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.598 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -100.24 163.91 17.37 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.514 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.598 ' HD2' ' HB2' ' A' ' 66' ' ' GLN . 32.8 Cg_endo -64.12 79.27 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.542 2.162 . . . . 0.0 113.784 -175.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.469 HG12 ' HG2' ' A' ' 66' ' ' GLN . 40.1 mm -117.83 -63.35 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 171.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.518 ' HB2' ' HD2' ' A' ' 35' ' ' PRO . 14.8 m-20 -96.62 149.55 35.95 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 168.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.45 150.51 34.02 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.633 2.222 . . . . 0.0 112.893 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.0 tt -55.14 -38.5 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.629 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -66.18 -37.39 85.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.107 0.48 . . . . 0.0 110.419 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.4 m -61.35 -35.01 76.25 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.387 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.477 ' HA ' ' HG3' ' A' ' 35' ' ' PRO . 10.9 t -67.67 -41.0 85.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.114 178.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.801 ' HA ' HG22 ' A' ' 78' ' ' VAL . 41.8 mtp180 -69.08 -32.82 72.54 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.368 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.75 -38.81 92.01 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 175.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.466 ' HE1' ' SD ' ' A' ' 44' ' ' MET . 7.7 t80 -67.85 -48.68 65.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.267 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.801 HG22 ' HA ' ' A' ' 75' ' ' ARG . 25.8 m -62.9 -31.93 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -177.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.479 ' HB3' ' HE2' ' A' ' 79' ' ' LYS . 44.9 mtpt -74.64 -54.27 7.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.75 0.309 . . . . 0.0 111.408 177.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -65.71 -41.29 92.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.918 -171.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -89.75 -21.76 22.51 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.604 -175.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.0 75.48 0.91 Allowed Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.429 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.64 HD22 HG12 ' A' ' 78' ' ' VAL . 10.6 mp -95.26 112.32 58.18 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 120.798 0.332 . . . . 0.0 111.107 -177.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -81.0 -11.41 12.33 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.185 2.59 . . . . 0.0 113.326 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.471 ' HE1' HD13 ' A' ' 48' ' ' ILE . 29.1 p90 -91.06 145.21 24.88 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 176.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.41 ' HB ' ' CD2' ' A' ' 62' ' ' LEU . 19.4 m -71.83 118.21 14.4 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.976 -172.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.46 HG22 ' HB3' ' A' ' 63' ' ' ALA . 39.0 t -107.49 129.26 61.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.573 -178.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.511 ' SD ' ' HB ' ' A' ' 18' ' ' VAL . 70.9 mtm -119.85 171.17 8.61 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.45 178.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -137.48 115.27 11.39 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.741 0.305 . . . . 0.0 110.329 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.593 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 47.8 t0 -98.73 102.41 14.13 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.36 -28.27 61.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.723 -176.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -83.71 -7.11 59.55 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.872 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.3 pttp 47.41 25.2 0.57 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.214 1.005 . . . . 0.0 111.774 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -81.59 -34.38 31.03 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.601 -172.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.539 HG22 ' OD2' ' A' ' 90' ' ' ASP . 31.5 m -76.31 -30.68 20.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 119.989 -0.684 . . . . 0.0 109.604 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -69.92 -38.51 75.17 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 172.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 -69.97 -23.75 63.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.567 -0.317 . . . . 0.0 111.346 176.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.42 -36.33 71.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.667 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -86.86 -19.27 29.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.082 176.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 81.84 41.94 9.32 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.904 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.562 HG22 HG21 ' A' ' 106' ' ' THR . 50.4 p -76.15 86.86 3.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.223 0.535 . . . . 0.0 111.054 -178.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -93.09 -45.23 7.99 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.638 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.558 ' HB ' HG22 ' A' ' 121' ' ' VAL . 21.3 t -100.28 123.41 53.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.981 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -104.09 144.37 28.55 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.077 -177.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -76.47 165.27 85.67 Favored 'Cis proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.724 -1.365 . . . . 0.0 113.304 0.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.562 HG21 HG22 ' A' ' 101' ' ' THR . 5.5 m -129.54 125.93 37.4 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.82 174.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.443 ' HB3' HD11 ' A' ' 29' ' ' LEU . 16.5 m -111.62 114.51 27.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.857 0.36 . . . . 0.0 110.884 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.527 HG22 HG23 ' A' ' 119' ' ' THR . 47.3 t -105.98 130.82 56.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.325 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.547 HD12 ' HB3' ' A' ' 118' ' ' LYS . 85.8 mt -101.7 120.2 39.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.567 -178.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.466 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 31.1 mt -112.58 144.13 20.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.405 179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.697 ' O ' ' HA ' ' A' ' 27' ' ' VAL . . . -72.88 -112.03 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 121.117 -0.563 . . . . 0.0 113.071 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 18.0 pttm -140.54 -8.06 1.12 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -173.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -121.44 -9.75 8.97 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 173.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 127.9 -4.41 6.94 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.592 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 115' ' ' GLU . 5.9 pm0 -58.36 116.95 3.95 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.43 0.633 . . . . 0.0 110.225 -177.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.45 HG13 ' H ' ' A' ' 5' ' ' ALA . 60.7 mt -78.12 112.33 15.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.589 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.404 ' CD1' ' HB2' ' A' ' 136' ' ' ALA . 61.3 mt -90.17 -50.5 5.96 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.416 -173.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.547 ' HB3' HD12 ' A' ' 109' ' ' LEU . 18.0 tptm -152.08 158.35 42.87 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.427 -167.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.527 HG23 HG22 ' A' ' 108' ' ' VAL . 32.0 m -143.15 103.73 4.19 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.147 0.498 . . . . 0.0 110.526 174.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -88.93 106.21 18.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.075 174.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.558 HG22 ' HB ' ' A' ' 103' ' ' VAL . 7.7 p -95.92 121.43 46.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.265 0.555 . . . . 0.0 110.711 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 105.14 -80.6 0.3 Allowed Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.11 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -138.82 118.57 9.53 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.89 143.12 20.51 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.629 2.219 . . . . 0.0 113.323 -177.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.53 ' O ' ' HB2' ' A' ' 129' ' ' LEU . 24.8 t0 -77.45 107.6 10.01 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 172.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -66.35 -43.49 85.88 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -174.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.25 -43.75 98.65 Favored Glycine 0 C--O 1.239 0.437 0 C-N-CA 120.261 -0.971 . . . . 0.0 111.161 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.638 ' HB2' ' NZ ' ' A' ' 128' ' ' LYS . 1.7 ttmp? -71.82 -31.59 66.69 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.21 -0.495 . . . . 0.0 109.994 178.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.533 ' O ' HG13 ' A' ' 133' ' ' ILE . 0.2 OUTLIER -56.55 -48.01 78.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.001 177.397 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -65.92 -48.97 69.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.386 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.45 ' HG2' ' HA ' ' A' ' 128' ' ' LYS . 3.3 pt20 -68.36 -32.23 72.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.964 0.412 . . . . 0.0 111.459 -177.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -74.68 -32.66 62.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.322 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.533 HG13 ' O ' ' A' ' 129' ' ' LEU . 59.5 mt -62.85 -49.69 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 172.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.562 ' O ' ' HG2' ' A' ' 138' ' ' ARG . 14.9 t70 -56.65 -38.23 71.89 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.409 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 88.0 m -55.48 -40.62 71.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.012 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.404 ' HB2' ' CD1' ' A' ' 117' ' ' LEU . . . -64.12 -30.86 71.9 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.039 0.447 . . . . 0.0 111.039 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.462 ' NE1' HG21 ' A' ' 27' ' ' VAL . 11.3 m0 -72.94 -29.57 63.2 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.106 177.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.562 ' HG2' ' O ' ' A' ' 134' ' ' ASP . 22.5 mmt180 -85.13 -17.89 35.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.507 -178.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -80.88 66.85 6.56 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.57 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 11.2 p -95.08 -59.53 1.88 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.382 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -88.21 92.86 9.31 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.942 -175.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.57 -19.15 23.05 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.967 174.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 56.22 -98.03 0.08 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.001 -1.0 . . . . 0.0 112.798 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.01 40.18 81.55 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -170.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -70.47 75.75 0.56 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.085 0.469 . . . . 0.0 112.179 -170.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -137.62 -2.52 1.95 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.086 172.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -84.18 108.45 17.08 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.814 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -80.2 149.45 30.46 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.509 175.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 -99.35 -13.35 19.65 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 168.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 . . . . . 0 C--O 1.244 0.786 0 CA-C-N 113.711 -1.586 . . . . 0.0 107.674 -179.884 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.591 ' OD2' ' HG3' ' A' ' 3' ' ' LYS . 25.4 t70 . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.2 m 73.33 17.67 3.88 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.77 0.669 . . . . 0.0 112.37 169.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.591 ' HG3' ' OD2' ' A' ' 1' ' ' ASP . 0.4 OUTLIER -125.19 168.88 12.82 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 175.193 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.713 HG22 ' HA3' ' A' ' 114' ' ' GLY . 63.6 p 51.86 53.97 11.71 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.265 0.555 . . . . 0.0 111.084 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.543 ' H ' HG13 ' A' ' 116' ' ' ILE . . . 63.74 163.42 0.12 Allowed Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 114.372 -1.285 . . . . 0.0 112.021 -178.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -57.84 141.24 95.75 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 121.74 1.626 . . . . 0.0 109.991 168.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -50.94 104.67 0.08 Allowed 'General case' 0 C--N 1.331 -0.231 0 O-C-N 123.461 0.475 . . . . 0.0 111.587 -175.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -129.14 135.55 49.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.624 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.3 t -150.2 88.89 1.54 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 171.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.477 HD11 ' HB3' ' A' ' 88' ' ' MET . 1.4 pt? -121.71 155.25 60.21 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.593 -178.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.601 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 8.1 Cg_exo -73.23 130.3 15.06 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.633 2.222 . . . . 0.0 112.522 177.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.54 160.81 31.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.516 173.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.453 HD12 HG11 ' A' ' 78' ' ' VAL . 41.4 mt -60.91 -24.01 65.67 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 -174.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -83.14 -11.7 57.69 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.06 -15.07 16.18 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 121.167 -0.54 . . . . 0.0 113.256 174.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -76.37 121.44 23.03 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.869 0.335 . . . . 0.0 111.114 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.601 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 20.5 m -69.75 123.18 20.76 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 172.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.9 t -119.56 130.01 74.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.981 0.42 . . . . 0.0 110.778 -176.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.9 t -132.05 173.99 10.65 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.494 178.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.756 ' HA ' HD13 ' A' ' 23' ' ' LEU . 30.0 p-10 -61.01 -22.8 64.88 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -172.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.618 ' HA ' HE21 ' A' ' 24' ' ' GLN . . . -67.68 -27.95 67.28 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 178.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -67.63 -32.81 73.77 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.18 0.514 . . . . 0.0 110.93 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.756 HD13 ' HA ' ' A' ' 20' ' ' ASN . 5.2 mp -71.46 -20.36 62.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.064 -175.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.618 HE21 ' HA ' ' A' ' 21' ' ' ALA . 46.5 mt-30 -68.21 98.5 0.81 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.211 -177.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 132.17 -22.85 4.18 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.079 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.4 mtmm -111.47 162.56 14.97 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -103.46 123.34 56.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 168.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.53 ' HB ' HD12 ' A' ' 110' ' ' ILE . 11.0 m -126.59 150.9 48.6 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.092 0.472 . . . . 0.0 111.842 -164.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.422 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 51.9 tp -123.71 120.45 32.74 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.921 174.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.982 ' HB ' HG12 ' A' ' 108' ' ' VAL . 34.5 mm -97.19 132.79 40.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 175.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -128.17 125.07 38.33 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.245 0.545 . . . . 0.0 109.879 174.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.413 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 48.3 m-85 -90.56 122.63 33.54 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.991 176.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.474 ' NE1' ' HB1' ' A' ' 63' ' ' ALA . 6.1 p-90 -148.4 -169.84 3.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.454 -177.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -159.4 143.8 11.17 Favored Pre-proline 0 C--N 1.321 -0.656 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 174.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.494 ' HG2' ' CB ' ' A' ' 69' ' ' ASP . 12.8 Cg_endo -59.0 158.93 23.31 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.414 2.076 . . . . 0.0 111.521 176.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.8 m 68.32 18.41 9.14 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.19 -177.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.475 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 52.8 t -101.3 136.78 19.59 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.547 177.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.482 ' O ' HG22 ' A' ' 41' ' ' VAL . 19.9 Cg_exo -67.15 -13.8 40.99 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 123.014 2.476 . . . . 0.0 112.919 178.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.42 -4.78 19.13 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 121.515 -0.374 . . . . 0.0 113.467 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.707 ' O ' ' HB2' ' A' ' 44' ' ' MET . 61.0 m -63.22 -34.88 78.61 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 122.725 -0.28 . . . . 0.0 110.897 176.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 38' ' ' PRO . 33.0 m -67.98 -33.99 64.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.176 -177.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.9 p -88.87 -56.41 3.3 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.575 ' HG2' ' HG3' ' A' ' 105' ' ' PRO . 1.4 mp0 -84.09 -34.77 24.09 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -168.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.707 ' HB2' ' O ' ' A' ' 40' ' ' CYS . 8.6 mmt -61.12 -48.11 93.0 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -175.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 44' ' ' MET . 13.2 Cg_endo -57.25 -34.19 97.38 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 121.838 1.692 . . . . 0.0 112.305 175.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.48 ' HD2' ' HA ' ' A' ' 43' ' ' GLU . 93.9 mttt -64.32 -51.66 62.34 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 176.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.674 HG23 HG11 ' A' ' 61' ' ' VAL . 45.1 mm -57.43 -46.91 85.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.834 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.469 HG12 ' O ' ' A' ' 44' ' ' MET . 46.1 mm -56.57 -53.36 42.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.184 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -69.3 -51.34 38.22 Favored 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.384 -174.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 62.4 m -57.2 -42.39 81.18 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.071 0.463 . . . . 0.0 111.196 -176.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.04 -31.5 70.32 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.751 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -73.88 -45.5 50.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.783 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -54.59 -51.58 64.86 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.745 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.606 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 61.6 m-85 -97.22 8.53 44.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.433 -175.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.516 ' HE3' ' HA ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -60.54 -45.62 93.19 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.254 0.55 . . . . 0.0 110.169 -179.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -89.95 33.56 0.86 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.617 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.606 ' HE2' ' HA ' ' A' ' 54' ' ' TYR . 0.7 OUTLIER -126.08 -68.35 0.83 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.7 171.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 177.03 13.72 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.767 -177.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.422 ' HZ ' ' HB2' ' A' ' 29' ' ' LEU . 22.1 t80 -99.96 147.52 25.49 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.032 -173.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.507 ' O ' ' HA ' ' A' ' 28' ' ' THR . 50.5 tp60 -138.91 147.3 42.15 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.918 -177.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.674 HG11 HG23 ' A' ' 47' ' ' ILE . 86.9 t -129.2 129.64 67.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.748 0.309 . . . . 0.0 110.465 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.843 ' HG ' ' HB ' ' A' ' 86' ' ' THR . 9.9 mp -121.53 121.91 38.53 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.78 177.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.474 ' HB1' ' NE1' ' A' ' 33' ' ' TRP . . . -101.44 119.63 39.06 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.347 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.9 t -97.29 107.65 20.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.916 0.389 . . . . 0.0 110.748 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 89' ' ' TYR . . . -91.5 126.42 36.58 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.101 177.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.617 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 2.8 pt20 -97.91 168.78 9.45 Favored Pre-proline 0 C--N 1.317 -0.839 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.491 -178.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.652 ' HD2' ' HG3' ' A' ' 93' ' ' LYS . 98.7 Cg_endo -75.91 45.07 1.42 Allowed 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 122.81 2.34 . . . . 0.0 114.85 -165.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 50.7 mm -78.67 -32.61 16.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 171.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.494 ' CB ' ' HG2' ' A' ' 35' ' ' PRO . 0.2 OUTLIER -136.48 136.32 21.94 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 114.64 -1.164 . . . . 0.0 107.926 170.792 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 69' ' ' ASP . 35.7 Cg_exo -58.2 174.02 0.82 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.079 2.519 . . . . 0.0 113.681 -175.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.532 ' HA ' HG12 ' A' ' 74' ' ' VAL . 19.8 tt -71.87 -27.07 26.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.591 -169.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.414 ' OE2' ' HB2' ' A' ' 70' ' ' PRO . 9.2 pm0 -74.02 -28.81 61.62 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.671 175.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 63.0 m -64.51 -48.63 74.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.98 0.419 . . . . 0.0 110.35 174.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.532 HG12 ' HA ' ' A' ' 71' ' ' ILE . 9.6 p -67.62 -34.36 67.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.65 -178.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.872 ' HA ' HG22 ' A' ' 78' ' ' VAL . 66.7 mtt180 -71.66 -29.01 64.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.999 175.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -64.76 -41.52 95.82 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 173.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -64.78 -51.73 60.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.073 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.104 ' HA ' HD23 ' A' ' 83' ' ' LEU . 35.8 m -61.8 -26.63 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.379 -178.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.701 ' HZ2' ' HB3' ' A' ' 79' ' ' LYS . 1.6 ttpm? -72.06 -49.43 36.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.303 0.573 . . . . 0.0 110.052 174.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.48 -48.07 77.91 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.681 -1.145 . . . . 0.0 112.857 -173.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -103.19 4.41 36.78 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.428 -174.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 57.12 55.27 31.22 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 116.037 -0.529 . . . . 0.0 113.101 177.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 1.104 HD23 ' HA ' ' A' ' 78' ' ' VAL . 3.1 mm? -71.18 111.65 10.79 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-O 120.784 0.326 . . . . 0.0 110.556 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -85.59 -6.99 8.8 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.11 2.54 . . . . 0.0 113.77 -173.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.55 ' CE2' HD12 ' A' ' 83' ' ' LEU . 28.7 p90 -90.54 169.87 10.66 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.936 0.398 . . . . 0.0 110.929 -178.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.843 ' HB ' ' HG ' ' A' ' 62' ' ' LEU . 18.3 m -75.25 132.13 40.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.174 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.2 t -130.06 130.9 66.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -177.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.477 ' HB3' HD11 ' A' ' 10' ' ' LEU . 57.5 mtt -111.94 163.76 13.87 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.42 -178.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 92.4 t80 -126.42 115.18 19.21 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.835 176.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.507 ' OD2' HG22 ' A' ' 95' ' ' VAL . 40.0 t0 -87.56 127.08 35.26 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.53 -30.12 59.65 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -177.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.588 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 17.2 t70 -127.22 -10.94 5.85 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -169.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.652 ' HG3' ' HD2' ' A' ' 67' ' ' PRO . 25.0 mtpp 76.69 14.09 2.23 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -169.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.634 ' HA ' HE21 ' A' ' 97' ' ' GLN . . . -61.17 -44.41 97.34 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -170.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.507 HG22 ' OD2' ' A' ' 90' ' ' ASP . 27.7 m -72.32 -33.55 46.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.197 -178.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -70.23 -33.9 69.2 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.499 -0.857 . . . . 0.0 111.086 173.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.634 HE21 ' HA ' ' A' ' 94' ' ' ALA . 14.8 mt-30 -71.43 -24.29 62.0 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 122.751 0.42 . . . . 0.0 110.722 176.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.59 -35.42 73.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.185 173.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -82.43 -11.31 58.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.855 175.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 76.73 32.34 50.6 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.383 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 38.0 p -80.21 96.2 6.51 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.248 0.547 . . . . 0.0 111.466 -177.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -89.34 -31.46 17.79 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.365 0.602 . . . . 0.0 109.618 174.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.3 p -107.1 150.22 9.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.181 -176.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.413 ' CE1' ' HB3' ' A' ' 32' ' ' PHE . 93.6 m-85 -140.02 155.41 70.81 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.399 -178.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.575 ' HG3' ' HG2' ' A' ' 43' ' ' GLU . 90.5 Cg_endo -77.73 162.58 89.69 Favored 'Cis proline' 0 C--N 1.343 0.259 0 C-N-CA 123.293 -1.545 . . . . 0.0 112.796 0.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.504 HG23 HG12 ' A' ' 121' ' ' VAL . 55.1 m -138.28 131.34 29.99 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.824 178.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 35.1 p -116.25 148.52 40.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.015 0.436 . . . . 0.0 111.376 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.982 HG12 ' HB ' ' A' ' 30' ' ' ILE . 1.9 p -124.57 148.4 28.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 176.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.49 ' O ' ' HB2' ' A' ' 117' ' ' LEU . 4.3 mm? -100.51 123.55 44.87 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 121.002 0.43 . . . . 0.0 109.986 -177.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.774 HG23 ' HA ' ' A' ' 115' ' ' GLU . 59.6 mt -109.01 130.21 62.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.693 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.545 ' HA2' ' HB1' ' A' ' 136' ' ' ALA . . . -84.6 -152.25 15.69 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.12 175.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -110.56 15.1 22.28 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.0 mtpp -104.72 19.22 20.83 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 113.6 -1.636 . . . . 0.0 109.646 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.713 ' HA3' HG22 ' A' ' 4' ' ' THR . . . 108.25 -77.98 0.23 Allowed Glycine 0 C--O 1.223 -0.562 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.546 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.774 ' HA ' HG23 ' A' ' 110' ' ' ILE . 0.7 OUTLIER -166.83 161.08 15.11 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 117.689 0.745 . . . . 0.0 112.322 -179.823 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.543 HG13 ' H ' ' A' ' 5' ' ' ALA . 13.5 mt 75.93 85.24 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 125.826 1.65 . . . . 0.0 112.761 177.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.494 HD23 ' H ' ' A' ' 111' ' ' GLY . 1.3 mm? -110.74 -51.5 2.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.372 171.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.52 ' HG3' ' OE2' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -155.27 174.55 15.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.768 -174.726 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 21.0 m -141.53 133.94 28.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.668 0.27 . . . . 0.0 110.919 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.482 ' HD1' HD23 ' A' ' 109' ' ' LEU . 54.1 m-85 -132.31 110.19 10.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.567 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.504 HG12 HG23 ' A' ' 106' ' ' THR . 22.6 m -92.9 141.57 14.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.025 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 70.38 -113.71 5.03 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.447 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -94.55 109.92 46.02 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.73 121.16 4.97 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.425 2.084 . . . . 0.0 112.428 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.556 ' CG ' ' HG2' ' A' ' 128' ' ' LYS . 8.3 t0 -57.14 105.16 0.2 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 175.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -61.72 -31.34 71.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.852 -175.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -63.35 -49.31 71.43 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.468 -0.872 . . . . 0.0 111.381 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.556 ' HG2' ' CG ' ' A' ' 125' ' ' ASP . 33.2 mmtm -70.54 -34.97 72.85 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.57 ' O ' HG13 ' A' ' 133' ' ' ILE . 0.2 OUTLIER -56.34 -47.92 77.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.385 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -64.27 -55.72 19.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.778 -0.192 . . . . 0.0 110.867 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -58.25 -32.2 68.13 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.372 0.606 . . . . 0.0 111.337 -177.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.52 ' OE2' ' HG3' ' A' ' 118' ' ' LYS . 24.7 tt0 -80.59 -29.59 36.94 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.677 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.57 HG13 ' O ' ' A' ' 129' ' ' LEU . 51.5 mt -62.62 -44.77 99.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 171.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -59.06 -31.03 68.5 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.348 0.594 . . . . 0.0 110.517 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 132' ' ' GLU . 92.3 m -66.43 -35.91 81.47 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.431 176.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.545 ' HB1' ' HA2' ' A' ' 111' ' ' GLY . . . -69.92 -36.6 75.47 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.069 0.462 . . . . 0.0 110.388 176.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 10.0 m0 -60.26 -53.16 61.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.545 174.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 138' ' ' ARG . 34.9 ttp-105 -74.88 -59.13 2.87 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.213 -174.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -67.69 124.56 23.6 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.48 0.657 . . . . 0.0 111.177 -173.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.9 m -131.29 -12.29 3.56 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.166 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -81.35 -96.16 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 113.969 -1.469 . . . . 0.0 112.971 -169.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . 70.95 -59.25 0.55 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.828 0.851 . . . . 0.0 109.594 -167.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.454 ' HB2' ' CE1' ' A' ' 145' ' ' HIS . 0.9 OUTLIER -179.16 -41.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.527 -0.761 . . . . 0.0 108.961 172.451 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 59.49 36.19 88.34 Favored Glycine 0 C--N 1.332 0.334 0 CA-C-N 115.363 -0.835 . . . . 0.0 114.303 170.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.694 ' HA ' ' HB2' ' A' ' 148' ' ' HIS . 30.2 p-80 -151.91 10.58 0.55 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.49 0.645 . . . . 0.0 112.363 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -60.74 -33.63 73.21 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.957 0.408 . . . . 0.0 110.841 175.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -153.34 37.91 0.48 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.353 175.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . 0.694 ' HB2' ' HA ' ' A' ' 145' ' ' HIS . 3.2 t60 -63.29 -30.88 71.94 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -110.01 132.52 54.09 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.978 171.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 11.1 p80 . . . . . 0 C--N 1.317 -0.806 0 CA-C-O 117.444 -1.265 . . . . 0.0 109.438 174.394 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.439 ' HB3' ' OG1' ' A' ' 4' ' ' THR . 21.8 t70 . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.4 m -60.57 -29.04 68.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.817 0.341 . . . . 0.0 111.132 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.7 mttp -91.09 -46.19 8.26 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.959 0.885 . . . . 0.0 109.857 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.439 ' OG1' ' HB3' ' A' ' 1' ' ' ASP . 6.6 p -105.83 87.3 2.55 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 114.138 -1.392 . . . . 0.0 111.525 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.711 ' H ' HG13 ' A' ' 116' ' ' ILE . . . 59.74 100.87 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.506 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 175.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.613 ' HD3' HD11 ' A' ' 116' ' ' ILE . 27.5 Cg_exo -63.17 146.35 94.11 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.699 2.266 . . . . 0.0 111.169 173.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.45 114.58 22.02 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.868 -177.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 19' ' ' SER . 55.9 p90 -135.63 137.25 41.69 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.331 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.513 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 40.7 m -149.39 88.85 1.6 Allowed 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 173.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.417 ' H ' HD23 ' A' ' 10' ' ' LEU . 1.7 pt? -122.29 146.16 46.25 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.141 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 16.6 Cg_exo -68.25 137.2 39.59 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.285 1.99 . . . . 0.0 111.083 172.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.419 ' CG ' ' H ' ' A' ' 14' ' ' HIS . 0.8 OUTLIER -69.58 -179.29 1.68 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.548 HD21 HG21 ' A' ' 78' ' ' VAL . 2.9 pp -70.76 -9.2 56.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.741 0.305 . . . . 0.0 111.759 -176.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.419 ' H ' ' CG ' ' A' ' 12' ' ' ASP . 22.9 t-80 -92.24 -55.8 3.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.493 172.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 150.46 22.5 0.06 OUTLIER Glycine 0 CA--C 1.522 0.472 0 C-N-CA 120.06 -1.066 . . . . 0.0 114.175 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 41.1 tttm -105.8 126.24 51.93 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 117.445 0.623 . . . . 0.0 109.941 175.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 7.0 t -65.28 127.67 32.71 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.054 0.454 . . . . 0.0 109.79 174.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 9' ' ' SER . 46.8 t -111.12 124.57 68.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 8' ' ' PHE . 50.4 p -129.38 -175.11 3.47 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.216 -173.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -73.8 -23.97 59.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.928 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.78 -27.48 68.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.015 177.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -69.25 -24.44 63.99 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.484 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.693 HD13 HG21 ' A' ' 110' ' ' ILE . 38.5 mt -82.22 -44.1 16.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.23 -174.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -60.85 126.26 26.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.363 0.601 . . . . 0.0 111.208 -175.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.37 -25.3 10.59 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.639 -176.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.624 ' O ' ' HA ' ' A' ' 112' ' ' LYS . 65.9 mttm -131.72 175.44 9.19 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.988 0.423 . . . . 0.0 110.049 177.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 58.9 t -103.48 146.88 10.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 170.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.596 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 22.2 m -134.67 143.65 47.37 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 121.782 -0.574 . . . . 0.0 111.862 -170.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.675 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 53.8 tp -113.92 113.92 25.51 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 171.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.673 ' HB ' ' CG1' ' A' ' 108' ' ' VAL . 30.2 mt -96.82 112.13 28.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 175.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -111.49 130.66 55.65 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.28 0.562 . . . . 0.0 109.867 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.522 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 94.3 m-85 -98.69 119.24 37.08 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.755 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.657 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 7.7 p-90 -139.1 -177.36 4.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.859 -174.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.637 ' HB3' ' OE1' ' A' ' 66' ' ' GLN . 33.0 p90 -157.9 150.62 18.12 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.837 175.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.49 157.59 35.74 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.116 1.877 . . . . 0.0 110.862 173.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.2 m 65.33 17.61 11.05 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.98 0.419 . . . . 0.0 111.2 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 51.9 t -80.13 133.41 57.56 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.846 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 26.1 Cg_exo -63.72 -26.59 68.39 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.64 2.227 . . . . 0.0 111.557 174.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.58 -16.78 78.77 Favored Glycine 0 C--O 1.225 -0.465 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.659 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 48.9 t -57.81 -30.85 66.04 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 122.446 0.299 . . . . 0.0 111.673 -175.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.1 p -61.1 -33.15 54.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.156 0.503 . . . . 0.0 110.21 177.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.606 ' O ' ' HE3' ' A' ' 46' ' ' LYS . 15.2 m -89.11 -49.76 6.56 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.097 175.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.546 ' O ' HG12 ' A' ' 47' ' ' ILE . 41.9 mt-10 -59.27 -52.68 64.61 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.85 -172.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.682 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 41.1 tpp -59.21 -58.06 22.38 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.402 -170.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.682 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 50.4 Cg_exo -57.05 -36.86 99.43 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.088 1.859 . . . . 0.0 112.56 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.606 ' HE3' ' O ' ' A' ' 42' ' ' SER . 0.0 OUTLIER -65.3 -51.26 61.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.482 179.217 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.546 HG12 ' O ' ' A' ' 43' ' ' GLU . 49.5 mm -60.91 -42.2 91.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.152 -178.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.634 HD13 ' HE1' ' A' ' 85' ' ' PHE . 47.7 mm -54.6 -53.26 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.803 0.335 . . . . 0.0 110.861 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -67.73 -51.49 48.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.405 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.456 ' O ' ' HD2' ' A' ' 54' ' ' TYR . 89.2 m -58.51 -47.0 85.58 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.263 -177.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . -69.15 -24.29 64.06 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -177.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -68.85 -51.73 37.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.265 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -68.17 -52.64 32.27 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.607 0.718 . . . . 0.0 111.002 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 1.034 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 54.6 m-85 -64.58 -21.85 66.81 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.107 -173.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -53.95 -49.6 68.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.0 0.428 . . . . 0.0 110.752 179.82 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 -88.08 -18.58 28.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.426 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.463 ' HE3' ' HB2' ' A' ' 57' ' ' LYS . 4.5 tppp? -61.26 -71.88 0.13 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.055 176.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.54 ' HB3' ' CZ3' ' A' ' 137' ' ' TRP . 3.7 t-20 169.35 31.29 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 1.034 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 50.7 t80 -140.02 156.2 46.73 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.983 -171.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.452 ' O ' ' HA ' ' A' ' 28' ' ' THR . 10.6 pt20 -148.85 159.14 44.45 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.291 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 86.3 t -123.96 130.69 73.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.465 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.404 HD23 ' HB ' ' A' ' 86' ' ' THR . 85.6 mt -113.17 104.59 12.51 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.596 178.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.407 ' HB1' ' NE1' ' A' ' 33' ' ' TRP . . . -89.5 102.47 15.14 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.378 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 59.0 t -99.23 114.67 37.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.053 0.454 . . . . 0.0 110.444 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.657 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -86.17 134.44 33.79 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.722 175.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.637 ' OE1' ' HB3' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -100.78 163.93 17.13 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.622 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.621 ' HD2' ' HB2' ' A' ' 93' ' ' LYS . 33.0 Cg_endo -61.87 89.88 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.324 2.016 . . . . 0.0 113.365 -174.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 41.2 mm -130.82 -66.18 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 172.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.427 ' OD1' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -92.78 147.7 34.6 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 171.244 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.427 ' HD2' ' OD1' ' A' ' 69' ' ' ASP . 54.3 Cg_exo -53.78 158.51 8.32 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 122.656 2.238 . . . . 0.0 113.698 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.606 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 5.9 tp -56.52 -33.16 38.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.167 178.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.486 ' OE2' ' HD2' ' A' ' 75' ' ' ARG . 6.1 tp10 -64.25 -41.35 97.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.233 0.539 . . . . 0.0 110.222 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.5 m -60.14 -44.47 94.91 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.824 -177.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.46 ' O ' HG23 ' A' ' 78' ' ' VAL . 7.5 p -70.65 -33.62 53.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.852 -179.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.606 ' HG3' ' O ' ' A' ' 71' ' ' ILE . 98.7 mtt180 -55.29 -53.16 59.55 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.4 0.619 . . . . 0.0 110.327 175.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -63.66 -45.11 91.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.705 -176.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -55.4 -45.19 76.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.047 -176.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.657 ' HA ' HD22 ' A' ' 83' ' ' LEU . 86.1 t -64.36 -44.85 97.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.497 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.756 ' HA ' ' HE3' ' A' ' 79' ' ' LYS . 1.3 mmmt -76.96 -33.59 57.65 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.276 -0.57 . . . . 0.0 112.336 -175.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.94 -48.14 77.71 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 123.412 0.445 . . . . 0.0 110.909 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.457 ' HB2' ' CD1' ' A' ' 83' ' ' LEU . 80.8 m-85 -97.57 12.92 31.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.901 0.381 . . . . 0.0 111.18 -178.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.64 -60.49 4.35 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 121.103 -0.57 . . . . 0.0 113.029 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.657 HD22 ' HA ' ' A' ' 78' ' ' VAL . 10.2 mp 48.71 87.12 0.13 Allowed Pre-proline 0 N--CA 1.467 0.407 0 C-N-CA 123.756 0.822 . . . . 0.0 112.346 -177.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -79.27 44.52 1.71 Allowed 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.409 2.739 . . . . 0.0 112.953 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.634 ' HE1' HD13 ' A' ' 48' ' ' ILE . 21.1 p90 -152.27 157.5 41.48 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.404 ' HB ' HD23 ' A' ' 62' ' ' LEU . 18.7 m -74.78 117.9 17.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.96 0.409 . . . . 0.0 111.001 -174.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 36.0 t -110.2 126.62 67.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.577 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.415 ' SD ' ' HB ' ' A' ' 18' ' ' VAL . 76.0 mtm -119.13 167.73 11.53 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.626 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.426 ' HD1' ' HB3' ' A' ' 65' ' ' ALA . 78.2 t80 -138.56 117.18 12.17 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.559 ' OD2' HG22 ' A' ' 95' ' ' VAL . 43.9 t0 -92.13 128.72 38.08 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.68 -32.08 62.09 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -177.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' A' ' 93' ' ' LYS . 25.9 t70 -112.1 -11.88 13.75 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.795 0.331 . . . . 0.0 110.807 -175.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.621 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 33.8 ttmt 73.15 15.68 4.4 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.533 -177.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.406 ' HA ' HE21 ' A' ' 97' ' ' GLN . . . -61.83 -39.84 93.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.423 -173.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.559 HG22 ' OD2' ' A' ' 90' ' ' ASP . 27.0 m -70.85 -31.93 47.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.863 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -72.1 -34.09 61.79 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 174.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.462 ' HG3' ' O ' ' A' ' 93' ' ' LYS . 44.5 mt-30 -64.35 -29.16 70.24 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 122.554 0.342 . . . . 0.0 110.482 176.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.22 -38.87 65.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.02 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -80.44 -13.14 59.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.823 0.344 . . . . 0.0 111.158 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.01 45.6 5.34 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.938 176.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 56.9 p -75.7 89.54 2.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.172 0.51 . . . . 0.0 111.2 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.6 mm100 -96.39 -52.52 3.94 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.251 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.451 ' HB ' ' CG2' ' A' ' 121' ' ' VAL . 47.1 t -106.73 134.68 47.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.613 177.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -105.1 145.83 31.5 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -75.95 165.41 85.57 Favored 'Cis proline' 0 C--N 1.342 0.227 0 C-N-CA 123.333 -1.528 . . . . 0.0 112.902 -0.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.7 m -124.19 133.67 53.48 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 176.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.532 ' HB3' HD11 ' A' ' 29' ' ' LEU . 25.0 m -127.47 110.57 12.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.863 0.363 . . . . 0.0 111.159 -175.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.673 ' CG1' ' HB ' ' A' ' 30' ' ' ILE . 12.3 p -106.97 138.54 32.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.972 0.415 . . . . 0.0 110.36 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.741 ' HB2' ' HB2' ' A' ' 118' ' ' LYS . 88.2 mt -102.01 124.52 47.76 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.268 0.556 . . . . 0.0 110.355 -177.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.693 HG21 HD13 ' A' ' 23' ' ' LEU . 18.7 mm -108.31 138.36 35.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.994 -174.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -86.22 -177.4 49.82 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.652 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.624 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 98.5 mttt -73.53 1.99 8.82 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.98 0.419 . . . . 0.0 111.557 -177.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 19.9 tptp -134.21 6.55 3.6 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.554 ' HA2' ' CG2' ' A' ' 110' ' ' ILE . . . 85.81 -104.41 2.85 Favored Glycine 0 N--CA 1.433 -1.543 0 CA-C-N 114.376 -1.283 . . . . 0.0 110.346 -172.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.5 ' H ' ' HB2' ' A' ' 5' ' ' ALA . 1.1 mm-40 52.72 -9.1 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.215 1.806 . . . . 0.0 115.772 174.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.711 HG13 ' H ' ' A' ' 5' ' ' ALA . 13.2 mt 68.17 115.43 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 122.969 0.508 . . . . 0.0 111.189 -178.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 79.6 mt -101.85 -48.14 4.37 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.183 0.516 . . . . 0.0 111.235 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.741 ' HB2' ' HB2' ' A' ' 109' ' ' LEU . 5.0 mmmm -146.48 155.13 42.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.777 -169.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 18.4 m -135.98 110.76 8.71 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.643 178.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -112.67 146.91 37.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.243 176.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.451 ' CG2' ' HB ' ' A' ' 103' ' ' VAL . 7.3 p -123.67 133.52 68.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.892 177.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 79.88 -140.37 22.34 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.921 -178.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -85.23 112.31 42.8 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -81.25 162.94 19.96 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.651 2.234 . . . . 0.0 113.256 -177.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.614 ' OD2' ' HB3' ' A' ' 128' ' ' LYS . 7.4 p-10 -75.5 76.9 2.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.308 177.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.41 ' CE2' ' HG2' ' A' ' 46' ' ' LYS . 18.4 m-85 -52.26 -40.41 61.66 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -175.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -57.91 -51.23 59.44 Favored Glycine 0 C--O 1.24 0.511 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.229 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.614 ' HB3' ' OD2' ' A' ' 125' ' ' ASP . 1.9 ttpm? -80.11 -18.75 49.03 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.676 ' O ' HG12 ' A' ' 133' ' ' ILE . 10.0 tt -70.95 -44.82 65.3 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 174.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -57.67 -55.59 32.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.665 0.269 . . . . 0.0 110.701 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.453 ' HG2' ' HA ' ' A' ' 128' ' ' LYS . 9.9 pt20 -61.69 -27.7 68.88 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.043 0.449 . . . . 0.0 110.988 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.454 ' OE2' ' HG3' ' A' ' 118' ' ' LYS . 32.0 tt0 -72.59 -42.86 64.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.555 178.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.676 HG12 ' O ' ' A' ' 129' ' ' LEU . 45.1 mm -69.65 -49.91 54.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.225 179.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.569 ' HA ' ' NE1' ' A' ' 137' ' ' TRP . 5.1 m-20 -64.48 -16.4 62.42 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.965 0.412 . . . . 0.0 111.411 -178.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.409 ' HA ' ' HE ' ' A' ' 138' ' ' ARG . 15.4 m -66.74 -29.11 69.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.958 0.408 . . . . 0.0 110.705 171.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.13 -18.2 64.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.464 -178.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.569 ' NE1' ' HA ' ' A' ' 134' ' ' ASP . 3.7 m95 -74.95 -38.42 61.73 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 174.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 138' ' ' ARG . 34.4 mtm105 -84.95 -60.01 2.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.099 -172.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 50.69 31.57 5.99 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.057 -177.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.8 m -105.14 17.36 24.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.605 0.717 . . . . 0.0 110.034 -176.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -83.75 36.56 0.55 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.831 -175.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.83 112.08 11.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.148 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 26.6 tp10 -96.19 24.15 5.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 122.038 0.923 . . . . 0.0 109.986 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -82.54 54.67 4.94 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.423 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -69.77 142.42 53.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.982 0.42 . . . . 0.0 110.306 178.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -92.12 175.81 6.73 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.341 0.591 . . . . 0.0 111.477 -169.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 45.3 m80 -114.9 99.61 7.6 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 172.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -117.93 89.07 3.04 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.016 0.436 . . . . 0.0 111.676 -172.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 40.3 t60 -178.27 131.91 0.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.667 174.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 7.5 p80 . . . . . 0 C--O 1.246 0.921 0 CA-C-O 118.747 -0.645 . . . . 0.0 110.254 178.078 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.417 ' OD2' ' HG3' ' A' ' 3' ' ' LYS . 6.8 p-10 . . . . . 0 N--CA 1.481 1.124 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.4 p -61.96 -26.76 68.39 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -177.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.594 ' O ' ' HB ' ' A' ' 4' ' ' THR . 58.4 mttp -43.64 109.73 0.16 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.648 HG21 ' HB3' ' A' ' 20' ' ' ASN . 14.0 t 151.49 -25.17 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 O-C-N 124.702 1.251 . . . . 0.0 109.276 177.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.726 ' HB1' ' HD2' ' A' ' 6' ' ' PRO . . . 165.2 -159.72 0.0 OUTLIER Pre-proline 0 C--N 1.315 -0.904 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 -168.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.726 ' HD2' ' HB1' ' A' ' 5' ' ' ALA . 9.6 Cg_endo -57.89 163.69 9.06 Favored 'Trans proline' 0 C--N 1.347 0.498 0 CA-C-N 121.163 1.451 . . . . 0.0 109.394 154.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -52.29 104.75 0.09 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.089 0.471 . . . . 0.0 110.449 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -104.13 111.87 24.64 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 122.377 1.084 . . . . 0.0 112.621 -170.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.5 m -150.35 89.6 1.59 Allowed 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 113.388 -1.733 . . . . 0.0 108.102 171.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.526 ' HB3' ' HE2' ' A' ' 88' ' ' MET . 23.8 tp -120.65 139.17 28.48 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.855 -169.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 10' ' ' LEU . 8.4 Cg_exo -73.58 141.77 31.69 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.394 2.063 . . . . 0.0 111.556 172.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.458 ' CG ' ' H ' ' A' ' 14' ' ' HIS . 0.6 OUTLIER -87.35 -176.04 5.49 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 177.847 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.7 mt -73.01 -1.14 15.95 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -177.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.458 ' H ' ' CG ' ' A' ' 12' ' ' ASP . 67.7 m80 -109.92 8.61 24.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.997 0.427 . . . . 0.0 109.998 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.72 34.95 59.14 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.363 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 16' ' ' LYS . 28.5 mmtm -115.29 134.0 55.53 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 175.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.5 m -79.0 122.46 26.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.826 0.346 . . . . 0.0 110.506 -178.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.8 t -112.48 122.36 66.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 90.4 p -108.13 178.86 4.38 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.313 0.578 . . . . 0.0 110.713 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.648 ' HB3' HG21 ' A' ' 4' ' ' THR . 31.6 p-10 -76.17 -21.22 56.79 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.498 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.03 -28.91 69.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.715 175.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -73.6 -13.93 61.1 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.32 0.581 . . . . 0.0 110.583 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 61.6 mt -83.69 -48.29 10.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.186 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -56.25 150.84 13.68 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.254 0.55 . . . . 0.0 111.864 -175.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.25 -19.5 46.43 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -172.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.53 ' HZ3' ' HB2' ' A' ' 26' ' ' LYS . 4.4 mtmp? -135.39 167.92 20.15 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.428 HG21 ' CD1' ' A' ' 137' ' ' TRP . 35.2 t -108.04 140.52 26.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 175.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.451 HG23 ' HG3' ' A' ' 60' ' ' GLN . 29.9 m -134.32 140.86 46.67 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.013 0.435 . . . . 0.0 111.867 -171.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.464 HD11 ' HB3' ' A' ' 107' ' ' SER . 47.7 tp -113.85 115.45 27.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.305 173.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.852 HG12 ' HB2' ' A' ' 62' ' ' LEU . 46.2 mt -107.01 112.77 41.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.558 ' HA ' ' O ' ' A' ' 106' ' ' THR . 23.6 p-10 -113.9 129.39 56.6 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.246 0.546 . . . . 0.0 111.248 -178.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -83.09 128.74 34.75 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.048 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.592 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 5.5 p-90 -154.12 -175.71 5.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.49 -176.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.786 ' HB3' HE22 ' A' ' 66' ' ' GLN . 13.1 p90 -171.44 159.86 5.03 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.084 174.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' A' ' 34' ' ' PHE . 19.8 Cg_endo -62.86 156.25 55.07 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.119 1.879 . . . . 0.0 111.639 176.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.5 m 67.59 13.56 9.31 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.653 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 49.2 t -83.83 136.26 41.91 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.81 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.541 ' O ' HG12 ' A' ' 41' ' ' VAL . 35.9 Cg_exo -60.13 -25.83 80.9 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.615 2.21 . . . . 0.0 112.25 176.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.21 -13.7 65.17 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 121.228 -0.51 . . . . 0.0 113.145 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 88.1 m -63.25 -30.79 71.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.783 0.292 . . . . 0.0 111.684 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.541 HG12 ' O ' ' A' ' 38' ' ' PRO . 14.6 p -65.39 -37.55 80.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.814 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.447 ' O ' ' HE2' ' A' ' 46' ' ' LYS . 22.8 m -87.11 -56.6 3.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.997 0.427 . . . . 0.0 111.284 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.514 ' HA ' ' HE2' ' A' ' 46' ' ' LYS . 74.4 mm-40 -69.99 -41.55 74.26 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.205 0.816 . . . . 0.0 113.205 -169.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.73 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 39.6 tpp -49.32 -59.96 5.66 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -169.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.73 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 31.2 Cg_exo -58.74 -44.3 37.48 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 121.84 1.693 . . . . 0.0 112.27 -178.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.514 ' HE2' ' HA ' ' A' ' 43' ' ' GLU . 45.1 mtmt -60.2 -51.3 70.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.442 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.6 mm -62.64 -38.3 81.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.367 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.578 HG12 ' O ' ' A' ' 44' ' ' MET . 30.4 mm -54.91 -54.02 27.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 116.807 -0.179 . . . . 0.0 110.956 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.573 ' NZ ' ' HB2' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -75.48 -38.77 59.34 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 119.659 -0.817 . . . . 0.0 110.815 -178.628 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.557 ' O ' ' HD2' ' A' ' 54' ' ' TYR . 91.6 m -58.39 -44.85 89.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.826 0.346 . . . . 0.0 110.811 -178.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.0 -44.65 79.81 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.127 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -67.26 -50.45 60.48 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.747 0.308 . . . . 0.0 111.088 -178.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.63 -45.38 73.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.257 0.551 . . . . 0.0 111.035 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 1.07 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 50.6 m-85 -82.28 -26.24 33.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.308 -174.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.475 ' NZ ' ' HB3' ' A' ' 60' ' ' GLN . 18.0 tppt? -61.93 -32.45 72.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.899 0.381 . . . . 0.0 110.117 176.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -84.76 45.84 1.19 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.464 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.472 ' HE2' ' HA ' ' A' ' 54' ' ' TYR . 9.0 pttm -166.07 -58.48 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.681 170.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.479 ' OD1' ' HG2' ' A' ' 26' ' ' LYS . 59.7 t30 176.46 38.06 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 120.989 0.424 . . . . 0.0 111.521 -177.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 1.07 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 44.4 t80 -138.5 157.42 46.22 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 122.003 -0.435 . . . . 0.0 109.828 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.475 ' HB3' ' NZ ' ' A' ' 55' ' ' LYS . 11.1 pt20 -152.16 152.33 32.15 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.935 0.398 . . . . 0.0 110.985 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 90.2 t -117.96 126.19 74.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.669 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.852 ' HB2' HG12 ' A' ' 30' ' ' ILE . 86.1 mt -112.13 106.46 15.09 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.484 ' HB1' ' CD1' ' A' ' 33' ' ' TRP . . . -90.85 105.86 18.12 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.682 -176.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 91.9 t -90.44 115.86 30.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.936 0.398 . . . . 0.0 110.716 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.592 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -88.0 111.27 21.32 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.791 176.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.786 HE22 ' HB3' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -83.17 163.04 52.35 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.015 -177.29 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.578 ' HD2' ' HB2' ' A' ' 66' ' ' GLN . 57.1 Cg_endo -69.62 97.35 0.62 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.352 2.035 . . . . 0.0 113.073 -171.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 52.6 mt -141.19 -65.05 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.332 173.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.34 144.42 30.9 Favored Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 166.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.95 152.56 23.11 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.442 2.095 . . . . 0.0 112.471 178.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.61 ' HA ' HG22 ' A' ' 74' ' ' VAL . 12.8 tt -58.38 -23.24 21.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.021 176.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -65.83 -45.13 83.41 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.613 174.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.4 m -59.77 -41.13 90.41 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.506 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.61 HG22 ' HA ' ' A' ' 71' ' ' ILE . 13.0 m -68.85 -33.91 61.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.972 -177.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.681 ' HA ' HG22 ' A' ' 78' ' ' VAL . 76.2 mtt180 -70.69 -39.88 73.24 Favored 'General case' 0 C--O 1.22 -0.488 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 174.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -61.31 -37.45 83.3 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -63.35 -53.8 46.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.206 176.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.681 HG22 ' HA ' ' A' ' 75' ' ' ARG . 35.0 m -63.4 -27.26 42.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.996 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 75' ' ' ARG . 5.6 mmmp? -75.69 -40.16 56.27 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -73.3 -49.63 26.53 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.659 0.599 . . . . 0.0 111.798 -172.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -88.58 -1.89 58.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.493 -174.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 58.03 51.2 59.72 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.257 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.531 ' CD1' ' HA ' ' A' ' 78' ' ' VAL . 1.2 mp -74.61 117.06 59.24 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 121.011 0.434 . . . . 0.0 111.151 -175.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.59 -28.37 4.39 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.28 2.654 . . . . 0.0 114.415 -172.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -71.3 146.39 48.91 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.402 -178.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.431 ' HB ' HD23 ' A' ' 62' ' ' LEU . 12.3 m -70.4 113.42 7.52 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.453 -172.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.9 t -99.41 132.58 44.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.244 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.526 ' HE2' ' HB3' ' A' ' 10' ' ' LEU . 60.3 mtp -118.65 164.71 14.93 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.513 -0.767 . . . . 0.0 108.964 -177.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -120.6 129.35 53.71 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.283 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.795 ' OD2' ' HA ' ' A' ' 93' ' ' LYS . 10.7 t0 -102.07 115.75 31.21 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.322 177.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.15 -47.46 24.23 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -172.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -115.04 -10.96 12.17 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -169.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.795 ' HA ' ' OD2' ' A' ' 90' ' ' ASP . 34.9 ttmt 68.63 18.65 8.78 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 122.826 0.45 . . . . 0.0 111.506 177.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.03 -33.95 76.65 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.589 -0.694 . . . . 0.0 109.65 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.8 p -63.39 -47.63 90.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.723 172.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.92 -36.81 93.53 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.207 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -64.59 -30.48 71.51 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 122.542 0.337 . . . . 0.0 111.016 178.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.492 ' HB3' ' HG3' ' A' ' 6' ' ' PRO . . . -67.63 -34.2 76.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.935 0.398 . . . . 0.0 110.451 176.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.533 ' HB2' HG23 ' A' ' 101' ' ' THR . 65.4 m-85 -83.21 -17.9 41.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.031 174.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.8 31.76 38.97 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.942 -175.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.533 HG23 ' HB2' ' A' ' 99' ' ' PHE . 78.1 p -78.36 91.11 4.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.538 0.685 . . . . 0.0 111.98 -175.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 73.6 mm-40 -108.95 -26.39 10.24 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 171.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.5 m -109.18 140.48 27.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.527 174.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.569 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 37.2 m-85 -127.87 160.61 60.32 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.373 -173.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.569 ' HA ' ' HB3' ' A' ' 104' ' ' TYR . 87.3 Cg_endo -78.95 166.52 79.06 Favored 'Cis proline' 0 C--N 1.347 0.484 0 C-N-CA 123.866 -1.306 . . . . 0.0 113.269 0.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.558 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 22.1 m -126.03 120.47 30.35 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.99 175.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.464 ' HB3' HD11 ' A' ' 29' ' ' LEU . 33.9 m -107.89 113.17 26.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.009 0.433 . . . . 0.0 111.496 -174.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.601 HG22 HG23 ' A' ' 119' ' ' THR . 45.8 t -105.54 129.19 58.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.377 -178.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.569 ' HB2' ' HB3' ' A' ' 118' ' ' LYS . 96.5 mt -102.74 126.25 49.78 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.466 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 65.7 mt -116.87 125.36 73.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.086 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.473 ' H ' HD23 ' A' ' 117' ' ' LEU . . . -72.84 177.63 41.26 Favored Glycine 0 N--CA 1.453 -0.224 0 CA-C-N 115.896 -0.593 . . . . 0.0 113.21 -175.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 7.2 ptpp? -68.48 -6.2 23.7 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -175.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.846 ' HE3' ' HB3' ' A' ' 143' ' ' GLU . 7.7 ptmm? -105.97 6.99 31.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.684 0.278 . . . . 0.0 110.438 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.33 70.68 1.01 Allowed Glycine 0 C--O 1.225 -0.449 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 -177.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.577 ' CA ' ' HA ' ' A' ' 4' ' ' THR . 23.2 tt0 -153.72 165.21 36.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.551 0.215 . . . . 0.0 110.466 -174.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 86.7 mt -72.97 103.32 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.087 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.473 HD23 ' H ' ' A' ' 111' ' ' GLY . 3.1 mm? -97.92 -44.05 6.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.615 177.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.569 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -163.18 152.51 14.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.839 0.352 . . . . 0.0 111.872 -175.775 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.601 HG23 HG22 ' A' ' 108' ' ' VAL . 38.0 m -138.77 102.93 4.7 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.845 168.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -79.54 138.38 37.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.653 174.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.3 p -103.86 114.99 44.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 173.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 94.13 -157.91 22.88 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.889 -177.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -80.59 119.73 77.12 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 120.72 0.295 . . . . 0.0 110.681 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -87.56 151.47 7.63 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.818 2.345 . . . . 0.0 112.716 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.96 127.86 33.02 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.583 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 7.6 m-85 -71.57 -18.8 62.22 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -176.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -68.23 -54.48 16.7 Favored Glycine 0 C--O 1.238 0.367 0 C-N-CA 120.096 -1.049 . . . . 0.0 111.648 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.708 ' HA ' HE21 ' A' ' 131' ' ' GLN . 5.2 ttpp -74.87 -20.82 59.57 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 176.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.583 ' HB3' ' HA ' ' A' ' 126' ' ' PHE . 63.0 tp -65.7 -48.02 73.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.049 175.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 14.9 m-30 -61.56 -52.72 63.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.263 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.708 HE21 ' HA ' ' A' ' 128' ' ' LYS . 19.8 pt20 -65.92 -27.54 68.26 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.863 0.363 . . . . 0.0 111.909 -177.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -80.02 -37.26 34.49 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.184 -0.323 . . . . 0.0 110.428 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 129' ' ' LEU . 51.2 mt -65.64 -48.49 82.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.717 176.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.425 ' CG ' HH21 ' A' ' 138' ' ' ARG . 0.0 OUTLIER -64.67 -25.37 67.92 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 -177.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.459 ' HA ' ' HG2' ' A' ' 138' ' ' ARG . 68.7 m -60.99 -43.69 98.49 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.067 0.461 . . . . 0.0 110.145 173.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.52 -23.86 64.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.637 178.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.79 ' HZ2' ' HB2' ' A' ' 59' ' ' PHE . 14.3 m95 -78.13 -54.36 6.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.098 175.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.459 ' HG2' ' HA ' ' A' ' 135' ' ' THR . 5.0 ptp180 -65.63 -36.16 82.89 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.745 -173.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -71.19 102.78 2.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.725 0.298 . . . . 0.0 110.434 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.8 p -71.49 -76.02 0.12 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.281 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -112.21 53.63 0.73 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.901 -176.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.94 -35.29 80.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.381 0.61 . . . . 0.0 109.804 175.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.846 ' HB3' ' HE3' ' A' ' 113' ' ' LYS . 0.7 OUTLIER -118.37 172.56 7.37 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 177.542 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.572 ' H ' ' CD ' ' A' ' 143' ' ' GLU . . . 98.04 19.57 23.59 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -174.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 18.6 m170 -91.76 14.44 15.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.023 -0.588 . . . . 0.0 110.916 -174.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -68.96 -9.46 52.26 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.967 0.413 . . . . 0.0 110.592 -178.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -78.06 -5.53 51.77 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.375 0.607 . . . . 0.0 110.06 175.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 73.3 m-70 -125.53 144.26 50.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.892 175.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 21.0 p80 -155.73 161.73 40.66 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.623 178.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 54.4 p-80 . . . . . 0 C--O 1.245 0.846 0 CA-C-O 118.588 -0.72 . . . . 0.0 109.641 -179.92 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 . . . . . 0 N--CA 1.482 1.168 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.3 m 53.17 72.71 0.41 Allowed 'General case' 0 C--O 1.235 0.331 0 O-C-N 123.571 0.544 . . . . 0.0 109.642 -175.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.525 ' HE2' HD12 ' A' ' 116' ' ' ILE . 14.7 mmmm 67.27 -168.84 0.2 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.834 -166.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.502 HG21 ' H ' ' A' ' 147' ' ' HIS . 12.4 m 60.9 18.5 8.85 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.216 0.531 . . . . 0.0 110.821 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 68.13 150.06 0.12 Allowed Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.293 -176.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.543 ' HG3' ' HA ' ' A' ' 95' ' ' VAL . 69.6 Cg_endo -88.96 178.88 2.56 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.435 2.09 . . . . 0.0 111.309 175.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.95 83.73 7.46 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 172.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -110.56 112.93 25.16 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.596 0.712 . . . . 0.0 111.319 -173.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.4 m -96.15 90.04 5.36 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 169.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.483 HD12 ' HD2' ' A' ' 11' ' ' PRO . 29.7 tp -102.73 123.35 42.75 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.259 -169.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.542 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 8.4 Cg_exo -72.96 147.06 42.94 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.819 2.346 . . . . 0.0 112.222 176.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.08 -177.91 5.3 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 174.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.3 mt -63.5 -22.73 67.05 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -177.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -89.22 -54.53 4.06 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.053 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.22 18.25 0.05 OUTLIER Glycine 0 CA--C 1.523 0.548 0 C-N-CA 119.61 -1.281 . . . . 0.0 114.683 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 11' ' ' PRO . 51.2 mttt -92.0 140.39 29.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 118.026 0.913 . . . . 0.0 110.119 174.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.6 m -88.26 122.36 31.7 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.1 0.476 . . . . 0.0 111.397 -177.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.0 t -107.25 132.66 54.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.737 174.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -140.81 -177.3 5.01 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.44 -173.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -58.21 -23.33 55.32 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.702 -176.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.86 -27.92 69.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.483 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -83.04 -19.59 36.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.148 0.499 . . . . 0.0 110.541 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.632 ' HB3' ' HA2' ' A' ' 114' ' ' GLY . 9.3 mp -83.53 -20.08 34.52 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.306 -176.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -95.74 134.58 38.5 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.063 0.459 . . . . 0.0 110.942 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.97 -7.13 82.28 Favored Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.752 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.582 ' HG2' ' OD1' ' A' ' 58' ' ' ASN . 29.9 mtpp -129.61 168.19 16.81 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -103.25 130.93 52.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 174.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.475 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 21.0 m -133.26 146.41 51.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.98 0.419 . . . . 0.0 112.057 -166.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.519 HD21 ' HB3' ' A' ' 107' ' ' SER . 8.0 tt -131.73 124.22 29.3 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 174.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.823 ' HB ' HG12 ' A' ' 108' ' ' VAL . 45.0 mm -109.89 125.35 67.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -109.38 112.87 25.24 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -84.79 119.57 25.45 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.593 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 4.2 p-90 -154.32 177.11 11.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.2 0.524 . . . . 0.0 111.484 -176.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.63 ' HB3' ' OE1' ' A' ' 66' ' ' GLN . 9.3 p90 -148.81 136.32 10.99 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.602 172.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 34' ' ' PHE . 44.8 Cg_exo -59.59 -15.71 32.46 Favored 'Trans proline' 0 N--CA 1.475 0.396 0 C-N-CA 123.421 2.747 . . . . 0.0 114.414 -173.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.4 p -95.45 13.81 24.72 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 122.017 -0.427 . . . . 0.0 111.991 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.446 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 25.0 p -88.37 146.0 36.88 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.854 0.359 . . . . 0.0 111.375 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 5.8 Cg_exo -79.09 -8.68 15.41 Favored 'Trans proline' 0 CA--C 1.532 0.406 0 C-N-CA 123.119 2.546 . . . . 0.0 113.011 176.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -86.18 -61.27 1.67 Allowed Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.676 -173.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' A' ' 33' ' ' TRP . 82.0 m -52.06 -30.06 24.05 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -169.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.8 p -56.12 -24.52 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.112 0.482 . . . . 0.0 111.16 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.657 ' HB2' ' OE2' ' A' ' 43' ' ' GLU . 1.7 m -86.23 -45.15 11.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.952 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.657 ' OE2' ' HB2' ' A' ' 42' ' ' SER . 3.9 mp0 -80.13 -33.36 38.65 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -174.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.596 ' O ' HG12 ' A' ' 48' ' ' ILE . 13.2 ptp -57.43 -38.9 72.83 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -166.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.56 ' HD3' ' CG ' ' A' ' 44' ' ' MET . 47.2 Cg_exo -58.28 -43.94 42.68 Favored 'Trans proline' 0 C--N 1.361 1.225 0 CA-C-N 121.749 1.66 . . . . 0.0 111.797 175.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -59.16 -38.09 78.91 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.483 176.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.2 mt -68.52 -36.42 74.62 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.4 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.733 177.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.596 HG12 ' O ' ' A' ' 44' ' ' MET . 47.2 mm -53.57 -55.49 13.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-O 120.799 0.333 . . . . 0.0 110.32 -175.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -75.86 -53.74 7.98 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.272 -177.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.8 m -58.01 -45.03 87.52 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -174.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.509 ' HB1' HG21 ' A' ' 61' ' ' VAL . . . -70.03 -36.05 74.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.874 -0.148 . . . . 0.0 111.32 -178.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -68.78 -45.43 71.36 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.017 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -59.77 -27.28 66.4 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.779 176.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.48 ' O ' ' HB3' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -87.18 -39.48 15.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.946 -179.649 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.409 ' C ' ' HD2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -60.07 -31.27 69.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.296 -175.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -80.34 37.54 0.39 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -174.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.57 65.84 0.21 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.073 0.463 . . . . 0.0 111.068 172.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.582 ' OD1' ' HG2' ' A' ' 26' ' ' LYS . 66.9 t30 66.1 11.0 7.5 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.525 176.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.495 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 43.9 t80 -105.57 148.69 27.0 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -141.4 126.33 18.22 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.135 0.493 . . . . 0.0 111.506 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.509 HG21 ' HB1' ' A' ' 51' ' ' ALA . 58.2 t -106.07 117.39 51.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.686 177.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.5 mp -120.2 117.82 28.87 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.017 0.437 . . . . 0.0 110.227 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.442 ' O ' ' HA ' ' A' ' 87' ' ' VAL . . . -94.22 114.26 26.33 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.839 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.3 p -101.23 119.95 50.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.353 0.596 . . . . 0.0 111.137 -176.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.593 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -89.59 129.68 36.01 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.447 175.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.63 ' OE1' ' HB3' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -104.74 165.88 12.5 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.594 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.621 ' HD3' ' O ' ' A' ' 90' ' ' ASP . 57.7 Cg_endo -70.83 80.15 1.21 Allowed 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.291 1.994 . . . . 0.0 113.525 -169.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 70.6 mt -120.78 -43.9 2.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 172.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.451 ' OD1' ' HD2' ' A' ' 35' ' ' PRO . 5.3 p-10 -121.78 141.43 33.84 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 163.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 69' ' ' ASP . 36.4 Cg_exo -57.66 158.33 20.35 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.056 2.504 . . . . 0.0 113.176 -174.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.618 ' O ' ' HG2' ' A' ' 75' ' ' ARG . 13.1 tt -53.69 -28.35 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.288 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.571 ' HA ' ' CG ' ' A' ' 75' ' ' ARG . 22.6 tp10 -64.16 -36.75 85.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.117 0.484 . . . . 0.0 110.958 178.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.0 t -68.71 -34.96 76.52 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 178.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.48 ' O ' HG23 ' A' ' 78' ' ' VAL . 24.0 t -60.35 -44.38 95.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.216 173.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.618 ' HG2' ' O ' ' A' ' 71' ' ' ILE . 14.1 mmt180 -52.83 -51.93 59.03 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.751 0.786 . . . . 0.0 109.601 176.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -61.47 -42.04 98.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.157 -1.383 . . . . 0.0 111.781 -175.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -70.99 -43.21 68.47 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.076 -176.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.554 HG13 ' HB2' ' A' ' 83' ' ' LEU . 80.1 t -59.89 -43.84 93.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.341 -177.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -74.0 -28.57 61.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.662 0.268 . . . . 0.0 111.348 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -73.37 -48.58 32.99 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.352 -175.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -97.42 -2.77 41.47 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -177.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 64.44 64.08 3.85 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.555 178.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.554 ' HB2' HG13 ' A' ' 78' ' ' VAL . 10.3 mp -79.67 115.34 52.95 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-O 120.644 0.259 . . . . 0.0 110.914 -178.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.423 ' CD ' HD12 ' A' ' 48' ' ' ILE . 93.4 Cg_endo -89.6 -21.45 1.09 Allowed 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.004 2.469 . . . . 0.0 113.568 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -76.19 155.56 34.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.799 0.333 . . . . 0.0 110.503 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 29.5 m -73.41 121.19 20.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.344 -175.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 63' ' ' ALA . 38.9 t -109.42 138.7 35.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.677 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 71.6 mtm -122.25 171.29 9.13 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 176.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -139.47 115.24 10.1 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.545 -0.169 . . . . 0.0 110.545 -178.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.621 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 13.3 t70 -107.83 127.53 53.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.898 0.38 . . . . 0.0 110.793 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.48 -28.12 56.35 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -175.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -112.65 -12.96 13.34 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -165.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.4 ' HG2' ' HB2' ' A' ' 66' ' ' GLN . 57.0 mtpt 69.42 7.63 6.34 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 122.739 0.415 . . . . 0.0 110.978 178.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.35 -32.53 70.19 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.246 0.546 . . . . 0.0 110.192 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.543 ' HA ' ' HG3' ' A' ' 6' ' ' PRO . 2.0 p -60.43 -49.8 82.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.42 173.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -67.18 -33.67 83.69 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.938 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -58.82 -51.65 69.11 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 122.653 0.381 . . . . 0.0 111.485 177.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.79 -29.67 62.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.888 -177.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.728 ' HA ' HD11 ' A' ' 116' ' ' ILE . 17.2 m-85 -76.35 -27.79 56.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.753 0.311 . . . . 0.0 111.093 177.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.36 46.43 4.67 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.785 -0.722 . . . . 0.0 111.718 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 24.5 m -118.43 99.35 6.77 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.981 0.42 . . . . 0.0 111.158 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -91.82 -48.78 6.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.9 176.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 9.2 p -100.4 159.44 3.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.327 -174.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.431 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 34.1 m-85 -135.49 156.85 77.45 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -175.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.437 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 89.4 Cg_endo -85.16 141.59 32.38 Favored 'Cis proline' 0 C--N 1.347 0.478 0 C-N-CA 123.524 -1.449 . . . . 0.0 112.725 -0.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 89.5 m -129.77 129.98 44.79 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.379 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.519 ' HB3' HD21 ' A' ' 29' ' ' LEU . 14.0 m -111.79 131.92 55.02 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.148 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.823 HG12 ' HB ' ' A' ' 30' ' ' ILE . 8.3 p -105.97 142.77 18.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 120.887 0.375 . . . . 0.0 109.995 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.751 HD21 HD11 ' A' ' 129' ' ' LEU . 66.5 mt -103.86 127.86 51.35 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.779 177.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.496 HD13 HD23 ' A' ' 23' ' ' LEU . 72.5 mt -115.62 127.38 73.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.859 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.63 -97.84 0.01 OUTLIER Glycine 0 C--N 1.334 0.44 0 O-C-N 123.953 0.783 . . . . 0.0 112.716 -177.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.484 ' HG2' ' OE2' ' A' ' 143' ' ' GLU . 8.8 ptpp? -150.97 13.27 0.69 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.011 0.434 . . . . 0.0 110.649 176.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 49.1 mttp -111.9 -3.11 14.96 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.48 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.632 ' HA2' ' HB3' ' A' ' 23' ' ' LEU . . . 76.65 42.45 21.54 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.654 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.428 ' CD ' ' H ' ' A' ' 146' ' ' HIS . 10.7 pt-20 -139.14 165.15 27.92 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.741 0.305 . . . . 0.0 110.335 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.728 HD11 ' HA ' ' A' ' 99' ' ' PHE . 59.5 mt -69.74 116.69 11.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.667 -177.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 19.5 tp -105.71 -51.65 2.96 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.283 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.608 ' HB2' ' HB2' ' A' ' 109' ' ' LEU . 3.1 mmmm -139.56 169.65 17.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.091 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 23.2 m -148.88 129.62 14.16 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.767 0.318 . . . . 0.0 110.746 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -126.29 118.49 25.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.771 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.7 p -110.99 139.67 33.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.762 -178.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 73.52 66.71 1.95 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.093 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 65.48 116.21 0.02 OUTLIER Pre-proline 0 N--CA 1.464 0.264 0 C-N-CA 123.45 0.7 . . . . 0.0 111.805 -175.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.75 117.76 3.69 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.181 1.92 . . . . 0.0 111.633 174.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 129' ' ' LEU . 14.5 t70 -61.49 105.58 0.54 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 175.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -64.49 -31.65 72.96 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -171.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.473 ' HA2' ' CZ ' ' A' ' 130' ' ' TYR . . . -58.86 -54.07 41.01 Favored Glycine 0 C--O 1.238 0.371 0 C-N-CA 120.371 -0.918 . . . . 0.0 111.661 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.591 ' HA ' ' HG2' ' A' ' 131' ' ' GLN . 35.7 mtmm -76.16 -17.95 59.33 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.657 0.265 . . . . 0.0 110.637 177.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.751 HD11 HD21 ' A' ' 109' ' ' LEU . 18.6 tp -69.17 -51.22 40.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.662 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.479 ' HB3' ' HE2' ' A' ' 54' ' ' TYR . 2.0 p90 -73.94 -33.94 64.12 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 119.579 -0.848 . . . . 0.0 112.249 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.591 ' HG2' ' HA ' ' A' ' 128' ' ' LYS . 3.3 pt20 -68.47 -30.73 69.65 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.79 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -76.12 -45.33 34.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.7 177.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 129' ' ' LEU . 78.0 mt -63.54 -38.88 83.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.628 178.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.594 ' O ' ' HG2' ' A' ' 138' ' ' ARG . 12.3 t70 -56.65 -40.26 75.16 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.01 0.433 . . . . 0.0 110.218 176.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 89.6 m -58.32 -35.28 71.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.657 177.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.759 ' HA ' ' ND2' ' A' ' 139' ' ' ASN . . . -75.72 -17.92 59.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.198 178.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.442 ' HB2' ' O ' ' A' ' 134' ' ' ASP . 11.7 m0 -74.03 -35.12 64.33 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 171.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.594 ' HG2' ' O ' ' A' ' 134' ' ' ASP . 20.7 mmt180 -84.82 -30.87 24.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.367 -174.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.759 ' ND2' ' HA ' ' A' ' 136' ' ' ALA . 37.5 p30 -69.76 131.52 44.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.815 0.817 . . . . 0.0 111.437 -175.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.9 m -89.73 92.0 8.87 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.293 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 33.2 t70 73.64 -26.41 0.19 Allowed 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.77 175.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -73.01 76.43 1.2 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.098 0.475 . . . . 0.0 111.77 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.484 ' OE2' ' HG2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -155.54 -57.15 0.1 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.193 175.813 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -126.83 167.55 19.24 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.486 174.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -158.2 17.02 0.22 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.827 0.313 . . . . 0.0 110.86 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.428 ' H ' ' CD ' ' A' ' 115' ' ' GLU . 31.6 m170 63.33 103.76 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.704 0.802 . . . . 0.0 112.998 176.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.502 ' H ' HG21 ' A' ' 4' ' ' THR . 1.7 t-160 71.67 -7.46 1.23 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.24 175.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -88.56 -24.42 22.88 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 172.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -94.98 117.48 30.22 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 174.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 35.9 m-70 . . . . . 0 C--O 1.245 0.823 0 CA-C-O 118.567 -0.73 . . . . 0.0 110.795 -175.474 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.534 ' O ' ' HB1' ' A' ' 98' ' ' ALA . 26.0 t0 . . . . . 0 N--CA 1.483 1.178 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.722 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 50.0 m -86.53 126.46 34.47 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -173.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.527 ' HA ' HG13 ' A' ' 116' ' ' ILE . 2.5 mppt? 68.62 139.56 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 171.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.646 ' H ' HG12 ' A' ' 116' ' ' ILE . 11.1 m 71.93 17.37 5.28 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.701 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.518 ' N ' ' HD3' ' A' ' 6' ' ' PRO . . . 49.1 56.55 18.15 Favored Pre-proline 0 N--CA 1.468 0.432 0 CA-C-N 115.076 -0.966 . . . . 0.0 112.918 177.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.518 ' HD3' ' N ' ' A' ' 5' ' ' ALA . 15.9 Cg_exo -70.4 106.7 1.83 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.827 2.351 . . . . 0.0 112.766 -177.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 48.63 88.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 O-C-N 124.552 1.157 . . . . 0.0 113.121 173.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.508 ' CE1' ' HB1' ' A' ' 5' ' ' ALA . 7.0 p90 -148.59 143.85 26.85 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.099 175.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.3 m -149.0 98.33 2.82 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 175.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.559 HD12 ' HD2' ' A' ' 11' ' ' PRO . 25.4 tp -114.39 126.87 27.42 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.196 -175.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.559 ' HD2' HD12 ' A' ' 10' ' ' LEU . 50.1 Cg_endo -70.17 150.53 65.84 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.388 2.059 . . . . 0.0 112.405 177.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.466 ' CG ' ' H ' ' A' ' 14' ' ' HIS . 0.8 OUTLIER -81.49 -174.26 4.86 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 176.277 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.735 HD13 ' HA ' ' A' ' 75' ' ' ARG . 70.4 mt -69.98 -16.36 63.18 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.466 ' H ' ' CG ' ' A' ' 12' ' ' ASP . 33.7 t-80 -87.98 -42.75 12.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.712 176.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.37 12.07 1.11 Allowed Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.294 177.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 11' ' ' PRO . 66.3 tttt -86.77 116.18 24.7 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 177.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 8.9 t -69.33 123.54 21.48 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.318 0.58 . . . . 0.0 109.617 175.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.501 ' HB ' ' CE ' ' A' ' 88' ' ' MET . 53.9 t -112.87 126.95 70.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.273 -177.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.419 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 61.0 p -132.32 -176.22 4.01 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.254 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -62.03 -23.29 66.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.072 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.419 ' HA ' ' NE2' ' A' ' 24' ' ' GLN . . . -67.03 -30.63 70.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.948 0.404 . . . . 0.0 110.837 178.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -82.45 -25.03 33.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.043 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.765 HD21 HD11 ' A' ' 62' ' ' LEU . 70.2 mt -83.19 -48.34 10.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.125 -175.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.616 ' HA ' ' H ' ' A' ' 113' ' ' LYS . 10.5 pt20 -51.22 144.31 9.69 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.384 0.611 . . . . 0.0 112.602 -171.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.67 -24.71 22.28 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.298 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.508 ' NZ ' ' HB2' ' A' ' 26' ' ' LYS . 7.7 mtmp? -121.96 171.29 9.05 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 14.1 t -101.9 140.47 20.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -178.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.585 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 17.0 m -131.78 145.65 51.71 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.139 0.495 . . . . 0.0 111.871 -171.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.677 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 6.2 tt -121.98 114.01 20.38 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 172.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.679 ' HB ' ' CG2' ' A' ' 108' ' ' VAL . 36.0 mt -98.54 112.6 31.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -118.21 121.21 39.91 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.569 0.223 . . . . 0.0 110.47 -178.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -92.73 119.77 32.44 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.561 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.49 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 10.5 p-90 -141.73 -176.36 4.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.142 -175.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -168.92 156.64 7.13 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 175.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.614 ' HD3' HG12 ' A' ' 74' ' ' VAL . 33.1 Cg_exo -59.68 158.92 26.2 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.544 2.163 . . . . 0.0 112.326 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 81.6 p 60.77 11.05 2.97 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.031 0.932 . . . . 0.0 112.141 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.731 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 34.6 t -72.96 129.96 85.75 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 177.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.69 -20.73 66.68 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.965 2.443 . . . . 0.0 112.461 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.82 -19.47 61.43 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.755 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.907 ' HA ' ' HG2' ' A' ' 43' ' ' GLU . 93.6 m -63.33 -30.78 71.85 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -174.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.3 m -64.16 -29.07 46.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.111 0.481 . . . . 0.0 110.417 177.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.519 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 29.4 t -88.94 -56.09 3.43 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.21 176.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.907 ' HG2' ' HA ' ' A' ' 40' ' ' CYS . 17.1 pt-20 -64.6 -50.14 68.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.092 -0.503 . . . . 0.0 112.043 -170.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.653 ' O ' HG12 ' A' ' 48' ' ' ILE . 33.5 ttm -57.87 -55.08 48.74 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -167.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.56 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 52.7 Cg_exo -53.35 -47.35 27.86 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.899 1.733 . . . . 0.0 112.433 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.519 ' HD3' ' O ' ' A' ' 42' ' ' SER . 23.9 mtpt -64.41 -40.04 95.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.09 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.471 HG12 ' O ' ' A' ' 43' ' ' GLU . 29.6 mm -64.31 -37.65 80.49 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.307 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.9 177.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.653 HG12 ' O ' ' A' ' 44' ' ' MET . 50.4 mm -54.67 -50.6 58.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 121.296 0.569 . . . . 0.0 109.939 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -67.69 -53.62 26.12 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.16 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 14.4 p -62.02 -54.69 38.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.912 -176.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.12 -39.0 91.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.841 -174.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -71.55 -35.36 70.61 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.411 -174.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -77.1 -48.53 17.52 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.299 -0.561 . . . . 0.0 110.463 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.751 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 25.6 m-85 -62.68 -27.77 69.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.801 0.334 . . . . 0.0 110.939 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.545 ' HA ' ' O ' ' A' ' 59' ' ' PHE . 36.9 ttpt -53.88 -37.4 63.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.797 173.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -89.13 10.04 23.33 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.683 -177.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.406 ' CG ' ' HA ' ' A' ' 54' ' ' TYR . 0.3 OUTLIER -105.23 -66.68 0.96 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.293 0.568 . . . . 0.0 109.689 177.375 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.491 ' OD1' ' HA ' ' A' ' 26' ' ' LYS . 21.0 t-20 174.25 21.71 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.111 -174.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.751 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 34.0 t80 -122.82 132.09 54.05 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.731 -168.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.504 ' O ' ' HA ' ' A' ' 28' ' ' THR . 4.1 pt20 -121.63 137.64 54.66 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.221 178.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.438 HG22 ' HE1' ' A' ' 59' ' ' PHE . 97.6 t -110.19 124.85 67.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.433 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.765 HD11 HD21 ' A' ' 23' ' ' LEU . 86.9 mt -106.4 95.83 6.03 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.52 177.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.74 97.23 10.78 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.562 ' HA ' ' HB2' ' A' ' 88' ' ' MET . 15.0 t -85.08 110.12 18.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.117 -176.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -87.0 117.17 25.54 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.86 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.516 ' HB2' ' CD ' ' A' ' 67' ' ' PRO . 4.1 pt20 -81.11 -178.01 1.08 Allowed Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.569 ' HD3' ' O ' ' A' ' 90' ' ' ASP . 16.1 Cg_exo -69.0 -135.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 122.25 1.967 . . . . 0.0 112.812 -176.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.548 ' HB ' ' O ' ' A' ' 67' ' ' PRO . 90.7 mt 77.14 -57.65 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -175.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.41 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -104.78 133.64 20.06 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 168.309 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.505 ' O ' HG22 ' A' ' 74' ' ' VAL . 21.6 Cg_exo -65.52 173.31 6.71 Favored 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 122.843 2.362 . . . . 0.0 113.351 -174.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.608 ' HA ' ' CG2' ' A' ' 74' ' ' VAL . 7.1 tp -63.76 -33.01 59.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.726 -170.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.436 ' HA ' ' HD2' ' A' ' 75' ' ' ARG . 0.6 OUTLIER -73.4 -32.85 64.68 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.605 178.782 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 75.2 m -67.42 -51.13 55.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.889 176.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.614 HG12 ' HD3' ' A' ' 35' ' ' PRO . 3.1 m -61.45 -42.64 94.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.354 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.735 ' HA ' HD13 ' A' ' 13' ' ' LEU . 4.4 ptm180 -74.46 -34.02 63.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.135 -176.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -71.12 -36.94 72.32 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 110.329 -0.248 . . . . 0.0 110.329 177.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -55.1 -44.05 74.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.276 0.56 . . . . 0.0 109.52 178.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.796 HG13 ' HB2' ' A' ' 83' ' ' LEU . 84.1 t -59.84 -48.76 86.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.742 175.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -75.14 -29.34 60.48 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -173.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -74.29 -46.94 38.03 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.804 0.335 . . . . 0.0 111.222 -176.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -85.77 -10.77 55.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.743 0.306 . . . . 0.0 111.523 -176.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.96 53.65 3.88 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.821 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.796 ' HB2' HG13 ' A' ' 78' ' ' VAL . 9.9 mp -78.74 111.23 17.95 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-O 120.692 0.282 . . . . 0.0 110.508 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -92.73 32.76 0.25 Allowed 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.2 2.6 . . . . 0.0 113.237 -177.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.604 ' HE2' HD13 ' A' ' 48' ' ' ILE . 29.0 p90 -135.64 165.37 25.71 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.9 m -74.51 128.11 34.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.091 0.472 . . . . 0.0 111.277 -175.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.9 t -120.43 137.08 55.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.075 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.562 ' HB2' ' HA ' ' A' ' 64' ' ' VAL . 48.8 mtt -111.47 175.87 5.25 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.328 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.42 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 73.3 t80 -131.83 107.57 8.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.32 175.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.569 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 67.3 t0 -91.51 91.87 8.26 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.76 -35.07 62.58 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -175.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.431 ' O ' ' HB3' ' A' ' 93' ' ' LYS . 3.6 p30 -94.44 -12.49 27.66 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.821 -0.351 . . . . 0.0 111.86 -173.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.438 ' HE3' ' HB3' ' A' ' 93' ' ' LYS . 0.6 OUTLIER 72.39 -10.93 0.86 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 120.989 0.423 . . . . 0.0 111.126 174.514 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.85 -22.64 39.72 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 122.271 -0.268 . . . . 0.0 110.371 -177.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 83.6 t -59.83 -49.76 82.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 172.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -58.99 -32.97 71.97 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.303 174.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 93' ' ' LYS . 43.7 mt-30 -69.71 -34.22 73.59 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 122.801 -0.235 . . . . 0.0 111.12 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.722 ' O ' ' HA ' ' A' ' 2' ' ' SER . . . -66.24 -37.44 85.51 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.088 0.47 . . . . 0.0 110.736 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -76.71 -26.98 55.28 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.026 0.441 . . . . 0.0 110.521 176.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.6 44.68 2.08 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.798 174.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.495 ' HA ' HG21 ' A' ' 106' ' ' THR . 29.9 p -69.77 100.77 1.57 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.199 0.523 . . . . 0.0 111.116 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.05 -61.65 1.74 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.457 0.646 . . . . 0.0 109.262 177.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.9 p -139.55 140.84 36.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.576 -177.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.406 ' HA ' ' C ' ' A' ' 105' ' ' PRO . 72.9 m-85 -94.8 147.5 33.23 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 -173.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.568 ' HD2' ' HA2' ' A' ' 122' ' ' GLY . 6.4 Cg_exo -73.63 146.44 86.92 Favored 'Cis proline' 0 C--O 1.234 0.321 0 C-N-CA 123.663 -1.39 . . . . 0.0 112.558 0.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.495 HG21 ' HA ' ' A' ' 101' ' ' THR . 19.9 m -115.26 112.24 22.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.18 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.0 m -109.47 112.26 24.26 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.611 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.679 ' CG2' ' HB ' ' A' ' 30' ' ' ILE . 15.3 m -105.75 142.96 17.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.132 0.491 . . . . 0.0 110.71 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.454 HD11 HD22 ' A' ' 129' ' ' LEU . 81.6 mt -101.42 125.81 48.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.288 -176.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.585 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 10.0 mm -114.33 110.04 30.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 O-C-N 124.59 1.181 . . . . 0.0 109.136 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.5 ' O ' ' HG3' ' A' ' 112' ' ' LYS . . . -61.99 -59.29 9.83 Favored Glycine 0 C--O 1.225 -0.414 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.383 -178.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.527 ' O ' ' HB2' ' A' ' 113' ' ' LYS . 19.3 mttt -169.46 166.89 10.13 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 178.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.616 ' H ' ' HA ' ' A' ' 24' ' ' GLN . 28.6 mttt 77.45 -52.12 0.54 Allowed 'General case' 0 C--N 1.323 -0.563 0 O-C-N 123.642 0.588 . . . . 0.0 111.814 176.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 137.49 3.57 2.08 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.247 -177.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -68.29 144.58 54.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.892 0.377 . . . . 0.0 110.722 -179.127 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.646 HG12 ' H ' ' A' ' 4' ' ' THR . 51.0 mm -90.5 108.02 19.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.512 HD13 ' CD2' ' A' ' 145' ' ' HIS . 21.6 mt -94.39 -68.24 0.81 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.811 -173.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.444 ' HB3' HD12 ' A' ' 109' ' ' LEU . 21.4 tptm -122.78 148.24 45.6 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.865 -172.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 28.7 m -128.75 107.6 9.8 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.859 0.361 . . . . 0.0 111.046 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.496 ' CE1' ' HB3' ' A' ' 125' ' ' ASP . 51.4 m-85 -104.44 137.39 42.37 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.368 176.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.0 m -118.42 128.99 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-O 120.821 0.343 . . . . 0.0 110.977 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.568 ' HA2' ' HD2' ' A' ' 105' ' ' PRO . . . 79.32 -69.69 2.93 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.756 178.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.424 ' OE1' ' HD2' ' A' ' 124' ' ' PRO . 6.9 tp10 -126.49 114.54 23.1 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.424 ' HD2' ' OE1' ' A' ' 123' ' ' GLU . 56.4 Cg_endo -72.25 122.25 8.21 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.386 2.057 . . . . 0.0 112.366 177.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.593 ' O ' ' HB2' ' A' ' 129' ' ' LEU . 3.7 t0 -61.5 105.2 0.49 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.34 175.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.492 ' HA ' ' CB ' ' A' ' 129' ' ' LEU . 75.6 m-85 -69.26 -21.84 63.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.695 -172.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -63.64 -54.46 31.34 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 119.793 -1.194 . . . . 0.0 111.448 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -81.63 -17.29 48.66 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.633 -0.283 . . . . 0.0 110.907 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.593 ' HB2' ' O ' ' A' ' 125' ' ' ASP . 0.9 OUTLIER -61.42 -49.04 78.48 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 174.584 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -71.61 -40.72 69.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.964 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -61.12 -43.5 98.79 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.319 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -62.39 -47.26 84.94 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.73 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 129' ' ' LEU . 68.0 mt -58.24 -45.13 89.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.097 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -64.54 -38.65 91.75 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.996 0.427 . . . . 0.0 111.005 177.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 87.8 m -60.59 -39.29 87.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.393 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.09 -30.93 58.47 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.17 176.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.738 ' HH2' ' HB2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -56.66 -58.16 9.26 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.237 0.541 . . . . 0.0 110.596 176.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 43.1 mtm105 -86.06 -25.54 25.82 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.244 -177.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.5 40.43 17.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.679 175.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.6 p -70.2 -19.25 63.18 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.135 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -119.78 157.28 28.94 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 173.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -58.27 152.09 18.08 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 123.072 0.232 . . . . 0.0 110.575 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.484 ' HG2' ' HB2' ' A' ' 112' ' ' LYS . 17.1 mp0 -55.58 -60.21 3.76 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -70.37 99.73 0.75 Allowed Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.471 -1.051 . . . . 0.0 110.471 172.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.512 ' CD2' HD13 ' A' ' 117' ' ' LEU . 88.4 m-70 -65.76 175.69 1.83 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.964 0.411 . . . . 0.0 111.534 -173.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -75.98 70.37 2.69 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.281 0.562 . . . . 0.0 111.608 -171.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 40.2 p-80 -91.43 85.14 5.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.708 0.766 . . . . 0.0 109.883 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 35.4 p80 -97.88 6.34 47.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.244 -176.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 80.3 t60 69.02 155.02 0.12 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.414 0.626 . . . . 0.0 111.783 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 . . . . . 0 C--O 1.245 0.827 0 CA-C-O 118.273 -0.87 . . . . 0.0 109.864 171.985 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.5 t70 . . . . . 0 N--CA 1.477 0.925 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.537 ' O ' ' HG2' ' A' ' 3' ' ' LYS . 7.8 t 53.42 88.64 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -168.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.537 ' HG2' ' O ' ' A' ' 2' ' ' SER . 0.0 OUTLIER 75.14 164.94 0.27 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.488 1.115 . . . . 0.0 109.426 -165.305 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 115' ' ' GLU . 4.6 m 60.66 25.13 14.9 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.352 0.596 . . . . 0.0 110.229 -174.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 114' ' ' GLY . . . 69.59 120.09 0.03 OUTLIER Pre-proline 0 C--O 1.235 0.319 0 CA-C-N 114.89 -1.05 . . . . 0.0 112.264 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.488 ' HG2' ' CD1' ' A' ' 8' ' ' PHE . 38.1 Cg_endo -68.7 162.42 41.22 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.33 2.02 . . . . 0.0 111.505 175.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.63 51.37 1.26 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.073 0.463 . . . . 0.0 110.909 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.488 ' CD1' ' HG2' ' A' ' 6' ' ' PRO . 13.8 p90 -96.18 131.17 42.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.313 0.578 . . . . 0.0 110.907 -176.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.9 m -129.23 90.51 3.03 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 169.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.579 HD12 ' HD2' ' A' ' 11' ' ' PRO . 30.5 tp -114.65 128.53 25.79 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.292 -167.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.646 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 56.1 Cg_endo -73.43 126.61 11.1 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.371 2.047 . . . . 0.0 111.434 170.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.581 ' HA ' ' HG2' ' A' ' 88' ' ' MET . 0.9 OUTLIER -71.91 166.73 21.52 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.913 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.412 HD13 ' HB3' ' A' ' 75' ' ' ARG . 1.5 pp -77.71 8.45 4.47 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -171.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.483 ' HD1' ' CG ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -105.08 -17.99 14.3 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 170.41 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.79 23.35 3.69 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 115.445 0.938 . . . . 0.0 115.445 170.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.572 ' HZ2' HG12 ' A' ' 18' ' ' VAL . 48.5 tttm -115.05 126.87 55.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 118.638 1.219 . . . . 0.0 110.712 173.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.646 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 9.6 t -76.51 129.31 36.3 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.075 0.464 . . . . 0.0 109.794 173.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.572 HG12 ' HZ2' ' A' ' 16' ' ' LYS . 28.1 m -116.12 142.74 28.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.547 174.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.5 t -145.47 -173.4 4.11 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -62.9 -22.08 66.48 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.969 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.16 -27.74 68.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.413 176.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -78.78 -22.55 46.18 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.196 0.522 . . . . 0.0 110.181 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.407 HD13 HG21 ' A' ' 110' ' ' ILE . 43.4 mt -84.46 -38.49 20.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.8 -174.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -59.77 129.76 43.46 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -171.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.33 -14.03 64.84 Favored Glycine 0 C--N 1.331 0.294 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.986 175.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.473 ' HE3' ' CD ' ' A' ' 60' ' ' GLN . 0.0 OUTLIER -137.17 -178.74 5.34 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 -177.468 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.612 HG13 ' HA ' ' A' ' 59' ' ' PHE . 6.9 p -114.05 149.56 16.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -174.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 61.2 m -148.41 139.39 23.11 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.669 0.271 . . . . 0.0 111.127 -171.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.721 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 43.4 tp -105.73 127.26 52.97 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.358 173.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.3 mt -113.3 112.46 40.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 171.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -112.43 111.06 21.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.485 -175.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.455 ' HB2' HG22 ' A' ' 106' ' ' THR . 79.5 m-85 -81.37 119.65 23.96 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 177.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.477 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 4.3 p-90 -150.53 -173.01 4.34 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.455 -176.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -154.85 144.9 15.68 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 170.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.648 ' HD2' ' HB2' ' A' ' 69' ' ' ASP . 57.4 Cg_exo -40.39 -43.49 4.05 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 123.606 2.871 . . . . 0.0 114.886 -175.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.4 p -80.44 16.77 1.22 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -176.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.44 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 24.9 m -68.04 132.39 92.04 Favored Pre-proline 0 C--N 1.33 -0.252 0 O-C-N 122.066 -0.396 . . . . 0.0 111.533 178.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 16.4 Cg_exo -68.43 -26.16 34.94 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.034 2.489 . . . . 0.0 112.272 177.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.28 -15.13 72.22 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 121.155 -0.545 . . . . 0.0 113.229 -177.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.771 ' HA ' ' HG2' ' A' ' 44' ' ' MET . 73.1 m -52.99 -36.44 60.38 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -178.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 38' ' ' PRO . 27.2 m -64.63 -38.61 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-O 120.695 0.283 . . . . 0.0 111.438 -178.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.7 m -88.37 -55.53 3.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.985 0.421 . . . . 0.0 111.62 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.496 ' O ' HG12 ' A' ' 47' ' ' ILE . 32.7 mt-10 -72.29 -50.1 29.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.324 -170.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.771 ' HG2' ' HA ' ' A' ' 40' ' ' CYS . 20.0 mmt -57.84 -46.78 99.7 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -167.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 40' ' ' CYS . 51.4 Cg_exo -55.75 -43.32 58.52 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 121.746 1.63 . . . . 0.0 112.203 177.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -66.52 -33.95 76.83 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.933 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 43' ' ' GLU . 41.9 mm -67.58 -38.79 81.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.449 177.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.591 HG12 ' O ' ' A' ' 44' ' ' MET . 49.1 mm -54.55 -53.45 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 120.857 0.361 . . . . 0.0 110.289 178.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.415 ' HB3' ' HE3' ' A' ' 49' ' ' LYS . 14.9 ttpp -55.09 -52.3 63.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.491 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.54 ' O ' ' HD2' ' A' ' 54' ' ' TYR . 17.0 m -67.48 -47.51 69.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.428 -174.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.61 ' HB1' HG21 ' A' ' 61' ' ' VAL . . . -67.5 -28.3 67.72 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.891 -174.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -75.87 -50.17 15.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.833 0.349 . . . . 0.0 111.09 -178.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -64.72 -47.98 76.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.097 -0.502 . . . . 0.0 112.326 -173.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.836 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 96.5 m-85 -77.35 1.79 17.83 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -170.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 37.8 mmtm -56.15 -49.91 72.61 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.286 0.565 . . . . 0.0 110.317 174.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -95.07 21.11 8.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.117 -177.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.663 ' HB2' ' HA ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -113.76 -65.85 1.14 Allowed 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.442 179.42 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 24.1 p30 171.6 -11.93 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.836 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 68.5 t80 -98.68 125.96 44.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.062 0.458 . . . . 0.0 109.876 -174.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.473 ' CD ' ' HE3' ' A' ' 26' ' ' LYS . 27.8 mt-30 -102.19 167.31 10.08 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 121.448 0.642 . . . . 0.0 110.943 -178.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.61 HG21 ' HB1' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -148.33 111.43 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.775 -171.806 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.534 HD23 ' HB ' ' A' ' 86' ' ' THR . 78.4 mt -124.22 97.34 5.29 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.585 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.727 ' HB3' HG12 ' A' ' 87' ' ' VAL . . . -86.15 101.79 13.31 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.727 178.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.585 HG12 ' HB2' ' A' ' 90' ' ' ASP . 12.2 t -85.92 108.27 17.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.216 -176.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -85.78 115.93 23.73 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.107 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.671 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 3.9 pt20 -78.29 -174.66 0.47 Allowed Pre-proline 0 C--N 1.315 -0.892 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.671 ' HD2' ' HB2' ' A' ' 66' ' ' GLN . 47.6 Cg_endo -69.33 -146.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 121.552 1.501 . . . . 0.0 112.366 -177.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.554 ' HB ' ' O ' ' A' ' 67' ' ' PRO . 62.8 mt 77.54 -61.1 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -172.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.648 ' HB2' ' HD2' ' A' ' 35' ' ' PRO . 34.2 m-20 -97.1 128.97 33.43 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 171.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.45 ' HD2' ' OG ' ' A' ' 73' ' ' SER . 51.5 Cg_exo -57.14 165.61 5.13 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.667 2.245 . . . . 0.0 112.505 175.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.598 ' O ' ' HG2' ' A' ' 75' ' ' ARG . 6.6 tt -66.52 -29.3 46.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.894 0.378 . . . . 0.0 110.675 -177.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.718 ' HA ' ' HE ' ' A' ' 75' ' ' ARG . 2.1 pm0 -69.65 -28.85 66.24 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 122.112 -0.367 . . . . 0.0 110.666 175.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.45 ' OG ' ' HD2' ' A' ' 70' ' ' PRO . 67.0 m -64.66 -43.85 92.31 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.664 0.268 . . . . 0.0 110.358 175.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.522 ' HA ' ' HG3' ' A' ' 35' ' ' PRO . 13.8 p -71.6 -39.8 70.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.113 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.816 ' HA ' HG22 ' A' ' 78' ' ' VAL . 28.9 ptt180 -75.19 -25.55 58.33 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 122.312 -0.242 . . . . 0.0 111.475 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -70.29 -41.27 73.6 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 169.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -62.17 -47.2 85.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.202 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.816 HG22 ' HA ' ' A' ' 75' ' ' ARG . 33.0 m -67.15 -28.74 43.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.069 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.7 tptp -73.09 -55.78 6.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.373 0.606 . . . . 0.0 111.459 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -65.52 -49.03 70.47 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.896 -171.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -81.05 -19.55 43.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.754 -177.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.07 65.02 2.1 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.904 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.467 HD22 HG12 ' A' ' 78' ' ' VAL . 8.6 mp -84.27 113.51 48.89 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-O 120.695 0.283 . . . . 0.0 110.933 -177.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -81.25 -2.77 11.83 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.879 2.386 . . . . 0.0 113.371 -177.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.507 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 28.4 p90 -99.02 140.28 33.42 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 122.149 -0.344 . . . . 0.0 110.532 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.534 ' HB ' HD23 ' A' ' 62' ' ' LEU . 10.7 m -67.93 137.9 55.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.742 -176.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.727 HG12 ' HB3' ' A' ' 63' ' ' ALA . 10.8 m -122.97 137.19 57.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.398 0.618 . . . . 0.0 111.708 -176.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.581 ' HG2' ' HA ' ' A' ' 12' ' ' ASP . 79.6 mtm -115.95 176.01 5.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.497 -0.774 . . . . 0.0 108.988 175.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 37.9 t80 -125.34 112.35 16.24 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.216 0.531 . . . . 0.0 111.041 -178.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.703 ' OD2' ' HA ' ' A' ' 93' ' ' LYS . 23.0 t70 -84.63 74.83 10.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.553 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.22 -42.4 62.68 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.476 -174.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -83.02 -12.99 56.74 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.226 -177.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.703 ' HA ' ' OD2' ' A' ' 90' ' ' ASP . 2.6 mtpm? 64.54 -5.2 0.37 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.35 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.22 -32.03 38.56 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -168.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.477 ' O ' ' HD1' ' A' ' 99' ' ' PHE . 31.2 m -66.8 -34.35 69.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.495 174.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -67.56 -34.08 83.05 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.41 172.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.615 ' HG3' ' O ' ' A' ' 93' ' ' LYS . 79.9 mt-30 -63.59 -39.06 93.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.646 -0.277 . . . . 0.0 110.408 175.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.69 -34.11 77.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.052 178.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.477 ' HD1' ' O ' ' A' ' 95' ' ' VAL . 42.2 m-85 -72.31 -24.01 61.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.822 174.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.31 23.17 49.08 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.494 -178.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.533 ' HB ' HG21 ' A' ' 106' ' ' THR . 50.9 p -86.07 110.02 19.24 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.007 0.432 . . . . 0.0 111.064 -176.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -108.66 -24.55 11.29 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.786 177.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.9 t -99.63 131.98 45.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.909 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -128.66 143.39 48.27 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.334 -178.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.424 ' HG2' ' OE1' ' A' ' 43' ' ' GLU . 5.3 Cg_exo -74.78 160.33 96.62 Favored 'Cis proline' 0 C--N 1.346 0.407 0 C-N-CA 123.715 -1.369 . . . . 0.0 112.161 0.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.533 HG21 ' HB ' ' A' ' 101' ' ' THR . 9.8 t -142.46 120.93 12.43 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.712 0.768 . . . . 0.0 111.239 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.599 ' HB3' HD11 ' A' ' 29' ' ' LEU . 25.5 m -95.8 111.97 23.81 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.253 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 55.3 t -105.5 128.48 59.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.261 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.612 HD12 ' HB3' ' A' ' 118' ' ' LYS . 95.3 mt -101.97 122.97 45.07 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.778 -176.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 23' ' ' LEU . 41.6 mt -110.61 130.09 64.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.475 178.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -88.31 -158.11 33.08 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.235 -0.983 . . . . 0.0 112.973 -178.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 44.0 mtpt -87.67 -17.98 30.59 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.976 0.893 . . . . 0.0 109.72 -168.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.771 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -81.07 -14.22 58.03 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.416 177.881 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 5' ' ' ALA . . . 91.41 -7.97 79.57 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -173.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 11.6 tp10 -72.21 146.88 47.02 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.165 0.507 . . . . 0.0 110.975 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.476 HG13 ' HA ' ' A' ' 3' ' ' LYS . 47.0 mm -81.12 110.4 16.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.025 178.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.8 mt -90.7 -59.82 2.08 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -170.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.612 ' HB3' HD12 ' A' ' 109' ' ' LEU . 23.6 tptm -133.36 153.19 51.8 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.248 -170.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.3 m -134.59 128.03 32.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.522 177.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.442 ' OH ' ' HB2' ' A' ' 128' ' ' LYS . 80.5 m-85 -116.88 141.47 48.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.83 174.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.6 m -124.86 109.64 22.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.699 0.285 . . . . 0.0 111.304 178.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 68.52 97.66 0.04 OUTLIER Glycine 0 C--N 1.331 0.286 0 C-N-CA 121.174 -0.536 . . . . 0.0 113.07 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.423 ' HA ' ' HG2' ' A' ' 43' ' ' GLU . 9.0 tp10 66.13 92.92 0.06 OUTLIER Pre-proline 0 C--O 1.235 0.316 0 CA-C-O 121.509 0.671 . . . . 0.0 110.217 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -77.23 141.62 20.74 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.494 2.129 . . . . 0.0 113.019 -176.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.52 ' OD1' ' HG2' ' A' ' 128' ' ' LYS . 10.6 t0 -65.75 96.05 0.27 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.6 174.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.595 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 50.1 m-85 -69.19 -14.36 62.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.867 -178.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -68.36 -50.63 37.14 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.271 -0.966 . . . . 0.0 110.854 174.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.52 ' HG2' ' OD1' ' A' ' 125' ' ' ASP . 31.1 mmtm -77.95 -20.56 52.5 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.595 ' HB3' ' HA ' ' A' ' 126' ' ' PHE . 3.2 tm? -63.59 -47.9 79.56 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 174.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -68.18 -45.65 72.84 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.236 178.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -60.88 -36.47 79.29 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.938 0.348 . . . . 0.0 111.938 178.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -66.63 -51.77 52.5 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 67.9 mt -57.27 -43.03 81.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.902 0.382 . . . . 0.0 110.392 176.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -56.7 -40.32 75.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.85 177.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 63.8 m -62.07 -44.07 97.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.316 176.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.68 -28.18 69.72 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.191 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 12.6 m0 -69.62 -55.64 9.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.963 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 57.0 mtt180 -70.62 -43.41 69.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.592 -173.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -68.75 110.22 4.21 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.236 0.541 . . . . 0.0 111.756 -174.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 18.1 p -67.99 102.69 1.33 Allowed 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.151 171.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -72.12 146.24 47.61 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.644 -174.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.98 162.68 16.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.266 -177.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -51.82 116.13 2.0 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.249 -176.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -89.15 -156.28 31.47 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.899 -175.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -68.69 105.9 2.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.129 0.49 . . . . 0.0 110.63 -178.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 13.3 p80 -128.69 135.52 49.37 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.762 179.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 61.6 t60 -172.5 107.76 0.19 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.35 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -125.14 96.89 5.01 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.55 0.69 . . . . 0.0 109.329 173.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -75.26 124.58 27.33 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.402 -173.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 . . . . . 0 C--N 1.319 -0.748 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.508 -179.379 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.552 ' HA ' ' HA ' ' A' ' 6' ' ' PRO . 2.0 m-20 . . . . . 0 N--CA 1.482 1.149 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.567 ' O ' ' HB2' ' A' ' 3' ' ' LYS . 45.3 m 57.47 91.87 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 O-C-N 123.926 0.766 . . . . 0.0 109.832 -171.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.619 ' H ' HD12 ' A' ' 116' ' ' ILE . 3.8 mmmp? 76.14 144.2 0.08 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.979 -171.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.6 m 58.3 30.64 19.81 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.688 0.756 . . . . 0.0 111.08 177.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.462 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . . . 69.27 150.4 0.12 Allowed Pre-proline 0 N--CA 1.467 0.382 0 CA-C-N 114.677 -1.147 . . . . 0.0 112.705 175.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.552 ' HA ' ' HA ' ' A' ' 1' ' ' ASP . 1.8 Cg_endo -85.95 171.41 8.09 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.292 2.662 . . . . 0.0 112.192 174.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -92.87 25.62 3.09 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.394 0.616 . . . . 0.0 110.03 176.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.593 ' HB2' HG12 ' A' ' 95' ' ' VAL . 13.0 p90 -67.4 148.17 51.94 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.384 -175.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.0 m -142.59 89.79 2.17 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 172.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.647 HD11 ' HB3' ' A' ' 89' ' ' TYR . 35.5 tp -115.88 120.59 35.4 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.597 -173.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.558 ' HD2' HD12 ' A' ' 10' ' ' LEU . 24.3 Cg_exo -64.44 144.43 85.36 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.584 2.189 . . . . 0.0 111.799 176.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.717 ' HA ' ' HA ' ' A' ' 88' ' ' MET . 1.6 p-10 -81.95 -173.21 4.35 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.502 HD21 ' HA ' ' A' ' 89' ' ' TYR . 73.8 mt -87.02 2.27 50.14 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.672 -177.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.451 ' H ' ' CG ' ' A' ' 12' ' ' ASP . 64.3 t60 -95.69 -40.49 9.36 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 172.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.22 22.76 0.79 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.109 -1.043 . . . . 0.0 114.121 174.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.427 ' HE2' HG22 ' A' ' 18' ' ' VAL . 2.3 ptmt -114.31 134.51 54.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.72 0.76 . . . . 0.0 110.244 175.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 16.1 m -67.93 121.59 16.37 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.314 177.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.427 HG22 ' HE2' ' A' ' 16' ' ' LYS . 46.3 t -97.28 128.77 48.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 177.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 63.6 p -129.01 -175.59 3.6 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.874 0.369 . . . . 0.0 111.025 -175.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -68.95 -22.28 64.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.78 177.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.86 -28.95 69.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.736 176.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -67.01 -21.08 65.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.942 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 74.2 mt -80.7 -20.53 42.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.432 -176.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.455 ' HA ' ' OE1' ' A' ' 24' ' ' GLN . 15.9 mm-40 -78.59 138.61 38.44 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.077 0.465 . . . . 0.0 112.137 -172.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.98 3.38 89.18 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.771 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 112' ' ' LYS . 41.1 mtmt -146.75 165.03 30.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.668 0.271 . . . . 0.0 110.527 -177.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 26.0 t -103.16 138.62 26.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 173.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.631 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 11.1 m -131.93 145.29 51.41 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.63 -0.428 . . . . 0.0 112.126 -168.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.665 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 6.9 tt -119.5 108.75 14.9 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 170.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.8 mt -94.6 111.12 24.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -104.97 125.11 50.61 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.459 -177.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.466 ' CE2' ' HA2' ' A' ' 96' ' ' GLY . 87.0 m-85 -96.26 118.18 32.3 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 9.1 p-90 -144.59 -176.49 5.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.484 -175.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -159.63 151.96 17.46 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.239 176.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.33 155.58 51.06 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.404 2.069 . . . . 0.0 111.887 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.3 m 65.08 16.51 10.6 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.588 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.523 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 42.7 t -84.14 130.76 53.25 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.596 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -61.13 -26.82 83.19 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.7 2.267 . . . . 0.0 111.922 176.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -64.52 -30.02 76.74 Favored Glycine 0 C--O 1.227 -0.303 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.473 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.523 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 83.9 m -58.26 -30.5 66.63 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 122.16 0.184 . . . . 0.0 111.445 -178.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.6 t -61.18 -38.14 79.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.211 0.529 . . . . 0.0 110.157 177.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.463 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 32.6 m -87.09 -51.28 6.09 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.513 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -70.21 -45.06 67.36 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -171.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.569 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 39.2 tpp -54.72 -51.35 79.58 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -171.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.569 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 57.3 Cg_exo -53.28 -36.44 78.2 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 121.962 1.775 . . . . 0.0 112.47 175.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.633 ' HB3' ' CZ ' ' A' ' 126' ' ' PHE . 30.5 mmtm -65.16 -47.52 76.72 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.238 0.542 . . . . 0.0 109.796 177.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.7 mm -65.5 -38.65 82.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.823 -177.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.528 HG12 ' O ' ' A' ' 44' ' ' MET . 47.2 mm -54.68 -53.34 32.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 120.777 0.322 . . . . 0.0 110.188 177.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.1 tttm -62.16 -57.69 10.58 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.632 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 29.0 m -60.32 -44.82 95.12 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -171.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . -69.31 -36.08 76.62 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.118 -0.233 . . . . 0.0 111.598 -175.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -77.06 -40.35 46.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.158 0.504 . . . . 0.0 110.626 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -55.28 -53.04 61.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.902 -1.045 . . . . 0.0 111.15 -177.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.542 ' CB ' ' HB3' ' A' ' 59' ' ' PHE . 67.1 m-85 -96.88 8.16 45.01 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.465 -175.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -62.25 -52.31 64.24 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.093 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -82.4 66.81 8.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.802 176.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.705 ' HB2' ' HZ2' ' A' ' 57' ' ' LYS . 0.3 OUTLIER -166.94 -75.31 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.597 -173.819 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 6.9 t-20 173.62 7.96 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.203 0.525 . . . . 0.0 110.415 -176.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.665 ' HZ ' ' HB2' ' A' ' 29' ' ' LEU . 41.0 t80 -110.43 135.22 51.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.914 0.388 . . . . 0.0 110.581 -173.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.605 ' HG3' HG23 ' A' ' 28' ' ' THR . 21.4 pt20 -125.75 144.48 50.61 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.725 178.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 97.2 t -113.93 111.52 36.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 97.9 mt -95.03 95.57 8.68 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 177.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -86.6 95.65 9.83 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.574 ' HA ' ' HB2' ' A' ' 88' ' ' MET . 2.4 p -88.08 118.53 33.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.117 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 90' ' ' ASP . . . -89.53 162.69 15.56 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.948 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.41 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 18.6 pt20 -137.54 154.38 75.06 Favored Pre-proline 0 C--N 1.305 -1.358 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 169.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 1.074 ' HD3' ' HA ' ' A' ' 91' ' ' ALA . 56.2 Cg_endo -59.36 -92.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.038 1.826 . . . . 0.0 113.965 -150.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.3 mm 65.66 -70.34 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -175.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.41 ' OD1' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -94.57 147.23 32.88 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 171.316 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.41 ' HD2' ' OD1' ' A' ' 69' ' ' ASP . 65.6 Cg_exo -52.88 157.66 7.57 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 122.869 2.38 . . . . 0.0 113.902 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.4 ' O ' HG12 ' A' ' 74' ' ' VAL . 4.0 tp -53.85 -33.74 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.875 179.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.448 ' CD ' HH21 ' A' ' 75' ' ' ARG . 9.1 tp10 -68.87 -29.59 67.92 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 122.154 -0.341 . . . . 0.0 110.289 178.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.6 m -70.29 -48.65 55.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.951 0.405 . . . . 0.0 110.63 -177.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' ' 71' ' ' ILE . 11.1 p -61.43 -32.82 54.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-O 121.929 0.871 . . . . 0.0 109.305 175.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.656 ' HA ' HG22 ' A' ' 78' ' ' VAL . 50.5 ttp180 -75.28 -29.24 60.06 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.592 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -70.41 -41.7 72.62 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 172.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -57.06 -51.28 69.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.285 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.656 HG22 ' HA ' ' A' ' 75' ' ' ARG . 24.2 m -61.59 -36.94 76.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.127 -178.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -75.3 -52.22 11.36 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -58.6 -48.52 80.67 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.165 -170.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -92.58 1.11 57.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.388 -175.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 54.46 60.01 9.24 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.458 -179.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.488 HD22 HG12 ' A' ' 78' ' ' VAL . 10.8 mp -60.87 109.71 2.32 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.867 0.365 . . . . 0.0 111.462 -176.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -85.18 37.82 0.62 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.339 2.693 . . . . 0.0 113.044 -175.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -149.56 159.57 44.2 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.197 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.49 109.34 4.76 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.84 -176.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.2 t -101.96 136.78 32.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.515 177.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.717 ' HA ' ' HA ' ' A' ' 12' ' ' ASP . 80.1 mtp -111.24 162.17 15.25 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.267 -174.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.647 ' HB3' HD11 ' A' ' 10' ' ' LEU . 12.6 t80 -62.73 141.55 58.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.469 0.652 . . . . 0.0 112.087 -174.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.544 ' O ' ' N ' ' A' ' 92' ' ' ASP . 5.1 p-10 -56.52 -135.21 0.0 OUTLIER 'General case' 0 C--O 1.217 -0.649 0 CA-C-N 113.659 -1.609 . . . . 0.0 111.56 162.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 1.074 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . . . -28.66 -6.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 120.583 3.549 . . . . 0.0 120.583 -146.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.613 ' HB3' HD13 ' A' ' 10' ' ' LEU . 37.5 t70 -71.73 38.73 0.07 Allowed 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 120.31 1.414 . . . . 0.0 108.809 163.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.542 ' H ' ' C ' ' A' ' 91' ' ' ALA . 0.0 OUTLIER -58.47 -3.72 0.32 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.194 0.998 . . . . 0.0 112.675 -174.4 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.63 -23.91 67.41 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 122.77 0.428 . . . . 0.0 111.179 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.593 HG12 ' HB2' ' A' ' 8' ' ' PHE . 35.9 m -60.73 -37.38 75.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.106 0.479 . . . . 0.0 110.099 174.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.466 ' HA2' ' CE2' ' A' ' 32' ' ' PHE . . . -67.87 -32.17 77.01 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 174.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -69.78 -28.84 66.08 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.006 -0.597 . . . . 0.0 110.719 177.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.45 -28.34 61.91 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.074 0.464 . . . . 0.0 110.89 176.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.402 ' HD2' ' O ' ' A' ' 95' ' ' VAL . 50.4 m-85 -79.86 -24.53 41.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.738 173.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.74 -8.02 76.83 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.936 -0.65 . . . . 0.0 111.843 -177.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.579 ' HB ' HG21 ' A' ' 106' ' ' THR . 18.1 p -78.94 91.89 4.86 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.736 0.303 . . . . 0.0 111.396 -177.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -105.82 0.19 25.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.029 0.442 . . . . 0.0 111.311 177.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.5 m -97.95 125.81 51.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.513 173.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -121.28 149.77 52.61 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.526 -172.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -85.31 164.79 58.25 Favored 'Cis proline' 0 C--N 1.343 0.277 0 C-N-CA 123.548 -1.438 . . . . 0.0 112.002 -0.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.579 HG21 ' HB ' ' A' ' 101' ' ' THR . 5.9 t -151.88 142.79 23.03 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.895 -177.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.477 ' HB3' HD21 ' A' ' 29' ' ' LEU . 56.4 m -120.51 122.85 41.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.367 177.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.3 t -105.85 137.13 37.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.331 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.401 HD22 ' N ' ' A' ' 109' ' ' LEU . 2.8 mm? -101.82 122.34 43.79 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.18 -177.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.631 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 8.5 mm -110.13 129.94 64.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.344 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -79.35 -176.47 48.82 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.326 -0.94 . . . . 0.0 111.87 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 16.8 pttm -92.52 43.21 1.12 Allowed 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 122.532 1.158 . . . . 0.0 107.93 -178.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 51.3 mmtt -140.32 -5.77 1.23 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 113.302 -1.772 . . . . 0.0 111.367 -168.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.47 12.66 82.19 Favored Glycine 0 C--O 1.226 -0.371 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.464 -172.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -103.17 147.97 26.36 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 -178.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.619 HD12 ' H ' ' A' ' 3' ' ' LYS . 51.5 mt -91.97 111.55 24.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -85.11 -61.52 1.75 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.195 -173.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.434 ' HD2' ' HA ' ' A' ' 118' ' ' LYS . 6.7 mmmm -141.27 167.7 21.55 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -169.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 62.1 m -146.3 105.87 3.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.366 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -102.87 113.16 26.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.577 177.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 106' ' ' THR . 22.2 m -88.54 141.0 14.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 120.849 0.357 . . . . 0.0 110.985 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 71.62 -150.93 47.29 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.438 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.455 ' OE2' ' HB3' ' A' ' 42' ' ' SER . 6.3 tp10 -70.2 111.64 9.99 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -84.45 140.08 8.25 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.47 2.114 . . . . 0.0 113.195 -176.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -66.89 102.88 1.02 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.989 173.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.633 ' CZ ' ' HB3' ' A' ' 46' ' ' LYS . 25.3 m-85 -70.32 -19.42 63.08 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -175.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -63.69 -54.08 33.82 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 119.932 -1.128 . . . . 0.0 111.055 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -79.68 -26.78 40.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.614 -0.293 . . . . 0.0 110.608 177.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.629 ' HB3' ' HA ' ' A' ' 126' ' ' PHE . 41.8 tp -63.18 -47.67 81.62 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.432 178.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -66.34 -47.21 74.23 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.741 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -56.9 -34.17 67.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.99 0.424 . . . . 0.0 111.991 176.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -80.37 -37.96 31.35 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.015 -179.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 129' ' ' LEU . 78.8 mt -65.46 -38.06 81.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.153 0.502 . . . . 0.0 110.002 174.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.699 ' HA ' ' CD1' ' A' ' 137' ' ' TRP . 12.2 t70 -67.05 -23.38 65.88 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.686 176.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 87.6 m -67.27 -30.71 70.65 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 172.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.24 -28.58 59.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.318 174.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.699 ' CD1' ' HA ' ' A' ' 134' ' ' ASP . 3.2 m95 -67.79 -56.55 8.77 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.809 0.814 . . . . 0.0 109.684 172.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 21.7 ttm180 -60.16 -51.04 71.31 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 113.429 -1.714 . . . . 0.0 112.962 -169.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -56.66 108.28 0.48 Allowed 'General case' 0 C--O 1.239 0.507 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -172.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.0 p -79.94 100.3 8.02 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 169.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -120.6 19.57 11.9 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.731 -168.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -108.84 -62.42 1.47 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.497 0.665 . . . . 0.0 109.279 177.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.57 ' CD ' ' H ' ' A' ' 143' ' ' GLU . 0.1 OUTLIER -67.76 -41.26 83.58 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.636 171.935 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.9 102.79 1.7 Allowed Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 173.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -74.45 97.62 3.13 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.191 0.519 . . . . 0.0 110.915 -176.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -69.86 94.6 0.84 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.608 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 16.8 p80 -61.72 145.94 50.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.36 177.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -104.43 177.19 4.92 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.052 -177.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.427 ' O ' ' HB3' ' A' ' 150' ' ' HIS . 53.5 t-80 -174.26 -59.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 O-C-N 123.3 0.375 . . . . 0.0 110.668 176.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.427 ' HB3' ' O ' ' A' ' 149' ' ' HIS . 83.3 t60 . . . . . 0 C--O 1.244 0.813 0 CA-C-O 117.568 -1.206 . . . . 0.0 108.594 -167.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 120.303 0.097 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.3 m -101.6 158.0 16.41 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 122.2 -0.312 . . . . 0.0 110.674 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.467 ' HG3' ' H ' ' A' ' 4' ' ' THR . 3.8 tptm -89.56 -175.59 4.74 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 170.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.563 ' HB ' ' HA ' ' A' ' 115' ' ' GLU . 32.5 p 53.75 -160.79 0.13 Allowed 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 -161.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.444 ' HB2' ' H ' ' A' ' 115' ' ' GLU . . . -66.69 109.08 2.91 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 119.049 0.84 . . . . 0.0 109.86 179.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.404 ' HD3' HD11 ' A' ' 116' ' ' ILE . 65.0 Cg_endo -73.86 169.52 22.21 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.0 2.466 . . . . 0.0 112.822 -170.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.17 67.07 9.85 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.331 0.586 . . . . 0.0 110.051 -178.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -106.57 132.76 52.2 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.728 -177.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.7 m -114.9 90.76 3.42 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 172.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.597 HD22 HG21 ' A' ' 95' ' ' VAL . 36.6 tp -102.51 121.23 50.58 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.825 -172.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.553 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 3.9 Cg_exo -80.58 137.2 11.38 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.023 2.482 . . . . 0.0 112.059 176.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.62 ' HB3' ' HB3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -67.99 172.6 5.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.006 175.152 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.6 mt -55.21 -29.64 58.35 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -175.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -102.54 -26.05 13.37 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.453 -176.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.62 16.97 0.43 Allowed Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.073 -1.061 . . . . 0.0 113.917 175.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.62 ' HB3' ' HB3' ' A' ' 12' ' ' ASP . 1.8 tpmt? -81.8 96.85 7.73 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 117.441 0.621 . . . . 0.0 109.84 176.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 23.8 m -86.45 124.33 32.66 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.057 -177.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.5 m -127.16 163.16 30.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.619 179.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 62.1 p -132.17 -173.83 3.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.045 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.401 ' HB2' ' HB1' ' A' ' 5' ' ' ALA . 29.7 p30 -67.91 -22.19 65.09 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.765 0.317 . . . . 0.0 111.508 -177.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.506 ' HA ' HE21 ' A' ' 24' ' ' GLN . . . -66.92 -27.35 67.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.067 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -70.39 -28.76 65.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.88 0.371 . . . . 0.0 110.25 178.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 45.3 mt -69.72 -20.34 63.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.806 -178.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.699 ' HG2' ' HA ' ' A' ' 113' ' ' LYS . 50.6 mt-30 -73.22 132.88 43.71 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.163 -174.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.66 -25.31 19.43 Favored Glycine 0 N--CA 1.452 -0.282 0 CA-C-N 115.954 -0.567 . . . . 0.0 113.167 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 112' ' ' LYS . 52.0 mtmt -108.25 -175.08 2.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.923 0.392 . . . . 0.0 110.675 -178.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.54 HG21 ' CZ3' ' A' ' 137' ' ' TRP . 8.3 t -127.53 141.45 46.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 173.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.557 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 85.5 m -145.58 145.31 30.94 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.121 0.486 . . . . 0.0 111.995 -169.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.584 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 27.9 tp -114.15 112.99 24.08 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.129 170.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.671 ' HB ' ' CG1' ' A' ' 108' ' ' VAL . 41.6 mt -97.28 112.52 29.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 176.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.427 ' HA ' ' O ' ' A' ' 106' ' ' THR . 46.6 t30 -114.39 114.48 25.93 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.099 -177.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 92.5 m-85 -83.74 123.76 30.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.172 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.563 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 6.1 p-90 -143.93 -177.57 5.5 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.398 0.618 . . . . 0.0 111.321 -173.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -162.67 153.4 14.34 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.848 174.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -63.27 158.08 46.51 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.157 1.905 . . . . 0.0 111.472 175.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.8 m 65.7 14.38 9.49 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 123.465 0.478 . . . . 0.0 111.42 -177.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 29.9 t -84.98 133.88 42.36 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.594 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.8 -22.49 68.29 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 122.523 2.149 . . . . 0.0 111.967 176.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.61 -12.13 75.86 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.287 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 21.6 p -69.19 -45.72 69.25 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 117.85 0.825 . . . . 0.0 110.53 -177.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.6 p -65.06 -25.57 37.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.123 0.487 . . . . 0.0 110.593 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.7 m -86.7 -49.51 7.43 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.684 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.424 ' CD ' ' HZ1' ' A' ' 46' ' ' LYS . 22.2 mm-40 -85.13 -41.48 15.66 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -172.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.509 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 47.2 tpp -51.48 -50.2 78.03 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -171.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 44' ' ' MET . 9.8 Cg_endo -51.88 -44.77 42.85 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 122.285 1.99 . . . . 0.0 112.603 177.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.424 ' HZ1' ' CD ' ' A' ' 43' ' ' GLU . 8.0 mppt? -68.79 -40.12 79.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.722 178.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.0 mm -60.45 -43.53 94.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.699 178.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.592 HD13 ' HE1' ' A' ' 85' ' ' PHE . 43.9 mm -55.78 -52.99 42.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.775 178.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.53 -46.52 85.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.886 0.374 . . . . 0.0 110.622 -177.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 29.2 m -65.99 -51.59 57.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.552 -175.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.562 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . -67.86 -36.31 80.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.834 -174.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.403 HD22 ' HA ' ' A' ' 52' ' ' ASN . 2.5 t-20 -74.03 -29.83 62.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.043 0.449 . . . . 0.0 110.592 -177.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -74.49 -50.4 18.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.152 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 1.066 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 66.4 m-85 -80.59 -10.08 59.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.933 -175.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 22.1 tptm -58.41 -33.27 69.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.194 0.521 . . . . 0.0 110.401 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 44.3 m-20 -95.06 20.86 8.44 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.643 -176.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.718 ' HE3' ' HA ' ' A' ' 54' ' ' TYR . 33.1 mtmt -125.98 -63.27 1.12 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.477 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 172.33 -13.29 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 O-C-N 123.322 0.389 . . . . 0.0 111.37 -172.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 1.066 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 56.7 t80 -100.72 122.78 43.93 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.093 0.473 . . . . 0.0 110.356 -177.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.52 HE21 HD11 ' A' ' 62' ' ' LEU . 12.7 pt20 -122.75 154.92 37.51 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.666 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.551 HG22 ' HB3' ' A' ' 29' ' ' LEU . 94.2 t -115.27 128.66 72.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.267 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.52 HD11 HE21 ' A' ' 60' ' ' GLN . 11.0 mp -108.12 109.26 20.64 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.542 177.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.45 98.35 10.81 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.169 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 51.3 t -91.79 116.16 32.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.331 -177.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -96.56 126.53 41.8 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.481 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.592 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 4.7 pm0 -96.0 161.5 27.08 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.679 ' HD3' ' O ' ' A' ' 90' ' ' ASP . 53.0 Cg_endo -70.43 84.95 0.73 Allowed 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.296 1.997 . . . . 0.0 113.515 -171.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 48.2 mm -115.7 -44.94 3.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 172.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.597 ' OD1' ' HD2' ' A' ' 70' ' ' PRO . 0.7 OUTLIER -116.8 141.99 29.05 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 172.595 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.597 ' HD2' ' OD1' ' A' ' 69' ' ' ASP . 61.2 Cg_exo -42.1 155.27 0.1 OUTLIER 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.676 2.917 . . . . 0.0 114.438 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.594 HG23 ' OE1' ' A' ' 72' ' ' GLU . 3.3 tp -58.7 -36.79 62.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.026 -176.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.598 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -59.4 -39.32 83.03 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.534 176.125 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.8 m -58.15 -42.44 85.95 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.304 0.573 . . . . 0.0 109.974 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.2 t -67.72 -52.2 42.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.016 178.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.598 ' HG2' ' HA ' ' A' ' 72' ' ' GLU . 16.0 ptt180 -68.3 -33.46 74.38 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -174.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -65.61 -42.04 92.03 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 178.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -56.36 -47.82 78.06 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.971 178.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.6 HG22 HD22 ' A' ' 83' ' ' LEU . 41.2 t -63.1 -53.0 51.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.328 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 75' ' ' ARG . 95.6 mttt -63.01 -36.61 84.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.726 0.298 . . . . 0.0 111.669 -175.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -75.07 -48.29 24.65 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -176.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -98.48 7.37 46.26 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -173.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.5 -70.09 2.66 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.949 -0.644 . . . . 0.0 112.743 175.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.6 HD22 HG22 ' A' ' 78' ' ' VAL . 10.3 mp 52.25 84.72 0.2 Allowed Pre-proline 0 N--CA 1.468 0.472 0 C-N-CA 122.959 0.504 . . . . 0.0 111.732 -178.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -76.92 16.52 0.95 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.365 2.71 . . . . 0.0 113.563 -176.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.592 ' HE1' HD13 ' A' ' 48' ' ' ILE . 23.1 p90 -117.73 159.4 23.06 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.4 m -74.76 112.08 10.61 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.342 0.591 . . . . 0.0 111.081 -174.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.7 t -99.64 136.74 29.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.831 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.569 ' HG2' ' HA ' ' A' ' 12' ' ' ASP . 62.5 mtt -131.23 166.45 21.14 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.415 -176.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -130.07 117.06 19.42 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.099 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.679 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 67.2 t0 -103.28 108.05 19.12 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 179.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.4 -21.95 59.4 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -176.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.528 ' OD2' ' HB2' ' A' ' 94' ' ' ALA . 28.3 t70 -106.44 -11.43 15.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.08 0.467 . . . . 0.0 110.691 -174.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 97' ' ' GLN . 17.4 ttpp 65.85 17.7 10.91 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.496 -177.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.528 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . . . -67.92 -31.95 72.07 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.418 -174.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.597 HG21 HD22 ' A' ' 10' ' ' LEU . 46.8 t -67.92 -42.6 85.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 177.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.79 -33.99 87.47 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.538 175.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.414 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 15.0 mm100 -64.6 -42.81 95.31 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 122.607 0.363 . . . . 0.0 111.494 177.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.94 -47.18 66.31 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.331 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.511 ' HA ' HD13 ' A' ' 116' ' ' ILE . 36.9 m-85 -72.24 -27.21 62.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.735 -177.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.37 55.21 1.72 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.605 176.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.403 ' HA ' HG21 ' A' ' 106' ' ' THR . 20.1 p -68.99 104.75 2.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.942 0.401 . . . . 0.0 111.57 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 48.4 tp60 -69.45 -58.32 4.13 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.533 0.682 . . . . 0.0 110.108 178.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.4 p -148.36 143.37 19.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.271 -176.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -94.57 141.9 24.06 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.715 -175.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.56 151.42 97.01 Favored 'Cis proline' 0 C--N 1.346 0.405 0 C-N-CA 123.385 -1.506 . . . . 0.0 113.18 0.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 26.3 m -119.54 116.08 25.32 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.884 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.538 ' HB2' HD11 ' A' ' 29' ' ' LEU . 4.3 p -105.56 111.84 24.7 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.085 0.469 . . . . 0.0 111.035 -177.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.671 ' CG1' ' HB ' ' A' ' 30' ' ' ILE . 11.7 p -106.68 143.25 17.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.053 0.454 . . . . 0.0 110.455 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.604 ' HB2' ' HB3' ' A' ' 118' ' ' LYS . 96.3 mt -100.98 121.43 41.75 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.123 -178.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.781 HG23 ' HA2' ' A' ' 114' ' ' GLY . 43.2 mm -102.49 127.29 56.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.303 -176.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -85.64 -168.27 44.51 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.98 177.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.424 ' HE3' ' HB2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -76.69 44.97 0.39 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 117.038 0.419 . . . . 0.0 111.779 -178.495 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.699 ' HA ' ' HG2' ' A' ' 24' ' ' GLN . 64.4 tttm 177.31 -29.63 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -178.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.781 ' HA2' HG23 ' A' ' 110' ' ' ILE . . . 115.62 -87.04 0.43 Allowed Glycine 0 N--CA 1.437 -1.285 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.832 177.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.563 ' HA ' ' HB ' ' A' ' 4' ' ' THR . 2.6 mm-40 55.68 2.79 0.07 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.545 1.138 . . . . 0.0 113.56 178.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.511 HD13 ' HA ' ' A' ' 99' ' ' PHE . 4.8 mt 49.54 77.27 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 121.574 0.702 . . . . 0.0 109.934 -174.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.8 mt -77.15 -73.62 0.29 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.435 -171.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.604 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 21.7 tptm -119.21 149.2 42.15 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.678 -170.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 31.5 m -134.19 118.69 17.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.023 0.439 . . . . 0.0 111.348 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -109.55 145.66 35.97 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.393 175.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.2 m -105.21 121.39 57.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.543 176.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.76 -126.48 8.47 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.466 -0.874 . . . . 0.0 111.649 -177.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -87.07 119.06 70.83 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.678 0.275 . . . . 0.0 111.074 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -77.37 121.62 5.73 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.42 2.08 . . . . 0.0 111.091 172.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -60.73 112.0 1.85 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.3 0.571 . . . . 0.0 110.304 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.57 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 81.3 m-85 -59.47 -29.64 67.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.317 -0.856 . . . . 0.0 113.024 -171.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -57.05 -53.93 40.78 Favored Glycine 0 C--O 1.237 0.289 0 C-N-CA 120.156 -1.021 . . . . 0.0 112.081 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.599 ' HA ' ' HG2' ' A' ' 131' ' ' GLN . 5.9 ttpm? -80.18 -28.22 38.78 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.57 ' HB3' ' HA ' ' A' ' 126' ' ' PHE . 48.7 tp -61.15 -47.58 85.53 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 177.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -62.45 -48.84 77.86 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.369 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.599 ' HG2' ' HA ' ' A' ' 128' ' ' LYS . 4.2 pt20 -68.47 -31.4 70.66 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.494 -178.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -71.79 -39.14 70.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.73 0.3 . . . . 0.0 110.338 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 80.4 mt -67.82 -39.37 81.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 173.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.563 ' HA ' ' HB2' ' A' ' 137' ' ' TRP . 27.6 t70 -63.56 -27.9 69.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.47 176.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 88.1 m -64.16 -45.73 87.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.335 -0.393 . . . . 0.0 109.96 174.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -65.56 -31.11 71.98 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.29 176.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.563 ' HB2' ' HA ' ' A' ' 134' ' ' ASP . 0.6 OUTLIER -62.16 -44.39 96.71 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.668 174.088 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.442 HH11 ' HD3' ' A' ' 138' ' ' ARG . 34.8 mmt180 -74.99 -31.08 61.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.51 -178.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.96 88.97 2.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.11 0.481 . . . . 0.0 110.798 -178.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 20.8 p -81.39 95.11 6.94 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.231 176.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -67.92 98.92 0.79 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.628 0.728 . . . . 0.0 111.165 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -163.35 -53.16 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.749 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -150.31 136.08 18.35 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 174.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -161.65 21.88 0.21 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.285 -177.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 50.71 81.79 0.06 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.307 0.575 . . . . 0.0 111.892 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -127.85 126.34 41.44 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.237 179.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -158.18 77.78 0.8 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.709 175.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -168.67 -59.45 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.569 ' O ' ' HB2' ' A' ' 150' ' ' HIS . 56.6 t-80 -100.65 66.52 1.22 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 167.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.569 ' HB2' ' O ' ' A' ' 149' ' ' HIS . 77.3 m-70 . . . . . 0 C--O 1.247 0.958 0 O-C-N 124.845 1.34 . . . . 0.0 109.056 -161.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.482 1.144 0 N-CA-C 110.665 -0.124 . . . . 0.0 110.665 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.5 m -55.85 133.94 51.56 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 123.446 0.466 . . . . 0.0 111.026 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.2 ptmt -85.29 175.09 9.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.444 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.413 ' HB ' ' HG3' ' A' ' 115' ' ' GLU . 47.1 p 49.94 68.82 0.69 Allowed 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 123.421 0.689 . . . . 0.0 111.782 -173.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.552 ' HB2' ' O ' ' A' ' 114' ' ' GLY . . . 60.75 107.45 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.403 0 CA-C-N 114.572 -1.194 . . . . 0.0 112.85 177.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 5' ' ' ALA . 3.7 Cg_exo -81.15 16.0 1.74 Allowed 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 123.169 2.579 . . . . 0.0 113.122 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 56.58 28.79 14.46 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.13 0.572 . . . . 0.0 112.251 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.459 ' HD1' ' HD2' ' A' ' 6' ' ' PRO . 54.5 p90 -66.02 137.99 57.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.884 -178.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.8 m -143.69 94.48 2.6 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.195 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.411 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 1.5 pt? -119.96 156.48 54.33 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-O 120.555 0.217 . . . . 0.0 110.581 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.592 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 3.7 Cg_exo -77.37 144.48 23.02 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 123.046 2.497 . . . . 0.0 112.416 178.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.418 ' HA ' ' HG2' ' A' ' 88' ' ' MET . 2.3 p30 -95.7 -176.88 3.87 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 175.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.551 HD11 HG12 ' A' ' 74' ' ' VAL . 63.2 mt -60.33 -20.75 60.51 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -173.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -76.77 -11.39 59.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.821 0.343 . . . . 0.0 110.771 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.7 16.55 58.19 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.839 -0.695 . . . . 0.0 112.377 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 11' ' ' PRO . 21.0 pttp -114.84 151.23 34.25 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 177.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.592 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 23.6 m -93.57 123.63 37.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.015 0.436 . . . . 0.0 112.083 -174.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.4 m -97.81 153.65 3.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 173.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.2 p -141.01 -178.5 5.59 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.198 0.523 . . . . 0.0 111.326 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.487 ' OD1' ' HB1' ' A' ' 5' ' ' ALA . 0.9 OUTLIER -68.54 -22.0 64.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.583 177.639 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.48 -31.75 72.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.051 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -70.69 -20.82 62.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.016 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.594 HD13 HG21 ' A' ' 110' ' ' ILE . 24.6 mt -83.26 -22.04 33.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.126 -174.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -62.92 144.37 56.82 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.631 -173.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.67 -25.24 4.02 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.791 -0.641 . . . . 0.0 113.847 173.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -121.26 -176.01 3.19 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 122.412 -0.464 . . . . 0.0 110.626 -174.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.2 t -108.46 141.89 22.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 175.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.602 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 33.1 m -133.93 137.98 45.21 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.83 0.347 . . . . 0.0 111.281 -174.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.578 HD11 ' HB2' ' A' ' 107' ' ' SER . 52.3 tp -109.63 107.51 17.59 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.23 175.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.669 ' HB ' ' CG2' ' A' ' 108' ' ' VAL . 50.6 mt -93.74 112.41 26.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 172.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -119.82 124.22 45.59 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.872 0.368 . . . . 0.0 110.862 -176.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.406 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 95.9 m-85 -90.47 125.43 35.58 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.827 -178.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.557 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 10.5 p-90 -146.17 -174.06 4.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.057 -178.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -156.92 146.57 15.39 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 172.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.446 ' HG3' ' HA ' ' A' ' 74' ' ' VAL . 78.3 Cg_exo -43.96 -59.17 1.15 Allowed 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 123.781 2.988 . . . . 0.0 114.744 -175.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.3 t -83.44 24.78 0.8 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.99 0.424 . . . . 0.0 111.322 -173.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 54.0 t -75.62 132.84 74.49 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.346 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -61.88 -19.01 64.17 Favored 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 122.662 2.242 . . . . 0.0 112.022 176.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.97 -10.98 84.08 Favored Glycine 0 C--O 1.224 -0.521 0 C-N-CA 121.226 -0.511 . . . . 0.0 112.99 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 25.4 p -58.12 -39.37 78.51 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 117.213 0.506 . . . . 0.0 111.648 -175.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.1 p -62.24 -34.42 63.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.855 0.36 . . . . 0.0 110.929 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.8 m -88.03 -54.72 4.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.052 0.453 . . . . 0.0 111.03 178.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.402 ' O ' HG12 ' A' ' 47' ' ' ILE . 73.7 mm-40 -66.27 -50.14 64.75 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -172.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.726 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 49.6 tpp -53.3 -55.53 33.48 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -168.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.726 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 24.5 Cg_exo -64.51 -36.02 45.62 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 121.822 1.682 . . . . 0.0 112.264 178.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -64.36 -40.06 95.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.577 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 43' ' ' GLU . 30.5 mm -60.87 -46.68 95.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.699 177.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 49.2 mm -55.66 -53.32 38.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.43 -177.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -69.37 -43.11 74.21 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.606 -174.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.3 m -65.26 -44.92 86.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.994 0.426 . . . . 0.0 110.921 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.52 ' HB1' HG21 ' A' ' 61' ' ' VAL . . . -65.65 -42.84 90.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.806 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -56.26 -40.05 73.59 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.51 -178.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -68.38 -51.14 47.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.341 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 1.006 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 60.5 m-85 -74.8 -28.99 60.95 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -174.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -59.44 -27.02 65.69 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 122.479 0.312 . . . . 0.0 111.61 -177.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -73.92 -22.51 59.66 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -172.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 1.006 ' HE2' ' HA ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -95.78 -62.08 1.35 Allowed 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.625 176.121 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 176.96 68.46 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.806 0.813 . . . . 0.0 111.303 -173.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.506 ' HZ ' ' HB2' ' A' ' 29' ' ' LEU . 41.2 t80 -135.83 132.43 36.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.287 -178.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -105.89 143.07 34.55 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.52 HG21 ' HB1' ' A' ' 51' ' ' ALA . 43.7 t -122.8 115.38 45.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.087 -177.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 88.5 mt -116.69 95.91 5.25 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.335 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.07 105.46 17.83 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 43.0 t -98.94 114.09 35.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 120.969 0.414 . . . . 0.0 110.564 -175.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.557 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -82.71 117.57 22.73 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.723 176.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.623 ' HG3' HG12 ' A' ' 68' ' ' ILE . 3.5 pt20 -74.1 163.43 68.39 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.965 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.604 ' HD2' ' HB2' ' A' ' 66' ' ' GLN . 72.1 Cg_endo -74.91 55.09 3.79 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.735 2.29 . . . . 0.0 114.035 -172.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.623 HG12 ' HG3' ' A' ' 66' ' ' GLN . 50.0 mm -93.12 -69.99 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 172.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -81.74 153.55 70.37 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.779 176.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -61.26 157.26 41.05 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.479 2.119 . . . . 0.0 112.33 177.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.0 tp -57.26 -31.3 37.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.917 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -64.54 -42.92 95.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.532 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.3 m -63.27 -34.76 78.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.814 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.551 HG12 HD11 ' A' ' 13' ' ' LEU . 34.8 t -64.13 -44.92 97.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.17 176.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -65.53 -34.62 78.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.651 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -62.48 -41.78 99.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.888 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.88 -43.1 97.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.751 -0.204 . . . . 0.0 110.863 178.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.563 ' HA ' HD12 ' A' ' 83' ' ' LEU . 42.1 t -63.16 -37.44 79.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.156 0.503 . . . . 0.0 110.345 176.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.0 tttm -61.97 -55.25 31.32 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.655 0.74 . . . . 0.0 111.141 176.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.03 -39.39 69.16 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.539 -1.21 . . . . 0.0 113.204 -173.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -104.99 0.76 28.02 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -174.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.05 -82.25 1.68 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.192 177.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.563 HD12 ' HA ' ' A' ' 78' ' ' VAL . 54.6 mt 61.59 93.33 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.417 0.627 . . . . 0.0 112.523 171.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -87.33 2.36 6.84 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 123.11 2.54 . . . . 0.0 113.667 -177.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -90.91 166.02 13.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.636 0.255 . . . . 0.0 110.625 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 20.2 m -77.04 113.52 14.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.069 0.462 . . . . 0.0 110.908 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.407 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 14.8 t -107.67 125.49 64.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.599 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.418 ' HG2' ' HA ' ' A' ' 12' ' ' ASP . 72.4 mtm -116.67 173.09 6.82 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.149 177.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -132.04 122.55 25.66 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.865 0.364 . . . . 0.0 110.245 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.544 ' HB3' ' HA ' ' A' ' 66' ' ' GLN . 45.8 t0 -82.81 119.23 24.1 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 176.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.74 -42.44 61.12 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -171.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -126.89 15.26 7.43 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.527 0.203 . . . . 0.0 111.124 -174.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.413 ' NZ ' ' HB3' ' A' ' 93' ' ' LYS . 5.9 ttpm? 68.35 20.34 8.68 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.544 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -77.23 -25.65 51.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.967 -174.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 41.0 t -74.82 -40.47 46.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.93 -38.9 96.07 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.485 173.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -68.72 -26.48 65.28 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 122.546 0.338 . . . . 0.0 111.173 176.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.94 -47.03 72.91 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.832 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -82.89 -26.9 31.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.484 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 95.64 55.4 1.33 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.404 178.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.452 HG22 HG21 ' A' ' 106' ' ' THR . 21.3 p -63.31 112.14 2.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.085 0.469 . . . . 0.0 111.71 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -77.52 -58.16 3.42 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.014 177.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.466 HG12 ' HB ' ' A' ' 121' ' ' VAL . 7.8 p -145.71 147.44 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.656 -175.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.485 ' HA ' ' C ' ' A' ' 105' ' ' PRO . 76.5 m-85 -102.54 147.44 34.02 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.036 -174.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.485 ' C ' ' HA ' ' A' ' 104' ' ' TYR . 38.1 Cg_endo -70.06 154.45 94.07 Favored 'Cis proline' 0 C--N 1.346 0.436 0 C-N-CA 123.305 -1.54 . . . . 0.0 112.838 0.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.452 HG21 HG22 ' A' ' 101' ' ' THR . 24.7 m -121.7 112.45 18.42 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.163 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.578 ' HB2' HD11 ' A' ' 29' ' ' LEU . 5.4 p -110.49 114.18 27.4 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.271 0.558 . . . . 0.0 111.176 -177.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.669 ' CG2' ' HB ' ' A' ' 30' ' ' ILE . 17.2 m -105.74 142.33 19.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.058 0.456 . . . . 0.0 110.737 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.554 ' HB2' ' HB2' ' A' ' 118' ' ' LYS . 81.5 mt -102.35 125.36 49.04 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.715 -177.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.602 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 12.1 mm -103.95 137.18 33.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.717 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -86.85 -167.6 43.91 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.274 -177.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.72 ' HD3' ' HA ' ' A' ' 141' ' ' ASP . 36.8 mttm -86.97 34.44 0.67 Allowed 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 122.003 0.906 . . . . 0.0 108.967 -175.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.519 ' HB3' ' OE1' ' A' ' 115' ' ' GLU . 29.0 mmtm -148.59 -35.46 0.2 Allowed 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 114.206 -1.361 . . . . 0.0 110.846 -165.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.552 ' O ' ' HB2' ' A' ' 5' ' ' ALA . . . 113.65 -28.7 8.35 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -174.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.519 ' OE1' ' HB3' ' A' ' 113' ' ' LYS . 1.2 mp0 -54.61 141.23 32.48 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 114.89 -0.655 . . . . 0.0 110.944 176.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.411 HG13 ' H ' ' A' ' 5' ' ' ALA . 6.7 mt -80.19 122.96 36.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.592 -178.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.6 mt -98.88 -60.53 1.52 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.048 0.451 . . . . 0.0 111.466 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.554 ' HB2' ' HB2' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -124.95 159.22 31.71 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.989 -170.542 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 57.9 m -141.13 103.58 4.48 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.414 170.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -92.46 131.87 37.25 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.4 176.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.466 ' HB ' HG12 ' A' ' 103' ' ' VAL . 6.0 m -101.22 116.04 44.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.906 178.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 83.48 -106.82 2.86 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.191 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -89.68 114.11 59.35 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-O 120.524 0.202 . . . . 0.0 110.783 -176.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.24 98.34 0.92 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.375 2.05 . . . . 0.0 111.85 175.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -49.67 111.97 0.58 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.92 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.403 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 80.8 m-85 -66.73 -34.11 77.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.179 -175.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -60.12 -52.18 54.32 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.597 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.581 ' HA ' ' HG2' ' A' ' 131' ' ' GLN . 25.9 mtmm -76.86 -24.31 52.65 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.678 -0.261 . . . . 0.0 110.837 178.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.439 ' O ' HG13 ' A' ' 133' ' ' ILE . 53.5 tp -62.48 -48.76 78.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.913 0.387 . . . . 0.0 110.087 175.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -63.3 -46.22 87.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.412 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.581 ' HG2' ' HA ' ' A' ' 128' ' ' LYS . 13.5 pt20 -70.93 -34.13 71.2 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.418 -176.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.411 ' O ' ' HB ' ' A' ' 135' ' ' THR . 20.3 tt0 -78.96 -31.88 45.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.57 0.224 . . . . 0.0 110.746 -177.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.444 ' O ' ' HB2' ' A' ' 137' ' ' TRP . 59.0 mt -61.28 -47.52 93.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 172.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.513 ' O ' ' HG2' ' A' ' 138' ' ' ARG . 21.5 t70 -60.14 -32.98 71.54 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.594 175.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 132' ' ' GLU . 69.9 m -57.25 -52.06 66.86 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.856 0.36 . . . . 0.0 110.459 177.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.34 -24.09 57.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.32 0.581 . . . . 0.0 110.616 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.444 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 21.7 t-105 -66.07 -30.62 71.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.263 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.513 ' HG2' ' O ' ' A' ' 134' ' ' ASP . 7.2 mmp_? -85.35 -37.14 20.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.11 178.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -87.59 107.35 18.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.204 -171.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 11.6 t 59.74 70.3 0.65 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.466 175.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.72 ' HA ' ' HD3' ' A' ' 112' ' ' LYS . 9.7 t70 -59.24 -42.83 91.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.127 177.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -120.85 -66.43 1.06 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.669 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -123.05 171.31 9.37 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -75.07 -72.07 1.08 Allowed Glycine 0 CA--C 1.521 0.457 0 C-N-CA 121.362 -0.447 . . . . 0.0 114.068 -175.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 -159.23 30.39 0.2 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 117.095 0.448 . . . . 0.0 110.773 -172.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 31.4 m80 64.04 51.88 2.16 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.667 0.746 . . . . 0.0 109.383 -170.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 -69.67 147.68 50.3 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.746 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -69.19 155.12 40.93 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.007 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -75.64 -18.16 59.76 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.305 0.574 . . . . 0.0 109.587 176.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 74.7 t60 . . . . . 0 C--O 1.244 0.785 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.326 174.728 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.599 ' HA ' ' HB3' ' A' ' 6' ' ' PRO . 3.5 p30 . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 110.585 -0.154 . . . . 0.0 110.585 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.1 m 61.56 -169.62 0.17 Allowed 'General case' 0 C--O 1.234 0.254 0 O-C-N 123.859 0.724 . . . . 0.0 111.612 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.0 tttm 60.96 -101.47 0.11 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.724 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.3 p -122.63 80.04 1.7 Allowed 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.714 -178.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.675 ' H ' HG13 ' A' ' 116' ' ' ILE . . . 67.94 128.73 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.4 0 CA-C-N 114.826 -1.079 . . . . 0.0 113.087 176.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.599 ' HB3' ' HA ' ' A' ' 1' ' ' ASP . 86.3 Cg_endo -90.26 -174.19 0.76 Allowed 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 123.016 2.478 . . . . 0.0 110.905 171.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.86 83.42 2.54 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.909 0.385 . . . . 0.0 110.117 175.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.438 ' HZ ' HD11 ' A' ' 23' ' ' LEU . 34.3 p90 -114.33 140.95 48.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.222 0.534 . . . . 0.0 111.005 -176.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.5 t -139.7 90.22 2.38 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 173.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.552 HD22 ' HD2' ' A' ' 11' ' ' PRO . 1.8 tm? -116.9 119.83 34.76 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.261 -166.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.565 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 40.0 Cg_endo -68.41 128.48 17.37 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.749 2.299 . . . . 0.0 112.213 176.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.557 ' HA ' ' HG3' ' A' ' 88' ' ' MET . 0.0 OUTLIER -62.67 164.91 7.05 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.416 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 87' ' ' VAL . 4.2 pp -66.3 -18.22 65.22 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.668 -172.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 16.6 t-80 -84.7 -25.95 28.03 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.926 0.393 . . . . 0.0 110.373 176.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.475 ' C ' ' HE2' ' A' ' 16' ' ' LYS . . . 123.6 8.54 6.28 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.572 -0.823 . . . . 0.0 113.735 174.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.475 ' HE2' ' C ' ' A' ' 15' ' ' GLY . 0.8 OUTLIER -94.55 120.31 34.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 117.378 0.589 . . . . 0.0 110.612 179.147 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 10.3 m -67.28 126.09 28.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.448 -177.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.534 HG12 ' O ' ' A' ' 10' ' ' LEU . 1.7 p -116.55 135.31 57.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 177.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.5 m -146.54 -173.08 4.11 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 122.11 -0.369 . . . . 0.0 111.303 -177.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -54.81 -39.66 68.73 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -176.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.04 -27.21 66.74 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -177.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -73.2 -25.93 60.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.021 0.438 . . . . 0.0 110.515 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.582 HD22 HG21 ' A' ' 28' ' ' THR . 33.5 mt -83.39 -51.7 7.16 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.087 -176.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.4 ' HB3' HE21 ' A' ' 24' ' ' GLN . 3.3 pt20 -56.11 130.92 46.09 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.367 -172.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.76 -25.15 28.45 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.104 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.585 ' HG2' ' OD1' ' A' ' 58' ' ' ASN . 8.1 mtpm? -124.49 172.97 8.77 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -177.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.511 HG21 ' HZ3' ' A' ' 137' ' ' TRP . 11.1 t -103.82 139.71 24.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 176.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.805 HG23 HD13 ' A' ' 62' ' ' LEU . 85.2 m -126.73 139.14 53.36 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -168.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.718 ' HB2' ' CE2' ' A' ' 59' ' ' PHE . 27.0 tp -110.02 107.37 17.23 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.74 172.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.554 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 28.6 mt -98.62 111.35 28.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.316 173.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -109.29 122.84 48.22 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.106 -177.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.436 ' CE1' ' HA2' ' A' ' 96' ' ' GLY . 97.2 m-85 -91.15 118.93 30.84 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.86 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.664 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 10.6 p-90 -148.5 -178.86 6.56 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.829 -177.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.558 ' O ' ' HB2' ' A' ' 37' ' ' CYS . 41.0 p90 -155.09 144.84 15.49 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 178.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.838 ' HG2' ' HB3' ' A' ' 69' ' ' ASP . 12.4 Cg_endo -59.71 152.03 65.98 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.168 1.912 . . . . 0.0 111.433 174.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.9 m 68.89 18.81 8.46 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 123.529 0.518 . . . . 0.0 111.091 -177.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.558 ' HB2' ' O ' ' A' ' 34' ' ' PHE . 45.1 t -68.33 140.45 92.8 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.452 -178.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -72.61 -22.96 20.27 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.821 2.347 . . . . 0.0 111.893 173.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.3 -1.21 88.08 Favored Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.923 -0.581 . . . . 0.0 113.147 -176.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.43 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 90.9 m -56.92 -30.4 63.94 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.876 0.338 . . . . 0.0 111.672 -177.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.4 t -49.97 -50.11 19.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.081 0.467 . . . . 0.0 110.641 177.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.4 m -87.2 -54.87 4.08 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.05 177.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.506 ' HA ' ' HD3' ' A' ' 46' ' ' LYS . 49.3 mm-40 -59.79 -40.85 89.7 Favored 'General case' 0 C--O 1.226 -0.139 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -168.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.817 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -59.12 -60.86 9.17 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -169.667 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.817 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 19.5 Cg_exo -67.11 -29.48 39.77 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 121.958 1.772 . . . . 0.0 111.488 178.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.506 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 64.8 tttt -59.79 -42.91 94.42 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.09 177.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.435 HG12 ' O ' ' A' ' 43' ' ' GLU . 41.0 mm -71.63 -38.95 68.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.352 177.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.722 HD13 ' HE2' ' A' ' 85' ' ' PHE . 47.6 mm -55.46 -53.63 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.2 -179.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -66.03 -49.33 68.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.287 -178.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 31.6 m -61.8 -54.67 39.12 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.782 -174.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.52 -33.59 73.03 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -173.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -75.79 -40.48 55.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.816 0.341 . . . . 0.0 111.173 -178.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -70.93 -42.99 69.12 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.844 0.354 . . . . 0.0 110.769 -176.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.617 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 42.8 m-85 -76.06 -10.32 59.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.714 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -56.71 -27.65 59.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.041 0.448 . . . . 0.0 110.954 -178.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -102.89 14.81 31.04 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.519 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.591 ' HD3' ' HA ' ' A' ' 54' ' ' TYR . 13.6 mptt -111.62 23.49 13.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.755 176.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.585 ' OD1' ' HG2' ' A' ' 26' ' ' LYS . 66.2 t30 68.11 18.46 9.37 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 122.078 0.942 . . . . 0.0 109.795 -176.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.718 ' CE2' ' HB2' ' A' ' 29' ' ' LEU . 38.5 t80 -100.03 162.01 13.25 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.557 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -150.42 152.55 34.5 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.248 0.547 . . . . 0.0 112.064 -177.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 1.026 HG11 ' HB3' ' A' ' 85' ' ' PHE . 1.5 p -101.08 125.88 54.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 114.816 -1.083 . . . . 0.0 111.119 -178.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.805 HD13 HG23 ' A' ' 28' ' ' THR . 8.7 mp -128.63 94.31 3.83 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 169.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -101.05 102.01 12.9 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.546 -176.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.979 HG12 ' HB2' ' A' ' 88' ' ' MET . 26.7 m -97.08 127.47 49.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.441 0.638 . . . . 0.0 111.118 -176.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.664 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -95.2 135.83 36.28 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.676 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.679 ' HB2' ' HG2' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -95.2 161.47 28.0 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 175.231 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.607 ' HD2' ' HB2' ' A' ' 66' ' ' GLN . 73.8 Cg_endo -74.04 54.03 3.05 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.903 2.402 . . . . 0.0 114.555 -168.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 45.7 mm -83.27 -27.85 7.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 170.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.838 ' HB3' ' HG2' ' A' ' 35' ' ' PRO . 0.6 OUTLIER -138.89 136.17 18.24 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 173.44 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -51.83 163.98 1.18 Allowed 'Trans proline' 0 N--CA 1.477 0.553 0 C-N-CA 123.509 2.806 . . . . 0.0 114.587 -175.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.8 tp -56.73 -34.92 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.574 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -66.47 -35.47 80.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.195 0.522 . . . . 0.0 110.419 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 27.3 m -64.89 -47.69 76.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.306 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.491 ' HB ' ' HG3' ' A' ' 35' ' ' PRO . 9.2 p -67.18 -33.95 66.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.652 0.263 . . . . 0.0 110.814 -178.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -65.89 -37.54 86.39 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.005 0.431 . . . . 0.0 110.993 176.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -69.76 -36.55 75.89 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -64.2 -50.75 66.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.979 -178.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.635 HG23 ' HB2' ' A' ' 83' ' ' LEU . 10.4 p -60.5 -30.21 46.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-O 120.754 0.312 . . . . 0.0 110.643 178.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -70.67 -55.37 8.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.239 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -66.25 -48.38 70.7 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.117 -174.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -82.55 -18.41 41.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.441 -176.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 69.08 63.74 3.31 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.98 177.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.635 ' HB2' HG23 ' A' ' 78' ' ' VAL . 8.4 mp -87.64 111.03 39.21 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 120.633 0.254 . . . . 0.0 110.383 178.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -89.98 24.54 0.62 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.899 2.399 . . . . 0.0 113.168 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 1.026 ' HB3' HG11 ' A' ' 61' ' ' VAL . 13.0 m-85 -121.15 155.28 34.85 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.1 m -68.2 123.56 21.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.1 0.476 . . . . 0.0 111.86 -173.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.448 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 48.7 t -122.62 135.19 63.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.822 -178.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.979 ' HB2' HG12 ' A' ' 64' ' ' VAL . 2.3 mpt? -117.13 175.5 5.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 93.6 t80 -138.51 117.18 12.21 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.241 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.598 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 21.1 t0 -103.98 114.26 28.38 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.0 -14.87 61.09 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -174.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -122.4 0.67 9.49 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.46 -175.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.679 ' HG2' ' HB2' ' A' ' 66' ' ' GLN . 49.3 mtmt 64.37 15.1 9.28 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 123.58 0.55 . . . . 0.0 109.903 -171.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.9 -44.27 93.47 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -165.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.545 HG22 ' OD2' ' A' ' 90' ' ' ASP . 28.2 m -74.14 -29.32 24.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.231 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.436 ' HA2' ' CE1' ' A' ' 32' ' ' PHE . . . -72.1 -34.78 61.3 Favored Glycine 0 CA--C 1.509 -0.282 0 C-N-CA 120.541 -0.837 . . . . 0.0 111.29 174.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.606 ' HA ' HE21 ' A' ' 97' ' ' GLN . 0.0 OUTLIER -71.03 -28.84 64.69 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.007 -0.596 . . . . 0.0 110.224 174.652 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.402 ' HB1' ' HB2' ' A' ' 1' ' ' ASP . . . -74.21 -22.71 59.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.233 175.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -87.65 -22.91 24.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.998 176.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 93.23 62.99 1.09 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.574 176.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.9 p -103.95 127.16 51.49 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.878 0.371 . . . . 0.0 111.244 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -87.81 -50.75 6.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.127 0.489 . . . . 0.0 110.31 176.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.4 p -145.08 149.15 17.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.087 -176.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.556 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 59.2 m-85 -106.21 161.46 22.78 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.215 -176.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.556 ' HA ' ' HB3' ' A' ' 104' ' ' TYR . 74.4 Cg_endo -74.39 165.5 85.24 Favored 'Cis proline' 0 C--N 1.351 0.684 0 C-N-CA 123.772 -1.345 . . . . 0.0 113.233 0.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.3 m -139.77 132.44 28.92 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.623 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.546 ' HB3' ' HB2' ' A' ' 120' ' ' TYR . 18.8 t -112.33 112.15 23.52 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.697 HG22 HG22 ' A' ' 119' ' ' THR . 55.5 t -105.99 131.6 55.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.898 0.38 . . . . 0.0 111.489 -175.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 90.2 mt -102.98 125.73 49.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.997 177.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.566 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 53.6 mt -118.05 141.09 38.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 123.445 0.466 . . . . 0.0 110.715 -179.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -85.8 -167.17 43.11 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 116.155 -0.475 . . . . 0.0 113.574 -177.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.4 -20.58 50.87 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -173.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.416 ' HB3' ' CD ' ' A' ' 115' ' ' GLU . 3.7 ttmp? -99.17 -3.18 35.01 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.554 0.692 . . . . 0.0 109.2 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.543 ' O ' ' HB2' ' A' ' 5' ' ' ALA . . . 97.29 12.64 48.01 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.67 -178.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.416 ' CD ' ' HB3' ' A' ' 113' ' ' LYS . 3.7 mp0 -68.15 122.15 17.68 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -178.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.675 HG13 ' H ' ' A' ' 5' ' ' ALA . 29.8 mt -74.01 93.76 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 174.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 93.4 mt -75.38 -70.3 0.43 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.596 -171.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.452 ' HD2' ' HA ' ' A' ' 118' ' ' LYS . 22.7 mmmt -125.44 144.72 50.4 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.148 -171.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.697 HG22 HG22 ' A' ' 108' ' ' VAL . 1.6 p -120.99 104.16 9.59 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.374 175.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.546 ' HB2' ' HB3' ' A' ' 107' ' ' SER . 22.6 m-85 -85.05 103.43 14.07 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.87 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.6 t -83.0 109.74 17.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.988 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 86.31 -116.83 4.48 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.375 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.453 ' OE1' ' HD2' ' A' ' 124' ' ' PRO . 7.1 tp10 -103.72 116.63 61.49 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-O 120.531 0.205 . . . . 0.0 110.812 -174.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.492 ' HB3' ' CG ' ' A' ' 120' ' ' TYR . 93.2 Cg_endo -86.54 -159.58 0.1 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 123.027 2.485 . . . . 0.0 112.254 175.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.848 ' HB3' ' HG2' ' A' ' 128' ' ' LYS . 18.2 t70 -125.27 124.27 41.29 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.861 177.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -65.54 -37.53 86.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.504 -175.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.77 -50.98 55.69 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.201 -178.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.848 ' HG2' ' HB3' ' A' ' 125' ' ' ASP . 11.9 ptmm? -67.5 -26.13 66.19 Favored 'General case' 0 C--O 1.221 -0.443 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.184 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 51.4 tp -61.08 -47.36 86.69 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.233 0.333 . . . . 0.0 110.224 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -62.24 -54.48 40.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.149 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.492 ' HG2' ' HA ' ' A' ' 128' ' ' LYS . 13.7 pt20 -65.99 -33.88 76.82 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -175.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -71.02 -45.78 63.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.477 0.18 . . . . 0.0 110.69 -177.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 72.7 mt -66.51 -36.26 76.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 177.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.616 ' HA ' ' CD1' ' A' ' 137' ' ' TRP . 14.2 t70 -61.46 -47.87 83.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.61 175.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 45.0 m -55.57 -35.23 65.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.185 0.517 . . . . 0.0 110.328 176.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.6 -18.5 62.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.162 -178.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.616 ' CD1' ' HA ' ' A' ' 134' ' ' ASP . 2.9 m95 -56.71 -56.96 14.8 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.304 0.573 . . . . 0.0 109.848 177.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.429 ' HD3' ' HB2' ' A' ' 137' ' ' TRP . 0.1 OUTLIER -88.76 -57.55 2.87 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.015 -179.166 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -87.4 91.3 8.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.669 -169.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 20.5 m -110.86 78.38 1.11 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 171.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -143.23 169.34 17.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.906 -171.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -78.55 -0.5 29.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.933 0.397 . . . . 0.0 110.893 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -80.7 5.92 14.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.973 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.3 -61.85 6.66 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 121.253 -0.498 . . . . 0.0 112.861 -178.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -141.9 136.42 30.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.62 0.248 . . . . 0.0 110.394 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -90.71 -2.58 57.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.008 0.432 . . . . 0.0 111.068 178.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -98.11 118.56 35.01 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 171.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -76.99 81.78 3.52 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.415 0.626 . . . . 0.0 111.085 -174.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 50.6 m-70 -119.59 -177.06 3.29 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.308 173.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 . . . . . 0 C--O 1.246 0.869 0 CA-C-O 118.885 -0.578 . . . . 0.0 109.707 -179.302 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.788 ' HB2' ' HB3' ' A' ' 8' ' ' PHE . 4.5 t70 . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.55 ' HB2' ' HG2' ' A' ' 6' ' ' PRO . 16.3 m -167.03 -70.28 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -178.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -161.92 142.34 10.41 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 175.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.559 ' H ' HD12 ' A' ' 116' ' ' ILE . 10.8 m 69.63 31.16 3.72 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 122.083 0.944 . . . . 0.0 110.274 -178.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.499 ' N ' ' HD3' ' A' ' 6' ' ' PRO . . . 58.9 61.52 4.7 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 114.245 -1.343 . . . . 0.0 114.116 173.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.582 ' HD2' ' CG ' ' A' ' 1' ' ' ASP . 17.3 Cg_exo -73.76 39.59 0.51 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.156 2.57 . . . . 0.0 112.473 167.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.403 ' H ' ' C ' ' A' ' 5' ' ' ALA . . . 75.27 113.65 0.07 Allowed 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.954 0.901 . . . . 0.0 112.893 174.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.788 ' HB3' ' HB2' ' A' ' 1' ' ' ASP . 27.3 p90 -141.78 131.58 24.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.912 171.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 26.0 p -149.35 103.09 3.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.868 0.365 . . . . 0.0 110.921 -179.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.451 ' H ' HD23 ' A' ' 10' ' ' LEU . 1.6 pt? -120.1 157.27 53.49 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.766 178.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.13 150.65 26.33 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 121.992 1.795 . . . . 0.0 112.228 177.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.591 ' HA ' ' HG3' ' A' ' 88' ' ' MET . 0.0 OUTLIER -81.41 176.6 9.57 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.035 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 87' ' ' VAL . 78.4 mt -57.42 -26.25 60.85 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -177.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 47.4 t60 -91.29 -40.84 11.27 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 121.355 -0.138 . . . . 0.0 110.783 178.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.93 4.01 0.87 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.063 -1.065 . . . . 0.0 113.804 176.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -78.47 126.74 31.19 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 117.468 0.634 . . . . 0.0 110.212 178.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.7 m -66.97 130.51 43.38 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.851 0.358 . . . . 0.0 110.12 176.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 9' ' ' SER . 9.8 p -118.21 138.13 49.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.0 p -138.69 -177.63 4.95 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.312 0.577 . . . . 0.0 112.091 -173.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -71.36 -21.7 62.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.665 175.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.65 -31.34 72.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.682 178.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -63.72 -23.26 67.3 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.805 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.62 HD22 HG21 ' A' ' 28' ' ' THR . 25.0 mt -84.06 -20.53 32.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.125 -172.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.418 ' HA ' ' OE1' ' A' ' 24' ' ' GLN . 14.7 mm-40 -60.82 113.09 2.31 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -172.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 113.23 -19.57 19.97 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.341 174.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.449 ' HB2' ' OE1' ' A' ' 60' ' ' GLN . 68.0 mttm -124.87 169.84 11.65 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.036 0.418 . . . . 0.0 110.945 -176.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.612 HG13 ' CD1' ' A' ' 59' ' ' PHE . 3.3 p -102.63 123.77 56.18 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.625 -177.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.62 HG21 HD22 ' A' ' 23' ' ' LEU . 39.0 m -116.01 142.99 46.07 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -160.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.498 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 55.7 tp -112.04 111.04 21.67 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.712 170.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.596 ' HB ' ' HB ' ' A' ' 108' ' ' VAL . 62.8 mt -97.9 111.96 28.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 171.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -112.73 122.39 47.54 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.5 -176.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.505 ' HB2' ' HB ' ' A' ' 106' ' ' THR . 89.5 m-85 -94.85 119.89 34.16 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.515 178.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.557 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 18.0 p-90 -147.54 175.33 10.93 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.338 -177.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -154.43 145.04 16.02 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 174.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.526 ' HG2' ' HB3' ' A' ' 69' ' ' ASP . 6.0 Cg_exo -39.12 -66.3 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 124.323 3.349 . . . . 0.0 114.419 -173.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.8 m -77.12 57.12 1.35 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.005 0.431 . . . . 0.0 112.049 -178.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.3 t -117.27 132.74 23.36 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.292 177.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.588 ' O ' HG12 ' A' ' 41' ' ' VAL . 31.4 Cg_exo -60.42 -20.05 61.6 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.565 2.177 . . . . 0.0 112.174 176.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.69 -22.46 78.68 Favored Glycine 0 C--O 1.224 -0.521 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.76 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.682 ' HA ' ' HG3' ' A' ' 44' ' ' MET . 64.1 m -60.36 -35.08 74.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.912 0.356 . . . . 0.0 111.464 -177.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.588 HG12 ' O ' ' A' ' 38' ' ' PRO . 13.5 p -67.33 -40.23 84.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.168 -176.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.8 p -89.25 -49.72 6.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.942 0.401 . . . . 0.0 111.894 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.511 ' O ' HG12 ' A' ' 47' ' ' ILE . 27.0 mm-40 -80.18 -41.2 25.75 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -168.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.682 ' HG3' ' HA ' ' A' ' 40' ' ' CYS . 59.0 mtp -58.28 -49.46 93.46 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -172.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -59.12 -36.37 96.1 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 121.945 1.763 . . . . 0.0 111.811 175.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.419 ' HB3' ' O ' ' A' ' 43' ' ' GLU . 33.7 ttmt -63.42 -38.04 89.6 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.162 177.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.511 HG12 ' O ' ' A' ' 43' ' ' GLU . 46.0 mm -67.4 -35.41 73.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.202 176.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.519 HG12 ' O ' ' A' ' 44' ' ' MET . 47.2 mm -54.73 -52.36 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.616 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.432 ' C ' ' HD3' ' A' ' 49' ' ' LYS . 12.7 tmtt? -59.65 -56.25 24.25 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.892 178.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 27.7 m -54.02 -51.96 62.34 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.903 -174.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.569 ' HB1' HG11 ' A' ' 61' ' ' VAL . . . -68.91 -44.76 72.51 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.138 -174.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -75.82 -37.35 59.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.737 -173.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -74.48 -52.45 11.94 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -175.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -78.62 -2.87 41.06 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.82 0.343 . . . . 0.0 111.244 -175.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 24.0 tptm -59.58 -35.74 74.87 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.245 177.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -88.6 2.9 52.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.626 -177.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -96.19 -66.16 0.92 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.327 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 66.2 t30 174.63 18.59 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.436 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.612 ' CD1' HG13 ' A' ' 27' ' ' VAL . 20.7 t80 -104.03 148.47 26.19 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.236 -172.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.449 ' OE1' ' HB2' ' A' ' 26' ' ' LYS . 51.1 mt-30 -122.89 150.9 42.3 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.01 0.524 . . . . 0.0 109.967 178.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.569 HG11 ' HB1' ' A' ' 51' ' ' ALA . 5.9 p -127.1 121.06 56.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 121.175 0.512 . . . . 0.0 110.594 177.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 8.6 mp -126.77 96.31 4.61 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.443 177.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.55 113.36 25.6 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.536 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 63.7 t -98.19 116.39 40.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.026 0.441 . . . . 0.0 110.132 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.557 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -87.7 121.56 30.28 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.789 175.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.701 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 4.8 pm0 -89.65 169.16 13.2 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.701 ' HD2' ' HB2' ' A' ' 66' ' ' GLN . 30.0 Cg_endo -62.26 -138.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 122.701 2.267 . . . . 0.0 113.825 -178.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.539 ' HB ' ' O ' ' A' ' 67' ' ' PRO . 90.6 mt 78.9 -49.36 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 C-N-CA 123.163 0.585 . . . . 0.0 109.771 -173.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.526 ' HB3' ' HG2' ' A' ' 35' ' ' PRO . 0.6 OUTLIER -107.03 138.53 19.85 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 173.249 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 69' ' ' ASP . 33.8 Cg_exo -59.18 158.31 26.53 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.749 2.299 . . . . 0.0 112.821 -178.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.0 tp -62.26 -31.27 51.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.396 -175.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -66.57 -29.2 69.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.905 177.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.1 t -68.48 -40.55 80.92 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.7 t -62.66 -42.74 97.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.209 176.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -62.79 -36.0 81.71 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.176 177.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -61.46 -45.02 96.05 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.825 0.345 . . . . 0.0 110.75 -177.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -63.43 -52.49 61.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.303 -179.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.538 ' HA ' HD13 ' A' ' 83' ' ' LEU . 10.0 p -65.23 -26.53 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-O 121.035 0.445 . . . . 0.0 111.038 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -73.31 -54.77 7.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.356 0.598 . . . . 0.0 110.661 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -73.38 -48.87 30.54 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.862 -172.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -91.77 -4.49 54.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.523 -174.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.08 -58.0 4.59 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.755 177.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.538 HD13 ' HA ' ' A' ' 78' ' ' VAL . 11.2 mp 63.62 95.28 0.05 OUTLIER Pre-proline 0 N--CA 1.466 0.355 0 CA-C-O 121.275 0.56 . . . . 0.0 111.666 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -75.94 10.58 1.97 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.574 2.85 . . . . 0.0 113.07 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -120.38 145.03 47.57 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.2 m -67.68 124.46 23.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.16 -176.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.482 HG21 HD23 ' A' ' 83' ' ' LEU . 33.3 t -118.87 134.38 62.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.702 -179.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.591 ' HG3' ' HA ' ' A' ' 12' ' ' ASP . 3.2 mpp? -123.66 175.25 6.95 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -134.93 125.46 26.73 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.123 -177.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.566 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 56.4 t0 -107.68 111.16 23.23 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 174.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.11 -24.76 60.67 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -174.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.59 7.01 22.27 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.081 -174.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.4 pttp 46.45 32.0 1.47 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.992 0.917 . . . . 0.0 111.563 -179.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.33 -35.12 58.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.661 -173.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.546 HG22 ' OD2' ' A' ' 90' ' ' ASP . 32.6 m -73.44 -29.88 28.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 175.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -68.99 -39.5 84.92 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 172.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -58.83 -32.75 69.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.025 0.44 . . . . 0.0 111.142 175.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.95 -47.7 65.01 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.043 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.469 ' HD2' ' CZ ' ' A' ' 32' ' ' PHE . 30.2 m-85 -81.27 -14.17 57.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.978 -176.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 93.34 38.46 5.34 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.233 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.499 HG23 ' OG1' ' A' ' 106' ' ' THR . 39.9 m -75.9 89.22 2.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.285 0.564 . . . . 0.0 111.18 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 52.5 tp60 -101.44 -57.85 2.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.703 175.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.446 ' CG1' ' HB ' ' A' ' 121' ' ' VAL . 8.4 p -98.95 148.72 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.823 -177.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -114.65 144.28 31.57 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.968 -173.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.505 ' HG3' ' HG3' ' A' ' 43' ' ' GLU . 94.1 Cg_endo -85.58 165.23 55.92 Favored 'Cis proline' 0 N--CA 1.463 -0.279 0 C-N-CA 123.232 -1.57 . . . . 0.0 112.307 -0.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.505 ' HB ' ' HB2' ' A' ' 32' ' ' PHE . 36.5 m -110.45 134.07 52.69 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 176.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.5 m -121.72 110.18 15.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.992 0.425 . . . . 0.0 110.559 -176.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.596 ' HB ' ' HB ' ' A' ' 30' ' ' ILE . 46.4 t -109.41 125.13 66.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.513 -179.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.717 HD11 HD11 ' A' ' 129' ' ' LEU . 85.4 mt -103.4 136.3 43.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.545 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.564 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 51.8 mt -124.49 138.12 55.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 176.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.512 ' O ' ' HA ' ' A' ' 27' ' ' VAL . . . -78.06 -92.98 0.28 Allowed Glycine 0 C--O 1.223 -0.572 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.137 -172.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -144.63 -2.79 0.83 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.402 0.601 . . . . 0.0 111.351 -178.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.474 ' HB2' ' OE2' ' A' ' 115' ' ' GLU . 10.4 mtmp? -126.15 13.74 7.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.816 0.341 . . . . 0.0 110.89 -174.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.02 28.74 73.91 Favored Glycine 0 C--O 1.227 -0.316 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.246 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.512 ' CD ' ' H ' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -90.48 -11.05 41.46 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.856 0.36 . . . . 0.0 110.75 -176.292 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.559 HD12 ' H ' ' A' ' 4' ' ' THR . 19.3 mt 62.9 91.67 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.556 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.55 -34.55 72.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.934 -1.03 . . . . 0.0 112.699 -173.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.63 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 2.4 tppp? -155.43 139.87 16.8 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -168.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.56 HG23 HG22 ' A' ' 108' ' ' VAL . 18.3 m -126.07 101.99 7.03 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 120.91 0.386 . . . . 0.0 110.375 170.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.53 ' CD2' ' HB3' ' A' ' 124' ' ' PRO . 41.9 m-85 -94.07 137.69 32.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.285 173.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.446 ' HB ' ' CG1' ' A' ' 103' ' ' VAL . 3.7 m -102.59 108.9 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-O 121.247 0.546 . . . . 0.0 109.737 170.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 99.85 -162.91 19.38 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.341 -0.703 . . . . 0.0 111.341 -174.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -83.09 125.88 73.71 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.812 0.306 . . . . 0.0 110.352 176.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.53 ' HB3' ' CD2' ' A' ' 120' ' ' TYR . 96.5 Cg_endo -80.1 175.13 10.69 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.726 2.284 . . . . 0.0 112.435 177.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.485 ' HB2' ' HB3' ' A' ' 128' ' ' LYS . 7.1 m-20 -65.52 110.43 2.7 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 173.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -63.39 -39.7 95.23 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -170.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -73.21 -46.82 25.77 Favored Glycine 0 C--O 1.237 0.338 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.856 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.485 ' HB3' ' HB2' ' A' ' 125' ' ' ASP . 51.1 tttm -60.71 -36.86 79.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.653 0.263 . . . . 0.0 110.476 177.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.717 HD11 HD11 ' A' ' 109' ' ' LEU . 28.0 tp -58.92 -46.85 86.93 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.719 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -56.54 -45.29 81.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.848 0.356 . . . . 0.0 110.803 178.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -68.4 -37.23 80.16 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.865 -178.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.505 ' HG2' ' HA ' ' A' ' 129' ' ' LEU . 8.9 pt-20 -77.02 -23.65 52.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.78 0.324 . . . . 0.0 110.145 -179.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.2 mp -62.64 -48.72 86.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.017 172.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -61.89 -34.93 76.93 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.273 0.559 . . . . 0.0 110.316 177.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 35.6 m -60.65 -40.84 93.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.376 178.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.1 -32.16 68.71 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.986 177.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 37.8 m0 -62.01 -37.61 85.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.068 0.461 . . . . 0.0 110.408 176.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 -86.26 -43.96 12.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.751 -176.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.474 HD21 ' HB2' ' A' ' 142' ' ' ALA . 52.4 t30 -74.13 92.71 2.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.105 0.479 . . . . 0.0 111.185 -175.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.0 m -104.73 -13.83 15.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.891 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -92.49 15.12 14.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.227 -176.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.474 ' HB2' HD21 ' A' ' 139' ' ' ASN . . . -88.6 99.96 12.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.563 176.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -128.75 133.81 48.23 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.963 179.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -136.5 76.29 0.38 Allowed Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.659 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -128.94 19.7 6.0 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 122.706 -0.291 . . . . 0.0 110.734 -178.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -60.01 -36.79 77.97 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.893 0.378 . . . . 0.0 110.625 -178.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -121.81 112.56 18.51 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.783 177.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -76.32 135.11 39.57 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.982 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -91.5 3.74 54.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.457 0.646 . . . . 0.0 109.391 175.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 30.9 p80 . . . . . 0 C--O 1.24 0.588 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.164 177.338 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.529 ' HB2' ' HB3' ' A' ' 6' ' ' PRO . 5.1 p-10 . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.9 m 69.39 93.39 0.08 Allowed 'General case' 0 C--O 1.234 0.242 0 O-C-N 123.884 0.74 . . . . 0.0 111.389 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? 66.42 168.99 0.23 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.603 -178.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.5 m 59.31 28.42 17.76 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.26 0.552 . . . . 0.0 111.107 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.427 ' H ' HG12 ' A' ' 116' ' ' ILE . . . 63.04 103.77 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.332 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.012 177.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.529 ' HB3' ' HB2' ' A' ' 1' ' ' ASP . 21.3 Cg_endo -60.13 150.72 77.66 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.907 2.405 . . . . 0.0 112.045 178.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.573 ' HA ' ' HB2' ' A' ' 20' ' ' ASN . . . -76.12 73.08 2.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.146 0.498 . . . . 0.0 110.973 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.423 ' CZ ' HD11 ' A' ' 23' ' ' LEU . 50.3 p90 -86.43 148.68 25.45 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 176.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.9 t -149.56 88.76 1.58 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.529 ' H ' HD23 ' A' ' 10' ' ' LEU . 2.4 pt? -123.14 147.11 50.9 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.582 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.644 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 16.5 Cg_exo -68.67 132.23 24.66 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.445 2.097 . . . . 0.0 110.928 172.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.602 ' HA ' ' HG2' ' A' ' 88' ' ' MET . 0.0 OUTLIER -70.43 171.08 10.66 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.055 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.558 HD23 HG21 ' A' ' 78' ' ' VAL . 13.5 tp -81.54 10.38 5.99 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-O 121.403 0.621 . . . . 0.0 111.291 -171.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.453 ' H ' ' CG ' ' A' ' 12' ' ' ASP . 77.3 m80 -109.58 -27.52 9.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.48 170.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 124.13 16.69 3.17 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.687 177.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.468 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 59.0 mttp -112.8 115.39 28.41 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 122.649 -0.324 . . . . 0.0 110.619 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.644 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 35.4 m -61.16 127.22 30.48 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.987 0.423 . . . . 0.0 111.574 -178.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.7 t -111.69 125.81 69.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 174.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.8 p -131.51 175.25 9.31 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.196 0.522 . . . . 0.0 111.433 -176.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.573 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . 4.7 t-20 -58.17 -31.44 67.26 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.094 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.47 -28.09 67.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.651 -178.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -74.1 -18.66 60.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.212 0.53 . . . . 0.0 110.605 -177.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.465 HD12 HD22 ' A' ' 20' ' ' ASN . 79.9 mt -79.4 -19.73 49.35 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.434 -178.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -71.01 98.58 1.65 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.699 -172.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.59 -8.23 19.93 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.711 175.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 112' ' ' LYS . 56.2 mttm -115.98 167.47 10.93 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.415 ' HB ' ' HD2' ' A' ' 59' ' ' PHE . 22.5 t -104.12 139.81 24.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 174.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.796 HG23 ' HG3' ' A' ' 60' ' ' GLN . 4.6 m -129.81 142.23 50.72 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.042 0.448 . . . . 0.0 112.095 -166.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.685 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 7.4 tt -123.69 105.75 9.96 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 171.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.69 ' HB ' ' CG1' ' A' ' 108' ' ' VAL . 61.2 mt -97.49 115.1 36.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.459 ' HA ' ' O ' ' A' ' 106' ' ' THR . 27.4 t-20 -109.5 113.43 26.22 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.366 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.517 ' HE1' HG23 ' A' ' 95' ' ' VAL . 90.4 m-85 -81.92 119.71 24.29 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 175.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 9.7 p-90 -141.78 -179.06 5.97 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.287 0.565 . . . . 0.0 110.775 -175.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -158.12 149.94 17.18 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.766 174.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -63.04 170.08 8.11 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.445 2.097 . . . . 0.0 111.972 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.8 m 63.5 5.58 2.18 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.985 178.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 51.7 t -84.65 131.11 50.69 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.771 0.319 . . . . 0.0 111.046 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -61.62 -22.43 74.41 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.805 2.337 . . . . 0.0 112.112 176.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.37 -19.1 66.18 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.312 -0.471 . . . . 0.0 112.644 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 72.0 m -62.17 -33.41 74.46 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.663 0.268 . . . . 0.0 110.764 178.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 52.8 t -62.76 -35.63 71.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.231 0.538 . . . . 0.0 110.411 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.3 m -86.39 -53.29 5.09 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.944 -177.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.419 ' O ' HG12 ' A' ' 47' ' ' ILE . 17.7 mm-40 -84.46 -31.78 24.39 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -168.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.612 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 50.0 tpp -57.59 -52.1 76.86 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 111.998 0.369 . . . . 0.0 111.998 -174.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.612 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 54.4 Cg_exo -53.39 -39.8 80.4 Favored 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 121.927 1.751 . . . . 0.0 112.404 176.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.429 ' HD3' ' CZ ' ' A' ' 126' ' ' PHE . 56.2 mttp -59.78 -51.45 69.69 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.12 178.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.419 HG12 ' O ' ' A' ' 43' ' ' GLU . 49.8 mm -61.24 -42.11 92.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.224 -177.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.583 HG12 ' O ' ' A' ' 44' ' ' MET . 49.3 mm -55.03 -53.29 35.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.588 0.232 . . . . 0.0 111.434 -178.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.409 ' HB3' ' NZ ' ' A' ' 49' ' ' LYS . 0.2 OUTLIER -74.98 -47.39 29.54 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.793 -175.085 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.5 m -63.88 -44.06 94.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.757 0.313 . . . . 0.0 111.362 -176.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.468 ' HB2' HG21 ' A' ' 61' ' ' VAL . . . -69.22 -33.12 72.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.796 -0.184 . . . . 0.0 110.734 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -56.4 -50.94 70.16 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.366 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -68.93 -51.09 43.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.122 0.487 . . . . 0.0 111.034 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 1.048 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 8.8 m-85 -66.5 -31.07 71.56 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -172.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -63.49 -27.3 69.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.083 0.468 . . . . 0.0 110.397 178.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -96.5 19.4 12.25 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.127 0.489 . . . . 0.0 110.499 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 58' ' ' ASN . 0.0 OUTLIER -121.16 -65.4 1.14 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.728 178.131 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 66.6 t30 171.17 19.68 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.646 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 1.048 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 55.4 t80 -114.74 128.27 56.21 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -176.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.796 ' HG3' HG23 ' A' ' 28' ' ' THR . 4.5 pt20 -114.24 128.34 56.31 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.192 0.52 . . . . 0.0 111.151 -175.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.468 HG21 ' HB2' ' A' ' 51' ' ' ALA . 88.5 t -102.87 121.03 53.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.587 175.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.435 ' HB2' HG12 ' A' ' 30' ' ' ILE . 79.5 mt -113.39 101.58 9.52 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.846 -177.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.69 100.46 12.84 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.396 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.3 t -88.52 106.36 16.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.467 -176.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.86 133.08 34.32 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 174.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.608 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 3.4 pt20 -109.3 164.86 13.78 Favored Pre-proline 0 C--N 1.316 -0.89 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.608 ' HD2' ' HB2' ' A' ' 66' ' ' GLN . 37.8 Cg_endo -64.9 95.79 0.25 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.312 2.008 . . . . 0.0 113.485 -174.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 45.9 mm -128.13 -65.01 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 171.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -89.53 151.64 46.26 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.046 169.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -58.22 160.25 16.72 Favored 'Trans proline' 0 C--O 1.236 0.411 0 C-N-CA 122.506 2.137 . . . . 0.0 112.504 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.0 tp -56.63 -33.2 39.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.793 -176.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.644 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -65.89 -38.55 89.05 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 122.257 -0.277 . . . . 0.0 110.469 179.418 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.8 m -63.86 -44.86 91.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.776 0.322 . . . . 0.0 110.734 -178.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.47 -35.7 52.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.348 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.644 ' HG2' ' HA ' ' A' ' 72' ' ' GLU . 11.8 ptt180 -73.9 -35.42 64.67 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.569 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -64.98 -39.56 93.66 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 176.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -54.61 -55.21 31.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.405 178.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.07 ' HA ' HD23 ' A' ' 83' ' ' LEU . 61.9 t -60.01 -37.86 74.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.658 -178.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.578 ' HG2' ' O ' ' A' ' 75' ' ' ARG . 33.3 mmtp -69.59 -51.21 37.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.81 0.338 . . . . 0.0 110.987 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -63.95 -48.96 74.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.026 -173.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.409 ' HB2' ' CD2' ' A' ' 83' ' ' LEU . 96.9 m-85 -88.23 -2.89 58.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.371 -175.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 59.87 53.47 45.63 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.919 176.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 1.07 HD23 ' HA ' ' A' ' 78' ' ' VAL . 2.9 mm? -69.92 114.1 22.51 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 120.789 0.328 . . . . 0.0 110.646 -179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -84.24 -20.32 4.22 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.036 2.491 . . . . 0.0 113.964 -174.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.511 ' CE1' HD12 ' A' ' 83' ' ' LEU . 40.0 p90 -79.99 169.6 17.64 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.693 0.282 . . . . 0.0 110.486 -179.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 24.2 m -78.48 105.46 9.76 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.562 0.696 . . . . 0.0 111.22 -175.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.1 t -99.59 141.91 16.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.233 177.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.602 ' HG2' ' HA ' ' A' ' 12' ' ' ASP . 60.6 mtm -136.63 168.98 18.47 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -134.97 104.74 6.08 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.879 0.371 . . . . 0.0 110.743 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.548 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 20.0 t70 -91.11 101.99 14.74 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.34 -10.64 59.96 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.226 -171.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.474 ' OD2' ' HB2' ' A' ' 94' ' ' ALA . 13.5 t70 -105.14 -12.05 16.29 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.544 -0.463 . . . . 0.0 111.345 -176.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 63.2 tttp 65.32 4.97 2.88 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 121.349 0.595 . . . . 0.0 111.365 177.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.474 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . . . -70.62 -29.49 65.89 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -170.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.517 HG23 ' HE1' ' A' ' 32' ' ' PHE . 22.5 m -73.08 -33.94 43.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.353 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -70.89 -33.89 65.81 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 173.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -70.6 -32.03 69.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.213 -0.493 . . . . 0.0 110.876 176.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.69 -45.57 89.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.87 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -73.11 -27.07 61.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.986 0.422 . . . . 0.0 110.814 175.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.31 39.63 7.24 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.873 -0.68 . . . . 0.0 111.782 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.8 p -84.08 115.24 22.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.624 0.25 . . . . 0.0 110.601 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -103.23 -40.03 6.59 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.998 0.428 . . . . 0.0 110.148 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 40.1 t -98.75 145.27 10.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.967 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.411 ' HB3' ' HA ' ' A' ' 105' ' ' PRO . 87.0 m-85 -132.62 155.82 80.78 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.411 ' HA ' ' HB3' ' A' ' 104' ' ' TYR . 86.9 Cg_endo -78.63 160.28 90.94 Favored 'Cis proline' 0 C--N 1.345 0.373 0 C-N-CA 123.25 -1.562 . . . . 0.0 112.772 0.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 53.9 m -131.71 123.83 28.54 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.727 178.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.1 m -107.99 117.69 34.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.52 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.69 ' CG1' ' HB ' ' A' ' 30' ' ' ILE . 10.1 p -106.09 135.9 42.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.939 0.4 . . . . 0.0 110.144 178.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.55 HD23 ' HB2' ' A' ' 118' ' ' LYS . 2.3 mm? -102.84 124.99 49.4 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.244 -178.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.575 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 53.5 mt -109.26 133.96 52.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.964 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -80.04 159.11 43.17 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.289 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 46.8 pttt -67.68 86.15 0.21 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.75 0.786 . . . . 0.0 111.112 -177.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 4.6 ttmp? 165.73 -30.02 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.373 -178.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.46 39.97 1.84 Allowed Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.345 -176.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -113.35 132.35 55.62 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.428 HD13 HG12 ' A' ' 110' ' ' ILE . 49.2 mm -78.46 117.91 24.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.827 0.346 . . . . 0.0 110.083 -178.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.2 mt -103.14 -68.59 0.83 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.769 -175.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.55 ' HB2' HD23 ' A' ' 109' ' ' LEU . 20.1 mmmt -124.33 157.3 35.32 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -168.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -138.32 108.74 6.51 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.026 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -108.8 109.37 20.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.202 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 36.5 t -96.92 138.19 22.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.08 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 90.12 -77.63 1.58 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.124 178.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -151.71 119.81 3.33 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 178.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.54 ' HB2' HD22 ' A' ' 129' ' ' LEU . 38.1 Cg_endo -67.81 130.23 21.43 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.561 2.174 . . . . 0.0 112.427 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.616 ' OD1' ' HG2' ' A' ' 128' ' ' LYS . 12.7 t70 -69.32 110.85 4.86 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 177.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.429 ' CZ ' ' HD3' ' A' ' 46' ' ' LYS . 34.6 m-85 -58.58 -44.15 89.7 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -173.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -56.66 -52.89 47.72 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.915 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.616 ' HG2' ' OD1' ' A' ' 125' ' ' ASP . 38.4 mmtm -63.93 -48.87 74.83 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.54 HD22 ' HB2' ' A' ' 124' ' ' PRO . 28.0 tp -63.16 -48.66 77.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.989 -171.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -64.39 -37.88 89.06 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.958 -177.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -73.34 -39.73 64.98 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.43 178.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.489 ' OE1' ' HG3' ' A' ' 118' ' ' LYS . 9.5 pt-20 -75.24 -38.13 60.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.276 -174.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 57.6 mt -64.37 -45.97 94.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 175.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.472 ' HA ' ' HB3' ' A' ' 137' ' ' TRP . 21.0 t70 -61.32 -32.18 72.04 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.002 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 90.4 m -58.37 -47.43 83.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.975 0.417 . . . . 0.0 110.653 177.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.99 -28.25 57.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.077 0.465 . . . . 0.0 111.062 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.472 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . 40.0 t-105 -73.41 -55.19 6.7 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.331 -177.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 34.4 ttp-105 -65.95 -35.47 80.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.8 -172.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -77.23 109.94 11.52 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.08 0.466 . . . . 0.0 110.371 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 11.9 p -130.1 -29.65 2.05 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.31 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -82.07 93.33 6.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.06 0.457 . . . . 0.0 110.114 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -112.82 -176.13 2.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.959 -178.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -114.35 -174.82 2.55 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.303 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -97.6 -99.15 2.01 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.535 173.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 64.3 -83.45 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.117 0.567 . . . . 0.0 110.666 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -168.82 44.03 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 25.9 t60 75.95 -45.86 0.54 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.527 -178.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -89.55 135.75 33.42 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.302 176.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -77.46 129.53 35.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.904 0.383 . . . . 0.0 110.823 177.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 21.3 t60 . . . . . 0 C--O 1.243 0.731 0 CA-C-O 118.356 -0.83 . . . . 0.0 109.125 173.273 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.578 ' OD2' ' HA ' ' A' ' 7' ' ' ALA . 36.5 t70 . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.6 m -157.29 119.2 3.77 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.558 ' HD2' ' H ' ' A' ' 4' ' ' THR . 28.0 tptp 65.95 163.74 0.17 Allowed 'General case' 0 N--CA 1.466 0.375 0 O-C-N 123.525 0.516 . . . . 0.0 109.827 -178.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.619 ' O ' ' HA ' ' A' ' 115' ' ' GLU . 4.2 m 74.94 -0.33 3.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 122.121 0.962 . . . . 0.0 109.4 -174.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.695 ' HB2' ' HB3' ' A' ' 20' ' ' ASN . . . 175.42 168.49 0.36 Allowed Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 113.973 -1.467 . . . . 0.0 108.701 -178.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.567 ' HD2' ' HB1' ' A' ' 5' ' ' ALA . 39.3 Cg_endo -69.74 24.93 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.629 2.22 . . . . 0.0 113.239 174.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.578 ' HA ' ' OD2' ' A' ' 1' ' ' ASP . . . 62.2 58.92 1.7 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.905 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.531 ' CE1' ' HB1' ' A' ' 5' ' ' ALA . 37.7 p90 -119.07 144.41 46.59 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.353 0.597 . . . . 0.0 111.558 -174.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.2 p -149.43 88.58 1.58 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.85 170.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.56 ' H ' HD23 ' A' ' 10' ' ' LEU . 2.6 pt? -121.98 155.71 60.5 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.896 -174.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.92 145.7 19.99 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.742 2.295 . . . . 0.0 111.584 173.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 51.7 p-10 -89.53 -172.65 3.67 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.141 177.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.6 mt -79.06 20.7 0.47 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.765 0.316 . . . . 0.0 111.441 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -118.33 -24.34 6.93 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 174.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.45 14.93 14.81 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.719 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -113.37 141.61 46.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.972 0.386 . . . . 0.0 110.315 178.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.2 m -75.27 122.53 23.84 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.404 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.5 t -108.01 142.84 19.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.733 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.5 p -145.35 -173.8 4.21 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.202 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.695 ' HB3' ' HB2' ' A' ' 5' ' ' ALA . 20.8 p30 -66.47 -22.73 66.2 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -176.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.63 -31.73 71.83 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.833 0.349 . . . . 0.0 111.81 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.62 -37.03 84.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.45 0.643 . . . . 0.0 109.704 177.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.493 HD22 HG21 ' A' ' 28' ' ' THR . 21.7 mt -72.21 -21.33 61.42 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.475 -174.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -64.8 102.1 0.55 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.248 0.547 . . . . 0.0 111.686 -174.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.05 -26.04 10.22 Favored Glycine 0 CA--C 1.511 -0.208 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.991 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.708 ' O ' ' HA ' ' A' ' 112' ' ' LYS . 31.5 mttp -97.18 163.09 13.06 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 177.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.471 HG22 ' HB3' ' A' ' 112' ' ' LYS . 4.9 t -103.08 127.3 57.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 175.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.59 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 27.7 m -131.33 142.23 50.06 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.397 0.618 . . . . 0.0 112.361 -168.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.474 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 24.8 tp -115.69 115.27 26.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.396 172.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.819 ' HB ' ' CG2' ' A' ' 108' ' ' VAL . 51.2 mt -94.27 112.86 27.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 176.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -117.0 118.3 32.01 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.855 0.36 . . . . 0.0 110.932 -176.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.483 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 87.7 m-85 -84.25 125.09 31.9 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.406 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.532 ' CD1' ' HB1' ' A' ' 63' ' ' ALA . 22.7 p-90 -147.07 175.54 10.62 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.217 0.532 . . . . 0.0 111.097 -177.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.425 ' HD2' ' OD2' ' A' ' 69' ' ' ASP . 27.2 p90 -161.67 149.58 12.23 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.714 173.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.583 ' HD2' ' HB2' ' A' ' 69' ' ' ASP . 84.7 Cg_exo -49.61 -46.69 25.85 Favored 'Trans proline' 0 N--CA 1.474 0.375 0 C-N-CA 123.422 2.748 . . . . 0.0 114.284 -174.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.1 m -79.35 17.81 0.78 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -174.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.612 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 48.0 t -85.2 126.5 67.23 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 120.704 0.288 . . . . 0.0 110.734 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 17.0 Cg_exo -67.79 -19.32 47.16 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.963 2.442 . . . . 0.0 112.305 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.24 -11.52 84.93 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.803 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.612 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 89.2 m -60.96 -43.57 98.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.704 0.252 . . . . 0.0 111.381 -178.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.9 m -59.71 -27.86 38.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.02 0.438 . . . . 0.0 111.403 -177.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.9 m -87.45 -55.14 3.92 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.265 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.445 ' O ' HG12 ' A' ' 47' ' ' ILE . 26.5 mm-40 -84.55 -33.18 23.5 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -168.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.649 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 47.9 tpp -57.52 -53.76 62.11 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -172.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.649 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 43.2 Cg_exo -57.15 -36.59 99.18 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 122.096 1.864 . . . . 0.0 111.98 178.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.464 ' HB3' ' HE2' ' A' ' 46' ' ' LYS . 4.6 tmmm? -66.74 -39.8 88.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.108 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 43' ' ' GLU . 34.1 mm -63.52 -39.4 85.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.581 177.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.548 HD13 ' HE1' ' A' ' 85' ' ' PHE . 44.9 mm -54.62 -53.38 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.287 178.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -63.24 -51.5 65.93 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.803 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 30.9 m -56.02 -47.17 78.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.945 0.402 . . . . 0.0 111.491 -176.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . -65.62 -41.09 93.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.433 -177.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -73.76 -37.76 64.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.954 -176.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.07 -49.54 76.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.689 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -92.08 -1.49 57.17 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.524 -174.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 24.2 tptm -59.26 -35.32 73.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.102 0.477 . . . . 0.0 110.49 178.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -74.85 -24.25 58.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.403 -176.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -71.35 -70.35 0.32 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 175.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 171.63 22.24 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.456 -176.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.474 ' HZ ' ' HB2' ' A' ' 29' ' ' LEU . 29.5 t80 -100.48 139.72 35.75 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.969 -174.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.501 ' O ' ' HA ' ' A' ' 28' ' ' THR . 12.1 pt20 -134.64 137.15 43.4 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.147 176.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.447 HG22 ' HE1' ' A' ' 59' ' ' PHE . 98.3 t -104.98 119.16 53.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.47 HD23 ' HB ' ' A' ' 86' ' ' THR . 70.0 mt -104.04 98.59 8.39 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.7 177.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.532 ' HB1' ' CD1' ' A' ' 33' ' ' TRP . . . -84.52 109.29 17.82 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.271 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.509 HG11 HG11 ' A' ' 95' ' ' VAL . 86.4 t -93.93 108.37 20.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.257 0.551 . . . . 0.0 110.495 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -80.14 127.83 32.79 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 174.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.759 ' HG2' HG12 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -99.85 162.34 21.41 Favored Pre-proline 0 C--N 1.318 -0.785 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -179.135 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.603 ' HD2' ' HB2' ' A' ' 66' ' ' GLN . 58.6 Cg_endo -70.9 42.4 0.42 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.994 2.463 . . . . 0.0 115.157 -170.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.759 HG12 ' HG2' ' A' ' 66' ' ' GLN . 43.6 mm -84.09 -30.96 7.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 172.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.583 ' HB2' ' HD2' ' A' ' 35' ' ' PRO . 23.6 m-20 -125.12 150.93 68.39 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.784 169.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -58.12 154.76 37.8 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.352 2.035 . . . . 0.0 111.954 176.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.699 ' HA ' HG22 ' A' ' 74' ' ' VAL . 11.9 tt -63.0 -27.62 43.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.633 0.254 . . . . 0.0 111.177 -178.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.446 ' HA ' ' NE ' ' A' ' 75' ' ' ARG . 10.1 pt-20 -67.38 -33.97 76.32 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.189 177.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.6 m -68.92 -45.0 71.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.27 175.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.699 HG22 ' HA ' ' A' ' 71' ' ' ILE . 5.2 m -70.39 -35.79 63.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.973 -175.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.446 ' NE ' ' HA ' ' A' ' 72' ' ' GLU . 30.5 ptt180 -75.27 -27.53 59.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.561 -179.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 -68.52 -37.83 80.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.369 176.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -63.48 -47.84 80.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.075 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.688 HG13 ' HB2' ' A' ' 83' ' ' LEU . 43.6 t -61.24 -42.18 92.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.682 177.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.4 tttt -62.84 -55.95 21.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.005 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -63.03 -48.81 77.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.306 -170.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -83.59 -17.6 41.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.711 0.291 . . . . 0.0 111.294 -176.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.0 60.8 4.02 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.961 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.688 ' HB2' HG13 ' A' ' 78' ' ' VAL . 9.9 mp -67.6 118.73 60.05 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.723 -0.238 . . . . 0.0 110.533 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -75.84 -28.89 7.46 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.787 2.324 . . . . 0.0 112.862 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.548 ' HE1' HD13 ' A' ' 48' ' ' ILE . 33.6 p90 -80.34 150.98 29.69 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.47 ' HB ' HD23 ' A' ' 62' ' ' LEU . 22.2 m -75.21 131.32 40.32 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.117 0.484 . . . . 0.0 111.335 -173.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.465 HG22 ' HB3' ' A' ' 63' ' ' ALA . 68.5 t -114.09 139.46 39.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.418 -179.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 70.1 mtm -127.26 167.56 15.93 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 176.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -137.72 112.0 8.58 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.563 0.22 . . . . 0.0 110.441 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.56 ' OD2' HG12 ' A' ' 95' ' ' VAL . 55.8 t0 -91.53 119.07 31.14 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.56 -20.84 60.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.928 -176.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -111.64 -11.7 13.99 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -175.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.412 ' HE2' ' HB3' ' A' ' 93' ' ' LYS . 32.2 ttpt 65.52 16.57 10.58 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.965 0.412 . . . . 0.0 109.964 175.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.09 -29.27 70.2 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.608 0.718 . . . . 0.0 109.59 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.56 HG12 ' OD2' ' A' ' 90' ' ' ASP . 7.7 p -60.65 -46.53 95.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.136 174.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.402 ' N ' HG13 ' A' ' 95' ' ' VAL . . . -76.13 -33.2 50.38 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.888 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -58.6 -36.34 73.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.014 0.435 . . . . 0.0 111.242 177.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.03 -46.33 52.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.305 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.459 ' CE2' ' HG3' ' A' ' 6' ' ' PRO . 27.0 m-85 -72.76 -27.58 62.1 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 95.13 36.58 5.42 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -175.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.502 HG23 ' OG1' ' A' ' 106' ' ' THR . 20.0 m -76.51 88.15 3.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.134 0.492 . . . . 0.0 111.2 -177.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -103.12 -46.03 4.75 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.317 177.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 38.4 t -101.82 131.43 49.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.0 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -104.98 149.21 37.32 Favored Pre-proline 0 C--N 1.317 -0.826 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -178.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -79.73 165.99 78.43 Favored 'Cis proline' 0 C--N 1.344 0.319 0 C-N-CA 124.123 -1.199 . . . . 0.0 112.907 0.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.502 ' OG1' HG23 ' A' ' 101' ' ' THR . 58.1 m -131.43 114.95 15.57 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.205 176.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.6 m -108.74 115.39 30.0 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.026 0.441 . . . . 0.0 110.368 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.819 ' CG2' ' HB ' ' A' ' 30' ' ' ILE . 26.9 m -106.16 148.85 10.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.312 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.7 ' HB2' ' HB3' ' A' ' 118' ' ' LYS . 11.0 mp -101.09 124.32 46.62 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.943 -174.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.59 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 25.8 mm -112.3 118.59 58.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.027 174.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -71.04 -168.33 8.15 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.72 178.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.708 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 10.7 ptmm? -95.79 21.06 8.95 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 122.687 1.232 . . . . 0.0 107.935 -175.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.498 ' HD2' ' HA ' ' A' ' 113' ' ' LYS . 1.8 mmmp? -106.39 -1.2 23.52 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 113.439 -1.71 . . . . 0.0 108.866 174.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.4 ' O ' HG22 ' A' ' 4' ' ' THR . . . 61.97 46.48 93.99 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 114.952 -1.022 . . . . 0.0 113.326 177.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.619 ' HA ' ' O ' ' A' ' 4' ' ' THR . 16.4 pt-20 -148.53 167.01 26.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.023 0.439 . . . . 0.0 111.632 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.2 mt -61.87 127.46 21.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.703 -178.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 36.9 mt -121.28 -61.06 1.58 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.477 174.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.7 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 1.7 tppt? -133.63 154.96 50.49 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -174.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.668 HG23 HG12 ' A' ' 108' ' ' VAL . 42.8 m -131.86 102.23 5.77 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.11 172.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.634 ' CE2' ' HE3' ' A' ' 118' ' ' LYS . 45.9 m-85 -88.63 136.63 32.9 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.887 0.375 . . . . 0.0 110.914 169.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 6.0 p -123.17 123.1 67.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.258 0.551 . . . . 0.0 110.739 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 95.55 -62.91 1.38 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.285 175.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -167.09 116.57 0.71 Allowed Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 120.501 0.191 . . . . 0.0 111.349 -173.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -93.86 163.17 2.21 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 123.159 2.573 . . . . 0.0 113.087 177.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -99.05 108.79 21.54 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.411 0.624 . . . . 0.0 109.605 174.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.668 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 34.8 m-85 -70.19 -30.21 67.26 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -164.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -59.9 -54.12 40.2 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 119.663 -1.256 . . . . 0.0 111.807 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.421 ' HE2' ' HB3' ' A' ' 128' ' ' LYS . 22.0 ttpt -66.14 -35.29 80.1 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.959 -0.62 . . . . 0.0 110.008 176.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.668 ' HB3' ' HA ' ' A' ' 126' ' ' PHE . 2.9 tm? -61.45 -47.3 86.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.961 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -60.24 -38.59 83.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.813 0.34 . . . . 0.0 110.299 178.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -71.83 -33.07 68.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.762 178.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.614 ' HG2' ' HA ' ' A' ' 129' ' ' LEU . 18.7 pt-20 -80.96 -23.6 38.69 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.419 -177.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 56.1 mt -67.0 -42.12 88.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 168.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -63.13 -27.02 69.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.302 174.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.527 ' HB ' ' O ' ' A' ' 132' ' ' GLU . 52.3 m -60.81 -31.45 70.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.819 176.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.0 -31.38 72.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.042 0.449 . . . . 0.0 110.296 177.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.42 ' HE1' HG21 ' A' ' 27' ' ' VAL . 10.8 m0 -77.86 -40.53 39.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.472 0.653 . . . . 0.0 109.683 177.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -71.11 -16.93 62.59 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.601 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 135' ' ' THR . 62.6 t30 -79.15 -15.29 58.33 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.33 -174.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.3 p -101.2 -35.78 9.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.42 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 66.25 -80.43 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 O-C-N 123.635 0.584 . . . . 0.0 111.136 -176.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -178.31 -33.88 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.774 -175.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -119.16 88.48 2.94 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.93 175.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -69.11 -4.09 40.76 Favored Glycine 0 N--CA 1.454 -0.129 0 CA-C-N 115.621 -0.718 . . . . 0.0 113.389 -172.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 14.9 t60 -65.06 -20.57 66.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.756 0.312 . . . . 0.0 110.692 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -77.9 -25.73 48.66 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.014 0.435 . . . . 0.0 110.464 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -97.17 -34.72 11.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.745 -177.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 32.5 m80 70.01 -68.42 0.2 Allowed 'General case' 0 N--CA 1.47 0.573 0 O-C-N 123.793 0.683 . . . . 0.0 109.789 -176.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 14.3 t60 179.33 -36.99 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 . . . . . 0 C--O 1.249 1.057 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.186 175.632 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 . . . . . 0 N--CA 1.484 1.249 0 CA-C-O 120.86 0.362 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.755 ' H ' ' HA ' ' A' ' 6' ' ' PRO . 50.6 m 63.07 -74.45 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.786 -170.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -74.34 142.18 45.14 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 172.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.567 HG22 ' HG3' ' A' ' 115' ' ' GLU . 33.2 p 47.9 77.39 0.09 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.17 0.51 . . . . 0.0 111.426 -175.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.675 ' H ' HG13 ' A' ' 116' ' ' ILE . . . 65.8 118.74 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.774 -176.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.755 ' HA ' ' H ' ' A' ' 2' ' ' SER . 3.1 Cg_exo -76.58 15.47 1.05 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.825 2.35 . . . . 0.0 113.704 -177.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.506 ' HA ' ' OD1' ' A' ' 20' ' ' ASN . . . 51.12 41.38 27.53 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.238 0.542 . . . . 0.0 110.74 -177.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.531 ' HD1' ' HD2' ' A' ' 6' ' ' PRO . 51.2 p90 -80.48 150.44 29.69 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.773 -171.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.5 m -136.1 96.3 3.37 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 173.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.489 HD13 ' HD2' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -119.6 126.14 27.11 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.249 -171.161 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.489 ' HD2' HD13 ' A' ' 10' ' ' LEU . 47.2 Cg_endo -71.19 131.56 19.47 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.102 1.868 . . . . 0.0 111.558 173.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.28 177.84 7.59 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.613 HD11 HG12 ' A' ' 74' ' ' VAL . 51.8 mt -64.41 -31.27 72.42 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -176.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.81 -17.03 42.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.661 0.267 . . . . 0.0 111.261 -175.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.12 32.1 3.13 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.419 -0.896 . . . . 0.0 114.017 170.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -114.4 135.35 54.18 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.128 0.464 . . . . 0.0 110.086 172.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.1 m -77.65 124.48 27.99 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 175.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 31.0 m -124.56 153.55 31.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.873 0.368 . . . . 0.0 110.277 177.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 51.1 p -140.35 -179.6 6.1 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.486 -177.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.506 ' OD1' ' HA ' ' A' ' 7' ' ' ALA . 4.4 p-10 -73.88 -20.89 60.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.571 178.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.448 ' HA ' HE21 ' A' ' 24' ' ' GLN . . . -62.61 -27.56 69.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.012 174.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -68.33 -29.44 68.18 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.269 0.557 . . . . 0.0 110.329 176.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.957 HD13 HG21 ' A' ' 110' ' ' ILE . 25.3 mt -74.07 -19.31 60.65 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.16 -175.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.448 HE21 ' HA ' ' A' ' 21' ' ' ALA . 76.3 mt-30 -55.58 128.6 35.36 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.361 -178.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.9 -24.66 10.19 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.515 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -95.98 -171.25 2.29 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.372 0.605 . . . . 0.0 111.019 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 0.7 OUTLIER -133.05 138.01 52.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 169.422 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.634 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 89.2 m -141.57 150.01 41.5 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.697 -169.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.665 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 6.5 tt -127.23 123.03 35.59 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 173.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.653 ' HB ' ' CG2' ' A' ' 108' ' ' VAL . 44.5 mt -104.1 115.16 45.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.843 0.354 . . . . 0.0 110.585 -178.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -107.8 117.44 34.13 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.582 -178.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.535 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 96.1 m-85 -90.3 119.08 30.3 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 177.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.515 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 5.3 p-90 -146.23 -176.8 5.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.106 -175.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -153.45 159.12 32.52 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.256 -0.884 . . . . 0.0 108.767 177.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -51.8 128.02 25.04 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.279 1.986 . . . . 0.0 112.16 177.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.7 t 71.62 26.06 3.2 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.427 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.537 ' O ' ' HB3' ' A' ' 40' ' ' CYS . 42.9 t -63.41 134.02 95.7 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.011 176.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -57.25 -49.14 14.82 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.977 2.452 . . . . 0.0 112.657 178.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.551 ' HA3' ' HG3' ' A' ' 105' ' ' PRO . . . -66.64 -24.85 72.75 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.292 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.537 ' HB3' ' O ' ' A' ' 37' ' ' CYS . 29.6 t -58.26 -33.57 69.53 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 122.624 0.37 . . . . 0.0 111.106 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.2 t -62.17 -36.69 75.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.947 0.403 . . . . 0.0 110.543 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.9 m -87.9 -54.68 4.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.001 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.488 ' O ' HG13 ' A' ' 47' ' ' ILE . 54.8 mt-10 -63.81 -50.18 69.96 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -172.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.588 ' O ' HG12 ' A' ' 48' ' ' ILE . 40.5 ttm -51.29 -50.26 77.03 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -170.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.425 ' HD3' ' HB3' ' A' ' 44' ' ' MET . 86.9 Cg_exo -48.57 -48.55 17.07 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 122.205 1.937 . . . . 0.0 112.857 176.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -63.1 -46.23 88.32 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.144 177.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 43' ' ' GLU . 51.1 mt -60.39 -35.33 62.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.961 -178.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.588 HG12 ' O ' ' A' ' 44' ' ' MET . 46.7 mm -58.69 -52.9 54.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.925 0.393 . . . . 0.0 110.376 176.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -70.68 -39.38 73.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.121 -177.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.561 ' O ' ' HD1' ' A' ' 54' ' ' TYR . 87.7 m -68.37 -54.75 15.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.938 -178.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.627 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . -65.73 -34.74 78.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.236 -174.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -63.82 -48.39 77.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.905 0.383 . . . . 0.0 110.722 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -69.37 -51.64 34.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.01 0.433 . . . . 0.0 111.166 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 1.064 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 77.2 m-85 -70.79 -12.08 61.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.559 -175.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.627 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 16.0 tptm -60.99 -35.78 77.74 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 175.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -84.79 -6.2 59.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.342 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.489 ' O ' ' HB2' ' A' ' 58' ' ' ASN . 43.5 mmtm -89.57 -69.65 0.7 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 176.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 63.3 t30 164.03 12.13 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 114.904 -1.043 . . . . 0.0 109.241 -175.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 1.064 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 60.6 t80 -105.74 129.43 53.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.542 -178.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.404 ' O ' ' HA ' ' A' ' 28' ' ' THR . 12.7 pt20 -126.68 140.86 52.09 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.952 0.405 . . . . 0.0 110.501 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 91.9 t -104.59 126.9 59.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.866 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.56 ' HB3' ' HE3' ' A' ' 88' ' ' MET . 75.7 mt -114.21 99.57 7.71 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.605 -179.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.01 106.29 18.38 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.695 -178.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 41.9 t -94.66 115.25 33.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.047 0.451 . . . . 0.0 110.516 -178.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -82.45 138.24 34.44 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.859 176.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.698 ' HB2' ' HG2' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -101.83 163.45 17.77 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.808 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.698 ' HD3' ' O ' ' A' ' 90' ' ' ASP . 37.4 Cg_endo -66.19 82.08 0.28 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.538 2.158 . . . . 0.0 113.688 -173.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 50.7 mm -112.22 -44.29 5.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 170.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -129.67 153.59 80.8 Favored Pre-proline 0 C--O 1.237 0.403 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 173.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -54.64 161.89 5.43 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.932 2.422 . . . . 0.0 114.714 -175.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.7 tp -51.16 -35.46 15.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.488 177.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -62.1 -46.18 90.19 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.049 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.6 m -58.32 -41.95 85.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.131 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.613 HG12 HD11 ' A' ' 13' ' ' LEU . 26.4 t -65.05 -46.57 90.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.357 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.525 ' HG2' ' HB3' ' A' ' 13' ' ' LEU . 67.1 mtt180 -60.16 -34.95 74.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.012 177.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.444 ' HA ' ' NZ ' ' A' ' 79' ' ' LYS . 50.3 tp60 -61.27 -53.48 56.26 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.591 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -55.86 -48.86 74.78 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.242 -176.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.66 ' HA ' HD12 ' A' ' 83' ' ' LEU . 61.9 t -56.36 -44.29 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 112.26 0.466 . . . . 0.0 112.26 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.56 ' HB2' ' NZ ' ' A' ' 79' ' ' LYS . 9.6 mtmp? -67.56 -48.56 66.58 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.59 0.709 . . . . 0.0 110.487 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.32 -39.93 93.06 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.497 -1.229 . . . . 0.0 112.456 -170.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -95.82 -9.99 30.15 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.475 -178.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 63.15 67.32 2.12 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.209 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.66 HD12 ' HA ' ' A' ' 78' ' ' VAL . 1.1 mt -94.25 127.57 44.05 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-O 120.94 0.4 . . . . 0.0 111.891 -174.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -83.48 -12.96 8.77 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.456 2.77 . . . . 0.0 114.553 -172.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.456 ' CZ ' HD22 ' A' ' 83' ' ' LEU . 26.8 p90 -93.16 153.61 18.54 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.421 178.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.401 ' HB ' HD23 ' A' ' 62' ' ' LEU . 14.5 m -78.59 126.76 31.19 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.596 -175.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.489 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 47.0 t -110.52 135.74 48.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.011 0.434 . . . . 0.0 110.63 -178.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.56 ' HE3' ' HB3' ' A' ' 62' ' ' LEU . 52.3 mtt -116.0 172.1 7.37 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.59 178.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -140.53 109.6 6.12 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.622 0.249 . . . . 0.0 110.548 176.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.698 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 38.4 t0 -91.57 118.39 30.56 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 176.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.72 -14.97 60.79 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -175.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.53 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 24.2 t70 -125.62 -9.66 6.79 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 122.149 -0.344 . . . . 0.0 111.514 -173.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.698 ' HG2' ' HB2' ' A' ' 66' ' ' GLN . 51.8 mtpt 78.18 5.23 2.72 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.881 0.872 . . . . 0.0 111.679 -177.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.05 -40.63 81.43 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -169.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.555 HG22 ' OD2' ' A' ' 90' ' ' ASP . 22.1 m -70.21 -35.23 62.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 119.977 -0.689 . . . . 0.0 109.834 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -71.68 -33.23 63.59 Favored Glycine 0 N--CA 1.451 -0.321 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 176.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.602 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 8.5 mm-40 -61.69 -32.54 72.75 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.087 0.47 . . . . 0.0 110.552 176.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.24 -40.17 64.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.177 176.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -74.03 -22.66 59.48 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.715 0.293 . . . . 0.0 111.25 179.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.91 50.5 1.77 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.664 177.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 22.6 p -72.75 88.42 1.31 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.041 0.448 . . . . 0.0 111.002 176.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -84.23 -51.76 6.77 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.38 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 46.8 t -128.91 142.41 44.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.87 -179.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -86.41 137.76 34.36 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.551 ' HG3' ' HA3' ' A' ' 39' ' ' GLY . 94.4 Cg_endo -90.74 166.47 30.39 Favored 'Cis proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.88 -1.3 . . . . 0.0 112.808 -0.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 33.0 m -128.16 112.65 14.77 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.484 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.477 ' HB3' HD21 ' A' ' 29' ' ' LEU . 73.1 m -110.5 112.62 24.66 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.979 0.419 . . . . 0.0 110.83 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.653 ' CG2' ' HB ' ' A' ' 30' ' ' ILE . 15.9 m -106.83 148.7 10.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.537 -176.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.774 ' HB2' ' HB3' ' A' ' 118' ' ' LYS . 10.8 mp -101.91 132.87 47.46 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.033 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.957 HG21 HD13 ' A' ' 23' ' ' LEU . 31.3 mm -114.38 133.45 60.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.93 -174.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -85.86 -174.29 49.73 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.929 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 24' ' ' GLN . 62.1 mttm -74.97 21.49 0.12 Allowed 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -172.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.53 ' HD3' ' HB3' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -150.59 11.31 0.68 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.059 0.457 . . . . 0.0 110.604 -179.55 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.422 ' C ' ' HB2' ' A' ' 5' ' ' ALA . . . 87.07 -14.19 57.86 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.52 -0.847 . . . . 0.0 111.669 -176.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.567 ' HG3' HG22 ' A' ' 4' ' ' THR . 38.7 tt0 -54.93 135.13 48.72 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.234 0.614 . . . . 0.0 111.096 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.675 HG13 ' H ' ' A' ' 5' ' ' ALA . 4.0 mt -80.3 111.77 17.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.014 -174.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 79.9 mt -91.42 -40.16 11.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.598 -175.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.774 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 19.8 tptm -152.5 153.71 34.02 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.618 -170.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.8 m -136.61 108.79 7.24 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.937 177.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -99.33 118.16 35.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.341 174.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 61.3 t -108.49 123.12 63.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.732 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 90.74 -72.75 1.87 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.959 176.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -132.42 105.45 13.28 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-O 120.726 0.298 . . . . 0.0 110.624 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -82.66 126.57 4.67 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.549 2.166 . . . . 0.0 112.563 176.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -65.46 102.47 0.7 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 176.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -67.15 -45.73 76.17 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -172.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -57.97 -48.17 84.28 Favored Glycine 0 C--O 1.239 0.408 0 C-N-CA 120.434 -0.889 . . . . 0.0 111.874 178.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -67.39 -31.28 71.4 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-N 115.491 -0.354 . . . . 0.0 110.404 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.687 ' O ' HG12 ' A' ' 133' ' ' ILE . 2.6 tm? -59.32 -45.26 91.81 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 176.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -61.68 -49.89 74.67 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -178.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -69.83 -27.51 64.93 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.959 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -73.5 -37.43 65.7 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.052 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.687 HG12 ' O ' ' A' ' 129' ' ' LEU . 50.8 mm -64.38 -41.92 93.79 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 172.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.409 ' O ' ' HG2' ' A' ' 138' ' ' ARG . 12.8 t70 -57.15 -38.42 73.52 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.159 178.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 32.6 m -66.33 -38.12 86.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.62 178.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.53 -22.88 65.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.02 178.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 9.8 m0 -75.6 -26.57 57.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.792 176.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 138' ' ' ARG . 11.6 mmt180 -72.59 -40.89 66.22 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.228 -179.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -68.44 106.96 2.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.624 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.4 t -147.91 111.12 4.88 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.747 -178.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -75.69 101.51 5.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.816 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -146.53 175.71 10.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.932 0.396 . . . . 0.0 111.568 -175.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.471 ' OE1' ' HB2' ' A' ' 145' ' ' HIS . 0.5 OUTLIER -90.33 158.95 16.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.753 -178.868 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -108.15 28.55 11.72 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.675 -175.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.471 ' HB2' ' OE1' ' A' ' 143' ' ' GLU . 4.6 t-80 -74.93 96.33 3.13 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -61.02 -48.34 82.27 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.048 -175.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -82.49 76.03 9.37 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -84.52 -17.55 38.59 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.393 178.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 177.66 -34.96 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -178.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 . . . . . 0 C--O 1.244 0.787 0 CA-C-N 113.881 -1.509 . . . . 0.0 108.532 173.046 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 24.9 t70 . . . . . 0 N--CA 1.479 0.98 0 CA-C-O 120.552 0.215 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.9 m -144.15 168.67 19.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.842 0.353 . . . . 0.0 110.791 -176.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.473 ' HB3' HD12 ' A' ' 116' ' ' ILE . 50.4 mttp -90.58 -162.39 0.9 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.084 175.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.463 ' HA ' ' H ' ' A' ' 116' ' ' ILE . 3.6 m 64.49 25.61 13.3 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.335 0.588 . . . . 0.0 110.045 -177.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 64.01 96.07 0.05 OUTLIER Pre-proline 0 CA--C 1.53 0.196 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.908 -178.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.53 35.35 0.5 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 123.19 2.593 . . . . 0.0 113.824 -174.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 57.16 84.9 0.09 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.364 0.666 . . . . 0.0 111.03 -177.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -111.86 130.27 55.88 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.098 0.475 . . . . 0.0 111.157 -175.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 63.7 p -110.46 90.23 3.26 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 172.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.591 HD12 ' HD2' ' A' ' 11' ' ' PRO . 22.6 tp -111.51 126.92 27.68 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.751 -172.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.591 ' HD2' HD12 ' A' ' 10' ' ' LEU . 58.3 Cg_endo -73.3 147.55 42.15 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.308 2.006 . . . . 0.0 112.136 176.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.452 ' CG ' ' H ' ' A' ' 14' ' ' HIS . 0.2 OUTLIER -80.46 -175.65 5.28 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 176.948 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 53.8 mt -70.37 -18.68 63.06 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -176.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.452 ' H ' ' CG ' ' A' ' 12' ' ' ASP . 76.6 m80 -89.65 -48.25 7.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.775 0.321 . . . . 0.0 110.427 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.56 24.91 0.19 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.374 -0.917 . . . . 0.0 113.668 176.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 11' ' ' PRO . 67.6 mttm -101.17 139.56 36.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.314 0.557 . . . . 0.0 110.152 175.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.4 m -84.77 123.38 30.35 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.899 0.381 . . . . 0.0 111.089 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.2 t -107.93 134.82 48.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.509 176.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 36.6 m -145.25 177.48 8.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.746 0.308 . . . . 0.0 111.462 -177.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -51.64 -32.28 28.62 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.641 0.776 . . . . 0.0 112.849 -175.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.47 -27.48 64.45 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -174.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -82.94 -23.32 33.5 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.456 -176.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.614 HD23 HG21 ' A' ' 110' ' ' ILE . 7.7 mp -80.88 -26.94 36.52 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -173.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -64.53 130.86 45.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.189 0.518 . . . . 0.0 111.517 -176.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.34 -12.14 70.28 Favored Glycine 0 C--N 1.329 0.154 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.338 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 112' ' ' LYS . 79.4 mttt -115.71 -173.28 2.31 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 15.9 t -126.51 139.0 52.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 171.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.571 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 26.7 m -137.14 145.74 44.17 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.687 -168.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.611 ' HB2' ' HZ ' ' A' ' 59' ' ' PHE . 31.8 tp -115.89 105.84 13.13 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 172.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.8 mt -89.46 111.67 23.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 175.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.512 ' HA ' ' O ' ' A' ' 106' ' ' THR . 7.9 t30 -117.01 111.17 19.19 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.827 0.346 . . . . 0.0 110.864 -175.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 63.5 m-85 -81.38 131.55 35.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.652 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.616 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 4.2 p-90 -158.19 -170.47 3.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.416 -175.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.453 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 24.5 p90 -158.86 138.69 8.66 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 171.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.763 ' HG2' ' HA ' ' A' ' 74' ' ' VAL . 50.6 Cg_exo -56.48 -28.31 72.87 Favored 'Trans proline' 0 N--CA 1.473 0.299 0 C-N-CA 123.358 2.705 . . . . 0.0 114.051 -173.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.7 t -89.84 26.57 1.76 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.023 0.439 . . . . 0.0 110.984 -178.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 53.5 t -100.32 132.11 23.02 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.255 -179.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 37.2 Cg_exo -61.73 -28.39 82.04 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.799 2.333 . . . . 0.0 112.009 175.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.74 -22.3 69.92 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.388 179.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 46.9 t -63.3 -40.17 96.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.761 0.315 . . . . 0.0 110.315 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.4 t -58.77 -35.9 58.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.105 -178.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.0 m -87.45 -49.44 7.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.852 -178.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.447 ' OE1' ' HG3' ' A' ' 46' ' ' LYS . 12.4 mm-40 -84.68 -28.21 26.54 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -170.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.575 ' O ' HG12 ' A' ' 48' ' ' ILE . 27.7 ttm -55.18 -47.26 98.95 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 120.249 -0.581 . . . . 0.0 111.91 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -51.05 -41.59 56.24 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.093 1.862 . . . . 0.0 112.314 172.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.447 ' HG3' ' OE1' ' A' ' 43' ' ' GLU . 26.0 mmtp -59.7 -48.16 82.77 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 43' ' ' GLU . 45.2 mm -61.71 -44.19 98.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.209 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.575 HG12 ' O ' ' A' ' 44' ' ' MET . 45.1 mm -54.87 -53.97 28.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.685 -175.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -70.88 -38.34 73.07 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.432 -175.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.9 m -67.58 -48.79 65.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.967 0.413 . . . . 0.0 110.88 -178.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.565 ' O ' ' HB2' ' A' ' 55' ' ' LYS . . . -65.95 -45.28 82.38 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.988 -178.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -55.13 -44.21 74.85 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.831 0.348 . . . . 0.0 110.996 -177.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -67.23 -51.4 53.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.662 -179.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 1.011 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 54.2 m-85 -79.6 -20.55 46.62 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -173.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.565 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 9.0 tmtt? -60.71 -39.02 87.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.073 0.463 . . . . 0.0 109.944 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -86.18 6.21 30.43 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.736 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 58' ' ' ASN . 14.4 tppt? -98.68 -67.5 0.84 Allowed 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 175.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.422 ' H ' ' H ' ' A' ' 59' ' ' PHE . 65.6 t30 171.79 19.45 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.878 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 1.011 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 45.1 t80 -117.68 120.28 37.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.637 -177.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.441 ' HG3' HG23 ' A' ' 28' ' ' THR . 29.8 pt20 -114.78 148.56 38.25 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.083 0.468 . . . . 0.0 110.601 -178.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.42 HG22 ' HB3' ' A' ' 29' ' ' LEU . 84.9 t -109.87 120.27 60.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.237 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.44 HD23 ' HB ' ' A' ' 86' ' ' THR . 90.2 mt -103.03 95.64 6.27 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.387 177.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.401 ' HB1' ' NE1' ' A' ' 33' ' ' TRP . . . -86.11 106.92 17.58 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.826 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 32' ' ' PHE . 25.7 t -100.09 120.38 49.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 120.961 0.41 . . . . 0.0 110.411 -176.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.616 ' HA ' ' O ' ' A' ' 33' ' ' TRP . . . -94.82 127.94 41.19 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.701 176.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.424 ' HB2' ' CD ' ' A' ' 67' ' ' PRO . 3.4 pt20 -97.12 170.94 6.57 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -178.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 90' ' ' ASP . 17.6 Cg_exo -67.0 79.11 0.39 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.806 2.337 . . . . 0.0 113.884 -175.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 47.7 mm -112.39 -68.63 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 167.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.496 ' OD1' ' HD2' ' A' ' 35' ' ' PRO . 3.5 p-10 -93.66 153.72 41.15 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 167.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -63.04 159.25 39.48 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 122.537 2.158 . . . . 0.0 113.266 -177.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.4 tp -53.95 -34.76 26.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.482 -178.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -60.69 -42.15 96.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.899 0.38 . . . . 0.0 110.899 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 51.0 m -62.98 -38.57 91.67 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.393 -177.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.763 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 20.0 t -60.77 -41.94 90.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.425 176.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.729 ' HA ' HG22 ' A' ' 78' ' ' VAL . 89.6 mtt180 -68.03 -32.53 72.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.819 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -61.71 -41.65 97.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.185 0.516 . . . . 0.0 109.863 177.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -67.72 -48.11 67.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.472 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.729 HG22 ' HA ' ' A' ' 75' ' ' ARG . 27.3 m -67.96 -29.08 43.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.988 -178.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -74.3 -55.09 6.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.146 0.498 . . . . 0.0 110.755 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -64.23 -48.35 76.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.339 -173.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -88.07 -21.49 24.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.728 0.299 . . . . 0.0 111.488 -175.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 71.47 59.9 4.65 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.271 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.553 HD22 HG12 ' A' ' 78' ' ' VAL . 10.8 mp -63.38 121.79 71.95 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 120.603 0.24 . . . . 0.0 110.901 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -82.26 -23.06 4.53 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.055 2.503 . . . . 0.0 113.377 -177.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -84.15 148.94 26.5 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.44 ' HB ' HD23 ' A' ' 62' ' ' LEU . 21.4 m -69.21 116.44 9.65 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.167 0.508 . . . . 0.0 111.305 -174.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 39.3 t -107.42 132.15 55.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.676 -178.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 73.3 mtm -123.4 173.72 7.81 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.491 ' CD1' HG21 ' A' ' 74' ' ' VAL . 60.1 t80 -140.0 116.49 10.71 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.564 ' HA ' HD11 ' A' ' 10' ' ' LEU . 10.0 p-10 -97.26 95.44 7.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.908 0.861 . . . . 0.0 110.23 178.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.484 ' HA ' ' HG3' ' A' ' 67' ' ' PRO . . . -73.28 -10.98 60.33 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.136 -176.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.443 ' C ' ' H ' ' A' ' 94' ' ' ALA . 19.1 m-20 -92.8 -14.95 27.12 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.352 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.518 ' HA ' ' OD2' ' A' ' 90' ' ' ASP . 37.0 ttpt 63.36 -24.96 0.07 Allowed 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 175.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.443 ' H ' ' C ' ' A' ' 92' ' ' ASP . . . -61.9 -25.3 67.48 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -173.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.424 ' O ' ' HD1' ' A' ' 99' ' ' PHE . 26.8 m -70.95 -41.73 77.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.249 179.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.5 -36.36 91.37 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.109 174.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.504 ' HG3' ' O ' ' A' ' 93' ' ' LYS . 24.8 mt-30 -62.3 -33.13 74.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.249 -0.475 . . . . 0.0 110.418 176.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.85 -41.6 71.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.068 177.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.424 ' HD1' ' O ' ' A' ' 95' ' ' VAL . 7.8 m-85 -66.71 -27.3 67.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.481 178.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 94.1 39.19 4.91 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.106 177.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.534 ' HB ' ' CE1' ' A' ' 104' ' ' TYR . 39.9 p -71.26 100.73 2.17 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.063 0.459 . . . . 0.0 111.154 -178.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -86.56 -58.41 2.63 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.363 0.601 . . . . 0.0 109.997 177.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.521 HG12 ' HB ' ' A' ' 121' ' ' VAL . 14.6 p -122.01 143.67 33.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.755 -177.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.534 ' CE1' ' HB ' ' A' ' 101' ' ' THR . 39.7 m-85 -111.01 148.53 38.83 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.58 -174.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -75.26 152.65 98.07 Favored 'Cis proline' 0 CA--C 1.529 0.261 0 C-N-CA 123.272 -1.553 . . . . 0.0 112.869 0.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 23.8 m -111.48 112.65 24.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.0 177.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.463 ' HB3' HD11 ' A' ' 29' ' ' LEU . 24.4 m -94.73 110.17 22.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.243 0.544 . . . . 0.0 110.841 -178.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.566 HG22 HG23 ' A' ' 119' ' ' THR . 60.7 t -107.79 134.33 49.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.316 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.532 ' HB2' ' HB3' ' A' ' 118' ' ' LYS . 7.2 mp -101.58 130.88 47.97 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.906 0.384 . . . . 0.0 110.039 -177.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.614 HG21 HD23 ' A' ' 23' ' ' LEU . 40.0 mm -110.83 130.27 64.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.206 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -77.38 -170.56 34.35 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.435 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 79.0 mttt -78.73 -7.56 57.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.715 0.769 . . . . 0.0 109.482 -174.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.31 -7.17 32.66 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.579 -1.191 . . . . 0.0 111.103 -172.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.08 60.94 3.17 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.673 -176.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.424 ' HB2' HG23 ' A' ' 4' ' ' THR . 12.7 pt-20 -161.51 153.81 19.92 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -178.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.473 HD12 ' HB3' ' A' ' 3' ' ' LYS . 53.6 mt -66.7 105.46 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.925 -178.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.439 HD22 ' HA ' ' A' ' 117' ' ' LEU . 0.2 OUTLIER -84.07 -38.58 20.64 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.744 179.469 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.532 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 22.4 tptm -153.41 154.09 33.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.082 -174.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.566 HG23 HG22 ' A' ' 108' ' ' VAL . 33.0 m -140.66 116.84 10.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.059 0.457 . . . . 0.0 111.501 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -109.49 134.36 51.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.471 173.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.521 ' HB ' HG12 ' A' ' 103' ' ' VAL . 3.4 m -105.73 112.56 39.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.028 0.442 . . . . 0.0 110.442 175.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 91.76 -159.65 25.91 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.583 -176.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 54.7 tt0 -73.15 119.44 75.7 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.78 0.324 . . . . 0.0 110.54 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -88.36 165.19 6.73 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.833 2.356 . . . . 0.0 112.753 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.643 ' HB2' ' HE2' ' A' ' 128' ' ' LYS . 4.9 m-20 -67.87 102.81 1.32 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 173.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -62.95 -40.37 97.47 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -173.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -58.44 -47.81 87.67 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.444 -0.884 . . . . 0.0 111.605 177.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.643 ' HE2' ' HB2' ' A' ' 125' ' ' ASP . 33.6 ttpt -69.15 -36.99 78.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.438 -0.381 . . . . 0.0 110.33 177.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -61.48 -46.0 91.88 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.6 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -61.44 -47.91 83.58 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.62 0.248 . . . . 0.0 110.937 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -67.45 -38.62 84.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.399 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -65.44 -38.79 90.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.713 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 38.1 mt -60.59 -46.29 95.88 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 172.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -60.51 -36.54 78.61 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.963 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 66.5 m -60.97 -43.45 98.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.765 176.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.55 -29.96 59.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.224 0.535 . . . . 0.0 110.809 176.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -65.24 -55.41 18.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.792 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 47.3 mtm180 -79.37 -45.25 19.92 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.984 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.597 ' HB3' ' OE2' ' A' ' 143' ' ' GLU . 19.3 t-20 51.65 -89.81 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 O-C-N 124.382 1.052 . . . . 0.0 113.111 174.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.591 ' HB2' ' HG3' ' A' ' 143' ' ' GLU . 33.2 m -94.03 -20.48 19.9 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 121.251 -0.18 . . . . 0.0 111.438 -175.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 21.1 t70 72.31 -40.07 0.47 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.447 0.699 . . . . 0.0 111.972 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.35 19.99 1.14 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.093 0.473 . . . . 0.0 110.941 178.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.597 ' OE2' ' HB3' ' A' ' 139' ' ' ASN . 46.2 mt-10 -79.87 152.3 29.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.643 179.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 169.11 -128.92 1.76 Allowed Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.742 178.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -99.92 -44.55 6.0 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 175.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -175.81 102.33 0.07 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.277 175.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -83.39 85.62 7.2 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.281 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -162.87 120.6 2.0 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.517 174.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -158.57 154.44 26.62 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 20.1 p80 . . . . . 0 C--O 1.247 0.93 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 172.115 . . . . . . . . 0 0 . 1 stop_ save_